Citrus Sinensis ID: 007433
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 604 | 2.2.26 [Sep-21-2011] | |||||||
| Q0DCT8 | 589 | Protein kinase G11A OS=Or | no | no | 0.806 | 0.826 | 0.755 | 0.0 | |
| A2YBX5 | 589 | Protein kinase G11A OS=Or | N/A | no | 0.806 | 0.826 | 0.755 | 0.0 | |
| P15792 | 609 | Protein kinase PVPK-1 OS= | N/A | no | 0.738 | 0.732 | 0.744 | 0.0 | |
| Q05999 | 578 | Serine/threonine-protein | no | no | 0.786 | 0.821 | 0.651 | 1e-173 | |
| Q9LFA2 | 934 | Serine/threonine-protein | no | no | 0.731 | 0.473 | 0.588 | 1e-158 | |
| Q64FQ2 | 525 | Protein kinase PINOID 2 O | no | no | 0.662 | 0.761 | 0.480 | 1e-116 | |
| Q94E49 | 493 | Protein kinase PINOID 2 O | no | no | 0.624 | 0.764 | 0.512 | 1e-110 | |
| O64682 | 438 | Protein kinase PINOID OS= | no | no | 0.662 | 0.913 | 0.471 | 1e-107 | |
| Q2QM77 | 484 | Protein kinase PINOID OS= | no | no | 0.599 | 0.747 | 0.462 | 1e-104 | |
| Q9ST27 | 907 | Phototropin-2 OS=Oryza sa | no | no | 0.559 | 0.372 | 0.459 | 5e-98 |
| >sp|Q0DCT8|G11A_ORYSJ Protein kinase G11A OS=Oryza sativa subsp. japonica GN=Os06g0291600 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 777 bits (2007), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/499 (75%), Positives = 422/499 (84%), Gaps = 12/499 (2%)
Query: 117 VGEQEKKPSEAGPASAKVSDGTS-----SLPKTSGSAKISDRGDYVESG-KSSMCRGSTS 170
+ ++EK E G A+ + ++ + SGSA++ R + E G SS CR STS
Sbjct: 92 LADEEKGVVEDGIANGSLKSSSALGKEHGIASASGSARLVGRSETGERGFSSSRCRPSTS 151
Query: 171 SDVSDESTCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVY 230
SDVSDES CSS+SS V KPHKAND++WEAIQ +R +DG+LG+ HF+LLKKLGCGDIGSVY
Sbjct: 152 SDVSDESACSSISS-VTKPHKANDSRWEAIQMIRTRDGILGLSHFKLLKKLGCGDIGSVY 210
Query: 231 LSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290
LSEL+GTK YFAMKVMDKASL RKKLLRAQTE+EILQ LDHPFLPTLYTHFETDKFSCL
Sbjct: 211 LSELSGTKSYFAMKVMDKASLASRKKLLRAQTEKEILQCLDHPFLPTLYTHFETDKFSCL 270
Query: 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE 350
VMEFCPGGDLHTLRQRQ GKYF EQAVKFYVAE+LLA+EYLHMLGI+YRDLKPENVLVRE
Sbjct: 271 VMEFCPGGDLHTLRQRQRGKYFPEQAVKFYVAEILLAMEYLHMLGIIYRDLKPENVLVRE 330
Query: 351 DGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRK-NPVYCVQPACIEPSC-IQPSCIAPT 408
DGHIMLSDFDLSLRCAVSPT+++SS ++E LRK N YCVQPAC+EPSC IQPSC PT
Sbjct: 331 DGHIMLSDFDLSLRCAVSPTLIRSSNPDAEALRKNNQAYCVQPACVEPSCMIQPSCATPT 390
Query: 409 TCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGH 468
TCF PRFFSKSKK +KPK E+ NQVSP PELIAEP++ARSMSFVGTHEYLAPEIIKGEGH
Sbjct: 391 TCFGPRFFSKSKKDRKPKPEVVNQVSPWPELIAEPSDARSMSFVGTHEYLAPEIIKGEGH 450
Query: 469 GSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLL 528
GSAVDWWTFGIFLYELLFGKTPFKGS NRATL+NV+GQPLRFPE PVVSFSARDLI+GLL
Sbjct: 451 GSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVIGQPLRFPEYPVVSFSARDLIRGLL 510
Query: 529 VKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPKPVEIVHSPAPALSTKAKAV 588
VKEPQ RL C+RGATEIKQHPFF+GVNWALIRCASPPE+P+PVEI P +ST A
Sbjct: 511 VKEPQQRLGCKRGATEIKQHPFFEGVNWALIRCASPPEVPRPVEIERPPKQPVSTSEPAA 570
Query: 589 AAGNADH---NNYLEFDFF 604
A +A ++YLEFDFF
Sbjct: 571 APSDAAQKSSDSYLEFDFF 589
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. japonica (taxid: 39947) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|A2YBX5|G11A_ORYSI Protein kinase G11A OS=Oryza sativa subsp. indica GN=OsI_021818 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 777 bits (2007), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/499 (75%), Positives = 421/499 (84%), Gaps = 12/499 (2%)
Query: 117 VGEQEKKPSEAGPASAKVSDGTS-----SLPKTSGSAKISDRGDYVESG-KSSMCRGSTS 170
+ ++EK E G A+ + ++ + SGSA++ R + E G SS CR STS
Sbjct: 92 LADEEKGVVEDGIANGSLKSSSALGKEHGIASASGSARLVGRSETGERGFSSSRCRPSTS 151
Query: 171 SDVSDESTCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVY 230
SDVSDES CSS+SS V KPHKAND++WEAIQ +R +DG+LG+ HF+LLKKLGCGDIGSVY
Sbjct: 152 SDVSDESACSSISS-VTKPHKANDSRWEAIQMIRTRDGILGLSHFKLLKKLGCGDIGSVY 210
Query: 231 LSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290
LSEL GTK YFAMKVMDKASL RKKLLRAQTE+EILQ LDHPFLPTLYTHFETDKFSCL
Sbjct: 211 LSELNGTKSYFAMKVMDKASLASRKKLLRAQTEKEILQCLDHPFLPTLYTHFETDKFSCL 270
Query: 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE 350
VMEFCPGGDLHTLRQRQ GKYF EQAVKFYVAE+LLA+EYLHMLGI+YRDLKPENVLVRE
Sbjct: 271 VMEFCPGGDLHTLRQRQRGKYFPEQAVKFYVAEILLAMEYLHMLGIIYRDLKPENVLVRE 330
Query: 351 DGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRK-NPVYCVQPACIEPSC-IQPSCIAPT 408
DGHIMLSDFDLSLRCAVSPT+++SS ++E LRK N YCVQPAC+EPSC IQPSC PT
Sbjct: 331 DGHIMLSDFDLSLRCAVSPTLIRSSNPDAEALRKNNQAYCVQPACVEPSCMIQPSCATPT 390
Query: 409 TCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGH 468
TCF PRFFSKSKK +KPK E+ NQVSP PELIAEP++ARSMSFVGTHEYLAPEIIKGEGH
Sbjct: 391 TCFGPRFFSKSKKDRKPKPEVVNQVSPWPELIAEPSDARSMSFVGTHEYLAPEIIKGEGH 450
Query: 469 GSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLL 528
GSAVDWWTFGIFLYELLFGKTPFKGS NRATL+NV+GQPLRFPE PVVSFSARDLI+GLL
Sbjct: 451 GSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVIGQPLRFPEYPVVSFSARDLIRGLL 510
Query: 529 VKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPKPVEIVHSPAPALSTKAKAV 588
VKEPQ RL C+RGATEIKQHPFF+GVNWALIRCASPPE+P+PVEI P +ST A
Sbjct: 511 VKEPQQRLGCKRGATEIKQHPFFEGVNWALIRCASPPEVPRPVEIERPPKQPVSTSEPAA 570
Query: 589 AAGNADH---NNYLEFDFF 604
A +A ++YLEFDFF
Sbjct: 571 APSDAAQKSSDSYLEFDFF 589
|
May play a role in the regulation of metabolism and signal transduction processes. Oryza sativa subsp. indica (taxid: 39946) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P15792|KPK1_PHAVU Protein kinase PVPK-1 OS=Phaseolus vulgaris PE=2 SV=1 | Back alignment and function description |
|---|
Score = 686 bits (1770), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 346/465 (74%), Positives = 391/465 (84%), Gaps = 19/465 (4%)
Query: 145 SGSAKISDRGDYVESGKSSMCRGSTSSDVSDESTCSSLSSSVNKPHKANDAQWEAIQAVR 204
S +++++ D+ ES K+S+CR ST SD SDES+ SSLSS + KPHKAND +WEAIQAVR
Sbjct: 159 SCESEVANSSDFNESRKTSICRASTGSDASDESSTSSLSSVLYKPHKANDIRWEAIQAVR 218
Query: 205 VKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTER 264
+DG+L + HFRLLKKLGCGDIGSVYL+EL+GT+ FAMKVM+K L RKKLLRAQTER
Sbjct: 219 TRDGMLEMRHFRLLKKLGCGDIGSVYLAELSGTRTSFAMKVMNKTELANRKKLLRAQTER 278
Query: 265 EILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEV 324
EILQSLDHPFLPTLYTHFET+ FSCLVMEFCPGGDLH LRQRQPGKYFSE AV+FYVAEV
Sbjct: 279 EILQSLDHPFLPTLYTHFETEIFSCLVMEFCPGGDLHALRQRQPGKYFSEHAVRFYVAEV 338
Query: 325 LLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSS-TLESEPLR 383
LL+LEYLHMLGI+YRDLKPENVLVREDGHIMLSDFDLSLRC+VSPT+VKSS L++
Sbjct: 339 LLSLEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDLSLRCSVSPTLVKSSNNLQT---- 394
Query: 384 KNPVYCVQPACIEPSCI-QPSCIAPTTCFSPRFF---SKSKKAQKPKNEMGNQVSPLPEL 439
K+ YCVQP+CIEP+C+ QP CI P +CF+PRF SK K KPKN+M NQV+PLPEL
Sbjct: 395 KSSGYCVQPSCIEPTCVMQPDCIKP-SCFTPRFLSGKSKKDKKSKPKNDMHNQVTPLPEL 453
Query: 440 IAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRAT 499
IAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFG+TPFKGS NRAT
Sbjct: 454 IAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGRTPFKGSANRAT 513
Query: 500 LYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALI 559
L+NV+GQPLRFPESP VSF+ARDLI+GLLVKEPQ+RLA RRGATEIKQHPFFQ VNWALI
Sbjct: 514 LFNVIGQPLRFPESPTVSFAARDLIRGLLVKEPQHRLAYRRGATEIKQHPFFQNVNWALI 573
Query: 560 RCASPPEIPKPVEIVHSPAPALSTKAKAVAAGNADHNNYLEFDFF 604
RCA+PPE+P+ V + L K NYL+ DFF
Sbjct: 574 RCATPPEVPRQVINLPQTEKDLGVKPSG---------NYLDIDFF 609
|
Phaseolus vulgaris (taxid: 3885) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05999|KPK7_ARATH Serine/threonine-protein kinase AtPK7 OS=Arabidopsis thaliana GN=PK7 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 609 bits (1570), Expect = e-173, Method: Compositional matrix adjust.
Identities = 323/496 (65%), Positives = 374/496 (75%), Gaps = 21/496 (4%)
Query: 124 PSEAGPASAKVSDGTSSLPKTSGSAKISDRGDYVESGKSSMCRGSTSSDVSDESTCSSLS 183
P+ AK S + + + + I G +E + RGS SDVSDES+ S LS
Sbjct: 89 PTNTFYTEAKQSFTNTEFSECASISTIGIGGIDLEKNGVMIYRGSIGSDVSDESSSSGLS 148
Query: 184 SSVNKPHK-ANDAQWEAIQAVRVKDGV-LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYF 241
++ KPH+ ND +W AIQ VR + G L F+L+KKLG GDIG+VYL+EL GT F
Sbjct: 149 NAAYKPHRDNNDKRWVAIQEVRSRVGSSLEAKDFKLIKKLGGGDIGNVYLAELIGTGVSF 208
Query: 242 AMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLH 301
A+KVM+KA++ RKKL+RAQTE+EILQSLDHPFLPTLY+HFET+ SCLVMEFCPGGDLH
Sbjct: 209 AVKVMEKAAIAARKKLVRAQTEKEILQSLDHPFLPTLYSHFETEMNSCLVMEFCPGGDLH 268
Query: 302 TLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDL 361
+LRQ+Q GKYF EQA +FYVAEVLLA+EYLHMLGI+YRDLKPENVLVREDGHIMLSDFDL
Sbjct: 269 SLRQKQRGKYFPEQAARFYVAEVLLAMEYLHMLGIIYRDLKPENVLVREDGHIMLSDFDL 328
Query: 362 SLRCAVSPTVVK--SSTLESEPLRKNPVYCVQPACI-EPSCI-QPSCIAPTTCFSPRFFS 417
SLRCAVSPT+V+ + TLES K+ YC+QP C+ + SCI QP CI P CF+PRF S
Sbjct: 329 SLRCAVSPTLVRFAAITLES----KSSSYCIQPTCVDQSSCIVQPDCIQPV-CFTPRFLS 383
Query: 418 KSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTF 477
K K +K N+M Q+ PLPELIAEPT+ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTF
Sbjct: 384 KGKHRKK-SNDMSRQIRPLPELIAEPTSARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTF 442
Query: 478 GIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLA 537
GIFLYELLFG TPF+G +NRATL+NVVGQPLRFPE P VSF+ARDLI+GLLVKEPQ+RLA
Sbjct: 443 GIFLYELLFGITPFRGGDNRATLFNVVGQPLRFPEHPNVSFAARDLIRGLLVKEPQHRLA 502
Query: 538 CRRGATEIKQHPFFQGVNWALIRCASPPEIP---KPVEIVHSPAPALSTKAKAVAAGN-- 592
RRGATEIKQHPFFQ VNWALIRC SPP+IP KP++ HS S V
Sbjct: 503 YRRGATEIKQHPFFQSVNWALIRCTSPPQIPQPVKPMDQAHSVRHGFSQGHGHVGYDKPP 562
Query: 593 ----ADHNNYLEFDFF 604
NYLE DFF
Sbjct: 563 TVDVKPSGNYLEIDFF 578
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LFA2|KIPK_ARATH Serine/threonine-protein kinase KIPK OS=Arabidopsis thaliana GN=KIPK PE=1 SV=1 | Back alignment and function description |
|---|
Score = 558 bits (1437), Expect = e-158, Method: Compositional matrix adjust.
Identities = 278/472 (58%), Positives = 340/472 (72%), Gaps = 30/472 (6%)
Query: 151 SDRGDYVESGKSSMCRGSTSSDVSDESTCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVL 210
S++ ++ S K S+ S S+ +S+ES S S NKPH + D +WEAI+ ++V+ G L
Sbjct: 475 SEKFEFSLSSKDSLGDYSRSTSISEESNLSRFSCG-NKPHMSMDVRWEAIKHIKVQYGSL 533
Query: 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL 270
G+ HF LLKKLGCGDIG+VYL+EL GT C FA+KVMD L +RKK RAQ EREIL+ L
Sbjct: 534 GLRHFNLLKKLGCGDIGTVYLAELIGTNCLFAIKVMDNEFLARRKKSPRAQAEREILKML 593
Query: 271 DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEY 330
DHPFLPTLY F +D SCLVME+CPGGDLH LRQ+Q G+ F E A +FYVAE+LLALEY
Sbjct: 594 DHPFLPTLYAQFTSDNLSCLVMEYCPGGDLHVLRQKQLGRCFPEPAARFYVAEILLALEY 653
Query: 331 LHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCV 390
LHMLGI+YRDLKPEN+LVREDGHIML+DFDLSLRCAV+PT+V+S++ P K+P
Sbjct: 654 LHMLGIIYRDLKPENILVREDGHIMLTDFDLSLRCAVNPTLVRSNS----PPGKDPARIS 709
Query: 391 QP----ACIEPSCI-QPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVS--------PLP 437
P CI+P CI +PSC +CFSPR S ++ +KPK G+ +S LP
Sbjct: 710 GPYNTSNCIQPFCITEPSC--QVSCFSPRLSSNQQQGRKPKR--GDHLSKTQQHLSRSLP 765
Query: 438 ELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR 497
+L+AEPT ARS SFVGTHEYLAPEIIKGEGHG+AVDWWTFG+ LYELL+GKTPFKG N
Sbjct: 766 QLVAEPTEARSNSFVGTHEYLAPEIIKGEGHGAAVDWWTFGVLLYELLYGKTPFKGYNND 825
Query: 498 ATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557
TL NVV Q L+FP+SP+VSF A+DLI+GLLVKEP+NRL +G+ EIK+HPFF+G+NWA
Sbjct: 826 ETLANVVLQNLKFPDSPLVSFQAKDLIRGLLVKEPENRLGSEKGSVEIKRHPFFEGLNWA 885
Query: 558 LIRCASPPEIPKPVEIVHSP-----APALSTKAKAVAAGNADHNNYLEFDFF 604
LIRCA PPE+P E P +P S DH LEF+ F
Sbjct: 886 LIRCAIPPELPDFYEYGGGPEAAADSPGGSNNRYLECKAIGDH---LEFELF 934
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q64FQ2|PID2_ARATH Protein kinase PINOID 2 OS=Arabidopsis thaliana GN=PID2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 419 bits (1077), Expect = e-116, Method: Compositional matrix adjust.
Identities = 217/452 (48%), Positives = 278/452 (61%), Gaps = 52/452 (11%)
Query: 170 SSDVSDESTCSSLSSSVN---------KPHKANDAQWEAIQAVRVKDG-VLGVGHFRLLK 219
SS + +CSS+S N KPHKAN WEA+ +R G +G+ HFRLLK
Sbjct: 32 SSSFTASPSCSSISHLSNHGLNSYNQSKPHKANQVAWEAMARLRRCCGRAVGLEHFRLLK 91
Query: 220 KLGCGDIGSVYLSELTGT--KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPT 277
+LG GDIGSVYL ++ G+ ++AMKV+DK ++ +KKL RA+ E++IL LDHPF PT
Sbjct: 92 RLGSGDIGSVYLCQIRGSPETAFYAMKVVDKEAVAVKKKLGRAEMEKKILGMLDHPFCPT 151
Query: 278 LYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIV 337
LY FE +S LVME+CPGGDL+ +R RQP K F+ + +FY AE L+ALEYLHM+GIV
Sbjct: 152 LYAAFEASHYSFLVMEYCPGGDLYAVRLRQPSKRFTISSTRFYAAETLVALEYLHMMGIV 211
Query: 338 YRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEP 397
YRDLKPENVL+REDGH+MLSDFDLS +C V P + + + + ++ C P
Sbjct: 212 YRDLKPENVLIREDGHVMLSDFDLSFKCDVVPQFLSDNDRDRGHQEDDDDISIRRKCSTP 271
Query: 398 SCIQPSCIAPTTCFSP--------------------------------RFFSKS-KKAQK 424
SC +CFSP R FS+S +
Sbjct: 272 SCTTTPLNPVISCFSPTSSRRRKKNVVTTTIHENAAGTSDSVKSNDVSRTFSRSPSSCSR 331
Query: 425 PKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYEL 484
N + + P + AEP NARS SFVGTHEYLAPE+I G+GHGSAVDWWT+GIFLYE+
Sbjct: 332 VSNGLRDISGGCPSIFAEPINARSKSFVGTHEYLAPEVISGQGHGSAVDWWTYGIFLYEM 391
Query: 485 LFGKTPFKGSENRATLYNVVGQPLRFPESPVVS-------FSARDLIKGLLVKEPQNRLA 537
+FG+TPFKG N TL N++ PL FP+ V S +A+DLI LLVK P+ RL
Sbjct: 392 IFGRTPFKGDNNEKTLVNILKAPLTFPKVIVNSPKEYEDMVNAQDLIIKLLVKNPKKRLG 451
Query: 538 CRRGATEIKQHPFFQGVNWALIRCASPPEIPK 569
+G+ EIK+H FF+GVNWALIR PP +PK
Sbjct: 452 SLKGSIEIKRHEFFEGVNWALIRSIKPPWVPK 483
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Plays a minor role in the regulation of cellular auxin efflux and cotyledon organogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q94E49|PID2_ORYSJ Protein kinase PINOID 2 OS=Oryza sativa subsp. japonica GN=PID2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 399 bits (1024), Expect = e-110, Method: Compositional matrix adjust.
Identities = 208/406 (51%), Positives = 266/406 (65%), Gaps = 29/406 (7%)
Query: 183 SSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSEL-------- 234
SS KPHKAN A+WEAI+ +R G +G+ HFRL+++LG GD+G+VYL L
Sbjct: 48 SSCRYKPHKANQAEWEAIRRLRAGAGRVGLEHFRLVRRLGSGDLGNVYLCRLREPWSSSS 107
Query: 235 ---TGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291
T C +AMKV+DK +L RKKL RA+ ER+IL++LDHPFLPTLY FE ++CLV
Sbjct: 108 MTTTAGGCLYAMKVVDKDALAFRKKLRRAEVERDILRTLDHPFLPTLYADFEASHYACLV 167
Query: 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRED 351
MEFCPGGDLH RQRQPG+ F+ + +FYVAE +LALEYLHM+G+VYRDLKPENVLVR D
Sbjct: 168 MEFCPGGDLHVARQRQPGRRFTVSSTRFYVAETVLALEYLHMMGVVYRDLKPENVLVRGD 227
Query: 352 GHIMLSDFDLSLRCAVSPTVV---KSSTLESEPLRKNPVYCVQPACIEP--SCI---QPS 403
GHIMLSDFDLSL+C V P ++ +S+ +P P CV P I+P SCI
Sbjct: 228 GHIMLSDFDLSLKCDVVPKLLRPARSAAAGGKPPLPPPSSCVPPT-IQPVLSCIFRGVHK 286
Query: 404 CIAPTTC-FSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEI 462
C C + E + + ++ EP ARS SFVGTHEYLAPE+
Sbjct: 287 CHHAKECAGGGAAAGNNGDGDGNDEEAETETAEPEVVVVEPVAARSKSFVGTHEYLAPEV 346
Query: 463 IKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSF---- 518
I G+GHGSAVDWWT G+F+YE+L+G+TPFKG N TL N++ QP+ FP +
Sbjct: 347 ISGQGHGSAVDWWTLGVFMYEMLYGRTPFKGESNEKTLINIIKQPVTFPRLAGAAAAGEW 406
Query: 519 ----SARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIR 560
+A+DL+ LL K P+ RL G+ E+K+HPFF+GVNWAL+R
Sbjct: 407 EEMKTAQDLMLQLLAKNPKKRLGSTMGSAEVKRHPFFKGVNWALVR 452
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64682|PID_ARATH Protein kinase PINOID OS=Arabidopsis thaliana GN=PID PE=1 SV=1 | Back alignment and function description |
|---|
Score = 389 bits (998), Expect = e-107, Method: Compositional matrix adjust.
Identities = 213/452 (47%), Positives = 283/452 (62%), Gaps = 52/452 (11%)
Query: 130 ASAKVSDGTSSLPKTSGSAKISDRGDYVESGKSSMCRGSTSSDVSDESTCSSLSSSVNKP 189
+ ++S GT++ P +SG+ S S + + S + +E + SL KP
Sbjct: 5 SDGEMSLGTTNSPISSGTESCS--------SFSRLSFDAPPSTIPEEESFLSL-----KP 51
Query: 190 HKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTK-----CYFAMK 244
H+++D + I+ R K L FRL++++G GDIG+VYL L G + YFAMK
Sbjct: 52 HRSSDFAYAEIR--RRKKQGLTFRDFRLMRRIGAGDIGTVYLCRLAGDEEESRSSYFAMK 109
Query: 245 VMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLR 304
V+DK +L +KK+ RA+ E+ IL+ LDHPFLPTLY FE FSC+VME+C GGDLH+LR
Sbjct: 110 VVDKEALALKKKMHRAEMEKTILKMLDHPFLPTLYAEFEASHFSCIVMEYCSGGDLHSLR 169
Query: 305 QRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLR 364
RQP + FS + +FY AEVL+ALEYLHMLGI+YRDLKPEN+LVR DGHIMLSDFDLSL
Sbjct: 170 HRQPHRRFSLSSARFYAAEVLVALEYLHMLGIIYRDLKPENILVRSDGHIMLSDFDLSL- 228
Query: 365 CAVSPTVVKSSTL--ESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKA 422
C+ S V+SS+ E++ LR +P + A R F + ++
Sbjct: 229 CSDSIAAVESSSSSPENQQLR-SPRRFTRLA--------------------RLFQRVLRS 267
Query: 423 QKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLY 482
+K + + P +AEP ARS SFVGTHEY+APE+ G HG+AVDWW FG+FLY
Sbjct: 268 KKVQT-----LEPTRLFVAEPVTARSGSFVGTHEYVAPEVASGGSHGNAVDWWAFGVFLY 322
Query: 483 ELLFGKTPFKGSENRATLYNVVGQPLRFP-ESPVVSFS--ARDLIKGLLVKEPQNRLACR 539
E+++GKTPF N L N+V + L FP +SP F AR+LI GLL K+P RL R
Sbjct: 323 EMIYGKTPFVAPTNDVILRNIVKRQLSFPTDSPATMFELHARNLISGLLNKDPTKRLGSR 382
Query: 540 RGATEIKQHPFFQGVNWALIRCASPPEIPKPV 571
RGA E+K HPFF+G+N+ALIR +PPEIP V
Sbjct: 383 RGAAEVKVHPFFKGLNFALIRTLTPPEIPSSV 414
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. Acts as a positive regulator of cellular auxin efflux and regulates organ development by enhancing polar auxin transport. Phosphorylates conserved serine residues in the PIN auxin efflux carriers. Phosphorylation of PIN proteins is required and sufficient for apical-basal PIN polarity that enables directional intercellular auxin fluxes, which mediate differential growth, tissue patterning and organogenesis. Acts in association with PIN1 to control the establishment of bilateral symmetry and promotion of cotyledon outgrowth. Regulates root gravitropism through modulation of PIN2-dependent basipetal auxin transport. Required for polarization of PIN3-dependent auxin transport for hypocotyl gravitropic response. The protein kinase activity of PID is essential for its auxin efflux regulatory function. PID kinase and PP2A phosphatase activities antagonistically regulate phosphorylation of PIN proteins, affecting PIN sorting. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2QM77|PID_ORYSJ Protein kinase PINOID OS=Oryza sativa subsp. japonica GN=PID PE=2 SV=1 | Back alignment and function description |
|---|
Score = 378 bits (970), Expect = e-104, Method: Compositional matrix adjust.
Identities = 187/404 (46%), Positives = 254/404 (62%), Gaps = 42/404 (10%)
Query: 177 STCSSLSSSVN-KPHKANDAQWEAIQAVRVKDGV-LGVGHFRLLKKLGCGDIGSVYLSEL 234
++CS +SV +PH++ D W AI+A LG F+L++++G GDIG+VYL L
Sbjct: 71 TSCSPPRASVLLRPHRSGDVAWAAIRAASTTSAAPLGPRDFKLVRRIGGGDIGTVYLCRL 130
Query: 235 TGTK-----CYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFE-TDKFS 288
+ C +AMKV+D+ ++ +++KL RA E+ IL+ LDHPFLPTL+ F+ T FS
Sbjct: 131 RSSPERESPCMYAMKVVDRRAVARKQKLGRAAAEKRILRQLDHPFLPTLFADFDATPHFS 190
Query: 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV 348
C VMEFCPGGDLH+LR R P + F + +FY AEVLLA+EYLHM+GIVYRDLKPENVL+
Sbjct: 191 CAVMEFCPGGDLHSLRHRMPSRRFPLPSARFYAAEVLLAIEYLHMMGIVYRDLKPENVLI 250
Query: 349 REDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPT 408
R DGHIML+DFDLSL+ SP++ + + E
Sbjct: 251 RADGHIMLTDFDLSLQSTTSPSLDGDTDTDDE-----------------------ASGGA 287
Query: 409 TCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGH 468
+CF + ++ +N + +P P +AEP +ARS SFVGTHEY+APE+ G H
Sbjct: 288 SCFPDHLL----RFKRRRNAVA---APRPRFVAEPVDARSCSFVGTHEYVAPEVASGGAH 340
Query: 469 GSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESP----VVSFSARDLI 524
G+AVDWW +G+FLYEL++G+TPF G+ N ATL N+V +PL FP ARDLI
Sbjct: 341 GAAVDWWAYGVFLYELIYGRTPFAGATNEATLRNIVRRPLAFPSGSGSCGPADADARDLI 400
Query: 525 KGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIP 568
LL K+P RL RRGA ++K HPFF+ +N AL+R + PP +P
Sbjct: 401 ARLLAKDPAARLGSRRGAADVKSHPFFKSLNLALLRSSRPPVVP 444
|
Serine/threonine-protein kinase involved in the regulation of auxin signaling. May control polar auxin transport and probably plays a role in the pattern formation and organogenesis in the rice shoot. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ST27|PHOT2_ORYSJ Phototropin-2 OS=Oryza sativa subsp. japonica GN=PHOT2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 358 bits (920), Expect = 5e-98, Method: Compositional matrix adjust.
Identities = 178/387 (45%), Positives = 233/387 (60%), Gaps = 49/387 (12%)
Query: 188 KPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMD 247
KPHK N+ W AI+ +G+ HF+ +K LGCGD GSV+L EL G+ FAMK MD
Sbjct: 549 KPHKRNNPSWIAIEKATNLGEKIGLKHFKPVKPLGCGDTGSVHLVELQGSGELFAMKAMD 608
Query: 248 KASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQ 307
K+ + R K+ RA EREI LDHPFLPTLYT F+T CL+ +FCPGG+L + RQ
Sbjct: 609 KSVMLNRNKVHRACIEREIYALLDHPFLPTLYTSFQTPTHVCLITDFCPGGELFAVLDRQ 668
Query: 308 PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAV 367
P K F E+ +FY AEV++ LEYLH LGI+YRDLKPEN+L++ DGHI+L+DFDLS
Sbjct: 669 PMKIFREECARFYAAEVVIGLEYLHCLGIIYRDLKPENILLQADGHIVLTDFDLSFLTTS 728
Query: 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKN 427
P V+K+ST S R++ + EPS
Sbjct: 729 KPHVIKNST--SLKRRRSQEFLPPTFVSEPST---------------------------- 758
Query: 428 EMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFG 487
P+N SFVGT EY+APE+I G GH SA+DWW GI LYE+L+G
Sbjct: 759 ---------------PSN----SFVGTEEYIAPEVITGAGHTSAIDWWALGILLYEMLYG 799
Query: 488 KTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547
+TPF+G + T YN++ + L FP S VS +A+ LI GLL ++P NR+ GA +IKQ
Sbjct: 800 RTPFRGKNRKKTFYNILHKDLTFPSSIPVSLAAKQLIHGLLQRDPSNRIGSNAGANDIKQ 859
Query: 548 HPFFQGVNWALIRCASPPEIPKPVEIV 574
H FFQ +NW LIRC SPPE+ P++++
Sbjct: 860 HSFFQDINWPLIRCMSPPELDVPLKLI 886
|
Protein kinase that acts as a blue-light photoreceptor in a signal-transduction pathway for phototropic responses. Regulates a wide range of physiological activities in plants that maximize the efficiency of photosynthesis, such as chloroplast relocations, stomata opening, and leaf expansion. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 604 | ||||||
| 225461963 | 611 | PREDICTED: protein kinase G11A-like [Vit | 1.0 | 0.988 | 0.795 | 0.0 | |
| 341833970 | 611 | serine/threonine protein kinase-like pro | 0.998 | 0.986 | 0.770 | 0.0 | |
| 255579150 | 612 | serine/threonine protein kinase, putativ | 0.995 | 0.982 | 0.744 | 0.0 | |
| 359494858 | 620 | PREDICTED: protein kinase G11A-like [Vit | 0.975 | 0.95 | 0.740 | 0.0 | |
| 356532843 | 608 | PREDICTED: protein kinase G11A-like [Gly | 0.985 | 0.978 | 0.722 | 0.0 | |
| 356555777 | 608 | PREDICTED: LOW QUALITY PROTEIN: protein | 0.986 | 0.980 | 0.727 | 0.0 | |
| 224137196 | 493 | predicted protein [Populus trichocarpa] | 0.801 | 0.981 | 0.855 | 0.0 | |
| 449532394 | 607 | PREDICTED: protein kinase G11A-like [Cuc | 0.824 | 0.820 | 0.822 | 0.0 | |
| 449443506 | 607 | PREDICTED: protein kinase G11A-like [Cuc | 0.824 | 0.820 | 0.822 | 0.0 | |
| 357448091 | 604 | Protein kinase [Medicago truncatula] gi| | 0.976 | 0.976 | 0.715 | 0.0 |
| >gi|225461963|ref|XP_002266700.1| PREDICTED: protein kinase G11A-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 952 bits (2460), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 486/611 (79%), Positives = 532/611 (87%), Gaps = 7/611 (1%)
Query: 1 MASKLGMRSSPEKQRKPIGSQPSEGNFGRPSPLQNTKTSKSDPFTPRKIPRSAQQIASKQ 60
MASK G R+SP++Q++ GSQ EGN RPSPLQ TKTSKS+P TP+K PRS Q +A KQ
Sbjct: 1 MASKSGARTSPDRQKRTFGSQTLEGNSRRPSPLQITKTSKSEPVTPKKTPRSVQPVALKQ 60
Query: 61 DSIATPTVEKSLNSSKEESLNSLADKVGSSLTLGDLKQVPTSVGTEVSQTKGSLEDVGEQ 120
+ + SL+S ++ S NSL DK+GSSL+LGD +Q PT V S+ GSL+ +Q
Sbjct: 61 VDVEASDDKNSLSSHQKGSANSLTDKLGSSLSLGDSQQTPTIVTPVASEVTGSLDGGADQ 120
Query: 121 EKKPSEAGPAS--AKVSDGTSSLPKTSGSAKISDRGDYVESGKSSMCRGSTSSDVSDEST 178
EKK SE G ++ AKVSDGT SL KTSGSAKISDR ++VESGKSSMCRGSTSSDVSDEST
Sbjct: 121 EKKTSEHGHSTVAAKVSDGTGSLAKTSGSAKISDRVEFVESGKSSMCRGSTSSDVSDEST 180
Query: 179 CSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTK 238
CSSLSSS++KPHKAND++WEAIQ VR KDG LG+ HFRLLK+LGCGDIGSVYLSEL GTK
Sbjct: 181 CSSLSSSISKPHKANDSRWEAIQVVRAKDGALGLNHFRLLKRLGCGDIGSVYLSELKGTK 240
Query: 239 CYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGG 298
CYFAMKVMDK SL RKKLLRAQTEREILQSLDHPFLPTLYTHFET+KFSCLVMEFCPGG
Sbjct: 241 CYFAMKVMDKGSLASRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGG 300
Query: 299 DLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSD 358
DLHTLRQRQPGK+FSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSD
Sbjct: 301 DLHTLRQRQPGKHFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSD 360
Query: 359 FDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFF-S 417
FDLSLRC VSPT+VKSS+ ++EPLR+NPVYCVQP CIEPSCIQPSC+APTTCFSPR F S
Sbjct: 361 FDLSLRCTVSPTLVKSSSFDTEPLRRNPVYCVQPTCIEPSCIQPSCVAPTTCFSPRLFSS 420
Query: 418 KSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTF 477
KSKK +KPKNE+GNQVSPLPELIAEPT ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTF
Sbjct: 421 KSKKDRKPKNEIGNQVSPLPELIAEPTGARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTF 480
Query: 478 GIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLA 537
GIFLYELLFGKTPFKGS NRATL+NVVGQPLRFPESPVVSFSARDLI+GLLVKEPQ+RLA
Sbjct: 481 GIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFSARDLIRGLLVKEPQHRLA 540
Query: 538 CRRGATEIKQHPFFQGVNWALIRCASPPEIPKPVEIVHSPAPALSTKAKAVAAGNADH-- 595
+RGATEIKQHPFF+GVNWALIRCASPPEIPKPVEI PAPA S+ KA AA
Sbjct: 541 YKRGATEIKQHPFFEGVNWALIRCASPPEIPKPVEIERVPAPAASSSEKAAAAMAGPDQK 600
Query: 596 --NNYLEFDFF 604
+NYLEFDFF
Sbjct: 601 SCDNYLEFDFF 611
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|341833970|gb|AEK94320.1| serine/threonine protein kinase-like protein [Pyrus x bretschneideri] | Back alignment and taxonomy information |
|---|
Score = 948 bits (2450), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 470/610 (77%), Positives = 519/610 (85%), Gaps = 7/610 (1%)
Query: 1 MASKLGMRSS-PEKQRKPIGSQPSEGNFGRPSPLQNTKTSKSDPFTPRKIPRSAQQIASK 59
MASK G RSS PE QRK I SQ +E NF RPSPL TKTSKS+P TP+K+PR QQ A K
Sbjct: 3 MASKSGARSSSPETQRKLIASQTTERNFRRPSPLPITKTSKSEPVTPKKLPRHVQQDAPK 62
Query: 60 QDSIATPTVEKSLNSSKEESLNSLADKVGSSLTLGDLKQVPTSVGTEVSQTKGSLEDVGE 119
Q S T + ++ES +LAD++GS+L+LGD KQVP V S+T+ + G+
Sbjct: 63 QVSTETTEEKNYKIPYQKESAKTLADQLGSALSLGDAKQVPADVDPVASETR-NFPGGGD 121
Query: 120 QEKKPSEAG--PASAKVSDG-TSSLPKTSGSAKISDRGDYVESGKSSMCRGSTSSDVSDE 176
Q+KK S G P SAK SD TSS+ KTSG+AK+S R D+VESGKSS+CRGSTSSD+SDE
Sbjct: 122 QKKKTSANGICPTSAKASDDRTSSIAKTSGNAKMSGRADFVESGKSSICRGSTSSDISDE 181
Query: 177 STCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTG 236
STCSS SS++NKPHKAND WEAIQAVR +DGV G+GHFRLLKKLGCGDIGSVYLSELTG
Sbjct: 182 STCSSFSSAINKPHKANDIHWEAIQAVRSRDGVFGLGHFRLLKKLGCGDIGSVYLSELTG 241
Query: 237 TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCP 296
TKCYFAMKVMDKASL RKKLLRAQTEREILQ LDHPFLPTLYTHFET+K+SCLVMEFCP
Sbjct: 242 TKCYFAMKVMDKASLANRKKLLRAQTEREILQCLDHPFLPTLYTHFETEKYSCLVMEFCP 301
Query: 297 GGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIML 356
GGDLHTLRQRQPGK+F+EQAVKFYVAEVLL LEYLHMLGIVYRD KPENVLVR+DGHIML
Sbjct: 302 GGDLHTLRQRQPGKHFTEQAVKFYVAEVLLTLEYLHMLGIVYRDFKPENVLVRDDGHIML 361
Query: 357 SDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFF 416
SDFDLSLRCAVSPT+VKSS +SEP R+N YCVQPACIEPSCIQPSC+ TTCFSPRFF
Sbjct: 362 SDFDLSLRCAVSPTLVKSSAPDSEPFRRNSAYCVQPACIEPSCIQPSCVMLTTCFSPRFF 421
Query: 417 -SKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWW 475
SKSKK +KPKNEMGNQV PLPEL+AEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWW
Sbjct: 422 SSKSKKDRKPKNEMGNQVRPLPELMAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWW 481
Query: 476 TFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNR 535
TFGIFLYELLFGKTPFKGS NRATL+NVVGQPL+FPE+PVVSFSA+DLI+GLLVKEPQ+R
Sbjct: 482 TFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLKFPEAPVVSFSAKDLIRGLLVKEPQHR 541
Query: 536 LACRRGATEIKQHPFFQGVNWALIRCASPPEIPKPVEIVHSPAPALSTKAKAVAAG-NAD 594
LA +RGATEIKQHPFF+ VNWALIRCASPP+IPKPVE AP +S KA AA + D
Sbjct: 542 LAYKRGATEIKQHPFFEDVNWALIRCASPPDIPKPVEFERISAPPVSASDKATAAATHPD 601
Query: 595 HNNYLEFDFF 604
NNYLEFDFF
Sbjct: 602 QNNYLEFDFF 611
|
Source: Pyrus x bretschneideri Species: Pyrus x bretschneideri Genus: Pyrus Family: Rosaceae Order: Rosales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255579150|ref|XP_002530422.1| serine/threonine protein kinase, putative [Ricinus communis] gi|223530030|gb|EEF31953.1| serine/threonine protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 898 bits (2321), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 457/614 (74%), Positives = 516/614 (84%), Gaps = 13/614 (2%)
Query: 1 MASKLGMRSSPEKQRKPIGSQPSEGNFGRPSPLQNTKTSKSDPFTPRKIPRSAQQIASKQ 60
MASK G ++SP+ Q K +G Q +E N + Q ++TSKSD K+ RS + KQ
Sbjct: 2 MASK-GSKASPKPQLKSVGVQKAEANNLKTLSSQVSETSKSDLINHDKVQRSIEN-TPKQ 59
Query: 61 DSIATPTVEKSLNSSKEESLNSLADKVGSSLTLGDLKQVPTSVGTEVSQTKGSLEDVGEQ 120
+ +K NS+K+E+ +SL+ K+GSS ++ L+ + +++T+GS + +Q
Sbjct: 60 VMLEFSEDKKLSNSNKKETADSLSIKLGSSSSIPTLEHASIVADSSINETRGSQDVSLDQ 119
Query: 121 EKKPSEAGPASAKVS-----DGTSSLPKTSGSAKISDRGDYVESGKSSMCRGSTSSDVSD 175
EKK SE G + DG SSL KTSGSAKISDR +YVESGKSS+CRGSTSSD+SD
Sbjct: 120 EKKTSEYGSVKSSSVSAKVSDGASSLAKTSGSAKISDRVEYVESGKSSLCRGSTSSDISD 179
Query: 176 ESTCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELT 235
ESTCSS SSS++KPHKAND +WEAIQAVR KDGVLG+ HFRLLK+LGCGDIGSVYLSEL+
Sbjct: 180 ESTCSSFSSSISKPHKANDLRWEAIQAVRAKDGVLGLSHFRLLKRLGCGDIGSVYLSELS 239
Query: 236 GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFC 295
GTKCYFAMKVMDK SL RKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFC
Sbjct: 240 GTKCYFAMKVMDKGSLASRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFC 299
Query: 296 PGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIM 355
PGGDLHTLRQRQPGK+F EQAVKFY+AEVLLALEYLHMLGI+YRDLKPENVLVREDGHIM
Sbjct: 300 PGGDLHTLRQRQPGKHFPEQAVKFYIAEVLLALEYLHMLGIIYRDLKPENVLVREDGHIM 359
Query: 356 LSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRF 415
LSDFDLSLRCAVSPT+VK+S+LESEPLRKNPVYCVQPACIEPSCIQPSC+APTTCFSPR
Sbjct: 360 LSDFDLSLRCAVSPTLVKTSSLESEPLRKNPVYCVQPACIEPSCIQPSCVAPTTCFSPRL 419
Query: 416 F-SKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDW 474
F SKSKK +KPK+E+GNQVSPLPELIAEPT+ARSMSFVGTHEYLAPEIIKGEGHGSAVDW
Sbjct: 420 FSSKSKKDRKPKSELGNQVSPLPELIAEPTDARSMSFVGTHEYLAPEIIKGEGHGSAVDW 479
Query: 475 WTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQN 534
WTFGIFLYELLFGKTPFKGS NRATL+NVVGQPLRFPESPVVSF+ARDLI+GLLVKEPQ+
Sbjct: 480 WTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQH 539
Query: 535 RLACRRGATEIKQHPFFQGVNWALIRCASPPEIPKPVEIVHSPAPALSTKAKAVAA---- 590
RLA +RGATEIKQHPFF+GVNWALIRCA+PPEIPKPVE+ P PA ST KA +A
Sbjct: 540 RLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEVERVPVPA-STSEKATSAPAVP 598
Query: 591 GNADHNNYLEFDFF 604
+NYLEFDFF
Sbjct: 599 DKKGSDNYLEFDFF 612
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359494858|ref|XP_003634855.1| PREDICTED: protein kinase G11A-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 890 bits (2300), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 453/612 (74%), Positives = 504/612 (82%), Gaps = 23/612 (3%)
Query: 13 KQRKPI-GSQPSEGNFGRPSPLQNTKTSKSDPFTPRKIPRSAQQIASKQDSIATPTVEKS 71
+QRK G+Q N +P PL+ +KTSK + + + + Q KQ ++ ++KS
Sbjct: 12 QQRKLTSGAQAVGANELKPLPLEVSKTSKPELVSTEQ---KSVQTTPKQVTVEASEIKKS 68
Query: 72 LNSSKEESLNSLADKVGSSLTLGDLKQVPTSVGTEVSQTKGSLEDVGEQEKKPSEAGPA- 130
S ++ S + L K SS + +Q T V V+ ++GSLE +QEKK SE G
Sbjct: 69 PTSGQKGSADLLPIKFDSSSSSAGAEQASTEVDPSVNGSRGSLEASVDQEKKTSEYGSVK 128
Query: 131 ----SAKVSDGTSSLPKTSGSAKISDRGDYVESGKSSMCRGSTSSDVSDESTCSSLSSSV 186
SAKVSDG SSL KTSGSAK+SDRGD+VESGKSSMCRGSTSSDVSDESTCSS SSS+
Sbjct: 129 DSSVSAKVSDGASSLAKTSGSAKVSDRGDFVESGKSSMCRGSTSSDVSDESTCSSFSSSI 188
Query: 187 NKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVM 246
NKPHKAND++WEAIQAVR +DGVLG+ HFRLLK+LGCGDIGSVYLSEL+GTK YFAMKVM
Sbjct: 189 NKPHKANDSRWEAIQAVRARDGVLGLSHFRLLKRLGCGDIGSVYLSELSGTKSYFAMKVM 248
Query: 247 DKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQR 306
DK SL RKKLLRAQTEREILQSLDHPFLPTLYTHFET+KFSCLVMEFCPGGDLHTLRQR
Sbjct: 249 DKGSLASRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQR 308
Query: 307 QPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366
QPGK+F+EQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVR+DGHIMLSDFDLSLRCA
Sbjct: 309 QPGKHFTEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRDDGHIMLSDFDLSLRCA 368
Query: 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFF-SKSKKAQKP 425
VSPT+VK+ +LES+P RKNPVYCVQPACIEPSCIQPSC+APTTCF+PR F SKS+K +KP
Sbjct: 369 VSPTLVKTCSLESDPFRKNPVYCVQPACIEPSCIQPSCVAPTTCFTPRLFSSKSRKDRKP 428
Query: 426 KNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL 485
KNE+GNQVSPLPELIAEPT ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL
Sbjct: 429 KNEVGNQVSPLPELIAEPTGARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL 488
Query: 486 FGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEI 545
FGKTPFKGS NRATL+NVVGQPLRFPESPVVSFSARDLI+GLLVKEPQ+RLA +RGATEI
Sbjct: 489 FGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFSARDLIRGLLVKEPQHRLAFKRGATEI 548
Query: 546 KQHPFFQGVNWALIRCASPPEIPKPVEIVHSPAPALSTKAKA-------------VAAGN 592
KQHPFF+GVNWALIRCA+PPEIPKPVEI PAP ST K V
Sbjct: 549 KQHPFFEGVNWALIRCATPPEIPKPVEIERIPAPTASTSEKVPPAAKATAPIAAAVVPDQ 608
Query: 593 ADHNNYLEFDFF 604
+NYLEFDFF
Sbjct: 609 KSSDNYLEFDFF 620
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356532843|ref|XP_003534979.1| PREDICTED: protein kinase G11A-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 875 bits (2261), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 446/617 (72%), Positives = 503/617 (81%), Gaps = 22/617 (3%)
Query: 1 MASKLGMRSSPEKQRKPIGSQ-PSEGNFGRPSPLQNTKTSKSDPFTPRKIPRSAQQIASK 59
M SK RS P+ +K G + P + G S Q K K++ P + +SA ASK
Sbjct: 1 MDSKTSSRSLPKHHQKTAGIRTPETKDAG--SSFQ--KMGKTELAAPVDLLKSAAN-ASK 55
Query: 60 QDSIATPTVEKSLNSSKEESLNSLADKVGSSLTLGDLKQVPTSVGTEVSQTKGSLEDVGE 119
Q++ T ++K + + S +SL++K GS + L + + + GS E +
Sbjct: 56 QNTGETAEIKKLGGLTLKGSADSLSNKSGSGASSYVLDKSVRAANENI----GSQESPID 111
Query: 120 QEKKPSEAGPA-----SAKVSDGTSSLPKTSGSAKISDRGDYVESGKSSMCRGSTSSDVS 174
Q+KK SE G SAKVSDG SSL KTSGSAKIS+R D+VESGKSS+CRGSTSSDVS
Sbjct: 112 QDKKTSEDGSVKNSSVSAKVSDGASSLAKTSGSAKISNRADFVESGKSSICRGSTSSDVS 171
Query: 175 DESTCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSEL 234
DESTCSS SS++NKPHKAND +WEAIQAVR +DGVLG+GHFRLLK+LGCGDIGSVYLSEL
Sbjct: 172 DESTCSSFSSTINKPHKANDLRWEAIQAVRSRDGVLGLGHFRLLKRLGCGDIGSVYLSEL 231
Query: 235 TGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEF 294
+GTKCYFAMKVMDK SL RKKLLRAQTEREILQSLDHPFLPTLYTHFET+KFSCLVMEF
Sbjct: 232 SGTKCYFAMKVMDKGSLASRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEF 291
Query: 295 CPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHI 354
CPGGDLHTLRQ+QPGK+F EQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVR+DGHI
Sbjct: 292 CPGGDLHTLRQKQPGKHFPEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRDDGHI 351
Query: 355 MLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIE-PSCIQPSCIAPTTCFSP 413
MLSDFDLSLRCAVSPT+VK+S+ +SEPLRKN YCVQPACIE PSCIQPSC+APTTCFSP
Sbjct: 352 MLSDFDLSLRCAVSPTLVKTSSTDSEPLRKNSAYCVQPACIEPPSCIQPSCVAPTTCFSP 411
Query: 414 RFF-SKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAV 472
R F SKSKK +KPK E+GNQVSPLPELIAEPT+ARSMSFVGTHEYLAPEIIKGEGHGSAV
Sbjct: 412 RLFSSKSKKDRKPKTEIGNQVSPLPELIAEPTDARSMSFVGTHEYLAPEIIKGEGHGSAV 471
Query: 473 DWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEP 532
DWWTFGIFLYELLFGKTPFKGS NRATL+NVVGQPLRFPE+PVVSF+ARDLI+GLLVKEP
Sbjct: 472 DWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPEAPVVSFAARDLIRGLLVKEP 531
Query: 533 QNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPKPVEIVHSPAPALSTKAKAVA--- 589
Q+RLA +RGATEIKQHPFF+GVNWALIRCA+PPEIPK VE P+PA S+ + A
Sbjct: 532 QHRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKAVEFEKIPSPASSSGGEKAANHI 591
Query: 590 --AGNADHNNYLEFDFF 604
A +NYLEFDFF
Sbjct: 592 SIANQKGSDNYLEFDFF 608
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356555777|ref|XP_003546206.1| PREDICTED: LOW QUALITY PROTEIN: protein kinase G11A-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 859 bits (2220), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 448/616 (72%), Positives = 501/616 (81%), Gaps = 20/616 (3%)
Query: 1 MASKLGMRSSPEKQRKPIGSQPSEGNFGRPSPLQNTKTSKSDPFTPRKIPRSAQQIASKQ 60
M SK R+ P+ +K G Q E S LQ K K++ P + A ASKQ
Sbjct: 1 MDSKTSSRALPKHHQKTAGIQTLEAK-DTGSSLQ--KGEKTELAAPVDLSMYAAN-ASKQ 56
Query: 61 DSIATPTVEKSLNSSKEESLNSLADKVGSSLTLGDLKQVPTSVGTEVSQTKGSLEDVGEQ 120
++ T ++K + + S +S++ K GS + L +V + + GS E +
Sbjct: 57 NTGETAEIKKLGGLTLKGSADSMSIKSGSGASSSVLDKVVHAANENI----GSQESSIDL 112
Query: 121 EKKPSEAGPA-----SAKVSDGTSSLPKTSGSAKISDRGDYVESGKSSMCRGSTSSDVSD 175
+KK SE G SAKVSDG SSL KTSGSAKIS+R D+VESGKSS+CRGSTSSDVSD
Sbjct: 113 DKKTSEDGSVKNSSVSAKVSDGASSLAKTSGSAKISNRADFVESGKSSICRGSTSSDVSD 172
Query: 176 ESTCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELT 235
ESTCSS SSS+NKPHKAND +WEAIQAVR +DGVLG+GHFRLLK+LGCGDIGSVYLSEL+
Sbjct: 173 ESTCSSFSSSINKPHKANDLRWEAIQAVRSRDGVLGLGHFRLLKRLGCGDIGSVYLSELS 232
Query: 236 GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFC 295
GTKCYFAMKVMDK SL RKKLLR QTEREILQSLDHPFLPTLYTHFET+KFSCLVMEFC
Sbjct: 233 GTKCYFAMKVMDKGSLASRKKLLRXQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFC 292
Query: 296 PGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIM 355
PGGDLHTLRQ+QPGK+F EQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVR+DGHIM
Sbjct: 293 PGGDLHTLRQKQPGKHFPEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRDDGHIM 352
Query: 356 LSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIE-PSCIQPSCIAPTTCFSPR 414
LSDFDLSLRCAVSPT+VK+S+ +SEPLRKN VYCVQPACIE PSCIQPSC+APTTCFSPR
Sbjct: 353 LSDFDLSLRCAVSPTLVKTSSTDSEPLRKNAVYCVQPACIEPPSCIQPSCVAPTTCFSPR 412
Query: 415 FF-SKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVD 473
F SKSKK +KPKNE+GNQVSPLPELIAEPT+ARSMSFVGTHEYLAPEIIKGEGHGSAVD
Sbjct: 413 LFSSKSKKDRKPKNEIGNQVSPLPELIAEPTDARSMSFVGTHEYLAPEIIKGEGHGSAVD 472
Query: 474 WWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQ 533
WWTFGIFLYELLFGKTPFKGS NRATL+NVVGQPLRFPE+PVVSF+ARDLI+GLLVKEPQ
Sbjct: 473 WWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPEAPVVSFAARDLIRGLLVKEPQ 532
Query: 534 NRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPKPVEIVHSPAPALSTKA-KAV---- 588
+RLA +RGATEIKQHPFF+GVNWALIRCA+PPEIPK VE P+PA S+ KAV
Sbjct: 533 HRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKAVEFEKIPSPASSSGGEKAVNHMS 592
Query: 589 AAGNADHNNYLEFDFF 604
A +NYLEFDFF
Sbjct: 593 IANQKGSDNYLEFDFF 608
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224137196|ref|XP_002322497.1| predicted protein [Populus trichocarpa] gi|222867127|gb|EEF04258.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 858 bits (2216), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 422/493 (85%), Positives = 451/493 (91%), Gaps = 9/493 (1%)
Query: 121 EKKPSEAGPA-----SAKVSDGTSSLPKTSGSAKISDRGDYVESGKSSMCRGSTSSDVSD 175
EKK SE G SAKVSDGTSSL KTSGSAK+SDR DY ESGK S+CRGSTSSDVSD
Sbjct: 1 EKKISEYGSVKNSSVSAKVSDGTSSLAKTSGSAKMSDRVDYAESGKRSLCRGSTSSDVSD 60
Query: 176 ESTCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELT 235
ESTCSS SSS+NKPHKAND +WEAIQAVR KDGVLG+ HFRLLK+LGCGDIGSVYLSEL+
Sbjct: 61 ESTCSSFSSSINKPHKANDLRWEAIQAVRAKDGVLGLSHFRLLKRLGCGDIGSVYLSELS 120
Query: 236 GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFC 295
GTKCYFAMKVMDK SL RKKLLRAQTEREILQSLDHPFLP+LYTHFETDKFSCLVMEFC
Sbjct: 121 GTKCYFAMKVMDKGSLASRKKLLRAQTEREILQSLDHPFLPSLYTHFETDKFSCLVMEFC 180
Query: 296 PGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIM 355
PGGDLHTLRQRQPGK+F EQAVKFYVAEVLLALEYLHMLGI+YRDLKPENVLVR+DGHIM
Sbjct: 181 PGGDLHTLRQRQPGKHFLEQAVKFYVAEVLLALEYLHMLGIIYRDLKPENVLVRDDGHIM 240
Query: 356 LSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRF 415
LSDFDLSLRCAVSPT+VK+++LE++P RKNPVYCVQPACIEPSCIQPSC+APTTCF PR
Sbjct: 241 LSDFDLSLRCAVSPTLVKTASLEADPFRKNPVYCVQPACIEPSCIQPSCVAPTTCFGPRL 300
Query: 416 F-SKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDW 474
F SKSKK +KPKNE+GNQVSPLPELIAEPT+ARSMSFVGTHEYLAPEIIKGEGHGSAVDW
Sbjct: 301 FSSKSKKDRKPKNELGNQVSPLPELIAEPTDARSMSFVGTHEYLAPEIIKGEGHGSAVDW 360
Query: 475 WTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQN 534
WTFGIFLYELLFGKTPFKGS NRATL+NVVGQPLRFPESPVVSF+ARDLI+GLLVKEPQ+
Sbjct: 361 WTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRGLLVKEPQH 420
Query: 535 RLACRRGATEIKQHPFFQGVNWALIRCASPPEIPKPVEIVHSPAPA-LSTKAKAVAA--G 591
RLA +RGATEIKQHPFF+GVNWALIRCA+PPEIPKPVEI PAPA S KA VAA G
Sbjct: 421 RLASKRGATEIKQHPFFEGVNWALIRCATPPEIPKPVEIERIPAPASTSEKATTVAAAPG 480
Query: 592 NADHNNYLEFDFF 604
+NYLEFDFF
Sbjct: 481 QKGSDNYLEFDFF 493
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449532394|ref|XP_004173166.1| PREDICTED: protein kinase G11A-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 852 bits (2201), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 418/508 (82%), Positives = 454/508 (89%), Gaps = 10/508 (1%)
Query: 107 VSQTKGSLEDVGEQEKKPSEAGPA-----SAKVSDGTSSLPKTSGSAKISDRGDYVESGK 161
++ T+G ED + +KK SE G SAKVSDGT+S+ KTSGSAKISDR + VESGK
Sbjct: 100 LNGTQGLAEDSIDSKKKISECGSGKDSSVSAKVSDGTNSISKTSGSAKISDRVEMVESGK 159
Query: 162 SSMCRGSTSSDVSDESTCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKL 221
SSMCRGSTSSD+SDESTCSS SSS++KPHKAND +WEAIQAVR +DG+LG+GHFRLLK+L
Sbjct: 160 SSMCRGSTSSDISDESTCSSFSSSISKPHKANDLRWEAIQAVRARDGILGLGHFRLLKRL 219
Query: 222 GCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTH 281
GCGDIGSVYLSEL+GTKCYFAMKVMDK SL RKKLLRAQTEREILQSLDHPFLPTLYTH
Sbjct: 220 GCGDIGSVYLSELSGTKCYFAMKVMDKGSLASRKKLLRAQTEREILQSLDHPFLPTLYTH 279
Query: 282 FETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDL 341
FETDKFSCLVMEFCPGGDLHTLRQRQPGK+F+EQAVKFYVAEVLLALEYLHMLGIVYRDL
Sbjct: 280 FETDKFSCLVMEFCPGGDLHTLRQRQPGKHFTEQAVKFYVAEVLLALEYLHMLGIVYRDL 339
Query: 342 KPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQ 401
KPENVLVREDGHIMLSDFDLSLRCAVSPT+VK S ESEPLRKN YCVQPACIEPSCIQ
Sbjct: 340 KPENVLVREDGHIMLSDFDLSLRCAVSPTLVKGSCSESEPLRKNSTYCVQPACIEPSCIQ 399
Query: 402 PSCIAPTTCFSPRFF-SKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAP 460
PSC+ PTTCF+PR F SKSKK +KPK E+GNQV+PLPELIAEPT ARSMSFVGTHEYLAP
Sbjct: 400 PSCVVPTTCFTPRLFSSKSKKDRKPKTEIGNQVTPLPELIAEPTEARSMSFVGTHEYLAP 459
Query: 461 EIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSA 520
EIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS NRATL+NVVGQPLRFPESPVVSF+A
Sbjct: 460 EIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAA 519
Query: 521 RDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPKPVEIVHSPAPA 580
RDLI+GLLVKEPQ+RLA +RGATEIKQHPFF+GVNWALIRCASPPE+PKPVEI P+PA
Sbjct: 520 RDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCASPPEVPKPVEIERIPSPA 579
Query: 581 LSTKAKAVAA----GNADHNNYLEFDFF 604
KA+ A + +NYLEFDFF
Sbjct: 580 PPVSGKAIMARPGPDSKSSDNYLEFDFF 607
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449443506|ref|XP_004139518.1| PREDICTED: protein kinase G11A-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 852 bits (2200), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 418/508 (82%), Positives = 454/508 (89%), Gaps = 10/508 (1%)
Query: 107 VSQTKGSLEDVGEQEKKPSEAGPA-----SAKVSDGTSSLPKTSGSAKISDRGDYVESGK 161
++ T+G ED + +KK SE G SAKVSDGT+S+ KTSGSAKISDR + VESGK
Sbjct: 100 LNGTQGLAEDSIDSKKKISECGSGKDSSVSAKVSDGTNSISKTSGSAKISDRIEMVESGK 159
Query: 162 SSMCRGSTSSDVSDESTCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKL 221
SSMCRGSTSSD+SDESTCSS SSS++KPHKAND +WEAIQAVR +DG+LG+GHFRLLK+L
Sbjct: 160 SSMCRGSTSSDISDESTCSSFSSSISKPHKANDLRWEAIQAVRARDGILGLGHFRLLKRL 219
Query: 222 GCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTH 281
GCGDIGSVYLSEL+GTKCYFAMKVMDK SL RKKLLRAQTEREILQSLDHPFLPTLYTH
Sbjct: 220 GCGDIGSVYLSELSGTKCYFAMKVMDKGSLASRKKLLRAQTEREILQSLDHPFLPTLYTH 279
Query: 282 FETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDL 341
FETDKFSCLVMEFCPGGDLHTLRQRQPGK+F+EQAVKFYVAEVLLALEYLHMLGIVYRDL
Sbjct: 280 FETDKFSCLVMEFCPGGDLHTLRQRQPGKHFTEQAVKFYVAEVLLALEYLHMLGIVYRDL 339
Query: 342 KPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQ 401
KPENVLVREDGHIMLSDFDLSLRCAVSPT+VK S ESEPLRKN YCVQPACIEPSCIQ
Sbjct: 340 KPENVLVREDGHIMLSDFDLSLRCAVSPTLVKGSCSESEPLRKNSTYCVQPACIEPSCIQ 399
Query: 402 PSCIAPTTCFSPRFF-SKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAP 460
PSC+ PTTCF+PR F SKSKK +KPK E+GNQV+PLPELIAEPT ARSMSFVGTHEYLAP
Sbjct: 400 PSCVVPTTCFTPRLFSSKSKKDRKPKTEIGNQVTPLPELIAEPTEARSMSFVGTHEYLAP 459
Query: 461 EIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSA 520
EIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS NRATL+NVVGQPLRFPESPVVSF+A
Sbjct: 460 EIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAA 519
Query: 521 RDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPKPVEIVHSPAPA 580
RDLI+GLLVKEPQ+RLA +RGATEIKQHPFF+GVNWALIRCASPPE+PKPVEI P+PA
Sbjct: 520 RDLIRGLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALIRCASPPEVPKPVEIERIPSPA 579
Query: 581 LSTKAKAVAA----GNADHNNYLEFDFF 604
KA+ A + +NYLEFDFF
Sbjct: 580 PPVSGKAIMARPGPDSKSSDNYLEFDFF 607
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357448091|ref|XP_003594321.1| Protein kinase [Medicago truncatula] gi|355483369|gb|AES64572.1| Protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 851 bits (2199), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 442/618 (71%), Positives = 495/618 (80%), Gaps = 28/618 (4%)
Query: 1 MASKLGMRSSPEKQRKPIGSQPSEGNFGRPSPLQNTKTSKSDPFTPRKIPRSAQQIASKQ 60
M SK RS ++ +K G Q E + S L KT KS+P + +S Q + +
Sbjct: 1 MDSKSSARSLSKQHQKTSGIQTPEAKDLKFSSLSLQKTGKSEP---EDLSKSVQNTSKQN 57
Query: 61 DSIATPTVEKSLNSSKEESLNSLADKVGSSLTLGDLKQVPTSVGTEVSQTKGSLEDVGEQ 120
+ + + S K S +SL+ K GS + +SV V+ GS E +Q
Sbjct: 58 IGEIYESKKFGVPSQKGSSADSLSSKFGSGAS--------SSV---VNVNTGSQESSIDQ 106
Query: 121 EKKPSEAGPA-----SAKVSDGTSSLPKTSGSAKISDRGDYVESGKSSMCRGSTSSDVSD 175
+KK SE G SAK SDG SS+ KTSGSAKISDR D+VESGKSS+CRGSTSSDVSD
Sbjct: 107 DKKTSEYGSVKNSSVSAKASDGASSIAKTSGSAKISDRADFVESGKSSICRGSTSSDVSD 166
Query: 176 ESTCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELT 235
ESTCSS SSSVNKPHKAND +WEAIQ VR +DG LG+GHFRLLK+LGCGDIGSVYLSEL+
Sbjct: 167 ESTCSSFSSSVNKPHKANDMRWEAIQVVRTRDGALGLGHFRLLKRLGCGDIGSVYLSELS 226
Query: 236 GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFC 295
GTKCYFAMKVMDK SL RKKLLRAQTEREILQSLDHPFLPTLYTHFET+KFSCLVMEFC
Sbjct: 227 GTKCYFAMKVMDKGSLASRKKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFC 286
Query: 296 PGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIM 355
PGGDLHTLRQ+QPGK+F EQAVKFYVAEVLLA+EYLHMLGIVYRDLKPENVLVR+DGHIM
Sbjct: 287 PGGDLHTLRQKQPGKHFPEQAVKFYVAEVLLAMEYLHMLGIVYRDLKPENVLVRDDGHIM 346
Query: 356 LSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIE-PSCIQPSCIAPTTCFSPR 414
LSDFDLSLRCAVSPT+VKSS+++SEPLRKN YC QPACIE PSCIQPSC+APT+CFSPR
Sbjct: 347 LSDFDLSLRCAVSPTLVKSSSIDSEPLRKNTGYCAQPACIEPPSCIQPSCVAPTSCFSPR 406
Query: 415 FF-SKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVD 473
F SKSKK +K K E+GNQVSPLPELIAEPT+ARSMSFVGTHEYLAPEIIKGEGHGSAVD
Sbjct: 407 LFSSKSKKERKAKTELGNQVSPLPELIAEPTDARSMSFVGTHEYLAPEIIKGEGHGSAVD 466
Query: 474 WWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQ 533
WWT+GIFLYELLFGKTPFKGS NRATL+NVVGQPLRFPE+PVVSF+ARDLI+GLLVKEPQ
Sbjct: 467 WWTYGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPEAPVVSFAARDLIRGLLVKEPQ 526
Query: 534 NRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPKPVEIVHSPAPALSTKA-KAV---- 588
+RLA +RGATEIKQHPFF+GVNWALIRCA+PPEIPK VE P+PA S+ KAV
Sbjct: 527 HRLAYKRGATEIKQHPFFEGVNWALIRCATPPEIPKAVEFEKIPSPAASSAGEKAVVNHM 586
Query: 589 --AAGNADHNNYLEFDFF 604
A +NYLEFDFF
Sbjct: 587 STAPNQKGSDNYLEFDFF 604
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 604 | ||||||
| TAIR|locus:2160922 | 586 | D6PKL2 "D6 protein kinase like | 0.951 | 0.981 | 0.678 | 2e-207 | |
| TAIR|locus:2133837 | 506 | D6PKL1 "D6 protein kinase like | 0.771 | 0.920 | 0.738 | 9.1e-191 | |
| TAIR|locus:2178388 | 498 | D6PK "D6 protein kinase" [Arab | 0.807 | 0.979 | 0.702 | 2.8e-185 | |
| UNIPROTKB|Q5I6E9 | 700 | Adi3 "AvrPto-dependent Pto-int | 0.769 | 0.664 | 0.666 | 1.3e-173 | |
| TAIR|locus:2055017 | 765 | AT2G44830 [Arabidopsis thalian | 0.817 | 0.645 | 0.603 | 2.2e-160 | |
| TAIR|locus:2091443 | 578 | ATPK7 [Arabidopsis thaliana (t | 0.826 | 0.863 | 0.611 | 4.9e-156 | |
| TAIR|locus:2174885 | 499 | AT5G40030 [Arabidopsis thalian | 0.801 | 0.969 | 0.586 | 1.9e-147 | |
| TAIR|locus:2207470 | 555 | AGC1.7 "AGC kinase 1.7" [Arabi | 0.773 | 0.841 | 0.584 | 1.8e-144 | |
| TAIR|locus:2049485 | 949 | AT2G36350 [Arabidopsis thalian | 0.806 | 0.513 | 0.545 | 1.5e-138 | |
| TAIR|locus:2085191 | 934 | KIPK "KCBP-interacting protein | 0.665 | 0.430 | 0.625 | 1.3e-137 |
| TAIR|locus:2160922 D6PKL2 "D6 protein kinase like 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 2006 (711.2 bits), Expect = 2.0e-207, P = 2.0e-207
Identities = 405/597 (67%), Positives = 458/597 (76%)
Query: 15 RKPIGSQPSEGNFGRPSPLQNTKTSKSDPFTPRKIPRSAQQIASKQDSIATPTVXXXXXX 74
RKP G R S +TK++K++ F P ++ RS + ++ P
Sbjct: 5 RKPSGHGAEVEAQKRSSSNSSTKSAKAETFEPMQLQRSV----TNPRAVGIPESKRLPES 60
Query: 75 XXXXXXXXXADKVGSSLTLGDLKQVPTSVGTEVSQTKGSLEDVGEQEKKPSEAGPASAKV 134
K S +L + + S+ + +T G G K S A SAK+
Sbjct: 61 FRKRSSDPAVCKPDFS-SLSTVLEHVDSLTIDEKKTSG----FGSV--KTSSA---SAKL 110
Query: 135 SDGTSSLPKTSGSAKISDRGDYVESGKSSMCRGXXXXXXXXXXXXXXXXXXXNKPHKAND 194
SDGTSSL KTSGSAK+S R D++ESGKSS+CRG NKPHKAND
Sbjct: 111 SDGTSSLGKTSGSAKLSGRLDFMESGKSSICRGSTSSDVSDESSCSSFSSTVNKPHKAND 170
Query: 195 AQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKR 254
+WEAIQAVRV+DG+LG+ HFRLLK+LGCGDIGSVYLSEL+GTKCYFAMKVMDK SL R
Sbjct: 171 LRWEAIQAVRVRDGLLGLSHFRLLKRLGCGDIGSVYLSELSGTKCYFAMKVMDKTSLASR 230
Query: 255 KKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSE 314
KKLLRAQTEREILQSLDHPFLPTLYTHFET+KFSCLVMEFCPGGDLHTLRQRQPGK+FSE
Sbjct: 231 KKLLRAQTEREILQSLDHPFLPTLYTHFETEKFSCLVMEFCPGGDLHTLRQRQPGKHFSE 290
Query: 315 QAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKS 374
QAVKFY+AE LLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC VSPT+VKS
Sbjct: 291 QAVKFYIAESLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCLVSPTLVKS 350
Query: 375 STLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFS-KSKKAQKPKNEMGNQV 433
+ +ES+PLRKN VYCVQPACIEPSCIQPSC PTTCFSPR FS KSKK +KPKN+ NQV
Sbjct: 351 AAIESDPLRKN-VYCVQPACIEPSCIQPSCTVPTTCFSPRLFSSKSKKDRKPKNDTANQV 409
Query: 434 SPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKG 493
PLPEL+AEPT+ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFG+TPFKG
Sbjct: 410 RPLPELVAEPTDARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGRTPFKG 469
Query: 494 SENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
S NR TL+NVVGQPLRFPE+PVVSF+ARDLI+GLL+KEPQ RL +RGATE+KQHPFF+G
Sbjct: 470 SGNRQTLFNVVGQPLRFPETPVVSFAARDLIRGLLMKEPQQRLGFKRGATEVKQHPFFEG 529
Query: 554 VNWALIRCASPPEIPKPVEIVHSPAP-ALSTKAKAVAAG---NADH--NNYLEFDFF 604
VNWALIRCA+PPEIPKPVE+ A + ++ AAG NA +NYLEFDFF
Sbjct: 530 VNWALIRCATPPEIPKPVELEKGAVSVAEAPSSQKTAAGLVLNAQKGSDNYLEFDFF 586
|
|
| TAIR|locus:2133837 D6PKL1 "D6 protein kinase like 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1827 (648.2 bits), Expect = 9.1e-191, Sum P(2) = 9.1e-191
Identities = 355/481 (73%), Positives = 398/481 (82%)
Query: 127 AGPASAKVSDGTSSLPKTSGSAKISDRGDYVESGKSSMCRGXXXXXXXXXXXXXXXXXXX 186
A S+ +S SS KT G K +++ D +SGKS+ CR
Sbjct: 38 ADQVSSTLSFAPSSDSKTGGEVKFNEKSD--QSGKSNTCRPSTSSDISDESTCSSFSGN- 94
Query: 187 NKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVM 246
NKPHKAND +WEAIQAVR K GVLG+ HFRLLK+LGCGDIG+V+L+EL GT+C+FAMKVM
Sbjct: 95 NKPHKANDVRWEAIQAVRTKHGVLGLNHFRLLKRLGCGDIGTVHLAELHGTRCFFAMKVM 154
Query: 247 DKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQR 306
DK +L RKKLLRAQTEREILQ LDHPFLPTLY+HFET+KFSCLVMEFCPGGDLHTLRQR
Sbjct: 155 DKGALASRKKLLRAQTEREILQCLDHPFLPTLYSHFETEKFSCLVMEFCPGGDLHTLRQR 214
Query: 307 QPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366
QPGK FSEQA KFYVAEVLLA+EYLHMLGI+YRDLKPENVLVR+DGH+MLSDFDLSLRC
Sbjct: 215 QPGKRFSEQAAKFYVAEVLLAMEYLHMLGIIYRDLKPENVLVRDDGHVMLSDFDLSLRCT 274
Query: 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCI-APTTCFSPRFFS-KSKKAQK 424
VSPTVV+S+ L SE +KN YC QPACI+ QPSCI APTTCFSPR+FS KSKK +K
Sbjct: 275 VSPTVVRSTVLASEG-QKNSGYCAQPACIQ----QPSCISAPTTCFSPRYFSSKSKKDKK 329
Query: 425 PKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYEL 484
KNE GNQVSPLPEL+AEPT+ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYEL
Sbjct: 330 MKNETGNQVSPLPELVAEPTSARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYEL 389
Query: 485 LFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATE 544
LFGKTPFKGS NRATL+NVVGQPLRFPESPVVSF+ARDLI+ LLVKEPQ+RLA +RGATE
Sbjct: 390 LFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAARDLIRSLLVKEPQHRLAYKRGATE 449
Query: 545 IKQHPFFQGVNWALIRCASPPEIPKPVEIVHSPA-PALSTKAKAVAAGNADHNNYLEFDF 603
+KQHPFF+GVNWAL+RCASPPEIPKPV+ +PA PA +T +D +NYLEFDF
Sbjct: 450 MKQHPFFEGVNWALVRCASPPEIPKPVDYESAPATPAAATSTSV----KSDQSNYLEFDF 505
Query: 604 F 604
F
Sbjct: 506 F 506
|
|
| TAIR|locus:2178388 D6PK "D6 protein kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1797 (637.6 bits), Expect = 2.8e-185, P = 2.8e-185
Identities = 354/504 (70%), Positives = 407/504 (80%)
Query: 108 SQT-KGSLEDVGEQEKKPSEAGPASAKVSDGTSSLPKTSGSAKISDRGDYVESGKSSMCR 166
S+T +GSL + + + A S+ +S S +G++KI+++G ESGKSS CR
Sbjct: 4 SKTPEGSLTNSSQSMSINTLADQVSSSLSFADPSSDGKTGNSKINEQG---ESGKSSTCR 60
Query: 167 GXXXXXXXXXXXXXXXXXXXNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDI 226
NKPHKAND +WEAIQAVR K G LG+ HFRLLK+LGCGDI
Sbjct: 61 PSTSSDISDESTCSSFSSSINKPHKANDVRWEAIQAVRTKHGGLGLNHFRLLKRLGCGDI 120
Query: 227 GSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286
G+V+L+EL GT+CYFAMKVMDK +L RKKLLRAQTEREILQ LDHPFLPTLY+HFET+K
Sbjct: 121 GTVHLAELNGTRCYFAMKVMDKTALASRKKLLRAQTEREILQCLDHPFLPTLYSHFETEK 180
Query: 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENV 346
FSCLVMEFCPGGDLHTLRQRQPGK F+EQA KFYVAEVLLA+EYLHMLGI+YRDLKPENV
Sbjct: 181 FSCLVMEFCPGGDLHTLRQRQPGKRFTEQAAKFYVAEVLLAMEYLHMLGIIYRDLKPENV 240
Query: 347 LVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQ-PACIEPSCIQPSCI 405
LVR+DGH+MLSDFDLSLRC VS ++V+S+ + SE L KN V C Q PACI+ QPSCI
Sbjct: 241 LVRDDGHVMLSDFDLSLRCTVSLSIVRSANVGSEGLSKNSVSCSQQPACIQ----QPSCI 296
Query: 406 --APTTCFSPRFFS-KSKKAQKPKNEMGN-QVSPLPELIAEPTNARSMSFVGTHEYLAPE 461
APT+CF PRFFS KSKK +KPK E GN QV+PLPEL+AEPT ARSMSFVGTHEYLAPE
Sbjct: 297 SMAPTSCFGPRFFSSKSKKDKKPKTENGNHQVTPLPELVAEPTGARSMSFVGTHEYLAPE 356
Query: 462 IIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSAR 521
IIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS NRATL+NVVGQPLRFPESPVVSF+AR
Sbjct: 357 IIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSGNRATLFNVVGQPLRFPESPVVSFAAR 416
Query: 522 DLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPKPVEI-VHSPAPA 580
DLI+ LLVKEPQ+RLA +RGATEIKQHPFF+GVNWAL+RCASPPEIPKPV++ +P P
Sbjct: 417 DLIRSLLVKEPQHRLAYKRGATEIKQHPFFEGVNWALVRCASPPEIPKPVDLEALNPTPT 476
Query: 581 LSTKAKAVAAGNADHNNYLEFDFF 604
+ A A ++ +D +NYLEFDFF
Sbjct: 477 VP--AAASSSVRSDQSNYLEFDFF 498
|
|
| UNIPROTKB|Q5I6E9 Adi3 "AvrPto-dependent Pto-interacting protein 3" [Solanum lycopersicum (taxid:4081)] | Back alignment and assigned GO terms |
|---|
Score = 1687 (598.9 bits), Expect = 1.3e-173, P = 1.3e-173
Identities = 320/480 (66%), Positives = 380/480 (79%)
Query: 134 VSDGTSSLPKTSGSAKISDRGDYVESGKSSMCRGXXXXXXXXXXXXXXXXXXXNKPHKAN 193
+SDG S+ + S K S RGD +ESGK+S+ R NKPHK N
Sbjct: 227 MSDGMLSVDRNYESTKGSIRGDSLESGKTSLSRASDSSGLSDDSNWSNITGSANKPHKGN 286
Query: 194 DAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEK 253
D +W+AI A+R +DG+LG+ HF+LLK+LGCGDIGSVYLSEL+GT+CYFAMKVMDKASL
Sbjct: 287 DPRWKAILAIRARDGILGMSHFKLLKRLGCGDIGSVYLSELSGTRCYFAMKVMDKASLAS 346
Query: 254 RKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFS 313
RKKL RAQTEREILQ LDHPFLPTLYTHFETD+FSCLVME+CPGGDLHTLRQRQPGK+FS
Sbjct: 347 RKKLTRAQTEREILQLLDHPFLPTLYTHFETDRFSCLVMEYCPGGDLHTLRQRQPGKHFS 406
Query: 314 EQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373
E A +FY AEVLLALEYLHMLG+VYRDLKPENVLVR+DGHIMLSDFDLSLRCAVSPT+++
Sbjct: 407 EYAARFYAAEVLLALEYLHMLGVVYRDLKPENVLVRDDGHIMLSDFDLSLRCAVSPTLIR 466
Query: 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFF-SKSKK-AQKPKNEMGN 431
S+ +P ++ +CVQPACIEP+ + C+ P CF PR F KSKK KP+ + G
Sbjct: 467 ISS--DDPSKRGAAFCVQPACIEPTTV---CMQPA-CFLPRLFPQKSKKKTPKPRADSGF 520
Query: 432 QVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPF 491
Q + +PEL+AEPT+ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFL+ELL+GKTPF
Sbjct: 521 QANSMPELVAEPTSARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLHELLYGKTPF 580
Query: 492 KGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551
KGS NRATL+NVVGQ L+FP+SP S+++RDLI+GLLVKEPQNRL +RGATEIKQHPFF
Sbjct: 581 KGSGNRATLFNVVGQQLKFPDSPATSYASRDLIRGLLVKEPQNRLGVKRGATEIKQHPFF 640
Query: 552 QGVNWALIRCASPPEIPKPVEIVH-------SPAPALSTKAKAVAAGNADHNNYLEFDFF 604
+GVNWALIRC++PPE+P+PVE + +P +T + V A YL+F+FF
Sbjct: 641 EGVNWALIRCSTPPEVPRPVEPDYPAKYGQVNPVGVGNTSKRVVGADAKSGGKYLDFEFF 700
|
|
| TAIR|locus:2055017 AT2G44830 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1562 (554.9 bits), Expect = 2.2e-160, P = 2.2e-160
Identities = 315/522 (60%), Positives = 382/522 (73%)
Query: 105 TEVSQTKGSLEDVGEQEKKP---SEAGPASAKVSDGTSSLPKTSGSAKISDRGDYVESGK 161
T VS S+E + S + ++ + SD S+ K IS D ES K
Sbjct: 250 TNVSPHSSSVESMNLARAMSIANSSSATSTTQRSDVVLSMDKNYFDRSISMVLDSFESTK 309
Query: 162 SSMCRGXXXXXXXXXXXXXXXXXXXNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKL 221
+S R NKPHK ND W AI A+R +DG+LG+ HF+LLK+L
Sbjct: 310 TSASRASDSSGLSEESSWSNFTGSLNKPHKGNDPWWNAILAIRTRDGILGMSHFKLLKRL 369
Query: 222 GCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTH 281
GCGDIGSVYL+EL+GT+C+FA+KVMDKASLE RKKL RAQTER+ILQ LDHPFLPTLYTH
Sbjct: 370 GCGDIGSVYLAELSGTRCHFAVKVMDKASLEDRKKLNRAQTERDILQLLDHPFLPTLYTH 429
Query: 282 FETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDL 341
FETD+FSCLVME+CPGGDLHTLRQRQPGK+FSE A +FY AEVLLALEYLHMLG+VYRDL
Sbjct: 430 FETDRFSCLVMEYCPGGDLHTLRQRQPGKHFSEYAARFYAAEVLLALEYLHMLGVVYRDL 489
Query: 342 KPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPS--C 399
KPENVLVR+DGHIMLSDFDLSLRCAVSPT++K T +S+P R+ +CVQPAC+EP+ C
Sbjct: 490 KPENVLVRDDGHIMLSDFDLSLRCAVSPTLIK--TFDSDPSRRG-AFCVQPACMEPTSAC 546
Query: 400 I-QPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVS-PLPELIAEPTNARSMSFVGTHEY 457
I QPSC P + F + +K K++K + + S LPEL+AEP N RSMSFVGTHEY
Sbjct: 547 IIQPSCFLPRSIFPNK--NKKNKSRKTQADFFKSHSGSLPELVAEP-NTRSMSFVGTHEY 603
Query: 458 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVS 517
LAPEIIKGEGHGSAVDWWTFGIF++ELL+GKTPFKGS NRATL+NVVG+ L+FPESP S
Sbjct: 604 LAPEIIKGEGHGSAVDWWTFGIFVHELLYGKTPFKGSGNRATLFNVVGEQLKFPESPATS 663
Query: 518 FSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPKPVEIVHSP 577
++ RDLI+ LLVK+P+NRL +RGATEIKQHPFF+GVNWALIRC++PPE+P+ +E P
Sbjct: 664 YAGRDLIQALLVKDPKNRLGTKRGATEIKQHPFFEGVNWALIRCSTPPEVPRQMETEPPP 723
Query: 578 --AP----ALSTKAK------AVAAGNADHNN---YLEFDFF 604
P + +K AV+A AD + +L+F+FF
Sbjct: 724 KYGPIDPVGFGSNSKRMMGPPAVSAAAADTKSGGKFLDFEFF 765
|
|
| TAIR|locus:2091443 ATPK7 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1521 (540.5 bits), Expect = 4.9e-156, P = 4.9e-156
Identities = 319/522 (61%), Positives = 374/522 (71%)
Query: 101 TSVGTEVSQTKGSLEDVGEQEKKPSEAGPASAKVSDGTSSLPKTSGS--AKISDRG-DYV 157
+SV E S+T S+ +Q + + P + ++ S T S A IS G +
Sbjct: 62 SSVSAE-SETPISIIRKKKQSEPRFYSSPTNTFYTEAKQSFTNTEFSECASISTIGIGGI 120
Query: 158 ESGKSSMC--RGXXXXXXXXXXXXXXXXXXXNKPHKAN-DAQWEAIQAVRVKDGV-LGVG 213
+ K+ + RG KPH+ N D +W AIQ VR + G L
Sbjct: 121 DLEKNGVMIYRGSIGSDVSDESSSSGLSNAAYKPHRDNNDKRWVAIQEVRSRVGSSLEAK 180
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
F+L+KKLG GDIG+VYL+EL GT FA+KVM+KA++ RKKL+RAQTE+EILQSLDHP
Sbjct: 181 DFKLIKKLGGGDIGNVYLAELIGTGVSFAVKVMEKAAIAARKKLVRAQTEKEILQSLDHP 240
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
FLPTLY+HFET+ SCLVMEFCPGGDLH+LRQ+Q GKYF EQA +FYVAEVLLA+EYLHM
Sbjct: 241 FLPTLYSHFETEMNSCLVMEFCPGGDLHSLRQKQRGKYFPEQAARFYVAEVLLAMEYLHM 300
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPA 393
LGI+YRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT+V+ + + E K+ YC+QP
Sbjct: 301 LGIIYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTLVRFAAITLES--KSSSYCIQPT 358
Query: 394 CIEPS-CI-QPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451
C++ S CI QP CI P CF+PRF SK K +K N+M Q+ PLPELIAEPT+ARSMSF
Sbjct: 359 CVDQSSCIVQPDCIQPV-CFTPRFLSKGKHRKK-SNDMSRQIRPLPELIAEPTSARSMSF 416
Query: 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFP 511
VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFG TPF+G +NRATL+NVVGQPLRFP
Sbjct: 417 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGITPFRGGDNRATLFNVVGQPLRFP 476
Query: 512 ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIP--- 568
E P VSF+ARDLI+GLLVKEPQ+RLA RRGATEIKQHPFFQ VNWALIRC SPP+IP
Sbjct: 477 EHPNVSFAARDLIRGLLVKEPQHRLAYRRGATEIKQHPFFQSVNWALIRCTSPPQIPQPV 536
Query: 569 KPVEIVHSPAPALSTKAKAVAAGN---AD---HNNYLEFDFF 604
KP++ HS S V D NYLE DFF
Sbjct: 537 KPMDQAHSVRHGFSQGHGHVGYDKPPTVDVKPSGNYLEIDFF 578
|
|
| TAIR|locus:2174885 AT5G40030 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1440 (512.0 bits), Expect = 1.9e-147, P = 1.9e-147
Identities = 292/498 (58%), Positives = 354/498 (71%)
Query: 113 SLEDVGEQEKKPSEAGPASAKVSDGTSSLPKTSGSAKISDRGDYVESGK-SSMCRGXXXX 171
SL+D + A P S S TSS S + S SS
Sbjct: 10 SLQDCSSSNYNNANASPVSGSASFKTSSNGSEDVRLNNSISLSFCSSNSVSSEANLEKTQ 69
Query: 172 XXXXXXXXXXXXXXXNKPHKANDAQWEAIQAVRV-KDGVLGVGHFRLLKKLGCGDIGSVY 230
+KPHK ND +W+AIQ V+ K+ LG+GHFRLLKKLGCGDIGSVY
Sbjct: 70 SFDANEANFKRVFAPSKPHKGNDLRWDAIQNVKCSKNEDLGLGHFRLLKKLGCGDIGSVY 129
Query: 231 LSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290
L+EL C+FAMKVMDK L RKKL+RAQTEREIL LDHPFLPTLY+HFET+KFSCL
Sbjct: 130 LAELREMGCFFAMKVMDKGMLIGRKKLVRAQTEREILGLLDHPFLPTLYSHFETEKFSCL 189
Query: 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE 350
+MEFC GGDLH LRQ+QPGK+FSE A +FY +EVLLALEYLHM+G+VYRDLKPENV+VRE
Sbjct: 190 LMEFCSGGDLHILRQKQPGKHFSELAARFYASEVLLALEYLHMMGVVYRDLKPENVMVRE 249
Query: 351 DGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQP-SCIAPTT 409
DGHIMLSDFDLSL+ VSPT+++S+ S+P YC+QP CI+PSC P +CI P+
Sbjct: 250 DGHIMLSDFDLSLQSFVSPTLIQST---SQPSCHIASYCIQPPCIDPSCKLPVACIQPS- 305
Query: 410 CFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHG 469
CF PRF + K +K K E S LP LIAEPT ARSMSFVGTHEYLAPEII+G+GHG
Sbjct: 306 CFKPRFLNN--KPRKAKTEKAGSDS-LPMLIAEPTAARSMSFVGTHEYLAPEIIRGDGHG 362
Query: 470 SAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529
S+VDWWTFGIFLYELL GKTPFKG+ NR TL+NVVGQPL+FPE + SF+A+DLI+GLL
Sbjct: 363 SSVDWWTFGIFLYELLTGKTPFKGNGNRETLFNVVGQPLKFPEGSI-SFAAKDLIRGLLT 421
Query: 530 KEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPKPVEI-VHSPAPALSTKAKAV 588
K+P+ RL ++GATEIKQHPFF VNWALIR +PPEIPKP+++ + + S + +
Sbjct: 422 KDPKKRLGFKKGATEIKQHPFFNNVNWALIRSTTPPEIPKPIDLSILNETLKSSVQQQGK 481
Query: 589 AAGNADHNN--YLEFDFF 604
+ +D ++ YL+F+FF
Sbjct: 482 HSKQSDSSSGPYLDFEFF 499
|
|
| TAIR|locus:2207470 AGC1.7 "AGC kinase 1.7" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1382 (491.5 bits), Expect = 1.8e-144, Sum P(2) = 1.8e-144
Identities = 280/479 (58%), Positives = 341/479 (71%)
Query: 123 KPSEAGPASAKVSDGTSSLPKTSGSAKISDRGDYVESGKSSMCRGXXXXXXXXXXXXXXX 182
KP AG + + + +P + GS +++ + + ++
Sbjct: 55 KPEPAGFTNHHRPNPSPKIPSSPGS-NMTESQSNLNTKPNNNNSNNNSNMSSRSNSIEST 113
Query: 183 XXXXNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFA 242
+KPH D +W+A+ + K LG+ FRLLK+LG GDIGSVYL EL GT YFA
Sbjct: 114 SSNPSKPHTGGDIRWDAVNTLTSKGVQLGISDFRLLKRLGYGDIGSVYLVELRGTITYFA 173
Query: 243 MKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT 302
MKVMDKASL R KLLRAQTEREIL LDHPFLPTLY+HFETDKF CLVMEFC GG+L++
Sbjct: 174 MKVMDKASLASRNKLLRAQTEREILSQLDHPFLPTLYSHFETDKFYCLVMEFCGGGNLYS 233
Query: 303 LRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
LRQ+QP K F+E A +F+ +EVLLALEYLHMLGIVYRDLKPENVLVR+DGHIMLSDFDLS
Sbjct: 234 LRQKQPNKCFTEDAARFFASEVLLALEYLHMLGIVYRDLKPENVLVRDDGHIMLSDFDLS 293
Query: 363 LRCAVSPTVVKSSTLESE---PLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKS 419
LRC+VSPT+VKSS++ + PV + E + +Q CI P+T F PR S
Sbjct: 294 LRCSVSPTLVKSSSVHAAGGGSGSSRPVGLID----EDAAVQ-GCIQPSTFF-PRILQSS 347
Query: 420 KKAQKPKNEMGNQVS-PLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFG 478
KK +K K++ G V+ +PEL+AEPTN +SMSFVGTHEYLAPEII+GEGHGSAVDWWTFG
Sbjct: 348 KKNRKAKSDFGLFVNGSMPELMAEPTNVKSMSFVGTHEYLAPEIIRGEGHGSAVDWWTFG 407
Query: 479 IFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLAC 538
IF+YELL+G TPFKG NRATL+NV+GQ LRFPE P VS +ARDLIKGLLVKEPQ R+A
Sbjct: 408 IFIYELLYGATPFKGQGNRATLHNVIGQALRFPEVPHVSSAARDLIKGLLVKEPQKRIAY 467
Query: 539 RRGATEIKQHPFFQGVNWALIRCASPPEIPKPVEIVHSPAPALSTKAKAVAAGNADHNN 597
+RGATEIKQHPFF+GVNWALIR A+PP +P+PV+ + + A AV G +NN
Sbjct: 468 KRGATEIKQHPFFEGVNWALIRSATPPHVPEPVDFSCYASKDKESMA-AVDGGGKKNNN 525
|
|
| TAIR|locus:2049485 AT2G36350 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1356 (482.4 bits), Expect = 1.5e-138, P = 1.5e-138
Identities = 280/513 (54%), Positives = 352/513 (68%)
Query: 101 TSVGTEVSQTKGSLEDVGEQEKKPSEAGPASAKVSDGTSSLPKTSGSAKISDRGDYVESG 160
+S EVS + G V +QE PS S K D + S S++ D+ S
Sbjct: 454 SSDSCEVSDS-GEAVIVMKQEVSPSNY---SGK-GDADEQIRANPTS---SEKFDFSLSS 505
Query: 161 KSSMCRGXXXXXXXXXXXXXXXXXXXNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKK 220
K+S+ NKPH + D +WEA++ V+++ G LG+ HF LLKK
Sbjct: 506 KNSL-GDYSSSTSMSEESNLSRFSCGNKPHMSMDVRWEAVKHVKLQYGSLGLRHFNLLKK 564
Query: 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYT 280
LGCGDIG+VYL+EL GT C FA+KVMD L +RKK RAQ ER IL+ LDHPFLPTLY
Sbjct: 565 LGCGDIGTVYLAELVGTNCLFAIKVMDNEFLARRKKTPRAQAERAILKMLDHPFLPTLYA 624
Query: 281 HFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRD 340
F +D SCLVME+CPGGDLH LRQ+Q + FSE A +FYVAE+LLALEYLHMLG++YRD
Sbjct: 625 QFTSDNLSCLVMEYCPGGDLHVLRQKQLSRCFSEPATRFYVAEILLALEYLHMLGVIYRD 684
Query: 341 LKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKS-STLESEPLRKNPVYCVQPACIEPSC 399
LKPEN+LVREDGHIML+DFDLSLRCAV+PT+++S S E +P R + Y CI+P C
Sbjct: 685 LKPENILVREDGHIMLTDFDLSLRCAVNPTLLRSTSPPEKDPARMSGPYSTSN-CIQPLC 743
Query: 400 IQPSCIAPTTCFSPRFFS---KSKKAQKPKNE--MGNQVSPLPELIAEPTNARSMSFVGT 454
I+PSC P CFSPR S +++K +KPK + Q LP+L+AEPT ARS SFVGT
Sbjct: 744 IEPSCRVP--CFSPRLLSTQARNQKPRKPKRPDLLTQQFRSLPQLVAEPTEARSNSFVGT 801
Query: 455 HEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESP 514
HEYLAPEIIKGEGHG+AVDWWTFG+ LYELL+GKTPFKG +N TL NVV Q L+FP+SP
Sbjct: 802 HEYLAPEIIKGEGHGAAVDWWTFGVLLYELLYGKTPFKGYDNEETLSNVVYQNLKFPDSP 861
Query: 515 VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPKPVE-- 572
+VSF A++LI+ LLVK+P++RL +GA EIK+HPFF+G+NWALIRCA PPE+P +
Sbjct: 862 LVSFQAKELIRRLLVKDPESRLGSEKGAAEIKRHPFFEGLNWALIRCAIPPELPDIYDNG 921
Query: 573 IVHSPAPALSTK-AKAVAAGNADHNNYLEFDFF 604
+ +P + + + A G DH LEF+ F
Sbjct: 922 ATEATSPEGNNRYLECKAIG--DH---LEFELF 949
|
|
| TAIR|locus:2085191 KIPK "KCBP-interacting protein kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1347 (479.2 bits), Expect = 1.3e-137, P = 1.3e-137
Identities = 265/424 (62%), Positives = 322/424 (75%)
Query: 187 NKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVM 246
NKPH + D +WEAI+ ++V+ G LG+ HF LLKKLGCGDIG+VYL+EL GT C FA+KVM
Sbjct: 510 NKPHMSMDVRWEAIKHIKVQYGSLGLRHFNLLKKLGCGDIGTVYLAELIGTNCLFAIKVM 569
Query: 247 DKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQR 306
D L +RKK RAQ EREIL+ LDHPFLPTLY F +D SCLVME+CPGGDLH LRQ+
Sbjct: 570 DNEFLARRKKSPRAQAEREILKMLDHPFLPTLYAQFTSDNLSCLVMEYCPGGDLHVLRQK 629
Query: 307 QPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366
Q G+ F E A +FYVAE+LLALEYLHMLGI+YRDLKPEN+LVREDGHIML+DFDLSLRCA
Sbjct: 630 QLGRCFPEPAARFYVAEILLALEYLHMLGIIYRDLKPENILVREDGHIMLTDFDLSLRCA 689
Query: 367 VSPTVVKSSTLES-EPLRKNPVYCVQPACIEPSCI-QPSCIAPTTCFSPRFFSKSKKAQK 424
V+PT+V+S++ +P R + Y CI+P CI +PSC +CFSPR S ++ +K
Sbjct: 690 VNPTLVRSNSPPGKDPARISGPYNTSN-CIQPFCITEPSC--QVSCFSPRLSSNQQQGRK 746
Query: 425 PKNEMGNQVSP--------LPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWT 476
PK G+ +S LP+L+AEPT ARS SFVGTHEYLAPEIIKGEGHG+AVDWWT
Sbjct: 747 PKR--GDHLSKTQQHLSRSLPQLVAEPTEARSNSFVGTHEYLAPEIIKGEGHGAAVDWWT 804
Query: 477 FGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRL 536
FG+ LYELL+GKTPFKG N TL NVV Q L+FP+SP+VSF A+DLI+GLLVKEP+NRL
Sbjct: 805 FGVLLYELLYGKTPFKGYNNDETLANVVLQNLKFPDSPLVSFQAKDLIRGLLVKEPENRL 864
Query: 537 ACRRGATEIKQHPFFQGVNWALIRCASPPEIPKPVEIVHSPAPALSTKAKAVAAGNADHN 596
+G+ EIK+HPFF+G+NWALIRCA PPE+P E P +A A + G ++ N
Sbjct: 865 GSEKGSVEIKRHPFFEGLNWALIRCAIPPELPDFYEYGGGP------EAAADSPGGSN-N 917
Query: 597 NYLE 600
YLE
Sbjct: 918 RYLE 921
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q0DCT8 | G11A_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.7555 | 0.8062 | 0.8268 | no | no |
| A2YBX5 | G11A_ORYSI | 2, ., 7, ., 1, 1, ., 1 | 0.7555 | 0.8062 | 0.8268 | N/A | no |
| P15792 | KPK1_PHAVU | 2, ., 7, ., 1, 1, ., 1 | 0.7440 | 0.7384 | 0.7323 | N/A | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.XVI.574.1 | hypothetical protein (493 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 604 | |||
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.0 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-76 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 5e-72 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 1e-62 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 3e-57 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-57 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 3e-55 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-49 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-47 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-45 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-44 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-43 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-43 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-41 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 2e-41 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 6e-41 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 8e-39 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 4e-38 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 5e-38 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-36 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-36 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 2e-35 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 5e-35 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 5e-35 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 8e-35 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-34 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-33 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-33 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 3e-33 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-33 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-33 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 4e-33 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-33 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-32 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-31 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-31 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-31 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-31 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 8e-31 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 8e-31 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-30 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-30 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-30 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-29 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-29 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 9e-29 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-28 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 4e-28 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-28 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 1e-27 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-27 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 1e-27 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 2e-27 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-27 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-27 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-27 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 5e-27 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 8e-27 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-26 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-26 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-26 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 4e-26 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-26 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-26 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-26 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 9e-26 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-25 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-25 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 2e-25 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-25 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-25 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-25 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-25 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-25 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 5e-25 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-25 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 8e-25 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 8e-25 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-25 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-24 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-24 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-24 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-24 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-24 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-24 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-24 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 4e-24 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-24 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 8e-24 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 9e-24 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-23 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-23 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-23 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-23 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-23 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-23 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-23 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 9e-23 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-22 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-22 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-22 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-22 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-22 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-22 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 6e-22 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-21 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-21 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 2e-21 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-21 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-21 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-21 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-21 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 5e-21 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 6e-21 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 6e-21 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 7e-21 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-21 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-21 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-20 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-20 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-20 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-20 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-20 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-20 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-20 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 5e-20 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-19 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-19 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-19 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-19 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-19 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-19 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 4e-19 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 4e-19 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 4e-19 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 5e-19 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 6e-19 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-19 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-18 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-18 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-18 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-18 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 4e-18 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-18 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-18 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-17 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-17 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-17 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-17 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-17 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-16 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 1e-16 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 1e-16 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 2e-16 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-16 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 8e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-16 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-16 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-15 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-15 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 3e-15 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-15 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-15 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 7e-15 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 7e-15 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-15 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-14 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-14 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 6e-14 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-13 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 3e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-13 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 7e-13 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 9e-13 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 9e-13 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-12 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-12 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-12 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 3e-12 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 3e-12 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-12 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-12 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 7e-12 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 7e-12 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-11 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-11 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-11 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 2e-11 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-11 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-11 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-11 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 4e-11 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-11 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-11 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 6e-11 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 7e-11 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 8e-11 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-10 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-10 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-10 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-10 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 2e-10 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-10 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 4e-10 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-10 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-10 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 5e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-10 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-10 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-10 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-10 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 9e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-10 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-09 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 1e-09 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-09 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-09 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-09 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-09 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-09 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-09 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-09 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-09 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 3e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 3e-09 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-09 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-09 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 5e-09 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-09 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 5e-09 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 5e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-09 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 7e-09 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 8e-09 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-09 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 9e-09 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-08 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 1e-08 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-08 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-08 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 1e-08 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-08 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-08 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-08 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-08 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-08 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-08 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 3e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 3e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-08 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-08 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-08 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-08 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 4e-08 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-08 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-08 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-08 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 5e-08 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-08 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-08 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-08 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 8e-08 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 9e-08 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-07 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-07 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 1e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 2e-07 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-07 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-07 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-07 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-07 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-07 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-07 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 4e-07 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-07 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-07 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-07 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-07 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-07 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-07 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 5e-07 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 5e-07 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 5e-07 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 5e-07 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 6e-07 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-07 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-07 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 8e-07 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-06 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-06 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-06 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-06 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-06 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-06 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-06 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-06 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 3e-06 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-06 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-06 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 5e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 6e-06 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 8e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-06 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 8e-06 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 8e-06 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 8e-06 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-06 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 9e-06 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-05 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 1e-05 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-05 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 1e-05 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-05 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 1e-05 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-05 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-05 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-05 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-05 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 2e-05 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 2e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-05 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-05 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-05 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-05 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-05 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-05 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-05 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-05 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 3e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-05 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-05 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 4e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 4e-05 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 4e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 4e-05 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-05 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-05 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-05 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 5e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 6e-05 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 6e-05 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 7e-05 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 7e-05 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 8e-05 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 8e-05 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 8e-05 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 8e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-04 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-04 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-04 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-04 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-04 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-04 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 2e-04 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 2e-04 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 2e-04 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-04 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-04 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-04 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-04 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 3e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-04 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 3e-04 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 4e-04 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 4e-04 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 4e-04 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-04 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-04 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 5e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 5e-04 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 5e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 5e-04 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-04 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 6e-04 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-04 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 7e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 7e-04 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 7e-04 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 7e-04 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 8e-04 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 9e-04 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 0.001 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 0.001 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 0.001 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 0.001 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 0.001 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 0.001 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 0.001 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 0.001 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 0.002 | |
| COG0478 | 304 | COG0478, COG0478, RIO-like serine/threonine protei | 0.002 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 0.003 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 0.003 | |
| TIGR03724 | 199 | TIGR03724, arch_bud32, Kae1-associated kinase Bud3 | 0.003 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.003 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 0.004 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 0.004 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 0.004 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 0.004 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 0.004 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 0.004 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 0.004 | |
| pfam13885 | 45 | pfam13885, Keratin_B2_2, Keratin, high sulfur B2 p | 0.004 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.004 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.004 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 524 bits (1352), Expect = 0.0
Identities = 185/360 (51%), Positives = 229/360 (63%), Gaps = 47/360 (13%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
HF+ +K LG GD+G V+L L GT FA+KV+DK + KR K+ R TE+EIL +LDHP
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHP 61
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
FLPTLY F+T+ + CLVM++CPGG+L L QRQPGK SE+ +FY AEVLLALEYLH+
Sbjct: 62 FLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHL 121
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPA 393
LGIVYRDLKPEN+L+ E GHIMLSDFDLS + V P
Sbjct: 122 LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP----------------------- 158
Query: 394 CIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453
P + K +++ S E +E + RS SFVG
Sbjct: 159 -------------------PVSKALRKGSRRSSVN-----SIPSETFSEEPSFRSNSFVG 194
Query: 454 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPES 513
T EY+APE+I G+GHGSAVDWWT GI LYE+L+G TPFKGS T N++ + + FP S
Sbjct: 195 TEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGS 254
Query: 514 PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPKPVEI 573
P VS SARDLI+ LLVK+P RL +RGA EIKQHPFF+GVNWALIR +PP IP+P +
Sbjct: 255 PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRPDDG 314
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 245 bits (628), Expect = 4e-76
Identities = 118/361 (32%), Positives = 182/361 (50%), Gaps = 63/361 (17%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F ++K +G G G V+L T +AMKV+ K+ + KR ++ + ER+IL D P+
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ LY F+ ++ LVME+ PGGDL L R+ F E+ +FY+AE++LAL+ +H L
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL 120
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPAC 394
G ++RD+KP+N+L+ DGHI L+DF L +
Sbjct: 121 GFIHRDIKPDNILIDADGHIKLADFGLCKK------------------------------ 150
Query: 395 IEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEP----TNARSMS 450
+K+K + N+ N + L+ R+ S
Sbjct: 151 ---------------------MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANS 189
Query: 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG--QPL 508
VGT +Y+APE+++G +G DWW+ G+ LYE+L+G PF + T ++ + L
Sbjct: 190 TVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESL 249
Query: 509 RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIP 568
RFP P VS A DLI LL +P++RL EIK HPFF+G++W +R PP +P
Sbjct: 250 RFPPDPPVSPEAIDLICRLLC-DPEDRL---GSFEEIKSHPFFKGIDWENLRETKPPFVP 305
Query: 569 K 569
+
Sbjct: 306 E 306
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 232 bits (594), Expect = 5e-72
Identities = 106/342 (30%), Positives = 164/342 (47%), Gaps = 69/342 (20%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HP 273
F+ K +G G +V L++ T +A+K++DK L K KK+ + E+E+L L+ HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 274 FLPTLYTHFETDKFSCL--VMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALEY 330
+ LY F+ + L V+E+ P G+L +R+ E+ +FY AE+LLALEY
Sbjct: 63 GIIKLYYTFQDE--ENLYFVLEYAPNGELLQYIRKY---GSLDEKCTRFYAAEILLALEY 117
Query: 331 LHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCV 390
LH GI++RDLKPEN+L+ +D HI ++DF ++ +
Sbjct: 118 LHSKGIIHRDLKPENILLDKDMHIKITDFG-------------TAKVLD----------- 153
Query: 391 QPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450
S + + T S ++ + A S
Sbjct: 154 -----PNSSPESNKGDATNIDSQIEKNRRRFA---------------------------S 181
Query: 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRF 510
FVGT EY++PE++ + G + D W G +Y++L GK PF+GS T ++ F
Sbjct: 182 FVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241
Query: 511 PES-PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551
P + P A+DLI+ LLV +PQ+RL G E+K HPFF
Sbjct: 242 PPNFPPD---AKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 210 bits (537), Expect = 1e-62
Identities = 115/361 (31%), Positives = 181/361 (50%), Gaps = 52/361 (14%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F +K +G G G V L + T +AMK + K+ + +++++ + ER+IL D+P+
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ LY F+ + + L+ME+ PGGD+ TL ++ F+E+ +FY+AE +LA++ +H L
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKL 120
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSS--TLESEPLRKNPVYCVQP 392
G ++RD+KP+N+L+ GHI LSDF L T +K S T L
Sbjct: 121 GYIHRDIKPDNLLLDAKGHIKLSDFGLC-------TGLKKSHRTEFYRILSHA------- 166
Query: 393 ACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF- 451
P S +KA+ K N R++++
Sbjct: 167 ---------LPSNFLDFISKPM--SSKRKAETWKR-----------------NRRALAYS 198
Query: 452 -VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG--QPL 508
VGT +Y+APE+ G+ DWW+ G+ +YE+L G PF + T ++ + L
Sbjct: 199 TVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETL 258
Query: 509 RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIP 568
+FP+ +S A+DLIK L E + RL G EIK HPFF+GV+W IR P IP
Sbjct: 259 QFPDEVPLSPEAKDLIKRLCC-EAERRLG-NNGVNEIKSHPFFKGVDWEHIRERPAPIIP 316
Query: 569 K 569
+
Sbjct: 317 E 317
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 192 bits (491), Expect = 3e-57
Identities = 67/142 (47%), Positives = 94/142 (66%), Gaps = 2/142 (1%)
Query: 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYT 280
LG G G V L T +AMKV+ K + KRK++ TER IL ++HPF+ L+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 281 HFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRD 340
F+T++ LV+E+ PGG+L + ++ FSE+ +FY AE++LALEYLH LGI+YRD
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRD 118
Query: 341 LKPENVLVREDGHIMLSDFDLS 362
LKPEN+L+ DGHI L+DF L+
Sbjct: 119 LKPENILLDADGHIKLTDFGLA 140
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 196 bits (499), Expect = 5e-57
Identities = 114/375 (30%), Positives = 166/375 (44%), Gaps = 72/375 (19%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
F +K +G G G V L T +AMK + KA + R + + ER+IL D+
Sbjct: 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNE 61
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
++ LY F+ VM++ PGGD+ +L R F E +FY+AE+ A+E +H
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHK 119
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPA 393
+G ++RD+KP+N+L+ DGHI L+DF L
Sbjct: 120 MGFIHRDIKPDNILIDRDGHIKLTDFGL-------------------------------- 147
Query: 394 CIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR------ 447
C R+ SK QK + + + P E +E R
Sbjct: 148 ----------------CTGFRWTHDSKYYQKGDHHRQDSMEP-SEEWSEIDRCRLKPLER 190
Query: 448 ----------SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR 497
+ S VGT Y+APE++ G+ DWW+ G+ LYE+L G+ PF
Sbjct: 191 RRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPA 250
Query: 498 ATLYNVVG--QPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555
T V+ L P +S A DLI L ++RL + GA EIK HPFF+G++
Sbjct: 251 ETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLG-KNGADEIKAHPFFKGID 308
Query: 556 WA-LIRCASPPEIPK 569
+A LIR P IPK
Sbjct: 309 FASLIRRQKAPYIPK 323
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 187 bits (477), Expect = 3e-55
Identities = 66/148 (44%), Positives = 94/148 (63%), Gaps = 4/148 (2%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
+ +L+KLG G G VYL+ T A+KV+ K ++K ++ R E +IL+ L HP
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRE--RILREIKILKKLKHPN 58
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ LY FE + LVME+C GGDL L +++ SE +FY+ ++L ALEYLH
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKR--GRLSEDEARFYLRQILSALEYLHSK 116
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLS 362
GIV+RDLKPEN+L+ EDGH+ L+DF L+
Sbjct: 117 GIVHRDLKPENILLDEDGHVKLADFGLA 144
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 1e-49
Identities = 69/145 (47%), Positives = 94/145 (64%), Gaps = 2/145 (1%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F +K LG G G V L G+ Y+A+K++ KA + K K++ E+ ILQS+ HPF
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
L LY F+ D LVME+ PGG+L + R+ G+ F E +FY A+V+LALEYLH L
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSH-LRKSGR-FPEPVARFYAAQVVLALEYLHSL 120
Query: 335 GIVYRDLKPENVLVREDGHIMLSDF 359
IVYRDLKPEN+L+ DG+I ++DF
Sbjct: 121 DIVYRDLKPENLLLDSDGYIKITDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 169 bits (428), Expect = 4e-47
Identities = 112/358 (31%), Positives = 179/358 (50%), Gaps = 52/358 (14%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F LK +G G G V L + T +AMK++ KA + +++++ + ER+IL D +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ ++ F+ + L+MEF PGGD+ TL ++ SE+A +FY+AE +LA++ +H L
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQL 120
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPAC 394
G ++RD+KP+N+L+ GH+ LSDF L T +K + +N +
Sbjct: 121 GFIHRDIKPDNLLLDAKGHVKLSDFGLC-------TGLKKA--HRTEFYRNLTH------ 165
Query: 395 IEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF--V 452
P + FS + + +KA+ K N R +++ V
Sbjct: 166 -----------NPPSDFSFQNMNSKRKAETWKK-----------------NRRQLAYSTV 197
Query: 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG--QPLRF 510
GT +Y+APE+ G+ DWW+ G+ +YE+L G PF + T V+ + L F
Sbjct: 198 GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVF 257
Query: 511 PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIP 568
P +S A+DLI + +NR+ G EIK HPFF+GV+W IR P IP
Sbjct: 258 PPEVPISEKAKDLILRFCT-DSENRIG-SNGVEEIKSHPFFEGVDWGHIR-ERPAAIP 312
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 164 bits (416), Expect = 3e-45
Identities = 118/369 (31%), Positives = 180/369 (48%), Gaps = 47/369 (12%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F +K LG G G V L+ TK +AMK + K + R ++ + ER+IL D+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ LY F+ VM++ PGGD+ +L R F E +FY+AE+ A+E +H +
Sbjct: 63 VVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKM 120
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLES-EPLRKNPVYCVQPA 393
G ++RD+KP+N+L+ DGHI L+DF L C S +S + +R++ +
Sbjct: 121 GFIHRDIKPDNILIDRDGHIKLTDFGL---CTGFRWTHDSKYYQSGDHVRQDSM------ 171
Query: 394 CIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKN-EMGNQVSPLPELIAEPTNARSM--S 450
S + P N G+++ PL E A + R + S
Sbjct: 172 -----------------------DFSNEWGDPANCRCGDRLKPL-ERRAARQHQRCLAHS 207
Query: 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG--QPL 508
VGT Y+APE++ G+ DWW+ G+ LYE+L G+ PF T V+ L
Sbjct: 208 LVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSL 267
Query: 509 RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWAL-IRCASPPEI 567
P +S A DLI L + P++RL + GA EIK HPFF+ ++++ +R S P I
Sbjct: 268 HIPPQAKLSPEASDLIIK-LCRGPEDRLG-KNGADEIKAHPFFKTIDFSSDLRQQSAPYI 325
Query: 568 PKPVEIVHS 576
PK I H
Sbjct: 326 PK---ITHP 331
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 157 bits (400), Expect = 5e-44
Identities = 58/139 (41%), Positives = 88/139 (63%), Gaps = 2/139 (1%)
Query: 224 GDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFE 283
G G V+L++ T +A+KV+ KA + ++ ++ + TER+IL P++ LY F+
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 284 TDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKP 343
K LVME+ PGGDL +L G E + Y+AE++LALEYLH GI++RDLKP
Sbjct: 64 GKKNLYLVMEYLPGGDLASL-LENVG-SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKP 121
Query: 344 ENVLVREDGHIMLSDFDLS 362
+N+L+ +GH+ L+DF LS
Sbjct: 122 DNILIDSNGHLKLTDFGLS 140
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 1e-43
Identities = 117/408 (28%), Positives = 184/408 (45%), Gaps = 55/408 (13%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F +K LG G G V L+ T +AMK + K + R ++ + ER+IL D+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ LY F+ VM++ PGGD+ +L R + F E +FY+AE+ LA+E +H +
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKM 120
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPAC 394
G ++RD+KP+N+L+ DGHI L+DF L T + + N Y + +
Sbjct: 121 GFIHRDIKPDNILIDLDGHIKLTDFGLC-------TGFRWT--------HNSKYYQKGSH 165
Query: 395 IEPSCIQPS----CIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450
I ++PS ++ C R + ++A K + + S
Sbjct: 166 IRQDSMEPSDLWDDVSNCRC-GDRLKTLEQRATK-----------------QHQRCLAHS 207
Query: 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG--QPL 508
VGT Y+APE++ +G+ DWW+ G+ L+E+L G+ PF T V+ L
Sbjct: 208 LVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL 267
Query: 509 RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWAL-IRCASPPEI 567
P +S A DLI L + RL R GA +IK HPFF V+++ IR P +
Sbjct: 268 HIPPQVKLSPEAVDLI-TKLCCSAEERLG-RNGADDIKAHPFFSEVDFSSDIRTQPAPYV 325
Query: 568 PK-----------PVEIVHSPAPALSTKAKAVAAGNADHNNYLEFDFF 604
PK PVE A + + + + E F+
Sbjct: 326 PKISHPMDTSNFDPVEEESPWNDASGDSTRTWDTLCSPNGKHPEHAFY 373
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 2e-43
Identities = 64/160 (40%), Positives = 91/160 (56%), Gaps = 3/160 (1%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
+ LL+KLG G G+VY ++ GT A+K++ K EK KK A+ E IL+ L HP
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKK-RSEKSKKDQTARREIRILRRLSHPN 59
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ L FE LVME+C GGDL R G SE K ++L LEYLH
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSR--GGPLSEDEAKKIALQILRGLEYLHSN 117
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKS 374
GI++RDLKPEN+L+ E+G + ++DF L+ + S + + +
Sbjct: 118 GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT 157
|
Length = 260 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 152 bits (384), Expect = 2e-41
Identities = 105/340 (30%), Positives = 158/340 (46%), Gaps = 83/340 (24%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREIL-QSLDHPFLPT 277
K +G G G V L+ + ++A+KV+ K ++ K+K+ +ER +L +++ HPFL
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 278 LYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIV 337
L+ F+T V+++ GG+L QR+ + F E +FY AE+ AL YLH L IV
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIV 118
Query: 338 YRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEP 397
YRDLKPEN+L+ GHI+L+DF L C E
Sbjct: 119 YRDLKPENILLDSQGHIVLTDFGL--------------------------------CKEN 146
Query: 398 SCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEY 457
I+ + T C +P + + PE++ + R+
Sbjct: 147 --IEHNGTTSTFCGTPEYLA-------------------PEVLHKQPYDRT--------- 176
Query: 458 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY-NVVGQPLRFPESPVV 516
VDWW G LYE+L+G PF S N A +Y N++ +PL+ P +
Sbjct: 177 --------------VDWWCLGAVLYEMLYGLPPFY-SRNTAEMYDNILNKPLQL--KPNI 219
Query: 517 SFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNW 556
+ SAR L++GLL K+ RL + EIK H FF +NW
Sbjct: 220 TNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINW 259
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 149 bits (380), Expect = 2e-41
Identities = 86/343 (25%), Positives = 145/343 (42%), Gaps = 90/343 (26%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+ ++K++G G G VYL + +K +D +++ ++++ A E +IL+ L+HP
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKERE-DALNEVKILKKLNHP 59
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTL--RQRQPGKYFSEQAVKFYVAEVLLALEYL 331
+ Y FE C+VME+ GGDL +Q++ GK F E+ + + ++ LAL+YL
Sbjct: 60 NIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQ 391
H I++RD+KP+N+ + +G + L DF +S + V SST++
Sbjct: 120 HSRKILHRDIKPQNIFLTSNGLVKLGDFGIS-K-------VLSSTVDL------------ 159
Query: 392 PACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451
A T +P + S PEL
Sbjct: 160 --------------AKTVVGTPYYLS-------------------PELC----------- 175
Query: 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV-GQPLRF 510
+ + + D W+ G LYEL K PF+G ++ GQ
Sbjct: 176 ------------QNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI 223
Query: 511 PESPVVSFSA--RDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551
P +S+ R+L+ LL K+P+ R + +I Q PF
Sbjct: 224 PS----QYSSELRNLVSSLLQKDPEERPS----IAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 148 bits (377), Expect = 6e-41
Identities = 58/109 (53%), Positives = 74/109 (67%), Gaps = 5/109 (4%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN- 502
+R+ +F GT EYLAPE++ G+G+G AVDWW+ G+ LYE+L GK PF E+R +Y
Sbjct: 146 EGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYA-EDRKEIYEK 204
Query: 503 VVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551
++ PLRFPE +S ARDLI GLL K+P RL GA EIK HPFF
Sbjct: 205 ILKDPLRFPEF--LSPEARDLISGLLQKDPTKRLGS-GGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 8e-39
Identities = 57/143 (39%), Positives = 81/143 (56%), Gaps = 4/143 (2%)
Query: 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYT 280
LG G G+VYL+ T A+K++ K + E EIL+ L+HP + LY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLE--ELLREIEILKKLNHPNIVKLYG 58
Query: 281 HFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRD 340
FE + LVME+C GG L L + GK SE + + ++L LEYLH GI++RD
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGK-LSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 341 LKPENVLV-REDGHIMLSDFDLS 362
LKPEN+L+ ++G + L+DF LS
Sbjct: 118 LKPENILLDSDNGKVKLADFGLS 140
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 4e-38
Identities = 62/151 (41%), Positives = 97/151 (64%), Gaps = 6/151 (3%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
HF LL+ +G G G V + + TK FAMK M+K ++ + ER ILQ L+HP
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDL--HTLRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
FL L+ F+ ++ LV++ GGDL H ++ + FSE+ VKF++ E++LALEYL
Sbjct: 61 FLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVK----FSEEQVKFWICEIVLALEYL 116
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
H GI++RD+KP+N+L+ E GH+ ++DF+++
Sbjct: 117 HSKGIIHRDIKPDNILLDEQGHVHITDFNIA 147
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 144 bits (363), Expect = 5e-38
Identities = 104/356 (29%), Positives = 171/356 (48%), Gaps = 48/356 (13%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F LK +G G G V L + T +AMK++ KA + +++++ + ER+IL D +
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ ++ F+ L+MEF PGGD+ TL ++ +E+ +FY+AE +LA++ +H L
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQL 120
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPAC 394
G ++RD+KP+N+L+ GH+ LSDF L T +K + +N + +
Sbjct: 121 GFIHRDIKPDNLLLDSKGHVKLSDFGLC-------TGLKKA--HRTEFYRNLNHSL---- 167
Query: 395 IEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGT 454
PS S R K++ ++ + ++ P+ IA
Sbjct: 168 -------PSDFTFQNMNSKR---KAETWKRNRRQLAFSTVGTPDYIA------------- 204
Query: 455 HEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG--QPLRFPE 512
PE+ G+ DWW+ G+ +YE+L G PF + T V+ + L FP
Sbjct: 205 -----PEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPP 259
Query: 513 SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIP 568
+S A+DLI E ++R+ G EIK +PFF+GV+W IR P IP
Sbjct: 260 EVPISEKAKDLILRFCC-EWEHRIGA-PGVEEIKTNPFFEGVDWEHIR-ERPAAIP 312
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 1e-36
Identities = 66/154 (42%), Positives = 103/154 (66%), Gaps = 9/154 (5%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTK---CYFAMKVMDKAS-LEKRKKLLRAQTEREILQSL 270
F LL+ LG G G V+L G +AMKV+ KA+ ++K K +TER++L+++
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 271 DH-PFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLAL 328
PFL TL+ F+TD L++++ GG+L T L QR+ +F+E V+ Y+AE++LAL
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE---HFTESEVRVYIAEIVLAL 118
Query: 329 EYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++LH LGI+YRD+K EN+L+ +GH++L+DF LS
Sbjct: 119 DHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 136 bits (346), Expect = 2e-36
Identities = 59/140 (42%), Positives = 86/140 (61%), Gaps = 4/140 (2%)
Query: 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYT 280
LG G G V L ++ FA+K + K + + + +E+EIL+ +HPF+ LY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 281 HFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYR 339
F+ K+ ++ME+C GG+L T LR R G F E +FY+A V+LA EYLH GI+YR
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDR--GL-FDEYTARFYIACVVLAFEYLHNRGIIYR 117
Query: 340 DLKPENVLVREDGHIMLSDF 359
DLKPEN+L+ +G++ L DF
Sbjct: 118 DLKPENLLLDSNGYVKLVDF 137
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 70/148 (47%), Positives = 103/148 (69%), Gaps = 6/148 (4%)
Query: 218 LKKLGCGDIGSVYL-SELTGTKC--YFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
LK LG G G V+L ++TG +AMKV+ KA+L+ R ++ R + ER+IL ++HPF
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRV-RTKMERDILAEVNHPF 59
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ L+ F+T+ L+++F GGDL T ++ F+E+ VKFY+AE+ LAL++LH L
Sbjct: 60 IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL 117
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLS 362
GI+YRDLKPEN+L+ E+GHI L+DF LS
Sbjct: 118 GIIYRDLKPENILLDEEGHIKLTDFGLS 145
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 5e-35
Identities = 50/110 (45%), Positives = 67/110 (60%), Gaps = 6/110 (5%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNV 503
+ +FVGT EY+APE++ G+G+G AVD W+ G+ LYELL GK PF G + L+
Sbjct: 149 PGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKK 208
Query: 504 VGQPLRFPESPVVSFS--ARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551
+G+P P S A+DLI+ LLVK+P+ RL A E QHPFF
Sbjct: 209 IGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRL----TAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 56/146 (38%), Positives = 87/146 (59%), Gaps = 4/146 (2%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
+K +G G G V+L ++ Y+A+KVM + + K+ E+ +L+ + HPF
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
+ L+ +F ++ME+ PGG+L + LR G+ FS FY +E++ ALEYLH
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNS--GR-FSNSTGLFYASEIVCALEYLHS 119
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDF 359
IVYRDLKPEN+L+ ++GHI L+DF
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDF 145
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 8e-35
Identities = 53/127 (41%), Positives = 71/127 (55%), Gaps = 5/127 (3%)
Query: 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ 506
R+ + GT EYLAPEII +G+G AVDWW GI +YE+L G PF ++
Sbjct: 154 RTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG 213
Query: 507 PLRFPESPVVSFSARDLIKGLLVKEPQNRLAC-RRGATEIKQHPFFQGVNW-ALI-RCAS 563
+RFP S A+DLI+ LL + RL + G +IK HP+F G++W AL+ R
Sbjct: 214 KVRFPSF--FSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIE 271
Query: 564 PPEIPKP 570
P IPK
Sbjct: 272 APFIPKV 278
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-34
Identities = 56/146 (38%), Positives = 88/146 (60%), Gaps = 3/146 (2%)
Query: 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLP 276
LK + G GSVYL++ T YFA+KV+ K+ + + ++ + ER I+ + P++
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 277 TLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGI 336
LY F++ + LVME+ GGD +L + E K Y+AEV+L +E LH GI
Sbjct: 61 KLYYSFQSKDYLYLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGI 118
Query: 337 VYRDLKPENVLVREDGHIMLSDFDLS 362
++RD+KPEN+L+ + GH+ L+DF LS
Sbjct: 119 IHRDIKPENLLIDQTGHLKLTDFGLS 144
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 48/119 (40%), Positives = 65/119 (54%), Gaps = 1/119 (0%)
Query: 438 ELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR 497
++ VGT +Y+APE+I G+GH VDWW+ G LYE L G PF G
Sbjct: 148 QINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPE 207
Query: 498 ATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNW 556
N++ + +PE VS A DLI LLV +P+ RL + EIK HPFF+G++W
Sbjct: 208 EIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGA-KSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 2e-33
Identities = 59/150 (39%), Positives = 86/150 (57%), Gaps = 2/150 (1%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH 272
F++L ++G G G V+L++ T A+K M K+ L K ++ TER+IL +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
+L L F+ D++ L ME+ PGGD TL SE +FY+AE+ A++ LH
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALH 118
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
LG ++RDLKPEN L+ GHI L+DF LS
Sbjct: 119 ELGYIHRDLKPENFLIDASGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 63/148 (42%), Positives = 92/148 (62%), Gaps = 2/148 (1%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F +K + G G+VYL T+ FAMK ++K +L R ++ + ER+IL ++PF
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ +++ FET + C+VME+ GGD TL + G + A + Y AE +LALEYLH
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATL-LKNIGALPVDMA-RMYFAETVLALEYLHNY 120
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLS 362
GIV+RDLKP+N+L+ GHI L+DF LS
Sbjct: 121 GIVHRDLKPDNLLITSMGHIKLTDFGLS 148
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 3e-33
Identities = 70/154 (45%), Positives = 103/154 (66%), Gaps = 9/154 (5%)
Query: 215 FRLLKKLGCGDIGSVYL-SELTG--TKCYFAMKVMDKASLEKRKKLLR-AQTEREILQSL 270
F LLK LG G G V+L ++TG T +AMKV+ KA+L ++ K + +TER +L+ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 271 -DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLAL 328
PFL TL+ F+T+ L++++ GG++ T L QR FSE V+FY E++LAL
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRD---NFSEDEVRFYSGEIILAL 118
Query: 329 EYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
E+LH LGIVYRD+K EN+L+ +GH++L+DF LS
Sbjct: 119 EHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 3e-33
Identities = 60/148 (40%), Positives = 92/148 (62%), Gaps = 2/148 (1%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F +K +G G G V L + T +AMK + K+ + K+ +L + ER++L D P+
Sbjct: 3 FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ +LY F+ ++ L+MEF PGGDL T+ + FSE +FY+AE +LA+E +H L
Sbjct: 63 VVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKL 120
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLS 362
G ++RD+KP+N+L+ GHI LSDF LS
Sbjct: 121 GFIHRDIKPDNILIDRGGHIKLSDFGLS 148
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 129 bits (325), Expect = 4e-33
Identities = 58/150 (38%), Positives = 80/150 (53%), Gaps = 6/150 (4%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQ---SLD 271
FR L LG G G V L+E T +A+K + K + R ++ E+ I + S
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
HPFL L+ F+T+ C VME+ GGDL FSE FY A V+L L+YL
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYL 117
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDL 361
H IVYRDLK +N+L+ +G + ++DF L
Sbjct: 118 HENKIVYRDLKLDNLLLDTEGFVKIADFGL 147
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 9e-33
Identities = 51/154 (33%), Positives = 76/154 (49%), Gaps = 9/154 (5%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMD--KASLEKRKKLLRAQTEREILQSLDH 272
+ + LG G GSVYL+ T A+K ++ S E+ + L R E IL SL H
Sbjct: 2 WTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALER---EIRILSSLQH 58
Query: 273 PFLPTLYTHF--ETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEY 330
P + Y E + +E+ GG L +L ++ E ++ Y ++L L Y
Sbjct: 59 PNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGK--LPEPVIRKYTRQILEGLAY 116
Query: 331 LHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLR 364
LH GIV+RD+K N+LV DG + L+DF + R
Sbjct: 117 LHSNGIVHRDIKGANILVDSDGVVKLADFGCAKR 150
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 59/147 (40%), Positives = 86/147 (58%), Gaps = 7/147 (4%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREIL-QSLDHPFLPT 277
K LG G G V L+EL GT +A+KV+ K + + + TE+ +L + HPFL
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 278 LYTHFETDKFSCLVMEFCPGGDL--HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLG 335
L++ F+T VME+ GGDL H R + F E +FY AE++L L++LH G
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGR----FDEPRARFYAAEIVLGLQFLHERG 116
Query: 336 IVYRDLKPENVLVREDGHIMLSDFDLS 362
I+YRDLK +NVL+ +GHI ++DF +
Sbjct: 117 IIYRDLKLDNVLLDSEGHIKIADFGMC 143
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 56/150 (37%), Positives = 87/150 (58%), Gaps = 2/150 (1%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F + + LG G G V +++ GT Y+A+K + K + K K++ E+ IL L HPF
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ + F+ + ++EF GG+L T R+ G+ F KFY AE++LA EYLH
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFT-HLRKAGR-FPNDVAKFYHAELVLAFEYLHSK 137
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLSLR 364
I+YRDLKPEN+L+ GH+ ++DF + +
Sbjct: 138 DIIYRDLKPENLLLDNKGHVKVTDFGFAKK 167
|
Length = 329 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 2e-31
Identities = 68/155 (43%), Positives = 104/155 (67%), Gaps = 9/155 (5%)
Query: 214 HFRLLKKLGCGDIGSVYL-SELTG--TKCYFAMKVMDKASL-EKRKKLLRAQTEREILQS 269
+F LLK LG G G V+L +++G + +AMKV+ KA++ +K K +TER++L+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 270 LDH-PFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLA 327
+ PFL TL+ F+TD L++++ GG+L T L QR+ F EQ V+ Y E++LA
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRE---RFKEQEVQIYSGEIVLA 117
Query: 328 LEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
LE+LH LGI+YRD+K EN+L+ +GH++L+DF LS
Sbjct: 118 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLS 152
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 3e-31
Identities = 45/113 (39%), Positives = 69/113 (61%), Gaps = 3/113 (2%)
Query: 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRA-TLYNVVG 505
++ +F GT EY+APEII +G+ +VD+W+ GI LYELL G+ PF + +YN +
Sbjct: 148 KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL 207
Query: 506 QPLRFPESP-VVSFSARDLIKGLLVKEPQNRLACRR-GATEIKQHPFFQGVNW 556
+ E P + +A+DLIK LL + P+ RL + G +IK+H +F G +W
Sbjct: 208 KGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDW 260
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 4e-31
Identities = 61/148 (41%), Positives = 89/148 (60%), Gaps = 6/148 (4%)
Query: 218 LKKLGCGDIGSVYLSE-LTGTKC--YFAMKVMDKASLEKRKK-LLRAQTEREILQSLDHP 273
LK LG G G V+ +TG FAMKV+ KA++ + +K + ER IL+++ HP
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHP 60
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
F+ L F+T L++E+ GG+L +R+ F E FY++E+ LALE+LH
Sbjct: 61 FIVDLIYAFQTGGKLYLILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQ 118
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDL 361
GI+YRDLKPEN+L+ GH+ L+DF L
Sbjct: 119 QGIIYRDLKPENILLDAQGHVKLTDFGL 146
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 56/144 (38%), Positives = 87/144 (60%), Gaps = 3/144 (2%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREIL-QSLDHPFLPT 277
K +G G G V L++ ++A+KV+ K ++ K+K+ ER +L +++ HPFL
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 278 LYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIV 337
L+ F+T V+++ GG+L QR+ + F E +FY AE+ AL YLH L I+
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNII 118
Query: 338 YRDLKPENVLVREDGHIMLSDFDL 361
YRDLKPEN+L+ GH++L+DF L
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL 142
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 61/145 (42%), Positives = 84/145 (57%), Gaps = 6/145 (4%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTL 278
K LG G G V L T Y+AMK++ K + + ++ TE +LQ+ HPFL L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 279 YTHFETDKFSCLVMEFCPGGDL--HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGI 336
F+T C VME+ GG+L H R+R FSE +FY AE++ AL YLH +
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALGYLHSCDV 116
Query: 337 VYRDLKPENVLVREDGHIMLSDFDL 361
VYRDLK EN+++ +DGHI ++DF L
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 48/127 (37%), Positives = 75/127 (59%), Gaps = 5/127 (3%)
Query: 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG 505
+ +F GT +Y+APEI+ + +G AVDWW G+ LYE+L G++PF+G + +++
Sbjct: 151 VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE 210
Query: 506 QPLRFPESPVVSFSARDLIKGLLVKEPQNRLAC-RRGATEIKQHPFFQGVNW-ALIRCA- 562
+R+P +S A+ ++K L K P+ RL C G +IK HPFF+ ++W L R
Sbjct: 211 DEVRYPRW--LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEI 268
Query: 563 SPPEIPK 569
PP PK
Sbjct: 269 KPPFKPK 275
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 3e-30
Identities = 59/129 (45%), Positives = 82/129 (63%), Gaps = 6/129 (4%)
Query: 447 RSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG 505
R+ SF GT EY+APEII+G+ GHG AVDWW+ GI ++ELL G +PF R T V
Sbjct: 162 RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSR 221
Query: 506 QPLRF--PESPVVSFSARDLIKGLLVKEPQNRL-ACRRGATEIKQHPFFQGVNWALI--R 560
+ L+ P + A+DL+ LL K+P+ RL A +GA+EIK+HPFF+G++W + R
Sbjct: 222 RILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALR 281
Query: 561 CASPPEIPK 569
+PP P
Sbjct: 282 KVNPPFRPS 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 7e-30
Identities = 59/144 (40%), Positives = 81/144 (56%), Gaps = 4/144 (2%)
Query: 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYT 280
LG G G V ++ T +A K +DK L+KRK A E++IL+ + F+ +L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60
Query: 281 HFETDKFSCLVMEFCPGGDL--HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVY 338
FET CLVM GGDL H +PG F E FY A+++ LE+LH IVY
Sbjct: 61 AFETKDDLCLVMTLMNGGDLKYHIYNVGEPG--FPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 339 RDLKPENVLVREDGHIMLSDFDLS 362
RDLKPENVL+ + G++ +SD L+
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 1e-29
Identities = 55/139 (39%), Positives = 76/139 (54%), Gaps = 5/139 (3%)
Query: 436 LPELIAEPTNARSMSFVGTHEYLAPEIIKG--EGHGSAVDWWTFGIFLYELLFGKTPFKG 493
L + R+ SF GT EY+APE+I+G GH AVDWW+ G+ +ELL G +PF
Sbjct: 151 LSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210
Query: 494 SENRATLYNVVGQPLRF--PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551
+ + + + L+ P +S ARD I+ LL K+P+ RL GA EIK HPFF
Sbjct: 211 DGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGA-NGADEIKNHPFF 269
Query: 552 QGVNWALIRCASPPEIPKP 570
QG++W + P KP
Sbjct: 270 QGIDWDDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-29
Identities = 59/158 (37%), Positives = 89/158 (56%), Gaps = 1/158 (0%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F + +G G G V + T +AMKVM K+ L ++ + + ER+IL + P+
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+P L F+ LVME+ PGGDL +L R + F E +FY+AE++LA+ +H +
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ-FDEDMAQFYLAELVLAIHSVHQM 121
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372
G V+RD+KPENVL+ GHI L+DF + R + V
Sbjct: 122 GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN 159
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 3e-29
Identities = 52/155 (33%), Positives = 83/155 (53%), Gaps = 8/155 (5%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
F +L+K+G G G VY + T A+KV+ S EK++K++ E +IL+ HP
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN---EIQILKKCKHP 57
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQ--RQPGKYFSEQAVKFYVAEVLLALEYL 331
+ Y + +VMEFC GG +L+ + + +E + + E+L LEYL
Sbjct: 58 NIVKYYGSYLKKDELWIVMEFCSGG---SLKDLLKSTNQTLTESQIAYVCKELLKGLEYL 114
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366
H GI++RD+K N+L+ DG + L DF LS + +
Sbjct: 115 HSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLS 149
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 9e-29
Identities = 51/124 (41%), Positives = 67/124 (54%), Gaps = 4/124 (3%)
Query: 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ 506
R+ + GT EYLAPE+I+ +GHG AVDWWT G+ LYE + G PF ++
Sbjct: 171 RTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG 230
Query: 507 PLRFPESPVVSFSARDLIKGLLVKEPQNRL-ACRRGATEIKQHPFFQGVNW-ALIRCASP 564
L+FP ARDL+KGLL + RL + G ++K HP+F G NW L P
Sbjct: 231 RLKFPNW--FDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDKLYARYYP 288
Query: 565 PEIP 568
IP
Sbjct: 289 APIP 292
|
Length = 329 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-28
Identities = 60/145 (41%), Positives = 86/145 (59%), Gaps = 6/145 (4%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTL 278
K LG G G V L T Y+AMK++ K + + ++ TE +LQ+ HPFL L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 279 YTHFETDKFSCLVMEFCPGGDL--HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGI 336
F+T C VME+ GG+L H R+R F+E+ +FY AE++ ALEYLH +
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRER----VFTEERARFYGAEIVSALEYLHSRDV 116
Query: 337 VYRDLKPENVLVREDGHIMLSDFDL 361
VYRD+K EN+++ +DGHI ++DF L
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 58/142 (40%), Positives = 84/142 (59%), Gaps = 3/142 (2%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQ-SLDHPFLPT 277
K LG G G V L+EL GT +FA+K + K + + + ER +L + +HPFL
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 278 LYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIV 337
L+ F+T + VME+ GGDL + Q F E +FY AE++ L++LH GI+
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDL--MFHIQSSGRFDEARARFYAAEIICGLQFLHKKGII 118
Query: 338 YRDLKPENVLVREDGHIMLSDF 359
YRDLK +NVL+ +DGHI ++DF
Sbjct: 119 YRDLKLDNVLLDKDGHIKIADF 140
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 5e-28
Identities = 60/142 (42%), Positives = 83/142 (58%), Gaps = 3/142 (2%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQ-SLDHPFLPT 277
K LG G G V L+EL GT +A+KV+ K + + + TE+ IL + HPFL
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 278 LYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIV 337
L+ F+T VME+ GGDL + Q Q + F E +FY AEV LAL +LH G++
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDL--MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVI 118
Query: 338 YRDLKPENVLVREDGHIMLSDF 359
YRDLK +N+L+ +GH L+DF
Sbjct: 119 YRDLKLDNILLDAEGHCKLADF 140
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 52/127 (40%), Positives = 74/127 (58%), Gaps = 7/127 (5%)
Query: 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN-VVG 505
R+ + GT EYLAPE+I+ +GH AVDWW GI +YE+L G PF +N +Y ++
Sbjct: 154 RTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFD-DNPFGIYEKILA 212
Query: 506 QPLRFPESPVVSFSARDLIKGLLVKEPQNRLAC-RRGATEIKQHPFFQGVNWALI--RCA 562
L FP + A+DLIK LLV + RL + GA ++K H +F+ V+W + R
Sbjct: 213 GKLEFPRH--LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDDVPQRKL 270
Query: 563 SPPEIPK 569
PP +PK
Sbjct: 271 KPPIVPK 277
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 59/152 (38%), Positives = 84/152 (55%), Gaps = 4/152 (2%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
FR + LG G G V ++ T +A K ++K ++KRK A E++IL+ ++ F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDL--HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
+ +L +ET CLV+ GGDL H PG F E+ FY AE+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPG--FDEERAVFYAAEITCGLEDLH 119
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLSLR 364
IVYRDLKPEN+L+ + GHI +SD L++
Sbjct: 120 RERIVYRDLKPENILLDDYGHIRISDLGLAVE 151
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 1e-27
Identities = 61/152 (40%), Positives = 87/152 (57%), Gaps = 6/152 (3%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+R+L+KLG G G VYL+ A+KV+ K K K++ R E +IL SL+HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 274 -FLPTLYTHFETDKFSCLVMEFCPGGDLHTL-RQRQPGKYFSEQAVKFYVAEVLLALEYL 331
+ LY F+ + LVME+ GG L L ++ SE F +A++L ALEYL
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 332 HMLGIVYRDLKPENVLVREDGH-IMLSDFDLS 362
H GI++RD+KPEN+L+ DG + L DF L+
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLA 149
|
Length = 384 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 61/169 (36%), Positives = 86/169 (50%), Gaps = 22/169 (13%)
Query: 445 NARSMSF--VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN 502
N R M++ VGT +Y+APEI +G+G DWW+ G ++E L G PF SEN Y
Sbjct: 200 NRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPF-CSENSHETYR 258
Query: 503 VV---GQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALI 559
+ + L FP+ +S A DLI+ L+ +NRL R GA EIK HPFF+GV+W I
Sbjct: 259 KIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLG-RGGAHEIKSHPFFRGVDWDTI 316
Query: 560 RCASPPEIPK----------PVE----IVHSPAPALSTKAKAVAAGNAD 594
R P IP+ P + + +PA + A+ + D
Sbjct: 317 RQIRAPFIPQLKSITDTSYFPTDELEQVPEAPALKQAAPAQQEESVELD 365
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 51/123 (41%), Positives = 73/123 (59%), Gaps = 6/123 (4%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY-NVVGQPL 508
+F GT EYLAPE+++ + + VDWW G LYE+L+G PF S + A +Y N++ +PL
Sbjct: 155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFY-SRDTAEMYDNILNKPL 213
Query: 509 RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA--LIRCASPPE 566
R P +S SAR L++GLL K+ RL + EIK H FF +NW + + +PP
Sbjct: 214 RLK--PNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDDLVNKKITPPF 271
Query: 567 IPK 569
P
Sbjct: 272 NPN 274
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 57/160 (35%), Positives = 95/160 (59%), Gaps = 1/160 (0%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F +LK +G G G V + ++ T +AMK+++K + KR + + ER++L + D +
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ L+ F+ + LVM++ GGDL TL + E +FY+AE++LA++ +H L
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQL 121
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKS 374
G V+RD+KP+NVL+ ++GHI L+DF LR TV +
Sbjct: 122 GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSN 161
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 5e-27
Identities = 62/145 (42%), Positives = 85/145 (58%), Gaps = 5/145 (3%)
Query: 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQS---LDHPFLPT 277
+G G G VY T+ +AMKV+ K + +K++ ER IL + PF+
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 278 LYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIV 337
L F+TD LV ++ GG+L Q++ G+ FSE KFY+AE++LALE+LH IV
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKE-GR-FSEDRAKFYIAELVLALEHLHKYDIV 118
Query: 338 YRDLKPENVLVREDGHIMLSDFDLS 362
YRDLKPEN+L+ GHI L DF LS
Sbjct: 119 YRDLKPENILLDATGHIALCDFGLS 143
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 5e-27
Identities = 59/152 (38%), Positives = 84/152 (55%), Gaps = 4/152 (2%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
FR + LG G G V ++ T +A K ++K ++KRK A E++IL+ ++ F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDL--HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
+ L +ET CLV+ GGDL H PG F E+ FY AE+L LE LH
Sbjct: 62 VVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FEEERALFYAAEILCGLEDLH 119
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLSLR 364
VYRDLKPEN+L+ + GHI +SD L+++
Sbjct: 120 RENTVYRDLKPENILLDDYGHIRISDLGLAVK 151
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 8e-27
Identities = 58/142 (40%), Positives = 85/142 (59%), Gaps = 7/142 (4%)
Query: 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREIL-QSLDHPFLPTLY 279
+G G V L EL T+ +AMKV+ K + + + QTE+ + + +HPFL L+
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 280 THFETDKFSCLVMEFCPGGDL--HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIV 337
+ F+T+ V+EF GGDL H RQR+ E+ +FY AE+ LAL +LH GI+
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRK----LPEEHARFYSAEISLALNFLHERGII 118
Query: 338 YRDLKPENVLVREDGHIMLSDF 359
YRDLK +NVL+ +GHI L+D+
Sbjct: 119 YRDLKLDNVLLDAEGHIKLTDY 140
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 48/113 (42%), Positives = 63/113 (55%), Gaps = 10/113 (8%)
Query: 445 NARSMSFVGTHEYLAPEIIK-GEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR---ATL 500
++ +FVGT Y+APE++ G G+G VD W+ G+ LYELL GK PF G +
Sbjct: 152 SSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLI 211
Query: 501 YNVVGQPLRFPESPVVSFS--ARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551
++G PL F E S S A+DLIK L K+P R A EI QHP+F
Sbjct: 212 RRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRP----TAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 2e-26
Identities = 66/175 (37%), Positives = 99/175 (56%), Gaps = 10/175 (5%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREIL-QSLDHPFLPT 277
K +G G G V L++ ++A+KV+ K ++ K+K+ ER +L ++L HPFL
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 278 LYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIV 337
L+ F+T + V+++ GG+L QR+ + F E +FY AEV A+ YLH L I+
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNII 118
Query: 338 YRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSS------TLESEPLRKNP 386
YRDLKPEN+L+ GH++L+DF L + V P S+ L E LRK P
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGLC-KEGVEPEETTSTFCGTPEYLAPEVLRKEP 172
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-26
Identities = 56/125 (44%), Positives = 77/125 (61%), Gaps = 7/125 (5%)
Query: 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY-NVVG 505
++ +F GT EYLAPE++ G G+ AVDWWT G+ LYE+L G PF EN +Y ++
Sbjct: 149 KTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY-DENVNEMYRKILQ 207
Query: 506 QPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA--LIRCAS 563
+PLRFP+ A+DL+ GLL ++P RL GA EIK HPFF ++W L++
Sbjct: 208 EPLRFPDG--FDRDAKDLLIGLLSRDPTRRLGY-NGAQEIKNHPFFSQLSWKKLLMKGIQ 264
Query: 564 PPEIP 568
PP P
Sbjct: 265 PPFKP 269
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 109 bits (272), Expect = 4e-26
Identities = 60/145 (41%), Positives = 86/145 (59%), Gaps = 6/145 (4%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTL 278
K LG G G V L + Y+AMK++ K + + ++ TE +L++ HPFL +L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 279 YTHFETDKFSCLVMEFCPGGDL--HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGI 336
F+T C VME+ GG+L H R+R FSE +FY AE++ AL+YLH I
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRER----VFSEDRTRFYGAEIVSALDYLHSGKI 116
Query: 337 VYRDLKPENVLVREDGHIMLSDFDL 361
VYRDLK EN+++ +DGHI ++DF L
Sbjct: 117 VYRDLKLENLMLDKDGHIKITDFGL 141
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-26
Identities = 61/146 (41%), Positives = 86/146 (58%), Gaps = 7/146 (4%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTL 278
K LG G G V L + T Y+AMK++ K + + ++ TE +LQ+ HPFL L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 279 YTHFETDKFSCLVMEFCPGGDL--HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM-LG 335
F+T C VME+ GG+L H R+R FSE +FY AE++ AL+YLH
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRER----VFSEDRARFYGAEIVSALDYLHSEKN 116
Query: 336 IVYRDLKPENVLVREDGHIMLSDFDL 361
+VYRDLK EN+++ +DGHI ++DF L
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGL 142
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 7e-26
Identities = 54/136 (39%), Positives = 80/136 (58%), Gaps = 9/136 (6%)
Query: 442 EPTNARSMSFVGTHEYLAPEIIKG--EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRAT 499
E R+ SF GT EY+AP+I++G GH AVDWW+ G+ +YELL G +PF + +
Sbjct: 157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS 216
Query: 500 LYNVVGQPLR----FPESPVVSFSARDLIKGLLVKEPQNRLAC-RRGATEIKQHPFFQGV 554
+ + L+ +P+ +S A+D+I+ LL+K+P+ RL C A EIK+HPFFQ +
Sbjct: 217 QAEISRRILKSEPPYPQE--MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKI 274
Query: 555 NWALIRCASPPEIPKP 570
NW + P KP
Sbjct: 275 NWDDLAAKKVPAPFKP 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-26
Identities = 59/180 (32%), Positives = 99/180 (55%), Gaps = 11/180 (6%)
Query: 198 EAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKL 257
E I +R+K F ++K +G G G V L +K +AMK++ K + KR
Sbjct: 33 EKITKLRMK-----AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDS 87
Query: 258 LRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKY-FSEQA 316
ER+I+ + ++ L+ F+ DK+ +VME+ PGGDL L Y E+
Sbjct: 88 AFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM----SNYDIPEKW 143
Query: 317 VKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSST 376
+FY AEV+LAL+ +H +G ++RD+KP+N+L+ + GH+ L+DF ++ + +V+ T
Sbjct: 144 ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD-ANGMVRCDT 202
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 57/144 (39%), Positives = 82/144 (56%), Gaps = 3/144 (2%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQ-SLDHPFLPT 277
K LG G G V+L+EL GT +FA+K + K + + E+ +L + +HPFL
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 278 LYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIV 337
LY F+T + VME+ GGDL + Q F FY AE++ L++LH GIV
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 338 YRDLKPENVLVREDGHIMLSDFDL 361
YRDLK +N+L+ DGHI ++DF +
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGM 142
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 1e-25
Identities = 56/173 (32%), Positives = 89/173 (51%), Gaps = 25/173 (14%)
Query: 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG 505
++ +F GT +Y+APEI+KG+ + +VDWW+FG+ LYE+L G++PF G + +++
Sbjct: 151 GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILN 210
Query: 506 QPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALI--RCAS 563
FP +S A+D + L ++P RL +I+QHPFF+G++W + R
Sbjct: 211 DRPHFPRW--ISKEAKDCLSKLFERDPTKRLGVD---GDIRQHPFFRGIDWERLEKREIP 265
Query: 564 PPEIPKPVEIVHSPA-------------PALSTKAKAVAAGNADHNNYLEFDF 603
PP PK V SP+ LS K + A + D + F F
Sbjct: 266 PPFKPK----VKSPSDASNFDREFTNEKVRLSPVDKKLLA-SMDQEQFRGFSF 313
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 45/153 (29%), Positives = 79/153 (51%), Gaps = 7/153 (4%)
Query: 214 HFRLLKKLGCGDIGSVY--LSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD 271
+++L +G G G VY L+ TG + A+K + + K + L E ++L++L
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGD--FVAIKQISLEKI-KEEALKSIMQEIDLLKNLK 57
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
HP + ET +++E+ G L + ++ F E V YV +VL L YL
Sbjct: 58 HPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP--FPESLVAVYVYQVLQGLAYL 115
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLSLR 364
H G+++RD+K N+L +DG + L+DF ++ +
Sbjct: 116 HEQGVIHRDIKAANILTTKDGVVKLADFGVATK 148
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 2e-25
Identities = 61/181 (33%), Positives = 94/181 (51%), Gaps = 18/181 (9%)
Query: 183 SSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSEL-TGTKCYF 241
S S +P + N ++E F ++ LG G G V L+
Sbjct: 15 SDSTKEPKRKNKMKYE---------------DFNFIRTLGTGSFGRVILATYKNEDFPPV 59
Query: 242 AMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLH 301
A+K +K+ + K+K++ +ER+IL ++HPF LY F+ + + LV+EF GG+
Sbjct: 60 AIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFF 119
Query: 302 TLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDL 361
T +R K F FY A+++L EYL L IVYRDLKPEN+L+ +DG I ++DF
Sbjct: 120 TFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGF 177
Query: 362 S 362
+
Sbjct: 178 A 178
|
Length = 340 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-25
Identities = 57/148 (38%), Positives = 85/148 (57%), Gaps = 2/148 (1%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F ++K + G G VYL +A+KV+ KA + + + + Q ER+ L PF
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPF 65
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ LY ++ LVME+ GGD+ +L YF E+ Y++EV LAL+YLH
Sbjct: 66 IVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRH 123
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLS 362
GI++RDLKP+N+L+ +GHI L+DF LS
Sbjct: 124 GIIHRDLKPDNMLISNEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 3e-25
Identities = 45/127 (35%), Positives = 80/127 (62%), Gaps = 7/127 (5%)
Query: 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV 504
+A++ +F GT +Y+APEI+ G+ + ++VDWW+FG+ LYE+L G++PF G + ++
Sbjct: 150 DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR 209
Query: 505 GQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALI--RCA 562
+P ++ A+D++ L V+EP+ RL + +I+QHPFF+ ++W+ + R
Sbjct: 210 MDNPCYPR--WLTREAKDILVKLFVREPERRLGVK---GDIRQHPFFREIDWSALEEREI 264
Query: 563 SPPEIPK 569
PP PK
Sbjct: 265 EPPFKPK 271
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 56/147 (38%), Positives = 81/147 (55%), Gaps = 6/147 (4%)
Query: 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYT 280
LG G G V ++ T +A K ++K L+KRK A E+ IL + F+ +L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 281 HFETDKFSCLVMEFCPGGDL----HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGI 336
F+T CLVM GGDL + + + PG F E FY A+++ LE+LH I
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG--FPEPRACFYTAQIISGLEHLHQRRI 118
Query: 337 VYRDLKPENVLVREDGHIMLSDFDLSL 363
+YRDLKPENVL+ DG++ +SD L++
Sbjct: 119 IYRDLKPENVLLDNDGNVRISDLGLAV 145
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 46/108 (42%), Positives = 58/108 (53%), Gaps = 3/108 (2%)
Query: 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRF 510
FVGT +YLAPE I G G DWW+ G ++E LFG PF A N++ + + +
Sbjct: 153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINW 212
Query: 511 PESPVVSFS--ARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNW 556
PE S A DLI LL +P RL G EIK HPFF+ +NW
Sbjct: 213 PEEVKEFCSPEAVDLINRLLCMDPAKRLGA-NGYQEIKSHPFFKSINW 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-25
Identities = 52/122 (42%), Positives = 71/122 (58%), Gaps = 5/122 (4%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR 509
+F GT EY+APEI+ GHG AVDWW+ G +Y++L G PF + T+ ++ L
Sbjct: 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN 218
Query: 510 FPESPVVSFSARDLIKGLLVKEPQNRLACRRG-ATEIKQHPFFQGVNW--ALIRCASPPE 566
P P ++ ARDL+K LL + P +RL G A E++ HPFF+ VNW L R PP
Sbjct: 219 LP--PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVEPPF 276
Query: 567 IP 568
P
Sbjct: 277 KP 278
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 5e-25
Identities = 48/130 (36%), Positives = 66/130 (50%), Gaps = 10/130 (7%)
Query: 447 RSMSFVGTHEYLAPEIIKGEGH----GSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN 502
R + VGT +Y++PE++K +G G DWW+ G+FLYE+L G TPF T
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 258
Query: 503 VVGQ--PLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG--VNWAL 558
++ L FP+ +S A+DLI L RL R G EIK HPFF+ +
Sbjct: 259 IMDHKNSLTFPDDIEISKQAKDLICAFLTDREV-RLG-RNGVDEIKSHPFFKNDQWTFDN 316
Query: 559 IRCASPPEIP 568
IR P +P
Sbjct: 317 IRETVAPVVP 326
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 6e-25
Identities = 55/146 (37%), Positives = 81/146 (55%), Gaps = 3/146 (2%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP- 273
F L LG G G V L+E GT +A+K++ K + + + E+ +L P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
FL L++ F+T VME+ GGDL +Q GK+ AV FY AE+ + L +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDL-MYHIQQVGKFKEPHAV-FYAAEIAIGLFFLHS 119
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDF 359
GI+YRDLK +NV++ +GHI ++DF
Sbjct: 120 KGIIYRDLKLDNVMLDAEGHIKIADF 145
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 8e-25
Identities = 51/136 (37%), Positives = 76/136 (55%), Gaps = 7/136 (5%)
Query: 438 ELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR 497
E I R+ F GT +Y+APEII + +G +VDWW FG+ LYE+L G+ PF G +
Sbjct: 150 ENIFGGKTTRT--FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED 207
Query: 498 ATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLAC-RRGATEIKQHPFFQGVNW 556
+++ + +P+S +S A + KGLL K P RL C G +I++H FF+ ++W
Sbjct: 208 ELFQSIMEHNVSYPKS--LSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDW 265
Query: 557 ALI--RCASPPEIPKP 570
+ R PP PK
Sbjct: 266 EKLERREIQPPFKPKV 281
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 8e-25
Identities = 45/151 (29%), Positives = 75/151 (49%), Gaps = 7/151 (4%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKAS-LEKRKKLLRAQTEREILQSLDH 272
+K LG G G VY T +A+K + E RK+LLR E + L+S +
Sbjct: 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLR---ELKTLRSCES 58
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
P++ Y F + +V+E+ GG L L ++ E + + ++L L+YLH
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGK--IPEPVLAYIARQILKGLDYLH 116
Query: 333 -MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
I++RD+KP N+L+ G + ++DF +S
Sbjct: 117 TKRHIIHRDIKPSNLLINSKGEVKIADFGIS 147
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 8e-25
Identities = 64/177 (36%), Positives = 95/177 (53%), Gaps = 14/177 (7%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREIL-QSLDHPFLPT 277
K +G G G V L++ +A+KV+ K + RK+ ER +L +++ HPFL
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 278 LYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIV 337
L+ F+T + V++F GG+L QR+ + F E +FY AE+ AL YLH + IV
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIV 118
Query: 338 YRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSST--------LESEPLRKNP 386
YRDLKPEN+L+ GH++L+DF L C ++T L E +RK P
Sbjct: 119 YRDLKPENILLDSQGHVVLTDFGL---CKEGIAQSDTTTTFCGTPEYLAPEVIRKQP 172
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 1e-24
Identities = 48/127 (37%), Positives = 77/127 (60%), Gaps = 4/127 (3%)
Query: 445 NARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNV 503
N + +F GT EYLAPE++ E G+ VD+W+ G+ ++E+ G +PF + + N+
Sbjct: 150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209
Query: 504 VGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALI--RC 561
+RFP++ V+S R +KGLL + PQ+RL R A E+K+HPFF ++W L+ +
Sbjct: 210 AFGKVRFPKN-VLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQ 268
Query: 562 ASPPEIP 568
+PP P
Sbjct: 269 ITPPFKP 275
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 2e-24
Identities = 56/160 (35%), Positives = 95/160 (59%), Gaps = 1/160 (0%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F ++K +G G G V + ++ T+ +AMK+++K + KR + + ER +L + D +
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ TL+ F+ + + LVM++ GGDL TL + + E +FY+AE++LA+ +H L
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYIAEMVLAIHSIHQL 121
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKS 374
V+RD+KP+NVL+ +GHI L+DF L+ TV S
Sbjct: 122 HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSS 161
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 2e-24
Identities = 60/189 (31%), Positives = 103/189 (54%), Gaps = 23/189 (12%)
Query: 204 RVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTE 263
+++D + + ++K +G G G V L T+ +AMK++ K + KR E
Sbjct: 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 264 REILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQ--PGKYFSEQAVKFYV 321
R+I+ + P++ L+ F+ D++ +VME+ PGGDL L P K+ +FY
Sbjct: 94 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKW-----ARFYT 148
Query: 322 AEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDF--------DLSLRCA------- 366
AEV+LAL+ +H +G ++RD+KP+N+L+ + GH+ L+DF + +RC
Sbjct: 149 AEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 208
Query: 367 -VSPTVVKS 374
+SP V+KS
Sbjct: 209 YISPEVLKS 217
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-24
Identities = 69/205 (33%), Positives = 100/205 (48%), Gaps = 7/205 (3%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
FR + LG G G V ++ T +A K ++K ++KRK A E++IL+ ++ F
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDL--HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
+ +L +ET CLV+ GGDL H + G F E FY AE+ LE LH
Sbjct: 62 VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAG--FEEGRAVFYAAEICCGLEDLH 119
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV---VKSSTLESEPLRKNPVYC 389
IVYRDLKPEN+L+ + GHI +SD L++ T+ V + + + KN Y
Sbjct: 120 QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT 179
Query: 390 VQPACIEPSCIQPSCIAPTTCFSPR 414
P C+ IA + F R
Sbjct: 180 FSPDWWALGCLLYEMIAGQSPFQQR 204
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 4e-24
Identities = 47/125 (37%), Positives = 74/125 (59%), Gaps = 5/125 (4%)
Query: 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ 506
++ SF GT EY+APE++ GH + DWW+FG+ ++E+L G PF+G + + T+ ++
Sbjct: 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKA 213
Query: 507 PLRFPESPVVSFSARDLIKGLLVKEPQNRL-ACRRGATEIKQHPFFQGVNWALI--RCAS 563
L P+ +S A+ L++ L + P NRL A G EIK+HPFF ++W + R
Sbjct: 214 KLGMPQ--FLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIK 271
Query: 564 PPEIP 568
PP P
Sbjct: 272 PPFKP 276
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 45/126 (35%), Positives = 67/126 (53%), Gaps = 10/126 (7%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS---ENRATLYN---V 503
S VG+ +Y+APE+++G+G+ VD+W+ G LYE L G PF GS E L
Sbjct: 157 SVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET 216
Query: 504 VGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCAS 563
+ +P+ +S A DLI L+ +P R +IK HPFF+ V+W +R
Sbjct: 217 LQRPVYDDPRFNLSDEAWDLITKLI-NDPSRRF---GSLEDIKNHPFFKEVDWNELRELK 272
Query: 564 PPEIPK 569
PP +P+
Sbjct: 273 PPFVPE 278
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 48/110 (43%), Positives = 62/110 (56%), Gaps = 3/110 (2%)
Query: 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE 512
GT EY+APE+I +G+G VDWW GI LYE L G PF G V+ + +PE
Sbjct: 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPE 237
Query: 513 S-PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNW-ALIR 560
+ A+DLI LL + P RL GA E+KQH FF G++W L+R
Sbjct: 238 GDEALPADAQDLISRLLRQNPLERLGT-GGAFEVKQHRFFLGLDWNGLLR 286
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 4e-24
Identities = 48/130 (36%), Positives = 75/130 (57%), Gaps = 10/130 (7%)
Query: 447 RSMSFVGTHEYLAPEIIK----GEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATLY 501
+S VGT +Y++PEI++ G+G G DWW+ G+ +YE+L+G+TPF T
Sbjct: 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218
Query: 502 NVVGQPLRF---PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWAL 558
++ F P+ VS A+DLI+ L+ P+ RL R G + K HPFF+G++W
Sbjct: 219 KIMNHKEHFQFPPDVTDVSEEAKDLIRRLICS-PETRLG-RNGLQDFKDHPFFEGIDWDN 276
Query: 559 IRCASPPEIP 568
IR ++ P +P
Sbjct: 277 IRNSTAPYVP 286
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 7e-24
Identities = 50/157 (31%), Positives = 82/157 (52%), Gaps = 14/157 (8%)
Query: 424 KPKN----EMGN-QVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFG 478
KP+N + GN ++S L + + GT Y+APE+++GE + +VDW+ G
Sbjct: 122 KPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALG 181
Query: 479 IFLYELLFGKTPFKGS----ENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQN 534
LYE++ G++PF+ E + + +P+ S A+DL + LL K+P+
Sbjct: 182 CTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDK--FSPEAKDLCEALLQKDPEK 239
Query: 535 RLACR-RGATEIKQHPFFQGVNWALIRCA--SPPEIP 568
RL CR A E+++HP F+ +NW + PP IP
Sbjct: 240 RLGCRGGSADEVREHPLFKDLNWRRLEAGMLEPPFIP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 8e-24
Identities = 57/142 (40%), Positives = 80/142 (56%), Gaps = 3/142 (2%)
Query: 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQ-SLDHPFLPTLY 279
LG G G V L+ L + +A+KV+ K + + + TE+ IL + +HPFL LY
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 280 THFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYR 339
F+T VMEF GGDL + Q + F E +FY AE+ AL +LH GI+YR
Sbjct: 63 CCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 340 DLKPENVLVREDGHIMLSDFDL 361
DLK +NVL+ +GH L+DF +
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGM 142
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 9e-24
Identities = 46/124 (37%), Positives = 66/124 (53%), Gaps = 5/124 (4%)
Query: 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFP 511
VGT Y+APE++K E + + DWW G +YE++ GK+PF+ + + V +
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQ 221
Query: 512 ESPVVSFS--ARDLIKGLLVKEPQNRLACRR-GATEIKQHPFFQGVNWALIRCA--SPPE 566
E FS AR + + LL K+P RL CR GA E+K HPFF+ N+ + PP
Sbjct: 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGMLEPPF 281
Query: 567 IPKP 570
P P
Sbjct: 282 CPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 1e-23
Identities = 56/160 (35%), Positives = 95/160 (59%), Gaps = 1/160 (0%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F +LK +G G G V + +L FAMK+++K + KR + + ER++L + D+ +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ TL+ F+ + LVM++ GGDL TL + + E +FY+AE+++A++ +H L
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDR-LPEDMARFYLAEMVIAIDSVHQL 121
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKS 374
V+RD+KP+N+L+ +GHI L+DF L+ TV S
Sbjct: 122 HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSS 161
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 1e-23
Identities = 57/142 (40%), Positives = 85/142 (59%), Gaps = 3/142 (2%)
Query: 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREIL-QSLDHPFLPTLY 279
+G G V L L T+ +AMKV+ K + + + QTE+ + Q+ +HPFL L+
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 280 THFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYR 339
+ F+T+ V+E+ GGDL QRQ + E+ +FY AE+ LAL YLH GI+YR
Sbjct: 63 SCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 340 DLKPENVLVREDGHIMLSDFDL 361
DLK +NVL+ +GHI L+D+ +
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGM 142
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 44/125 (35%), Positives = 74/125 (59%), Gaps = 5/125 (4%)
Query: 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ 506
R+ +F GT E+LAPE++ + AVDWW G+ +YE+L G++PF G + ++V
Sbjct: 157 RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND 216
Query: 507 PLRFPESPVVSFSARDLIKGLLVKEPQNRL-ACRRGATEIKQHPFFQGVNWA--LIRCAS 563
+R+P +S A +++ LL + P+ RL + + A ++K+ PFF+ +NW L R
Sbjct: 217 EVRYPR--FLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKIK 274
Query: 564 PPEIP 568
PP +P
Sbjct: 275 PPFVP 279
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 48/133 (36%), Positives = 77/133 (57%), Gaps = 15/133 (11%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFK--GSENRAT------LY 501
+F GT Y+APEI++GE +G +VDWW G+ ++E++ G++PF G + L+
Sbjct: 155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLF 214
Query: 502 NVV-GQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRR--GATEIKQHPFFQGVNWAL 558
V+ + +R P S +S A ++KG L K+P+ RL C G +IK HPFF+ ++W L
Sbjct: 215 QVILEKQIRIPRS--LSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDL 272
Query: 559 I--RCASPPEIPK 569
+ + PP P
Sbjct: 273 LEQKQVLPPYKPN 285
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 2e-23
Identities = 61/159 (38%), Positives = 85/159 (53%), Gaps = 4/159 (2%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
FR + LG G G V ++ T +A K ++K ++KRK A E+ IL+ ++ F
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDL--HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
+ +L +ET CLV+ GGDL H PG F EQ FY AE+ LE L
Sbjct: 62 VVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPG--FDEQRAIFYAAELCCGLEDLQ 119
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371
IVYRDLKPEN+L+ + GHI +SD L+++ TV
Sbjct: 120 RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV 158
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 4e-23
Identities = 58/152 (38%), Positives = 82/152 (53%), Gaps = 9/152 (5%)
Query: 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL----DHPFLP 276
+G G G VY T +AMK +DK ++ ++ A ER I+ SL D PF+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER-IMLSLVSTGDCPFIV 60
Query: 277 TLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGI 336
+ F T +++ GGDLH Q G FSE ++FY AE++L LE++H +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLH-YHLSQHG-VFSEAEMRFYAAEIILGLEHMHNRFV 118
Query: 337 VYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368
VYRDLKP N+L+ E GH+ +S DL L C S
Sbjct: 119 VYRDLKPANILLDEHGHVRIS--DLGLACDFS 148
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-23
Identities = 59/176 (33%), Positives = 97/176 (55%), Gaps = 19/176 (10%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
+ ++K +G G G V L ++ +AMK++ K + KR ER+I+ + P+
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ L+ F+ DK+ +VME+ PGGDL L E+ KFY AEV+LAL+ +H +
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD---VPEKWAKFYTAEVVLALDAIHSM 161
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLSL--------RCA--------VSPTVVKS 374
G+++RD+KP+N+L+ + GH+ L+DF + RC +SP V+KS
Sbjct: 162 GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKS 217
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 9e-23
Identities = 43/115 (37%), Positives = 69/115 (60%), Gaps = 4/115 (3%)
Query: 444 TNARSMS-FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN 502
++ +M F GT EYLAPE+++ +G AVDWW G+ +YE++ G+ PF ++
Sbjct: 147 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206
Query: 503 VVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRL-ACRRGATEIKQHPFFQGVNW 556
++ + +RFP + +S A+ L+ GLL K+P+ RL A EI +H FF +NW
Sbjct: 207 ILMEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINW 259
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 1e-22
Identities = 56/144 (38%), Positives = 83/144 (57%), Gaps = 7/144 (4%)
Query: 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREIL-QSLDHPFLPTLY 279
+G G V L L +AMKV+ K + + + QTE+ + Q+ +PFL L+
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 280 THFETDKFSCLVMEFCPGGDL--HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIV 337
+ F+T LV+E+ GGDL H RQR+ E+ +FY AE+ +AL +LH GI+
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRK----LPEEHARFYAAEICIALNFLHERGII 118
Query: 338 YRDLKPENVLVREDGHIMLSDFDL 361
YRDLK +NVL+ DGHI L+D+ +
Sbjct: 119 YRDLKLDNVLLDADGHIKLTDYGM 142
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 37/110 (33%), Positives = 53/110 (48%), Gaps = 3/110 (2%)
Query: 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN 502
+ + S GT Y+APE++ +G+ AVDWW+ G+ YE L GK P++G
Sbjct: 151 TPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210
Query: 503 VVGQPLRFPESPVV-SFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551
Q P S A D I LL ++PQ RL ++K HP+F
Sbjct: 211 RAKQETADVLYPATWSTEAIDAINKLLERDPQKRLGDN--LKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 2e-22
Identities = 53/141 (37%), Positives = 78/141 (55%), Gaps = 2/141 (1%)
Query: 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYT 280
+G G G V T+ +A+K + KA + R ++ ER +L ++ PF+ L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 281 HFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRD 340
F++ + LV+ F GG+L QR+ G+ F +FY AE+L ALE LH ++YRD
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQRE-GR-FDLSRARFYTAELLCALENLHKFNVIYRD 118
Query: 341 LKPENVLVREDGHIMLSDFDL 361
LKPEN+L+ GHI L DF L
Sbjct: 119 LKPENILLDYQGHIALCDFGL 139
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 2e-22
Identities = 46/131 (35%), Positives = 78/131 (59%), Gaps = 13/131 (9%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFK------GSENRATLYNV 503
+F GT Y+APEI++GE +G +VDWW G+ ++E++ G++PF L+ V
Sbjct: 155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQV 214
Query: 504 V-GQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACR--RGATEIKQHPFFQGVNWALI- 559
+ +P+R P +S A ++KG L K+P+ RL C+ G ++IK H FF+ ++W L+
Sbjct: 215 ILEKPIRIPRF--LSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLE 272
Query: 560 -RCASPPEIPK 569
+ +PP P+
Sbjct: 273 KKQVTPPFKPQ 283
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 2e-22
Identities = 56/144 (38%), Positives = 80/144 (55%), Gaps = 3/144 (2%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQ-SLDHPFLPT 277
K LG G G V L+EL G YFA+K + K + + E+ +L + ++PFL
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 278 LYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIV 337
LY F+T + VMEF GGDL + Q F FY AE++ L++LH GI+
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDL--MFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGII 118
Query: 338 YRDLKPENVLVREDGHIMLSDFDL 361
YRDLK +NV++ DGHI ++DF +
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGM 142
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 98.1 bits (244), Expect = 2e-22
Identities = 47/123 (38%), Positives = 74/123 (60%), Gaps = 5/123 (4%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR 509
+F GT +Y+APEII + +G +VDWW FG+ LYE+L G+ PF+G + +++ +
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA 219
Query: 510 FPESPVVSFSARDLIKGLLVKEPQNRLAC-RRGATEIKQHPFFQGVNWALI--RCASPPE 566
+P+S +S A + KGL+ K P RL C G +IK+H FF+ ++W + + PP
Sbjct: 220 YPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEVQPPY 277
Query: 567 IPK 569
PK
Sbjct: 278 KPK 280
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 6e-22
Identities = 46/123 (37%), Positives = 73/123 (59%), Gaps = 5/123 (4%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR 509
+F GT +Y+APEII + +G +VDWW +G+ LYE+L G+ PF G + +++ +
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS 219
Query: 510 FPESPVVSFSARDLIKGLLVKEPQNRLAC-RRGATEIKQHPFFQGVNWALI--RCASPPE 566
+P+S +S A + KGL+ K P RL C G +I++H FF+ ++W + R PP
Sbjct: 220 YPKS--LSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKLENREIQPPF 277
Query: 567 IPK 569
PK
Sbjct: 278 KPK 280
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 96.3 bits (239), Expect = 1e-21
Identities = 46/115 (40%), Positives = 72/115 (62%), Gaps = 4/115 (3%)
Query: 444 TNARSM-SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN 502
T+A +M +F GT EYLAPE+++ +G AVDWW G+ +YE++ G+ PF ++
Sbjct: 147 TDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 206
Query: 503 VVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRL-ACRRGATEIKQHPFFQGVNW 556
++ + ++FP + +S A+ L+ GLL+K+P RL A EI +H FF GVNW
Sbjct: 207 ILMEDIKFPRT--LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNW 259
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 50/173 (28%), Positives = 78/173 (45%), Gaps = 10/173 (5%)
Query: 216 RLLKKLGCGDIGSVYLSELTGTKCYFAMKV-----MDKASLEKRKKLLRAQTEREILQSL 270
L KKLG G G VY L G ++V + AS ++ ++ LR E I++ L
Sbjct: 2 TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLR---EARIMRKL 58
Query: 271 DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEY 330
DHP + L ++ +VME+ PGGDL ++ K S + + ++ +EY
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEY 118
Query: 331 LHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLR 383
L ++RDL N LV E+ + +SDF LS + P+R
Sbjct: 119 LESKNFIHRDLAARNCLVGENLVVKISDFGLS--RDLYDDDYYKVKGGKLPIR 169
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-21
Identities = 45/130 (34%), Positives = 76/130 (58%), Gaps = 6/130 (4%)
Query: 444 TNARSM-SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN 502
++ +M +F GT EYLAPE+++ +G AVDWW G+ +YE++ G+ PF ++
Sbjct: 147 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 206
Query: 503 VVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRL-ACRRGATEIKQHPFFQGVNW--ALI 559
++ + +RFP + +S A+ L+ GLL K+P+ RL A E+ +H FF +NW +
Sbjct: 207 ILMEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ 264
Query: 560 RCASPPEIPK 569
+ PP P+
Sbjct: 265 KKLLPPFKPQ 274
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 95.0 bits (236), Expect = 2e-21
Identities = 45/133 (33%), Positives = 75/133 (56%), Gaps = 11/133 (8%)
Query: 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ 506
R+ +F GT +Y+APEI++G + +VDWW+FG+ LYE+L G++PF G + ++
Sbjct: 152 RASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD 211
Query: 507 PLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALI--RCASP 564
+P ++ ++D+++ L ++P RL I+ HPFF+ +NW + R P
Sbjct: 212 TPHYPRW--ITKESKDILEKLFERDPTRRLGV---VGNIRGHPFFKTINWTALEKRELDP 266
Query: 565 PEIPKPVEIVHSP 577
P PK V SP
Sbjct: 267 PFKPK----VKSP 275
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 94.3 bits (235), Expect = 2e-21
Identities = 48/159 (30%), Positives = 75/159 (47%), Gaps = 9/159 (5%)
Query: 217 LLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLP 276
K+G G G VY + T A+K + + K + E ++L+ L HP L
Sbjct: 4 RGNKIGGGTFGKVYTAVNLDTGELMAVKEI-RIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 277 TLY---THFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
Y H E + ME+C GG L L + G+ E ++ Y ++L L YLH
Sbjct: 63 KYYGVEVHREK---VYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHS 117
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372
GIV+RD+KP N+ + +G I L DF +++ + T +
Sbjct: 118 HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM 156
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 63/177 (35%), Positives = 91/177 (51%), Gaps = 14/177 (7%)
Query: 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL----DHPFLP 276
+G G G VY T +AMK +DK ++ ++ A ER I+ SL D PF+
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNER-IMLSLVSTGDCPFIV 60
Query: 277 TLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGI 336
+ F T C +++ GGDLH Q G FSE+ ++FY E++L LE++H +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLH-YHLSQHG-VFSEKEMRFYATEIILGLEHMHNRFV 118
Query: 337 VYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSST-----LESEPLRKNPVY 388
VYRDLKP N+L+ E GH+ +S DL L C S +S + E L+K Y
Sbjct: 119 VYRDLKPANILLDEHGHVRIS--DLGLACDFSKKKPHASVGTHGYMAPEVLQKGTAY 173
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-21
Identities = 67/191 (35%), Positives = 96/191 (50%), Gaps = 18/191 (9%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP- 273
F L LG G G V L+E GT +A+K++ K + + + E+ +L D P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPP 61
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
FL L++ F+T VME+ GGDL Q Q GK+ QAV FY AE+ + L +LH
Sbjct: 62 FLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQ-QVGKFKEPQAV-FYAAEISVGLFFLHR 119
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPA 393
GI+YRDLK +NV++ +GHI ++DF + K ++ R +C P
Sbjct: 120 RGIIYRDLKLDNVMLDSEGHIKIADFGM----------CKEHMVDGVTTR---TFCGTPD 166
Query: 394 CIEPSCI--QP 402
I P I QP
Sbjct: 167 YIAPEIIAYQP 177
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 5e-21
Identities = 52/139 (37%), Positives = 74/139 (53%), Gaps = 8/139 (5%)
Query: 442 EPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY 501
EP S +F GT EYLAPE+++ E + VDWW G LYE+L+G PF +
Sbjct: 148 EPEETTS-TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD 206
Query: 502 NVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALI-- 559
N++ +PL+ P V +A DL+ GLL K+ + RL + EIK H FF +NW +
Sbjct: 207 NILHKPLQLPGGKTV--AACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDDLYH 264
Query: 560 -RCASP--PEIPKPVEIVH 575
R P P + P ++ H
Sbjct: 265 KRITPPYNPNVAGPADLRH 283
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 6e-21
Identities = 43/124 (34%), Positives = 71/124 (57%), Gaps = 5/124 (4%)
Query: 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFP 511
VGT Y+APE++ + + + D+W G +YE++ G++PF+G + + V + L
Sbjct: 162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE 221
Query: 512 ESPVVSFS--ARDLIKGLLVKEPQNRLACRR-GATEIKQHPFFQGVNWALIRCA--SPPE 566
E FS A+ + K LL K+P+ RL C+ GA E+K+HPFF+ +N+ + PP
Sbjct: 222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPF 281
Query: 567 IPKP 570
+P P
Sbjct: 282 VPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 92.1 bits (229), Expect = 6e-21
Identities = 47/150 (31%), Positives = 81/150 (54%), Gaps = 3/150 (2%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F++LKKLG G GSVY + ++A+K +D S+ ++++ A E IL S++HP
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKERE-DAVNEIRILASVNHPN 60
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTL--RQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
+ + F C+VME+ P GDL ++++ K EQ + ++L L+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
I++RDLK N+L+ + + + D +S
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGIS 150
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 7e-21
Identities = 46/129 (35%), Positives = 71/129 (55%), Gaps = 13/129 (10%)
Query: 448 SMSFVGTHEYLAPEI---IKGEG---HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY 501
S VGT +Y+APE+ + G+G +G DWW+ G+ YE+++G++PF + T
Sbjct: 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN 219
Query: 502 NVVG--QPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALI 559
N++ + L+FPE P VS DLI+ LL + RL + HPFF ++W I
Sbjct: 220 NIMNFQRFLKFPEDPKVSSDFLDLIQSLLCG-QKERLGYEG----LCCHPFFSKIDWNNI 274
Query: 560 RCASPPEIP 568
R + PP +P
Sbjct: 275 RNSLPPFVP 283
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 7e-21
Identities = 46/123 (37%), Positives = 72/123 (58%), Gaps = 5/123 (4%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR 509
+F GT EYLAPE+++ +G AVDWW G+ +YE++ G+ PF ++ ++ + +R
Sbjct: 155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIR 214
Query: 510 FPESPVVSFSARDLIKGLLVKEPQNRL-ACRRGATEIKQHPFFQGVNWALI--RCASPPE 566
FP + +S A+ L+ GLL K+P+ RL A EI QH FF G+ W + + PP
Sbjct: 215 FPRT--LSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQDVYEKKLVPPF 272
Query: 567 IPK 569
P+
Sbjct: 273 KPQ 275
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 7e-21
Identities = 46/126 (36%), Positives = 71/126 (56%), Gaps = 3/126 (2%)
Query: 448 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP 507
+ +F GT EYLAPE+I+ + + + VDWW G LYE+L+G PF + N++ +P
Sbjct: 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP 212
Query: 508 LRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA-LIRCASPPE 566
L P S +A +++ LL K+ Q RL + EI++HPFF+ ++W L + PP
Sbjct: 213 LVL--RPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTDLEQKKIPPP 270
Query: 567 IPKPVE 572
VE
Sbjct: 271 FNPNVE 276
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 93.1 bits (231), Expect = 1e-20
Identities = 56/148 (37%), Positives = 83/148 (56%), Gaps = 3/148 (2%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQ-SLDHP 273
F L LG G G V L+E GT +A+K++ K + + + E+ +L S P
Sbjct: 2 FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPP 61
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
FL L++ F+T VME+ GGDL Q Q G++ AV FY AE+ + L +LH
Sbjct: 62 FLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQ-QVGRFKEPHAV-FYAAEIAIGLFFLHS 119
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDL 361
GI+YRDLK +NV++ +GHI ++DF +
Sbjct: 120 KGIIYRDLKLDNVMLDSEGHIKIADFGM 147
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 1e-20
Identities = 49/176 (27%), Positives = 87/176 (49%), Gaps = 5/176 (2%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F +L K+G G G V+ K +AMK +D + + +R++ A E +L LD +
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRRERE-EAIDEARVLAKLDSSY 60
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAV-KFYVAEVLLALEYLHM 333
+ Y F +VME+ GDLH L + Q G+ E V +F++ ++LL L +LH
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFI-QILLGLAHLHS 119
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYC 389
I++RD+K N+ + ++ + D ++ +S ++T+ P +P C
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAK--LLSDNTNFANTIVGTPYYLSPELC 173
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 8/125 (6%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN-VVGQPL 508
+F GT +Y+APEI++ +G +VDWW G+ LYE+L G PF+ +EN L+ ++ +
Sbjct: 155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE-AENEDDLFEAILNDEV 213
Query: 509 RFPESPVVSFSARDLIKGLLVKEPQNRLAC--RRGATEIKQHPFFQGVNWALI--RCASP 564
+P +S A D++K + K P RL G I +HPFF+ ++W + R P
Sbjct: 214 VYPTW--LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEP 271
Query: 565 PEIPK 569
P P+
Sbjct: 272 PFRPR 276
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 91.0 bits (227), Expect = 2e-20
Identities = 50/155 (32%), Positives = 74/155 (47%), Gaps = 13/155 (8%)
Query: 215 FRLLKKLGCGDIGSVYL------SELTGTKCYFAMKVM-DKASLEKRKKLLRAQTEREIL 267
L KKLG G G VY E T TK A+K + + AS E+R++ L E I+
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKV--AVKTLKEGASEEEREEFLE---EASIM 55
Query: 268 QSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLA 327
+ L HP + L + +V E+ PGGDL ++ K + ++ ++
Sbjct: 56 KKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQM-ALQIAKG 114
Query: 328 LEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+EYL V+RDL N LV E+ + +SDF LS
Sbjct: 115 MEYLESKNFVHRDLAARNCLVTENLVVKISDFGLS 149
|
Length = 258 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 53/146 (36%), Positives = 77/146 (52%), Gaps = 4/146 (2%)
Query: 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYT 280
LG G G V ++ T +A K +DK L+K+ A E+EIL+ ++ PF+ L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 281 HFETDKFSCLVMEFCPGGDL--HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVY 338
FE+ CLVM GGDL H + G V Y A++ + +LH + IVY
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMER--VIHYSAQITCGILHLHSMDIVY 118
Query: 339 RDLKPENVLVREDGHIMLSDFDLSLR 364
RD+KPENVL+ + G+ LSD L++
Sbjct: 119 RDMKPENVLLDDQGNCRLSDLGLAVE 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 3e-20
Identities = 45/122 (36%), Positives = 70/122 (57%), Gaps = 5/122 (4%)
Query: 452 VGTHEYLAPEII-KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRF 510
VGTH Y+APE++ KG + S+ DW++ G L++LL G +PF+ + +
Sbjct: 156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 215
Query: 511 PESP-VVSFSARDLIKGLLVKEPQNRLACR-RGATEIKQHPFFQGVNWALI--RCASPPE 566
E P S R L++GLL ++ RL C RGA E+K+HPFF+ ++W ++ + PP
Sbjct: 216 VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPPPL 275
Query: 567 IP 568
IP
Sbjct: 276 IP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 89.9 bits (224), Expect = 4e-20
Identities = 51/174 (29%), Positives = 81/174 (46%), Gaps = 13/174 (7%)
Query: 216 RLLKKLGCGDIGSVYLSELTGTKCYFAMKV-----MDKASLEKRKKLLRAQTEREILQSL 270
L KKLG G G VY +L G ++V + AS ++ ++ LR E I++ L
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLR---EARIMRKL 58
Query: 271 DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALE 329
DHP + L ++ +VME+ GGDL + LR+ +P S + + ++ +E
Sbjct: 59 DHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRP--KLSLSDLLSFALQIARGME 116
Query: 330 YLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLR 383
YL ++RDL N LV E+ + +SDF LS + P+R
Sbjct: 117 YLESKNFIHRDLAARNCLVGENLVVKISDFGLS--RDLYDDDYYRKRGGKLPIR 168
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 91.3 bits (226), Expect = 5e-20
Identities = 48/131 (36%), Positives = 77/131 (58%), Gaps = 15/131 (11%)
Query: 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFK--GSENRAT------LYN 502
F GT Y+APEI++GE +G +VDWW G+ ++E++ G++PF GS + L+
Sbjct: 156 FCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 215
Query: 503 VV-GQPLRFPESPVVSFSARDLIKGLLVKEPQNRLAC--RRGATEIKQHPFFQGVNWALI 559
V+ + +R P S +S A ++K L K+P+ RL C + G +I+ HPFF+ V+W L+
Sbjct: 216 VILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLM 273
Query: 560 --RCASPPEIP 568
+ PP P
Sbjct: 274 EQKQVVPPFKP 284
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 1e-19
Identities = 46/138 (33%), Positives = 75/138 (54%), Gaps = 10/138 (7%)
Query: 441 AEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATL 500
A+ + R+ + GT EY+APEI+ GHG A DWWT GIF+YE+L G PF +E
Sbjct: 178 AKVVDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY 237
Query: 501 YNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLA-CRRGATEIKQHPFFQGVNWALI 559
++ + FP+ + + + L+K LL + R ++GA +K+HP+F ++W +
Sbjct: 238 QKILEGIIYFPK--FLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVSL 295
Query: 560 RCASPPEIPKPVEIVHSP 577
+ K VE+ + P
Sbjct: 296 -------LHKNVEVPYKP 306
|
Length = 340 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 51/147 (34%), Positives = 73/147 (49%), Gaps = 10/147 (6%)
Query: 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQSLDHPFLPTL 278
LG G GSVY +FA+K + A + + Q E+EI L L HP +
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 279 Y-THFETDKFSCLVMEFCPGGDLHTLRQRQPGKY--FSEQAVKFYVAEVLLALEYLHMLG 335
T E D + +E PGG L L + KY F E ++ Y ++LL LEYLH
Sbjct: 68 LGTEREEDNL-YIFLELVPGGSLAKLLK----KYGSFPEPVIRLYTRQILLGLEYLHDRN 122
Query: 336 IVYRDLKPENVLVREDGHIMLSDFDLS 362
V+RD+K N+LV +G + L+DF ++
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMA 149
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 3e-19
Identities = 45/131 (34%), Positives = 76/131 (58%), Gaps = 9/131 (6%)
Query: 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY-NV 503
+ +F GT +Y+APEI++ +G +VDWW G+ +YE++ G+ PF+ ++N L+ ++
Sbjct: 150 GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFE-ADNEDDLFESI 208
Query: 504 VGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLAC---RRGATEIKQHPFFQGVNWALI- 559
+ + +P +S A ++K + K P RL C + G IKQHPFF+ ++W L+
Sbjct: 209 LHDDVLYP--VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLE 266
Query: 560 -RCASPPEIPK 569
R PP PK
Sbjct: 267 QRKIKPPFKPK 277
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 46/155 (29%), Positives = 75/155 (48%), Gaps = 20/155 (12%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVM----DKASLEKRKKLLRAQTEREILQSL 270
F +L+KLG G GSVY + T A+KV+ D + K E IL+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIK---------EISILKQC 55
Query: 271 DHPFLPTLYTHFETDKFSCLVMEFCPGG---DLHTLRQRQPGKYFSEQAVKFYVAEVLLA 327
D P++ Y + + +VME+C G D+ + + +E+ + + + L
Sbjct: 56 DSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKT----LTEEEIAAILYQTLKG 111
Query: 328 LEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
LEYLH ++RD+K N+L+ E+G L+DF +S
Sbjct: 112 LEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVS 146
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 3e-19
Identities = 45/146 (30%), Positives = 73/146 (50%), Gaps = 5/146 (3%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
++ L+K+G G G VY + T A+K M + K+L+ E I++ HP
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK--QNKELII--NEILIMKDCKHP 75
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
+ Y + +VME+ GG L T Q +E + + EVL LEYLH
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSL-TDIITQNFVRMNEPQIAYVCREVLQGLEYLHS 134
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDF 359
+++RD+K +N+L+ +DG + L+DF
Sbjct: 135 QNVIHRDIKSDNILLSKDGSVKLADF 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 87.3 bits (217), Expect = 3e-19
Identities = 45/159 (28%), Positives = 79/159 (49%), Gaps = 12/159 (7%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASL-EKRKKLLRAQTEREILQSLDH 272
+ +L+ +G G G+V K +D ++ EK K+ L + E IL+ L H
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVS--EVNILRELKH 58
Query: 273 PFLPTLYTHF--ETDKFSCLVMEFCPGGDLHTL--RQRQPGKYFSEQAVKFYVAEVLLAL 328
P + Y +++ +VME+C GGDL L + ++ KY E+ + + ++LLAL
Sbjct: 59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 329 EYLHMLG-----IVYRDLKPENVLVREDGHIMLSDFDLS 362
H +++RDLKP N+ + + ++ L DF L+
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLA 157
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 91.1 bits (226), Expect = 4e-19
Identities = 46/120 (38%), Positives = 71/120 (59%), Gaps = 5/120 (4%)
Query: 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFP 511
+GT +YLAPE++ G+ HG AVDWW G+ L+E L G PF + N++ + + +P
Sbjct: 541 LGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 512 E-SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPKP 570
E +S +A++ I+ LL +P R G E+KQHP F GV+W ++ + P IP+P
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTK----RAGLKELKQHPLFHGVDWENLQNQTMPFIPQP 656
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-19
Identities = 49/126 (38%), Positives = 71/126 (56%), Gaps = 10/126 (7%)
Query: 452 VGTHEYLAPEIIKGEG----HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ- 506
VGT +Y++PE++K +G +G DWW+ G+FL+E+L G TPF T ++
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHK 263
Query: 507 -PLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG--VNWALIRCAS 563
L FPE +S A++LI L + + RL R G EIKQHPFF+ NW IR +
Sbjct: 264 NSLNFPEDVEISKHAKNLICAFLT-DREVRLG-RNGVEEIKQHPFFKNDQWNWDNIRETA 321
Query: 564 PPEIPK 569
P +P+
Sbjct: 322 APVVPE 327
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (218), Expect = 4e-19
Identities = 47/155 (30%), Positives = 74/155 (47%), Gaps = 17/155 (10%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQSLDH 272
+ + ++G G G VY + T A+K K +E K+ REI LQ L H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALK---KIRMENEKEGFPITAIREIKLLQKLRH 57
Query: 273 PFLPTLY----THFETDKFSCLVMEFCPGGDLHTLRQ--RQPGKYFSEQAVKFYVAEVLL 326
P + L + + + +V E+ H L P F+E +K Y+ ++L
Sbjct: 58 PNIVRLKEIVTSKGKGSIY--MVFEYMD----HDLTGLLDSPEVKFTESQIKCYMKQLLE 111
Query: 327 ALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDL 361
L+YLH GI++RD+K N+L+ DG + L+DF L
Sbjct: 112 GLQYLHSNGILHRDIKGSNILINNDGVLKLADFGL 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 46/124 (37%), Positives = 67/124 (54%), Gaps = 5/124 (4%)
Query: 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFP 511
VGT Y+APE++K E + + DWW G LYE++ G++PF+ + + V
Sbjct: 162 VGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ 221
Query: 512 ESPVVSFS--ARDLIKGLLVKEPQNRLACR-RGATEIKQHPFFQGVNWALIRCA--SPPE 566
E FS AR L K LL K+P+ RL C+ GA E+K+HP F+ +N+ + PP
Sbjct: 222 EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLEPPF 281
Query: 567 IPKP 570
P P
Sbjct: 282 KPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (216), Expect = 6e-19
Identities = 52/156 (33%), Positives = 77/156 (49%), Gaps = 16/156 (10%)
Query: 219 KKLGCGDIGSVYLSELT---GTKCYFAMKVM-DKASLEKRKKLLRAQTEREILQSLDHPF 274
KKLG G G VY +L G A+K + + AS E+RK L+ E +++ L HP
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLK---EARVMKKLGHPN 57
Query: 275 LPTLYTHFETDKFS-CLVMEFCPGGDLHT-LRQRQP------GKYFSEQAVKFYVAEVLL 326
+ L T++ LV+E+ GGDL LR+ +P S + + + ++
Sbjct: 58 VVRLL-GVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAK 116
Query: 327 ALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+EYL V+RDL N LV ED + +SDF LS
Sbjct: 117 GMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS 152
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 9e-19
Identities = 53/155 (34%), Positives = 84/155 (54%), Gaps = 16/155 (10%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDK--ASLEKRKKLLRAQTEREILQSL-- 270
++++K+LG G GSVYL+ T A+K M K S E+ L RE+ +SL
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL------REV-KSLRK 53
Query: 271 --DHPFLPTLYTHF-ETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLA 327
+HP + L F E D+ V E+ G +L+ L + + GK FSE ++ + ++L
Sbjct: 54 LNEHPNIVKLKEVFRENDEL-YFVFEYMEG-NLYQLMKDRKGKPFSESVIRSIIYQILQG 111
Query: 328 LEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
L ++H G +RDLKPEN+LV + ++DF L+
Sbjct: 112 LAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 51/144 (35%), Positives = 81/144 (56%), Gaps = 13/144 (9%)
Query: 440 IAEPTNARSMSFVGTHEYLAPEIIK----GEG-HGSAVDWWTFGIFLYELLFGKTPFKGS 494
+ E +S VGT +Y++PEI++ G+G +G DWW+ G+ +YE+L+G+TPF
Sbjct: 152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE 211
Query: 495 ENRATLYNVVGQPLRF---PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551
T ++ RF + VS A+DLI+ L+ ++RL + G + KQHPFF
Sbjct: 212 SLVETYGKIMNHKERFQFPAQVTDVSEDAKDLIRRLICSR-EHRLG-QNGIEDFKQHPFF 269
Query: 552 QGVNWALIR-CASP--PEIPKPVE 572
G++W IR C +P PE+ P +
Sbjct: 270 TGIDWDNIRNCEAPYIPEVSSPTD 293
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 35/129 (27%), Positives = 70/129 (54%), Gaps = 9/129 (6%)
Query: 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS----ENRATLYN 502
++ + GT ++APE+++GE + +VD++ G+ LYE++ + PF+ EN+
Sbjct: 153 KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQR 212
Query: 503 VVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGA-TEIKQHPFFQGVNWALIRC 561
++ + +P+ S +++ + LL K+P+ RL R G ++ HP F+ +NW +
Sbjct: 213 ILNDSVTYPDK--FSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWRQLEA 270
Query: 562 A--SPPEIP 568
PP +P
Sbjct: 271 GMLPPPFVP 279
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-18
Identities = 47/131 (35%), Positives = 70/131 (53%), Gaps = 10/131 (7%)
Query: 447 RSMSFVGTHEYLAPEIIKGEG----HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN 502
R + VGT +Y++PE++K +G +G DWW+ G+FLYE+L G TPF T
Sbjct: 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSK 258
Query: 503 VVGQ--PLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWAL-- 558
++ L FP+ +S A++LI L + + RL R G EIK+H FF+ WA
Sbjct: 259 IMNHKNSLTFPDDNDISKEAKNLICAFLT-DREVRLG-RNGVEEIKRHLFFKNDQWAWET 316
Query: 559 IRCASPPEIPK 569
+R P +P
Sbjct: 317 LRDTVAPVVPD 327
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 47/144 (32%), Positives = 71/144 (49%), Gaps = 5/144 (3%)
Query: 432 QVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPF 491
++S L + P VGT Y+APE+I E + + DWW G +YE++ G++PF
Sbjct: 142 RISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
Query: 492 KGSENRATLYNVVGQPLRFPESPVVSFS--ARDLIKGLLVKEPQNRLACR-RGATEIKQH 548
+ + R V + E FS A+ + + LL K P+ RL CR GA +KQH
Sbjct: 202 RKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH 261
Query: 549 PFFQGVNWALIRC--ASPPEIPKP 570
P F+ +N+ + PP P P
Sbjct: 262 PIFKNINFKRLEANMLEPPFCPDP 285
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 4e-18
Identities = 49/136 (36%), Positives = 75/136 (55%), Gaps = 16/136 (11%)
Query: 452 VGTHEYLAPEIIK----GEG-HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ 506
VGT +Y++PEI++ G G +G DWW+ G+ +YE+L+G+TPF T ++
Sbjct: 164 VGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 223
Query: 507 PLRFPESPV----VSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCA 562
RF + P VS A+DLI+ L+ + RL + G + K+H FF+G++W IR
Sbjct: 224 EERF-QFPSHITDVSEEAKDLIQRLICSR-ERRLG-QNGIEDFKKHAFFEGIDWENIRNL 280
Query: 563 SPPEIPKPVEIVHSPA 578
P IP V SP+
Sbjct: 281 EAPYIPD----VSSPS 292
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 4e-18
Identities = 46/154 (29%), Positives = 73/154 (47%), Gaps = 11/154 (7%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKR----KKLLRAQTEREILQS 269
+ L++ +G G VY + A+K +D LEK +L + E + +
Sbjct: 2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRID---LEKCQTSVDELRK---EVQAMSQ 55
Query: 270 LDHPFLPTLYTHFETDKFSCLVMEFCPGGD-LHTLRQRQPGKYFSEQAVKFYVAEVLLAL 328
+HP + YT F LVM + GG L ++ P E + + EVL L
Sbjct: 56 CNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGL 115
Query: 329 EYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
EYLH G ++RD+K N+L+ EDG + ++DF +S
Sbjct: 116 EYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVS 149
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.1 bits (209), Expect = 7e-18
Identities = 49/150 (32%), Positives = 78/150 (52%), Gaps = 7/150 (4%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQSLDH 272
+ L+KLG G G VY + T A+K + L+ ++ + + REI L+ L H
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI---RLDNEEEGIPSTALREISLLKELKH 57
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
P + L T++ LV E+C DL ++PG S +K + ++L L Y H
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGP-LSPNLIKSIMYQLLRGLAYCH 115
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
I++RDLKP+N+L+ DG + L+DF L+
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLA 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 9e-18
Identities = 49/152 (32%), Positives = 81/152 (53%), Gaps = 11/152 (7%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQSLDH 272
+++L ++G G G V+ ++ T A+K K +L + + + Q REI LQ+ H
Sbjct: 2 YKILGRIGEGAHGIVFKAKDRETGETVALK---KVALRRLEGGIPNQALREIKALQACQH 58
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHTL--RQRQPGKYFSEQAVKFYVAEVLLALEY 330
P++ L F LVME+ P DL + + +P E VK Y+ +L + Y
Sbjct: 59 PYVVKLLDVFPHGSGFVLVMEYMPS-DLSEVLRDEERP---LPEAQVKSYMRMLLKGVAY 114
Query: 331 LHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+H GI++RDLKP N+L+ DG + ++DF L+
Sbjct: 115 MHANGIMHRDLKPANLLISADGVLKIADFGLA 146
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 2e-17
Identities = 49/150 (32%), Positives = 76/150 (50%), Gaps = 6/150 (4%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+ L++++G G G VY + T A+KV+ LE Q E +L+ HP
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRHP 60
Query: 274 FLPTLY-THFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
+ + ++ DK +VME+C GG L + Q G SE + + E L L YLH
Sbjct: 61 NIVAYFGSYLRRDKL-WIVMEYCGGGSLQDIYQVTRGP-LSELQIAYVCRETLKGLAYLH 118
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
G ++RD+K N+L+ EDG + L+DF +S
Sbjct: 119 ETGKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 2e-17
Identities = 49/160 (30%), Positives = 80/160 (50%), Gaps = 13/160 (8%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL- 270
G F L++ +G G G VY + T A+K+MD +E ++ + E IL+
Sbjct: 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD--IIEDEEE--EIKEEYNILRKYS 60
Query: 271 DHPFLPTLYTHFETDKFSC------LVMEFCPGGDLHTLRQ--RQPGKYFSEQAVKFYVA 322
+HP + T Y F LVME C GG + L + R+ GK E+ + + +
Sbjct: 61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILR 120
Query: 323 EVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
E L L YLH +++RD+K +N+L+ ++ + L DF +S
Sbjct: 121 ETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (203), Expect = 3e-17
Identities = 45/150 (30%), Positives = 69/150 (46%), Gaps = 6/150 (4%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKAS-LEKRKKLLRAQTEREILQSLDHP 273
L +LG G+ G V T A+K + +K++LR E +IL + P
Sbjct: 3 LEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILR---ELDILHKCNSP 59
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH- 332
++ Y F + + ME+ GG L + + G+ E+ + VL L YLH
Sbjct: 60 YIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGR-IPERILGKIAVAVLKGLTYLHE 118
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
I++RD+KP N+LV G I L DF +S
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVS 148
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 49/129 (37%), Positives = 74/129 (57%), Gaps = 19/129 (14%)
Query: 452 VGTHEYLAPEII-KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE-------NRATLYNV 503
VGTH Y+APE++ KG + S+ DW++ G L++LL G +PF+ + +R TL
Sbjct: 156 VGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVN 215
Query: 504 VGQPLRF-PESPVVSFSARDLIKGLLVKEPQNRLACR-RGATEIKQHPFFQGVNW--ALI 559
V P F PE + L++GLL ++ RL C RGA E+K+H FF+G++W +
Sbjct: 216 VELPDSFSPE-------LKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQVYL 268
Query: 560 RCASPPEIP 568
+ PP IP
Sbjct: 269 QKYPPPLIP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 4e-17
Identities = 47/149 (31%), Positives = 76/149 (51%), Gaps = 1/149 (0%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
H+ ++ LG G G L T K ++ L ++++ A E IL L HP
Sbjct: 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRD-ALNEIVILSLLQHP 59
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
+ Y HF D + ME+ GG L+ RQ G+ F E+ V +Y+ +++ A+ Y+H
Sbjct: 60 NIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK 119
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLS 362
GI++RD+K N+ + + G I L DF +S
Sbjct: 120 AGILHRDIKTLNIFLTKAGLIKLGDFGIS 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.4 bits (199), Expect = 1e-16
Identities = 49/148 (33%), Positives = 74/148 (50%), Gaps = 5/148 (3%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F LL+ +G G G VY + T A+KV+D E + + Q E + L P+
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDI--QQEIQFLSQCRSPY 60
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ Y F ++ME+C GG L + E + F + EVLL LEYLH
Sbjct: 61 ITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK---LDETYIAFILREVLLGLEYLHEE 117
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLS 362
G ++RD+K N+L+ E+G + L+DF +S
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGVS 145
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.2 bits (201), Expect = 1e-16
Identities = 46/159 (28%), Positives = 74/159 (46%), Gaps = 19/159 (11%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKA--SLEKRKKLLRAQTEREILQSLD 271
++ L +G G G V + T T A+K + + S K R E +L+ +D
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAK---RTYRELRLLKHMD 72
Query: 272 HP--------FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAE 323
H F P + E + LV G DL+ + + Q S+ ++F V +
Sbjct: 73 HENVIGLLDVFTPA--SSLEDFQDVYLVTHLM-GADLNNIVKCQK---LSDDHIQFLVYQ 126
Query: 324 VLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+L L+Y+H GI++RDLKP N+ V ED + + DF L+
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 48/173 (27%), Positives = 88/173 (50%), Gaps = 5/173 (2%)
Query: 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPT 277
++ +G G G V+L + +K + + K ++L AQ E ++L+ L HP +
Sbjct: 5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERL-AAQNECQVLKLLSHPNIIE 63
Query: 278 LYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIV 337
Y +F DK +VME+ PGG L Q++ E + + ++LLAL ++H I+
Sbjct: 64 YYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123
Query: 338 YRDLKPENVLVREDGHIM-LSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYC 389
+RDLK +N+L+ + ++ + DF +S + + K+ T+ P +P C
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGIS---KILSSKSKAYTVVGTPCYISPELC 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 46/178 (25%), Positives = 91/178 (51%), Gaps = 12/178 (6%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
+ ++KK+G G G +YL++ + +K +D + ++K ++ E +L + HP
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKE-ASKKEVILLAKMKHPN 60
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ T + F+ + +VME+C GGDL RQ G FSE + + ++ L L+++H
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120
Query: 335 GIVYRDLKPENVLVREDGHIM-LSDF----------DLSLRCAVSPTVVKSSTLESEP 381
I++RD+K +N+ + ++G + L DF +L+ C +P + ++ P
Sbjct: 121 KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP 178
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 3e-16
Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 20/204 (9%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
+ ++ +LG G G VY ++ T A KV++ S E+ + + E EIL + +HP+
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYM---VEIEILATCNHPY 70
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ L F D +++EFCPGG + + + + +E ++ ++L AL+YLH +
Sbjct: 71 IVKLLGAFYWDGKLWIMIEFCPGGAVDAI-MLELDRGLTEPQIQVICRQMLEALQYLHSM 129
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLSLRCA---------------VSPTVVKSSTLES 379
I++RDLK NVL+ DG I L+DF +S + ++P VV T++
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 380 EPLR-KNPVYCVQPACIEPSCIQP 402
P K ++ + IE + I+P
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEP 213
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 79.5 bits (197), Expect = 3e-16
Identities = 49/156 (31%), Positives = 68/156 (43%), Gaps = 4/156 (2%)
Query: 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQSLDHPFL 275
KKLG G VY + T A+K + ++ K + REI LQ L HP +
Sbjct: 5 GKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNI 64
Query: 276 PTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLG 335
L F LV EF DL + + + +K Y+ L LEYLH
Sbjct: 65 IGLLDVFGHKSNINLVFEFMET-DLEKV-IKDKSIVLTPADIKSYMLMTLRGLEYLHSNW 122
Query: 336 IVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371
I++RDLKP N+L+ DG + L+DF L+
Sbjct: 123 ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK 158
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 52/156 (33%), Positives = 80/156 (51%), Gaps = 10/156 (6%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMK-VMDKASLEKRKKLLRAQTEREILQSLD 271
L +LG G GSV L T FA+K + + + +K++LR E EI +S
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILR---ELEINKSCK 57
Query: 272 HPFLPTLYTHFETDKFSCL--VMEFCPGGDLHTL--RQRQPGKYFSEQAVKFYVAE-VLL 326
P++ Y F + S + ME+C GG L ++ + ++ G E+ V +AE VL
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEK-VLGKIAESVLK 116
Query: 327 ALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
L YLH I++RD+KP N+L+ G + L DF +S
Sbjct: 117 GLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVS 152
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 8e-16
Identities = 45/151 (29%), Positives = 81/151 (53%), Gaps = 7/151 (4%)
Query: 217 LLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRK--KLLRAQTEREILQSLDHPF 274
L ++LG G G+VYL + +KV+ + + + + ++A E ++L LDHP
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 275 LPTLYTHF-ETDKFSCLVMEFCPGGDLHTLRQ--RQPGKYFSEQAVKFYVAEVLLALEYL 331
+ + F E D F C++ E+C G DL + + GK SE V + ++LL + Y+
Sbjct: 64 IVKFHASFLERDAF-CIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
H I++RDLK +N+ ++ + + + DF +S
Sbjct: 123 HQRRILHRDLKAKNIFLKNN-LLKIGDFGVS 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 8e-16
Identities = 42/149 (28%), Positives = 80/149 (53%), Gaps = 4/149 (2%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+ ++ +LG G G VY ++ T + A K++ +E ++L E +IL HP
Sbjct: 6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQ---IESEEELEDFMVEIDILSECKHP 62
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
+ LY + + +++EFC GG L ++ + + +E +++ ++L AL +LH
Sbjct: 63 NIVGLYEAYFYENKLWILIEFCDGGALDSIML-ELERGLTEPQIRYVCRQMLEALNFLHS 121
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+++RDLK N+L+ DG + L+DF +S
Sbjct: 122 HKVIHRDLKAGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 8e-16
Identities = 52/154 (33%), Positives = 75/154 (48%), Gaps = 8/154 (5%)
Query: 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQSLDHPFL 275
L K+G G G VY + T A+K K L + + REI L+ L+HP +
Sbjct: 4 LGKIGEGTYGVVYKARDKLTGEIVAIK---KIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 276 PTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLG 335
L F LV EF ++ RQ G E +K Y+ ++L L + H G
Sbjct: 61 IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRG--LPESLIKSYLYQLLQGLAFCHSHG 118
Query: 336 IVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369
I++RDLKPEN+L+ +G + L+DF L+ R SP
Sbjct: 119 ILHRDLKPENLLINTEGVLKLADFGLA-RSFGSP 151
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 37/117 (31%), Positives = 52/117 (44%), Gaps = 7/117 (5%)
Query: 440 IAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR-- 497
+ E T + +FVGT Y++PE I+GE + A D W+ G+ L E GK PF
Sbjct: 149 VLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSF 208
Query: 498 -ATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
+ + P + S RD I L K+P R A E+ QHPF +
Sbjct: 209 FELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDP----KKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (190), Expect = 3e-15
Identities = 45/159 (28%), Positives = 80/159 (50%), Gaps = 19/159 (11%)
Query: 214 HFRLLKKLGCGDIGSVYLS--ELTGTKCYFAMKVMDKA--SLEKRKKLLRAQTEREILQS 269
+ LLK +G G G V + + TG K A+K + L K++LR E ++L+
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRK--VAIKKISNVFDDLIDAKRILR---EIKLLRH 55
Query: 270 LDHPF---LPTLYTHFETDKFS--CLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAE 323
L H L + + F+ +V E DLH ++ QP ++ +++++ +
Sbjct: 56 LRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQP---LTDDHIQYFLYQ 111
Query: 324 VLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+L L+YLH +++RDLKP N+LV + + + DF L+
Sbjct: 112 ILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 44/170 (25%), Positives = 86/170 (50%), Gaps = 10/170 (5%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
++ L+ +G G G+VY + T A+K+++ + + + Q E +L L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDD--DVSDIQREVALLSQLRQSQ 60
Query: 275 LPTLYTHFET---DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
P + ++ + ++ME+ GG + TL + P +E+ + + EVL+AL+Y+
Sbjct: 61 PPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGP---IAEKYISVIIREVLVALKYI 117
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEP 381
H +G+++RD+K N+LV G++ L DF ++ ++ K ST P
Sbjct: 118 HKVGVIHRDIKAANILVTNTGNVKLCDFGVA--ALLNQNSSKRSTFVGTP 165
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 4e-15
Identities = 33/110 (30%), Positives = 48/110 (43%), Gaps = 6/110 (5%)
Query: 442 EPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSEN-RATL 500
T AR + VGT ++APE+I G+ + D W+ GI EL GK P+ +A
Sbjct: 149 SDTKAR-NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALF 207
Query: 501 YNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPF 550
P S +D +K L K P+ R A ++ +HPF
Sbjct: 208 KIATNGPPGLRNPEKWSDEFKDFLKKCLQKNPEKRP----TAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.9 bits (184), Expect = 6e-15
Identities = 49/149 (32%), Positives = 76/149 (51%), Gaps = 10/149 (6%)
Query: 221 LGCGDIGSVYLSELTGTKCYFAMKVMD----KASLEKRKKLLRAQTEREI--LQSLDHP- 273
+G G GSVYL + A+K ++ AS + RK+ + REI L+ L H
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
+ L + + D + + +E+ PGG + L F E V+ +V ++L L YLH
Sbjct: 68 IVQYLGSSLDADHLN-IFLEYVPGGSVAALLNNYGA--FEETLVRNFVRQILKGLNYLHN 124
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLS 362
GI++RD+K N+LV G I +SDF +S
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGIS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 68/231 (29%), Positives = 105/231 (45%), Gaps = 29/231 (12%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+ ++ +LG G G VY ++ T A KV+D S E+ + + E +IL S DHP
Sbjct: 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYM---VEIDILASCDHP 62
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGG--DLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
+ L F + +++EFC GG D L +P +E ++ + L AL YL
Sbjct: 63 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERP---LTEPQIRVVCKQTLEALNYL 119
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA---------------VSPTVVKSST 376
H I++RDLK N+L DG I L+DF +S + ++P VV T
Sbjct: 120 HENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCET 179
Query: 377 LESEPLR-KNPVYCVQPACIEPSCIQPSCIAPTTCFSP-RFFSKSKKAQKP 425
+ P K V+ + IE + I+P P +P R K K++ P
Sbjct: 180 SKDRPYDYKADVWSLGITLIEMAQIEP----PHHELNPMRVLLKIAKSEPP 226
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 7e-15
Identities = 39/145 (26%), Positives = 78/145 (53%), Gaps = 1/145 (0%)
Query: 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPT 277
+KK+G G G L + + +K ++ + + +++ ++ E +L ++ HP +
Sbjct: 5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKERE-ESRKEVAVLSNMKHPNIVQ 63
Query: 278 LYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIV 337
FE + +VM++C GGDL+ Q G F E + + ++ LAL+++H I+
Sbjct: 64 YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKIL 123
Query: 338 YRDLKPENVLVREDGHIMLSDFDLS 362
+RD+K +N+ + +DG I L DF ++
Sbjct: 124 HRDIKSQNIFLTKDGTIKLGDFGIA 148
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 9e-15
Identities = 52/150 (34%), Positives = 81/150 (54%), Gaps = 11/150 (7%)
Query: 221 LGCGDIGSVYLS------ELTGTKCYFAMKVMDKASLEKRKKLLRA-QTEREILQSLDHP 273
+G G G VYL+ E+ K + ++K +++A ++E E L+ LDH
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 274 FLPTLYTHFETDKFS-CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
+ Y FET + + +E+ PGG + + R G+ F EQ V+F+ +VL L YLH
Sbjct: 69 NIVQ-YLGFETTEEYLSIFLEYVPGGSIGSC-LRTYGR-FEEQLVRFFTEQVLEGLAYLH 125
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
GI++RDLK +N+LV DG +SDF +S
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGIS 155
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 1e-14
Identities = 37/123 (30%), Positives = 67/123 (54%), Gaps = 7/123 (5%)
Query: 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPL---- 508
GT+ Y+APEI+K E + VDW+ G +YE++ G+TPFK + + + + L
Sbjct: 156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEV 215
Query: 509 RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCA--SPPE 566
+F E + ++D+ + L K+P++RL R + ++H FF+ +N+ + PP
Sbjct: 216 KF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEAGLIPPPF 274
Query: 567 IPK 569
+P
Sbjct: 275 VPD 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 2e-14
Identities = 44/159 (27%), Positives = 80/159 (50%), Gaps = 11/159 (6%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVM----DKASLEKRKKLLRAQTEREILQSL 270
+ +L+ +G G G L + + +AMK + +++E +K E +L +
Sbjct: 2 YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRK------EAVLLAKM 55
Query: 271 DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEY 330
HP + FE D +VME+C GGDL + Q GK F E + + ++ L +++
Sbjct: 56 KHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQH 115
Query: 331 LHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369
+H +++RD+K +N+ + ++G + L DF S R SP
Sbjct: 116 IHEKRVLHRDIKSKNIFLTQNGKVKLGDFG-SARLLTSP 153
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 36/106 (33%), Positives = 52/106 (49%), Gaps = 5/106 (4%)
Query: 254 RKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFS 313
+K LR E ++L+ L H + L F LV E+ L L G
Sbjct: 44 KKTALR---EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGG--LP 98
Query: 314 EQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDF 359
AV+ Y+ ++L A+ Y H I++RD+KPEN+LV E G + L DF
Sbjct: 99 PDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 6e-14
Identities = 37/113 (32%), Positives = 56/113 (49%), Gaps = 15/113 (13%)
Query: 262 TEREI-----LQSLDHPFLPTLY-------THFETDKFSCLVMEFCPGGDLHTLRQRQPG 309
T REI L+S +HP + L T E LV E DL T + P
Sbjct: 45 TLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLT--LVFEHVDQ-DLATYLSKCPK 101
Query: 310 KYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ +K + ++L +++LH IV+RDLKP+N+LV DG + ++DF L+
Sbjct: 102 PGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLA 154
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 36/106 (33%), Positives = 55/106 (51%), Gaps = 9/106 (8%)
Query: 450 SFVGTHEYLAPEIIKG---EGHGSAVDWWTFGIFLYELLFGKTPFKGSENR-ATLYNV-V 504
S GT Y+APE+I G +GHG A D W+ G + E+ GK P+ +N +++V
Sbjct: 162 SLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA 221
Query: 505 GQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPF 550
G P+S +S +D + L +P+ R A+E+ QHPF
Sbjct: 222 GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPT----ASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 70.5 bits (173), Expect = 3e-13
Identities = 50/164 (30%), Positives = 75/164 (45%), Gaps = 19/164 (11%)
Query: 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTERE--ILQ 268
V + L K+G G G V+ + TK A+K K +E K+ RE ILQ
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALK---KVLMENEKEGFPITALREIKILQ 66
Query: 269 SLDHP----------FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVK 318
L H T Y ++ + LV EFC DL L + K F+ +K
Sbjct: 67 LLKHENVVNLIEICRTKATPYNRYKGSFY--LVFEFCEH-DLAGLLSNKNVK-FTLSEIK 122
Query: 319 FYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ +L L Y+H I++RD+K N+L+ +DG + L+DF L+
Sbjct: 123 KVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA 166
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 3e-13
Identities = 49/173 (28%), Positives = 83/173 (47%), Gaps = 9/173 (5%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F L++++G G G VY + T A+KV+ LE + Q E +++ H
Sbjct: 11 FELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQEIIMMKDCKHSN 67
Query: 275 LPTLY-THFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
+ + ++ DK + MEFC GG L + SE + + E L L YLH
Sbjct: 68 IVAYFGSYLRRDKL-WICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHS 124
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNP 386
G ++RD+K N+L+ ++GH+ L+DF +S + ++ T+ K + P P
Sbjct: 125 KGKMHRDIKGANILLTDNGHVKLADFGVSAQ--ITATIAKRKSFIGTPYWMAP 175
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 7e-13
Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 11/169 (6%)
Query: 216 RLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEK-RKKLLRAQTEREILQSLDHPF 274
+ LG G+ GSV + T A KV+ + RK++LR E +I+ P+
Sbjct: 8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILR---ELQIMHECRSPY 64
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLH-TLRQRQPGKYFSEQAVKFYVAEVLLALEYLH- 332
+ + Y F + C+ MEF G L ++ P + + V+ L YL+
Sbjct: 65 IVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGP---IPVEILGKIAVAVVEGLTYLYN 121
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLS--LRCAVSPTVVKSSTLES 379
+ I++RD+KP N+LV G I L DF +S L +++ T V +ST S
Sbjct: 122 VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMS 170
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 9e-13
Identities = 48/153 (31%), Positives = 75/153 (49%), Gaps = 6/153 (3%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVM--DKASLEKRKKLLRAQTEREILQSLDH 272
+R K LG G G VYL T A+K + D S E +K++ + E ++L++L H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQH 63
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
+ Y D+ + ME+ PGG + L+ +E + Y ++L +EYL
Sbjct: 64 ERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA---LTETVTRKYTRQILEGVEYL 120
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLSLR 364
H IV+RD+K N+L G++ L DF S R
Sbjct: 121 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 153
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 9e-13
Identities = 52/179 (29%), Positives = 84/179 (46%), Gaps = 10/179 (5%)
Query: 217 LLKKLGCGDIGSVYLSELTGTKCYFAMKVMD--KASLEKRKKLLRAQTEREILQSLDHPF 274
++ +G G G V L + +K ++ AS +RK A+ E ++L L HP
Sbjct: 4 FVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKA---AEQEAQLLSQLKHPN 60
Query: 275 LPTLYTHFE-TDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
+ +E D +VM FC GGDL+ + Q GK E V + ++ +AL+YLH
Sbjct: 61 IVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFD----LSLRCAVSPTVVKSSTLESEPLRKNPVY 388
I++RDLK +NV + I + D L +C ++ T++ + S L N Y
Sbjct: 121 KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPY 179
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 68.6 bits (168), Expect = 1e-12
Identities = 41/155 (26%), Positives = 72/155 (46%), Gaps = 9/155 (5%)
Query: 214 HFRLLKKLGCGDIGSVYLSELT----GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQS 269
H + +K+LG G G V L T A+K ++ + E+ + + E EIL++
Sbjct: 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDF--EREIEILRT 62
Query: 270 LDHPFLPTLYTHFETD--KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLA 327
LDH + E + L+ME+ P G L QR + ++ + F ++
Sbjct: 63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSS-QICKG 121
Query: 328 LEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++YL ++RDL N+LV + + +SDF L+
Sbjct: 122 MDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 48/152 (31%), Positives = 79/152 (51%), Gaps = 16/152 (10%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKA--SLEKRKKLLRAQTEREI--LQSL 270
+++L K+G G V ++ T Y+A+K M K SLE+ L REI L+ L
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNL------REIQALRRL 54
Query: 271 -DHPFLPTLYTHFETDKFSC--LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLA 327
HP + L K LV E ++ R+ + E+ VK Y+ ++L +
Sbjct: 55 SPHPNILRLIEVLFDRKTGRLALVFELMDMNLYELIKGRK--RPLPEKRVKSYMYQLLKS 112
Query: 328 LEYLHMLGIVYRDLKPENVLVREDGHIMLSDF 359
L+++H GI +RD+KPEN+L+++D + L+DF
Sbjct: 113 LDHMHRNGIFHRDIKPENILIKDD-ILKLADF 143
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 37/103 (35%), Positives = 51/103 (49%), Gaps = 9/103 (8%)
Query: 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR----ATLYNVVGQPL 508
GT +Y +PE IKG + + DWW G+ YELL GK PFK E+ +L + L
Sbjct: 168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKL 227
Query: 509 RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551
F + VS +A D ++ +L RL EI +HPF
Sbjct: 228 PFIK--NVSKNANDFVQSMLKYNINYRL---TNYNEIIKHPFL 265
|
Length = 267 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-12
Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD 271
+G+F++ KK+G G VY + A+K + + K E ++L+ LD
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDL-----HTLRQRQPGKYFSEQAVKFYVAEVLL 326
HP + F + +V+E GDL H +Q++ E+ + Y ++
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRL---IPERTIWKYFVQLCS 117
Query: 327 ALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDL 361
ALE++H I++RD+KP NV + G + L D L
Sbjct: 118 ALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 3e-12
Identities = 55/187 (29%), Positives = 82/187 (43%), Gaps = 25/187 (13%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD- 271
G F L++ +G G G VY T A+KVMD E E EI Q ++
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----------EEEIKQEINM 55
Query: 272 ------HPFLPTLYTHF------ETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKF 319
H + T Y F D LVMEFC G + L + G E+ + +
Sbjct: 56 LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY 115
Query: 320 YVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLES 379
E+L L +LH +++RD+K +NVL+ E+ + L DF +S + + TV + +T
Sbjct: 116 ICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRNTFIG 173
Query: 380 EPLRKNP 386
P P
Sbjct: 174 TPYWMAP 180
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 3e-12
Identities = 53/181 (29%), Positives = 82/181 (45%), Gaps = 13/181 (7%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH 272
G F L++ +G G G VY T A+KVMD E+ + + E +L+ H
Sbjct: 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEE----IKLEINMLKKYSH 71
Query: 273 PF-LPTLYTHF------ETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVL 325
+ T Y F D LVMEFC G + L + G E + + E+L
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 326 LALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKN 385
L +LH +++RD+K +NVL+ E+ + L DF +S + + TV + +T P
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ--LDRTVGRRNTFIGTPYWMA 189
Query: 386 P 386
P
Sbjct: 190 P 190
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 83/374 (22%), Positives = 130/374 (34%), Gaps = 111/374 (29%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQ---------TERE--IL 267
LG G G V + T T A+K + + R T RE I+
Sbjct: 15 AHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIM 74
Query: 268 QSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLA 327
+ H + L + F LVM+ DL + R+ +E VK + ++L
Sbjct: 75 NEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRK--IRLTESQVKCILLQILNG 131
Query: 328 LEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPV 387
L LH ++RDL P N+ + G ++DF L+ R
Sbjct: 132 LNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA-RRYG-------------------- 170
Query: 388 YCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSK-KAQKPKNEMGNQVSPLPELIAEPTNA 446
+ P + SK + + + EM ++V L
Sbjct: 171 -----------------------YPPYSDTLSKDETMQRREEMTSKVVTL---------- 197
Query: 447 RSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENR----ATLY 501
Y APE++ G E + AVD W+ G ELL GK F G EN ++
Sbjct: 198 ---------WYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPG-ENEIDQLGRIF 247
Query: 502 NVVGQP--LRFPES---------------------PVVSFSARDLIKGLLVKEPQNRLAC 538
++G P +P++ P S A DL++ LL P R++
Sbjct: 248 ELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS- 306
Query: 539 RRGATEIKQHPFFQ 552
A E +H +F+
Sbjct: 307 ---AKEALKHEYFK 317
|
Length = 335 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 43/149 (28%), Positives = 68/149 (45%), Gaps = 12/149 (8%)
Query: 219 KKLGCGDIGSV---YLSELTGTKCYFAMKVM-DKASLEKRKKLLRAQTEREILQSLDHPF 274
K+LG G+ GSV +G + A+K + + +K+ LR E ++ LDHP
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLR---EASVMAQLDHPC 57
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
+ L + + LVME P G L L++R+ +K +V + + YL
Sbjct: 58 IVRLIGVCKGEPL-MLVMELAPLGPLLKYLKKRR---EIPVSDLKELAHQVAMGMAYLES 113
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLS 362
V+RDL NVL+ +SDF +S
Sbjct: 114 KHFVHRDLAARNVLLVNRHQAKISDFGMS 142
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 7e-12
Identities = 31/102 (30%), Positives = 49/102 (48%), Gaps = 4/102 (3%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR 509
S GT +++PE+I GEG+G D W+ G + E+L K P+ E A ++ + QP
Sbjct: 166 SVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN 225
Query: 510 FPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551
VS AR+ ++ V+ R A E+ +H F
Sbjct: 226 PQLPSHVSPDARNFLRRTFVEN----AKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 39/140 (27%), Positives = 63/140 (45%), Gaps = 5/140 (3%)
Query: 222 GCGDIGSVYLSELTGTKCYFAMKV--MDKASLEKRKKLLRAQTEREILQSLDHPFLPTLY 279
D+ V+L++ T A+K +D S E K L Q E + L HP +
Sbjct: 9 CFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLL---QQEIITSRQLQHPNILPYV 65
Query: 280 THFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYR 339
T F D +V G L + + E A+ F + +VL AL+Y+H G ++R
Sbjct: 66 TSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHR 125
Query: 340 DLKPENVLVREDGHIMLSDF 359
+K ++L+ DG ++LS
Sbjct: 126 SVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 65.5 bits (159), Expect = 1e-11
Identities = 50/179 (27%), Positives = 84/179 (46%), Gaps = 7/179 (3%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F L+K+G G G V+ T+ A+K++D E ++ Q E +L D P+
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE--EAEDEIEDIQQEITVLSQCDSPY 63
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ Y + D ++ME+ GG L + P E + + E+L L+YLH
Sbjct: 64 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHSE 120
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPA 393
++RD+K NVL+ E G + L+DF ++ + ++ T +K +T P P Q A
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNTFVGTPFWMAPEVIKQSA 177
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 1e-11
Identities = 46/150 (30%), Positives = 74/150 (49%), Gaps = 6/150 (4%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQSLDH 272
F+ ++K+G G G VY + T A+K K L+ + + + REI L+ L+H
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALK---KIRLDTETEGVPSTAIREISLLKELNH 58
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
P + L T+ LV EF DL P +K Y+ ++L L + H
Sbjct: 59 PNIVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH 117
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+++RDLKP+N+L+ +G I L+DF L+
Sbjct: 118 SHRVLHRDLKPQNLLINTEGAIKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 1e-11
Identities = 45/152 (29%), Positives = 62/152 (40%), Gaps = 16/152 (10%)
Query: 219 KKLGCGDIGSVYLSELT---GTKCYFAMKVMDKASLEKRKKLLRAQT----EREILQSLD 271
KKLG G G V E + G A+K + K KL E I+ SLD
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCL------KSDKLSDIMDDFLKEAAIMHSLD 54
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALEY 330
H L LY T +V E P G L LR+ G +F + Y ++ + Y
Sbjct: 55 HENLIRLYGVVLTHPLM-MVTELAPLGSLLDRLRKDALG-HFLISTLCDYAVQIANGMRY 112
Query: 331 LHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
L ++RDL N+L+ D + + DF L
Sbjct: 113 LESKRFIHRDLAARNILLASDDKVKIGDFGLM 144
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 34/98 (34%), Positives = 50/98 (51%), Gaps = 4/98 (4%)
Query: 264 REI--LQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYV 321
REI L+ L HP L L F + LV E+C L+ L + G E +K +
Sbjct: 49 REIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG--VPEHLIKKII 106
Query: 322 AEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDF 359
+ L A+ + H ++RD+KPEN+L+ + G I L DF
Sbjct: 107 WQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 2e-11
Identities = 45/148 (30%), Positives = 73/148 (49%), Gaps = 10/148 (6%)
Query: 216 RLLKKLGCGDIGSVYLSELTGTKCYFAMKVMD-KASLEKRKKLLRAQTEREILQSLDHPF 274
+ + LG G+ G+VY + T+ A+KV+ ++E +K+++ +E EIL D P+
Sbjct: 4 QYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIM---SELEILYKCDSPY 60
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ Y F + + EF GG L R+ E + V+ L YL L
Sbjct: 61 IIGFYGAFFVENRISICTEFMDGGSLDVYRK------IPEHVLGRIAVAVVKGLTYLWSL 114
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLS 362
I++RD+KP N+LV G + L DF +S
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVS 142
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 53/176 (30%), Positives = 79/176 (44%), Gaps = 34/176 (19%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTERE-------ILQSLD 271
K+G G G V ++ T A+K MD LR Q RE I++
Sbjct: 25 VKIGEGSTGIVCIATDKSTGRQVAVKKMD----------LRKQQRRELLFNEVVIMRDYQ 74
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDL-----HTLRQRQPGKYFSEQAVKFYVAEVLL 326
HP + +Y+ + +VMEF GG L HT +E+ + VL
Sbjct: 75 HPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHT--------RMNEEQIATVCLAVLK 126
Query: 327 ALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA-VSPTVVKSSTLESEP 381
AL +LH G+++RD+K +++L+ DG + LSDF CA VS V + +L P
Sbjct: 127 ALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGF---CAQVSKEVPRRKSLVGTP 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 53/170 (31%), Positives = 82/170 (48%), Gaps = 14/170 (8%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQS 269
V F L ++G G G VY + T + A+K K ++ + + + REI L +
Sbjct: 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALK---KVRMDNERDGIPISSLREITLLLN 62
Query: 270 LDHPFLPTLYTHFETDKFSC--LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLA 327
L HP + L LVME+C DL +L P FSE VK + ++L
Sbjct: 63 LRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTP-FSESQVKCLMLQLLRG 120
Query: 328 LEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAV-----SPTVV 372
L+YLH I++RDLK N+L+ + G + ++DF L+ + +P VV
Sbjct: 121 LQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVV 170
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 49/179 (27%), Positives = 84/179 (46%), Gaps = 7/179 (3%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F L+++G G G V+ T+ A+K++D E ++ Q E +L D P+
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLE--EAEDEIEDIQQEITVLSQCDSPY 63
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ Y + ++ME+ GG L + P F E + + E+L L+YLH
Sbjct: 64 VTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP---FDEFQIATMLKEILKGLDYLHSE 120
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPA 393
++RD+K NVL+ E G + L+DF ++ + ++ T +K +T P P Q A
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQ--LTDTQIKRNTFVGTPFWMAPEVIQQSA 177
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 2e-11
Identities = 50/179 (27%), Positives = 83/179 (46%), Gaps = 7/179 (3%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F L+++G G G VY TK A+K++D E ++ Q E +L D P+
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLE--EAEDEIEDIQQEITVLSQCDSPY 63
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ Y + ++ME+ GG L + P E + + E+L L+YLH
Sbjct: 64 ITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP---LEETYIATILREILKGLDYLHSE 120
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPA 393
++RD+K NVL+ E G + L+DF ++ + ++ T +K +T P P Q A
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQ--LTDTQIKRNTFVGTPFWMAPEVIKQSA 177
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 64.8 bits (156), Expect = 4e-11
Identities = 39/124 (31%), Positives = 57/124 (45%), Gaps = 18/124 (14%)
Query: 443 PTNARSMSFVGTHEYLAPEIIKGEGH---GSAVDWWTFGIFLYELLFGKTPFKGSENRAT 499
A + VGT Y+APE++ G S+ D W+ GI LYELL G PF+G +N +
Sbjct: 160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA 219
Query: 500 L-----------YNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548
+ PL ++S +A DL+K LL K+P+NRL ++ H
Sbjct: 220 TSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRL----SSSSDLSH 275
Query: 549 PFFQ 552
Sbjct: 276 DLLA 279
|
Length = 384 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 64.3 bits (157), Expect = 4e-11
Identities = 44/167 (26%), Positives = 81/167 (48%), Gaps = 14/167 (8%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKAS--LEKRKKLLRAQTEREILQSLDH 272
++ ++ +G G G V + T + A+K + A K+ LR E +IL+ H
Sbjct: 7 YKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLR---ELKILRHFKH 63
Query: 273 PFLPTLYTHFETD----KFSCLVMEFCPGGDLH-TLRQRQPGKYFSEQAVKFYVAEVLLA 327
+ + K +VM+ DLH + QP +E+ +++++ ++L
Sbjct: 64 DNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQP---LTEEHIRYFLYQLLRG 119
Query: 328 LEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKS 374
L+Y+H +++RDLKP N+LV ED + + DF ++ + SPT K
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY 166
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 63.3 bits (155), Expect = 5e-11
Identities = 32/93 (34%), Positives = 47/93 (50%), Gaps = 3/93 (3%)
Query: 271 DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEY 330
D+P LY T K L+M++ GDL L +++ SE VK + +++ AL
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALND 124
Query: 331 LHMLGIVYRDLKPENVL-VREDGHIMLSDFDLS 362
LH I++ D+K ENVL R I L D+ L
Sbjct: 125 LHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLC 157
|
Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 6e-11
Identities = 46/162 (28%), Positives = 82/162 (50%), Gaps = 16/162 (9%)
Query: 215 FRLLKKLGCGDIGSVY-LSELTGTKCYFAMKVMD-------KASLEKRKKLLRAQTEREI 266
+ +L+ LG G G VY + + + A+K ++ K E+ K + +E I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 267 L-QSLDHPFLPTLYTHF-ETDKFSCLVMEF---CPGGDLHTLRQRQPGKYFSEQAVKFYV 321
+ + L HP + Y F E D+ +VM+ P G+ H ++ + F+E+ +
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLY-IVMDLIEGAPLGE-HFNSLKEKKQRFTEERIWNIF 119
Query: 322 AEVLLALEYLHMLG-IVYRDLKPENVLVREDGHIMLSDFDLS 362
+++LAL YLH IV+RDL P N+++ ED + ++DF L+
Sbjct: 120 VQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA 161
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 7e-11
Identities = 44/155 (28%), Positives = 72/155 (46%), Gaps = 8/155 (5%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD 271
+ +FR+ KK+G G VY + A+K + L K E ++L+ L+
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDL-----HTLRQRQPGKYFSEQAVKFYVAEVLL 326
HP + Y F D +V+E GDL H +Q+ + E+ V Y ++
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQK---RLIPEKTVWKYFVQLCS 117
Query: 327 ALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDL 361
ALE++H +++RD+KP NV + G + L D L
Sbjct: 118 ALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 8e-11
Identities = 33/103 (32%), Positives = 51/103 (49%), Gaps = 5/103 (4%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR 509
S GT +++PE+I GEG+G D W+ G + E+L K P+ E A ++ + QP
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN 227
Query: 510 FPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
+S ARD + + V+ R A E+ +HPF Q
Sbjct: 228 PQLPSHISEHARDFLGCIFVEARH-----RPSAEELLRHPFAQ 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 8e-11
Identities = 52/168 (30%), Positives = 78/168 (46%), Gaps = 10/168 (5%)
Query: 220 KLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLY 279
K+G G G V ++ T A+K MD ++R+ L E I++ H + +Y
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLF---NEVVIMRDYHHENVVDMY 85
Query: 280 THFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYR 339
+ +VMEF GG L + +E+ + VL AL YLH G+++R
Sbjct: 86 NSYLVGDELWVVMEFLEGGALTDIVTHT---RMNEEQIATVCLSVLRALSYLHNQGVIHR 142
Query: 340 DLKPENVLVREDGHIMLSDFDLSLRCA-VSPTVVKSSTLESEPLRKNP 386
D+K +++L+ DG I LSDF CA VS V K +L P P
Sbjct: 143 DIKSDSILLTSDGRIKLSDFGF---CAQVSKEVPKRKSLVGTPYWMAP 187
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 61.8 bits (151), Expect = 1e-10
Identities = 36/109 (33%), Positives = 55/109 (50%), Gaps = 5/109 (4%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNV 503
T + S GT ++APE+I+GE +G A D W+ G + E+ GK P+ N
Sbjct: 156 TGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYK 215
Query: 504 VGQPLRFPESPV-VSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551
+G PE P +S A+D ++ L ++P+ R A E+ QHPF
Sbjct: 216 IGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRP----TADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 62.4 bits (152), Expect = 1e-10
Identities = 45/150 (30%), Positives = 72/150 (48%), Gaps = 5/150 (3%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQSLDH 272
+ ++K+G G G VY T AMK K LE ++ + + REI L+ L H
Sbjct: 2 YTKIEKIGEGTYGVVYKGRNKKTGQIVAMK---KIRLESEEEGVPSTAIREISLLKELQH 58
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
P + L + L+ EF L G+Y + VK Y+ ++L + + H
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCH 118
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+++RDLKP+N+L+ G I L+DF L+
Sbjct: 119 SRRVLHRDLKPQNLLIDNKGVIKLADFGLA 148
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 45/153 (29%), Positives = 71/153 (46%), Gaps = 18/153 (11%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMD---KASLEKRKKLLRAQTEREILQSLD 271
F L+++G G G+VY + T A+K M K S EK + +++ E LQ L
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK---EVRFLQQLR 73
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGG-----DLHTLRQRQPGKYFSEQAVKFYVAEVLL 326
HP + + + LVME+C G ++H ++P E + L
Sbjct: 74 HPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVH----KKP---LQEVEIAAICHGALQ 126
Query: 327 ALEYLHMLGIVYRDLKPENVLVREDGHIMLSDF 359
L YLH ++RD+K N+L+ E G + L+DF
Sbjct: 127 GLAYLHSHERIHRDIKAGNILLTEPGTVKLADF 159
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 1e-10
Identities = 54/182 (29%), Positives = 83/182 (45%), Gaps = 10/182 (5%)
Query: 221 LGCGDIGSVYLSELTGTKCYFAMK--VMDKAS-LEKRKKLLRAQTEREILQSLDHPFLPT 277
LG G G+VY LT A+K +D ++ L K+ + Q E ++L+SL H +
Sbjct: 8 LGKGAYGTVYCG-LTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQ 66
Query: 278 LYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIV 337
D + MEF PGG + ++ R E Y ++L + YLH +V
Sbjct: 67 YLGTCLDDNTISIFMEFVPGGSISSILNRFGP--LPEPVFCKYTKQILDGVAYLHNNCVV 124
Query: 338 YRDLKPENVLVREDGHIMLSDFDLSLR-CAVSPTVVKSSTLESEPLRKNPVYCVQPACIE 396
+RD+K NV++ +G I L DF + R V S+ L+S + P Y + P I
Sbjct: 125 HRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKS--MHGTP-YWMAPEVIN 181
Query: 397 PS 398
S
Sbjct: 182 ES 183
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 2e-10
Identities = 35/125 (28%), Positives = 55/125 (44%), Gaps = 13/125 (10%)
Query: 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNV-VG 505
R S VGT ++APE+I +G+ VD W+ GI + E++ G+ P+ + +
Sbjct: 171 RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN 230
Query: 506 QPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPP 565
P + VS R + +LV++P R A E+ HPF + A PP
Sbjct: 231 LPPKLKNLHKVSPRLRSFLDRMLVRDPAQRAT----AAELLNHPF--------LAKAGPP 278
Query: 566 EIPKP 570
P
Sbjct: 279 SSIVP 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 60.9 bits (148), Expect = 3e-10
Identities = 49/164 (29%), Positives = 74/164 (45%), Gaps = 17/164 (10%)
Query: 216 RLLKKLGCGDIGSVYLSELTG-TKCYFAMKVMDKASLEKRKKLLRA--QTEREILQSLDH 272
R L++LG G G VY ELTG + A V K E + ++ + E E++ L H
Sbjct: 8 RFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQH 67
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQP----GKYFSEQAVK--------- 318
P + L ++ +C++ E+ GDLH L + P G ++ VK
Sbjct: 68 PNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFL 127
Query: 319 FYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++ +EYL V+RDL N LV E + +SDF LS
Sbjct: 128 HIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS 171
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 10/151 (6%)
Query: 215 FRLLKKLGCGDIGSVY--LSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQSL 270
++ ++K+G G G VY +LTG A+K K LE + + + REI L+ L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGE--IVALK---KIRLETEDEGVPSTAIREISLLKEL 55
Query: 271 DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEY 330
+HP + L ++ LV EF DL P +K Y+ ++L + Y
Sbjct: 56 NHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAY 114
Query: 331 LHMLGIVYRDLKPENVLVREDGHIMLSDFDL 361
H +++RDLKP+N+L+ +G + L+DF L
Sbjct: 115 CHSHRVLHRDLKPQNLLIDREGALKLADFGL 145
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 34/112 (30%), Positives = 55/112 (49%), Gaps = 13/112 (11%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN 502
+ + SF G+ ++APE+I +G +G A D W+ G + E+ GK P+ E A ++
Sbjct: 154 EFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK 213
Query: 503 VVGQPLRFPESPVV----SFSARDLIKGLLVKEPQNRLACRRGATEIKQHPF 550
+ R E P + S A+D I L ++P R A E+ +HPF
Sbjct: 214 IG----RSKELPPIPDHLSDEAKDFILKCLQRDPSLRPT----AAELLEHPF 257
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 5e-10
Identities = 28/90 (31%), Positives = 45/90 (50%), Gaps = 4/90 (4%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE-NRATLYNVVGQPL 508
S VGT Y++PE I G+ D W+ G LYE+ ++PF G + N +L + +
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEK-C 223
Query: 509 RFPESPVVSFSA--RDLIKGLLVKEPQNRL 536
+P P +S RDL+ + +P+ R
Sbjct: 224 DYPPLPADHYSEELRDLVSRCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 60.7 bits (147), Expect = 5e-10
Identities = 46/171 (26%), Positives = 80/171 (46%), Gaps = 16/171 (9%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
+ +K+G G G+VY + T A+K M+ K++ ++ E +++ HP
Sbjct: 21 YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELII---NEILVMRENKHPN 77
Query: 275 LPTLYTHFETDKFSCLVMEFCPGG---DLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
+ + +VME+ GG D+ T G+ + E L ALE+L
Sbjct: 78 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ------IAAVCRECLQALEFL 131
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA-VSPTVVKSSTLESEP 381
H +++RD+K +N+L+ DG + L+DF CA ++P K ST+ P
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGF---CAQITPEQSKRSTMVGTP 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 51/161 (31%), Positives = 78/161 (48%), Gaps = 11/161 (6%)
Query: 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKL-LRAQTEREILQSLDHPFLP 276
L+KLG G +V+ T+ A+K + LE + A E +L+ L H +
Sbjct: 11 LEKLGEGTYATVFKGRSKLTENLVALK---EIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 277 TLYTHFETDKFSCLVMEFCPGGDLHTLRQRQP--GKYFSEQAVKFYVAEVLLALEYLHML 334
TL+ TDK LV E+ L+Q G S VK ++ ++L L Y H
Sbjct: 68 TLHDIVHTDKSLTLVFEYLD----KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR 123
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSS 375
+++RDLKP+N+L+ E G + L+DF L+ R PT S+
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLA-RAKSVPTKTYSN 163
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 6e-10
Identities = 44/146 (30%), Positives = 73/146 (50%), Gaps = 6/146 (4%)
Query: 217 LLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLP 276
LK+LG G G V+L + G K A+K++ + ++ + + E +++ L HP L
Sbjct: 8 FLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAMSEDDFI----EEAKVMMKLSHPNLV 62
Query: 277 TLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGI 336
LY + +V E+ G L + + GK +E + ++V A+EYL G
Sbjct: 63 QLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDM-CSDVCEAMEYLESNGF 121
Query: 337 VYRDLKPENVLVREDGHIMLSDFDLS 362
++RDL N LV ED + +SDF L+
Sbjct: 122 IHRDLAARNCLVGEDNVVKVSDFGLA 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (146), Expect = 7e-10
Identities = 35/119 (29%), Positives = 56/119 (47%), Gaps = 13/119 (10%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRAT---- 499
N+ + +FVGT Y+APE I+G + D W+ G+ L EL G+ P+ +
Sbjct: 152 VNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFE 211
Query: 500 -LYNVVGQPLRFPESPVVSFSA--RDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555
L +V +P P P FS +D + L+K+P+ R E+ +HPF +
Sbjct: 212 LLQYIVNEPP--PRLPSGKFSPDFQDFVNLCLIKDPRE----RPSYKELLEHPFIKKYE 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 7e-10
Identities = 45/148 (30%), Positives = 73/148 (49%), Gaps = 4/148 (2%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
+ L+KLG G +VY + A+KV+ E+ A E +L+ L H
Sbjct: 7 YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQ--EEEGTPFTAIREASLLKGLKHAN 64
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ L+ T + LV E+ DL + PG E VK ++ ++L L Y+H
Sbjct: 65 IVLLHDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPEN-VKLFLFQLLRGLSYIHQR 122
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLS 362
I++RDLKP+N+L+ + G + L+DF L+
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 8e-10
Identities = 33/102 (32%), Positives = 50/102 (49%), Gaps = 5/102 (4%)
Query: 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPL 508
S GT +++PE+I GEG+G D W+ G + E+L K P+ E A ++ + QP
Sbjct: 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPT 226
Query: 509 RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPF 550
P VS RD +K + V+ R A E+ +H F
Sbjct: 227 NPVLPPHVSDHCRDFLKRIFVEAKL-----RPSADELLRHTF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 59.4 bits (144), Expect = 9e-10
Identities = 45/161 (27%), Positives = 77/161 (47%), Gaps = 14/161 (8%)
Query: 215 FRLLKKLGCGDIGSVY---LSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD 271
+L K LG G+ GSV LS+ G++ A+K M K + ++ +E ++ D
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFD 59
Query: 272 HPFLPTL----YTHFETDKFS--CLVMEFCPGGDLHT--LRQRQPG--KYFSEQAVKFYV 321
HP + L + K +++ F GDLH+ L R G + Q + ++
Sbjct: 60 HPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFM 119
Query: 322 AEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++ L +EYL ++RDL N ++RED + ++DF LS
Sbjct: 120 VDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 9e-10
Identities = 48/168 (28%), Positives = 78/168 (46%), Gaps = 10/168 (5%)
Query: 220 KLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLY 279
K+G G G V ++ + + A+K MD ++R+ L E I++ H + +Y
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLF---NEVVIMRDYQHENVVEMY 83
Query: 280 THFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYR 339
+ +VMEF GG L + +E+ + VL AL LH G+++R
Sbjct: 84 NSYLVGDELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHR 140
Query: 340 DLKPENVLVREDGHIMLSDFDLSLRCA-VSPTVVKSSTLESEPLRKNP 386
D+K +++L+ DG + LSDF CA VS V + +L P P
Sbjct: 141 DIKSDSILLTHDGRVKLSDFGF---CAQVSKEVPRRKSLVGTPYWMAP 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.2 bits (144), Expect = 1e-09
Identities = 33/110 (30%), Positives = 51/110 (46%), Gaps = 10/110 (9%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNV 503
T ++ +FVGT ++APE+IK G+ D W+ GI EL G+ P L+ +
Sbjct: 151 TMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI 210
Query: 504 VGQPLRFP---ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPF 550
P P E S +D + L K+P+ R + A E+ +H F
Sbjct: 211 ---PKNNPPSLEGNKFSKPFKDFVSLCLNKDPKERPS----AKELLKHKF 253
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 9/103 (8%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPL- 508
S GT +++PE+I GEG+G D W+ + E+L K P+ E A ++ + QP
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTK 227
Query: 509 -RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPF 550
P+ VS + RD +K + V+E + A + +HPF
Sbjct: 228 PMLPDG--VSDACRDFLKQIFVEEKRRPTAE-----FLLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 55/171 (32%), Positives = 82/171 (47%), Gaps = 11/171 (6%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVM--DKASLEKRKKLLRAQTEREILQSLD 271
++RL K LG G G VYL T A+K + D S E K++ + E ++L++L
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 272 HPFLPTLYTHF---ETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLAL 328
H + Y E K S V E+ PGG + Q + +E + Y ++L +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFV-EYMPGGSIKD--QLKAYGALTENVTRRYTRQILQGV 119
Query: 329 EYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA---VSPTVVKSST 376
YLH IV+RD+K N+L G++ L DF S R +S T +KS T
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT 170
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 15/156 (9%)
Query: 215 FRLLKKLGCGDIGSV--YLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH 272
+R LK++G G G+V L TG K A+K + + + RA E +L+ + H
Sbjct: 17 YRDLKQVGSGAYGTVCSALDRRTGAKV--AIKKLYRP-FQSELFAKRAYRELRLLKHMKH 73
Query: 273 PFLPTLYTHFETD----KFS--CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLL 326
+ L F D +F LVM F G DL L + + SE ++F V ++L
Sbjct: 74 ENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEK---LSEDRIQFLVYQMLK 129
Query: 327 ALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
L+Y+H GI++RDLKP N+ V ED + + DF L+
Sbjct: 130 GLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 1e-09
Identities = 49/159 (30%), Positives = 76/159 (47%), Gaps = 7/159 (4%)
Query: 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKL-LRAQTEREILQSLDHPFLP 276
L KLG G +V+ T+ A+K + LE + A E +L++L H +
Sbjct: 10 LDKLGEGTYATVFKGRSKLTENLVALK---EIRLEHEEGAPCTAIREVSLLKNLKHANIV 66
Query: 277 TLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGI 336
TL+ T++ LV E+ L G S VK ++ ++L L Y H I
Sbjct: 67 TLHDIIHTERCLTLVFEYLDSDLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRKI 124
Query: 337 VYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSS 375
++RDLKP+N+L+ E G + L+DF L+ R PT S+
Sbjct: 125 LHRDLKPQNLLINEKGELKLADFGLA-RAKSVPTKTYSN 162
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 52/170 (30%), Positives = 81/170 (47%), Gaps = 9/170 (5%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVM--DKASLEKRKKLLRAQTEREILQSLD 271
++RL K LG G G VYL T A+K + D S E K++ + E ++L++L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 272 HPFLPTLYTHFE--TDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALE 329
H + Y ++ + ME PGG + Q + +E + Y ++L +
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIKD--QLKSYGALTENVTRKYTRQILEGVS 120
Query: 330 YLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLR---CAVSPTVVKSST 376
YLH IV+RD+K N+L G++ L DF S R +S T +KS T
Sbjct: 121 YLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVT 170
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 46/154 (29%), Positives = 79/154 (51%), Gaps = 21/154 (13%)
Query: 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQSLDHPFL 275
L+K+G G G+V+ ++ T A+K + L+ + + + REI L+ L H +
Sbjct: 5 LEKIGEGTYGTVFKAKNRETHEIVALK---RVRLDDDDEGVPSSALREICLLKELKHKNI 61
Query: 276 PTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSE-------QAVKFYVAEVLLAL 328
LY +DK LV E+C DL KYF + VK ++ ++L L
Sbjct: 62 VRLYDVLHSDKKLTLVFEYC-DQDLK--------KYFDSCNGDIDPEIVKSFMFQLLKGL 112
Query: 329 EYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ H +++RDLKP+N+L+ ++G + L+DF L+
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLA 146
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 48/168 (28%), Positives = 81/168 (48%), Gaps = 10/168 (5%)
Query: 220 KLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLY 279
K+G G G V ++ + A+K+MD ++R+ L E I++ H + +Y
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLF---NEVVIMRDYQHQNVVEMY 84
Query: 280 THFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYR 339
+ + ++MEF GG L + + +E+ + VL AL YLH G+++R
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIVSQT---RLNEEQIATVCESVLQALCYLHSQGVIHR 141
Query: 340 DLKPENVLVREDGHIMLSDFDLSLRCA-VSPTVVKSSTLESEPLRKNP 386
D+K +++L+ DG + LSDF CA +S V K +L P P
Sbjct: 142 DIKSDSILLTLDGRVKLSDFGF---CAQISKDVPKRKSLVGTPYWMAP 186
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 2e-09
Identities = 51/181 (28%), Positives = 83/181 (45%), Gaps = 24/181 (13%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-D 271
+ +++ +G G G VY A+K++D S + + E ILQSL +
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEE----IEAEYNILQSLPN 77
Query: 272 HPFLPTLYTHF-ETDKFS----CLVMEFCPGGDLHTLRQ--RQPGKYFSEQAVKFYVAEV 324
HP + Y F + DK LV+E C GG + L + G+ E + + +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137
Query: 325 LLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRK 384
LL L++LH I++RD+K N+L+ +G + L DF + S+ L S LR+
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV------------SAQLTSTRLRR 185
Query: 385 N 385
N
Sbjct: 186 N 186
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 2e-09
Identities = 39/99 (39%), Positives = 46/99 (46%), Gaps = 13/99 (13%)
Query: 457 YLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFK---GSENRATLYNVVGQPLRFPES 513
Y APE+ A DWW+ G L+ELL GKT + N T L PE
Sbjct: 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTHT-------TLNIPEW 200
Query: 514 PVVSFSARDLIKGLLVKEPQNRL-ACRRGATEIKQHPFF 551
VS AR L++ LL P RL A G +IK HPFF
Sbjct: 201 --VSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 2e-09
Identities = 42/158 (26%), Positives = 71/158 (44%), Gaps = 10/158 (6%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMD---KASLEKRKKLLRAQTEREILQSLDHPFL 275
++LG G S Y + T A+K + S E+ + + + E ++ L+HP +
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 276 PTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKY--FSEQAVKFYVAEVLLALEYLHM 333
+ D L +E+ GG + L KY F E + Y ++L L YLH
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLHE 121
Query: 334 LGIVYRDLKPENVLVREDGHIM-LSDFDLSLRCAVSPT 370
I++RD+K N+L+ G + ++DF + R A T
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 41/142 (28%), Positives = 65/142 (45%), Gaps = 2/142 (1%)
Query: 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPT 277
L ++G G G+VY + + T A+K M + + +K E + LQ L HP
Sbjct: 26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIE 85
Query: 278 LYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIV 337
+ + + LVME+C G L + K E + L L YLH ++
Sbjct: 86 YKGCYLKEHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSHNMI 143
Query: 338 YRDLKPENVLVREDGHIMLSDF 359
+RD+K N+L+ E G + L+DF
Sbjct: 144 HRDIKAGNILLTEPGQVKLADF 165
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 58.0 bits (141), Expect = 3e-09
Identities = 36/115 (31%), Positives = 54/115 (46%), Gaps = 7/115 (6%)
Query: 441 AEPTNARSM--SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTP-FKGSENR 497
A+ T +S S VGT ++APE+IK + +G VD W+ GI E+ G+ P + R
Sbjct: 164 AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR 223
Query: 498 ATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
A S +D + LVK+P+ R + A E+ QHPF +
Sbjct: 224 ALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVKDPEKRPS----AEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 3e-09
Identities = 44/138 (31%), Positives = 67/138 (48%), Gaps = 14/138 (10%)
Query: 224 GDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFE 283
G I V L T T+ F +K + K+S R ER + P + L+ +
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRKSSEYSR--------ERLTIIPHCVPNMVCLHKYIV 55
Query: 284 TDKFSCLVMEFCPGGDL--HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDL 341
++ LV++ GG L H + E+ VK + AE+++AL+ LH GIV RDL
Sbjct: 56 SEDSVFLVLQHAEGGKLWSHISKFLN----IPEECVKRWAAEMVVALDALHREGIVCRDL 111
Query: 342 KPENVLVREDGHIMLSDF 359
P N+L+ + GHI L+ F
Sbjct: 112 NPNNILLDDRGHIQLTYF 129
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 3e-09
Identities = 47/148 (31%), Positives = 69/148 (46%), Gaps = 5/148 (3%)
Query: 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYT 280
LG G G VY + T+ A+K + + + L E + L H +
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPL---HEEIALHSYLKHRNIVQYLG 72
Query: 281 HFETDKFSCLVMEFCPGGDLHTLRQRQPGK-YFSEQAVKFYVAEVLLALEYLHMLGIVYR 339
+ F + ME PGG L L + + G +EQ + FY ++L L+YLH IV+R
Sbjct: 73 SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHR 132
Query: 340 DLKPENVLVRE-DGHIMLSDFDLSLRCA 366
D+K +NVLV G + +SDF S R A
Sbjct: 133 DIKGDNVLVNTYSGVVKISDFGTSKRLA 160
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 52/169 (30%), Positives = 80/169 (47%), Gaps = 22/169 (13%)
Query: 220 KLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI-----LQSLDHPF 274
++G G G+VY + + + A+K ++ + L T RE+ L++ DHP
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALK---SVRVQTNEDGLPLSTVREVALLKRLEAFDHPN 63
Query: 275 L-------PTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLA 327
+ T T ET LV E DL T + P + +K + + L
Sbjct: 64 IVRLMDVCATSRTDRETK--VTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFLRG 120
Query: 328 LEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDL----SLRCAVSPTVV 372
L++LH IV+RDLKPEN+LV G + L+DF L S + A++P VV
Sbjct: 121 LDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV 169
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 36/111 (32%), Positives = 50/111 (45%), Gaps = 19/111 (17%)
Query: 438 ELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR 497
ELI N+ + +FVGT Y++PE I+G + D W+ GI + EL GK PF S
Sbjct: 153 ELI----NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNID 208
Query: 498 AT-----------LYNVVGQPLRFPESPVVSFSA--RDLIKGLLVKEPQNR 535
L +V +P P P F RD + L+K+P R
Sbjct: 209 DDGQDDPMGILDLLQQIVQEPP--PRLPSSDFPEDLRDFVDACLLKDPTER 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 5e-09
Identities = 36/116 (31%), Positives = 57/116 (49%), Gaps = 12/116 (10%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTP-FKGSENRATLYNVVGQPL 508
S VGT ++APE+I +G+ VD W+ GI + E++ G+ P F S +A P
Sbjct: 176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP 235
Query: 509 RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASP 564
+ + +S RD ++ +L +EPQ R A E+ HPF L++ P
Sbjct: 236 KLKNAHKISPVLRDFLERMLTREPQERAT----AQELLDHPF-------LLQTGLP 280
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 5e-09
Identities = 43/173 (24%), Positives = 81/173 (46%), Gaps = 9/173 (5%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
+ L++++G G G VY + T A+K++ LE Q E +++ H
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVKECKHCN 67
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQ-RQPGKYFSEQAVKFYVAEVLLALEYLHM 333
+ + + + + + ME+C GG L + P SE + + E L L YLH
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGP---LSELQIAYVCRETLQGLAYLHS 124
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNP 386
G ++RD+K N+L+ ++G + L+DF ++ + ++ T+ K + P P
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVAAK--ITATIAKRKSFIGTPYWMAP 175
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 36/110 (32%), Positives = 61/110 (55%), Gaps = 11/110 (10%)
Query: 258 LRAQTEREI--LQSLDHPFLPTLYTHF---ETDKFSCLVMEFCPGGDLHTLRQRQPGKYF 312
L +T RE+ L+ L H + +L F D + V E G DLH L +P
Sbjct: 52 LAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY--FVTELL-GTDLHRLLTSRP---L 105
Query: 313 SEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+Q +++++ ++L L+Y+H G+V+RDLKP N+L+ E+ + + DF L+
Sbjct: 106 EKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLA 155
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 5e-09
Identities = 49/180 (27%), Positives = 83/180 (46%), Gaps = 15/180 (8%)
Query: 220 KLGCGDIGSVY--LSELTGTKCYFAMKVMDKASLEK--RKKLLRAQTEREILQSLDHPFL 275
+LG G+ G V + ++ + A+KV+ K EK R +++R E EI+ LD+P++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVL-KNENEKSVRDEMMR---EAEIMHQLDNPYI 57
Query: 276 PTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLG 335
+ E + LVME GG L+ + + V+ + +V + ++YL
Sbjct: 58 VRMIGVCEAEAL-MLVMEMASGGPLNKFLSGKKDEITVSNVVEL-MHQVSMGMKYLEGKN 115
Query: 336 IVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACI 395
V+RDL NVL+ + +SDF LS + K+ + PL+ P CI
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK-----WYAPECI 170
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 57.4 bits (138), Expect = 6e-09
Identities = 41/145 (28%), Positives = 66/145 (45%), Gaps = 2/145 (1%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F L+++G G G+VY + T A+K M + + +K E + LQ + HP
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ + + LVME+C G L + K E + L L YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAITHGALQGLAYLHSH 144
Query: 335 GIVYRDLKPENVLVREDGHIMLSDF 359
+++RD+K N+L+ E G + L+DF
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADF 169
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 16/155 (10%)
Query: 215 FRLLKKLGCGDIGSVY--LSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH 272
F+ L+KLG G +VY + TG A+K + + E A E +++ L H
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGE--IVALKEIHLDAEEGTPS--TAIREISLMKELKH 57
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGG-----DLHTLRQRQPGKYFSEQAVKFYVAEVLLA 327
+ L+ T+ LV E+ D H +R VK + ++L
Sbjct: 58 ENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALD-----PNTVKSFTYQLLKG 112
Query: 328 LEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ + H +++RDLKP+N+L+ + G + L+DF L+
Sbjct: 113 IAFCHENRVLHRDLKPQNLLINKRGELKLADFGLA 147
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 7e-09
Identities = 37/106 (34%), Positives = 54/106 (50%), Gaps = 4/106 (3%)
Query: 256 KLLRAQTEREI--LQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFS 313
K+++ REI L+ L H L L F K LV EF L L + G
Sbjct: 41 KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG--LD 98
Query: 314 EQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDF 359
E V+ Y+ ++L +E+ H I++RD+KPEN+LV + G + L DF
Sbjct: 99 ESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 7e-09
Identities = 47/154 (30%), Positives = 74/154 (48%), Gaps = 18/154 (11%)
Query: 218 LKKLGCGDIGSV--YLSELTGTKCYFAMKVMDK-------ASLEKRKKLLRAQTEREILQ 268
LK++G G GSV + + TG K A+K + + A R+ L + E +
Sbjct: 20 LKQVGSGAYGSVCSAIDKRTGEKV--AIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVI 77
Query: 269 SLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLAL 328
L F + D + LVM + + T Q+ G SE V++ V ++L L
Sbjct: 78 GLLDVFTSAVSGDEFQDFY--LVMPY-----MQTDLQKIMGHPLSEDKVQYLVYQMLCGL 130
Query: 329 EYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+Y+H GI++RDLKP N+ V ED + + DF L+
Sbjct: 131 KYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA 164
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 8e-09
Identities = 43/158 (27%), Positives = 84/158 (53%), Gaps = 16/158 (10%)
Query: 215 FRLLKKLGCGDIGSVY--LSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-D 271
+ +++ +G G G V+ L++ G+K A+K++D + + E IL++L D
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKA--AVKILDPIHDIDEE----IEAEYNILKALSD 73
Query: 272 HPFLPTLY-THFETDKFS----CLVMEFCPGGDLHTLRQ--RQPGKYFSEQAVKFYVAEV 324
HP + Y +++ D + LV+E C GG + L + + G+ E + + + E
Sbjct: 74 HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEA 133
Query: 325 LLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
L+ L++LH+ ++RD+K N+L+ +G + L DF +S
Sbjct: 134 LMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 38/123 (30%), Positives = 59/123 (47%), Gaps = 13/123 (10%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ-PL 508
S VGT ++APE+I +G+ VD W+ GI + E++ G+ P+ + + P
Sbjct: 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPP 236
Query: 509 RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIP 568
R +S VS R + +LV+EP R A E+ QHPF ++ A PP
Sbjct: 237 RVKDSHKVSSVLRGFLDLMLVREPSQRAT----AQELLQHPF--------LKLAGPPSCI 284
Query: 569 KPV 571
P+
Sbjct: 285 VPL 287
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 9e-09
Identities = 46/155 (29%), Positives = 71/155 (45%), Gaps = 12/155 (7%)
Query: 242 AMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET-DKFSCLVMEFCPGGDL 300
A+K++ + E+ + R + E + L HP + L E V E+ PG
Sbjct: 7 AIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPG--- 63
Query: 301 HTLRQR--QPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG---HIM 355
TLR+ G + + + + +VL AL H GIV+RDLKP+N++V + G H
Sbjct: 64 RTLREVLAADGALPAGETGRL-MLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAK 122
Query: 356 LSDFDLS-LRCAVSPTVVKSSTLESEPLRKNPVYC 389
+ DF + L V V + T +E L P YC
Sbjct: 123 VLDFGIGTLLPGVRDADVATLTRTTEVL-GTPTYC 156
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.3 bits (137), Expect = 1e-08
Identities = 36/131 (27%), Positives = 50/131 (38%), Gaps = 37/131 (28%)
Query: 454 THE-----YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATLY---NVV 504
THE Y APEI+ G H +AVD W+ G E++ GK F G L+ ++
Sbjct: 156 THEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQIL 215
Query: 505 GQP---------------LRFPESPVVSFS---------ARDLIKGLLVKEPQNRLACRR 540
G P FP+ P DL+ +L P R+
Sbjct: 216 GTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRI---- 271
Query: 541 GATEIKQHPFF 551
A E +HP+F
Sbjct: 272 SAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 50/161 (31%), Positives = 76/161 (47%), Gaps = 11/161 (6%)
Query: 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKL-LRAQTEREILQSLDHPFLP 276
L KLG G +VY T A+K + LE + A E +L+ L H +
Sbjct: 11 LDKLGEGTYATVYKGRSKLTDNLVALK---EIRLEHEEGAPCTAIREVSLLKDLKHANIV 67
Query: 277 TLYTHFETDKFSCLVMEFCPGGDLHTLRQ--RQPGKYFSEQAVKFYVAEVLLALEYLHML 334
TL+ T+K LV E+ L+Q G + VK ++ ++L L Y H
Sbjct: 68 TLHDIIHTEKSLTLVFEYLD----KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR 123
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSS 375
+++RDLKP+N+L+ E G + L+DF L+ R PT S+
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLA-RAKSIPTKTYSN 163
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 1e-08
Identities = 41/145 (28%), Positives = 63/145 (43%), Gaps = 2/145 (1%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F L+++G G G+VY + A+K M + + +K E LQ L HP
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ + + LVME+C G L + K E + L L YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH 134
Query: 335 GIVYRDLKPENVLVREDGHIMLSDF 359
+++RD+K N+L+ E G + L DF
Sbjct: 135 NMIHRDVKAGNILLSEPGLVKLGDF 159
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 1e-08
Identities = 85/392 (21%), Positives = 144/392 (36%), Gaps = 97/392 (24%)
Query: 207 DGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI 266
DG + + ++KK+G G G V+L + T+ +F K + L++R+K + E +
Sbjct: 7 DGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREK-SQLVIEVNV 65
Query: 267 LQSLDHPFLPTLYTHF--ETDKFSCLVMEFCPGGDLHTLRQ---RQPGKYFSEQAVKFYV 321
++ L H + F + ++ ++MEFC GDL Q + GK E A+
Sbjct: 66 MRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGK-IEEHAIVDIT 124
Query: 322 AEVLLALEYLHMLG-------IVYRDLKPENVL----VREDGHIMLSDFDLSLRCAVSPT 370
++L AL Y H L +++RDLKP+N+ +R G I
Sbjct: 125 RQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI---------------- 168
Query: 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMG 430
+++ L P+ K + + I + SC+ +SP K+ K++M
Sbjct: 169 TAQANNLNGRPIAKIGDFGLSKN-IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDM- 226
Query: 431 NQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTP 490
W G +YEL GKTP
Sbjct: 227 --------------------------------------------WALGCIIYELCSGKTP 242
Query: 491 FKGSENRATLYNVVGQPLRFPESPVVSFSAR--DLIKGLLVKEPQNRLACRRGATEIKQH 548
F + N + L + + R P+ P+ S LIK LL + R +
Sbjct: 243 FHKANNFSQL---ISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSA---------- 289
Query: 549 PFFQGVNWALIRCASPPEIPKPVEIVHSPAPA 580
Q + + +I+ PP + AP
Sbjct: 290 --LQCLGYQIIKNVGPPVGAAGGGAGVAAAPG 319
|
Length = 1021 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 1e-08
Identities = 36/147 (24%), Positives = 64/147 (43%), Gaps = 15/147 (10%)
Query: 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH--PFL 275
+K L G VYL + +K+ R+K + E ILQ L +
Sbjct: 3 IKLLKGGLTNRVYLLGTKDED--YVLKI-----NPSREKGADREREVAILQLLARKGLPV 55
Query: 276 PTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLG 335
P + E+D +S L+ME+ G L + + + + +AE+L L L +L
Sbjct: 56 PKVLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQ------LAELLAKLHQLPLLV 109
Query: 336 IVYRDLKPENVLVREDGHIMLSDFDLS 362
+ + DL P N+LV + + + D++ +
Sbjct: 110 LCHGDLHPGNILVDDGKILGIIDWEYA 136
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 42/156 (26%), Positives = 72/156 (46%), Gaps = 12/156 (7%)
Query: 213 GHFRLLKKLGCGDIGSVY----LSELTGTKCYFAMKVM-DKASLEKRKKLLRAQTEREIL 267
+K LG G G+VY + E K A+KV+ ++ S + K++L E ++
Sbjct: 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILD---EAYVM 63
Query: 268 QSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQ-RQPGKYFSEQAVKFYVAEVLL 326
S+DHP + L + + L+ + P G L L R Q + + ++
Sbjct: 64 ASVDHPHVVRLLGICLSSQV-QLITQLMPLGCL--LDYVRNHKDNIGSQYLLNWCVQIAK 120
Query: 327 ALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ YL +V+RDL NVLV+ H+ ++DF L+
Sbjct: 121 GMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 2e-08
Identities = 47/154 (30%), Positives = 72/154 (46%), Gaps = 6/154 (3%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVM--DKASLEKRKKLLRAQTEREILQSLDH 272
+R K LG G G VYL T A K + D S E K++ + E ++L++L H
Sbjct: 4 WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQH 63
Query: 273 PFLPTLYTHFE--TDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEY 330
+ Y +K + ME+ PGG + Q + +E + Y ++L + Y
Sbjct: 64 ERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKD--QLKAYGALTESVTRKYTRQILEGMSY 121
Query: 331 LHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLR 364
LH IV+RD+K N+L G++ L DF S R
Sbjct: 122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKR 155
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 2e-08
Identities = 45/150 (30%), Positives = 63/150 (42%), Gaps = 8/150 (5%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+L +G G+ G V L + G K A+K + S + L A + +L HP
Sbjct: 7 ELKLGATIGKGEFGDVMLGDYRGQKV--AVKCLKDDSTAAQAFLAEASV----MTTLRHP 60
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
L L +V E+ G L LR R Q + F + +V +EYL
Sbjct: 61 NLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFAL-DVCEGMEYLE 119
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
V+RDL NVLV ED +SDF L+
Sbjct: 120 EKNFVHRDLAARNVLVSEDLVAKVSDFGLA 149
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 45/147 (30%), Positives = 67/147 (45%), Gaps = 10/147 (6%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYFAMKV--MDKASLEKRKKLLRAQTEREILQSLDHPFLP 276
+K+G G+ G VY L G A+K KRK L E EIL+ DHP +
Sbjct: 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFL----QEAEILKQYDHPNIV 55
Query: 277 TLYTHFETDKFSCL-VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLG 335
L K VME PGG L T +++ + ++ ++ + +EYL
Sbjct: 56 KL-IGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQM-SLDAAAGMEYLESKN 113
Query: 336 IVYRDLKPENVLVREDGHIMLSDFDLS 362
++RDL N LV E+ + +SDF +S
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMS 140
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 2e-08
Identities = 48/154 (31%), Positives = 70/154 (45%), Gaps = 15/154 (9%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTERE--ILQSLDH 272
F L +LG G+ G V + A K++ LE K +R Q RE +L +
Sbjct: 3 FEKLGELGAGNGGVVTKVLHRPSGLIMARKLI---HLEI-KPAIRNQIIRELKVLHECNS 58
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLH-TLRQ--RQPGKYFSEQAVKFYVAEVLLALE 329
P++ Y F +D + ME GG L L++ R P + ++ VL L
Sbjct: 59 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIA-----VLRGLT 113
Query: 330 YLH-MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
YL I++RD+KP N+LV G I L DF +S
Sbjct: 114 YLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 147
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 38/152 (25%), Positives = 72/152 (47%), Gaps = 2/152 (1%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD 271
+ +F++ KK+G G VY + + A+K + + K E ++L+ L+
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN 60
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQ--RQPGKYFSEQAVKFYVAEVLLALE 329
HP + F D +V+E GDL + + ++ + E+ V Y ++ A+E
Sbjct: 61 HPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE 120
Query: 330 YLHMLGIVYRDLKPENVLVREDGHIMLSDFDL 361
++H +++RD+KP NV + G + L D L
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGL 152
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 3e-08
Identities = 27/103 (26%), Positives = 41/103 (39%), Gaps = 38/103 (36%)
Query: 448 SMSFVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ 506
+ VGT Y+APE++ G+G+ D W+ G+ LYEL
Sbjct: 150 LKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------------- 187
Query: 507 PLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHP 549
+DLI+ +L K+P+ R A EI +H
Sbjct: 188 -----------PELKDLIRKMLQKDPEKRP----SAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 49/148 (33%), Positives = 73/148 (49%), Gaps = 10/148 (6%)
Query: 218 LKKLGCGDIGSVY--LSELTGTKCYFAMKVMDKASLEKRKKL-LRAQTEREILQSLDHPF 274
L KLG G +VY S+LTG A+K + LE + A E +L+ L H
Sbjct: 10 LDKLGEGSYATVYKGRSKLTGQ--LVALKEI---RLEHEEGAPFTAIREASLLKDLKHAN 64
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ TL+ T K LV E+ DL G S V+ ++ ++L L Y H
Sbjct: 65 IVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGG-GLSMHNVRLFLFQLLRGLAYCHQR 122
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLS 362
+++RDLKP+N+L+ E G + L+DF L+
Sbjct: 123 RVLHRDLKPQNLLISERGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 3e-08
Identities = 42/168 (25%), Positives = 75/168 (44%), Gaps = 28/168 (16%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH 272
+ L+ LGCG G V+ + + A+K K L + + A E +I++ LDH
Sbjct: 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVK---KIVLTDPQSVKHALREIKIIRRLDH 61
Query: 273 PFLPTLY-----------------THFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQ 315
+ +Y T + +V E DL + ++ P SE+
Sbjct: 62 DNIVKVYEVLGPSGSDLTEDVGSLTELNS---VYIVQE-YMETDLANVLEQGP---LSEE 114
Query: 316 AVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVR-EDGHIMLSDFDLS 362
+ ++ ++L L+Y+H +++RDLKP NV + ED + + DF L+
Sbjct: 115 HARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA 162
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-08
Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 16/157 (10%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKAS-LEKRKKLLRAQTEREILQSLDHP 273
L ++G G G VY T A+K M + E+ K++L +L+S D P
Sbjct: 17 LENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILM--DLDVVLKSHDCP 74
Query: 274 FLPTLYTHF--ETDKFSCL-VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEY 330
++ Y +F ++D F C+ +M C L L +R E + ++ AL Y
Sbjct: 75 YIVKCYGYFITDSDVFICMELMSTC----LDKLLKRI-QGPIPEDILGKMTVAIVKALHY 129
Query: 331 L---HMLGIVYRDLKPENVLVREDGHIMLSDFDLSLR 364
L H G+++RD+KP N+L+ G++ L DF +S R
Sbjct: 130 LKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGR 164
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 55.4 bits (134), Expect = 3e-08
Identities = 44/168 (26%), Positives = 70/168 (41%), Gaps = 23/168 (13%)
Query: 208 GVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI- 266
G + + +L KLG G G VY + T A+K K + K REI
Sbjct: 3 GCSKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALK---KILMHNEKDGFPITALREIK 59
Query: 267 -LQSLDHP-FLPTL---YTHFETDKFS--CLVMEFCP------GGDLHTLRQRQPGKYFS 313
L+ L HP +P + + K + M P G L + +
Sbjct: 60 ILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVT-PYMDHDLSGLLENPSVK-----LT 113
Query: 314 EQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDL 361
E +K Y+ ++L + YLH I++RD+K N+L+ G + ++DF L
Sbjct: 114 ESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL 161
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 3e-08
Identities = 38/148 (25%), Positives = 65/148 (43%), Gaps = 4/148 (2%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F L +KLG G G V+ L + A+K++ L K++ Q E + L+ L H
Sbjct: 8 FTLERKLGSGYFGEVW-EGLWKNRVRVAIKILKSDDLLKQQDF---QKEVQALKRLRHKH 63
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
L +L+ + ++ E G L + G+ ++ +V + YL
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLS 362
++RDL N+LV ED ++DF L+
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLA 151
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 32/107 (29%), Positives = 48/107 (44%), Gaps = 9/107 (8%)
Query: 450 SFVGTHEYLAPEIIK-GEGHGSAVDWWTFGIFLYELLFGKTPF-KGSENRATLYNVVGQP 507
+FVGT ++APE+++ G+ D W+FGI EL G P+ K + + + P
Sbjct: 165 TFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDP 224
Query: 508 LRFPE---SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551
S S R +I L K+P R A E+ +H FF
Sbjct: 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPT----AEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 4e-08
Identities = 38/110 (34%), Positives = 58/110 (52%), Gaps = 9/110 (8%)
Query: 445 NARSMSFVGTHEYLAPEII-KG-EGHGSAVDWWTFGIFLYELLFGKTPF-KGSENRATLY 501
N + +F GT +Y+APE+I KG G+G+ D W+ G + E+ GK PF + E +A ++
Sbjct: 163 NPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF 222
Query: 502 NVVGQPLRFPESP-VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPF 550
VG PE P +S A++ I +P R A A ++ Q PF
Sbjct: 223 K-VGMFKIHPEIPESLSAEAKNFILRCFEPDPDKR-AS---AHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 4e-08
Identities = 47/163 (28%), Positives = 79/163 (48%), Gaps = 6/163 (3%)
Query: 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYT 280
LG G+ G V+ L K A+K K L + K+ + +E IL+ DHP + L
Sbjct: 3 LGKGNFGEVFKGTLK-DKTPVAVKTC-KEDLPQELKI-KFLSEARILKQYDHPNIVKLIG 59
Query: 281 HFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRD 340
+ +VME PGGD + +++ + ++Q VKF + + + YL ++RD
Sbjct: 60 VCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFAL-DAAAGMAYLESKNCIHRD 118
Query: 341 LKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLR 383
L N LV E+ + +SDF +S + + SS L+ P++
Sbjct: 119 LAARNCLVGENNVLKISDFGMSRQ--EDDGIYSSSGLKQIPIK 159
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 54.7 bits (132), Expect = 4e-08
Identities = 47/176 (26%), Positives = 70/176 (39%), Gaps = 29/176 (16%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTKCY----------------FAMKVM-DKASLEKRK 255
++KLG G G V+L E G + + A+KV+ AS R+
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64
Query: 256 KLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSE 314
L+ E +IL L P + L D C++ME+ GDL L++
Sbjct: 65 DFLK---EVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLA 121
Query: 315 QAVKFYVAEVLL--------ALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
K LL + YL L V+RDL N LV ++ I ++DF +S
Sbjct: 122 CNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 5e-08
Identities = 30/101 (29%), Positives = 48/101 (47%), Gaps = 11/101 (10%)
Query: 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFP 511
+GT Y+APE+ KG + D W+ G LYE+ PF+ + L V Q ++P
Sbjct: 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEA-RSMQDLRYKV-QRGKYP 219
Query: 512 ESPVVSFSARDL---IKGLLVKEPQNRLACRRGATEIKQHP 549
P+ ++DL I+ +L +P+ R C +I P
Sbjct: 220 --PIPPIYSQDLQNFIRSMLQVKPKLRPNC----DKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-08
Identities = 34/87 (39%), Positives = 45/87 (51%), Gaps = 3/87 (3%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV-GQPL 508
SF GT YLAPE+ + + + D W+ G+ LYELL PFKG R + V+ G+
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD 289
Query: 509 RFPESPVVSFSARDLIKGLLVKEPQNR 535
FP VS + L+ LL K P R
Sbjct: 290 PFPCP--VSSGMKALLDPLLSKNPALR 314
|
Length = 478 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 7e-08
Identities = 47/173 (27%), Positives = 87/173 (50%), Gaps = 17/173 (9%)
Query: 214 HFRLLKKLGCGDIGSVYLS-ELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI-----L 267
+ + ++G G G V+ + +L + A+K + ++ ++ + T RE+ L
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALK---RVRVQTGEEGMPLSTIREVAVLRHL 58
Query: 268 QSLDHPFLPTLY---THFETDKFSCLVMEF-CPGGDLHTLRQRQPGKYFSEQAVKFYVAE 323
++ +HP + L+ T TD+ + L + F DL T + P + +K + +
Sbjct: 59 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 118
Query: 324 VLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDL----SLRCAVSPTVV 372
+L L++LH +V+RDLKP+N+LV G I L+DF L S + A++ VV
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (131), Expect = 8e-08
Identities = 42/142 (29%), Positives = 59/142 (41%), Gaps = 34/142 (23%)
Query: 440 IAEPTNARSMSFVGTHEYLAPEIIKGEGHGS-AVDWWTFGIFLYELLFGKTPFKGSENRA 498
+A T+ +V T Y APEI+ H + VD W+ G + ELL GKT F GS++
Sbjct: 164 LARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID 223
Query: 499 TL---YNVVGQPLR-----------------FPESPVVSFS---------ARDLIKGLLV 529
L N+VG P P+ P F A DL++ +LV
Sbjct: 224 QLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLV 283
Query: 530 KEPQNRLACRRGATEIKQHPFF 551
+P R+ A E HP+
Sbjct: 284 LDPDKRIT----AAEALAHPYL 301
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 8e-08
Identities = 29/106 (27%), Positives = 53/106 (50%), Gaps = 11/106 (10%)
Query: 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPF---KGSENRATLYNVVG-- 505
+GT ++APE+++GE +G + D W+ G + E+ K P+ K S + A ++ +
Sbjct: 168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASAT 227
Query: 506 QPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551
PE +S RD+ L +P++ R + E+ +HP F
Sbjct: 228 TAPSIPEH--LSPGLRDVTLRCLELQPED----RPPSRELLKHPVF 267
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 54.1 bits (131), Expect = 8e-08
Identities = 51/166 (30%), Positives = 80/166 (48%), Gaps = 33/166 (19%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEK--RKKLLRA--------QTER 264
+ +L+KLG G G V+ K +D+ + E KK+ A +T R
Sbjct: 9 YEILQKLGKGAYGIVW-------------KAIDRRTKEVVALKKIFDAFRNATDAQRTFR 55
Query: 265 EI--LQSL-DHPFLPTLYTHF--ETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKF 319
EI LQ L DHP + L E DK LV E+ DLH + + + ++
Sbjct: 56 EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYMET-DLHAVIRA---NILEDVHKRY 111
Query: 320 YVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365
+ ++L AL+Y+H +++RDLKP N+L+ D + L+DF L+ R
Sbjct: 112 IMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLA-RS 156
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 8e-08
Identities = 48/163 (29%), Positives = 78/163 (47%), Gaps = 17/163 (10%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKK--LLRAQTEREILQS 269
V F ++ ++G G G VY + T A+K K L+ K+ + A E +IL+
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALK---KVRLDNEKEGFPITAIREIKILRQ 62
Query: 270 LDHPFLPTLY---------THFETDKFSC-LVMEFCPGGDLHTLRQRQPGKYFSEQAVKF 319
L+H + L F+ DK + LV E+ DL L + +FSE +K
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-DHDLMGLLESGL-VHFSEDHIKS 120
Query: 320 YVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++ ++L L Y H ++RD+K N+L+ G I L+DF L+
Sbjct: 121 FMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.5 bits (129), Expect = 9e-08
Identities = 44/162 (27%), Positives = 72/162 (44%), Gaps = 21/162 (12%)
Query: 217 LLKKLGCGDIGSVY-------LSELTGTKCYFAMK-VMDKASLEKRKKLLRAQTEREILQ 268
L+++LG G G VY + T+ A+K V + AS+ +R + L E +++
Sbjct: 10 LIRELGQGSFGMVYEGLAKGVVKGEPETRV--AIKTVNENASMRERIEFLN---EASVMK 64
Query: 269 SLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQP-----GKYFSEQAVKFY-- 320
+ + L T + + +VME GDL + LR R+P KF
Sbjct: 65 EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124
Query: 321 VAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
AE+ + YL V+RDL N +V ED + + DF ++
Sbjct: 125 AAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMT 166
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 9e-08
Identities = 44/148 (29%), Positives = 75/148 (50%), Gaps = 10/148 (6%)
Query: 218 LKKLGCGDIGSVY--LSELTGTKCYFAMKVMDKASLEKRKKL-LRAQTEREILQSLDHPF 274
L+KLG G +VY +S + G A+KV+ S++ + + A E +L+ L H
Sbjct: 10 LEKLGEGSYATVYKGISRINGQ--LVALKVI---SMKTEEGVPFTAIREASLLKGLKHAN 64
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ L+ T + V E+ DL + PG V+ ++ ++L L Y+H
Sbjct: 65 IVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYN-VRLFMFQLLRGLAYIHGQ 122
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLS 362
I++RDLKP+N+L+ G + L+DF L+
Sbjct: 123 HILHRDLKPQNLLISYLGELKLADFGLA 150
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.0 bits (128), Expect = 1e-07
Identities = 31/103 (30%), Positives = 49/103 (47%), Gaps = 7/103 (6%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP-L 508
S VGT ++APE+I+ G +A D W+ G + ELL G P+ A L+ +V
Sbjct: 158 SVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP 217
Query: 509 RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551
PE +S +D + K+P R A ++ +HP+
Sbjct: 218 PLPEG--ISPELKDFLMQCFQKDPNLRPT----AKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 28/97 (28%), Positives = 53/97 (54%), Gaps = 7/97 (7%)
Query: 444 TNARSMSFVGTHEYLAPEII-KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSEN-RATLY 501
+++ +FVGT ++APE+I +G+ + + D W+ GI +YE+ G P+ + RA +
Sbjct: 154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML 213
Query: 502 NVVGQPLRFPESPVVSFSA--RDLIKGLLVKEPQNRL 536
+P R ++ +S R+ + L +EP+ RL
Sbjct: 214 IPKSKPPRLEDN---GYSKLLREFVAACLDEEPKERL 247
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 45/167 (26%), Positives = 78/167 (46%), Gaps = 19/167 (11%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQSL- 270
+ L+K+LG G G V + T + + K + KK+L + RE+ L+
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAI-KKITNVFSKKILAKRALRELKLLRHFR 59
Query: 271 DHPFLPTLYTH--FETDKFSCL-----VMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVA 322
H + LY F+ L +ME DLH +R QP ++ + ++
Sbjct: 60 GHKNITCLYDMDIVFPGNFNELYLYEELMEA----DLHQIIRSGQP---LTDAHFQSFIY 112
Query: 323 EVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369
++L L+Y+H +++RDLKP N+LV D + + DF L+ + +P
Sbjct: 113 QILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP 159
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 44/150 (29%), Positives = 62/150 (41%), Gaps = 9/150 (6%)
Query: 217 LLKKLGCGDIGSVY---LSELTGTKCYFAMKVMDK-ASLEKRKKLLRAQTEREILQSLDH 272
L + +G G G VY K A+K S R+K L+ E I++ DH
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQ---EAYIMRQFDH 66
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
P + L T+ +VME P G+L + Q + Y ++ AL YL
Sbjct: 67 PHIVKL-IGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLIL-YSYQLSTALAYLE 124
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
V+RD+ NVLV + L DF LS
Sbjct: 125 SKRFVHRDIAARNVLVSSPDCVKLGDFGLS 154
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 2e-07
Identities = 43/151 (28%), Positives = 75/151 (49%), Gaps = 16/151 (10%)
Query: 219 KKLGCGDIGSV---YLSELTGTKCYFAMKVM----DKASLEKRKKLLRAQTEREILQSLD 271
+LG G+ G+V K A+K++ + +L + +LLR E ++Q LD
Sbjct: 1 GELGSGNFGTVKKGMYKMKKSEKT-VAVKILKNDNNDPAL--KDELLR---EANVMQQLD 54
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
+P++ + E + + LVME G L+ Q+ K+ +E+ + V +V + ++YL
Sbjct: 55 NPYIVRMIGICEAESW-MLVMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYL 111
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
V+RDL NVL+ + +SDF LS
Sbjct: 112 EETNFVHRDLAARNVLLVTQHYAKISDFGLS 142
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 2e-07
Identities = 40/149 (26%), Positives = 66/149 (44%), Gaps = 6/149 (4%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
LK+LG G G V + G + A+K++ + S+ + + + A+ ++ L H
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAK----VMMKLSHE 59
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
L LY + +V E+ G L R+ GK F + +V + YL
Sbjct: 60 KLVQLYGVCTKQRPIYIVTEYMSNGCLLNY-LREHGKRFQPSQLLEMCKDVCEGMAYLES 118
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++RDL N LV + G + +SDF LS
Sbjct: 119 KQFIHRDLAARNCLVDDQGCVKVSDFGLS 147
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 2e-07
Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 12/170 (7%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYFAMKV-MDKASLEKRKKLLRAQTEREILQSLDHPFLPT 277
+K+G G G+V+ T +V + + +L+K+ K E +++ L +P +
Sbjct: 25 EKIGQGASGTVF----TAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVN 80
Query: 278 LYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIV 337
F +VME+ GG L + E + E L ALE+LH ++
Sbjct: 81 FLDSFLVGDELFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVI 137
Query: 338 YRDLKPENVLVREDGHIMLSDFDLSLRCA-VSPTVVKSSTLESEPLRKNP 386
+RD+K +NVL+ DG + L+DF CA ++P K ST+ P P
Sbjct: 138 HRDIKSDNVLLGMDGSVKLTDFGF---CAQITPEQSKRSTMVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 3e-07
Identities = 36/113 (31%), Positives = 59/113 (52%), Gaps = 13/113 (11%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNV 503
T A+ + +GT ++APE+I+ G+ + D W+ GI E+ GK P+ ++ +
Sbjct: 152 TMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI 211
Query: 504 VGQP---LRFPE--SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551
+P L PE SP F+ D +K LVK+P+ R + A ++ QHPF
Sbjct: 212 PNKPPPTLSDPEKWSP--EFN--DFVKKCLVKDPEERPS----AIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 3e-07
Identities = 37/118 (31%), Positives = 57/118 (48%), Gaps = 21/118 (17%)
Query: 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPF-KGSENRATLYNV 503
N+ + ++VGT+ Y+APE I GE +G D W+ GI EL G+ P+ + +N+ +L
Sbjct: 147 NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSL--- 203
Query: 504 VGQPLRF---------PESPVVSFSAR--DLIKGLLVKEPQNRLACRRGATEIKQHPF 550
PL+ P PV FS + I + K+P+ R A + HPF
Sbjct: 204 --MPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPA----PENLMDHPF 255
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 35/117 (29%), Positives = 59/117 (50%), Gaps = 8/117 (6%)
Query: 251 LEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-----LRQ 305
L ++ A++E L + DH + + F++D L+ME+ GGDL+ L++
Sbjct: 103 LNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKE 162
Query: 306 RQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
P F E V +++LAL+ +H +++RDLK N+ + G I L DF S
Sbjct: 163 HLP---FQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFS 216
|
Length = 478 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-07
Identities = 35/115 (30%), Positives = 58/115 (50%), Gaps = 13/115 (11%)
Query: 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN 502
P ++ + VGT ++APE++ + +G VD W+ GI E++ G+ P+ LY
Sbjct: 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226
Query: 503 VV--GQP-LRFPE--SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
+ G P L+ PE SP+ RD + L + + R + A E+ QHPF +
Sbjct: 227 IATNGTPELQNPEKLSPIF----RDFLNRCLEMDVEKRGS----AKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 52.4 bits (125), Expect = 3e-07
Identities = 36/114 (31%), Positives = 56/114 (49%), Gaps = 11/114 (9%)
Query: 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN 502
P ++ + VGT ++APE++ + +G VD W+ GI E++ G+ P+ LY
Sbjct: 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226
Query: 503 VV--GQP-LRFPESPVVSFSARDLIKGLLVKEPQNRLACRRG-ATEIKQHPFFQ 552
+ G P L+ PE F RD + L + RRG A E+ QHPF +
Sbjct: 227 IATNGTPELQNPERLSAVF--RDFLNRCLEMDVD-----RRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 3e-07
Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 15/154 (9%)
Query: 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYT 280
LG G G+V ++ FA+KV+D + + K RAQ E L + D F +
Sbjct: 40 LGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKN-RAQAEVCCLLNCD--FFSIVKC 96
Query: 281 HFETDK----------FSCLVMEFCPGGDL-HTLRQR-QPGKYFSEQAVKFYVAEVLLAL 328
H + K LV+++ GDL ++ R + + F E +VLLA+
Sbjct: 97 HEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAV 156
Query: 329 EYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++H +++RD+K N+L+ +G + L DF S
Sbjct: 157 HHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS 190
|
Length = 496 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 4e-07
Identities = 43/129 (33%), Positives = 54/129 (41%), Gaps = 33/129 (25%)
Query: 452 VGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGS---ENRATLYNVVGQP 507
V T Y APE++ G VD W G ELL G F G E A ++ +G P
Sbjct: 161 VATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTP 220
Query: 508 ----------------LRFPES---------PVVSFSARDLIKGLLVKEPQNRLACRRGA 542
+ FPES P S A DL+KGLLV +P RL+ A
Sbjct: 221 NEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS----A 276
Query: 543 TEIKQHPFF 551
E +HP+F
Sbjct: 277 AEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 4e-07
Identities = 28/86 (32%), Positives = 40/86 (46%), Gaps = 1/86 (1%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR 509
+ VGT Y++PE+ +G + D W G LYELL K F + N L + Q
Sbjct: 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT-NPLNLVVKIVQGNY 218
Query: 510 FPESPVVSFSARDLIKGLLVKEPQNR 535
P V S L+ LL ++P+ R
Sbjct: 219 TPVVSVYSSELISLVHSLLQQDPEKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 4e-07
Identities = 33/124 (26%), Positives = 56/124 (45%), Gaps = 15/124 (12%)
Query: 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN 502
P ++ + VGT ++APE++ + +G VD W+ GI E++ G+ P+ LY
Sbjct: 167 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226
Query: 503 VV--GQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIR 560
+ G P +S RD + L + + R + A E+ QHPF ++
Sbjct: 227 IATNGTP-ELQNPEKLSAIFRDFLNRCLEMDVEKRGS----AKELLQHPF--------LK 273
Query: 561 CASP 564
A P
Sbjct: 274 IAKP 277
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 44/170 (25%), Positives = 78/170 (45%), Gaps = 10/170 (5%)
Query: 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPT 277
+K+G G G+VY + T A+K M+ K++ ++ E +++ +P +
Sbjct: 24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELII---NEILVMRENKNPNIVN 80
Query: 278 LYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIV 337
+ +VME+ GG L + E + E L AL++LH ++
Sbjct: 81 YLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVI 137
Query: 338 YRDLKPENVLVREDGHIMLSDFDLSLRCA-VSPTVVKSSTLESEPLRKNP 386
+RD+K +N+L+ DG + L+DF CA ++P K ST+ P P
Sbjct: 138 HRDIKSDNILLGMDGSVKLTDFGF---CAQITPEQSKRSTMVGTPYWMAP 184
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 22/161 (13%)
Query: 214 HFRLLKKLGCGDIGSV----Y--LSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREIL 267
H + +++LG G+ GSV Y L + TG A+K + ++ E + R E EIL
Sbjct: 5 HLKFIQQLGKGNFGSVELCRYDPLQDNTGE--VVAVKKLQHSTAEHLRDFER---EIEIL 59
Query: 268 QSLDHPFLPTLYTHFETDKFSC------LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYV 321
+SL H + ++ +S LVME+ P G L Q+ + + + Y
Sbjct: 60 KSLQHDNI----VKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLL-LYA 114
Query: 322 AEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+++ +EYL V+RDL N+LV + + + DF L+
Sbjct: 115 SQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLT 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 4e-07
Identities = 44/157 (28%), Positives = 73/157 (46%), Gaps = 16/157 (10%)
Query: 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQSLDH-PF 274
L+K+G G G VY + T A+K K LE ++ + REI LQ L +
Sbjct: 6 LEKIGEGTYGKVYKARDKNTGKLVALK---KTRLEMDEEGIPPTALREISLLQMLSESIY 62
Query: 275 LPTLYT--HFETDKFSC---LVMEFCPGGDLHT---LRQRQPGKYFSEQAVKFYVAEVLL 326
+ L H E LV E+ DL R PG+ + +K ++ ++L
Sbjct: 63 IVRLLDVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLK 121
Query: 327 ALEYLHMLGIVYRDLKPENVLVREDGHIM-LSDFDLS 362
+ + H G+++RDLKP+N+LV + ++ ++D L
Sbjct: 122 GVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 4e-07
Identities = 26/66 (39%), Positives = 42/66 (63%), Gaps = 3/66 (4%)
Query: 297 GGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIML 356
G DL+ + + Q S++ V+F + ++L L+Y+H GI++RDLKP NV V ED + +
Sbjct: 103 GADLNNIVKCQK---LSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRI 159
Query: 357 SDFDLS 362
DF L+
Sbjct: 160 LDFGLA 165
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 40/149 (26%), Positives = 74/149 (49%), Gaps = 16/149 (10%)
Query: 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVM----DKASLEKRKKLLRAQTEREILQSLDHP 273
+ ++G G G+VY T +A+KV+ + R+++ R E EIL+ ++HP
Sbjct: 79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTV---RRQICR---EIEILRDVNHP 132
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
+ + F+ + +++EF GG L EQ + ++L + YLH
Sbjct: 133 NVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHR 186
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLS 362
IV+RD+KP N+L+ ++ ++DF +S
Sbjct: 187 RHIVHRDIKPSNLLINSAKNVKIADFGVS 215
|
Length = 353 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 5e-07
Identities = 32/106 (30%), Positives = 51/106 (48%), Gaps = 5/106 (4%)
Query: 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ 506
R S VGT ++APE+I +G VD W+ GI + E++ G+ P+ + +
Sbjct: 172 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN 231
Query: 507 -PLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551
P + VS S + + LLV++P R A E+ +HPF
Sbjct: 232 LPPKLKNLHKVSPSLKGFLDRLLVRDPAQRAT----AAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 51.3 bits (123), Expect = 5e-07
Identities = 42/164 (25%), Positives = 64/164 (39%), Gaps = 21/164 (12%)
Query: 217 LLKKLGCGDIGSVYLSEL-----TGTKCYFAMKVM-DKASLEKRKKLLRAQTEREILQSL 270
L ++LG G G V+L E K A+K + + AS + RK R E E+L +
Sbjct: 9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFER---EAELLTNF 65
Query: 271 DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LR-----------QRQPGKYFSEQAVK 318
H + Y +V E+ GDL+ LR P + +
Sbjct: 66 QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLL 125
Query: 319 FYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++ + YL V+RDL N LV D + + DF +S
Sbjct: 126 QIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 45/181 (24%), Positives = 69/181 (38%), Gaps = 31/181 (17%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTK----CYFAMKVMDKASLEKRKKLLRAQT------ 262
GH +KLG G G V+L E+ + F V L K+LR
Sbjct: 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARN 64
Query: 263 ----EREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDL------HTLRQRQ----- 307
E +IL L P + L + C++ E+ GDL H L ++
Sbjct: 65 DFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGND 124
Query: 308 ------PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDL 361
S ++ ++ ++YL L V+RDL N LV E+ I ++DF +
Sbjct: 125 AVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGM 184
Query: 362 S 362
S
Sbjct: 185 S 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 44/146 (30%), Positives = 72/146 (49%), Gaps = 8/146 (5%)
Query: 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPT 277
+K+LG G G V+L + + A+K +++ ++ + + E +++ L HP L
Sbjct: 9 MKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFI----EEAKVMMKLSHPKLVQ 63
Query: 278 LYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGI 336
LY K +V EF G L + LRQRQ GK S+ + +V +EYL
Sbjct: 64 LYGVCTQQKPLYIVTEFMENGCLLNYLRQRQ-GK-LSKDMLLSMCQDVCEGMEYLERNSF 121
Query: 337 VYRDLKPENVLVREDGHIMLSDFDLS 362
++RDL N LV G + +SDF ++
Sbjct: 122 IHRDLAARNCLVSSTGVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 6e-07
Identities = 36/100 (36%), Positives = 48/100 (48%), Gaps = 5/100 (5%)
Query: 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFP 511
VGT YL+PEI + + + D W+ G LYEL K PF+G+ N L + Q P
Sbjct: 163 VGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN-NLHQLVLKICQGYFAP 221
Query: 512 ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551
SP S R LI L P++R + T I + PF
Sbjct: 222 ISPNFSRDLRSLISQLFKVSPRDRPS----ITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 31/115 (26%), Positives = 50/115 (43%), Gaps = 10/115 (8%)
Query: 444 TNARSMSFVGTHEYLAPEII-----KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRA 498
T + +F+GT ++APE++ K + D W+ GI L EL + P
Sbjct: 156 TLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR 215
Query: 499 TLYNVV-GQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
L ++ +P + S S D +K LVK+P +R E+ +HPF
Sbjct: 216 VLLKILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAA----ELLKHPFVS 266
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 8e-07
Identities = 34/130 (26%), Positives = 51/130 (39%), Gaps = 33/130 (25%)
Query: 451 FVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY---NVVGQ 506
+V T Y APE++ G +G+ + VD W+ G ELL + F G L+ +G
Sbjct: 158 YVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGT 217
Query: 507 P----------------LRFPES---------PVVSFSARDLIKGLLVKEPQNRLACRRG 541
P FP+ P S A DL+ +L +P R+
Sbjct: 218 PDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRIT---- 273
Query: 542 ATEIKQHPFF 551
A + HP+F
Sbjct: 274 AEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 8e-07
Identities = 42/148 (28%), Positives = 71/148 (47%), Gaps = 8/148 (5%)
Query: 216 RLLKKLGCGDIGSVYL-SELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
L++++G G G V+L L K A+K + + ++ + + E +++ L HP
Sbjct: 7 TLVQEIGSGQFGLVWLGYWLEKRKV--AIKTIREGAMSEEDFI----EEAQVMMKLSHPK 60
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
L LY CLV EF G L + Q GK FS++ + +V + YL
Sbjct: 61 LVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGMAYLESS 119
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLS 362
+++RDL N LV E+ + +SDF ++
Sbjct: 120 NVIHRDLAARNCLVGENQVVKVSDFGMT 147
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 51/184 (27%), Positives = 84/184 (45%), Gaps = 12/184 (6%)
Query: 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPT 277
L +LG G+ GSVY T AMK + + L++ K + E +IL P++
Sbjct: 6 LDELGKGNYGSVYKVLHRPTGVTMAMKEI-RLELDE-SKFNQIIMELDILHKAVSPYIVD 63
Query: 278 LYTHFETDKFSCLVMEFCPGGDLHTLR-QRQPGKYFSEQAVKFYVAEVLLALEYL-HMLG 335
Y F + + ME+ G L L + E ++ V+ L++L
Sbjct: 64 FYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123
Query: 336 IVYRDLKPENVLVREDGHIMLSDFDLS--LRCAVSPTVVKSST------LESEPLRKNPV 387
I++RD+KP NVLV +G + L DF +S L +++ T + + ++S +NP
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNPT 183
Query: 388 YCVQ 391
Y VQ
Sbjct: 184 YTVQ 187
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 50.5 bits (120), Expect = 1e-06
Identities = 44/170 (25%), Positives = 78/170 (45%), Gaps = 10/170 (5%)
Query: 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPT 277
+K+G G G+VY + T A++ M+ K++ ++ E +++ +P +
Sbjct: 25 FEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII---NEILVMRENKNPNIVN 81
Query: 278 LYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIV 337
+ +VME+ GG L + E + E L ALE+LH ++
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVI 138
Query: 338 YRDLKPENVLVREDGHIMLSDFDLSLRCA-VSPTVVKSSTLESEPLRKNP 386
+RD+K +N+L+ DG + L+DF CA ++P K ST+ P P
Sbjct: 139 HRDIKSDNILLGMDGSVKLTDFGF---CAQITPEQSKRSTMVGTPYWMAP 185
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 1e-06
Identities = 46/171 (26%), Positives = 71/171 (41%), Gaps = 22/171 (12%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKV--MDKASLEKRKKLLRAQT--------- 262
RL +KLG G G V+L E G + D + K+LRA
Sbjct: 6 QLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFL 65
Query: 263 -EREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYF-------- 312
E +I+ L +P + L +D C++ E+ GDL+ L QR+ F
Sbjct: 66 KEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPS 125
Query: 313 -SEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
S + + ++ ++YL L V+RDL N LV I ++DF +S
Sbjct: 126 VSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 44/158 (27%), Positives = 73/158 (46%), Gaps = 19/158 (12%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDK--ASLEKRKKLLRAQTEREILQSLDH 272
++ L +G G GSV + T T A+K + + S+ K+ R E +L+ + H
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR---ELRLLKHMKH 75
Query: 273 P--------FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEV 324
F P E LV G DL+ + + Q ++ V+F + ++
Sbjct: 76 ENVIGLLDVFTPA--RSLEEFNDVYLVTHLM-GADLNNIVKCQK---LTDDHVQFLIYQI 129
Query: 325 LLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
L L+Y+H I++RDLKP N+ V ED + + DF L+
Sbjct: 130 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 167
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 38/151 (25%), Positives = 64/151 (42%), Gaps = 21/151 (13%)
Query: 220 KLGCGDIGSVYLSELTGTKCYFAMKVMDKASLE----KRKKLLRAQTEREILQSLDHPFL 275
+ G G L T FA +D + E K + TE IL++++HP +
Sbjct: 86 RAGIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRGGTATEAHILRAINHPSI 145
Query: 276 PTLYTHFETDKFSCLVME------FCPGGDLHTLRQRQP-GKYFSEQAVKFYVAEVLLAL 328
L F +KF+CL++ +C ++ + + VL A+
Sbjct: 146 IQLKGTFTYNKFTCLILPRYKTDLYCYLAA----KRNIAICDILAIER------SVLRAI 195
Query: 329 EYLHMLGIVYRDLKPENVLVREDGHIMLSDF 359
+YLH I++RD+K EN+ + G + L DF
Sbjct: 196 QYLHENRIIHRDIKAENIFINHPGDVCLGDF 226
|
Length = 391 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 39/148 (26%), Positives = 65/148 (43%), Gaps = 5/148 (3%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
+L +KLG G G V++ GT A+K + ++ L AQ I++ L H
Sbjct: 8 LKLERKLGAGQFGEVWMGTWNGT-TKVAVKTLKPGTMSPEAFLQEAQ----IMKKLRHDK 62
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
L LY ++ +V E+ G L + GK + A++ + YL
Sbjct: 63 LVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR 122
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLS 362
++RDL N+LV E+ ++DF L+
Sbjct: 123 NYIHRDLAARNILVGENLVCKIADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 49.5 bits (119), Expect = 2e-06
Identities = 23/76 (30%), Positives = 40/76 (52%), Gaps = 2/76 (2%)
Query: 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVR 349
+VME+ DL +L + F + VK + ++L + +LH I++RDLK N+L+
Sbjct: 83 MVMEYVEH-DLKSLMETMKQP-FLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLN 140
Query: 350 EDGHIMLSDFDLSLRC 365
G + + DF L+
Sbjct: 141 NRGILKICDFGLAREY 156
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 47/172 (27%), Positives = 74/172 (43%), Gaps = 12/172 (6%)
Query: 216 RLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFL 275
+LL+KLG G G V+ T A+K + +++ + L AQ I++ L HP L
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTP-VAVKTLKPGTMDPKDFLAEAQ----IMKKLRHPKL 63
Query: 276 PTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLG 335
LY ++ +V E G L Q G+ + A+V + YL
Sbjct: 64 IQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN 123
Query: 336 IVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPV 387
++RDL NVLV E+ ++DF L+ V+K E+ K P+
Sbjct: 124 YIHRDLAARNVLVGENNICKVADFGLA-------RVIKEDIYEAREGAKFPI 168
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-06
Identities = 42/150 (28%), Positives = 75/150 (50%), Gaps = 11/150 (7%)
Query: 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQSLDHPFL 275
++K+G G G VY + T A+K K LE+ + + + REI L+ + H +
Sbjct: 7 VEKIGEGTYGVVYKARDRVTNETIALK---KIRLEQEDEGVPSTAIREISLLKEMQHGNI 63
Query: 276 PTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSE--QAVKFYVAEVLLALEYLHM 333
L ++K LV E+ DL + F++ + +K Y+ ++L + Y H
Sbjct: 64 VRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHS 120
Query: 334 LGIVYRDLKPENVLV-REDGHIMLSDFDLS 362
+++RDLKP+N+L+ R + L+DF L+
Sbjct: 121 HRVLHRDLKPQNLLIDRRTNALKLADFGLA 150
|
Length = 294 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 43/167 (25%), Positives = 72/167 (43%), Gaps = 23/167 (13%)
Query: 219 KKLGCGDIGSVYLSELTGTKCY----FAMKVMDKASLEKRKKLLRAQT----------ER 264
+KLG G G V+L E G + + F++ V + K+LR E
Sbjct: 11 EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70
Query: 265 EILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQA-------- 316
+I+ L P + L T C++ E+ GDL+ R + +E+A
Sbjct: 71 KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130
Query: 317 -VKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ F ++ ++YL L V+RDL N LV ++ I ++DF +S
Sbjct: 131 TLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.7 bits (117), Expect = 4e-06
Identities = 34/144 (23%), Positives = 53/144 (36%), Gaps = 35/144 (24%)
Query: 442 EPTNARSMS-FVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRAT 499
+ ++ +V T Y APE++ A+D W+ G ELL K F G +
Sbjct: 156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ 215
Query: 500 L---YNVVGQP-----------------LRFPESPVVSFS---------ARDLIKGLLVK 530
L V+G P P+ P S A DL++ +LV
Sbjct: 216 LNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVF 275
Query: 531 EPQNRLACRRGATEIKQHPFFQGV 554
+P+ R+ A E HP+ +
Sbjct: 276 DPKKRIT----ADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 4e-06
Identities = 40/148 (27%), Positives = 67/148 (45%), Gaps = 6/148 (4%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
RL KLG G G V++ GT A+K + ++ L AQ +++ L H
Sbjct: 8 LRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQ----VMKKLRHEK 62
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
L LY + +V E+ G L + + GKY + A++ + Y+ +
Sbjct: 63 LVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM 121
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLS 362
V+RDL+ N+LV E+ ++DF L+
Sbjct: 122 NYVHRDLRAANILVGENLVCKVADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 48.2 bits (114), Expect = 5e-06
Identities = 33/113 (29%), Positives = 55/113 (48%), Gaps = 9/113 (7%)
Query: 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN 502
P ++ + VGT ++APE++ + +G VD W+ GI E++ G+ P+ LY
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227
Query: 503 VV--GQP-LRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
+ G P L+ PE F RD + L + + R + A E+ QH F +
Sbjct: 228 IATNGTPELQNPEKLSAIF--RDFLNRCLDMDVEKRGS----AKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 48.0 bits (114), Expect = 5e-06
Identities = 48/186 (25%), Positives = 77/186 (41%), Gaps = 14/186 (7%)
Query: 200 IQAVRVK-DGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEK-RKKL 257
I A +K + V+G G F G++ S L + A+K + EK R+
Sbjct: 1 IDASCIKIEKVIGAGEF--------GEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDF 52
Query: 258 LRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAV 317
L E I+ DHP + L K +V E+ G L ++ G++ Q V
Sbjct: 53 LS---EASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLV 109
Query: 318 KFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTL 377
+ + ++YL +G V+RDL N+LV + +SDF LS P ++
Sbjct: 110 GM-LRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRG 168
Query: 378 ESEPLR 383
P+R
Sbjct: 169 GKIPIR 174
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 6e-06
Identities = 27/87 (31%), Positives = 46/87 (52%), Gaps = 3/87 (3%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR 509
+F GT Y+APEI + + + D ++ G+ LYELL K PF G ++ + R
Sbjct: 204 TFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAG--R 261
Query: 510 F-PESPVVSFSARDLIKGLLVKEPQNR 535
+ P P +S ++++ LL +P+ R
Sbjct: 262 YDPLPPSISPEMQEIVTALLSSDPKRR 288
|
Length = 496 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 44/166 (26%), Positives = 70/166 (42%), Gaps = 23/166 (13%)
Query: 216 RLLKKLGCGDIGSVYLSELTGTKC-----YFAMKVM-DKASLEKRKKLLRAQTEREILQS 269
R +++LG G VY L GT A+K + DKA R++ R LQ
Sbjct: 8 RFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQ- 66
Query: 270 LDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQP----GKYFSEQAVK------ 318
HP + L ++ ++ +C DLH L R P G ++ VK
Sbjct: 67 --HPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA 124
Query: 319 ---FYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDL 361
V ++ +E+L +V++DL NVLV + ++ +SD L
Sbjct: 125 DFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL 170
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 8e-06
Identities = 40/148 (27%), Positives = 66/148 (44%), Gaps = 6/148 (4%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
RL KLG G G V++ GT A+K + ++ L AQ I++ L H
Sbjct: 8 LRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMMPEAFLQEAQ----IMKKLRHDK 62
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
L LY + +V EF G L + GKY + A++ + Y+ +
Sbjct: 63 LVPLYAVVSEEPIY-IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM 121
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLS 362
++RDL+ N+LV ++ ++DF L+
Sbjct: 122 NYIHRDLRAANILVGDNLVCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-06
Identities = 46/151 (30%), Positives = 69/151 (45%), Gaps = 9/151 (5%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTERE--ILQSLDH 272
F + +LG G+ G V + + A K++ LE K +R Q RE +L +
Sbjct: 7 FERISELGAGNGGVVTKVQHKPSGLIMARKLI---HLEI-KPAIRNQIIRELQVLHECNS 62
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYL- 331
P++ Y F +D + ME GG L + + K E+ + VL L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLR 120
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
I++RD+KP N+LV G I L DF +S
Sbjct: 121 EKHQIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 8e-06
Identities = 42/151 (27%), Positives = 66/151 (43%), Gaps = 8/151 (5%)
Query: 216 RLLKKLGCGDIGSVYLS--ELTGTKCYF-AMKVMDKASLEK-RKKLLRAQTEREILQSLD 271
+ K +G G+ G V +L G K A+K + S +K R L TE I+ D
Sbjct: 7 TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFL---TEASIMGQFD 63
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
HP + L + ++ E+ G L + GK+ Q V + + ++YL
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGM-LRGIASGMKYL 122
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ V+RDL N+LV + +SDF LS
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLS 153
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 42/159 (26%), Positives = 75/159 (47%), Gaps = 15/159 (9%)
Query: 217 LLKKLGCGDIGSVYLSELTGTKCYF--AMKVMDKASLEKRKKLLRAQTEREILQSLDHP- 273
L K LG G+ GSV +L A+K M K ++ R ++ +E ++ DHP
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHPN 61
Query: 274 ---FLPTLYTHFETDKFSC--LVMEFCPGGDLHT--LRQR---QPGKYFSEQAVKFYVAE 323
+ E++ + +++ F GDLH+ L R P ++ VKF + +
Sbjct: 62 VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF-MTD 120
Query: 324 VLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ +EYL ++RDL N ++ E+ ++ ++DF LS
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 41/144 (28%), Positives = 57/144 (39%), Gaps = 37/144 (25%)
Query: 440 IAEPTNARSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSENRA 498
+ + +V T Y APE++ G+ +G VD W G + ELL G+ F G +
Sbjct: 150 LRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDID 209
Query: 499 TLY---NVVGQPL-----------------RFPESPV-----------VSFSARDLIKGL 527
LY +G PL FPE VS A D +K
Sbjct: 210 QLYLIQKCLG-PLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKAC 268
Query: 528 LVKEPQNRLACRRGATEIKQHPFF 551
L +P+ RL C E+ QHP+F
Sbjct: 269 LRMDPKERLTCD----ELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 10/153 (6%)
Query: 215 FRLLKKLGCGDIGSVY----LSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL 270
F+ +K LG G G+VY + E K A+K + +A+ K K E ++ S+
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK--EILDEAYVMASV 66
Query: 271 DHPFLPTLYTHFETDKFSCLVMEFCP-GGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALE 329
D+P + L T L+ + P G L +R+ + Q + + ++ +
Sbjct: 67 DNPHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHK--DNIGSQYLLNWCVQIAKGMN 123
Query: 330 YLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
YL +V+RDL NVLV+ H+ ++DF L+
Sbjct: 124 YLEERRLVHRDLAARNVLVKTPQHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (113), Expect = 1e-05
Identities = 39/130 (30%), Positives = 54/130 (41%), Gaps = 33/130 (25%)
Query: 451 FVGTHEYLAPEII-KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY---NVVGQ 506
+V T Y APEI+ + + S VD W G + EL + F GS LY +V+G
Sbjct: 158 YVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGT 217
Query: 507 P----------------LRFPESPVVSFS---------ARDLIKGLLVKEPQNRLACRRG 541
P RFP+ S A DLIK +L +P+ R
Sbjct: 218 PTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT---- 273
Query: 542 ATEIKQHPFF 551
A++ QHP+F
Sbjct: 274 ASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 32/119 (26%), Positives = 51/119 (42%), Gaps = 14/119 (11%)
Query: 442 EPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPF--KGSENRAT 499
E N+ + +F GT Y+APE I+G+ + D W+ G+ L E+ + PF +G
Sbjct: 154 ELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGP 213
Query: 500 L----YNVVGQPLRFPESPVV----SFSARDLIKGLLVKEPQNRLACRRGATEIKQHPF 550
+ Y V + P S +D IK L K+P R + +HP+
Sbjct: 214 IELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWD----MLEHPW 268
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 32/112 (28%), Positives = 54/112 (48%), Gaps = 10/112 (8%)
Query: 445 NARSMSFVGTHEYLAPEII--KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN 502
N ++MS G+ ++APE+I +G+ + VD W+ G + E+ G+ P+ E A ++
Sbjct: 164 NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223
Query: 503 VVGQ----PLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPF 550
+ + P+ S +S A D + P NR A E+ QHPF
Sbjct: 224 LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPT----ARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 30/95 (31%), Positives = 43/95 (45%), Gaps = 8/95 (8%)
Query: 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATL---- 500
++ S VGT Y PEI+K E +G D W FG LY++ + PF S N +L
Sbjct: 167 ESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFY-STNMLSLATKI 225
Query: 501 YNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNR 535
V +PL + S D+I L + + R
Sbjct: 226 VEAVYEPL---PEGMYSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-05
Identities = 36/121 (29%), Positives = 54/121 (44%), Gaps = 21/121 (17%)
Query: 440 IAEPTNARSMSFVGTHEYLAPEIIKG--EGH-GSAVDWWTFGIFLYELLFGKTPFKGSEN 496
+ P N SFVGT ++APE+I EG VD W+ GI EL K P
Sbjct: 164 LVSPAN----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219
Query: 497 RATLYNVVGQPLRFPESPVVSFSA-----RDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551
+ LY++ +SP +S + R+ + L K PQ+R + + E+ +H F
Sbjct: 220 MSALYHIAQN-----DSPTLSSNDWSDYFRNFVDSCLQKIPQDRPS----SEELLKHRFV 270
Query: 552 Q 552
Sbjct: 271 L 271
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-05
Identities = 47/162 (29%), Positives = 64/162 (39%), Gaps = 37/162 (22%)
Query: 424 KPKNEMGNQVSPLPEL---IAEPTNARSMSFVGTHEYLAPEIIKGEGH-GSAVDWWTFGI 479
KP N N+ L L +A +A +V T Y APE+I H VD W+ G
Sbjct: 144 KPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGC 203
Query: 480 FLYELLFGKTPFKGS---ENRATLYNVVGQP-----------------LRFPESPVVSFS 519
+ E+L GKT FKG + + V G P P+ P FS
Sbjct: 204 IMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFS 263
Query: 520 ---------ARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
A DL++ +L + RL ATE +HP+F
Sbjct: 264 TLFPKASPQAVDLLEKMLELDVDKRLT----ATEALEHPYFD 301
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 29/161 (18%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
++L +G G G VY + T A+K + + K ++LL I+++L+H
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELL-------IMKNLNHIN 120
Query: 275 LPTLYTHFETDKFS--------CLVMEFCPGGDLHTLRQRQPGKYFSEQ-------AVKF 319
+ L ++ T+ F +VMEF P T+ + K+++ VK
Sbjct: 121 IIFLKDYYYTECFKKNEKNIFLNVVMEFIP----QTVHKYM--KHYARNNHALPLFLVKL 174
Query: 320 YVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIM-LSDF 359
Y ++ AL Y+H I +RDLKP+N+L+ + H + L DF
Sbjct: 175 YSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215
|
Length = 440 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.7 bits (114), Expect = 1e-05
Identities = 41/157 (26%), Positives = 74/157 (47%), Gaps = 17/157 (10%)
Query: 214 HFRLLKKLGCGDIGSVYLS--ELTGTKCYFAMKVMDKAS-LEKRKKLLRAQTEREILQSL 270
++ L +G G G V + + TG K A+K K S E + R E +IL+
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKV--AIK---KISPFEHQTFCQRTLREIKILRRF 60
Query: 271 DHPFLPTLY-----THFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVL 325
H + + FE+ +V E DL+ L + Q S +++++ ++L
Sbjct: 61 KHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQH---LSNDHIQYFLYQIL 116
Query: 326 LALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
L+Y+H +++RDLKP N+L+ + + + DF L+
Sbjct: 117 RGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA 153
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (113), Expect = 1e-05
Identities = 21/43 (48%), Positives = 30/43 (69%)
Query: 317 VKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDF 359
+K + +VL L LH +GIV+RD+KPEN+LV DG + + DF
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDF 353
|
Length = 507 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 36/147 (24%), Positives = 66/147 (44%), Gaps = 6/147 (4%)
Query: 216 RLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFL 275
+L+KKLG G G V++ G A+K + + S+ L E +++ L HP L
Sbjct: 9 KLVKKLGAGQFGEVWMGYYNGHT-KVAIKSLKQGSMSPEAFL----AEANLMKQLQHPRL 63
Query: 276 PTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLG 335
LY T + ++ E+ G L + G + + A++ + ++
Sbjct: 64 VRLYA-VVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN 122
Query: 336 IVYRDLKPENVLVREDGHIMLSDFDLS 362
++RDL+ N+LV E ++DF L+
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 1e-05
Identities = 23/64 (35%), Positives = 37/64 (57%), Gaps = 2/64 (3%)
Query: 299 DLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSD 358
DLH + S VK ++ ++L L+YLH GI++RD+KP N+LV + + + D
Sbjct: 89 DLHKIIVSPQP--LSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICD 146
Query: 359 FDLS 362
F L+
Sbjct: 147 FGLA 150
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-05
Identities = 74/280 (26%), Positives = 108/280 (38%), Gaps = 32/280 (11%)
Query: 126 EAGPASAKVSDGTSSLP-----KTSGSAKISDRGDYVESGKSSMCRGSTSSDVSDESTCS 180
E S+KVSD +L +G SD D K C D D + +
Sbjct: 2 ECHTDSSKVSDSNINLGYEAIFSLTGGTDTSDSKDTT-GDKFDDC--DELGDSDDVTHAT 58
Query: 181 SLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVG-HFRLLKKLGCGDIGSVYLSELTGTKC 239
+ D E + D V + +L L G G V++ G +
Sbjct: 59 DYDADEESLSPQTDVCQEPCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQ 118
Query: 240 YFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEF--CPG 297
KV+ KA + E +IL+++ H + L + C+VM C
Sbjct: 119 --RKKVIVKAVTGGKT----PGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC-- 170
Query: 298 GDLHTLRQRQPGKYFSEQAVKFYVAEVLL-ALEYLHMLGIVYRDLKPENVLVREDGHIML 356
DL T R G EQA + LL AL YLH GI++RD+K EN+ + E + +L
Sbjct: 171 -DLFTYVDRS-GPLPLEQA--ITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVL 226
Query: 357 SDFDLSLRCAVSPTVVK----SSTLES---EPLRKNPVYC 389
DF + + P + S TLE+ E L +P YC
Sbjct: 227 GDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDP-YC 265
|
Length = 392 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 30/102 (29%), Positives = 53/102 (51%), Gaps = 7/102 (6%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV-GQPL 508
+F GT Y++PE +K +G+ S D W+ G LYE+ F+G + + +V G
Sbjct: 164 TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTP 223
Query: 509 RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPF 550
PE+ ++ +++ +L K+P R + A EI ++PF
Sbjct: 224 SLPETYSRQLNS--IMQSMLNKDPSLRPS----AAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 2e-05
Identities = 30/107 (28%), Positives = 51/107 (47%), Gaps = 11/107 (10%)
Query: 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY---NV 503
+SM GT ++APE+I G+G D W+ G ++E+ GK P + A ++
Sbjct: 166 KSMH--GTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAH 223
Query: 504 VGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPF 550
G R P+S S +A D + L ++ R + A ++ +H F
Sbjct: 224 RGLMPRLPDS--FSAAAIDFVTSCLTRDQHERPS----ALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 2e-05
Identities = 43/162 (26%), Positives = 66/162 (40%), Gaps = 37/162 (22%)
Query: 424 KPKNEMGNQVSPLPEL---IAEPTNARSMSFVGTHEYLAPEIIKGEGHGS-AVDWWTFGI 479
KP N N+ L L +A T++ +V T Y APE+I H + VD W+ G
Sbjct: 145 KPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGC 204
Query: 480 FLYELLFGKTPFKGSENRATL---YNVVGQPLRFPESPVVSFSARDLIKGL--------- 527
+ E+L GK FKG ++ L V G P + + S A++ +K L
Sbjct: 205 IMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFR 264
Query: 528 -----------------LVKEPQNRLACRRGATEIKQHPFFQ 552
LV + ++R+ A E HP+F+
Sbjct: 265 SLLPNANPLAVNVLEKMLVLDAESRIT----AAEALAHPYFE 302
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 37/141 (26%), Positives = 59/141 (41%), Gaps = 34/141 (24%)
Query: 440 IAEPTNARSMSFVGTHEYLAPEI-IKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRA 498
+A + + +V T Y APEI + + + VD W+ G E+L GK F G ++
Sbjct: 154 LARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN 213
Query: 499 TLY---NVVGQP-------------LRFPES-------------PVVSFSARDLIKGLLV 529
+++G P LRF +S SA DL++ +LV
Sbjct: 214 QFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLV 273
Query: 530 KEPQNRLACRRGATEIKQHPF 550
+PQ R++ A E HP+
Sbjct: 274 FDPQKRIS----AAEALAHPY 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 34/131 (25%), Positives = 54/131 (41%), Gaps = 34/131 (25%)
Query: 451 FVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV----- 504
+V T Y APE++ G+ +G AVD W G + E+L G+ F G + LY+++
Sbjct: 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGN 219
Query: 505 --------------GQPLRFPES----------PVVSFSARDLIKGLLVKEPQNRLACRR 540
+R PE P +S DL K L +P +R +
Sbjct: 220 LIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSS-- 277
Query: 541 GATEIKQHPFF 551
+++ H FF
Sbjct: 278 --SQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 2e-05
Identities = 40/132 (30%), Positives = 51/132 (38%), Gaps = 34/132 (25%)
Query: 451 FVGTHEYLAPEIIKGEGHGS-AVDWWTFGIFLYELLFGKTPFKG---------------- 493
+V T Y APEI+ G + VD W+ G L E+L GK F G
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231
Query: 494 ----------SENRATLYNVVGQPLRFPES---PVVSFSARDLIKGLLVKEPQNRLACRR 540
S AT+ + + R P P S A DL+K LLV P RL
Sbjct: 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLT--- 288
Query: 541 GATEIKQHPFFQ 552
A E +HP+
Sbjct: 289 -AEEALEHPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 46.6 bits (111), Expect = 2e-05
Identities = 21/57 (36%), Positives = 32/57 (56%), Gaps = 1/57 (1%)
Query: 307 QPGKYFSEQAVKFYVAEVLLALEYLH-MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
G E + ++ ALEYLH L +++RD+KP NVL+ +G + L DF +S
Sbjct: 95 DKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 37/148 (25%), Positives = 65/148 (43%), Gaps = 6/148 (4%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
+L+KKLG G G V++ G A+K + ++ L AQ I++ L H
Sbjct: 8 LQLIKKLGNGQFGEVWMGTWNGNT-KVAVKTLKPGTMSPESFLEEAQ----IMKKLRHDK 62
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
L LY + +V E+ G L + G+ + A+V + Y+ +
Sbjct: 63 LVQLYAVVSEEPIY-IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM 121
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLS 362
++RDL+ N+LV + ++DF L+
Sbjct: 122 NYIHRDLRSANILVGDGLVCKIADFGLA 149
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 46/151 (30%), Positives = 71/151 (47%), Gaps = 9/151 (5%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTERE--ILQSLDH 272
F + +LG G+ G V+ + A K++ LE K +R Q RE +L +
Sbjct: 7 FEKISELGAGNGGVVFKVSHKPSGLIMARKLI---HLEI-KPAIRNQIIRELQVLHECNS 62
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYL- 331
P++ Y F +D + ME GG L + ++ G+ EQ + V+ L YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA-GR-IPEQILGKVSIAVIKGLTYLR 120
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
I++RD+KP N+LV G I L DF +S
Sbjct: 121 EKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 151
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 48/153 (31%), Positives = 68/153 (44%), Gaps = 16/153 (10%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQT---EREILQSLD 271
+LL+ +G G+ G V L + G K A+K + K AQ E ++ L
Sbjct: 8 LKLLQTIGKGEFGDVMLGDYRGNKV--AVKCI--------KNDATAQAFLAEASVMTQLR 57
Query: 272 HPFLPTLYTHFETDKFSC-LVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALE 329
H L L +K +V E+ G L LR R + +KF + +V A+E
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSL-DVCEAME 116
Query: 330 YLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
YL V+RDL NVLV ED +SDF L+
Sbjct: 117 YLEANNFVHRDLAARNVLVSEDNVAKVSDFGLT 149
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 3e-05
Identities = 27/93 (29%), Positives = 43/93 (46%), Gaps = 9/93 (9%)
Query: 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNV-- 503
A ++ VGT YL+PE+ + + + D W G+ LYE GK PF + A + +
Sbjct: 158 ANTI--VGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215
Query: 504 -VGQPLRFPESPVVSFSARDLIKGLLVKEPQNR 535
V P+ S ++ LI L K+ + R
Sbjct: 216 GVFPPVSQMYSQQLA----QLIDQCLTKDYRQR 244
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (109), Expect = 3e-05
Identities = 33/116 (28%), Positives = 48/116 (41%), Gaps = 16/116 (13%)
Query: 444 TNARSMSFVGTHEYLAPEII---KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATL 500
T A+ SF+GT ++APE+ + G+ D W GI EL + P L
Sbjct: 154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL 213
Query: 501 YNVVGQPLRFPESPVV------SFSARDLIKGLLVKEPQNRLACRRGATEIKQHPF 550
+ + P + S D IK L K+P+ R AT++ QHPF
Sbjct: 214 FLI---SKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPT----ATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 37/111 (33%), Positives = 51/111 (45%), Gaps = 17/111 (15%)
Query: 450 SFVGTHEYLAPEII-----KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE--NRATLYN 502
S VGT Y++PE I G G A D W+ G+ + E G+ PF + A+L
Sbjct: 227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMC 286
Query: 503 VV--GQPLRFPESPV-VSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPF 550
+ QP PE+P S R I L +EP R + A ++ QHPF
Sbjct: 287 AICMSQP---PEAPATASREFRHFISCCLQREPAKRWS----AMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 3e-05
Identities = 34/134 (25%), Positives = 54/134 (40%), Gaps = 34/134 (25%)
Query: 449 MSFVGTHEYLAPE-IIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE--NRATLY-NVV 504
+V T Y APE ++ + +A+D W+ G ELL K F G + ++ L ++
Sbjct: 166 TEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELL 225
Query: 505 GQP----LRF-------------PESPVVSFSAR---------DLIKGLLVKEPQNRLAC 538
G P L F P +P SF+ DL++ +LV +P R+
Sbjct: 226 GSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT- 284
Query: 539 RRGATEIKQHPFFQ 552
E HP+
Sbjct: 285 ---VEEALAHPYLA 295
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 44.9 bits (107), Expect = 4e-05
Identities = 24/105 (22%), Positives = 41/105 (39%), Gaps = 13/105 (12%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR 509
++VGT Y++PE + + D W+ G +YEL PF A + ++
Sbjct: 169 TYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPF-----TARNQLQLASKIK 223
Query: 510 F-PESPVVSFSARDL---IKGLLVKEPQNRLACRRGATEIKQHPF 550
+ + +L IK +L +P R E+ Q P
Sbjct: 224 EGKFRRIPYRYSSELNEVIKSMLNVDPD----KRPSTEELLQLPL 264
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 4e-05
Identities = 36/113 (31%), Positives = 48/113 (42%), Gaps = 25/113 (22%)
Query: 453 GTHEYLAPEIIKGEGHGSAV----DWWTFGIFLYELLFG-------KTPFKGSENRATLY 501
G Y+APE I E + D W+ GI + EL G KTPF+ L
Sbjct: 165 GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ------QLK 218
Query: 502 NVVGQPLRFPESPVVSFSA--RDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
VV +P P+ P FS +D + L K + R E+ QHPFF+
Sbjct: 219 QVVEEPS--PQLPAEKFSPEFQDFVNKCLKKNYKERPNYP----ELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 4e-05
Identities = 20/65 (30%), Positives = 39/65 (60%), Gaps = 4/65 (6%)
Query: 299 DLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLS 357
DLH +R Q S+ ++++ ++L L+Y+H +++RDLKP N+L+ + + +
Sbjct: 94 DLHQIIRSSQT---LSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 150
Query: 358 DFDLS 362
DF L+
Sbjct: 151 DFGLA 155
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 33/100 (33%), Positives = 48/100 (48%), Gaps = 8/100 (8%)
Query: 263 EREILQSLDHP-FLPTLYTHFETDKFSCLVMEFCPG--GDLHTLRQRQPGKYFSEQAVKF 319
E +L+ L HP L L +CLV+ P DL+T + + V
Sbjct: 210 EARLLRRLSHPAVLALLDVR-VVGGLTCLVL---PKYRSDLYTYLGARL-RPLGLAQVTA 264
Query: 320 YVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDF 359
++L A++Y+H GI++RD+K ENVLV I L DF
Sbjct: 265 VARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDF 304
|
Length = 461 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 50/163 (30%), Positives = 74/163 (45%), Gaps = 21/163 (12%)
Query: 217 LLKKLGCGDIGSVYLSELTG-----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD 271
L ++LG G G V+L+E K A+K + AS RK R E E+L +L
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHR---EAELLTNLQ 65
Query: 272 HPFLPTLY-THFETDKFSCLVMEFCPGGDLHT-LRQRQP-------GKYFSE--QAVKFY 320
H + Y E D +V E+ GDL+ LR P G +E Q+ +
Sbjct: 66 HEHIVKFYGVCVEGDPL-IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 321 VAEVLLA-LEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+A+ + A + YL V+RDL N LV E+ + + DF +S
Sbjct: 125 IAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMS 167
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 4e-05
Identities = 42/158 (26%), Positives = 71/158 (44%), Gaps = 8/158 (5%)
Query: 209 VLGVGHFRLLKKLGCGDIGSVY----LSELTGTKCYFAMKVMDKASLEKRKKLLRAQTER 264
+L + +K LG G G+VY + E K A+K++++ + K + E
Sbjct: 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKAN--VEFMDEA 60
Query: 265 EILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEV 324
I+ S+DHP L L + LV + P G L S+ + + V ++
Sbjct: 61 LIMASMDHPHLVRLLGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCV-QI 118
Query: 325 LLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ YL +V+RDL NVLV+ H+ ++DF L+
Sbjct: 119 AKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 4e-05
Identities = 41/166 (24%), Positives = 75/166 (45%), Gaps = 15/166 (9%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEK---RKKLLRAQTEREILQ 268
+ + +++ +G G +G VYL+ A+K + + E +K+ LR E +I
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLR---EAKIAA 57
Query: 269 SLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQ--RQPGKYFSEQAVKFYVAEVL- 325
L HP + +Y+ M + G L +L + Q E A K V L
Sbjct: 58 DLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLS 117
Query: 326 ------LALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365
+EY+H G+++RDLKP+N+L+ G +++ D+ ++
Sbjct: 118 IFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFK 163
|
Length = 932 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 4e-05
Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 3/137 (2%)
Query: 222 GCGDIGSVYLSELTGTKCYFAMKVMDKASL-EKRKKLLRAQTEREILQSLDHPFLPTLYT 280
G ++ SVYL+ T T +++ D + E+ K L Q E + HP + T +T
Sbjct: 9 GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKAL--QNEVVLSHFFRHPNIMTSWT 66
Query: 281 HFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRD 340
F T + ++ F G ++L + + SE + + L L YLH G ++R+
Sbjct: 67 VFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRN 126
Query: 341 LKPENVLVREDGHIMLS 357
+K ++L+ DG + LS
Sbjct: 127 IKASHILISGDGLVSLS 143
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.2 bits (108), Expect = 5e-05
Identities = 36/145 (24%), Positives = 53/145 (36%), Gaps = 43/145 (29%)
Query: 446 ARSMSFVG---------THEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGS- 494
AR + T Y PE++ G G VD W+ G L EL GK F+GS
Sbjct: 147 ARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206
Query: 495 --ENRATLYNVVGQP----------------LRFPESPVVSF----------SARDLIKG 526
E ++ + G P L+ + SA DL+
Sbjct: 207 ELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDK 266
Query: 527 LLVKEPQNRLACRRGATEIKQHPFF 551
LL +P+ R++ A + QH +F
Sbjct: 267 LLTLDPKKRIS----ADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 5e-05
Identities = 35/125 (28%), Positives = 62/125 (49%), Gaps = 17/125 (13%)
Query: 259 RAQTEREILQSLDHPFLPTLYTHFETDK----FS--CLVMEFCPGGDLHTLRQRQPGKYF 312
RA E +++ ++H + L F K F LVME +L + Q
Sbjct: 61 RAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELM-DANLCQVIQMD----L 115
Query: 313 SEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA-----V 367
+ + + + ++L +++LH GI++RDLKP N++V+ D + + DF L+ R A +
Sbjct: 116 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA-RTAGTSFMM 174
Query: 368 SPTVV 372
+P VV
Sbjct: 175 TPYVV 179
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 6e-05
Identities = 25/73 (34%), Positives = 37/73 (50%), Gaps = 1/73 (1%)
Query: 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVR 349
L+MEF P G L R K +Q +K Y ++ ++YL V+RDL NVLV
Sbjct: 85 LIMEFLPSGSLKEYLPRNKNKINLKQQLK-YAVQICKGMDYLGSRQYVHRDLAARNVLVE 143
Query: 350 EDGHIMLSDFDLS 362
+ + + DF L+
Sbjct: 144 SEHQVKIGDFGLT 156
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 6e-05
Identities = 48/202 (23%), Positives = 78/202 (38%), Gaps = 34/202 (16%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGT-----KCYFAMKVM-DKASLEKRKKLLRAQTEREI 266
+ ++ +G G G V+ + G A+K++ ++AS + + R E +
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQR---EAAL 61
Query: 267 LQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYV---- 321
+ DHP + L K CL+ E+ GDL+ LR R P
Sbjct: 62 MAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSP--RAQCSLSHSTSSARK 119
Query: 322 -----------------AEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLR 364
+V + YL V+RDL N LV E+ + ++DF LS R
Sbjct: 120 CGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS-R 178
Query: 365 CAVSPTVVKSSTLESEPLRKNP 386
S K+S ++ P+R P
Sbjct: 179 NIYSADYYKASENDAIPIRWMP 200
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 28/89 (31%), Positives = 44/89 (49%), Gaps = 4/89 (4%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE-NRATLYNVVGQPL 508
S VGT Y++PE I G+ D W+ G LYE+ ++PF G + N +L + Q
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ-C 223
Query: 509 RFPESPVVSFSA--RDLIKGLLVKEPQNR 535
+P P +S R+L+ + +P R
Sbjct: 224 DYPPLPTEHYSEKLRELVSMCIYPDPDQR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 51/170 (30%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQ 268
+L + L + +G G+ G+V E TG K A+K + K + + L E ++
Sbjct: 2 LLNLQKLTLGEIIGEGEFGAVLQGEYTGQKV--AVKNI-KCDVTAQAFL----EETAVMT 54
Query: 269 SLDHPFLPTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLA 327
L H L L + +VME G+L + LR R Q ++F + +V
Sbjct: 55 KLHHKNLVRLLGVILHNGLY-IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL-DVAEG 112
Query: 328 LEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTL 377
+EYL +V+RDL N+LV EDG +SDF L+ V V +S L
Sbjct: 113 MEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLA---RVGSMGVDNSKL 159
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 44.5 bits (105), Expect = 8e-05
Identities = 27/95 (28%), Positives = 46/95 (48%), Gaps = 7/95 (7%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNV 503
+ +++ + VGT Y++PE+ +G+ + D W G LYEL K F+ A L +
Sbjct: 154 SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEA----ANLPAL 209
Query: 504 VGQPLRFPESPV---VSFSARDLIKGLLVKEPQNR 535
V + + +P+ S R LI +L +P R
Sbjct: 210 VLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 8e-05
Identities = 37/145 (25%), Positives = 64/145 (44%), Gaps = 5/145 (3%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYFAMK-VMDKASLEKRKKLLRAQTEREILQSLDHPFLPT 277
+++G G+ G V+ L A+K + + + K L+ E IL+ HP +
Sbjct: 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQ---EARILKQYSHPNIVR 57
Query: 278 LYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIV 337
L + +VME GGD T + + + ++ ++ V +EYL +
Sbjct: 58 LIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQM-VENAAAGMEYLESKHCI 116
Query: 338 YRDLKPENVLVREDGHIMLSDFDLS 362
+RDL N LV E + +SDF +S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMS 141
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-05
Identities = 42/164 (25%), Positives = 62/164 (37%), Gaps = 44/164 (26%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSEN---RATL 500
TN +V T Y APE+I G G+ VD W+ G + EL+ G F+G+++ +
Sbjct: 175 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKV 234
Query: 501 YNVVGQP-LRF---------------PESPVVSFS---------------------ARDL 523
+G P F P+ P +SF ARDL
Sbjct: 235 IEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDL 294
Query: 524 IKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEI 567
+ +LV +P R E +HP+ A PP+I
Sbjct: 295 LSKMLVIDPD----KRISVDEALRHPYITVWYDPAEAEAPPPQI 334
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 43/171 (25%), Positives = 69/171 (40%), Gaps = 31/171 (18%)
Query: 216 RLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKL---------LRAQTEREI 266
R +++LG G +Y K + + MD A L K L Q E +
Sbjct: 8 RFMEELGECAFGKIY-------KGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASL 60
Query: 267 LQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPG-------------KYF 312
+ L HP + L ++ C++ E+ GDLH L R P K
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120
Query: 313 SEQAVKFYVA-EVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ ++A ++ +EYL V++DL N+L+ E H+ +SD LS
Sbjct: 121 LDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLS 171
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 8e-05
Identities = 43/159 (27%), Positives = 77/159 (48%), Gaps = 21/159 (13%)
Query: 215 FRLLKKLGCGDIGSV--YLSELTGTKCYFAMK--------VMDKASLEKRKKLLRAQTER 264
+++ + +G G G V + TG K A+K V D + + KLLR
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKV--AIKKINDVFEHVSDATRILREIKLLRLLRHP 59
Query: 265 EILQSLDHPFLPTLYTHFETDKFSCL-VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAE 323
+I++ + H LP F+ D + +ME DLH + + + + +F++ +
Sbjct: 60 DIVE-IKHIMLPPSRREFK-DIYVVFELME----SDLHQVIKANDD--LTPEHHQFFLYQ 111
Query: 324 VLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+L AL+Y+H + +RDLKP+N+L D + + DF L+
Sbjct: 112 LLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLA 150
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 8e-05
Identities = 41/161 (25%), Positives = 64/161 (39%), Gaps = 21/161 (13%)
Query: 220 KLGCGDIGSVYLSELTG-----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
+LG G G V+L+E K A+K + +AS R+ Q E E+L L H
Sbjct: 12 ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDF---QREAELLTVLQHQH 68
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQA------------VKFYV 321
+ Y + +V E+ GDL+ LR P +
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 322 AEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+++ + YL L V+RDL N LV + + + DF +S
Sbjct: 129 SQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-04
Identities = 30/97 (30%), Positives = 48/97 (49%), Gaps = 2/97 (2%)
Query: 439 LIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRA 498
L+ P A + ++VGT Y+ PEI + + + D W+ G LYEL K PF+ + +
Sbjct: 149 LLTSPG-AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN 207
Query: 499 TLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNR 535
+ V Q P S+ R LIK + + P++R
Sbjct: 208 LILKVC-QGSYKPLPSHYSYELRSLIKQMFKRNPRSR 243
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 31/109 (28%), Positives = 49/109 (44%), Gaps = 9/109 (8%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNV 503
T + +FVGT ++APE+I+ + S D W+ GI EL G+ P L+ +
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI 213
Query: 504 VGQPLRFPESPVVSFSA--RDLIKGLLVKEPQNRLACRRGATEIKQHPF 550
P + FS ++ I L K+P + R A E+ +H F
Sbjct: 214 PKNN---PPTLTGEFSKPFKEFIDACLNKDP----SFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 1e-04
Identities = 33/104 (31%), Positives = 44/104 (42%), Gaps = 17/104 (16%)
Query: 440 IAEPTNARSMSFVGTHEYLAPEIIKGEGHGS---AVDWWTFGIFLYELLFGKTPFKGSEN 496
I P N FVGT ++APE+I G VD W+ GI EL K P
Sbjct: 164 IMAPAN----XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219
Query: 497 RATLYNVVGQPLRFPESPVV-----SFSARDLIKGLLVKEPQNR 535
+ LY++ ESP + S R+ + L K PQ+R
Sbjct: 220 MSALYHIAQN-----ESPALQSGHWSEYFRNFVDSCLQKIPQDR 258
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 37/130 (28%), Positives = 52/130 (40%), Gaps = 34/130 (26%)
Query: 451 FVGTHEYLAPEI-IKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATL---YNVVGQ 506
+V T Y APEI + + + A+D W+ G L ELL K FKG + L V+G
Sbjct: 169 YVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT 228
Query: 507 P----LR-------------FPESPVVSFS---------ARDLIKGLLVKEPQNRLACRR 540
P L P P F A DL++ LL +P R++
Sbjct: 229 PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVE- 287
Query: 541 GATEIKQHPF 550
E +HP+
Sbjct: 288 ---EALEHPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 1e-04
Identities = 42/158 (26%), Positives = 66/158 (41%), Gaps = 14/158 (8%)
Query: 214 HFRLLKK---LGCGDIGSV----YLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI 266
H R LKK LG G G V Y GT A+K + + ++ + E I
Sbjct: 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKK--EINI 59
Query: 267 LQSLDHPFLPTLYTHFET--DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEV 324
L++L H + K L+ME+ P L +LR P + + + ++
Sbjct: 60 LKTLYHENIVKYKGCCSEQGGKGLQLIMEYVP---LGSLRDYLPKHKLNLAQLLLFAQQI 116
Query: 325 LLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ YLH ++RDL NVL+ D + + DF L+
Sbjct: 117 CEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLA 154
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 2e-04
Identities = 36/131 (27%), Positives = 54/131 (41%), Gaps = 34/131 (25%)
Query: 451 FVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV----- 504
+V T Y APE++ G+ +G VD W G ELL G+ + G + LY +
Sbjct: 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGD 219
Query: 505 ----------------GQPLRFPES--------PVVSFSARDLIKGLLVKEPQNRLACRR 540
G + PE+ P +S A +KG L +P RL+C
Sbjct: 220 LIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSC-- 277
Query: 541 GATEIKQHPFF 551
E+ +HP+F
Sbjct: 278 --EELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 27/90 (30%), Positives = 45/90 (50%), Gaps = 6/90 (6%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG--QP 507
S VGT Y++PE I G+ D W+ G LYE+ ++PF G ++ LY++ +
Sbjct: 165 SLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQ 222
Query: 508 LRFPESPVVSFSA--RDLIKGLLVKEPQNR 535
+P P +S R L+ + +P+ R
Sbjct: 223 CDYPPLPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 37/111 (33%), Positives = 52/111 (46%), Gaps = 7/111 (6%)
Query: 424 KPKNEMGNQVSPLPEL---IAEPTNARSMSFVGTHEYLAPEIIKGEGH-GSAVDWWTFGI 479
KP N N+ L L +A T+ +V T Y APEI+ H VD W+ G
Sbjct: 147 KPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 206
Query: 480 FLYELLFGKTPFKGSENRATL---YNVVGQPLRFPESPVVSFSARDLIKGL 527
+ ELL G+T F G+++ L +VG P + S SAR+ I+ L
Sbjct: 207 IMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSL 257
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 2e-04
Identities = 36/144 (25%), Positives = 56/144 (38%), Gaps = 36/144 (25%)
Query: 442 EPTNARSMSF-VGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGS---EN 496
EP ++ M+ V T Y APEI+ G H SAVD W+ G ELL + F+ +
Sbjct: 154 EPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQ 213
Query: 497 RATLYNVVGQP----------------LRFPESPV-----------VSFSARDLIKGLLV 529
+ +++G P LR P P + A L+ +LV
Sbjct: 214 LDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLV 273
Query: 530 KEPQNRLACRRGATEIKQHPFFQG 553
+P R++ + HP+
Sbjct: 274 FDPDKRISA----ADALAHPYLDE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 42/168 (25%), Positives = 77/168 (45%), Gaps = 13/168 (7%)
Query: 202 AVRVKDGVLGV-GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRA 260
+V+V D V ++ LK +G G G V + T A+K + + + + RA
Sbjct: 9 SVQVADSTFTVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-PFQNQTHAKRA 67
Query: 261 QTEREILQSLDHPFLPTLYTHFETDK----FS--CLVMEFCPGGDLHTLRQRQPGKYFSE 314
E +L+ ++H + +L F K F LVME +
Sbjct: 68 YRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHME-----LDH 122
Query: 315 QAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ + + + ++L +++LH GI++RDLKP N++V+ D + + DF L+
Sbjct: 123 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 170
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 37/148 (25%), Positives = 69/148 (46%), Gaps = 7/148 (4%)
Query: 216 RLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFL 275
+L+KKLG G G V++ A+K + ++ + L E ++++L H L
Sbjct: 9 KLVKKLGAGQFGEVWMG-YYNNSTKVAVKTLKPGTMSVQAFL----EEANLMKTLQHDKL 63
Query: 276 PTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
LY ++ ++ E+ G L L+ + GK + + F A++ + Y+
Sbjct: 64 VRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDF-SAQIAEGMAYIERK 122
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLS 362
++RDL+ NVLV E ++DF L+
Sbjct: 123 NYIHRDLRAANVLVSESLMCKIADFGLA 150
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 22/64 (34%), Positives = 34/64 (53%)
Query: 440 IAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRAT 499
++E +NA +V T Y +PE++ G +G AVD W+ G L EL G+ F G
Sbjct: 150 LSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQ 209
Query: 500 LYNV 503
L+ +
Sbjct: 210 LFTI 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 28/97 (28%), Positives = 45/97 (46%)
Query: 261 QTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFY 320
Q E + + +HP + F D +V F G L SE A+ +
Sbjct: 47 QGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYI 106
Query: 321 VAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLS 357
+ VL AL+Y+H +G V+R +K ++L+ DG + LS
Sbjct: 107 LQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS 143
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 3e-04
Identities = 32/109 (29%), Positives = 52/109 (47%), Gaps = 9/109 (8%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNV 503
T + +FVGT ++APE+IK + S D W+ GI EL G+ P L+ +
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLI 213
Query: 504 VGQPLRFPESPVVSFSA--RDLIKGLLVKEPQNRLACRRGATEIKQHPF 550
P P + ++S ++ ++ L KEP + R A E+ +H F
Sbjct: 214 ---PKNNPPTLEGNYSKPLKEFVEACLNKEP----SFRPTAKELLKHKF 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 36/139 (25%), Positives = 53/139 (38%), Gaps = 34/139 (24%)
Query: 448 SM--SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPF--KGSENRATLYNV 503
SM SFVGT Y++PE ++G + D W+ G+ L E+ G+ P ++ ++
Sbjct: 153 SMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGR 212
Query: 504 VGQPLRFPESPV-VSFSARD-----LIKGLL---VKEPQNRL--------------AC-- 538
ES VS D I LL V EP +L C
Sbjct: 213 PVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLK 272
Query: 539 -----RRGATEIKQHPFFQ 552
R E+ +HPF +
Sbjct: 273 KNPKERADLKELTKHPFIK 291
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 51/225 (22%), Positives = 90/225 (40%), Gaps = 29/225 (12%)
Query: 136 DGTSSLPKTSGSAKISDRGDYVESGKSSMCRGSTSSDVSD-ESTCSSLSSSVNKPHKAND 194
D T LP S S +D Y SD+SD + S S+ +D
Sbjct: 5 DTTPPLPPRSYSGGAADEDLY--------------SDISDGDLEYSDDDSASESDDDDDD 50
Query: 195 AQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKR 254
Q R LG + ++K L G G V+++ G +K+ K +
Sbjct: 51 GLIPTKQKAREVVASLG---YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---- 103
Query: 255 KKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSE 314
E +LQ+++HP + + + +C+V+ DL+T ++ +
Sbjct: 104 -----TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPID 157
Query: 315 QAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDF 359
QA+ ++L L YLH I++RD+K EN+ + + + + D
Sbjct: 158 QALII-EKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDL 201
|
Length = 357 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 3e-04
Identities = 34/114 (29%), Positives = 49/114 (42%), Gaps = 12/114 (10%)
Query: 446 ARSMSFVGTHEYLAPEII---KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR-ATLY 501
A++ G Y+APE I +G+ D W+ GI LYE+ GK P+ + L
Sbjct: 163 AKTRD-AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLT 221
Query: 502 NVV-GQPLRFPESPVVSFSAR--DLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
VV G P S FS + I L+K+ R E+ +HPF +
Sbjct: 222 QVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPK----YKELLEHPFIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 43.2 bits (101), Expect = 3e-04
Identities = 40/174 (22%), Positives = 76/174 (43%), Gaps = 13/174 (7%)
Query: 202 AVRVKDGVLGV-GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRA 260
+V V D V ++ LK +G G G V + A+K + + + + RA
Sbjct: 5 SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-FQNQTHAKRA 63
Query: 261 QTEREILQSLDHPFLPTLYTHFETDKF------SCLVMEFCPGGDLHTLRQRQPGKYFSE 314
E +++ ++H + +L F K LVME ++
Sbjct: 64 YRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQME-----LDH 118
Query: 315 QAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368
+ + + + ++L +++LH GI++RDLKP N++V+ D + + DF L+ S
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 39/144 (27%), Positives = 65/144 (45%), Gaps = 6/144 (4%)
Query: 220 KLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLY 279
KLG G G VY A+K + + ++E + L E +++ + HP L L
Sbjct: 13 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFL----KEAAVMKEIKHPNLVQLL 68
Query: 280 THFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVA-EVLLALEYLHMLGIVY 338
+ ++ EF G+L R+ + V Y+A ++ A+EYL ++
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDY-LRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 127
Query: 339 RDLKPENVLVREDGHIMLSDFDLS 362
RDL N LV E+ + ++DF LS
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLS 151
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 4e-04
Identities = 25/87 (28%), Positives = 43/87 (49%), Gaps = 7/87 (8%)
Query: 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR-- 509
+GT YL+PEI + + + D W G LYE+ K F+ + N+V + +R
Sbjct: 162 IGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEA----GNMKNLVLKIIRGS 217
Query: 510 FPESPV-VSFSARDLIKGLLVKEPQNR 535
+P S+ R+L+ L + P++R
Sbjct: 218 YPPVSSHYSYDLRNLVSQLFKRNPRDR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 42.4 bits (100), Expect = 4e-04
Identities = 32/137 (23%), Positives = 51/137 (37%), Gaps = 34/137 (24%)
Query: 446 ARSMS-FVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATL--- 500
A+ M+ V T Y APE++ G + +A+D W G L ELL K G L
Sbjct: 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLI 221
Query: 501 -----------------------YNVVGQPLRF--PESPVVSFSARDLIKGLLVKEPQNR 535
+ + QP + P +S + L+ LL+ +P+ R
Sbjct: 222 IQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKR 281
Query: 536 LACRRGATEIKQHPFFQ 552
A E + +F+
Sbjct: 282 AT----AEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 4e-04
Identities = 48/174 (27%), Positives = 78/174 (44%), Gaps = 31/174 (17%)
Query: 217 LLKKLGCGDIGSV---YLSELTGTKCY--FAMKVMDK-ASLEKRKKLLRAQTEREILQSL 270
L K LG G+ G V L G Y A+K++ + AS + + LL +E +L+ +
Sbjct: 4 LGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLL---SEFNLLKQV 60
Query: 271 DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTL----RQRQPGKYFS------------- 313
+HP + LY D L++E+ G L + R+ P S
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 314 EQAVKF-----YVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
E+A+ + ++ ++YL + +V+RDL NVLV E + +SDF LS
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLS 174
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 29/109 (26%), Positives = 48/109 (44%), Gaps = 10/109 (9%)
Query: 264 REI--LQSLDHPFLPTLYTHFETDKFSC--LVMEFCPGGDLHTLR-QRQP-GKYFSEQAV 317
REI L+ L H + +L F L+ ++ ++ RQ V
Sbjct: 51 REIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 318 KFYVAEVLLALEYLHMLGIVYRDLKPENVLV----REDGHIMLSDFDLS 362
K + ++L + YLH +++RDLKP N+LV E G + + D L+
Sbjct: 111 KSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 42.2 bits (100), Expect = 5e-04
Identities = 29/122 (23%), Positives = 43/122 (35%), Gaps = 31/122 (25%)
Query: 457 YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGS---ENRATLYNVVGQP----- 507
Y APE++ G H G VD W+ G ELL G + ++ +G P
Sbjct: 168 YRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENW 227
Query: 508 ---------LRFPESPVVSFSAR---------DLIKGLLVKEPQNRLACRRGATEIKQHP 549
+ F P DL++ LL P R+ A + +HP
Sbjct: 228 PGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT----ARQALEHP 283
Query: 550 FF 551
+F
Sbjct: 284 YF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 5e-04
Identities = 29/109 (26%), Positives = 50/109 (45%), Gaps = 9/109 (8%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNV 503
T + +FVGT ++APE+IK + D W+ GI EL G+ P L+ +
Sbjct: 154 TQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLI 213
Query: 504 VGQPLRFPESPVVSFSA--RDLIKGLLVKEPQNRLACRRGATEIKQHPF 550
P P + +S ++ ++ L K+P+ R + E+ +H F
Sbjct: 214 ---PKNSPPTLEGQYSKPFKEFVEACLNKDPRFRPTAK----ELLKHKF 255
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 5e-04
Identities = 39/185 (21%), Positives = 80/185 (43%), Gaps = 19/185 (10%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI-----------L 267
K +GCG G VY ++ C V +LE ++ I +
Sbjct: 18 KLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNI 77
Query: 268 QSLDHPFLPTLYT--HFETDK--FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAE 323
++DH +P Y F+ + + +++E +T + K +++ +K + +
Sbjct: 78 HNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV---ENTKEIFKRIKCKNKKLIKNIMKD 134
Query: 324 VLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLR 383
+L LEY+H GI + D+KPEN++V + + D+ ++ + ++ S E + L
Sbjct: 135 MLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSK-EQKDLH 193
Query: 384 KNPVY 388
+ +Y
Sbjct: 194 RGTLY 198
|
Length = 294 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 42/162 (25%), Positives = 71/162 (43%), Gaps = 16/162 (9%)
Query: 215 FRLLKKLGCGDIGSV---YLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD 271
F L + LG G+ GSV L G+ A+K++ KA + + E ++ D
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 272 HPFLPTLY---THFETDK---FSCLVMEFCPGGDLHT--LRQR---QPGKYFSEQAVKFY 320
HP + L +++ F GDLHT L R +P + V+F
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 321 VAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ ++ +EYL ++RDL N ++ E+ + ++DF LS
Sbjct: 120 I-DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 41/160 (25%), Positives = 70/160 (43%), Gaps = 22/160 (13%)
Query: 221 LGCGDIGSVYLSELT-----GT-KCYFAMKVMDK-ASLEKRKKLLRAQTEREILQSLDHP 273
LG G G VY T G+ A+K + K A+ +++K+ L+ E ++ + +HP
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLK---EAHLMSNFNHP 59
Query: 274 -FLPTLYTHFETDKFSCLVMEFCPGGDL-HTLR----QRQPGKYFSEQAVKFYVAEVLLA 327
+ L + ++ME GGDL LR +R + + + +V
Sbjct: 60 NIVKLLGVCLLNEPQY-IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 328 LEYLHMLGIVYRDLKPENVLVREDGH-----IMLSDFDLS 362
YL + ++RDL N LV E G+ + + DF L+
Sbjct: 119 CVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 33/99 (33%), Positives = 44/99 (44%), Gaps = 7/99 (7%)
Query: 440 IAEPTNARSMSFVGTHEYLAPEIIKGEGHGS---AVDWWTFGIFLYELLFGKTPFKGSEN 496
IA P N SFVGT ++APE+I G VD W+ GI EL K P
Sbjct: 174 IASPAN----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 229
Query: 497 RATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNR 535
+ LY++ +S S R+ + L K PQ+R
Sbjct: 230 MSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQKIPQDR 268
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 6e-04
Identities = 40/147 (27%), Positives = 68/147 (46%), Gaps = 7/147 (4%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVM--DKASLEKRKKLLRAQTEREILQSLDH 272
F +L +G G G V TK A+K + + E ++ LR E ++L++L
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLR---ELKMLRTLKQ 59
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
+ L F LV E+ L L + G + V+ Y+ +++ A+ + H
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGV--PPEKVRSYIYQLIKAIHWCH 117
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDF 359
IV+RD+KPEN+L+ + + L DF
Sbjct: 118 KNDIVHRDIKPENLLISHNDVLKLCDF 144
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 6e-04
Identities = 17/54 (31%), Positives = 34/54 (62%)
Query: 315 QAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368
+ + + + ++L +++LH GI++RDLKP N++V+ D + + DF L+ S
Sbjct: 126 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 179
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 41.9 bits (99), Expect = 7e-04
Identities = 32/134 (23%), Positives = 51/134 (38%), Gaps = 34/134 (25%)
Query: 450 SFVGTHEYLAPEII-KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATL---YNVVG 505
+V T Y APE++ + +A+D W+ G E+L + F G L +V+G
Sbjct: 170 EYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLG 229
Query: 506 QP------------LR-----FPESPVVSFS---------ARDLIKGLLVKEPQNRLACR 539
P +R P V +S A DL+ +L +P+ R+
Sbjct: 230 SPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT-- 287
Query: 540 RGATEIKQHPFFQG 553
+ QHPF
Sbjct: 288 --VEQALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 7e-04
Identities = 29/110 (26%), Positives = 45/110 (40%), Gaps = 18/110 (16%)
Query: 452 VGTHEYLAPEIIKGEGHGSAV------DWWTFGIFLYELLFGKTPFKGSENRATLYN--- 502
+G Y+APE IK G D W+ G+ + E+ G+ P+ E A ++
Sbjct: 162 IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP-PETYANIFAQLS 220
Query: 503 --VVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPF 550
V G P P S A+D + L K P R ++ +HP+
Sbjct: 221 AIVDGDPPTLPSG--YSDDAQDFVAKCLNKIP----NRRPTYAQLLEHPW 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 7e-04
Identities = 19/54 (35%), Positives = 30/54 (55%), Gaps = 1/54 (1%)
Query: 310 KYFSEQAVKFYVAEVLLALEYL-HMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
E+ + + AL YL L I++RD+KP N+L+ +G+I L DF +S
Sbjct: 102 SVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 7e-04
Identities = 40/159 (25%), Positives = 74/159 (46%), Gaps = 10/159 (6%)
Query: 209 VLGVGHFRLLKKLGCGDIGSVY----LSELTGTKCYFAMKVM-DKASLEKRKKLLRAQTE 263
+L + +K LG G G+VY + + K A+KV+ + S + K++L E
Sbjct: 3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEIL---DE 59
Query: 264 REILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAE 323
++ + P++ L T LV + P G L + + S+ + + V +
Sbjct: 60 AYVMAGVGSPYVCRLLGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCV-Q 117
Query: 324 VLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ + YL + +V+RDL NVLV+ H+ ++DF L+
Sbjct: 118 IAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 7e-04
Identities = 40/146 (27%), Positives = 66/146 (45%), Gaps = 8/146 (5%)
Query: 221 LGCGDIGSVYLSELT--GTKCYF-AMKVMDKASLEK-RKKLLRAQTEREILQSLDHPFLP 276
+G G+ G V L G + F A+K + EK R+ L +E I+ DHP +
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFL---SEASIMGQFDHPNII 68
Query: 277 TLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGI 336
L + ++ EF G L + ++ G++ Q V + + ++YL +
Sbjct: 69 HLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGM-LRGIAAGMKYLSEMNY 127
Query: 337 VYRDLKPENVLVREDGHIMLSDFDLS 362
V+RDL N+LV + +SDF LS
Sbjct: 128 VHRDLAARNILVNSNLVCKVSDFGLS 153
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 8e-04
Identities = 41/149 (27%), Positives = 54/149 (36%), Gaps = 49/149 (32%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFK----------------- 492
+ V T Y +PE++ G G + D W+ G +YEL GK +
Sbjct: 304 AIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGR 363
Query: 493 ---------GSENRATLYNVVGQ--PLRFPESPVVSFSAR------------DLIKGLLV 529
G+E LYN GQ P P+ AR DLI GLL
Sbjct: 364 LPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLH 423
Query: 530 KEPQNRLACRRGAT---------EIKQHP 549
+ Q RL R+ T E +QHP
Sbjct: 424 YDRQKRLNARQMTTHPYVLKYYPECRQHP 452
|
Length = 467 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 9e-04
Identities = 31/108 (28%), Positives = 50/108 (46%), Gaps = 7/108 (6%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNV 503
TN S G+ ++APE++K + D W+ G + E+L GK PF ++
Sbjct: 165 TNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFK- 223
Query: 504 VGQPLRFPESPV-VSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPF 550
+G+ PE P +S A D ++ E + R A E+ +HPF
Sbjct: 224 IGENAS-PEIPSNISSEAIDFLEKTF--EIDHNK--RPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.7 bits (96), Expect = 0.001
Identities = 34/115 (29%), Positives = 49/115 (42%), Gaps = 14/115 (12%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAV-----DWWTFGIFLYELLFGKTPFKGSENRA 498
T R +F+GT ++APE+I + A D W+ GI EL GK P
Sbjct: 166 TLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR 225
Query: 499 TLYNVVGQP---LRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPF 550
L+ + P L+ PE+ F D I L+K + R E+ +HPF
Sbjct: 226 ALFKIPRNPPPTLKSPENWSKKF--NDFISECLIKNYEQRPF----MEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.001
Identities = 33/129 (25%), Positives = 53/129 (41%), Gaps = 32/129 (24%)
Query: 451 FVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGS---ENRATLYNVVGQ 506
++ T Y APE + +G +G +D W G +E+L F G+ + A +++V+G
Sbjct: 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGT 217
Query: 507 P---------------LRFPES---------PVVSFSARDLIKGLLVKEPQNRLACRRGA 542
P FP P S DL+K LL +P R+ A
Sbjct: 218 PDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT----A 273
Query: 543 TEIKQHPFF 551
+ +HP+F
Sbjct: 274 KQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 35/114 (30%), Positives = 49/114 (42%), Gaps = 11/114 (9%)
Query: 440 IAEPTNARSMSFVGTHEYLAPEIIKGEGHGS---AVDWWTFGIFLYELLFGKTPFKGSEN 496
+ P N SFVGT ++APE+I G VD W+ GI EL K P
Sbjct: 170 KSSPAN----SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 225
Query: 497 RATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPF 550
+ LY++ +S + S R + L K PQ R A + E+ +H F
Sbjct: 226 MSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQKIPQERPA----SAELLRHDF 275
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 39/126 (30%), Positives = 52/126 (41%), Gaps = 7/126 (5%)
Query: 424 KPKNEMGNQVSPLPEL---IAEPTNARSMSFVGTHEYLAPEIIKGEGH-GSAVDWWTFGI 479
KP N N+ L L +A + +V T Y APEI+ H VD W+ G
Sbjct: 145 KPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGC 204
Query: 480 FLYELLFGKTPFKGS---ENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRL 536
+ ELL GK F G+ + + VVG P + S AR I+ L Q+
Sbjct: 205 IMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLK 264
Query: 537 ACRRGA 542
RGA
Sbjct: 265 KIFRGA 270
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 0.001
Identities = 20/59 (33%), Positives = 33/59 (55%), Gaps = 1/59 (1%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPL 508
SFVGT Y++PE ++G + D W+ G+ L EL G+ P + + L + G+P+
Sbjct: 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-ELEAIFGRPV 218
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.001
Identities = 44/165 (26%), Positives = 69/165 (41%), Gaps = 22/165 (13%)
Query: 217 LLKKLGCGDIGSVYLSEL-----TGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD 271
L ++LG G G V+L+E T K A+K + +L RK Q E E+L +L
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF---QREAELLTNLQ 65
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-----------LRQRQPGKYFSEQAVK-- 318
H + Y +V E+ GDL+ L QP + E +
Sbjct: 66 HEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQM 125
Query: 319 FYVA-EVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++A ++ + YL V+RDL N LV + + + DF +S
Sbjct: 126 LHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.001
Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 22/166 (13%)
Query: 217 LLKKLGCGDIGSVYLSELTGT-----KCYFAMKVMDKASLEKRKKLLRAQTEREILQSL- 270
L K LG G G V +E G A+K++ + EK L +E E+++ +
Sbjct: 16 LGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEK--DLSDLVSEMEMMKMIG 73
Query: 271 DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQP-GKYFS-------EQAVKFY- 320
H + L + +V+E+ G+L LR R+P G+Y S E+ +
Sbjct: 74 KHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKD 133
Query: 321 ----VAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+V +E+L ++RDL NVLV ED + ++DF L+
Sbjct: 134 LVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLA 179
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 42/151 (27%), Positives = 63/151 (41%), Gaps = 11/151 (7%)
Query: 219 KKLGCGDIGSVYLSE----LTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
K++G G G V L E T + + + E+ K L AQ R +
Sbjct: 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQH---SNL 57
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQ--AVKFYVAEVLLALEYL 331
L L E + LVMEFCP GDL LR + + + ++ E+ L L +L
Sbjct: 58 LQCLGQCTEVTPY-LLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL 116
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
H ++ DL N L+ D + + D+ LS
Sbjct: 117 HKNNFIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.4 bits (95), Expect = 0.002
Identities = 34/131 (25%), Positives = 48/131 (36%), Gaps = 37/131 (28%)
Query: 454 THE-----YLAPEIIKGEGHGS-AVDWWTFGIFLYELLFGKTPFKG-SE----------- 495
THE Y APEI+ G S VD W+ G E++ + F G SE
Sbjct: 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTL 216
Query: 496 ---NRATLYNVVGQP---LRFPESPVVSFS---------ARDLIKGLLVKEPQNRLACRR 540
+ V P FP+ S DL+ +LV +P R++ +
Sbjct: 217 GTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKA 276
Query: 541 GATEIKQHPFF 551
QHP+F
Sbjct: 277 AL----QHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.002
Identities = 31/105 (29%), Positives = 48/105 (45%), Gaps = 15/105 (14%)
Query: 258 LRAQTEREILQSLDHPF---LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSE 314
L A+ E E LQ L +P +P +VME+ G +L+ LR E
Sbjct: 154 LAAEREFEALQRL-YPEGVKVPKPIAW----NRHAVVMEYIEGVELYRLRLDV------E 202
Query: 315 QAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDF 359
+ ++L + + GIV+ DL N+LV EDG I++ D+
Sbjct: 203 NPDEIL-DKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDW 246
|
Length = 304 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.003
Identities = 34/137 (24%), Positives = 57/137 (41%), Gaps = 33/137 (24%)
Query: 443 PTNARSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATL- 500
P N S + V T Y AP+++ G + +++D W+ G + E++ G+ F G+ N L
Sbjct: 153 PVNTFS-NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLL 211
Query: 501 --YNVVGQP---------------LRFPESPVVSFS---------ARDLIKGLLVKEPQN 534
+ ++G P FP P DL+ LL P+
Sbjct: 212 KIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPEL 271
Query: 535 RLACRRGATEIKQHPFF 551
R++ A + QHP+F
Sbjct: 272 RIS----AHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.003
Identities = 33/132 (25%), Positives = 52/132 (39%), Gaps = 34/132 (25%)
Query: 451 FVGTHEYLAPEI-IKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATL---YNVVGQ 506
+V T Y APEI + +G+ A+D W+ G L E+L + F G + L V+G
Sbjct: 169 YVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGT 228
Query: 507 P----------------LR-FPESPVVSFS---------ARDLIKGLLVKEPQNRLACRR 540
P ++ P P V ++ A DL+ +L P R+
Sbjct: 229 PSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT--- 285
Query: 541 GATEIKQHPFFQ 552
E HP+ +
Sbjct: 286 -VEEALAHPYLE 296
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.003
Identities = 25/87 (28%), Positives = 40/87 (45%), Gaps = 12/87 (13%)
Query: 276 PTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLG 335
P +Y + D + +VME+ G L + + + E + V + LH G
Sbjct: 62 PVVYD-VDPDNKT-IVMEYIEGKPLKDVIEEGNDELLRE--IGRLVGK-------LHKAG 110
Query: 336 IVYRDLKPENVLVREDGHIMLSDFDLS 362
IV+ DL N++VR+D + L DF L
Sbjct: 111 IVHGDLTTSNIIVRDDK-LYLIDFGLG 136
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 34/142 (23%), Positives = 65/142 (45%), Gaps = 11/142 (7%)
Query: 229 VYLSELTGTKCYFAMK-VMDKASLEKRKKLLRAQTEREILQSLDHP-FLPTLYTHFETDK 286
+ + E G + +K V D AS + LL E +L L H LP L+ E +
Sbjct: 26 ILIDEKPGKEEEVFVKTVKDHASEIQVTLLL---QESCLLYGLSHQNILPILHVCIEDGE 82
Query: 287 FSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVK-----FYVAEVLLALEYLHMLGIVYRD 340
++ + G+L L+Q + G+ + QA+ ++ + YLH G++++D
Sbjct: 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKD 142
Query: 341 LKPENVLVREDGHIMLSDFDLS 362
+ N ++ E+ + ++D LS
Sbjct: 143 IAARNCVIDEELQVKITDNALS 164
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.004
Identities = 21/60 (35%), Positives = 32/60 (53%), Gaps = 4/60 (6%)
Query: 457 YLAPEIIKGEGH-GSAVDWWTFGIFLYELL-FGKTPFKGSENRATLYNVV-GQPLRFPES 513
++APE +K EG S D W+FG+ L+E+ G+ P+ G N L + G L P +
Sbjct: 169 WMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQPPN 227
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 39.1 bits (92), Expect = 0.004
Identities = 24/81 (29%), Positives = 38/81 (46%), Gaps = 4/81 (4%)
Query: 457 YLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKGSENRATLYNVV-GQPLRFPESP 514
++APE +K S D W+FG+ L+E+ G TP+ G N L + G L PE
Sbjct: 173 WMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEY- 231
Query: 515 VVSFSARDLIKGLLVKEPQNR 535
+L+ +P++R
Sbjct: 232 -CPDELYELMLSCWQLDPEDR 251
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 24/97 (24%), Positives = 43/97 (44%), Gaps = 3/97 (3%)
Query: 440 IAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRAT 499
+ E + + +GT Y++PE+ + + D W G +YE+ K F + +
Sbjct: 151 VLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL 210
Query: 500 LYNVVGQPLRFPESPV-VSFSARDLIKGLLVKEPQNR 535
+Y ++ L P P S +LI +L K P+ R
Sbjct: 211 VYRIIEGKL--PPMPKDYSPELGELIATMLSKRPEKR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 34/117 (29%), Positives = 51/117 (43%), Gaps = 14/117 (11%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGE-----GHGSAVDWWTFGIFLYELLFGKTPFKGSENRA 498
T R + VGT ++APE+I E + + D W+ GI EL G P
Sbjct: 181 TRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVK 240
Query: 499 TLYNVVGQP---LRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
TL+ + P L PE SF+ I L+K+ + R + T + +HPF +
Sbjct: 241 TLFKIPRNPPPTLLHPEKWCRSFN--HFISQCLIKDFEARPS----VTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 32/139 (23%), Positives = 55/139 (39%), Gaps = 34/139 (24%)
Query: 443 PTNARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGS---ENRA 498
PT S V T Y P+I+ G + + +D W G YE+ G+ F GS E
Sbjct: 157 PTKTYSNEVV-TLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH 215
Query: 499 TLYNVVGQPL-------------------RFPESPVVSFSAR------DLIKGLLVKEPQ 533
++ ++G P ++ + + + R +L+ LL E +
Sbjct: 216 FIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGR 275
Query: 534 NRLACRRGATEIKQHPFFQ 552
R++ A E +HP+F
Sbjct: 276 KRIS----AEEAMKHPYFH 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.004
Identities = 36/130 (27%), Positives = 55/130 (42%), Gaps = 36/130 (27%)
Query: 454 THE-----YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKG-SENRATL--YNVV 504
THE Y APE++ G H + VD W+ G E+ + F G SE + L + ++
Sbjct: 169 THEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLL 228
Query: 505 GQP----------LR----FPE---------SPVVSFSARDLIKGLLVKEPQNRLACRRG 541
G P LR FP+ P +S DL++ +L +P R++
Sbjct: 229 GTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS---- 284
Query: 542 ATEIKQHPFF 551
A HP+F
Sbjct: 285 AKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 0.004
Identities = 39/158 (24%), Positives = 58/158 (36%), Gaps = 44/158 (27%)
Query: 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS---------------- 494
+V T Y APE+I G G+ VD W+ G + E++ G F G+
Sbjct: 185 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTP 244
Query: 495 ----------------ENRA--------TLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530
ENR L+ V P + + + ARDL+ +LV
Sbjct: 245 CPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVI 304
Query: 531 EPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIP 568
+ R++ E QHP+ A PP+IP
Sbjct: 305 DASKRIS----VDEALQHPYINVWYDPSEAEAPPPKIP 338
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|222435 pfam13885, Keratin_B2_2, Keratin, high sulfur B2 protein | Back alignment and domain information |
|---|
Score = 35.0 bits (81), Expect = 0.004
Identities = 13/22 (59%), Positives = 16/22 (72%)
Query: 389 CVQPACIEPSCIQPSCIAPTTC 410
C QP+C +PSC QPSC P+ C
Sbjct: 6 CCQPSCCQPSCCQPSCCQPSCC 27
|
Length = 45 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 0.004
Identities = 37/164 (22%), Positives = 68/164 (41%), Gaps = 32/164 (19%)
Query: 215 FRLLKKLGCGDIGSV----YLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI-LQS 269
R LK LG G G+V ++ E K A+K + S ++ + T+ + + S
Sbjct: 9 LRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS---GRQTFQEITDHMLAMGS 65
Query: 270 LDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQ-----------RQPGKYFSEQAVK 318
LDH ++ L + CPG L + Q RQ Q +
Sbjct: 66 LDHAYIVRL-------------LGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLL 112
Query: 319 FYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ ++ + YL +V+R+L N+L++ D + ++DF ++
Sbjct: 113 NWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVA 156
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.004
Identities = 23/90 (25%), Positives = 38/90 (42%), Gaps = 15/90 (16%)
Query: 276 PTLYTHFETDKFSCLVMEFCPGGDLHTL---RQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
P +Y + + F +VME+ G L L + + E + V + LH
Sbjct: 64 PAVY-FVDPENFI-IVMEYIEGEPLKDLINSNGMEELELSRE--IGRLVGK-------LH 112
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
GI++ DL N+++ I L DF L+
Sbjct: 113 SAGIIHGDLTTSNMILSGGK-IYLIDFGLA 141
|
Length = 211 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 604 | |||
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.98 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.98 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.96 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.95 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.94 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.89 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.88 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.85 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.85 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.82 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.8 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.79 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.78 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.78 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.77 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.73 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.7 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.69 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.68 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.55 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.52 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.49 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.47 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.43 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.43 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.42 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.4 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.28 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.26 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.22 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.2 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.17 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.08 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.07 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.82 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.78 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.76 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.65 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.64 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.62 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.49 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.44 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.41 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.33 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.3 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.24 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.2 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.11 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.02 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.99 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.95 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.8 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.8 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.79 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.76 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.73 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.66 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.62 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.57 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.48 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.44 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.41 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.41 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.0 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.97 | |
| PLN02236 | 344 | choline kinase | 96.89 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.75 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.72 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 96.69 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.62 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.5 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.45 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.36 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.27 | |
| PTZ00384 | 383 | choline kinase; Provisional | 96.17 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.01 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 95.94 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.55 | |
| PTZ00296 | 442 | choline kinase; Provisional | 95.49 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.3 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.28 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.24 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.91 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 94.78 |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-84 Score=662.54 Aligned_cols=386 Identities=73% Similarity=1.213 Sum_probs=347.1
Q ss_pred CCCCCCCCcccCCCCCCCCCCCCChhHHHHHhhee-ecCceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecc
Q 007433 170 SSDVSDESTCSSLSSSVNKPHKANDAQWEAIQAVR-VKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDK 248 (604)
Q Consensus 170 ss~~s~~s~~ss~sss~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~ 248 (604)
+++.+..+..+..++....|+...+..|..+..+. ..++.++.++|+++++||+|..|+||++++.+++++||||+|++
T Consensus 33 s~~~~~~s~~~~~s~~~~kph~~~d~~w~a~~~~~~~~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK 112 (459)
T KOG0610|consen 33 SSDLSDESSLSNPSSSGNKPHKGNDVRWEAISSIRNSKDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDK 112 (459)
T ss_pred cCCccccccccccCcccCCCCCCCchhhhhhccccccCCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecH
Confidence 44444445555566778899999999999998777 68889999999999999999999999999999999999999999
Q ss_pred hhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHH
Q 007433 249 ASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLAL 328 (604)
Q Consensus 249 ~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL 328 (604)
..+..++++.+++.|.+||+.++||++++||.+|+.+++.|||||||+||+|+.++++++++.|++..+++|+.+|+.||
T Consensus 113 ~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~AL 192 (459)
T KOG0610|consen 113 ESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLAL 192 (459)
T ss_pred HHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHH
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCC
Q 007433 329 EYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPT 408 (604)
Q Consensus 329 ~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (604)
+|||..|||+||||||||||.++|||+|+||+|+.++...++.+.......... ++. |+. ...
T Consensus 193 EYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~--------~~~-----~~~----~~~ 255 (459)
T KOG0610|consen 193 EYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGS--------QPS-----CRS----RQP 255 (459)
T ss_pred HHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCC--------Ccc-----ccc----ccc
Confidence 999999999999999999999999999999999999988888887654332221 222 222 145
Q ss_pred ccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCC
Q 007433 409 TCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGK 488 (604)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~ 488 (604)
.||+++.+...++..+ .+...+ ..++++.+++++.++++||||.+|+|||+++|++++.++|||+|||+|||||+|.
T Consensus 256 s~f~~r~~~~~~~~~k--~~~~~~-~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~ 332 (459)
T KOG0610|consen 256 SCFSPRCLSSSKKRKK--KDESAS-RSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGT 332 (459)
T ss_pred cccccchhcccccccc--cccccc-ccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCC
Confidence 6788885554333333 334444 7889999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhhhhcCCCCCCC
Q 007433 489 TPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIP 568 (604)
Q Consensus 489 ~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~~~~~~~~~p 568 (604)
+||+|.++.+++.+|+.+++.||..+.++..++|||++||++||.+|+.++++|+||.+||||++|+|+++++..||.+|
T Consensus 333 TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVnWaLir~~~PP~iP 412 (459)
T KOG0610|consen 333 TPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVNWALIRCARPPEIP 412 (459)
T ss_pred CCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCChhheeccCCCcCC
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCcccC
Q 007433 569 KPVEIVH 575 (604)
Q Consensus 569 ~~~~~~~ 575 (604)
.+.+...
T Consensus 413 ~~~d~~~ 419 (459)
T KOG0610|consen 413 KPVDGGL 419 (459)
T ss_pred CccccCc
Confidence 9988754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-61 Score=486.62 Aligned_cols=283 Identities=42% Similarity=0.752 Sum_probs=254.1
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
..++|++++.||+|+||+||.++.+++++.||+|+|+|....+.........|..||..++||+||.|+..|++...+||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 45799999999999999999999999999999999999988887788888999999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
|+||+.||+|+..+++. +.|+|..+++|+++|+.||.|||++||||||||||||||+.+|+++|+||||+.....
T Consensus 103 Vld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~--- 177 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLK--- 177 (357)
T ss_pred EEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhccc---
Confidence 99999999999999987 7899999999999999999999999999999999999999999999999999842110
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
.+....+
T Consensus 178 -------------------------------------------------------------------------~~~~t~t 184 (357)
T KOG0598|consen 178 -------------------------------------------------------------------------DGDATRT 184 (357)
T ss_pred -------------------------------------------------------------------------CCCcccc
Confidence 1123346
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
+|||++|||||++.+.+|+.++|||||||++||||+|.+||.+.+....+.+|..++..++. ..++.++++||+++|.+
T Consensus 185 fcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p-~~ls~~ardll~~LL~r 263 (357)
T KOG0598|consen 185 FCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP-GYLSEEARDLLKKLLKR 263 (357)
T ss_pred ccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC-ccCCHHHHHHHHHHhcc
Confidence 89999999999999999999999999999999999999999999999999999988743322 24899999999999999
Q ss_pred CCCCcccccCCHHHHhcCCCCCCCChhhh--hcCCCCCCCCCCc
Q 007433 531 EPQNRLACRRGATEIKQHPFFQGVNWALI--RCASPPEIPKPVE 572 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~Hpff~~~~~~~~--~~~~~~~~p~~~~ 572 (604)
||++|+.....+++|.+||||.+++|..+ +...||..|....
T Consensus 264 dp~~RLg~~~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~~ 307 (357)
T KOG0598|consen 264 DPRQRLGGPGDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVTG 307 (357)
T ss_pred CHHHhcCCCCChHHhhcCcccccCCHHHHHhcCCCCCeecCCCC
Confidence 99999976778999999999999999875 4455666665443
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-60 Score=498.31 Aligned_cols=336 Identities=36% Similarity=0.635 Sum_probs=268.9
Q ss_pred eeecCceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeE
Q 007433 203 VRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHF 282 (604)
Q Consensus 203 ~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 282 (604)
++..-..+..++|.+++.||+|+||.||+|+-+.||.+||||+++|..+-....+..+..|..||...++++||+||..|
T Consensus 131 lR~~R~r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF 210 (550)
T KOG0605|consen 131 LRLRRTRLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF 210 (550)
T ss_pred HHhccccCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe
Confidence 44444567789999999999999999999999999999999999999998889999999999999999999999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 283 ETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 283 ~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
++..++||||||++|||+.+++.+. ..|++..+++|+.+++.|++-||++|||||||||+|+||+..||+||+||||+
T Consensus 211 QD~~~LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs 288 (550)
T KOG0605|consen 211 QDKEYLYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLS 288 (550)
T ss_pred cCCCeeEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeecccccc
Confidence 9999999999999999999999886 68999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccC
Q 007433 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442 (604)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (604)
.-+.......... .+... +..-.. -..+......++...+ + + ..-+ ..-..
T Consensus 289 ~gl~~~~~~~~~~---~~~~~-------~~~~~~--~~~~~~~~~~~~~~~~--~-~------~~~~--------~~w~~ 339 (550)
T KOG0605|consen 289 TGLDKKHRIESYR---LDEQM-------QINLSE--AKPSDFPKFNTPRSTM--S-R------REQL--------QTWKR 339 (550)
T ss_pred chhhhhhhhhhhc---chhhh-------hhhhcc--CCCccccccccccchh--h-H------HHHH--------HHHHh
Confidence 4332111100000 00000 000000 0000000000000000 0 0 0000 00000
Q ss_pred CCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC--CCCCCCCCCCCHHH
Q 007433 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ--PLRFPESPVVSFSA 520 (604)
Q Consensus 443 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~--~~~~p~~~~~s~~l 520 (604)
..-....+++|||.|||||++.+.+|+..+||||||||+||||.|.+||.+.+..+++.+|+.- .+.+|....++.++
T Consensus 340 nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA 419 (550)
T KOG0605|consen 340 NRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEA 419 (550)
T ss_pred hhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHH
Confidence 0111234689999999999999999999999999999999999999999999999999998754 48888888899999
Q ss_pred HHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhhhhcCCCCCCCCCC
Q 007433 521 RDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPKPV 571 (604)
Q Consensus 521 ~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~~~~~~~~~p~~~ 571 (604)
+|||.+||+ ||++|+. ..+++||.+||||++|+|..++...+|.+|...
T Consensus 420 ~DLI~rll~-d~~~RLG-~~G~~EIK~HPfF~~v~W~~l~~~~apfvP~v~ 468 (550)
T KOG0605|consen 420 KDLITRLLC-DPENRLG-SKGAEEIKKHPFFKGVDWDHLREMPAPFVPQVN 468 (550)
T ss_pred HHHHHHHhc-CHHHhcC-cccHHHHhcCCccccCCcchhhcCCCCCCCCCC
Confidence 999999999 9999998 778999999999999999999999999998754
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-58 Score=488.24 Aligned_cols=287 Identities=39% Similarity=0.679 Sum_probs=258.5
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCee
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 288 (604)
....+|...+.||+|+|++|++|+...+++.||||++.|..+.+.++..-+.+|.++|.+| +||.|++||..|+++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3457999999999999999999999999999999999999998888888889999999999 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|+|+||+++|+|.++|.+. +.|++..+++|+.||+.||+|||++||||||||||||||+.||++||+|||-|..+...
T Consensus 150 YFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~ 227 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPS 227 (604)
T ss_pred EEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChh
Confidence 9999999999999999998 78999999999999999999999999999999999999999999999999988554322
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
..... +++ .......+.
T Consensus 228 ~~~~~-----------~~~----------------------------------------------------~~~~a~s~~ 244 (604)
T KOG0592|consen 228 QKSQE-----------NPV----------------------------------------------------DPNQASSRR 244 (604)
T ss_pred hcccc-----------Ccc----------------------------------------------------CcccccCcc
Confidence 11000 000 000112223
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
.+||||..|.+||+|.....++.+|||+||||||.|+.|.+||.+.++..++.+|+...+.||.. +++.++|||+++|
T Consensus 245 ~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~--fp~~a~dLv~KLL 322 (604)
T KOG0592|consen 245 SSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEG--FPEDARDLIKKLL 322 (604)
T ss_pred cceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCC--CCHHHHHHHHHHH
Confidence 68999999999999999999999999999999999999999999999999999999988888765 8999999999999
Q ss_pred hcCCCCcccccCCHHHHhcCCCCCCCChhhhhcCCCCCC
Q 007433 529 VKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEI 567 (604)
Q Consensus 529 ~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~~~~~~~~~ 567 (604)
+.||.+|++ +.+|.+||||++|+|..++...||.+
T Consensus 323 v~dp~~Rlt----~~qIk~HpFF~~Vdw~nlw~~~PP~l 357 (604)
T KOG0592|consen 323 VRDPSDRLT----SQQIKAHPFFEGVDWENLWQQTPPKL 357 (604)
T ss_pred ccCcccccc----HHHHhhCcccccCChhhhhhcCCCcc
Confidence 999999999 99999999999999999999988887
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-58 Score=455.29 Aligned_cols=276 Identities=41% Similarity=0.773 Sum_probs=255.7
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
..+++|+.++.||.|+||+|.+++.+.++.+||+|++++...-+.+.......|..||+.+.||++++|++.|.+..++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 66789999999999999999999999999999999999998888888888899999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
|||||++||.|+.++++. ++|++..+++|+.||+.||+|||+++|++||||||||||+.+|++||+|||+|.+..
T Consensus 121 mvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~--- 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS--- 195 (355)
T ss_pred EEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec---
Confidence 999999999999999886 689999999999999999999999999999999999999999999999999996532
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
.+..
T Consensus 196 ----------------------------------------------------------------------------~rT~ 199 (355)
T KOG0616|consen 196 ----------------------------------------------------------------------------GRTW 199 (355)
T ss_pred ----------------------------------------------------------------------------CcEE
Confidence 1234
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
+.||||+|+|||++...+|+.++|||||||++|||+.|.+||.+.+..+++.+|+.+.+.||.. ++.+++|||.++|+
T Consensus 200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~--fs~~~kdLl~~LL~ 277 (355)
T KOG0616|consen 200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSY--FSSDAKDLLKKLLQ 277 (355)
T ss_pred EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcc--cCHHHHHHHHHHHh
Confidence 6789999999999999999999999999999999999999999999999999999999999876 99999999999999
Q ss_pred cCCCCccc-ccCCHHHHhcCCCCCCCChhhhhcC--CCCCCC
Q 007433 530 KEPQNRLA-CRRGATEIKQHPFFQGVNWALIRCA--SPPEIP 568 (604)
Q Consensus 530 ~dP~~Rpt-~~~~a~elL~Hpff~~~~~~~~~~~--~~~~~p 568 (604)
.|-.+|.. .+++..+|.+||||++++|..+... .+|..|
T Consensus 278 vD~t~R~gnlknG~~dIk~H~wF~~v~W~~i~~r~ie~P~~p 319 (355)
T KOG0616|consen 278 VDLTKRFGNLKNGVEDIKNHPWFKGVDWEAILQRKIEPPFEP 319 (355)
T ss_pred hhhHhhhcCcCCCccccccCcccccccHHHHhhccccCCCCC
Confidence 99999966 4668999999999999999876543 344444
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-56 Score=478.77 Aligned_cols=255 Identities=32% Similarity=0.573 Sum_probs=241.3
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
.+|...+.||+|||+.||++++..+|..||+|++.+..+.+.....++.+||+|.+.|+|||||++|++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 47999999999999999999999999999999999988887777888899999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
|+|+.++|..++++. +.|+|.+++.|++||+.||.|||+++|||||||..||||+++.+|||+|||||.++.
T Consensus 98 ELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le------ 169 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLE------ 169 (592)
T ss_pred EecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeec------
Confidence 999999999999865 789999999999999999999999999999999999999999999999999996543
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
..+.+.+++|
T Consensus 170 ----------------------------------------------------------------------~~~Erk~TlC 179 (592)
T KOG0575|consen 170 ----------------------------------------------------------------------YDGERKKTLC 179 (592)
T ss_pred ----------------------------------------------------------------------Ccccccceec
Confidence 1234567889
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEP 532 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP 532 (604)
|||.|+|||++...+++..+||||+|||||-||+|++||...+-.+++.+|....+.+|.. ++.+++|||.+||..||
T Consensus 180 GTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~--ls~~A~dLI~~lL~~~P 257 (592)
T KOG0575|consen 180 GTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSH--LSAEAKDLIRKLLRPNP 257 (592)
T ss_pred CCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccc--cCHHHHHHHHHHhcCCc
Confidence 9999999999999999999999999999999999999999999999999999999999884 99999999999999999
Q ss_pred CCcccccCCHHHHhcCCCC
Q 007433 533 QNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 533 ~~Rpt~~~~a~elL~Hpff 551 (604)
.+||+ +++||.|+||
T Consensus 258 ~~Rps----l~~vL~h~Ff 272 (592)
T KOG0575|consen 258 SERPS----LDEVLDHPFF 272 (592)
T ss_pred ccCCC----HHHHhcCHhh
Confidence 99999 9999999999
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-57 Score=464.54 Aligned_cols=261 Identities=32% Similarity=0.491 Sum_probs=228.5
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHH----HHHHHHHHHHHHHHHhCCCCCccccceeEecCCe
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEK----RKKLLRAQTEREILQSLDHPFLPTLYTHFETDKF 287 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~----~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 287 (604)
.+.|.+.+.||+|+||.|-+|..+.|++.||||++++..... ......+++|++||++|+|||||+++++|+..+.
T Consensus 171 ~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds 250 (475)
T KOG0615|consen 171 NDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDS 250 (475)
T ss_pred cceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCc
Confidence 367999999999999999999999999999999999875543 2344557899999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccC---CcEEEeccccccc
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRED---GHIMLSDFDLSLR 364 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~---g~vkL~DFGla~~ 364 (604)
.||||||++||+|.+.+-.+ +.+.+..-+.+++||+.||.|||++||+||||||+|||+..+ -.+||+|||+|..
T Consensus 251 ~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 251 SYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred eEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 99999999999999988776 679999999999999999999999999999999999999876 6899999999943
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
.+ .
T Consensus 329 ~g-----------------------------------------------------------------------------~ 331 (475)
T KOG0615|consen 329 SG-----------------------------------------------------------------------------E 331 (475)
T ss_pred cc-----------------------------------------------------------------------------c
Confidence 22 1
Q ss_pred CCcccccccCccccCcceecCCCC---CccchHHHHHHHHHHHhhCCCCCCCCChHH-HHHHHHcCCCCC--CCCCCCCH
Q 007433 445 NARSMSFVGTHEYLAPEIIKGEGH---GSAVDWWTFGIFLYELLFGKTPFKGSENRA-TLYNVVGQPLRF--PESPVVSF 518 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l~~~~~---~~~~DiWSLGviL~eLltG~~PF~~~~~~~-~l~~i~~~~~~~--p~~~~~s~ 518 (604)
.....++|||+.|.|||++.+.++ ..++|||||||+||-+|+|.+||.+..... ....|..+.+.| +.+..+++
T Consensus 332 ~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~~Ise 411 (475)
T KOG0615|consen 332 GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWDRISE 411 (475)
T ss_pred ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhhhhhH
Confidence 223457899999999999998764 458899999999999999999999876555 556677776665 35677999
Q ss_pred HHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCC
Q 007433 519 SARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 519 ~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
++++||.+||..||++|++ +.|+|+||||+.+.
T Consensus 412 ea~dlI~~mL~VdP~~R~s----~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 412 EALDLINWMLVVDPENRPS----ADEALNHPWFKDAP 444 (475)
T ss_pred HHHHHHHHhhEeCcccCcC----HHHHhcChhhhccc
Confidence 9999999999999999999 99999999998654
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-56 Score=483.54 Aligned_cols=282 Identities=39% Similarity=0.768 Sum_probs=253.6
Q ss_pred ceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEecCC
Q 007433 208 GVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFETDK 286 (604)
Q Consensus 208 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~ 286 (604)
+.+.+++|++++.||+|.||+|++|..++++++||||+++|...-.+..+.....|..|+.... ||+++.|+..|++..
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 4567789999999999999999999999999999999999998777788888889999998874 999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
++|+||||+.|||+..+++ ...|++..+++|++.|+.||.|||++||||||||.+||||+.+|++||+||||++.-.
T Consensus 443 ~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m 519 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM 519 (694)
T ss_pred eEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccC
Confidence 9999999999999544333 3679999999999999999999999999999999999999999999999999873210
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
..+.
T Consensus 520 ----------------------------------------------------------------------------~~g~ 523 (694)
T KOG0694|consen 520 ----------------------------------------------------------------------------GQGD 523 (694)
T ss_pred ----------------------------------------------------------------------------CCCC
Confidence 0123
Q ss_pred cccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007433 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKG 526 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~ 526 (604)
+..+|+|||.|||||++.+..|+.++|||+|||+|||||.|..||.|.++.+.+..|+...+.+|.+ ++.++.+++++
T Consensus 524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~--ls~ea~~il~~ 601 (694)
T KOG0694|consen 524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRF--LSKEAIAIMRR 601 (694)
T ss_pred ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCc--ccHHHHHHHHH
Confidence 5668999999999999999999999999999999999999999999999999999999998888876 99999999999
Q ss_pred hhhcCCCCcccc-cCCHHHHhcCCCCCCCChhhh--hcCCCCCCCCC
Q 007433 527 LLVKEPQNRLAC-RRGATEIKQHPFFQGVNWALI--RCASPPEIPKP 570 (604)
Q Consensus 527 lL~~dP~~Rpt~-~~~a~elL~Hpff~~~~~~~~--~~~~~~~~p~~ 570 (604)
||.+||++|+.+ .+.+++|.+||||++++|..+ +...||..|..
T Consensus 602 ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i 648 (694)
T KOG0694|consen 602 LLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTI 648 (694)
T ss_pred HhccCcccccCCCCCCchhhhhCCccccCCHHHHhhccCCCCCCccc
Confidence 999999999996 467899999999999999876 44567666653
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-54 Score=437.22 Aligned_cols=256 Identities=31% Similarity=0.491 Sum_probs=227.3
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC-eeEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK-FSCL 290 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-~~~l 290 (604)
.++.+.++.||+|..|+||+++++.|++.+|+|++.... +.....++.+|++|++.++|||||.+|+.|..+. .++|
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~--~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI--DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC--CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence 457778899999999999999999999999999994332 2345556789999999999999999999999988 5999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH-cCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM-LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
+||||.||+|..++... ++++|.....|+.+|++||.|||+ ++||||||||+||||+..|+|||||||.+..+..
T Consensus 156 ~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn-- 231 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN-- 231 (364)
T ss_pred ehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh--
Confidence 99999999999998876 679999999999999999999996 9999999999999999999999999998844321
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
+...
T Consensus 232 ----------------------------------------------------------------------------S~a~ 235 (364)
T KOG0581|consen 232 ----------------------------------------------------------------------------SIAN 235 (364)
T ss_pred ----------------------------------------------------------------------------hhcc
Confidence 1234
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCC-----ChHHHHHHHHcC-CCCCCCCCCCCHHHHHH
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS-----ENRATLYNVVGQ-PLRFPESPVVSFSARDL 523 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~-----~~~~~l~~i~~~-~~~~p~~~~~s~~l~dL 523 (604)
+++||..|||||.+.+..|+.++||||||++|+||++|+.||... +..+.+..|+.+ +..+|.. .+|+++++|
T Consensus 236 tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~-~fS~ef~~F 314 (364)
T KOG0581|consen 236 TFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG-EFSPEFRSF 314 (364)
T ss_pred cccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc-cCCHHHHHH
Confidence 789999999999999999999999999999999999999999874 566777888874 4556654 699999999
Q ss_pred HHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 524 IKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 524 I~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
|..||.+||.+|++ +.||++|||+...
T Consensus 315 V~~CL~Kdp~~R~s----~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 315 VSCCLRKDPSERPS----AKQLLQHPFIKKF 341 (364)
T ss_pred HHHHhcCCcccCCC----HHHHhcCHHHhhc
Confidence 99999999999999 9999999999743
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-53 Score=420.16 Aligned_cols=260 Identities=30% Similarity=0.474 Sum_probs=220.7
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
+.|+.+.++|+|+||+||+|+++.||+.||||.+....- +.....-+.||+++|+.|+|+|+|.|+++|.....++||+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 578899999999999999999999999999999865432 2233345679999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
|||+..-|++ +++.+ ..++...++.|++|++.|+.|+|+++|||||||||||||+.+|.+||||||+|+.+.....
T Consensus 81 E~~dhTvL~e-Le~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd-- 156 (396)
T KOG0593|consen 81 EYCDHTVLHE-LERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD-- 156 (396)
T ss_pred eecchHHHHH-HHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcc--
Confidence 9996555544 55554 5689999999999999999999999999999999999999999999999999965432111
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
..+.++
T Consensus 157 --------------------------------------------------------------------------~YTDYV 162 (396)
T KOG0593|consen 157 --------------------------------------------------------------------------NYTDYV 162 (396)
T ss_pred --------------------------------------------------------------------------hhhhhh
Confidence 123468
Q ss_pred cCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC-------------------CCCCCC
Q 007433 453 GTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ-------------------PLRFPE 512 (604)
Q Consensus 453 GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~-------------------~~~~p~ 512 (604)
.|.||+|||++.| ..|+..+||||+||++.||++|.+.|+|.++.++++.|+.. .+++|+
T Consensus 163 ATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~ 242 (396)
T KOG0593|consen 163 ATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPE 242 (396)
T ss_pred hhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCC
Confidence 9999999999998 67999999999999999999999999999999998877632 122333
Q ss_pred C----------CCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCC
Q 007433 513 S----------PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 513 ~----------~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
. +.++.-+.||+++||..||.+|++ .+++|.|+||+++-
T Consensus 243 ~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~s----c~qll~H~yFd~~~ 291 (396)
T KOG0593|consen 243 PEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLS----CEQLLHHPYFDGFI 291 (396)
T ss_pred CCCccchhhhcccchHHHHHHHHHHhcCCcccccc----HHHHhcChHHHHHH
Confidence 2 345667889999999999999999 89999999996543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-52 Score=424.78 Aligned_cols=258 Identities=29% Similarity=0.536 Sum_probs=226.3
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|.+.++||.|+||+||+|+++.++..||||.|.+..+. .+...-+..|+.||+.++|||||.|+++++.++++|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~-~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLN-KKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccC-HHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 47999999999999999999999999999999999988653 24445567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccC------CcEEEecccccccc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRED------GHIMLSDFDLSLRC 365 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~------g~vkL~DFGla~~~ 365 (604)
||||.||||..++++. +.++|..++.++.||+.||++||+++||||||||.||||+.. -.+||+|||+|+.+
T Consensus 88 MEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L 165 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL 165 (429)
T ss_pred EEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence 9999999999999987 589999999999999999999999999999999999999865 35899999999654
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
...
T Consensus 166 ~~~----------------------------------------------------------------------------- 168 (429)
T KOG0595|consen 166 QPG----------------------------------------------------------------------------- 168 (429)
T ss_pred Cch-----------------------------------------------------------------------------
Confidence 311
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC-CCCCCHHHHHHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE-SPVVSFSARDLI 524 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~-~~~~s~~l~dLI 524 (604)
....+.+|++.|||||++....|+.|+|+||+|++||+|++|+.||...+..+.+..+.......+. ...++..+.+|+
T Consensus 169 ~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~s~~~~~Ll 248 (429)
T KOG0595|consen 169 SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAELSNPLRELL 248 (429)
T ss_pred hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhccCchhhhh
Confidence 1122567999999999999999999999999999999999999999998888888776655433332 234777788999
Q ss_pred HHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
..+|.+||.+|.+ ..+-+.|+|+..
T Consensus 249 ~~ll~~~~~~~~~----~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 249 ISLLQRNPKDRIS----FEDFFDHPFLAA 273 (429)
T ss_pred hHHHhcCccccCc----hHHhhhhhhccc
Confidence 9999999999999 899999998853
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-51 Score=427.14 Aligned_cols=268 Identities=34% Similarity=0.616 Sum_probs=230.5
Q ss_pred CceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHH-----------HHHHHHHHHHHHHHhCCCCCc
Q 007433 207 DGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKR-----------KKLLRAQTEREILQSLDHPFL 275 (604)
Q Consensus 207 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~-----------~~~~~~~~Ei~iL~~l~HpnI 275 (604)
++...+++|++++.||.|.||.|-+|++..+++.||||++.+..+... ..+.+.++||.||++|+||||
T Consensus 91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV 170 (576)
T KOG0585|consen 91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV 170 (576)
T ss_pred ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence 445567899999999999999999999999999999999988654322 224577899999999999999
Q ss_pred cccceeEec--CCeeEEEEeecCCCCHHHHHHhcCCCC-CcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC
Q 007433 276 PTLYTHFET--DKFSCLVMEFCPGGDLHTLRQRQPGKY-FSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG 352 (604)
Q Consensus 276 v~l~~~~~~--~~~~~lV~E~~~ggsL~~ll~~~~~~~-l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g 352 (604)
|+|+++..+ .+.+|||+|||..|.+...- ..+. |++.+++.|+++++.||+|||.+|||||||||+|+||+.+|
T Consensus 171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDG 247 (576)
T ss_pred eEEEEeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCC
Confidence 999999986 56899999999988886532 2234 99999999999999999999999999999999999999999
Q ss_pred cEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCC
Q 007433 353 HIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQ 432 (604)
Q Consensus 353 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (604)
++||+|||.+..+..+.
T Consensus 248 ~VKIsDFGVs~~~~~~~--------------------------------------------------------------- 264 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGS--------------------------------------------------------------- 264 (576)
T ss_pred cEEeeccceeeecccCC---------------------------------------------------------------
Confidence 99999999874322110
Q ss_pred CCCCcccccCCCCCcccccccCccccCcceecCCC----CCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC
Q 007433 433 VSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEG----HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPL 508 (604)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~----~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~ 508 (604)
.+..+..-...+|||.|||||.+.++. .+.+.|||||||+||.|+.|+.||.+....+++.+|+..++
T Consensus 265 --------~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~pL 336 (576)
T KOG0585|consen 265 --------DEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVNDPL 336 (576)
T ss_pred --------ccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcCcc
Confidence 000011111257999999999988733 37799999999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCC
Q 007433 509 RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 509 ~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
.||..+.+.++++|||.+||++||++|++ +.+|..|||..
T Consensus 337 ~fP~~pe~~e~~kDli~~lL~KdP~~Ri~----l~~ik~Hpwvt 376 (576)
T KOG0585|consen 337 EFPENPEINEDLKDLIKRLLEKDPEQRIT----LPDIKLHPWVT 376 (576)
T ss_pred cCCCcccccHHHHHHHHHHhhcChhheee----hhhheecceec
Confidence 99999999999999999999999999999 99999999985
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-52 Score=434.75 Aligned_cols=259 Identities=31% Similarity=0.504 Sum_probs=224.0
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEecCC-ee
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFETDK-FS 288 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~-~~ 288 (604)
..++|.++++||.|.||.||+|+...++..||||.|++.... .+.+.+ .||+.-|++|+ ||||++|.+++.+.+ .+
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~n-LREvksL~kln~hpniikL~Evi~d~~~~L 85 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMN-LREVKSLRKLNPHPNIIKLKEVIRDNDRIL 85 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHH-HHHHHHHHhcCCCCcchhhHHHhhccCceE
Confidence 357999999999999999999999999999999999765433 333333 57999999998 999999999998877 99
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|+||||| ..+|+++++.+ ++.|++..++.|++||++||+|+|.+|++||||||||||+.....+||+|||||+.....
T Consensus 86 ~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk 163 (538)
T KOG0661|consen 86 YFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK 163 (538)
T ss_pred eeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC
Confidence 9999999 78999999987 689999999999999999999999999999999999999998889999999999543211
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
+ ..
T Consensus 164 p-----------------------------------------------------------------------------PY 166 (538)
T KOG0661|consen 164 P-----------------------------------------------------------------------------PY 166 (538)
T ss_pred C-----------------------------------------------------------------------------Cc
Confidence 1 12
Q ss_pred cccccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc---CC----------------C
Q 007433 449 MSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG---QP----------------L 508 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~---~~----------------~ 508 (604)
+.+|-|.||+|||+|... .|+.++||||+|||++|+.+-++.|.|.++.+++++|+. .+ +
T Consensus 167 TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf 246 (538)
T KOG0661|consen 167 TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNF 246 (538)
T ss_pred chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhcc
Confidence 356899999999997655 579999999999999999999999999999999988763 21 2
Q ss_pred CCCCC---------CCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 509 RFPES---------PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 509 ~~p~~---------~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
+||.- +..+.++.+||.+||.+||.+||| |.++|+||||+.-
T Consensus 247 ~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpT----A~~al~~pffq~~ 297 (538)
T KOG0661|consen 247 RFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPT----ASQALQHPFFQVG 297 (538)
T ss_pred CCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCcc----HHHHhcCcccccc
Confidence 33322 336788999999999999999999 9999999999854
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-51 Score=434.86 Aligned_cols=261 Identities=35% Similarity=0.598 Sum_probs=231.6
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHH-H-HHHHHHHHHHHHHHHhCC-CCCccccceeEecCC
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLE-K-RKKLLRAQTEREILQSLD-HPFLPTLYTHFETDK 286 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~-~-~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~ 286 (604)
...+.|.+.+.||+|+||+|++|.+..++..||+|++++.... . ......+.+|+.+|+.+. ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 3457999999999999999999999999999999988875222 1 123345568999999998 999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccC-CcEEEecccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRED-GHIMLSDFDLSLRC 365 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~-g~vkL~DFGla~~~ 365 (604)
.+|+|||||.||+|++++... +++.|..++.+++||+.||+|||++||+||||||||||++.+ +++||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~ 171 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS 171 (370)
T ss_pred eEEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence 999999999999999999884 689999999999999999999999999999999999999999 99999999998432
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
. ..+
T Consensus 172 ~----------------------------------------------------------------------------~~~ 175 (370)
T KOG0583|consen 172 P----------------------------------------------------------------------------GED 175 (370)
T ss_pred C----------------------------------------------------------------------------CCC
Confidence 1 011
Q ss_pred CcccccccCccccCcceecCCC-C-CccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEG-H-GSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDL 523 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~-~-~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dL 523 (604)
....+++||+.|+|||++.+.. | +.++||||+||+||.|++|+.||...+...++..|....+.+|.+-. +.++++|
T Consensus 176 ~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~-S~~~~~L 254 (370)
T KOG0583|consen 176 GLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLL-SPEARSL 254 (370)
T ss_pred CcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcC-CHHHHHH
Confidence 2344678999999999999987 7 58999999999999999999999998888888899998888888733 9999999
Q ss_pred HHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 524 IKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 524 I~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
|.+||..||.+|++ +.++++||||+.
T Consensus 255 i~~mL~~~P~~R~t----~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 255 IEKMLVPDPSTRIT----LLEILEHPWFQK 280 (370)
T ss_pred HHHHcCCCcccCCC----HHHHhhChhhcc
Confidence 99999999999999 999999999985
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-51 Score=440.18 Aligned_cols=259 Identities=31% Similarity=0.535 Sum_probs=234.6
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.+-|++.+.||.|+.|.|-+|++..||+.+|||++.+...........+.+||-||+.+.||||++||++|++..++|||
T Consensus 11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylv 90 (786)
T KOG0588|consen 11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLV 90 (786)
T ss_pred ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEE
Confidence 36899999999999999999999999999999999987444445556778999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
+||++||.|++++-+. +.|++.++.++++||+.||.|+|..+||||||||||+||+..+++||+|||+|..-
T Consensus 91 lEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe------ 162 (786)
T KOG0588|consen 91 LEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLE------ 162 (786)
T ss_pred EEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecc------
Confidence 9999999999998886 67999999999999999999999999999999999999999999999999998210
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
..+..-.+.
T Consensus 163 -----------------------------------------------------------------------~~gklLeTS 171 (786)
T KOG0588|consen 163 -----------------------------------------------------------------------VPGKLLETS 171 (786)
T ss_pred -----------------------------------------------------------------------cCCcccccc
Confidence 011122245
Q ss_pred ccCccccCcceecCCCC-CccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 452 VGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~-~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
||+|.|.|||++.|.+| +.++||||.|||||.||+|++||.+.+-+.++.++..+.+.+|. .++.++++||++||..
T Consensus 172 CGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs--~Is~eaQdLLr~ml~V 249 (786)
T KOG0588|consen 172 CGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPS--NISSEAQDLLRRMLDV 249 (786)
T ss_pred CCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCC--cCCHHHHHHHHHHhcc
Confidence 79999999999999998 88999999999999999999999998888999999999888885 4999999999999999
Q ss_pred CCCCcccccCCHHHHhcCCCCCCCC
Q 007433 531 EPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
||++|+| .+||++|||+.+..
T Consensus 250 Dp~~RiT----~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 250 DPSTRIT----TEEILKHPFLSGYT 270 (786)
T ss_pred Ccccccc----HHHHhhCchhhcCC
Confidence 9999999 99999999998764
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-52 Score=466.28 Aligned_cols=285 Identities=39% Similarity=0.709 Sum_probs=256.7
Q ss_pred cCceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC
Q 007433 206 KDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD 285 (604)
Q Consensus 206 ~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 285 (604)
....+..++|.+++.||+|+||.|.+++++.+++.||+|+++|...-++....-+..|..||..-+.+-|+.|+..|+++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 34456678999999999999999999999999999999999997666666666677899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
+++||||||++||||-.++.++. .+++..+++|+.+|+.||+-||+.|+|||||||+||||+..||+||+|||-+.++
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm 225 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKM 225 (1317)
T ss_pred cceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhc
Confidence 99999999999999999999983 8999999999999999999999999999999999999999999999999987665
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
...+++
T Consensus 226 ~~dG~V-------------------------------------------------------------------------- 231 (1317)
T KOG0612|consen 226 DADGTV-------------------------------------------------------------------------- 231 (1317)
T ss_pred CCCCcE--------------------------------------------------------------------------
Confidence 433222
Q ss_pred CcccccccCccccCcceecC-----CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC--CCCCCCCCCCCH
Q 007433 446 ARSMSFVGTHEYLAPEIIKG-----EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ--PLRFPESPVVSF 518 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~-----~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~--~~~~p~~~~~s~ 518 (604)
++..-||||.|++||+|.. ..|+..+|||||||++||||+|.+||......+++-+|+.. .+.||....+|.
T Consensus 232 -~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSe 310 (1317)
T KOG0612|consen 232 -RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSE 310 (1317)
T ss_pred -EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCH
Confidence 2334589999999999962 45899999999999999999999999999999999999876 678887778999
Q ss_pred HHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhhhhcCCCCCCCC
Q 007433 519 SARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPK 569 (604)
Q Consensus 519 ~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~~~~~~~~~p~ 569 (604)
++++||.++|+ +|+.|+. +.+++++.+||||.+++|..||...||.+|.
T Consensus 311 eakdLI~~ll~-~~e~RLg-rngiedik~HpFF~g~~W~~iR~~~pP~vPe 359 (1317)
T KOG0612|consen 311 EAKDLIEALLC-DREVRLG-RNGIEDIKNHPFFEGIDWDNIRESVPPVVPE 359 (1317)
T ss_pred HHHHHHHHHhc-Chhhhcc-cccHHHHHhCccccCCChhhhhhcCCCCCCc
Confidence 99999999886 7889997 8899999999999999999999999999875
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-50 Score=421.76 Aligned_cols=267 Identities=38% Similarity=0.750 Sum_probs=236.9
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
..++|++.+.||.|+||.||+|++..+++.||||++.+...........+.+|+.+|+.++||||++++++|.+++.+|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 35789999999999999999999999999999999987655444555677889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++.....
T Consensus 96 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~--- 170 (329)
T PTZ00263 96 LLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD--- 170 (329)
T ss_pred EEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC---
Confidence 99999999999988775 5789999999999999999999999999999999999999999999999998743210
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
....
T Consensus 171 ----------------------------------------------------------------------------~~~~ 174 (329)
T PTZ00263 171 ----------------------------------------------------------------------------RTFT 174 (329)
T ss_pred ----------------------------------------------------------------------------Ccce
Confidence 0113
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
.+||+.|+|||++.+..++.++|||||||+||||++|+.||.+......+..+....+.++.. ++..+++||.+||..
T Consensus 175 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~--~~~~~~~li~~~L~~ 252 (329)
T PTZ00263 175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNW--FDGRARDLVKGLLQT 252 (329)
T ss_pred ecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCC--CCHHHHHHHHHHhhc
Confidence 469999999999999999999999999999999999999999888888888888776666544 889999999999999
Q ss_pred CCCCcccc-cCCHHHHhcCCCCCCCChhhhh
Q 007433 531 EPQNRLAC-RRGATEIKQHPFFQGVNWALIR 560 (604)
Q Consensus 531 dP~~Rpt~-~~~a~elL~Hpff~~~~~~~~~ 560 (604)
||.+|++. +..+++|++||||.+++|..+.
T Consensus 253 dP~~R~~~~~~~~~~ll~hp~f~~~~~~~~~ 283 (329)
T PTZ00263 253 DHTKRLGTLKGGVADVKNHPYFHGANWDKLY 283 (329)
T ss_pred CHHHcCCCCCCCHHHHhcCCccCCCCHHHHH
Confidence 99999973 4468999999999999998764
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-50 Score=425.61 Aligned_cols=305 Identities=33% Similarity=0.597 Sum_probs=237.3
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++|+||+++++.|.++..+||||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998766555555667788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
|||+||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||++..+.......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~ 158 (363)
T cd05628 81 EFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158 (363)
T ss_pred cCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence 999999999998775 579999999999999999999999999999999999999999999999999985443211000
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
...... .. .+.. +....... .... +.............+
T Consensus 159 ~~~~~~-~~---------~~~~----------------~~~~~~~~-----~~~~----------~~~~~~~~~~~~~~~ 197 (363)
T cd05628 159 FYRNLN-HS---------LPSD----------------FTFQNMNS-----KRKA----------ETWKRNRRQLAFSTV 197 (363)
T ss_pred cccccc-cc---------cccc----------------cccccccc-----cccc----------chhhhcccccccccc
Confidence 000000 00 0000 00000000 0000 000000111223568
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc--CCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG--QPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~--~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
||+.|+|||++.+..++.++|||||||+||||++|+.||.+....+.+.++.. ..+.+|....++.++++||.+|++
T Consensus 198 Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~- 276 (363)
T cd05628 198 GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC- 276 (363)
T ss_pred CCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-
Confidence 99999999999999999999999999999999999999998888777777765 345566655689999999999886
Q ss_pred CCCCcccccCCHHHHhcCCCCCCCChhhhhcC
Q 007433 531 EPQNRLACRRGATEIKQHPFFQGVNWALIRCA 562 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~Hpff~~~~~~~~~~~ 562 (604)
+|.+|+. +..++||++||||++++|..++..
T Consensus 277 ~~~~r~~-r~~~~ei~~hp~f~~~~~~~~~~~ 307 (363)
T cd05628 277 EWEHRIG-APGVEEIKTNPFFEGVDWEHIRER 307 (363)
T ss_pred ChhhcCC-CCCHHHHhCCCCCCCCCHHHHHhC
Confidence 6666643 233999999999999999988654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-51 Score=433.01 Aligned_cols=255 Identities=32% Similarity=0.556 Sum_probs=232.6
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|-+.+.||+|.||.||+|+.+.+.++||||++.|..-. .+.+..+++|++|++.|+||||++++++|++..++|+|.
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~-~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN-EKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc-hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 5899999999999999999999999999999999887543 356677889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
|||.| +|+.++... +.|+|+.++.|+.|++.||.|||+++|+|||+||.|||+..+|++|+||||+|+-+... +.
T Consensus 81 e~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~-t~- 155 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN-TS- 155 (808)
T ss_pred hhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC-ce-
Confidence 99965 999999886 67999999999999999999999999999999999999999999999999999543311 11
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
..+++.
T Consensus 156 --------------------------------------------------------------------------vltsik 161 (808)
T KOG0597|consen 156 --------------------------------------------------------------------------VLTSIK 161 (808)
T ss_pred --------------------------------------------------------------------------eeeecc
Confidence 123567
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEP 532 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP 532 (604)
|||.|||||++.+..|+..+|+|||||+||||++|++||....-.+.+..|+..+..+|. ..+..+++||+++|.+||
T Consensus 162 GtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~--~~S~~f~nfl~gLL~kdP 239 (808)
T KOG0597|consen 162 GTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS--TASSSFVNFLQGLLIKDP 239 (808)
T ss_pred CcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc--cccHHHHHHHHHHhhcCh
Confidence 999999999999999999999999999999999999999999888999999998888776 599999999999999999
Q ss_pred CCcccccCCHHHHhcCCCCCC
Q 007433 533 QNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 533 ~~Rpt~~~~a~elL~Hpff~~ 553 (604)
.+|++ +.+++.|||.++
T Consensus 240 ~~Rlt----W~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 240 AQRLT----WTDLLGHPFWKG 256 (808)
T ss_pred hhccc----HHHHhcChHHhh
Confidence 99999 999999999875
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-49 Score=421.08 Aligned_cols=315 Identities=35% Similarity=0.636 Sum_probs=242.1
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++++.||.|+||+||+|++..+++.||||++.+...........+.+|+++|+.++|+||++++++|.+++++||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765544455566788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
|||+||+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|.++|+|||++..+.......
T Consensus 81 E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 158 (364)
T cd05599 81 EYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE 158 (364)
T ss_pred CCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence 999999999998765 469999999999999999999999999999999999999999999999999985442211100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.............+.+ ........ ...............+.+
T Consensus 159 ~~~~~~~~~~~~~~~~---------------------------~~~~~~~~-----------~~~~~~~~~~~~~~~~~~ 200 (364)
T cd05599 159 FYRILSHALPSNFLDF---------------------------ISKPMSSK-----------RKAETWKRNRRALAYSTV 200 (364)
T ss_pred cccccccccccccccc---------------------------cccccccc-----------ccccchhhcccccccccc
Confidence 0000000000000000 00000000 000000000111223468
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC--CCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ--PLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~--~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
||+.|+|||++.+..++.++|||||||+||||++|..||.+.+..+.+..+... .+.++....++.++++||.+||.
T Consensus 201 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~- 279 (364)
T cd05599 201 GTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC- 279 (364)
T ss_pred cCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-
Confidence 999999999999999999999999999999999999999988877777777653 34455555679999999999997
Q ss_pred CCCCcccccCCHHHHhcCCCCCCCChhhhhcCCCCCCCC
Q 007433 531 EPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPK 569 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~Hpff~~~~~~~~~~~~~~~~p~ 569 (604)
+|.+|++. ..+.++|+||||++++|..++...++.+|.
T Consensus 280 ~p~~R~~~-~~~~~ll~h~~~~~~~~~~~~~~~~~~~~~ 317 (364)
T cd05599 280 EAERRLGN-NGVNEIKSHPFFKGVDWEHIRERPAPIIPE 317 (364)
T ss_pred CHhhcCCC-CCHHHHhcCCCcCCCCHHHHhhcCCCCCCC
Confidence 99999973 459999999999999998876655555443
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=411.68 Aligned_cols=266 Identities=37% Similarity=0.708 Sum_probs=234.1
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++++.||.|+||.||+|.+..+++.||||++.............+.+|+++|+.++||||+++++++.+++.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999997665444444556778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 81 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~----- 153 (291)
T cd05612 81 EYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD----- 153 (291)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----
Confidence 999999999998765 5689999999999999999999999999999999999999999999999998732210
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.....+
T Consensus 154 --------------------------------------------------------------------------~~~~~~ 159 (291)
T cd05612 154 --------------------------------------------------------------------------RTWTLC 159 (291)
T ss_pred --------------------------------------------------------------------------Cccccc
Confidence 011346
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEP 532 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP 532 (604)
||+.|+|||++.+..++.++|||||||+||||++|+.||.+......+..+......++.. ++..+++||++||..||
T Consensus 160 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~--~~~~~~~li~~~l~~dp 237 (291)
T cd05612 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRH--LDLYAKDLIKKLLVVDR 237 (291)
T ss_pred CChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCcc--CCHHHHHHHHHHcCCCH
Confidence 9999999999999999999999999999999999999999988877788887777666544 78999999999999999
Q ss_pred CCccc-ccCCHHHHhcCCCCCCCChhhhhc
Q 007433 533 QNRLA-CRRGATEIKQHPFFQGVNWALIRC 561 (604)
Q Consensus 533 ~~Rpt-~~~~a~elL~Hpff~~~~~~~~~~ 561 (604)
.+|++ ++..+.++++||||+.++|.....
T Consensus 238 ~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~ 267 (291)
T cd05612 238 TRRLGNMKNGADDVKNHRWFKSVDWDDVPQ 267 (291)
T ss_pred HHccCCccCCHHHHhcCccccCCCHHHHhc
Confidence 99995 344599999999999999986543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-49 Score=420.32 Aligned_cols=277 Identities=36% Similarity=0.703 Sum_probs=238.2
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCc-eEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTK-CYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
..++|++++.||.|+||.||+|.+..++ ..||+|++.+...........+.+|+.+|+.++||||++++++|.+++.+|
T Consensus 28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 107 (340)
T PTZ00426 28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLY 107 (340)
T ss_pred ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEE
Confidence 4578999999999999999999876654 689999998765544455667788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
+||||++||+|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus 108 lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~-- 183 (340)
T PTZ00426 108 LVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-- 183 (340)
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC--
Confidence 999999999999998875 5699999999999999999999999999999999999999999999999998732210
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
...
T Consensus 184 -----------------------------------------------------------------------------~~~ 186 (340)
T PTZ00426 184 -----------------------------------------------------------------------------RTY 186 (340)
T ss_pred -----------------------------------------------------------------------------Ccc
Confidence 011
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
..+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+....+..+......+|. .++..+++||++||.
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~l~ 264 (340)
T PTZ00426 187 TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK--FLDNNCKHLMKKLLS 264 (340)
T ss_pred eecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHcc
Confidence 346999999999999999999999999999999999999999988877777788777666654 488999999999999
Q ss_pred cCCCCccc-ccCCHHHHhcCCCCCCCChhhhhc--CCCCCCCCC
Q 007433 530 KEPQNRLA-CRRGATEIKQHPFFQGVNWALIRC--ASPPEIPKP 570 (604)
Q Consensus 530 ~dP~~Rpt-~~~~a~elL~Hpff~~~~~~~~~~--~~~~~~p~~ 570 (604)
.||++|++ ++.+++++++||||++++|..+.. ..+|..|+.
T Consensus 265 ~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~ 308 (340)
T PTZ00426 265 HDLTKRYGNLKKGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKY 308 (340)
T ss_pred cCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCC
Confidence 99999974 234499999999999999987653 334455543
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=426.66 Aligned_cols=325 Identities=35% Similarity=0.611 Sum_probs=242.3
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++++.||.|+||+||+|++..+++.||||++.+........+..+.+|+++|+.++||||++++++|.+++++||||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999998765544555667888999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
|||+||+|.+++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.++.++|+|||++..+.......
T Consensus 81 E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~ 158 (377)
T cd05629 81 EFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158 (377)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence 999999999998765 579999999999999999999999999999999999999999999999999985432211000
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
....... ...+..+............+ +. . ...... ............+.+
T Consensus 159 ~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~----~~-~-----~~~~~~--------~~~~~~~~~~~~~~~ 209 (377)
T cd05629 159 YYQKLLQ-----------GKSNKNRIDNRNSVAVDSIN----LT-M-----SSKDQI--------ATWKKNRRLMAYSTV 209 (377)
T ss_pred ccccccc-----------cccccccccccccccccccc----cc-c-----cchhhh--------hhhhhcccccccccC
Confidence 0000000 00000000000000000000 00 0 000000 000000011122468
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc--CCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG--QPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~--~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
||+.|+|||++.+..++.++|||||||+||||++|..||.+....+.+..+.. ..+.++....++.++++||.+||.
T Consensus 210 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~- 288 (377)
T cd05629 210 GTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT- 288 (377)
T ss_pred CCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-
Confidence 99999999999999999999999999999999999999998777776666654 345556655689999999999997
Q ss_pred CCCCcccccCCHHHHhcCCCCCCCChhhhhcCCCCCCCCC
Q 007433 531 EPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPKP 570 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~Hpff~~~~~~~~~~~~~~~~p~~ 570 (604)
+|.+|+. +..+.|+++||||.+++|+.++....+.+|..
T Consensus 289 ~~~~r~~-r~~~~~~l~hp~~~~~~~~~~~~~~~~~~~~~ 327 (377)
T cd05629 289 NAENRLG-RGGAHEIKSHPFFRGVDWDTIRQIRAPFIPQL 327 (377)
T ss_pred CHhhcCC-CCCHHHHhcCCCcCCCCHHHHccCCCCcccCC
Confidence 7887762 22399999999999999998887777776653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-49 Score=416.86 Aligned_cols=262 Identities=39% Similarity=0.714 Sum_probs=227.7
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCCC
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGG 298 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 298 (604)
+.||+|+||.||+|++..+++.||||++.+...........+.+|+.+|+.++||||++++++|..++.+||||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999999999999999998765544555567778999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCccc
Q 007433 299 DLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLE 378 (604)
Q Consensus 299 sL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 378 (604)
+|..++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.....
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~----------- 147 (323)
T cd05571 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS----------- 147 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc-----------
Confidence 999988765 5789999999999999999999999999999999999999999999999998732100
Q ss_pred CCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCcccc
Q 007433 379 SEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYL 458 (604)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~ 458 (604)
.......++||+.|+
T Consensus 148 -----------------------------------------------------------------~~~~~~~~~gt~~y~ 162 (323)
T cd05571 148 -----------------------------------------------------------------DGATMKTFCGTPEYL 162 (323)
T ss_pred -----------------------------------------------------------------CCCcccceecCcccc
Confidence 000112357999999
Q ss_pred CcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccc
Q 007433 459 APEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLAC 538 (604)
Q Consensus 459 APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~ 538 (604)
|||++.+..++.++|||||||++|||++|+.||.+.+....+..+......++. .++.++++||.+||.+||++||+.
T Consensus 163 aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~ 240 (323)
T cd05571 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGG 240 (323)
T ss_pred ChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHccCCHHHcCCC
Confidence 999999999999999999999999999999999988777777777766666654 489999999999999999999932
Q ss_pred c-CCHHHHhcCCCCCCCChhhhh
Q 007433 539 R-RGATEIKQHPFFQGVNWALIR 560 (604)
Q Consensus 539 ~-~~a~elL~Hpff~~~~~~~~~ 560 (604)
. ..+.++++||||.+++|..+.
T Consensus 241 ~~~~~~~ll~h~~f~~~~~~~~~ 263 (323)
T cd05571 241 GPEDAKEIMEHRFFASINWQDVV 263 (323)
T ss_pred CCCCHHHHHcCCCcCCCCHHHHH
Confidence 1 139999999999999998764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=416.84 Aligned_cols=285 Identities=36% Similarity=0.659 Sum_probs=252.7
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.+.|+..+.||.||||.||-++.+.||+.||+|.+.|..+..+..-..+..|..||.+++.++||.|-..|++.+.+|||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 47899999999999999999999999999999999999888888888889999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|..|.||||.-.|.......|++..+++|+.+|+.||++||+.+||+|||||+|||||+.|+++|+|.|||..+..
T Consensus 264 LtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~---- 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE---- 339 (591)
T ss_pred EEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC----
Confidence 9999999999988888777899999999999999999999999999999999999999999999999999944321
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
.....+.
T Consensus 340 -------------------------------------------------------------------------g~~~~~r 346 (591)
T KOG0986|consen 340 -------------------------------------------------------------------------GKPIRGR 346 (591)
T ss_pred -------------------------------------------------------------------------CCccccc
Confidence 1112234
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChH----HHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR----ATLYNVVGQPLRFPESPVVSFSARDLIKGL 527 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~----~~l~~i~~~~~~~p~~~~~s~~l~dLI~~l 527 (604)
+||.+|||||++.++.|+...|||+|||+||||+.|+.||...... +.-..+...+..++ ..+|+++++|.+.+
T Consensus 347 vGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~--~kFS~eakslc~~L 424 (591)
T KOG0986|consen 347 VGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS--DKFSEEAKSLCEGL 424 (591)
T ss_pred cCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc--cccCHHHHHHHHHH
Confidence 8999999999999999999999999999999999999999875433 33344555566666 45999999999999
Q ss_pred hhcCCCCccccc-CCHHHHhcCCCCCCCChhhhh--cCCCCCCCCCCcccC
Q 007433 528 LVKEPQNRLACR-RGATEIKQHPFFQGVNWALIR--CASPPEIPKPVEIVH 575 (604)
Q Consensus 528 L~~dP~~Rpt~~-~~a~elL~Hpff~~~~~~~~~--~~~~~~~p~~~~~~~ 575 (604)
|++||++|+.++ .++.++.+||||+.+||..+. ...||.+|.|-.+..
T Consensus 425 L~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~aVya 475 (591)
T KOG0986|consen 425 LTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPGAVYA 475 (591)
T ss_pred HccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCCccccch
Confidence 999999999998 799999999999999998764 457888888776543
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=389.88 Aligned_cols=259 Identities=35% Similarity=0.598 Sum_probs=240.5
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
+.+++|.+.+.||.|-||.||+|+.+.++-.||+|++.|..+.....-..+.+|++|-..|+||||+++|++|.+...+|
T Consensus 19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riy 98 (281)
T KOG0580|consen 19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIY 98 (281)
T ss_pred cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeE
Confidence 45689999999999999999999999999999999999988776666667889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
|++||..+|.|...++..+...|++.....|++|++.||.|+|.++||||||||+|+|++.+|.+||+|||.+..
T Consensus 99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~----- 173 (281)
T KOG0580|consen 99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVH----- 173 (281)
T ss_pred EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceee-----
Confidence 999999999999999977778999999999999999999999999999999999999999999999999998721
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
.+ ..+.+
T Consensus 174 ------------------------------------------------------------------------~p-~~kR~ 180 (281)
T KOG0580|consen 174 ------------------------------------------------------------------------AP-SNKRK 180 (281)
T ss_pred ------------------------------------------------------------------------cC-CCCce
Confidence 11 23456
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
++|||..|.+||+..+..++..+|+|++|++.||+|.|.+||......+++.+|....+.+|. .++.+++|||.+||.
T Consensus 181 tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~--~is~~a~dlI~~ll~ 258 (281)
T KOG0580|consen 181 TLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPS--TISGGAADLISRLLV 258 (281)
T ss_pred eeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCc--ccChhHHHHHHHHhc
Confidence 789999999999999999999999999999999999999999999989999999998888884 599999999999999
Q ss_pred cCCCCcccccCCHHHHhcCCCCC
Q 007433 530 KEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
++|.+|.+ +.|++.|||..
T Consensus 259 ~~p~~r~~----l~~v~~hpwI~ 277 (281)
T KOG0580|consen 259 KNPIERLA----LTEVMDHPWIV 277 (281)
T ss_pred cCcccccc----HHHHhhhHHHH
Confidence 99999999 99999999985
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-49 Score=405.30 Aligned_cols=270 Identities=35% Similarity=0.589 Sum_probs=226.9
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
.|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+|+.++|+||++++++|.+++..|+|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999987655443444456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
|+++|+|..++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~----- 155 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEG----- 155 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC-----
Confidence 999999998876654457999999999999999999999999999999999999999999999999987432100
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
......+|
T Consensus 156 ------------------------------------------------------------------------~~~~~~~g 163 (285)
T cd05631 156 ------------------------------------------------------------------------ETVRGRVG 163 (285)
T ss_pred ------------------------------------------------------------------------CeecCCCC
Confidence 00113469
Q ss_pred CccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHH---HH-HHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 454 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRAT---LY-NVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 454 T~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~---l~-~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
|+.|+|||++.+..++.++|||||||+||||++|+.||.+...... +. .+..... .....++.++.+||++||.
T Consensus 164 ~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~~li~~~l~ 241 (285)
T cd05631 164 TVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE--EYSEKFSEDAKSICRMLLT 241 (285)
T ss_pred CCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccc--cCCccCCHHHHHHHHHHhh
Confidence 9999999999999999999999999999999999999987654322 22 2222222 2334589999999999999
Q ss_pred cCCCCccccc-CCHHHHhcCCCCCCCChhhhhcC
Q 007433 530 KEPQNRLACR-RGATEIKQHPFFQGVNWALIRCA 562 (604)
Q Consensus 530 ~dP~~Rpt~~-~~a~elL~Hpff~~~~~~~~~~~ 562 (604)
.||++|++++ ..++++++||||++++|..+...
T Consensus 242 ~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~~~~ 275 (285)
T cd05631 242 KNPKERLGCRGNGAAGVKQHPIFKNINFKRLEAN 275 (285)
T ss_pred cCHHHhcCCCCCCHHHHhcCHhhcCCCHHHHHhC
Confidence 9999999853 35899999999999999988655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-51 Score=404.06 Aligned_cols=279 Identities=38% Similarity=0.698 Sum_probs=248.6
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
.+++|..++.||+|.||.|.+++.+.++++||||+++|...-....+..-..|-.+|+..+||++..|...|++.+++|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 35789999999999999999999999999999999999877666677777889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
||||..||.|+..+.+. ..|+|...++|..+|+.||.|||+++||+||||.+|+||+.||++||+||||...--
T Consensus 246 VMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I---- 319 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI---- 319 (516)
T ss_pred EEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcc----
Confidence 99999999999888775 689999999999999999999999999999999999999999999999999862100
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
.......+
T Consensus 320 ------------------------------------------------------------------------~~g~t~kT 327 (516)
T KOG0690|consen 320 ------------------------------------------------------------------------KYGDTTKT 327 (516)
T ss_pred ------------------------------------------------------------------------cccceecc
Confidence 01223457
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
|||||+|+|||++....|+.++|||.+||++|||++|++||...+....+.-|+-+.++||.. ++++++.|+.++|.+
T Consensus 328 FCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~--ls~eAktLLsGLL~k 405 (516)
T KOG0690|consen 328 FCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRT--LSPEAKTLLSGLLKK 405 (516)
T ss_pred ccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCcc--CCHHHHHHHHHHhhc
Confidence 899999999999999999999999999999999999999999988888888888888999875 999999999999999
Q ss_pred CCCCcccc-cCCHHHHhcCCCCCCCChhhh-h-cCCCCCCCC
Q 007433 531 EPQNRLAC-RRGATEIKQHPFFQGVNWALI-R-CASPPEIPK 569 (604)
Q Consensus 531 dP~~Rpt~-~~~a~elL~Hpff~~~~~~~~-~-~~~~~~~p~ 569 (604)
||.+|+.. ...+.||.+|+||.+|+|.-. + ...||.-|+
T Consensus 406 dP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfKPq 447 (516)
T KOG0690|consen 406 DPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFKPQ 447 (516)
T ss_pred ChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCCCC
Confidence 99999985 457999999999999999743 3 334444443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-50 Score=419.17 Aligned_cols=260 Identities=32% Similarity=0.466 Sum_probs=220.4
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC--Cee
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD--KFS 288 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~ 288 (604)
..+.|+.+++||+|.||.||+|++..+++.||+|.++.+.... ....-+.+||.||++|+||||++|.+..... ..+
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~-~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKE-GFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCC-cchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 3468999999999999999999999999999999998775433 3344567899999999999999999998765 789
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|||+||| .-||.-++.. ++-.|++.+++.|++||+.||+|||.+||+|||||.+||||+.+|.+||+|||||+.+...
T Consensus 194 YlVFeYM-dhDL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 194 YLVFEYM-DHDLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEEecc-cchhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999999 6799888765 3578999999999999999999999999999999999999999999999999999543211
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
. ....
T Consensus 272 ~---------------------------------------------------------------------------~~~~ 276 (560)
T KOG0600|consen 272 G---------------------------------------------------------------------------SAPY 276 (560)
T ss_pred C---------------------------------------------------------------------------Cccc
Confidence 1 1113
Q ss_pred cccccCccccCcceecCCC-CCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHH---cCCC-------CCCC-----
Q 007433 449 MSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV---GQPL-------RFPE----- 512 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~---~~~~-------~~p~----- 512 (604)
++.|-|+||+|||+|.|.. |+.++|+||.||||.||+.|++.|.|.++.+++..|. +.+- .+|.
T Consensus 277 T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~k 356 (560)
T KOG0600|consen 277 TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFK 356 (560)
T ss_pred ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccC
Confidence 3568999999999999975 8999999999999999999999999998887776554 3221 1111
Q ss_pred ------------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCC
Q 007433 513 ------------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 513 ------------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
...++..+.+|+..||+.||.+|.| |.++|+|+||.
T Consensus 357 p~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~t----A~~aL~seyF~ 404 (560)
T KOG0600|consen 357 PQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGT----ASSALQSEYFT 404 (560)
T ss_pred CCCcccchHHHHhccCCHHHHHHHHHHhccCcccccc----HHHHhcCcccc
Confidence 0335677889999999999999999 99999999994
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=420.45 Aligned_cols=308 Identities=32% Similarity=0.584 Sum_probs=233.3
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
.|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+++|+.++|+||++++++|.+++++|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 69999999999999999999999999999999987765555566678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
||+||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.+|+++|+|||++..+........
T Consensus 82 ~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~ 159 (381)
T cd05626 82 YIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKY 159 (381)
T ss_pred cCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCccccccccccc
Confidence 99999999998775 5699999999999999999999999999999999999999999999999999754321110000
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCC--CCccCCcccccccccccCCccccCCCCCCCcc-cccCCCCCcccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIA--PTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPE-LIAEPTNARSMS 450 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 450 (604)
.. .. ......-..+.... ...|.. +.....+.. ...........+
T Consensus 160 ~~--------~~-------~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~ 207 (381)
T cd05626 160 YQ--------KG-------SHIRQDSMEPSDLWDDVSNCRC-----------------GDRLKTLEQRATKQHQRCLAHS 207 (381)
T ss_pred cc--------cc-------ccccccccCccccccccccccc-----------------ccccchhhcccccccccccccc
Confidence 00 00 00000000000000 000000 000000000 000001112346
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc--CCCCCCCCCCCCHHHHHHHHHhh
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG--QPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~--~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
++||+.|+|||++.+..++.++|||||||+||||++|+.||......+...++.. ..+.++....++.++++||.+||
T Consensus 208 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll 287 (381)
T cd05626 208 LVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLC 287 (381)
T ss_pred ccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHc
Confidence 7899999999999999999999999999999999999999998877766666654 34555665668999999999977
Q ss_pred hcCC--CCcccccCCHHHHhcCCCCCCCChhhh
Q 007433 529 VKEP--QNRLACRRGATEIKQHPFFQGVNWALI 559 (604)
Q Consensus 529 ~~dP--~~Rpt~~~~a~elL~Hpff~~~~~~~~ 559 (604)
+.++ ..|++ +.++++||||++++|...
T Consensus 288 ~~~~~~~~R~~----~~~~l~hp~f~~~~~~~~ 316 (381)
T cd05626 288 CSAEERLGRNG----ADDIKAHPFFSEVDFSSD 316 (381)
T ss_pred cCcccccCCCC----HHHHhcCcccCCCChhHH
Confidence 6544 44898 999999999999999753
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-49 Score=421.13 Aligned_cols=310 Identities=33% Similarity=0.609 Sum_probs=236.0
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
.+|.+++.||+|+||+||+|++..+++.||||++.+...........+.+|+++|+.++|+||+++++.|.+++.+||||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 36999999999999999999999999999999998765545556667889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc--
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT-- 370 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~-- 370 (604)
|||+||+|.+++.+. ..+++..++.++.||+.||+|||++|||||||||+||||+.+|++||+|||++..+.....
T Consensus 81 E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~ 158 (382)
T cd05625 81 DYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (382)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence 999999999998775 5689999999999999999999999999999999999999999999999999743321110
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcc-cccCCCCCccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPE-LIAEPTNARSM 449 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ 449 (604)
...... ..+.. ..-++. ....+..|...... ..... ...........
T Consensus 159 ~~~~~~----~~~~~------~~~~~~-----~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~ 206 (382)
T cd05625 159 YYQSGD----HVRQD------SMDFSN-----EWGDPANCRCGDRL-----------------KPLERRAARQHQRCLAH 206 (382)
T ss_pred cccccc----ccccc------cccccc-----cccccccccccccc-----------------cchhhhhcccccccccc
Confidence 000000 00000 000000 00000000000000 00000 00001111234
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc--CCCCCCCCCCCCHHHHHHHHHh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG--QPLRFPESPVVSFSARDLIKGL 527 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~--~~~~~p~~~~~s~~l~dLI~~l 527 (604)
+++||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+...++.. ..+.+|....++.++.+||.+|
T Consensus 207 ~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l 286 (382)
T cd05625 207 SLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKL 286 (382)
T ss_pred ccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHH
Confidence 57899999999999999999999999999999999999999998887777777664 3345565567899999999997
Q ss_pred hhcCCCCcccccCCHHHHhcCCCCCCCChhh
Q 007433 528 LVKEPQNRLACRRGATEIKQHPFFQGVNWAL 558 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~ 558 (604)
+ .||++|++ +..+.++++||||+.++|..
T Consensus 287 ~-~~p~~R~~-~~~~~ei~~hp~f~~~~~~~ 315 (382)
T cd05625 287 C-RGPEDRLG-KNGADEIKAHPFFKTIDFSS 315 (382)
T ss_pred c-cCHhHcCC-CCCHHHHhcCCCcCCcChHH
Confidence 6 59999997 45699999999999999975
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-50 Score=424.97 Aligned_cols=255 Identities=27% Similarity=0.497 Sum_probs=229.0
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
...|...++||+|+.|.||.|+...+++.||||.|+......++. +.+|+.+|+.++|+|||.+++.|..++.+++|
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keL---ilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKEL---LLNEILVMRDLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhh---hHHHHHHHHhccchHHHHHHHHhcccceeEEE
Confidence 367999999999999999999999999999999999876555443 45799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||++||+|.+++... .|+|.++..|++++|.||+|||.+||+|||||.+|||+..+|.+||+|||++..+..
T Consensus 349 MEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~---- 421 (550)
T KOG0578|consen 349 MEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE---- 421 (550)
T ss_pred EeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc----
Confidence 9999999999998875 599999999999999999999999999999999999999999999999998643221
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......+.
T Consensus 422 ------------------------------------------------------------------------~~~KR~Tm 429 (550)
T KOG0578|consen 422 ------------------------------------------------------------------------EQSKRSTM 429 (550)
T ss_pred ------------------------------------------------------------------------ccCccccc
Confidence 11134467
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHH-cCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV-GQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~-~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
+|||+|||||++....|++++||||||+|++||+-|++||-..+....++.|. .+.+.+.....+|..++|||.+||+.
T Consensus 430 VGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdFL~~cL~~ 509 (550)
T KOG0578|consen 430 VGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDFLDRCLVV 509 (550)
T ss_pred cCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHHHHHHhhc
Confidence 99999999999999999999999999999999999999999777777777665 45667777788999999999999999
Q ss_pred CCCCcccccCCHHHHhcCCCCC
Q 007433 531 EPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
|+++|++ |.|||+||||+
T Consensus 510 dv~~Ras----A~eLL~HpFl~ 527 (550)
T KOG0578|consen 510 DVEQRAS----AKELLEHPFLK 527 (550)
T ss_pred chhcCCC----HHHHhcChhhh
Confidence 9999999 99999999994
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=411.65 Aligned_cols=273 Identities=38% Similarity=0.624 Sum_probs=235.6
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+++|+.++||||+++++++..++..||||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765544445566778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----- 153 (333)
T cd05600 81 EYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----- 153 (333)
T ss_pred eCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----
Confidence 999999999999765 5689999999999999999999999999999999999999999999999998832210
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.....+
T Consensus 154 --------------------------------------------------------------------------~~~~~~ 159 (333)
T cd05600 154 --------------------------------------------------------------------------YANSVV 159 (333)
T ss_pred --------------------------------------------------------------------------ccCCcc
Confidence 112346
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC--CCCCCC----CCCCHHHHHHHHH
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP--LRFPES----PVVSFSARDLIKG 526 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~--~~~p~~----~~~s~~l~dLI~~ 526 (604)
||+.|+|||++.+..++.++|||||||+||||++|..||.+.+..+.+..+.... +..+.. ..++.++.+||.+
T Consensus 160 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~ 239 (333)
T cd05600 160 GSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITK 239 (333)
T ss_pred cCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHH
Confidence 9999999999999999999999999999999999999999887766665554322 222222 2468999999999
Q ss_pred hhhcCCCCcccccCCHHHHhcCCCCCCCChhhhhcCCCCCCCCC
Q 007433 527 LLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPKP 570 (604)
Q Consensus 527 lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~~~~~~~~~p~~ 570 (604)
||..+|.+|++ +.++++||||..++|..+....++.+|..
T Consensus 240 ~l~~~~~rr~s----~~~ll~h~~~~~~~~~~~~~~~~~~~~~~ 279 (333)
T cd05600 240 LINDPSRRFGS----LEDIKNHPFFKEVDWNELRELKPPFVPEL 279 (333)
T ss_pred HhhChhhhcCC----HHHHHhCcccCCCCHHHHhhCCCCCCCCC
Confidence 99999999999 99999999999999998876666666543
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=415.49 Aligned_cols=305 Identities=34% Similarity=0.614 Sum_probs=238.3
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+|..++|+||+++++.|.+++++||||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765545555667788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
|||+||+|.+++.+. ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|+++|+|||++..+.......
T Consensus 81 E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~ 158 (360)
T cd05627 81 EFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158 (360)
T ss_pred eCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence 999999999998765 569999999999999999999999999999999999999999999999999985443211100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
....... .+...++....... ...+...........+.+
T Consensus 159 ~~~~~~~--------------------------~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~ 197 (360)
T cd05627 159 FYRNLTH--------------------------NPPSDFSFQNMNSK---------------RKAETWKKNRRQLAYSTV 197 (360)
T ss_pred ccccccc--------------------------CCcccccccccccc---------------cccccccccccccccccC
Confidence 0000000 00000000000000 000000011112233568
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC--CCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ--PLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~--~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
||+.|+|||++.+..++.++|||||||+||||++|+.||.+......+.++... .+.++....++.++++||.+|+ .
T Consensus 198 gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~ 276 (360)
T cd05627 198 GTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-T 276 (360)
T ss_pred CCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-c
Confidence 999999999999999999999999999999999999999988877777777643 3445555558899999999987 4
Q ss_pred CCCCcccccCCHHHHhcCCCCCCCChhhhhcC
Q 007433 531 EPQNRLACRRGATEIKQHPFFQGVNWALIRCA 562 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~Hpff~~~~~~~~~~~ 562 (604)
||.+|++ +..+.|+++||||++++|..+...
T Consensus 277 ~p~~R~~-~~~~~ei~~hp~f~~~~~~~~~~~ 307 (360)
T cd05627 277 DSENRIG-SNGVEEIKSHPFFEGVDWGHIRER 307 (360)
T ss_pred ChhhcCC-CCCHHHHhcCCCCCCCCHHHHhcC
Confidence 9999996 234899999999999999987644
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=418.86 Aligned_cols=310 Identities=33% Similarity=0.573 Sum_probs=234.2
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+++|+.++|+||+++++.|.+++.+||||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765544455566788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
|||+||+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.++|+|||++..+.......
T Consensus 81 E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~ 158 (376)
T cd05598 81 DYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK 158 (376)
T ss_pred eCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence 999999999998775 578999999999999999999999999999999999999999999999999974332111000
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcc-cccCCCCCccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPE-LIAEPTNARSMSF 451 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 451 (604)
...... ..+.. ..... ... .....| ....+.. ............+
T Consensus 159 ~~~~~~--~~~~~------~~~~~-~~~----~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~ 204 (376)
T cd05598 159 YYQKGD--HHRQD------SMEPS-EEW----SEIDRC---------------------RLKPLERRRKRQHQRCLAHSL 204 (376)
T ss_pred cccccc--ccccc------ccccc-ccc----cccccc---------------------cccchhhhhhhhccccccccc
Confidence 000000 00000 00000 000 000000 0000000 0000111123457
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC--CCCCCCCCCCCHHHHHHHHHhhh
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ--PLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~--~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
+||+.|||||++.+..++.++|||||||+||||++|+.||.+....+....+... .+.++....++.++.+||.+|+
T Consensus 205 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~- 283 (376)
T cd05598 205 VGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC- 283 (376)
T ss_pred CCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-
Confidence 8999999999999999999999999999999999999999988777766666543 3344555568999999999976
Q ss_pred cCCCCcccccCCHHHHhcCCCCCCCChhhhh
Q 007433 530 KEPQNRLACRRGATEIKQHPFFQGVNWALIR 560 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~~ 560 (604)
.+|.+|+.. ..+.++++||||++++|....
T Consensus 284 ~~p~~R~~~-~t~~ell~h~~~~~~~~~~~~ 313 (376)
T cd05598 284 CGAEDRLGK-NGADEIKAHPFFKGIDFASLI 313 (376)
T ss_pred cCHhhcCCC-CCHHHHhCCCCcCCCCHHHHh
Confidence 599999921 129999999999999998773
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-49 Score=405.09 Aligned_cols=268 Identities=30% Similarity=0.434 Sum_probs=230.6
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
...++|++...||.|..++||+|++..++.+||||+++.+.... .+..+++|+..|..++||||++++..|..+..+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 34579999999999999999999999999999999998876543 3678889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
+||.||.+|++.++++......|+|..+..|++++|.||.|||.+|.||||||+.||||+.+|.|||+|||.+..+...+
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999999999998766789999999999999999999999999999999999999999999999999875433211
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
+.. -.+..
T Consensus 181 ~R~------------------------------------------------------------------------~~rf~ 188 (516)
T KOG0582|consen 181 DRQ------------------------------------------------------------------------VTRFN 188 (516)
T ss_pred cee------------------------------------------------------------------------eEeec
Confidence 000 00114
Q ss_pred ccccCccccCcceecC--CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC--------CCCCCCCHH
Q 007433 450 SFVGTHEYLAPEIIKG--EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRF--------PESPVVSFS 519 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~--~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~--------p~~~~~s~~ 519 (604)
+++||+.|||||++.. .+|+.|+|||||||+..||.+|..||........+...+...+.. ......+..
T Consensus 189 tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ks 268 (516)
T KOG0582|consen 189 TFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKS 268 (516)
T ss_pred cccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHH
Confidence 6799999999999654 478999999999999999999999999888777665555444322 222446677
Q ss_pred HHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCC
Q 007433 520 ARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 520 l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
++.+|..||++||.+||+ ++++|+|+||+...
T Consensus 269 f~e~i~~CL~kDP~kRpt----AskLlkh~FFk~~k 300 (516)
T KOG0582|consen 269 FREMIALCLVKDPSKRPT----ASKLLKHAFFKKAK 300 (516)
T ss_pred HHHHHHHHhhcCcccCCC----HHHHhccHHHhhcc
Confidence 899999999999999999 99999999998654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=408.22 Aligned_cols=260 Identities=30% Similarity=0.484 Sum_probs=218.1
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC--eeEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK--FSCL 290 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--~~~l 290 (604)
.+|...+.||+|+||+||++.+..++..+|||.+....... ...+.+|+.+|.+|+|||||+++|...... .+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 46888899999999999999999999999999997762221 556778999999999999999999855444 7999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc-CCcEEEecccccccccCCC
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE-DGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~-~g~vkL~DFGla~~~~~~~ 369 (604)
+|||+++|+|.+++.+..+ .|++..++.|.+||++||+|||++|||||||||+||||+. +|.+||+|||++.......
T Consensus 94 ~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 9999999999999999865 8999999999999999999999999999999999999999 7999999999985432100
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
.......
T Consensus 173 -------------------------------------------------------------------------~~~~~~~ 179 (313)
T KOG0198|consen 173 -------------------------------------------------------------------------TKSDSEL 179 (313)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0011223
Q ss_pred ccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCC-CChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007433 450 SFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKG-SENRATLYNVVGQPLRFPESPVVSFSARDLIKGL 527 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~-~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~l 527 (604)
.+.||+.|||||++.+ ...+.++|||||||++.||+||+.||.. ....+.+..+.........+..++.++++||.+|
T Consensus 180 ~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C 259 (313)
T KOG0198|consen 180 SVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEAKDFLRKC 259 (313)
T ss_pred cccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHHHHHHHHH
Confidence 5679999999999996 3334599999999999999999999998 4555556666544422233345999999999999
Q ss_pred hhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 528 LVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
|.+||++||| |.++|+|||.+.
T Consensus 260 ~~~~p~~Rpt----a~eLL~hpf~~~ 281 (313)
T KOG0198|consen 260 FKRDPEKRPT----AEELLEHPFLKQ 281 (313)
T ss_pred hhcCcccCcC----HHHHhhChhhhc
Confidence 9999999999 999999999965
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=398.17 Aligned_cols=263 Identities=27% Similarity=0.366 Sum_probs=221.9
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec--CC
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET--DK 286 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~ 286 (604)
.-..+.|+.+.+|++|+||.||+|+++.|++.||+|.++.+.- ....-....+||.+|.+++|||||.+.++... -+
T Consensus 72 Crsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmeke-k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 72 CRSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKE-KEGFPITSLREINILLKARHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred cccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccc-cCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccc
Confidence 3445789999999999999999999999999999999976542 22223345689999999999999999999874 35
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
.+||||||| .-||..++...+ ..|...+++.++.|+|.||+|||.+.|+||||||+|+|++..|.+||+|||||+.++
T Consensus 151 ~iy~VMe~~-EhDLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 151 KIYIVMEYV-EHDLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eeeeeHHHH-HhhHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhc
Confidence 799999999 679999999874 689999999999999999999999999999999999999999999999999996654
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
... .
T Consensus 229 sp~----------------------------------------------------------------------------k 232 (419)
T KOG0663|consen 229 SPL----------------------------------------------------------------------------K 232 (419)
T ss_pred CCc----------------------------------------------------------------------------c
Confidence 210 1
Q ss_pred cccccccCccccCcceecCCC-CCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc---CC---------------
Q 007433 447 RSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG---QP--------------- 507 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~---~~--------------- 507 (604)
..+..+-|+||+|||++.|.. |+.++||||+|||+.||+++++.|.|....+++.+|.. .+
T Consensus 233 ~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k 312 (419)
T KOG0663|consen 233 PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVK 312 (419)
T ss_pred cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhh
Confidence 123467899999999999875 89999999999999999999999999988877766542 21
Q ss_pred -CCCCCC-----------CCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 508 -LRFPES-----------PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 508 -~~~p~~-----------~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
..++.. ..+++...+|++++|.+||.+|+| |+|.|+|.||.+.
T Consensus 313 ~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~t----A~~~L~h~~F~e~ 367 (419)
T KOG0663|consen 313 KMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRIT----AEDGLKHEYFRET 367 (419)
T ss_pred ccccCCCCchhhhhhccccccchhHHHHHHHHhccCcccccc----HHHhhcccccccC
Confidence 111111 115688889999999999999999 9999999999864
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-48 Score=405.50 Aligned_cols=268 Identities=35% Similarity=0.687 Sum_probs=231.1
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCC-CccccceeEecCCeeEEEE
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP-FLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hp-nIv~l~~~~~~~~~~~lV~ 292 (604)
+|++++.||+|+||.||+|++..+++.||||++.+...........+..|++++..++|+ +|+.++++|.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 589999999999999999999999999999999876544444556677899999999765 6888999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||++||+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.++|+|||++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~---- 154 (324)
T cd05587 81 EYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG---- 154 (324)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCC----
Confidence 999999999988765 56899999999999999999999999999999999999999999999999987321100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.......+
T Consensus 155 ------------------------------------------------------------------------~~~~~~~~ 162 (324)
T cd05587 155 ------------------------------------------------------------------------GKTTRTFC 162 (324)
T ss_pred ------------------------------------------------------------------------CCceeeec
Confidence 00112346
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEP 532 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP 532 (604)
||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......++. .++.++.+||.+||.+||
T Consensus 163 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~P 240 (324)
T cd05587 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK--SLSKEAVSICKGLLTKHP 240 (324)
T ss_pred CCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhcCH
Confidence 999999999999999999999999999999999999999998888888888777666554 489999999999999999
Q ss_pred CCccccc-CCHHHHhcCCCCCCCChhhhhc
Q 007433 533 QNRLACR-RGATEIKQHPFFQGVNWALIRC 561 (604)
Q Consensus 533 ~~Rpt~~-~~a~elL~Hpff~~~~~~~~~~ 561 (604)
.+|++.. ....++++||||+.++|..+..
T Consensus 241 ~~R~~~~~~~~~~~~~hp~~~~~~~~~~~~ 270 (324)
T cd05587 241 AKRLGCGPTGERDIREHAFFRRIDWEKLER 270 (324)
T ss_pred HHcCCCCCCCHHHHhcCCCcCCCCHHHHHh
Confidence 9999842 3458999999999999987643
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-49 Score=383.90 Aligned_cols=258 Identities=31% Similarity=0.468 Sum_probs=220.0
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
.+|..+++||+|.||.||+|++..+++.||||.+......+ ..-..+.|||+.|+.++|+||+.|+++|-+...+-||+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 47889999999999999999999999999999997664322 22345779999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+ ..||..+++.. ...|+...++.|+.++++||+|||.+.|+||||||.|+||+.+|.+||+|||+|+.++....
T Consensus 81 Efm-~tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~-- 156 (318)
T KOG0659|consen 81 EFM-PTDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR-- 156 (318)
T ss_pred Eec-cccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc--
Confidence 999 67999988765 47899999999999999999999999999999999999999999999999999954432110
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.....|
T Consensus 157 --------------------------------------------------------------------------~~~~~V 162 (318)
T KOG0659|consen 157 --------------------------------------------------------------------------IQTHQV 162 (318)
T ss_pred --------------------------------------------------------------------------ccccce
Confidence 111227
Q ss_pred cCccccCcceecCCC-CCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc---CCC--C---------------CC
Q 007433 453 GTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG---QPL--R---------------FP 511 (604)
Q Consensus 453 GT~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~---~~~--~---------------~p 511 (604)
-|.||+|||++.|.. |+..+||||.||++.||+.|.+-|.|.++.+++..|.. .+. . +|
T Consensus 163 ~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P 242 (318)
T KOG0659|consen 163 VTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFP 242 (318)
T ss_pred eeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCC
Confidence 899999999999875 89999999999999999999999999999888765543 221 0 11
Q ss_pred C------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 512 E------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 512 ~------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
. .+..+.++.||+.+||.+||.+|++ +.|+|+|+||..
T Consensus 243 ~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rit----a~qaL~~~yf~~ 286 (318)
T KOG0659|consen 243 KPPLNNLFPAASSDALDLLSKMLTYNPKKRIT----ASQALKHPYFKS 286 (318)
T ss_pred CCccccccccccHHHHHHHHhhhccCchhccc----HHHHhcchhhhc
Confidence 1 1345677899999999999999999 999999999974
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=411.66 Aligned_cols=303 Identities=37% Similarity=0.688 Sum_probs=243.1
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|.+++.||+|+||+||+|++..+++.||||++.+...........+.+|+++|+.++|+||++++++|.+++++|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998765544455566788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+++++|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.++|+|||++..+.......
T Consensus 81 e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (350)
T cd05573 81 EYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158 (350)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence 999999999998876 579999999999999999999999999999999999999999999999999986543221100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
..... .....+ .....+. ..............+
T Consensus 159 ~~~~~----------------~~~~~~-----~~~~~~~--------------------------~~~~~~~~~~~~~~~ 191 (350)
T cd05573 159 YYLND----------------SHNLLF-----RDNVLVR--------------------------RRDHKQRRVRANSTV 191 (350)
T ss_pred ccccc----------------cccccc-----ccccccc--------------------------ccccccccccccccc
Confidence 00000 000000 0000000 000000011223457
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc--CCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG--QPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~--~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
||+.|+|||++.+..++.++|||||||+||||++|+.||.+......+.++.. ....++....++.++++||.+||.
T Consensus 192 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~- 270 (350)
T cd05573 192 GTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC- 270 (350)
T ss_pred cCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-
Confidence 99999999999999999999999999999999999999999887777777776 556667666689999999999997
Q ss_pred CCCCcccccCCHHHHhcCCCCCCCChhhhhcCCCCCCC
Q 007433 531 EPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIP 568 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~Hpff~~~~~~~~~~~~~~~~p 568 (604)
||.+|++. +.++|+||||++++|.......++.+|
T Consensus 271 dp~~R~~s---~~~ll~hp~~~~~~~~~~~~~~~~~~~ 305 (350)
T cd05573 271 DPEDRLGS---FEEIKSHPFFKGIDWENLRETKPPFVP 305 (350)
T ss_pred ChhhcCCC---HHHHhcCCCcCCCCHHHHhhCCCCcCC
Confidence 99999983 899999999999999987755555544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=405.45 Aligned_cols=256 Identities=30% Similarity=0.556 Sum_probs=236.9
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
.+|++.+.||.|.||.|-+|.....|+.||||.|+++...+..++..+.+||+||..|+||||+.+|++|++.+.+.|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 58999999999999999999999999999999999999998899999999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||..+|.|++++... +.|+|.++++|++||+.|+.|+|.+++||||||.+||||+.++++||+||||+-.+..
T Consensus 133 EYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~----- 205 (668)
T KOG0611|consen 133 EYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD----- 205 (668)
T ss_pred EecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc-----
Confidence 999999999999987 6799999999999999999999999999999999999999999999999999833221
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
..--++||
T Consensus 206 ------------------------------------------------------------------------~kfLqTFC 213 (668)
T KOG0611|consen 206 ------------------------------------------------------------------------KKFLQTFC 213 (668)
T ss_pred ------------------------------------------------------------------------ccHHHHhc
Confidence 11234789
Q ss_pred cCccccCcceecCCCC-CccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007433 453 GTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~-~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~d 531 (604)
|++-|.+||++.|.+| ++.+|.|||||+||.|+.|.+||+|.+....+..|..+.++-|. .+.++.-||+.||..|
T Consensus 214 GSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~---~PSdA~gLIRwmLmVN 290 (668)
T KOG0611|consen 214 GSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE---TPSDASGLIRWMLMVN 290 (668)
T ss_pred CCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC---CCchHHHHHHHHHhcC
Confidence 9999999999999998 88999999999999999999999999998899999888888766 4667889999999999
Q ss_pred CCCcccccCCHHHHhcCCCCCCCChh
Q 007433 532 PQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 532 P~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
|++|.| +++|-.|.|+ ||.
T Consensus 291 P~RRAT----ieDiAsHWWv---Nwg 309 (668)
T KOG0611|consen 291 PERRAT----IEDIASHWWV---NWG 309 (668)
T ss_pred cccchh----HHHHhhhhee---ecc
Confidence 999999 9999999886 565
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=408.35 Aligned_cols=262 Identities=39% Similarity=0.728 Sum_probs=225.8
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCCC
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGG 298 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 298 (604)
+.||+|+||.||++++..+++.||||++.+...........+.+|+.+|+.++||||++++++|..++.+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36899999999999999999999999998765544455667788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCccc
Q 007433 299 DLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLE 378 (604)
Q Consensus 299 sL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 378 (604)
+|..++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~---------- 148 (328)
T cd05593 81 ELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITD---------- 148 (328)
T ss_pred CHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCc----------
Confidence 999888765 57999999999999999999999999999999999999999999999999987321000
Q ss_pred CCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCcccc
Q 007433 379 SEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYL 458 (604)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~ 458 (604)
......++||+.|+
T Consensus 149 ------------------------------------------------------------------~~~~~~~~gt~~y~ 162 (328)
T cd05593 149 ------------------------------------------------------------------AATMKTFCGTPEYL 162 (328)
T ss_pred ------------------------------------------------------------------ccccccccCCcCcc
Confidence 00112346999999
Q ss_pred CcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccc
Q 007433 459 APEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLAC 538 (604)
Q Consensus 459 APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~ 538 (604)
|||++.+..++.++|||||||+||||++|+.||.+.+....+..+......++. .++.++.+||.+||.+||++|++.
T Consensus 163 aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~ 240 (328)
T cd05593 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPR--TLSADAKSLLSGLLIKDPNKRLGG 240 (328)
T ss_pred ChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCC--CCCHHHHHHHHHHcCCCHHHcCCC
Confidence 999999999999999999999999999999999987777776666666655554 489999999999999999999832
Q ss_pred -cCCHHHHhcCCCCCCCChhhhh
Q 007433 539 -RRGATEIKQHPFFQGVNWALIR 560 (604)
Q Consensus 539 -~~~a~elL~Hpff~~~~~~~~~ 560 (604)
...+.++++||||.+++|..+.
T Consensus 241 ~~~~~~~il~h~~~~~~~~~~~~ 263 (328)
T cd05593 241 GPDDAKEIMRHSFFTGVNWQDVY 263 (328)
T ss_pred CCCCHHHHhcCCCcCCCCHHHHH
Confidence 1239999999999999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=400.55 Aligned_cols=311 Identities=59% Similarity=1.023 Sum_probs=257.3
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
.+|++.+.||.|+||+||+|.+..+++.||||.+.+...........+..|+++|+.++|+||+++++++.++...|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 37999999999999999999999999999999998775554455667788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+.|++|.+++...++..+++..+..++.||+.||+|||+.||+||||||+||||+.++.++|+|||++..........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999999987766789999999999999999999999999999999999999999999999999885432211100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
...... .........+.......+.......++
T Consensus 161 ~~~~~~-----------------------------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (316)
T cd05574 161 SKALRK-----------------------------------------------GSRRSSVNSIPSETFSEEPSFRSNSFV 193 (316)
T ss_pred cccccc-----------------------------------------------ccccccccccchhhhcccccCCCCCCc
Confidence 000000 000000000111122223333445678
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEP 532 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP 532 (604)
||..|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.++......++....++..+++||.+||..||
T Consensus 194 g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 273 (316)
T cd05574 194 GTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDP 273 (316)
T ss_pred CccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCH
Confidence 99999999999999999999999999999999999999999888888888887777777666689999999999999999
Q ss_pred CCcccccCCHHHHhcCCCCCCCChhhhhcCCCCCCCCC
Q 007433 533 QNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPKP 570 (604)
Q Consensus 533 ~~Rpt~~~~a~elL~Hpff~~~~~~~~~~~~~~~~p~~ 570 (604)
++||+.+..++|+|+||||++++|..++-..+|.+|.+
T Consensus 274 ~~R~s~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~ 311 (316)
T cd05574 274 SKRLGSKRGAAEIKQHPFFRGVNWALIRHTTPPIIPRP 311 (316)
T ss_pred hHCCCchhhHHHHHcCchhhcCChhhcccCCCCCCCCc
Confidence 99999888899999999999999999998777777554
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-48 Score=406.31 Aligned_cols=263 Identities=38% Similarity=0.708 Sum_probs=226.9
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCCC
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGG 298 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 298 (604)
+.||+|+||.||++++..++..||+|++.+...........+.+|+++|+.++||||++++++|..++.+||||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 46999999999999999999999999998765444455566778999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCccc
Q 007433 299 DLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLE 378 (604)
Q Consensus 299 sL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 378 (604)
+|..++.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus 81 ~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~---------- 148 (323)
T cd05595 81 ELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD---------- 148 (323)
T ss_pred cHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCC----------
Confidence 999888765 57999999999999999999999999999999999999999999999999987321000
Q ss_pred CCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCcccc
Q 007433 379 SEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYL 458 (604)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~ 458 (604)
......+.||+.|+
T Consensus 149 ------------------------------------------------------------------~~~~~~~~gt~~y~ 162 (323)
T cd05595 149 ------------------------------------------------------------------GATMKTFCGTPEYL 162 (323)
T ss_pred ------------------------------------------------------------------CCccccccCCcCcC
Confidence 00011346999999
Q ss_pred CcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccc
Q 007433 459 APEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLAC 538 (604)
Q Consensus 459 APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~ 538 (604)
|||++.+..++.++|||||||+||||++|+.||...+....+..+......++. .++.++++||.+||.+||++|++.
T Consensus 163 aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~~ 240 (323)
T cd05595 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGLLKKDPKQRLGG 240 (323)
T ss_pred CcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHccCCHHHhCCC
Confidence 999999999999999999999999999999999988777777777766666654 489999999999999999999932
Q ss_pred c-CCHHHHhcCCCCCCCChhhhhc
Q 007433 539 R-RGATEIKQHPFFQGVNWALIRC 561 (604)
Q Consensus 539 ~-~~a~elL~Hpff~~~~~~~~~~ 561 (604)
. ..+.++++||||.+++|..+..
T Consensus 241 ~~~~~~~~l~h~~~~~~~~~~~~~ 264 (323)
T cd05595 241 GPSDAKEVMEHRFFLSINWQDVVQ 264 (323)
T ss_pred CCCCHHHHHcCCCcCCCCHHHHHh
Confidence 1 2399999999999999987643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=403.38 Aligned_cols=265 Identities=37% Similarity=0.711 Sum_probs=226.8
Q ss_pred eEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHH---HhCCCCCccccceeEecCCeeEEE
Q 007433 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREIL---QSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 215 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL---~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
|++++.||+|+||.||+|.+..+++.||||++.+...........+.+|+.++ +.++||||++++++|.+++..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999876544444445566666554 567899999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||++|++|..++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||++.....
T Consensus 81 ~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~---- 153 (324)
T cd05589 81 MEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG---- 153 (324)
T ss_pred EcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC----
Confidence 999999999887754 4699999999999999999999999999999999999999999999999998732110
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
.......+
T Consensus 154 ------------------------------------------------------------------------~~~~~~~~ 161 (324)
T cd05589 154 ------------------------------------------------------------------------FGDRTSTF 161 (324)
T ss_pred ------------------------------------------------------------------------CCCccccc
Confidence 00011245
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~d 531 (604)
+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+......++. .++..+.+||.+||..|
T Consensus 162 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~L~~d 239 (324)
T cd05589 162 CGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPR--FLSREAISIMRRLLRRN 239 (324)
T ss_pred ccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHhhcC
Confidence 7999999999999999999999999999999999999999998888887777776666554 48999999999999999
Q ss_pred CCCccccc-CCHHHHhcCCCCCCCChhhhh
Q 007433 532 PQNRLACR-RGATEIKQHPFFQGVNWALIR 560 (604)
Q Consensus 532 P~~Rpt~~-~~a~elL~Hpff~~~~~~~~~ 560 (604)
|.+||+.. ..+.++++||||+.++|....
T Consensus 240 P~~R~~~~~~~~~~l~~~~~f~~~~~~~~~ 269 (324)
T cd05589 240 PERRLGSGEKDAEDVKKQPFFRDINWDDLL 269 (324)
T ss_pred HhHcCCCCCCCHHHHhhCCCcCCCCHHHHH
Confidence 99999643 259999999999999998653
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-48 Score=403.40 Aligned_cols=259 Identities=39% Similarity=0.717 Sum_probs=226.3
Q ss_pred EccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCCCCH
Q 007433 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDL 300 (604)
Q Consensus 221 LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 300 (604)
||+|+||.||+|++..+++.||+|++.+...........+.+|+.+|+.++||||++++++|.+++..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 79999999999999999999999999876554455566778899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcccCC
Q 007433 301 HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESE 380 (604)
Q Consensus 301 ~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~ 380 (604)
.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++......
T Consensus 81 ~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~------------ 146 (312)
T cd05585 81 FHHLQRE--GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKD------------ 146 (312)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccC------------
Confidence 9988765 56999999999999999999999999999999999999999999999999987321100
Q ss_pred cccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccccCc
Q 007433 381 PLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAP 460 (604)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP 460 (604)
.......+||+.|+||
T Consensus 147 ----------------------------------------------------------------~~~~~~~~gt~~y~aP 162 (312)
T cd05585 147 ----------------------------------------------------------------DDKTNTFCGTPEYLAP 162 (312)
T ss_pred ----------------------------------------------------------------CCccccccCCcccCCH
Confidence 0011234699999999
Q ss_pred ceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccC
Q 007433 461 EIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRR 540 (604)
Q Consensus 461 E~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~ 540 (604)
|++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......++. .++.++++||.+||..||.+|++..
T Consensus 163 E~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~R~~~~- 239 (312)
T cd05585 163 ELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPD--GFDRDAKDLLIGLLSRDPTRRLGYN- 239 (312)
T ss_pred HHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCC--cCCHHHHHHHHHHcCCCHHHcCCCC-
Confidence 9999999999999999999999999999999988887777888877766664 4899999999999999999998632
Q ss_pred CHHHHhcCCCCCCCChhhhh
Q 007433 541 GATEIKQHPFFQGVNWALIR 560 (604)
Q Consensus 541 ~a~elL~Hpff~~~~~~~~~ 560 (604)
.+.|+|+||||..++|....
T Consensus 240 ~~~e~l~hp~~~~~~~~~~~ 259 (312)
T cd05585 240 GAQEIKNHPFFSQLSWKKLL 259 (312)
T ss_pred CHHHHHcCCCcCCCCHHHHH
Confidence 28999999999999987553
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-48 Score=407.70 Aligned_cols=275 Identities=37% Similarity=0.662 Sum_probs=236.2
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|.+.+.||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++|+||+++++++.+++..||||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765544445566778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+++++|.+++.+.. ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++..+.....
T Consensus 81 e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~-- 157 (330)
T cd05601 81 EYQPGGDLLSLLNRYE-DQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-- 157 (330)
T ss_pred CCCCCCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc--
Confidence 9999999999988753 4799999999999999999999999999999999999999999999999998843221000
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
......+
T Consensus 158 -------------------------------------------------------------------------~~~~~~~ 164 (330)
T cd05601 158 -------------------------------------------------------------------------VNSKLPV 164 (330)
T ss_pred -------------------------------------------------------------------------eeeeccc
Confidence 0011236
Q ss_pred cCccccCcceec------CCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC--CCCCCCCCCCCHHHHHHH
Q 007433 453 GTHEYLAPEIIK------GEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ--PLRFPESPVVSFSARDLI 524 (604)
Q Consensus 453 GT~~Y~APE~l~------~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~--~~~~p~~~~~s~~l~dLI 524 (604)
||+.|+|||++. +..++.++|||||||+||||++|+.||........+.++... ...++....++.++++||
T Consensus 165 gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 244 (330)
T cd05601 165 GTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSDFLDLI 244 (330)
T ss_pred CCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHH
Confidence 999999999987 456788999999999999999999999988777777776643 345666667899999999
Q ss_pred HHhhhcCCCCcccccCCHHHHhcCCCCCCCChhhhhcCCCCCCC
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIP 568 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~~~~~~~~~p 568 (604)
.+||. ||.+||+ ++++++||||..++|..+....++..|
T Consensus 245 ~~ll~-~p~~R~t----~~~l~~h~~~~~~~~~~~~~~~~~~~~ 283 (330)
T cd05601 245 QSLLC-GQKERLG----YEGLCCHPFFSKIDWNNIRNSLPPFVP 283 (330)
T ss_pred HHHcc-ChhhCCC----HHHHhCCCCcCCCCHHHHhhCCCCccC
Confidence 99998 9999999 999999999999999988776555544
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=389.01 Aligned_cols=258 Identities=30% Similarity=0.535 Sum_probs=230.5
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.+.|.+.+.||+|.|+.||++.+..+|+.||+|+++-..+..+ ..+.+.+|+.|-+.|+||||++|.+.+..+.+.|||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 3689999999999999999999999999999999987766554 567788999999999999999999999999999999
Q ss_pred EeecCCCCHHH-HHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccC---CcEEEecccccccccC
Q 007433 292 MEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRED---GHIMLSDFDLSLRCAV 367 (604)
Q Consensus 292 ~E~~~ggsL~~-ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~---g~vkL~DFGla~~~~~ 367 (604)
+|++.|++|.. +.++ ..++|..+-++++|||++|.|+|.+||||||+||+|+||-.. .-+||+|||+|..+..
T Consensus 89 Fe~m~G~dl~~eIV~R---~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~ 165 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVAR---EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVND 165 (355)
T ss_pred EecccchHHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCC
Confidence 99999999975 4444 478999999999999999999999999999999999999643 3699999999954430
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
...
T Consensus 166 -----------------------------------------------------------------------------g~~ 168 (355)
T KOG0033|consen 166 -----------------------------------------------------------------------------GEA 168 (355)
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 011
Q ss_pred ccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC--CCCCCCHHHHHHHH
Q 007433 448 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFP--ESPVVSFSARDLIK 525 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p--~~~~~s~~l~dLI~ 525 (604)
-..++|||.|||||+++..+|+..+|||+-||+||-||.|.+||.+.+....+..|..+.+.++ +++.+++++++||+
T Consensus 169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~Lvr 248 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSLIR 248 (355)
T ss_pred cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHHHH
Confidence 1256899999999999999999999999999999999999999999999899999998887765 57889999999999
Q ss_pred HhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 526 GLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
+||..||.+|+| +.|+|+|||+.+-
T Consensus 249 rML~~dP~kRIt----a~EAL~HpWi~~r 273 (355)
T KOG0033|consen 249 RMLTVNPKKRIT----ADEALKHPWICNR 273 (355)
T ss_pred HHhccChhhhcc----HHHHhCCchhcch
Confidence 999999999999 9999999999754
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=402.68 Aligned_cols=269 Identities=35% Similarity=0.676 Sum_probs=232.5
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCeeEEEE
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
+|++++.||+|+||.||+|++..+++.||||++.+..............|+.++..+ +|++|+.++++|.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 589999999999999999999999999999999876544444455566788888877 5899999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+++|+|..++... ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~---- 154 (323)
T cd05616 81 EYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD---- 154 (323)
T ss_pred cCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCC----
Confidence 999999999988765 56999999999999999999999999999999999999999999999999987321100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.......+
T Consensus 155 ------------------------------------------------------------------------~~~~~~~~ 162 (323)
T cd05616 155 ------------------------------------------------------------------------GVTTKTFC 162 (323)
T ss_pred ------------------------------------------------------------------------CCccccCC
Confidence 00112346
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEP 532 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP 532 (604)
||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+....+..+......+|. .++.++.+||.+||.+||
T Consensus 163 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~l~~~p 240 (323)
T cd05616 163 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK--SMSKEAVAICKGLMTKHP 240 (323)
T ss_pred CChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--cCCHHHHHHHHHHcccCH
Confidence 999999999999999999999999999999999999999998888888888877766664 489999999999999999
Q ss_pred CCccccc-CCHHHHhcCCCCCCCChhhhhcC
Q 007433 533 QNRLACR-RGATEIKQHPFFQGVNWALIRCA 562 (604)
Q Consensus 533 ~~Rpt~~-~~a~elL~Hpff~~~~~~~~~~~ 562 (604)
.+|+++. ....++++||||+.++|..+...
T Consensus 241 ~~R~~~~~~~~~~i~~h~~~~~~~~~~~~~~ 271 (323)
T cd05616 241 GKRLGCGPEGERDIKEHAFFRYIDWEKLERK 271 (323)
T ss_pred HhcCCCCCCCHHHHhcCCCcCCCCHHHHHhC
Confidence 9999853 34689999999999999877543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-50 Score=393.82 Aligned_cols=248 Identities=27% Similarity=0.437 Sum_probs=215.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccce-eEecCCe-eE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYT-HFETDKF-SC 289 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~-~~~~~~~-~~ 289 (604)
+.+|+++++||.|.||+||++.+..++..||+|.+.-..+. .+..+....|+.+|+.|+|||||++|+ .|..++. ++
T Consensus 18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md-~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMD-AKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhcc-HHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 46899999999999999999999999999999999855443 345556778999999999999999999 4555555 89
Q ss_pred EEEeecCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHH--cC--eEeccCCCCcEEEccCCcEEEecccccc
Q 007433 290 LVMEFCPGGDLHTLRQRQ--PGKYFSEQAVKFYVAEVLLALEYLHM--LG--IVYRDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~--~~~~l~e~~~~~i~~qil~aL~yLH~--~g--IvHrDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
||||||.+|||..++++. ..+.++|..++.|+.|++.||..||. .. |+||||||.||+|+.+|.+||+||||++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 999999999999998854 35689999999999999999999998 44 9999999999999999999999999985
Q ss_pred cccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCC
Q 007433 364 RCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEP 443 (604)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (604)
.+...
T Consensus 177 ~l~s~--------------------------------------------------------------------------- 181 (375)
T KOG0591|consen 177 FLSSK--------------------------------------------------------------------------- 181 (375)
T ss_pred Hhcch---------------------------------------------------------------------------
Confidence 43211
Q ss_pred CCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC-CCCCCCCCHHHHH
Q 007433 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR-FPESPVVSFSARD 522 (604)
Q Consensus 444 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~-~p~~~~~s~~l~d 522 (604)
..-..++||||.||+||.+.+.+|+.++|||||||+||||+.-..||.|.+-.+...+|..+.+. +| ....|.+++.
T Consensus 182 -~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p-~~~YS~~l~~ 259 (375)
T KOG0591|consen 182 -TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP-DEHYSTDLRE 259 (375)
T ss_pred -hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc-HHHhhhHHHH
Confidence 11123689999999999999999999999999999999999999999999877888888877543 33 1358899999
Q ss_pred HHHHhhhcCCCCccc
Q 007433 523 LIKGLLVKEPQNRLA 537 (604)
Q Consensus 523 LI~~lL~~dP~~Rpt 537 (604)
||.-|++.||+.||+
T Consensus 260 li~~ci~vd~~~RP~ 274 (375)
T KOG0591|consen 260 LINMCIAVDPEQRPD 274 (375)
T ss_pred HHHHHccCCcccCCC
Confidence 999999999999998
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-48 Score=403.48 Aligned_cols=262 Identities=36% Similarity=0.678 Sum_probs=225.1
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCeeEEEEeecCC
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSCLVMEFCPG 297 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 297 (604)
+.||+|+||+||+|++..+++.||||++.+..............|+.++..+ +||||++++++|.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 3699999999999999999999999999876544444455667788888876 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcc
Q 007433 298 GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTL 377 (604)
Q Consensus 298 gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 377 (604)
|+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~--------- 149 (320)
T cd05590 81 GDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN--------- 149 (320)
T ss_pred chHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC---------
Confidence 9999988765 56999999999999999999999999999999999999999999999999987321100
Q ss_pred cCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccc
Q 007433 378 ESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEY 457 (604)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 457 (604)
.......+||+.|
T Consensus 150 -------------------------------------------------------------------~~~~~~~~gt~~y 162 (320)
T cd05590 150 -------------------------------------------------------------------GKTTSTFCGTPDY 162 (320)
T ss_pred -------------------------------------------------------------------CCcccccccCccc
Confidence 0011234699999
Q ss_pred cCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCccc
Q 007433 458 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLA 537 (604)
Q Consensus 458 ~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt 537 (604)
+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......++. .++.++++||++||.+||++|++
T Consensus 163 ~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~L~~dP~~R~~ 240 (320)
T cd05590 163 IAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--WLSQDAVDILKAFMTKNPTMRLG 240 (320)
T ss_pred cCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHcccCHHHCCC
Confidence 9999999999999999999999999999999999998888888788776665554 48999999999999999999999
Q ss_pred cc--CCHHHHhcCCCCCCCChhhhh
Q 007433 538 CR--RGATEIKQHPFFQGVNWALIR 560 (604)
Q Consensus 538 ~~--~~a~elL~Hpff~~~~~~~~~ 560 (604)
+. ...+++++||||+.++|..+.
T Consensus 241 ~~~~~~~~~~~~h~~f~~~~~~~~~ 265 (320)
T cd05590 241 SLTLGGEEAILRHPFFKELDWEKLN 265 (320)
T ss_pred CCCCCCHHHHHcCCCcCCCCHHHHH
Confidence 42 123899999999999998754
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-48 Score=403.39 Aligned_cols=263 Identities=37% Similarity=0.712 Sum_probs=227.4
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCeeEEEEeecCC
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSCLVMEFCPG 297 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 297 (604)
+.||+|+||.||+|++..+++.||||++.+..............|++++..+ +||||++++++|.+++.+||||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 3699999999999999999999999999876554445555667788998866 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcc
Q 007433 298 GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTL 377 (604)
Q Consensus 298 gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 377 (604)
++|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.++|+|||++......
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~--------- 149 (321)
T cd05591 81 GDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN--------- 149 (321)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccC---------
Confidence 9999888765 56999999999999999999999999999999999999999999999999987321100
Q ss_pred cCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccc
Q 007433 378 ESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEY 457 (604)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 457 (604)
.......+||+.|
T Consensus 150 -------------------------------------------------------------------~~~~~~~~gt~~y 162 (321)
T cd05591 150 -------------------------------------------------------------------GVTTTTFCGTPDY 162 (321)
T ss_pred -------------------------------------------------------------------CccccccccCccc
Confidence 0011234699999
Q ss_pred cCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCccc
Q 007433 458 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLA 537 (604)
Q Consensus 458 ~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt 537 (604)
+|||++.+..++.++|||||||++|||++|+.||.+.+....+..+......++. .++.++.+||.+||.+||++|++
T Consensus 163 ~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~ll~~~L~~dp~~R~~ 240 (321)
T cd05591 163 IAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPV--WLSKEAVSILKAFMTKNPNKRLG 240 (321)
T ss_pred cCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhccCHHHcCC
Confidence 9999999999999999999999999999999999998888888888877666554 48999999999999999999995
Q ss_pred ccC---CHHHHhcCCCCCCCChhhhhc
Q 007433 538 CRR---GATEIKQHPFFQGVNWALIRC 561 (604)
Q Consensus 538 ~~~---~a~elL~Hpff~~~~~~~~~~ 561 (604)
+.. .+.++++||||..++|..+..
T Consensus 241 ~~~~~~~~~~~~~hp~~~~~~~~~~~~ 267 (321)
T cd05591 241 CVASQGGEDAIKQHPFFKEIDWVLLEQ 267 (321)
T ss_pred CCCCCCCHHHHhcCCccCCCCHHHHHh
Confidence 432 499999999999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=401.89 Aligned_cols=262 Identities=38% Similarity=0.712 Sum_probs=225.3
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHH-HHHhCCCCCccccceeEecCCeeEEEEeecCC
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTERE-ILQSLDHPFLPTLYTHFETDKFSCLVMEFCPG 297 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 297 (604)
+.||+|+||+||+|++..+++.||||++.+...........+..|.. +++.++||||+++++.|.+++.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 46999999999999999999999999998765444344444555555 56789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcc
Q 007433 298 GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTL 377 (604)
Q Consensus 298 gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 377 (604)
|+|..++.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++.....
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~---------- 148 (323)
T cd05575 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE---------- 148 (323)
T ss_pred CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc----------
Confidence 9999988765 5799999999999999999999999999999999999999999999999998732100
Q ss_pred cCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccc
Q 007433 378 ESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEY 457 (604)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 457 (604)
........+||+.|
T Consensus 149 ------------------------------------------------------------------~~~~~~~~~gt~~y 162 (323)
T cd05575 149 ------------------------------------------------------------------HSKTTSTFCGTPEY 162 (323)
T ss_pred ------------------------------------------------------------------CCCccccccCChhh
Confidence 00011234699999
Q ss_pred cCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCccc
Q 007433 458 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLA 537 (604)
Q Consensus 458 ~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt 537 (604)
+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+......++. .++..+.+||.+||..||.+|++
T Consensus 163 ~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~ 240 (323)
T cd05575 163 LAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKP--NISVSARHLLEGLLQKDRTKRLG 240 (323)
T ss_pred cChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhcCHHhCCC
Confidence 9999999999999999999999999999999999988877777778777665543 47999999999999999999999
Q ss_pred ccCCHHHHhcCCCCCCCChhhhh
Q 007433 538 CRRGATEIKQHPFFQGVNWALIR 560 (604)
Q Consensus 538 ~~~~a~elL~Hpff~~~~~~~~~ 560 (604)
.+..+.++++||||..++|..+.
T Consensus 241 ~~~~~~~il~~~~~~~~~~~~~~ 263 (323)
T cd05575 241 AKDDFLEIKNHVFFSSINWDDLV 263 (323)
T ss_pred CCCCHHHHHcCCCcCCCCHHHHh
Confidence 87778999999999999997664
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=410.08 Aligned_cols=270 Identities=34% Similarity=0.635 Sum_probs=231.5
Q ss_pred CceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 207 DGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 207 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
...+..++|++++.||+|+||.||+|++..++..||+|++.+...........+.+|+.+|+.++||||++++++|.+++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~ 116 (370)
T cd05596 37 KLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDK 116 (370)
T ss_pred cCCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 33455689999999999999999999999999999999998765444444455678999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
++|+|||||+||+|..++... .+++..+..++.||+.||+|||++||+||||||+||||+.+|.+||+|||++....
T Consensus 117 ~~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 117 YLYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 999999999999999988653 58999999999999999999999999999999999999999999999999874321
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
... ..
T Consensus 194 ~~~---------------------------------------------------------------------------~~ 198 (370)
T cd05596 194 ANG---------------------------------------------------------------------------MV 198 (370)
T ss_pred CCC---------------------------------------------------------------------------cc
Confidence 100 00
Q ss_pred cccccccCccccCcceecCC----CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC--CCCCCCCCCCHHH
Q 007433 447 RSMSFVGTHEYLAPEIIKGE----GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP--LRFPESPVVSFSA 520 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~----~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~--~~~p~~~~~s~~l 520 (604)
.....+||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.+....+.++.... +.++....++.++
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA 278 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence 11234699999999998764 37889999999999999999999999988777777776543 5566666789999
Q ss_pred HHHHHHhhhcCCCC--cccccCCHHHHhcCCCCCCCChhh
Q 007433 521 RDLIKGLLVKEPQN--RLACRRGATEIKQHPFFQGVNWAL 558 (604)
Q Consensus 521 ~dLI~~lL~~dP~~--Rpt~~~~a~elL~Hpff~~~~~~~ 558 (604)
++||.+||..+|.+ |++ ++++++||||+..+|..
T Consensus 279 ~~li~~~L~~~p~r~~R~s----~~ell~h~~~~~~~~~~ 314 (370)
T cd05596 279 KDLICAFLTDREVRLGRNG----VDEIKSHPFFKNDQWTF 314 (370)
T ss_pred HHHHHHHccChhhccCCCC----HHHHhcCcccCCCChhh
Confidence 99999999999987 888 99999999999988864
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-48 Score=404.31 Aligned_cols=262 Identities=39% Similarity=0.722 Sum_probs=225.3
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCCC
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGG 298 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 298 (604)
+.||+|+||.||++++..+++.||+|++.+..........++.+|+++++.++||||++++++|..++.+||||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999999999999999998765544445566778999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH-cCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcc
Q 007433 299 DLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM-LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTL 377 (604)
Q Consensus 299 sL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 377 (604)
+|..++.+. ..+++..++.++.||+.||+|||+ +||+||||||+||||+.+|.+||+|||++......
T Consensus 81 ~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~--------- 149 (325)
T cd05594 81 ELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--------- 149 (325)
T ss_pred cHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCC---------
Confidence 999888765 579999999999999999999997 79999999999999999999999999987321100
Q ss_pred cCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccc
Q 007433 378 ESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEY 457 (604)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 457 (604)
.......+||+.|
T Consensus 150 -------------------------------------------------------------------~~~~~~~~gt~~y 162 (325)
T cd05594 150 -------------------------------------------------------------------GATMKTFCGTPEY 162 (325)
T ss_pred -------------------------------------------------------------------CcccccccCCccc
Confidence 0001134699999
Q ss_pred cCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCccc
Q 007433 458 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLA 537 (604)
Q Consensus 458 ~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt 537 (604)
+|||++.+..++.++|||||||+||||++|+.||.+.+....+..+......++. .++.++.+||.+||.+||++|++
T Consensus 163 ~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~L~~dP~~R~~ 240 (325)
T cd05594 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLSPEAKSLLSGLLKKDPKQRLG 240 (325)
T ss_pred CCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHhhcCHHHhCC
Confidence 9999999999999999999999999999999999988777777777666666654 48999999999999999999983
Q ss_pred cc-CCHHHHhcCCCCCCCChhhhh
Q 007433 538 CR-RGATEIKQHPFFQGVNWALIR 560 (604)
Q Consensus 538 ~~-~~a~elL~Hpff~~~~~~~~~ 560 (604)
.. ..+.++++||||.++.|....
T Consensus 241 ~~~~~~~~il~h~~~~~~~~~~~~ 264 (325)
T cd05594 241 GGPDDAKEIMQHKFFAGIVWQDVY 264 (325)
T ss_pred CCCCCHHHHhcCCCcCCCCHHHHH
Confidence 21 139999999999999998654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=410.75 Aligned_cols=279 Identities=35% Similarity=0.657 Sum_probs=231.4
Q ss_pred ceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCe
Q 007433 208 GVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKF 287 (604)
Q Consensus 208 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 287 (604)
.....++|++++.||+|+||.||++++..+++.||+|++.+...........+.+|+.+++.++||||++++++|.+++.
T Consensus 38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (370)
T cd05621 38 LQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKY 117 (370)
T ss_pred cCCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCE
Confidence 34456899999999999999999999999999999999987544444444566789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccC
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAV 367 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~ 367 (604)
+|+|||||+||+|.+++... .+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 118 LYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 99999999999999998654 589999999999999999999999999999999999999999999999998843211
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
.. ...
T Consensus 195 ~~---------------------------------------------------------------------------~~~ 199 (370)
T cd05621 195 TG---------------------------------------------------------------------------MVR 199 (370)
T ss_pred CC---------------------------------------------------------------------------cee
Confidence 00 001
Q ss_pred ccccccCccccCcceecCCC----CCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC--CCCCCCCCCCHHHH
Q 007433 448 SMSFVGTHEYLAPEIIKGEG----HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP--LRFPESPVVSFSAR 521 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~~~----~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~--~~~p~~~~~s~~l~ 521 (604)
....+||+.|+|||++.+.. ++.++|||||||+||||++|+.||.+.+....+.++.... +.++....++..++
T Consensus 200 ~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~ 279 (370)
T cd05621 200 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAK 279 (370)
T ss_pred cccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHHHH
Confidence 12346999999999997653 7889999999999999999999999888777777777543 55566556899999
Q ss_pred HHHHHhhhcCCCC--cccccCCHHHHhcCCCCCCCChh--hhhcCCCCCCC
Q 007433 522 DLIKGLLVKEPQN--RLACRRGATEIKQHPFFQGVNWA--LIRCASPPEIP 568 (604)
Q Consensus 522 dLI~~lL~~dP~~--Rpt~~~~a~elL~Hpff~~~~~~--~~~~~~~~~~p 568 (604)
+||.+||..++.+ |++ +.|+++||||+...|. .++...++..|
T Consensus 280 ~li~~~L~~~~~r~~R~~----~~e~l~hp~~~~~~~~~~~~~~~~~~~~p 326 (370)
T cd05621 280 NLICAFLTDREVRLGRNG----VEEIKQHPFFKNDQWNWDNIRETAAPVVP 326 (370)
T ss_pred HHHHHHccCchhccCCCC----HHHHhcCcccCCCCcChHhcCCCCCCcCC
Confidence 9999999855543 677 9999999999986554 44433444444
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-47 Score=401.97 Aligned_cols=264 Identities=37% Similarity=0.736 Sum_probs=222.5
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCeeEEEEeecCC
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSCLVMEFCPG 297 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 297 (604)
+.||+|+||.||+|++..+++.||||++.+...........+.+|+.+++.+ +||||++++++|.+++.+|||||||+|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 3689999999999999999999999999876555555556677899999998 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcc
Q 007433 298 GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTL 377 (604)
Q Consensus 298 gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 377 (604)
|+|..++.+. ..+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 81 g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~---------- 148 (329)
T cd05588 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIR---------- 148 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCcccccccc----------
Confidence 9999888765 5799999999999999999999999999999999999999999999999998732100
Q ss_pred cCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccc
Q 007433 378 ESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEY 457 (604)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 457 (604)
.......++||+.|
T Consensus 149 ------------------------------------------------------------------~~~~~~~~~gt~~y 162 (329)
T cd05588 149 ------------------------------------------------------------------PGDTTSTFCGTPNY 162 (329)
T ss_pred ------------------------------------------------------------------CCCccccccCCccc
Confidence 00011235799999
Q ss_pred cCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCC--------hHH-HHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 458 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE--------NRA-TLYNVVGQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 458 ~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~--------~~~-~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
+|||++.+..++.++|||||||++|||++|+.||.... ..+ ....+......+|. .++.++.+||++||
T Consensus 163 ~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L 240 (329)
T cd05588 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKASSVLKGFL 240 (329)
T ss_pred cCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHh
Confidence 99999999999999999999999999999999996321 112 23345555555554 48899999999999
Q ss_pred hcCCCCccccc--CCHHHHhcCCCCCCCChhhhhcC
Q 007433 529 VKEPQNRLACR--RGATEIKQHPFFQGVNWALIRCA 562 (604)
Q Consensus 529 ~~dP~~Rpt~~--~~a~elL~Hpff~~~~~~~~~~~ 562 (604)
.+||.+|+++. .++.++++||||..++|..+...
T Consensus 241 ~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~ 276 (329)
T cd05588 241 NKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQK 276 (329)
T ss_pred ccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhC
Confidence 99999999854 34899999999999999877543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-47 Score=398.45 Aligned_cols=269 Identities=35% Similarity=0.689 Sum_probs=232.0
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEecCCeeEEEE
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~ 292 (604)
+|++.+.||+|+||+||+|++..+++.||||++.+..............|+.+++.+. |++|++++++|.+++.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4889999999999999999999999999999998765444445556677889998885 577889999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||++||+|..++... ..+++..++.|+.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~---- 154 (323)
T cd05615 81 EYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD---- 154 (323)
T ss_pred cCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCC----
Confidence 999999999988765 56999999999999999999999999999999999999999999999999987321100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
........
T Consensus 155 ------------------------------------------------------------------------~~~~~~~~ 162 (323)
T cd05615 155 ------------------------------------------------------------------------GVTTRTFC 162 (323)
T ss_pred ------------------------------------------------------------------------CccccCcc
Confidence 00112346
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEP 532 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP 532 (604)
||+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..+......++. .++.++++||.+||.+||
T Consensus 163 gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~l~~~p 240 (323)
T cd05615 163 GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPK--SLSKEAVSICKGLMTKHP 240 (323)
T ss_pred CCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHHHHcccCH
Confidence 999999999999999999999999999999999999999998888888888777666654 488999999999999999
Q ss_pred CCccccc-CCHHHHhcCCCCCCCChhhhhcC
Q 007433 533 QNRLACR-RGATEIKQHPFFQGVNWALIRCA 562 (604)
Q Consensus 533 ~~Rpt~~-~~a~elL~Hpff~~~~~~~~~~~ 562 (604)
.+|++.. ....++++||||+.++|..+...
T Consensus 241 ~~R~~~~~~~~~~i~~h~~f~~~~~~~~~~~ 271 (323)
T cd05615 241 SKRLGCGPEGERDIREHAFFRRIDWDKLENR 271 (323)
T ss_pred hhCCCCCCCCHHHHhcCcccCCCCHHHHhcC
Confidence 9999853 35789999999999999877554
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-47 Score=399.50 Aligned_cols=277 Identities=35% Similarity=0.646 Sum_probs=231.6
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++++.||+|+||.||++++..+++.||+|++.+...........+.+|+.++..++|+||+.+++.+.+++.+||||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999998755444444455678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+++|+|.+++.+. ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~--- 156 (332)
T cd05623 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG--- 156 (332)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC---
Confidence 999999999998764 2468999999999999999999999999999999999999999999999999874321000
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.......+
T Consensus 157 ------------------------------------------------------------------------~~~~~~~~ 164 (332)
T cd05623 157 ------------------------------------------------------------------------TVQSSVAV 164 (332)
T ss_pred ------------------------------------------------------------------------cceecccc
Confidence 00011246
Q ss_pred cCccccCcceecC-----CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC--CCCC-CCCCHHHHHHH
Q 007433 453 GTHEYLAPEIIKG-----EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR--FPES-PVVSFSARDLI 524 (604)
Q Consensus 453 GT~~Y~APE~l~~-----~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~--~p~~-~~~s~~l~dLI 524 (604)
||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.+..+.+.++.....+ ++.. ..++.++++||
T Consensus 165 gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~~~~li 244 (332)
T cd05623 165 GTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDAKDLI 244 (332)
T ss_pred cCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHHHHHHH
Confidence 9999999999863 45788999999999999999999999998888888877765433 3322 35799999999
Q ss_pred HHhhhcCCCC--cccccCCHHHHhcCCCCCCCChhhhhcCCCCCCCC
Q 007433 525 KGLLVKEPQN--RLACRRGATEIKQHPFFQGVNWALIRCASPPEIPK 569 (604)
Q Consensus 525 ~~lL~~dP~~--Rpt~~~~a~elL~Hpff~~~~~~~~~~~~~~~~p~ 569 (604)
++||+.++.+ |++ +.|+++||||.+++|..++....+.+|.
T Consensus 245 ~~ll~~~~~r~~r~~----~~~~~~h~~f~~~~~~~~~~~~~~~~~~ 287 (332)
T cd05623 245 RRLICSREHRLGQNG----IEDFKQHPFFTGIDWDNIRNCEAPYIPE 287 (332)
T ss_pred HHHccChhhhcCCCC----HHHHhCCCCcCCCCHHHHhhCCCCccCC
Confidence 9999875544 455 9999999999999999887666555543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-47 Score=398.86 Aligned_cols=276 Identities=36% Similarity=0.664 Sum_probs=229.4
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++++.||+|+||+||++++..+++.||||++.+...........+.+|+.+++.++|+||++++++|.+++++|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765544555566778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||++||+|.+++.+. ...+++..++.++.||+.||+|||++||+||||||+||||+.+|.++|+|||++..+.....
T Consensus 81 e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-- 157 (331)
T cd05597 81 DYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-- 157 (331)
T ss_pred ecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC--
Confidence 999999999998764 35799999999999999999999999999999999999999999999999998743221000
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
......+
T Consensus 158 -------------------------------------------------------------------------~~~~~~~ 164 (331)
T cd05597 158 -------------------------------------------------------------------------VQSNVAV 164 (331)
T ss_pred -------------------------------------------------------------------------cccccee
Confidence 0011236
Q ss_pred cCccccCcceecC-----CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC--CCCCC-CCCCCHHHHHHH
Q 007433 453 GTHEYLAPEIIKG-----EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP--LRFPE-SPVVSFSARDLI 524 (604)
Q Consensus 453 GT~~Y~APE~l~~-----~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~--~~~p~-~~~~s~~l~dLI 524 (604)
||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.+..+.... +.++. ...++..+++||
T Consensus 165 gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li 244 (331)
T cd05597 165 GTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEEAKDLI 244 (331)
T ss_pred ccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHHHHHHH
Confidence 9999999999874 346889999999999999999999999877777776666533 23322 234789999999
Q ss_pred HHhhhcCCCC--cccccCCHHHHhcCCCCCCCChhhhhcCCCCCCC
Q 007433 525 KGLLVKEPQN--RLACRRGATEIKQHPFFQGVNWALIRCASPPEIP 568 (604)
Q Consensus 525 ~~lL~~dP~~--Rpt~~~~a~elL~Hpff~~~~~~~~~~~~~~~~p 568 (604)
++||+.++++ |++ +.++++||||.+++|..+....++.+|
T Consensus 245 ~~ll~~~~~r~~r~~----~~~~l~hp~~~~~~~~~~~~~~~~~~~ 286 (331)
T cd05597 245 RRLICSPETRLGRNG----LQDFKDHPFFEGIDWDNIRNSTAPYVP 286 (331)
T ss_pred HHHccCcccccCCCC----HHHHhcCCCCCCCCHHHHhhCCCCccC
Confidence 9999764433 566 999999999999999988766555444
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=398.08 Aligned_cols=260 Identities=36% Similarity=0.710 Sum_probs=220.6
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCeeEEEEeecCC
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSCLVMEFCPG 297 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 297 (604)
+.||+|+||.||+|++..++..||||++.+..............|+.++..+ +||||++++++|.+++++|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999999999999999999876443333444556688888754 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcc
Q 007433 298 GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTL 377 (604)
Q Consensus 298 gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 377 (604)
++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 81 g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~---------- 148 (316)
T cd05620 81 GDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF---------- 148 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc----------
Confidence 9999888764 5689999999999999999999999999999999999999999999999998732100
Q ss_pred cCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccc
Q 007433 378 ESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEY 457 (604)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 457 (604)
.......++||+.|
T Consensus 149 ------------------------------------------------------------------~~~~~~~~~gt~~y 162 (316)
T cd05620 149 ------------------------------------------------------------------GDNRASTFCGTPDY 162 (316)
T ss_pred ------------------------------------------------------------------CCCceeccCCCcCc
Confidence 00011235699999
Q ss_pred cCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCccc
Q 007433 458 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLA 537 (604)
Q Consensus 458 ~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt 537 (604)
+|||++.+..++.++|||||||++|||++|+.||.+.+....+..+......++. .++.++++||.+||..||++|++
T Consensus 163 ~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~dP~~R~~ 240 (316)
T cd05620 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPR--WITKESKDILEKLFERDPTRRLG 240 (316)
T ss_pred cCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHccCCHHHcCC
Confidence 9999999999999999999999999999999999988777777666655555554 48899999999999999999999
Q ss_pred ccCCHHHHhcCCCCCCCChhhhhc
Q 007433 538 CRRGATEIKQHPFFQGVNWALIRC 561 (604)
Q Consensus 538 ~~~~a~elL~Hpff~~~~~~~~~~ 561 (604)
+ .+++++||||+.++|..+..
T Consensus 241 ~---~~~~~~h~~f~~~~~~~~~~ 261 (316)
T cd05620 241 V---VGNIRGHPFFKTINWTALEK 261 (316)
T ss_pred C---hHHHHcCCCcCCCCHHHHHh
Confidence 2 36899999999999986543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-47 Score=398.12 Aligned_cols=265 Identities=36% Similarity=0.713 Sum_probs=223.4
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCeeEEEEeecCC
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSCLVMEFCPG 297 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 297 (604)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++..+ +|+||+.++++|.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999887655555566778899999888 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcc
Q 007433 298 GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTL 377 (604)
Q Consensus 298 gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 377 (604)
++|..++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~--------- 149 (327)
T cd05617 81 GDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP--------- 149 (327)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCC---------
Confidence 9999888765 56999999999999999999999999999999999999999999999999987321100
Q ss_pred cCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccc
Q 007433 378 ESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEY 457 (604)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 457 (604)
......++||+.|
T Consensus 150 -------------------------------------------------------------------~~~~~~~~gt~~y 162 (327)
T cd05617 150 -------------------------------------------------------------------GDTTSTFCGTPNY 162 (327)
T ss_pred -------------------------------------------------------------------CCceecccCCccc
Confidence 0011235699999
Q ss_pred cCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCC------ChHH-HHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 458 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS------ENRA-TLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 458 ~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~------~~~~-~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
+|||++.+..++.++|||||||+||||++|+.||... ...+ ....+...+..+|. .++..+.+||.+||.+
T Consensus 163 ~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~--~~~~~~~~li~~~L~~ 240 (327)
T cd05617 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPR--FLSVKASHVLKGFLNK 240 (327)
T ss_pred CCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHhcc
Confidence 9999999999999999999999999999999999642 2222 33344455555554 4889999999999999
Q ss_pred CCCCccccc--CCHHHHhcCCCCCCCChhhhhcCC
Q 007433 531 EPQNRLACR--RGATEIKQHPFFQGVNWALIRCAS 563 (604)
Q Consensus 531 dP~~Rpt~~--~~a~elL~Hpff~~~~~~~~~~~~ 563 (604)
||.+|+++. ..+.++++||||+.++|..+....
T Consensus 241 dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~ 275 (327)
T cd05617 241 DPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQ 275 (327)
T ss_pred CHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCC
Confidence 999999853 457899999999999999875443
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-47 Score=397.36 Aligned_cols=260 Identities=38% Similarity=0.764 Sum_probs=221.3
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHh-CCCCCccccceeEecCCeeEEEEeecCC
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQS-LDHPFLPTLYTHFETDKFSCLVMEFCPG 297 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~g 297 (604)
+.||+|+||.||+|++..+++.||||++.+..............|..++.. ++||||+++++++..++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999999999999999987654333444455567777765 4899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcc
Q 007433 298 GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTL 377 (604)
Q Consensus 298 gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 377 (604)
|+|..++... ..+++..+..|+.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus 81 g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~--------- 149 (316)
T cd05592 81 GDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG--------- 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC---------
Confidence 9999988765 56999999999999999999999999999999999999999999999999987321100
Q ss_pred cCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccc
Q 007433 378 ESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEY 457 (604)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 457 (604)
.......+||+.|
T Consensus 150 -------------------------------------------------------------------~~~~~~~~gt~~y 162 (316)
T cd05592 150 -------------------------------------------------------------------EGKASTFCGTPDY 162 (316)
T ss_pred -------------------------------------------------------------------CCccccccCCccc
Confidence 0011234699999
Q ss_pred cCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCccc
Q 007433 458 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLA 537 (604)
Q Consensus 458 ~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt 537 (604)
+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......++. .++.++.+||.+||..||.+|++
T Consensus 163 ~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~ll~~~l~~~P~~R~~ 240 (316)
T cd05592 163 IAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPR--WISKEAKDCLSKLFERDPTKRLG 240 (316)
T ss_pred cCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHccCCHHHcCC
Confidence 9999999999999999999999999999999999998887777777665555443 48899999999999999999998
Q ss_pred ccCCHHHHhcCCCCCCCChhhhhc
Q 007433 538 CRRGATEIKQHPFFQGVNWALIRC 561 (604)
Q Consensus 538 ~~~~a~elL~Hpff~~~~~~~~~~ 561 (604)
. ..++++||||..++|..+..
T Consensus 241 ~---~~~l~~h~~~~~~~~~~~~~ 261 (316)
T cd05592 241 V---DGDIRQHPFFRGIDWERLEK 261 (316)
T ss_pred C---hHHHHcCcccCCCCHHHHHh
Confidence 2 45899999999999987643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=399.62 Aligned_cols=279 Identities=35% Similarity=0.660 Sum_probs=232.0
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++++.||+|+||+||++++..+++.||+|++.+...........+.+|+.++..++|+||+.++++|.++++.||||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998754444444556778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||++||+|..++.+.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 81 Ey~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~-- 157 (331)
T cd05624 81 DYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-- 157 (331)
T ss_pred eCCCCCcHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc--
Confidence 9999999999987642 5789999999999999999999999999999999999999999999999998843321000
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
......+
T Consensus 158 -------------------------------------------------------------------------~~~~~~~ 164 (331)
T cd05624 158 -------------------------------------------------------------------------VQSSVAV 164 (331)
T ss_pred -------------------------------------------------------------------------eeecccc
Confidence 0011246
Q ss_pred cCccccCcceecC-----CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC--CCCC-CCCCHHHHHHH
Q 007433 453 GTHEYLAPEIIKG-----EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR--FPES-PVVSFSARDLI 524 (604)
Q Consensus 453 GT~~Y~APE~l~~-----~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~--~p~~-~~~s~~l~dLI 524 (604)
||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.+..+.+..+.....+ ++.. ..++.++++||
T Consensus 165 gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~~li 244 (331)
T cd05624 165 GTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEEAKDLI 244 (331)
T ss_pred CCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHHHHHHH
Confidence 9999999999876 45788999999999999999999999988877777777654433 3322 34789999999
Q ss_pred HHhhhcCCCCcccccCCHHHHhcCCCCCCCChhhhhcCCCCCCCC
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPK 569 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~~~~~~~~~p~ 569 (604)
.+||+.++. |+. +..++++++||||++++|..++...++.+|.
T Consensus 245 ~~ll~~~~~-~~~-~~~~~~~~~h~~f~~~~~~~~~~~~~~~~p~ 287 (331)
T cd05624 245 QRLICSRER-RLG-QNGIEDFKKHAFFEGIDWENIRNLEAPYIPD 287 (331)
T ss_pred HHHccCchh-hcC-CCCHHHHhcCCCcCCCCHHHHhhCCCCccCC
Confidence 999997654 432 2349999999999999999888766666554
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=399.28 Aligned_cols=263 Identities=37% Similarity=0.682 Sum_probs=225.1
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHH-HHHhCCCCCccccceeEecCCeeEEEEeecCC
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTERE-ILQSLDHPFLPTLYTHFETDKFSCLVMEFCPG 297 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 297 (604)
+.||.|+||+||+|++..+++.||||++.+...........+..|+. +++.++||||++++++|..++.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999999999999999998764433344444555655 56789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcc
Q 007433 298 GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTL 377 (604)
Q Consensus 298 gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 377 (604)
|+|..++.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++.....
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~---------- 148 (325)
T cd05604 81 GELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA---------- 148 (325)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC----------
Confidence 9999888764 5799999999999999999999999999999999999999999999999998732100
Q ss_pred cCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccc
Q 007433 378 ESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEY 457 (604)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 457 (604)
........+||+.|
T Consensus 149 ------------------------------------------------------------------~~~~~~~~~gt~~y 162 (325)
T cd05604 149 ------------------------------------------------------------------QSDTTTTFCGTPEY 162 (325)
T ss_pred ------------------------------------------------------------------CCCCcccccCChhh
Confidence 00011235699999
Q ss_pred cCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCccc
Q 007433 458 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLA 537 (604)
Q Consensus 458 ~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt 537 (604)
+|||++.+..++.++|||||||++|||++|..||.+.+..+.+.++......++ +..+..+.++|++||..||.+||+
T Consensus 163 ~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ll~~ll~~~p~~R~~ 240 (325)
T cd05604 163 LAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR--PGASLTAWSILEELLEKDRQRRLG 240 (325)
T ss_pred CCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC--CCCCHHHHHHHHHHhccCHHhcCC
Confidence 999999999999999999999999999999999998887777777776655443 348899999999999999999999
Q ss_pred ccCCHHHHhcCCCCCCCChhhhhc
Q 007433 538 CRRGATEIKQHPFFQGVNWALIRC 561 (604)
Q Consensus 538 ~~~~a~elL~Hpff~~~~~~~~~~ 561 (604)
.+..+.++++||||..++|..+..
T Consensus 241 ~~~~~~~i~~h~~f~~~~~~~~~~ 264 (325)
T cd05604 241 AKEDFLEIQEHPFFESLSWTDLEQ 264 (325)
T ss_pred CCCCHHHHhcCCCcCCCCHHHHHh
Confidence 888889999999999999977654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-47 Score=406.52 Aligned_cols=259 Identities=36% Similarity=0.579 Sum_probs=233.7
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEecCCeeEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~l 290 (604)
...|.+.+.||.|.||.||+|+.+.+|+.||+|++.+...........+.+|+.||++|. |||||.++++|++...+|+
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l 113 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL 113 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence 368999999999999999999999999999999999887654445566789999999998 9999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccC----CcEEEeccccccccc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRED----GHIMLSDFDLSLRCA 366 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~----g~vkL~DFGla~~~~ 366 (604)
|||+|.||.|++.+.+. .++|..+..+++||+.++.|||+.|||||||||||+|+... +.+|++|||++....
T Consensus 114 vmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 114 VMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 99999999999988876 39999999999999999999999999999999999999743 479999999995433
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
. ..
T Consensus 191 ~-----------------------------------------------------------------------------~~ 193 (382)
T KOG0032|consen 191 P-----------------------------------------------------------------------------GE 193 (382)
T ss_pred C-----------------------------------------------------------------------------Cc
Confidence 1 12
Q ss_pred cccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC--CCCCCCHHHHHHH
Q 007433 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFP--ESPVVSFSARDLI 524 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p--~~~~~s~~l~dLI 524 (604)
+....+||++|+|||++.+.+|+..+||||+||++|.||+|.+||.+......+.++....+.|. .++.++..+++||
T Consensus 194 ~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~akd~i 273 (382)
T KOG0032|consen 194 RLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISESAKDFI 273 (382)
T ss_pred eEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHHHHHHH
Confidence 23456899999999999999999999999999999999999999999999999999998877654 5677899999999
Q ss_pred HHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
++||..||.+|++ +.++|+|||+++.
T Consensus 274 ~~ll~~dp~~R~t----a~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 274 RKLLEFDPRKRLT----AAQALQHPWIKSI 299 (382)
T ss_pred HHhcccCcccCCC----HHHHhcCccccCC
Confidence 9999999999999 9999999998764
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=387.92 Aligned_cols=271 Identities=36% Similarity=0.601 Sum_probs=225.4
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
.|++.+.||.|+||+||++.+..+++.||+|++.+...........+.+|+.+|+.++|+||+++++.+..++++|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999977654444444456689999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
|+++++|..++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~----- 155 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEG----- 155 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCC-----
Confidence 999999998887654457999999999999999999999999999999999999999999999999987432100
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
......+|
T Consensus 156 ------------------------------------------------------------------------~~~~~~~~ 163 (285)
T cd05605 156 ------------------------------------------------------------------------ETIRGRVG 163 (285)
T ss_pred ------------------------------------------------------------------------CccccccC
Confidence 00113468
Q ss_pred CccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHH----HHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 454 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN----VVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 454 T~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~----i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
|+.|+|||++.+..++.++|||||||++|||++|+.||.+......... +......+ ...++..+.+||.+||.
T Consensus 164 ~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~ 241 (285)
T cd05605 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEY--SEKFSEAARSICRQLLT 241 (285)
T ss_pred CCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhccccc--CcccCHHHHHHHHHHcc
Confidence 9999999999998899999999999999999999999987654333222 22222222 23488999999999999
Q ss_pred cCCCCccccc-CCHHHHhcCCCCCCCChhhhhcCC
Q 007433 530 KEPQNRLACR-RGATEIKQHPFFQGVNWALIRCAS 563 (604)
Q Consensus 530 ~dP~~Rpt~~-~~a~elL~Hpff~~~~~~~~~~~~ 563 (604)
.||++||+++ ..++++++||||..++|..+....
T Consensus 242 ~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 276 (285)
T cd05605 242 KDPGFRLGCRGEGAEEVKAHPFFRTANFKRLEAGM 276 (285)
T ss_pred CCHHHhcCCCCCCHHHHhcCcCccCCCHHHHhhCC
Confidence 9999999421 139999999999999999775543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-48 Score=395.17 Aligned_cols=313 Identities=35% Similarity=0.647 Sum_probs=263.1
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEecCCee
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFETDKFS 288 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~ 288 (604)
+...+|..+..||.|+||.|.+|..+++...||||+++++..-....+.--..|.++|.... -|++++|+..|++-+.+
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 34579999999999999999999999999999999999886544444444456778888774 57999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|+||||+.||+|-..++.. +.|-|..+.+|+.+|+-||-|||++|||+||||.+||||+.+|++||+|||+...-..
T Consensus 426 yFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~- 502 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF- 502 (683)
T ss_pred eeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccccc-
Confidence 9999999999998888876 6799999999999999999999999999999999999999999999999998732100
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
.+...
T Consensus 503 ---------------------------------------------------------------------------~~~TT 507 (683)
T KOG0696|consen 503 ---------------------------------------------------------------------------DGVTT 507 (683)
T ss_pred ---------------------------------------------------------------------------CCcce
Confidence 11234
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
.+|+|||.|+|||++...+|+..+||||+||+|||||.|++||.+.++.+.+..|......+|.+ +|.++.++++++|
T Consensus 508 kTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKs--lSkEAv~ickg~l 585 (683)
T KOG0696|consen 508 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKS--LSKEAVAICKGLL 585 (683)
T ss_pred eeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCccc--ccHHHHHHHHHHh
Confidence 57899999999999999999999999999999999999999999999999999999999888876 9999999999999
Q ss_pred hcCCCCcccc-cCCHHHHhcCCCCCCCChhhhhcC--CCCCCCCCCc---------ccCCCCCCCchhhHhhhccCCCCC
Q 007433 529 VKEPQNRLAC-RRGATEIKQHPFFQGVNWALIRCA--SPPEIPKPVE---------IVHSPAPALSTKAKAVAAGNADHN 596 (604)
Q Consensus 529 ~~dP~~Rpt~-~~~a~elL~Hpff~~~~~~~~~~~--~~~~~p~~~~---------~~~~p~~~~~~~~~~~~~~~~~~~ 596 (604)
.+.|.+|+.+ ..+-.+|..||||+.++|..+... .||.-|++.- ....-++.+++..+.+.. |.|++
T Consensus 586 tK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k~~r~~eNFD~~Ft~~~~~lTPpD~~v~~-nldq~ 664 (683)
T KOG0696|consen 586 TKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPFKPKIKCGRDAENFDKFFTREPTDLTPPDKLVMM-NLDQS 664 (683)
T ss_pred hcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCCCCccccCCchhhhhHHHhcCCCCCCCchHHHHh-cCchh
Confidence 9999999997 346678999999999999987554 3444454411 112224555665555544 67888
Q ss_pred CCCCCcc
Q 007433 597 NYLEFDF 603 (604)
Q Consensus 597 ~~~~~~~ 603 (604)
++..|-|
T Consensus 665 eF~gFsf 671 (683)
T KOG0696|consen 665 EFEGFSF 671 (683)
T ss_pred hcCceee
Confidence 8877765
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=394.82 Aligned_cols=262 Identities=38% Similarity=0.704 Sum_probs=224.5
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHH-HHHhCCCCCccccceeEecCCeeEEEEeecCC
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTERE-ILQSLDHPFLPTLYTHFETDKFSCLVMEFCPG 297 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 297 (604)
+.||.|+||.||+|++..+++.||+|++.+...........+..|+. +++.++||||++++++|.+.+..|+|||||+|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999999999999999998765444344444555554 67889999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcc
Q 007433 298 GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTL 377 (604)
Q Consensus 298 gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 377 (604)
++|...+... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++......
T Consensus 81 ~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--------- 149 (321)
T cd05603 81 GELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP--------- 149 (321)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCC---------
Confidence 9999887764 56899999999999999999999999999999999999999999999999987321000
Q ss_pred cCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccc
Q 007433 378 ESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEY 457 (604)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 457 (604)
......++||+.|
T Consensus 150 -------------------------------------------------------------------~~~~~~~~gt~~y 162 (321)
T cd05603 150 -------------------------------------------------------------------EETTSTFCGTPEY 162 (321)
T ss_pred -------------------------------------------------------------------CCccccccCCccc
Confidence 0011234699999
Q ss_pred cCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCccc
Q 007433 458 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLA 537 (604)
Q Consensus 458 ~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt 537 (604)
+|||++.+..++.++|||||||++|||++|..||.+.+....+..+...+..++. ..+..+.++|.+||..||.+|++
T Consensus 163 ~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~~ 240 (321)
T cd05603 163 LAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPG--GKTVAACDLLVGLLHKDQRRRLG 240 (321)
T ss_pred CCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHccCCHhhcCC
Confidence 9999999999999999999999999999999999988877777777777666554 47889999999999999999999
Q ss_pred ccCCHHHHhcCCCCCCCChhhhh
Q 007433 538 CRRGATEIKQHPFFQGVNWALIR 560 (604)
Q Consensus 538 ~~~~a~elL~Hpff~~~~~~~~~ 560 (604)
....+.++++|+||..++|..+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~ 263 (321)
T cd05603 241 AKADFLEIKNHVFFSPINWDDLY 263 (321)
T ss_pred CCCCHHHHhCCCCcCCCCHHHHh
Confidence 77778899999999999998654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-47 Score=404.42 Aligned_cols=283 Identities=35% Similarity=0.668 Sum_probs=232.8
Q ss_pred cCceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC
Q 007433 206 KDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD 285 (604)
Q Consensus 206 ~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 285 (604)
.+..+..++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||++++++|.++
T Consensus 36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~ 115 (371)
T cd05622 36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD 115 (371)
T ss_pred hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 34455668999999999999999999999999999999999875544444445567899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
.++|+|||||+||+|..++... .+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||++...
T Consensus 116 ~~~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~ 192 (371)
T cd05622 116 RYLYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM 192 (371)
T ss_pred CEEEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEc
Confidence 9999999999999999998754 5899999999999999999999999999999999999999999999999998432
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
.... .
T Consensus 193 ~~~~---------------------------------------------------------------------------~ 197 (371)
T cd05622 193 NKEG---------------------------------------------------------------------------M 197 (371)
T ss_pred CcCC---------------------------------------------------------------------------c
Confidence 1100 0
Q ss_pred CcccccccCccccCcceecCCC----CCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC--CCCCCCCCCCHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEG----HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP--LRFPESPVVSFS 519 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~----~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~--~~~p~~~~~s~~ 519 (604)
......+||+.|+|||++.+.. ++.++|||||||+||||++|+.||.+.+....+.++.... +.++....++..
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 277 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHH
Confidence 0112356999999999997643 7889999999999999999999999888777777777643 556666678999
Q ss_pred HHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh--hhhcCCCCCCC
Q 007433 520 ARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA--LIRCASPPEIP 568 (604)
Q Consensus 520 l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~--~~~~~~~~~~p 568 (604)
+++||.+||. +|..|++ +..++++++|+||++..|+ .++...+|.+|
T Consensus 278 ~~~li~~~L~-~~~~r~~-r~~~~ei~~h~~~~~~~~~~~~~~~~~~~~~~ 326 (371)
T cd05622 278 AKNLICAFLT-DREVRLG-RNGVEEIKRHLFFKNDQWAWETLRDTVAPVVP 326 (371)
T ss_pred HHHHHHHHcC-ChhhhcC-CCCHHHHhcCcccCCCChhHHhcCCCCCCCCC
Confidence 9999999998 5555443 2239999999999986654 44433334333
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=394.50 Aligned_cols=262 Identities=39% Similarity=0.758 Sum_probs=224.8
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCeeEEEEeecCC
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSCLVMEFCPG 297 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 297 (604)
+.||+|+||+||+|++..++..||||++.+.............+|+++++.+ +||||++++++|.+.+++|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999999999999999999877554445555667899999888 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcc
Q 007433 298 GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTL 377 (604)
Q Consensus 298 gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 377 (604)
++|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~--------- 149 (318)
T cd05570 81 GDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--------- 149 (318)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcC---------
Confidence 9999888765 47999999999999999999999999999999999999999999999999987321000
Q ss_pred cCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccc
Q 007433 378 ESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEY 457 (604)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 457 (604)
.......+||+.|
T Consensus 150 -------------------------------------------------------------------~~~~~~~~g~~~y 162 (318)
T cd05570 150 -------------------------------------------------------------------GVTTSTFCGTPDY 162 (318)
T ss_pred -------------------------------------------------------------------CCcccceecCccc
Confidence 0011234699999
Q ss_pred cCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCccc
Q 007433 458 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLA 537 (604)
Q Consensus 458 ~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt 537 (604)
+|||++.+..++.++|||||||++|||++|+.||.+.+....+..+......++. .++..+.+||++||..||.+||+
T Consensus 163 ~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~dP~~R~s 240 (318)
T cd05570 163 IAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPR--WLSKEAKSILKSFLTKNPEKRLG 240 (318)
T ss_pred cCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC--cCCHHHHHHHHHHccCCHHHcCC
Confidence 9999999999999999999999999999999999988877777777766665554 48999999999999999999999
Q ss_pred c-cCCHHHHhcCCCCCCCChhhhh
Q 007433 538 C-RRGATEIKQHPFFQGVNWALIR 560 (604)
Q Consensus 538 ~-~~~a~elL~Hpff~~~~~~~~~ 560 (604)
+ .....++++||||..++|....
T Consensus 241 ~~~~~~~~ll~~~~~~~~~~~~~~ 264 (318)
T cd05570 241 CLPTGEQDIKGHPFFREIDWDKLE 264 (318)
T ss_pred CCCCCHHHHhcCCCcCCCCHHHHH
Confidence 2 1122999999999999997643
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=395.34 Aligned_cols=263 Identities=40% Similarity=0.734 Sum_probs=223.3
Q ss_pred EEEEccCCcEEEEEEEEc---CCceEEEEEEecchhHH-HHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 218 LKKLGCGDIGSVYLSELT---GTKCYFAMKVMDKASLE-KRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 218 ~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
++.||+|+||.||++++. .+++.||||++.+.... .......+.+|+++|+.++||||++++++|..++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999874 46789999999875432 22334456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
|++|++|.+++.+. ..+.+..+..++.||+.||+|||++||+||||||+||||+.+|.+||+|||++......
T Consensus 81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~----- 153 (323)
T cd05584 81 YLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE----- 153 (323)
T ss_pred CCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccC-----
Confidence 99999999988765 56889999999999999999999999999999999999999999999999987321100
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
........|
T Consensus 154 -----------------------------------------------------------------------~~~~~~~~g 162 (323)
T cd05584 154 -----------------------------------------------------------------------GTVTHTFCG 162 (323)
T ss_pred -----------------------------------------------------------------------CCcccccCC
Confidence 001123469
Q ss_pred CccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCC
Q 007433 454 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQ 533 (604)
Q Consensus 454 T~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~ 533 (604)
|+.|+|||++.+..++.++|||||||+||||++|+.||.+.+....+..+......++. .++..+++||.+||.+||+
T Consensus 163 t~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~ 240 (323)
T cd05584 163 TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP--YLTPEARDLLKKLLKRNPS 240 (323)
T ss_pred CccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHcccCHh
Confidence 99999999999999999999999999999999999999998887777888776655543 4899999999999999999
Q ss_pred Ccccc-cCCHHHHhcCCCCCCCChhhhh
Q 007433 534 NRLAC-RRGATEIKQHPFFQGVNWALIR 560 (604)
Q Consensus 534 ~Rpt~-~~~a~elL~Hpff~~~~~~~~~ 560 (604)
+|++. ...+.++++||||....|..+.
T Consensus 241 ~R~~~~~~~~~~l~~h~~~~~~~~~~~~ 268 (323)
T cd05584 241 SRLGAGPGDAAEVQSHPFFRHVNWDDLL 268 (323)
T ss_pred HcCCCCCCCHHHHhcCCCcCCCCHHHHh
Confidence 99931 1239999999999999997664
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=411.88 Aligned_cols=255 Identities=26% Similarity=0.382 Sum_probs=202.6
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC------CCCccccceeEec
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD------HPFLPTLYTHFET 284 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~------HpnIv~l~~~~~~ 284 (604)
..++|+++++||+|+||+||+|.+..+++.||||+++.... .......|+++++.+. |.+|+.++++|..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 35789999999999999999999999999999999965321 1123345777776664 4568889998876
Q ss_pred C-CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH-cCeEeccCCCCcEEEccCC----------
Q 007433 285 D-KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM-LGIVYRDLKPENVLVREDG---------- 352 (604)
Q Consensus 285 ~-~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDIKpeNILl~~~g---------- 352 (604)
+ .++|||||++ |++|.+++.+. ..+++..++.|+.||+.||+|||. .|||||||||+||||+.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 4 6899999999 88998888765 579999999999999999999998 5999999999999998765
Q ss_pred ------cEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCc
Q 007433 353 ------HIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPK 426 (604)
Q Consensus 353 ------~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (604)
.+||+|||++....
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~------------------------------------------------------------ 299 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDER------------------------------------------------------------ 299 (467)
T ss_pred cCCCCceEEECCCCccccCc------------------------------------------------------------
Confidence 49999999762100
Q ss_pred cccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC
Q 007433 427 NEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ 506 (604)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~ 506 (604)
.....++||+.|+|||++.+..|+.++|||||||+||||++|++||.+.++.+.+..+...
T Consensus 300 -------------------~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 360 (467)
T PTZ00284 300 -------------------HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKT 360 (467)
T ss_pred -------------------cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 0112457999999999999999999999999999999999999999987766554433221
Q ss_pred CCCCCC----------------------------------------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHh
Q 007433 507 PLRFPE----------------------------------------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIK 546 (604)
Q Consensus 507 ~~~~p~----------------------------------------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL 546 (604)
...+|. ....+..+.|||.+||++||++||+ ++|+|
T Consensus 361 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t----a~e~L 436 (467)
T PTZ00284 361 LGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN----ARQMT 436 (467)
T ss_pred cCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC----HHHHh
Confidence 100000 0012355779999999999999999 99999
Q ss_pred cCCCCCCCC
Q 007433 547 QHPFFQGVN 555 (604)
Q Consensus 547 ~Hpff~~~~ 555 (604)
+||||+...
T Consensus 437 ~Hp~~~~~~ 445 (467)
T PTZ00284 437 THPYVLKYY 445 (467)
T ss_pred cCccccccC
Confidence 999998643
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-46 Score=394.26 Aligned_cols=259 Identities=37% Similarity=0.751 Sum_probs=220.5
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHh-CCCCCccccceeEecCCeeEEEEeecCC
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQS-LDHPFLPTLYTHFETDKFSCLVMEFCPG 297 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~g 297 (604)
+.||+|+||.||+|++..+++.||||++.+..............|..++.. ++||||+++++++.+++.+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 469999999999999999999999999987644333334455667888876 4999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcc
Q 007433 298 GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTL 377 (604)
Q Consensus 298 gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 377 (604)
|+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~--------- 149 (316)
T cd05619 81 GDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--------- 149 (316)
T ss_pred CcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCC---------
Confidence 9999988764 56899999999999999999999999999999999999999999999999987321100
Q ss_pred cCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccc
Q 007433 378 ESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEY 457 (604)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 457 (604)
.......+||+.|
T Consensus 150 -------------------------------------------------------------------~~~~~~~~gt~~y 162 (316)
T cd05619 150 -------------------------------------------------------------------DAKTCTFCGTPDY 162 (316)
T ss_pred -------------------------------------------------------------------CCceeeecCCccc
Confidence 0011234699999
Q ss_pred cCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCccc
Q 007433 458 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLA 537 (604)
Q Consensus 458 ~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt 537 (604)
+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......++. .++.++++||.+||.+||++|++
T Consensus 163 ~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~~l~~~P~~R~~ 240 (316)
T cd05619 163 IAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR--WLTREAKDILVKLFVREPERRLG 240 (316)
T ss_pred cCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHHHHhccCHhhcCC
Confidence 9999999999999999999999999999999999988877777666655444443 48899999999999999999999
Q ss_pred ccCCHH-HHhcCCCCCCCChhhhhc
Q 007433 538 CRRGAT-EIKQHPFFQGVNWALIRC 561 (604)
Q Consensus 538 ~~~~a~-elL~Hpff~~~~~~~~~~ 561 (604)
+. ++++||||+.++|..+..
T Consensus 241 ----~~~~l~~h~~~~~~~~~~~~~ 261 (316)
T cd05619 241 ----VKGDIRQHPFFREIDWSALEE 261 (316)
T ss_pred ----ChHHHHcCcccCCCCHHHHHh
Confidence 64 899999999999987643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=397.02 Aligned_cols=263 Identities=37% Similarity=0.721 Sum_probs=219.7
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCeeEEEEeecCC
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSCLVMEFCPG 297 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 297 (604)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++..+ +||||++++++|.+++.+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999999999999999999876544444555677898888776 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcc
Q 007433 298 GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTL 377 (604)
Q Consensus 298 gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 377 (604)
++|..++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus 81 ~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~--------- 149 (329)
T cd05618 81 GDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--------- 149 (329)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCC---------
Confidence 9999887765 57999999999999999999999999999999999999999999999999987321000
Q ss_pred cCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccc
Q 007433 378 ESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEY 457 (604)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 457 (604)
......++||+.|
T Consensus 150 -------------------------------------------------------------------~~~~~~~~gt~~y 162 (329)
T cd05618 150 -------------------------------------------------------------------GDTTSTFCGTPNY 162 (329)
T ss_pred -------------------------------------------------------------------CCccccccCCccc
Confidence 0011235699999
Q ss_pred cCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCC--------ChHH-HHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 458 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS--------ENRA-TLYNVVGQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 458 ~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~--------~~~~-~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
+|||++.+..++.++|||||||++|||++|+.||... .... ....+......+|. .++..+.+||++||
T Consensus 163 ~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~ll~~~L 240 (329)
T cd05618 163 IAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKAASVLKSFL 240 (329)
T ss_pred cCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCC--CCCHHHHHHHHHHh
Confidence 9999999999999999999999999999999999531 1122 23334455555554 48899999999999
Q ss_pred hcCCCCccccc--CCHHHHhcCCCCCCCChhhhhc
Q 007433 529 VKEPQNRLACR--RGATEIKQHPFFQGVNWALIRC 561 (604)
Q Consensus 529 ~~dP~~Rpt~~--~~a~elL~Hpff~~~~~~~~~~ 561 (604)
.+||++|+++. .++.++++||||+.++|.....
T Consensus 241 ~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~ 275 (329)
T cd05618 241 NKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQ 275 (329)
T ss_pred cCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHc
Confidence 99999999853 3468999999999999986643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=395.08 Aligned_cols=262 Identities=39% Similarity=0.707 Sum_probs=223.7
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHH-HHHHhCCCCCccccceeEecCCeeEEEEeecCC
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTER-EILQSLDHPFLPTLYTHFETDKFSCLVMEFCPG 297 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei-~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 297 (604)
+.||+|+||+||+|++..+++.||+|++.+...........+..|. .+++.++|+||++++++|..++.+|+||||++|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 3699999999999999999999999999876443333333344444 457889999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcc
Q 007433 298 GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTL 377 (604)
Q Consensus 298 gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 377 (604)
++|..++... ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.++|+|||++......
T Consensus 81 ~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~--------- 149 (325)
T cd05602 81 GELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH--------- 149 (325)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccC---------
Confidence 9999988765 56889999999999999999999999999999999999999999999999987321100
Q ss_pred cCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccc
Q 007433 378 ESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEY 457 (604)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 457 (604)
......++||+.|
T Consensus 150 -------------------------------------------------------------------~~~~~~~~gt~~y 162 (325)
T cd05602 150 -------------------------------------------------------------------NGTTSTFCGTPEY 162 (325)
T ss_pred -------------------------------------------------------------------CCCcccccCCccc
Confidence 0011235699999
Q ss_pred cCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCccc
Q 007433 458 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLA 537 (604)
Q Consensus 458 ~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt 537 (604)
+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......++ +.++..+.+||.+||.+||.+|++
T Consensus 163 ~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~~ 240 (325)
T cd05602 163 LAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK--PNITNSARHLLEGLLQKDRTKRLG 240 (325)
T ss_pred cCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC--CCCCHHHHHHHHHHcccCHHHCCC
Confidence 999999999999999999999999999999999998888777777776655543 358999999999999999999999
Q ss_pred ccCCHHHHhcCCCCCCCChhhhh
Q 007433 538 CRRGATEIKQHPFFQGVNWALIR 560 (604)
Q Consensus 538 ~~~~a~elL~Hpff~~~~~~~~~ 560 (604)
....+.++++|+||..++|..+.
T Consensus 241 ~~~~~~~i~~~~~~~~~~~~~~~ 263 (325)
T cd05602 241 AKDDFMEIKNHIFFSPINWDDLI 263 (325)
T ss_pred CCCCHHHHhcCcccCCCCHHHHH
Confidence 88788899999999999997664
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=395.34 Aligned_cols=269 Identities=43% Similarity=0.793 Sum_probs=220.0
Q ss_pred CeEEEEEEccCCcEEEEEEEEc---CCceEEEEEEecchhHH-HHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCee
Q 007433 214 HFRLLKKLGCGDIGSVYLSELT---GTKCYFAMKVMDKASLE-KRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 288 (604)
+|++++.||+|+||+||++++. .+++.||+|++.+.... .........+|+.+|+.+ +|+||++++++|..++.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 46889999999875432 223345667899999999 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|+||||+++|+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++..+...
T Consensus 81 ~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~ 158 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE 158 (332)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc
Confidence 9999999999999988765 56999999999999999999999999999999999999999999999999987432110
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
.....
T Consensus 159 ---------------------------------------------------------------------------~~~~~ 163 (332)
T cd05614 159 ---------------------------------------------------------------------------EKERT 163 (332)
T ss_pred ---------------------------------------------------------------------------CCCcc
Confidence 00011
Q ss_pred cccccCccccCcceecCCC-CCccchHHHHHHHHHHHhhCCCCCCCCCh----HHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 007433 449 MSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSEN----RATLYNVVGQPLRFPESPVVSFSARDL 523 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~PF~~~~~----~~~l~~i~~~~~~~p~~~~~s~~l~dL 523 (604)
..++||+.|+|||++.+.. ++.++|||||||+||||++|+.||..... ......+......++ ..++..+++|
T Consensus 164 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l 241 (332)
T cd05614 164 YSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP--SFIGPEAQDL 241 (332)
T ss_pred ccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCHHHHHH
Confidence 2356999999999998754 78899999999999999999999975322 222233444333333 4589999999
Q ss_pred HHHhhhcCCCCcccc-cCCHHHHhcCCCCCCCChhhhhc
Q 007433 524 IKGLLVKEPQNRLAC-RRGATEIKQHPFFQGVNWALIRC 561 (604)
Q Consensus 524 I~~lL~~dP~~Rpt~-~~~a~elL~Hpff~~~~~~~~~~ 561 (604)
|.+||..||++|+++ ...++++++||||+.++|.....
T Consensus 242 i~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~~~~ 280 (332)
T cd05614 242 LHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALAL 280 (332)
T ss_pred HHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHHHh
Confidence 999999999999953 22489999999999999976643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=381.78 Aligned_cols=261 Identities=31% Similarity=0.492 Sum_probs=228.9
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhH-----HHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCC
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASL-----EKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDK 286 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 286 (604)
..|.-.+.||.|..++|-++.++.++..+|+|+|..... ..........+|+.||+++ .||+|+++.++|+.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 467778899999999999999999999999999974321 1223344556899999998 7999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
++++|+|.|+.|.|++++... -.++|...+.|++||+.|++|||.++||||||||+|||++++.+++|+|||++.++.
T Consensus 97 F~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~ 174 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE 174 (411)
T ss_pred hhhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence 999999999999999999876 679999999999999999999999999999999999999999999999999985543
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
.+.
T Consensus 175 ~Ge----------------------------------------------------------------------------- 177 (411)
T KOG0599|consen 175 PGE----------------------------------------------------------------------------- 177 (411)
T ss_pred Cch-----------------------------------------------------------------------------
Confidence 221
Q ss_pred cccccccCccccCcceecC------CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC--CCCCCCCH
Q 007433 447 RSMSFVGTHEYLAPEIIKG------EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRF--PESPVVSF 518 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~------~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~--p~~~~~s~ 518 (604)
+-...||||+|+|||.++. .+|+..+|+|++||++|.||.|.+||....+...+..|+.+.+.| |++..++.
T Consensus 178 kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadis~ 257 (411)
T KOG0599|consen 178 KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADISA 257 (411)
T ss_pred hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhccc
Confidence 2234589999999999864 468999999999999999999999999888888888999887766 56778999
Q ss_pred HHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCCh
Q 007433 519 SARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNW 556 (604)
Q Consensus 519 ~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~ 556 (604)
+.+|||.+||+.||.+|+| ++|+|+||||..+-.
T Consensus 258 ~~KdLIsrlLqVdp~~Rit----ake~LaHpff~q~~~ 291 (411)
T KOG0599|consen 258 TVKDLISRLLQVDPTKRIT----AKEALAHPFFIQIAQ 291 (411)
T ss_pred cHHHHHHHHHeeCchhccc----HHHHhcChHHHHHHH
Confidence 9999999999999999999 999999999965433
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=398.85 Aligned_cols=262 Identities=40% Similarity=0.716 Sum_probs=224.1
Q ss_pred EccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC---CCCCccccceeEecCCeeEEEEeecCC
Q 007433 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL---DHPFLPTLYTHFETDKFSCLVMEFCPG 297 (604)
Q Consensus 221 LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~~~~~~lV~E~~~g 297 (604)
||+|+||+||+|++..+++.||||++.+..............|..++..+ +||||+.++++|.++..+|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 79999999999999999999999999876554444455556677777765 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcc
Q 007433 298 GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTL 377 (604)
Q Consensus 298 gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 377 (604)
|+|..++.+. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.++|+|||++......
T Consensus 81 g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~--------- 149 (330)
T cd05586 81 GELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTD--------- 149 (330)
T ss_pred ChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCC---------
Confidence 9999888765 57999999999999999999999999999999999999999999999999987321100
Q ss_pred cCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccc
Q 007433 378 ESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEY 457 (604)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 457 (604)
......++||+.|
T Consensus 150 -------------------------------------------------------------------~~~~~~~~gt~~y 162 (330)
T cd05586 150 -------------------------------------------------------------------NKTTNTFCGTTEY 162 (330)
T ss_pred -------------------------------------------------------------------CCCccCccCCccc
Confidence 0011235699999
Q ss_pred cCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcc
Q 007433 458 LAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRL 536 (604)
Q Consensus 458 ~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rp 536 (604)
+|||++.+. .++.++|||||||+||||++|+.||.+.+..+.+.++......++.. .++.++++||++||..||.+||
T Consensus 163 ~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~li~~~L~~~P~~R~ 241 (330)
T cd05586 163 LAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN-VLSDEGRQFVKGLLNRNPQHRL 241 (330)
T ss_pred cCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCc-cCCHHHHHHHHHHcCCCHHHCC
Confidence 999998765 47899999999999999999999999888777777777666666543 4789999999999999999999
Q ss_pred cccCCHHHHhcCCCCCCCChhhhhc
Q 007433 537 ACRRGATEIKQHPFFQGVNWALIRC 561 (604)
Q Consensus 537 t~~~~a~elL~Hpff~~~~~~~~~~ 561 (604)
+++..+.++++||||..++|..+..
T Consensus 242 ~~~~~~~~ll~h~~~~~~~~~~~~~ 266 (330)
T cd05586 242 GAHRDAVELKEHPFFADIDWDLLSK 266 (330)
T ss_pred CCCCCHHHHhcCccccCCCHHHHHh
Confidence 8777799999999999999987643
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=385.28 Aligned_cols=263 Identities=32% Similarity=0.594 Sum_probs=219.3
Q ss_pred EccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCCCCH
Q 007433 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDL 300 (604)
Q Consensus 221 LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 300 (604)
||+|+||+||++.+..+++.||+|++.+...........+..|+++|+.++|+||++++++|..+..+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 79999999999999999999999999876555555556677899999999999999999999999999999999999999
Q ss_pred HHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCccc
Q 007433 301 HTLRQRQ--PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLE 378 (604)
Q Consensus 301 ~~ll~~~--~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 378 (604)
..++... ....+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~--------- 151 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ--------- 151 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC---------
Confidence 8877542 23569999999999999999999999999999999999999999999999999874321100
Q ss_pred CCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCcccc
Q 007433 379 SEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYL 458 (604)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~ 458 (604)
.......||+.|+
T Consensus 152 -------------------------------------------------------------------~~~~~~~g~~~y~ 164 (280)
T cd05608 152 -------------------------------------------------------------------SKTKGYAGTPGFM 164 (280)
T ss_pred -------------------------------------------------------------------ccccccCCCcCcc
Confidence 0011346899999
Q ss_pred CcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChH----HHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCC
Q 007433 459 APEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR----ATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQN 534 (604)
Q Consensus 459 APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~----~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~ 534 (604)
|||++.+..++.++|||||||++|||++|+.||...... .....+......++ ..++..+.+||.+||..||++
T Consensus 165 aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P~~ 242 (280)
T cd05608 165 APELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYP--DKFSPASKSFCEALLAKDPEK 242 (280)
T ss_pred CHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCc--ccCCHHHHHHHHHHhcCCHHH
Confidence 999999999999999999999999999999999865432 22223333333333 458899999999999999999
Q ss_pred cccccC-CHHHHhcCCCCCCCChhhhhc
Q 007433 535 RLACRR-GATEIKQHPFFQGVNWALIRC 561 (604)
Q Consensus 535 Rpt~~~-~a~elL~Hpff~~~~~~~~~~ 561 (604)
|++.+. .++++++||||++++|..+..
T Consensus 243 R~~~~~~~~~~~l~h~~~~~~~~~~~~~ 270 (280)
T cd05608 243 RLGFRDGNCDGLRTHPLFRDLNWRQLEA 270 (280)
T ss_pred hcCCCCCCHHHHhcChhhhcCCHhHHhh
Confidence 996543 599999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=385.32 Aligned_cols=257 Identities=28% Similarity=0.419 Sum_probs=211.7
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++.+.||+|+||+||+|++..+++.||||++...... ......+.+|+++++.++|+||++++++|..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 4799999999999999999999999999999999764322 123345668999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||++++.|..+.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--- 154 (287)
T cd07848 80 EYVEKNMLELLEEMP--NGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS--- 154 (287)
T ss_pred ecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc---
Confidence 999887776554432 569999999999999999999999999999999999999999999999999884321100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
........
T Consensus 155 ------------------------------------------------------------------------~~~~~~~~ 162 (287)
T cd07848 155 ------------------------------------------------------------------------NANYTEYV 162 (287)
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00011346
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-------------------CCCCC-
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP-------------------LRFPE- 512 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~-------------------~~~p~- 512 (604)
||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+.... ..++.
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (287)
T cd07848 163 ATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAV 242 (287)
T ss_pred cccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcc
Confidence 8999999999999889999999999999999999999999876655544332210 11111
Q ss_pred ----------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 513 ----------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 513 ----------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
...++.++.+||++||.+||++||+ ++++|+||||
T Consensus 243 ~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s----~~~~l~hp~f 287 (287)
T cd07848 243 NHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYL----TEQCLNHPAF 287 (287)
T ss_pred cCcccHHHhhhcccCHHHHHHHHHHccCCcccCCC----HHHHhcCCCC
Confidence 1236788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=386.55 Aligned_cols=261 Identities=27% Similarity=0.421 Sum_probs=219.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec-----CC
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET-----DK 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-----~~ 286 (604)
..+|..++.||.|+||.|+.|.++.+|..||||.+.. .+.......+..+|+.+|+.++|+||+.+++.+.. -+
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~-~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILN-PFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhh-hhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 3567778999999999999999999999999999853 23445667788999999999999999999999865 46
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
.+|+|+|+| +-||+.+++.+ ..|++..++.+++|||+||.|+|+.+|+||||||.|+|++.+..+||+|||+|+...
T Consensus 100 DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 100 DVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred eeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecc
Confidence 789999999 88999999886 459999999999999999999999999999999999999999999999999995432
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
.. +.+.
T Consensus 177 ~~--------------------------------------------------------------------------~~~~ 182 (359)
T KOG0660|consen 177 KF--------------------------------------------------------------------------FEDG 182 (359)
T ss_pred cc--------------------------------------------------------------------------Cccc
Confidence 10 0111
Q ss_pred cccccccCccccCcceec-CCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc---CC---------------
Q 007433 447 RSMSFVGTHEYLAPEIIK-GEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG---QP--------------- 507 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~-~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~---~~--------------- 507 (604)
..+.++-|.||+|||++. ...|+.++||||+||||+|||+|++.|.|.+..+.+..|+. .+
T Consensus 183 ~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~ 262 (359)
T KOG0660|consen 183 FMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARP 262 (359)
T ss_pred chhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHH
Confidence 234578999999999975 45689999999999999999999999999877666544432 11
Q ss_pred -----CCCC------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 508 -----LRFP------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 508 -----~~~p------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
...| ..+..++.+.||+.+||+.||.+|+| ++|+|+||||...
T Consensus 263 yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRit----a~eAL~hPYl~~~ 316 (359)
T KOG0660|consen 263 YIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRIT----AEEALAHPYLAPY 316 (359)
T ss_pred HHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCC----HHHHhcChhhhhh
Confidence 1111 11457888999999999999999999 9999999999764
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=382.83 Aligned_cols=264 Identities=31% Similarity=0.543 Sum_probs=219.4
Q ss_pred EccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCCCCH
Q 007433 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDL 300 (604)
Q Consensus 221 LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 300 (604)
||+|+||.||++++..+++.||+|++.+...........+..|+++|+.++||||++++++|.++.++|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 79999999999999999999999999765443322333445699999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcccCC
Q 007433 301 HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESE 380 (604)
Q Consensus 301 ~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~ 380 (604)
..++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~----------- 149 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK----------- 149 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-----------
Confidence 988876655568999999999999999999999999999999999999999999999999874321100
Q ss_pred cccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccccCc
Q 007433 381 PLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAP 460 (604)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP 460 (604)
......||..|+||
T Consensus 150 ------------------------------------------------------------------~~~~~~~~~~y~aP 163 (277)
T cd05607 150 ------------------------------------------------------------------TITQRAGTNGYMAP 163 (277)
T ss_pred ------------------------------------------------------------------eeeccCCCCCccCH
Confidence 00123588999999
Q ss_pred ceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCCh----HHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcc
Q 007433 461 EIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSEN----RATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRL 536 (604)
Q Consensus 461 E~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~----~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rp 536 (604)
|++.+..++.++|||||||++|||++|+.||..... .+...........++ ...++.++++||.+||.+||++||
T Consensus 164 E~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~~P~~R~ 242 (277)
T cd05607 164 EILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE-HQNFTEESKDICRLFLAKKPEDRL 242 (277)
T ss_pred HHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc-cccCCHHHHHHHHHHhccCHhhCC
Confidence 999998899999999999999999999999976432 223333333333332 235789999999999999999999
Q ss_pred cccCCHHHHhcCCCCCCCChhhhhcC
Q 007433 537 ACRRGATEIKQHPFFQGVNWALIRCA 562 (604)
Q Consensus 537 t~~~~a~elL~Hpff~~~~~~~~~~~ 562 (604)
+++...++++.||||++++|..+...
T Consensus 243 ~~~~~~~~~~~h~~f~~~~~~~~~~~ 268 (277)
T cd05607 243 GSREKNDDPRKHEFFKTINFPRLEAG 268 (277)
T ss_pred CCccchhhhhcChhhcCCCHHHHhcC
Confidence 97666689999999999999877654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=396.08 Aligned_cols=267 Identities=32% Similarity=0.514 Sum_probs=238.1
Q ss_pred ecCceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec
Q 007433 205 VKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET 284 (604)
Q Consensus 205 ~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 284 (604)
+.++.+. +-|.+.+.||+|.|+.|-+|++.-+|..||||+++|..+..... ..+.+|+..|+.++|||||+||++..+
T Consensus 11 i~DgkIA-GLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st-~hlfqEVRCMKLVQHpNiVRLYEViDT 88 (864)
T KOG4717|consen 11 IYDGKIA-GLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLST-GHLFQEVRCMKLVQHPNIVRLYEVIDT 88 (864)
T ss_pred cccccee-eeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhh-hHHHHHHHHHHHhcCcCeeeeeehhcc
Confidence 3455543 78999999999999999999999999999999999987754333 345679999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEc-cCCcEEEecccccc
Q 007433 285 DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVR-EDGHIMLSDFDLSL 363 (604)
Q Consensus 285 ~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~-~~g~vkL~DFGla~ 363 (604)
...+|||+|+-.+|+|++++-++. ..+.|..+++|++||+.|+.|+|+..+||||||||||++- .-|-|||+|||++-
T Consensus 89 QTKlyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSN 167 (864)
T KOG4717|consen 89 QTKLYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSN 167 (864)
T ss_pred cceEEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccc
Confidence 999999999999999999988764 6799999999999999999999999999999999998775 57899999999984
Q ss_pred cccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCC
Q 007433 364 RCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEP 443 (604)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (604)
.+.++
T Consensus 168 kf~PG--------------------------------------------------------------------------- 172 (864)
T KOG4717|consen 168 KFQPG--------------------------------------------------------------------------- 172 (864)
T ss_pred cCCCc---------------------------------------------------------------------------
Confidence 33211
Q ss_pred CCCcccccccCccccCcceecCCCCC-ccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 007433 444 TNARSMSFVGTHEYLAPEIIKGEGHG-SAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARD 522 (604)
Q Consensus 444 ~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~d 522 (604)
..-.++||++.|-|||++.|..|+ +++||||||||||.|++|++||...++.+++..|+++.+..|.. ++.+++|
T Consensus 173 --~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPsh--vS~eCrd 248 (864)
T KOG4717|consen 173 --KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSH--VSKECRD 248 (864)
T ss_pred --chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchh--hhHHHHH
Confidence 123367899999999999999984 68999999999999999999999999999999999999888876 9999999
Q ss_pred HHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 523 LIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 523 LI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
||..||+.||.+|.+ ++||..|+|++.++..
T Consensus 249 LI~sMLvRdPkkRAs----lEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 249 LIQSMLVRDPKKRAS----LEEIVSTSWLQAGDRG 279 (864)
T ss_pred HHHHHHhcCchhhcc----HHHHhccccccCCCCC
Confidence 999999999999999 9999999999988754
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=387.85 Aligned_cols=261 Identities=28% Similarity=0.428 Sum_probs=209.7
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|+++++||.|+||.||+|++..+++.||||++...... .....+.+|+.+|+.++||||+++++++.++...|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE--GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc--ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 36899999999999999999999999999999999754321 1223456799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+ +++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 82 ~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 157 (303)
T cd07869 82 FEYV-HTDLCQYMDKHP-GGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-- 157 (303)
T ss_pred EECC-CcCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC--
Confidence 9999 578887776543 568999999999999999999999999999999999999999999999999873211000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 158 --------------------------------------------------------------------------~~~~~~ 163 (303)
T cd07869 158 --------------------------------------------------------------------------HTYSNE 163 (303)
T ss_pred --------------------------------------------------------------------------ccCCCC
Confidence 001123
Q ss_pred ccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHH---cCCCC----------------C
Q 007433 452 VGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENR-ATLYNVV---GQPLR----------------F 510 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~-~~l~~i~---~~~~~----------------~ 510 (604)
+||+.|+|||++.+. .++.++|||||||+||||++|..||.+..+. +.+..+. +.+.. +
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (303)
T cd07869 164 VVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERF 243 (303)
T ss_pred cccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccc
Confidence 589999999998764 5788999999999999999999999876443 2222221 11100 0
Q ss_pred ----C-------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCCh
Q 007433 511 ----P-------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNW 556 (604)
Q Consensus 511 ----p-------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~ 556 (604)
+ .....+..+++||.+||++||++||+ +.|+|+||||+.+.+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s----~~~~l~h~~f~~~~~ 296 (303)
T cd07869 244 TLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLS----AQAALSHEYFSDLPP 296 (303)
T ss_pred cccCCccHHHHhhccCCChHHHHHHHHHhccCchhccC----HHHHhcCcccccCCh
Confidence 0 00123567899999999999999999 999999999998764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-46 Score=385.32 Aligned_cols=256 Identities=29% Similarity=0.465 Sum_probs=211.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
+++|+++++||.|+||+||+|++..++..||+|++...... .....+.+|+.+|+.++||||+++++++.+++..|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 46899999999999999999999999999999999754221 1223456899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+. ++|.+++... +..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 82 ~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-- 157 (288)
T cd07871 82 FEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-- 157 (288)
T ss_pred EeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC--
Confidence 99996 5999888764 3468999999999999999999999999999999999999999999999999873221000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 158 --------------------------------------------------------------------------~~~~~~ 163 (288)
T cd07871 158 --------------------------------------------------------------------------KTYSNE 163 (288)
T ss_pred --------------------------------------------------------------------------ccccCc
Confidence 001123
Q ss_pred ccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc---CC----------------CCCC
Q 007433 452 VGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG---QP----------------LRFP 511 (604)
Q Consensus 452 ~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~---~~----------------~~~p 511 (604)
.||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+.. .+ ..++
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (288)
T cd07871 164 VVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFP 243 (288)
T ss_pred eecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccC
Confidence 58999999999876 4689999999999999999999999998776665544332 11 0011
Q ss_pred C---------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 512 E---------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 512 ~---------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
. .+.++.+++|||.+||.+||.+|+| ++|+|+||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t----~~~~l~hp~f 288 (288)
T cd07871 244 QYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRIS----AEAALRHSYF 288 (288)
T ss_pred ccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCC----HHHHhcCCCC
Confidence 1 1346788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=391.99 Aligned_cols=263 Identities=41% Similarity=0.795 Sum_probs=225.0
Q ss_pred EEEEccCCcEEEEEEEE---cCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEee
Q 007433 218 LKKLGCGDIGSVYLSEL---TGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEF 294 (604)
Q Consensus 218 ~~~LG~G~fG~Vy~a~~---~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 294 (604)
++.||+|+||.||++++ ..+++.||+|++.+..... ....+..+|+++|++++||||++++++|.+++.+|+||||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 79 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKV-RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDF 79 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhh-hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcC
Confidence 36799999999999986 3578899999998764432 2334566899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccccc
Q 007433 295 CPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKS 374 (604)
Q Consensus 295 ~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~ 374 (604)
+++++|.+++.+. ..+++..++.++.||+.||.|||++||+||||||+||||+.++.++|+|||++......
T Consensus 80 ~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~------ 151 (318)
T cd05582 80 LRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH------ 151 (318)
T ss_pred CCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCC------
Confidence 9999999988765 56999999999999999999999999999999999999999999999999987321100
Q ss_pred CcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccC
Q 007433 375 STLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGT 454 (604)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT 454 (604)
......+.||
T Consensus 152 ----------------------------------------------------------------------~~~~~~~~g~ 161 (318)
T cd05582 152 ----------------------------------------------------------------------EKKAYSFCGT 161 (318)
T ss_pred ----------------------------------------------------------------------CCceecccCC
Confidence 0011235699
Q ss_pred ccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCC
Q 007433 455 HEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQN 534 (604)
Q Consensus 455 ~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~ 534 (604)
+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......++. .++..+++||++||..||++
T Consensus 162 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~l~~~P~~ 239 (318)
T cd05582 162 VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQ--FLSPEAQSLLRALFKRNPAN 239 (318)
T ss_pred hhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhcCHhH
Confidence 9999999999999999999999999999999999999988887777777776665554 48999999999999999999
Q ss_pred cccccC-CHHHHhcCCCCCCCChhhhhc
Q 007433 535 RLACRR-GATEIKQHPFFQGVNWALIRC 561 (604)
Q Consensus 535 Rpt~~~-~a~elL~Hpff~~~~~~~~~~ 561 (604)
||++.. .+.++++||||+.++|..+..
T Consensus 240 R~~a~~~~~~~~~~~~~~~~~~~~~~~~ 267 (318)
T cd05582 240 RLGAGPDGVEEIKRHPFFSTIDWNKLYR 267 (318)
T ss_pred cCCCCCCCHHHHhCCCCcCCCCHHHHHh
Confidence 999533 478899999999999987654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-47 Score=384.70 Aligned_cols=262 Identities=28% Similarity=0.453 Sum_probs=219.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCC-ccccceeEecCC----
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF-LPTLYTHFETDK---- 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~---- 286 (604)
...|..+++||+|+||+||+|+.+.+|+.||+|.++-.... +.--..+.+|+.+|+.|+|+| |+.|++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 34677888999999999999999999999999999765332 112234568999999999999 999999999877
Q ss_pred --eeEEEEeecCCCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 287 --FSCLVMEFCPGGDLHTLRQRQPG--KYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 287 --~~~lV~E~~~ggsL~~ll~~~~~--~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
.++|||||+ .-+|..++...+. ..++...++.+++||+.||+|||++||+||||||.||||+.+|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 899999999 7899999998753 46888999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccC
Q 007433 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442 (604)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (604)
+-+..... |
T Consensus 168 ra~~ip~~---------------------------------------~-------------------------------- 176 (323)
T KOG0594|consen 168 RAFSIPMR---------------------------------------T-------------------------------- 176 (323)
T ss_pred HHhcCCcc---------------------------------------c--------------------------------
Confidence 53321111 0
Q ss_pred CCCCcccccccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHH---cCC-----------
Q 007433 443 PTNARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV---GQP----------- 507 (604)
Q Consensus 443 ~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~---~~~----------- 507 (604)
...-++|.+|+|||++.|. .|+..+||||+|||++||++++..|.+..+.+++..|. +.+
T Consensus 177 -----yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~ 251 (323)
T KOG0594|consen 177 -----YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSL 251 (323)
T ss_pred -----ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCcccc
Confidence 1234799999999999998 68999999999999999999999999999888876664 322
Q ss_pred ----CCCCCC----------CCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCC
Q 007433 508 ----LRFPES----------PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 508 ----~~~p~~----------~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
..++.+ +..+.+..+|+.+||+++|.+|++ +..+|.||||+.+.
T Consensus 252 ~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~S----a~~al~h~yf~~~~ 309 (323)
T KOG0594|consen 252 PDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRIS----AKGALTHPYFSELP 309 (323)
T ss_pred ccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcC----HHHHhcChhhcccc
Confidence 112211 223357889999999999999999 99999999998763
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=379.42 Aligned_cols=270 Identities=36% Similarity=0.608 Sum_probs=223.3
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
.|++.+.||+|+||.||++.+..+++.||+|.+.+...........+.+|+.+|+.++|+||+.+++.+.+++..|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 37888999999999999999999999999999976544333333455679999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
|++|++|.+++.......+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~----- 155 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG----- 155 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCC-----
Confidence 999999999887665567999999999999999999999999999999999999999999999999987321100
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
.......|
T Consensus 156 ------------------------------------------------------------------------~~~~~~~g 163 (285)
T cd05630 156 ------------------------------------------------------------------------QTIKGRVG 163 (285)
T ss_pred ------------------------------------------------------------------------ccccCCCC
Confidence 00012358
Q ss_pred CccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChH---HHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 454 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR---ATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 454 T~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~---~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
|+.|+|||++.+..++.++|||||||++|+|++|+.||...... .....+... ........++.++++||.+||+.
T Consensus 164 ~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~ 242 (285)
T cd05630 164 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQEEYSEKFSPDARSLCKMLLCK 242 (285)
T ss_pred CccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-hhhhcCccCCHHHHHHHHHHhhc
Confidence 99999999999999999999999999999999999999875432 222222211 11112245788999999999999
Q ss_pred CCCCccccc-CCHHHHhcCCCCCCCChhhhhc
Q 007433 531 EPQNRLACR-RGATEIKQHPFFQGVNWALIRC 561 (604)
Q Consensus 531 dP~~Rpt~~-~~a~elL~Hpff~~~~~~~~~~ 561 (604)
||++|+++. ..++|+++||||++++|..+..
T Consensus 243 ~p~~R~s~~~~~~~~~~~h~~~~~~~~~~~~~ 274 (285)
T cd05630 243 DPKERLGCQGGGAREVKEHPLFKQINFKRLEA 274 (285)
T ss_pred CHHHccCCCCCchHHHHcChhhhccCHHHHhc
Confidence 999999843 2478999999999999997755
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=404.64 Aligned_cols=255 Identities=30% Similarity=0.458 Sum_probs=217.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-C-----CCccccceeEecC
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-H-----PFLPTLYTHFETD 285 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-H-----pnIv~l~~~~~~~ 285 (604)
..+|.+++.||+|+||.|.+|.+..|++.||||+++.. .....+.+.|+.||..|+ | -|||+++++|...
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr 260 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR 260 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence 34999999999999999999999999999999999754 244556778999999996 4 3899999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC--cEEEecccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG--HIMLSDFDLSL 363 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g--~vkL~DFGla~ 363 (604)
+++|||+|++ .-+|+++++.+.-..|+...++.|+.|||.||.+||++||||+|||||||||...+ .|||+|||.+.
T Consensus 261 ~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc 339 (586)
T KOG0667|consen 261 NHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC 339 (586)
T ss_pred cceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence 9999999999 88999999988778899999999999999999999999999999999999997644 79999999872
Q ss_pred cccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCC
Q 007433 364 RCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEP 443 (604)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (604)
..
T Consensus 340 ~~------------------------------------------------------------------------------ 341 (586)
T KOG0667|consen 340 FE------------------------------------------------------------------------------ 341 (586)
T ss_pred cc------------------------------------------------------------------------------
Confidence 11
Q ss_pred CCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---CC------------
Q 007433 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---PL------------ 508 (604)
Q Consensus 444 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~~------------ 508 (604)
.....+++.+..|+|||+|.|.+|+.+.||||||||++||++|.+.|.|.++.+++..|+.- +.
T Consensus 342 -~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~k 420 (586)
T KOG0667|consen 342 -SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHK 420 (586)
T ss_pred -CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccce
Confidence 01122567899999999999999999999999999999999999999999988887666521 10
Q ss_pred -------------------------------------CCC-CC-------C-CCCHHHHHHHHHhhhcCCCCcccccCCH
Q 007433 509 -------------------------------------RFP-ES-------P-VVSFSARDLIKGLLVKEPQNRLACRRGA 542 (604)
Q Consensus 509 -------------------------------------~~p-~~-------~-~~s~~l~dLI~~lL~~dP~~Rpt~~~~a 542 (604)
..| .. . .-...+.|||++||.+||.+|+| .
T Consensus 421 ff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t----p 496 (586)
T KOG0667|consen 421 FFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT----P 496 (586)
T ss_pred ehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC----H
Confidence 001 00 0 11134679999999999999999 9
Q ss_pred HHHhcCCCCCCC
Q 007433 543 TEIKQHPFFQGV 554 (604)
Q Consensus 543 ~elL~Hpff~~~ 554 (604)
.++|+||||.+.
T Consensus 497 ~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 497 AQALNHPFLTGT 508 (586)
T ss_pred HHHhcCcccccc
Confidence 999999999853
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=387.54 Aligned_cols=253 Identities=27% Similarity=0.400 Sum_probs=205.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|+++++||.|+||.||+|++..+++.||||++..... ......+.+|+++|+.++|+||++++++|..++.+|+|
T Consensus 73 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 150 (353)
T PLN00034 73 LSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE--DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVL 150 (353)
T ss_pred HHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc--HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEE
Confidence 3578889999999999999999999999999999965432 22334567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+.+++|... ..+.+..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 151 ~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-- 222 (353)
T PLN00034 151 LEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-- 222 (353)
T ss_pred EecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc--
Confidence 999999998642 346788889999999999999999999999999999999999999999999874321000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 223 --------------------------------------------------------------------------~~~~~~ 228 (353)
T PLN00034 223 --------------------------------------------------------------------------DPCNSS 228 (353)
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 001134
Q ss_pred ccCccccCcceecC-----CCCCccchHHHHHHHHHHHhhCCCCCCCCChHH---HHHHHHcCCCCCCCCCCCCHHHHHH
Q 007433 452 VGTHEYLAPEIIKG-----EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRA---TLYNVVGQPLRFPESPVVSFSARDL 523 (604)
Q Consensus 452 ~GT~~Y~APE~l~~-----~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~---~l~~i~~~~~~~p~~~~~s~~l~dL 523 (604)
+||..|+|||++.. ..++.++|||||||+||||++|+.||......+ .+..+. ..........++.++++|
T Consensus 229 ~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~l 307 (353)
T PLN00034 229 VGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC-MSQPPEAPATASREFRHF 307 (353)
T ss_pred ccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh-ccCCCCCCCccCHHHHHH
Confidence 69999999999853 234578999999999999999999997433221 222222 112222234588999999
Q ss_pred HHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 524 IKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 524 I~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
|.+||..||++||+ +.|+|+||||..
T Consensus 308 i~~~l~~~P~~Rpt----~~ell~hp~~~~ 333 (353)
T PLN00034 308 ISCCLQREPAKRWS----AMQLLQHPFILR 333 (353)
T ss_pred HHHHccCChhhCcC----HHHHhcCccccc
Confidence 99999999999999 999999999975
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=400.20 Aligned_cols=320 Identities=32% Similarity=0.602 Sum_probs=254.6
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
+....|..++.||-|+||.|.+++-.+|...||+|.++|...-.+..+..+..|..||..-+.+-||+||..|++.+.+|
T Consensus 626 MdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLY 705 (1034)
T KOG0608|consen 626 MDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLY 705 (1034)
T ss_pred ccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceE
Confidence 34567999999999999999999999999999999999988878888888889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc--cC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC--AV 367 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~--~~ 367 (604)
+||||++|||+-.++-+. +.|+|..+++|+++|..|+++.|..|+|||||||+||||+.||+|||+||||..-+ ..
T Consensus 706 FVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 706 FVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred EEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999999999998886 78999999999999999999999999999999999999999999999999997433 22
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
...++... +..|.. .+... +.......|...=.+- -+. ...-..
T Consensus 784 dskYYq~g----dH~RqD------Smep~-----~e~~d~~~~lkvL~~r----------a~~-----------~h~r~~ 827 (1034)
T KOG0608|consen 784 DSKYYQEG----DHHRQD------SMEPS-----PEWADISKCLKVLERR----------AMR-----------QHQRIL 827 (1034)
T ss_pred ccccccCC----Cccccc------cCCCc-----hhhccccccchHHHHH----------HHh-----------hhhhhh
Confidence 22222211 111100 00000 0011111110000000 000 000012
Q ss_pred ccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHH--cCCCCCCCCCCCCHHHHHHHH
Q 007433 448 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV--GQPLRFPESPVVSFSARDLIK 525 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~--~~~~~~p~~~~~s~~l~dLI~ 525 (604)
..+.+||+.|+|||+|...+|+.-+||||.|||||||+.|+.||-.....++.++++ ...+.++....++.++.+||.
T Consensus 828 ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~ 907 (1034)
T KOG0608|consen 828 AHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQ 907 (1034)
T ss_pred hhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHH
Confidence 336799999999999999999999999999999999999999999887777666553 345778888889999999999
Q ss_pred HhhhcCCCCcccccCCHHHHhcCCCCCCCChhhhhcCCCCCCCC
Q 007433 526 GLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPK 569 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~~~~~~~~~p~ 569 (604)
+| +.+++.|+. +.++++|..||||++++|..+|....+-||.
T Consensus 908 kL-c~sad~RLG-kng~d~vKaHpfFkgIDfsslRkq~ApYIP~ 949 (1034)
T KOG0608|consen 908 KL-CCSADSRLG-KNGADQVKAHPFFKGIDFSSLRKQRAPYIPR 949 (1034)
T ss_pred HH-hcChhhhhc-ccchhhhhcCccccccchHhhhhccCCcCcc
Confidence 86 668999997 7789999999999999999998887776664
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=400.12 Aligned_cols=275 Identities=36% Similarity=0.663 Sum_probs=249.2
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
+.+.+++++..||.||||.|-++........||+|+++|....+.+....+..|..||..++.|+||+||..|.+++++|
T Consensus 417 v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvY 496 (732)
T KOG0614|consen 417 VKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVY 496 (732)
T ss_pred cchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhh
Confidence 34578888999999999999999998887789999999988877777778889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
++||-|-||.|.++++.. +.|.+..+++|+..+++|++|||.+|||+|||||||+||+.+|-+||.|||+|..++.
T Consensus 497 mLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~-- 572 (732)
T KOG0614|consen 497 MLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGS-- 572 (732)
T ss_pred hhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhcc--
Confidence 999999999999999876 6899999999999999999999999999999999999999999999999999966542
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
+.+.-
T Consensus 573 ---------------------------------------------------------------------------g~KTw 577 (732)
T KOG0614|consen 573 ---------------------------------------------------------------------------GRKTW 577 (732)
T ss_pred ---------------------------------------------------------------------------CCcee
Confidence 22345
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
+|+||++|.|||++.+.+++.++|.||||+++||||+|.+||.+.+...++..|+.+--.+..+..++..+.+||+++-.
T Consensus 578 TFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik~LCr 657 (732)
T KOG0614|consen 578 TFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIKKLCR 657 (732)
T ss_pred eecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHHHHHh
Confidence 78999999999999999999999999999999999999999999999999888887643333445699999999999999
Q ss_pred cCCCCcccc-cCCHHHHhcCCCCCCCChhhhhcCC
Q 007433 530 KEPQNRLAC-RRGATEIKQHPFFQGVNWALIRCAS 563 (604)
Q Consensus 530 ~dP~~Rpt~-~~~a~elL~Hpff~~~~~~~~~~~~ 563 (604)
.+|.+|+.+ +.++.+|.+|.||.+++|.-++..+
T Consensus 658 ~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~ 692 (732)
T KOG0614|consen 658 DNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRT 692 (732)
T ss_pred cCcHhhhccccCChHHHHhhhhhhcCChhhhhhcc
Confidence 999999996 5789999999999999999876654
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=387.66 Aligned_cols=263 Identities=26% Similarity=0.389 Sum_probs=210.0
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC-----Cee
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD-----KFS 288 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~~ 288 (604)
+|++.+.||+|+||.||+|.+..++..||||++..... ......++.+|+++|+.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 59999999999999999999999999999999864321 122334567899999999999999999988643 358
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|+||||| +++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 80 ~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 156 (338)
T cd07859 80 YVVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156 (338)
T ss_pred EEEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence 9999999 67999888765 46999999999999999999999999999999999999999999999999988432100
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
.. .....
T Consensus 157 ~~-------------------------------------------------------------------------~~~~~ 163 (338)
T cd07859 157 TP-------------------------------------------------------------------------TAIFW 163 (338)
T ss_pred cC-------------------------------------------------------------------------ccccc
Confidence 00 00011
Q ss_pred cccccCccccCcceecC--CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHH---cC-----------------
Q 007433 449 MSFVGTHEYLAPEIIKG--EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV---GQ----------------- 506 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~--~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~---~~----------------- 506 (604)
...+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+. +.
T Consensus 164 ~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~ 243 (338)
T cd07859 164 TDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRY 243 (338)
T ss_pred cCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHH
Confidence 23469999999999876 578899999999999999999999998765443322111 00
Q ss_pred ------CCCCC---CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 507 ------PLRFP---ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 507 ------~~~~p---~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
....+ ..+.++..+.+||.+||..||++||+ +.|+|+||||+++...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~e~l~hp~f~~~~~~ 299 (338)
T cd07859 244 LSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPT----AEEALADPYFKGLAKV 299 (338)
T ss_pred HHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCC----HHHHhcCchhhhcCcc
Confidence 00000 11346788999999999999999999 9999999999876653
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=390.19 Aligned_cols=253 Identities=28% Similarity=0.453 Sum_probs=216.8
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC-eeEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK-FSCL 290 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-~~~l 290 (604)
.....+.+.||.|+||+||+|.+.++. .||||++......... ...+.+|+.+|.+|+|||||+++|++.... .++|
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~g~~-~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~i 117 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWRGTD-VVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCI 117 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeCCce-eEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEE
Confidence 345566677999999999999998875 4999999876544433 667889999999999999999999999877 7999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcC-eEeccCCCCcEEEccCC-cEEEecccccccccCC
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLG-IVYRDLKPENVLVREDG-HIMLSDFDLSLRCAVS 368 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~g-IvHrDIKpeNILl~~~g-~vkL~DFGla~~~~~~ 368 (604)
||||+++|+|..++.......|++..+..|+.||++||+|||+++ ||||||||+||||+.++ ++||+|||+++.....
T Consensus 118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999999999998854578999999999999999999999999 99999999999999998 9999999998432210
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
. ...
T Consensus 198 ~----------------------------------------------------------------------------~~~ 201 (362)
T KOG0192|consen 198 K----------------------------------------------------------------------------TSM 201 (362)
T ss_pred c----------------------------------------------------------------------------ccc
Confidence 0 011
Q ss_pred cccccCccccCcceec--CCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007433 449 MSFVGTHEYLAPEIIK--GEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKG 526 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~--~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~ 526 (604)
+...||+.|||||++. ...|+.++|||||||+||||+||+.||.+....+....++....+.+....++..+..||.+
T Consensus 202 ~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~ 281 (362)
T KOG0192|consen 202 TSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPPHLSSLMER 281 (362)
T ss_pred cCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHHHH
Confidence 2256999999999999 56899999999999999999999999999988777777776666655555599999999999
Q ss_pred hhhcCCCCcccccCCHHHHh
Q 007433 527 LLVKEPQNRLACRRGATEIK 546 (604)
Q Consensus 527 lL~~dP~~Rpt~~~~a~elL 546 (604)
||..||..||+ ..+++
T Consensus 282 CW~~dp~~RP~----f~ei~ 297 (362)
T KOG0192|consen 282 CWLVDPSRRPS----FLEIV 297 (362)
T ss_pred hCCCCCCcCCC----HHHHH
Confidence 99999999999 55554
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=384.94 Aligned_cols=258 Identities=26% Similarity=0.404 Sum_probs=215.0
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
..++|++++.||+|+||.||++++..++..||+|++..... .....++.+|+++|+.++||||+++++++..++..|+
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 34799999999999999999999999999999999976422 2234467789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHc-CeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML-GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
||||+++++|.+++... ..+++..+..++.|++.||.|||++ +|+||||||+|||++.++.++|+|||++.....
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-- 156 (331)
T cd06649 81 CMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 156 (331)
T ss_pred EeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc--
Confidence 99999999999998775 4689999999999999999999986 699999999999999999999999998732210
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
....
T Consensus 157 ----------------------------------------------------------------------------~~~~ 160 (331)
T cd06649 157 ----------------------------------------------------------------------------SMAN 160 (331)
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0011
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC-----------------------
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ----------------------- 506 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~----------------------- 506 (604)
..+||+.|+|||++.+..++.++|||||||+||||++|+.||...+..+. ..+.+.
T Consensus 161 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd06649 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL-EAIFGRPVVDGEEGEPHSISPRPRPPGRP 239 (331)
T ss_pred cCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHhcccccccccCCccccCccccccccc
Confidence 34689999999999999999999999999999999999999976544332 222111
Q ss_pred ------------------------CCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCC
Q 007433 507 ------------------------PLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 507 ------------------------~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
.........++.++++||.+||.+||++||+ +.|||+||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt----~~ell~h~~~~~~~ 308 (331)
T cd06649 240 VSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERAD----LKMLMNHTFIKRSE 308 (331)
T ss_pred ccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCC----HHHHhcChHHhhcc
Confidence 0000011246789999999999999999999 99999999997543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=396.43 Aligned_cols=256 Identities=28% Similarity=0.447 Sum_probs=226.3
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
..|+.+++||+|.||.||+|.+..+++.||+|+++.+... ..+..+++|+.+|..++++||.++|+.|..+..++++|
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcc--hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 4688889999999999999999999999999999876433 34556788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
|||.||++.++++.. ..+.|..+..++++++.||.|||.++.+|||||+.||||..+|.+||+|||++..+.
T Consensus 91 ey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~------ 162 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLT------ 162 (467)
T ss_pred HHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeee------
Confidence 999999999999875 456999999999999999999999999999999999999999999999999883321
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.+..+..+|+
T Consensus 163 ----------------------------------------------------------------------~~~~rr~tfv 172 (467)
T KOG0201|consen 163 ----------------------------------------------------------------------NTVKRRKTFV 172 (467)
T ss_pred ----------------------------------------------------------------------chhhcccccc
Confidence 1222346889
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEP 532 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP 532 (604)
||+.|||||++++.+|+.++||||||++.|||++|.+||........++.|-...+..-.. .++..+++||..||.+||
T Consensus 173 GTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~-~~S~~~kEFV~~CL~k~P 251 (467)
T KOG0201|consen 173 GTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDG-DFSPPFKEFVEACLDKNP 251 (467)
T ss_pred ccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCcccc-ccCHHHHHHHHHHhhcCc
Confidence 9999999999999999999999999999999999999999988876666665544332222 689999999999999999
Q ss_pred CCcccccCCHHHHhcCCCCCC
Q 007433 533 QNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 533 ~~Rpt~~~~a~elL~Hpff~~ 553 (604)
+.||+ |.+||+|+|++.
T Consensus 252 ~~Rps----A~~LLKh~FIk~ 268 (467)
T KOG0201|consen 252 EFRPS----AKELLKHKFIKR 268 (467)
T ss_pred ccCcC----HHHHhhhHHHHh
Confidence 99999 999999999975
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=395.52 Aligned_cols=253 Identities=23% Similarity=0.346 Sum_probs=205.6
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
...+|+++++||+|+||.||+|.+..+++.||||..... .+.+|+++|+.|+||||++++++|..+...|+
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~---------~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRG---------GTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhh---------hhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 346899999999999999999999999999999976432 34579999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
|||++ +++|..++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++.++|+|||++......
T Consensus 161 v~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-- 235 (391)
T PHA03212 161 ILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-- 235 (391)
T ss_pred EEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc--
Confidence 99999 67898887664 46899999999999999999999999999999999999999999999999988321100
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
.......
T Consensus 236 -------------------------------------------------------------------------~~~~~~~ 242 (391)
T PHA03212 236 -------------------------------------------------------------------------NANKYYG 242 (391)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0001123
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCCh-------HHHHHHHHc------------------
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSEN-------RATLYNVVG------------------ 505 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~-------~~~l~~i~~------------------ 505 (604)
.+||+.|+|||++.+..++.++|||||||+||||++|..||..... ...+..++.
T Consensus 243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~ 322 (391)
T PHA03212 243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLD 322 (391)
T ss_pred ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHH
Confidence 5799999999999999999999999999999999999988754211 111111110
Q ss_pred --------CCCCCCC-------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 506 --------QPLRFPE-------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 506 --------~~~~~p~-------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
.....+. ...++.++.+||.+||.+||++||+ +.|+|+||||+.+
T Consensus 323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpt----a~elL~hp~f~~~ 382 (391)
T PHA03212 323 EIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPS----AEALLDFAAFQDI 382 (391)
T ss_pred HHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCC----HHHHhcChhhccC
Confidence 0000000 0124668999999999999999999 9999999999763
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-45 Score=374.33 Aligned_cols=279 Identities=34% Similarity=0.590 Sum_probs=228.8
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
.|+..+.||.|+||+||+|.+..+++.||+|++.+...........+.+|+++|+.++|+||+.+++.|..++..|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 47889999999999999999999999999999977654444444456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
|+++++|..++.......+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~----- 155 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEG----- 155 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCC-----
Confidence 999999998887654457999999999999999999999999999999999999999999999999987432100
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
.......|
T Consensus 156 ------------------------------------------------------------------------~~~~~~~g 163 (285)
T cd05632 156 ------------------------------------------------------------------------ESIRGRVG 163 (285)
T ss_pred ------------------------------------------------------------------------CcccCCCC
Confidence 00112358
Q ss_pred CccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC--CCCCCCCCCCCHHHHHHHHHhhhcC
Q 007433 454 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ--PLRFPESPVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 454 T~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~--~~~~p~~~~~s~~l~dLI~~lL~~d 531 (604)
++.|+|||++.+..++.++|+|||||++|||++|..||.+.........+... .........++.++.+||.+||..|
T Consensus 164 ~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 243 (285)
T cd05632 164 TVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKD 243 (285)
T ss_pred CcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHccCC
Confidence 99999999999989999999999999999999999999876654433333221 1111223457889999999999999
Q ss_pred CCCccccc-CCHHHHhcCCCCCCCChhhhhc--CCCCCCCC
Q 007433 532 PQNRLACR-RGATEIKQHPFFQGVNWALIRC--ASPPEIPK 569 (604)
Q Consensus 532 P~~Rpt~~-~~a~elL~Hpff~~~~~~~~~~--~~~~~~p~ 569 (604)
|++||++. .++.++++|+||..++|..+.. ..|+.+|.
T Consensus 244 P~~R~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05632 244 PKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPFVPD 284 (285)
T ss_pred HhHcCCCcccChHHHHcChhhhcCCHHHHhcCcCCCCCCCC
Confidence 99999964 3588999999999999986543 33444443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=380.92 Aligned_cols=255 Identities=29% Similarity=0.491 Sum_probs=213.2
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec--CC---e
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET--DK---F 287 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~---~ 287 (604)
-.|.-.+.+|.|+||.||.|....++..||||.+-.+.- . -.+|++||+.++|||||+|..+|.. +. +
T Consensus 24 i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~---knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 24 ISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----Y---KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----c---CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhH
Confidence 368999999999999999999999999999998865421 1 1369999999999999999999863 22 5
Q ss_pred eEEEEeecCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccC-CcEEEeccccccc
Q 007433 288 SCLVMEFCPGGDLHTLRQRQ--PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRED-GHIMLSDFDLSLR 364 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~--~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~-g~vkL~DFGla~~ 364 (604)
..|||||+ ..+|..+++.. .+..++.-.++-|++||++||.|||++|||||||||.|||++.+ |.+||||||.|..
T Consensus 97 lnlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 97 LNLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 67899999 67999888752 24679999999999999999999999999999999999999965 9999999998865
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
+..
T Consensus 176 L~~----------------------------------------------------------------------------- 178 (364)
T KOG0658|consen 176 LVK----------------------------------------------------------------------------- 178 (364)
T ss_pred ecc-----------------------------------------------------------------------------
Confidence 432
Q ss_pred CCcccccccCccccCcceecCCC-CCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc---CC-------------
Q 007433 445 NARSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG---QP------------- 507 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~---~~------------- 507 (604)
+..+.++.-|..|+|||++.|.. |+.++||||.||+++||+.|++.|.|.+..+++..|++ .+
T Consensus 179 ~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~ 258 (364)
T KOG0658|consen 179 GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYT 258 (364)
T ss_pred CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccc
Confidence 12234667899999999998864 89999999999999999999999999888777765543 11
Q ss_pred -CCCC----------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCCh
Q 007433 508 -LRFP----------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNW 556 (604)
Q Consensus 508 -~~~p----------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~ 556 (604)
..+| ....+++++.||+.++|.++|.+|.+ +.|+|+||||+.++-
T Consensus 259 ~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~----~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 259 EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLS----ALEALAHPFFDELRD 314 (364)
T ss_pred cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCC----HHHHhcchhhHHhhC
Confidence 1111 12457889999999999999999999 999999999987653
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=370.97 Aligned_cols=265 Identities=43% Similarity=0.788 Sum_probs=231.7
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++.+.||.|+||.||++.+..+++.||+|++.+...........+.+|+++|++++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765545555667788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||+|.||||+.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~---- 154 (290)
T cd05580 81 EYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR---- 154 (290)
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence 999999999998876 57999999999999999999999999999999999999999999999999987332100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.....
T Consensus 155 ---------------------------------------------------------------------------~~~~~ 159 (290)
T cd05580 155 ---------------------------------------------------------------------------TYTLC 159 (290)
T ss_pred ---------------------------------------------------------------------------CCCCC
Confidence 11235
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEP 532 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP 532 (604)
|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+......++. .++..++++|.+||..||
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~~~l~~~p 237 (290)
T cd05580 160 GTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPS--FFSPDAKDLIRNLLQVDL 237 (290)
T ss_pred CCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCc--cCCHHHHHHHHHHccCCH
Confidence 889999999998888899999999999999999999999887766666677666555554 478999999999999999
Q ss_pred CCccc-ccCCHHHHhcCCCCCCCChhhhh
Q 007433 533 QNRLA-CRRGATEIKQHPFFQGVNWALIR 560 (604)
Q Consensus 533 ~~Rpt-~~~~a~elL~Hpff~~~~~~~~~ 560 (604)
.+|++ ....++|+++||||+.++|..+.
T Consensus 238 ~~R~~~~~~~~~~l~~~~~~~~~~~~~~~ 266 (290)
T cd05580 238 TKRLGNLKNGVNDIKNHPWFAGIDWIALL 266 (290)
T ss_pred HHccCcccCCHHHHHcCcccccCCHHHHh
Confidence 99993 23349999999999999998775
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=374.78 Aligned_cols=256 Identities=27% Similarity=0.406 Sum_probs=207.3
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcC-CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC---CCCCccccceeEe-----
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTG-TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL---DHPFLPTLYTHFE----- 283 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~----- 283 (604)
.+|++++.||+|+||.||+|++.. ++..||+|++....... .......+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 379999999999999999999854 46789999987543221 1112334566666655 7999999999885
Q ss_pred cCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccc
Q 007433 284 TDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 284 ~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
....+|+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.
T Consensus 80 ~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccC-CCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 345789999999 5799999887666679999999999999999999999999999999999999999999999999874
Q ss_pred cccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCC
Q 007433 364 RCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEP 443 (604)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (604)
.....
T Consensus 159 ~~~~~--------------------------------------------------------------------------- 163 (290)
T cd07862 159 IYSFQ--------------------------------------------------------------------------- 163 (290)
T ss_pred eccCC---------------------------------------------------------------------------
Confidence 32100
Q ss_pred CCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-----CCCC-------
Q 007433 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP-----LRFP------- 511 (604)
Q Consensus 444 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~-----~~~p------- 511 (604)
.......||+.|+|||++.+..++.++|||||||++|||++|++||.+....+.+..+.... ..++
T Consensus 164 --~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 241 (290)
T cd07862 164 --MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPR 241 (290)
T ss_pred --cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccc
Confidence 01113468999999999999899999999999999999999999999988777766664311 0000
Q ss_pred -------------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 512 -------------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 512 -------------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
..+.++..+++||.+||.+||++||+ +.|+|+||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~~~l~hp~f 290 (290)
T cd07862 242 QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSALSHPYF 290 (290)
T ss_pred hhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCC----HHHHhcCCCC
Confidence 01346778899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=400.03 Aligned_cols=257 Identities=27% Similarity=0.438 Sum_probs=208.0
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC------
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD------ 285 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------ 285 (604)
..+|++++.||+|+||.||+|.+..+++.||||.+..... ...+|+.+|+.++|+||++++++|...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ-------YKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 4689999999999999999999999999999999865421 123699999999999999999987532
Q ss_pred --CeeEEEEeecCCCCHHHHHHh--cCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC-cEEEeccc
Q 007433 286 --KFSCLVMEFCPGGDLHTLRQR--QPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG-HIMLSDFD 360 (604)
Q Consensus 286 --~~~~lV~E~~~ggsL~~ll~~--~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g-~vkL~DFG 360 (604)
.++|+||||++ ++|..++.. .....+++..++.|+.||+.||+|||++|||||||||+||||+.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 35789999995 577776653 2346799999999999999999999999999999999999999665 69999999
Q ss_pred ccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccc
Q 007433 361 LSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELI 440 (604)
Q Consensus 361 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (604)
++..+...
T Consensus 217 la~~~~~~------------------------------------------------------------------------ 224 (440)
T PTZ00036 217 SAKNLLAG------------------------------------------------------------------------ 224 (440)
T ss_pred cchhccCC------------------------------------------------------------------------
Confidence 98432110
Q ss_pred cCCCCCcccccccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---C---------
Q 007433 441 AEPTNARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---P--------- 507 (604)
Q Consensus 441 ~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~--------- 507 (604)
......+||+.|+|||++.+. .|+.++|||||||+||||++|.+||.+....+.+.+++.. +
T Consensus 225 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~ 299 (440)
T PTZ00036 225 -----QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN 299 (440)
T ss_pred -----CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhc
Confidence 011234689999999998765 6899999999999999999999999988766665554321 1
Q ss_pred -----CCCCC----------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 508 -----LRFPE----------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 508 -----~~~p~----------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
..++. ....+.++++||.+||.+||.+|++ +.|+|+||||+.+.+.
T Consensus 300 ~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~t----a~e~l~hp~f~~~~~~ 360 (440)
T PTZ00036 300 PNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLN----PIEALADPFFDDLRDP 360 (440)
T ss_pred hhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcC----HHHHhCChhHHhhhcc
Confidence 11111 1236788999999999999999999 9999999999876553
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=393.45 Aligned_cols=260 Identities=29% Similarity=0.499 Sum_probs=234.7
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCe-eEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKF-SCL 290 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~-~~l 290 (604)
.++|.+++.+|.|+||.+++++++..+..|++|.++-.....+... .+..|+.+++++.|||||.+++.|+.++. +||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~-~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERR-SAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhH-HHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 4689999999999999999999999999999999988766554443 56789999999999999999999998887 999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
||+||+||+|.+++.++.+..|+|+.+..|+.|++.||.|||++.|+|||||+.|||++.++.|+|.|||+|+.+...
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~-- 159 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE-- 159 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc--
Confidence 999999999999999988899999999999999999999999999999999999999999999999999999654321
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
.....+
T Consensus 160 --------------------------------------------------------------------------~~~a~t 165 (426)
T KOG0589|consen 160 --------------------------------------------------------------------------DSLAST 165 (426)
T ss_pred --------------------------------------------------------------------------hhhhhe
Confidence 112336
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
.+||+.||.||++.+.+|+.++|||||||++|||++-+.+|.+.+-...+.+|.... -.|.+...+.+++.||..||..
T Consensus 166 vvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~-~~Plp~~ys~el~~lv~~~l~~ 244 (426)
T KOG0589|consen 166 VVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL-YSPLPSMYSSELRSLVKSMLRK 244 (426)
T ss_pred ecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc-CCCCCccccHHHHHHHHHHhhc
Confidence 789999999999999999999999999999999999999999988888888887665 4456667999999999999999
Q ss_pred CCCCcccccCCHHHHhcCCCCCC
Q 007433 531 EPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
+|++||+ +.+||.+|.++.
T Consensus 245 ~P~~RPs----a~~LL~~P~l~~ 263 (426)
T KOG0589|consen 245 NPEHRPS----ALELLRRPHLLR 263 (426)
T ss_pred CCccCCC----HHHHhhChhhhh
Confidence 9999999 999999998863
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=364.04 Aligned_cols=280 Identities=38% Similarity=0.744 Sum_probs=243.6
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCee
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 288 (604)
+++++|.+++.||+|+|+.|.++++..|.+.||+|++++..+.+.+.+.-++.|..+...- +||++|-|+.+|+++..+
T Consensus 247 l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrl 326 (593)
T KOG0695|consen 247 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRL 326 (593)
T ss_pred cccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceE
Confidence 5678999999999999999999999999999999999999888888888889999998776 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
++|.||++||+|--.++++ ..|+|+.+++|..+|+.||.|||++|||+||||.+|+||+..|++||+|+|+...-.
T Consensus 327 ffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l-- 402 (593)
T KOG0695|consen 327 FFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-- 402 (593)
T ss_pred EEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCC--
Confidence 9999999999998888877 679999999999999999999999999999999999999999999999999762110
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
. .....
T Consensus 403 -------------------------------------------------------------------------~-~gd~t 408 (593)
T KOG0695|consen 403 -------------------------------------------------------------------------G-PGDTT 408 (593)
T ss_pred -------------------------------------------------------------------------C-CCccc
Confidence 0 01123
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCC-------CChHHHHHH-HHcCCCCCCCCCCCCHHH
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKG-------SENRATLYN-VVGQPLRFPESPVVSFSA 520 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~-------~~~~~~l~~-i~~~~~~~p~~~~~s~~l 520 (604)
.+|+|||.|+|||+++|+.|+..+|||+|||++|||+.|+.||.- .+..+.++. |+....+.|.+ ++-.+
T Consensus 409 stfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprs--lsvka 486 (593)
T KOG0695|consen 409 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRS--LSVKA 486 (593)
T ss_pred ccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccce--eehhh
Confidence 478999999999999999999999999999999999999999952 233445554 45566777665 77788
Q ss_pred HHHHHHhhhcCCCCccccc--CCHHHHhcCCCCCCCChhhhhc--CCCCCCCC
Q 007433 521 RDLIKGLLVKEPQNRLACR--RGATEIKQHPFFQGVNWALIRC--ASPPEIPK 569 (604)
Q Consensus 521 ~dLI~~lL~~dP~~Rpt~~--~~a~elL~Hpff~~~~~~~~~~--~~~~~~p~ 569 (604)
..++++.|.+||.+|+.++ .++.++..|+||+.++|..+.. ..||.-|.
T Consensus 487 s~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~ 539 (593)
T KOG0695|consen 487 SHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQ 539 (593)
T ss_pred HHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCc
Confidence 8999999999999999985 4899999999999999997744 34555554
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=386.44 Aligned_cols=260 Identities=24% Similarity=0.391 Sum_probs=210.7
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcC--CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTG--TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
..+|.+++.||.|+||.||+|...+ ++..||+|.+.... ...+|+++|+.|+|+||++++++|..+...|
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~ 162 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKSTVC 162 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence 4689999999999999999997654 56789999986542 2346999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
+|||++ +++|..++... ..+++..++.|+.||+.||.|||++|||||||||+||||+.++.++|+|||++..+....
T Consensus 163 lv~e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 163 MVMPKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEehhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 999999 57888888543 579999999999999999999999999999999999999999999999999884332110
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
. .....
T Consensus 240 ~--------------------------------------------------------------------------~~~~~ 245 (392)
T PHA03207 240 D--------------------------------------------------------------------------TPQCY 245 (392)
T ss_pred c--------------------------------------------------------------------------ccccc
Confidence 0 00112
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCCh---HHHHHHHHc----CCCCCCC----------
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSEN---RATLYNVVG----QPLRFPE---------- 512 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~---~~~l~~i~~----~~~~~p~---------- 512 (604)
.++||+.|+|||++.+..++.++|||||||+||||++|+.||.+... ...+..++. .+..++.
T Consensus 246 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~ 325 (392)
T PHA03207 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHF 325 (392)
T ss_pred ccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHH
Confidence 35799999999999999999999999999999999999999976532 222222221 0111110
Q ss_pred ------------------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhhhh
Q 007433 513 ------------------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIR 560 (604)
Q Consensus 513 ------------------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~~ 560 (604)
...++.++++||.+||.+||++||+ +.|+|+||||....|..++
T Consensus 326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rps----a~e~l~~p~f~~~~~~~~~ 387 (392)
T PHA03207 326 KQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPS----AQDILSLPLFTKEPINLLN 387 (392)
T ss_pred HhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCC----HHHHhhCchhhccchhhhc
Confidence 0134678899999999999999999 9999999999988777654
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=382.79 Aligned_cols=255 Identities=27% Similarity=0.446 Sum_probs=206.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC------
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD------ 285 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------ 285 (604)
.++|++++.||.|+||.||++.+..++..||||++.+... ......++.+|+.+++.++||||++++++|...
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 4799999999999999999999999999999999975432 223344667899999999999999999998654
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
..+|+||||+. ++|...+.. .+++..+..++.||+.||+|||++||+||||||+||||+.+|.+||+|||++...
T Consensus 99 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~ 173 (359)
T cd07876 99 QDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 173 (359)
T ss_pred ceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence 35799999995 566665543 4889999999999999999999999999999999999999999999999987321
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
.. .
T Consensus 174 ~~-----------------------------------------------------------------------------~ 176 (359)
T cd07876 174 CT-----------------------------------------------------------------------------N 176 (359)
T ss_pred cc-----------------------------------------------------------------------------C
Confidence 10 0
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc--------------------
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG-------------------- 505 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~-------------------- 505 (604)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+..
T Consensus 177 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (359)
T cd07876 177 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNY 256 (359)
T ss_pred ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHH
Confidence 001124689999999999999999999999999999999999999988765443322211
Q ss_pred --CCCCCC------------------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 506 --QPLRFP------------------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 506 --~~~~~p------------------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
....++ .....+..+++||.+||.+||++||+ +.|+|+||||..
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l~hp~~~~ 320 (359)
T cd07876 257 VENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRIS----VDEALRHPYITV 320 (359)
T ss_pred HhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCC----HHHHhcCchhhh
Confidence 111110 01124577899999999999999999 999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=382.24 Aligned_cols=255 Identities=27% Similarity=0.431 Sum_probs=208.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC------
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD------ 285 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------ 285 (604)
.++|++++.||+|+||.||+|.+..+++.||||++.+... ......++.+|+.+++.++||||++++++|...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 4799999999999999999999999999999999975422 122334567899999999999999999988643
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
..+|+||||+. ++|..++.. .+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++...
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~ 176 (364)
T cd07875 102 QDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 176 (364)
T ss_pred CeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence 46799999994 577776653 3889999999999999999999999999999999999999999999999998432
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
...
T Consensus 177 ~~~----------------------------------------------------------------------------- 179 (364)
T cd07875 177 GTS----------------------------------------------------------------------------- 179 (364)
T ss_pred CCC-----------------------------------------------------------------------------
Confidence 100
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC------------------
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP------------------ 507 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~------------------ 507 (604)
......+||..|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+.+++...
T Consensus 180 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (364)
T cd07875 180 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTY 259 (364)
T ss_pred CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHH
Confidence 00113468999999999999999999999999999999999999999877666555443210
Q ss_pred ----CC--------------CC----CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 508 ----LR--------------FP----ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 508 ----~~--------------~p----~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
.. ++ .....+..+++||.+||..||.+||| +.++|+||||+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t----~~e~L~hp~~~~ 323 (364)
T cd07875 260 VENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS----VDEALQHPYINV 323 (364)
T ss_pred HhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCC----HHHHhcCccccc
Confidence 00 00 01123467899999999999999999 999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=367.99 Aligned_cols=287 Identities=38% Similarity=0.649 Sum_probs=233.5
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++++.||.|+||.||++.+..+++.||+|.+.+...........+.+|+++++.++||||+++++.+.+++++|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 37999999999999999999999999999999998765444455567778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||++|++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||||+.+|.++|+|||++..........
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~ 158 (305)
T cd05609 81 EYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158 (305)
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence 999999999999775 468999999999999999999999999999999999999999999999999874211100000
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.... . ..............
T Consensus 159 ~~~~---------------------------------------------------~----------~~~~~~~~~~~~~~ 177 (305)
T cd05609 159 LYEG---------------------------------------------------H----------IEKDTREFLDKQVC 177 (305)
T ss_pred cccc---------------------------------------------------c----------cccchhhccccCCc
Confidence 0000 0 00000000111245
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCC-CCCCHHHHHHHHHhhhcC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPES-PVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~-~~~s~~l~dLI~~lL~~d 531 (604)
|+..|+|||.+.+..++.++|+|||||++|||++|..||.+....+.+..+.......+.. ..++.++++||.+||..|
T Consensus 178 ~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 257 (305)
T cd05609 178 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQN 257 (305)
T ss_pred cCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccC
Confidence 8899999999998889999999999999999999999999887777777766655444433 257889999999999999
Q ss_pred CCCcccccCCHHHHhcCCCCCCCChhhhhcCC
Q 007433 532 PQNRLACRRGATEIKQHPFFQGVNWALIRCAS 563 (604)
Q Consensus 532 P~~Rpt~~~~a~elL~Hpff~~~~~~~~~~~~ 563 (604)
|++||+. ..+.++|+||||...+|+......
T Consensus 258 P~~R~~~-~~~~~ll~~~~~~~~~~~~~~~~~ 288 (305)
T cd05609 258 PLERLGT-GGAFEVKQHRFFLGLDWNGLLRQK 288 (305)
T ss_pred hhhccCc-cCHHHHHhCccccCCCHHHHhhcC
Confidence 9999984 347999999999999999765443
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=379.32 Aligned_cols=258 Identities=26% Similarity=0.407 Sum_probs=212.9
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
..++|++.++||.|+||.||++.+..++..+|+|++..... ......+.+|+++|+.++|+||++++++|.+++++||
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 34799999999999999999999999999999999875422 2233456789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHc-CeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML-GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
||||+++++|.+++... ..+++..+..++.||+.||.|||+. +|+||||||+|||++.+|.+||+|||++..+...
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 81 CMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred EEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 99999999999998775 4689999999999999999999975 7999999999999999999999999987332100
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
...
T Consensus 158 -----------------------------------------------------------------------------~~~ 160 (333)
T cd06650 158 -----------------------------------------------------------------------------MAN 160 (333)
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 011
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHH---------------------------
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN--------------------------- 502 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~--------------------------- 502 (604)
.+.||..|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (333)
T cd06650 161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSS 240 (333)
T ss_pred cCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhh
Confidence 23689999999999998899999999999999999999999976543322111
Q ss_pred -----------------HHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 503 -----------------VVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 503 -----------------i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
+............++.++++||.+||.+||++||+ +.|+++||||+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt----~~ell~h~~~~~~ 305 (333)
T cd06650 241 YGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERAD----LKQLMVHAFIKRS 305 (333)
T ss_pred hcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcC----HHHHhhCHHHhcC
Confidence 00110000011236788999999999999999999 9999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=374.13 Aligned_cols=259 Identities=28% Similarity=0.445 Sum_probs=211.2
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|.+++.||.|+||.||+|++..++..||+|++....... ....+.+|+++++.++|+||+++++++..++..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 468999999999999999999999999999999997543221 122456799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||++ ++|..++... +..+++..++.++.||+.||+|||++||+||||||+||||+.++.++|+|||++.......
T Consensus 83 ~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-- 158 (309)
T cd07872 83 FEYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT-- 158 (309)
T ss_pred EeCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc--
Confidence 99995 5888877654 3468999999999999999999999999999999999999999999999999873221000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 159 --------------------------------------------------------------------------~~~~~~ 164 (309)
T cd07872 159 --------------------------------------------------------------------------KTYSNE 164 (309)
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 000123
Q ss_pred ccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc---CC----------------CCCC
Q 007433 452 VGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG---QP----------------LRFP 511 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~---~~----------------~~~p 511 (604)
.||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+.. .+ ..++
T Consensus 165 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (309)
T cd07872 165 VVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFP 244 (309)
T ss_pred cccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcC
Confidence 578999999998764 578999999999999999999999988766554433321 11 1111
Q ss_pred ---------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 512 ---------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 512 ---------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
..+.++.++++||.+||..||.+|++ +.|+|+||||+.+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~~e~l~h~~~~~~ 292 (309)
T cd07872 245 KYKPQPLINHAPRLDTEGIELLTKFLQYESKKRIS----AEEAMKHAYFRSL 292 (309)
T ss_pred ccCCCchhhhccCCCHHHHHHHHHhccCChhhCCC----HHHHhcChhhhhc
Confidence 11346889999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=368.75 Aligned_cols=255 Identities=29% Similarity=0.453 Sum_probs=205.6
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC---CCCCccccceeEec-----C
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL---DHPFLPTLYTHFET-----D 285 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~-----~ 285 (604)
+|++++.||+|+||+||+|++..+++.||+|++....... .......+|+++++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 5899999999999999999999999999999987542211 1112234566666655 79999999998864 3
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
..+++||||+. ++|..++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 56899999995 58988888765567999999999999999999999999999999999999999999999999987322
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
...
T Consensus 159 ~~~----------------------------------------------------------------------------- 161 (288)
T cd07863 159 SCQ----------------------------------------------------------------------------- 161 (288)
T ss_pred cCc-----------------------------------------------------------------------------
Confidence 100
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---C--------CCCC---
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---P--------LRFP--- 511 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~--------~~~p--- 511 (604)
.......||+.|+|||++.+..++.++|||||||++|||++|++||.+....+.+.++... + ...+
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd07863 162 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGA 241 (288)
T ss_pred ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccc
Confidence 0011235899999999999999999999999999999999999999887766655544321 0 0000
Q ss_pred -----------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 512 -----------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 512 -----------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
..+.++..+++||.+||++||++||+ +.|+++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~~~l~hp~f 288 (288)
T cd07863 242 FSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRIS----AFRALQHPFF 288 (288)
T ss_pred cCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCC----HHHHhcCCCC
Confidence 01246778899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=358.10 Aligned_cols=260 Identities=29% Similarity=0.440 Sum_probs=221.4
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHH--HHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLE--KRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
++|.+.+.||.|++|.||+|.+..+++.||||++...... .......+.+|++++++++||||+++++++.++...|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4799999999999999999999999999999998754322 22334567789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
||||+++++|.+++... ..+++..++.++.||+.||.|||+.||+||||+|+|||++.++.++|+|||++........
T Consensus 82 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~ 159 (263)
T cd06625 82 FMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS 159 (263)
T ss_pred EEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence 99999999999998775 4689999999999999999999999999999999999999999999999998743211000
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
.......
T Consensus 160 -------------------------------------------------------------------------~~~~~~~ 166 (263)
T cd06625 160 -------------------------------------------------------------------------SGTGMKS 166 (263)
T ss_pred -------------------------------------------------------------------------ccccccC
Confidence 0000012
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
..|+..|+|||++.+..++.++|||||||++|||++|+.||...........+............++..+.+||.+||..
T Consensus 167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 246 (263)
T cd06625 167 VTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTFVE 246 (263)
T ss_pred CCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHHHHHhhc
Confidence 35888999999999999999999999999999999999999887777766666655444444456899999999999999
Q ss_pred CCCCcccccCCHHHHhcCCCC
Q 007433 531 EPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~Hpff 551 (604)
+|++||+ +.++++||||
T Consensus 247 ~p~~Rpt----~~~ll~~~~~ 263 (263)
T cd06625 247 NAKKRPS----AEELLRHFFV 263 (263)
T ss_pred CcccCCC----HHHHhhCCCC
Confidence 9999999 9999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=383.05 Aligned_cols=261 Identities=25% Similarity=0.335 Sum_probs=212.3
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC-----ee
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK-----FS 288 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-----~~ 288 (604)
+|++++.||+|+||.||++.+..+++.||||.+..... ......++.+|+++|+.++|+||+++++++.... ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 48899999999999999999999999999999865321 2223446778999999999999999999998776 88
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|+||||+ +++|..++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus 80 ~lv~e~~-~~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~ 156 (372)
T cd07853 80 YVVTELM-QSDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD 156 (372)
T ss_pred EEEeecc-ccCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence 9999999 56888877654 57999999999999999999999999999999999999999999999999988432100
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
. ....
T Consensus 157 ~---------------------------------------------------------------------------~~~~ 161 (372)
T cd07853 157 E---------------------------------------------------------------------------SKHM 161 (372)
T ss_pred c---------------------------------------------------------------------------cccC
Confidence 0 0001
Q ss_pred cccccCccccCcceecCCC-CCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc----------------------
Q 007433 449 MSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG---------------------- 505 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~---------------------- 505 (604)
...+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+.+..+..
T Consensus 162 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~ 241 (372)
T cd07853 162 TQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHIL 241 (372)
T ss_pred CCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHH
Confidence 1235889999999998754 78999999999999999999999988766554443321
Q ss_pred -CCCCC-------CCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 506 -QPLRF-------PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 506 -~~~~~-------p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
..... ......+.++.+||.+||..||++||+ +.|+|+||||++..+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l~hp~~~~~~~~ 297 (372)
T cd07853 242 RGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRIS----AADALAHPYLDEGRLR 297 (372)
T ss_pred hCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcC----HHHHhcCHhhCCCcch
Confidence 11111 112346788999999999999999999 9999999999986644
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=378.39 Aligned_cols=255 Identities=27% Similarity=0.435 Sum_probs=206.4
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC------
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD------ 285 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------ 285 (604)
.++|++++.||+|+||.||+|.+..+++.||||++.+.... .....++.+|+.+++.++|+||++++++|...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-hHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 47999999999999999999999999999999999754322 22344567899999999999999999998643
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
...|+||||+. ++|...+.. .+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++...
T Consensus 95 ~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~ 169 (355)
T cd07874 95 QDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 169 (355)
T ss_pred ceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence 35799999995 567666643 4889999999999999999999999999999999999999999999999988432
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
...
T Consensus 170 ~~~----------------------------------------------------------------------------- 172 (355)
T cd07874 170 GTS----------------------------------------------------------------------------- 172 (355)
T ss_pred CCc-----------------------------------------------------------------------------
Confidence 100
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC-------------------
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ------------------- 506 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~------------------- 506 (604)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+..++..
T Consensus 173 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (355)
T cd07874 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNY 252 (355)
T ss_pred cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHH
Confidence 0011346899999999999999999999999999999999999999887654443322211
Q ss_pred ---CCC-----CC-------------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 507 ---PLR-----FP-------------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 507 ---~~~-----~p-------------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
... ++ .....+.++++||.+||..||++||+ +.|+|+||||+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps----~~ell~hp~~~~ 316 (355)
T cd07874 253 VENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS----VDEALQHPYINV 316 (355)
T ss_pred HhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCC----HHHHhcCcchhc
Confidence 000 00 01124567899999999999999999 999999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=391.11 Aligned_cols=260 Identities=31% Similarity=0.500 Sum_probs=228.0
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.+.|.|+..||.|+||.||+|..+.++...|.|+|.... ...+..+.-||+||..++||+||+|++.|..++.++|+
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks---eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS---EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc---hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 367899999999999999999999999888899997553 34455667899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
.|||.||-+..++-.. +..|.+.+++.+++|+|.||.|||+++|||||||..|||++.+|.++|+|||.+.....
T Consensus 108 iEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~---- 182 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS---- 182 (1187)
T ss_pred EeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh----
Confidence 9999999999887765 47899999999999999999999999999999999999999999999999998733110
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
+-.+..+|
T Consensus 183 ------------------------------------------------------------------------t~qkRDsF 190 (1187)
T KOG0579|consen 183 ------------------------------------------------------------------------TRQKRDSF 190 (1187)
T ss_pred ------------------------------------------------------------------------HHhhhccc
Confidence 11123478
Q ss_pred ccCccccCcceec-----CCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc-CCCCCCCCCCCCHHHHHHHH
Q 007433 452 VGTHEYLAPEIIK-----GEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG-QPLRFPESPVVSFSARDLIK 525 (604)
Q Consensus 452 ~GT~~Y~APE~l~-----~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~-~~~~~p~~~~~s~~l~dLI~ 525 (604)
+|||+|||||+.. ..+|++++|||||||+|.||..+.+|-...+....+.+|.. .+..+-.+...+..+.||+.
T Consensus 191 IGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws~~F~DfLk 270 (1187)
T KOG0579|consen 191 IGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWSRSFSDFLK 270 (1187)
T ss_pred cCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhhhHHHHHHH
Confidence 9999999999864 55799999999999999999999999999888888877765 45556666678999999999
Q ss_pred HhhhcCCCCcccccCCHHHHhcCCCCCCCC
Q 007433 526 GLLVKEPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
+||.+||..||+ +.+||+||||+.+.
T Consensus 271 ~cL~Knp~~Rp~----aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 271 RCLVKNPRNRPP----AAQLLKHPFVQNAP 296 (1187)
T ss_pred HHHhcCCccCCC----HHHHhhCcccccCC
Confidence 999999999999 99999999999665
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=360.04 Aligned_cols=261 Identities=31% Similarity=0.493 Sum_probs=218.8
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCeeEEEEeecCC
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSCLVMEFCPG 297 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 297 (604)
+.||+|+|+.|.-+....++..||||+++|.....+ .++.+|++++..+ .|+||++|++||+++..+|||||-+.|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR---~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~G 160 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSR---SRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRG 160 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHH---HHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccC
Confidence 469999999999999999999999999998754443 3566899999988 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC---cEEEecccccccccCCCccccc
Q 007433 298 GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG---HIMLSDFDLSLRCAVSPTVVKS 374 (604)
Q Consensus 298 gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g---~vkL~DFGla~~~~~~~~~~~~ 374 (604)
|.|...++++ +.|+|.++.+++++|+.||+|||.+||.||||||||||..... -+|||||+|.-.+..
T Consensus 161 GplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~------- 231 (463)
T KOG0607|consen 161 GPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKL------- 231 (463)
T ss_pred chHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeecccccccccc-------
Confidence 9999988887 7899999999999999999999999999999999999998665 489999998722110
Q ss_pred CcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccC
Q 007433 375 STLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGT 454 (604)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT 454 (604)
..+|. | .....-.+-+|+
T Consensus 232 ---------------------~~~~s-p----------------------------------------astP~L~tPvGS 249 (463)
T KOG0607|consen 232 ---------------------NNDCS-P----------------------------------------ASTPELLTPVGS 249 (463)
T ss_pred ---------------------CCCCC-C----------------------------------------CCCccccCcccc
Confidence 00011 0 001112245899
Q ss_pred ccccCcceec-----CCCCCccchHHHHHHHHHHHhhCCCCCCCCC---------------hHHHHHHHHcCCCCCCC--
Q 007433 455 HEYLAPEIIK-----GEGHGSAVDWWTFGIFLYELLFGKTPFKGSE---------------NRATLYNVVGQPLRFPE-- 512 (604)
Q Consensus 455 ~~Y~APE~l~-----~~~~~~~~DiWSLGviL~eLltG~~PF~~~~---------------~~~~l~~i~~~~~~~p~-- 512 (604)
.+|||||+.. ...|+.++|+||||||||-||.|.+||.|.- +..++..|..+.+.||+
T Consensus 250 AEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGkYeFPdkd 329 (463)
T KOG0607|consen 250 AEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKYEFPDKD 329 (463)
T ss_pred hhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccCCcCChhh
Confidence 9999999863 2358899999999999999999999998752 34556778888999986
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 513 SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 513 ~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
|..+|.+++|||..+|.+|+..|++ +.++++|||++.+..+
T Consensus 330 WahIS~eakdlisnLlvrda~~rls----a~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 330 WAHISSEAKDLISNLLVRDAKQRLS----AAQVLNHPWVQRCAPE 370 (463)
T ss_pred hHHhhHHHHHHHHHHHhccHHhhhh----hhhccCCccccccchh
Confidence 4569999999999999999999999 9999999999876433
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=391.48 Aligned_cols=260 Identities=27% Similarity=0.393 Sum_probs=220.0
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCC-ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGT-KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~-~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
..|.+.+.||.|+||.||+|.+..+ +..||+|.+..... .....+.+|+.+|+.++||||++++++|..++++|||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE---RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 3599999999999999999998877 78899998754432 2334566899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 292 MEFCPGGDLHTLRQRQ--PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~--~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
|||++||+|.+++... ....+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999999887542 23468999999999999999999999999999999999999999999999999985432100
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
. .....
T Consensus 224 ~--------------------------------------------------------------------------~~~~~ 229 (478)
T PTZ00267 224 S--------------------------------------------------------------------------LDVAS 229 (478)
T ss_pred c--------------------------------------------------------------------------ccccc
Confidence 0 00112
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
.++||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.+..+...... +....++.++++||.+||.
T Consensus 230 ~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~ 308 (478)
T PTZ00267 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD-PFPCPVSSGMKALLDPLLS 308 (478)
T ss_pred ccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCccCCHHHHHHHHHHhc
Confidence 457999999999999999999999999999999999999999988887777777654432 2234588999999999999
Q ss_pred cCCCCcccccCCHHHHhcCCCCCCC
Q 007433 530 KEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
.||++||+ +.++++|+|++.+
T Consensus 309 ~dP~~Rps----~~~~l~~~~~~~~ 329 (478)
T PTZ00267 309 KNPALRPT----TQQLLHTEFLKYV 329 (478)
T ss_pred cChhhCcC----HHHHHhCHHHHHH
Confidence 99999999 9999999999654
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=374.27 Aligned_cols=257 Identities=20% Similarity=0.315 Sum_probs=205.0
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEc-----CCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEec
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELT-----GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFET 284 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~ 284 (604)
..++|++.++||.|+||.||+|.+. .++..||||++...... .....+.+|+.+|+.+ +||||+++++++..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATA--SEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccch--HHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 3478999999999999999999853 34567999999754221 2334577899999999 89999999998875
Q ss_pred -CCeeEEEEeecCCCCHHHHHHhcC-------------------------------------------------------
Q 007433 285 -DKFSCLVMEFCPGGDLHTLRQRQP------------------------------------------------------- 308 (604)
Q Consensus 285 -~~~~~lV~E~~~ggsL~~ll~~~~------------------------------------------------------- 308 (604)
+..+|+|||||++|+|.+++....
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 456899999999999999887532
Q ss_pred -----CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcccCCccc
Q 007433 309 -----GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLR 383 (604)
Q Consensus 309 -----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~ 383 (604)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~------------ 230 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY------------ 230 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcch------------
Confidence 124788899999999999999999999999999999999999999999999998432110000
Q ss_pred CCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccccCccee
Q 007433 384 KNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEII 463 (604)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l 463 (604)
.......+++.|+|||++
T Consensus 231 --------------------------------------------------------------~~~~~~~~~~~y~aPE~~ 248 (338)
T cd05102 231 --------------------------------------------------------------VRKGSARLPLKWMAPESI 248 (338)
T ss_pred --------------------------------------------------------------hcccCCCCCccccCcHHh
Confidence 001122467889999999
Q ss_pred cCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCH
Q 007433 464 KGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGA 542 (604)
Q Consensus 464 ~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a 542 (604)
.+..++.++|||||||+||||++ |..||.+......+...+...........++..+.+||.+||..||++||+ +
T Consensus 249 ~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs----~ 324 (338)
T cd05102 249 FDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERPT----F 324 (338)
T ss_pred hcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCcC----H
Confidence 99999999999999999999997 999998865544444444333333334468899999999999999999999 7
Q ss_pred HHHhc
Q 007433 543 TEIKQ 547 (604)
Q Consensus 543 ~elL~ 547 (604)
.||++
T Consensus 325 ~el~~ 329 (338)
T cd05102 325 SALVE 329 (338)
T ss_pred HHHHH
Confidence 88765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=375.09 Aligned_cols=254 Identities=29% Similarity=0.446 Sum_probs=208.5
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC------C
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD------K 286 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------~ 286 (604)
++|++++.||.|+||+||+|.+..++..||||++.+.... .....++.+|+.+|+.++|+||++++++|... .
T Consensus 15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 93 (343)
T cd07878 15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN 93 (343)
T ss_pred hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence 6899999999999999999999999999999999764322 22334566899999999999999999988643 4
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
..|++||++ +++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus 94 ~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~ 169 (343)
T cd07878 94 EVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD 169 (343)
T ss_pred cEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceecC
Confidence 579999998 8999888764 469999999999999999999999999999999999999999999999999884321
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
.
T Consensus 170 ~------------------------------------------------------------------------------- 170 (343)
T cd07878 170 D------------------------------------------------------------------------------- 170 (343)
T ss_pred C-------------------------------------------------------------------------------
Confidence 0
Q ss_pred cccccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---C---------------
Q 007433 447 RSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---P--------------- 507 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~--------------- 507 (604)
....++||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+.+..+... +
T Consensus 171 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (343)
T cd07878 171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARK 250 (343)
T ss_pred CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHH
Confidence 0113468999999999987 46889999999999999999999999887655544433211 0
Q ss_pred -----CCCCC------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 508 -----LRFPE------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 508 -----~~~p~------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
...+. ....+..+.+||.+||..||.+||+ +.|+|+||||...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s----~~ell~hp~~~~~ 304 (343)
T cd07878 251 YIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRIS----ASEALAHPYFSQY 304 (343)
T ss_pred HhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCcchhcc
Confidence 00010 1235667899999999999999999 9999999999753
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=363.70 Aligned_cols=264 Identities=30% Similarity=0.465 Sum_probs=220.3
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.+.|+++++||.|+||.||+|++..++..||+|++..... .....+.+|+.+++.++|+||+++++.|..++..|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH---HHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 4679999999999999999999999999999999976532 3344567799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+++++|..++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 88 ~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~--- 163 (292)
T cd06644 88 IEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT--- 163 (292)
T ss_pred EecCCCCcHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc---
Confidence 99999999988776542 56899999999999999999999999999999999999999999999999987332100
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
.......
T Consensus 164 -------------------------------------------------------------------------~~~~~~~ 170 (292)
T cd06644 164 -------------------------------------------------------------------------LQRRDSF 170 (292)
T ss_pred -------------------------------------------------------------------------cccccee
Confidence 0001134
Q ss_pred ccCccccCcceecC-----CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC-CCCCCCCCCHHHHHHHH
Q 007433 452 VGTHEYLAPEIIKG-----EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPL-RFPESPVVSFSARDLIK 525 (604)
Q Consensus 452 ~GT~~Y~APE~l~~-----~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~-~~p~~~~~s~~l~dLI~ 525 (604)
.|++.|+|||++.+ ..++.++|||||||++|||++|..||...+....+.++..... .......++.++.+||.
T Consensus 171 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 250 (292)
T cd06644 171 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLSQPSKWSMEFRDFLK 250 (292)
T ss_pred cCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCCCCcccCHHHHHHHH
Confidence 58889999999853 3467899999999999999999999987766555555544322 22333457889999999
Q ss_pred HhhhcCCCCcccccCCHHHHhcCCCCCCCChhhh
Q 007433 526 GLLVKEPQNRLACRRGATEIKQHPFFQGVNWALI 559 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~ 559 (604)
+||..||++||+ +.++++||||..++|...
T Consensus 251 ~~l~~~p~~Rp~----~~~il~~~~~~~~~~~~~ 280 (292)
T cd06644 251 TALDKHPETRPS----AAQLLEHPFVSSVTSNRP 280 (292)
T ss_pred HHhcCCcccCcC----HHHHhcCccccccccchh
Confidence 999999999999 999999999998887753
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=359.72 Aligned_cols=261 Identities=36% Similarity=0.609 Sum_probs=217.9
Q ss_pred EccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCCCCH
Q 007433 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDL 300 (604)
Q Consensus 221 LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 300 (604)
||.|+||+||+|.+..+++.||+|++.+...........+..|+++|+.++||||+++++.|..++..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 69999999999999999999999999876544444444566899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcccCC
Q 007433 301 HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESE 380 (604)
Q Consensus 301 ~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~ 380 (604)
.+++.......+++..+..++.||+.||.|||++||+||||+|+|||++.++.++|+|||++......
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~------------ 148 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG------------ 148 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC------------
Confidence 99988765457999999999999999999999999999999999999999999999999987432100
Q ss_pred cccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccccCc
Q 007433 381 PLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAP 460 (604)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP 460 (604)
.......|+..|+||
T Consensus 149 -----------------------------------------------------------------~~~~~~~~~~~y~~P 163 (277)
T cd05577 149 -----------------------------------------------------------------KKIKGRAGTPGYMAP 163 (277)
T ss_pred -----------------------------------------------------------------CccccccCCCCcCCH
Confidence 001123478899999
Q ss_pred ceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChH----HHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcc
Q 007433 461 EIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR----ATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRL 536 (604)
Q Consensus 461 E~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~----~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rp 536 (604)
|++.+..++.++|||||||++|+|++|+.||...... .....+...... ....++..+++||.+||..||.+||
T Consensus 164 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~ 241 (277)
T cd05577 164 EVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVE--YPDKFSPEAKDLCEALLQKDPEKRL 241 (277)
T ss_pred HHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccccccc--CCccCCHHHHHHHHHHccCChhHcc
Confidence 9998888999999999999999999999999875432 122222222222 2334789999999999999999999
Q ss_pred cccC-CHHHHhcCCCCCCCChhhhh
Q 007433 537 ACRR-GATEIKQHPFFQGVNWALIR 560 (604)
Q Consensus 537 t~~~-~a~elL~Hpff~~~~~~~~~ 560 (604)
+.+. .+.++++||||..++|..+.
T Consensus 242 ~~~~~~~~~ll~h~~~~~~~~~~~~ 266 (277)
T cd05577 242 GCRGGSADEVREHPLFKDLNWRRLE 266 (277)
T ss_pred CCCcccHHHHHhChhhhcCChhhhh
Confidence 6655 69999999999999998774
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=391.62 Aligned_cols=263 Identities=25% Similarity=0.431 Sum_probs=221.3
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC-----
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK----- 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----- 286 (604)
.++|++.+.||+|+||+||+|++..+++.||||++....... ....++.+|+.+|..++|+||+++++.|....
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~-~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSE-ADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 469999999999999999999999999999999997654432 34456778999999999999999988775322
Q ss_pred ---eeEEEEeecCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccc
Q 007433 287 ---FSCLVMEFCPGGDLHTLRQRQ--PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDL 361 (604)
Q Consensus 287 ---~~~lV~E~~~ggsL~~ll~~~--~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGl 361 (604)
.+++||||+++|+|.+++... ....+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||+
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGl 189 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGF 189 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEeccc
Confidence 478999999999999988653 235799999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccccc
Q 007433 362 SLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIA 441 (604)
Q Consensus 362 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (604)
+..+....
T Consensus 190 s~~~~~~~------------------------------------------------------------------------ 197 (496)
T PTZ00283 190 SKMYAATV------------------------------------------------------------------------ 197 (496)
T ss_pred Ceeccccc------------------------------------------------------------------------
Confidence 84432100
Q ss_pred CCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHH
Q 007433 442 EPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSAR 521 (604)
Q Consensus 442 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~ 521 (604)
.......++||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+...... +....++.++.
T Consensus 198 --~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~ 274 (496)
T PTZ00283 198 --SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYD-PLPPSISPEMQ 274 (496)
T ss_pred --cccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCC-CCCCCCCHHHH
Confidence 000112357999999999999999999999999999999999999999988777777666654332 33456899999
Q ss_pred HHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 522 DLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 522 dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
+||.+||..||.+||+ +.++++|||++..
T Consensus 275 ~li~~~L~~dP~~RPs----~~ell~~p~~~~~ 303 (496)
T PTZ00283 275 EIVTALLSSDPKRRPS----SSKLLNMPICKLF 303 (496)
T ss_pred HHHHHHcccChhhCcC----HHHHHhCHHHHHh
Confidence 9999999999999999 9999999998753
|
|
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=364.31 Aligned_cols=260 Identities=28% Similarity=0.450 Sum_probs=211.6
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|.+++.||.|+||.||+|++..++..||+|.+...... .....+.+|+.+++.++|+||+++++++..++..|+|
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv 82 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 82 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEE
Confidence 57899999999999999999999999999999998754321 1122456799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+. ++|..++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 83 ~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-- 158 (301)
T cd07873 83 FEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT-- 158 (301)
T ss_pred Eeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC--
Confidence 99995 6898887664 3468999999999999999999999999999999999999999999999999873221000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 159 --------------------------------------------------------------------------~~~~~~ 164 (301)
T cd07873 159 --------------------------------------------------------------------------KTYSNE 164 (301)
T ss_pred --------------------------------------------------------------------------Cccccc
Confidence 000122
Q ss_pred ccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc---CC----------------CCCC
Q 007433 452 VGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG---QP----------------LRFP 511 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~---~~----------------~~~p 511 (604)
.+++.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+..+.. .+ ..++
T Consensus 165 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (301)
T cd07873 165 VVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYP 244 (301)
T ss_pred ceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccC
Confidence 478899999998764 478899999999999999999999988766544433221 10 0111
Q ss_pred C---------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCC
Q 007433 512 E---------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 512 ~---------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
. ...++..+++||.+||..||.+||+ +.|+|+||||+.+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t----~~eil~h~~f~~~~ 293 (301)
T cd07873 245 KYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRIS----AEEAMKHPYFHCLG 293 (301)
T ss_pred ccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcC----HHHHhcCccccccc
Confidence 1 1347888999999999999999999 99999999998654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=398.84 Aligned_cols=152 Identities=38% Similarity=0.646 Sum_probs=138.9
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
+++|.++++||+|+||+||+|++..+++.||||++.+...........+.+|+.+++.++|+||+++++++....++|||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 46899999999999999999999999999999999876544444456678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
|||+.|++|..++... ..+++..++.|+.||+.||+|||.+|||||||||+||||+.++.++|+|||++...
T Consensus 83 mEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~ 154 (669)
T cd05610 83 MEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVT 154 (669)
T ss_pred EeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCccc
Confidence 9999999999998765 56899999999999999999999999999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-43 Score=372.14 Aligned_cols=251 Identities=23% Similarity=0.402 Sum_probs=201.7
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
..+|++++.||+|+||.||+|++..++..||+|+..+.. ...|+.+|+.++|+||+++++++..+...|+|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 357999999999999999999999999999999865432 23589999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+ .++|..++... ...+++..++.|+.||+.||.|||++|||||||||+|||++.++.++|+|||++.....
T Consensus 136 ~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---- 209 (357)
T PHA03209 136 LPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---- 209 (357)
T ss_pred EEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc----
Confidence 9999 56888887654 35799999999999999999999999999999999999999999999999998732100
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
.......
T Consensus 210 -------------------------------------------------------------------------~~~~~~~ 216 (357)
T PHA03209 210 -------------------------------------------------------------------------APAFLGL 216 (357)
T ss_pred -------------------------------------------------------------------------Ccccccc
Confidence 0001134
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCC-CCCCh---------HHHHHHHHcC----CCCCC------
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPF-KGSEN---------RATLYNVVGQ----PLRFP------ 511 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF-~~~~~---------~~~l~~i~~~----~~~~p------ 511 (604)
.||+.|+|||++.+..++.++|||||||++|||+++..++ ..... ...+..++.. +..++
T Consensus 217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 296 (357)
T PHA03209 217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSR 296 (357)
T ss_pred cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccH
Confidence 6999999999999999999999999999999999855444 33211 1111121110 11111
Q ss_pred ----------------------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 512 ----------------------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 512 ----------------------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
....++.++.+||.+||.+||.+||+ +.|||+||||+.+
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpt----a~e~l~hp~f~~~ 357 (357)
T PHA03209 297 LVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPS----AEEILNYPMFAQL 357 (357)
T ss_pred HHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcC----HHHHhcCchhccC
Confidence 01235667888999999999999999 9999999999753
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=354.31 Aligned_cols=258 Identities=37% Similarity=0.719 Sum_probs=219.6
Q ss_pred EccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCCCCH
Q 007433 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDL 300 (604)
Q Consensus 221 LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 300 (604)
||.|+||.||+|++..++..||+|++.+...........+.+|+.+++.++|+||+++++.+.++...|+||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 69999999999999999999999999876544444456678899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcccCC
Q 007433 301 HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESE 380 (604)
Q Consensus 301 ~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~ 380 (604)
.+++.+. ..+++..+..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~----------- 147 (262)
T cd05572 81 WTILRDR--GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ----------- 147 (262)
T ss_pred HHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-----------
Confidence 9998775 458999999999999999999999999999999999999999999999999874321100
Q ss_pred cccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccccCc
Q 007433 381 PLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAP 460 (604)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP 460 (604)
......|+..|++|
T Consensus 148 ------------------------------------------------------------------~~~~~~~~~~~~~P 161 (262)
T cd05572 148 ------------------------------------------------------------------KTWTFCGTPEYVAP 161 (262)
T ss_pred ------------------------------------------------------------------ccccccCCcCccCh
Confidence 01123588899999
Q ss_pred ceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCC--hHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCccc-
Q 007433 461 EIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE--NRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLA- 537 (604)
Q Consensus 461 E~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~--~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt- 537 (604)
|++.+..++.++|+||||+++|+|++|..||.... ....+.++.............+.++++||.+||..||++|++
T Consensus 162 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~ 241 (262)
T cd05572 162 EIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGN 241 (262)
T ss_pred hHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChhhCcCC
Confidence 99988889999999999999999999999998776 555566666333333333346899999999999999999998
Q ss_pred ccCCHHHHhcCCCCCCCChh
Q 007433 538 CRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 538 ~~~~a~elL~Hpff~~~~~~ 557 (604)
+...+.|+++||||++++|.
T Consensus 242 ~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 242 LKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred cccCHHHHhcChhhhCCCCC
Confidence 34568999999999999985
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=383.55 Aligned_cols=259 Identities=31% Similarity=0.508 Sum_probs=234.1
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
..+.|.+++.||.|.|+.|.+|++..++..||||++++..+.... +..+.+|+++|+.|+|||||+++.+.+....+|+
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~-~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSK-RQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHH-HHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 357899999999999999999999999999999999998776543 3347899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
||||+.+|.+++++.++ +++.+..++.++.|++.|++|||.++|||||||.+||||+.+.++||+|||++..+.
T Consensus 133 V~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~---- 206 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD---- 206 (596)
T ss_pred EEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec----
Confidence 99999999999999987 678889999999999999999999999999999999999999999999999984332
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
......+
T Consensus 207 -------------------------------------------------------------------------~~~~lqt 213 (596)
T KOG0586|consen 207 -------------------------------------------------------------------------YGLMLQT 213 (596)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 1122346
Q ss_pred cccCccccCcceecCCCC-CccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 451 FVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~-~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
++|++.|.|||++.|..| ++++|+|+||++||-|+.|.+||.+......-.+++...++.|.. ++.++.+||+++|.
T Consensus 214 ~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~--ms~dce~lLrk~lv 291 (596)
T KOG0586|consen 214 FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFY--MSCDCEDLLRKFLV 291 (596)
T ss_pred cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccce--eechhHHHHHHhhc
Confidence 789999999999999987 789999999999999999999999988877777888888888876 89999999999999
Q ss_pred cCCCCcccccCCHHHHhcCCCCCCCC
Q 007433 530 KEPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
.+|.+|++ ++++..|.|.....
T Consensus 292 l~Pskr~~----~dqim~~~W~n~~~ 313 (596)
T KOG0586|consen 292 LNPSKRGP----CDQIMKDRWRNDLL 313 (596)
T ss_pred cCccccCC----HHHhhhhcccchhh
Confidence 99999999 99999999986543
|
|
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=368.96 Aligned_cols=265 Identities=23% Similarity=0.358 Sum_probs=209.0
Q ss_pred EEEEEccC--CcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEee
Q 007433 217 LLKKLGCG--DIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEF 294 (604)
Q Consensus 217 l~~~LG~G--~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 294 (604)
+++.||+| +|++||++.+..+++.||||+++..... ......+.+|+++++.++||||++++++|..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 46789999 7899999999999999999999765332 22334566899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccccc
Q 007433 295 CPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKS 374 (604)
Q Consensus 295 ~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~ 374 (604)
+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+||+.............
T Consensus 81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~- 159 (327)
T cd08227 81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR- 159 (327)
T ss_pred cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc-
Confidence 9999999998765445699999999999999999999999999999999999999999999999986522110000000
Q ss_pred CcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccC
Q 007433 375 STLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGT 454 (604)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT 454 (604)
.........+++
T Consensus 160 --------------------------------------------------------------------~~~~~~~~~~~~ 171 (327)
T cd08227 160 --------------------------------------------------------------------VVHDFPKYSVKV 171 (327)
T ss_pred --------------------------------------------------------------------ccccccccccce
Confidence 000001123577
Q ss_pred ccccCcceecC--CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC-----------------------
Q 007433 455 HEYLAPEIIKG--EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR----------------------- 509 (604)
Q Consensus 455 ~~Y~APE~l~~--~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~----------------------- 509 (604)
..|+|||++.+ ..++.++|||||||++|||++|+.||........+.........
T Consensus 172 ~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (327)
T cd08227 172 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGAN 251 (327)
T ss_pred ecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCc
Confidence 88999999976 45889999999999999999999999876544433332221110
Q ss_pred ---------------------CCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCC
Q 007433 510 ---------------------FPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 510 ---------------------~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
.+....++..+.+||.+||.+||++||+ +.||++||||+.+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~ell~~p~f~~~~ 314 (327)
T cd08227 252 SGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPS----ASTLLNHSFFKQIK 314 (327)
T ss_pred CCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCC----HHHHhcChhhhhcc
Confidence 0011234678999999999999999999 99999999998754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=366.40 Aligned_cols=251 Identities=27% Similarity=0.418 Sum_probs=192.4
Q ss_pred EEEEccCCcEEEEEEEEc--CCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec--CCeeEEEEe
Q 007433 218 LKKLGCGDIGSVYLSELT--GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET--DKFSCLVME 293 (604)
Q Consensus 218 ~~~LG~G~fG~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~lV~E 293 (604)
.++||+|+||+||+|++. .+++.||+|.+...... ..+.+|+++|+.++||||++++++|.. +..+|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc-----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 368999999999999975 46689999999754322 234579999999999999999999854 567899999
Q ss_pred ecCCCCHHHHHHhcC-------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEE----ccCCcEEEeccccc
Q 007433 294 FCPGGDLHTLRQRQP-------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV----REDGHIMLSDFDLS 362 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~-------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl----~~~g~vkL~DFGla 362 (604)
|+ +++|..++.... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred cc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 99 668888765321 2358999999999999999999999999999999999999 45678999999998
Q ss_pred ccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccC
Q 007433 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442 (604)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (604)
..+.....
T Consensus 160 ~~~~~~~~------------------------------------------------------------------------ 167 (317)
T cd07868 160 RLFNSPLK------------------------------------------------------------------------ 167 (317)
T ss_pred eccCCCCc------------------------------------------------------------------------
Confidence 43221000
Q ss_pred CCCCcccccccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCCh---------HHHHH---HHHcCCC-
Q 007433 443 PTNARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSEN---------RATLY---NVVGQPL- 508 (604)
Q Consensus 443 ~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~---------~~~l~---~i~~~~~- 508 (604)
........+||+.|+|||++.+. .++.++|||||||++|||++|++||.+... ...+. ++.+.+.
T Consensus 168 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (317)
T cd07868 168 -PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPAD 246 (317)
T ss_pred -cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCCh
Confidence 00011234689999999999874 578999999999999999999999975432 11111 1111100
Q ss_pred -------CCC-------------------------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 509 -------RFP-------------------------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 509 -------~~p-------------------------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
.++ .....+..+.+||.+||.+||.+||| ++|+|+||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t----~~e~l~hp~f 317 (317)
T cd07868 247 KDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT----SEQAMQDPYF 317 (317)
T ss_pred HHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCC----HHHHhcCCCC
Confidence 000 00123567889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=354.90 Aligned_cols=254 Identities=39% Similarity=0.680 Sum_probs=211.6
Q ss_pred eEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEee
Q 007433 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEF 294 (604)
Q Consensus 215 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 294 (604)
|++++.||+|+||+||++++..+++.||+|++.......... ....+|+.+++.++|+||+++++++.+....|+||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~-~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEER-EENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHH-HHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccccccc-chhhhhhhccccccccccccccccccccccccccccc
Confidence 899999999999999999999999999999998875544332 2334599999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccccc
Q 007433 295 CPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKS 374 (604)
Q Consensus 295 ~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~ 374 (604)
+.+++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 80 ~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~------- 150 (260)
T PF00069_consen 80 CPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE------- 150 (260)
T ss_dssp ETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-------
T ss_pred ccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-------
Confidence 9999999999844 5789999999999999999999999999999999999999999999999998743200
Q ss_pred CcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccC
Q 007433 375 STLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGT 454 (604)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT 454 (604)
.........||
T Consensus 151 ---------------------------------------------------------------------~~~~~~~~~~~ 161 (260)
T PF00069_consen 151 ---------------------------------------------------------------------NNENFNPFVGT 161 (260)
T ss_dssp ---------------------------------------------------------------------TTSEBSSSSSS
T ss_pred ---------------------------------------------------------------------ccccccccccc
Confidence 00011234689
Q ss_pred ccccCcceec-CCCCCccchHHHHHHHHHHHhhCCCCCCCCC---hHHHHHHHHcCCCCCCC--CCCCCHHHHHHHHHhh
Q 007433 455 HEYLAPEIIK-GEGHGSAVDWWTFGIFLYELLFGKTPFKGSE---NRATLYNVVGQPLRFPE--SPVVSFSARDLIKGLL 528 (604)
Q Consensus 455 ~~Y~APE~l~-~~~~~~~~DiWSLGviL~eLltG~~PF~~~~---~~~~l~~i~~~~~~~p~--~~~~s~~l~dLI~~lL 528 (604)
..|+|||++. +..++.++||||||+++|+|++|..||.... ....+............ .......+.+||.+||
T Consensus 162 ~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 241 (260)
T PF00069_consen 162 PEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKML 241 (260)
T ss_dssp GGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHc
Confidence 9999999998 7888999999999999999999999999873 23333333332211111 1123478999999999
Q ss_pred hcCCCCcccccCCHHHHhcCCCC
Q 007433 529 VKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 529 ~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
..||++||+ +.++++||||
T Consensus 242 ~~~p~~R~~----~~~l~~~~~~ 260 (260)
T PF00069_consen 242 SKDPEQRPS----AEELLKHPWF 260 (260)
T ss_dssp SSSGGGSTT----HHHHHTSGGG
T ss_pred cCChhHCcC----HHHHhcCCCC
Confidence 999999999 9999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=348.37 Aligned_cols=256 Identities=27% Similarity=0.435 Sum_probs=219.2
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
+|.+.+.||+|+||.||+|.+..++..|++|.+....... .....+.+|+++++.++||||+++++++..++..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNR-REREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCH-HHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 5889999999999999999999999999999987653332 234467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
|++|++|.+++....+..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~---- 155 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNT---- 155 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCcc----
Confidence 9999999999987656789999999999999999999999999999999999999999999999999874322100
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
.......|
T Consensus 156 ------------------------------------------------------------------------~~~~~~~~ 163 (256)
T cd08529 156 ------------------------------------------------------------------------NFANTIVG 163 (256)
T ss_pred ------------------------------------------------------------------------chhhcccc
Confidence 00112358
Q ss_pred CccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCC
Q 007433 454 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQ 533 (604)
Q Consensus 454 T~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~ 533 (604)
++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+....... ....++..+.++|.+||..+|+
T Consensus 164 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~ 242 (256)
T cd08529 164 TPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPP-VSQMYSQQLAQLIDQCLTKDYR 242 (256)
T ss_pred CccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC-CccccCHHHHHHHHHHccCCcc
Confidence 889999999999889999999999999999999999998887766666665543221 2225788999999999999999
Q ss_pred CcccccCCHHHHhcCCCC
Q 007433 534 NRLACRRGATEIKQHPFF 551 (604)
Q Consensus 534 ~Rpt~~~~a~elL~Hpff 551 (604)
+||+ +.++++|||+
T Consensus 243 ~Rp~----~~~ll~~~~~ 256 (256)
T cd08529 243 QRPD----TFQLLRNPSL 256 (256)
T ss_pred cCcC----HHHHhhCCCC
Confidence 9999 9999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=348.62 Aligned_cols=256 Identities=25% Similarity=0.448 Sum_probs=216.3
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec-CCeeEEEE
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET-DKFSCLVM 292 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~~lV~ 292 (604)
+|++++.||.|+||.||++.+..+++.||+|.+....... .....+.+|+++++.++|+||+++++.+.. +..+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASR-RERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 5899999999999999999999999999999997543322 233456789999999999999999998874 55789999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~--- 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC--- 156 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC---
Confidence 99999999998887655679999999999999999999999999999999999999999999999999874321000
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.......
T Consensus 157 -------------------------------------------------------------------------~~~~~~~ 163 (257)
T cd08223 157 -------------------------------------------------------------------------DMASTLI 163 (257)
T ss_pred -------------------------------------------------------------------------Ccccccc
Confidence 0011345
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEP 532 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP 532 (604)
|++.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+....+. +....++..+.+||.+||..||
T Consensus 164 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p 242 (257)
T cd08223 164 GTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP-PMPKDYSPELGELIATMLSKRP 242 (257)
T ss_pred CCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC-CCccccCHHHHHHHHHHhccCc
Confidence 889999999999998999999999999999999999999887766666666554332 1224588999999999999999
Q ss_pred CCcccccCCHHHHhcCCCC
Q 007433 533 QNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 533 ~~Rpt~~~~a~elL~Hpff 551 (604)
++||+ +.++++||||
T Consensus 243 ~~Rp~----~~~~l~~~~~ 257 (257)
T cd08223 243 EKRPS----VKSILRQPYI 257 (257)
T ss_pred ccCCC----HHHHhcCCCC
Confidence 99999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=357.04 Aligned_cols=256 Identities=29% Similarity=0.450 Sum_probs=213.4
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEec------
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFET------ 284 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~------ 284 (604)
.+.|++.+.||.|+||.||+|.+..+++.||+|++...... ...+..|+.+++.+ +|+||++++++|..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 36799999999999999999999999999999999754321 23456789999998 79999999999874
Q ss_pred CCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccc
Q 007433 285 DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLR 364 (604)
Q Consensus 285 ~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~ 364 (604)
+..+|+||||+.+++|.+++.......+++..+..++.||+.||.|||+++|+||||||+|||++.++.++|+|||++..
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~ 160 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 160 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCcee
Confidence 35689999999999999998876556799999999999999999999999999999999999999999999999998743
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
....
T Consensus 161 ~~~~---------------------------------------------------------------------------- 164 (272)
T cd06637 161 LDRT---------------------------------------------------------------------------- 164 (272)
T ss_pred cccc----------------------------------------------------------------------------
Confidence 2100
Q ss_pred CCcccccccCccccCcceec-----CCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHH
Q 007433 445 NARSMSFVGTHEYLAPEIIK-----GEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFS 519 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l~-----~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~ 519 (604)
........|++.|+|||++. +..++.++|||||||++|||++|..||...........+............++..
T Consensus 165 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (272)
T cd06637 165 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKWSKK 244 (272)
T ss_pred cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCCCCCCcCHH
Confidence 00112346899999999986 3457889999999999999999999998766655555544443333333457889
Q ss_pred HHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 520 ARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 520 l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
+++||.+||..||.+||+ +.+++.||||
T Consensus 245 ~~~li~~~l~~~p~~Rpt----~~~il~~~~~ 272 (272)
T cd06637 245 FQSFIESCLVKNHSQRPT----TEQLMKHPFI 272 (272)
T ss_pred HHHHHHHHcCCChhhCCC----HHHHhhCCCC
Confidence 999999999999999999 9999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=350.66 Aligned_cols=265 Identities=40% Similarity=0.749 Sum_probs=224.1
Q ss_pred EccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCCCCH
Q 007433 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDL 300 (604)
Q Consensus 221 LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 300 (604)
||.|+||.||++++..+++.||+|++.............+.+|+++++.++|+||+++++.+..+...|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999877655555666788899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcccCC
Q 007433 301 HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESE 380 (604)
Q Consensus 301 ~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~ 380 (604)
.+++.+. ..+++..+..++.||+.||.|||++||+||||+|+|||++.++.++|+|||++...........
T Consensus 81 ~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~------- 151 (265)
T cd05579 81 ASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINL------- 151 (265)
T ss_pred HHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccc-------
Confidence 9999876 3789999999999999999999999999999999999999999999999998743221100000
Q ss_pred cccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccccCc
Q 007433 381 PLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAP 460 (604)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP 460 (604)
...........++..|+||
T Consensus 152 -------------------------------------------------------------~~~~~~~~~~~~~~~~~~P 170 (265)
T cd05579 152 -------------------------------------------------------------NDDEKEDKRIVGTPDYIAP 170 (265)
T ss_pred -------------------------------------------------------------ccccccccCcccCccccCH
Confidence 0000011234588899999
Q ss_pred ceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccC
Q 007433 461 EIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRR 540 (604)
Q Consensus 461 E~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~ 540 (604)
|++.+..++.++||||||+++|+|++|..||........+..+..+...++....++..+.+||.+||..+|.+||++.
T Consensus 171 e~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~- 249 (265)
T cd05579 171 EVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLVPDPEKRLGAK- 249 (265)
T ss_pred HHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhcCCHhhcCCCc-
Confidence 9999888999999999999999999999999988877777777766666665544689999999999999999999921
Q ss_pred CHHHHhcCCCCCCCCh
Q 007433 541 GATEIKQHPFFQGVNW 556 (604)
Q Consensus 541 ~a~elL~Hpff~~~~~ 556 (604)
.+.++|+||||..++|
T Consensus 250 ~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 250 SIEEIKNHPFFKGIDW 265 (265)
T ss_pred cHHHHhcCccccCCCC
Confidence 1399999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=361.42 Aligned_cols=253 Identities=28% Similarity=0.447 Sum_probs=211.1
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++.++||+|+||.||++.+..++..||+|.+..... ......+.+|++++++++||||+++++.|.+++++|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK--PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 379999999999999999999999999999999875422 223445678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH-cCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM-LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
||++|++|.+++.+. ..+++..+..++.||+.||.|||+ ++|+||||||+|||++.++.++|+|||++.....
T Consensus 79 ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---- 152 (308)
T cd06615 79 EHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 152 (308)
T ss_pred eccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccc----
Confidence 999999999998875 568999999999999999999997 6999999999999999999999999998732110
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
.....+
T Consensus 153 --------------------------------------------------------------------------~~~~~~ 158 (308)
T cd06615 153 --------------------------------------------------------------------------SMANSF 158 (308)
T ss_pred --------------------------------------------------------------------------cccccC
Confidence 001134
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC------------------------
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP------------------------ 507 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~------------------------ 507 (604)
+|++.|+|||++.+..++.++|+|||||++|+|++|+.||...+... +..+....
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (308)
T cd06615 159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSGHPPDSPRPM 237 (308)
T ss_pred CCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccccCCcccccCCCCCccchh
Confidence 68899999999988889999999999999999999999997654322 22222111
Q ss_pred --------------CCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 508 --------------LRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 508 --------------~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
...+. ..++.++++||.+||..||++||+ +.+|++||||..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~~~~~~~ 292 (308)
T cd06615 238 AIFELLDYIVNEPPPKLPS-GAFSDEFQDFVDKCLKKNPKERAD----LKELTKHPFIKR 292 (308)
T ss_pred hHHHHHHHHhcCCCccCcC-cccCHHHHHHHHHHccCChhhCcC----HHHHhcChhhhh
Confidence 01111 136778999999999999999999 999999999964
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=356.75 Aligned_cols=259 Identities=34% Similarity=0.660 Sum_probs=205.4
Q ss_pred EEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHH---HHHhCCCCCccccceeEecCCeeEEEEeecC
Q 007433 220 KLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTERE---ILQSLDHPFLPTLYTHFETDKFSCLVMEFCP 296 (604)
Q Consensus 220 ~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~---iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 296 (604)
.||+|+||.||++.+..+++.||+|++.+.............+|.. ++...+|+||+.++++|..++..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 3899999999999999999999999997654322221122233443 3444589999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCc
Q 007433 297 GGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSST 376 (604)
Q Consensus 297 ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 376 (604)
+++|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 ~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-------- 150 (279)
T cd05633 81 GGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-------- 150 (279)
T ss_pred CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc--------
Confidence 99999888765 56999999999999999999999999999999999999999999999999987322100
Q ss_pred ccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCcc
Q 007433 377 LESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHE 456 (604)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 456 (604)
......||+.
T Consensus 151 ----------------------------------------------------------------------~~~~~~~~~~ 160 (279)
T cd05633 151 ----------------------------------------------------------------------KPHASVGTHG 160 (279)
T ss_pred ----------------------------------------------------------------------CccCcCCCcC
Confidence 0012258999
Q ss_pred ccCcceec-CCCCCccchHHHHHHHHHHHhhCCCCCCCCCh--HHHHHHH-HcCCCCCCCCCCCCHHHHHHHHHhhhcCC
Q 007433 457 YLAPEIIK-GEGHGSAVDWWTFGIFLYELLFGKTPFKGSEN--RATLYNV-VGQPLRFPESPVVSFSARDLIKGLLVKEP 532 (604)
Q Consensus 457 Y~APE~l~-~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~--~~~l~~i-~~~~~~~p~~~~~s~~l~dLI~~lL~~dP 532 (604)
|+|||++. +..++.++|||||||++|||++|..||..... ...+... ......+ ...++.++++||.+||..||
T Consensus 161 y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p 238 (279)
T cd05633 161 YMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVEL--PDSFSPELKSLLEGLLQRDV 238 (279)
T ss_pred ccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCC--ccccCHHHHHHHHHHhcCCH
Confidence 99999986 45688999999999999999999999976432 1222222 1222222 33588999999999999999
Q ss_pred CCcccc-cCCHHHHhcCCCCCCCChhhhh
Q 007433 533 QNRLAC-RRGATEIKQHPFFQGVNWALIR 560 (604)
Q Consensus 533 ~~Rpt~-~~~a~elL~Hpff~~~~~~~~~ 560 (604)
++|++. ...+.|+++||||++++|....
T Consensus 239 ~~R~~~~~~~~~~~~~h~~~~~~~~~~~~ 267 (279)
T cd05633 239 SKRLGCLGRGAQEVKEHVFFKGIDWQQVY 267 (279)
T ss_pred HHhcCCCCCCHHHHHhCccccCCCHhHHh
Confidence 999942 2349999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=355.40 Aligned_cols=253 Identities=29% Similarity=0.437 Sum_probs=208.7
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++++.||+|+||.||+|.+..++..||+|++..... ......+.+|+++|++++||||++++++|..++..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 368899999999999999999999999999999876532 122345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+++++|..+ ..+++..+..++.||+.||+|||++||+|+||||+|||++.++.++|+|||++......
T Consensus 79 e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---- 148 (279)
T cd06619 79 EFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---- 148 (279)
T ss_pred ecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc----
Confidence 99999999654 24789999999999999999999999999999999999999999999999987332100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.....+
T Consensus 149 --------------------------------------------------------------------------~~~~~~ 154 (279)
T cd06619 149 --------------------------------------------------------------------------IAKTYV 154 (279)
T ss_pred --------------------------------------------------------------------------cccCCC
Confidence 011246
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCCh-------HHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSEN-------RATLYNVVGQPLRFPESPVVSFSARDLIK 525 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~-------~~~l~~i~~~~~~~p~~~~~s~~l~dLI~ 525 (604)
||..|+|||++.+..++.++|+|||||++|+|++|+.||..... ......+.............+.++++||.
T Consensus 155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (279)
T cd06619 155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFIT 234 (279)
T ss_pred CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHHHHHH
Confidence 89999999999999999999999999999999999999965321 11122222221111122347889999999
Q ss_pred HhhhcCCCCcccccCCHHHHhcCCCCCCCC
Q 007433 526 GLLVKEPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
+||..||++||+ +.|+++||||...+
T Consensus 235 ~~l~~~P~~Rp~----~~eil~~~~~~~~~ 260 (279)
T cd06619 235 QCMRKQPKERPA----PENLMDHPFIVQYN 260 (279)
T ss_pred HHhhCChhhCCC----HHHHhcCccccccc
Confidence 999999999999 99999999998654
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=355.69 Aligned_cols=256 Identities=28% Similarity=0.452 Sum_probs=208.2
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
+|++++.||.|+||.||+|++..++..||||++...... ......+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 589999999999999999999999999999998654321 1222356679999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 294 FCPGGDLHTLRQRQP-GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
|++ ++|.+++.... +..+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++........
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-- 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR-- 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--
Confidence 996 68888876543 35799999999999999999999999999999999999999999999999998743211000
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
......
T Consensus 157 --------------------------------------------------------------------------~~~~~~ 162 (285)
T cd07861 157 --------------------------------------------------------------------------VYTHEV 162 (285)
T ss_pred --------------------------------------------------------------------------cccCCc
Confidence 001225
Q ss_pred cCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---CC---------------CC---
Q 007433 453 GTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---PL---------------RF--- 510 (604)
Q Consensus 453 GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~~---------------~~--- 510 (604)
|++.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+.+..+... .. .+
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (285)
T cd07861 163 VTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKW 242 (285)
T ss_pred ccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhcccc
Confidence 78899999998764 4688999999999999999999999887655444332210 00 00
Q ss_pred ------CCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 511 ------PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 511 ------p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
.....++.++++||++||..||++||+ +.+|+.||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~~ll~~~~~ 285 (285)
T cd07861 243 KKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRIS----AKKALNHPYF 285 (285)
T ss_pred CcchhHHhcCCCCHHHHHHHHHHhcCChhhCCC----HHHHhcCCCC
Confidence 012347889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=375.24 Aligned_cols=253 Identities=25% Similarity=0.339 Sum_probs=203.7
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
..+|.+.+.||.|+||.||+|.+..+++.||||..... ...+|+++|++|+|+|||++++++..++..|||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~---------~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYA---------SSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccccc---------CHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 45899999999999999999999999999999975322 234799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
||++ .++|..++.... ..+++..++.|+.||+.||.|||++|||||||||+||||+.++.++|+|||++..+....
T Consensus 239 ~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~-- 314 (461)
T PHA03211 239 LPKY-RSDLYTYLGARL-RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW-- 314 (461)
T ss_pred EEcc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccc--
Confidence 9999 578888876542 469999999999999999999999999999999999999999999999999984321000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
.......+
T Consensus 315 ------------------------------------------------------------------------~~~~~~~~ 322 (461)
T PHA03211 315 ------------------------------------------------------------------------STPFHYGI 322 (461)
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00001135
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCC-------hHHHHHHHHcC-CC---CCC---------
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE-------NRATLYNVVGQ-PL---RFP--------- 511 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~-------~~~~l~~i~~~-~~---~~p--------- 511 (604)
+||+.|+|||++.+..++.++|||||||+||||++|..++.... ....+.+++.. .. .++
T Consensus 323 ~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~ 402 (461)
T PHA03211 323 AGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVS 402 (461)
T ss_pred CCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHH
Confidence 69999999999999999999999999999999999886653321 11222222211 10 000
Q ss_pred --------------------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 512 --------------------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 512 --------------------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
....++.++.+||.+||.+||.+||+ +.|||+||||+.
T Consensus 403 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPs----a~elL~hp~f~~ 460 (461)
T PHA03211 403 QYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPS----AAELLRLPLFQS 460 (461)
T ss_pred HHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcC----HHHHhhCcccCC
Confidence 01135568899999999999999999 999999999974
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=350.00 Aligned_cols=256 Identities=39% Similarity=0.724 Sum_probs=214.1
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHH-HhCCCCCccccceeEecCCeeEEEEeecCC
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREIL-QSLDHPFLPTLYTHFETDKFSCLVMEFCPG 297 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL-~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 297 (604)
+.||.|+||.||+|.+..+++.||||++.+..............|..++ ..++|+||+++++++..++.+|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999999776443333333344555544 455899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcc
Q 007433 298 GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTL 377 (604)
Q Consensus 298 gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 377 (604)
++|..++... ..+++..+..++.||+.||.|||++||+||||+|+|||++.++.++|+|||++.....
T Consensus 82 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---------- 149 (260)
T cd05611 82 GDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---------- 149 (260)
T ss_pred CCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc----------
Confidence 9999998765 4689999999999999999999999999999999999999999999999998732110
Q ss_pred cCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccc
Q 007433 378 ESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEY 457 (604)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 457 (604)
...+.|++.|
T Consensus 150 ----------------------------------------------------------------------~~~~~~~~~y 159 (260)
T cd05611 150 ----------------------------------------------------------------------NKKFVGTPDY 159 (260)
T ss_pred ----------------------------------------------------------------------cccCCCCcCc
Confidence 1123588899
Q ss_pred cCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC--CCCCCHHHHHHHHHhhhcCCCCc
Q 007433 458 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE--SPVVSFSARDLIKGLLVKEPQNR 535 (604)
Q Consensus 458 ~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~--~~~~s~~l~dLI~~lL~~dP~~R 535 (604)
+|||.+.+..++.++||||||+++|+|++|..||...+....+..+......++. ...++.++.+||.+||..||++|
T Consensus 160 ~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R 239 (260)
T cd05611 160 LAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKR 239 (260)
T ss_pred cChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHHc
Confidence 9999999888899999999999999999999999988777666666554444332 23478999999999999999999
Q ss_pred ccccCCHHHHhcCCCCCCCChh
Q 007433 536 LACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 536 pt~~~~a~elL~Hpff~~~~~~ 557 (604)
|++ ..++|+|.||||..++|.
T Consensus 240 ~~~-~~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 240 LGA-NGYQEIKSHPFFKSINWD 260 (260)
T ss_pred cCC-CcHHHHHcChHhhcCCCC
Confidence 972 226899999999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=354.94 Aligned_cols=256 Identities=30% Similarity=0.446 Sum_probs=212.7
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEe------c
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFE------T 284 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~------~ 284 (604)
.+.|++.+.||.|+||.||+|++..++..||+|++..... ....+..|+.+++++ +|+||++++++|. .
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 90 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED----EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGH 90 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH----HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCC
Confidence 4789999999999999999999999999999999876532 223456788999988 7999999999985 3
Q ss_pred CCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccc
Q 007433 285 DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLR 364 (604)
Q Consensus 285 ~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~ 364 (604)
+..+|+||||+++++|.+++.......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus 91 ~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~ 170 (282)
T cd06636 91 DDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 170 (282)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhh
Confidence 56889999999999999999876666789999999999999999999999999999999999999999999999998733
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
....
T Consensus 171 ~~~~---------------------------------------------------------------------------- 174 (282)
T cd06636 171 LDRT---------------------------------------------------------------------------- 174 (282)
T ss_pred hhcc----------------------------------------------------------------------------
Confidence 2100
Q ss_pred CCcccccccCccccCcceec-----CCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHH
Q 007433 445 NARSMSFVGTHEYLAPEIIK-----GEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFS 519 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l~-----~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~ 519 (604)
.......+|++.|+|||++. +..++.++|||||||++|||++|..||........+..+............++.+
T Consensus 175 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (282)
T cd06636 175 VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKWSKK 254 (282)
T ss_pred ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCCCcccccCHH
Confidence 00112346899999999986 3457889999999999999999999998766655555444332222223357889
Q ss_pred HHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 520 ARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 520 l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
+.+||.+||..||.+||+ +.|||+||||
T Consensus 255 ~~~li~~cl~~~p~~Rp~----~~ell~~~~~ 282 (282)
T cd06636 255 FIDFIEGCLVKNYLSRPS----TEQLLKHPFI 282 (282)
T ss_pred HHHHHHHHhCCChhhCcC----HHHHhcCCCC
Confidence 999999999999999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=401.08 Aligned_cols=269 Identities=28% Similarity=0.414 Sum_probs=220.1
Q ss_pred ecCceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec
Q 007433 205 VKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET 284 (604)
Q Consensus 205 ~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 284 (604)
+.++....++|.++++||.|+||+||+|++..++..||+|++....... .....+..|+.+|+.|+|||||+++++|.+
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e-~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE-REKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 3455566789999999999999999999999999999999997654332 234467789999999999999999999864
Q ss_pred --CCeeEEEEeecCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHc-------CeEeccCCCCcEEEcc---
Q 007433 285 --DKFSCLVMEFCPGGDLHTLRQRQ--PGKYFSEQAVKFYVAEVLLALEYLHML-------GIVYRDLKPENVLVRE--- 350 (604)
Q Consensus 285 --~~~~~lV~E~~~ggsL~~ll~~~--~~~~l~e~~~~~i~~qil~aL~yLH~~-------gIvHrDIKpeNILl~~--- 350 (604)
...+|||||||++++|..++... ....|++..++.|+.||+.||.|||+. +||||||||+||||+.
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 46799999999999999988753 124699999999999999999999985 4999999999999964
Q ss_pred --------------CCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccc
Q 007433 351 --------------DGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFF 416 (604)
Q Consensus 351 --------------~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 416 (604)
.+.+||+|||++..+...
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~------------------------------------------------ 195 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGIE------------------------------------------------ 195 (1021)
T ss_pred ccccccccccccCCCCceEEccCCcccccccc------------------------------------------------
Confidence 235899999988432100
Q ss_pred cccccccCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecCC--CCCccchHHHHHHHHHHHhhCCCCCCCC
Q 007433 417 SKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGE--GHGSAVDWWTFGIFLYELLFGKTPFKGS 494 (604)
Q Consensus 417 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--~~~~~~DiWSLGviL~eLltG~~PF~~~ 494 (604)
......+||+.|+|||++.+. .++.++||||||||||||++|..||...
T Consensus 196 -----------------------------s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~ 246 (1021)
T PTZ00266 196 -----------------------------SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA 246 (1021)
T ss_pred -----------------------------ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence 001134699999999998654 4788999999999999999999999877
Q ss_pred ChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCCh
Q 007433 495 ENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNW 556 (604)
Q Consensus 495 ~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~ 556 (604)
.....+...+.....++. ...+.++.+||..||..+|.+||+ +.++|+|+||..+..
T Consensus 247 ~~~~qli~~lk~~p~lpi-~~~S~eL~dLI~~~L~~dPeeRPS----a~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 247 NNFSQLISELKRGPDLPI-KGKSKELNILIKNLLNLSAKERPS----ALQCLGYQIIKNVGP 303 (1021)
T ss_pred CcHHHHHHHHhcCCCCCc-CCCCHHHHHHHHHHhcCChhHCcC----HHHHhccHHHhhcCC
Confidence 766666555544433332 346889999999999999999999 999999999987654
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=353.31 Aligned_cols=262 Identities=33% Similarity=0.629 Sum_probs=208.1
Q ss_pred EEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHH---HHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecC
Q 007433 220 KLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKK---LLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCP 296 (604)
Q Consensus 220 ~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~---~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 296 (604)
.||+|+||.||+|++..+++.||||++.+........ ......++.+++..+||||+.++++|..++..|+||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 3899999999999999999999999997654322111 1122233445566789999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCc
Q 007433 297 GGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSST 376 (604)
Q Consensus 297 ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 376 (604)
|++|..++... ..+++..++.++.|++.||+|||+++|+||||||+|||++.++.++|+|||++..+...
T Consensus 81 g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-------- 150 (278)
T cd05606 81 GGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-------- 150 (278)
T ss_pred CCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc--------
Confidence 99999888764 57999999999999999999999999999999999999999999999999987322100
Q ss_pred ccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCcc
Q 007433 377 LESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHE 456 (604)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 456 (604)
......|+..
T Consensus 151 ----------------------------------------------------------------------~~~~~~~~~~ 160 (278)
T cd05606 151 ----------------------------------------------------------------------KPHASVGTHG 160 (278)
T ss_pred ----------------------------------------------------------------------CCcCcCCCcC
Confidence 0012358999
Q ss_pred ccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCC---hHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCC
Q 007433 457 YLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSE---NRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEP 532 (604)
Q Consensus 457 Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~---~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP 532 (604)
|+|||++.+. .++.++|||||||++|||++|+.||.+.. .......+......++ ..++..+.+||.+||..||
T Consensus 161 y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~l~~~p 238 (278)
T cd05606 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP--DSFSPELRSLLEGLLQRDV 238 (278)
T ss_pred CcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCC--CcCCHHHHHHHHHHhhcCH
Confidence 9999998754 68899999999999999999999998753 2222222222233333 3478999999999999999
Q ss_pred CCccccc-CCHHHHhcCCCCCCCChhhhhcCC
Q 007433 533 QNRLACR-RGATEIKQHPFFQGVNWALIRCAS 563 (604)
Q Consensus 533 ~~Rpt~~-~~a~elL~Hpff~~~~~~~~~~~~ 563 (604)
.+|+..+ ..+.++++||||..++|..+....
T Consensus 239 ~~R~~~~~~~~~~ll~~~~~~~~~~~~~~~~~ 270 (278)
T cd05606 239 NRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQK 270 (278)
T ss_pred HhccCCCCCCHHHHHhCccccCCCchHhhhcc
Confidence 9999221 129999999999999999875443
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=355.55 Aligned_cols=259 Identities=27% Similarity=0.473 Sum_probs=218.9
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|+++++||.|+||.||++.+..++..||+|++..... .....+.+|+++++.++|+||+++++++..+...|+||
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESE---EELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCH---HHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 579999999999999999999998999999999975432 23345668999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+++++|..++... +..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~---- 156 (280)
T cd06611 82 EFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST---- 156 (280)
T ss_pred eccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc----
Confidence 999999999988764 246999999999999999999999999999999999999999999999999987332100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
........
T Consensus 157 ------------------------------------------------------------------------~~~~~~~~ 164 (280)
T cd06611 157 ------------------------------------------------------------------------LQKRDTFI 164 (280)
T ss_pred ------------------------------------------------------------------------ccccceee
Confidence 00112346
Q ss_pred cCccccCcceecC-----CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC-CCCCCCCCCHHHHHHHHH
Q 007433 453 GTHEYLAPEIIKG-----EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPL-RFPESPVVSFSARDLIKG 526 (604)
Q Consensus 453 GT~~Y~APE~l~~-----~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~-~~p~~~~~s~~l~dLI~~ 526 (604)
||+.|+|||++.. ..++.++|+|||||++|||++|+.||...+....+.++..... .+.....++.++.+||.+
T Consensus 165 ~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 244 (280)
T cd06611 165 GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSSFNDFLKS 244 (280)
T ss_pred cchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHHHHHHHHH
Confidence 8899999999853 3467799999999999999999999998777666666655432 333344688999999999
Q ss_pred hhhcCCCCcccccCCHHHHhcCCCCCCCC
Q 007433 527 LLVKEPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 527 lL~~dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
||..||.+||+ +.++|+||||....
T Consensus 245 ~l~~~p~~Rps----~~~il~~~~~~~~~ 269 (280)
T cd06611 245 CLVKDPDDRPT----AAELLKHPFVSDQS 269 (280)
T ss_pred HhccChhhCcC----HHHHhcChhhcccc
Confidence 99999999999 99999999998654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-42 Score=347.02 Aligned_cols=260 Identities=30% Similarity=0.448 Sum_probs=214.7
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchh--HHHHHHHHHHHHHHHHHHhCCCCCccccceeEec--CCee
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKAS--LEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET--DKFS 288 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~ 288 (604)
.+|++.+.||+|+||.||++.+..+++.||||++.... .........+.+|+.+++.++|+||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47999999999999999999999999999999986432 1122345567789999999999999999999876 3578
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|+||||+++++|.+++.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~ 159 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI 159 (265)
T ss_pred EEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence 8999999999999998765 45889999999999999999999999999999999999999999999999987432100
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
.. .....
T Consensus 160 ~~-------------------------------------------------------------------------~~~~~ 166 (265)
T cd06652 160 CL-------------------------------------------------------------------------SGTGM 166 (265)
T ss_pred cc-------------------------------------------------------------------------ccccc
Confidence 00 00001
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
....|+..|+|||++.+..++.++|||||||++|||++|+.||........+..+...+........++..+.++|.+||
T Consensus 167 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l 246 (265)
T cd06652 167 KSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFLKRIF 246 (265)
T ss_pred ccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHh
Confidence 12358899999999998889999999999999999999999998876666666655544333233457788999999999
Q ss_pred hcCCCCcccccCCHHHHhcCCCCC
Q 007433 529 VKEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 529 ~~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
. +|++||+ ++|+++|||++
T Consensus 247 ~-~p~~Rp~----~~~il~~~~~~ 265 (265)
T cd06652 247 V-EAKLRPS----ADELLRHTFVH 265 (265)
T ss_pred c-ChhhCCC----HHHHhcCcccC
Confidence 5 9999999 99999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=348.47 Aligned_cols=260 Identities=30% Similarity=0.455 Sum_probs=214.0
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhH--HHHHHHHHHHHHHHHHHhCCCCCccccceeEec--CCee
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASL--EKRKKLLRAQTEREILQSLDHPFLPTLYTHFET--DKFS 288 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~ 288 (604)
.+|++.+.||+|+||.||+|.+..++..||+|++..... ........+.+|+.+++.++|+||+++++++.+ +..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 378999999999999999999999999999999865422 222344567789999999999999999999875 4678
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
++||||+++++|.+++... ..+++..+..++.||+.||+|||+++|+||||||+||+++.++.++|+|||++......
T Consensus 82 ~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI 159 (266)
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence 9999999999999988765 46899999999999999999999999999999999999999999999999988432100
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
.. .....
T Consensus 160 ~~-------------------------------------------------------------------------~~~~~ 166 (266)
T cd06651 160 CM-------------------------------------------------------------------------SGTGI 166 (266)
T ss_pred cc-------------------------------------------------------------------------cCCcc
Confidence 00 00001
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
....|+..|+|||++.+..++.++|||||||++|||++|+.||........+..+............++..+++|| +||
T Consensus 167 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li-~~~ 245 (266)
T cd06651 167 RSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFL-GCI 245 (266)
T ss_pred ccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHHH-HHh
Confidence 1235889999999999988999999999999999999999999887766666655544332222334788899999 577
Q ss_pred hcCCCCcccccCCHHHHhcCCCCC
Q 007433 529 VKEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 529 ~~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
..||++||+ ++||++||||+
T Consensus 246 ~~~p~~Rp~----~~eil~hp~~~ 265 (266)
T cd06651 246 FVEARHRPS----AEELLRHPFAQ 265 (266)
T ss_pred cCChhhCcC----HHHHhcCcccc
Confidence 789999999 99999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=348.16 Aligned_cols=255 Identities=38% Similarity=0.699 Sum_probs=216.4
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
+|++.+.||.|+||.||+|.+..++..||+|++.+...........+.+|++++++++||||+++++.+.++...|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 58999999999999999999999999999999987654444455677889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
|+.|++|..++... ..+++..+..++.||+.||.|||++||+|+||+|+|||++.++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~---- 154 (258)
T cd05578 81 LLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT---- 154 (258)
T ss_pred CCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc----
Confidence 99999999998775 578999999999999999999999999999999999999999999999999873321000
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
......|
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (258)
T cd05578 155 -------------------------------------------------------------------------LTTSTSG 161 (258)
T ss_pred -------------------------------------------------------------------------cccccCC
Confidence 0112347
Q ss_pred CccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCCh--HHHHHHHHc-CCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 454 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSEN--RATLYNVVG-QPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 454 T~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~--~~~l~~i~~-~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
+..|+|||++.+..++.++|+||||+++|+|++|..||..... ...+..... ....++ ..++..+.++|.+||..
T Consensus 162 ~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~ 239 (258)
T cd05578 162 TPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYP--ATWSTEAIDAINKLLER 239 (258)
T ss_pred ChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCc--ccCcHHHHHHHHHHccC
Confidence 8899999999988899999999999999999999999987664 333333333 222333 45789999999999999
Q ss_pred CCCCcccccCCHHHHhcCCCC
Q 007433 531 EPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~Hpff 551 (604)
||.+|++.. +.|+++||||
T Consensus 240 ~p~~R~~~~--~~~l~~~~~~ 258 (258)
T cd05578 240 DPQKRLGDN--LKDLKNHPYF 258 (258)
T ss_pred ChhHcCCcc--HHHHhcCCCC
Confidence 999999922 3999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=352.42 Aligned_cols=254 Identities=28% Similarity=0.451 Sum_probs=211.9
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++.+.||.|+||.||+|++..+++.||+|++..... .....+.+|+.+++.++||||+++++.+..++..|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 3588999999999999999999999999999999875532 2234566899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+++++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06645 85 MEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-- 160 (267)
T ss_pred EeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc--
Confidence 9999999999998765 579999999999999999999999999999999999999999999999999874321000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 161 --------------------------------------------------------------------------~~~~~~ 166 (267)
T cd06645 161 --------------------------------------------------------------------------AKRKSF 166 (267)
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 001134
Q ss_pred ccCccccCcceec---CCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC---CCCCCCHHHHHHHH
Q 007433 452 VGTHEYLAPEIIK---GEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFP---ESPVVSFSARDLIK 525 (604)
Q Consensus 452 ~GT~~Y~APE~l~---~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p---~~~~~s~~l~dLI~ 525 (604)
.|+..|+|||++. ...++.++|+|||||++|+|++|..||........+..........+ ....++..+.+||.
T Consensus 167 ~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (267)
T cd06645 167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVK 246 (267)
T ss_pred cCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHH
Confidence 6899999999975 44578899999999999999999999977655554444433322222 22246788999999
Q ss_pred HhhhcCCCCcccccCCHHHHhcCCC
Q 007433 526 GLLVKEPQNRLACRRGATEIKQHPF 550 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~elL~Hpf 550 (604)
+||..||++||+ +.+|++|||
T Consensus 247 ~~l~~~P~~R~~----~~~ll~~~~ 267 (267)
T cd06645 247 MALTKNPKKRPT----AEKLLQHPF 267 (267)
T ss_pred HHccCCchhCcC----HHHHhcCCC
Confidence 999999999999 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=377.30 Aligned_cols=255 Identities=28% Similarity=0.389 Sum_probs=227.9
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
..|.-++.||.|+||.||.|++..+...||||.|........++...+.+|+..|++|.|||++.+.++|..+...||||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 35777889999999999999999999999999998877677788888999999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||| -|+-.+++.-.. +.|.+-.+..|+.+.|.||.|||+++.||||||..||||++.|.|||+|||.|-..
T Consensus 106 EYC-lGSAsDlleVhk-KplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~------- 176 (948)
T KOG0577|consen 106 EYC-LGSASDLLEVHK-KPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIM------- 176 (948)
T ss_pred HHH-hccHHHHHHHHh-ccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhc-------
Confidence 999 778888887663 67999999999999999999999999999999999999999999999999977211
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
....+|+
T Consensus 177 -------------------------------------------------------------------------~PAnsFv 183 (948)
T KOG0577|consen 177 -------------------------------------------------------------------------APANSFV 183 (948)
T ss_pred -------------------------------------------------------------------------Cchhccc
Confidence 1234789
Q ss_pred cCccccCcceecC---CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 453 GTHEYLAPEIIKG---EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 453 GT~~Y~APE~l~~---~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
|||+|||||++.. +.|+-++|||||||+..||.-.++|+...+....++.|.......-.....+..+++||..||.
T Consensus 184 GTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fvd~CLq 263 (948)
T KOG0577|consen 184 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQ 263 (948)
T ss_pred CCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHHHHHHh
Confidence 9999999999753 4588999999999999999999999999999999999876554444456689999999999999
Q ss_pred cCCCCcccccCCHHHHhcCCCCCC
Q 007433 530 KEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
+-|.+||| .+++|.|+|...
T Consensus 264 KipqeRpt----se~ll~H~fv~R 283 (948)
T KOG0577|consen 264 KIPQERPT----SEELLKHRFVLR 283 (948)
T ss_pred hCcccCCc----HHHHhhcchhcc
Confidence 99999999 999999999853
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=361.43 Aligned_cols=255 Identities=27% Similarity=0.445 Sum_probs=224.4
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
-|.++.+||+|+||.||+|.++.+|..+|||.+.-+ ..++++.+|+.||++++.++||++|+.|.....+++|||
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME 108 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME 108 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence 477788999999999999999999999999998654 456678899999999999999999999998889999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
||..|++.++++.+ .+.|+|+++..+++.-|.||+|||...-||||||..||||+.+|+.||+|||.|-.+.
T Consensus 109 YCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLT------- 180 (502)
T KOG0574|consen 109 YCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLT------- 180 (502)
T ss_pred hcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhh-------
Confidence 99999999998765 4789999999999999999999999999999999999999999999999999883221
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
.+-+...+.+|
T Consensus 181 ---------------------------------------------------------------------DTMAKRNTVIG 191 (502)
T KOG0574|consen 181 ---------------------------------------------------------------------DTMAKRNTVIG 191 (502)
T ss_pred ---------------------------------------------------------------------hhHHhhCcccc
Confidence 12223446789
Q ss_pred CccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC-CCCCCCCCCCCHHHHHHHHHhhhcCC
Q 007433 454 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ-PLRFPESPVVSFSARDLIKGLLVKEP 532 (604)
Q Consensus 454 T~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~-~~~~p~~~~~s~~l~dLI~~lL~~dP 532 (604)
|+.|||||++..-+|+.++||||||++..||..|++||.+......++.|-.. +..|..+...+.++.|||++||.++|
T Consensus 192 TPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~P 271 (502)
T KOG0574|consen 192 TPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKP 271 (502)
T ss_pred CcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCH
Confidence 99999999999999999999999999999999999999987776666665433 34455555688999999999999999
Q ss_pred CCcccccCCHHHHhcCCCCCCC
Q 007433 533 QNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 533 ~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
++|-| +.+|++|||.++.
T Consensus 272 E~R~T----A~~L~~H~FiknA 289 (502)
T KOG0574|consen 272 EERKT----ALRLCEHTFIKNA 289 (502)
T ss_pred HHHHH----HHHHhhhhhhcCC
Confidence 99999 9999999999753
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=347.58 Aligned_cols=261 Identities=27% Similarity=0.439 Sum_probs=216.7
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHH------HHHHHHHHHHHHHHHHhCCCCCccccceeEecCCe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLE------KRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKF 287 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 287 (604)
+|.+.+.||.|+||.||+|.+..++..||+|.+...... .......+.+|+.+++.++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 477889999999999999999988999999998654221 22334567789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccC
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAV 367 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~ 367 (604)
.++||||+++++|..++... ..+++..+..++.|++.||+|||++|++||||+|+|||++.++.++|+|||++..+..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEA 158 (267)
T ss_pred cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccc
Confidence 99999999999999999775 5689999999999999999999999999999999999999999999999998854321
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
.... ......
T Consensus 159 ~~~~----------------------------------------------------------------------~~~~~~ 168 (267)
T cd06628 159 NSLS----------------------------------------------------------------------TKTNGA 168 (267)
T ss_pred cccc----------------------------------------------------------------------CCcccc
Confidence 0000 000001
Q ss_pred ccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007433 448 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGL 527 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~l 527 (604)
...+.|+..|+|||.+.+..++.++|+|||||++|+|++|+.||........+.++.... .......++..+.+||++|
T Consensus 169 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~ 247 (267)
T cd06628 169 RPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA-SPEIPSNISSEAIDFLEKT 247 (267)
T ss_pred ccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC-CCcCCcccCHHHHHHHHHH
Confidence 113458899999999999889999999999999999999999999877666666554421 1112234789999999999
Q ss_pred hhcCCCCcccccCCHHHHhcCCCC
Q 007433 528 LVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
|..||.+||+ +.++++||||
T Consensus 248 l~~~p~~Rp~----~~~il~~~~~ 267 (267)
T cd06628 248 FEIDHNKRPT----AAELLKHPFL 267 (267)
T ss_pred ccCCchhCcC----HHHHhhCCCC
Confidence 9999999999 9999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-42 Score=351.99 Aligned_cols=256 Identities=29% Similarity=0.447 Sum_probs=214.9
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
.|++++.||.|+||.||++.+..++..+|+|.+..... .....+.+|+++++.++|+||++++++|..++..|+|||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH---HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 47888999999999999999999999999999975432 234456779999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
|+++++|..++.+. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++......
T Consensus 83 ~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~----- 156 (282)
T cd06643 83 FCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT----- 156 (282)
T ss_pred ecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccc-----
Confidence 99999999877653 256899999999999999999999999999999999999999999999999987432100
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
......+.|
T Consensus 157 -----------------------------------------------------------------------~~~~~~~~~ 165 (282)
T cd06643 157 -----------------------------------------------------------------------IQRRDSFIG 165 (282)
T ss_pred -----------------------------------------------------------------------ccccccccc
Confidence 000113458
Q ss_pred CccccCcceec-----CCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-CCCCCCCCCCHHHHHHHHHh
Q 007433 454 THEYLAPEIIK-----GEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP-LRFPESPVVSFSARDLIKGL 527 (604)
Q Consensus 454 T~~Y~APE~l~-----~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~-~~~p~~~~~s~~l~dLI~~l 527 (604)
|+.|+|||++. +..++.++|||||||++|||++|+.||...+....+.++.... ........++.++++||.+|
T Consensus 166 ~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 245 (282)
T cd06643 166 TPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFKDFLKKC 245 (282)
T ss_pred cccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHHHHHHHH
Confidence 89999999984 3456789999999999999999999998877766666655432 22333445789999999999
Q ss_pred hhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 528 LVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
|..||.+||+ +.++++||||..
T Consensus 246 l~~~p~~Rp~----~~~il~~~~~~~ 267 (282)
T cd06643 246 LEKNVDARWT----TTQLLQHPFVTV 267 (282)
T ss_pred ccCChhhCcC----HHHHhcCCCEec
Confidence 9999999999 999999999964
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=342.89 Aligned_cols=255 Identities=28% Similarity=0.460 Sum_probs=217.2
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
+|++.+.||+|+||.||+|.+..++..||||.+....... .....+.+|+++|+.++|+||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTK-DERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccccc-HHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 5899999999999999999999999999999997654332 234567789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccC-CcEEEecccccccccCCCccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRED-GHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~-g~vkL~DFGla~~~~~~~~~~ 372 (604)
|+++++|.+++....+..+++..+..++.|++.||+|||++||+||||||+|||++.+ +.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---- 155 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---- 155 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC----
Confidence 9999999999987655678999999999999999999999999999999999999865 46899999987432110
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.......
T Consensus 156 -------------------------------------------------------------------------~~~~~~~ 162 (256)
T cd08220 156 -------------------------------------------------------------------------SKAYTVV 162 (256)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0011235
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEP 532 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP 532 (604)
|+..|+|||.+.+..++.++|||||||++|+|++|+.||.+.+.......+..... .+....++..+++||.+||..||
T Consensus 163 ~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p 241 (256)
T cd08220 163 GTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF-APISDRYSPDLRQLILSMLNLDP 241 (256)
T ss_pred cCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-CCCCCCcCHHHHHHHHHHccCCh
Confidence 88899999999988889999999999999999999999988776666555554322 22334588999999999999999
Q ss_pred CCcccccCCHHHHhcCCCC
Q 007433 533 QNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 533 ~~Rpt~~~~a~elL~Hpff 551 (604)
++||+ +.|+++||||
T Consensus 242 ~~Rpt----~~~ll~~p~~ 256 (256)
T cd08220 242 SKRPQ----LSQIMAQPIC 256 (256)
T ss_pred hhCCC----HHHHhhCCCC
Confidence 99999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-42 Score=346.76 Aligned_cols=261 Identities=26% Similarity=0.390 Sum_probs=214.4
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchh---HHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKAS---LEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
+|++.+.||.|+||.||+|.+. ++..+|+|.+.... .........+.+|+++|+.++|+||+++++++.+++..|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 5888999999999999999874 67789999986432 1223344567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
||||+++++|.+++.+. ..+++..+..++.||+.||+|||+.||+|+||+|+|||++.++.++|+|||++........
T Consensus 80 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 157 (265)
T cd06631 80 FMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL 157 (265)
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence 99999999999998765 4689999999999999999999999999999999999999999999999998743321000
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
.. ........
T Consensus 158 ~~----------------------------------------------------------------------~~~~~~~~ 167 (265)
T cd06631 158 HG----------------------------------------------------------------------THSNMLKS 167 (265)
T ss_pred cc----------------------------------------------------------------------cccccccc
Confidence 00 00001123
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC-CCCCCCCHHHHHHHHHhhh
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRF-PESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~-p~~~~~s~~l~dLI~~lL~ 529 (604)
..|+..|+|||++.+..++.++|+|||||++|+|++|..||...+.......+....... .....++.++.+||++||.
T Consensus 168 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 247 (265)
T cd06631 168 MHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAAIDFVTSCLT 247 (265)
T ss_pred cCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHHHHHHHHHhc
Confidence 458999999999999889999999999999999999999998776665555444332122 2234588999999999999
Q ss_pred cCCCCcccccCCHHHHhcCCCC
Q 007433 530 KEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~Hpff 551 (604)
.||++||+ +.++|+||||
T Consensus 248 ~~p~~Rp~----~~~~l~~~~~ 265 (265)
T cd06631 248 RDQHERPS----ALQLLRHDFL 265 (265)
T ss_pred CCcccCCC----HHHHhcCCCC
Confidence 99999999 9999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=354.30 Aligned_cols=255 Identities=27% Similarity=0.436 Sum_probs=204.1
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
+|++++.||.|+||.||+|++..++..||+|.+...... ......+.+|+++++.++|+||+++++++.+....|+|||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~-~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeeccccc-ccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 589999999999999999999999999999999754221 1222345679999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
|+. ++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 80 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--- 154 (284)
T cd07839 80 YCD-QDLKKYFDSCN-GDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--- 154 (284)
T ss_pred cCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC---
Confidence 995 68888776542 5699999999999999999999999999999999999999999999999998743211000
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
......+
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (284)
T cd07839 155 -------------------------------------------------------------------------CYSAEVV 161 (284)
T ss_pred -------------------------------------------------------------------------CcCCCcc
Confidence 0012247
Q ss_pred CccccCcceecCCC-CCccchHHHHHHHHHHHhhCCCCCCC-CChHHHHHHHHc---CC--------------CCC----
Q 007433 454 THEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKG-SENRATLYNVVG---QP--------------LRF---- 510 (604)
Q Consensus 454 T~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~PF~~-~~~~~~l~~i~~---~~--------------~~~---- 510 (604)
++.|+|||++.+.. ++.++|||||||++|||++|..||.. .+..+.+..+.. .+ ..+
T Consensus 162 ~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd07839 162 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYP 241 (284)
T ss_pred ccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCC
Confidence 88999999987754 68999999999999999999988643 333333322211 00 000
Q ss_pred ------CCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 511 ------PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 511 ------p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
...+.++.++++||++||..||.+||+ ++++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~~il~h~~f 284 (284)
T cd07839 242 ATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRIS----AEEALQHPYF 284 (284)
T ss_pred CcchhhhhcccCCHHHHHHHHHHhcCChhhcCC----HHHHhcCCCC
Confidence 011347889999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-42 Score=351.33 Aligned_cols=256 Identities=30% Similarity=0.470 Sum_probs=209.9
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++++.||+|+||.||+|.+..+++.||+|++....... .....+.+|+++++.++|+||++++++|..+...|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDP-VIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCc-cccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 47999999999999999999999999999999986542111 12234567999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||++++.|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--- 154 (286)
T cd07847 80 EYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG--- 154 (286)
T ss_pred eccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc---
Confidence 999998888876554 468999999999999999999999999999999999999999999999999884321100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.......
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (286)
T cd07847 155 -------------------------------------------------------------------------DDYTDYV 161 (286)
T ss_pred -------------------------------------------------------------------------ccccCcc
Confidence 0011235
Q ss_pred cCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-------------------CCCCC
Q 007433 453 GTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP-------------------LRFPE 512 (604)
Q Consensus 453 GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~-------------------~~~p~ 512 (604)
++..|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.++.+.... ...+.
T Consensus 162 ~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (286)
T cd07847 162 ATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPE 241 (286)
T ss_pred cccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCC
Confidence 7889999999877 447889999999999999999999999877665554433210 01111
Q ss_pred ----------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 513 ----------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 513 ----------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
...++..+.+||.+||..||++||+ +.|+++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~----~~eil~~~~f 286 (286)
T cd07847 242 PETREPLESKFPNISSPALSFLKGCLQMDPTERLS----CEELLEHPYF 286 (286)
T ss_pred cccccCHHHHhccCCHHHHHHHHHHhcCCccccCC----HHHHhcCCCC
Confidence 1246788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=350.76 Aligned_cols=258 Identities=30% Similarity=0.485 Sum_probs=218.1
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++.+.||.|+||.||+|.+..++..||+|++..... ......+.+|+++++.++|+||+++++++.++...|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 478999999999999999999999999999999976532 223345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+++++|.+++... .+++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--- 152 (274)
T cd06609 79 EYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--- 152 (274)
T ss_pred EeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc---
Confidence 999999999988764 68999999999999999999999999999999999999999999999999884432110
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.......
T Consensus 153 -------------------------------------------------------------------------~~~~~~~ 159 (274)
T cd06609 153 -------------------------------------------------------------------------SKRNTFV 159 (274)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0111345
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEP 532 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP 532 (604)
|++.|+|||++.+..++.++|||||||++|+|++|..||...+.......+............++.++.++|.+||..||
T Consensus 160 ~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~p 239 (274)
T cd06609 160 GTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCLNKDP 239 (274)
T ss_pred CCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHhhCCh
Confidence 88899999999998899999999999999999999999987766555555444322221222278899999999999999
Q ss_pred CCcccccCCHHHHhcCCCCCCCC
Q 007433 533 QNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 533 ~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
++||+ ++++++||||....
T Consensus 240 ~~Rpt----~~~il~~~~~~~~~ 258 (274)
T cd06609 240 KERPS----AKELLKHKFIKKAK 258 (274)
T ss_pred hhCcC----HHHHhhChhhcCCC
Confidence 99999 99999999997654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=372.11 Aligned_cols=247 Identities=25% Similarity=0.418 Sum_probs=213.4
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
+....+++++.||+|-||.||+|.++++. .||+|.+....+... .+.+|++||++|+|+|||+||+++..++.+|
T Consensus 203 i~r~~l~l~~~LG~G~FG~V~~g~~~~~~-~vavk~ik~~~m~~~----~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piy 277 (468)
T KOG0197|consen 203 IPREELKLIRELGSGQFGEVWLGKWNGST-KVAVKTIKEGSMSPE----AFLREAQIMKKLRHEKLVKLYGVCTKQEPIY 277 (468)
T ss_pred ecHHHHHHHHHhcCCccceEEEEEEcCCC-cccceEEeccccChh----HHHHHHHHHHhCcccCeEEEEEEEecCCceE
Confidence 33456778899999999999999998875 699999977654433 3347999999999999999999999988999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
|||||++.|+|.++++...+..+.......|+.||++|++||+++++|||||...||||+++..+||+|||||+.....
T Consensus 278 IVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~- 356 (468)
T KOG0197|consen 278 IVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD- 356 (468)
T ss_pred EEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC-
Confidence 9999999999999999877789999999999999999999999999999999999999999999999999999632211
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
.+......
T Consensus 357 -~Y~~~~~~----------------------------------------------------------------------- 364 (468)
T KOG0197|consen 357 -EYTASEGG----------------------------------------------------------------------- 364 (468)
T ss_pred -ceeecCCC-----------------------------------------------------------------------
Confidence 11110000
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
.-..-|.|||.+....++.++|||||||+||||+| |+.||.+..+.+.+..+. ..+++|.+..+|.++.+++..||
T Consensus 365 --kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le-~GyRlp~P~~CP~~vY~lM~~CW 441 (468)
T KOG0197|consen 365 --KFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLE-RGYRLPRPEGCPDEVYELMKSCW 441 (468)
T ss_pred --CCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHh-ccCcCCCCCCCCHHHHHHHHHHh
Confidence 01246999999999999999999999999999997 999999999988876654 56788888899999999999999
Q ss_pred hcCCCCccc
Q 007433 529 VKEPQNRLA 537 (604)
Q Consensus 529 ~~dP~~Rpt 537 (604)
..+|++|||
T Consensus 442 ~~~P~~RPt 450 (468)
T KOG0197|consen 442 HEDPEDRPT 450 (468)
T ss_pred hCCcccCCC
Confidence 999999999
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-42 Score=353.91 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=215.8
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
.+|++++.||.|+||.||++.+..++..||+|.+....... ...+.+|+.+++.++|+||+++++.|..+.+.|+||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~---~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcch---HHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 68999999999999999999999999999999997654322 234668999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+++++|.+++... .+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 97 e~~~~~~L~~~~~~~---~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~---- 169 (296)
T cd06654 97 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---- 169 (296)
T ss_pred cccCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc----
Confidence 999999999988653 5899999999999999999999999999999999999999999999999987322100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
........
T Consensus 170 ------------------------------------------------------------------------~~~~~~~~ 177 (296)
T cd06654 170 ------------------------------------------------------------------------QSKRSTMV 177 (296)
T ss_pred ------------------------------------------------------------------------ccccCccc
Confidence 00011235
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-CCCCCCCCCCHHHHHHHHHhhhcC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP-LRFPESPVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~-~~~p~~~~~s~~l~dLI~~lL~~d 531 (604)
|++.|+|||.+.+..++.++|||||||++|+|++|+.||........+..+.... ...+....++..+.+||.+||..|
T Consensus 178 ~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 257 (296)
T cd06654 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257 (296)
T ss_pred CCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHHHHHHHHHCcCC
Confidence 8899999999998889999999999999999999999998876655544443322 222233457889999999999999
Q ss_pred CCCcccccCCHHHHhcCCCCCC
Q 007433 532 PQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 532 P~~Rpt~~~~a~elL~Hpff~~ 553 (604)
|++||+ +.++++||||..
T Consensus 258 p~~Rpt----~~eil~~~~~~~ 275 (296)
T cd06654 258 VEKRGS----AKELLQHQFLKI 275 (296)
T ss_pred cccCcC----HHHHhhChhhhc
Confidence 999999 999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-42 Score=345.25 Aligned_cols=261 Identities=28% Similarity=0.417 Sum_probs=218.3
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++.+.||.|+||+||+|.+..++..+|+|++....... ....+.+|+++|+.++|+||+++++.+..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999999899999999997654332 4456778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 293 EFCPGGDLHTLRQRQPG-KYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
||+++++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..+......
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999999876432 57899999999999999999999999999999999999999999999999987433211000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
........
T Consensus 159 ------------------------------------------------------------------------~~~~~~~~ 166 (267)
T cd06610 159 ------------------------------------------------------------------------TRKVRKTF 166 (267)
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00011234
Q ss_pred ccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC-CCCCC---CCCCHHHHHHHHH
Q 007433 452 VGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPL-RFPES---PVVSFSARDLIKG 526 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~-~~p~~---~~~s~~l~dLI~~ 526 (604)
+|+..|+|||++... .++.++|+|||||++|+|++|+.||...+....+.++..... .++.. ..++..+++||.+
T Consensus 167 ~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 246 (267)
T cd06610 167 VGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISL 246 (267)
T ss_pred cCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHH
Confidence 689999999998776 788999999999999999999999988776666655554322 22221 2578899999999
Q ss_pred hhhcCCCCcccccCCHHHHhcCCCC
Q 007433 527 LLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 527 lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
||.+||++||+ +.+|++||||
T Consensus 247 ~l~~~p~~Rp~----~~~ll~~p~~ 267 (267)
T cd06610 247 CLQKDPSKRPT----AEELLKHKFF 267 (267)
T ss_pred HcCCChhhCcC----HHHHhhCCCC
Confidence 99999999999 9999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-42 Score=353.72 Aligned_cols=256 Identities=26% Similarity=0.423 Sum_probs=217.6
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
.+|++++.||.|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++|+||+++++++..++.+|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 5799999999999999999999999999999999754332 2345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+++++|..++... .+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~--- 169 (296)
T cd06655 96 EYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ--- 169 (296)
T ss_pred EecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc---
Confidence 999999999988653 58999999999999999999999999999999999999999999999999873221000
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.......
T Consensus 170 -------------------------------------------------------------------------~~~~~~~ 176 (296)
T cd06655 170 -------------------------------------------------------------------------SKRSTMV 176 (296)
T ss_pred -------------------------------------------------------------------------ccCCCcC
Confidence 0011235
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-CCCCCCCCCCHHHHHHHHHhhhcC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP-LRFPESPVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~-~~~p~~~~~s~~l~dLI~~lL~~d 531 (604)
|++.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+....+..+.... ..+.....++..+++||.+||..|
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~d 256 (296)
T cd06655 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRCLEMD 256 (296)
T ss_pred CCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHhhcC
Confidence 8899999999999889999999999999999999999999877766655554322 222333458889999999999999
Q ss_pred CCCcccccCCHHHHhcCCCCCCC
Q 007433 532 PQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 532 P~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
|++||+ +.++++||||+..
T Consensus 257 p~~Rpt----~~~il~~~~~~~~ 275 (296)
T cd06655 257 VEKRGS----AKELLQHPFLKLA 275 (296)
T ss_pred hhhCCC----HHHHhhChHhhhc
Confidence 999999 9999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-42 Score=350.69 Aligned_cols=256 Identities=30% Similarity=0.458 Sum_probs=210.4
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
+|++++.||.|+||.||+|++..++..||||.+...... ......+.+|++++++++||||+++++++.+++..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccc-cccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 589999999999999999999999999999998754321 1222356689999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
|+. ++|..++.......+++..++.++.||+.||+|||++|++||||+|+|||++.++.++|+|||++.......
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~---- 154 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---- 154 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc----
Confidence 994 689988877666789999999999999999999999999999999999999999999999999873321100
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
.......+
T Consensus 155 ------------------------------------------------------------------------~~~~~~~~ 162 (284)
T cd07860 155 ------------------------------------------------------------------------RTYTHEVV 162 (284)
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00012247
Q ss_pred CccccCcceecCCC-CCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---CC---------------CCCC--
Q 007433 454 THEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---PL---------------RFPE-- 512 (604)
Q Consensus 454 T~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~~---------------~~p~-- 512 (604)
++.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+....+..+... +. .++.
T Consensus 163 ~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd07860 163 TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWA 242 (284)
T ss_pred cccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhccccc
Confidence 88999999987755 588999999999999999999999887765555443321 00 0110
Q ss_pred -------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 513 -------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 513 -------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
.+.++.++++||.+||..||.+||+ +.++++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~~l~~~~f 284 (284)
T cd07860 243 RQDFSKVVPPLDEDGRDLLSQMLHYDPNKRIS----AKAALAHPFF 284 (284)
T ss_pred ccCHHHHcccCCHHHHHHHHHhcCCCcccCCC----HHHHhcCCCC
Confidence 1246788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=341.75 Aligned_cols=256 Identities=30% Similarity=0.476 Sum_probs=220.6
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
+|++++.||.|+||.||.+++..++..+++|.+....... .....+.+|+++|++++|+||++++++|.+.+..++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE-KERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccch-hHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 6999999999999999999999999999999987654332 233456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
||++++|.+++....+..+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~---- 155 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY---- 155 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc----
Confidence 9999999999987655679999999999999999999999999999999999999999999999999874321100
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
.......|
T Consensus 156 ------------------------------------------------------------------------~~~~~~~~ 163 (256)
T cd08221 156 ------------------------------------------------------------------------SMAETVVG 163 (256)
T ss_pred ------------------------------------------------------------------------ccccccCC
Confidence 00112458
Q ss_pred CccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCC
Q 007433 454 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQ 533 (604)
Q Consensus 454 T~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~ 533 (604)
++.|+|||++.+..++.++|||||||++|||++|..||......+....+....+. +....++.++.++|.+||..||.
T Consensus 164 ~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~ 242 (256)
T cd08221 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYT-PVVSVYSSELISLVHSLLQQDPE 242 (256)
T ss_pred CccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCC-CCccccCHHHHHHHHHHcccCcc
Confidence 89999999999888899999999999999999999999987777777776654433 23356789999999999999999
Q ss_pred CcccccCCHHHHhcCCCC
Q 007433 534 NRLACRRGATEIKQHPFF 551 (604)
Q Consensus 534 ~Rpt~~~~a~elL~Hpff 551 (604)
+||+ +.++|+|+|+
T Consensus 243 ~R~s----~~~ll~~~~l 256 (256)
T cd08221 243 KRPT----ADEVLDQPLL 256 (256)
T ss_pred cCCC----HHHHhhCcCC
Confidence 9999 9999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=342.65 Aligned_cols=256 Identities=25% Similarity=0.463 Sum_probs=218.5
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
+|++++.||.|+||.||++.+..+++.||+|.+....... .....+.+|+.+++.++|+||+++++++...++.|+|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSP-KEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCCh-HHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 5999999999999999999999999999999987543322 223466789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
|+.+++|.+++.......+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~---- 155 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV---- 155 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch----
Confidence 9999999998877555578999999999999999999999999999999999999999999999999874321000
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
.......|
T Consensus 156 ------------------------------------------------------------------------~~~~~~~~ 163 (256)
T cd08218 156 ------------------------------------------------------------------------ELARTCIG 163 (256)
T ss_pred ------------------------------------------------------------------------hhhhhccC
Confidence 00112358
Q ss_pred CccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCC
Q 007433 454 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQ 533 (604)
Q Consensus 454 T~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~ 533 (604)
++.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+.+..+..+... +....++.++.++|.+||..+|.
T Consensus 164 ~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~ 242 (256)
T cd08218 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYP-PVSSHYSYDLRNLVSQLFKRNPR 242 (256)
T ss_pred CccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCC-CCcccCCHHHHHHHHHHhhCChh
Confidence 88999999999888899999999999999999999999887777776666544322 22345788999999999999999
Q ss_pred CcccccCCHHHHhcCCCC
Q 007433 534 NRLACRRGATEIKQHPFF 551 (604)
Q Consensus 534 ~Rpt~~~~a~elL~Hpff 551 (604)
+||+ +.++++||||
T Consensus 243 ~Rp~----~~~vl~~~~~ 256 (256)
T cd08218 243 DRPS----VNSILEKNFI 256 (256)
T ss_pred hCcC----HHHHhhCcCC
Confidence 9999 9999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=382.43 Aligned_cols=266 Identities=20% Similarity=0.319 Sum_probs=197.7
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCc-eEEEEE--------------EecchhHHHHHHHHHHHHHHHHHHhCCCCCcc
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTK-CYFAMK--------------VMDKASLEKRKKLLRAQTEREILQSLDHPFLP 276 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~-~~vAiK--------------~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv 276 (604)
.++|+++++||+|+||+||+|.++... ..+++| ++.+...........+.+|+.+|+.++|+||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 478999999999999999999765432 122222 11111111122334567899999999999999
Q ss_pred ccceeEecCCeeEEEEeecCCCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCc
Q 007433 277 TLYTHFETDKFSCLVMEFCPGGDLHTLRQRQP---GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGH 353 (604)
Q Consensus 277 ~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~---~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~ 353 (604)
++++++..++..|+|||++ +++|..++.... ........++.|+.||+.||+|||++|||||||||+||||+.+|.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 9999999999999999999 667777665421 123446678899999999999999999999999999999999999
Q ss_pred EEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCC
Q 007433 354 IMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQV 433 (604)
Q Consensus 354 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (604)
+||+|||++..+....
T Consensus 306 vkL~DFGla~~~~~~~---------------------------------------------------------------- 321 (501)
T PHA03210 306 IVLGDFGTAMPFEKER---------------------------------------------------------------- 321 (501)
T ss_pred EEEEeCCCceecCccc----------------------------------------------------------------
Confidence 9999999984332100
Q ss_pred CCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCC-CC--ChHHHHHHHHcC----
Q 007433 434 SPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFK-GS--ENRATLYNVVGQ---- 506 (604)
Q Consensus 434 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~-~~--~~~~~l~~i~~~---- 506 (604)
......++||+.|+|||++.+..++.++|||||||+||||++|..++. .. .....+.+++..
T Consensus 322 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 390 (501)
T PHA03210 322 -----------EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVC 390 (501)
T ss_pred -----------ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccC
Confidence 001123579999999999999999999999999999999999886543 22 222222222210
Q ss_pred CCCCC--------------------------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 507 PLRFP--------------------------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 507 ~~~~p--------------------------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
...++ ....++.++.++|.+||.+||.+||+ +.|+|+||||....+.
T Consensus 391 ~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rps----a~elL~hp~f~~~~~~ 463 (501)
T PHA03210 391 DEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPG----AAELLALPLFSAEEEE 463 (501)
T ss_pred hhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcC----HHHHhhChhhhcCCch
Confidence 00011 01125567888999999999999999 9999999999876644
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=344.76 Aligned_cols=261 Identities=25% Similarity=0.415 Sum_probs=213.0
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhH---HHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASL---EKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~---~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
+|+..+.||+|+||.||++.+..++..||+|++..... ........+.+|+++|+.++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 48888999999999999999999999999999975431 122345677889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC-cEEEecccccccccCCC
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG-HIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g-~vkL~DFGla~~~~~~~ 369 (604)
||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++ .++|+|||++.......
T Consensus 81 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~ 158 (268)
T cd06630 81 FVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKG 158 (268)
T ss_pred EEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccc
Confidence 99999999999998765 4689999999999999999999999999999999999998776 59999999874432110
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
.. ......
T Consensus 159 ~~------------------------------------------------------------------------~~~~~~ 166 (268)
T cd06630 159 TG------------------------------------------------------------------------AGEFQG 166 (268)
T ss_pred cc------------------------------------------------------------------------CCcccc
Confidence 00 000012
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChH---HHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR---ATLYNVVGQPLRFPESPVVSFSARDLIKG 526 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~---~~l~~i~~~~~~~p~~~~~s~~l~dLI~~ 526 (604)
...||..|+|||++.+..++.++|+|+|||++|+|++|+.||...... ..+..+............++.++.++|.+
T Consensus 167 ~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 246 (268)
T cd06630 167 QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLR 246 (268)
T ss_pred ccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHH
Confidence 346899999999999888999999999999999999999999754432 22222222222222223478899999999
Q ss_pred hhhcCCCCcccccCCHHHHhcCCCCC
Q 007433 527 LLVKEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 527 lL~~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
||..||++||+ +.++++||||+
T Consensus 247 ~l~~~p~~R~~----~~~ll~~~~~~ 268 (268)
T cd06630 247 CLELQPEDRPP----SRELLKHPVFR 268 (268)
T ss_pred HcCCCcccCcC----HHHHhcCcccC
Confidence 99999999999 99999999994
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-42 Score=348.04 Aligned_cols=254 Identities=25% Similarity=0.414 Sum_probs=210.4
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++.+.||+|+||.||+|++..+++.||+|++...... ....+.+|+.+++.++|+||+++++++..++.+|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD---DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc---hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 36899999999999999999999999999999999754221 223456899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-- 160 (267)
T cd06646 85 MEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI-- 160 (267)
T ss_pred EeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc--
Confidence 9999999999988764 468999999999999999999999999999999999999999999999999884432100
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 161 --------------------------------------------------------------------------~~~~~~ 166 (267)
T cd06646 161 --------------------------------------------------------------------------AKRKSF 166 (267)
T ss_pred --------------------------------------------------------------------------cccCcc
Confidence 001123
Q ss_pred ccCccccCcceec---CCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC---CCCCCCHHHHHHHH
Q 007433 452 VGTHEYLAPEIIK---GEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFP---ESPVVSFSARDLIK 525 (604)
Q Consensus 452 ~GT~~Y~APE~l~---~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p---~~~~~s~~l~dLI~ 525 (604)
.|+..|+|||.+. ...++.++|||||||++|||++|+.||...........+....+..+ ....++..+.+||+
T Consensus 167 ~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 246 (267)
T cd06646 167 IGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVK 246 (267)
T ss_pred ccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHH
Confidence 5889999999985 34467899999999999999999999976655444443333322222 22346889999999
Q ss_pred HhhhcCCCCcccccCCHHHHhcCCC
Q 007433 526 GLLVKEPQNRLACRRGATEIKQHPF 550 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~elL~Hpf 550 (604)
+||..||++||+ +++||+|+|
T Consensus 247 ~~l~~~P~~Rp~----~~~il~~l~ 267 (267)
T cd06646 247 ISLTKNPKKRPT----AERLLTHLF 267 (267)
T ss_pred HHhhCChhhCcC----HHHHhcCCC
Confidence 999999999999 999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=345.91 Aligned_cols=279 Identities=36% Similarity=0.621 Sum_probs=225.9
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEecCCeeEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV 291 (604)
++|.+.+.||.|+||.||++.+..++..||+|++.+...........+.+|+++++++. |+||++++++|.+++..|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998765444444566778999999998 99999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+++++|.+++.+. ..+++..++.++.||+.||.|||++|++|+||+|+||+++.+|.++|+|||++.........
T Consensus 81 ~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~ 158 (280)
T cd05581 81 LEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP 158 (280)
T ss_pred EcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence 9999999999998876 47999999999999999999999999999999999999999999999999998544311100
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
..... .+ + ...............+
T Consensus 159 ~~~~~----------~~---------------------~-------------------------~~~~~~~~~~~~~~~~ 182 (280)
T cd05581 159 ESNKG----------DA---------------------T-------------------------NIDSQIEKNRRRFASF 182 (280)
T ss_pred ccCCC----------CC---------------------c-------------------------cccccccccccccccc
Confidence 00000 00 0 0000000111223356
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~d 531 (604)
.|+..|+|||++.+..++.++|+|||||++++|++|+.||........+..+......++. .++..+.+||.+||..|
T Consensus 183 ~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~ 260 (280)
T cd05581 183 VGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPP--NFPPDAKDLIEKLLVLD 260 (280)
T ss_pred cCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCCCC--ccCHHHHHHHHHHhcCC
Confidence 7899999999999888999999999999999999999999988776666666654444443 47899999999999999
Q ss_pred CCCcccccCCHHHHhcCCCC
Q 007433 532 PQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 532 P~~Rpt~~~~a~elL~Hpff 551 (604)
|.+||++....+++|+||||
T Consensus 261 p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 261 PQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HhhCCCcccCHHHHhcCCCC
Confidence 99999932233999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=352.94 Aligned_cols=242 Identities=15% Similarity=0.191 Sum_probs=204.9
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec----CCeeEEEEee
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET----DKFSCLVMEF 294 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~~lV~E~ 294 (604)
..||+|++|.||+|.+ +++.||||++.+...........+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 4689999999999998 567899999987644333445567789999999999999999999876 3578999999
Q ss_pred cCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH-cCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 295 CPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM-LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 295 ~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
|++|+|.+++... ..+++.....++.|++.||.|||. .+++||||||+|||++.++.+||+|||++..+..
T Consensus 104 ~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~------ 175 (283)
T PHA02988 104 CTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS------ 175 (283)
T ss_pred CCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc------
Confidence 9999999998765 568999999999999999999998 5999999999999999999999999998742210
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
.....+|
T Consensus 176 -------------------------------------------------------------------------~~~~~~~ 182 (283)
T PHA02988 176 -------------------------------------------------------------------------PPFKNVN 182 (283)
T ss_pred -------------------------------------------------------------------------ccccccC
Confidence 0012358
Q ss_pred CccccCcceecC--CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007433 454 THEYLAPEIIKG--EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 454 T~~Y~APE~l~~--~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~d 531 (604)
|..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+.....+++....++..+++||.+||+.|
T Consensus 183 ~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~d 262 (283)
T PHA02988 183 FMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHD 262 (283)
T ss_pred cccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCC
Confidence 899999999976 678999999999999999999999999887777777766554454444468999999999999999
Q ss_pred CCCcccccCCHHHHhc
Q 007433 532 PQNRLACRRGATEIKQ 547 (604)
Q Consensus 532 P~~Rpt~~~~a~elL~ 547 (604)
|++||+ +.||++
T Consensus 263 p~~Rps----~~ell~ 274 (283)
T PHA02988 263 SIKRPN----IKEILY 274 (283)
T ss_pred cccCcC----HHHHHH
Confidence 999999 777764
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=324.62 Aligned_cols=257 Identities=28% Similarity=0.486 Sum_probs=216.3
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
.|.-+++||+|.||+||+|+...+++.||+|.++.+... ...-..+.+|+-+|+.|+|.|||++++....++.+-||+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddd-egvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC-CCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 567788999999999999999999999999999765322 1223457789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
|| ..+|..+..... +.+..+.++.++.|+++||.|+|++++.||||||.|+||+.+|.+||+|||+++-++.
T Consensus 82 ~c-dqdlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi------ 153 (292)
T KOG0662|consen 82 FC-DQDLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI------ 153 (292)
T ss_pred Hh-hHHHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC------
Confidence 99 779988877664 6789999999999999999999999999999999999999999999999999965542
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
|..||++ -+-
T Consensus 154 ---------------------------------pvrcysa-------------------------------------evv 163 (292)
T KOG0662|consen 154 ---------------------------------PVRCYSA-------------------------------------EVV 163 (292)
T ss_pred ---------------------------------ceEeeec-------------------------------------eee
Confidence 2334431 257
Q ss_pred CccccCcceecCCC-CCccchHHHHHHHHHHHh-hCCCCCCCCChHHHHHHHHcC---CC--------C------CCCC-
Q 007433 454 THEYLAPEIIKGEG-HGSAVDWWTFGIFLYELL-FGKTPFKGSENRATLYNVVGQ---PL--------R------FPES- 513 (604)
Q Consensus 454 T~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLl-tG~~PF~~~~~~~~l~~i~~~---~~--------~------~p~~- 513 (604)
|.+|++|.++.|.. |+...|+||.||++.||. .|++.|.+.+..+++.+|... +- . +|..
T Consensus 164 tlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~yp 243 (292)
T KOG0662|consen 164 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYP 243 (292)
T ss_pred eeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCcc
Confidence 89999999999876 788999999999999998 599999999888887766532 11 0 1111
Q ss_pred ---------CCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 514 ---------PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 514 ---------~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
+.+...-+||++++|.-+|.+|++ ++++|+||||..
T Consensus 244 attswsqivp~lns~grdllqkll~cnp~qris----aeaalqhpyf~d 288 (292)
T KOG0662|consen 244 ATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRIS----AEAALQHPYFSD 288 (292)
T ss_pred ccchHHHHhhhhcchhHHHHHHHhccCcccccC----HHHHhcCccccc
Confidence 223455789999999999999999 999999999975
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-42 Score=354.14 Aligned_cols=256 Identities=25% Similarity=0.414 Sum_probs=214.7
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
.+|++++.||.|+||.||++.+..++..||||.+....... ...+.+|+.+++.++|+||++++++|..+++.|+||
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 68999999999999999999999999999999997643322 234567999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+++++|.+++... .+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~--- 169 (297)
T cd06656 96 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 169 (297)
T ss_pred cccCCCCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCc---
Confidence 999999999988653 58999999999999999999999999999999999999999999999999873221000
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.......
T Consensus 170 -------------------------------------------------------------------------~~~~~~~ 176 (297)
T cd06656 170 -------------------------------------------------------------------------SKRSTMV 176 (297)
T ss_pred -------------------------------------------------------------------------cCcCccc
Confidence 0001235
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG-QPLRFPESPVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~-~~~~~p~~~~~s~~l~dLI~~lL~~d 531 (604)
|++.|+|||.+.+..++.++|+|||||++|+|++|+.||.+.+....+..+.. ..........++..+++||.+||..|
T Consensus 177 ~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 256 (297)
T cd06656 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRCLEMD 256 (297)
T ss_pred CCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHHHHHHHHccCC
Confidence 88899999999998899999999999999999999999987665444333322 22222233457888999999999999
Q ss_pred CCCcccccCCHHHHhcCCCCCCC
Q 007433 532 PQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 532 P~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
|++||+ +.++++||||+..
T Consensus 257 p~~Rps----~~~il~~~~~~~~ 275 (297)
T cd06656 257 VDRRGS----AKELLQHPFLKLA 275 (297)
T ss_pred hhhCcC----HHHHhcCchhccc
Confidence 999999 9999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=345.22 Aligned_cols=256 Identities=30% Similarity=0.483 Sum_probs=212.4
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecC-----
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETD----- 285 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~----- 285 (604)
.++|++.+.||.|+||.||+|.+..++..|++|++..... ....+.+|+.+++++ +|+||++++++|...
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4799999999999999999999998899999999976543 223567899999999 799999999999754
Q ss_pred -CeeEEEEeecCCCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 286 -KFSCLVMEFCPGGDLHTLRQRQP--GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 286 -~~~~lV~E~~~ggsL~~ll~~~~--~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
..+|+||||+++++|.+++.... +..+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||++
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~ 160 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVS 160 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccc
Confidence 45899999999999999887543 467999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccC
Q 007433 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442 (604)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (604)
......
T Consensus 161 ~~~~~~-------------------------------------------------------------------------- 166 (275)
T cd06608 161 AQLDST-------------------------------------------------------------------------- 166 (275)
T ss_pred eecccc--------------------------------------------------------------------------
Confidence 432100
Q ss_pred CCCCcccccccCccccCcceecCC-----CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC-CCCCCCCC
Q 007433 443 PTNARSMSFVGTHEYLAPEIIKGE-----GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPL-RFPESPVV 516 (604)
Q Consensus 443 ~~~~~~~~~~GT~~Y~APE~l~~~-----~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~-~~p~~~~~ 516 (604)
........|+..|+|||++... .++.++|||||||+||+|++|..||........+..+..... ........
T Consensus 167 --~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (275)
T cd06608 167 --LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKSPENW 244 (275)
T ss_pred --hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCchhhc
Confidence 0001123588999999998643 367789999999999999999999987766666666554432 22222336
Q ss_pred CHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 517 SFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 517 s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
+.++++||.+||..||++||+ +.++++|||+
T Consensus 245 ~~~~~~li~~~l~~dp~~Rpt----~~~ll~~~~~ 275 (275)
T cd06608 245 SKKFNDFISECLIKNYEQRPF----MEELLEHPFI 275 (275)
T ss_pred CHHHHHHHHHHhhcChhhCcC----HHHHhcCCCC
Confidence 789999999999999999999 9999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=341.38 Aligned_cols=254 Identities=30% Similarity=0.480 Sum_probs=215.3
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++.+.||.|+||.||+|.+..++..+|+|++...... ....+.+|+++++.++||||+++++.+..++.+|+||
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 5899999999999999999999998889999999765332 3456778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+++++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..+...
T Consensus 80 e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~---- 154 (262)
T cd06613 80 EYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT---- 154 (262)
T ss_pred eCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh----
Confidence 999999999988764 246899999999999999999999999999999999999999999999999987432110
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
........
T Consensus 155 ------------------------------------------------------------------------~~~~~~~~ 162 (262)
T cd06613 155 ------------------------------------------------------------------------IAKRKSFI 162 (262)
T ss_pred ------------------------------------------------------------------------hhcccccc
Confidence 00011245
Q ss_pred cCccccCcceecCC---CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC---CCCCCCCCHHHHHHHHH
Q 007433 453 GTHEYLAPEIIKGE---GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR---FPESPVVSFSARDLIKG 526 (604)
Q Consensus 453 GT~~Y~APE~l~~~---~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~---~p~~~~~s~~l~dLI~~ 526 (604)
|+..|+|||++.+. .++.++|+|||||++|||++|+.||.+.........+....+. .......+.++++||.+
T Consensus 163 ~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 242 (262)
T cd06613 163 GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKK 242 (262)
T ss_pred CCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHH
Confidence 88899999999877 7889999999999999999999999887766665555444222 12223467889999999
Q ss_pred hhhcCCCCcccccCCHHHHhcCCC
Q 007433 527 LLVKEPQNRLACRRGATEIKQHPF 550 (604)
Q Consensus 527 lL~~dP~~Rpt~~~~a~elL~Hpf 550 (604)
||..||.+||+ +.+++.|+|
T Consensus 243 ~l~~~p~~Rpt----~~~il~~~~ 262 (262)
T cd06613 243 CLTKDPKKRPT----ATKLLQHPF 262 (262)
T ss_pred HcCCChhhCCC----HHHHhcCCC
Confidence 99999999999 999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=346.11 Aligned_cols=257 Identities=33% Similarity=0.495 Sum_probs=211.8
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
+|++.+.||.|+||.||+|.+..++..||+|++....... .....+.+|+.+++.++|+||+++++++..+...|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEG-GIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccc-hhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 5899999999999999999999999999999997654321 233456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
|+ +++|.+++.... ..+++..++.++.||+.||+|||++||+|+||||+||+++.++.++|+|||++........
T Consensus 80 ~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--- 154 (286)
T cd07832 80 YM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP--- 154 (286)
T ss_pred cc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC---
Confidence 99 999999887653 5699999999999999999999999999999999999999999999999998743211000
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
.......|
T Consensus 155 ------------------------------------------------------------------------~~~~~~~~ 162 (286)
T cd07832 155 ------------------------------------------------------------------------RLYSHQVA 162 (286)
T ss_pred ------------------------------------------------------------------------CccccccC
Confidence 00112358
Q ss_pred CccccCcceecCCC-CCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-------------------CCCCC-
Q 007433 454 THEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP-------------------LRFPE- 512 (604)
Q Consensus 454 T~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~-------------------~~~p~- 512 (604)
+..|+|||++.+.. ++.++|||||||++|||++|.++|.+..+...+..+.... ..++.
T Consensus 163 ~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (286)
T cd07832 163 TRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPES 242 (286)
T ss_pred cccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCC
Confidence 99999999987654 5889999999999999999999998877665554443210 00110
Q ss_pred --------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCC
Q 007433 513 --------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 513 --------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
.+..+..+.+||.+||.+||++||+ ++++|+||||.
T Consensus 243 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~----~~~~l~h~~~~ 286 (286)
T cd07832 243 KPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS----AAEALRHPYFT 286 (286)
T ss_pred CcchHHHhCCCccHHHHHHHHHHhccChhhCCC----HHHHhhCcCcC
Confidence 1235688999999999999999999 99999999993
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=347.27 Aligned_cols=258 Identities=28% Similarity=0.429 Sum_probs=211.8
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecC----
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETD---- 285 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~---- 285 (604)
..++|.+.+.||.|+||.||++.+..+++.+|+|++..... ....+.+|+.+++++ +|+||++++++|...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD----VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc----HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 35789999999999999999999999999999999965421 123455788999998 899999999998743
Q ss_pred -CeeEEEEeecCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 286 -KFSCLVMEFCPGGDLHTLRQRQ--PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 286 -~~~~lV~E~~~ggsL~~ll~~~--~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
...|+||||++|++|.+++... .+..+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||++
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 4689999999999999987642 2457899999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccC
Q 007433 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442 (604)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (604)
.......
T Consensus 176 ~~~~~~~------------------------------------------------------------------------- 182 (291)
T cd06639 176 AQLTSTR------------------------------------------------------------------------- 182 (291)
T ss_pred hhccccc-------------------------------------------------------------------------
Confidence 4321000
Q ss_pred CCCCcccccccCccccCcceecCCC-----CCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-CCCCCCCCC
Q 007433 443 PTNARSMSFVGTHEYLAPEIIKGEG-----HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP-LRFPESPVV 516 (604)
Q Consensus 443 ~~~~~~~~~~GT~~Y~APE~l~~~~-----~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~-~~~p~~~~~ 516 (604)
.......|+..|+|||++.... ++.++|||||||++|||++|+.||........+..+.... ..+......
T Consensus 183 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (291)
T cd06639 183 ---LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKW 259 (291)
T ss_pred ---ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCCccccc
Confidence 0011235888999999986543 5789999999999999999999998877666666654432 223233446
Q ss_pred CHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCC
Q 007433 517 SFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 517 s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
+..+.+||.+||..||++||+ +.|+++||||+
T Consensus 260 ~~~l~~li~~~l~~~p~~Rps----~~~il~~~~~~ 291 (291)
T cd06639 260 CRSFNHFISQCLIKDFEARPS----VTHLLEHPFIK 291 (291)
T ss_pred CHHHHHHHHHHhhcChhhCcC----HHHHhcCcccC
Confidence 788999999999999999999 99999999994
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=341.59 Aligned_cols=253 Identities=30% Similarity=0.488 Sum_probs=215.2
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++.+.||.|+||.||+|.+..++..||+|.+..... ...+.+|+++++.++|+||+++++++..+...|+||
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 589999999999999999999999889999999975522 446778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+++++|.+++... +..+++..++.++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++......
T Consensus 78 e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~---- 152 (256)
T cd06612 78 EYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT---- 152 (256)
T ss_pred ecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccC----
Confidence 999999999998754 357899999999999999999999999999999999999999999999999987432100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
........
T Consensus 153 ------------------------------------------------------------------------~~~~~~~~ 160 (256)
T cd06612 153 ------------------------------------------------------------------------MAKRNTVI 160 (256)
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00011234
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-CCCCCCCCCCHHHHHHHHHhhhcC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP-LRFPESPVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~-~~~p~~~~~s~~l~dLI~~lL~~d 531 (604)
|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+.... ..+.....++.++.+||.+||..|
T Consensus 161 ~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~ 240 (256)
T cd06612 161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVKKCLVKD 240 (256)
T ss_pred CCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHHHHHhcC
Confidence 7889999999999999999999999999999999999998776655544443322 222233457789999999999999
Q ss_pred CCCcccccCCHHHHhcCCCC
Q 007433 532 PQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 532 P~~Rpt~~~~a~elL~Hpff 551 (604)
|++||+ +.|+|+||||
T Consensus 241 P~~Rps----~~~il~~~~~ 256 (256)
T cd06612 241 PEERPS----AIQLLQHPFI 256 (256)
T ss_pred hhhCcC----HHHHhcCCCC
Confidence 999999 9999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=346.74 Aligned_cols=259 Identities=27% Similarity=0.399 Sum_probs=208.0
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHH-HHhCCCCCccccceeEecCCeeEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI-LQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~i-L~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
++|++++.||+|+||.||++.+..++..||||++........ ..+...|+.+ ++.++|+||+++++++..++..|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~--~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE--QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH--HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 479999999999999999999999999999999976533221 1233445554 6778999999999999999999999
Q ss_pred EeecCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHc-CeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 292 MEFCPGGDLHTLRQRQ--PGKYFSEQAVKFYVAEVLLALEYLHML-GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~--~~~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|||+ .++|..++... ....+++..+..++.||+.||+|||++ +++||||||+|||++.++.+||+|||++..+...
T Consensus 79 ~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVM-DTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhh-cccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9999 47888777642 235799999999999999999999997 9999999999999999999999999987432100
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
...
T Consensus 158 -----------------------------------------------------------------------------~~~ 160 (283)
T cd06617 158 -----------------------------------------------------------------------------VAK 160 (283)
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 000
Q ss_pred cccccCccccCcceecC----CCCCccchHHHHHHHHHHHhhCCCCCCCC-ChHHHHHHHHcCC-CCCCCCCCCCHHHHH
Q 007433 449 MSFVGTHEYLAPEIIKG----EGHGSAVDWWTFGIFLYELLFGKTPFKGS-ENRATLYNVVGQP-LRFPESPVVSFSARD 522 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~----~~~~~~~DiWSLGviL~eLltG~~PF~~~-~~~~~l~~i~~~~-~~~p~~~~~s~~l~d 522 (604)
....|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||... ...+.+..+.... ..++. ..++.++.+
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~ 239 (283)
T cd06617 161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPA-EKFSPEFQD 239 (283)
T ss_pred ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCc-cccCHHHHH
Confidence 12358889999999865 45688999999999999999999999753 3334444444332 22222 347899999
Q ss_pred HHHHhhhcCCCCcccccCCHHHHhcCCCCCCCCh
Q 007433 523 LIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNW 556 (604)
Q Consensus 523 LI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~ 556 (604)
||.+||..+|++||+ +.++++||||+...+
T Consensus 240 li~~~l~~~p~~Rp~----~~~il~~~~~~~~~~ 269 (283)
T cd06617 240 FVNKCLKKNYKERPN----YPELLQHPFFELHLS 269 (283)
T ss_pred HHHHHccCChhhCcC----HHHHhcCchhhhccc
Confidence 999999999999999 999999999986543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=348.97 Aligned_cols=256 Identities=30% Similarity=0.455 Sum_probs=209.5
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++++.||.|+||.||+|.+..+++.||+|++.+..... .....+.+|+++|+.++|+||++++++|..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 47999999999999999999999999999999986543222 22334567999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||++++.|..+.... ..+++..++.++.||+.||.|||++||+||||+|+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~--- 154 (286)
T cd07846 80 EFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG--- 154 (286)
T ss_pred ecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc---
Confidence 999999998876554 458999999999999999999999999999999999999999999999999874321100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.......
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (286)
T cd07846 155 -------------------------------------------------------------------------EVYTDYV 161 (286)
T ss_pred -------------------------------------------------------------------------cccCccc
Confidence 0011235
Q ss_pred cCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC-------------------CCCCCC
Q 007433 453 GTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ-------------------PLRFPE 512 (604)
Q Consensus 453 GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~-------------------~~~~p~ 512 (604)
|+..|+|||++.+. .++.++|||||||++|||++|++||......+.+..+... ....+.
T Consensus 162 ~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (286)
T cd07846 162 ATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPE 241 (286)
T ss_pred ceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccccc
Confidence 88999999998764 4678999999999999999999999876654444333311 011111
Q ss_pred ----------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 513 ----------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 513 ----------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
.+.++..+.+||.+||..||++||+ +.++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~----~~~il~~~~~ 286 (286)
T cd07846 242 VKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS----SSQLLHHEFF 286 (286)
T ss_pred ccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchh----HHHHhcCCCC
Confidence 2346788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=352.53 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=190.6
Q ss_pred EEEccCCcEEEEEEEEcC--CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEe--cCCeeEEEEee
Q 007433 219 KKLGCGDIGSVYLSELTG--TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFE--TDKFSCLVMEF 294 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~--~~~~~~lV~E~ 294 (604)
.+||+|+||+||+|++.. ++..||+|.+...... ..+.+|+++|+.++||||++++++|. .+..+|+||||
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc-----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 689999999999999754 5678999998765322 23567999999999999999999985 46688999999
Q ss_pred cCCCCHHHHHHhc-------CCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEE----ccCCcEEEecccccc
Q 007433 295 CPGGDLHTLRQRQ-------PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV----REDGHIMLSDFDLSL 363 (604)
Q Consensus 295 ~~ggsL~~ll~~~-------~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl----~~~g~vkL~DFGla~ 363 (604)
+ +++|..++... ....+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 82 ~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 A-EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred e-CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 9 56787776532 12358999999999999999999999999999999999999 456799999999984
Q ss_pred cccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCC
Q 007433 364 RCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEP 443 (604)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (604)
.+.....
T Consensus 161 ~~~~~~~------------------------------------------------------------------------- 167 (317)
T cd07867 161 LFNSPLK------------------------------------------------------------------------- 167 (317)
T ss_pred ccCCCcc-------------------------------------------------------------------------
Confidence 3321000
Q ss_pred CCCcccccccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChH---------HHHH---HHHcCC---
Q 007433 444 TNARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENR---------ATLY---NVVGQP--- 507 (604)
Q Consensus 444 ~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~---------~~l~---~i~~~~--- 507 (604)
........+||+.|+|||++.+. .++.++|||||||++|||++|++||....+. ..+. ...+.+
T Consensus 168 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (317)
T cd07867 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADK 247 (317)
T ss_pred cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChh
Confidence 00011234689999999999774 4789999999999999999999999754321 1111 111100
Q ss_pred --------CCC----------------------CCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 508 --------LRF----------------------PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 508 --------~~~----------------------p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
..+ ......+..+.+||.+||..||.+||| +.|+|+||||
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t----~~e~l~hp~f 317 (317)
T cd07867 248 DWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRIT----SEQALQDPYF 317 (317)
T ss_pred hhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccC----HHHHhcCCCC
Confidence 000 001123566889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=343.54 Aligned_cols=258 Identities=30% Similarity=0.487 Sum_probs=213.2
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHH-------HHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLE-------KRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
+|.+.+.||.|+||.||+|.+..++..||+|.+...... .......+.+|+.+++.++|+||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 588999999999999999999999999999998643211 1122345678999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
..++||||+++++|.+++.+. ..+++..++.++.||+.||.|||++|++||||+|+||+++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~ 159 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSD 159 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccc
Confidence 999999999999999998776 578999999999999999999999999999999999999999999999999873321
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
... ...
T Consensus 160 ~~~--------------------------------------------------------------------------~~~ 165 (272)
T cd06629 160 DIY--------------------------------------------------------------------------DND 165 (272)
T ss_pred ccc--------------------------------------------------------------------------ccc
Confidence 000 000
Q ss_pred cccccccCccccCcceecCCC--CCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC--CCCC--CCCCCHHH
Q 007433 447 RSMSFVGTHEYLAPEIIKGEG--HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPL--RFPE--SPVVSFSA 520 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~--~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~--~~p~--~~~~s~~l 520 (604)
......|+..|+|||++.... ++.++|+||||+++|||++|..||........+.++..... .++. ...++..+
T Consensus 166 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (272)
T cd06629 166 QNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVA 245 (272)
T ss_pred ccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccCCHHH
Confidence 011235889999999987754 78899999999999999999999987666666655543322 2222 13468899
Q ss_pred HHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 521 RDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 521 ~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
++||.+||..||++||+ +.++|+||||
T Consensus 246 ~~li~~~l~~~p~~Rps----~~~il~~~~~ 272 (272)
T cd06629 246 LDFLNACFTINPDNRPT----ARELLQHPFI 272 (272)
T ss_pred HHHHHHHhcCChhhCCC----HHHHhhCCCC
Confidence 99999999999999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=348.07 Aligned_cols=265 Identities=22% Similarity=0.318 Sum_probs=213.1
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcC-----CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTG-----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD 285 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 285 (604)
..++|++.+.||.|+||.||+|.++. .+..||+|.+...... .....+.+|+.+++.++|+||+++++++...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL--RERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 45799999999999999999997653 3457999998754322 2223466899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcC--------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEe
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQP--------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLS 357 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~--------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~ 357 (604)
...|+||||+++|+|.+++.... ...++...+..++.||+.||.|||++||+||||||+|||++.++.++|+
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 99999999999999999987532 1235677889999999999999999999999999999999999999999
Q ss_pred cccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCc
Q 007433 358 DFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLP 437 (604)
Q Consensus 358 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (604)
|||++........
T Consensus 162 Dfg~~~~~~~~~~------------------------------------------------------------------- 174 (288)
T cd05061 162 DFGMTRDIYETDY------------------------------------------------------------------- 174 (288)
T ss_pred cCCcccccccccc-------------------------------------------------------------------
Confidence 9998743211000
Q ss_pred ccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 007433 438 ELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVV 516 (604)
Q Consensus 438 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~ 516 (604)
........++..|+|||.+.+..++.++|+|||||++|||++ |..||.+....+.+..+..... .+....+
T Consensus 175 -------~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~ 246 (288)
T cd05061 175 -------YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY-LDQPDNC 246 (288)
T ss_pred -------ccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-CCCCCCC
Confidence 000011245678999999998889999999999999999998 8999988777666555554322 2222346
Q ss_pred CHHHHHHHHHhhhcCCCCcccccCCHHHHhc------CCCCCCCCh
Q 007433 517 SFSARDLIKGLLVKEPQNRLACRRGATEIKQ------HPFFQGVNW 556 (604)
Q Consensus 517 s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~------Hpff~~~~~ 556 (604)
+..+++||.+||..||++||+ +.++++ ||||.+++|
T Consensus 247 ~~~~~~li~~~l~~~p~~Rps----~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 247 PERVTDLMRMCWQFNPKMRPT----FLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred CHHHHHHHHHHcCCChhHCcC----HHHHHHHHHhhcCCCCCCCCC
Confidence 889999999999999999999 666654 999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=344.02 Aligned_cols=254 Identities=20% Similarity=0.264 Sum_probs=209.7
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEc---CCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCe
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELT---GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKF 287 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 287 (604)
...+|++.+.||+|+||.||+|.+. ..+..||+|.+...... .....+.+|+.+|+.++||||+++++++..++.
T Consensus 3 ~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD--KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred chHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 3468999999999999999999875 45678999999765322 223456789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccC
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAV 367 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~ 367 (604)
.||||||+++|+|.+++.... ..+++..++.++.||+.||+|||++|++||||||+|||++.++.++|+|||++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHE-GQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 999999999999999987653 4789999999999999999999999999999999999999999999999997622100
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
.. ...
T Consensus 160 ~~---------------------------------------------------------------------------~~~ 164 (266)
T cd05064 160 EA---------------------------------------------------------------------------IYT 164 (266)
T ss_pred cc---------------------------------------------------------------------------hhc
Confidence 00 000
Q ss_pred ccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007433 448 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKG 526 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~ 526 (604)
.....++..|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+... ...+....++..+.+++.+
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 243 (266)
T cd05064 165 TMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDG-FRLPAPRNCPNLLHQLMLD 243 (266)
T ss_pred ccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHH
Confidence 011235678999999999999999999999999999775 99999988776666655443 3445556688999999999
Q ss_pred hhhcCCCCcccccCCHHHHhc
Q 007433 527 LLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 527 lL~~dP~~Rpt~~~~a~elL~ 547 (604)
||..+|.+||+ +.+|++
T Consensus 244 c~~~~p~~RP~----~~~i~~ 260 (266)
T cd05064 244 CWQKERGERPR----FSQIHS 260 (266)
T ss_pred HcCCCchhCCC----HHHHHH
Confidence 99999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=367.29 Aligned_cols=254 Identities=21% Similarity=0.322 Sum_probs=207.8
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
+..+.+.+..+||+|.||+||+|++.++ ||||+++....... .++.+..|+.+|++-+|.||+-+.|++..+.. .
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~pt~~-qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDPTPE-QLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred cCHHHhhccceeccccccceeecccccc---eEEEEEecCCCCHH-HHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 3446788899999999999999999884 99999988766554 77888999999999999999999999999888 8
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
||+.+|+|-+|+.+++... ..|.....+.|++||++|+.|||.++|||||||..||||.+++.|||+||||+..
T Consensus 464 IiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatv----- 537 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATV----- 537 (678)
T ss_pred eeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceee-----
Confidence 9999999999999988653 6799999999999999999999999999999999999999999999999999821
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
+..+.+. ....
T Consensus 538 ---k~~w~g~------------------------------------------------------------------~q~~ 548 (678)
T KOG0193|consen 538 ---KTRWSGE------------------------------------------------------------------QQLE 548 (678)
T ss_pred ---eeeeccc------------------------------------------------------------------cccC
Confidence 1111000 0001
Q ss_pred ccccCccccCcceecC---CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC---CCCCCCCCHHHHHH
Q 007433 450 SFVGTHEYLAPEIIKG---EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR---FPESPVVSFSARDL 523 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~---~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~---~p~~~~~s~~l~dL 523 (604)
.-.|..-|||||+++. .+|++.+|||||||++|||++|.+||......+.++.+=.+.+. .......+.++++|
T Consensus 549 qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~L 628 (678)
T KOG0193|consen 549 QPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRL 628 (678)
T ss_pred CCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHH
Confidence 1247788999999974 35899999999999999999999999955555555554333221 11223467799999
Q ss_pred HHHhhhcCCCCcccccCCHHHHhc
Q 007433 524 IKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 524 I~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
+..||.+++++||. +.+||.
T Consensus 629 l~~C~~~~~~eRP~----F~~il~ 648 (678)
T KOG0193|consen 629 LSDCWKFDREERPL----FPQLLS 648 (678)
T ss_pred HHHHHhcCcccCcc----HHHHHH
Confidence 99999999999999 666654
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=385.33 Aligned_cols=260 Identities=28% Similarity=0.396 Sum_probs=213.2
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccce-eEec---
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYT-HFET--- 284 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~-~~~~--- 284 (604)
++..++++.+.|.+|||+.||+|++...+..||+|++-.. +...+..+.+||++|+.|. |+|||.+++ +...
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 3446788999999999999999999999889999998654 3455667789999999995 999999999 3321
Q ss_pred ---CCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcC--eEeccCCCCcEEEccCCcEEEecc
Q 007433 285 ---DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLG--IVYRDLKPENVLVREDGHIMLSDF 359 (604)
Q Consensus 285 ---~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~g--IvHrDIKpeNILl~~~g~vkL~DF 359 (604)
...++|.||||.||.|-++|..+-..+|+|.++.+|++|+++||.+||.+. |||||||-|||||..+|+.|||||
T Consensus 111 ~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDF 190 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDF 190 (738)
T ss_pred CCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcc
Confidence 246789999999999999998665567999999999999999999999998 999999999999999999999999
Q ss_pred cccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccc
Q 007433 360 DLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPEL 439 (604)
Q Consensus 360 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (604)
|-+.-....++. +....
T Consensus 191 GSatt~~~~~~~-----------------------------------------~~e~~---------------------- 207 (738)
T KOG1989|consen 191 GSATTKILSPTS-----------------------------------------AQEVN---------------------- 207 (738)
T ss_pred cccccccCCCcc-----------------------------------------HHHHH----------------------
Confidence 987321111100 00000
Q ss_pred ccCCCCCcccccccCccccCccee---cCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 007433 440 IAEPTNARSMSFVGTHEYLAPEII---KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVV 516 (604)
Q Consensus 440 ~~~~~~~~~~~~~GT~~Y~APE~l---~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~ 516 (604)
.. .......-|+.|+|||++ .+.+.+.|+|||+|||+||.|++...||...... .|+...+.||..+..
T Consensus 208 ~v----e~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~l----aIlng~Y~~P~~p~y 279 (738)
T KOG1989|consen 208 YV----EEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKL----AILNGNYSFPPFPNY 279 (738)
T ss_pred HH----HHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcce----eEEeccccCCCCccH
Confidence 00 001123478999999986 5778899999999999999999999999987553 567788999998999
Q ss_pred CHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 517 SFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 517 s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
+..+.+||+.||+.||.+||+ +-+++.
T Consensus 280 s~~l~~LI~~mL~~nP~~RPn----I~Qv~~ 306 (738)
T KOG1989|consen 280 SDRLKDLIRTMLQPNPDERPN----IYQVLE 306 (738)
T ss_pred HHHHHHHHHHHhccCcccCCC----HHHHHH
Confidence 999999999999999999999 666663
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-42 Score=366.06 Aligned_cols=256 Identities=20% Similarity=0.301 Sum_probs=208.6
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCC-----ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecC
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGT-----KCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETD 285 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 285 (604)
.++|++.+.||+|+||.||+|.+... +..||||++...... .....+.+|+++|+.+ +|+||++++++|...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 46899999999999999999986543 357999999765322 2234567899999999 899999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcC---------------------------------------------------------
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQP--------------------------------------------------------- 308 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~--------------------------------------------------------- 308 (604)
+..|+|||||++|+|.+++....
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 99999999999999999876431
Q ss_pred -----------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcc
Q 007433 309 -----------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTL 377 (604)
Q Consensus 309 -----------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 377 (604)
...+++..+..|+.||+.||+|||++||+||||||+|||++.++.++|+|||++.........
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~------ 268 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY------ 268 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce------
Confidence 124788899999999999999999999999999999999999999999999988432110000
Q ss_pred cCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccc
Q 007433 378 ESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEY 457 (604)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 457 (604)
.......++..|
T Consensus 269 --------------------------------------------------------------------~~~~~~~~~~~y 280 (374)
T cd05106 269 --------------------------------------------------------------------VVKGNARLPVKW 280 (374)
T ss_pred --------------------------------------------------------------------eeccCCCCccce
Confidence 000112356789
Q ss_pred cCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcc
Q 007433 458 LAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRL 536 (604)
Q Consensus 458 ~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rp 536 (604)
||||++.+..++.++|||||||+||||++ |+.||........+..+............++.++.+||.+||..||++||
T Consensus 281 ~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 360 (374)
T cd05106 281 MAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERP 360 (374)
T ss_pred eCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcCCChhhCc
Confidence 99999998889999999999999999997 99999887665556666555444444455789999999999999999999
Q ss_pred cccCCHHHHhc
Q 007433 537 ACRRGATEIKQ 547 (604)
Q Consensus 537 t~~~~a~elL~ 547 (604)
+ +.+|++
T Consensus 361 s----~~~l~~ 367 (374)
T cd05106 361 T----FSQISQ 367 (374)
T ss_pred C----HHHHHH
Confidence 9 777765
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=365.52 Aligned_cols=257 Identities=19% Similarity=0.293 Sum_probs=209.0
Q ss_pred ecCeEEEEEEccCCcEEEEEEEE-----cCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecC
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSEL-----TGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETD 285 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 285 (604)
.++|++.+.||+|+||.||+|.+ ..++..||||++...... .....+.+|+.+|+.+ +||||+++++++..+
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 45899999999999999999974 345678999999654322 2234567899999999 899999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcC---------------------------------------------------------
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQP--------------------------------------------------------- 308 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~--------------------------------------------------------- 308 (604)
+..|+|||||++|+|.+++....
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 99999999999999999886532
Q ss_pred ----------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 309 ----------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 309 ----------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~- 270 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY- 270 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc-
Confidence 124788899999999999999999999999999999999999999999999998432210000
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.......
T Consensus 271 -------------------------------------------------------------------------~~~~~~~ 277 (375)
T cd05104 271 -------------------------------------------------------------------------VVKGNAR 277 (375)
T ss_pred -------------------------------------------------------------------------cccCCCC
Confidence 0000123
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~d 531 (604)
++..|+|||++.+..++.++|||||||+||||++ |..||........+.+++............+.++++||.+||..|
T Consensus 278 ~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d 357 (375)
T cd05104 278 LPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDAD 357 (375)
T ss_pred CCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHHHHHccCC
Confidence 5678999999999999999999999999999997 999998876655555555554444444457889999999999999
Q ss_pred CCCcccccCCHHHHhcC
Q 007433 532 PQNRLACRRGATEIKQH 548 (604)
Q Consensus 532 P~~Rpt~~~~a~elL~H 548 (604)
|++||+ +.||++.
T Consensus 358 P~~RPs----~~eil~~ 370 (375)
T cd05104 358 PLKRPT----FKQIVQL 370 (375)
T ss_pred hhHCcC----HHHHHHH
Confidence 999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=358.88 Aligned_cols=254 Identities=28% Similarity=0.466 Sum_probs=206.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC------
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD------ 285 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------ 285 (604)
.++|++++.||+|+||.||+|.+..+++.||||++.+... ......++.+|+.+++.++|+||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 4789999999999999999999999999999999865322 122334566799999999999999999998643
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
...|+||||+ +++|...+... +++..+..++.||+.||+|||.+||+||||||+|||++.++.++|+|||++...
T Consensus 94 ~~~~lv~e~~-~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~ 168 (353)
T cd07850 94 QDVYLVMELM-DANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 168 (353)
T ss_pred CcEEEEEecc-CCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence 3579999999 56888877543 899999999999999999999999999999999999999999999999988432
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
...
T Consensus 169 ~~~----------------------------------------------------------------------------- 171 (353)
T cd07850 169 GTS----------------------------------------------------------------------------- 171 (353)
T ss_pred CCC-----------------------------------------------------------------------------
Confidence 100
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---C---------------
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---P--------------- 507 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~--------------- 507 (604)
.......||..|+|||++.+..++.++|||||||++|+|++|+.||...+....+.++... +
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (353)
T cd07850 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNY 251 (353)
T ss_pred CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHH
Confidence 0011235889999999999999999999999999999999999999877654443333210 0
Q ss_pred ----CC--------------CCC-----CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCC
Q 007433 508 ----LR--------------FPE-----SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 508 ----~~--------------~p~-----~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
.. ++. ....+..+++||.+||..||++||+ +.|+|+||||+
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~eiL~~~~~~ 315 (353)
T cd07850 252 VENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRIS----VDDALQHPYIN 315 (353)
T ss_pred hhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcC----HHHHhcChhHh
Confidence 00 000 1124567899999999999999999 99999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=344.94 Aligned_cols=258 Identities=26% Similarity=0.414 Sum_probs=209.5
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEe-----
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFE----- 283 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~----- 283 (604)
...++|++++.||+|+||.||++.+..++..||+|++...... ...+.+|+.+++.+ +|+||+++++++.
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI----DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch----HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 3457999999999999999999999999999999998653221 12455789999999 7999999999873
Q ss_pred cCCeeEEEEeecCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccc
Q 007433 284 TDKFSCLVMEFCPGGDLHTLRQRQ--PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDL 361 (604)
Q Consensus 284 ~~~~~~lV~E~~~ggsL~~ll~~~--~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGl 361 (604)
.++..|+||||++|++|.+++... ....+++..+..++.|++.||.|||+++|+||||||+||+++.++.++|+|||+
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~ 170 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV 170 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCc
Confidence 456799999999999999887632 235689999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccccc
Q 007433 362 SLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIA 441 (604)
Q Consensus 362 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (604)
+.......
T Consensus 171 ~~~~~~~~------------------------------------------------------------------------ 178 (286)
T cd06638 171 SAQLTSTR------------------------------------------------------------------------ 178 (286)
T ss_pred eeecccCC------------------------------------------------------------------------
Confidence 74321100
Q ss_pred CCCCCcccccccCccccCcceecC-----CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-CCCCCCCC
Q 007433 442 EPTNARSMSFVGTHEYLAPEIIKG-----EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP-LRFPESPV 515 (604)
Q Consensus 442 ~~~~~~~~~~~GT~~Y~APE~l~~-----~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~-~~~p~~~~ 515 (604)
.......|++.|+|||++.. ..++.++|||||||++|||++|+.||........+..+.... ........
T Consensus 179 ----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (286)
T cd06638 179 ----LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQPEL 254 (286)
T ss_pred ----CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCCcccCCCC
Confidence 00112358999999999863 347889999999999999999999998776655544433221 22223334
Q ss_pred CCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 516 VSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 516 ~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
++..+.+||.+||..||++||+ +.||++|+||
T Consensus 255 ~~~~~~~li~~~l~~~p~~Rps----~~ell~~~~~ 286 (286)
T cd06638 255 WSNEFNDFIRKCLTKDYEKRPT----VSDLLQHVFI 286 (286)
T ss_pred cCHHHHHHHHHHccCCcccCCC----HHHHhhcccC
Confidence 6788999999999999999999 9999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=348.45 Aligned_cols=258 Identities=31% Similarity=0.434 Sum_probs=210.8
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHH--HHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLE--KRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
+|++++.||.|+||.||+|.+..+++.||||.+...... .......+..|+++++.++|+||+++++++.+++..|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 588999999999999999999999999999999765433 112234456799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.++|+|||++..+....
T Consensus 81 ~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-- 156 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN-- 156 (298)
T ss_pred Eccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC--
Confidence 9999 999999987653 479999999999999999999999999999999999999999999999999884332100
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 157 --------------------------------------------------------------------------~~~~~~ 162 (298)
T cd07841 157 --------------------------------------------------------------------------RKMTHQ 162 (298)
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 000112
Q ss_pred ccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---CC-------------------
Q 007433 452 VGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---PL------------------- 508 (604)
Q Consensus 452 ~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~~------------------- 508 (604)
.+++.|+|||++.+ ..++.++|||||||++|||++|.++|.+....+.+.++... +.
T Consensus 163 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (298)
T cd07841 163 VVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPF 242 (298)
T ss_pred ccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccccccc
Confidence 46788999999865 45688999999999999999999989877665554443221 00
Q ss_pred -CCC---CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 509 -RFP---ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 509 -~~p---~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
..+ .....+..+.+||.+||.+||++||+ +.|+++|+||++
T Consensus 243 ~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~e~l~~~~~~~ 287 (298)
T cd07841 243 PPTPLKQIFPAASDDALDLLQRLLTLNPNKRIT----ARQALEHPYFSN 287 (298)
T ss_pred CCcchhhhcccccHHHHHHHHHHhcCCcccCcC----HHHHhhCccccC
Confidence 000 01235678999999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-41 Score=337.89 Aligned_cols=255 Identities=30% Similarity=0.482 Sum_probs=214.7
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhH--HHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASL--EKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
+|+..+.||+|+||.||+|.+..++..|++|++..... ........+.+|+++|+.++|+||+++++++..+..+|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 47788999999999999999998889999999875432 1223445677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+++++|.+++.+. ..+++..+..++.||+.||.|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-- 156 (258)
T cd06632 81 LELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-- 156 (258)
T ss_pred EEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc--
Confidence 9999999999998775 468999999999999999999999999999999999999999999999999874321000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
.....
T Consensus 157 ---------------------------------------------------------------------------~~~~~ 161 (258)
T cd06632 157 ---------------------------------------------------------------------------FAKSF 161 (258)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 01124
Q ss_pred ccCccccCcceecCCC-CCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 452 VGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
.|+..|++||.+.... ++.++|+|||||++|+|++|+.||...........+............++..+.+||.+||..
T Consensus 162 ~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 241 (258)
T cd06632 162 KGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQR 241 (258)
T ss_pred CCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHHHhhc
Confidence 5889999999988776 889999999999999999999999877666665555442222222345789999999999999
Q ss_pred CCCCcccccCCHHHHhcCCCC
Q 007433 531 EPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~Hpff 551 (604)
||++||+ +.+++.|||+
T Consensus 242 ~p~~Rp~----~~~~l~~~~~ 258 (258)
T cd06632 242 DPSLRPT----AAELLEHPFV 258 (258)
T ss_pred CcccCcC----HHHHhcCCCC
Confidence 9999999 9999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=338.63 Aligned_cols=252 Identities=27% Similarity=0.487 Sum_probs=214.1
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
+|++.+.||.|+||.||++.+..++..||+|.++..... .....+.+|+.+++.++|+||+++++.|.+++.+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS--SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch--HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 589999999999999999999999999999998654322 233456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
|+++++|.+++....+..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~---- 154 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG---- 154 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeecccc----
Confidence 9999999998876656678999999999999999999999999999999999999999999999999874321100
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
.......|
T Consensus 155 ------------------------------------------------------------------------~~~~~~~~ 162 (255)
T cd08219 155 ------------------------------------------------------------------------AYACTYVG 162 (255)
T ss_pred ------------------------------------------------------------------------cccccccC
Confidence 00113458
Q ss_pred CccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCC
Q 007433 454 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQ 533 (604)
Q Consensus 454 T~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~ 533 (604)
++.|+|||++.+..++.++|+||||+++|+|++|..||...+....+..+...... +....++..+++||.+||..||+
T Consensus 163 ~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~ 241 (255)
T cd08219 163 TPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYK-PLPSHYSYELRSLIKQMFKRNPR 241 (255)
T ss_pred CccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCC-CCCcccCHHHHHHHHHHHhCCcc
Confidence 89999999999988999999999999999999999999987766666665544332 23345788999999999999999
Q ss_pred CcccccCCHHHHhcC
Q 007433 534 NRLACRRGATEIKQH 548 (604)
Q Consensus 534 ~Rpt~~~~a~elL~H 548 (604)
+||+ +.+++.-
T Consensus 242 ~Rp~----~~~il~~ 252 (255)
T cd08219 242 SRPS----ATTILSR 252 (255)
T ss_pred cCCC----HHHHhhc
Confidence 9999 8998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=350.83 Aligned_cols=260 Identities=29% Similarity=0.415 Sum_probs=210.3
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC--Cee
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD--KFS 288 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~ 288 (604)
..++|++.+.||.|+||.||+|.+..++..||+|++....... .......+|+.+|+.++|+||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 3578999999999999999999999999999999986543211 1122345799999999999999999999754 578
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|+||||+. ++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 84 ~lv~e~~~-~~l~~~l~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~ 161 (309)
T cd07845 84 FLVMEYCE-QDLASLLDNMP-TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161 (309)
T ss_pred EEEEecCC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence 99999994 68988877643 57999999999999999999999999999999999999999999999999988432210
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
. ...
T Consensus 162 ~----------------------------------------------------------------------------~~~ 165 (309)
T cd07845 162 A----------------------------------------------------------------------------KPM 165 (309)
T ss_pred c----------------------------------------------------------------------------CCC
Confidence 0 000
Q ss_pred cccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-------------------C
Q 007433 449 MSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP-------------------L 508 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~-------------------~ 508 (604)
....+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+.... .
T Consensus 166 ~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (309)
T cd07845 166 TPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKF 245 (309)
T ss_pred CcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccc
Confidence 11236788999999876 457899999999999999999999999887777665554310 0
Q ss_pred CCCC---------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 509 RFPE---------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 509 ~~p~---------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
.++. ....+..+.+||.+||..||++||+ +.++|+||||+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t----~~~il~h~~f~~ 295 (309)
T cd07845 246 TLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRAT----AEEALESSYFKE 295 (309)
T ss_pred cccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcC----HHHHhcChhhcc
Confidence 1110 0225788899999999999999999 999999999974
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=348.87 Aligned_cols=255 Identities=29% Similarity=0.438 Sum_probs=212.9
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++++.||+|+||+||++.+..++..||+|++..... ......+.+|+++++.++||||+++++++.....+|+|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc--chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 4689999999999999999999999999999999875422 22344677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH-cCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM-LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
|||+++++|..++... +.+++..++.++.|++.||.|||+ +|++||||||+|||++.++.++|+|||++......
T Consensus 82 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-- 157 (284)
T cd06620 82 MEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157 (284)
T ss_pred EecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence 9999999999988765 468999999999999999999997 69999999999999999999999999987321100
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
....
T Consensus 158 ----------------------------------------------------------------------------~~~~ 161 (284)
T cd06620 158 ----------------------------------------------------------------------------IADT 161 (284)
T ss_pred ----------------------------------------------------------------------------ccCc
Confidence 0012
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChH-----------HHHHHHHcCC-CCCCCCCCCCH
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR-----------ATLYNVVGQP-LRFPESPVVSF 518 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~-----------~~l~~i~~~~-~~~p~~~~~s~ 518 (604)
.+|+..|+|||++.+..++.++|||||||++|+|++|+.||...... +.+..+.... ..++ ...++.
T Consensus 162 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 240 (284)
T cd06620 162 FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP-SSDFPE 240 (284)
T ss_pred cccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC-chhcCH
Confidence 35899999999998888999999999999999999999999865432 2233333322 2222 123778
Q ss_pred HHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 519 SARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 519 ~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
++.+||.+||..||++||+ +.|+++|+||..
T Consensus 241 ~~~~li~~~l~~dp~~Rpt----~~e~~~~~~~~~ 271 (284)
T cd06620 241 DLRDFVDACLLKDPTERPT----PQQLCAMPPFIQ 271 (284)
T ss_pred HHHHHHHHHhcCCcccCcC----HHHHhcCccccc
Confidence 8999999999999999999 999999999953
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=344.06 Aligned_cols=255 Identities=30% Similarity=0.464 Sum_probs=213.8
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++.+.||.|+||.||++.+..+++.||+|++...... .....+.+|+++++.++||||+++++.+..++..|+||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 3688889999999999999999999999999999775432 33345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH-cCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM-LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
||+++++|.+++.... ..+++..+..++.||+.||+|||+ .|++||||||+||+++.++.++|+|||++......
T Consensus 79 e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~--- 154 (265)
T cd06605 79 EYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS--- 154 (265)
T ss_pred EecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH---
Confidence 9999999999988653 578999999999999999999999 99999999999999999999999999987322100
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
.....
T Consensus 155 ---------------------------------------------------------------------------~~~~~ 159 (265)
T cd06605 155 ---------------------------------------------------------------------------LAKTF 159 (265)
T ss_pred ---------------------------------------------------------------------------Hhhcc
Confidence 00014
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCC-----hHHHHHHHHcCCC-CCCCCCCCCHHHHHHHH
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE-----NRATLYNVVGQPL-RFPESPVVSFSARDLIK 525 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~-----~~~~l~~i~~~~~-~~p~~~~~s~~l~dLI~ 525 (604)
.|+..|+|||++.+..++.++|||||||++|+|++|..||.... ....+..+..... ..+. ..++.++++||.
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~ 238 (265)
T cd06605 160 VGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPS-GKFSPDFQDFVN 238 (265)
T ss_pred cCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCCh-hhcCHHHHHHHH
Confidence 58889999999999999999999999999999999999997542 2233333433321 2222 127889999999
Q ss_pred HhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 526 GLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
+||..||++||+ +.+++.||||+.
T Consensus 239 ~~l~~~p~~Rpt----~~~ll~~~~~~~ 262 (265)
T cd06605 239 LCLIKDPRERPS----YKELLEHPFIKK 262 (265)
T ss_pred HHcCCCchhCcC----HHHHhhCchhhc
Confidence 999999999999 999999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=347.81 Aligned_cols=261 Identities=25% Similarity=0.401 Sum_probs=212.4
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++.+.||.|++|+||+|.+..+++.||||.+....... .....+.+|+++++.++|+||+++++++..+...|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDE-GVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccc-cchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 58999999999999999999999999999999986543221 22234567999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc-CCcEEEecccccccccCCCcc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE-DGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~-~g~vkL~DFGla~~~~~~~~~ 371 (604)
||+ +++|..++.......+++..++.++.||+.||+|||++||+||||+|+|||++. ++.+||+|||++........
T Consensus 81 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~- 158 (294)
T PLN00009 81 EYL-DLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR- 158 (294)
T ss_pred ecc-cccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc-
Confidence 999 568888777665556789999999999999999999999999999999999985 56799999998843221000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
.....
T Consensus 159 ---------------------------------------------------------------------------~~~~~ 163 (294)
T PLN00009 159 ---------------------------------------------------------------------------TFTHE 163 (294)
T ss_pred ---------------------------------------------------------------------------ccccC
Confidence 00123
Q ss_pred ccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc---CCCC---------------CC-
Q 007433 452 VGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG---QPLR---------------FP- 511 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~---~~~~---------------~p- 511 (604)
.|++.|+|||++.+. .++.++|||||||++|+|++|+.||......+.+.++.. .+.. ++
T Consensus 164 ~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (294)
T PLN00009 164 VVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPK 243 (294)
T ss_pred ceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhccc
Confidence 578899999998764 578899999999999999999999988776666655432 1100 00
Q ss_pred --------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCC
Q 007433 512 --------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 512 --------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
..+.++.++.+||.+||..||++||+ +.++++||||++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps----~~~~l~~~~~~~~~ 291 (294)
T PLN00009 244 WPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRIT----ARAALEHEYFKDLG 291 (294)
T ss_pred CCCCCHHHhCcCCChHHHHHHHHHccCChhhCcC----HHHHhcCchHhHHh
Confidence 11346788999999999999999999 99999999998764
|
|
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=346.58 Aligned_cols=256 Identities=29% Similarity=0.475 Sum_probs=204.5
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++.+.||.|+||.||+|.+..+++.||||.+...... .......+|+++++.++|+||+++++++.++++.|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE--GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc--CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 46899999999999999999999989999999998754321 1112345799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+. ++|.+++.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++........
T Consensus 82 ~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~- 158 (291)
T cd07844 82 FEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK- 158 (291)
T ss_pred EecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence 99996 59999887654 4789999999999999999999999999999999999999999999999998732110000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
.....
T Consensus 159 ---------------------------------------------------------------------------~~~~~ 163 (291)
T cd07844 159 ---------------------------------------------------------------------------TYSNE 163 (291)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00012
Q ss_pred ccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCCh-HHHHHHHH---cCC----------------CCC
Q 007433 452 VGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSEN-RATLYNVV---GQP----------------LRF 510 (604)
Q Consensus 452 ~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~-~~~l~~i~---~~~----------------~~~ 510 (604)
.++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+... .+.+..+. +.+ ..+
T Consensus 164 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (291)
T cd07844 164 VVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSF 243 (291)
T ss_pred ccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccc
Confidence 46788999999876 4578899999999999999999999976552 22222111 110 000
Q ss_pred C---------CCCCCC--HHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 511 P---------ESPVVS--FSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 511 p---------~~~~~s--~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
+ ....++ ..+.+||.+||..||++||+ +.|+++||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps----~~e~l~~~~f 291 (291)
T cd07844 244 PFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRIS----AAEAMKHPYF 291 (291)
T ss_pred cccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccC----HHHHhcCCCC
Confidence 0 001234 78889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=337.47 Aligned_cols=256 Identities=30% Similarity=0.515 Sum_probs=216.8
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
+|.+.+.||.|+||.||++.+..++..||+|.+....... .....+.+|+++++.++|+||+++++.+..+...|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPV-KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccc-hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 5899999999999999999999999999999997653322 223456689999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC-cEEEecccccccccCCCccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG-HIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g-~vkL~DFGla~~~~~~~~~~ 372 (604)
|+++++|.+++....+..+++..+..++.||+.||.|||+++|+|+||||+|||++.++ .++|+|||++.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~--- 156 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM--- 156 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc---
Confidence 99999999998876656789999999999999999999999999999999999999876 46999999874321100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.......
T Consensus 157 -------------------------------------------------------------------------~~~~~~~ 163 (257)
T cd08225 157 -------------------------------------------------------------------------ELAYTCV 163 (257)
T ss_pred -------------------------------------------------------------------------ccccccC
Confidence 0001234
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEP 532 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP 532 (604)
|++.|+|||++.+..++.++|+|||||++|||++|..||...+....+..+...... +..+.++..++++|.+||..+|
T Consensus 164 ~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p 242 (257)
T cd08225 164 GTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFA-PISPNFSRDLRSLISQLFKVSP 242 (257)
T ss_pred CCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCC-CCCCCCCHHHHHHHHHHhccCh
Confidence 889999999998888999999999999999999999999887766666665544322 2334578899999999999999
Q ss_pred CCcccccCCHHHHhcCCCC
Q 007433 533 QNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 533 ~~Rpt~~~~a~elL~Hpff 551 (604)
++||+ +.++++||||
T Consensus 243 ~~Rpt----~~~ll~~~~~ 257 (257)
T cd08225 243 RDRPS----ITSILKRPFL 257 (257)
T ss_pred hhCcC----HHHHhhCCCC
Confidence 99999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=349.38 Aligned_cols=255 Identities=22% Similarity=0.308 Sum_probs=203.2
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcC----------------CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCc
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTG----------------TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFL 275 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~----------------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI 275 (604)
.++|++.++||+|+||.||+|.+.. ++..||+|++...... .....+.+|+++|++++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANK--NARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCH--HHHHHHHHHHHHHhhcCCCCe
Confidence 4689999999999999999998632 3457999999764322 233456789999999999999
Q ss_pred cccceeEecCCeeEEEEeecCCCCHHHHHHhcC-----------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEe
Q 007433 276 PTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQP-----------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVY 338 (604)
Q Consensus 276 v~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~-----------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvH 338 (604)
+++++++.+.+..|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 999999999999999999999999999886532 124678889999999999999999999999
Q ss_pred ccCCCCcEEEccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccc
Q 007433 339 RDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSK 418 (604)
Q Consensus 339 rDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (604)
|||||+||||+.++.+||+|||++..+......
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~----------------------------------------------- 194 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYY----------------------------------------------- 194 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCcee-----------------------------------------------
Confidence 999999999999999999999988432110000
Q ss_pred cccccCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh--CCCCCCCCCh
Q 007433 419 SKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF--GKTPFKGSEN 496 (604)
Q Consensus 419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt--G~~PF~~~~~ 496 (604)
.......++..|+|||++.+..++.++|||||||++|||++ +..||.+...
T Consensus 195 ---------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~ 247 (304)
T cd05096 195 ---------------------------RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTD 247 (304)
T ss_pred ---------------------------EecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCCH
Confidence 00012346788999999998889999999999999999986 6788887666
Q ss_pred HHHHHHHHc------CCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHh
Q 007433 497 RATLYNVVG------QPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIK 546 (604)
Q Consensus 497 ~~~l~~i~~------~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL 546 (604)
.+.+.++.. ........+.++..+.+||.+||..||++||+ +.+|.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs----~~~i~ 299 (304)
T cd05096 248 EQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPS----FSDIH 299 (304)
T ss_pred HHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcC----HHHHH
Confidence 555443321 11112223457889999999999999999999 88884
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=345.97 Aligned_cols=256 Identities=24% Similarity=0.371 Sum_probs=212.3
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCc-----eEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTK-----CYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
.++|++++.||.|+||.||+|.+...+ ..||+|.+..... ......+.+|+.+|+.++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE--PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC--HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 468999999999999999999986655 6899999875432 223345678999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcCC--------------CCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPG--------------KYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG 352 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~--------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g 352 (604)
..|++|||+++++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 99999999999999999876421 4588999999999999999999999999999999999999999
Q ss_pred cEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCC
Q 007433 353 HIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQ 432 (604)
Q Consensus 353 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (604)
.++|+|||++........
T Consensus 162 ~~~L~dfg~~~~~~~~~~-------------------------------------------------------------- 179 (283)
T cd05048 162 TVKISDFGLSRDIYSADY-------------------------------------------------------------- 179 (283)
T ss_pred cEEECCCcceeecccccc--------------------------------------------------------------
Confidence 999999998843211000
Q ss_pred CCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCC
Q 007433 433 VSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFP 511 (604)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p 511 (604)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.... ..+
T Consensus 180 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~ 246 (283)
T cd05048 180 ------------YRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ-LLP 246 (283)
T ss_pred ------------ccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-cCC
Confidence 000112347889999999998889999999999999999997 999999877766666555443 223
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 512 ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 512 ~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
....++.++.+|+.+||..||.+||+ +.||+++
T Consensus 247 ~~~~~~~~~~~l~~~c~~~~p~~Rp~----~~~i~~~ 279 (283)
T cd05048 247 CPEDCPARVYALMIECWNEIPARRPR----FKDIHTR 279 (283)
T ss_pred CcccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 34568999999999999999999999 8898875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=346.52 Aligned_cols=258 Identities=26% Similarity=0.404 Sum_probs=207.0
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEecCCe----
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFETDKF---- 287 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~---- 287 (604)
++|++.+.||+|+||.||+|.+..+++.||||++...... ......+.+|+.+++.+. |+||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 4799999999999999999999999999999998654321 112235667999999995 6999999999987655
Q ss_pred -eEEEEeecCCCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc-CCcEEEeccccc
Q 007433 288 -SCLVMEFCPGGDLHTLRQRQP---GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE-DGHIMLSDFDLS 362 (604)
Q Consensus 288 -~~lV~E~~~ggsL~~ll~~~~---~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~-~g~vkL~DFGla 362 (604)
.|+||||+++ +|..++.... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.++|+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999965 8888776532 246899999999999999999999999999999999999998 889999999987
Q ss_pred ccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccC
Q 007433 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442 (604)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (604)
..+....
T Consensus 159 ~~~~~~~------------------------------------------------------------------------- 165 (295)
T cd07837 159 RAFSIPV------------------------------------------------------------------------- 165 (295)
T ss_pred eecCCCc-------------------------------------------------------------------------
Confidence 4331100
Q ss_pred CCCCcccccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---CCC---------
Q 007433 443 PTNARSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---PLR--------- 509 (604)
Q Consensus 443 ~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~~~--------- 509 (604)
.......+++.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+.++... +..
T Consensus 166 ---~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (295)
T cd07837 166 ---KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKL 242 (295)
T ss_pred ---cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhc
Confidence 00011246789999998875 45789999999999999999999999987776665544321 000
Q ss_pred -----CC---------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCC
Q 007433 510 -----FP---------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 510 -----~p---------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
++ ..+.++.++.+||.+||.+||.+||+ +.|+|+||||+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~----~~eil~~~~~~ 295 (295)
T cd07837 243 RDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRIS----AKAALTHPYFD 295 (295)
T ss_pred cchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCC----HHHHhcCCCcC
Confidence 00 01347888999999999999999999 99999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=351.01 Aligned_cols=255 Identities=29% Similarity=0.465 Sum_probs=214.4
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
+.|.....||.|+||.||++.+..++..||||.+..... .....+.+|+.+++.++|+||+++++.|..++..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ---QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH---HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 456667889999999999999999999999999865432 23345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+++++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 99 e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~--- 172 (292)
T cd06658 99 EFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV--- 172 (292)
T ss_pred eCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc---
Confidence 99999999998754 358999999999999999999999999999999999999999999999999873221000
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.......
T Consensus 173 -------------------------------------------------------------------------~~~~~~~ 179 (292)
T cd06658 173 -------------------------------------------------------------------------PKRKSLV 179 (292)
T ss_pred -------------------------------------------------------------------------ccCceee
Confidence 0011245
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC-CCCCCCCCCCCHHHHHHHHHhhhcC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ-PLRFPESPVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~-~~~~p~~~~~s~~l~dLI~~lL~~d 531 (604)
|+..|+|||++.+..++.++|||||||++|||++|+.||.+......+..+... +..++....++..+.+||.+||..|
T Consensus 180 ~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 259 (292)
T cd06658 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVRE 259 (292)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHHHHHccCC
Confidence 889999999999888999999999999999999999999887766655544332 2223333457889999999999999
Q ss_pred CCCcccccCCHHHHhcCCCCCC
Q 007433 532 PQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 532 P~~Rpt~~~~a~elL~Hpff~~ 553 (604)
|.+||+ ++++++||||+.
T Consensus 260 P~~Rpt----~~~il~~~~~~~ 277 (292)
T cd06658 260 PSQRAT----AQELLQHPFLKL 277 (292)
T ss_pred hhHCcC----HHHHhhChhhhc
Confidence 999999 999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=338.56 Aligned_cols=258 Identities=29% Similarity=0.467 Sum_probs=218.1
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++.+.||.|++|.||+|.+..+++.||||++...... .....+.+|+.++..++|+||+++++++..++..|+||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 3799999999999999999999999999999999776432 33456778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH-cCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM-LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
||+++++|.+++... ..+++..+..++.||+.||.|||+ +|++||||+|+||+++.++.++|+|||++.......
T Consensus 79 e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~-- 154 (264)
T cd06623 79 EYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL-- 154 (264)
T ss_pred EecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC--
Confidence 999999999998875 568999999999999999999999 999999999999999999999999999874321000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 155 --------------------------------------------------------------------------~~~~~~ 160 (264)
T cd06623 155 --------------------------------------------------------------------------DQCNTF 160 (264)
T ss_pred --------------------------------------------------------------------------Ccccce
Confidence 000123
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCC---hHHHHHHHHcCCCCCCCCCC-CCHHHHHHHHHh
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE---NRATLYNVVGQPLRFPESPV-VSFSARDLIKGL 527 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~---~~~~l~~i~~~~~~~p~~~~-~s~~l~dLI~~l 527 (604)
.|+..|+|||.+.+..++.++|+|+||+++|+|++|+.||.... ..+....+..... ...... ++..+.++|.+|
T Consensus 161 ~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~ 239 (264)
T cd06623 161 VGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP-PSLPAEEFSPEFRDFISAC 239 (264)
T ss_pred eecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC-CCCCcccCCHHHHHHHHHH
Confidence 58889999999999889999999999999999999999998764 3344444443322 222333 788999999999
Q ss_pred hhcCCCCcccccCCHHHHhcCCCCCCCC
Q 007433 528 LVKEPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
|..+|++||+ +.++++||||+.++
T Consensus 240 l~~~p~~R~~----~~~ll~~~~~~~~~ 263 (264)
T cd06623 240 LQKDPKKRPS----AAELLQHPFIKKAD 263 (264)
T ss_pred ccCChhhCCC----HHHHHhCHHHHhcc
Confidence 9999999999 99999999998654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-40 Score=337.68 Aligned_cols=259 Identities=29% Similarity=0.437 Sum_probs=216.4
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchh--HHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC--Cee
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKAS--LEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD--KFS 288 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~ 288 (604)
.+|++.+.||+|+||.||+|.+..++..||+|++.... .........+.+|+++++.++|+||+++++++.+. +.+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 47999999999999999999999999999999985431 12234455778899999999999999999998763 568
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++......
T Consensus 82 ~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 159 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI 159 (264)
T ss_pred EEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence 9999999999999988765 45899999999999999999999999999999999999999999999999988432100
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
. ......
T Consensus 160 ~-------------------------------------------------------------------------~~~~~~ 166 (264)
T cd06653 160 C-------------------------------------------------------------------------MSGTGI 166 (264)
T ss_pred c-------------------------------------------------------------------------ccCccc
Confidence 0 000011
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
..+.|+..|+|||++.+..++.++|+|||||++|+|++|+.||........+..+...+.....+..++..+.++|.+||
T Consensus 167 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~i~~~l 246 (264)
T cd06653 167 KSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRDFLKQIF 246 (264)
T ss_pred cccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHHHHHHHh
Confidence 23468999999999999889999999999999999999999998877777666666554443344568899999999999
Q ss_pred hcCCCCcccccCCHHHHhcCCCC
Q 007433 529 VKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 529 ~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
. +|..||+ +.+++.|||.
T Consensus 247 ~-~~~~r~~----~~~~~~~~~~ 264 (264)
T cd06653 247 V-EEKRRPT----AEFLLRHPFV 264 (264)
T ss_pred c-CcccCcc----HHHHhcCCCC
Confidence 9 5799999 9999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=345.91 Aligned_cols=256 Identities=27% Similarity=0.432 Sum_probs=210.0
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++++.||.|+||.||++.+..++..||+|.+.... .......+.+|++++++++|+||+++++.|..++..|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 37899999999999999999999999999999986542 1223346678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHH-cCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 293 EFCPGGDLHTLRQRQ-PGKYFSEQAVKFYVAEVLLALEYLHM-LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 293 E~~~ggsL~~ll~~~-~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
||+++++|..++... ....+++..+..++.||+.||.|||+ +||+||||||+|||++.++.++|+|||++..+...
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 156 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-- 156 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC--
Confidence 999999999888753 12479999999999999999999997 59999999999999999999999999987322100
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
....
T Consensus 157 ----------------------------------------------------------------------------~~~~ 160 (286)
T cd06622 157 ----------------------------------------------------------------------------LAKT 160 (286)
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0112
Q ss_pred cccCccccCcceecCCC------CCccchHHHHHHHHHHHhhCCCCCCCCChHHHHH---HHHcC-CCCCCCCCCCCHHH
Q 007433 451 FVGTHEYLAPEIIKGEG------HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY---NVVGQ-PLRFPESPVVSFSA 520 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~------~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~---~i~~~-~~~~p~~~~~s~~l 520 (604)
..|++.|+|||++.+.. ++.++|||||||++|+|++|+.||.......... .+... +..++ ..++.++
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~ 238 (286)
T cd06622 161 NIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLP--SGYSDDA 238 (286)
T ss_pred CCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCC--cccCHHH
Confidence 35788999999986543 4789999999999999999999997654433222 22222 22222 3488999
Q ss_pred HHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 521 RDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 521 ~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
.+||.+||..+|++||+ +.++++||||...
T Consensus 239 ~~li~~~l~~~p~~Rp~----~~~l~~~~~~~~~ 268 (286)
T cd06622 239 QDFVAKCLNKIPNRRPT----YAQLLEHPWLVKY 268 (286)
T ss_pred HHHHHHHcccCcccCCC----HHHHhcChhhhhc
Confidence 99999999999999999 9999999999643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=343.66 Aligned_cols=257 Identities=30% Similarity=0.468 Sum_probs=210.3
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++.+.||.|+||.||+|.+..+++.||||+++..... ......+.+|+++|+.++|+||+++++++..++..|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDD-EDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhccc-ccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 4799999999999999999999999999999998654322 223345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||++++.|..++.+. ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++........
T Consensus 80 e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-- 155 (288)
T cd07833 80 EYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-- 155 (288)
T ss_pred ecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc--
Confidence 999887776655543 4589999999999999999999999999999999999999999999999998743211000
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.....++
T Consensus 156 -------------------------------------------------------------------------~~~~~~~ 162 (288)
T cd07833 156 -------------------------------------------------------------------------SPLTDYV 162 (288)
T ss_pred -------------------------------------------------------------------------ccccCcc
Confidence 0111346
Q ss_pred cCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-------------------CCCC-
Q 007433 453 GTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP-------------------LRFP- 511 (604)
Q Consensus 453 GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~-------------------~~~p- 511 (604)
|+..|+|||++.+. .++.++||||||+++|+|++|+.||.+....+.+..+.... ..++
T Consensus 163 ~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (288)
T cd07833 163 ATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPE 242 (288)
T ss_pred cccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCC
Confidence 88999999999888 78999999999999999999999998776655444332100 0010
Q ss_pred ----------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 512 ----------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 512 ----------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
....++.++++||++||..||++||+ +.++++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~il~~~~f 288 (288)
T cd07833 243 PSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT----CDELLQHPYF 288 (288)
T ss_pred CCCcHHHHHhcCCccchHHHHHHHHHhccCchhccc----HHHHhcCCCC
Confidence 01234788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=353.48 Aligned_cols=265 Identities=27% Similarity=0.401 Sum_probs=214.9
Q ss_pred heeecCceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCC--C----Cc
Q 007433 202 AVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH--P----FL 275 (604)
Q Consensus 202 ~~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~H--p----nI 275 (604)
.+.+..+....++|.++..||+|.||.|-.+.+..++..||||+++.- .+....+.-|+++|+++.+ | -+
T Consensus 78 H~v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rc 153 (415)
T KOG0671|consen 78 HYVYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRC 153 (415)
T ss_pred eEEEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEE
Confidence 344555555578999999999999999999999999999999999532 2233445679999999943 2 38
Q ss_pred cccceeEecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccC----
Q 007433 276 PTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRED---- 351 (604)
Q Consensus 276 v~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~---- 351 (604)
+++.+||+..++.|||+|.+ |.++++++..+....|+...++.+++||+.+++|||+.+++|.||||||||+-..
T Consensus 154 v~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~ 232 (415)
T KOG0671|consen 154 VQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFK 232 (415)
T ss_pred EeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEE
Confidence 89999999999999999999 8899999999888899999999999999999999999999999999999999432
Q ss_pred ----------------CcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCccc
Q 007433 352 ----------------GHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRF 415 (604)
Q Consensus 352 ----------------g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 415 (604)
-.|+|+|||-|..-
T Consensus 233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~-------------------------------------------------- 262 (415)
T KOG0671|consen 233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFD-------------------------------------------------- 262 (415)
T ss_pred EeccCCccceeccCCCcceEEEecCCccee--------------------------------------------------
Confidence 24677888866210
Q ss_pred ccccccccCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCC
Q 007433 416 FSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE 495 (604)
Q Consensus 416 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~ 495 (604)
.....+++.|..|+|||++.+.+|+.++||||+||||+||.+|...|.+.+
T Consensus 263 -----------------------------~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 263 -----------------------------HEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred -----------------------------ccCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 111246789999999999999999999999999999999999999999988
Q ss_pred hHHHH---HHHHcCC------------------CCCCCC-----------------------CCCCHHHHHHHHHhhhcC
Q 007433 496 NRATL---YNVVGQP------------------LRFPES-----------------------PVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 496 ~~~~l---~~i~~~~------------------~~~p~~-----------------------~~~s~~l~dLI~~lL~~d 531 (604)
+.+.+ ..|++.. +.+++. ...--++.|||++||.+|
T Consensus 314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 77743 3444421 111111 000123669999999999
Q ss_pred CCCcccccCCHHHHhcCCCCCCC
Q 007433 532 PQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 532 P~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
|.+|+| +.|+|+||||...
T Consensus 394 P~~RiT----l~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 394 PARRIT----LREALSHPFFARL 412 (415)
T ss_pred cccccc----HHHHhcCHHhhcC
Confidence 999999 9999999999754
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=342.68 Aligned_cols=268 Identities=41% Similarity=0.761 Sum_probs=216.5
Q ss_pred CeEEEEEEccCCcEEEEEEEEc---CCceEEEEEEecchhHHH-HHHHHHHHHHHHHHHhC-CCCCccccceeEecCCee
Q 007433 214 HFRLLKKLGCGDIGSVYLSELT---GTKCYFAMKVMDKASLEK-RKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 288 (604)
+|++.+.||.|+||.||+|++. .++..||+|++....... .....++.+|+.+|+.+ +|+||+.+++.|+.+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 5899999999999999999885 467899999997653322 22334567899999999 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|+||||+++++|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++..+...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~ 158 (290)
T cd05613 81 HLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHED 158 (290)
T ss_pred EEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccc
Confidence 9999999999999988765 56899999999999999999999999999999999999999999999999987432110
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
. ....
T Consensus 159 ~---------------------------------------------------------------------------~~~~ 163 (290)
T cd05613 159 E---------------------------------------------------------------------------VERA 163 (290)
T ss_pred c---------------------------------------------------------------------------cccc
Confidence 0 0001
Q ss_pred cccccCccccCcceecCC--CCCccchHHHHHHHHHHHhhCCCCCCCCChH----HHHHHHHcCCCCCCCCCCCCHHHHH
Q 007433 449 MSFVGTHEYLAPEIIKGE--GHGSAVDWWTFGIFLYELLFGKTPFKGSENR----ATLYNVVGQPLRFPESPVVSFSARD 522 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~--~~~~~~DiWSLGviL~eLltG~~PF~~~~~~----~~l~~i~~~~~~~p~~~~~s~~l~d 522 (604)
..+.|+..|+|||++.+. .++.++|||||||++|+|++|..||...... .....+......+ ...++..+.+
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 241 (290)
T cd05613 164 YSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY--PQEMSALAKD 241 (290)
T ss_pred ccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC--CccCCHHHHH
Confidence 134688999999998753 4678999999999999999999999754322 2222232322222 3457889999
Q ss_pred HHHHhhhcCCCCcccc-cCCHHHHhcCCCCCCCChhhhh
Q 007433 523 LIKGLLVKEPQNRLAC-RRGATEIKQHPFFQGVNWALIR 560 (604)
Q Consensus 523 LI~~lL~~dP~~Rpt~-~~~a~elL~Hpff~~~~~~~~~ 560 (604)
||.+||..||++|+++ ...+.+++.||||+.++|..+.
T Consensus 242 ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~~~ 280 (290)
T cd05613 242 IIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLA 280 (290)
T ss_pred HHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHHHh
Confidence 9999999999999853 3459999999999999997663
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-43 Score=344.68 Aligned_cols=254 Identities=30% Similarity=0.471 Sum_probs=215.1
Q ss_pred ecCeEEEE-EEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHH-HhCCCCCccccceeEec----C
Q 007433 212 VGHFRLLK-KLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREIL-QSLDHPFLPTLYTHFET----D 285 (604)
Q Consensus 212 ~~~y~l~~-~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL-~~l~HpnIv~l~~~~~~----~ 285 (604)
+++|++-. .||-|-.|.|-.+.++.|++.||+|++... .++++|+++. ..-.|||||.++++|++ .
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 46787764 699999999999999999999999998544 2455788774 44589999999999874 4
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc---CCcEEEeccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE---DGHIMLSDFDLS 362 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~---~g~vkL~DFGla 362 (604)
+++.+|||+++||.|+..++.+....|+|.++..|++||+.|+.|||+.+|.||||||||+|... |..+||+|||+|
T Consensus 132 kcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA 211 (400)
T KOG0604|consen 132 KCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA 211 (400)
T ss_pred eeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence 67889999999999999999887788999999999999999999999999999999999999975 457999999999
Q ss_pred ccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccC
Q 007433 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442 (604)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (604)
.+-..
T Consensus 212 K~t~~--------------------------------------------------------------------------- 216 (400)
T KOG0604|consen 212 KETQE--------------------------------------------------------------------------- 216 (400)
T ss_pred cccCC---------------------------------------------------------------------------
Confidence 43210
Q ss_pred CCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChH----HHHHHHHcCCCCCCC--CCCC
Q 007433 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR----ATLYNVVGQPLRFPE--SPVV 516 (604)
Q Consensus 443 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~----~~l~~i~~~~~~~p~--~~~~ 516 (604)
+...++-+-|++|.|||++-.+.|+..+|+|||||++|-||+|.+||...... ..-.+|..+.+.||. |..+
T Consensus 217 --~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~V 294 (400)
T KOG0604|consen 217 --PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCV 294 (400)
T ss_pred --CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHH
Confidence 01122346799999999999999999999999999999999999999765332 233567777777764 5679
Q ss_pred CHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 517 SFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 517 s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
|++++|+|++||..+|.+|+| +++++.|||+.+.
T Consensus 295 Se~aKdlIR~LLkt~PteRlT----I~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 295 SEAAKDLIRKLLKTEPTERLT----IEEVMDHPWINQY 328 (400)
T ss_pred HHHHHHHHHHHhcCCchhhee----HHHhhcCchhccc
Confidence 999999999999999999999 9999999999653
|
|
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=335.02 Aligned_cols=259 Identities=31% Similarity=0.554 Sum_probs=216.3
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
+|++.+.||.|+||.||++.+..+++.||+|++...... ......+..|+++++.++|+||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 689999999999999999999989999999999766443 3456678899999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
|+++++|.+++... ..+++..++.++.|++.||.|||++||+||||+|+||+++.++.++|+|||++..........
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~- 156 (264)
T cd06626 80 YCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM- 156 (264)
T ss_pred cCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc-
Confidence 99999999998764 468999999999999999999999999999999999999999999999999884432110000
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
........|
T Consensus 157 -----------------------------------------------------------------------~~~~~~~~~ 165 (264)
T cd06626 157 -----------------------------------------------------------------------GEEVQSLAG 165 (264)
T ss_pred -----------------------------------------------------------------------cccccCCcC
Confidence 000012357
Q ss_pred CccccCcceecCCC---CCccchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHH-cCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 454 THEYLAPEIIKGEG---HGSAVDWWTFGIFLYELLFGKTPFKGSENR-ATLYNVV-GQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 454 T~~Y~APE~l~~~~---~~~~~DiWSLGviL~eLltG~~PF~~~~~~-~~l~~i~-~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
+..|+|||++.+.. ++.++|||||||++|+|++|+.||...... ...+.+. .....++....++..+.+||.+||
T Consensus 166 ~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 245 (264)
T cd06626 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCL 245 (264)
T ss_pred CcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHHHHHHHc
Confidence 88999999998776 788999999999999999999999765433 3333333 233445555556899999999999
Q ss_pred hcCCCCcccccCCHHHHhcCCCC
Q 007433 529 VKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 529 ~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
..||++||+ +.+++.|||+
T Consensus 246 ~~~p~~R~~----~~~i~~~~~~ 264 (264)
T cd06626 246 ESDPKKRPT----ASELLQHPFV 264 (264)
T ss_pred cCCcccCCC----HHHHhcCCCC
Confidence 999999999 9999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=337.67 Aligned_cols=252 Identities=22% Similarity=0.345 Sum_probs=211.3
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
..++|+++++||+|+||.||+|.+... ..||+|.+...... ...+.+|+.+++.++|+||+++++.+..++..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~-~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05072 4 PRESIKLVKKLGAGQFGEVWMGYYNNS-TKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI 78 (261)
T ss_pred chHHeEEeeecCCcCCceEEEEEecCC-ceEEEEEccCCchh----HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEE
Confidence 357899999999999999999997654 57999998654322 3456789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
||||+++++|.+++....+..+++..+..++.||+.||+|||++|++||||||+|||++.++.++|+|||++........
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05072 79 ITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY 158 (261)
T ss_pred EEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence 99999999999999876667899999999999999999999999999999999999999999999999998843211000
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
.....
T Consensus 159 ---------------------------------------------------------------------------~~~~~ 163 (261)
T cd05072 159 ---------------------------------------------------------------------------TAREG 163 (261)
T ss_pred ---------------------------------------------------------------------------eccCC
Confidence 00011
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
..++..|+|||++.+..++.++|||||||++|+|++ |..||.+.........+... ...+....++.++.+||.+||.
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~ 242 (261)
T cd05072 164 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMPRMENCPDELYDIMKTCWK 242 (261)
T ss_pred CccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcc
Confidence 236678999999998889999999999999999998 99999887776666665543 4445555688999999999999
Q ss_pred cCCCCcccccCCHHHHhc
Q 007433 530 KEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~ 547 (604)
.||++||+ ++++++
T Consensus 243 ~~p~~Rp~----~~~i~~ 256 (261)
T cd05072 243 EKAEERPT----FDYLQS 256 (261)
T ss_pred CCcccCcC----HHHHHH
Confidence 99999999 777754
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=334.83 Aligned_cols=256 Identities=26% Similarity=0.434 Sum_probs=213.7
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec--CCeeEEE
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET--DKFSCLV 291 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~lV 291 (604)
+|++++.||.|+||.||++.+..++..||+|++....... ....++..|+++|+.++|+||+++++++.. +...|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE-KEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCH-HHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 5899999999999999999999999999999997654322 334566789999999999999999998753 5678999
Q ss_pred EeecCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHH-----HcCeEeccCCCCcEEEccCCcEEEeccccccc
Q 007433 292 MEFCPGGDLHTLRQRQ--PGKYFSEQAVKFYVAEVLLALEYLH-----MLGIVYRDLKPENVLVREDGHIMLSDFDLSLR 364 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~--~~~~l~e~~~~~i~~qil~aL~yLH-----~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~ 364 (604)
|||+++++|.+++... ....+++..+..++.||+.||+||| +.+|+||||||+|||++.++.++|+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 9999999999988753 2357899999999999999999999 89999999999999999999999999998743
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
.....
T Consensus 160 ~~~~~--------------------------------------------------------------------------- 164 (265)
T cd08217 160 LGHDS--------------------------------------------------------------------------- 164 (265)
T ss_pred ccCCc---------------------------------------------------------------------------
Confidence 21000
Q ss_pred CCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007433 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLI 524 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI 524 (604)
.......|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+...... ......+..+.+||
T Consensus 165 -~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~ 242 (265)
T cd08217 165 -SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR-RIPYRYSSELNEVI 242 (265)
T ss_pred -ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC-CCccccCHHHHHHH
Confidence 0011235889999999999988999999999999999999999999987765555555443322 22335788999999
Q ss_pred HHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
.+||..+|++||+ +.+|++|||+
T Consensus 243 ~~~l~~~p~~Rp~----~~~il~~~~~ 265 (265)
T cd08217 243 KSMLNVDPDKRPS----TEELLQLPLI 265 (265)
T ss_pred HHHccCCcccCCC----HHHHhhCCCC
Confidence 9999999999999 9999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=367.58 Aligned_cols=251 Identities=30% Similarity=0.475 Sum_probs=212.0
Q ss_pred EEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCCCC
Q 007433 220 KLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGD 299 (604)
Q Consensus 220 ~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggs 299 (604)
.||+|.||+||.|++..+....|||.+.... ....+.+..||.+.+.|.|.|||+++|.+..++++-|.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 5999999999999999999999999996543 2344566789999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCC--cHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc-CCcEEEecccccccccCCCcccccCc
Q 007433 300 LHTLRQRQPGKYF--SEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE-DGHIMLSDFDLSLRCAVSPTVVKSST 376 (604)
Q Consensus 300 L~~ll~~~~~~~l--~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~-~g~vkL~DFGla~~~~~~~~~~~~~~ 376 (604)
|..+++..- +.| +|..+.+|.+||++||.|||++.|||||||-+||||+. .|.+||+|||-+.|++.-.
T Consensus 659 LSsLLrskW-GPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin------- 730 (1226)
T KOG4279|consen 659 LSSLLRSKW-GPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN------- 730 (1226)
T ss_pred HHHHHHhcc-CCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC-------
Confidence 999988653 566 89999999999999999999999999999999999985 7899999999887764211
Q ss_pred ccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCcc
Q 007433 377 LESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHE 456 (604)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 456 (604)
.-..+|.||+.
T Consensus 731 ---------------------------------------------------------------------P~TETFTGTLQ 741 (1226)
T KOG4279|consen 731 ---------------------------------------------------------------------PCTETFTGTLQ 741 (1226)
T ss_pred ---------------------------------------------------------------------ccccccccchh
Confidence 11236789999
Q ss_pred ccCcceecCC--CCCccchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCC
Q 007433 457 YLAPEIIKGE--GHGSAVDWWTFGIFLYELLFGKTPFKGSENR-ATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQ 533 (604)
Q Consensus 457 Y~APE~l~~~--~~~~~~DiWSLGviL~eLltG~~PF~~~~~~-~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~ 533 (604)
|||||++... +|+.++|||||||++.||.||++||...... ..++++=--....+.+..++.+++.||.+|+..||.
T Consensus 742 YMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~FilrcFepd~~ 821 (1226)
T KOG4279|consen 742 YMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRCFEPDPC 821 (1226)
T ss_pred hhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHHcCCCcc
Confidence 9999999765 5899999999999999999999999875443 334443211122223334888999999999999999
Q ss_pred CcccccCCHHHHhcCCCCCCC
Q 007433 534 NRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 534 ~Rpt~~~~a~elL~Hpff~~~ 554 (604)
+||+ |.+||++||++.-
T Consensus 822 ~R~s----A~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 822 DRPS----AKDLLQDPFLQHN 838 (1226)
T ss_pred cCcc----HHHhccCcccccC
Confidence 9999 9999999999754
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=346.56 Aligned_cols=257 Identities=26% Similarity=0.424 Sum_probs=215.7
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|.+++.||+|+||.||++.+..++..||+|.+...... ....+.+|+.+++.++||||+++++.|..++..|+||
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP---KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch---HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 6899999999999999999999888889999998654322 2345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+++++|.+++... .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 96 e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~--- 169 (293)
T cd06647 96 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--- 169 (293)
T ss_pred ecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccc---
Confidence 999999999988753 58899999999999999999999999999999999999999999999999873221000
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.......
T Consensus 170 -------------------------------------------------------------------------~~~~~~~ 176 (293)
T cd06647 170 -------------------------------------------------------------------------SKRSTMV 176 (293)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0011235
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHH-cCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV-GQPLRFPESPVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~-~~~~~~p~~~~~s~~l~dLI~~lL~~d 531 (604)
|++.|+|||++.+..++.++|+|||||++|+|++|+.||........+..+. .....+.....++..+++||.+||..+
T Consensus 177 ~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 256 (293)
T cd06647 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEMD 256 (293)
T ss_pred CChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHHHHHHccCC
Confidence 8899999999988888999999999999999999999998766554444332 222333344457888999999999999
Q ss_pred CCCcccccCCHHHHhcCCCCCCCC
Q 007433 532 PQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 532 P~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
|++||+ +.++++|+||+..+
T Consensus 257 p~~Rp~----~~~il~h~~~~~~~ 276 (293)
T cd06647 257 VEKRGS----AKELLQHPFLKIAK 276 (293)
T ss_pred hhhCcC----HHHHhcCHHHhcCc
Confidence 999999 99999999997543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=337.27 Aligned_cols=253 Identities=21% Similarity=0.303 Sum_probs=211.6
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
..+|.+.+.||.|+||.||+|.+..+++.||+|++..... ....+.+|+++|+.++|+||+++++++..+..+++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch----HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 4579999999999999999999999999999999875532 234567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+++++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~- 159 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY- 159 (263)
T ss_pred EEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-
Confidence 9999999999998776556789999999999999999999999999999999999999999999999998743211000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 160 --------------------------------------------------------------------------~~~~~~ 165 (263)
T cd05052 160 --------------------------------------------------------------------------TAHAGA 165 (263)
T ss_pred --------------------------------------------------------------------------eccCCC
Confidence 000011
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
.++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+. ..........++.++.+||.+||..
T Consensus 166 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~ 244 (263)
T cd05052 166 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KGYRMERPEGCPPKVYELMRACWQW 244 (263)
T ss_pred CCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCCCCCCCCCHHHHHHHHHHccC
Confidence 24668999999999999999999999999999998 999998876655544443 3334444456889999999999999
Q ss_pred CCCCcccccCCHHHHhcC
Q 007433 531 EPQNRLACRRGATEIKQH 548 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~H 548 (604)
||++||+ +.++++.
T Consensus 245 ~p~~Rp~----~~~l~~~ 258 (263)
T cd05052 245 NPSDRPS----FAEIHQA 258 (263)
T ss_pred CcccCCC----HHHHHHH
Confidence 9999999 7787653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=343.69 Aligned_cols=256 Identities=28% Similarity=0.416 Sum_probs=202.6
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++++.||+|+||.||+|.+..++..||||++...... .....+.+|+++|+.++|+||+++++++..++..|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEE--GVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcC--CCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 36899999999999999999999999999999998654321 1122345799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+ +++|..++.... ..+++..++.++.||+.||.|||.+||+||||||+|||++.++.++|+|||++.......
T Consensus 82 ~e~~-~~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-- 157 (291)
T cd07870 82 FEYM-HTDLAQYMIQHP-GGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-- 157 (291)
T ss_pred Eecc-cCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC--
Confidence 9999 577777665543 467888899999999999999999999999999999999999999999999873211000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 158 --------------------------------------------------------------------------~~~~~~ 163 (291)
T cd07870 158 --------------------------------------------------------------------------QTYSSE 163 (291)
T ss_pred --------------------------------------------------------------------------CCCCCc
Confidence 000123
Q ss_pred ccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHc---CCC--------C--------C
Q 007433 452 VGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENR-ATLYNVVG---QPL--------R--------F 510 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~-~~l~~i~~---~~~--------~--------~ 510 (604)
.+++.|+|||++.+. .++.++|||||||+||||++|..||.+.... +.+.+++. .+. . +
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (291)
T cd07870 164 VVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWF 243 (291)
T ss_pred cccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhc
Confidence 478899999998764 5788999999999999999999999765432 22222211 000 0 0
Q ss_pred ----C-------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 511 ----P-------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 511 ----p-------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
+ .....+..+.+||.+||..||.+||+ +.|++.||||
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t----~~~~l~h~~~ 291 (291)
T cd07870 244 LPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRIS----AQDALLHPYF 291 (291)
T ss_pred cccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcC----HHHHhcCCCC
Confidence 0 00113567899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=338.29 Aligned_cols=256 Identities=24% Similarity=0.355 Sum_probs=208.5
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++.+.||.|+||.||+|++..+++.||||.+.............+.+|+++|+.++||||+++++++.+.+..|+||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 58999999999999999999999999999999886543333344456678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 293 EFCPGGDLHTLRQRQ--PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 293 E~~~ggsL~~ll~~~--~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
||+++++|.+++... ....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~- 160 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh-
Confidence 999999999887642 23468999999999999999999999999999999999999999999999999874321000
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
.....
T Consensus 161 ---------------------------------------------------------------------------~~~~~ 165 (267)
T cd08228 161 ---------------------------------------------------------------------------TAAHS 165 (267)
T ss_pred ---------------------------------------------------------------------------HHHhc
Confidence 00012
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCCh--HHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSEN--RATLYNVVGQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~--~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
..|++.|+|||.+.+..++.++|+||||+++|||++|+.||..... ......+......-......+..+.+||.+||
T Consensus 166 ~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl 245 (267)
T cd08228 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMCI 245 (267)
T ss_pred CCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHHHHHHHHHC
Confidence 3588899999999988899999999999999999999999975432 23333332222111112246788999999999
Q ss_pred hcCCCCcccccCCHHHHhcC
Q 007433 529 VKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 529 ~~dP~~Rpt~~~~a~elL~H 548 (604)
..+|++||+ +.++++.
T Consensus 246 ~~~p~~Rp~----~~~vl~~ 261 (267)
T cd08228 246 YPDPDQRPD----IGYVHQI 261 (267)
T ss_pred CCCcccCcC----HHHHHHH
Confidence 999999999 8998874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=340.49 Aligned_cols=268 Identities=41% Similarity=0.756 Sum_probs=216.4
Q ss_pred CeEEEEEEccCCcEEEEEEEEc---CCceEEEEEEecchhHH-HHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCee
Q 007433 214 HFRLLKKLGCGDIGSVYLSELT---GTKCYFAMKVMDKASLE-KRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 288 (604)
+|++.+.||.|+||.||++++. .++..||||++.+.... .......+.+|++++..+ +|+||+.+++.|..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 5899999999999999999864 35678999999765432 223344567899999999 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|+||||+.+++|..++... ..+++..++.++.|++.||.|||+.|++||||||+|||++.++.++|+|||++..+...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 158 (288)
T cd05583 81 HLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE 158 (288)
T ss_pred EEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc
Confidence 9999999999999988764 56899999999999999999999999999999999999999999999999987432110
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
. ....
T Consensus 159 ~---------------------------------------------------------------------------~~~~ 163 (288)
T cd05583 159 E---------------------------------------------------------------------------EERA 163 (288)
T ss_pred c---------------------------------------------------------------------------cccc
Confidence 0 0001
Q ss_pred cccccCccccCcceecCCC--CCccchHHHHHHHHHHHhhCCCCCCCCCh----HHHHHHHHcCCCCCCCCCCCCHHHHH
Q 007433 449 MSFVGTHEYLAPEIIKGEG--HGSAVDWWTFGIFLYELLFGKTPFKGSEN----RATLYNVVGQPLRFPESPVVSFSARD 522 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~--~~~~~DiWSLGviL~eLltG~~PF~~~~~----~~~l~~i~~~~~~~p~~~~~s~~l~d 522 (604)
..+.|+..|+|||.+.+.. ++.++|+||||+++|||++|..||..... .+....+..... +....++..+.+
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~ 241 (288)
T cd05583 164 YSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKP--PFPKTMSAEARD 241 (288)
T ss_pred ccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCC--CCCcccCHHHHH
Confidence 1245889999999987765 68899999999999999999999964332 222233333322 333457889999
Q ss_pred HHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhhhhc
Q 007433 523 LIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRC 561 (604)
Q Consensus 523 LI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~~~ 561 (604)
||.+||..||++||+++ .+.++|+||||+.++|..+..
T Consensus 242 li~~~l~~~p~~R~t~~-~~~~~l~~~~~~~~~~~~~~~ 279 (288)
T cd05583 242 FIQKLLEKDPKKRLGAN-GADEIKNHPFFQGIDWDDLAA 279 (288)
T ss_pred HHHHHhcCCHhhccCcc-hHHHHhcCcccccCCHHHHhh
Confidence 99999999999999843 478899999999999986643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=351.51 Aligned_cols=259 Identities=25% Similarity=0.415 Sum_probs=205.7
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC-----Ce
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD-----KF 287 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~ 287 (604)
++|++.+.||+|+||.||+|.+..++..||||++.... ......++.+|+.+|+.++|+||+++++++... ..
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 68999999999999999999999999999999986432 122344566899999999999999999987643 45
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccC
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAV 367 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~ 367 (604)
.|+||||+ +++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 83 ~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~ 158 (336)
T cd07849 83 VYIVQELM-ETDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADP 158 (336)
T ss_pred EEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeeccc
Confidence 89999999 5688877754 4699999999999999999999999999999999999999999999999998843221
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
... ....
T Consensus 159 ~~~-------------------------------------------------------------------------~~~~ 165 (336)
T cd07849 159 EHD-------------------------------------------------------------------------HTGF 165 (336)
T ss_pred ccc-------------------------------------------------------------------------ccCC
Confidence 000 0000
Q ss_pred ccccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHH---cCC----------------
Q 007433 448 SMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV---GQP---------------- 507 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~---~~~---------------- 507 (604)
....+||..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+. +.+
T Consensus 166 ~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (336)
T cd07849 166 LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNY 245 (336)
T ss_pred cCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhH
Confidence 112468999999998765 468899999999999999999999998765443332221 110
Q ss_pred ---C----CCC---CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 508 ---L----RFP---ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 508 ---~----~~p---~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
. ..+ ..+.++.++.+||.+||..||++||+ +.|+++||||+.+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~e~l~hp~~~~~ 298 (336)
T cd07849 246 IKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRIT----VEEALAHPYLEQY 298 (336)
T ss_pred HhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcC----HHHHhcCcccccc
Confidence 0 000 01235778999999999999999999 9999999999865
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=346.17 Aligned_cols=255 Identities=28% Similarity=0.391 Sum_probs=213.1
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
.+|++++.||.|+||+||+|.+..++..||+|++.............+.+|+++++.++||||+++++++.+++..|+||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 57999999999999999999999999999999987554333344556778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+. |+|.+++.... ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 95 e~~~-g~l~~~~~~~~-~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~----- 167 (307)
T cd06607 95 EYCL-GSASDILEVHK-KPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP----- 167 (307)
T ss_pred HhhC-CCHHHHHHHcc-cCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC-----
Confidence 9995 67777765432 4689999999999999999999999999999999999999999999999998732110
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
...+.
T Consensus 168 ---------------------------------------------------------------------------~~~~~ 172 (307)
T cd06607 168 ---------------------------------------------------------------------------ANSFV 172 (307)
T ss_pred ---------------------------------------------------------------------------CCCcc
Confidence 01235
Q ss_pred cCccccCcceec---CCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 453 GTHEYLAPEIIK---GEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 453 GT~~Y~APE~l~---~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
|+..|+|||++. ...++.++|||||||++|||++|+.||.+.+....+..+............++..+++||.+||.
T Consensus 173 ~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 252 (307)
T cd06607 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYFRNFVDSCLQ 252 (307)
T ss_pred CCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHHHHHHHHHhc
Confidence 788999999985 34578899999999999999999999988777666665544322211123467889999999999
Q ss_pred cCCCCcccccCCHHHHhcCCCCCC
Q 007433 530 KEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
.||++||+ +.++++||||..
T Consensus 253 ~~p~~Rp~----~~~il~~~~~~~ 272 (307)
T cd06607 253 KIPQDRPS----SEELLKHRFVLR 272 (307)
T ss_pred CChhhCcC----HHHHhcChhhcc
Confidence 99999999 999999999964
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=347.08 Aligned_cols=260 Identities=26% Similarity=0.375 Sum_probs=202.8
Q ss_pred CeEEEEEEccCCcEEEEEEEEcC--CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC--CeeE
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTG--TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD--KFSC 289 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~ 289 (604)
+|++++.||+|+||.||+|.+.. ++..||||++...............+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 58999999999999999999988 8899999999874321222233456799999999999999999999987 8899
Q ss_pred EEEeecCCCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc----CCcEEEeccccc
Q 007433 290 LVMEFCPGGDLHTLRQRQP---GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE----DGHIMLSDFDLS 362 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~---~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~----~g~vkL~DFGla 362 (604)
+||||++ ++|..++.... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++
T Consensus 81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 9999995 57777665322 236899999999999999999999999999999999999999 899999999988
Q ss_pred ccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccC
Q 007433 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442 (604)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (604)
..+.....
T Consensus 160 ~~~~~~~~------------------------------------------------------------------------ 167 (316)
T cd07842 160 RLFNAPLK------------------------------------------------------------------------ 167 (316)
T ss_pred cccCCCcc------------------------------------------------------------------------
Confidence 43221000
Q ss_pred CCCCcccccccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHH---------HHHHH---HcC---
Q 007433 443 PTNARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRA---------TLYNV---VGQ--- 506 (604)
Q Consensus 443 ~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~---------~l~~i---~~~--- 506 (604)
.........||..|+|||++.+. .++.++|||||||+||+|++|+.||.+..... .+..+ +..
T Consensus 168 -~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 246 (316)
T cd07842 168 -PLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTE 246 (316)
T ss_pred -cccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCch
Confidence 00011134688999999988764 57899999999999999999999998654321 11111 100
Q ss_pred --------------------CCCCC---------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 507 --------------------PLRFP---------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 507 --------------------~~~~p---------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
...++ .....+.++.++|.+||..||++||+ +.|+++||||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps----~~eil~~~~f 316 (316)
T cd07842 247 KDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRIT----AEEALEHPYF 316 (316)
T ss_pred hHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcC----HHHHhcCCCC
Confidence 00111 00146678999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=361.78 Aligned_cols=257 Identities=33% Similarity=0.518 Sum_probs=219.1
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCCC
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGG 298 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 298 (604)
+.||+|.||+||-|+++.+|+.||||+|+|..+..... ..++.|+.||+.++||.||.|...|++.+.+++|||-+ .|
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqe-sqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQE-SQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchH-HHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 67999999999999999999999999999887654322 46678999999999999999999999999999999999 55
Q ss_pred CHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC---cEEEecccccccccCCCcccccC
Q 007433 299 DLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG---HIMLSDFDLSLRCAVSPTVVKSS 375 (604)
Q Consensus 299 sL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g---~vkL~DFGla~~~~~~~~~~~~~ 375 (604)
|+.+++-....++|++...++++.|||.||.|||-++|||+|||||||||.... ++||||||+|+.++..
T Consensus 648 DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk------- 720 (888)
T KOG4236|consen 648 DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK------- 720 (888)
T ss_pred hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-------
Confidence 666655555568999999999999999999999999999999999999997543 7999999999654321
Q ss_pred cccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCc
Q 007433 376 TLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTH 455 (604)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~ 455 (604)
.-..+.+||+
T Consensus 721 ----------------------------------------------------------------------sFRrsVVGTP 730 (888)
T KOG4236|consen 721 ----------------------------------------------------------------------SFRRSVVGTP 730 (888)
T ss_pred ----------------------------------------------------------------------hhhhhhcCCc
Confidence 1123578999
Q ss_pred cccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCC--CCCCHHHHHHHHHhhhcCCC
Q 007433 456 EYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPES--PVVSFSARDLIKGLLVKEPQ 533 (604)
Q Consensus 456 ~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~--~~~s~~l~dLI~~lL~~dP~ 533 (604)
.|+|||+++..+|...-||||.|||+|--|.|..||.... ++-..|....+.+|.. ..++.++.|||..+|+..-.
T Consensus 731 AYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE--dIndQIQNAaFMyPp~PW~eis~~AidlIn~LLqVkm~ 808 (888)
T KOG4236|consen 731 AYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE--DINDQIQNAAFMYPPNPWSEISPEAIDLINNLLQVKMR 808 (888)
T ss_pred cccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc--chhHHhhccccccCCCchhhcCHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999999999997543 3344555556666643 45899999999999999999
Q ss_pred CcccccCCHHHHhcCCCCCCCC-hhhhh
Q 007433 534 NRLACRRGATEIKQHPFFQGVN-WALIR 560 (604)
Q Consensus 534 ~Rpt~~~~a~elL~Hpff~~~~-~~~~~ 560 (604)
+|.+ ++..|.|||+++.. |--+|
T Consensus 809 kRys----vdk~lsh~Wlq~yq~w~DLR 832 (888)
T KOG4236|consen 809 KRYS----VDKSLSHPWLQDYQTWLDLR 832 (888)
T ss_pred Hhcc----hHhhccchhhhcchHHHHHH
Confidence 9999 99999999999764 54443
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=364.57 Aligned_cols=239 Identities=29% Similarity=0.511 Sum_probs=212.4
Q ss_pred eEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEee
Q 007433 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEF 294 (604)
Q Consensus 215 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 294 (604)
..-++.||.|+.|.||+|+.... .||||.++.-. ..+|+.|++|+|+||+.+.+++.....+||||||
T Consensus 126 IsELeWlGSGaQGAVF~Grl~ne--tVAVKKV~elk----------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEf 193 (904)
T KOG4721|consen 126 ISELEWLGSGAQGAVFLGRLHNE--TVAVKKVRELK----------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEF 193 (904)
T ss_pred hhhhhhhccCcccceeeeeccCc--eehhHHHhhhh----------hhhHHHHHhccCcceeeEeeeecCCceeEEeeec
Confidence 34467799999999999998754 69999885321 2478899999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccccc
Q 007433 295 CPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKS 374 (604)
Q Consensus 295 ~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~ 374 (604)
|..|.|.++++.. ..+.......|..+|+.|+.|||.++|||||||.-||||..+..|||+|||-+....
T Consensus 194 Ca~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~-------- 263 (904)
T KOG4721|consen 194 CAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELS-------- 263 (904)
T ss_pred cccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhh--------
Confidence 9999999999875 678888899999999999999999999999999999999999999999999763221
Q ss_pred CcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccC
Q 007433 375 STLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGT 454 (604)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT 454 (604)
.-+..++|+||
T Consensus 264 ---------------------------------------------------------------------~~STkMSFaGT 274 (904)
T KOG4721|consen 264 ---------------------------------------------------------------------DKSTKMSFAGT 274 (904)
T ss_pred ---------------------------------------------------------------------hhhhhhhhhhh
Confidence 01245789999
Q ss_pred ccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCC
Q 007433 455 HEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQN 534 (604)
Q Consensus 455 ~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~ 534 (604)
..|||||+++.++.+.++|||||||+|||||||+.||.+.+..++++-+=..-+.+|-+..++..++-||+.||.-.|..
T Consensus 275 VaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRN 354 (904)
T KOG4721|consen 275 VAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRN 354 (904)
T ss_pred HhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCC
Confidence 99999999999999999999999999999999999999988888777666666778877889999999999999999999
Q ss_pred cccccCCHHHHhcC
Q 007433 535 RLACRRGATEIKQH 548 (604)
Q Consensus 535 Rpt~~~~a~elL~H 548 (604)
||+ +.++|.|
T Consensus 355 RPS----Frqil~H 364 (904)
T KOG4721|consen 355 RPS----FRQILLH 364 (904)
T ss_pred Ccc----HHHHHHH
Confidence 999 8999998
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=348.42 Aligned_cols=255 Identities=21% Similarity=0.306 Sum_probs=208.8
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCce----EEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKC----YFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
...+|++++.||+|+||.||+|.+..++. .||||++..... .....++.+|+.+++.++||||+++++++..+
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 34689999999999999999999866554 489999865422 22334567899999999999999999998765
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
..++|+||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred CceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccccc
Confidence 5679999999999999887653 468899999999999999999999999999999999999999999999999985432
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
......
T Consensus 161 ~~~~~~-------------------------------------------------------------------------- 166 (316)
T cd05108 161 ADEKEY-------------------------------------------------------------------------- 166 (316)
T ss_pred CCCcce--------------------------------------------------------------------------
Confidence 110000
Q ss_pred cccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007433 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIK 525 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~ 525 (604)
......++..|+|||++.+..++.++|||||||+||||++ |+.||.+....+ +..+......++....++.++.++|.
T Consensus 167 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~ 245 (316)
T cd05108 167 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE-ISSILEKGERLPQPPICTIDVYMIMV 245 (316)
T ss_pred eccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH-HHHHHhCCCCCCCCCCCCHHHHHHHH
Confidence 0001225678999999999999999999999999999997 999998765544 44555555566666678899999999
Q ss_pred HhhhcCCCCcccccCCHHHHhcC
Q 007433 526 GLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
+||..||++||+ +.+++.+
T Consensus 246 ~cl~~~p~~Rps----~~~l~~~ 264 (316)
T cd05108 246 KCWMIDADSRPK----FRELIIE 264 (316)
T ss_pred HHccCChhhCcC----HHHHHHH
Confidence 999999999999 7788765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=340.89 Aligned_cols=255 Identities=27% Similarity=0.425 Sum_probs=209.5
Q ss_pred eEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEee
Q 007433 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEF 294 (604)
Q Consensus 215 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 294 (604)
|++++.||.|++|.||+|.+..++..||+|++....... .....+.+|+++++.++|+||+++++++.+++..|+||||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDE-GVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccc-cchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 678899999999999999999999999999987553221 1223456799999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccccc
Q 007433 295 CPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKS 374 (604)
Q Consensus 295 ~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~ 374 (604)
+ +++|.+++.......+++..+..++.||+.||+|||+++++||||+|+|||++.++.++|+|||++........
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~---- 154 (283)
T cd07835 80 L-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR---- 154 (283)
T ss_pred c-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc----
Confidence 9 57999998876555799999999999999999999999999999999999999999999999998743211000
Q ss_pred CcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccC
Q 007433 375 STLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGT 454 (604)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT 454 (604)
......++
T Consensus 155 ------------------------------------------------------------------------~~~~~~~~ 162 (283)
T cd07835 155 ------------------------------------------------------------------------TYTHEVVT 162 (283)
T ss_pred ------------------------------------------------------------------------ccCccccc
Confidence 00112468
Q ss_pred ccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC------------------CC-----
Q 007433 455 HEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPL------------------RF----- 510 (604)
Q Consensus 455 ~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~------------------~~----- 510 (604)
..|+|||++.+. .++.++|||||||++|+|++|+.||.+.+....++++..... .+
T Consensus 163 ~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (283)
T cd07835 163 LWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWAR 242 (283)
T ss_pred cCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccc
Confidence 899999998765 468899999999999999999999988776665555432100 00
Q ss_pred ----CCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 511 ----PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 511 ----p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
.....++..+.+||.+||..||++||+ +.|+++||||
T Consensus 243 ~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~il~~~~~ 283 (283)
T cd07835 243 QDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS----AKAALQHPYF 283 (283)
T ss_pred cchhhhcCCCCHHHHHHHHHHhcCChhhCcC----HHHHhcCCCC
Confidence 012346788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-41 Score=342.14 Aligned_cols=256 Identities=27% Similarity=0.414 Sum_probs=214.9
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
..|+.+++||.|+||.||+|.+..++..||||++..... ......+.+|+.+++.++|+||+++++++.+++..|+||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIM 81 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 468889999999999999999999999999999875432 233456778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||++|++|.+++.. ..+++..+..++.|++.||+|||+++++|+||+|+||+++.++.++|+|||++..+....
T Consensus 82 e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--- 155 (277)
T cd06640 82 EYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--- 155 (277)
T ss_pred ecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc---
Confidence 99999999998865 358999999999999999999999999999999999999999999999999884321100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.......
T Consensus 156 -------------------------------------------------------------------------~~~~~~~ 162 (277)
T cd06640 156 -------------------------------------------------------------------------IKRNTFV 162 (277)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0011235
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEP 532 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP 532 (604)
++..|+|||++.+..++.++|+|||||++|||++|..||...........+.... .......++..+.+||.+||..+|
T Consensus 163 ~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p 241 (277)
T cd06640 163 GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNN-PPTLTGEFSKPFKEFIDACLNKDP 241 (277)
T ss_pred CcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCC-CCCCchhhhHHHHHHHHHHcccCc
Confidence 8889999999998889999999999999999999999998876655554443221 111122467889999999999999
Q ss_pred CCcccccCCHHHHhcCCCCCCC
Q 007433 533 QNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 533 ~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
++||+ +.++++|+||...
T Consensus 242 ~~Rp~----~~~il~~~~~~~~ 259 (277)
T cd06640 242 SFRPT----AKELLKHKFIVKN 259 (277)
T ss_pred ccCcC----HHHHHhChHhhhc
Confidence 99999 9999999999654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=340.64 Aligned_cols=255 Identities=27% Similarity=0.457 Sum_probs=214.7
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
+|...+.||.|++|.||++.+..++..||+|++...... ....+.+|+.+++.++|+||+++++++..+++.|+|||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e 96 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME 96 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence 566678999999999999999989999999998654322 23346689999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
|+.|++|.+++.. ..+++..+..++.||+.||+|||++||+||||+|+||+++.++.++|+|||++......
T Consensus 97 ~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~----- 168 (285)
T cd06648 97 FLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE----- 168 (285)
T ss_pred ccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC-----
Confidence 9999999998876 35899999999999999999999999999999999999999999999999976321100
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
........|
T Consensus 169 -----------------------------------------------------------------------~~~~~~~~~ 177 (285)
T cd06648 169 -----------------------------------------------------------------------VPRRKSLVG 177 (285)
T ss_pred -----------------------------------------------------------------------CcccccccC
Confidence 000112458
Q ss_pred CccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC-CCCCCCCCHHHHHHHHHhhhcCC
Q 007433 454 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR-FPESPVVSFSARDLIKGLLVKEP 532 (604)
Q Consensus 454 T~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~-~p~~~~~s~~l~dLI~~lL~~dP 532 (604)
++.|+|||++.+..++.++|||||||++|||++|+.||...+....+..+...... ......++..+.+||.+||..||
T Consensus 178 ~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p 257 (285)
T cd06648 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDP 257 (285)
T ss_pred CccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHHHcccCh
Confidence 89999999999888999999999999999999999999887766666665544322 22233478899999999999999
Q ss_pred CCcccccCCHHHHhcCCCCCCC
Q 007433 533 QNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 533 ~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
++||+ +.++++||||+..
T Consensus 258 ~~Rpt----~~~il~~~~~~~~ 275 (285)
T cd06648 258 AQRAT----AAELLNHPFLAKA 275 (285)
T ss_pred hhCcC----HHHHccCcccccC
Confidence 99999 9999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=345.62 Aligned_cols=261 Identities=25% Similarity=0.355 Sum_probs=209.0
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEecCCeeEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV 291 (604)
++|..++.||.|+||.||++.+..+++.||||.+.+.... .....+.+|+.++.++. |+||+++++++..++..+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 4677788999999999999999999999999999765332 23345678999999996 99999999999999999999
Q ss_pred EeecCCCCHHHHHH---hcCCCCCcHHHHHHHHHHHHHHHHHHHH-cCeEeccCCCCcEEEccCCcEEEecccccccccC
Q 007433 292 MEFCPGGDLHTLRQ---RQPGKYFSEQAVKFYVAEVLLALEYLHM-LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAV 367 (604)
Q Consensus 292 ~E~~~ggsL~~ll~---~~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~ 367 (604)
|||+ +++|.++.. ......+++..+..++.|++.||+|||+ .||+||||||+|||++.++.++|+|||++..+..
T Consensus 82 ~e~~-~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELM-DISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred Eecc-cCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 9998 456655432 2333679999999999999999999997 4999999999999999999999999998843211
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
.. .
T Consensus 161 ~~-----------------------------------------------------------------------------~ 163 (288)
T cd06616 161 SI-----------------------------------------------------------------------------A 163 (288)
T ss_pred CC-----------------------------------------------------------------------------c
Confidence 00 0
Q ss_pred ccccccCccccCcceecCC---CCCccchHHHHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcC-CCCCCC--CCCCCHHH
Q 007433 448 SMSFVGTHEYLAPEIIKGE---GHGSAVDWWTFGIFLYELLFGKTPFKGSEN-RATLYNVVGQ-PLRFPE--SPVVSFSA 520 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~~---~~~~~~DiWSLGviL~eLltG~~PF~~~~~-~~~l~~i~~~-~~~~p~--~~~~s~~l 520 (604)
.....|++.|+|||++.+. .++.++|||||||++|||++|+.||..... .+.+.++... ...++. ...++.++
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (288)
T cd06616 164 KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSF 243 (288)
T ss_pred cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHH
Confidence 0122488899999999876 688999999999999999999999976542 2233333322 222221 22478899
Q ss_pred HHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 521 RDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 521 ~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
.+||.+||..||++||+ +++|++||||+...|.
T Consensus 244 ~~li~~~l~~~p~~Rpt----~~~i~~~~~~~~~~~~ 276 (288)
T cd06616 244 VNFINLCLIKDESKRPK----YKELLEHPFIKDYEER 276 (288)
T ss_pred HHHHHHHccCChhhCcC----HHHHhcChhhhchhhc
Confidence 99999999999999999 9999999999876554
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=335.90 Aligned_cols=255 Identities=29% Similarity=0.413 Sum_probs=205.7
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
..+.+.....||+|+||.||+|.+..++..||+|.+...... ....+.+|+.+++.++|+||+++++++..++..|+
T Consensus 6 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 6 EYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR---YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred ccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH---HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 344555567899999999999999999999999998765332 23456789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCC--cHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc-CCcEEEecccccccccC
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYF--SEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE-DGHIMLSDFDLSLRCAV 367 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l--~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~-~g~vkL~DFGla~~~~~ 367 (604)
||||+++++|.+++.... ..+ ++..+..++.||+.||.|||++||+||||||+|||++. ++.++|+|||++.....
T Consensus 83 v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 83 FMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred EEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 999999999999887642 334 88899999999999999999999999999999999986 67999999998743210
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
. +..
T Consensus 162 ~----------------------------------------------------------------------------~~~ 165 (268)
T cd06624 162 I----------------------------------------------------------------------------NPC 165 (268)
T ss_pred C----------------------------------------------------------------------------CCc
Confidence 0 000
Q ss_pred ccccccCccccCcceecCCC--CCccchHHHHHHHHHHHhhCCCCCCCCChHH-HHHHHH--cCCCCCCCCCCCCHHHHH
Q 007433 448 SMSFVGTHEYLAPEIIKGEG--HGSAVDWWTFGIFLYELLFGKTPFKGSENRA-TLYNVV--GQPLRFPESPVVSFSARD 522 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~~~--~~~~~DiWSLGviL~eLltG~~PF~~~~~~~-~l~~i~--~~~~~~p~~~~~s~~l~d 522 (604)
.....|++.|+|||++.+.. ++.++|+|||||++|+|++|+.||....... ...... .....+ ...++.++++
T Consensus 166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ 243 (268)
T cd06624 166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI--PESLSAEAKN 243 (268)
T ss_pred cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCC--CcccCHHHHH
Confidence 11234788999999987643 7889999999999999999999997654322 222221 112222 2347889999
Q ss_pred HHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 523 LIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 523 LI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
||.+||..+|++||+ +.|++.||||
T Consensus 244 li~~~l~~~p~~Rpt----~~~ll~~~~~ 268 (268)
T cd06624 244 FILRCFEPDPDKRAS----AHDLLQDPFL 268 (268)
T ss_pred HHHHHcCCCchhCCC----HHHHHhCCCC
Confidence 999999999999999 9999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-41 Score=354.07 Aligned_cols=257 Identities=20% Similarity=0.318 Sum_probs=207.0
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcC-----CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEec-
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTG-----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFET- 284 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~- 284 (604)
.++|++.+.||.|+||.||+|.+.+ +++.||+|+++..... .....+.+|+++++++ +|+||+++++++..
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATA--SEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCH--HHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 3589999999999999999997644 3478999998754322 2334566899999999 89999999998764
Q ss_pred CCeeEEEEeecCCCCHHHHHHhcCC-------------------------------------------------------
Q 007433 285 DKFSCLVMEFCPGGDLHTLRQRQPG------------------------------------------------------- 309 (604)
Q Consensus 285 ~~~~~lV~E~~~ggsL~~ll~~~~~------------------------------------------------------- 309 (604)
+..+++||||+++++|.+++.....
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 5678999999999999998864321
Q ss_pred ----CCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcccCCcccCC
Q 007433 310 ----KYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKN 385 (604)
Q Consensus 310 ----~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~ 385 (604)
..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+......
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~-------------- 229 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-------------- 229 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcch--------------
Confidence 26889999999999999999999999999999999999999999999999998543211000
Q ss_pred CccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecC
Q 007433 386 PVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKG 465 (604)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 465 (604)
.......++..|+|||++.+
T Consensus 230 ------------------------------------------------------------~~~~~~~~~~~y~aPE~~~~ 249 (337)
T cd05054 230 ------------------------------------------------------------VRKGDARLPLKWMAPESIFD 249 (337)
T ss_pred ------------------------------------------------------------hhccCCCCCccccCcHHhcC
Confidence 00112346778999999999
Q ss_pred CCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHH
Q 007433 466 EGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATE 544 (604)
Q Consensus 466 ~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~e 544 (604)
..++.++|||||||+||||++ |..||.+....+.+................+.++.+++.+||+.+|++||+ +.|
T Consensus 250 ~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs----~~e 325 (337)
T cd05054 250 KVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPT----FSE 325 (337)
T ss_pred CCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcC----HHH
Confidence 999999999999999999997 999998765545554444443333334457889999999999999999999 889
Q ss_pred HhcC
Q 007433 545 IKQH 548 (604)
Q Consensus 545 lL~H 548 (604)
|++|
T Consensus 326 ll~~ 329 (337)
T cd05054 326 LVEI 329 (337)
T ss_pred HHHH
Confidence 8876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=346.36 Aligned_cols=258 Identities=27% Similarity=0.407 Sum_probs=214.1
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
.|+.++.||.|+||.||+|.+..++..||+|++...... .....+.+|+++++.++|+||++++++|..++..|+|||
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch--HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 567778899999999999999999999999998755322 233467789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
|+++++|.+++.. ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..+....
T Consensus 83 ~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~---- 155 (277)
T cd06642 83 YLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ---- 155 (277)
T ss_pred ccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc----
Confidence 9999999998764 468999999999999999999999999999999999999999999999999874321100
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
.......|
T Consensus 156 ------------------------------------------------------------------------~~~~~~~~ 163 (277)
T cd06642 156 ------------------------------------------------------------------------IKRNTFVG 163 (277)
T ss_pred ------------------------------------------------------------------------hhhhcccC
Confidence 00112358
Q ss_pred CccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCC
Q 007433 454 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQ 533 (604)
Q Consensus 454 T~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~ 533 (604)
+..|+|||++.+..++.++|+|||||++|||++|+.||...........+..... ......++.++.+||.+||..+|+
T Consensus 164 ~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~ 242 (277)
T cd06642 164 TPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-PTLEGQYSKPFKEFVEACLNKDPR 242 (277)
T ss_pred cccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCC-CCCCcccCHHHHHHHHHHccCCcc
Confidence 8899999999998899999999999999999999999987655554444332221 111234778899999999999999
Q ss_pred CcccccCCHHHHhcCCCCCCCChh
Q 007433 534 NRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 534 ~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
+||+ +.++++||||....+.
T Consensus 243 ~Rp~----~~~il~~~~~~~~~~~ 262 (277)
T cd06642 243 FRPT----AKELLKHKFITRYTKK 262 (277)
T ss_pred cCcC----HHHHHHhHHHHHHhhh
Confidence 9999 9999999999765443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=353.19 Aligned_cols=262 Identities=24% Similarity=0.362 Sum_probs=206.0
Q ss_pred EEEccC--CcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecC
Q 007433 219 KKLGCG--DIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCP 296 (604)
Q Consensus 219 ~~LG~G--~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 296 (604)
..||.| +||+||+|++..+++.||||++....... .....+.+|+.+++.++||||++++++|..++..|+||||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 346665 99999999999999999999997643322 334567789999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCc
Q 007433 297 GGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSST 376 (604)
Q Consensus 297 ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 376 (604)
+++|.+++.+.....+++..++.++.||+.||+|||++||+||||||+|||++.++.++++||+.+...........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~--- 159 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK--- 159 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc---
Confidence 99999998876555799999999999999999999999999999999999999999999999986532110000000
Q ss_pred ccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCcc
Q 007433 377 LESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHE 456 (604)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 456 (604)
. .........++..
T Consensus 160 --------------------------------------------------~----------------~~~~~~~~~~~~~ 173 (328)
T cd08226 160 --------------------------------------------------V----------------VYDFPQFSTSVLP 173 (328)
T ss_pred --------------------------------------------------c----------------cccccccccCccC
Confidence 0 0000001235677
Q ss_pred ccCcceecCC--CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC--------------------------
Q 007433 457 YLAPEIIKGE--GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPL-------------------------- 508 (604)
Q Consensus 457 Y~APE~l~~~--~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~-------------------------- 508 (604)
|+|||++.+. .++.++|||||||++|||++|+.||.+......+..+.....
T Consensus 174 y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (328)
T cd08226 174 WLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSG 253 (328)
T ss_pred ccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcc
Confidence 9999999774 478899999999999999999999987665554444332211
Q ss_pred -------------------CCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 509 -------------------RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 509 -------------------~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
..+....++..+.+||++||.+||++||+ +.|+|+||||+.+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt----a~e~l~~~~~~~~ 314 (328)
T cd08226 254 IGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPS----ASSLLSHAFFKQV 314 (328)
T ss_pred cccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCC----HHHHhhCHHHHHH
Confidence 11112235677899999999999999999 9999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=329.71 Aligned_cols=256 Identities=32% Similarity=0.553 Sum_probs=218.2
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
+|.+.+.||.|+||.||++.+..++..||+|++...... ......+.+|+++++.++|+|++++++.+..+...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 589999999999999999999999999999999765432 2333456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 294 FCPGGDLHTLRQRQP--GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~--~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|+++++|.+++.... +..+++..+..++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 999999999887653 4679999999999999999999999999999999999999999999999999874321100
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 158 --------------------------------------------------------------------------~~~~~~ 163 (258)
T cd08215 158 --------------------------------------------------------------------------DLAKTV 163 (258)
T ss_pred --------------------------------------------------------------------------ceecce
Confidence 001123
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~d 531 (604)
.|++.|+|||.+.+..++.++|+|+||+++|+|++|..||...+.......+...... +....++..+.++|.+||..+
T Consensus 164 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~ 242 (258)
T cd08215 164 VGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYP-PIPSQYSSELRNLVSSLLQKD 242 (258)
T ss_pred eeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHcCCC
Confidence 5889999999999888999999999999999999999999887766666655544322 222358899999999999999
Q ss_pred CCCcccccCCHHHHhcCCCC
Q 007433 532 PQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 532 P~~Rpt~~~~a~elL~Hpff 551 (604)
|++||+ +.++|+||||
T Consensus 243 p~~Rp~----~~~ll~~~~~ 258 (258)
T cd08215 243 PEERPS----IAQILQSPFI 258 (258)
T ss_pred hhhCcC----HHHHhcCCCC
Confidence 999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=338.52 Aligned_cols=251 Identities=27% Similarity=0.443 Sum_probs=201.7
Q ss_pred eEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEecC--CeeEEE
Q 007433 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFETD--KFSCLV 291 (604)
Q Consensus 215 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~--~~~~lV 291 (604)
|++++.||.|+||.||+|.+..++..||+|++.+..... .. ....+|+.+++++. |+||+++++++.++ +.+|+|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSL-EQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCc-hh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 788999999999999999999999999999987642211 11 12346888899885 99999999999987 899999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+. ++|.+.+.... ..+++..+..++.||+.||+|||++||+||||||+|||++. +.++|+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~--- 152 (282)
T cd07831 79 FELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK--- 152 (282)
T ss_pred EecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC---
Confidence 99995 57877776542 47899999999999999999999999999999999999999 99999999987432100
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 153 --------------------------------------------------------------------------~~~~~~ 158 (282)
T cd07831 153 --------------------------------------------------------------------------PPYTEY 158 (282)
T ss_pred --------------------------------------------------------------------------CCcCCC
Confidence 001123
Q ss_pred ccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc---C---------------CCCCCC
Q 007433 452 VGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG---Q---------------PLRFPE 512 (604)
Q Consensus 452 ~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~---~---------------~~~~p~ 512 (604)
.++..|+|||++.. ..++.++|||||||++|||++|..||.+.+..+.+..+.. . ...++.
T Consensus 159 ~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (282)
T cd07831 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPS 238 (282)
T ss_pred CCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcc
Confidence 57889999998654 4468899999999999999999999988766554433321 1 111111
Q ss_pred ---------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 513 ---------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 513 ---------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
...++..+.+||.+||.+||++||+ +.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~----~~~~l~~~~~ 282 (282)
T cd07831 239 KKGTGLRKLLPNASAEGLDLLKKLLAYDPDERIT----AKQALRHPYF 282 (282)
T ss_pred cccccHHHHcccccHHHHHHHHHHhccCcccccC----HHHHhhCCCC
Confidence 1246789999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=344.50 Aligned_cols=257 Identities=28% Similarity=0.395 Sum_probs=208.7
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC--CeeE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD--KFSC 289 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~ 289 (604)
.++|++.+.||.|+||.||+|.+..+++.||+|.+...... ......+.+|+++|+.++||||+++++++..+ +..|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 35899999999999999999999999999999999755332 22223456799999999999999999999877 8999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
+||||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus 83 lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 160 (293)
T cd07843 83 MVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160 (293)
T ss_pred EEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence 9999995 59999887653 469999999999999999999999999999999999999999999999999874432110
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
. ...
T Consensus 161 ~----------------------------------------------------------------------------~~~ 164 (293)
T cd07843 161 K----------------------------------------------------------------------------PYT 164 (293)
T ss_pred c----------------------------------------------------------------------------ccc
Confidence 0 001
Q ss_pred ccccCccccCcceecCCC-CCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---C------------------
Q 007433 450 SFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---P------------------ 507 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~------------------ 507 (604)
...+++.|+|||++.+.. ++.++|||||||++|||++|+.||......+.+.++... +
T Consensus 165 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (293)
T cd07843 165 QLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKT 244 (293)
T ss_pred cccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccc
Confidence 224788999999987654 588999999999999999999999887665554433210 0
Q ss_pred --------CCCCCCCC-CCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 508 --------LRFPESPV-VSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 508 --------~~~p~~~~-~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
+.-..... ++..+.+||++||..||++||+ +.|+|+||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t----~~ell~~~~f 293 (293)
T cd07843 245 FTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRIS----AEDALKHPYF 293 (293)
T ss_pred cccccchhhhccccccCCChHHHHHHHHHhccCccccCC----HHHHhcCCCC
Confidence 00000111 5788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=358.81 Aligned_cols=257 Identities=29% Similarity=0.472 Sum_probs=204.3
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCeeEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV 291 (604)
..|+++++||+||.+.||++...+.+ .||+|.+.... .+...+..+..|+.+|.+| +|.+||+||+|-..++++|||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 57999999999999999999887766 45555443322 2345566788999999999 599999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||= ..||..++++.. ..++...+++|..|+|.++.++|++||||.||||.|+|+- .|.+||+|||+|.-+....+
T Consensus 439 mE~G-d~DL~kiL~k~~-~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTT- 514 (677)
T KOG0596|consen 439 MECG-DIDLNKILKKKK-SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTT- 514 (677)
T ss_pred eecc-cccHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcccc-
Confidence 9986 789999998764 3455458999999999999999999999999999999985 68999999999843322111
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
+.-..+.
T Consensus 515 -------------------------------------------------------------------------sI~kdsQ 521 (677)
T KOG0596|consen 515 -------------------------------------------------------------------------SIVKDSQ 521 (677)
T ss_pred -------------------------------------------------------------------------ceeeccc
Confidence 1122356
Q ss_pred ccCccccCcceecCCC-----------CCccchHHHHHHHHHHHhhCCCCCCCCC-hHHHHHHHHcCC--CCCCCCCCCC
Q 007433 452 VGTHEYLAPEIIKGEG-----------HGSAVDWWTFGIFLYELLFGKTPFKGSE-NRATLYNVVGQP--LRFPESPVVS 517 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~-----------~~~~~DiWSLGviL~eLltG~~PF~~~~-~~~~l~~i~~~~--~~~p~~~~~s 517 (604)
+||+.||+||.+.... .+.++||||||||||+|+.|++||.... ....+..|..-. ..||..+. .
T Consensus 522 vGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~~~-~ 600 (677)
T KOG0596|consen 522 VGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDIPE-N 600 (677)
T ss_pred cCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCCCC-c
Confidence 8999999999985432 4679999999999999999999998654 334445555432 34554322 2
Q ss_pred HHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 518 FSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 518 ~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
.++.++++.||.+||.+||+ +.|||+|||++.
T Consensus 601 ~~li~~mK~CL~rdPkkR~s----i~eLLqhpFl~~ 632 (677)
T KOG0596|consen 601 DELIDVMKCCLARDPKKRWS----IPELLQHPFLQI 632 (677)
T ss_pred hHHHHHHHHHHhcCcccCCC----cHHHhcCccccc
Confidence 23999999999999999999 999999999963
|
|
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=336.72 Aligned_cols=255 Identities=26% Similarity=0.380 Sum_probs=208.7
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++.+.||.|+||.||+|++..++..||||.+.+...........+.+|+.+++.++|+||++++++|..++..++||
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 57999999999999999999999999999999987654444444566778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 293 EFCPGGDLHTLRQRQ--PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 293 E~~~ggsL~~ll~~~--~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
||+++++|.+++... ....+++..++.++.||+.||.|||++||+|+||||+|||++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~- 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC-
Confidence 999999999988742 23568999999999999999999999999999999999999999999999999873321000
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
.....
T Consensus 161 ---------------------------------------------------------------------------~~~~~ 165 (267)
T cd08229 161 ---------------------------------------------------------------------------TAAHS 165 (267)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00012
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCCh--HHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSEN--RATLYNVVGQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~--~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
..|+..|+|||++.+..++.++|+||||+++|+|++|..||.+... ......+............++..+++||.+||
T Consensus 166 ~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 245 (267)
T cd08229 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCI 245 (267)
T ss_pred ccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHHHHHHHhc
Confidence 3588999999999998899999999999999999999999976433 22223333222211122347889999999999
Q ss_pred hcCCCCcccccCCHHHHhc
Q 007433 529 VKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 529 ~~dP~~Rpt~~~~a~elL~ 547 (604)
..||++||+ +.+|++
T Consensus 246 ~~~p~~Rpt----~~~i~~ 260 (267)
T cd08229 246 NPDPEKRPD----ITYVYD 260 (267)
T ss_pred CCCcccCCC----HHHHHH
Confidence 999999999 776653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=338.31 Aligned_cols=258 Identities=29% Similarity=0.448 Sum_probs=209.3
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec--CCeeEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET--DKFSCL 290 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~l 290 (604)
++|...++||.|++|.||++.+..+++.||+|++...... ....++.+|+++|+.++|+||++++++|.. .+.+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 4799999999999999999999999999999999765322 333456789999999999999999998864 457899
Q ss_pred EEeecCCCCHHHHHHh--cCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 291 VMEFCPGGDLHTLRQR--QPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~--~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
||||++|++|.+++.. .....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999987654 22356899999999999999999999999999999999999999999999999987322100
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
..
T Consensus 159 ------------------------------------------------------------------------------~~ 160 (287)
T cd06621 159 ------------------------------------------------------------------------------LA 160 (287)
T ss_pred ------------------------------------------------------------------------------cc
Confidence 00
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCC-----hHHHHHHHHcCC-CCCCCC----CCCCH
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE-----NRATLYNVVGQP-LRFPES----PVVSF 518 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~-----~~~~l~~i~~~~-~~~p~~----~~~s~ 518 (604)
....++..|+|||.+.+..++.++|||+|||++|+|++|+.||.... ..+....+.... ..++.. ...+.
T Consensus 161 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (287)
T cd06621 161 GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSE 240 (287)
T ss_pred ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHH
Confidence 02347788999999998889999999999999999999999998652 223333333211 111111 22467
Q ss_pred HHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 519 SARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 519 ~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
.+++||.+||.+||.+||+ +.|+++||||...
T Consensus 241 ~~~~li~~~l~~~p~~Rpt----~~eil~~~~~~~~ 272 (287)
T cd06621 241 EFKDFIKQCLEKDPTRRPT----PWDMLEHPWIKAQ 272 (287)
T ss_pred HHHHHHHHHcCCCcccCCC----HHHHHhCcccccc
Confidence 8999999999999999999 9999999999643
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=342.87 Aligned_cols=261 Identities=30% Similarity=0.408 Sum_probs=203.3
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC-----
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK----- 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----- 286 (604)
.++|+++++||.|+||.||+|.+..++..||||.+....... .......+|++++++++||||+++++++....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYNR 89 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence 468999999999999999999999999999999986542211 11223457999999999999999999886543
Q ss_pred ---eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccc
Q 007433 287 ---FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 287 ---~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
..|+||||+ +++|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.
T Consensus 90 ~~~~~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~ 167 (310)
T cd07865 90 YKGSFYLVFEFC-EHDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR 167 (310)
T ss_pred CCceEEEEEcCC-CcCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence 459999999 56888877654 2468999999999999999999999999999999999999999999999999884
Q ss_pred cccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCC
Q 007433 364 RCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEP 443 (604)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (604)
.+......
T Consensus 168 ~~~~~~~~------------------------------------------------------------------------ 175 (310)
T cd07865 168 AFSLSKNS------------------------------------------------------------------------ 175 (310)
T ss_pred cccCCccc------------------------------------------------------------------------
Confidence 33211000
Q ss_pred CCCcccccccCccccCcceecCCC-CCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc---CC------------
Q 007433 444 TNARSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG---QP------------ 507 (604)
Q Consensus 444 ~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~---~~------------ 507 (604)
........+++..|+|||++.+.. ++.++||||||+++|||++|+.||.+.+....+..+.. ..
T Consensus 176 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (310)
T cd07865 176 KPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLE 255 (310)
T ss_pred CCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchh
Confidence 000011235788999999987654 68899999999999999999999987665433322111 00
Q ss_pred ----CCCCC-----------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 508 ----LRFPE-----------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 508 ----~~~p~-----------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
..++. ....+..+.+||.+||..||++||+ ++|+|+||||
T Consensus 256 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t----~~e~l~h~~f 310 (310)
T cd07865 256 LFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRID----ADTALNHDFF 310 (310)
T ss_pred hhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccC----HHHHhcCCCC
Confidence 00110 0123567889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=339.37 Aligned_cols=255 Identities=27% Similarity=0.433 Sum_probs=207.2
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
+|+++++||.|++|.||+|++..++..||||++...... .....+.+|+++++.++|+||+++++++.+++..|||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 589999999999999999999999999999999765322 122345679999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 294 FCPGGDLHTLRQRQP-GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
|++ ++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~--- 154 (284)
T cd07836 79 YMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV--- 154 (284)
T ss_pred cCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc---
Confidence 996 58888776542 2468999999999999999999999999999999999999999999999999873221000
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.......
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (284)
T cd07836 155 -------------------------------------------------------------------------NTFSNEV 161 (284)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0001224
Q ss_pred cCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---C---------------CCCCC-
Q 007433 453 GTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---P---------------LRFPE- 512 (604)
Q Consensus 453 GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~---------------~~~p~- 512 (604)
+|..|++||++.+. .++.++|||+|||++|+|++|+.||.+.+..+.+..+... + ..++.
T Consensus 162 ~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (284)
T cd07836 162 VTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRY 241 (284)
T ss_pred ccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCC
Confidence 78899999998764 4688999999999999999999999887665544433211 0 00010
Q ss_pred --------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 513 --------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 513 --------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
.+.++..++++|.+||..||.+||+ +.++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~----~~~~l~~~~f 284 (284)
T cd07836 242 PPQDLQQLFPHADPLGIDLLHRLLQLNPELRIS----AHDALQHPWF 284 (284)
T ss_pred ChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCC----HHHHhcCCCC
Confidence 1235778899999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=345.48 Aligned_cols=255 Identities=27% Similarity=0.463 Sum_probs=213.5
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
..|.....||.|+||.||+|.+..++..||||++....... ...+.+|+.+++.++||||++++++|..++..|+||
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~---~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQR---RELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccch---HHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 34555668999999999999999899999999997543222 234567999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+++++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 98 e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~---- 170 (297)
T cd06659 98 EFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD---- 170 (297)
T ss_pred ecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc----
Confidence 99999999987755 45899999999999999999999999999999999999999999999999987322100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.......+
T Consensus 171 ------------------------------------------------------------------------~~~~~~~~ 178 (297)
T cd06659 171 ------------------------------------------------------------------------VPKRKSLV 178 (297)
T ss_pred ------------------------------------------------------------------------ccccccee
Confidence 00011346
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC-CCCCCCCCHHHHHHHHHhhhcC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR-FPESPVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~-~p~~~~~s~~l~dLI~~lL~~d 531 (604)
|+..|+|||++.+..++.++|||||||++|||++|+.||........+..+...... ......++..+.+||.+||..|
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~ 258 (297)
T cd06659 179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTRE 258 (297)
T ss_pred cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHHhcCC
Confidence 889999999999888999999999999999999999999887766666555443221 2223457889999999999999
Q ss_pred CCCcccccCCHHHHhcCCCCCC
Q 007433 532 PQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 532 P~~Rpt~~~~a~elL~Hpff~~ 553 (604)
|++||+ +.++++||||..
T Consensus 259 P~~Rps----~~~ll~~~~~~~ 276 (297)
T cd06659 259 PQERAT----AQELLDHPFLLQ 276 (297)
T ss_pred cccCcC----HHHHhhChhhcc
Confidence 999999 999999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=334.93 Aligned_cols=255 Identities=24% Similarity=0.313 Sum_probs=211.0
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCC---ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCee
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGT---KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 288 (604)
.++|++.+.||+|+||+||+|.+..+ ...||||++...... .....+.+|+.+++.++|+||+++++++..++..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSD--KQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCCh--HHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 36899999999999999999998644 458999998765322 2233566799999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|+||||+++++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 81 MIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred EEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999987753 47899999999999999999999999999999999999999999999999998543210
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
.... ..
T Consensus 160 ~~~~--------------------------------------------------------------------------~~ 165 (266)
T cd05033 160 EATY--------------------------------------------------------------------------TT 165 (266)
T ss_pred ccce--------------------------------------------------------------------------ec
Confidence 0000 00
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGL 527 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~l 527 (604)
....+++.|+|||.+.+..++.++|||||||++|||++ |..||...........+.. ....+....++..+.+||.+|
T Consensus 166 ~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~li~~c 244 (266)
T cd05033 166 KGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVED-GYRLPPPMDCPSALYQLMLDC 244 (266)
T ss_pred cCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHH
Confidence 01135678999999999889999999999999999997 9999987776666555543 334444556889999999999
Q ss_pred hhcCCCCcccccCCHHHHhcC
Q 007433 528 LVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~H 548 (604)
|..||++||+ +.+++++
T Consensus 245 l~~~p~~Rp~----~~ei~~~ 261 (266)
T cd05033 245 WQKDRNERPT----FSQIVST 261 (266)
T ss_pred cCCCcccCcC----HHHHHHH
Confidence 9999999999 8888765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=338.22 Aligned_cols=257 Identities=20% Similarity=0.283 Sum_probs=208.3
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcC-----CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTG-----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD 285 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 285 (604)
..++|++.+.||+|+||.||+|.+.+ ++..||||.+...... .....+.+|+.+++.++|+||+++++++..+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 34789999999999999999998753 3567999998654221 2234567899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCC--------CCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEe
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPG--------KYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLS 357 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~--------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~ 357 (604)
...|+||||+++++|.+++..... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 999999999999999999875321 236788899999999999999999999999999999999999999999
Q ss_pred cccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCc
Q 007433 358 DFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLP 437 (604)
Q Consensus 358 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (604)
|||++..+......
T Consensus 162 dfg~~~~~~~~~~~------------------------------------------------------------------ 175 (277)
T cd05062 162 DFGMTRDIYETDYY------------------------------------------------------------------ 175 (277)
T ss_pred CCCCccccCCccee------------------------------------------------------------------
Confidence 99988433210000
Q ss_pred ccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 007433 438 ELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVV 516 (604)
Q Consensus 438 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~ 516 (604)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+......+..+..... ......+
T Consensus 176 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~-~~~~~~~ 246 (277)
T cd05062 176 --------RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGL-LDKPDNC 246 (277)
T ss_pred --------ecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-CCCCCCC
Confidence 00001246788999999998889999999999999999998 7999988777666655554432 2223457
Q ss_pred CHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 517 SFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 517 s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
+..+++||.+||..||++||+ +.|++++
T Consensus 247 ~~~~~~li~~~l~~~p~~Rps----~~e~l~~ 274 (277)
T cd05062 247 PDMLFELMRMCWQYNPKMRPS----FLEIISS 274 (277)
T ss_pred CHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 889999999999999999999 8888865
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=330.52 Aligned_cols=250 Identities=48% Similarity=0.857 Sum_probs=214.3
Q ss_pred EccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCCCCH
Q 007433 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDL 300 (604)
Q Consensus 221 LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 300 (604)
||.|+||.||++.+..++..||+|++.+...........+..|+++++.++|+||+++++.++.++..|+||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 69999999999999988999999999877655445566778899999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcccCC
Q 007433 301 HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESE 380 (604)
Q Consensus 301 ~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~ 380 (604)
.+++... ..+++..+..++.||+.||.|||+++++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----------- 147 (250)
T cd05123 81 FSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG----------- 147 (250)
T ss_pred HHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-----------
Confidence 9998875 468999999999999999999999999999999999999999999999999874321100
Q ss_pred cccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccccCc
Q 007433 381 PLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAP 460 (604)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP 460 (604)
.......|+..|++|
T Consensus 148 -----------------------------------------------------------------~~~~~~~~~~~~~~P 162 (250)
T cd05123 148 -----------------------------------------------------------------SRTNTFCGTPEYLAP 162 (250)
T ss_pred -----------------------------------------------------------------CcccCCcCCccccCh
Confidence 001123588899999
Q ss_pred ceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccC
Q 007433 461 EIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRR 540 (604)
Q Consensus 461 E~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~ 540 (604)
|.+.+..++.++|+|+||+++|+|++|..||...+.......+....+.++ ..++..+.+||++||..||++||+...
T Consensus 163 e~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 163 EVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP--EFLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred HHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC--CCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 999988889999999999999999999999988776666666655444433 447899999999999999999999322
Q ss_pred CHHHHhcCCCC
Q 007433 541 GATEIKQHPFF 551 (604)
Q Consensus 541 ~a~elL~Hpff 551 (604)
++++++||||
T Consensus 241 -~~~l~~~~~f 250 (250)
T cd05123 241 -AEEIKAHPFF 250 (250)
T ss_pred -HHHHHhCCCC
Confidence 3999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=332.91 Aligned_cols=250 Identities=22% Similarity=0.355 Sum_probs=207.6
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++++.||.|+||.||++.+... ..+|+|.+....... ..+.+|+++|+.++||||+++++++..+...|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~-~~~a~K~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQ-IKVAIKAINEGAMSE----EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccC-ceEEEEecccCCccH----HHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 36799999999999999999988654 479999987543322 2456799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~- 155 (256)
T cd05114 78 TEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY- 155 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce-
Confidence 99999999999887643 4689999999999999999999999999999999999999999999999998743211000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 156 --------------------------------------------------------------------------~~~~~~ 161 (256)
T cd05114 156 --------------------------------------------------------------------------TSSSGA 161 (256)
T ss_pred --------------------------------------------------------------------------eccCCC
Confidence 000112
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
.++..|+|||++.+..++.++|||||||++|||++ |+.||...+..+.+..+.... ........+..+.+||.+||..
T Consensus 162 ~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~li~~c~~~ 240 (256)
T cd05114 162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGF-RLYRPKLASMTVYEVMYSCWHE 240 (256)
T ss_pred CCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-CCCCCCCCCHHHHHHHHHHccC
Confidence 35678999999998889999999999999999999 999999887777777766543 2222344788899999999999
Q ss_pred CCCCcccccCCHHHHhc
Q 007433 531 EPQNRLACRRGATEIKQ 547 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~ 547 (604)
||++||+ +.++++
T Consensus 241 ~p~~Rps----~~~l~~ 253 (256)
T cd05114 241 KPEGRPT----FAELLR 253 (256)
T ss_pred CcccCcC----HHHHHH
Confidence 9999999 888875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=336.71 Aligned_cols=251 Identities=23% Similarity=0.350 Sum_probs=213.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
..+|+++++||.|+||.||+|.+.. +..+|+|++...... ....+.+|+.+|+.++|+||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLL---KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchh---hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 3579999999999999999999988 779999999765432 233466799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+++++|.+++....+..+++..+..++.||+.||.|||++||+||||||+||||+.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~- 159 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY- 159 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc-
Confidence 9999999999999876667899999999999999999999999999999999999999999999999998743211000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
.....
T Consensus 160 ---------------------------------------------------------------------------~~~~~ 164 (261)
T cd05148 160 ---------------------------------------------------------------------------LSSDK 164 (261)
T ss_pred ---------------------------------------------------------------------------cccCC
Confidence 00012
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
.++..|+|||++.+..++.++|||||||++|+|++ |+.||.+....+.+..+.. ....+....++..+.++|.+||..
T Consensus 165 ~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~ 243 (261)
T cd05148 165 KIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITA-GYRMPCPAKCPQEIYKIMLECWAA 243 (261)
T ss_pred CCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHh-CCcCCCCCCCCHHHHHHHHHHcCC
Confidence 35678999999998889999999999999999998 8999988777666666653 344455567899999999999999
Q ss_pred CCCCcccccCCHHHHhc
Q 007433 531 EPQNRLACRRGATEIKQ 547 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~ 547 (604)
||++||+ +.+|++
T Consensus 244 ~p~~Rpt----~~~l~~ 256 (261)
T cd05148 244 EPEDRPS----FKALRE 256 (261)
T ss_pred CchhCcC----HHHHHH
Confidence 9999999 777764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=339.12 Aligned_cols=255 Identities=22% Similarity=0.323 Sum_probs=210.8
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcC-----CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTG-----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
.++|.+++.||+|+||.||+|.+.. ++..||||++...... .....+.+|+++|+.++|+||+++++++..+.
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN--DARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH--HHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4679999999999999999998753 3578999999765332 23346678999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcC------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcE
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQP------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHI 354 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~v 354 (604)
..|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 9999999999999999987542 2458899999999999999999999999999999999999999999
Q ss_pred EEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCC
Q 007433 355 MLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVS 434 (604)
Q Consensus 355 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (604)
+|+|||++........
T Consensus 162 kl~d~g~~~~~~~~~~---------------------------------------------------------------- 177 (280)
T cd05049 162 KIGDFGMSRDVYTTDY---------------------------------------------------------------- 177 (280)
T ss_pred EECCcccceecccCcc----------------------------------------------------------------
Confidence 9999998742210000
Q ss_pred CCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCC
Q 007433 435 PLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPES 513 (604)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~ 513 (604)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.+......+..+....... ..
T Consensus 178 ----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~ 246 (280)
T cd05049 178 ----------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQ-RP 246 (280)
T ss_pred ----------eecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCC-CC
Confidence 000012246788999999999999999999999999999998 999998887777766666544332 23
Q ss_pred CCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 514 PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 514 ~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
..++..+++||.+||..||++||+ +.|+++
T Consensus 247 ~~~~~~~~~li~~~l~~~p~~Rp~----~~eil~ 276 (280)
T cd05049 247 RTCPSEVYDIMLGCWKRDPQQRIN----IKDIHE 276 (280)
T ss_pred CCCCHHHHHHHHHHcCCCcccCCC----HHHHHH
Confidence 458899999999999999999999 888875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=332.45 Aligned_cols=252 Identities=25% Similarity=0.338 Sum_probs=210.3
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
..++|++.+.||.|+||.||+|.+..+ ..||||.+...... ...+.+|+.++++++|+||+++++++..++..|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 78 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNT-TPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCC-eEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCeee
Confidence 456899999999999999999997654 57999999765332 2345679999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
||||+++++|.+++....+..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..+.....
T Consensus 79 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (261)
T cd05068 79 VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY 158 (261)
T ss_pred eeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence 99999999999998876556799999999999999999999999999999999999999999999999999854321000
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
.....
T Consensus 159 ---------------------------------------------------------------------------~~~~~ 163 (261)
T cd05068 159 ---------------------------------------------------------------------------EAREG 163 (261)
T ss_pred ---------------------------------------------------------------------------cccCC
Confidence 00001
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
..++..|+|||++.+..++.++|||||||++|||++ |+.||.+......+..+... ...+....++..+.+||.+||.
T Consensus 164 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~ 242 (261)
T cd05068 164 AKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMPCPPGCPKELYDIMLDCWK 242 (261)
T ss_pred CcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHHHHHhh
Confidence 123467999999999889999999999999999999 99999987776666655443 3344445688999999999999
Q ss_pred cCCCCcccccCCHHHHhc
Q 007433 530 KEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~ 547 (604)
.||.+||+ +.+|++
T Consensus 243 ~~P~~Rp~----~~~l~~ 256 (261)
T cd05068 243 EDPDDRPT----FETLQW 256 (261)
T ss_pred cCcccCCC----HHHHHH
Confidence 99999999 777754
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-40 Score=339.09 Aligned_cols=256 Identities=21% Similarity=0.328 Sum_probs=208.9
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEc----CCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCe
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELT----GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKF 287 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 287 (604)
..+|++.+.||+|+||+||+|.+. .++..||+|.+..... ......+.+|+++|+.++|+||+++++++..+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN--PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 468999999999999999999853 4557899999975432 2334466789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcC---------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC
Q 007433 288 SCLVMEFCPGGDLHTLRQRQP---------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG 352 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~---------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g 352 (604)
.|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 999999999999999885331 13578899999999999999999999999999999999999999
Q ss_pred cEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCC
Q 007433 353 HIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQ 432 (604)
Q Consensus 353 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (604)
.++|+|||++........
T Consensus 162 ~~kl~dfg~~~~~~~~~~-------------------------------------------------------------- 179 (283)
T cd05090 162 HVKISDLGLSREIYSADY-------------------------------------------------------------- 179 (283)
T ss_pred cEEeccccccccccCCcc--------------------------------------------------------------
Confidence 999999998844321000
Q ss_pred CCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCC
Q 007433 433 VSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFP 511 (604)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p 511 (604)
........++..|+|||++.+..++.++|||||||+||||++ |..||.+.........+... ..++
T Consensus 180 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~ 246 (283)
T cd05090 180 ------------YRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKR-QLLP 246 (283)
T ss_pred ------------eecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCC
Confidence 000112346778999999998889999999999999999998 99999887665555444433 3334
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 512 ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 512 ~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
....++..+.+||.+||..||++||+ +.+|+++
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rp~----~~~i~~~ 279 (283)
T cd05090 247 CSEDCPPRMYSLMTECWQEGPSRRPR----FKDIHTR 279 (283)
T ss_pred CCCCCCHHHHHHHHHHcccCcccCcC----HHHHHHH
Confidence 44568899999999999999999999 8888765
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=339.81 Aligned_cols=256 Identities=26% Similarity=0.461 Sum_probs=210.8
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC---CCCccccceeEecCCeeEE
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD---HPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~l 290 (604)
.|++++.||.|+||.||+|.+..++..||+|++..... ......+.+|+.+++.++ |+||+++++++..+...|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTP--DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCC--chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 58889999999999999999999999999999875422 123345668999999986 9999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
||||++|++|.+++... .+++..+..++.||+.||.|||+.||+||||+|+||+++.++.++|+|||++.......
T Consensus 80 v~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 155 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS- 155 (277)
T ss_pred EEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc-
Confidence 99999999999988653 68999999999999999999999999999999999999999999999999874332100
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
.....
T Consensus 156 ---------------------------------------------------------------------------~~~~~ 160 (277)
T cd06917 156 ---------------------------------------------------------------------------SKRST 160 (277)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00112
Q ss_pred cccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 451 FVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
..|+..|+|||++.+ ..++.++|+|||||++|+|++|..||.+.........+.............+.++.+||.+||.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 240 (277)
T cd06917 161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAACLD 240 (277)
T ss_pred ccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHHHcC
Confidence 358899999999875 4468899999999999999999999987765544433322211111112377899999999999
Q ss_pred cCCCCcccccCCHHHHhcCCCCCCC
Q 007433 530 KEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
.||++||+ +.+++.|+||+..
T Consensus 241 ~~p~~R~~----~~~il~~~~~~~~ 261 (277)
T cd06917 241 EEPKERLS----AEELLKSKWIKAH 261 (277)
T ss_pred CCcccCcC----HHHHhhChHhhcc
Confidence 99999999 9999999999754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=359.04 Aligned_cols=257 Identities=21% Similarity=0.304 Sum_probs=208.5
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCC-----ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEec
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGT-----KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFET 284 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~ 284 (604)
..++|.++++||.|+||.||+|.+... +..||||++...... .....+.+|+++|++++ ||||+++++++..
T Consensus 35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~ 112 (400)
T cd05105 35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS--SEKQALMSELKIMTHLGPHLNIVNLLGACTK 112 (400)
T ss_pred cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence 357899999999999999999987543 346999999754322 22345678999999996 9999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHhcC--------------------------------------------------------
Q 007433 285 DKFSCLVMEFCPGGDLHTLRQRQP-------------------------------------------------------- 308 (604)
Q Consensus 285 ~~~~~lV~E~~~ggsL~~ll~~~~-------------------------------------------------------- 308 (604)
....|||||||++|+|.+++....
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (400)
T cd05105 113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML 192 (400)
T ss_pred CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence 999999999999999998876531
Q ss_pred --------------------------------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc
Q 007433 309 --------------------------------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE 350 (604)
Q Consensus 309 --------------------------------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~ 350 (604)
...+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~ 272 (400)
T cd05105 193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence 124788889999999999999999999999999999999999
Q ss_pred CCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccC
Q 007433 351 DGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMG 430 (604)
Q Consensus 351 ~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (604)
++.+||+|||++..+.....
T Consensus 273 ~~~~kL~DfGla~~~~~~~~------------------------------------------------------------ 292 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSN------------------------------------------------------------ 292 (400)
T ss_pred CCEEEEEeCCcceecccccc------------------------------------------------------------
Confidence 99999999998843211000
Q ss_pred CCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCC
Q 007433 431 NQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLR 509 (604)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~ 509 (604)
........++..|+|||++.+..++.++|||||||+||||++ |..||........+...+.....
T Consensus 293 --------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~ 358 (400)
T cd05105 293 --------------YVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYR 358 (400)
T ss_pred --------------ccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCC
Confidence 000112347788999999999999999999999999999997 99999876555555555555445
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 510 FPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 510 ~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
.+....++.++.+||.+||..||++||+ +.+|.+
T Consensus 359 ~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~~l~~ 392 (400)
T cd05105 359 MAKPDHATQEVYDIMVKCWNSEPEKRPS----FLHLSD 392 (400)
T ss_pred CCCCccCCHHHHHHHHHHCccCHhHCcC----HHHHHH
Confidence 5555568899999999999999999999 666654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=342.67 Aligned_cols=256 Identities=29% Similarity=0.403 Sum_probs=214.2
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
+.|..++.||.|+||+||+|++..++..||+|++.............+.+|+++++.++|+||+++++++.++...|+||
T Consensus 21 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 21 EIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEE
Confidence 34788899999999999999999999999999997654333344456778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+ .++|.+++... ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++....
T Consensus 101 e~~-~~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~------ 172 (313)
T cd06633 101 EYC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS------ 172 (313)
T ss_pred ecC-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC------
Confidence 999 46787776654 2568999999999999999999999999999999999999999999999999762100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
......
T Consensus 173 --------------------------------------------------------------------------~~~~~~ 178 (313)
T cd06633 173 --------------------------------------------------------------------------PANSFV 178 (313)
T ss_pred --------------------------------------------------------------------------CCCCcc
Confidence 001235
Q ss_pred cCccccCcceec---CCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 453 GTHEYLAPEIIK---GEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 453 GT~~Y~APE~l~---~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
|+..|+|||++. ...++.++|||||||++|+|++|..||...+....+..+............++..+++||.+||.
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 258 (313)
T cd06633 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSFRGFVDYCLQ 258 (313)
T ss_pred ccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHHHHHHHHHcc
Confidence 888999999984 35578899999999999999999999988777676666654433222234567889999999999
Q ss_pred cCCCCcccccCCHHHHhcCCCCCCC
Q 007433 530 KEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
++|.+||+ +.++++||||+..
T Consensus 259 ~~P~~Rp~----~~~~l~~~~~~~~ 279 (313)
T cd06633 259 KIPQERPA----SAELLRHDFVRRD 279 (313)
T ss_pred CChhhCcC----HHHHhcCcccCCC
Confidence 99999999 9999999999753
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-40 Score=327.65 Aligned_cols=257 Identities=32% Similarity=0.476 Sum_probs=215.3
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC--CeeEEE
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD--KFSCLV 291 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~lV 291 (604)
+|++.+.||+|++|.||+|.+..++..|++|++...... ......+.+|++++++++|+||+++++.+... ...++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 588999999999999999999999999999999766432 33455677899999999999999999999988 899999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+++++|.+++.... .+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.+.........
T Consensus 80 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 157 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG 157 (260)
T ss_pred EEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence 99999999999988763 7999999999999999999999999999999999999999999999999987433211000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 158 --------------------------------------------------------------------------~~~~~~ 163 (260)
T cd06606 158 --------------------------------------------------------------------------EGTGSV 163 (260)
T ss_pred --------------------------------------------------------------------------ccccCC
Confidence 001123
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCC-hHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE-NRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~-~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
.++..|+|||.+.+..++.++||||||+++|+|++|..||.... ....+..+............++..+++||.+||..
T Consensus 164 ~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~ 243 (260)
T cd06606 164 RGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLRKCLRR 243 (260)
T ss_pred CCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHHHhCcC
Confidence 58889999999998889999999999999999999999998766 23333343321222222334689999999999999
Q ss_pred CCCCcccccCCHHHHhcCCCC
Q 007433 531 EPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~Hpff 551 (604)
||++||+ +.++++||||
T Consensus 244 ~p~~Rp~----~~~ll~~~~~ 260 (260)
T cd06606 244 DPKKRPT----ADELLQHPFL 260 (260)
T ss_pred ChhhCCC----HHHHhhCCCC
Confidence 9999999 9999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-40 Score=327.64 Aligned_cols=254 Identities=28% Similarity=0.490 Sum_probs=218.1
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
+|++.+.||.|++|.||++.+..+++.||+|.+...... ......+.+|++++++++|+||+++++++.+++..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 589999999999999999999999999999999876543 2344567889999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
|+++++|.+++... ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++........
T Consensus 80 ~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--- 154 (254)
T cd06627 80 YAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--- 154 (254)
T ss_pred cCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc---
Confidence 99999999998876 5799999999999999999999999999999999999999999999999998854321100
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
......|
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (254)
T cd06627 155 -------------------------------------------------------------------------DDASVVG 161 (254)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0112358
Q ss_pred CccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCC
Q 007433 454 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQ 533 (604)
Q Consensus 454 T~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~ 533 (604)
+..|+|||.+.+..++.++|||+||+++|+|++|..||........+..+.... .......++..++++|.+||..+|+
T Consensus 162 ~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~~p~ 240 (254)
T cd06627 162 TPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDD-HPPLPEGISPELKDFLMQCFQKDPN 240 (254)
T ss_pred chhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccC-CCCCCCCCCHHHHHHHHHHHhCChh
Confidence 889999999988888999999999999999999999998877666665554322 2223345789999999999999999
Q ss_pred CcccccCCHHHHhcCCCC
Q 007433 534 NRLACRRGATEIKQHPFF 551 (604)
Q Consensus 534 ~Rpt~~~~a~elL~Hpff 551 (604)
+||+ +.+++.||||
T Consensus 241 ~R~~----~~~~l~~~~~ 254 (254)
T cd06627 241 LRPT----AKQLLKHPWI 254 (254)
T ss_pred hCcC----HHHHhcCCCC
Confidence 9999 9999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=337.27 Aligned_cols=245 Identities=32% Similarity=0.503 Sum_probs=200.3
Q ss_pred cCeEEEEEE--ccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCeeE
Q 007433 213 GHFRLLKKL--GCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 213 ~~y~l~~~L--G~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~ 289 (604)
++|.+.+.+ |.|+||.||++.+..++..+|+|++....... .|+.+...+ +|+||+++++.|..++..|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 466676665 99999999999999999999999997643221 122222222 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC-cEEEecccccccccCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG-HIMLSDFDLSLRCAVS 368 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g-~vkL~DFGla~~~~~~ 368 (604)
+||||+++++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++ .++|+|||++.....
T Consensus 86 iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~- 162 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGT- 162 (267)
T ss_pred EEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCC-
Confidence 999999999999998775 3799999999999999999999999999999999999999988 999999998732210
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
.
T Consensus 163 -------------------------------------------------------------------------------~ 163 (267)
T PHA03390 163 -------------------------------------------------------------------------------P 163 (267)
T ss_pred -------------------------------------------------------------------------------C
Confidence 0
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHH----HHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRA----TLYNVVGQPLRFPESPVVSFSARDLI 524 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~----~l~~i~~~~~~~p~~~~~s~~l~dLI 524 (604)
....|+..|+|||++.+..++.++|||||||++|||++|+.||....... .+...... ..+....++..+++||
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li 241 (267)
T PHA03390 164 SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK--KLPFIKNVSKNANDFV 241 (267)
T ss_pred ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcc--cCCcccccCHHHHHHH
Confidence 12348889999999999899999999999999999999999998654332 12222222 2223346899999999
Q ss_pred HHhhhcCCCCcccccCCHHHHhcCCCCC
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
.+||..||.+|++. ++++|+||||.
T Consensus 242 ~~~l~~~p~~R~~~---~~~~l~h~~~~ 266 (267)
T PHA03390 242 QSMLKYNINYRLTN---YNEIIKHPFLK 266 (267)
T ss_pred HHHhccChhhCCch---HHHHhcCCccc
Confidence 99999999999961 59999999996
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=341.95 Aligned_cols=258 Identities=20% Similarity=0.312 Sum_probs=213.2
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEE-----cCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEe
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSEL-----TGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFE 283 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~ 283 (604)
+..++|.+.+.||.|+||.||++.+ ..++..||+|++...... .....+.+|+++++++ +|+||+++++++.
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS--SEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh--HHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 3457899999999999999999976 334568999998754321 2334567899999999 7999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccc
Q 007433 284 TDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 284 ~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
..+..|+||||+.+++|.+++.......+++..+..++.||+.||.|||+++|+|+||||+|||++.++.++|+|||++.
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999999999886544558999999999999999999999999999999999999999999999999874
Q ss_pred cccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCC
Q 007433 364 RCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEP 443 (604)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (604)
.+......
T Consensus 190 ~~~~~~~~------------------------------------------------------------------------ 197 (302)
T cd05055 190 DIMNDSNY------------------------------------------------------------------------ 197 (302)
T ss_pred cccCCCce------------------------------------------------------------------------
Confidence 32110000
Q ss_pred CCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 007433 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARD 522 (604)
Q Consensus 444 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~d 522 (604)
.......++..|+|||++.+..++.++|||||||++|||++ |..||......+.+.+..............+.++.+
T Consensus 198 --~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 275 (302)
T cd05055 198 --VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYD 275 (302)
T ss_pred --eecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence 00011236788999999999989999999999999999998 999998877666666666555444444567899999
Q ss_pred HHHHhhhcCCCCcccccCCHHHHhc
Q 007433 523 LIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 523 LI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
||.+||.++|++||+ +.|+++
T Consensus 276 li~~cl~~~p~~Rpt----~~ell~ 296 (302)
T cd05055 276 IMKTCWDADPLKRPT----FKQIVQ 296 (302)
T ss_pred HHHHHcCCCchhCcC----HHHHHH
Confidence 999999999999999 888875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=349.19 Aligned_cols=255 Identities=31% Similarity=0.446 Sum_probs=209.4
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC-----
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK----- 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----- 286 (604)
.++|++++.||.|+||.||+|.+..++..||||++.+... .......+.+|+++|+.++|+||++++++|..+.
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF 92 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence 3689999999999999999999999999999999865322 2223345678999999999999999999997653
Q ss_pred -eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 287 -FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 287 -~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
.+|+||||+ |++|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~ 168 (343)
T cd07880 93 HDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT 168 (343)
T ss_pred ceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence 468999999 8899988764 46899999999999999999999999999999999999999999999999987432
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
..
T Consensus 169 ~~------------------------------------------------------------------------------ 170 (343)
T cd07880 169 DS------------------------------------------------------------------------------ 170 (343)
T ss_pred cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred CcccccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC--------------
Q 007433 446 ARSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRF-------------- 510 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~-------------- 510 (604)
......+++.|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+....+..+.......
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07880 171 -EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAK 249 (343)
T ss_pred -CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHH
Confidence 0012357889999999876 457889999999999999999999998876655544433211100
Q ss_pred ------C---------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 511 ------P---------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 511 ------p---------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
+ ....++..+.++|.+||..||++||+ +.++++||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t----~~~~l~~~~~~~~ 304 (343)
T cd07880 250 NYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRIT----AAEALAHPYFEEF 304 (343)
T ss_pred HHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCC----HHHHhcCccHhhh
Confidence 0 11346788999999999999999999 9999999999865
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-40 Score=337.39 Aligned_cols=254 Identities=28% Similarity=0.433 Sum_probs=213.7
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
-|++++.||.|+||.||+|.+..++..||||++...... .....+.+|+.+++.++|+||++++++|..+...|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccch--HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 478899999999999999999989999999998654322 233466789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
|+++++|..++.. ..+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++..+...
T Consensus 83 ~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~----- 154 (277)
T cd06641 83 YLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT----- 154 (277)
T ss_pred eCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc-----
Confidence 9999999998865 35899999999999999999999999999999999999999999999999987432100
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
........|
T Consensus 155 -----------------------------------------------------------------------~~~~~~~~~ 163 (277)
T cd06641 155 -----------------------------------------------------------------------QIKRNTFVG 163 (277)
T ss_pred -----------------------------------------------------------------------hhhhccccC
Confidence 000112358
Q ss_pred CccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCC
Q 007433 454 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQ 533 (604)
Q Consensus 454 T~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~ 533 (604)
+..|+|||++.+..++.++|+|||||++|+|++|..||...........+...... .....++.++.++|.+||..+|.
T Consensus 164 ~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~p~ 242 (277)
T cd06641 164 TPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPP-TLEGNYSKPLKEFVEACLNKEPS 242 (277)
T ss_pred CccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCC-CCCcccCHHHHHHHHHHccCChh
Confidence 88999999998888899999999999999999999999876665555554333211 12234788999999999999999
Q ss_pred CcccccCCHHHHhcCCCCCC
Q 007433 534 NRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 534 ~Rpt~~~~a~elL~Hpff~~ 553 (604)
+||+ +.++++||||..
T Consensus 243 ~Rp~----~~~~l~~~~~~~ 258 (277)
T cd06641 243 FRPT----AKELLKHKFIVR 258 (277)
T ss_pred hCcC----HHHHHhCHHHhh
Confidence 9999 999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=336.78 Aligned_cols=263 Identities=30% Similarity=0.428 Sum_probs=207.5
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCce----EEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec-CC
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKC----YFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET-DK 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~ 286 (604)
+..|++++.||+|.||.||+|....++. .+|||.+....-. ...-..+-+|+.+++.|+||||+.|..+|.. +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~-tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDG-TGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCC-CCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 3579999999999999999997765542 6899988654111 0112345689999999999999999999987 89
Q ss_pred eeEEEEeecCCCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccC----CcEEEecc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQP---GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRED----GHIMLSDF 359 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~---~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~----g~vkL~DF 359 (604)
.++|++||. .-||..+++.+. .+.++...++.|+.||+.|+.|||++-|+||||||.||||..+ |.|||+||
T Consensus 102 ~v~l~fdYA-EhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYA-EHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhh-hhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 999999999 568888877532 3579999999999999999999999999999999999999988 89999999
Q ss_pred cccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccc
Q 007433 360 DLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPEL 439 (604)
Q Consensus 360 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (604)
|+++.+...-.-
T Consensus 181 GlaR~~~~plkp-------------------------------------------------------------------- 192 (438)
T KOG0666|consen 181 GLARLFNNPLKP-------------------------------------------------------------------- 192 (438)
T ss_pred cHHHHhhccccc--------------------------------------------------------------------
Confidence 999654321000
Q ss_pred ccCCCCCcccccccCccccCcceecCCC-CCccchHHHHHHHHHHHhhCCCCCCCCC------------hHHHHHHHHcC
Q 007433 440 IAEPTNARSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSE------------NRATLYNVVGQ 506 (604)
Q Consensus 440 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~PF~~~~------------~~~~l~~i~~~ 506 (604)
-......|-|.||+|||++.|.. |+.++|||++|||+.|||+-++.|.+.. ..+.++++++.
T Consensus 193 -----l~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~ 267 (438)
T KOG0666|consen 193 -----LASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGT 267 (438)
T ss_pred -----cccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCC
Confidence 00112457899999999999986 6889999999999999999999998742 23445555554
Q ss_pred CC--------CCCCC------------------------CCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 507 PL--------RFPES------------------------PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 507 ~~--------~~p~~------------------------~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
+- .+|+. ..-++...+|+.+||.+||.+|++ ++++|+|+||..
T Consensus 268 Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIt----a~qAleh~yF~~ 342 (438)
T KOG0666|consen 268 PTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRIT----AEQALEHPYFTE 342 (438)
T ss_pred CccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhcc----HHHHhccccccc
Confidence 31 11111 112344679999999999999999 999999999964
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=335.53 Aligned_cols=256 Identities=21% Similarity=0.286 Sum_probs=209.0
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCC-----ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGT-----KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD 285 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 285 (604)
..++|++.+.||.|+||.||+|.+... +..||+|.+...... .....+.+|+.+|+.++|+||+++++++..+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH--HHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 457899999999999999999998654 378999998655322 2233566899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcC--------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEe
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQP--------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLS 357 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~--------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~ 357 (604)
...|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 99999999999999999987532 1247888999999999999999999999999999999999999999999
Q ss_pred cccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCc
Q 007433 358 DFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLP 437 (604)
Q Consensus 358 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (604)
|||++.........
T Consensus 162 dfg~~~~~~~~~~~------------------------------------------------------------------ 175 (277)
T cd05032 162 DFGMTRDIYETDYY------------------------------------------------------------------ 175 (277)
T ss_pred CcccchhhccCccc------------------------------------------------------------------
Confidence 99987432210000
Q ss_pred ccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 007433 438 ELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVV 516 (604)
Q Consensus 438 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~ 516 (604)
.......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+....+..+.. .........+
T Consensus 176 --------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~ 246 (277)
T cd05032 176 --------RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID-GGHLDLPENC 246 (277)
T ss_pred --------ccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc-CCCCCCCCCC
Confidence 00112346788999999998889999999999999999998 9999988776665555553 2233333457
Q ss_pred CHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 517 SFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 517 s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
+..+.+||.+||..+|++||+ +.+|++
T Consensus 247 ~~~~~~li~~~l~~~p~~Rpt----~~~l~~ 273 (277)
T cd05032 247 PDKLLELMRMCWQYNPKMRPT----FLEIVS 273 (277)
T ss_pred CHHHHHHHHHHcCCChhhCCC----HHHHHH
Confidence 899999999999999999999 888875
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=343.97 Aligned_cols=254 Identities=22% Similarity=0.316 Sum_probs=206.0
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCce--EEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCe
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKC--YFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKF 287 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 287 (604)
..++|++.+.||.|+||.||+|.+..++. .+|+|.+.... .......+.+|+++|.++ +|+||+++++++..++.
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 45789999999999999999999877664 45777765432 123334567899999999 89999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCc
Q 007433 288 SCLVMEFCPGGDLHTLRQRQP--------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGH 353 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~--------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~ 353 (604)
+|+||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 999999999999999987542 236889999999999999999999999999999999999999999
Q ss_pred EEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCC
Q 007433 354 IMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQV 433 (604)
Q Consensus 354 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (604)
++|+|||++......
T Consensus 163 ~kl~dfg~~~~~~~~----------------------------------------------------------------- 177 (303)
T cd05088 163 AKIADFGLSRGQEVY----------------------------------------------------------------- 177 (303)
T ss_pred EEeCccccCcccchh-----------------------------------------------------------------
Confidence 999999987211000
Q ss_pred CCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCC
Q 007433 434 SPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPE 512 (604)
Q Consensus 434 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~ 512 (604)
.......++..|+|||++.+..++.++|||||||+||||++ |..||.+.+..+....+.. ......
T Consensus 178 ------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~~ 244 (303)
T cd05088 178 ------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLEK 244 (303)
T ss_pred ------------hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc-CCcCCC
Confidence 00001124567999999988889999999999999999998 9999987766655544433 233333
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 513 SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 513 ~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
...++.++.+||.+||..||++||+ +.+++++
T Consensus 245 ~~~~~~~~~~li~~~l~~~p~~Rp~----~~~il~~ 276 (303)
T cd05088 245 PLNCDDEVYDLMRQCWREKPYERPS----FAQILVS 276 (303)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 3457889999999999999999999 8888876
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-40 Score=330.69 Aligned_cols=254 Identities=26% Similarity=0.398 Sum_probs=207.7
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++.+.||.|+||.||+|.+..+++.||+|.+............++.+|+++++.++|+||++++++|..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 58999999999999999999999999999999987543333334556778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 293 EFCPGGDLHTLRQRQ--PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 293 E~~~ggsL~~ll~~~--~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
||+++++|..++... ....+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++.......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~- 160 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT- 160 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC-
Confidence 999999999988653 23568999999999999999999999999999999999999999999999999874321000
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
.....
T Consensus 161 ---------------------------------------------------------------------------~~~~~ 165 (267)
T cd08224 161 ---------------------------------------------------------------------------TAAHS 165 (267)
T ss_pred ---------------------------------------------------------------------------cccce
Confidence 00112
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCCh--HHHHHHHHcCCC-CCCCCCCCCHHHHHHHHHh
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSEN--RATLYNVVGQPL-RFPESPVVSFSARDLIKGL 527 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~--~~~l~~i~~~~~-~~p~~~~~s~~l~dLI~~l 527 (604)
..|+..|+|||++.+..++.++|||||||++|+|++|+.||..... ......+..... ..+ ...++..+.++|.+|
T Consensus 166 ~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~~c 244 (267)
T cd08224 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLP-ADHYSEELRDLVSRC 244 (267)
T ss_pred ecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCC-hhhcCHHHHHHHHHH
Confidence 3588899999999998899999999999999999999999965432 222223322211 112 125778999999999
Q ss_pred hhcCCCCcccccCCHHHHhc
Q 007433 528 LVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~ 547 (604)
|..+|++||+ +.+|++
T Consensus 245 l~~~p~~Rp~----~~~il~ 260 (267)
T cd08224 245 INPDPEKRPD----ISYVLQ 260 (267)
T ss_pred cCCCcccCCC----HHHHHH
Confidence 9999999999 777764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=348.40 Aligned_cols=258 Identities=25% Similarity=0.381 Sum_probs=207.4
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC-----Ce
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD-----KF 287 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~ 287 (604)
.+|++++.||.|+||+||+|++..+++.||||.+..... ......++.+|+.+|+.++|+||+++++++... ..
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 589999999999999999999999999999999875422 122234566899999999999999999988643 35
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccC
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAV 367 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~ 367 (604)
.|+||||+ +++|.+++... ..+++..++.++.||+.||.|||++|++||||||+|||++.++.++|+|||++.....
T Consensus 84 ~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 84 VYIVYELM-DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred EEEEEeCC-CCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 89999999 57898888764 5799999999999999999999999999999999999999999999999998743210
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
.. ..
T Consensus 161 ~~----------------------------------------------------------------------------~~ 164 (337)
T cd07858 161 KG----------------------------------------------------------------------------DF 164 (337)
T ss_pred Cc----------------------------------------------------------------------------cc
Confidence 00 00
Q ss_pred ccccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHH---cC-----------------
Q 007433 448 SMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV---GQ----------------- 506 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~---~~----------------- 506 (604)
.....|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+....+..+. +.
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (337)
T cd07858 165 MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRY 244 (337)
T ss_pred ccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHH
Confidence 112357889999998865 458899999999999999999999998764332222111 10
Q ss_pred ---CCCC------CCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 507 ---PLRF------PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 507 ---~~~~------p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
.... ...+.++.++.+||++||..||++||+ +.++|+||||..+
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps----~~ell~h~~~~~~ 297 (337)
T cd07858 245 IRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRIT----VEEALAHPYLASL 297 (337)
T ss_pred HHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccC----HHHHHcCcchhhh
Confidence 0000 012357888999999999999999999 9999999999765
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=363.96 Aligned_cols=255 Identities=26% Similarity=0.435 Sum_probs=214.3
Q ss_pred cCeE-EEEEEccCCcEEEEEEEEcCCceEEEEEEecchhH-HHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC--ee
Q 007433 213 GHFR-LLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASL-EKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK--FS 288 (604)
Q Consensus 213 ~~y~-l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--~~ 288 (604)
++|- ....||+|+|-+||+|.+..+|..||.-.+....+ .....+.++..|+++|+.|+|+||+++|.+|.+.. .+
T Consensus 39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~i 118 (632)
T KOG0584|consen 39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTI 118 (632)
T ss_pred CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCcee
Confidence 4443 34579999999999999999999999866654433 34456788899999999999999999999998654 58
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcC--eEeccCCCCcEEEcc-CCcEEEecccccccc
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLG--IVYRDLKPENVLVRE-DGHIMLSDFDLSLRC 365 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~g--IvHrDIKpeNILl~~-~g~vkL~DFGla~~~ 365 (604)
.+|+|++..|+|+.|++++ +.++...++.|++|||.||.|||++. |||||||.+||+|+. -|.|||+|+|||...
T Consensus 119 n~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~ 196 (632)
T KOG0584|consen 119 NFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLL 196 (632)
T ss_pred eeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHh
Confidence 8999999999999999998 67999999999999999999999986 999999999999985 689999999999432
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
. .
T Consensus 197 r------------------------------------------------------------------------------~ 198 (632)
T KOG0584|consen 197 R------------------------------------------------------------------------------K 198 (632)
T ss_pred h------------------------------------------------------------------------------c
Confidence 1 1
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHH-cCCCCCCCCCCCCHHHHHHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV-GQPLRFPESPVVSFSARDLI 524 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~-~~~~~~p~~~~~s~~l~dLI 524 (604)
+...+.+|||+|||||++. +.|+..+||||||+|++||+|+..||..-.+.+.+++.+ .+-..-.....-.+++++||
T Consensus 199 s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~kV~dPevr~fI 277 (632)
T KOG0584|consen 199 SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSKVKDPEVREFI 277 (632)
T ss_pred cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhccCCHHHHHHH
Confidence 1223468999999999988 789999999999999999999999998876666666544 44322223344578999999
Q ss_pred HHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
.+||.. ..+|++ +.|||+||||..
T Consensus 278 ekCl~~-~~~R~s----a~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 278 EKCLAT-KSERLS----AKELLKDPFFDE 301 (632)
T ss_pred HHHhcC-chhccC----HHHHhhChhhcc
Confidence 999999 889999 999999999975
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=394.01 Aligned_cols=259 Identities=31% Similarity=0.538 Sum_probs=221.0
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
+|.-..+||.|.||.||-|.+..+|...|+|.+...... .+.+..+.+|..+|..|+|||||++|++-.+++..+|.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 677778899999999999999999999999999765443 4555667789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
||.||+|.++++.. ...+|...+.|..|++.||.|||++|||||||||+||||+.+|.+|++|||.|..+...-
T Consensus 1315 yC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~---- 1388 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNA---- 1388 (1509)
T ss_pred HhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCch----
Confidence 99999999999875 678899999999999999999999999999999999999999999999999986543210
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
+..+..-...+|
T Consensus 1389 --------------------------------------------------------------------~~~~~el~~~~G 1400 (1509)
T KOG4645|consen 1389 --------------------------------------------------------------------QTMPGELQSMMG 1400 (1509)
T ss_pred --------------------------------------------------------------------hcCCHHHHhhcC
Confidence 000111235689
Q ss_pred CccccCcceecC---CCCCccchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHH-cCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 454 THEYLAPEIIKG---EGHGSAVDWWTFGIFLYELLFGKTPFKGSENR-ATLYNVV-GQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 454 T~~Y~APE~l~~---~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~-~~l~~i~-~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
|+.|||||++.+ .+++.+.|||||||++.||+||+.||...++. ++++++- +..+.+|+. ++.+.+|||.+||
T Consensus 1401 T~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~--ls~~g~dFle~Cl 1478 (1509)
T KOG4645|consen 1401 TPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPER--LSSEGRDFLEHCL 1478 (1509)
T ss_pred CchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchh--hhHhHHHHHHHHH
Confidence 999999999965 56888999999999999999999999886655 4444443 344566665 9999999999999
Q ss_pred hcCCCCcccccCCHHHHhcCCCCCC
Q 007433 529 VKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 529 ~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
..||++|++ +.|||.|.|-+.
T Consensus 1479 ~~dP~~Rw~----~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1479 EQDPKMRWT----ASQLLEHAFGKS 1499 (1509)
T ss_pred hcCchhhhH----HHHHHHhhcccc
Confidence 999999999 999999998753
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=337.32 Aligned_cols=254 Identities=23% Similarity=0.328 Sum_probs=209.0
Q ss_pred ecCeEEEEEEccCCcEEEEEEEE-----cCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSEL-----TGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
..+|.+.+.||.|+||.||++.+ ..++..+|+|.+..... .....+.+|+++|++++|+||+++++++..++
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD---NARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 35899999999999999999986 34556799999876532 23345678999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcC-----------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEE
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQP-----------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIM 355 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~-----------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vk 355 (604)
..|+||||+++++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 9999999999999999987542 13589999999999999999999999999999999999999999999
Q ss_pred EecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCC
Q 007433 356 LSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSP 435 (604)
Q Consensus 356 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (604)
|+|||++..+.....
T Consensus 161 l~dfg~~~~~~~~~~----------------------------------------------------------------- 175 (288)
T cd05093 161 IGDFGMSRDVYSTDY----------------------------------------------------------------- 175 (288)
T ss_pred eccCCccccccCCce-----------------------------------------------------------------
Confidence 999998743211000
Q ss_pred CcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCC
Q 007433 436 LPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESP 514 (604)
Q Consensus 436 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~ 514 (604)
........++..|+|||++.+..++.++|||||||++|||++ |..||......+.+..+...... ....
T Consensus 176 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~-~~~~ 245 (288)
T cd05093 176 ---------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVL-QRPR 245 (288)
T ss_pred ---------eecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcC-CCCC
Confidence 000012246788999999999999999999999999999998 99999888777777666654322 2234
Q ss_pred CCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 515 VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 515 ~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
.++.++.+||.+||..||.+||+ +.+++.
T Consensus 246 ~~~~~l~~li~~~l~~~p~~Rpt----~~~v~~ 274 (288)
T cd05093 246 TCPKEVYDLMLGCWQREPHMRLN----IKEIHS 274 (288)
T ss_pred CCCHHHHHHHHHHccCChhhCCC----HHHHHH
Confidence 57889999999999999999999 777743
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=324.98 Aligned_cols=258 Identities=27% Similarity=0.408 Sum_probs=215.5
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCeeEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~l 290 (604)
.++.+.+..||.|..|.||+++.+.++...|||.|.+.... +...+++..+.++-.. +.|+||+.+|+|..+..+++
T Consensus 91 indl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk--ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~I 168 (391)
T KOG0983|consen 91 INDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFI 168 (391)
T ss_pred hHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCH--HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHH
Confidence 34566778899999999999999999999999999887543 3445666777765554 58999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH-cCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM-LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
.||.| +.-+..++++. .+.++|..+-++..-++.||.||.+ +||+|||+||+||||++.|++||||||++-++..+.
T Consensus 169 cMelM-s~C~ekLlkri-k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk 246 (391)
T KOG0983|consen 169 CMELM-STCAEKLLKRI-KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK 246 (391)
T ss_pred HHHHH-HHHHHHHHHHh-cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence 99998 66677777665 3679999999999999999999986 689999999999999999999999999985543221
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
.. +
T Consensus 247 Ah-----------------------------------------------------------------------------t 249 (391)
T KOG0983|consen 247 AH-----------------------------------------------------------------------------T 249 (391)
T ss_pred cc-----------------------------------------------------------------------------c
Confidence 11 1
Q ss_pred ccccCccccCcceecCC---CCCccchHHHHHHHHHHHhhCCCCCCCC-ChHHHHHHHHcC-CCCCCCCCCCCHHHHHHH
Q 007433 450 SFVGTHEYLAPEIIKGE---GHGSAVDWWTFGIFLYELLFGKTPFKGS-ENRATLYNVVGQ-PLRFPESPVVSFSARDLI 524 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~---~~~~~~DiWSLGviL~eLltG~~PF~~~-~~~~~l~~i~~~-~~~~p~~~~~s~~l~dLI 524 (604)
...|-+.|||||.+.-. .|+.++|||||||.|+||.||..||.+. .+.+.+.++.+. +..++....+|..+++|+
T Consensus 250 rsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~~fv 329 (391)
T KOG0983|consen 250 RSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQSFV 329 (391)
T ss_pred cccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHHHHH
Confidence 22488999999998654 5888999999999999999999999984 456677777654 556666667999999999
Q ss_pred HHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
..||.+|+.+||. ..+||+|||+...
T Consensus 330 ~~CL~kd~r~RP~----Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 330 KDCLTKDHRKRPK----YNKLLEHPFIKRY 355 (391)
T ss_pred HHHhhcCcccCcc----hHHHhcCcceeec
Confidence 9999999999999 8999999999654
|
|
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=324.69 Aligned_cols=252 Identities=32% Similarity=0.530 Sum_probs=214.6
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
+|.+.+.||.|++|.||++.+..++..|++|++..... .....+.+|+++++.++|+||+++++++..+...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 58899999999999999999998899999999977643 234466789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
|+++++|.+++.... ..+++..+..++.|++.||.|||.+|++||||+|+||+++.++.++|+|||++.......
T Consensus 78 ~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~---- 152 (253)
T cd05122 78 FCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTK---- 152 (253)
T ss_pred cCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccc----
Confidence 999999999987753 578999999999999999999999999999999999999999999999999874321100
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
......|
T Consensus 153 -------------------------------------------------------------------------~~~~~~~ 159 (253)
T cd05122 153 -------------------------------------------------------------------------ARNTMVG 159 (253)
T ss_pred -------------------------------------------------------------------------cccceec
Confidence 0113458
Q ss_pred CccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHHhhhcCC
Q 007433 454 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG-QPLRFPESPVVSFSARDLIKGLLVKEP 532 (604)
Q Consensus 454 T~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~-~~~~~p~~~~~s~~l~dLI~~lL~~dP 532 (604)
+..|++||++.+..++.++|+||||+++|+|++|+.||...+....+..+.. ....++....++..+.+||.+||..||
T Consensus 160 ~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p 239 (253)
T cd05122 160 TPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKKCLQKNP 239 (253)
T ss_pred CCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHHHccCCh
Confidence 8899999999988889999999999999999999999988755555444433 223333333358899999999999999
Q ss_pred CCcccccCCHHHHhcCCC
Q 007433 533 QNRLACRRGATEIKQHPF 550 (604)
Q Consensus 533 ~~Rpt~~~~a~elL~Hpf 550 (604)
++||+ +.++++|||
T Consensus 240 ~~R~t----~~~~l~~~~ 253 (253)
T cd05122 240 EKRPT----AEQLLKHPF 253 (253)
T ss_pred hhCCC----HHHHhcCCC
Confidence 99999 999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=346.98 Aligned_cols=260 Identities=27% Similarity=0.389 Sum_probs=212.8
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC-----ee
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK-----FS 288 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-----~~ 288 (604)
+|++.+.||.|+||.||+|++..++..||||.+..... .......+.+|+.+++.++|+||+++++++.... .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 68999999999999999999999899999999876431 1233446778999999999999999999998765 88
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|+||||++ ++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 80 ~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~ 156 (330)
T cd07834 80 YIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD 156 (330)
T ss_pred EEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence 99999995 6898888765 47999999999999999999999999999999999999999999999999988543211
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
... ....
T Consensus 157 ~~~-------------------------------------------------------------------------~~~~ 163 (330)
T cd07834 157 EDE-------------------------------------------------------------------------KGFL 163 (330)
T ss_pred ccc-------------------------------------------------------------------------cccc
Confidence 000 0001
Q ss_pred cccccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC-----------------
Q 007433 449 MSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRF----------------- 510 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~----------------- 510 (604)
....||+.|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+..+.+..+.......
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~ 243 (330)
T cd07834 164 TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYL 243 (330)
T ss_pred cccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHH
Confidence 123588999999999888 78999999999999999999999998877655544433210000
Q ss_pred ---------C---CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 511 ---------P---ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 511 ---------p---~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
+ ..+.++..+.+||.+||.+||++||+ +.++++||||+++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~~~~~~~~ 295 (330)
T cd07834 244 KSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRIT----ADEALAHPYLAQL 295 (330)
T ss_pred hhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCC----HHHHHhCccHHhh
Confidence 0 01236788999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=378.60 Aligned_cols=268 Identities=21% Similarity=0.322 Sum_probs=208.1
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|+++++||+|+||.||+|.+..+++.||||++............++.+|+++++.++||||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 68999999999999999999999999999999997653333334456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcC---------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccc
Q 007433 293 EFCPGGDLHTLRQRQP---------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~---------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
||++|++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.++|+|||++.
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 9999999999886421 1245667788999999999999999999999999999999999999999999985
Q ss_pred cccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCC
Q 007433 364 RCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEP 443 (604)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (604)
............. .. ....| ..
T Consensus 162 ~i~~~~~~~~~l~-----------~~----------------~~~s~-------------------------------~s 183 (932)
T PRK13184 162 FKKLEEEDLLDID-----------VD----------------ERNIC-------------------------------YS 183 (932)
T ss_pred ecccccccccccc-----------cc----------------ccccc-------------------------------cc
Confidence 5421110000000 00 00000 00
Q ss_pred CCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHH-HHcCCCCCCCCCCCCHHHHH
Q 007433 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN-VVGQPLRFPESPVVSFSARD 522 (604)
Q Consensus 444 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~-i~~~~~~~p~~~~~s~~l~d 522 (604)
........+||+.|||||++.+..++.++|||||||++|||++|+.||........... ....+........++..+.+
T Consensus 184 ~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~ 263 (932)
T PRK13184 184 SMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQ 263 (932)
T ss_pred ccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhccccccCCHHHHH
Confidence 00112245799999999999999999999999999999999999999987554433322 22222223333457889999
Q ss_pred HHHHhhhcCCCCcccc
Q 007433 523 LIKGLLVKEPQNRLAC 538 (604)
Q Consensus 523 LI~~lL~~dP~~Rpt~ 538 (604)
++.+||..||++|++.
T Consensus 264 LI~rcL~~DP~kR~ss 279 (932)
T PRK13184 264 IAMKALAVDPAERYSS 279 (932)
T ss_pred HHHHHccCChhhCcCH
Confidence 9999999999999883
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=332.76 Aligned_cols=250 Identities=26% Similarity=0.366 Sum_probs=206.4
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++.++||+|+||.||+|.+..+. .||+|++....... ..+.+|+++++.++|+||+++++++.. ...|+|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~~~----~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv 78 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 78 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCccCH----HHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEE
Confidence 468999999999999999999987765 59999997643321 245679999999999999999998754 567999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+++++|.+++....+..+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||++..+.....
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~- 157 (262)
T cd05071 79 TEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY- 157 (262)
T ss_pred EEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc-
Confidence 9999999999999876556789999999999999999999999999999999999999999999999998843321100
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 158 --------------------------------------------------------------------------~~~~~~ 163 (262)
T cd05071 158 --------------------------------------------------------------------------TARQGA 163 (262)
T ss_pred --------------------------------------------------------------------------ccccCC
Confidence 000012
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
.++..|+|||++.+..++.++|||||||++|||++ |..||.+......+..+... ...+....++..+.+||.+||..
T Consensus 164 ~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~ 242 (262)
T cd05071 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHDLMCQCWRK 242 (262)
T ss_pred cccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcC-CCCCCccccCHHHHHHHHHHccC
Confidence 36778999999988889999999999999999999 89999887776666555433 23344456889999999999999
Q ss_pred CCCCcccccCCHHHHhc
Q 007433 531 EPQNRLACRRGATEIKQ 547 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~ 547 (604)
||++||+ +.++++
T Consensus 243 ~p~~Rp~----~~~~~~ 255 (262)
T cd05071 243 EPEERPT----FEYLQA 255 (262)
T ss_pred CcccCCC----HHHHHH
Confidence 9999999 776653
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=338.50 Aligned_cols=258 Identities=21% Similarity=0.329 Sum_probs=210.3
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCC-----ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEe
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGT-----KCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFE 283 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~ 283 (604)
+..++|++.+.||+|+||.||++.+... ...||+|.+...... .....+.+|+++++.+ +|+||+++++++.
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 86 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGVCT 86 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCH--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEc
Confidence 3457899999999999999999988644 378999999764322 2334577899999999 8999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHhc--------------CCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEc
Q 007433 284 TDKFSCLVMEFCPGGDLHTLRQRQ--------------PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVR 349 (604)
Q Consensus 284 ~~~~~~lV~E~~~ggsL~~ll~~~--------------~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~ 349 (604)
.++.+|+||||+++++|..++... ....+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 87 ~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~ 166 (293)
T cd05053 87 QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166 (293)
T ss_pred CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEc
Confidence 999999999999999999998652 245789999999999999999999999999999999999999
Q ss_pred cCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCcccc
Q 007433 350 EDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEM 429 (604)
Q Consensus 350 ~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (604)
.++.++|+|||++..+......
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~---------------------------------------------------------- 188 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYY---------------------------------------------------------- 188 (293)
T ss_pred CCCeEEeCccccccccccccce----------------------------------------------------------
Confidence 9999999999988432210000
Q ss_pred CCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCC
Q 007433 430 GNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPL 508 (604)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~ 508 (604)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+.. ..
T Consensus 189 ----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~-~~ 251 (293)
T cd05053 189 ----------------RKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKE-GY 251 (293)
T ss_pred ----------------eccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHc-CC
Confidence 00001124567999999999899999999999999999997 9999988766555544443 33
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 509 RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 509 ~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
........+..+.+||.+||..||++||+ +.|++++
T Consensus 252 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~eil~~ 287 (293)
T cd05053 252 RMEKPQNCTQELYHLMRDCWHEVPSQRPT----FKQLVED 287 (293)
T ss_pred cCCCCCCCCHHHHHHHHHHcccCcccCcC----HHHHHHH
Confidence 33444467889999999999999999999 8888875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=339.52 Aligned_cols=268 Identities=26% Similarity=0.406 Sum_probs=206.3
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC------
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD------ 285 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------ 285 (604)
.++|++++.||.|+||.||+|.+..+++.||||++....... .......+|+++|+.++|+||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 579999999999999999999999999999999986543211 1122345799999999999999999987543
Q ss_pred --CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccc
Q 007433 286 --KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 286 --~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
..+|+||||+ +++|...+... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.
T Consensus 86 ~~~~~~lv~~~~-~~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~ 163 (311)
T cd07866 86 KRGSVYMVTPYM-DHDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLAR 163 (311)
T ss_pred cCceEEEEEecC-CcCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccch
Confidence 3579999999 45777766543 3579999999999999999999999999999999999999999999999999885
Q ss_pred cccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCC
Q 007433 364 RCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEP 443 (604)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (604)
............ ...
T Consensus 164 ~~~~~~~~~~~~-----------------------------------------------------------------~~~ 178 (311)
T cd07866 164 PYDGPPPNPKGG-----------------------------------------------------------------GGG 178 (311)
T ss_pred hccCCCcccccC-----------------------------------------------------------------Ccc
Confidence 432111000000 000
Q ss_pred CCCcccccccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc---CCC--CC------C
Q 007433 444 TNARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG---QPL--RF------P 511 (604)
Q Consensus 444 ~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~---~~~--~~------p 511 (604)
........+|++.|+|||++.+. .++.++|||||||++|||++|++||.+.+....+..+.. .+. .+ +
T Consensus 179 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (311)
T cd07866 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLP 258 (311)
T ss_pred cccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcc
Confidence 00112245789999999988764 478899999999999999999999988776555444332 110 00 0
Q ss_pred -----------------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 512 -----------------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 512 -----------------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
.....+..+.+||.+||..||.+||+ +.|++.||||
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t----~~ell~~~~f 311 (311)
T cd07866 259 GCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLT----ASDALEHPYF 311 (311)
T ss_pred cccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcC----HHHHhcCCCC
Confidence 00224467889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-40 Score=331.36 Aligned_cols=251 Identities=22% Similarity=0.326 Sum_probs=207.6
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++++.||+|+||+||++++.+.. .+|+|.+....... ..+.+|+.+++.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~-~~aik~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQY-DVAIKMIKEGSMSE----DEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCC-cEEEEEcCCCcccH----HHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 358999999999999999999886543 69999987553322 3456799999999999999999999988899999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+.+++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.+||+|||++........
T Consensus 78 ~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~- 155 (256)
T cd05113 78 TEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY- 155 (256)
T ss_pred EEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-
Confidence 99999999999987653 3789999999999999999999999999999999999999999999999998743211000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 156 --------------------------------------------------------------------------~~~~~~ 161 (256)
T cd05113 156 --------------------------------------------------------------------------TSSVGS 161 (256)
T ss_pred --------------------------------------------------------------------------eecCCC
Confidence 000112
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
.++..|+|||++.+..++.++|||||||++|||++ |..||......+....+.... ........+..++++|.+||..
T Consensus 162 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~ 240 (256)
T cd05113 162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGL-RLYRPHLASEKVYAIMYSCWHE 240 (256)
T ss_pred ccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCC
Confidence 36678999999998889999999999999999998 999998877666655555432 2233345788999999999999
Q ss_pred CCCCcccccCCHHHHhcC
Q 007433 531 EPQNRLACRRGATEIKQH 548 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~H 548 (604)
||.+||+ +.+|+.+
T Consensus 241 ~p~~Rp~----~~~ll~~ 254 (256)
T cd05113 241 KAEERPT----FQQLLSS 254 (256)
T ss_pred CcccCCC----HHHHHHh
Confidence 9999999 8888864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=347.55 Aligned_cols=262 Identities=26% Similarity=0.415 Sum_probs=208.8
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec----CCee
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET----DKFS 288 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~ 288 (604)
++|.+.+.||.|+||.||+|.+..++..||+|++..... .......+.+|+.+|+.++|+||++++++|.. ...+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 689999999999999999999999999999999875422 12234456679999999999999999998863 4578
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|+||||+ +++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus 84 ~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 84 YVVMDLM-ESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred EEEEehh-hhhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 9999999 56898888654 45999999999999999999999999999999999999999999999999987432211
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
... .....
T Consensus 161 ~~~------------------------------------------------------------------------~~~~~ 168 (334)
T cd07855 161 PTE------------------------------------------------------------------------HKYFM 168 (334)
T ss_pred CcC------------------------------------------------------------------------CCccc
Confidence 000 00001
Q ss_pred cccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc---CC-----------------
Q 007433 449 MSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG---QP----------------- 507 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~---~~----------------- 507 (604)
...+|+..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..+.. .+
T Consensus 169 ~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~ 248 (334)
T cd07855 169 TEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYI 248 (334)
T ss_pred ccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHH
Confidence 13468999999999866 4578999999999999999999999987654433322111 00
Q ss_pred ------CCCC---CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 508 ------LRFP---ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 508 ------~~~p---~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
...+ ..+..+.++++||++||..||.+||+ +.++++||||+..
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~~l~~~~~~~~ 300 (334)
T cd07855 249 QNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERIT----VEQALQHPFLAQY 300 (334)
T ss_pred hhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcC----HHHHHhChhhhhc
Confidence 0000 01346889999999999999999999 9999999999754
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=329.82 Aligned_cols=247 Identities=23% Similarity=0.329 Sum_probs=201.2
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCCC
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGG 298 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 298 (604)
+.||.|+||.||+|.+..+++.||+|.+..... ......+.+|+++|+.++|+||+++++++......|+||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP--PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 368999999999999999999999999865422 223345678999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCccc
Q 007433 299 DLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLE 378 (604)
Q Consensus 299 sL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 378 (604)
+|.+++... +..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 79 ~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-------- 149 (252)
T cd05084 79 DFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY-------- 149 (252)
T ss_pred cHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccc--------
Confidence 999998754 34689999999999999999999999999999999999999999999999998743210000
Q ss_pred CCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCcccc
Q 007433 379 SEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYL 458 (604)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~ 458 (604)
........++..|+
T Consensus 150 ------------------------------------------------------------------~~~~~~~~~~~~y~ 163 (252)
T cd05084 150 ------------------------------------------------------------------ASTGGMKQIPVKWT 163 (252)
T ss_pred ------------------------------------------------------------------cccCCCCCCceeec
Confidence 00000011346799
Q ss_pred CcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCccc
Q 007433 459 APEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLA 537 (604)
Q Consensus 459 APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt 537 (604)
|||.+.+..++.++|||||||++|||++ |..||...........+.. ....+....++..+.+||.+||..||++||+
T Consensus 164 aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 242 (252)
T cd05084 164 APEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-GVRLPCPELCPDAVYRLMERCWEYDPGQRPS 242 (252)
T ss_pred CchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc-CCCCCCcccCCHHHHHHHHHHcCCChhhCcC
Confidence 9999998889999999999999999997 9999987666554444433 2333444457899999999999999999999
Q ss_pred ccCCHHHHhc
Q 007433 538 CRRGATEIKQ 547 (604)
Q Consensus 538 ~~~~a~elL~ 547 (604)
+.++++
T Consensus 243 ----~~~~~~ 248 (252)
T cd05084 243 ----FSTVHQ 248 (252)
T ss_pred ----HHHHHH
Confidence 888764
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=337.04 Aligned_cols=260 Identities=28% Similarity=0.446 Sum_probs=220.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.+.|++.+.||.|+||.||++.+..++..||+|++..... ....+.+|+++|+.++|+||+++++.+..+...|+|
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 4679999999999999999999998888999999976533 334566799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+++++|.+++.... ..+++..+..++.|++.||.|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus 94 ~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~-- 170 (286)
T cd06614 94 MEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK-- 170 (286)
T ss_pred EeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch--
Confidence 99999999999998763 479999999999999999999999999999999999999999999999999873221000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 171 --------------------------------------------------------------------------~~~~~~ 176 (286)
T cd06614 171 --------------------------------------------------------------------------SKRNSV 176 (286)
T ss_pred --------------------------------------------------------------------------hhhccc
Confidence 001123
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-CCCCCCCCCCHHHHHHHHHhhhc
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP-LRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~-~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
.|+..|++||++.+..++.++|+|||||++|+|++|+.||...........+.... ..+.....++..+++||.+||..
T Consensus 177 ~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 256 (286)
T cd06614 177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDFLNKCLVK 256 (286)
T ss_pred cCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHHHHHHHHhcc
Confidence 47889999999998889999999999999999999999998877665555554332 23333334788999999999999
Q ss_pred CCCCcccccCCHHHHhcCCCCCCCCh
Q 007433 531 EPQNRLACRRGATEIKQHPFFQGVNW 556 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~Hpff~~~~~ 556 (604)
+|.+||+ +.++++|+||....|
T Consensus 257 ~p~~Rpt----~~~il~~~~~~~~~~ 278 (286)
T cd06614 257 DPEKRPS----AEELLQHPFLKKACP 278 (286)
T ss_pred ChhhCcC----HHHHhhChHhhccCc
Confidence 9999999 999999999987443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=334.79 Aligned_cols=256 Identities=20% Similarity=0.305 Sum_probs=208.3
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcC-----CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTG-----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+....... ....+.+|+.+++.++|+||+++++++.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQ--DESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 4689999999999999999999987 77899999986543221 2234667999999999999999999999988
Q ss_pred eeEEEEeecCCCCHHHHHHhcCC-----CCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC---cEEEec
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPG-----KYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG---HIMLSD 358 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~-----~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g---~vkL~D 358 (604)
..|+||||++|++|.+++..... ..+++..+..++.||+.||+|||++|++||||||+|||++.++ .++|+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 99999999999999999876531 2589999999999999999999999999999999999998755 599999
Q ss_pred ccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcc
Q 007433 359 FDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPE 438 (604)
Q Consensus 359 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (604)
||++..+......
T Consensus 163 fg~~~~~~~~~~~------------------------------------------------------------------- 175 (277)
T cd05036 163 FGMARDIYRASYY------------------------------------------------------------------- 175 (277)
T ss_pred CccccccCCccce-------------------------------------------------------------------
Confidence 9988543110000
Q ss_pred cccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 007433 439 LIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVS 517 (604)
Q Consensus 439 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s 517 (604)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+......+..+... ........++
T Consensus 176 -------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~ 247 (277)
T cd05036 176 -------RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-GRLDPPKGCP 247 (277)
T ss_pred -------ecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCC
Confidence 00001124567999999998889999999999999999996 99999987766555444432 2233334578
Q ss_pred HHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 518 FSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 518 ~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
..+.+||.+||..||++||+ +.+|++|
T Consensus 248 ~~~~~~i~~cl~~~p~~Rps----~~~vl~~ 274 (277)
T cd05036 248 GPVYRIMTDCWQHTPEDRPN----FATILER 274 (277)
T ss_pred HHHHHHHHHHcCCCcccCcC----HHHHHHH
Confidence 99999999999999999999 9999987
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=331.90 Aligned_cols=255 Identities=23% Similarity=0.315 Sum_probs=209.2
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCc---eEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCee
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTK---CYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 288 (604)
.++|++.+.||+|+||.||+|++..++ ..+|+|.+...... .....+.+|+.+|+.++||||+++++++.+++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTE--KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCH--HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 468999999999999999999886443 47999998764322 2234567899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999987653 46899999999999999999999999999999999999999999999999987433211
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
.... ...
T Consensus 160 ~~~~-------------------------------------------------------------------------~~~ 166 (267)
T cd05066 160 PEAA-------------------------------------------------------------------------YTT 166 (267)
T ss_pred ccee-------------------------------------------------------------------------eec
Confidence 0000 000
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGL 527 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~l 527 (604)
....++..|+|||++.+..++.++|+|||||++|||++ |..||......+.+..+... ...+....++..+.+|+.+|
T Consensus 167 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~ 245 (267)
T cd05066 167 RGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLPAPMDCPAALHQLMLDC 245 (267)
T ss_pred CCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCC-CcCCCCCCCCHHHHHHHHHH
Confidence 01224568999999999889999999999999999886 99999887766655555443 44555556889999999999
Q ss_pred hhcCCCCcccccCCHHHHhc
Q 007433 528 LVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~ 547 (604)
|.++|.+||+ +.++++
T Consensus 246 l~~~p~~Rp~----~~~i~~ 261 (267)
T cd05066 246 WQKDRNERPK----FEQIVS 261 (267)
T ss_pred cccCchhCCC----HHHHHH
Confidence 9999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-40 Score=341.96 Aligned_cols=255 Identities=28% Similarity=0.402 Sum_probs=215.4
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
..|...+.||+|+||.||++++..++..||+|++.............+.+|+++|+.++|+||+++++++..+...|+||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 35888999999999999999999999999999997654333344556778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+. |+|.+++... ...+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++.....
T Consensus 105 e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~----- 177 (317)
T cd06635 105 EYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP----- 177 (317)
T ss_pred eCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence 9995 5787776544 35689999999999999999999999999999999999999999999999998632100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.....
T Consensus 178 ---------------------------------------------------------------------------~~~~~ 182 (317)
T cd06635 178 ---------------------------------------------------------------------------ANSFV 182 (317)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 01235
Q ss_pred cCccccCcceec---CCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 453 GTHEYLAPEIIK---GEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 453 GT~~Y~APE~l~---~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
|++.|+|||++. ...++.++|||||||++|||++|..||........+..+............++..+++||.+||.
T Consensus 183 ~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 262 (317)
T cd06635 183 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFVDSCLQ 262 (317)
T ss_pred CCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHHHHHHHcc
Confidence 888999999974 34578899999999999999999999988877777777765544333344578899999999999
Q ss_pred cCCCCcccccCCHHHHhcCCCCCC
Q 007433 530 KEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
.+|.+||+ +.++++|+|+..
T Consensus 263 ~~p~~Rpt----~~~il~~~~~~~ 282 (317)
T cd06635 263 KIPQDRPT----SEELLKHMFVLR 282 (317)
T ss_pred CCcccCcC----HHHHHhChhhhc
Confidence 99999999 999999999953
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=346.04 Aligned_cols=257 Identities=25% Similarity=0.395 Sum_probs=204.5
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC-------
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD------- 285 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------- 285 (604)
++|++.+.||.|+||.||+|.+..++..||+|.+..... .....+.+|+++|+.++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 689999999999999999999999999999999866533 2334566799999999999999999877643
Q ss_pred -------CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc-CCcEEEe
Q 007433 286 -------KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE-DGHIMLS 357 (604)
Q Consensus 286 -------~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~-~g~vkL~ 357 (604)
...|+||||+. ++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.++|+
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~ 157 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG 157 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence 35799999995 689887754 35899999999999999999999999999999999999974 5678999
Q ss_pred cccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCc
Q 007433 358 DFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLP 437 (604)
Q Consensus 358 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (604)
|||++........
T Consensus 158 dfg~~~~~~~~~~------------------------------------------------------------------- 170 (342)
T cd07854 158 DFGLARIVDPHYS------------------------------------------------------------------- 170 (342)
T ss_pred CcccceecCCccc-------------------------------------------------------------------
Confidence 9998743210000
Q ss_pred ccccCCCCCcccccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC---------
Q 007433 438 ELIAEPTNARSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP--------- 507 (604)
Q Consensus 438 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~--------- 507 (604)
........+|+..|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+..+....
T Consensus 171 ------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (342)
T cd07854 171 ------HKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRN 244 (342)
T ss_pred ------cccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence 0000011257889999998754 557889999999999999999999998776555544433211
Q ss_pred ----------------CCCC---CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 508 ----------------LRFP---ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 508 ----------------~~~p---~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
...+ ....++.++++||.+||..||++||+ +.++|+||||+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~ell~h~~~~~ 305 (342)
T cd07854 245 ELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT----AEEALMHPYMSC 305 (342)
T ss_pred hhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccC----HHHHhCCCcccc
Confidence 0000 01246788999999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=333.78 Aligned_cols=254 Identities=29% Similarity=0.450 Sum_probs=206.2
Q ss_pred eEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC---CCCCccccceeEecCCe----
Q 007433 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL---DHPFLPTLYTHFETDKF---- 287 (604)
Q Consensus 215 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~~~~---- 287 (604)
|++.+.||.|+||.||+|++..++..||+|++....... .....+.+|+.+++++ +|+||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 788999999999999999999889999999997543221 1122344577776665 69999999999987766
Q ss_pred -eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 288 -SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 288 -~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
+|++|||+. ++|.+++.......+++..++.++.||+.||.|||++|++|+||+|+|||++.++.++|+|||++....
T Consensus 80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 999999995 589988877655579999999999999999999999999999999999999999999999999874321
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
.. .
T Consensus 159 ~~-----------------------------------------------------------------------------~ 161 (287)
T cd07838 159 FE-----------------------------------------------------------------------------M 161 (287)
T ss_pred CC-----------------------------------------------------------------------------c
Confidence 10 0
Q ss_pred cccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-----CCCC----------
Q 007433 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP-----LRFP---------- 511 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~-----~~~p---------- 511 (604)
......++..|+|||++.+..++.++|||||||++|||++|++||.+....+.+.++.... ..++
T Consensus 162 ~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (287)
T cd07838 162 ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSF 241 (287)
T ss_pred ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhc
Confidence 0012347889999999999989999999999999999999999999877766666554310 0000
Q ss_pred -C---------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 512 -E---------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 512 -~---------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
. .+.++..+.+||.+||..||.+||+ +.++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~----~~~il~~~~~ 287 (287)
T cd07838 242 PSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS----AFEALQHPYF 287 (287)
T ss_pred ccccccchhhhhhhhhHHHHHHHHHHhccCCccCCC----HHHHhcCcCC
Confidence 0 0134577889999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=327.15 Aligned_cols=249 Identities=27% Similarity=0.392 Sum_probs=209.8
Q ss_pred EEEccCCcEEEEEEEEcCC---ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeec
Q 007433 219 KKLGCGDIGSVYLSELTGT---KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFC 295 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 295 (604)
+.||.|+||.||+|.+... +..||+|++....... ....+.+|+++++.++|+||+++++++.++..+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4689999999999999866 8899999997664332 3456778999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcC-------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 296 PGGDLHTLRQRQP-------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 296 ~ggsL~~ll~~~~-------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
++++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 9999999988752 367999999999999999999999999999999999999999999999999988443211
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
.. ....
T Consensus 159 ~~--------------------------------------------------------------------------~~~~ 164 (262)
T cd00192 159 DY--------------------------------------------------------------------------YRKK 164 (262)
T ss_pred cc--------------------------------------------------------------------------cccc
Confidence 00 0001
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGL 527 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~l 527 (604)
....++..|+|||.+.+..++.++|||||||++|||++ |..||...........+.. .........++.++.++|.+|
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~ 243 (262)
T cd00192 165 TGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK-GYRLPKPEYCPDELYELMLSC 243 (262)
T ss_pred cCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCCCCccCChHHHHHHHHH
Confidence 12357889999999998889999999999999999999 6999998877666666554 333444456799999999999
Q ss_pred hhcCCCCcccccCCHHHHhcC
Q 007433 528 LVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~H 548 (604)
|..||.+||+ +.++++|
T Consensus 244 l~~~p~~Rps----~~~l~~~ 260 (262)
T cd00192 244 WQLDPEDRPT----FSELVER 260 (262)
T ss_pred ccCCcccCcC----HHHHHHh
Confidence 9999999999 9999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=331.04 Aligned_cols=254 Identities=23% Similarity=0.329 Sum_probs=204.8
Q ss_pred eEEEEEEccCCcEEEEEEEEcC---CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCe----
Q 007433 215 FRLLKKLGCGDIGSVYLSELTG---TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKF---- 287 (604)
Q Consensus 215 y~l~~~LG~G~fG~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~---- 287 (604)
|++.+.||+|+||.||+|.+.. ++..||||++...... ......+.+|+++|+.++|+||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 6788999999999999998765 3478999998754322 2334567789999999999999999998865443
Q ss_pred --eEEEEeecCCCCHHHHHHhc----CCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccc
Q 007433 288 --SCLVMEFCPGGDLHTLRQRQ----PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDL 361 (604)
Q Consensus 288 --~~lV~E~~~ggsL~~ll~~~----~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGl 361 (604)
.++||||+++++|..++... ....+++..+..++.|++.||+|||++||+||||||+|||+++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 79999999999999887543 224689999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccccc
Q 007433 362 SLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIA 441 (604)
Q Consensus 362 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (604)
+.........
T Consensus 160 ~~~~~~~~~~---------------------------------------------------------------------- 169 (273)
T cd05035 160 SKKIYSGDYY---------------------------------------------------------------------- 169 (273)
T ss_pred eeeccccccc----------------------------------------------------------------------
Confidence 8433211000
Q ss_pred CCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHH
Q 007433 442 EPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSA 520 (604)
Q Consensus 442 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l 520 (604)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+..+.+.+..+.... .......++..+
T Consensus 170 ----~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~ 244 (273)
T cd05035 170 ----RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN-RLKQPEDCLDEL 244 (273)
T ss_pred ----cccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCcCCCHHH
Confidence 00001124678999999998889999999999999999999 999998877766665555432 233334588999
Q ss_pred HHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 521 RDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 521 ~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
.++|.+||..||++||+ +.|++++
T Consensus 245 ~~li~~~l~~~p~~Rp~----~~e~~~~ 268 (273)
T cd05035 245 YDLMYSCWRADPKDRPT----FTKLREV 268 (273)
T ss_pred HHHHHHHcCCChhhCcC----HHHHHHH
Confidence 99999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=331.06 Aligned_cols=250 Identities=24% Similarity=0.371 Sum_probs=207.1
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
.+|++.+.||+|+||.||++.+.. +..+|+|++.+..... ..+.+|+++++.++|+||+++++++...+..|+||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAMSE----DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCCCH----HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 478999999999999999998864 5589999987643322 23557999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||++|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 79 e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-- 155 (256)
T cd05059 79 EYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-- 155 (256)
T ss_pred ecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc--
Confidence 9999999999987653 4789999999999999999999999999999999999999999999999998743210000
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.......
T Consensus 156 -------------------------------------------------------------------------~~~~~~~ 162 (256)
T cd05059 156 -------------------------------------------------------------------------TSSQGTK 162 (256)
T ss_pred -------------------------------------------------------------------------cccCCCC
Confidence 0000112
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~d 531 (604)
++..|+|||++.+..++.++|||||||++|||++ |+.||......+....+.. ....+....++..+.+||.+||..+
T Consensus 163 ~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~~ 241 (256)
T cd05059 163 FPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSA-GYRLYRPKLAPTEVYTIMYSCWHEK 241 (256)
T ss_pred CCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHc-CCcCCCCCCCCHHHHHHHHHHhcCC
Confidence 4567999999999899999999999999999998 8999988777666655543 3334444568999999999999999
Q ss_pred CCCcccccCCHHHHhcC
Q 007433 532 PQNRLACRRGATEIKQH 548 (604)
Q Consensus 532 P~~Rpt~~~~a~elL~H 548 (604)
|++||+ +.|+++.
T Consensus 242 p~~Rpt----~~~~l~~ 254 (256)
T cd05059 242 PEDRPA----FKKLLSQ 254 (256)
T ss_pred hhhCcC----HHHHHHH
Confidence 999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=336.48 Aligned_cols=256 Identities=23% Similarity=0.341 Sum_probs=208.6
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCc----------------eEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCc
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTK----------------CYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFL 275 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~----------------~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI 275 (604)
.++|++++.||+|+||.||+|.+...+ ..||+|++...... .....+.+|+++|+.++|+||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCCE
Confidence 468999999999999999999876543 56899999765322 233456789999999999999
Q ss_pred cccceeEecCCeeEEEEeecCCCCHHHHHHhcC---------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcE
Q 007433 276 PTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQP---------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENV 346 (604)
Q Consensus 276 v~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~---------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNI 346 (604)
+++++++..+...++||||+++++|..++.... ...+++..+..++.|++.||+|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999987653 12689999999999999999999999999999999999
Q ss_pred EEccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCc
Q 007433 347 LVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPK 426 (604)
Q Consensus 347 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (604)
|++.++.++|+|||++........
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~-------------------------------------------------------- 185 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDY-------------------------------------------------------- 185 (296)
T ss_pred eecCCCceEEccccceeecccCcc--------------------------------------------------------
Confidence 999999999999998743211000
Q ss_pred cccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh--CCCCCCCCChHHHHHHHH
Q 007433 427 NEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF--GKTPFKGSENRATLYNVV 504 (604)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt--G~~PF~~~~~~~~l~~i~ 504 (604)
........+++.|+|||++.+..++.++|||||||++|||++ |..||........+.++.
T Consensus 186 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~ 247 (296)
T cd05051 186 ------------------YRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAG 247 (296)
T ss_pred ------------------eeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHH
Confidence 000112346788999999998889999999999999999998 788998776666655554
Q ss_pred cC------CCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 505 GQ------PLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 505 ~~------~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
.. ....+....++.++.+||.+||..||++||+ +.||++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt----~~el~~ 292 (296)
T cd05051 248 HFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPT----FREIHL 292 (296)
T ss_pred hccccccccccCCCccCCCHHHHHHHHHHhccChhcCCC----HHHHHH
Confidence 22 2223333457789999999999999999999 888865
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-40 Score=341.11 Aligned_cols=257 Identities=25% Similarity=0.348 Sum_probs=200.9
Q ss_pred CcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCCCCHHHHH
Q 007433 225 DIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLR 304 (604)
Q Consensus 225 ~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~ll 304 (604)
++|.||.++...+++.||||++...... ......+.+|+++|+.++|+||++++++|..++..|++|||+++++|.+++
T Consensus 12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l 90 (314)
T cd08216 12 DLMIVHLAKHKPTNTLVAVKKINLDSCS-KEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL 90 (314)
T ss_pred CCceEEEEEecCCCCEEEEEEEeccccc-hhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence 4466677777778899999999765322 234567889999999999999999999999999999999999999999999
Q ss_pred HhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcccCCcccC
Q 007433 305 QRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRK 384 (604)
Q Consensus 305 ~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~ 384 (604)
.......+++..+..++.||+.||+|||++||+||||||+|||++.+|.++|+|||.+..+........
T Consensus 91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~----------- 159 (314)
T cd08216 91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR----------- 159 (314)
T ss_pred HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccc-----------
Confidence 876556799999999999999999999999999999999999999999999999998743321000000
Q ss_pred CCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccccCcceec
Q 007433 385 NPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIK 464 (604)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 464 (604)
..........++..|+|||++.
T Consensus 160 ----------------------------------------------------------~~~~~~~~~~~~~~y~aPE~~~ 181 (314)
T cd08216 160 ----------------------------------------------------------VVHDFPKSSVKNLPWLSPEVLQ 181 (314)
T ss_pred ----------------------------------------------------------ccccccccccccccccCHHHhc
Confidence 0000012345788999999987
Q ss_pred CC--CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC--------------------------------CC
Q 007433 465 GE--GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPL--------------------------------RF 510 (604)
Q Consensus 465 ~~--~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~--------------------------------~~ 510 (604)
+. .++.++|||||||++|||++|+.||........+........ ..
T Consensus 182 ~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (314)
T cd08216 182 QNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDH 261 (314)
T ss_pred CCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhc
Confidence 63 578899999999999999999999987655443322221110 00
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCC
Q 007433 511 PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 511 p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
.....++.++.+||.+||.+||++||+ +.++|+||||+.+.
T Consensus 262 ~~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~ll~~p~~~~~~ 302 (314)
T cd08216 262 PYTRTFSEHFHQFVELCLQRDPESRPS----ASQLLNHSFFKQCK 302 (314)
T ss_pred chhhHHHHHHHHHHHHHhhcCCCcCcC----HHHHhcCchHhhhc
Confidence 011123457889999999999999999 99999999998764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=325.52 Aligned_cols=254 Identities=30% Similarity=0.467 Sum_probs=214.8
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
+|++.++||.|+||.||++.+..++..||+|.+....... ....++.+|+++++.++|+||+++++++.++...|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQ-KEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccH-HHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 5899999999999999999999999999999997654332 233456689999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 294 FCPGGDLHTLRQRQ--PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 294 ~~~ggsL~~ll~~~--~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|+++++|..++.+. .+..+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 99999999987662 2356899999999999999999999999999999999999999999999999987332110
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
.....
T Consensus 157 ---------------------------------------------------------------------------~~~~~ 161 (256)
T cd08530 157 ---------------------------------------------------------------------------MAKTQ 161 (256)
T ss_pred ---------------------------------------------------------------------------Ccccc
Confidence 00012
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~d 531 (604)
.|++.|++||.+.+..++.++|+||||+++|||++|+.||...+.......+...... +.....+.+++++|.+||..+
T Consensus 162 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~ 240 (256)
T cd08530 162 IGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP-PIPPIYSQDLQNFIRSMLQVK 240 (256)
T ss_pred cCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC-CCchhhCHHHHHHHHHHcCCC
Confidence 4788999999999988999999999999999999999999987766555555433222 222357889999999999999
Q ss_pred CCCcccccCCHHHHhcCCCC
Q 007433 532 PQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 532 P~~Rpt~~~~a~elL~Hpff 551 (604)
|++||+ +.++++||++
T Consensus 241 p~~Rp~----~~~~l~~p~~ 256 (256)
T cd08530 241 PKLRPN----CDKILASPAV 256 (256)
T ss_pred cccCCC----HHHHhcCCCC
Confidence 999999 9999999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-40 Score=346.87 Aligned_cols=255 Identities=31% Similarity=0.448 Sum_probs=206.3
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC------C
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD------K 286 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------~ 286 (604)
++|.+.+.||.|+||.||+|.+..++..||||++.+.... ......+.+|+.+++.++|+||++++++|... .
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 5899999999999999999999999999999998754221 12233566899999999999999999998754 3
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
.+|+||||+. .+|..++. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++....
T Consensus 94 ~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 94 DFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred eEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 5699999994 57776542 358999999999999999999999999999999999999999999999999873211
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
.
T Consensus 169 ~------------------------------------------------------------------------------- 169 (342)
T cd07879 169 A------------------------------------------------------------------------------- 169 (342)
T ss_pred C-------------------------------------------------------------------------------
Confidence 0
Q ss_pred cccccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC-------------------
Q 007433 447 RSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ------------------- 506 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~------------------- 506 (604)
......||..|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+..++..
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (342)
T cd07879 170 EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKS 249 (342)
T ss_pred CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHH
Confidence 0112357889999999876 45788999999999999999999999987655444333221
Q ss_pred ----CCCCCC------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCCh
Q 007433 507 ----PLRFPE------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNW 556 (604)
Q Consensus 507 ----~~~~p~------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~ 556 (604)
....+. .+..+..+.+||.+||..||++||+ +.++++||||+.+.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~----~~e~l~h~~f~~~~~ 305 (342)
T cd07879 250 YIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLT----ATEALEHPYFDSFRD 305 (342)
T ss_pred HHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcC----HHHHhcCcchhhccc
Confidence 000010 1246778999999999999999999 999999999998764
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=330.07 Aligned_cols=249 Identities=24% Similarity=0.371 Sum_probs=205.8
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|+++++||.|+||.||+|.+.. +..||+|.+....... ..+.+|+.+|++++|+||+++++++. +...|+|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~~~----~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (260)
T cd05070 5 RESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTMSP----ESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCCCH----HHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence 4689999999999999999998764 4479999997653322 24668999999999999999999885 4568899
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+++++|.+++.......+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEY- 157 (260)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccc-
Confidence 9999999999998876556789999999999999999999999999999999999999999999999998843211000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 158 --------------------------------------------------------------------------~~~~~~ 163 (260)
T cd05070 158 --------------------------------------------------------------------------TARQGA 163 (260)
T ss_pred --------------------------------------------------------------------------ccccCC
Confidence 000112
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
.++..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.+..+... ...+.....+..+.+||.+||..
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~ 242 (260)
T cd05070 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YRMPCPQDCPISLHELMLQCWKK 242 (260)
T ss_pred CCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHHHHHccc
Confidence 35678999999988889999999999999999999 99999887777666665543 33444456889999999999999
Q ss_pred CCCCcccccCCHHHHh
Q 007433 531 EPQNRLACRRGATEIK 546 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL 546 (604)
||++||+ +.+++
T Consensus 243 ~p~~Rpt----~~~l~ 254 (260)
T cd05070 243 DPEERPT----FEYLQ 254 (260)
T ss_pred CcccCcC----HHHHH
Confidence 9999999 77765
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=327.58 Aligned_cols=249 Identities=22% Similarity=0.322 Sum_probs=207.0
Q ss_pred EEEccCCcEEEEEEEEcC-C--ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeec
Q 007433 219 KKLGCGDIGSVYLSELTG-T--KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFC 295 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~-~--~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 295 (604)
+.||+|+||.||+|.+.. . ...||||++...... .....+.+|+.++++++|+||+++++++.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 368999999999999865 2 336999999876553 445567789999999999999999999988 8999999999
Q ss_pred CCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccC
Q 007433 296 PGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSS 375 (604)
Q Consensus 296 ~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 375 (604)
++++|.+++.......+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++..+........
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~-- 155 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV-- 155 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEecccccccccccccccee--
Confidence 999999998876435789999999999999999999999999999999999999999999999998854321110000
Q ss_pred cccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCc
Q 007433 376 TLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTH 455 (604)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~ 455 (604)
......++.
T Consensus 156 -----------------------------------------------------------------------~~~~~~~~~ 164 (257)
T cd05040 156 -----------------------------------------------------------------------MEEHLKVPF 164 (257)
T ss_pred -----------------------------------------------------------------------cccCCCCCc
Confidence 000234778
Q ss_pred cccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCC
Q 007433 456 EYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQN 534 (604)
Q Consensus 456 ~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~ 534 (604)
.|+|||++.+..++.++|||||||++|||++ |+.||......+.+..+.......+.....+..+.+||.+||..+|++
T Consensus 165 ~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 244 (257)
T cd05040 165 AWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHNPAD 244 (257)
T ss_pred eecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHHHCCCCccc
Confidence 8999999999889999999999999999998 999998877777666665444444444557899999999999999999
Q ss_pred cccccCCHHHHhc
Q 007433 535 RLACRRGATEIKQ 547 (604)
Q Consensus 535 Rpt~~~~a~elL~ 547 (604)
||+ +.++++
T Consensus 245 Rps----~~~~~~ 253 (257)
T cd05040 245 RPT----FAALRE 253 (257)
T ss_pred CCC----HHHHHH
Confidence 999 888765
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=332.01 Aligned_cols=255 Identities=21% Similarity=0.322 Sum_probs=206.1
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCce----EEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKC----YFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD 285 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 285 (604)
+...+|++++.||.|+||+||+|.+..++. .||+|++...... .....+.+|+.+++.++|+||+++++++...
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP--KANKEILDEAYVMAGVGSPYVCRLLGICLTS 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCH--HHHHHHHHHHHHHHhcCCCCCceEEEEEcCC
Confidence 345789999999999999999999876665 4899998754322 2234567899999999999999999998754
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
..+++|||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+
T Consensus 82 -~~~l~~~~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~ 159 (279)
T cd05109 82 -TVQLVTQLMPYGCLLDYVRENK-DRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLL 159 (279)
T ss_pred -CcEEEEEcCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeec
Confidence 5789999999999999887643 56999999999999999999999999999999999999999999999999988543
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
.......
T Consensus 160 ~~~~~~~------------------------------------------------------------------------- 166 (279)
T cd05109 160 DIDETEY------------------------------------------------------------------------- 166 (279)
T ss_pred cccccee-------------------------------------------------------------------------
Confidence 2110000
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLI 524 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI 524 (604)
......+++.|+|||.+.+..++.++|||||||++|||++ |..||.......... ++......+.....+.++.++|
T Consensus 167 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li 244 (279)
T cd05109 167 -HADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-LLEKGERLPQPPICTIDVYMIM 244 (279)
T ss_pred -ecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCcCCCCccCCHHHHHHH
Confidence 0001125678999999999889999999999999999998 999998766554433 3433334444556889999999
Q ss_pred HHhhhcCCCCcccccCCHHHHhc
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
.+||..||++||+ +.+++.
T Consensus 245 ~~~l~~dp~~Rp~----~~~l~~ 263 (279)
T cd05109 245 VKCWMIDSECRPR----FRELVD 263 (279)
T ss_pred HHHcCCChhhCcC----HHHHHH
Confidence 9999999999999 888874
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=328.59 Aligned_cols=250 Identities=22% Similarity=0.359 Sum_probs=207.3
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|+++++||.|+||.||+|.+.. ++.||+|.+....... ..+.+|+.+++.++|+||+++++++. ++..|+|
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSMSP----EAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYII 78 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCCcH----HHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEE
Confidence 4689999999999999999998765 5589999997654322 24567999999999999999999875 4568999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+.+++|.+++....+..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05067 79 TEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY- 157 (260)
T ss_pred EEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc-
Confidence 9999999999998876667899999999999999999999999999999999999999999999999998743211000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 158 --------------------------------------------------------------------------~~~~~~ 163 (260)
T cd05067 158 --------------------------------------------------------------------------TAREGA 163 (260)
T ss_pred --------------------------------------------------------------------------ccccCC
Confidence 000112
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
.++..|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+....+.. ....+.....+.++.+||.+||..
T Consensus 164 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~ 242 (260)
T cd05067 164 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER-GYRMPRPDNCPEELYELMRLCWKE 242 (260)
T ss_pred cccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHccC
Confidence 36678999999998889999999999999999998 9999998776666555543 334444456788999999999999
Q ss_pred CCCCcccccCCHHHHhc
Q 007433 531 EPQNRLACRRGATEIKQ 547 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~ 547 (604)
||++||+ +++++.
T Consensus 243 ~p~~Rp~----~~~l~~ 255 (260)
T cd05067 243 KPEERPT----FEYLRS 255 (260)
T ss_pred ChhhCCC----HHHHHH
Confidence 9999999 777764
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=331.28 Aligned_cols=256 Identities=20% Similarity=0.334 Sum_probs=214.0
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcC-----CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTG-----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
.++|++++.||.|+||.||+|+... ....||+|.+..... ......+.+|+++|++++|+||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc--hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 3689999999999999999999753 346799999865432 223456778999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCC-------CCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGK-------YFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDF 359 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~-------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DF 359 (604)
..|+||||+++++|.+++...... .+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999998865421 6899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccc
Q 007433 360 DLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPEL 439 (604)
Q Consensus 360 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (604)
|++.......
T Consensus 162 ~~~~~~~~~~---------------------------------------------------------------------- 171 (275)
T cd05046 162 SLSKDVYNSE---------------------------------------------------------------------- 171 (275)
T ss_pred ccccccCccc----------------------------------------------------------------------
Confidence 9873211000
Q ss_pred ccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCH
Q 007433 440 IAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSF 518 (604)
Q Consensus 440 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~ 518 (604)
........++..|+|||.+.+..++.++|||||||++|+|++ |..||........+..+..+...++....++.
T Consensus 172 -----~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (275)
T cd05046 172 -----YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPS 246 (275)
T ss_pred -----ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCCCCCCCH
Confidence 000112246778999999988888999999999999999998 89999887777777777666666655566889
Q ss_pred HHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 519 SARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 519 ~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
.+.++|.+||..||++||+ +.|++++
T Consensus 247 ~l~~~i~~~l~~~p~~Rp~----~~~~l~~ 272 (275)
T cd05046 247 RLYKLMTRCWAVNPKDRPS----FSELVSA 272 (275)
T ss_pred HHHHHHHHHcCCCcccCCC----HHHHHHH
Confidence 9999999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-40 Score=345.91 Aligned_cols=257 Identities=21% Similarity=0.318 Sum_probs=204.5
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEc-----CCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEec-
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELT-----GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFET- 284 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~- 284 (604)
.++|++.+.||.|+||.||+|.+. .+++.||||+++..... .....+.+|+.+|..+ +|+||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCCh--HHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 468999999999999999999853 45678999999754322 2344567899999999 68999999998764
Q ss_pred CCeeEEEEeecCCCCHHHHHHhcC--------------------------------------------------------
Q 007433 285 DKFSCLVMEFCPGGDLHTLRQRQP-------------------------------------------------------- 308 (604)
Q Consensus 285 ~~~~~lV~E~~~ggsL~~ll~~~~-------------------------------------------------------- 308 (604)
+..+|+|||||++|+|.+++....
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 557899999999999999886532
Q ss_pred ---------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcccC
Q 007433 309 ---------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLES 379 (604)
Q Consensus 309 ---------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 379 (604)
...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.........
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~-------- 235 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY-------- 235 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcch--------
Confidence 124678888999999999999999999999999999999999999999999988432110000
Q ss_pred CcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccccC
Q 007433 380 EPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLA 459 (604)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~A 459 (604)
.......++..|+|
T Consensus 236 ------------------------------------------------------------------~~~~~~~~~~~y~a 249 (343)
T cd05103 236 ------------------------------------------------------------------VRKGDARLPLKWMA 249 (343)
T ss_pred ------------------------------------------------------------------hhcCCCCCCcceEC
Confidence 00011235678999
Q ss_pred cceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccc
Q 007433 460 PEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLAC 538 (604)
Q Consensus 460 PE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~ 538 (604)
||++.+..++.++|||||||++|||++ |..||.+......+...+......+.....+.++.+++.+||..||++||+
T Consensus 250 PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~p~~Rps- 328 (343)
T cd05103 250 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT- 328 (343)
T ss_pred cHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCChhhCcC-
Confidence 999999889999999999999999996 999998765444444443333333333457889999999999999999999
Q ss_pred cCCHHHHhcC
Q 007433 539 RRGATEIKQH 548 (604)
Q Consensus 539 ~~~a~elL~H 548 (604)
+.||++|
T Consensus 329 ---~~eil~~ 335 (343)
T cd05103 329 ---FSELVEH 335 (343)
T ss_pred ---HHHHHHH
Confidence 9999887
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=337.79 Aligned_cols=160 Identities=31% Similarity=0.436 Sum_probs=138.5
Q ss_pred CCCCCCCChhHHHHHhheeecCceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHH
Q 007433 186 VNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTERE 265 (604)
Q Consensus 186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~ 265 (604)
....+..+++....++++.+++... .++|-+.++||+|-|++||+|.+....++||||+++... .....+..||+
T Consensus 52 ~~eqE~~~dY~kGGYHpV~IGD~F~-~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIk 126 (590)
T KOG1290|consen 52 DEEQEDPEDYRKGGYHPVRIGDVFN-GGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIK 126 (590)
T ss_pred cccccChhhhhcCCCceeecccccc-CceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHH
Confidence 3344566788888899999988654 479999999999999999999999999999999997553 33345667999
Q ss_pred HHHhCC-----C---CCccccceeEe----cCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH
Q 007433 266 ILQSLD-----H---PFLPTLYTHFE----TDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333 (604)
Q Consensus 266 iL~~l~-----H---pnIv~l~~~~~----~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~ 333 (604)
+|+++. | .+||+|+++|. ++.++|||+|++ |.+|..+|.+...+.++...++.|++|||.||.|||.
T Consensus 127 lL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ 205 (590)
T KOG1290|consen 127 LLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHR 205 (590)
T ss_pred HHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHH
Confidence 999882 3 36999999997 467999999999 9999999998888899999999999999999999996
Q ss_pred -cCeEeccCCCCcEEEccC
Q 007433 334 -LGIVYRDLKPENVLVRED 351 (604)
Q Consensus 334 -~gIvHrDIKpeNILl~~~ 351 (604)
+||||.||||||||+..+
T Consensus 206 ecgIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 206 ECGIIHTDLKPENVLLCST 224 (590)
T ss_pred hcCccccCCCcceeeeecc
Confidence 699999999999999644
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=343.46 Aligned_cols=272 Identities=27% Similarity=0.377 Sum_probs=211.0
Q ss_pred cCeEE-EEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHH-----------HHHHHHHHHHHHHhCCCCCccccce
Q 007433 213 GHFRL-LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRK-----------KLLRAQTEREILQSLDHPFLPTLYT 280 (604)
Q Consensus 213 ~~y~l-~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~-----------~~~~~~~Ei~iL~~l~HpnIv~l~~ 280 (604)
++|.. .+.||.|+||+||+|.+..+++.||||++......... ....+.+|+++|+.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 57765 46799999999999999999999999998754322100 0124568999999999999999999
Q ss_pred eEecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccc
Q 007433 281 HFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFD 360 (604)
Q Consensus 281 ~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFG 360 (604)
+|..++..|+||||+. ++|.+++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg 164 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFG 164 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCcc
Confidence 9999999999999995 6999888764 569999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccc
Q 007433 361 LSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELI 440 (604)
Q Consensus 361 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (604)
++.......... ... + ..
T Consensus 165 ~~~~~~~~~~~~-~~~--------~------------------------------------------~~----------- 182 (335)
T PTZ00024 165 LARRYGYPPYSD-TLS--------K------------------------------------------DE----------- 182 (335)
T ss_pred ceeecccccccc-ccc--------c------------------------------------------cc-----------
Confidence 885443211000 000 0 00
Q ss_pred cCCCCCcccccccCccccCcceecCCC-CCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc---CCCC--CCC--
Q 007433 441 AEPTNARSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG---QPLR--FPE-- 512 (604)
Q Consensus 441 ~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~---~~~~--~p~-- 512 (604)
............+++.|+|||++.+.. ++.++|||||||++|||++|..||.+.+..+.+..+.. .+.. ++.
T Consensus 183 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 262 (335)
T PTZ00024 183 TMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAK 262 (335)
T ss_pred cccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchh
Confidence 000000111235788999999987654 68899999999999999999999998877666554432 1110 000
Q ss_pred -------------------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 513 -------------------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 513 -------------------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
....+.++.+||.+||..||++||+ ++|+|.||||+.
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s----~~~~l~~~~~~~ 318 (335)
T PTZ00024 263 KLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERIS----AKEALKHEYFKS 318 (335)
T ss_pred hcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccC----HHHHhcCcccCC
Confidence 1235778999999999999999999 999999999975
|
|
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-40 Score=336.66 Aligned_cols=256 Identities=20% Similarity=0.298 Sum_probs=209.0
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCC-----ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGT-----KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
..+|++++.||.|+||.||+|.+..+ +..||||++..... ......+.+|+.++..++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 45788999999999999999987643 57899999975432 123345678999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQP--------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG 352 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~--------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g 352 (604)
..++++||+.+++|..++.... ...+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 9999999999999999875321 23588899999999999999999999999999999999999999
Q ss_pred cEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCC
Q 007433 353 HIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQ 432 (604)
Q Consensus 353 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (604)
.+||+|||++........
T Consensus 162 ~~kl~Dfg~~~~~~~~~~-------------------------------------------------------------- 179 (283)
T cd05091 162 NVKISDLGLFREVYAADY-------------------------------------------------------------- 179 (283)
T ss_pred ceEecccccccccccchh--------------------------------------------------------------
Confidence 999999998743211000
Q ss_pred CCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCC
Q 007433 433 VSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFP 511 (604)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p 511 (604)
........+++.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+..... .+
T Consensus 180 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~-~~ 246 (283)
T cd05091 180 ------------YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQV-LP 246 (283)
T ss_pred ------------eeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCc-CC
Confidence 000012246788999999988889999999999999999998 8999988777766666655442 23
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 512 ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 512 ~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
....++..+.+||.+||..||++||+ +.+|++.
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~RP~----~~~i~~~ 279 (283)
T cd05091 247 CPDDCPAWVYTLMLECWNEFPSRRPR----FKDIHSR 279 (283)
T ss_pred CCCCCCHHHHHHHHHHhCCCcccCCC----HHHHHHH
Confidence 33468899999999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=326.93 Aligned_cols=253 Identities=25% Similarity=0.359 Sum_probs=211.9
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
+..++|.+.+.||.|+||.||+|.+.++ ..||||.+...... ...+.+|+.+++.++|+||+++++++..+...|
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~-~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGT-TKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCC-ceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 3457999999999999999999998654 67999999765432 234667999999999999999999999989999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
+||||+++++|.+++....+..+++..+..++.||+.||.|||++||+||||||+||+|+.++.++|+|||++..+....
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 99999999999999987766689999999999999999999999999999999999999999999999999874332100
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
. ....
T Consensus 158 ~---------------------------------------------------------------------------~~~~ 162 (261)
T cd05034 158 Y---------------------------------------------------------------------------TARE 162 (261)
T ss_pred h---------------------------------------------------------------------------hhhh
Confidence 0 0000
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
...++..|+|||.+.+..++.++|||||||++|||++ |+.||.+......+..+... +..+.....+.++.++|.+||
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l 241 (261)
T cd05034 163 GAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YRMPRPPNCPEELYDLMLQCW 241 (261)
T ss_pred ccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHc
Confidence 1124568999999999889999999999999999998 99999988777766666543 344444557889999999999
Q ss_pred hcCCCCcccccCCHHHHhc
Q 007433 529 VKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 529 ~~dP~~Rpt~~~~a~elL~ 547 (604)
..||++||+ +.++++
T Consensus 242 ~~~p~~Rp~----~~~l~~ 256 (261)
T cd05034 242 DKDPEERPT----FEYLQS 256 (261)
T ss_pred ccCcccCCC----HHHHHH
Confidence 999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=339.42 Aligned_cols=255 Identities=28% Similarity=0.387 Sum_probs=212.9
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
..|...+.||.|+||.||+|++..++..||+|.+............++.+|+++++.++|+||+++++++..+...|+||
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 94 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence 45888899999999999999999999999999987543333334456678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+. ++|.+++... ...+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.....
T Consensus 95 e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~----- 167 (308)
T cd06634 95 EYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP----- 167 (308)
T ss_pred EccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC-----
Confidence 9995 6887776544 25689999999999999999999999999999999999999999999999998732110
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.....
T Consensus 168 ---------------------------------------------------------------------------~~~~~ 172 (308)
T cd06634 168 ---------------------------------------------------------------------------ANXFV 172 (308)
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 01235
Q ss_pred cCccccCcceecC---CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 453 GTHEYLAPEIIKG---EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 453 GT~~Y~APE~l~~---~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
|++.|+|||++.+ ..++.++|||||||++|+|++|..||........+..+............++..+++||.+||.
T Consensus 173 ~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 252 (308)
T cd06634 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 252 (308)
T ss_pred CCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHHHHHHHHhh
Confidence 8889999999753 4578899999999999999999999988766666666555433332334578889999999999
Q ss_pred cCCCCcccccCCHHHHhcCCCCCC
Q 007433 530 KEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
.+|++||+ +.++++||||..
T Consensus 253 ~~P~~Rp~----~~~ll~~~~~~~ 272 (308)
T cd06634 253 KIPQDRPT----SEVLLKHRFVLR 272 (308)
T ss_pred CCcccCCC----HHHHhhCccccc
Confidence 99999999 999999999965
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=344.72 Aligned_cols=254 Identities=30% Similarity=0.435 Sum_probs=209.7
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCe----
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKF---- 287 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~---- 287 (604)
.++|++.+.||.|+||.||+|++..++..||||++..... .......+.+|+.+++.++|+||+++++++..++.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4689999999999999999999999999999999865422 12233456689999999999999999998876554
Q ss_pred --eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 288 --SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 288 --~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
.|+|+||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 89999999 7899998875 46999999999999999999999999999999999999999999999999987432
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
..
T Consensus 169 ~~------------------------------------------------------------------------------ 170 (343)
T cd07851 169 DD------------------------------------------------------------------------------ 170 (343)
T ss_pred cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred CcccccccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC---------------
Q 007433 446 ARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR--------------- 509 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~--------------- 509 (604)
......++..|+|||++.+. .++.++|||||||++|||++|+.||.+......+..+......
T Consensus 171 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 249 (343)
T cd07851 171 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESAR 249 (343)
T ss_pred -cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHH
Confidence 01123578899999998653 5788999999999999999999999887766555544321100
Q ss_pred -------------CC-CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 510 -------------FP-ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 510 -------------~p-~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
+. .....+..+.+||.+||..||++||+ +.+|++||||+.
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt----~~ell~h~~~~~ 303 (343)
T cd07851 250 NYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRIT----AAEALAHPYLAE 303 (343)
T ss_pred HHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCC----HHHHhcCCCccc
Confidence 00 01235889999999999999999999 999999999985
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=329.06 Aligned_cols=256 Identities=28% Similarity=0.495 Sum_probs=209.6
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHH--HHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLE--KRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
+|.+.+.||.|+||.||++++...+..+++|++...... .......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 589999999999999999999888777777776543221 112233456789999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHh--cCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 292 MEFCPGGDLHTLRQR--QPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~--~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
|||+++++|..++.. ..+..+++..++.++.||+.||.|||++|++|+||||+||+++. +.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999998864 23457999999999999999999999999999999999999974 679999999874321100
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
. ...
T Consensus 160 ~----------------------------------------------------------------------------~~~ 163 (260)
T cd08222 160 D----------------------------------------------------------------------------LAT 163 (260)
T ss_pred c----------------------------------------------------------------------------ccc
Confidence 0 011
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
...|++.|+|||.+.+..++.++|+||||+++|+|++|..||...........+....... ....++.++.+||.+||.
T Consensus 164 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~ 242 (260)
T cd08222 164 TFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS-LPETYSRQLNSIMQSMLN 242 (260)
T ss_pred CCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC-CcchhcHHHHHHHHHHhc
Confidence 2347889999999988888999999999999999999999998776666666655433221 123578899999999999
Q ss_pred cCCCCcccccCCHHHHhcCCCC
Q 007433 530 KEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~Hpff 551 (604)
.||++||+ +.++++||||
T Consensus 243 ~~p~~Rp~----~~~il~~~~~ 260 (260)
T cd08222 243 KDPSLRPS----AAEILRNPFI 260 (260)
T ss_pred CChhhCcC----HHHHhhCCCC
Confidence 99999999 9999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=337.41 Aligned_cols=256 Identities=21% Similarity=0.296 Sum_probs=206.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCC-------ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEe
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGT-------KCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFE 283 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~ 283 (604)
.++|.+.+.||+|+||.||++++.+. ...||+|++..... ......+.+|+++++.+ +|+||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC--hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 46899999999999999999987542 34699999976422 22334567799999999 7999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHhcC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEc
Q 007433 284 TDKFSCLVMEFCPGGDLHTLRQRQP--------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVR 349 (604)
Q Consensus 284 ~~~~~~lV~E~~~ggsL~~ll~~~~--------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~ 349 (604)
.++..|+||||+++++|.+++.... ...+++..+..++.||+.||+|||++|++||||||+|||++
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 174 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 174 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEc
Confidence 9999999999999999999987642 13588999999999999999999999999999999999999
Q ss_pred cCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCcccc
Q 007433 350 EDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEM 429 (604)
Q Consensus 350 ~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (604)
.++.++|+|||++..+......
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~---------------------------------------------------------- 196 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYY---------------------------------------------------------- 196 (307)
T ss_pred CCCcEEECCCcccccccccchh----------------------------------------------------------
Confidence 9999999999987432110000
Q ss_pred CCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCC
Q 007433 430 GNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPL 508 (604)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~ 508 (604)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+ ....
T Consensus 197 ----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~ 259 (307)
T cd05098 197 ----------------KKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KEGH 259 (307)
T ss_pred ----------------hccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH-HcCC
Confidence 00001124568999999999889999999999999999998 89999876554444443 3333
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 509 RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 509 ~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
.......++.++.+||.+||..+|.+||+ +.+++++
T Consensus 260 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~evl~~ 295 (307)
T cd05098 260 RMDKPSNCTNELYMMMRDCWHAVPSQRPT----FKQLVED 295 (307)
T ss_pred CCCCCCcCCHHHHHHHHHHcccChhhCcC----HHHHHHH
Confidence 33444458899999999999999999999 8888765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=330.44 Aligned_cols=255 Identities=31% Similarity=0.481 Sum_probs=206.3
Q ss_pred eEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC--CeeEEEE
Q 007433 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD--KFSCLVM 292 (604)
Q Consensus 215 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~~~lV~ 292 (604)
|++++.||.|+||.||+|.+..++..||+|++.... ........+.+|+++++.++|+||+++++++... +..|+||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 788999999999999999999999999999998653 1222234456799999999999999999999987 8999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||++ ++|..++.... ..+++..++.++.||+.||+|||++|++|+||||+|||++.++.++|+|||++........
T Consensus 80 e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-- 155 (287)
T cd07840 80 EYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-- 155 (287)
T ss_pred cccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc--
Confidence 9995 58988876642 5799999999999999999999999999999999999999999999999998743221100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.......
T Consensus 156 -------------------------------------------------------------------------~~~~~~~ 162 (287)
T cd07840 156 -------------------------------------------------------------------------ADYTNRV 162 (287)
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0001124
Q ss_pred cCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---C--CCCCC--------------
Q 007433 453 GTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---P--LRFPE-------------- 512 (604)
Q Consensus 453 GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~--~~~p~-------------- 512 (604)
++..|+|||.+.+. .++.++|||||||++|||++|+.||...+....+..+... + ..++.
T Consensus 163 ~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (287)
T cd07840 163 ITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKK 242 (287)
T ss_pred cccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccc
Confidence 67889999988764 5789999999999999999999999887665544443321 0 00000
Q ss_pred ---------CCC-CCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 513 ---------SPV-VSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 513 ---------~~~-~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
... ++..+.++|++||..||.+||+ +.++++||||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~~l~~~~~ 287 (287)
T cd07840 243 PYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRIS----ADQALQHEYF 287 (287)
T ss_pred cchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcC----HHHHhhCcCC
Confidence 011 3788999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=343.67 Aligned_cols=254 Identities=27% Similarity=0.408 Sum_probs=206.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC------
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD------ 285 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------ 285 (604)
.++|.+++.||+|+||.||+|.+..++..||+|++.+.... ......+.+|++++++++|+||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 94 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccc
Confidence 37999999999999999999999999999999999764221 22334566899999999999999999988643
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
...|+|++++ |++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.++|+|||++...
T Consensus 95 ~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~ 170 (345)
T cd07877 95 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 170 (345)
T ss_pred ccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence 4578999988 8899988765 35899999999999999999999999999999999999999999999999987321
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
..
T Consensus 171 ~~------------------------------------------------------------------------------ 172 (345)
T cd07877 171 DD------------------------------------------------------------------------------ 172 (345)
T ss_pred cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred CcccccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-----------------
Q 007433 446 ARSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP----------------- 507 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~----------------- 507 (604)
......||..|+|||++.+ ..++.++|||||||++|||++|+.||...+....+..++...
T Consensus 173 -~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (345)
T cd07877 173 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 251 (345)
T ss_pred -cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHH
Confidence 0112358899999999876 467889999999999999999999998766544433322110
Q ss_pred ------CCCCC------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 508 ------LRFPE------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 508 ------~~~p~------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
...+. ....+.++++||.+||..||.+|++ +.++++||||+.
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~~e~l~h~~f~~ 305 (345)
T cd07877 252 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQALAHAYFAQ 305 (345)
T ss_pred HHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCC----HHHHhcChhhhh
Confidence 00000 1135778999999999999999999 999999999975
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=334.77 Aligned_cols=252 Identities=21% Similarity=0.309 Sum_probs=205.2
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCce--EEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCeeE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKC--YFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~ 289 (604)
++|++.+.||.|+||.||+|.+..++. .+++|.+.... .......+.+|++++.++ +||||+++++++.....+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 589999999999999999999877654 47888876422 122334567899999999 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEE
Q 007433 290 LVMEFCPGGDLHTLRQRQP--------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIM 355 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~--------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vk 355 (604)
+||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999987542 13588999999999999999999999999999999999999999999
Q ss_pred EecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCC
Q 007433 356 LSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSP 435 (604)
Q Consensus 356 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (604)
|+|||++......
T Consensus 160 l~dfg~~~~~~~~------------------------------------------------------------------- 172 (297)
T cd05089 160 IADFGLSRGEEVY------------------------------------------------------------------- 172 (297)
T ss_pred ECCcCCCccccce-------------------------------------------------------------------
Confidence 9999987311000
Q ss_pred CcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCC
Q 007433 436 LPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESP 514 (604)
Q Consensus 436 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~ 514 (604)
........+..|+|||++.+..++.++|||||||++|||++ |..||.+......+..+... ...+...
T Consensus 173 ----------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~-~~~~~~~ 241 (297)
T cd05089 173 ----------VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRMEKPR 241 (297)
T ss_pred ----------eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCCCCCC
Confidence 00000123457999999998889999999999999999997 99999887776666555443 3333444
Q ss_pred CCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 515 VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 515 ~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
.++..+++||.+||..||.+||+ ++++++.
T Consensus 242 ~~~~~~~~li~~~l~~~p~~Rp~----~~~i~~~ 271 (297)
T cd05089 242 NCDDEVYELMRQCWRDRPYERPP----FAQISVQ 271 (297)
T ss_pred CCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 58899999999999999999999 7888655
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=326.63 Aligned_cols=245 Identities=23% Similarity=0.311 Sum_probs=198.0
Q ss_pred EEccCCcEEEEEEEE--cCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCC
Q 007433 220 KLGCGDIGSVYLSEL--TGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPG 297 (604)
Q Consensus 220 ~LG~G~fG~Vy~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 297 (604)
.||+|+||.||+|.+ ..++..||+|++..... .......+.+|+.+|+.++|+||+++++++. ++..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999965 45678999999865432 2234456778999999999999999999876 4567899999999
Q ss_pred CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcc
Q 007433 298 GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTL 377 (604)
Q Consensus 298 gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 377 (604)
++|.+++... ..+++..+..++.||+.||+|||++||+||||||.|||++.++.++|+|||++..........
T Consensus 80 ~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~----- 152 (257)
T cd05116 80 GPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY----- 152 (257)
T ss_pred CcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee-----
Confidence 9999998765 468999999999999999999999999999999999999999999999999884332111000
Q ss_pred cCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccc
Q 007433 378 ESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEY 457 (604)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 457 (604)
.......++..|
T Consensus 153 --------------------------------------------------------------------~~~~~~~~~~~y 164 (257)
T cd05116 153 --------------------------------------------------------------------KAKTHGKWPVKW 164 (257)
T ss_pred --------------------------------------------------------------------eecCCCCCCccc
Confidence 000112356789
Q ss_pred cCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcc
Q 007433 458 LAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRL 536 (604)
Q Consensus 458 ~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rp 536 (604)
+|||.+....++.++|||||||++|||++ |..||.+....+....+... ...+....++.++.+||.+||..||++||
T Consensus 165 ~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~~~~~~p~~Rp 243 (257)
T cd05116 165 YAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESG-ERMECPQRCPPEMYDLMKLCWTYGVDERP 243 (257)
T ss_pred cCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHHHhccCchhCc
Confidence 99999988889999999999999999997 99999887766665555443 23333446899999999999999999999
Q ss_pred cccCCHHHHh
Q 007433 537 ACRRGATEIK 546 (604)
Q Consensus 537 t~~~~a~elL 546 (604)
+ +.+|.
T Consensus 244 ~----~~~i~ 249 (257)
T cd05116 244 G----FAVVE 249 (257)
T ss_pred C----HHHHH
Confidence 9 65554
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=326.42 Aligned_cols=250 Identities=26% Similarity=0.356 Sum_probs=205.9
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|.+.+.||.|+||.||+|.+..+. .+|+|.+...... ...+.+|+.+++.++|+||+++++++. ++..|+|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTMM----PEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCcc----HHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 368999999999999999999987765 6999998654322 234567999999999999999998875 4568899
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+.+++|.+++.......+++..+..++.||+.||+|||+.||+||||||+|||++.++.++|+|||++........
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~- 157 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY- 157 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc-
Confidence 9999999999999876556789999999999999999999999999999999999999999999999998843211000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 158 --------------------------------------------------------------------------~~~~~~ 163 (260)
T cd05069 158 --------------------------------------------------------------------------TARQGA 163 (260)
T ss_pred --------------------------------------------------------------------------cccCCC
Confidence 000012
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
.++..|+|||.+.+..++.++|||||||++|||++ |+.||.+....+.+..+... ...+.....+..+++||.+||.+
T Consensus 164 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~ 242 (260)
T cd05069 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG-YRMPCPQGCPESLHELMKLCWKK 242 (260)
T ss_pred ccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCcccCHHHHHHHHHHccC
Confidence 36678999999998889999999999999999999 99999987776666555443 33344456889999999999999
Q ss_pred CCCCcccccCCHHHHhc
Q 007433 531 EPQNRLACRRGATEIKQ 547 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~ 547 (604)
||++||+ ++++++
T Consensus 243 ~p~~Rp~----~~~i~~ 255 (260)
T cd05069 243 DPDERPT----FEYIQS 255 (260)
T ss_pred CcccCcC----HHHHHH
Confidence 9999999 777764
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=336.58 Aligned_cols=253 Identities=28% Similarity=0.464 Sum_probs=210.9
Q ss_pred eEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEee
Q 007433 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEF 294 (604)
Q Consensus 215 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 294 (604)
|....+||+|+||.||++.+..++..||||.+..... .....+.+|+.+++.++|+||+++++.|..++..|+||||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch---hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 3334679999999999999999999999999864332 2334567899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccccc
Q 007433 295 CPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKS 374 (604)
Q Consensus 295 ~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~ 374 (604)
+++++|.+++.. ..+++..+..++.|++.||+|||++||+||||+|+||+++.++.++|+|||++.......
T Consensus 99 ~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~----- 170 (292)
T cd06657 99 LEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----- 170 (292)
T ss_pred CCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc-----
Confidence 999999998754 358999999999999999999999999999999999999999999999999863221000
Q ss_pred CcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccC
Q 007433 375 STLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGT 454 (604)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT 454 (604)
.......|+
T Consensus 171 -----------------------------------------------------------------------~~~~~~~~~ 179 (292)
T cd06657 171 -----------------------------------------------------------------------PRRKSLVGT 179 (292)
T ss_pred -----------------------------------------------------------------------ccccccccC
Confidence 001123588
Q ss_pred ccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC-CCCCCCCCCCCHHHHHHHHHhhhcCCC
Q 007433 455 HEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ-PLRFPESPVVSFSARDLIKGLLVKEPQ 533 (604)
Q Consensus 455 ~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~-~~~~p~~~~~s~~l~dLI~~lL~~dP~ 533 (604)
+.|+|||++.+..++.++|+|||||++|+|++|..||.+......+..+... +..+.....++..+.++|.+||..||.
T Consensus 180 ~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~ 259 (292)
T cd06657 180 PYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPA 259 (292)
T ss_pred ccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHhCCcc
Confidence 9999999998888899999999999999999999999887665555444322 223334445789999999999999999
Q ss_pred CcccccCCHHHHhcCCCCCC
Q 007433 534 NRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 534 ~Rpt~~~~a~elL~Hpff~~ 553 (604)
+||+ +.++++||||..
T Consensus 260 ~R~~----~~~ll~~~~~~~ 275 (292)
T cd06657 260 QRAT----AAELLKHPFLAK 275 (292)
T ss_pred cCcC----HHHHhcChHHhc
Confidence 9999 999999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=328.60 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=202.6
Q ss_pred eEEEEEEccCCcEEEEEEEEcCCce--EEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec------CC
Q 007433 215 FRLLKKLGCGDIGSVYLSELTGTKC--YFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET------DK 286 (604)
Q Consensus 215 y~l~~~LG~G~fG~Vy~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------~~ 286 (604)
|.+.+.||+|+||.||+|.+..++. .||+|.+..... .......+.+|+++|+.++|+||+++++++.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567899999999999999887764 689999865422 22344567789999999999999999997642 23
Q ss_pred eeEEEEeecCCCCHHHHHHhc----CCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQ----PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~----~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
..++||||+.+|+|..++... ....+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 578999999999999876432 2245899999999999999999999999999999999999999999999999988
Q ss_pred ccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccC
Q 007433 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442 (604)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (604)
..+......
T Consensus 160 ~~~~~~~~~----------------------------------------------------------------------- 168 (272)
T cd05075 160 KKIYNGDYY----------------------------------------------------------------------- 168 (272)
T ss_pred cccCcccce-----------------------------------------------------------------------
Confidence 433210000
Q ss_pred CCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHH
Q 007433 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSAR 521 (604)
Q Consensus 443 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~ 521 (604)
.......+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.........+.... ..+....++..+.
T Consensus 169 ---~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 244 (272)
T cd05075 169 ---RQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN-RLKQPPDCLDGLY 244 (272)
T ss_pred ---ecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHH
Confidence 00001236678999999999999999999999999999999 899998877766655555432 2333446888999
Q ss_pred HHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 522 DLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 522 dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
++|.+||..||++||+ +.+|+++
T Consensus 245 ~li~~~l~~~p~~Rps----~~~l~~~ 267 (272)
T cd05075 245 SLMSSCWLLNPKDRPS----FETLRCE 267 (272)
T ss_pred HHHHHHcCCCcccCcC----HHHHHHH
Confidence 9999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=332.34 Aligned_cols=254 Identities=23% Similarity=0.337 Sum_probs=207.5
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcC-----CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTG-----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
..+|.+.+.||.|+||.||++++.. ++..+++|.+....... ...+.+|+++++.++|+||+++++++..+.
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAA---RKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHH---HHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 3579999999999999999998643 45679999986554322 234668999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQP--------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG 352 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~--------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g 352 (604)
..++||||+++++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 9999999999999999987642 23589999999999999999999999999999999999999999
Q ss_pred cEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCC
Q 007433 353 HIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQ 432 (604)
Q Consensus 353 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (604)
.++|+|||++........
T Consensus 161 ~~~l~dfg~a~~~~~~~~-------------------------------------------------------------- 178 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDY-------------------------------------------------------------- 178 (291)
T ss_pred cEEECCCCcccccCCCce--------------------------------------------------------------
Confidence 999999998843211000
Q ss_pred CCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCC
Q 007433 433 VSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFP 511 (604)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p 511 (604)
........|+..|+|||++.+..++.++|||||||++|||++ |..||......+.+..+...... .
T Consensus 179 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~ 245 (291)
T cd05094 179 ------------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVL-E 245 (291)
T ss_pred ------------eecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCC-C
Confidence 000112347889999999999999999999999999999998 99999887776666555443322 2
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 512 ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 512 ~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
.....+..+.+||.+||..||++||+ +.++++
T Consensus 246 ~~~~~~~~~~~li~~~l~~~P~~Rpt----~~~v~~ 277 (291)
T cd05094 246 RPRVCPKEVYDIMLGCWQREPQQRLN----IKEIYK 277 (291)
T ss_pred CCccCCHHHHHHHHHHcccChhhCcC----HHHHHH
Confidence 23457889999999999999999999 777654
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=327.65 Aligned_cols=255 Identities=22% Similarity=0.283 Sum_probs=208.7
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCce---EEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCee
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKC---YFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 288 (604)
.++|+..+.||+|+||.||+|.+..++. .+|+|.+...... .....+..|+++++.++|+||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE--KQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH--HHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 4689999999999999999999876543 7999998755322 2234566899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|+||||+++++|..++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 82 MIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999987643 56899999999999999999999999999999999999999999999999987433211
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
.... ...
T Consensus 161 ~~~~-------------------------------------------------------------------------~~~ 167 (268)
T cd05063 161 PEGT-------------------------------------------------------------------------YTT 167 (268)
T ss_pred cccc-------------------------------------------------------------------------eec
Confidence 0000 000
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGL 527 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~l 527 (604)
.....+..|+|||++.+..++.++|||||||++|||++ |+.||......+....+.. ....+....++..+.+||.+|
T Consensus 168 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~c 246 (268)
T cd05063 168 SGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIND-GFRLPAPMDCPSAVYQLMLQC 246 (268)
T ss_pred cCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhc-CCCCCCCCCCCHHHHHHHHHH
Confidence 01123467999999998889999999999999999997 9999988776666555543 344555556889999999999
Q ss_pred hhcCCCCcccccCCHHHHhc
Q 007433 528 LVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~ 547 (604)
|..||++||+ +.+|++
T Consensus 247 ~~~~p~~Rp~----~~~i~~ 262 (268)
T cd05063 247 WQQDRARRPR----FVDIVN 262 (268)
T ss_pred cCCCcccCcC----HHHHHH
Confidence 9999999999 788765
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=333.65 Aligned_cols=259 Identities=26% Similarity=0.398 Sum_probs=209.2
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCee
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 288 (604)
+..++|++.+.||.|+||.||+|.+..++..||||++.+..... ...++.+|+.++..+ +|+||+++++++.++...
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 89 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE--ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV 89 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH--HHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence 34578999999999999999999999989999999997653221 223445577766666 599999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH-cCeEeccCCCCcEEEccCCcEEEecccccccccC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM-LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAV 367 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~ 367 (604)
|+||||+ +++|..++.... ..+++..+..++.||+.||.|||+ +||+||||+|+|||++.++.++|+|||++..+..
T Consensus 90 ~~v~e~~-~~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 90 FICMELM-STCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred EEEeecc-CcCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 9999999 568888876643 479999999999999999999997 6999999999999999999999999998743211
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
.. .
T Consensus 168 ~~-----------------------------------------------------------------------------~ 170 (296)
T cd06618 168 SK-----------------------------------------------------------------------------A 170 (296)
T ss_pred CC-----------------------------------------------------------------------------c
Confidence 00 0
Q ss_pred ccccccCccccCcceecCCC----CCccchHHHHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCC-CCCCCCCCCCHHHH
Q 007433 448 SMSFVGTHEYLAPEIIKGEG----HGSAVDWWTFGIFLYELLFGKTPFKGSEN-RATLYNVVGQP-LRFPESPVVSFSAR 521 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~~~----~~~~~DiWSLGviL~eLltG~~PF~~~~~-~~~l~~i~~~~-~~~p~~~~~s~~l~ 521 (604)
.....|+..|+|||++.+.. ++.++|||||||++|+|++|+.||..... .+.+..+.... ...+....++.++.
T Consensus 171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 250 (296)
T cd06618 171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFC 250 (296)
T ss_pred ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCCCHHHH
Confidence 01124778899999997654 78899999999999999999999976433 34444544433 22333334788999
Q ss_pred HHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 522 DLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 522 dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
+||.+||..||++||+ +.++++||||+.
T Consensus 251 ~li~~~l~~~p~~Rp~----~~~il~~~~~~~ 278 (296)
T cd06618 251 SFVDLCLTKDHRKRPK----YRELLQHPFIRR 278 (296)
T ss_pred HHHHHHccCChhhCCC----HHHHhcChhhhc
Confidence 9999999999999999 999999999974
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=325.71 Aligned_cols=246 Identities=22% Similarity=0.320 Sum_probs=200.0
Q ss_pred EEEccCCcEEEEEEEEcCCc---eEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeec
Q 007433 219 KKLGCGDIGSVYLSELTGTK---CYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFC 295 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 295 (604)
++||+|+||.||+|.+..++ ..||+|.+...... .....+.+|+++|+.++|+||+++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 46999999999999876554 78999999866543 23345678999999999999999999876 45679999999
Q ss_pred CCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccC
Q 007433 296 PGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSS 375 (604)
Q Consensus 296 ~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 375 (604)
++++|.+++... ..+++..+..++.|++.||+|||.+||+||||||+|||++.++.++|+|||++..+........
T Consensus 78 ~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~-- 153 (257)
T cd05060 78 PLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR-- 153 (257)
T ss_pred CCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccc--
Confidence 999999999876 3789999999999999999999999999999999999999999999999998854321110000
Q ss_pred cccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCc
Q 007433 376 TLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTH 455 (604)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~ 455 (604)
......++.
T Consensus 154 -----------------------------------------------------------------------~~~~~~~~~ 162 (257)
T cd05060 154 -----------------------------------------------------------------------ATTAGRWPL 162 (257)
T ss_pred -----------------------------------------------------------------------cccCccccc
Confidence 000112456
Q ss_pred cccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCC
Q 007433 456 EYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQN 534 (604)
Q Consensus 456 ~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~ 534 (604)
.|+|||.+.+..++.++|||||||++|||++ |..||...+..+....+. .....+....++..+++||.+||..||++
T Consensus 163 ~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~cl~~~p~~ 241 (257)
T cd05060 163 KWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLE-SGERLPRPEECPQEIYSIMLSCWKYRPED 241 (257)
T ss_pred cccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCcCCCCCCCCHHHHHHHHHHhcCChhh
Confidence 8999999999899999999999999999997 999998876655544443 33334445568899999999999999999
Q ss_pred cccccCCHHHHhc
Q 007433 535 RLACRRGATEIKQ 547 (604)
Q Consensus 535 Rpt~~~~a~elL~ 547 (604)
||+ +.+|++
T Consensus 242 Rp~----~~~l~~ 250 (257)
T cd05060 242 RPT----FSELES 250 (257)
T ss_pred CcC----HHHHHH
Confidence 999 777764
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=334.36 Aligned_cols=258 Identities=19% Similarity=0.297 Sum_probs=209.2
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcC-------CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCcccccee
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTG-------TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTH 281 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~ 281 (604)
+..++|.+.+.||+|+||.||+|++.. .+..||+|.+..... ......+.+|+.+++.+ +|+||++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc--hHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 345789999999999999999997532 345799999875422 23345677899999999 89999999999
Q ss_pred EecCCeeEEEEeecCCCCHHHHHHhcC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEE
Q 007433 282 FETDKFSCLVMEFCPGGDLHTLRQRQP--------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVL 347 (604)
Q Consensus 282 ~~~~~~~~lV~E~~~ggsL~~ll~~~~--------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNIL 347 (604)
+..+...|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 999999999999999999999987642 235788899999999999999999999999999999999
Q ss_pred EccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCcc
Q 007433 348 VREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKN 427 (604)
Q Consensus 348 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 427 (604)
++.++.++|+|||++..+......
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~-------------------------------------------------------- 193 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYY-------------------------------------------------------- 193 (304)
T ss_pred EcCCCcEEECCCccceeccccccc--------------------------------------------------------
Confidence 999999999999988543211000
Q ss_pred ccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcC
Q 007433 428 EMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQ 506 (604)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~ 506 (604)
.......++..|+|||++.+..++.++|||||||+||||++ |..||.+....+....+...
T Consensus 194 ------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~ 255 (304)
T cd05101 194 ------------------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 255 (304)
T ss_pred ------------------ccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC
Confidence 00011236678999999999889999999999999999998 88999887766655555433
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 507 PLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 507 ~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
........++..+++||.+||..+|++||+ +.|+++.
T Consensus 256 -~~~~~~~~~~~~~~~li~~cl~~~p~~Rps----~~e~l~~ 292 (304)
T cd05101 256 -HRMDKPANCTNELYMMMRDCWHAIPSHRPT----FKQLVED 292 (304)
T ss_pred -CcCCCCCCCCHHHHHHHHHHcccChhhCCC----HHHHHHH
Confidence 333334458899999999999999999999 8888765
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=335.39 Aligned_cols=260 Identities=28% Similarity=0.385 Sum_probs=207.2
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC---
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK--- 286 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--- 286 (604)
...++|++.+.||.|+||.||+|.+..+++.||||+++...... .....+.+|+++++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKE-GFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccccc-CchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 34579999999999999999999999999999999997543211 12234567999999999999999999987654
Q ss_pred -------eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecc
Q 007433 287 -------FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDF 359 (604)
Q Consensus 287 -------~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DF 359 (604)
.+|+||||+++ +|..++... ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~df 160 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADF 160 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcc
Confidence 89999999965 777766654 347999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccc
Q 007433 360 DLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPEL 439 (604)
Q Consensus 360 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (604)
|++........
T Consensus 161 g~~~~~~~~~~--------------------------------------------------------------------- 171 (302)
T cd07864 161 GLARLYNSEES--------------------------------------------------------------------- 171 (302)
T ss_pred cccccccCCcc---------------------------------------------------------------------
Confidence 98743221000
Q ss_pred ccCCCCCcccccccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc---CCCC--C---
Q 007433 440 IAEPTNARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG---QPLR--F--- 510 (604)
Q Consensus 440 ~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~---~~~~--~--- 510 (604)
.......++..|+|||++.+. .++.++|||||||++|||++|++||...+....+..+.. .+.. +
T Consensus 172 ------~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (302)
T cd07864 172 ------RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDV 245 (302)
T ss_pred ------cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccc
Confidence 000112467789999988654 468899999999999999999999987766555443322 1100 0
Q ss_pred --------------------CCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 511 --------------------PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 511 --------------------p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
.....++..+.+||.+||..||.+||+ +.+++.||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~----~~~il~~~~~ 302 (302)
T cd07864 246 IKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCT----AEEALNSPWL 302 (302)
T ss_pred cccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCC----HHHHhcCCCC
Confidence 011246889999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=328.11 Aligned_cols=257 Identities=23% Similarity=0.324 Sum_probs=208.9
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCce---EEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCee
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKC---YFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 288 (604)
.++|++.+.||.|+||.||+|.+..+++ .||||++..... ......+..|+.+++.++||||+++++++.++...
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 4679999999999999999999877654 699999875421 22345677899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|+||||+++++|.+++.... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 81 MIITEFMENGALDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred EEEEecCCCCcHHHHHhhCC-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence 99999999999999887653 56899999999999999999999999999999999999999999999999987332110
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
... + .....
T Consensus 160 ~~~--------------~---------------------------------------------------------~~~~~ 168 (269)
T cd05065 160 TSD--------------P---------------------------------------------------------TYTSS 168 (269)
T ss_pred ccc--------------c---------------------------------------------------------ccccc
Confidence 000 0 00000
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGL 527 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~l 527 (604)
....++..|+|||++.+..++.++|||||||++|||++ |..||...........+. .....+....++..+.++|.+|
T Consensus 169 ~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~li~~~ 247 (269)
T cd05065 169 LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIE-QDYRLPPPMDCPTALHQLMLDC 247 (269)
T ss_pred cCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHH-cCCcCCCcccCCHHHHHHHHHH
Confidence 01113467999999998889999999999999999886 999998877666555553 3344555556888999999999
Q ss_pred hhcCCCCcccccCCHHHHhc
Q 007433 528 LVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~ 547 (604)
|..+|++||+ +.+|++
T Consensus 248 l~~~p~~Rp~----~~~i~~ 263 (269)
T cd05065 248 WQKDRNARPK----FGQIVS 263 (269)
T ss_pred cCCChhhCcC----HHHHHH
Confidence 9999999999 888875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=331.01 Aligned_cols=254 Identities=22% Similarity=0.326 Sum_probs=207.6
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEc-----CCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELT-----GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
..+|.+.++||.|+||.||++... .++..+|+|.+..... .....+.+|+++++.++|+||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE---SARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH---HHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 358899999999999999999753 3567899999875432 22345678999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcCC-------------CCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPG-------------KYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGH 353 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~-------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~ 353 (604)
..|+||||+++++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 99999999999999999876431 35889999999999999999999999999999999999999999
Q ss_pred EEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCC
Q 007433 354 IMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQV 433 (604)
Q Consensus 354 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (604)
++|+|||++........
T Consensus 161 ~kL~dfg~~~~~~~~~~--------------------------------------------------------------- 177 (280)
T cd05092 161 VKIGDFGMSRDIYSTDY--------------------------------------------------------------- 177 (280)
T ss_pred EEECCCCceeEcCCCce---------------------------------------------------------------
Confidence 99999998743211000
Q ss_pred CCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCC
Q 007433 434 SPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPE 512 (604)
Q Consensus 434 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~ 512 (604)
........+++.|+|||++.+..++.++|||||||++|||++ |..||......+.+..+.... ....
T Consensus 178 -----------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~~ 245 (280)
T cd05092 178 -----------YRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR-ELER 245 (280)
T ss_pred -----------eecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCc-cCCC
Confidence 000012236788999999999999999999999999999998 999998777666665554432 2233
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 513 SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 513 ~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
...++..+.+||.+||+.||++||+ +.||++
T Consensus 246 ~~~~~~~~~~li~~cl~~~P~~Rp~----~~~l~~ 276 (280)
T cd05092 246 PRTCPPEVYAIMQGCWQREPQQRMV----IKDIHS 276 (280)
T ss_pred CCCCCHHHHHHHHHHccCChhhCCC----HHHHHH
Confidence 3458899999999999999999999 788764
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-39 Score=329.17 Aligned_cols=253 Identities=34% Similarity=0.526 Sum_probs=206.2
Q ss_pred eEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEecCCeeEEEEe
Q 007433 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 215 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E 293 (604)
|.+.+.||.|+||+||+|.+..+++.||||.+....... ......+|+..+++++ |+||+++++++..++..|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 778899999999999999999999999999987643221 1122346889999998 9999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
|+ +++|.+++....+..+++..+..++.||+.+|.|||++||+|+||+|+||+++.++.++|+|||++.......
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~---- 153 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP---- 153 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC----
Confidence 99 8899988877654578999999999999999999999999999999999999999999999999873321000
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
......|
T Consensus 154 -------------------------------------------------------------------------~~~~~~~ 160 (283)
T cd07830 154 -------------------------------------------------------------------------PYTDYVS 160 (283)
T ss_pred -------------------------------------------------------------------------CcCCCCC
Confidence 0112358
Q ss_pred CccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc---CCC----------------CCCC-
Q 007433 454 THEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG---QPL----------------RFPE- 512 (604)
Q Consensus 454 T~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~---~~~----------------~~p~- 512 (604)
+..|+|||++.+ ..++.++|+||||+++|||++|+.||......+.+.++.. .+. .++.
T Consensus 161 ~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (283)
T cd07830 161 TRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQF 240 (283)
T ss_pred cccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccccccc
Confidence 889999998854 4578899999999999999999999988766555544321 100 0000
Q ss_pred --------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 513 --------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 513 --------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
....+..+++||++||..||++||+ +.|++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt----~~ei~~~~~~ 283 (283)
T cd07830 241 APTSLHQLIPNASPEAIDLIKDMLRWDPKKRPT----ASQALQHPYF 283 (283)
T ss_pred ccccHHHHcccCCHHHHHHHHHhcccCcccCCC----HHHHhhCCCC
Confidence 0123578999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=332.57 Aligned_cols=253 Identities=23% Similarity=0.351 Sum_probs=205.6
Q ss_pred CeEEEEEEccCCcEEEEEEEEcC-----CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCee
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTG-----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 288 (604)
+|++.+.||+|+||.||+|.+.. ....+|+|++...... .....+.+|+.+|+.++||||+++++.+..++..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS--SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH--HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58889999999999999998753 2357999998754322 2335677899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcC----------------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcE
Q 007433 289 CLVMEFCPGGDLHTLRQRQP----------------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENV 346 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~----------------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNI 346 (604)
|+||||+.+++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 99999999999999876421 13588999999999999999999999999999999999
Q ss_pred EEccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCc
Q 007433 347 LVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPK 426 (604)
Q Consensus 347 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (604)
||+.++.++|+|||++..........
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~------------------------------------------------------ 184 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYV------------------------------------------------------ 184 (290)
T ss_pred EEcCCCcEEeccccccccccCccchh------------------------------------------------------
Confidence 99999999999999874322110000
Q ss_pred cccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHc
Q 007433 427 NEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVG 505 (604)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~ 505 (604)
......++..|+|||++.+..++.++|||||||++|||++ |..||.+..... +.+...
T Consensus 185 --------------------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-~~~~~~ 243 (290)
T cd05045 185 --------------------KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER-LFNLLK 243 (290)
T ss_pred --------------------cccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH-HHHHHh
Confidence 0011235678999999998889999999999999999998 999998766544 444555
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 506 QPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 506 ~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
.....+....++.++.+||.+||..||++||+ +.++++
T Consensus 244 ~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~----~~~i~~ 281 (290)
T cd05045 244 TGYRMERPENCSEEMYNLMLTCWKQEPDKRPT----FADISK 281 (290)
T ss_pred CCCCCCCCCCCCHHHHHHHHHHccCCcccCCC----HHHHHH
Confidence 44555555568899999999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=330.32 Aligned_cols=255 Identities=18% Similarity=0.256 Sum_probs=203.8
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCce----EEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKC----YFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
..++|++++.||.|+||+||+|.+..++. .|++|.+.... ......++..|+.+++.++||||+++++++. +.
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~ 81 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GA 81 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CC
Confidence 45789999999999999999999977665 47777775332 1233446677888999999999999999875 45
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
..++||||+++|+|.+++.... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHR-DSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 5789999999999999987653 568999999999999999999999999999999999999999999999999884332
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
.... ..
T Consensus 161 ~~~~--------------------------------------------------------------------------~~ 166 (279)
T cd05111 161 PDDK--------------------------------------------------------------------------KY 166 (279)
T ss_pred CCCc--------------------------------------------------------------------------cc
Confidence 1000 00
Q ss_pred cccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007433 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIK 525 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~ 525 (604)
......|+..|+|||++.+..++.++|||||||++|||++ |..||.+...... ..++......+....++.++.+++.
T Consensus 167 ~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~ 245 (279)
T cd05111 167 FYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERLAQPQICTIDVYMVMV 245 (279)
T ss_pred ccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCCCCCCCCHHHHHHHH
Confidence 0112347778999999998889999999999999999998 9999987655433 3333333333434457788999999
Q ss_pred HhhhcCCCCcccccCCHHHHhcC
Q 007433 526 GLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
+||..||++||+ +.|+++.
T Consensus 246 ~c~~~~p~~Rps----~~el~~~ 264 (279)
T cd05111 246 KCWMIDENVRPT----FKELANE 264 (279)
T ss_pred HHcCCCcccCcC----HHHHHHH
Confidence 999999999999 7887663
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=325.36 Aligned_cols=246 Identities=22% Similarity=0.325 Sum_probs=203.7
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEe-cCCeeE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFE-TDKFSC 289 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-~~~~~~ 289 (604)
...+|++.+.||+|+||.||++... +..||+|.+..... ...+.+|+.+++.++|+||+++++++. .+...|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCch-----HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 3468999999999999999999876 45799999865432 234567999999999999999999764 567789
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
+||||+++++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~- 155 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 155 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceecccc-
Confidence 9999999999999988765556899999999999999999999999999999999999999999999999987422100
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
..
T Consensus 156 ------------------------------------------------------------------------------~~ 157 (256)
T cd05082 156 ------------------------------------------------------------------------------QD 157 (256)
T ss_pred ------------------------------------------------------------------------------CC
Confidence 00
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
...++..|+|||++.+..++.++|||||||++|||++ |+.||...........+... ........++..+.+||.+||
T Consensus 158 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l 236 (256)
T cd05082 158 TGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPVVYDVMKQCW 236 (256)
T ss_pred CCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCCCCCCCCHHHHHHHHHHh
Confidence 1124567999999999889999999999999999997 99999877665555555433 233334568899999999999
Q ss_pred hcCCCCcccccCCHHHHhc
Q 007433 529 VKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 529 ~~dP~~Rpt~~~~a~elL~ 547 (604)
..||++||+ +.++++
T Consensus 237 ~~~p~~Rpt----~~~l~~ 251 (256)
T cd05082 237 HLDAATRPS----FLQLRE 251 (256)
T ss_pred cCChhhCcC----HHHHHH
Confidence 999999999 788765
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=338.85 Aligned_cols=260 Identities=28% Similarity=0.406 Sum_probs=204.4
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCC--ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEec----CC
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGT--KCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFET----DK 286 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~----~~ 286 (604)
+|++.+.||.|+||.||++++..+ +..||||++.... ........+.+|+++++++ +|+||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 589999999999999999999988 8899999986432 1122334566799999999 59999999987542 25
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
.+|++|||+ +++|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.
T Consensus 80 ~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~ 156 (332)
T cd07857 80 ELYLYEELM-EADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156 (332)
T ss_pred cEEEEEecc-cCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence 678999999 57899888654 579999999999999999999999999999999999999999999999999985432
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
..... ...
T Consensus 157 ~~~~~------------------------------------------------------------------------~~~ 164 (332)
T cd07857 157 ENPGE------------------------------------------------------------------------NAG 164 (332)
T ss_pred ccccc------------------------------------------------------------------------ccc
Confidence 11000 000
Q ss_pred cccccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC-------------------
Q 007433 447 RSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ------------------- 506 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~------------------- 506 (604)
....++||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+....+..++..
T Consensus 165 ~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (332)
T cd07857 165 FMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQN 244 (332)
T ss_pred cccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHH
Confidence 1123579999999998766 46889999999999999999999999876543333221110
Q ss_pred ---------CCCCC-CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 507 ---------PLRFP-ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 507 ---------~~~~p-~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
...+. ..+.++..+.+||.+||..||++||+ +.++++||||+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~~ll~~~~~~~ 297 (332)
T cd07857 245 YIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRIS----VEEALEHPYLAI 297 (332)
T ss_pred HHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCC----HHHHhcChhhhh
Confidence 00011 11335788999999999999999999 999999999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=341.31 Aligned_cols=263 Identities=32% Similarity=0.460 Sum_probs=208.3
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEec--CCee
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFET--DKFS 288 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~--~~~~ 288 (604)
.++|.+.+.||.|+||.||+|.+..++..||||.+.+.... ......+.+|+.+++.+ +|+||++++++|.. +...
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRN-ATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCc-chhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 46899999999999999999999989999999988653211 12233456799999999 99999999999864 4478
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|+||||+. ++|..++... .+++..++.++.||+.||.|||++||+||||||+|||++.+|.++|+|||++..+...
T Consensus 85 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 85 YLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred EEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 99999995 6998887653 6889999999999999999999999999999999999999999999999988543211
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
... ......
T Consensus 161 ~~~-----------------------------------------------------------------------~~~~~~ 169 (337)
T cd07852 161 EEN-----------------------------------------------------------------------PENPVL 169 (337)
T ss_pred ccc-----------------------------------------------------------------------ccCcch
Confidence 000 000011
Q ss_pred cccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC-------------------
Q 007433 449 MSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPL------------------- 508 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~------------------- 508 (604)
..++||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..+.....
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (337)
T cd07852 170 TDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATML 249 (337)
T ss_pred hcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhh
Confidence 23568999999998865 4578899999999999999999999987665544333221100
Q ss_pred ---------CC-CCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 509 ---------RF-PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 509 ---------~~-p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
.+ ...+.++.++.+||.+||..||++||+ +.++++||||+.+
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps----~~~il~~~~~~~~ 301 (337)
T cd07852 250 DSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLT----AEEALEHPYVAQF 301 (337)
T ss_pred hhcccccccchhhhccCCCHHHHHHHHHhccCCcccccC----HHHHhhChhhhhh
Confidence 00 011236888999999999999999999 9999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=323.20 Aligned_cols=246 Identities=22% Similarity=0.310 Sum_probs=207.0
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++.+.||.|+||.||+|... ++.||+|.+..... ...++.+|+.+++.++|+||+++++++.++...|+|
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 468999999999999999999876 56899999976533 344667899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+++++|.+++.......+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-- 156 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-- 156 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc--
Confidence 999999999999987655579999999999999999999999999999999999999999999999999874321000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
...
T Consensus 157 -----------------------------------------------------------------------------~~~ 159 (256)
T cd05039 157 -----------------------------------------------------------------------------DSG 159 (256)
T ss_pred -----------------------------------------------------------------------------ccC
Confidence 011
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
.++..|+|||++.+..++.++|||||||++|||++ |..||...........+.. .........++..+.+||.+||..
T Consensus 160 ~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~ 238 (256)
T cd05039 160 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEK-GYRMEAPEGCPPEVYKVMKDCWEL 238 (256)
T ss_pred CCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhc-CCCCCCccCCCHHHHHHHHHHhcc
Confidence 24567999999998889999999999999999997 9999987765555444433 233333345789999999999999
Q ss_pred CCCCcccccCCHHHHhc
Q 007433 531 EPQNRLACRRGATEIKQ 547 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~ 547 (604)
+|++||+ +.|+++
T Consensus 239 ~p~~Rp~----~~~l~~ 251 (256)
T cd05039 239 DPAKRPT----FKQLRE 251 (256)
T ss_pred ChhhCcC----HHHHHH
Confidence 9999999 788765
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=349.78 Aligned_cols=259 Identities=21% Similarity=0.294 Sum_probs=211.5
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcC-----CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEe
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTG-----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFE 283 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~ 283 (604)
+..++|.+.++||+|+||.||+|++.+ ++..||||++...... .....+.+|+++|..+. ||||+++++++.
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--SEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--hHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 344678999999999999999999653 4568999999765322 22335678999999997 999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHhcCC------------------------------------------------------
Q 007433 284 TDKFSCLVMEFCPGGDLHTLRQRQPG------------------------------------------------------ 309 (604)
Q Consensus 284 ~~~~~~lV~E~~~ggsL~~ll~~~~~------------------------------------------------------ 309 (604)
..+..|+|||||.+|+|.+++.+...
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 99999999999999999999875321
Q ss_pred ------------------------------------------CCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEE
Q 007433 310 ------------------------------------------KYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVL 347 (604)
Q Consensus 310 ------------------------------------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNIL 347 (604)
..|++..+..|+.||+.||+|||++||+||||||+|||
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL 271 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL 271 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence 24677788999999999999999999999999999999
Q ss_pred EccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCcc
Q 007433 348 VREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKN 427 (604)
Q Consensus 348 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 427 (604)
++.++.++|+|||++..+......
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~-------------------------------------------------------- 295 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNY-------------------------------------------------------- 295 (401)
T ss_pred EeCCCEEEEEecCcceeccccccc--------------------------------------------------------
Confidence 999999999999998432110000
Q ss_pred ccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcC
Q 007433 428 EMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQ 506 (604)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~ 506 (604)
.......|+..|+|||++.+..++.++|||||||+||||++ |..||......+.+...+..
T Consensus 296 ------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~ 357 (401)
T cd05107 296 ------------------ISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKR 357 (401)
T ss_pred ------------------ccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHc
Confidence 00012347889999999999889999999999999999998 89999887766666666555
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 507 PLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 507 ~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
..+.+....++.++.+||.+||..||.+||+ +.+|++.
T Consensus 358 ~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs----~~ell~~ 395 (401)
T cd05107 358 GYRMAKPAHASDEIYEIMQKCWEEKFEIRPD----FSQLVHL 395 (401)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 5555455568899999999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=329.68 Aligned_cols=254 Identities=31% Similarity=0.487 Sum_probs=208.5
Q ss_pred eEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEee
Q 007433 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEF 294 (604)
Q Consensus 215 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 294 (604)
|++.+.||.|++|.||+|.+..++..+|+|.+....... .....+.+|+++|+.++|+||+++++++..+...|+||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESE-GIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccc-hhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 677899999999999999999999999999987653321 2334566799999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccccc
Q 007433 295 CPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKS 374 (604)
Q Consensus 295 ~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~ 374 (604)
++ ++|..++.... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||.+.......
T Consensus 80 ~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~----- 152 (283)
T cd05118 80 MD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV----- 152 (283)
T ss_pred cC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-----
Confidence 95 58888776643 578999999999999999999999999999999999999999999999999874322100
Q ss_pred CcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccC
Q 007433 375 STLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGT 454 (604)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT 454 (604)
.......++
T Consensus 153 -----------------------------------------------------------------------~~~~~~~~~ 161 (283)
T cd05118 153 -----------------------------------------------------------------------RPYTHYVVT 161 (283)
T ss_pred -----------------------------------------------------------------------ccccCccCc
Confidence 000113478
Q ss_pred ccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---C----------------CCCC---
Q 007433 455 HEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---P----------------LRFP--- 511 (604)
Q Consensus 455 ~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~----------------~~~p--- 511 (604)
..|+|||++.+. .++.++|+|||||++|+|++|+.||.+.+..+.+..+... + ..++
T Consensus 162 ~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (283)
T cd05118 162 RWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKA 241 (283)
T ss_pred ccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhcccc
Confidence 899999998876 6889999999999999999999999887766655444321 0 0000
Q ss_pred ------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 512 ------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 512 ------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
..+.++.++++||.+||..||.+||+ +.++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~ll~~~~~ 283 (283)
T cd05118 242 GMPLPKLFPNASPQALDLLSQMLHYDPHKRIT----AEQALAHPYF 283 (283)
T ss_pred ccCHHHhhhhhCHHHHHHHHHHhccCcccCcC----HHHHhhCCCC
Confidence 01236788999999999999999999 9999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=328.77 Aligned_cols=251 Identities=31% Similarity=0.463 Sum_probs=202.0
Q ss_pred EEEEEEccCCcEEEEEEEEc----CCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 216 RLLKKLGCGDIGSVYLSELT----GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 216 ~l~~~LG~G~fG~Vy~a~~~----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.+.+.||.|.||.||+|.+. ..+..|+||++..... ......+.+|+++|++++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSS--EEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSS--HHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccc--cccceeeeeccccccccccccccccccccccccccccc
Confidence 56789999999999999998 4567899999954322 22345677899999999999999999999988889999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
||||++|+|.+++.......+++..+..|+.||+.||.|||+++|+||||+++||||+.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999999875578999999999999999999999999999999999999999999999999988433110000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 160 --------------------------------------------------------------------------~~~~~~ 165 (259)
T PF07714_consen 160 --------------------------------------------------------------------------KNDSSQ 165 (259)
T ss_dssp --------------------------------------------------------------------------EESTTS
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 000112
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
.+...|+|||.+.+..++.++||||||+++|||++ |+.||......+....+. ...+.+....++..+.+||..||..
T Consensus 166 ~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~C~~~ 244 (259)
T PF07714_consen 166 QLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLK-QGQRLPIPDNCPKDIYSLIQQCWSH 244 (259)
T ss_dssp ESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHH-TTEETTSBTTSBHHHHHHHHHHT-S
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccc-ccccceeccchhHHHHHHHHHHcCC
Confidence 36678999999999889999999999999999999 789999887777666664 3444445556899999999999999
Q ss_pred CCCCcccccCCHHHHhc
Q 007433 531 EPQNRLACRRGATEIKQ 547 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~ 547 (604)
||++||+ +.+|++
T Consensus 245 ~p~~RPs----~~~i~~ 257 (259)
T PF07714_consen 245 DPEKRPS----FQEILQ 257 (259)
T ss_dssp SGGGS------HHHHHH
T ss_pred ChhhCcC----HHHHHh
Confidence 9999999 888864
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=332.94 Aligned_cols=256 Identities=22% Similarity=0.311 Sum_probs=204.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCC--------------ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccc
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGT--------------KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPT 277 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~--------------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~ 277 (604)
.++|++.++||+|+||.||+|++.++ ...||+|.+..... ......+.+|+++|+.++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCcCe
Confidence 36899999999999999999987543 33599999976432 123345678999999999999999
Q ss_pred cceeEecCCeeEEEEeecCCCCHHHHHHhcC----------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEE
Q 007433 278 LYTHFETDKFSCLVMEFCPGGDLHTLRQRQP----------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVL 347 (604)
Q Consensus 278 l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~----------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNIL 347 (604)
+++++..++..|+||||+.+++|.+++.... ...+++..+..++.||+.||.|||++|++||||||+|||
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 9999999999999999999999999886532 124688899999999999999999999999999999999
Q ss_pred EccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCcc
Q 007433 348 VREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKN 427 (604)
Q Consensus 348 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 427 (604)
++.++.+||+|||++..+.....
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~--------------------------------------------------------- 184 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDY--------------------------------------------------------- 184 (295)
T ss_pred EcCCCcEEecccccccccccCcc---------------------------------------------------------
Confidence 99999999999998743211000
Q ss_pred ccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh--CCCCCCCCChHHHHHHHHc
Q 007433 428 EMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF--GKTPFKGSENRATLYNVVG 505 (604)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt--G~~PF~~~~~~~~l~~i~~ 505 (604)
........++..|+|||++.+..++.++|||||||++|||++ |..||......+.+..+..
T Consensus 185 -----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~ 247 (295)
T cd05097 185 -----------------YRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGE 247 (295)
T ss_pred -----------------eeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHH
Confidence 000012246788999999998889999999999999999988 7788987766555444321
Q ss_pred ------CCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 506 ------QPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 506 ------~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
...........+..+.+||.+||..||++||+ +.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs----~~~i~~ 291 (295)
T cd05097 248 FFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPT----FNKIHH 291 (295)
T ss_pred hhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcC----HHHHHH
Confidence 11222233457889999999999999999999 788764
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=337.46 Aligned_cols=257 Identities=28% Similarity=0.408 Sum_probs=206.8
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec-CCe
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET-DKF 287 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~ 287 (604)
....++|++++.||.|+||.||+|.+..+++.||||++.+.... ......+.+|+++++.++||||++++++|.. +..
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 84 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLED 84 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCc
Confidence 34567999999999999999999999999999999998654221 1223345679999999999999999999875 568
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccC
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAV 367 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~ 367 (604)
.|+||||+ +++|..++.. ..+++..+..++.||+.||.|||++||+||||+|+|||++.++.++|+|||++....
T Consensus 85 ~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~- 159 (328)
T cd07856 85 IYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD- 159 (328)
T ss_pred EEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC-
Confidence 89999999 7799888764 358899999999999999999999999999999999999999999999999873210
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
..
T Consensus 160 ------------------------------------------------------------------------------~~ 161 (328)
T cd07856 160 ------------------------------------------------------------------------------PQ 161 (328)
T ss_pred ------------------------------------------------------------------------------CC
Confidence 00
Q ss_pred ccccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHH---HcC-----------------
Q 007433 448 SMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNV---VGQ----------------- 506 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i---~~~----------------- 506 (604)
....+++..|+|||++.+ ..++.++|||||||++|+|++|+.||.+......+..+ .+.
T Consensus 162 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (328)
T cd07856 162 MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRF 241 (328)
T ss_pred cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHH
Confidence 112357889999999866 56899999999999999999999999876543222111 110
Q ss_pred ------CCCCCC---CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 507 ------PLRFPE---SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 507 ------~~~~p~---~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
....+. .+.++..++++|.+||..||++||+ +++++.||||+.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t----~~ell~~~~~~~ 293 (328)
T cd07856 242 VQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRIS----AAEALAHPYLAP 293 (328)
T ss_pred HhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCCcccc
Confidence 001111 1346789999999999999999999 999999999963
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=322.43 Aligned_cols=250 Identities=21% Similarity=0.316 Sum_probs=206.3
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++.++||+|+||.||++.+... ..+|+|.+..... ....+.+|+++++.++|+||+++++++.. ...|+|
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~-~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v 78 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKH-TKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYII 78 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCC-ccEEEEecCCChh----HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEE
Confidence 47899999999999999999987654 4699999875432 22356679999999999999999999887 778999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+++++|.+++....+..+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++..+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 79 TEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred EEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 99999999999998766677899999999999999999999999999999999999999999999999987432110000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
.....
T Consensus 159 ---------------------------------------------------------------------------~~~~~ 163 (260)
T cd05073 159 ---------------------------------------------------------------------------AREGA 163 (260)
T ss_pred ---------------------------------------------------------------------------cccCC
Confidence 00012
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
.++..|+|||++.+..++.++|+|||||++|+|++ |+.||.+.+.......+.. ....+.....+.++.+++.+||..
T Consensus 164 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~ 242 (260)
T cd05073 164 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER-GYRMPRPENCPEELYNIMMRCWKN 242 (260)
T ss_pred cccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhC-CCCCCCcccCCHHHHHHHHHHccc
Confidence 35677999999998889999999999999999998 9999998776655554443 334444456889999999999999
Q ss_pred CCCCcccccCCHHHHhc
Q 007433 531 EPQNRLACRRGATEIKQ 547 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~ 547 (604)
||++||+ +.++++
T Consensus 243 ~p~~Rp~----~~~l~~ 255 (260)
T cd05073 243 RPEERPT----FEYIQS 255 (260)
T ss_pred CcccCcC----HHHHHH
Confidence 9999999 666653
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=330.43 Aligned_cols=256 Identities=23% Similarity=0.304 Sum_probs=202.7
Q ss_pred cCeEEEEEEccCCcEEEEEEEE----cCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC--C
Q 007433 213 GHFRLLKKLGCGDIGSVYLSEL----TGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD--K 286 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~ 286 (604)
..|++++.||+|+||.||+|+. ..++..||+|.+..... ......+.+|+++|+.++|+||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 3579999999999999999985 45678999999875432 22334677899999999999999999998764 6
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
..|+||||++|++|.+++.+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE 160 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccc
Confidence 7899999999999999987653 468999999999999999999999999999999999999999999999999885432
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
...... .
T Consensus 161 ~~~~~~-------------------------------------------------------------------------~ 167 (284)
T cd05079 161 TDKEYY-------------------------------------------------------------------------T 167 (284)
T ss_pred cCccce-------------------------------------------------------------------------e
Confidence 110000 0
Q ss_pred cccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCC--------------ChHHHHHHHHcCCCCCCC
Q 007433 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS--------------ENRATLYNVVGQPLRFPE 512 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~--------------~~~~~l~~i~~~~~~~p~ 512 (604)
......|+..|+|||++.+..++.++|||||||++|||+++..|+... ................+.
T Consensus 168 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (284)
T cd05079 168 VKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPR 247 (284)
T ss_pred ecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCC
Confidence 001234778899999999888999999999999999999987765321 111112222223334444
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 513 SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 513 ~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
...++..+.+||.+||..||++||+ +.+++++
T Consensus 248 ~~~~~~~~~~li~~~l~~~p~~Rpt----~~~il~~ 279 (284)
T cd05079 248 PPNCPEEVYQLMRKCWEFQPSKRTT----FQNLIEG 279 (284)
T ss_pred CCCCCHHHHHHHHHHccCCcccCcC----HHHHHHH
Confidence 5568899999999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-39 Score=333.83 Aligned_cols=255 Identities=21% Similarity=0.292 Sum_probs=205.4
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcC-------CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEe
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTG-------TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFE 283 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~ 283 (604)
.++|.+.+.||+|+||.||++++.+ ....||+|++..... ......+..|+++++.+ +||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 4689999999999999999998642 345799999875432 23344567899999999 6999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHhcC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEc
Q 007433 284 TDKFSCLVMEFCPGGDLHTLRQRQP--------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVR 349 (604)
Q Consensus 284 ~~~~~~lV~E~~~ggsL~~ll~~~~--------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~ 349 (604)
.++.+|+||||+++|+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 9999999999999999999987642 23588999999999999999999999999999999999999
Q ss_pred cCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCcccc
Q 007433 350 EDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEM 429 (604)
Q Consensus 350 ~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (604)
.++.++|+|||++.........
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~---------------------------------------------------------- 190 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYY---------------------------------------------------------- 190 (314)
T ss_pred CCCcEEEccccccccccccccc----------------------------------------------------------
Confidence 9999999999988432110000
Q ss_pred CCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCC
Q 007433 430 GNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPL 508 (604)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~ 508 (604)
.......++..|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+... .
T Consensus 191 ----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~ 253 (314)
T cd05099 191 ----------------KKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREG-H 253 (314)
T ss_pred ----------------cccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-C
Confidence 00001124467999999999889999999999999999998 89999887665555554443 2
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 509 RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 509 ~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
.......++.++++||.+||..||++||+ +.++++
T Consensus 254 ~~~~~~~~~~~l~~li~~cl~~~p~~Rps----~~~ll~ 288 (314)
T cd05099 254 RMDKPSNCTHELYMLMRECWHAVPTQRPT----FKQLVE 288 (314)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCCcccCcC----HHHHHH
Confidence 22233457889999999999999999999 777775
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=326.60 Aligned_cols=256 Identities=17% Similarity=0.232 Sum_probs=208.3
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcC----CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec-C
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTG----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET-D 285 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~ 285 (604)
..++|++.+.||+|+||.||+|.+.. ++..|++|.+.... .......+.+|+.+|+.++|+||+++++++.. +
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 35789999999999999999999876 35789999986442 22334566789999999999999999998765 5
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCC------CCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPG------KYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDF 359 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DF 359 (604)
...++++||+++++|..++..... ..+++..+..++.||+.||+|||+++++||||||+|||++.++.+||+||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 788999999999999999876422 46899999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccc
Q 007433 360 DLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPEL 439 (604)
Q Consensus 360 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (604)
|++..+.......
T Consensus 162 g~~~~~~~~~~~~------------------------------------------------------------------- 174 (280)
T cd05043 162 ALSRDLFPMDYHC------------------------------------------------------------------- 174 (280)
T ss_pred CCcccccCCceEE-------------------------------------------------------------------
Confidence 9985432111000
Q ss_pred ccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCH
Q 007433 440 IAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSF 518 (604)
Q Consensus 440 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~ 518 (604)
......++..|+|||++.+..++.++|||||||++|||++ |+.||...+..+.. ..+.....++....++.
T Consensus 175 -------~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 246 (280)
T cd05043 175 -------LGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA-AYLKDGYRLAQPINCPD 246 (280)
T ss_pred -------eCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHH-HHHHcCCCCCCCCcCCH
Confidence 0001236678999999999889999999999999999998 99999877655544 33333444445556789
Q ss_pred HHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 519 SARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 519 ~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
++.++|.+||..||++||+ +.++++
T Consensus 247 ~~~~li~~~l~~~p~~Rps----~~~~~~ 271 (280)
T cd05043 247 ELFAVMACCWALDPEERPS----FSQLVQ 271 (280)
T ss_pred HHHHHHHHHcCCChhhCCC----HHHHHH
Confidence 9999999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-39 Score=323.92 Aligned_cols=246 Identities=23% Similarity=0.317 Sum_probs=197.3
Q ss_pred EEccCCcEEEEEEEEc--CCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCC
Q 007433 220 KLGCGDIGSVYLSELT--GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPG 297 (604)
Q Consensus 220 ~LG~G~fG~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 297 (604)
.||+|+||.||+|.+. .++..||+|++..... ......+.+|+.+|+.++|+||+++++++.. ...|+||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE--KSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC--hHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 3899999999999775 4556799999875532 2333467789999999999999999998864 578999999999
Q ss_pred CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcc
Q 007433 298 GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTL 377 (604)
Q Consensus 298 gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 377 (604)
++|.+++... ...+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++...........
T Consensus 79 ~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~---- 153 (257)
T cd05115 79 GPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK---- 153 (257)
T ss_pred CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCcccee----
Confidence 9999988754 25789999999999999999999999999999999999999999999999998843221110000
Q ss_pred cCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccc
Q 007433 378 ESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEY 457 (604)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 457 (604)
......++..|
T Consensus 154 ---------------------------------------------------------------------~~~~~~~~~~y 164 (257)
T cd05115 154 ---------------------------------------------------------------------ARSAGKWPLKW 164 (257)
T ss_pred ---------------------------------------------------------------------ccCCCCCCccc
Confidence 00011245789
Q ss_pred cCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcc
Q 007433 458 LAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRL 536 (604)
Q Consensus 458 ~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rp 536 (604)
+|||++.+..++.++|||||||++|||++ |..||.+.........+... .........+.++.+||.+||.+||++||
T Consensus 165 ~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~c~~~~~~~Rp 243 (257)
T cd05115 165 YAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQG-KRLDCPAECPPEMYALMKDCWIYKWEDRP 243 (257)
T ss_pred CCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCC-CCCCCCCCCCHHHHHHHHHHcCCChhhCc
Confidence 99999998889999999999999999996 99999987776655544433 23334455789999999999999999999
Q ss_pred cccCCHHHHhc
Q 007433 537 ACRRGATEIKQ 547 (604)
Q Consensus 537 t~~~~a~elL~ 547 (604)
+ +.+|++
T Consensus 244 ~----~~~i~~ 250 (257)
T cd05115 244 N----FAKVEE 250 (257)
T ss_pred C----HHHHHH
Confidence 9 666654
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=329.40 Aligned_cols=255 Identities=22% Similarity=0.332 Sum_probs=207.0
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcC-----CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTG-----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
.++|++++.||.|+||.||+|.+.+ ++..||+|++...... .....+.+|+.+++.++||||+++++++.++.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCH--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 4689999999999999999998753 5778999998754321 22345678999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcC--------------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcE
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQP--------------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENV 346 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~--------------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNI 346 (604)
..|+||||+++++|.+++.... ...+++..+..++.||+.||+|||++|++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 9999999999999999987532 12478889999999999999999999999999999999
Q ss_pred EEccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCc
Q 007433 347 LVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPK 426 (604)
Q Consensus 347 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (604)
|++.++.++|+|||++..+.....
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~-------------------------------------------------------- 185 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADY-------------------------------------------------------- 185 (288)
T ss_pred EecCCCceEECccccceecccCcc--------------------------------------------------------
Confidence 999999999999998743210000
Q ss_pred cccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHc
Q 007433 427 NEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVG 505 (604)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~ 505 (604)
........++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+.+..+..
T Consensus 186 ------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~ 247 (288)
T cd05050 186 ------------------YKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRD 247 (288)
T ss_pred ------------------ccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc
Confidence 000001124567999999998899999999999999999997 8899988777666666554
Q ss_pred CCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 506 QPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 506 ~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
... .+....++.++.+||.+||..||++||+ +.||++
T Consensus 248 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt----~~el~~ 284 (288)
T cd05050 248 GNV-LSCPDNCPLELYNLMRLCWSKLPSDRPS----FASINR 284 (288)
T ss_pred CCC-CCCCCCCCHHHHHHHHHHcccCcccCCC----HHHHHH
Confidence 432 2333457899999999999999999999 777764
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=337.07 Aligned_cols=257 Identities=20% Similarity=0.299 Sum_probs=207.5
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCC-------ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGT-------KCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHF 282 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~ 282 (604)
...+|++.+.||+|+||.||+|++.+. ...||+|++..... ......+.+|+++++++ +|+||+++++++
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT--DKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC--HHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 345899999999999999999986432 23689998875422 22345667899999999 899999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHhcC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEE
Q 007433 283 ETDKFSCLVMEFCPGGDLHTLRQRQP--------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV 348 (604)
Q Consensus 283 ~~~~~~~lV~E~~~ggsL~~ll~~~~--------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl 348 (604)
..++..|+||||+++|+|.+++.... ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill 167 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 99999999999999999999987532 2357888999999999999999999999999999999999
Q ss_pred ccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccc
Q 007433 349 REDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNE 428 (604)
Q Consensus 349 ~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 428 (604)
+.++.++|+|||++.........
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~--------------------------------------------------------- 190 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYY--------------------------------------------------------- 190 (334)
T ss_pred cCCCcEEECCcccceeccccccc---------------------------------------------------------
Confidence 99999999999988432210000
Q ss_pred cCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCC
Q 007433 429 MGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQP 507 (604)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~ 507 (604)
.......++..|+|||++.+..++.++|||||||+||||++ |..||.+.+..+.+..+...
T Consensus 191 -----------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~- 252 (334)
T cd05100 191 -----------------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG- 252 (334)
T ss_pred -----------------ccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-
Confidence 00001124567999999999999999999999999999998 89999887766655555433
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 508 LRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 508 ~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
...+....++.++.+||.+||..+|++||+ +.|++++
T Consensus 253 ~~~~~~~~~~~~l~~li~~cl~~~p~~Rps----~~ell~~ 289 (334)
T cd05100 253 HRMDKPANCTHELYMIMRECWHAVPSQRPT----FKQLVED 289 (334)
T ss_pred CCCCCCCCCCHHHHHHHHHHcccChhhCcC----HHHHHHH
Confidence 333334457889999999999999999999 8888876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=325.19 Aligned_cols=254 Identities=21% Similarity=0.295 Sum_probs=206.5
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCce----EEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKC----YFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
..++|++++.||+|+||.||+|.+..++. .||+|.+..... ......+.+|+.+|+.++|+||+++++++.. .
T Consensus 5 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 5 KETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred CHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 34689999999999999999999876554 689999876643 2334466789999999999999999999987 7
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
..++||||+++|+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccccc
Confidence 8899999999999999987653 458999999999999999999999999999999999999999999999999885432
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
.....+.
T Consensus 161 ~~~~~~~------------------------------------------------------------------------- 167 (279)
T cd05057 161 VDEKEYH------------------------------------------------------------------------- 167 (279)
T ss_pred Cccccee-------------------------------------------------------------------------
Confidence 1100000
Q ss_pred cccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007433 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIK 525 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~ 525 (604)
.....++..|+|||.+....++.++|+|||||++|||++ |+.||.+....+....+. ....++.....+..+.++|.
T Consensus 168 -~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 245 (279)
T cd05057 168 -AEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE-KGERLPQPPICTIDVYMVLV 245 (279)
T ss_pred -cCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-CCCCCCCCCCCCHHHHHHHH
Confidence 001124568999999988889999999999999999998 999998876555444443 33344445567889999999
Q ss_pred HhhhcCCCCcccccCCHHHHhc
Q 007433 526 GLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
+||..||++||+ +.++++
T Consensus 246 ~~l~~~p~~Rp~----~~~l~~ 263 (279)
T cd05057 246 KCWMIDAESRPT----FKELIN 263 (279)
T ss_pred HHcCCChhhCCC----HHHHHH
Confidence 999999999999 666543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=326.52 Aligned_cols=254 Identities=24% Similarity=0.355 Sum_probs=201.2
Q ss_pred cCeEEEEEEccCCcEEEEEEEE----cCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec--CC
Q 007433 213 GHFRLLKKLGCGDIGSVYLSEL----TGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET--DK 286 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~ 286 (604)
.+|++++.||+|+||+||++.. ..++..||||.+..... .....+.+|+++|+.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA---EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH---HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 5899999999999999999974 45678999999875532 234456789999999999999999998753 45
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
.+|+||||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 159 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHR-ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLP 159 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcC-cCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCccccccc
Confidence 7899999999999999987642 468999999999999999999999999999999999999999999999999884432
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
.......
T Consensus 160 ~~~~~~~------------------------------------------------------------------------- 166 (284)
T cd05081 160 QDKEYYK------------------------------------------------------------------------- 166 (284)
T ss_pred CCCccee-------------------------------------------------------------------------
Confidence 1100000
Q ss_pred cccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChH---------------HHHHHHHcCCCCCC
Q 007433 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR---------------ATLYNVVGQPLRFP 511 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~---------------~~l~~i~~~~~~~p 511 (604)
......++..|+|||++.+..++.++|||||||++|||++|..++...... ..+.+++.....++
T Consensus 167 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (284)
T cd05081 167 VREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLP 246 (284)
T ss_pred ecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCC
Confidence 000112445699999999888999999999999999999988776433211 11223333444455
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 512 ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 512 ~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
....++.++.+||.+||..+|++||+ +.||++
T Consensus 247 ~~~~~~~~~~~li~~cl~~~p~~Rpt----~~ei~~ 278 (284)
T cd05081 247 APPGCPAEIYAIMKECWNNDPSQRPS----FSELAL 278 (284)
T ss_pred CCCCCCHHHHHHHHHHccCChhhCCC----HHHHHH
Confidence 55668899999999999999999999 888865
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=327.37 Aligned_cols=254 Identities=31% Similarity=0.478 Sum_probs=207.9
Q ss_pred eEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEee
Q 007433 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEF 294 (604)
Q Consensus 215 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 294 (604)
|++.+.||+|+||.||+|.+..+++.||+|++..... .......+..|+++++.++|+||+++++++...+..|+||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNE-EEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccc-cccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 6788999999999999999999999999999986541 222334556799999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccccc
Q 007433 295 CPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKS 374 (604)
Q Consensus 295 ~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~ 374 (604)
++ ++|.+++.+.. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~----- 152 (282)
T cd07829 80 CD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL----- 152 (282)
T ss_pred cC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc-----
Confidence 96 69999988753 469999999999999999999999999999999999999999999999999873321000
Q ss_pred CcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccC
Q 007433 375 STLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGT 454 (604)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT 454 (604)
.......++
T Consensus 153 -----------------------------------------------------------------------~~~~~~~~~ 161 (282)
T cd07829 153 -----------------------------------------------------------------------RTYTHEVVT 161 (282)
T ss_pred -----------------------------------------------------------------------cccCccccC
Confidence 000122467
Q ss_pred ccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC------------------CCCCCC---
Q 007433 455 HEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ------------------PLRFPE--- 512 (604)
Q Consensus 455 ~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~------------------~~~~p~--- 512 (604)
..|+|||++.+. .++.++|||||||++|||++|+.||.+......+.++... ...++.
T Consensus 162 ~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (282)
T cd07829 162 LWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPP 241 (282)
T ss_pred cCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCc
Confidence 789999998776 7889999999999999999999999887665554433220 000110
Q ss_pred ------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 513 ------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 513 ------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
.+.++..+.++|++||..||++||+ +.++++||||
T Consensus 242 ~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~----~~~~l~~p~~ 282 (282)
T cd07829 242 KDLEKVLPRLDPEGIDLLSKMLQYNPAKRIS----AKEALKHPYF 282 (282)
T ss_pred cchHHhcccccHHHHHHHHHhhccCcccCCC----HHHHhhCcCC
Confidence 1234778999999999999999999 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-40 Score=318.21 Aligned_cols=266 Identities=24% Similarity=0.354 Sum_probs=211.8
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC---
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD--- 285 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--- 285 (604)
.+..+||++.++||+|||+-||+++...++..||+|.+.... .+....+++|++..++++||||++++++...+
T Consensus 17 ~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~---~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 17 IINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS---QEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc---hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc
Confidence 345689999999999999999999999999999999997764 34556778999999999999999999987533
Q ss_pred --CeeEEEEeecCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHcC--eEeccCCCCcEEEccCCcEEEecc
Q 007433 286 --KFSCLVMEFCPGGDLHTLRQRQ--PGKYFSEQAVKFYVAEVLLALEYLHMLG--IVYRDLKPENVLVREDGHIMLSDF 359 (604)
Q Consensus 286 --~~~~lV~E~~~ggsL~~ll~~~--~~~~l~e~~~~~i~~qil~aL~yLH~~g--IvHrDIKpeNILl~~~g~vkL~DF 359 (604)
...||+++|...|+|.+.+.+. .+..++|..+..|+.+|++||++||+.. +.||||||.|||+...+.++|.||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~ 173 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDL 173 (302)
T ss_pred CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEec
Confidence 4589999999999999987753 3558999999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccc
Q 007433 360 DLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPEL 439 (604)
Q Consensus 360 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (604)
|.+.... + +...+.....-..
T Consensus 174 GS~~~a~---------------------------------i--------------~i~~~~~a~~lQe------------ 194 (302)
T KOG2345|consen 174 GSATQAP---------------------------------I--------------QIEGSRQALRLQE------------ 194 (302)
T ss_pred cCccccc---------------------------------e--------------EeechHHHHHHHH------------
Confidence 9762211 0 0000000000000
Q ss_pred ccCCCCCcccccccCccccCcceecCC---CCCccchHHHHHHHHHHHhhCCCCCCCCCh--HHHHHHHHcCCCCCCCCC
Q 007433 440 IAEPTNARSMSFVGTHEYLAPEIIKGE---GHGSAVDWWTFGIFLYELLFGKTPFKGSEN--RATLYNVVGQPLRFPESP 514 (604)
Q Consensus 440 ~~~~~~~~~~~~~GT~~Y~APE~l~~~---~~~~~~DiWSLGviL~eLltG~~PF~~~~~--~~~l~~i~~~~~~~p~~~ 514 (604)
-..-.-|..|+|||++.-. ..+.++|||||||+||+|++|.-||...-. ......+....+.+|...
T Consensus 195 --------~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~ 266 (302)
T KOG2345|consen 195 --------WAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNAQISIPNSS 266 (302)
T ss_pred --------HHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeeccccccCCCC
Confidence 0011367889999998654 457899999999999999999999963211 011123445567888888
Q ss_pred CCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 515 VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 515 ~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
..|+.+.+||+.||..||.+||+ +.+|+.+
T Consensus 267 ~yse~l~~lik~mlqvdP~qRP~----i~~ll~~ 296 (302)
T KOG2345|consen 267 RYSEALHQLIKSMLQVDPNQRPT----IPELLSK 296 (302)
T ss_pred CccHHHHHHHHHHhcCCcccCCC----HHHHHHH
Confidence 89999999999999999999999 8888765
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=329.71 Aligned_cols=256 Identities=23% Similarity=0.330 Sum_probs=203.5
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcC----------------CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCc
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTG----------------TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFL 275 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~----------------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI 275 (604)
.++|++.++||+|+||.||++++.. +...||+|++..... ......+.+|+++|+.++|+||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN--KNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCc
Confidence 3589999999999999999986543 345799999975422 2233456789999999999999
Q ss_pred cccceeEecCCeeEEEEeecCCCCHHHHHHhcCC---------CCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcE
Q 007433 276 PTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPG---------KYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENV 346 (604)
Q Consensus 276 v~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~---------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNI 346 (604)
+++++++..++..|+||||+++++|.+++..... ..+++..+..++.||+.||+|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 9999999999999999999999999998876421 2477889999999999999999999999999999999
Q ss_pred EEccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCc
Q 007433 347 LVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPK 426 (604)
Q Consensus 347 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (604)
|++.++.++|+|||++..+.....
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~-------------------------------------------------------- 185 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDY-------------------------------------------------------- 185 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcc--------------------------------------------------------
Confidence 999999999999998843211000
Q ss_pred cccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh--CCCCCCCCChHHHHHHHH
Q 007433 427 NEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF--GKTPFKGSENRATLYNVV 504 (604)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt--G~~PF~~~~~~~~l~~i~ 504 (604)
........++..|++||++.+..++.++|||||||++|||++ |..||......+.+.+..
T Consensus 186 ------------------~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~ 247 (296)
T cd05095 186 ------------------YRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTG 247 (296)
T ss_pred ------------------eeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHH
Confidence 000011235678999999888889999999999999999998 789998766555443321
Q ss_pred ------cCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 505 ------GQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 505 ------~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
.....++....++..+.+||.+||..||.+||+ +.+|++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~----~~~i~~ 292 (296)
T cd05095 248 EFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPS----FQEIHA 292 (296)
T ss_pred HHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCC----HHHHHH
Confidence 122233444557889999999999999999999 777754
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=319.81 Aligned_cols=251 Identities=27% Similarity=0.404 Sum_probs=208.6
Q ss_pred eEEEEEEccCCcEEEEEEEEcCCc----eEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 215 FRLLKKLGCGDIGSVYLSELTGTK----CYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 215 y~l~~~LG~G~fG~Vy~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
|++.+.||.|+||.||++.+...+ ..||+|++....... ....+..|+++|+.++|+||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQ--QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChH--HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 457789999999999999998766 899999997654321 33466789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
||||+++++|.+++.......+++..+..++.||+.||+|||++|++||||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 99999999999998875433399999999999999999999999999999999999999999999999998743321100
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
. ....
T Consensus 159 ~---------------------------------------------------------------------------~~~~ 163 (258)
T smart00219 159 Y---------------------------------------------------------------------------KKKG 163 (258)
T ss_pred c---------------------------------------------------------------------------cccc
Confidence 0 0001
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
..+++.|+|||.+.+..++.++|||||||++|+|++ |..||........+..+.... ........+.++.++|.+||.
T Consensus 164 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~ 242 (258)
T smart00219 164 GKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGY-RLPKPENCPPEIYKLMLQCWA 242 (258)
T ss_pred CCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCC-CCCCCCcCCHHHHHHHHHHCc
Confidence 126788999999988889999999999999999998 899998876666666655433 233344589999999999999
Q ss_pred cCCCCcccccCCHHHHhc
Q 007433 530 KEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~ 547 (604)
.||++||+ +.++++
T Consensus 243 ~~p~~Rpt----~~~ll~ 256 (258)
T smart00219 243 EDPEDRPT----FSELVE 256 (258)
T ss_pred CChhhCcC----HHHHHh
Confidence 99999999 888875
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=349.16 Aligned_cols=257 Identities=25% Similarity=0.397 Sum_probs=218.8
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCc----eEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTK----CYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET 284 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 284 (604)
.+.-++-.+.++||+|+||.||+|+....+ ..||+|.+.......+..+.++.+|.++|+.++|||||++||+...
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~ 232 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVL 232 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence 344566677799999999999999886542 2389999976443455677788899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccc
Q 007433 285 DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLR 364 (604)
Q Consensus 285 ~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~ 364 (604)
..-+|||||+|.||+|.+++++.++ .++..+...++.+.+.||+|||++++|||||-.+|+|+..++.+||+||||++.
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 9999999999999999999999853 799999999999999999999999999999999999999999999999999832
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
.. .|....
T Consensus 312 ~~--------------------~~~~~~---------------------------------------------------- 319 (474)
T KOG0194|consen 312 GS--------------------QYVMKK---------------------------------------------------- 319 (474)
T ss_pred Cc--------------------ceeecc----------------------------------------------------
Confidence 11 000000
Q ss_pred CCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 007433 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDL 523 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dL 523 (604)
....-...|+|||.+....|+.++|||||||++||+++ |..||.+....+....|+...++.+.+...+.++..+
T Consensus 320 ----~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~~~~ 395 (474)
T KOG0194|consen 320 ----FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKELAKV 395 (474)
T ss_pred ----ccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHHHHH
Confidence 00012357999999999999999999999999999998 8999999999999889878888888877899999999
Q ss_pred HHHhhhcCCCCcccccCCHHHHh
Q 007433 524 IKGLLVKEPQNRLACRRGATEIK 546 (604)
Q Consensus 524 I~~lL~~dP~~Rpt~~~~a~elL 546 (604)
+.+|+..||+.|++ +.++.
T Consensus 396 ~~~c~~~~p~~R~t----m~~i~ 414 (474)
T KOG0194|consen 396 MKQCWKKDPEDRPT----MSTIK 414 (474)
T ss_pred HHHhccCChhhccC----HHHHH
Confidence 99999999999999 55554
|
|
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=326.90 Aligned_cols=253 Identities=22% Similarity=0.289 Sum_probs=197.8
Q ss_pred cCe-EEEEEEccCCcEEEEEEE----EcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec--C
Q 007433 213 GHF-RLLKKLGCGDIGSVYLSE----LTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET--D 285 (604)
Q Consensus 213 ~~y-~l~~~LG~G~fG~Vy~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~ 285 (604)
++| ++++.||.|+||+||++. ...++..||+|++...... .....+.+|+++|+.++||||+++++++.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQ--QNTSGWKKEINILKTLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 455 999999999999998865 3456778999999764321 223345679999999999999999998765 4
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
..+|+||||+++++|.+++... .+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+
T Consensus 81 ~~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 81 KGLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred ceEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 4689999999999999998764 5999999999999999999999999999999999999999999999999988433
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
........
T Consensus 158 ~~~~~~~~------------------------------------------------------------------------ 165 (283)
T cd05080 158 PEGHEYYR------------------------------------------------------------------------ 165 (283)
T ss_pred CCcchhhc------------------------------------------------------------------------
Confidence 21100000
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChH--------------HHHHHHHcCCCCCC
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR--------------ATLYNVVGQPLRFP 511 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~--------------~~l~~i~~~~~~~p 511 (604)
......++..|+|||++.+..++.++|||||||++|||++|..||...... ..+..........+
T Consensus 166 -~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (283)
T cd05080 166 -VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLP 244 (283)
T ss_pred -cCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCC
Confidence 000113566799999999888999999999999999999999998653211 11111122222333
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 512 ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 512 ~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
....++.++.+|+.+||..||++||+ +.++++
T Consensus 245 ~~~~~~~~~~~li~~cl~~~p~~Rps----~~~i~~ 276 (283)
T cd05080 245 CPKNCPQEVYILMKNCWETEAKFRPT----FRSLIP 276 (283)
T ss_pred CCCCCCHHHHHHHHHHhccChhhCCC----HHHHHH
Confidence 34557889999999999999999999 777774
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=319.66 Aligned_cols=251 Identities=24% Similarity=0.376 Sum_probs=206.8
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
..+|++.+.||.|+||.||++.+.. +..+|+|.+....... ..+.+|+++++.++||||+++++++......|+|
T Consensus 3 ~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~~----~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 77 (256)
T cd05112 3 PSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMSE----EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLV 77 (256)
T ss_pred hhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCCH----HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEE
Confidence 3589999999999999999998864 5589999987654322 2356799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+.+++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++........
T Consensus 78 ~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 155 (256)
T cd05112 78 FEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY- 155 (256)
T ss_pred EEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc-
Confidence 99999999999887653 4689999999999999999999999999999999999999999999999998743211000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 156 --------------------------------------------------------------------------~~~~~~ 161 (256)
T cd05112 156 --------------------------------------------------------------------------TSSTGT 161 (256)
T ss_pred --------------------------------------------------------------------------cccCCC
Confidence 000112
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
.++..|+|||++.+..++.++|||||||++|||++ |..||........+..+... .........+..+.+|+.+||..
T Consensus 162 ~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~~~l~~ 240 (256)
T cd05112 162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG-FRLYKPRLASQSVYELMQHCWKE 240 (256)
T ss_pred ccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC-CCCCCCCCCCHHHHHHHHHHccc
Confidence 35678999999998889999999999999999998 99999887766666555433 22222344789999999999999
Q ss_pred CCCCcccccCCHHHHhcC
Q 007433 531 EPQNRLACRRGATEIKQH 548 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~H 548 (604)
+|++||+ +.+++++
T Consensus 241 ~p~~Rp~----~~~~l~~ 254 (256)
T cd05112 241 RPEDRPS----FSLLLHQ 254 (256)
T ss_pred ChhhCCC----HHHHHHh
Confidence 9999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=325.81 Aligned_cols=239 Identities=21% Similarity=0.271 Sum_probs=192.2
Q ss_pred EEEccCCcEEEEEEEEcCCce-------EEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 219 KKLGCGDIGSVYLSELTGTKC-------YFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~-------~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
+.||.|+||+||+|.+...+. .||+|.+.... ......+..|+.+|+.++||||+++++++..+...++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 368999999999999866543 38888876542 23334567799999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCc--------EEEecccccc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGH--------IMLSDFDLSL 363 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~--------vkL~DFGla~ 363 (604)
|||+++|+|..++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. ++|+|||++.
T Consensus 78 ~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~ 156 (258)
T cd05078 78 QEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI 156 (258)
T ss_pred EecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence 99999999999987653 46899999999999999999999999999999999999987765 6889998763
Q ss_pred cccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCC
Q 007433 364 RCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEP 443 (604)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (604)
...
T Consensus 157 ~~~----------------------------------------------------------------------------- 159 (258)
T cd05078 157 TVL----------------------------------------------------------------------------- 159 (258)
T ss_pred ccC-----------------------------------------------------------------------------
Confidence 211
Q ss_pred CCCcccccccCccccCcceecCC-CCCccchHHHHHHHHHHHhhC-CCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHH
Q 007433 444 TNARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFG-KTPFKGSENRATLYNVVGQPLRFPESPVVSFSAR 521 (604)
Q Consensus 444 ~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG-~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~ 521 (604)
....+.|+..|+|||++.+. .++.++|||||||++|||++| ..||...+.... ..+......++. ..+.++.
T Consensus 160 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~ 233 (258)
T cd05078 160 ---PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK-LQFYEDRHQLPA--PKWTELA 233 (258)
T ss_pred ---CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH-HHHHHccccCCC--CCcHHHH
Confidence 00123578899999999874 578899999999999999998 466665544433 233333444443 3668899
Q ss_pred HHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 522 DLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 522 dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
+||.+||..||++||+ ++++++.
T Consensus 234 ~li~~~l~~~p~~Rps----~~~il~~ 256 (258)
T cd05078 234 NLINQCMDYEPDFRPS----FRAIIRD 256 (258)
T ss_pred HHHHHHhccChhhCCC----HHHHHHh
Confidence 9999999999999999 8888864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=344.75 Aligned_cols=251 Identities=27% Similarity=0.341 Sum_probs=196.3
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC-ee
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK-FS 288 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-~~ 288 (604)
.++++|.--.+||+|+||.||+|...+. ..||||.+....... ..++.+|+++|.+++|||||+|+|||.+++ +.
T Consensus 72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~ 147 (361)
T KOG1187|consen 72 KATNNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHR 147 (361)
T ss_pred HHHhCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceE
Confidence 3458999999999999999999999876 689999887654321 234788999999999999999999999888 59
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcC---eEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLG---IVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~g---IvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
+||+||+++|+|.+.+.......|+|..+..|+.+++.||+|||+.. |||||||++|||||+++++||+|||+|..
T Consensus 148 ~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~- 226 (361)
T KOG1187|consen 148 LLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKL- 226 (361)
T ss_pred EEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCccc-
Confidence 99999999999999988764338899999999999999999999854 99999999999999999999999999832
Q ss_pred cCC-CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 366 AVS-PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 366 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
... ..
T Consensus 227 ~~~~~~-------------------------------------------------------------------------- 232 (361)
T KOG1187|consen 227 GPEGDT-------------------------------------------------------------------------- 232 (361)
T ss_pred CCcccc--------------------------------------------------------------------------
Confidence 110 00
Q ss_pred CCccccc-ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCC--hHHHHH-------------HHHcCCC
Q 007433 445 NARSMSF-VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE--NRATLY-------------NVVGQPL 508 (604)
Q Consensus 445 ~~~~~~~-~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~--~~~~l~-------------~i~~~~~ 508 (604)
..... .||.+|+|||++.....+.++|||||||+|+||++|+.+..... ....+. .+++..+
T Consensus 233 --~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l 310 (361)
T KOG1187|consen 233 --SVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRL 310 (361)
T ss_pred --ceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCc
Confidence 00011 59999999999998888999999999999999999998887532 111111 1112111
Q ss_pred CCCCCC--CCCHHHHHHHHHhhhcCCCCcccccCCHHHH
Q 007433 509 RFPESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEI 545 (604)
Q Consensus 509 ~~p~~~--~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~el 545 (604)
...... ..-..+..+..+|+..+|.+||+ +.|+
T Consensus 311 ~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~----m~~V 345 (361)
T KOG1187|consen 311 KEGEYPDEKEVKKLAELALRCLRPDPKERPT----MSQV 345 (361)
T ss_pred cCCCCChHHHHHHHHHHHHHHcCcCCCcCcC----HHHH
Confidence 100100 01122457889999999999999 5554
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=320.33 Aligned_cols=245 Identities=23% Similarity=0.309 Sum_probs=202.8
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
..++|++.+.||.|+||.||++.. +++.||+|.+..... ...+.+|+.+++.++|+||+++++++..+ ..|+
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~-----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVT-----AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcch-----HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 346899999999999999999875 566799999865422 23466799999999999999999998765 4799
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
||||+.+++|.+++.......+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++......
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999999998765567899999999999999999999999999999999999999999999999987321100
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
...
T Consensus 154 -----------------------------------------------------------------------------~~~ 156 (254)
T cd05083 154 -----------------------------------------------------------------------------VDN 156 (254)
T ss_pred -----------------------------------------------------------------------------CCC
Confidence 001
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
...+..|+|||++.+..++.++|+|||||++|||++ |+.||...........+.. .........++..+.+||.+||.
T Consensus 157 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~ 235 (254)
T cd05083 157 SKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEK-GYRMEPPEGCPADVYVLMTSCWE 235 (254)
T ss_pred CCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhC-CCCCCCCCcCCHHHHHHHHHHcC
Confidence 123467999999998889999999999999999997 9999988776555544433 33333345688999999999999
Q ss_pred cCCCCcccccCCHHHHhc
Q 007433 530 KEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~ 547 (604)
.+|++||+ +.+|+.
T Consensus 236 ~~p~~Rp~----~~~l~~ 249 (254)
T cd05083 236 TEPKKRPS----FHKLRE 249 (254)
T ss_pred CChhhCcC----HHHHHH
Confidence 99999999 777764
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=318.38 Aligned_cols=246 Identities=26% Similarity=0.364 Sum_probs=202.7
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCCC
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGG 298 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 298 (604)
++||.|+||.||+|.+.. ++.||+|.+...... .....+.+|+++++.++|+||+++++++.+....|+||||+.++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 368999999999999988 889999998765433 23345678999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCccc
Q 007433 299 DLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLE 378 (604)
Q Consensus 299 sL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 378 (604)
+|.+++.... ..+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||++.........
T Consensus 78 ~l~~~l~~~~-~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~------- 149 (251)
T cd05041 78 SLLTFLRKKK-NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT------- 149 (251)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcce-------
Confidence 9999887643 46889999999999999999999999999999999999999999999999987432100000
Q ss_pred CCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCcccc
Q 007433 379 SEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYL 458 (604)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~ 458 (604)
.......++..|+
T Consensus 150 -------------------------------------------------------------------~~~~~~~~~~~y~ 162 (251)
T cd05041 150 -------------------------------------------------------------------VSDGLKQIPIKWT 162 (251)
T ss_pred -------------------------------------------------------------------eccccCcceeccC
Confidence 0000112456799
Q ss_pred CcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCccc
Q 007433 459 APEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLA 537 (604)
Q Consensus 459 APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt 537 (604)
|||++.+..++.++|||||||++|||++ |..||...........+.. ....+....++..+.+||.+||..+|++||+
T Consensus 163 ~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 241 (251)
T cd05041 163 APEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIES-GYRMPAPQLCPEEIYRLMLQCWAYDPENRPS 241 (251)
T ss_pred ChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhc-CCCCCCCccCCHHHHHHHHHHhccChhhCcC
Confidence 9999998889999999999999999998 8999988766555444433 3344444568899999999999999999999
Q ss_pred ccCCHHHHhc
Q 007433 538 CRRGATEIKQ 547 (604)
Q Consensus 538 ~~~~a~elL~ 547 (604)
+.|+++
T Consensus 242 ----~~ell~ 247 (251)
T cd05041 242 ----FSEIYN 247 (251)
T ss_pred ----HHHHHH
Confidence 888876
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=321.54 Aligned_cols=254 Identities=26% Similarity=0.358 Sum_probs=205.9
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCC---ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCe
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGT---KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKF 287 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 287 (604)
...+|.+.+.||.|+||.||+|.+... ...||||....... ......+.+|+.+++.++|+||+++++++.+ ..
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~ 80 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NP 80 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CC
Confidence 346799999999999999999987544 45799999865532 1233456789999999999999999998875 45
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccC
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAV 367 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~ 367 (604)
.|+||||+++++|.+++.... ..+++..+..++.||+.||+|||++|++||||||+|||++.++.++|+|||++..+..
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 81 VWIVMELAPLGELRSYLQVNK-YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred cEEEEEcCCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 789999999999999987653 4689999999999999999999999999999999999999999999999998743211
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
.... .
T Consensus 160 ~~~~---------------------------------------------------------------------------~ 164 (270)
T cd05056 160 ESYY---------------------------------------------------------------------------K 164 (270)
T ss_pred ccce---------------------------------------------------------------------------e
Confidence 0000 0
Q ss_pred ccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007433 448 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKG 526 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~ 526 (604)
.....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....+.+..+..+ ...+....++..+.+||.+
T Consensus 165 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~ 243 (270)
T cd05056 165 ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENG-ERLPMPPNCPPTLYSLMTK 243 (270)
T ss_pred cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHHHHHHHH
Confidence 001124568999999988889999999999999999986 99999888776666555433 2334445688999999999
Q ss_pred hhhcCCCCcccccCCHHHHhcC
Q 007433 527 LLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 527 lL~~dP~~Rpt~~~~a~elL~H 548 (604)
||..+|.+||+ +.+++..
T Consensus 244 ~l~~~P~~Rpt----~~~~~~~ 261 (270)
T cd05056 244 CWAYDPSKRPR----FTELKAQ 261 (270)
T ss_pred HcCCChhhCcC----HHHHHHH
Confidence 99999999999 7777654
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=316.55 Aligned_cols=246 Identities=23% Similarity=0.345 Sum_probs=200.8
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCCC
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGG 298 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 298 (604)
+.||.|+||.||+|... ++..||+|++...... .....+.+|+++++.++|+||+++++++...+..|+||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQ--ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcCCH--HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 36899999999999865 5678999998765322 22235678999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCccc
Q 007433 299 DLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLE 378 (604)
Q Consensus 299 sL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 378 (604)
+|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 78 ~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-------- 148 (250)
T cd05085 78 DFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY-------- 148 (250)
T ss_pred cHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceecccccc--------
Confidence 9999887643 4689999999999999999999999999999999999999999999999998743210000
Q ss_pred CCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCcccc
Q 007433 379 SEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYL 458 (604)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~ 458 (604)
.......++..|+
T Consensus 149 -------------------------------------------------------------------~~~~~~~~~~~y~ 161 (250)
T cd05085 149 -------------------------------------------------------------------SSSGLKQIPIKWT 161 (250)
T ss_pred -------------------------------------------------------------------ccCCCCCCccccc
Confidence 0000112456799
Q ss_pred CcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCccc
Q 007433 459 APEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLA 537 (604)
Q Consensus 459 APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt 537 (604)
|||++.+..++.++|||||||++|+|++ |..||.+.........+... ........++..+.+||.+||..+|++||+
T Consensus 162 aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 240 (250)
T cd05085 162 APEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG-YRMSCPQKCPDDVYKVMQRCWDYKPENRPK 240 (250)
T ss_pred CHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHHcccCcccCCC
Confidence 9999998889999999999999999998 99999887766665555433 333334458899999999999999999999
Q ss_pred ccCCHHHHhcC
Q 007433 538 CRRGATEIKQH 548 (604)
Q Consensus 538 ~~~~a~elL~H 548 (604)
+.|+++.
T Consensus 241 ----~~~l~~~ 247 (250)
T cd05085 241 ----FSELQKE 247 (250)
T ss_pred ----HHHHHHH
Confidence 8887653
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=359.86 Aligned_cols=255 Identities=25% Similarity=0.380 Sum_probs=217.7
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcC-----CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTG-----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET 284 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 284 (604)
+...+-++.+.||+|+||+||+|+..+ ....||||.++..... .....+++|+++|..|+|||||+|+|++..
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~--~~~~dF~REaeLla~l~H~nIVrLlGVC~~ 560 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAEN--QARQDFRREAELLAELQHPNIVRLLGVCRE 560 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccH--HHHHHHHHHHHHHHhccCCCeEEEEEEEcc
Confidence 445678888999999999999998743 4568999999776432 344567899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHhcC--------CCC----CcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC
Q 007433 285 DKFSCLVMEFCPGGDLHTLRQRQP--------GKY----FSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG 352 (604)
Q Consensus 285 ~~~~~lV~E~~~ggsL~~ll~~~~--------~~~----l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g 352 (604)
++-+|||+|||..|||.+++.... +.. |+..+...|+.||+.|++||-++.+|||||-..|+||.++.
T Consensus 561 ~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l 640 (774)
T KOG1026|consen 561 GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENL 640 (774)
T ss_pred CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccce
Confidence 999999999999999999987532 223 88999999999999999999999999999999999999999
Q ss_pred cEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCC
Q 007433 353 HIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQ 432 (604)
Q Consensus 353 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (604)
.|||+||||++.. .+.++++..+.
T Consensus 641 ~VKIsDfGLsRdi-YssDYYk~~~~------------------------------------------------------- 664 (774)
T KOG1026|consen 641 VVKISDFGLSRDI-YSSDYYKVRGN------------------------------------------------------- 664 (774)
T ss_pred EEEecccccchhh-hhhhhhcccCC-------------------------------------------------------
Confidence 9999999998432 11122221110
Q ss_pred CCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCC
Q 007433 433 VSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFP 511 (604)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p 511 (604)
-.-...||+||.|....++.++|||||||+|||+++ |+.||.+..+.+.+..|..+.+ ++
T Consensus 665 ------------------t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~l-L~ 725 (774)
T KOG1026|consen 665 ------------------TLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQL-LS 725 (774)
T ss_pred ------------------ceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCc-cc
Confidence 013357999999999999999999999999999995 9999999999999999988877 88
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHH
Q 007433 512 ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEI 545 (604)
Q Consensus 512 ~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~el 545 (604)
.+..++.++.+|+..||..+|.+||+ +.||
T Consensus 726 ~Pe~CP~~vY~LM~~CW~~~P~~RPs----F~eI 755 (774)
T KOG1026|consen 726 CPENCPTEVYSLMLECWNENPKRRPS----FKEI 755 (774)
T ss_pred CCCCCCHHHHHHHHHHhhcCcccCCC----HHHH
Confidence 88889999999999999999999999 6665
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=322.87 Aligned_cols=244 Identities=23% Similarity=0.324 Sum_probs=197.3
Q ss_pred EEccCCcEEEEEEEEcCCce--EEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCeeEEEEeecC
Q 007433 220 KLGCGDIGSVYLSELTGTKC--YFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSCLVMEFCP 296 (604)
Q Consensus 220 ~LG~G~fG~Vy~a~~~~~~~--~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~ 296 (604)
.||.|+||.||+|++..++. .+|+|.+..... ......+.+|+++++++ +||||+++++++...+..|+||||++
T Consensus 2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC--HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 58999999999999988764 468888864321 12334566899999999 89999999999999999999999999
Q ss_pred CCCHHHHHHhcC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 297 GGDLHTLRQRQP--------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 297 ggsL~~ll~~~~--------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
+++|.+++.... ...+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 999999987542 235889999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccC
Q 007433 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442 (604)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (604)
......
T Consensus 160 ~~~~~~-------------------------------------------------------------------------- 165 (270)
T cd05047 160 RGQEVY-------------------------------------------------------------------------- 165 (270)
T ss_pred cccchh--------------------------------------------------------------------------
Confidence 211000
Q ss_pred CCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHH
Q 007433 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSAR 521 (604)
Q Consensus 443 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~ 521 (604)
........+..|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.+..+... ........++.++.
T Consensus 166 ---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 241 (270)
T cd05047 166 ---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLEKPLNCDDEVY 241 (270)
T ss_pred ---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC-CCCCCCCcCCHHHH
Confidence 00001123567999999988889999999999999999996 99999887666655554432 33333345788999
Q ss_pred HHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 522 DLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 522 dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
+||.+||..||.+||+ +.++++
T Consensus 242 ~li~~~l~~~p~~Rps----~~~il~ 263 (270)
T cd05047 242 DLMRQCWREKPYERPS----FAQILV 263 (270)
T ss_pred HHHHHHcccChhhCCC----HHHHHH
Confidence 9999999999999999 777765
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=319.23 Aligned_cols=233 Identities=33% Similarity=0.440 Sum_probs=190.9
Q ss_pred CCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCCCCHHHH
Q 007433 224 GDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTL 303 (604)
Q Consensus 224 G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~l 303 (604)
|.||.||++++..+++.||+|.+.+... ..+|...+....||||+++++++...+..|+||||++|++|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999976532 12344555566799999999999999999999999999999998
Q ss_pred HHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcccCCccc
Q 007433 304 RQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLR 383 (604)
Q Consensus 304 l~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~ 383 (604)
+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 76 l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--------------- 138 (237)
T cd05576 76 ISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--------------- 138 (237)
T ss_pred HHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc---------------
Confidence 8765 45999999999999999999999999999999999999999999999999976322100
Q ss_pred CCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccccCccee
Q 007433 384 KNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEII 463 (604)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l 463 (604)
.....++..|+|||++
T Consensus 139 ----------------------------------------------------------------~~~~~~~~~y~aPE~~ 154 (237)
T cd05576 139 ----------------------------------------------------------------CDGEAVENMYCAPEVG 154 (237)
T ss_pred ----------------------------------------------------------------cccCCcCccccCCccc
Confidence 0012356779999999
Q ss_pred cCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccc-cCCH
Q 007433 464 KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLAC-RRGA 542 (604)
Q Consensus 464 ~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~-~~~a 542 (604)
.+..++.++|+|||||++|||++|+.||...... ......+.....++..+++||.+||..||++|+++ ...+
T Consensus 155 ~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~ 228 (237)
T cd05576 155 GISEETEACDWWSLGAILFELLTGKTLVECHPSG------INTHTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGV 228 (237)
T ss_pred CCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------cccccccCCcccCCHHHHHHHHHHccCCHHHhcCCCccch
Confidence 8888999999999999999999999988643221 01111112224588999999999999999999984 2346
Q ss_pred HHHhcCCCC
Q 007433 543 TEIKQHPFF 551 (604)
Q Consensus 543 ~elL~Hpff 551 (604)
+++++||||
T Consensus 229 ~~~~~h~~~ 237 (237)
T cd05576 229 EDIKSHPFF 237 (237)
T ss_pred HHHHcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=350.15 Aligned_cols=244 Identities=33% Similarity=0.498 Sum_probs=204.5
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCeeEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~l 290 (604)
.+.|.+...+|.|+|+.|-.+.+..+++.+++|++.+... ..++|+.++... +||||+++++.+.++.+.|+
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~ 393 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL 393 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceeee
Confidence 4678888999999999999999999999999999977621 123577665554 89999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEE-ccCCcEEEecccccccccCCC
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV-REDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl-~~~g~vkL~DFGla~~~~~~~ 369 (604)
|||++.|+-|.+-+... ..+. ..+..|+++|+.||+|||++|||||||||+|||+ +..|+++|+|||.+......
T Consensus 394 v~e~l~g~ell~ri~~~--~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~- 469 (612)
T KOG0603|consen 394 VMELLDGGELLRRIRSK--PEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS- 469 (612)
T ss_pred eehhccccHHHHHHHhc--chhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-
Confidence 99999999887766654 2344 7788899999999999999999999999999999 68999999999987321100
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
..
T Consensus 470 ------------------------------------------------------------------------------~~ 471 (612)
T KOG0603|consen 470 ------------------------------------------------------------------------------CD 471 (612)
T ss_pred ------------------------------------------------------------------------------hc
Confidence 11
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
+-+-|..|.|||++...+|+.++||||||++||+||+|+.||........+...++. ..+ ...+|++++|||.+||+
T Consensus 472 tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~-~~~--s~~vS~~AKdLl~~LL~ 548 (612)
T KOG0603|consen 472 TPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQM-PKF--SECVSDEAKDLLQQLLQ 548 (612)
T ss_pred ccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcC-Ccc--ccccCHHHHHHHHHhcc
Confidence 224688999999999999999999999999999999999999887666344333322 122 25699999999999999
Q ss_pred cCCCCcccccCCHHHHhcCCCC
Q 007433 530 KEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~Hpff 551 (604)
.||.+|++ +.+++.||||
T Consensus 549 ~dP~~Rl~----~~~i~~h~w~ 566 (612)
T KOG0603|consen 549 VDPALRLG----ADEIGAHPWF 566 (612)
T ss_pred CChhhCcC----hhhhccCcch
Confidence 99999999 9999999999
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=322.12 Aligned_cols=255 Identities=25% Similarity=0.372 Sum_probs=206.4
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcC----CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec--CC
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTG----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET--DK 286 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~ 286 (604)
.+|++++.||+|+||.||+|.+.. ++..||||++...... .....+.+|+++++.++|+||+++++++.. +.
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 578999999999999999998653 4789999999765432 344567789999999999999999999887 66
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
..|+||||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 160 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP 160 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence 8999999999999999987753 369999999999999999999999999999999999999999999999999884432
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
.......
T Consensus 161 ~~~~~~~------------------------------------------------------------------------- 167 (284)
T cd05038 161 EDKDYYY------------------------------------------------------------------------- 167 (284)
T ss_pred cCCccee-------------------------------------------------------------------------
Confidence 1100000
Q ss_pred cccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCCh--------------HHHHHHHHcCCCCCCC
Q 007433 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSEN--------------RATLYNVVGQPLRFPE 512 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~--------------~~~l~~i~~~~~~~p~ 512 (604)
......++..|++||.+.+..++.++|||||||++|||++|..||..... ...+...+.....++.
T Consensus 168 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (284)
T cd05038 168 VKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPR 247 (284)
T ss_pred ccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCC
Confidence 00011245679999999988899999999999999999999999865322 2223334444445555
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 513 SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 513 ~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
...++.++.+|+.+||..||++||+ +.||++
T Consensus 248 ~~~~~~~~~~li~~cl~~~p~~Rpt----~~ei~~ 278 (284)
T cd05038 248 PPSCPDEVYDLMKLCWEAEPQDRPS----FADLIL 278 (284)
T ss_pred CccCCHHHHHHHHHHhccChhhCCC----HHHHHH
Confidence 5567889999999999999999999 777765
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-38 Score=321.97 Aligned_cols=247 Identities=22% Similarity=0.342 Sum_probs=199.9
Q ss_pred EEccCCcEEEEEEEEcCCc------eEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 220 KLGCGDIGSVYLSELTGTK------CYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 220 ~LG~G~fG~Vy~a~~~~~~------~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
.||.|+||.||+|++.... ..||||.+.+... ......+.+|+.+|+.++||||+++++++......|+|||
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 6899999999999986544 6899999865422 1233456789999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhc-----CCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC-----cEEEecccccc
Q 007433 294 FCPGGDLHTLRQRQ-----PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG-----HIMLSDFDLSL 363 (604)
Q Consensus 294 ~~~ggsL~~ll~~~-----~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g-----~vkL~DFGla~ 363 (604)
|+++++|.+++... ....+++..+..++.||+.||.|||+++++|+||||+|||++.++ .++|+|||++.
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 99999999988753 224588999999999999999999999999999999999999877 89999999874
Q ss_pred cccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCC
Q 007433 364 RCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEP 443 (604)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (604)
.+......
T Consensus 160 ~~~~~~~~------------------------------------------------------------------------ 167 (269)
T cd05044 160 DIYKSDYY------------------------------------------------------------------------ 167 (269)
T ss_pred cccccccc------------------------------------------------------------------------
Confidence 32110000
Q ss_pred CCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 007433 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARD 522 (604)
Q Consensus 444 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~d 522 (604)
.......++..|+|||++.+..++.++|||||||++|||++ |+.||....+.+....+.. ...+.....++..+.+
T Consensus 168 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~ 244 (269)
T cd05044 168 --RKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA-GGRLQKPENCPDKIYQ 244 (269)
T ss_pred --ccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhc-CCccCCcccchHHHHH
Confidence 00011235678999999999889999999999999999998 9999988777665555433 2233334558899999
Q ss_pred HHHHhhhcCCCCcccccCCHHHHhc
Q 007433 523 LIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 523 LI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
||.+||..+|++||+ +.++++
T Consensus 245 li~~~l~~~p~~Rp~----~~~i~~ 265 (269)
T cd05044 245 LMTNCWAQDPSERPT----FDRIQE 265 (269)
T ss_pred HHHHHcCCCcccCCC----HHHHHH
Confidence 999999999999999 777754
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=319.59 Aligned_cols=247 Identities=21% Similarity=0.338 Sum_probs=192.5
Q ss_pred EEccCCcEEEEEEEEcC--CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCC
Q 007433 220 KLGCGDIGSVYLSELTG--TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPG 297 (604)
Q Consensus 220 ~LG~G~fG~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 297 (604)
.||+|+||.||+|.... ....+|+|.+..... ......+.+|+++++.++|+||+++++.+.+....|+||||+++
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT--PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCC--hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 68999999999997543 345788998764432 22234567899999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCC---CCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccccc
Q 007433 298 GDLHTLRQRQPG---KYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKS 374 (604)
Q Consensus 298 gsL~~ll~~~~~---~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~ 374 (604)
|+|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--- 156 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY--- 156 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchhe---
Confidence 999999876532 34568888999999999999999999999999999999999999999999987321100000
Q ss_pred CcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccC
Q 007433 375 STLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGT 454 (604)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT 454 (604)
.......++
T Consensus 157 -----------------------------------------------------------------------~~~~~~~~~ 165 (269)
T cd05042 157 -----------------------------------------------------------------------ITKDCHAVP 165 (269)
T ss_pred -----------------------------------------------------------------------eccCCCCCc
Confidence 000122467
Q ss_pred ccccCcceecC-------CCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcC-CCCCCC---CCCCCHHHHH
Q 007433 455 HEYLAPEIIKG-------EGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQ-PLRFPE---SPVVSFSARD 522 (604)
Q Consensus 455 ~~Y~APE~l~~-------~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~-~~~~p~---~~~~s~~l~d 522 (604)
..|+|||++.. ..++.++|||||||++|||++ |..||....+.+.+..++.. ...++. ...++..+.+
T Consensus 166 ~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (269)
T cd05042 166 LRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYE 245 (269)
T ss_pred ccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHH
Confidence 78999999753 356789999999999999998 88999887776666655433 223222 2357788899
Q ss_pred HHHHhhhcCCCCcccccCCHHHHhc
Q 007433 523 LIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 523 LI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
++..|+ .||++||+ +++|++
T Consensus 246 ~~~~~~-~dp~~Rpt----~~~v~~ 265 (269)
T cd05042 246 VMQFCW-LDPETRPT----AEEVHE 265 (269)
T ss_pred HHHHHh-cCcccccC----HHHHHH
Confidence 999998 59999999 777764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-38 Score=326.75 Aligned_cols=255 Identities=22% Similarity=0.331 Sum_probs=205.5
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCce----EEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKC----YFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
..++|+.++.||+|+||.||+|.+..++. .||+|++...... .....+.+|+.+++.++|+||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP--KANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 45789999999999999999999877664 5789988754322 2223567899999999999999999998754
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
..++|+||+++|+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHK-DNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEcccccccccc
Confidence 4679999999999999887652 468999999999999999999999999999999999999999999999999885432
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
..... .
T Consensus 161 ~~~~~--------------------------------------------------------------------------~ 166 (303)
T cd05110 161 GDEKE--------------------------------------------------------------------------Y 166 (303)
T ss_pred Ccccc--------------------------------------------------------------------------c
Confidence 10000 0
Q ss_pred cccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007433 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIK 525 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~ 525 (604)
......++..|+|||++.+..++.++|||||||++|||++ |..||.+..... +..++.....++.....+..+.++|.
T Consensus 167 ~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~ 245 (303)
T cd05110 167 NADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE-IPDLLEKGERLPQPPICTIDVYMVMV 245 (303)
T ss_pred ccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-HHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 0011235678999999999889999999999999999997 999998765433 34444444455555667889999999
Q ss_pred HhhhcCCCCcccccCCHHHHhcC
Q 007433 526 GLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
+||..||++||+ +.++++.
T Consensus 246 ~c~~~~p~~Rp~----~~~l~~~ 264 (303)
T cd05110 246 KCWMIDADSRPK----FKELAAE 264 (303)
T ss_pred HHcCCChhhCcC----HHHHHHH
Confidence 999999999999 7777664
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=319.34 Aligned_cols=254 Identities=26% Similarity=0.425 Sum_probs=207.7
Q ss_pred CeEEEEEEccCCcEEEEEEEEcC-CceEEEEEEecchhH-------HHHHHHHHHHHHHHHHHh-CCCCCccccceeEec
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTG-TKCYFAMKVMDKASL-------EKRKKLLRAQTEREILQS-LDHPFLPTLYTHFET 284 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~-~~~~vAiK~i~~~~~-------~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~ 284 (604)
+|++.+.||.|+||.||++.+.. +++.+|+|.+..... ........+..|+.++.+ ++|+||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999988 678999999864321 122344556678888875 799999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHh--cCCCCCcHHHHHHHHHHHHHHHHHHHH-cCeEeccCCCCcEEEccCCcEEEecccc
Q 007433 285 DKFSCLVMEFCPGGDLHTLRQR--QPGKYFSEQAVKFYVAEVLLALEYLHM-LGIVYRDLKPENVLVREDGHIMLSDFDL 361 (604)
Q Consensus 285 ~~~~~lV~E~~~ggsL~~ll~~--~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDIKpeNILl~~~g~vkL~DFGl 361 (604)
++..|+||||++|++|.+++.. .....+++..++.++.|++.||.|||+ .||+||||||+|||++.++.++|+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999988754 223579999999999999999999996 7899999999999999999999999998
Q ss_pred cccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccccc
Q 007433 362 SLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIA 441 (604)
Q Consensus 362 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (604)
+.......
T Consensus 161 ~~~~~~~~------------------------------------------------------------------------ 168 (269)
T cd08528 161 AKQKQPES------------------------------------------------------------------------ 168 (269)
T ss_pred eeeccccc------------------------------------------------------------------------
Confidence 74321000
Q ss_pred CCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHH
Q 007433 442 EPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSAR 521 (604)
Q Consensus 442 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~ 521 (604)
......|+..|+|||++.+..++.++|+|||||++|||++|+.||...........+............++..+.
T Consensus 169 -----~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 243 (269)
T cd08528 169 -----KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMYSEDVT 243 (269)
T ss_pred -----ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcccCCHHHH
Confidence 011235888999999999888999999999999999999999999877666665555554433222335788999
Q ss_pred HHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 522 DLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 522 dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
+||.+||..||++||+ +.|+..+
T Consensus 244 ~li~~cl~~~p~~Rp~----~~e~~~~ 266 (269)
T cd08528 244 DVITSCLTPDAEARPD----IIQVSAM 266 (269)
T ss_pred HHHHHHCCCCCccCCC----HHHHHHH
Confidence 9999999999999999 7777543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=322.38 Aligned_cols=238 Identities=23% Similarity=0.277 Sum_probs=190.1
Q ss_pred EEccCCcEEEEEEEEcC------------------------CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCc
Q 007433 220 KLGCGDIGSVYLSELTG------------------------TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFL 275 (604)
Q Consensus 220 ~LG~G~fG~Vy~a~~~~------------------------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI 275 (604)
+||+|+||.||+|.... ....||+|++..... .....+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR---DIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH---HHHHHHHHHHHHHhcCCCCCe
Confidence 69999999999997532 224689999865432 233456678899999999999
Q ss_pred cccceeEecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC---
Q 007433 276 PTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG--- 352 (604)
Q Consensus 276 v~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g--- 352 (604)
+++++++..+...||||||+++++|..++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~ 157 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE 157 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence 99999999999999999999999999888654 35789999999999999999999999999999999999998654
Q ss_pred ----cEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccc
Q 007433 353 ----HIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNE 428 (604)
Q Consensus 353 ----~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 428 (604)
.++|+|||++.....
T Consensus 158 ~~~~~~kl~d~g~~~~~~~------------------------------------------------------------- 176 (274)
T cd05076 158 GTSPFIKLSDPGVSFTALS------------------------------------------------------------- 176 (274)
T ss_pred CccceeeecCCcccccccc-------------------------------------------------------------
Confidence 389999997632100
Q ss_pred cCCCCCCCcccccCCCCCcccccccCccccCcceecC-CCCCccchHHHHHHHHHHHh-hCCCCCCCCChHHHHHHHHcC
Q 007433 429 MGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELL-FGKTPFKGSENRATLYNVVGQ 506 (604)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLl-tG~~PF~~~~~~~~l~~i~~~ 506 (604)
.....++..|+|||.+.+ ..++.++|||||||++|||+ +|+.||........ ..+...
T Consensus 177 -------------------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~-~~~~~~ 236 (274)
T cd05076 177 -------------------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK-ERFYEK 236 (274)
T ss_pred -------------------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH-HHHHHh
Confidence 001247788999999876 55789999999999999985 79999987654433 233333
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 507 PLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 507 ~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
...++. ..+..+.+||.+||..+|++||+ +.++|++
T Consensus 237 ~~~~~~--~~~~~~~~li~~cl~~~p~~Rps----~~~il~~ 272 (274)
T cd05076 237 KHRLPE--PSCKELATLISQCLTYEPTQRPS----FRTILRD 272 (274)
T ss_pred ccCCCC--CCChHHHHHHHHHcccChhhCcC----HHHHHHh
Confidence 333443 25678999999999999999999 8898875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=318.57 Aligned_cols=239 Identities=21% Similarity=0.287 Sum_probs=190.0
Q ss_pred EEEccCCcEEEEEEEEcCC------------ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 219 KKLGCGDIGSVYLSELTGT------------KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~------------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
+.||+|+||.||+|..... ...||+|++.... ......+.+|+.+|+.++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3689999999999986432 3358899876542 223345667889999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCc-------EEEecc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGH-------IMLSDF 359 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~-------vkL~DF 359 (604)
..++||||+++++|..++... ...+++..+..++.||+.||+|||++||+||||||+||||+.++. ++|+||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~ 156 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP 156 (262)
T ss_pred CCEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence 999999999999999887654 246899999999999999999999999999999999999987664 899999
Q ss_pred cccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccc
Q 007433 360 DLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPEL 439 (604)
Q Consensus 360 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (604)
|++.....
T Consensus 157 g~~~~~~~------------------------------------------------------------------------ 164 (262)
T cd05077 157 GIPITVLS------------------------------------------------------------------------ 164 (262)
T ss_pred CCCccccC------------------------------------------------------------------------
Confidence 98732110
Q ss_pred ccCCCCCcccccccCccccCcceec-CCCCCccchHHHHHHHHHHHh-hCCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 007433 440 IAEPTNARSMSFVGTHEYLAPEIIK-GEGHGSAVDWWTFGIFLYELL-FGKTPFKGSENRATLYNVVGQPLRFPESPVVS 517 (604)
Q Consensus 440 ~~~~~~~~~~~~~GT~~Y~APE~l~-~~~~~~~~DiWSLGviL~eLl-tG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s 517 (604)
.....|+..|+|||++. +..++.++|||||||++|||+ .|..||......+. .......... ....+
T Consensus 165 --------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~-~~~~~~~~~~--~~~~~ 233 (262)
T cd05077 165 --------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK-ERFYEGQCML--VTPSC 233 (262)
T ss_pred --------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH-HHHHhcCccC--CCCCh
Confidence 01235788899999987 466889999999999999998 58888876543332 2222322222 22356
Q ss_pred HHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 518 FSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 518 ~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
.++.+||.+||..||.+||+ +.+|+++
T Consensus 234 ~~~~~li~~cl~~dp~~Rp~----~~~il~~ 260 (262)
T cd05077 234 KELADLMTHCMNYDPNQRPF----FRAIMRD 260 (262)
T ss_pred HHHHHHHHHHcCCChhhCcC----HHHHHHh
Confidence 78999999999999999999 8999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=321.90 Aligned_cols=257 Identities=16% Similarity=0.234 Sum_probs=191.5
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCC---ceEEEEEEecchhHH--HHHH------HHHHHHHHHHHHhCCCCCccccce
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGT---KCYFAMKVMDKASLE--KRKK------LLRAQTEREILQSLDHPFLPTLYT 280 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~i~~~~~~--~~~~------~~~~~~Ei~iL~~l~HpnIv~l~~ 280 (604)
.++|++.++||+|+||+||+|.+..+ +..+|+|+....... .... ......+...+..++|+||+++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~ 90 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG 90 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence 36899999999999999999999887 667888875432211 1000 011123344566779999999998
Q ss_pred eEecCC----eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEE
Q 007433 281 HFETDK----FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIML 356 (604)
Q Consensus 281 ~~~~~~----~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL 356 (604)
++.... ..|++||++ ..++.+++... ..+++..++.++.||+.||+|||+++|+||||||+|||++.++.++|
T Consensus 91 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l 167 (294)
T PHA02882 91 CGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI 167 (294)
T ss_pred eeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence 765433 457889988 56777777654 34688899999999999999999999999999999999999999999
Q ss_pred ecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCC
Q 007433 357 SDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPL 436 (604)
Q Consensus 357 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (604)
+|||++..+........
T Consensus 168 ~DFGla~~~~~~~~~~~--------------------------------------------------------------- 184 (294)
T PHA02882 168 IDYGIASHFIIHGKHIE--------------------------------------------------------------- 184 (294)
T ss_pred EEcCCceeeccCCcccc---------------------------------------------------------------
Confidence 99999855432110000
Q ss_pred cccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHH---------HHHHHcCC
Q 007433 437 PELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRAT---------LYNVVGQP 507 (604)
Q Consensus 437 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~---------l~~i~~~~ 507 (604)
..........||+.|+|||++.+..++.++|||||||+||||++|..||.+...... +..+....
T Consensus 185 ------~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (294)
T PHA02882 185 ------YSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAKCDFIKRLHEGK 258 (294)
T ss_pred ------cccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhHHHHHHHhhhhh
Confidence 000011234699999999999999999999999999999999999999987633221 12222222
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 508 LRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 508 ~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
..+ ...+..+.++++.|+..+|++||+ +.+|++
T Consensus 259 ~~~---~~~~~~~~~~~~~~~~~~~~~rp~----~~~l~~ 291 (294)
T PHA02882 259 IKI---KNANKFIYDFIECVTKLSYEEKPD----YDALIK 291 (294)
T ss_pred hcc---CCCCHHHHHHHHHHHhCCCCCCCC----HHHHHH
Confidence 222 346788999999999999999999 777764
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=314.84 Aligned_cols=250 Identities=18% Similarity=0.280 Sum_probs=195.0
Q ss_pred EEEccCCcEEEEEEEEcC---CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEe-cCCeeEEEEee
Q 007433 219 KKLGCGDIGSVYLSELTG---TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFE-TDKFSCLVMEF 294 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-~~~~~~lV~E~ 294 (604)
+.||+|+||.||+|.+.. ....||||.+..... ......+.+|+.+++.++||||+++++++. .++..|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD--LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCC--HHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 368999999999998653 346799999854321 223445668999999999999999999765 46678999999
Q ss_pred cCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccccc
Q 007433 295 CPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKS 374 (604)
Q Consensus 295 ~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~ 374 (604)
+.+++|.+++.... ..+++..+..++.||+.||+|||+++|+||||||+|||++.++.+||+|||++.........
T Consensus 79 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~--- 154 (262)
T cd05058 79 MKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY--- 154 (262)
T ss_pred CCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce---
Confidence 99999999987653 45677888899999999999999999999999999999999999999999987432110000
Q ss_pred CcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccC
Q 007433 375 STLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGT 454 (604)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT 454 (604)
.........++
T Consensus 155 ---------------------------------------------------------------------~~~~~~~~~~~ 165 (262)
T cd05058 155 ---------------------------------------------------------------------SVHNHTGAKLP 165 (262)
T ss_pred ---------------------------------------------------------------------eecccccCcCC
Confidence 00000112367
Q ss_pred ccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCC
Q 007433 455 HEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQ 533 (604)
Q Consensus 455 ~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~ 533 (604)
..|+|||++.+..++.++|||||||++|||++ |.+||...+..+....+... ...+....++..+.++|.+||..+|+
T Consensus 166 ~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~ 244 (262)
T cd05058 166 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG-RRLLQPEYCPDPLYEVMLSCWHPKPE 244 (262)
T ss_pred ccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC-CCCCCCCcCCHHHHHHHHHHcCCChh
Confidence 78999999998889999999999999999999 56777776665555544433 22333345788999999999999999
Q ss_pred CcccccCCHHHHhcC
Q 007433 534 NRLACRRGATEIKQH 548 (604)
Q Consensus 534 ~Rpt~~~~a~elL~H 548 (604)
+||+ +.++++.
T Consensus 245 ~Rp~----~~~il~~ 255 (262)
T cd05058 245 MRPT----FSELVSR 255 (262)
T ss_pred hCCC----HHHHHHH
Confidence 9999 8888753
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=317.59 Aligned_cols=248 Identities=22% Similarity=0.306 Sum_probs=192.5
Q ss_pred EEEccCCcEEEEEEEEcC--CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecC
Q 007433 219 KKLGCGDIGSVYLSELTG--TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCP 296 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 296 (604)
+.||+|+||.||+|.+.. ++..+|+|.+...... .....+.+|+.+++.++||||+++++++.+....|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 368999999999998653 4567999998765322 222356779999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 297 GGDLHTLRQRQP---GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 297 ggsL~~ll~~~~---~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
+|+|.+++.... ...+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~---- 154 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED---- 154 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcc----
Confidence 999999987532 2356778888999999999999999999999999999999999999999999873211000
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
.........|
T Consensus 155 ----------------------------------------------------------------------~~~~~~~~~~ 164 (269)
T cd05087 155 ----------------------------------------------------------------------YYVTPDQLWV 164 (269)
T ss_pred ----------------------------------------------------------------------eeecCCCcCC
Confidence 0000112357
Q ss_pred CccccCcceecCC-------CCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHH-HcCCCCCCCC---CCCCHHHH
Q 007433 454 THEYLAPEIIKGE-------GHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNV-VGQPLRFPES---PVVSFSAR 521 (604)
Q Consensus 454 T~~Y~APE~l~~~-------~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i-~~~~~~~p~~---~~~s~~l~ 521 (604)
+..|+|||++.+. .++.++|||||||++|||++ |+.||......+.+... ......++.. ...+..+.
T Consensus 165 ~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (269)
T cd05087 165 PLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWY 244 (269)
T ss_pred cccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHH
Confidence 8899999998643 35789999999999999996 99999876665544332 2323333222 24678899
Q ss_pred HHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 522 DLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 522 dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
+++..|+ .+|++||+ +.||++
T Consensus 245 ~l~~~c~-~~P~~Rpt----~~~l~~ 265 (269)
T cd05087 245 EVMQFCW-LQPEQRPS----AEEVHL 265 (269)
T ss_pred HHHHHHh-cCcccCCC----HHHHHH
Confidence 9999998 68999999 888864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-38 Score=314.66 Aligned_cols=236 Identities=22% Similarity=0.276 Sum_probs=190.8
Q ss_pred EEEccCCcEEEEEEEEcCCc----------eEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCee
Q 007433 219 KKLGCGDIGSVYLSELTGTK----------CYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~----------~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 288 (604)
+.||+|+||.||+|.+..++ ..+++|++...... ...+.+|+.+|+.++|+||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 36899999999999998776 35888887654221 3456789999999999999999999988 778
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC-------cEEEecccc
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG-------HIMLSDFDL 361 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g-------~vkL~DFGl 361 (604)
|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .++|+|||+
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~ 154 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI 154 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence 99999999999999988763 3789999999999999999999999999999999999999888 799999998
Q ss_pred cccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccccc
Q 007433 362 SLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIA 441 (604)
Q Consensus 362 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (604)
+.....
T Consensus 155 a~~~~~-------------------------------------------------------------------------- 160 (259)
T cd05037 155 PITVLS-------------------------------------------------------------------------- 160 (259)
T ss_pred cccccc--------------------------------------------------------------------------
Confidence 743210
Q ss_pred CCCCCcccccccCccccCcceecCC--CCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCH
Q 007433 442 EPTNARSMSFVGTHEYLAPEIIKGE--GHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSF 518 (604)
Q Consensus 442 ~~~~~~~~~~~GT~~Y~APE~l~~~--~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~ 518 (604)
.....++..|+|||++.+. .++.++|||||||++|||++ |..||...........+. .....+.. ...
T Consensus 161 ------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~--~~~ 231 (259)
T cd05037 161 ------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP--DCA 231 (259)
T ss_pred ------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC--Cch
Confidence 0012466789999999887 78999999999999999999 688887665333322222 22222222 337
Q ss_pred HHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 519 SARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 519 ~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
.+.+||.+||..||.+||+ +.++++
T Consensus 232 ~~~~li~~~l~~~p~~Rpt----~~~il~ 256 (259)
T cd05037 232 ELANLINQCWTYDPTKRPS----FRAILR 256 (259)
T ss_pred HHHHHHHHHhccChhhCCC----HHHHHH
Confidence 8999999999999999999 888875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=337.63 Aligned_cols=272 Identities=26% Similarity=0.422 Sum_probs=218.4
Q ss_pred hHHHHH-hheeecCceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC--
Q 007433 195 AQWEAI-QAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-- 271 (604)
Q Consensus 195 ~~~~~~-~~~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-- 271 (604)
..|... ..+.+.-|++..++|.+....|+|-|++|.+|.+...+..||||+|+.....- ..-++|++||++|+
T Consensus 413 DNWdDaEGYYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~A 488 (752)
T KOG0670|consen 413 DNWDDAEGYYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDA 488 (752)
T ss_pred cCcccccceEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh----hhhhHHHHHHHHhhcc
Confidence 345443 35666666777789999999999999999999999999999999998764322 22357999999994
Q ss_pred ----CCCccccceeEecCCeeEEEEeecCCCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcE
Q 007433 272 ----HPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQP-GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENV 346 (604)
Q Consensus 272 ----HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNI 346 (604)
.-|+++|+.+|.+.+++|||||-+ ..+|.+++++.. .-.|...+++.|+.||+.||..|-.+||+|.||||+||
T Consensus 489 D~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNi 567 (752)
T KOG0670|consen 489 DPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNI 567 (752)
T ss_pred CchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccce
Confidence 358999999999999999999999 789999999864 24688999999999999999999999999999999999
Q ss_pred EEccC-CcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCC
Q 007433 347 LVRED-GHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKP 425 (604)
Q Consensus 347 Ll~~~-g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (604)
||++. ..+||||||.|-..+..
T Consensus 568 LVNE~k~iLKLCDfGSA~~~~en--------------------------------------------------------- 590 (752)
T KOG0670|consen 568 LVNESKNILKLCDFGSASFASEN--------------------------------------------------------- 590 (752)
T ss_pred EeccCcceeeeccCccccccccc---------------------------------------------------------
Confidence 99974 46899999987322100
Q ss_pred ccccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc
Q 007433 426 KNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG 505 (604)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~ 505 (604)
.-+-+.-+..|+|||++.|..|++..|+||.||+||||.||+..|+|..+.+.+.-.+.
T Consensus 591 ---------------------eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me 649 (752)
T KOG0670|consen 591 ---------------------EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME 649 (752)
T ss_pred ---------------------cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence 00113455679999999999999999999999999999999999999887776533221
Q ss_pred --CCC-------------------CC---------------------C---------CCCCCC-------HHHHHHHHHh
Q 007433 506 --QPL-------------------RF---------------------P---------ESPVVS-------FSARDLIKGL 527 (604)
Q Consensus 506 --~~~-------------------~~---------------------p---------~~~~~s-------~~l~dLI~~l 527 (604)
+++ .| | ..+.++ ..+++||.+|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 110 00 0 000111 2477999999
Q ss_pred hhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 528 LVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
|..||++|++ +.++|+||||++
T Consensus 730 l~LdP~KRit----~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 730 LILDPEKRIT----VNQALKHPFITE 751 (752)
T ss_pred hccChhhcCC----HHHHhcCCcccC
Confidence 9999999999 999999999974
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=348.20 Aligned_cols=258 Identities=29% Similarity=0.476 Sum_probs=225.8
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEe-----cC
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFE-----TD 285 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~-----~~ 285 (604)
.+-|.+.+.||.|.+|.||+++...+++.+|+|+++...-.+ .++..|.+||+.+ +|||++.+|++|. .+
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d----eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE----EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc----HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 467999999999999999999999999999999998764322 2344577888887 7999999999996 46
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
+.++||||||.||+.-++++...+..+.|..+..|++.++.||.+||.+.++|||||-.|||++.+|.|||+|||+++.+
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQl 173 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 173 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeee
Confidence 79999999999999999999888899999999999999999999999999999999999999999999999999998543
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
.. +-
T Consensus 174 ds----------------------------------------------------------------------------T~ 177 (953)
T KOG0587|consen 174 DS----------------------------------------------------------------------------TV 177 (953)
T ss_pred ec----------------------------------------------------------------------------cc
Confidence 21 22
Q ss_pred CcccccccCccccCcceecCC-----CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-CCCCCCCCCCHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGE-----GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP-LRFPESPVVSFS 519 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~-----~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~-~~~p~~~~~s~~ 519 (604)
.+..+++||+.|||||++... .|+..+|+||||++-.||.-|.+|+.+......++.|-..+ +.+..+...+.+
T Consensus 178 grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPkLkrp~kWs~~ 257 (953)
T KOG0587|consen 178 GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKRPKKWSKK 257 (953)
T ss_pred ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCccccchhhHHHH
Confidence 244578999999999999754 46789999999999999999999999998888888887654 445556678999
Q ss_pred HHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 520 ARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 520 l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
+.|||..||.+|.++||+ ..++|+|||..+
T Consensus 258 FndFIs~cL~Kd~e~RP~----~~~ll~hpFi~e 287 (953)
T KOG0587|consen 258 FNDFISTCLVKDYEQRPS----TEELLKHPFITE 287 (953)
T ss_pred HHHHHHHHHhhccccCcc----hhhhccCCcccc
Confidence 999999999999999999 999999999963
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=314.98 Aligned_cols=254 Identities=22% Similarity=0.347 Sum_probs=201.2
Q ss_pred eEEEEEEccCCcEEEEEEEEc---CCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC-----
Q 007433 215 FRLLKKLGCGDIGSVYLSELT---GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK----- 286 (604)
Q Consensus 215 y~l~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----- 286 (604)
|++.+.||+|+||.||+|.+. +++..||||++...... ......+.+|+++|+.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 677889999999999999864 45789999999654322 233456778999999999999999999886432
Q ss_pred -eeEEEEeecCCCCHHHHHHhcC----CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccc
Q 007433 287 -FSCLVMEFCPGGDLHTLRQRQP----GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDL 361 (604)
Q Consensus 287 -~~~lV~E~~~ggsL~~ll~~~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGl 361 (604)
..++++||+.+|+|..++.... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 3478999999999988765321 13578999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccccc
Q 007433 362 SLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIA 441 (604)
Q Consensus 362 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (604)
+.........
T Consensus 160 ~~~~~~~~~~---------------------------------------------------------------------- 169 (273)
T cd05074 160 SKKIYSGDYY---------------------------------------------------------------------- 169 (273)
T ss_pred cccccCCcce----------------------------------------------------------------------
Confidence 8543211000
Q ss_pred CCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHH
Q 007433 442 EPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSA 520 (604)
Q Consensus 442 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l 520 (604)
.......+++.|++||.+.+..++.++|||||||++|||++ |+.||.+.+..+....+... ..+......+..+
T Consensus 170 ----~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 244 (273)
T cd05074 170 ----RQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-NRLKQPPDCLEDV 244 (273)
T ss_pred ----ecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-CcCCCCCCCCHHH
Confidence 00011235678999999999889999999999999999999 89999877665555544433 2233334578899
Q ss_pred HHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 521 RDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 521 ~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
.+|+.+||..+|++||+ +.+++++
T Consensus 245 ~~l~~~~l~~~p~~Rps----~~~~~~~ 268 (273)
T cd05074 245 YELMCQCWSPEPKCRPS----FQHLRDQ 268 (273)
T ss_pred HHHHHHHcCCChhhCcC----HHHHHHH
Confidence 99999999999999999 8888764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=330.82 Aligned_cols=268 Identities=28% Similarity=0.447 Sum_probs=218.6
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHH----HHHHHHHHHHHHHHHHhCCCCCccccceeEe-c
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLE----KRKKLLRAQTEREILQSLDHPFLPTLYTHFE-T 284 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~----~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-~ 284 (604)
...++|-++.+||+|||+.||+|.+....++||+|+-...... +......+-+|..|.+.|+||.||++|++|. +
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 4446888999999999999999999999999999996543222 2334556778999999999999999999997 4
Q ss_pred CCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcC--eEeccCCCCcEEEcc---CCcEEEecc
Q 007433 285 DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLG--IVYRDLKPENVLVRE---DGHIMLSDF 359 (604)
Q Consensus 285 ~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~g--IvHrDIKpeNILl~~---~g~vkL~DF 359 (604)
.+.+|-|+|||+|.||.-+++.+ +.++|.+++.|+-||+.||.||.+.. |||-||||.||||-. .|.+||+||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred cccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 56789999999999999999887 68999999999999999999999875 999999999999953 578999999
Q ss_pred cccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccc
Q 007433 360 DLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPEL 439 (604)
Q Consensus 360 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (604)
||+..+........
T Consensus 618 GLSKIMdddSy~~v------------------------------------------------------------------ 631 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSV------------------------------------------------------------------ 631 (775)
T ss_pred chhhhccCCccCcc------------------------------------------------------------------
Confidence 99965432211000
Q ss_pred ccCCCCCcccccccCccccCcceecCC----CCCccchHHHHHHHHHHHhhCCCCCCCCChH-HHHH--HH-HcCCCCCC
Q 007433 440 IAEPTNARSMSFVGTHEYLAPEIIKGE----GHGSAVDWWTFGIFLYELLFGKTPFKGSENR-ATLY--NV-VGQPLRFP 511 (604)
Q Consensus 440 ~~~~~~~~~~~~~GT~~Y~APE~l~~~----~~~~~~DiWSLGviL~eLltG~~PF~~~~~~-~~l~--~i-~~~~~~~p 511 (604)
..-.....+.||.||++||.+.-. ..+.++||||+|||+|.+++|+-||...... +++. .| ......||
T Consensus 632 ---dGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP 708 (775)
T KOG1151|consen 632 ---DGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFP 708 (775)
T ss_pred ---cceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCC
Confidence 000112345799999999987533 3588999999999999999999999764332 2222 12 23467899
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCC
Q 007433 512 ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 512 ~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
.-+.++.++++||++||++.-++|.. +.+|-.||||.
T Consensus 709 ~KPvVsseAkaFIRRCLaYRKeDR~D----V~qLA~dpyll 745 (775)
T KOG1151|consen 709 PKPVVSSEAKAFIRRCLAYRKEDRID----VQQLACDPYLL 745 (775)
T ss_pred CCCccCHHHHHHHHHHHHhhhhhhhh----HHHHccCcccc
Confidence 99999999999999999999999999 99999999995
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=359.36 Aligned_cols=270 Identities=27% Similarity=0.420 Sum_probs=206.2
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEe---------
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFE--------- 283 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~--------- 283 (604)
.+|+.++.||+||||.||+++++-+|+.||||.|.... ..+...++.+|+.+|.+|+|||||++|..|.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 57888999999999999999999999999999998764 4456667889999999999999999886540
Q ss_pred ---------------------------------------------------------------------cC---------
Q 007433 284 ---------------------------------------------------------------------TD--------- 285 (604)
Q Consensus 284 ---------------------------------------------------------------------~~--------- 285 (604)
++
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence 00
Q ss_pred --------------------------------CeeEEEEeecCCCCHHHHHHhcCCCCC-cHHHHHHHHHHHHHHHHHHH
Q 007433 286 --------------------------------KFSCLVMEFCPGGDLHTLRQRQPGKYF-SEQAVKFYVAEVLLALEYLH 332 (604)
Q Consensus 286 --------------------------------~~~~lV~E~~~ggsL~~ll~~~~~~~l-~e~~~~~i~~qil~aL~yLH 332 (604)
..+||-||||+.-.|.++++++ ... ....++++++||+.||.|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N--~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN--HFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc--ccchhhHHHHHHHHHHHHHHHHHH
Confidence 1368999999988888888875 222 47788999999999999999
Q ss_pred HcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCC
Q 007433 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFS 412 (604)
Q Consensus 333 ~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 412 (604)
++|||||||||.||+|+.++.|||+|||+|.......... ...
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~-----d~~-------------------------------- 757 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESI-----DQD-------------------------------- 757 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhH-----hhc--------------------------------
Confidence 9999999999999999999999999999984321100000 000
Q ss_pred cccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecCCC---CCccchHHHHHHHHHHHhhCCC
Q 007433 413 PRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEG---HGSAVDWWTFGIFLYELLFGKT 489 (604)
Q Consensus 413 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~~DiWSLGviL~eLltG~~ 489 (604)
..++ .......+...++.+||.-|+|||++.+.. |+.++|||||||+||||+.
T Consensus 758 ~~~~---------------------~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y--- 813 (1351)
T KOG1035|consen 758 LSFS---------------------TNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY--- 813 (1351)
T ss_pred cCcc---------------------ccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---
Confidence 0000 001112233456789999999999998765 8999999999999999985
Q ss_pred CCCCCChHHH-HHHHHcCCCCCC---CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCC
Q 007433 490 PFKGSENRAT-LYNVVGQPLRFP---ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 490 PF~~~~~~~~-l~~i~~~~~~~p---~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
||...-++.. +.++....+.++ ..+.. ..-..+|+.||.+||.+||| |.|||++.||.
T Consensus 814 PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~-~~e~slI~~Ll~hdP~kRPt----A~eLL~s~llp 875 (1351)
T KOG1035|consen 814 PFGTSMERASILTNLRKGSIPEPADFFDPEH-PEEASLIRWLLSHDPSKRPT----ATELLNSELLP 875 (1351)
T ss_pred cCCchHHHHHHHHhcccCCCCCCcccccccc-hHHHHHHHHHhcCCCccCCC----HHHHhhccCCC
Confidence 5766544433 444444444444 11122 23468999999999999999 99999999996
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=343.41 Aligned_cols=246 Identities=31% Similarity=0.476 Sum_probs=197.9
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC------
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK------ 286 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------ 286 (604)
..|..-+.||+||||.||+++++.+|+.||||.+++.... ....+.-+|++||++|+|+|||++++.-++..
T Consensus 13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~--r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL--RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred cceeehhhhcCCccceeeeecccccccchhHHhhhhhccc--chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence 3566778999999999999999999999999999886432 23345678999999999999999998876543
Q ss_pred eeEEEEeecCCCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEc--cCC--cEEEecccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQP-GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVR--EDG--HIMLSDFDL 361 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~--~~g--~vkL~DFGl 361 (604)
...+|||||.||||+.++.+.. ...|++.++..++.+++.||.|||++|||||||||+||++- .+| .-||+|||.
T Consensus 91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~ 170 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA 170 (732)
T ss_pred cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccc
Confidence 5689999999999999998643 35799999999999999999999999999999999999985 345 369999999
Q ss_pred cccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccccc
Q 007433 362 SLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIA 441 (604)
Q Consensus 362 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (604)
|+.+.
T Consensus 171 Arel~--------------------------------------------------------------------------- 175 (732)
T KOG4250|consen 171 ARELD--------------------------------------------------------------------------- 175 (732)
T ss_pred cccCC---------------------------------------------------------------------------
Confidence 85332
Q ss_pred CCCCCcccccccCccccCcceec-CCCCCccchHHHHHHHHHHHhhCCCCCCCC----ChHHHHHHHHcCC---------
Q 007433 442 EPTNARSMSFVGTHEYLAPEIIK-GEGHGSAVDWWTFGIFLYELLFGKTPFKGS----ENRATLYNVVGQP--------- 507 (604)
Q Consensus 442 ~~~~~~~~~~~GT~~Y~APE~l~-~~~~~~~~DiWSLGviL~eLltG~~PF~~~----~~~~~l~~i~~~~--------- 507 (604)
.+..-.+++||+.|++||++. ...|+..+|+|||||++|++.||..||... ++.+.++.+..++
T Consensus 176 --d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~ 253 (732)
T KOG4250|consen 176 --DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQ 253 (732)
T ss_pred --CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeee
Confidence 112344789999999999998 488899999999999999999999999653 2344555554322
Q ss_pred ----------CCCCCCCCCCHH----HHHHHHHhhhcCCCCccc
Q 007433 508 ----------LRFPESPVVSFS----ARDLIKGLLVKEPQNRLA 537 (604)
Q Consensus 508 ----------~~~p~~~~~s~~----l~dLI~~lL~~dP~~Rpt 537 (604)
..+|.+..++.. +-..+..+|..+|.+|..
T Consensus 254 ~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~ 297 (732)
T KOG4250|consen 254 EEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGH 297 (732)
T ss_pred cccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence 123333334443 347889999999999993
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=311.50 Aligned_cols=247 Identities=18% Similarity=0.252 Sum_probs=191.2
Q ss_pred EEccCCcEEEEEEEEcCC--ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCC
Q 007433 220 KLGCGDIGSVYLSELTGT--KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPG 297 (604)
Q Consensus 220 ~LG~G~fG~Vy~a~~~~~--~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 297 (604)
.||+|+||.||+++.... ...+++|.+...... .....+.+|+.+++.++||||+++++.+......|+||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASS--KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL 79 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCCh--HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence 589999999999976443 345677777654322 2234667899999999999999999999999999999999999
Q ss_pred CCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccC
Q 007433 298 GDLHTLRQRQP--GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSS 375 (604)
Q Consensus 298 gsL~~ll~~~~--~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~ 375 (604)
|+|.+++.... ...+++..++.++.||+.||+|||+++|+||||||+|||++.++.++|+|||++.......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~------ 153 (268)
T cd05086 80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED------ 153 (268)
T ss_pred CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcch------
Confidence 99999887642 2356778889999999999999999999999999999999999999999999873211000
Q ss_pred cccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCc
Q 007433 376 TLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTH 455 (604)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~ 455 (604)
.........|+.
T Consensus 154 --------------------------------------------------------------------~~~~~~~~~~~~ 165 (268)
T cd05086 154 --------------------------------------------------------------------YIETEDDKCVPL 165 (268)
T ss_pred --------------------------------------------------------------------hhhcccCCcCcc
Confidence 000011345888
Q ss_pred cccCcceecC-------CCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCC-CCCC---CCCCCCHHHHHH
Q 007433 456 EYLAPEIIKG-------EGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQP-LRFP---ESPVVSFSARDL 523 (604)
Q Consensus 456 ~Y~APE~l~~-------~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~-~~~p---~~~~~s~~l~dL 523 (604)
.|+|||++.. ..++.++|||||||++|||++ |..||....+.+.+..+.... ...+ ....++..+.++
T Consensus 166 ~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 245 (268)
T cd05086 166 RWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEV 245 (268)
T ss_pred cccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHH
Confidence 9999999853 234678999999999999996 578998777766666554332 2211 123478889999
Q ss_pred HHHhhhcCCCCcccccCCHHHHhc
Q 007433 524 IKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 524 I~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
|..|| .+|++||+ +.+|++
T Consensus 246 ~~~c~-~~P~~Rp~----~~~i~~ 264 (268)
T cd05086 246 LQFCW-LSPEKRAT----AEEVHR 264 (268)
T ss_pred HHHHh-hCcccCCC----HHHHHH
Confidence 99999 68999999 888764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=354.90 Aligned_cols=255 Identities=22% Similarity=0.351 Sum_probs=215.6
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCc-----eEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTK-----CYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
...-.+.+.||.|+||.||.|...+.. ..||||.+.+.. +......+.+|..+|+.++|||||+++|++.+..
T Consensus 691 ~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 691 RKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG 768 (1025)
T ss_pred hhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC
Confidence 567888999999999999999876543 348999987653 3455567889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcC-----CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQP-----GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDL 361 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~-----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGl 361 (604)
..+|++|||+||||..+++... ...|+......++.||+.|+.||+++++|||||...|+||+....+||+||||
T Consensus 769 ~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 769 PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccch
Confidence 9999999999999999998751 35788999999999999999999999999999999999999999999999999
Q ss_pred cccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccccc
Q 007433 362 SLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIA 441 (604)
Q Consensus 362 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (604)
|+-+-.. .+++...
T Consensus 849 ArDiy~~-~yyr~~~----------------------------------------------------------------- 862 (1025)
T KOG1095|consen 849 ARDIYDK-DYYRKHG----------------------------------------------------------------- 862 (1025)
T ss_pred hHhhhhc-hheeccC-----------------------------------------------------------------
Confidence 9522111 1111000
Q ss_pred CCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHH
Q 007433 442 EPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSA 520 (604)
Q Consensus 442 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l 520 (604)
.-.-...|||||.+....++.++|||||||+|||+++ |..||.+.++.+.+..++.+. +++.+..++..+
T Consensus 863 --------~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~~P~~CP~~l 933 (1025)
T KOG1095|consen 863 --------EAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLDPPSYCPEKL 933 (1025)
T ss_pred --------ccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccCCCCCCChHH
Confidence 0012247999999999999999999999999999997 999999999999988777666 777778899999
Q ss_pred HHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 521 RDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 521 ~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
.+++..||..+|++||+ +..|++
T Consensus 934 y~lM~~CW~~~pe~RP~----F~~i~~ 956 (1025)
T KOG1095|consen 934 YQLMLQCWKHDPEDRPS----FRTIVE 956 (1025)
T ss_pred HHHHHHHccCChhhCcc----HHHHHh
Confidence 99999999999999999 666654
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=314.36 Aligned_cols=265 Identities=29% Similarity=0.395 Sum_probs=211.6
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec----
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET---- 284 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~---- 284 (604)
....+.|.-+.+||+|.||.||+|+...+++.||+|.+-.+.. +...-..+.+|++||..|+|+|++.+++.+..
T Consensus 13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmene-KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp 91 (376)
T KOG0669|consen 13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATP 91 (376)
T ss_pred eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhcc-ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCC
Confidence 3445678888999999999999999999999999987644321 11223356789999999999999999988742
Q ss_pred ----CCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccc
Q 007433 285 ----DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFD 360 (604)
Q Consensus 285 ----~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFG 360 (604)
...+||||.+| .-||..++... ..+|+...++.++.+++.||.|+|...|+|||+|++|+||+.+|.+||+|||
T Consensus 92 ~~r~r~t~ylVf~~c-ehDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 92 TNRDRATFYLVFDFC-EHDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred cccccceeeeeHHHh-hhhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccc
Confidence 34589999999 66999888654 3689999999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccc
Q 007433 361 LSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELI 440 (604)
Q Consensus 361 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (604)
+++-+....+.++.
T Consensus 170 lar~fs~~~n~~kp------------------------------------------------------------------ 183 (376)
T KOG0669|consen 170 LARAFSTSKNVVKP------------------------------------------------------------------ 183 (376)
T ss_pred cccceecccccCCC------------------------------------------------------------------
Confidence 98554333222111
Q ss_pred cCCCCCcccccccCccccCcceecCCC-CCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc--CC----------
Q 007433 441 AEPTNARSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG--QP---------- 507 (604)
Q Consensus 441 ~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~--~~---------- 507 (604)
+.+..+-|++|++||.+.|.. |+++.|||..||++.||.+|.+.|.+..+..++.-|.. +.
T Consensus 184 ------rytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d 257 (376)
T KOG0669|consen 184 ------RYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVD 257 (376)
T ss_pred ------CcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcc
Confidence 122446899999999999875 89999999999999999999999999887777654431 00
Q ss_pred -------CC---CCC-----------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCC
Q 007433 508 -------LR---FPE-----------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 508 -------~~---~p~-----------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
+. ++. .-.-++++.||+.+||.+||.+|+. +.++|+|.||.
T Consensus 258 ~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~----ad~alnh~~F~ 319 (376)
T KOG0669|consen 258 NLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRID----ADQALNHDFFW 319 (376)
T ss_pred cchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcc----hHhhhchhhhh
Confidence 00 000 0112346789999999999999999 99999999994
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=344.11 Aligned_cols=260 Identities=21% Similarity=0.268 Sum_probs=180.9
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCC----ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeE---
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGT----KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHF--- 282 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~--- 282 (604)
+..++|.+.+.||+|+||.||+|.+..+ +..||||.+........ ... +.++...+.++..++..|
T Consensus 129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~-----~~~--e~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEI-----WMN--ERVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHH-----HHH--HHHHhhchhhHHHHHHhhhcc
Confidence 3467999999999999999999999988 88999999865322111 001 112222233333332222
Q ss_pred ---ecCCeeEEEEeecCCCCHHHHHHhcCC------------------CCCcHHHHHHHHHHHHHHHHHHHHcCeEeccC
Q 007433 283 ---ETDKFSCLVMEFCPGGDLHTLRQRQPG------------------KYFSEQAVKFYVAEVLLALEYLHMLGIVYRDL 341 (604)
Q Consensus 283 ---~~~~~~~lV~E~~~ggsL~~ll~~~~~------------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDI 341 (604)
..+..++|||||+.+++|.+++..... ....+..+..|+.||+.||+|||++|||||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 356789999999999999998875421 11224457789999999999999999999999
Q ss_pred CCCcEEEcc-CCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccc
Q 007433 342 KPENVLVRE-DGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSK 420 (604)
Q Consensus 342 KpeNILl~~-~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (604)
||+||||+. ++.+||+|||++..+....
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~--------------------------------------------------- 310 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGI--------------------------------------------------- 310 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCcccccccc---------------------------------------------------
Confidence 999999986 5799999999984321100
Q ss_pred cccCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecCC----------------------CCCccchHHHHH
Q 007433 421 KAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGE----------------------GHGSAVDWWTFG 478 (604)
Q Consensus 421 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~----------------------~~~~~~DiWSLG 478 (604)
......++||+.|||||++... .+..++||||||
T Consensus 311 ------------------------~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlG 366 (566)
T PLN03225 311 ------------------------NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAG 366 (566)
T ss_pred ------------------------ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHH
Confidence 0011245789999999966432 234467999999
Q ss_pred HHHHHHhhCCCCCCCCChHHHHHHHHcC-CCC-------------------CCCCCCCCHHHHHHHHHhhhcCCCCcccc
Q 007433 479 IFLYELLFGKTPFKGSENRATLYNVVGQ-PLR-------------------FPESPVVSFSARDLIKGLLVKEPQNRLAC 538 (604)
Q Consensus 479 viL~eLltG~~PF~~~~~~~~l~~i~~~-~~~-------------------~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~ 538 (604)
|+||||+++..++.. ....+..++.. ... +...........|||.+||.+||++||+
T Consensus 367 viL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~t- 443 (566)
T PLN03225 367 LIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRIS- 443 (566)
T ss_pred HHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCC-
Confidence 999999997766542 22222222111 000 0001112334569999999999999999
Q ss_pred cCCHHHHhcCCCCCCCChh
Q 007433 539 RRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 539 ~~~a~elL~Hpff~~~~~~ 557 (604)
+.++|+||||++..+.
T Consensus 444 ---a~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 444 ---AKAALAHPYFDREGLL 459 (566)
T ss_pred ---HHHHhCCcCcCCCCcc
Confidence 9999999999987765
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-36 Score=329.78 Aligned_cols=264 Identities=22% Similarity=0.274 Sum_probs=194.1
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEc----------------CCceEEEEEEecchhHHHHHHH-----------HHHHH
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELT----------------GTKCYFAMKVMDKASLEKRKKL-----------LRAQT 262 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~----------------~~~~~vAiK~i~~~~~~~~~~~-----------~~~~~ 262 (604)
+..++|.+.++||+|+||+||+|.+. ..++.||||.+..........+ .....
T Consensus 142 ~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~v 221 (507)
T PLN03224 142 WSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMV 221 (507)
T ss_pred ccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHH
Confidence 44679999999999999999999752 2346799999865432211111 12234
Q ss_pred HHHHHHhCCCCCc-----cccceeEec--------CCeeEEEEeecCCCCHHHHHHhcCC--------------------
Q 007433 263 EREILQSLDHPFL-----PTLYTHFET--------DKFSCLVMEFCPGGDLHTLRQRQPG-------------------- 309 (604)
Q Consensus 263 Ei~iL~~l~HpnI-----v~l~~~~~~--------~~~~~lV~E~~~ggsL~~ll~~~~~-------------------- 309 (604)
|+.++.+++|.++ ++++++|.. .+..||||||+++++|.++++...+
T Consensus 222 E~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~ 301 (507)
T PLN03224 222 EAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM 301 (507)
T ss_pred HHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence 7777777876554 677777652 3568999999999999998864311
Q ss_pred --CCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcccCCcccCCCc
Q 007433 310 --KYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPV 387 (604)
Q Consensus 310 --~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~ 387 (604)
..+++..++.++.||+.||.|||+++|+||||||+|||++.++.++|+|||++........
T Consensus 302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~----------------- 364 (507)
T PLN03224 302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN----------------- 364 (507)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc-----------------
Confidence 1345678899999999999999999999999999999999999999999998743210000
Q ss_pred cccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecCCC
Q 007433 388 YCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEG 467 (604)
Q Consensus 388 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~ 467 (604)
.......+|+.|+|||++....
T Consensus 365 ----------------------------------------------------------~~~~~g~~tp~Y~aPE~l~~~~ 386 (507)
T PLN03224 365 ----------------------------------------------------------FNPLYGMLDPRYSPPEELVMPQ 386 (507)
T ss_pred ----------------------------------------------------------cCccccCCCcceeChhhhcCCC
Confidence 0000123578999999986432
Q ss_pred --------------------CC--ccchHHHHHHHHHHHhhCCC-CCCCCCh-----------HHHHHHHHcCCCCCCCC
Q 007433 468 --------------------HG--SAVDWWTFGIFLYELLFGKT-PFKGSEN-----------RATLYNVVGQPLRFPES 513 (604)
Q Consensus 468 --------------------~~--~~~DiWSLGviL~eLltG~~-PF~~~~~-----------~~~l~~i~~~~~~~p~~ 513 (604)
|+ ..+||||+||+||+|++|.+ ||.+... ...+..+....+.++..
T Consensus 387 ~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~~~~~~ 466 (507)
T PLN03224 387 SCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKYDFSLL 466 (507)
T ss_pred CCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCCCcccc
Confidence 11 34799999999999999986 7754211 11122334456667777
Q ss_pred CCCCHHHHHHHHHhhhcCC---CCcccccCCHHHHhcCCCCC
Q 007433 514 PVVSFSARDLIKGLLVKEP---QNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 514 ~~~s~~l~dLI~~lL~~dP---~~Rpt~~~~a~elL~Hpff~ 552 (604)
...+..++|||.+||.++| .+|++ +.|+|+||||.
T Consensus 467 d~~s~~~~dLi~~LL~~~~~~~~~RlS----a~eaL~Hp~f~ 504 (507)
T PLN03224 467 DRNKEAGWDLACKLITKRDQANRGRLS----VGQALSHRFFL 504 (507)
T ss_pred cccChHHHHHHHHHhccCCCCcccCCC----HHHHhCCCCcC
Confidence 7789999999999999876 68999 99999999995
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=309.00 Aligned_cols=253 Identities=26% Similarity=0.440 Sum_probs=212.2
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC------
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD------ 285 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------ 285 (604)
..+|.-++.+|.|+- .|.-|.+.-.++.||+|.+... +.......++.+|+.++..+.|+||+.++.+|.-.
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 468999999999999 8889999999999999988665 33344556888999999999999999999999633
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
...|+||||+ ..+|...+.- .+.-..+..++.|++.|+.|||+.||+||||||+||++..++.+||.|||+|++.
T Consensus 94 ~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e 168 (369)
T KOG0665|consen 94 QEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE 168 (369)
T ss_pred HhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence 4679999999 7899988873 3778899999999999999999999999999999999999999999999998432
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
.. +
T Consensus 169 ~~-----------------------------------------------------------------------------~ 171 (369)
T KOG0665|consen 169 DT-----------------------------------------------------------------------------D 171 (369)
T ss_pred Cc-----------------------------------------------------------------------------c
Confidence 21 1
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC------------------
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP------------------ 507 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~------------------ 507 (604)
-+.+-++.|..|+|||++.+.+|...+||||+||++.||++|...|.|.+..+.+.+++...
T Consensus 172 ~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~y 251 (369)
T KOG0665|consen 172 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNY 251 (369)
T ss_pred cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHH
Confidence 12345689999999999999999999999999999999999999999987777665554321
Q ss_pred ---------C----CCCCC---------CCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCC
Q 007433 508 ---------L----RFPES---------PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 508 ---------~----~~p~~---------~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
. .||+. +.-+..++||+.+||..||++|++ +.++|+||||+
T Consensus 252 v~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ris----v~daL~HPY~~ 314 (369)
T KOG0665|consen 252 VENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRIS----VDDALRHPYIK 314 (369)
T ss_pred hhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhccc----HHHHhcCCeee
Confidence 0 11211 122345789999999999999999 99999999998
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=292.97 Aligned_cols=242 Identities=46% Similarity=0.788 Sum_probs=202.8
Q ss_pred CcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCCCCHHHHH
Q 007433 225 DIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLR 304 (604)
Q Consensus 225 ~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~ll 304 (604)
+||.||+|.+.+++..||+|++........ ...+.+|++++++++|+||+++++++..+...++||||+++++|..++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999999899999999976543221 456678999999999999999999999999999999999999999998
Q ss_pred HhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcccCCcccC
Q 007433 305 QRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRK 384 (604)
Q Consensus 305 ~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~ 384 (604)
.... .+++..+..++.+++.+|.|||+.||+|+||+|.||+++.++.++|+|||++.......
T Consensus 79 ~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--------------- 141 (244)
T smart00220 79 KKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--------------- 141 (244)
T ss_pred Hhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---------------
Confidence 7753 38999999999999999999999999999999999999999999999999884432110
Q ss_pred CCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccccCcceec
Q 007433 385 NPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIK 464 (604)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~ 464 (604)
......|+..|++||.+.
T Consensus 142 --------------------------------------------------------------~~~~~~~~~~~~~pE~~~ 159 (244)
T smart00220 142 --------------------------------------------------------------LLTTFVGTPEYMAPEVLL 159 (244)
T ss_pred --------------------------------------------------------------ccccccCCcCCCCHHHHc
Confidence 011235788999999999
Q ss_pred CCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-CCCCCCCC-CCHHHHHHHHHhhhcCCCCcccccCCH
Q 007433 465 GEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP-LRFPESPV-VSFSARDLIKGLLVKEPQNRLACRRGA 542 (604)
Q Consensus 465 ~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~-~~~p~~~~-~s~~l~dLI~~lL~~dP~~Rpt~~~~a 542 (604)
+..++.++|||+||+++|+|++|..||....+...+.+..... ........ ++.++.++|.+||..||++||+ +
T Consensus 160 ~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~----~ 235 (244)
T smart00220 160 GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT----A 235 (244)
T ss_pred cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC----H
Confidence 8888999999999999999999999998844444444444332 22222211 7889999999999999999999 9
Q ss_pred HHHhcCCCC
Q 007433 543 TEIKQHPFF 551 (604)
Q Consensus 543 ~elL~Hpff 551 (604)
.++++||||
T Consensus 236 ~~~~~~~~~ 244 (244)
T smart00220 236 EEALQHPFF 244 (244)
T ss_pred HHHhhCCCC
Confidence 999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=326.60 Aligned_cols=255 Identities=23% Similarity=0.341 Sum_probs=217.3
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCC---ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCee
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGT---KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 288 (604)
.++.++.++||+|.||.|++|.|+.. ...||||+++.+.+.. .+..+++|+.+|.+|+|+|+++|||+..+ ..+
T Consensus 109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-qp~ 185 (1039)
T KOG0199|consen 109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPA 185 (1039)
T ss_pred HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-chh
Confidence 35667788999999999999998643 3469999998876543 45567899999999999999999999987 678
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
.||||++++|+|.+.+++.....|.....-.|+.||+.||.||..+++|||||-..||||-....|||+||||.+-++..
T Consensus 186 mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~n 265 (1039)
T KOG0199|consen 186 MMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGEN 265 (1039)
T ss_pred hHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCC
Confidence 89999999999999998866678999999999999999999999999999999999999999889999999999766544
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
++.+. |+.+
T Consensus 266 ed~Yv-------------------------------------------------------m~p~---------------- 274 (1039)
T KOG0199|consen 266 EDMYV-------------------------------------------------------MAPQ---------------- 274 (1039)
T ss_pred CcceE-------------------------------------------------------ecCC----------------
Confidence 33221 0000
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGL 527 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~l 527 (604)
..-...|+|||.|+...++.++|+|+|||+||||++ |+.||.|....+++.+|- ..-+++....+++++.++++.|
T Consensus 275 --rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~~erLpRPk~csedIY~imk~c 351 (1039)
T KOG0199|consen 275 --RKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-AGERLPRPKYCSEDIYQIMKNC 351 (1039)
T ss_pred --CcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-ccccCCCCCCChHHHHHHHHHh
Confidence 012357999999999999999999999999999996 899999999988888876 5566777778999999999999
Q ss_pred hhcCCCCcccccCCHHHHhc
Q 007433 528 LVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~ 547 (604)
|+.+|++||+ +..|..
T Consensus 352 Wah~paDRpt----Fsair~ 367 (1039)
T KOG0199|consen 352 WAHNPADRPT----FSAIRE 367 (1039)
T ss_pred ccCCcccccc----HHHHHH
Confidence 9999999999 555543
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=301.36 Aligned_cols=257 Identities=26% Similarity=0.385 Sum_probs=206.4
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHH-HHhCCCCCccccceeEecCCeeEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI-LQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~i-L~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
++.+-+..||.|+||+|++..++.+|+..|||.++.... .+...+++.|++. ++.-+.||||++||....++..++.
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC 141 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC 141 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence 455556789999999999999999999999999987755 3444567778876 4555889999999999888889999
Q ss_pred EeecCCCCHHHHHHh---cCCCCCcHHHHHHHHHHHHHHHHHHHH-cCeEeccCCCCcEEEccCCcEEEecccccccccC
Q 007433 292 MEFCPGGDLHTLRQR---QPGKYFSEQAVKFYVAEVLLALEYLHM-LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAV 367 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~---~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~ 367 (604)
||+| ..+|..+.+. -....++|+.+-.|..-.+.||+||-+ ++||||||||+||||+..|.+||||||++-.+..
T Consensus 142 MELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 142 MELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 9999 7788665332 223679999999999999999999985 6899999999999999999999999998622110
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
.++.
T Consensus 221 -----------------------------------------------------------------------SiAk----- 224 (361)
T KOG1006|consen 221 -----------------------------------------------------------------------SIAK----- 224 (361)
T ss_pred -----------------------------------------------------------------------HHHh-----
Confidence 0000
Q ss_pred ccccccCccccCcceecC--CCCCccchHHHHHHHHHHHhhCCCCCCCC-ChHHHHHHHHcC-CCCCCCC---CCCCHHH
Q 007433 448 SMSFVGTHEYLAPEIIKG--EGHGSAVDWWTFGIFLYELLFGKTPFKGS-ENRATLYNVVGQ-PLRFPES---PVVSFSA 520 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~--~~~~~~~DiWSLGviL~eLltG~~PF~~~-~~~~~l~~i~~~-~~~~p~~---~~~s~~l 520 (604)
+.-.|-..|||||.+.. .+|+-++|+||||++|||+.||+.||.+- +..+++..++.+ +..+... ...+..+
T Consensus 225 -T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~ 303 (361)
T KOG1006|consen 225 -TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSM 303 (361)
T ss_pred -hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHH
Confidence 11248889999999864 46889999999999999999999999874 345666666554 3333222 3378999
Q ss_pred HHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 521 RDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 521 ~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
++||.-||.+|-.+||. ..+|+.+||++-
T Consensus 304 ~~fintCl~Kd~~~Rpk----y~~Lk~~~fyr~ 332 (361)
T KOG1006|consen 304 VRFINTCLIKDRSDRPK----YDDLKKFPFYRM 332 (361)
T ss_pred HHHHHHHhhcccccCcc----hhhhhcCchhhh
Confidence 99999999999999999 899999999964
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=311.59 Aligned_cols=251 Identities=21% Similarity=0.320 Sum_probs=216.5
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
..+..+.++||.|.||.||.|.|+.-...||||.++.+. ..+.+++.|..+|+.++|||+|+|+++|..+.-+|||
T Consensus 266 RtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDt----MeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIi 341 (1157)
T KOG4278|consen 266 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYII 341 (1157)
T ss_pred chheeeeeccCCCcccceeeeeeeccceeeehhhhhhcc----hhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEE
Confidence 346677889999999999999999999999999997664 4456677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
+|||..|+|.++++......++.-....++.||..|++||..+++|||||-..|+||.++..||++||||++.+. ..++
T Consensus 342 TEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt-gDTY 420 (1157)
T KOG4278|consen 342 TEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT-GDTY 420 (1157)
T ss_pred EecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc-CCce
Confidence 999999999999998877778888888999999999999999999999999999999999999999999995432 2222
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
..... -
T Consensus 421 TAHAG--------------------------------------------------------------------------A 426 (1157)
T KOG4278|consen 421 TAHAG--------------------------------------------------------------------------A 426 (1157)
T ss_pred ecccC--------------------------------------------------------------------------c
Confidence 11110 0
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
.-..-|.|||-|....++.++|||+|||+|||+.| |.-||.+.+. ..++.++...+++..+..+++...+|++.||.+
T Consensus 427 KFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl-SqVY~LLEkgyRM~~PeGCPpkVYeLMraCW~W 505 (1157)
T KOG4278|consen 427 KFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL-SQVYGLLEKGYRMDGPEGCPPKVYELMRACWNW 505 (1157)
T ss_pred cCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccH-HHHHHHHhccccccCCCCCCHHHHHHHHHHhcC
Confidence 11246999999999999999999999999999986 9999998754 556677777888888888999999999999999
Q ss_pred CCCCcccccCCHHHHh
Q 007433 531 EPQNRLACRRGATEIK 546 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL 546 (604)
.|.+||+ +.|+-
T Consensus 506 sPsDRPs----FaeiH 517 (1157)
T KOG4278|consen 506 SPSDRPS----FAEIH 517 (1157)
T ss_pred CcccCcc----HHHHH
Confidence 9999999 66663
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-37 Score=298.80 Aligned_cols=261 Identities=26% Similarity=0.375 Sum_probs=208.0
Q ss_pred eEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC-----CeeE
Q 007433 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD-----KFSC 289 (604)
Q Consensus 215 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~~~ 289 (604)
.+--+-||.|+||.||-..+..+++.||+|.+.. .+..-....++.+|+++|..++|.||+..++..+-. ..+|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pn-vfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPN-VFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcch-HHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 3344679999999999999999999999998843 233334456778899999999999999988877643 3578
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
+|+|++ ..||+.++-.. ..|+...++.+++||++||.|||+.+|.||||||.|+|++.|..+||||||+++-.....
T Consensus 134 V~TELm-QSDLHKIIVSP--Q~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 134 VLTELM-QSDLHKIIVSP--QALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HHHHHH-HhhhhheeccC--CCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence 999999 78999887654 679999999999999999999999999999999999999999999999999994321100
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
....+
T Consensus 211 ---------------------------------------------------------------------------~~hMT 215 (449)
T KOG0664|consen 211 ---------------------------------------------------------------------------RLNMT 215 (449)
T ss_pred ---------------------------------------------------------------------------hhhhH
Confidence 00122
Q ss_pred ccccCccccCcceecCCC-CCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHH-----------------------c
Q 007433 450 SFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV-----------------------G 505 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~-----------------------~ 505 (604)
.-+-|.+|+|||++.|.. |+.++||||.|||+.|||-.+..|...+..+.+..|. .
T Consensus 216 qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR 295 (449)
T KOG0664|consen 216 HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLR 295 (449)
T ss_pred HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhc
Confidence 346789999999999876 7889999999999999999999998877666554332 1
Q ss_pred CCCCCCCCC---------CCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhh
Q 007433 506 QPLRFPESP---------VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWAL 558 (604)
Q Consensus 506 ~~~~~p~~~---------~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~ 558 (604)
.+.+-|..+ .-.-+..+++..||..||.+|++ .++.++|+|..+.+...
T Consensus 296 ~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris----~~~A~~~~~~~e~R~r~ 353 (449)
T KOG0664|consen 296 AGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRIS----VEEALQHRYLEEGRLRF 353 (449)
T ss_pred cCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCccccc----Hhhhcccccccccceee
Confidence 222222211 12235678999999999999999 99999999998877554
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=286.62 Aligned_cols=263 Identities=27% Similarity=0.458 Sum_probs=209.2
Q ss_pred hheeecCceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccc
Q 007433 201 QAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLY 279 (604)
Q Consensus 201 ~~~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~ 279 (604)
+.+.+.-| ..++|++++++|+|-|+.||.|....++..++||+++.- +...+.+|+.||+.|. ||||++|+
T Consensus 28 E~~~i~wg--~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~ 99 (338)
T KOG0668|consen 28 ESLVIDWG--NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLL 99 (338)
T ss_pred hheeeecc--ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehh
Confidence 34444444 347999999999999999999999999999999999532 3345678999999995 99999999
Q ss_pred eeEecC--CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccC-CcEEE
Q 007433 280 THFETD--KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRED-GHIML 356 (604)
Q Consensus 280 ~~~~~~--~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~-g~vkL 356 (604)
+...+. ...-||+||+.+.+...+-. .|+...++.++.||+.||+|+|+.||+|||+||.|++|+.. -.++|
T Consensus 100 DiV~Dp~SktpaLiFE~v~n~Dfk~ly~-----tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrl 174 (338)
T KOG0668|consen 100 DIVKDPESKTPSLIFEYVNNTDFKQLYP-----TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRL 174 (338)
T ss_pred hhhcCccccCchhHhhhhccccHHHHhh-----hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeee
Confidence 999763 56779999999888877643 47888999999999999999999999999999999999964 47999
Q ss_pred ecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCC
Q 007433 357 SDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPL 436 (604)
Q Consensus 357 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (604)
+|+|||..+.+...
T Consensus 175 IDWGLAEFYHp~~e------------------------------------------------------------------ 188 (338)
T KOG0668|consen 175 IDWGLAEFYHPGKE------------------------------------------------------------------ 188 (338)
T ss_pred eecchHhhcCCCce------------------------------------------------------------------
Confidence 99999955432211
Q ss_pred cccccCCCCCcccccccCccccCcceecCCC-CCccchHHHHHHHHHHHhhCCCCC-CCCChHHHHHHHHc---------
Q 007433 437 PELIAEPTNARSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPF-KGSENRATLYNVVG--------- 505 (604)
Q Consensus 437 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~PF-~~~~~~~~l~~i~~--------- 505 (604)
-.-.+.+..|--||++-... |+..-|+|||||+|+.|++.+.|| .|.++.+++.+|..
T Consensus 189 -----------YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~ 257 (338)
T KOG0668|consen 189 -----------YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYA 257 (338)
T ss_pred -----------eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHH
Confidence 01235677889999987654 788999999999999999999886 56677666544321
Q ss_pred ------------------CCCC-----C--C-CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 506 ------------------QPLR-----F--P-ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 506 ------------------~~~~-----~--p-~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
+..+ | + ....+++++.|||.++|.+|-++|+| +.|++.||||..+..+
T Consensus 258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlT----akEam~HpyF~~~~~~ 331 (338)
T KOG0668|consen 258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLT----AKEAMAHPYFAPVREA 331 (338)
T ss_pred HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccc----hHHHhcCchHHHHHHH
Confidence 1000 1 1 11235689999999999999999999 9999999999866544
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=313.54 Aligned_cols=250 Identities=26% Similarity=0.372 Sum_probs=206.7
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcC----CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTG----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET 284 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 284 (604)
.+......+.++||.|-||.||.|.... ..-.||||..+.+... .....+..|..+|+.++||||++|+|++.+
T Consensus 385 el~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~--d~tekflqEa~iMrnfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 385 ELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP--DDTEKFLQEASIMRNFDHPHIIKLIGVCVE 462 (974)
T ss_pred eeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh--hhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence 3444556667789999999999997643 3446999998775322 223456679999999999999999999975
Q ss_pred CCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccc
Q 007433 285 DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLR 364 (604)
Q Consensus 285 ~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~ 364 (604)
. ..+||||+++-|.|..+++.+. ..|+......|+.||+.||.|||+..+|||||-..||||....-|||+||||++.
T Consensus 463 ~-P~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~ 540 (974)
T KOG4257|consen 463 Q-PMWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRY 540 (974)
T ss_pred c-ceeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhh
Confidence 4 5789999999999999998874 6799999999999999999999999999999999999999999999999999955
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
+.. ..+++..
T Consensus 541 ~ed-~~yYkaS--------------------------------------------------------------------- 550 (974)
T KOG4257|consen 541 LED-DAYYKAS--------------------------------------------------------------------- 550 (974)
T ss_pred ccc-cchhhcc---------------------------------------------------------------------
Confidence 432 2222211
Q ss_pred CCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHh-hCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 007433 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDL 523 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLl-tG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dL 523 (604)
...-..-|||||-+.-..++.++|||.|||++||+| .|..||.+..+.+.+..+-. .-++|.++.+++.+..|
T Consensus 551 -----~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEn-GeRlP~P~nCPp~LYsl 624 (974)
T KOG4257|consen 551 -----RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIEN-GERLPCPPNCPPALYSL 624 (974)
T ss_pred -----ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecC-CCCCCCCCCCChHHHHH
Confidence 011234699999999999999999999999999988 59999999888877765543 45677778899999999
Q ss_pred HHHhhhcCCCCcccc
Q 007433 524 IKGLLVKEPQNRLAC 538 (604)
Q Consensus 524 I~~lL~~dP~~Rpt~ 538 (604)
+.+||++||.+||..
T Consensus 625 mskcWayeP~kRPrf 639 (974)
T KOG4257|consen 625 MSKCWAYEPSKRPRF 639 (974)
T ss_pred HHHHhccCcccCCcH
Confidence 999999999999984
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-34 Score=304.19 Aligned_cols=257 Identities=21% Similarity=0.295 Sum_probs=209.7
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
+..+...+.++||+|-||.|.+|+..+ ...||+|.++...... ....+.+|+++|.+|+||||++|++++..++.+|
T Consensus 535 fPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~--~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePic 611 (807)
T KOG1094|consen 535 FPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKN--ARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLC 611 (807)
T ss_pred cchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchh--HHHHHHHHHHHHhccCCCCeeEEEeeeecCCchH
Confidence 334677889999999999999999876 5689999998764332 2346778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
+||||+++|+|..++.++.-..+.......|+.||+.||+||.+.++|||||.+.|+|++.++++||+|||+++.+-..
T Consensus 612 mI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg- 690 (807)
T KOG1094|consen 612 MITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSG- 690 (807)
T ss_pred HHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccC-
Confidence 9999999999999998873223344445669999999999999999999999999999999999999999998533211
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
+.++ -..
T Consensus 691 ~yy~-------------------------------------------------------------------------vqg 697 (807)
T KOG1094|consen 691 DYYR-------------------------------------------------------------------------VQG 697 (807)
T ss_pred Ccee-------------------------------------------------------------------------eec
Confidence 1111 111
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHh--hCCCCCCCCChHHHHHHHHcC------CCCCCCCCCCCHHHH
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL--FGKTPFKGSENRATLYNVVGQ------PLRFPESPVVSFSAR 521 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLl--tG~~PF~~~~~~~~l~~i~~~------~~~~p~~~~~s~~l~ 521 (604)
.++-...|||+|.+...+++.++|+|+||++|||++ +.+.||....+.+.+.+...- ..-++.+..++..+.
T Consensus 698 r~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~ly 777 (807)
T KOG1094|consen 698 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLY 777 (807)
T ss_pred ceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHH
Confidence 345667899999999999999999999999999976 588999988887777654321 122344567899999
Q ss_pred HHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 522 DLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 522 dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
+|+.+|+.+|-++||+ .++|..
T Consensus 778 elml~Cw~~es~~RPs----Fe~lh~ 799 (807)
T KOG1094|consen 778 ELMLRCWRRESEQRPS----FEQLHL 799 (807)
T ss_pred HHHHHHhchhhhcCCC----HHHHHH
Confidence 9999999999999999 888744
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=320.55 Aligned_cols=259 Identities=22% Similarity=0.329 Sum_probs=220.3
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCc---eEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTK---CYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD 285 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 285 (604)
++.....++.+.||.|-||.|++|+++..+ ..||||.++....+ +....++.|..||.+++||||++|.|+....
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyte--kqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTE--KQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccH--HHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 455667889999999999999999998665 46999999765433 3334577899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
+-+.||.|||++|+|..+++.+.+ .|+..+..-+++.|+.|+.||-+.|+|||||-..||||+.+-..|++||||++.+
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvl 781 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 781 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeec
Confidence 999999999999999999998865 5999999999999999999999999999999999999999999999999999654
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
..++...-+.
T Consensus 782 edd~~~~ytt---------------------------------------------------------------------- 791 (996)
T KOG0196|consen 782 EDDPEAAYTT---------------------------------------------------------------------- 791 (996)
T ss_pred ccCCCccccc----------------------------------------------------------------------
Confidence 3222100000
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHh-hCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLI 524 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLl-tG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI 524 (604)
..-.-...|.|||.+...+++.++||||+||+|||.+ +|+.||.+..+.+.+..|. +.+++|.+..++..+.+|+
T Consensus 792 ---~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-~gyRLPpPmDCP~aL~qLM 867 (996)
T KOG0196|consen 792 ---LGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-QGYRLPPPMDCPAALYQLM 867 (996)
T ss_pred ---cCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-hccCCCCCCCCcHHHHHHH
Confidence 0001235799999999999999999999999999976 6999999999988876664 5689999999999999999
Q ss_pred HHhhhcCCCCcccccCCHHHHhcC
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
..||++|-.+||. +.+|+.+
T Consensus 868 ldCWqkdR~~RP~----F~qiV~~ 887 (996)
T KOG0196|consen 868 LDCWQKDRNRRPK----FAQIVST 887 (996)
T ss_pred HHHHHHHhhcCCC----HHHHHHH
Confidence 9999999999999 7777754
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=318.27 Aligned_cols=256 Identities=28% Similarity=0.465 Sum_probs=222.2
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|.++.++|.|.||.||+|++..+++..|+|+++...- ..+.-++.|+-+++.++|+|||-+++.|..+..+++.|
T Consensus 15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~---dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicM 91 (829)
T KOG0576|consen 15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG---DDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICM 91 (829)
T ss_pred cchhheeeecCCcccchhhhcccccCchhhheeeeccCC---ccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEE
Confidence 689999999999999999999999999999999976532 34455678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
|||.||+|+++-+-. +.++|.++..++++.+.||+|||++|-+|||||-.|||+++.|.+||+|||.+..++
T Consensus 92 EycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqit------ 163 (829)
T KOG0576|consen 92 EYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQIT------ 163 (829)
T ss_pred EecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhh------
Confidence 999999999976554 689999999999999999999999999999999999999999999999999874332
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.+-.+..+|+
T Consensus 164 ----------------------------------------------------------------------ati~Krksfi 173 (829)
T KOG0576|consen 164 ----------------------------------------------------------------------ATIAKRKSFI 173 (829)
T ss_pred ----------------------------------------------------------------------hhhhhhhccc
Confidence 1223455789
Q ss_pred cCccccCccee---cCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---CCCCCCCCCCCHHHHHHHHH
Q 007433 453 GTHEYLAPEII---KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---PLRFPESPVVSFSARDLIKG 526 (604)
Q Consensus 453 GT~~Y~APE~l---~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~~~~p~~~~~s~~l~dLI~~ 526 (604)
||++|||||+. +..+|...+|||++|+.-.||---.+|.........++-.... +..+.+....++.+.+|++.
T Consensus 174 GtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~ 253 (829)
T KOG0576|consen 174 GTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKG 253 (829)
T ss_pred CCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHH
Confidence 99999999986 4557899999999999999999888887776666666655543 44455556788999999999
Q ss_pred hhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 527 LLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 527 lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
+|.++|++||+ ++.+|+|||...
T Consensus 254 altknpKkRpt----aeklL~h~fvs~ 276 (829)
T KOG0576|consen 254 ALTKNPKKRPT----AEKLLQHPFVSQ 276 (829)
T ss_pred HhcCCCccCCC----hhhheeceeecc
Confidence 99999999999 999999999864
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=306.12 Aligned_cols=202 Identities=31% Similarity=0.493 Sum_probs=177.4
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHH-----HHHHHHHHHHHHHHHhCC---CCCccccceeEe
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEK-----RKKLLRAQTEREILQSLD---HPFLPTLYTHFE 283 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~-----~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~ 283 (604)
..+|..++.||.|+||.|++|.++.....|+||.+.|...-. ..++-.+-.||+||..|+ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 467999999999999999999999999999999998875432 122233446999999997 999999999999
Q ss_pred cCCeeEEEEeec-CCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 284 TDKFSCLVMEFC-PGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 284 ~~~~~~lV~E~~-~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
+++++||+||-- +|.||++++... ..++|.+++.|++||+.|+++||++||||||||-|||.++.+|-+||+|||.+
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsa 717 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSA 717 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccch
Confidence 999999999984 778999999987 56999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccC
Q 007433 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442 (604)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (604)
.....
T Consensus 718 a~~ks--------------------------------------------------------------------------- 722 (772)
T KOG1152|consen 718 AYTKS--------------------------------------------------------------------------- 722 (772)
T ss_pred hhhcC---------------------------------------------------------------------------
Confidence 33211
Q ss_pred CCCCcccccccCccccCcceecCCCC-CccchHHHHHHHHHHHhhCCCCCCC
Q 007433 443 PTNARSMSFVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKG 493 (604)
Q Consensus 443 ~~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiWSLGviL~eLltG~~PF~~ 493 (604)
.....|+||..|.|||++.|+.| +..-|||+||++||.+++.+.||..
T Consensus 723 ---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 723 ---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 12236899999999999999988 8889999999999999999999864
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-34 Score=316.26 Aligned_cols=249 Identities=30% Similarity=0.426 Sum_probs=196.7
Q ss_pred eEEEEEEccCCcEE-EEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCeeEEEE
Q 007433 215 FRLLKKLGCGDIGS-VYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 215 y~l~~~LG~G~fG~-Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
|.-.+.+|.|+-|+ ||+|... ++.||||.+-.. ....+++||..|+.- +|||||++|+.-.++.+.||..
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIal 582 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIAL 582 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEe
Confidence 33345688998876 7899875 458999998543 334678999999988 6999999999999999999999
Q ss_pred eecCCCCHHHHHHhc-CCC-CCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc---CC--cEEEecccccccc
Q 007433 293 EFCPGGDLHTLRQRQ-PGK-YFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE---DG--HIMLSDFDLSLRC 365 (604)
Q Consensus 293 E~~~ggsL~~ll~~~-~~~-~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~---~g--~vkL~DFGla~~~ 365 (604)
|.| ..+|.++++.. ... .......+.++.|++.||++||+.+||||||||.||||.. ++ +++|+|||+++++
T Consensus 583 ELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 583 ELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred hHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 999 78999999874 111 1111345778999999999999999999999999999986 34 7899999999877
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
..+...++
T Consensus 662 ~~~~sS~~------------------------------------------------------------------------ 669 (903)
T KOG1027|consen 662 AGGKSSFS------------------------------------------------------------------------ 669 (903)
T ss_pred CCCcchhh------------------------------------------------------------------------
Confidence 64433221
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhC-CCCCCCCChHHHHHHHHcCCCCCCCC-CCCCHHHHHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFG-KTPFKGSENRATLYNVVGQPLRFPES-PVVSFSARDL 523 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG-~~PF~~~~~~~~l~~i~~~~~~~p~~-~~~s~~l~dL 523 (604)
+..+..||-+|+|||++.......++|||||||++|+.++| ..||...- +.-.+|+.....+-.. +....+++||
T Consensus 670 -r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~~~~L~~L~~~~d~eA~dL 746 (903)
T KOG1027|consen 670 -RLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTGNYTLVHLEPLPDCEAKDL 746 (903)
T ss_pred -cccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH--HhhhhhhcCccceeeeccCchHHHHHH
Confidence 12234599999999999999888999999999999999986 99998643 3344666655443211 1112289999
Q ss_pred HHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 524 IKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 524 I~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
|.+||.+||..||+ |.+||.||||
T Consensus 747 I~~ml~~dP~~RPs----a~~VL~HPlF 770 (903)
T KOG1027|consen 747 ISRMLNPDPQLRPS----ATDVLNHPLF 770 (903)
T ss_pred HHHhcCCCcccCCC----HHHHhCCCcc
Confidence 99999999999999 9999999999
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=336.04 Aligned_cols=239 Identities=19% Similarity=0.280 Sum_probs=186.0
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
..|...+.||+|+||.||+|++..++..||||.+...... ...|+++|++++|||||++++++.+++..|+||
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEE
Confidence 3566778899999999999999999999999998653211 124688999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH---HcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH---MLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH---~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
||+++|+|.++++. +++..+..|+.||+.||+||| +.+|+||||||+|||++.++..++. ||......
T Consensus 763 Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~--- 833 (968)
T PLN00113 763 EYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLC--- 833 (968)
T ss_pred eCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccc---
Confidence 99999999999853 789999999999999999999 6699999999999999988887775 55431000
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
...
T Consensus 834 -----------------------------------------------------------------------------~~~ 836 (968)
T PLN00113 834 -----------------------------------------------------------------------------TDT 836 (968)
T ss_pred -----------------------------------------------------------------------------cCC
Confidence 001
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCCh-HHHHHHHHc-------------CCCC--CCCC
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSEN-RATLYNVVG-------------QPLR--FPES 513 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~-~~~l~~i~~-------------~~~~--~p~~ 513 (604)
...||+.|||||++.+..++.++|||||||++|||++|+.||..... ...+..+.. .... .+..
T Consensus 837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 916 (968)
T PLN00113 837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN 916 (968)
T ss_pred CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCcc
Confidence 12588999999999999999999999999999999999999954211 111111110 0000 0000
Q ss_pred CCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 514 PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 514 ~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
.....++.+++.+||..||++||+ +.|+++.
T Consensus 917 ~~~~~~~~~l~~~Cl~~~P~~RPt----~~evl~~ 947 (968)
T PLN00113 917 QNEIVEVMNLALHCTATDPTARPC----ANDVLKT 947 (968)
T ss_pred HHHHHHHHHHHHhhCcCCchhCcC----HHHHHHH
Confidence 011235678999999999999999 8888765
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=294.44 Aligned_cols=294 Identities=26% Similarity=0.388 Sum_probs=208.7
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcC---CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCe
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTG---TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKF 287 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 287 (604)
...|.++++||.|.|++||+|.+.. ..++||+|.+...... .++..|+++|..+ .+.||+.+.+++..++.
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 4689999999999999999999877 7889999999766432 3577899999999 68999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc-CCcEEEeccccccccc
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE-DGHIMLSDFDLSLRCA 366 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~-~g~vkL~DFGla~~~~ 366 (604)
.++||||++.....++... ++...++.|++.++.||.++|.+|||||||||+|+|.+. .++-.|+|||||.+..
T Consensus 110 v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d 184 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYD 184 (418)
T ss_pred eEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHH
Confidence 9999999999988887654 678889999999999999999999999999999999984 6788999999996522
Q ss_pred CCCcccccCcc---cCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccc--c
Q 007433 367 VSPTVVKSSTL---ESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELI--A 441 (604)
Q Consensus 367 ~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~ 441 (604)
.......+... ...+. ....+ .|. +|.. ...+..... .
T Consensus 185 ~~~~~~~s~~~~~~~~~~~-~g~~~----~~~--~~~~------------------------------~~~p~g~~~~~~ 227 (418)
T KOG1167|consen 185 GYQQTEHSRSYSGRHATPA-MGKDV----HCQ--SVAT------------------------------ASKPAGYYRRCN 227 (418)
T ss_pred hhhhhhhhhhhhcccCCcc-ccCcc----ccc--cccc------------------------------ccCCCCceeccC
Confidence 11100000000 00000 00000 000 0000 000000000 0
Q ss_pred CCCCCcccccccCccccCcceecCCC-CCccchHHHHHHHHHHHhhCCCCCCCC-ChHHHHHHHH---------------
Q 007433 442 EPTNARSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGS-ENRATLYNVV--------------- 504 (604)
Q Consensus 442 ~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~PF~~~-~~~~~l~~i~--------------- 504 (604)
.......-...||++|+|||++...+ .+.++||||.|||++-+++++.||... ++.+.+.+++
T Consensus 228 ~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~ 307 (418)
T KOG1167|consen 228 DGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALP 307 (418)
T ss_pred CCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcC
Confidence 11112233567999999999987765 588999999999999999999998543 2111111110
Q ss_pred cC-------C-------------C-------------C-CCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCC
Q 007433 505 GQ-------P-------------L-------------R-FPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPF 550 (604)
Q Consensus 505 ~~-------~-------------~-------------~-~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpf 550 (604)
+. . + . .......+..+.||+.+||..||.+|++ ++++|+|||
T Consensus 308 g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRit----AEeALkHpF 383 (418)
T KOG1167|consen 308 GRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRIT----AEDALKHPF 383 (418)
T ss_pred CceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhccc----HHHHhcCcC
Confidence 00 0 0 0 0011224457889999999999999999 999999999
Q ss_pred CCCCCh
Q 007433 551 FQGVNW 556 (604)
Q Consensus 551 f~~~~~ 556 (604)
|...+.
T Consensus 384 F~~~~~ 389 (418)
T KOG1167|consen 384 FDEADR 389 (418)
T ss_pred Ccchhh
Confidence 986653
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.3e-32 Score=260.26 Aligned_cols=217 Identities=25% Similarity=0.386 Sum_probs=176.7
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHh-CCCCCccccceeEecCCeeEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQS-LDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~-l~HpnIv~l~~~~~~~~~~~l 290 (604)
.++...+..||+|+||.|-+.++..+|...|+|.+..... .+...+..+|+.+..+ ...|++|++|+.+..+..+++
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI 122 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI 122 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence 3455567789999999999999999999999999976533 2344566788887655 489999999999999999999
Q ss_pred EEeecCCCCHHHHHHh--cCCCCCcHHHHHHHHHHHHHHHHHHHHc-CeEeccCCCCcEEEccCCcEEEecccccccccC
Q 007433 291 VMEFCPGGDLHTLRQR--QPGKYFSEQAVKFYVAEVLLALEYLHML-GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAV 367 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~--~~~~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~ 367 (604)
.||.+ ..+|..+-.+ ..+..++|..+-+|+..|+.||+|||++ .|||||+||+||||+.+|++|+||||++-.+..
T Consensus 123 cME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 123 CMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred eHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 99999 7788765442 2357899999999999999999999985 799999999999999999999999998733221
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
+- +.
T Consensus 202 Si-----------------------------------------------------------------------Ak----- 205 (282)
T KOG0984|consen 202 SI-----------------------------------------------------------------------AK----- 205 (282)
T ss_pred hh-----------------------------------------------------------------------HH-----
Confidence 10 00
Q ss_pred ccccccCccccCcceecC----CCCCccchHHHHHHHHHHHhhCCCCCCC-CChHHHHHHHHcCCC
Q 007433 448 SMSFVGTHEYLAPEIIKG----EGHGSAVDWWTFGIFLYELLFGKTPFKG-SENRATLYNVVGQPL 508 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~----~~~~~~~DiWSLGviL~eLltG~~PF~~-~~~~~~l~~i~~~~~ 508 (604)
+--.|-..|||||.+.. .+|+-++||||||++++||.+++.||.. ....+++..++..+.
T Consensus 206 -t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~ 270 (282)
T KOG0984|consen 206 -TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPS 270 (282)
T ss_pred -HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCC
Confidence 00136778999999854 4789999999999999999999999965 567788888887653
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.6e-31 Score=303.10 Aligned_cols=255 Identities=25% Similarity=0.379 Sum_probs=206.7
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcC-------CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEe
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTG-------TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFE 283 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~ 283 (604)
.++..+.+.||+|.||.||+|...+ ....||||.+...... .....+..|+++|+.+ .|+||+.+++++.
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t 372 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACT 372 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeec
Confidence 3455677799999999999997542 1457999999765443 3445677899999999 5999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHhcC------C--------CCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEc
Q 007433 284 TDKFSCLVMEFCPGGDLHTLRQRQP------G--------KYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVR 349 (604)
Q Consensus 284 ~~~~~~lV~E~~~ggsL~~ll~~~~------~--------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~ 349 (604)
.++.+++|+|||..|+|..+++... . ..++......++.||+.|++||++..+|||||-..||||.
T Consensus 373 ~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~ 452 (609)
T KOG0200|consen 373 QDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT 452 (609)
T ss_pred cCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence 9999999999999999999988764 0 1388899999999999999999999999999999999999
Q ss_pred cCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCcccc
Q 007433 350 EDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEM 429 (604)
Q Consensus 350 ~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 429 (604)
.+..+||+|||+++...........
T Consensus 453 ~~~~~kIaDFGlar~~~~~~~y~~~------------------------------------------------------- 477 (609)
T KOG0200|consen 453 KNKVIKIADFGLARDHYNKDYYRTK------------------------------------------------------- 477 (609)
T ss_pred CCCEEEEccccceeccCCCCceEec-------------------------------------------------------
Confidence 9999999999999543222211100
Q ss_pred CCCCCCCcccccCCCCCcccccccC--ccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcC
Q 007433 430 GNQVSPLPELIAEPTNARSMSFVGT--HEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQ 506 (604)
Q Consensus 430 ~~~~~~~~~~~~~~~~~~~~~~~GT--~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~ 506 (604)
.-.|+ ..|||||.+....|+.++|||||||+|||+++ |..||.+......+.+.+..
T Consensus 478 --------------------~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~ 537 (609)
T KOG0200|consen 478 --------------------SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKE 537 (609)
T ss_pred --------------------CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhc
Confidence 01122 34999999999999999999999999999997 99999986633333556666
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 507 PLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 507 ~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
..+...+..++.++.++++.||..+|++||+ ..++.+
T Consensus 538 G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~----F~~~~~ 574 (609)
T KOG0200|consen 538 GNRMEQPEHCSDEIYDLMKSCWNADPEDRPT----FSECVE 574 (609)
T ss_pred CCCCCCCCCCCHHHHHHHHHHhCCCcccCCC----HHHHHH
Confidence 6666666678999999999999999999999 555543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=278.73 Aligned_cols=244 Identities=25% Similarity=0.342 Sum_probs=186.4
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHh--CCCCCccccceeEecCC-
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQS--LDHPFLPTLYTHFETDK- 286 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~~~- 286 (604)
......++++.||+|.||.||+|.+.+ +.||||++... ..+.++.|.+|... +.|+||+++++.-+...
T Consensus 207 ~~l~pl~l~eli~~Grfg~V~KaqL~~--~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 207 LELDPLQLLELIGRGRFGCVWKAQLDN--RLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA 278 (534)
T ss_pred ccCCchhhHHHhhcCccceeehhhccC--ceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence 345677888999999999999999876 68999999654 23456678888765 58999999999877544
Q ss_pred ---eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHc---------CeEeccCCCCcEEEccCCcE
Q 007433 287 ---FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML---------GIVYRDLKPENVLVREDGHI 354 (604)
Q Consensus 287 ---~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~---------gIvHrDIKpeNILl~~~g~v 354 (604)
.++||+||.+.|+|.+++..+ .++|....+++.-+++||+|||+. .|+|||||..||||..|+..
T Consensus 279 ~~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTc 355 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTC 355 (534)
T ss_pred cccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcE
Confidence 899999999999999999985 699999999999999999999962 49999999999999999999
Q ss_pred EEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCC
Q 007433 355 MLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVS 434 (604)
Q Consensus 355 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (604)
.|+|||||.++......
T Consensus 356 cIaDFGLAl~~~p~~~~--------------------------------------------------------------- 372 (534)
T KOG3653|consen 356 CIADFGLALRLEPGKPQ--------------------------------------------------------------- 372 (534)
T ss_pred EeeccceeEEecCCCCC---------------------------------------------------------------
Confidence 99999999876521100
Q ss_pred CCcccccCCCCCcccccccCccccCcceecCCCC------CccchHHHHHHHHHHHhhCCCCCC-C--------------
Q 007433 435 PLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGH------GSAVDWWTFGIFLYELLFGKTPFK-G-------------- 493 (604)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~------~~~~DiWSLGviL~eLltG~~PF~-~-------------- 493 (604)
.....-+||..|||||+|.|.-. -.+.||||+|.+||||++...-+. +
T Consensus 373 -----------~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG 441 (534)
T KOG3653|consen 373 -----------GDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG 441 (534)
T ss_pred -----------cchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence 00112489999999999977532 237899999999999998644332 1
Q ss_pred -CChHHHHHHHH-c--CCCCCCCC---CCCCHHHHHHHHHhhhcCCCCcccc
Q 007433 494 -SENRATLYNVV-G--QPLRFPES---PVVSFSARDLIKGLLVKEPQNRLAC 538 (604)
Q Consensus 494 -~~~~~~l~~i~-~--~~~~~p~~---~~~s~~l~dLI~~lL~~dP~~Rpt~ 538 (604)
....+.+++.+ . ++..+|.. ..--..+++.|..||..|++.|+|+
T Consensus 442 ~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA 493 (534)
T KOG3653|consen 442 NHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTA 493 (534)
T ss_pred CCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhh
Confidence 11223333332 2 22333321 0122457799999999999999994
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=292.76 Aligned_cols=246 Identities=22% Similarity=0.321 Sum_probs=205.9
Q ss_pred eEEEEEEccCCcEEEEEEEEcCCc----eEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 215 FRLLKKLGCGDIGSVYLSELTGTK----CYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 215 y~l~~~LG~G~fG~Vy~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
.+..+.||+|+||+||+|.+-..+ -.||||++..... .+...++..|.-+|.+|+||||++|++++.... +.|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~--~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS--PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC--chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 445578999999999999886544 3689999876543 334456778999999999999999999998776 789
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
|++|+++|.|.++.+.+. ..+-.+....|..||++||.|||++++|||||-..||||....++||.|||+++.+.....
T Consensus 775 vtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ 853 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK 853 (1177)
T ss_pred HHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence 999999999999988764 5788888999999999999999999999999999999999999999999999965543332
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
.+... .
T Consensus 854 ey~~~--------------------------------------------------------------------------~ 859 (1177)
T KOG1025|consen 854 EYSAP--------------------------------------------------------------------------G 859 (1177)
T ss_pred ccccc--------------------------------------------------------------------------c
Confidence 21111 0
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
..-.+.|||=|.+....|+.++|||||||++|||+| |..|+.+.... .+.+.+....+++.++.++.++.-++.+||.
T Consensus 860 gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~-eI~dlle~geRLsqPpiCtiDVy~~mvkCwm 938 (1177)
T KOG1025|consen 860 GKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE-EIPDLLEKGERLSQPPICTIDVYMVMVKCWM 938 (1177)
T ss_pred cccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH-HhhHHHhccccCCCCCCccHHHHHHHHHHhc
Confidence 112357999999999999999999999999999996 99999987654 4556666677788889999999999999999
Q ss_pred cCCCCccccc
Q 007433 530 KEPQNRLACR 539 (604)
Q Consensus 530 ~dP~~Rpt~~ 539 (604)
.|+..||+.+
T Consensus 939 id~~~rp~fk 948 (1177)
T KOG1025|consen 939 IDADSRPTFK 948 (1177)
T ss_pred cCcccCccHH
Confidence 9999999943
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.4e-30 Score=246.15 Aligned_cols=213 Identities=38% Similarity=0.627 Sum_probs=183.7
Q ss_pred EccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCCCCH
Q 007433 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDL 300 (604)
Q Consensus 221 LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL 300 (604)
||.|++|.||++.+..++..+++|++....... ....+.+|+++++.+.|++|+++++++......++||||+.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999999888999999997664321 234567899999999999999999999999999999999998999
Q ss_pred HHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc-CCcEEEecccccccccCCCcccccCcccC
Q 007433 301 HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE-DGHIMLSDFDLSLRCAVSPTVVKSSTLES 379 (604)
Q Consensus 301 ~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~-~g~vkL~DFGla~~~~~~~~~~~~~~~~~ 379 (604)
..++.... ..+++..+..++.+++.+|.|||++|++|+||+|.||+++. ++.++|+|||.+........
T Consensus 79 ~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--------- 148 (215)
T cd00180 79 KDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--------- 148 (215)
T ss_pred HHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc---------
Confidence 99987642 36899999999999999999999999999999999999999 89999999998743211000
Q ss_pred CcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccccC
Q 007433 380 EPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLA 459 (604)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~A 459 (604)
......+...|++
T Consensus 149 -------------------------------------------------------------------~~~~~~~~~~~~~ 161 (215)
T cd00180 149 -------------------------------------------------------------------LLKTIVGTPAYMA 161 (215)
T ss_pred -------------------------------------------------------------------hhhcccCCCCccC
Confidence 0112347788999
Q ss_pred cceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccc
Q 007433 460 PEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLAC 538 (604)
Q Consensus 460 PE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~ 538 (604)
||.+... .++.+.|+|+||+++++| ..+.++|.+||..||++||+
T Consensus 162 pe~~~~~~~~~~~~D~~~lg~~~~~l---------------------------------~~~~~~l~~~l~~~p~~R~~- 207 (215)
T cd00180 162 PEVLLGKGYYSEKSDIWSLGVILYEL---------------------------------PELKDLIRKMLQKDPEKRPS- 207 (215)
T ss_pred hhHhcccCCCCchhhhHHHHHHHHHH---------------------------------HHHHHHHHHHhhCCcccCcC-
Confidence 9999887 788999999999999999 67889999999999999999
Q ss_pred cCCHHHHhcCC
Q 007433 539 RRGATEIKQHP 549 (604)
Q Consensus 539 ~~~a~elL~Hp 549 (604)
+.++++|+
T Consensus 208 ---~~~l~~~~ 215 (215)
T cd00180 208 ---AKEILEHL 215 (215)
T ss_pred ---HHHHhhCC
Confidence 99999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=269.29 Aligned_cols=242 Identities=25% Similarity=0.355 Sum_probs=186.3
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHh--CCCCCccccceeEecC----C
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQS--LDHPFLPTLYTHFETD----K 286 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~~----~ 286 (604)
.+..+.+.||+|-||.||+|++++. .||||++..... ..+.+|.+|.+. |+|+||+.+++.-..+ .
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe--~VAVKiF~srdE------~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGE--DVAVKIFSSRDE------RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred heeEEEEEecCccccceeeccccCC--ceEEEEecccch------hhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 5788999999999999999999876 599999965422 235568888775 5999999999876543 2
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHc--------CeEeccCCCCcEEEccCCcEEEec
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML--------GIVYRDLKPENVLVREDGHIMLSD 358 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~--------gIvHrDIKpeNILl~~~g~vkL~D 358 (604)
+++||.+|.+.|+|++++.+. .++.....+++.-++.||++||.. .|.|||||..||||..+|...|+|
T Consensus 283 QLwLvTdYHe~GSL~DyL~r~---tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLNRN---TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred EEEEeeecccCCcHHHHHhhc---cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 689999999999999999985 689999999999999999999963 399999999999999999999999
Q ss_pred ccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcc
Q 007433 359 FDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPE 438 (604)
Q Consensus 359 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (604)
+|||.+.....+
T Consensus 360 LGLAv~h~~~t~-------------------------------------------------------------------- 371 (513)
T KOG2052|consen 360 LGLAVRHDSDTD-------------------------------------------------------------------- 371 (513)
T ss_pred ceeeEEecccCC--------------------------------------------------------------------
Confidence 999966432211
Q ss_pred cccCCCCCcccccccCccccCcceecCCC------CCccchHHHHHHHHHHHhhC----------CCCCCC----CChHH
Q 007433 439 LIAEPTNARSMSFVGTHEYLAPEIIKGEG------HGSAVDWWTFGIFLYELLFG----------KTPFKG----SENRA 498 (604)
Q Consensus 439 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~------~~~~~DiWSLGviL~eLltG----------~~PF~~----~~~~~ 498 (604)
..+......+||-.|||||+|...- ....+||||||.+|||++.. ++||.+ +...+
T Consensus 372 ----~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~e 447 (513)
T KOG2052|consen 372 ----TIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFE 447 (513)
T ss_pred ----cccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHH
Confidence 1122233568999999999986532 13468999999999999752 578854 34456
Q ss_pred HHHHHHc-CCCC--CCCCCCCCH---HHHHHHHHhhhcCCCCccc
Q 007433 499 TLYNVVG-QPLR--FPESPVVSF---SARDLIKGLLVKEPQNRLA 537 (604)
Q Consensus 499 ~l~~i~~-~~~~--~p~~~~~s~---~l~dLI~~lL~~dP~~Rpt 537 (604)
.+.+++- +.++ +|..=.-.+ .+..|++.||..||.-|.|
T Consensus 448 eMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRlt 492 (513)
T KOG2052|consen 448 EMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLT 492 (513)
T ss_pred HHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhH
Confidence 6666542 2222 222211122 3457899999999999999
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-30 Score=249.79 Aligned_cols=213 Identities=45% Similarity=0.704 Sum_probs=178.5
Q ss_pred eEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEee
Q 007433 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEF 294 (604)
Q Consensus 215 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 294 (604)
|.+.+.||.|++|.||++.+..++..+|+|.+...... .....+.+|++.++.++|+||+++++++..+...++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67889999999999999999998889999999876433 2345677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccccc
Q 007433 295 CPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKS 374 (604)
Q Consensus 295 ~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~ 374 (604)
+++++|.+++..... .+++..+..++.+++.+|.|||+++++|+||+|.||+++.++.++|+|||++.......
T Consensus 79 ~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~----- 152 (225)
T smart00221 79 CEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDL----- 152 (225)
T ss_pred cCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcc-----
Confidence 999999999887632 28999999999999999999999999999999999999999999999999874332110
Q ss_pred CcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccC
Q 007433 375 STLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGT 454 (604)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT 454 (604)
........++
T Consensus 153 ----------------------------------------------------------------------~~~~~~~~~~ 162 (225)
T smart00221 153 ----------------------------------------------------------------------AALLKTVKGT 162 (225)
T ss_pred ----------------------------------------------------------------------cccccceecc
Confidence 0011134578
Q ss_pred ccccCccee-cCCCCCccchHHHHHHHHHHHhhCCCCCCC-CChHHHHHHHHc
Q 007433 455 HEYLAPEII-KGEGHGSAVDWWTFGIFLYELLFGKTPFKG-SENRATLYNVVG 505 (604)
Q Consensus 455 ~~Y~APE~l-~~~~~~~~~DiWSLGviL~eLltG~~PF~~-~~~~~~l~~i~~ 505 (604)
..|++||++ ....++.++|+|+||+++|||++|+.||.. ..+...+.+.+.
T Consensus 163 ~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~ 215 (225)
T smart00221 163 PFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWS 215 (225)
T ss_pred CCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHh
Confidence 889999999 666778899999999999999999999987 555545554443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-31 Score=286.88 Aligned_cols=260 Identities=44% Similarity=0.719 Sum_probs=219.1
Q ss_pred EccCCcEEEEEEEE---cCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEecCCeeEEEEeecC
Q 007433 221 LGCGDIGSVYLSEL---TGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFETDKFSCLVMEFCP 296 (604)
Q Consensus 221 LG~G~fG~Vy~a~~---~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~ 296 (604)
+|.|.||.|++++- ...+..+|+|+..+......... ....|..++..++ ||++++++..|+.+...+++++|..
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 69999999998643 34567899999988755433332 4456888999997 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCc
Q 007433 297 GGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSST 376 (604)
Q Consensus 297 ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 376 (604)
||+|...+... ..+.+..++.+...++.+++++|..||+|||+|++||+++.+|++++.|||+++.....
T Consensus 81 gg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~-------- 150 (612)
T KOG0603|consen 81 GGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE-------- 150 (612)
T ss_pred cchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhh--------
Confidence 99998876665 57899999999999999999999999999999999999999999999999987432100
Q ss_pred ccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCcc
Q 007433 377 LESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHE 456 (604)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 456 (604)
...+||..
T Consensus 151 ------------------------------------------------------------------------~~~cgt~e 158 (612)
T KOG0603|consen 151 ------------------------------------------------------------------------KIACGTYE 158 (612)
T ss_pred ------------------------------------------------------------------------hhcccchh
Confidence 00169999
Q ss_pred ccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcc
Q 007433 457 YLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRL 536 (604)
Q Consensus 457 Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rp 536 (604)
|||||+++ ++..++|+||||+++|||++|..||.+ +++..|....+.+|. .++..+++++..|+.++|..|+
T Consensus 159 ymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~--~l~~~a~~~~~~l~~r~p~nrL 230 (612)
T KOG0603|consen 159 YRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR--ELSAEARSLFRQLFKRNPENRL 230 (612)
T ss_pred hhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch--hhhHHHHHHHHHHHhhCHHHHh
Confidence 99999999 778999999999999999999999998 677777776655554 4889999999999999999999
Q ss_pred ccc-CCHHHHhcCCCCCCCChhhhhcCCCCCCCCCC
Q 007433 537 ACR-RGATEIKQHPFFQGVNWALIRCASPPEIPKPV 571 (604)
Q Consensus 537 t~~-~~a~elL~Hpff~~~~~~~~~~~~~~~~p~~~ 571 (604)
... .++.|+++|+||+.++|..+.....+...+|.
T Consensus 231 g~~~~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~ 266 (612)
T KOG0603|consen 231 GAGPDGVDEIKQHEFFQSIDWNELEARSRPPPFKPG 266 (612)
T ss_pred ccCcchhHHHhccchheeeeHhhHhhcCCCCCCCCc
Confidence 864 68999999999999999977666555554444
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-30 Score=300.87 Aligned_cols=236 Identities=17% Similarity=0.208 Sum_probs=158.7
Q ss_pred hCCC-CCccccceeE-------ecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEecc
Q 007433 269 SLDH-PFLPTLYTHF-------ETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRD 340 (604)
Q Consensus 269 ~l~H-pnIv~l~~~~-------~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrD 340 (604)
.+.| .||+.++++| .....++++|||+ +++|++++... ...+++..++.|++||+.||+|||++||||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 3445 5788888887 2335678889988 77999999754 35699999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccc
Q 007433 341 LKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSK 420 (604)
Q Consensus 341 IKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (604)
|||+||||+..|.+|++|||++...+..... ......|+.+-.... ...
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~-----------------~~ki~DfG~a~~~~~------------~~~-- 154 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDA-----------------TTKSREIGSSRREEI------------LSE-- 154 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccC-----------------ccccccccccccccc------------ccc--
Confidence 9999999999999999999987432211000 000011111000000 000
Q ss_pred cccCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHH
Q 007433 421 KAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATL 500 (604)
Q Consensus 421 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l 500 (604)
.....+ ......+........+||++|||||++.+..|+.++|||||||+||||++|..||.... ..+
T Consensus 155 ---~~~~~~-------~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~ 222 (793)
T PLN00181 155 ---RRIEKL-------EEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTM 222 (793)
T ss_pred ---cchhhh-------hccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHH
Confidence 000000 00000001111223579999999999999999999999999999999999998876432 222
Q ss_pred HHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 501 YNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 501 ~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
..+....+. +..........+++.+||.+||.+||+ +.|+|+||||...
T Consensus 223 ~~~~~~~~~-~~~~~~~~~~~~~~~~~L~~~P~~Rps----~~eil~h~~~~~~ 271 (793)
T PLN00181 223 SSLRHRVLP-PQILLNWPKEASFCLWLLHPEPSCRPS----MSELLQSEFINEP 271 (793)
T ss_pred HHHHHhhcC-hhhhhcCHHHHHHHHHhCCCChhhCcC----hHHHhhchhhhhh
Confidence 222211111 111112456679999999999999999 9999999999753
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.1e-30 Score=250.64 Aligned_cols=253 Identities=25% Similarity=0.346 Sum_probs=191.3
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccce-eEecCCeeEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYT-HFETDKFSCL 290 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~-~~~~~~~~~l 290 (604)
+.|.+.+.||+|-||.+-+|++++++..+++|.+.+... .+..+++|...--.| .|.||+.-|+ .|++.+.+++
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t----t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT----TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh----hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 689999999999999999999999999999999987643 334556676654445 5889998776 4788889999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc--CCcEEEecccccccccCC
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE--DGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~--~g~vkL~DFGla~~~~~~ 368 (604)
+|||++.|||..-+.. ..+.|...+.++.|++.||+|||++++||||||.+||||-. .-++||||||+.+..+..
T Consensus 100 ~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t 176 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT 176 (378)
T ss_pred eeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCce
Confidence 9999999999886655 46889999999999999999999999999999999999953 348999999987543311
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
-.
T Consensus 177 V~------------------------------------------------------------------------------ 178 (378)
T KOG1345|consen 177 VK------------------------------------------------------------------------------ 178 (378)
T ss_pred eh------------------------------------------------------------------------------
Confidence 10
Q ss_pred cccccCccccCcceecC---CC--CCccchHHHHHHHHHHHhhCCCCCCCCC----hHHHHHHHHcC-CCCCCC-CCCCC
Q 007433 449 MSFVGTHEYLAPEIIKG---EG--HGSAVDWWTFGIFLYELLFGKTPFKGSE----NRATLYNVVGQ-PLRFPE-SPVVS 517 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~---~~--~~~~~DiWSLGviL~eLltG~~PF~~~~----~~~~l~~i~~~-~~~~p~-~~~~s 517 (604)
..--+..|.+||++.- +. ..+..|+|.|||++|.+|+|++||.... ....+..+.++ ....|. ...++
T Consensus 179 -~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~F~~fs 257 (378)
T KOG1345|consen 179 -YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKKFNPFS 257 (378)
T ss_pred -hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCchhhcccC
Confidence 0113456899997643 22 3678899999999999999999997432 22233344433 223332 23478
Q ss_pred HHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCC
Q 007433 518 FSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 518 ~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
+.+..+.++-|..++++|-.. +.+......-|.+
T Consensus 258 ~~a~r~Fkk~lt~~~~drcki-~~~kk~rk~~w~E 291 (378)
T KOG1345|consen 258 EKALRLFKKSLTPRFKDRCKI-WTAKKMRKCLWKE 291 (378)
T ss_pred HHHHHHHHHhcCCcccccchh-HHHHHHHHHHHHH
Confidence 899999999999999999321 1155555555553
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=281.92 Aligned_cols=253 Identities=37% Similarity=0.613 Sum_probs=194.6
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
.+|..++.|-.|+||.||+.+++.+.+.||+| +++..+-- + .||.....|++|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lil--------R--nilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLIL--------R--NILTFAGNPFVV---------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccchhh--------h--ccccccCCccee----------------
Confidence 58999999999999999999999999999994 55443211 1 144444555555
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||-.++++.. +.++... +.+++|||+.||||||+||+|+||..-|++|++|||++......-...
T Consensus 136 -----gDc~tllk~~--g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atn 200 (1205)
T KOG0606|consen 136 -----GDCATLLKNI--GPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATN 200 (1205)
T ss_pred -----chhhhhcccC--CCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccch
Confidence 5666666554 3455433 789999999999999999999999999999999999985543322211
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
....... .+...-.....+
T Consensus 201 l~eg~I~-------------------------------------------------------------k~t~Ef~dKqvc 219 (1205)
T KOG0606|consen 201 LKEGHIE-------------------------------------------------------------KDTHEFQDKQVC 219 (1205)
T ss_pred hhhcchH-------------------------------------------------------------HHHHHhhhcccc
Confidence 1110000 000001123468
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCC-CCCHHHHHHHHHhhhcC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESP-VVSFSARDLIKGLLVKE 531 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~-~~s~~l~dLI~~lL~~d 531 (604)
||++|+|||++...+|+..+|||+||+|+||.+.|+.||.+....+++-.++.....+|+.. .++.+++++|.+||..+
T Consensus 220 gTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qn 299 (1205)
T KOG0606|consen 220 GTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQN 299 (1205)
T ss_pred CCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhC
Confidence 99999999999999999999999999999999999999999999999988888888777653 47889999999999999
Q ss_pred CCCcccccCCHHHHhcCCCCCCCChhhhhcCCCCCCCC
Q 007433 532 PQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPK 569 (604)
Q Consensus 532 P~~Rpt~~~~a~elL~Hpff~~~~~~~~~~~~~~~~p~ 569 (604)
|.+|.... ++.+|.+|+||+.++|.-+-......+|.
T Consensus 300 p~~Rlgt~-ga~evk~h~ff~~LDw~~llRqkaefvpq 336 (1205)
T KOG0606|consen 300 PLCRLGTG-GALEVKQHGFFQLLDWKSLLRQKAEFVPQ 336 (1205)
T ss_pred hHhhcccc-hhhhhhhccceeecccchhhhhhcccccc
Confidence 99999744 79999999999999998544444455544
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-28 Score=245.70 Aligned_cols=260 Identities=16% Similarity=0.190 Sum_probs=205.1
Q ss_pred CceeeecCeEEEEEEccCCcEEEEEEEEcCCce-----EEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCcccccee
Q 007433 207 DGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKC-----YFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTH 281 (604)
Q Consensus 207 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 281 (604)
+..+...++++...+-+|.||.||+|.+++.+. .|-+|.+... ...-.+..+..|--+|..+.|||+..+.++
T Consensus 278 ~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 278 ELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred hhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 334455789999999999999999998875542 2445555332 234456677788888999999999999998
Q ss_pred Ee-cCCeeEEEEeecCCCCHHHHHHhcC------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcE
Q 007433 282 FE-TDKFSCLVMEFCPGGDLHTLRQRQP------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHI 354 (604)
Q Consensus 282 ~~-~~~~~~lV~E~~~ggsL~~ll~~~~------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~v 354 (604)
.. +....++++.+..-|+|..++.... .+.++..+...++.||+.|++|||.+||||.||-..|++|++.-++
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqV 435 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQV 435 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeE
Confidence 75 4567788999998899999987321 2457778888999999999999999999999999999999999999
Q ss_pred EEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCC
Q 007433 355 MLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVS 434 (604)
Q Consensus 355 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (604)
||+|-.+++-+-+.. +..-+..
T Consensus 436 kltDsaLSRDLFP~D-YhcLGDn--------------------------------------------------------- 457 (563)
T KOG1024|consen 436 KLTDSALSRDLFPGD-YHCLGDN--------------------------------------------------------- 457 (563)
T ss_pred EeccchhccccCccc-ccccCCC---------------------------------------------------------
Confidence 999999885432211 1100000
Q ss_pred CCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCC
Q 007433 435 PLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPES 513 (604)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~ 513 (604)
---...||+||.+....|+.++|+|||||+||||++ |+.|+..-+..+....+ ...+++..+
T Consensus 458 ----------------EnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~yl-kdGyRlaQP 520 (563)
T KOG1024|consen 458 ----------------ENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYL-KDGYRLAQP 520 (563)
T ss_pred ----------------CCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHH-hccceecCC
Confidence 012356999999999999999999999999999997 99999988887665544 445677777
Q ss_pred CCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 514 PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 514 ~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
..+++++..++..||+.+|++||+ .+++..
T Consensus 521 ~NCPDeLf~vMacCWallpeeRPs----f~Qlv~ 550 (563)
T KOG1024|consen 521 FNCPDELFTVMACCWALLPEERPS----FSQLVI 550 (563)
T ss_pred CCCcHHHHHHHHHHHhcCcccCCC----HHHHHH
Confidence 779999999999999999999999 777643
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-26 Score=230.94 Aligned_cols=262 Identities=39% Similarity=0.589 Sum_probs=204.9
Q ss_pred eEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCC-CccccceeEecCCeeEEEEe
Q 007433 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP-FLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 215 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hp-nIv~l~~~~~~~~~~~lV~E 293 (604)
|.+.+.||.|+||.||++.+. ..+++|++.............+.+|+.+++.+.|+ +|+++++++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 788999999999999999998 57999999876544433456777899999999988 79999999988888899999
Q ss_pred ecCCCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC-cEEEecccccccccCCCcc
Q 007433 294 FCPGGDLHTLRQRQPG-KYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG-HIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g-~vkL~DFGla~~~~~~~~~ 371 (604)
++.+++|..++..... ..+.+..+..++.|++.+|.|+|..|++||||||+|||++..+ .++++|||++.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 9999999977665421 2689999999999999999999999999999999999999988 7999999988422110000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
.. ........
T Consensus 159 ~~----------------------------------------------------------------------~~~~~~~~ 168 (384)
T COG0515 159 SS----------------------------------------------------------------------IPALPSTS 168 (384)
T ss_pred cc----------------------------------------------------------------------cccccccc
Confidence 00 00112356
Q ss_pred ccCccccCcceecC---CCCCccchHHHHHHHHHHHhhCCCCCCCCCh----HHHHHHHHcCCCC-CCCCCCC------C
Q 007433 452 VGTHEYLAPEIIKG---EGHGSAVDWWTFGIFLYELLFGKTPFKGSEN----RATLYNVVGQPLR-FPESPVV------S 517 (604)
Q Consensus 452 ~GT~~Y~APE~l~~---~~~~~~~DiWSLGviL~eLltG~~PF~~~~~----~~~l~~i~~~~~~-~p~~~~~------s 517 (604)
+||..|+|||.+.+ ..+....|+|++|++++++++|..||..... ......+...... ....... .
T Consensus 169 ~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (384)
T COG0515 169 VGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELIS 248 (384)
T ss_pred ccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhh
Confidence 79999999999988 5788999999999999999999999887663 3333333333322 2211111 1
Q ss_pred HHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 518 FSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 518 ~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
..+.+++.+++..+|..|.+ ..+...++|+..
T Consensus 249 ~~~~~~~~~~~~~~~~~r~~----~~~~~~~~~~~~ 280 (384)
T COG0515 249 KAASDLLKKLLAKDPKNRLS----SSSDLSHDLLAH 280 (384)
T ss_pred HHHHHHHHHHHhcCchhcCC----HHHHhhchHhhC
Confidence 57889999999999999999 777777655543
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.2e-27 Score=245.48 Aligned_cols=253 Identities=27% Similarity=0.352 Sum_probs=195.3
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCc-eEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCC----CCccccceeE-ecCCe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTK-CYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH----PFLPTLYTHF-ETDKF 287 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~H----pnIv~l~~~~-~~~~~ 287 (604)
+|++.++||+|+||.||++.+..++ ..+|+|+.......... .+..|+.+|..+.. .+++.+++.+ ..+.+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~---~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS---VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc---cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999998774 68999998764222111 34568888888863 5899999999 58889
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccC-----CcEEEeccccc
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRED-----GHIMLSDFDLS 362 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~-----g~vkL~DFGla 362 (604)
.|+||+.+ |.+|.+++...+.+.|+...+..++.|++.+|++||+.|+|||||||+|+++... ..+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999999 9999999988777899999999999999999999999999999999999999865 36999999999
Q ss_pred cccc--CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccc
Q 007433 363 LRCA--VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELI 440 (604)
Q Consensus 363 ~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (604)
+++. ...... ..+.+
T Consensus 175 r~~~~~~~~~~~------~~~~r--------------------------------------------------------- 191 (322)
T KOG1164|consen 175 RRFKYVGDSGGN------LRPPR--------------------------------------------------------- 191 (322)
T ss_pred ccccccCCCCcc------cccCC---------------------------------------------------------
Confidence 7322 111100 00000
Q ss_pred cCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC--CC-CCCCCC
Q 007433 441 AEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR--FP-ESPVVS 517 (604)
Q Consensus 441 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~--~p-~~~~~s 517 (604)
.....+.||..|+++..+.+...+.+.|+||++.++.||+.|.+||.+.........+...... .. .....+
T Consensus 192 -----~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (322)
T KOG1164|consen 192 -----PQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKP 266 (322)
T ss_pred -----CCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCCh
Confidence 0012456999999999999999999999999999999999999999876543333222221111 11 122355
Q ss_pred HHHHHHHHHhhhcCCCCcccc
Q 007433 518 FSARDLIKGLLVKEPQNRLAC 538 (604)
Q Consensus 518 ~~l~dLI~~lL~~dP~~Rpt~ 538 (604)
.++..+...+-..+...+|.+
T Consensus 267 ~~~~~~~~~~~~~~~~~~Pdy 287 (322)
T KOG1164|consen 267 EEFAKILEYIDSLDYEDKPDY 287 (322)
T ss_pred HHHHHHHHHhhccCCcCCCCH
Confidence 677788777777899999984
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=274.65 Aligned_cols=261 Identities=25% Similarity=0.375 Sum_probs=200.7
Q ss_pred EEEEEEccCCcEEEEEEEEcCCceEEEEEEecc---hhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 216 RLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDK---ASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 216 ~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~---~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
.....+|.|++|.|+.+........++.|.+.. .....+.....+..|.-+-..|.|+|++..+..+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 356679999999999888877766677766542 22223333333667777888899999988887777666555669
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
|||++ ||+.++... ..+....+..++.||+.||.|||..||.|||||++|+|+..+|.+||+|||.+..+....
T Consensus 401 E~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~--- 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW--- 474 (601)
T ss_pred hcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc---
Confidence 99998 999998875 568999999999999999999999999999999999999999999999999873221100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
+........++
T Consensus 475 ---------------------------------------------------------------------e~~~~~~~g~~ 485 (601)
T KOG0590|consen 475 ---------------------------------------------------------------------EKNIHESSGIV 485 (601)
T ss_pred ---------------------------------------------------------------------chhhhhhcCcc
Confidence 00011234578
Q ss_pred cCccccCcceecCCCCCc-cchHHHHHHHHHHHhhCCCCCCCCChHHHHH-HHH-cCCCC-----CCCCCCCCHHHHHHH
Q 007433 453 GTHEYLAPEIIKGEGHGS-AVDWWTFGIFLYELLFGKTPFKGSENRATLY-NVV-GQPLR-----FPESPVVSFSARDLI 524 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~-~~DiWSLGviL~eLltG~~PF~~~~~~~~l~-~i~-~~~~~-----~p~~~~~s~~l~dLI 524 (604)
|+-.|+|||++.+..|.+ .+||||.|++++.|++|+.||......+..+ ... ..... .+....++.+.+.+|
T Consensus 486 gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~ 565 (601)
T KOG0590|consen 486 GSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIII 565 (601)
T ss_pred cCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhchhhHHHHH
Confidence 999999999999999965 6899999999999999999998755443321 111 00000 111234778889999
Q ss_pred HHhhhcCCCCcccccCCHHHHhcCCCCCCCC
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
.+||+.||.+|++ +++|++.+||+.+.
T Consensus 566 ~~~l~~~P~~R~t----i~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 566 YRMLQLDPTKRIT----IEQILNDEWIRSIE 592 (601)
T ss_pred HHHccCChhheec----HHHHhhChHhhhcc
Confidence 9999999999999 99999999998764
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-27 Score=227.03 Aligned_cols=161 Identities=24% Similarity=0.226 Sum_probs=128.0
Q ss_pred CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcc
Q 007433 298 GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTL 377 (604)
Q Consensus 298 gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~ 377 (604)
|+|.+++... +..|++..++.|+.||+.||.|||+++ ||+|||++.++.+++ ||++.....
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~---------- 61 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP---------- 61 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc----------
Confidence 6899998764 357999999999999999999999998 999999999999999 998732110
Q ss_pred cCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccc
Q 007433 378 ESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEY 457 (604)
Q Consensus 378 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y 457 (604)
....||+.|
T Consensus 62 -----------------------------------------------------------------------~~~~g~~~y 70 (176)
T smart00750 62 -----------------------------------------------------------------------EQSRVDPYF 70 (176)
T ss_pred -----------------------------------------------------------------------ccCCCcccc
Confidence 011488999
Q ss_pred cCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHcCCCCC-----CCCCCCCH--HHHHHHHHhhh
Q 007433 458 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR-ATLYNVVGQPLRF-----PESPVVSF--SARDLIKGLLV 529 (604)
Q Consensus 458 ~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~-~~l~~i~~~~~~~-----p~~~~~s~--~l~dLI~~lL~ 529 (604)
||||++.+..++.++|||||||++|||++|+.||...... ..+..+....... +....++. ++++||.+||.
T Consensus 71 ~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~ 150 (176)
T smart00750 71 MAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVCAS 150 (176)
T ss_pred cChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHHHh
Confidence 9999999999999999999999999999999999765432 2333333222111 11112333 68999999999
Q ss_pred cCCCCcccccCCHHHHhcCCCCC
Q 007433 530 KEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
.||.+||+ +.|+++|+|+.
T Consensus 151 ~~p~~Rp~----~~~ll~~~~~~ 169 (176)
T smart00750 151 RLPQRREA----ANHYLAHCRAL 169 (176)
T ss_pred cccccccC----HHHHHHHHHHH
Confidence 99999999 99999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=217.22 Aligned_cols=278 Identities=19% Similarity=0.277 Sum_probs=204.8
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCC-CCccccceeEecCCee
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH-PFLPTLYTHFETDKFS 288 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~ 288 (604)
+..+.|+++++||+|+||.+|+|....+|..||||+-....-. -.+..|..+.+.|.| ..|+.++.++.+..+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 4458999999999999999999999999999999997654221 134468888888865 6899999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc---CCcEEEecccccccc
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE---DGHIMLSDFDLSLRC 365 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~---~g~vkL~DFGla~~~ 365 (604)
.|||+++ |.+|.++..-. ...|+..++..++-|++.-|+|+|.+++|||||||+|.|..- ...+.|+||||+.++
T Consensus 87 vlVMdLL-GPsLEdLfnfC-~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFC-SRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred eeeeecc-CccHHHHHHHH-hhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 9999999 99999987644 367999999999999999999999999999999999999974 347999999999776
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
-...+... .|.+
T Consensus 165 ~d~~t~~H------Ipyr-------------------------------------------------------------- 176 (341)
T KOG1163|consen 165 RDIRTRQH------IPYR-------------------------------------------------------------- 176 (341)
T ss_pred cccccccc------Cccc--------------------------------------------------------------
Confidence 43221110 0001
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCC---hHHHHHHHHcCCCCCCC---CCCCCHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE---NRATLYNVVGQPLRFPE---SPVVSFS 519 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~---~~~~l~~i~~~~~~~p~---~~~~s~~ 519 (604)
......||..|.+--.+.+...+.+.|+=|+|.+|..+.-|.+||.+.. ..+.+.+|.......+. ...++.+
T Consensus 177 -e~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~E 255 (341)
T KOG1163|consen 177 -EDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAE 255 (341)
T ss_pred -cCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHH
Confidence 1124579999999888888888999999999999999999999998853 33444455544333322 1345666
Q ss_pred HHHHHHHhhhcCCCCcccc---cCCH---HHHhcCCCCCCCChhhhhcCC
Q 007433 520 ARDLIKGLLVKEPQNRLAC---RRGA---TEIKQHPFFQGVNWALIRCAS 563 (604)
Q Consensus 520 l~dLI~~lL~~dP~~Rpt~---~~~a---~elL~Hpff~~~~~~~~~~~~ 563 (604)
+.-+|.-|-..-=++-|.+ ++.. -.-|+|.+=--.+|..+...+
T Consensus 256 F~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyDW~~lkqk~ 305 (341)
T KOG1163|consen 256 FAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYDWTMLKQKS 305 (341)
T ss_pred HHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEeeHHHHHHHh
Confidence 6666666654444444543 1111 112344444446788765433
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.6e-25 Score=223.59 Aligned_cols=215 Identities=25% Similarity=0.414 Sum_probs=176.5
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCeeEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV 291 (604)
-+|++.++||+|+||..++|...-++.+||||.-.+.+-.. .+..|-...+.| ..++|+..|.|...+.+-.||
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~AP-----QLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLV 102 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAP-----QLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILV 102 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccCCcc-----hHHHHHHHHHHHcCCCCCCceeeeccccchhhhh
Confidence 48999999999999999999999999999999975543221 234566777777 468999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC-----cEEEeccccccccc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG-----HIMLSDFDLSLRCA 366 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g-----~vkL~DFGla~~~~ 366 (604)
||++ |.+|.++.... ++.|+...+..++.|++.-++|+|++.+|+|||||+|.||...+ .|.|+|||+|..+-
T Consensus 103 idLL-GPSLEDLFD~C-gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Yr 180 (449)
T KOG1165|consen 103 IDLL-GPSLEDLFDLC-GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYR 180 (449)
T ss_pred hhhh-CcCHHHHHHHh-cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhc
Confidence 9999 99999988766 57899999999999999999999999999999999999997544 58999999996654
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
...+... .|.|
T Consensus 181 Dp~TkqH------IPYr--------------------------------------------------------------- 191 (449)
T KOG1165|consen 181 DPKTKQH------IPYR--------------------------------------------------------------- 191 (449)
T ss_pred Ccccccc------Cccc---------------------------------------------------------------
Confidence 3222110 0111
Q ss_pred cccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCC---ChHHHHHHH
Q 007433 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS---ENRATLYNV 503 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~---~~~~~l~~i 503 (604)
...+..||..||+-..+.|...+.+.|+=|||-++++.|-|.+||.|. ++.+.+.+|
T Consensus 192 E~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKI 251 (449)
T KOG1165|consen 192 EHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKI 251 (449)
T ss_pred cccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHh
Confidence 122456999999999999999999999999999999999999999874 444555444
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=237.55 Aligned_cols=141 Identities=23% Similarity=0.170 Sum_probs=113.4
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcC-CceEEEEEEecchhH--HHHHHHHHHHHHHHHHHhCCCCCccc-cceeEecCCe
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTG-TKCYFAMKVMDKASL--EKRKKLLRAQTEREILQSLDHPFLPT-LYTHFETDKF 287 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~-~~~~vAiK~i~~~~~--~~~~~~~~~~~Ei~iL~~l~HpnIv~-l~~~~~~~~~ 287 (604)
.++|.+.+.||+|+||+||+|++.. ++..||||++..... ........+.+|+++|+.|+|+||+. ++++ +.
T Consensus 17 ~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~----~~ 92 (365)
T PRK09188 17 SARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT----GK 92 (365)
T ss_pred cCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----CC
Confidence 4789999999999999999999876 677889998753311 11122345778999999999999985 4432 45
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccC-CCCcEEEccCCcEEEecccccccc
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDL-KPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDI-KpeNILl~~~g~vkL~DFGla~~~ 365 (604)
.|||||||+|++|... .. .. ...++.|++.+|.|||++||+|||| ||+|||++.++.++|+|||++..+
T Consensus 93 ~~LVmE~~~G~~L~~~-~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~ 162 (365)
T PRK09188 93 DGLVRGWTEGVPLHLA-RP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF 162 (365)
T ss_pred cEEEEEccCCCCHHHh-Cc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence 7999999999999732 11 11 1467899999999999999999999 999999999999999999999654
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-23 Score=203.44 Aligned_cols=142 Identities=21% Similarity=0.207 Sum_probs=110.9
Q ss_pred EEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHH-----------------------HHHHHHHHHHHHHhCCCCC
Q 007433 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRK-----------------------KLLRAQTEREILQSLDHPF 274 (604)
Q Consensus 218 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~-----------------------~~~~~~~Ei~iL~~l~Hpn 274 (604)
...||+|+||.||+|.+. +|+.||||+++........ ......+|+++|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 467999999999999997 8899999999765321100 0122345999999998888
Q ss_pred ccccceeEecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHH-HHcCeEeccCCCCcEEEccCCc
Q 007433 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYL-HMLGIVYRDLKPENVLVREDGH 353 (604)
Q Consensus 275 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yL-H~~gIvHrDIKpeNILl~~~g~ 353 (604)
|...+.+.... .+|||||++|++|...+... ..+++..+..++.|++.+|.|| |+.||+||||||+|||++ ++.
T Consensus 81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~ 155 (190)
T cd05147 81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGK 155 (190)
T ss_pred CCCCcEEEecC--CEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCc
Confidence 75544332222 38999999888776543332 4689999999999999999999 799999999999999998 578
Q ss_pred EEEecccccccc
Q 007433 354 IMLSDFDLSLRC 365 (604)
Q Consensus 354 vkL~DFGla~~~ 365 (604)
++|+|||++...
T Consensus 156 v~LiDFG~a~~~ 167 (190)
T cd05147 156 LYIIDVSQSVEH 167 (190)
T ss_pred EEEEEccccccC
Confidence 999999998544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.7e-23 Score=204.73 Aligned_cols=138 Identities=18% Similarity=0.209 Sum_probs=114.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHH------HHHHHHHHHhCCCCCccccceeEecC
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLR------AQTEREILQSLDHPFLPTLYTHFETD 285 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~------~~~Ei~iL~~l~HpnIv~l~~~~~~~ 285 (604)
.++|++++.||.|+||.||++... +..+|||+++...........+ +.+|+..+.++.|++|+.+..++...
T Consensus 30 ~~~y~~~~~l~~~~f~~v~l~~~~--~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 30 SYNIKTIKVFRNIDDTKVSLIDTD--YGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hCceEEEEEecCCCceEEEEEecC--CCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 479999999999999999997663 4579999997654444444334 46899999999999999999887643
Q ss_pred --------CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEe
Q 007433 286 --------KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLS 357 (604)
Q Consensus 286 --------~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~ 357 (604)
...+|||||++|.+|.++.. +++. ...+|+.+|..||++|++||||||+|||++.+| ++|+
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~li 176 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE------ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRII 176 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh------ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEE
Confidence 35789999999999987631 3332 456999999999999999999999999999988 9999
Q ss_pred ccccc
Q 007433 358 DFDLS 362 (604)
Q Consensus 358 DFGla 362 (604)
|||..
T Consensus 177 Dfg~~ 181 (232)
T PRK10359 177 DLSGK 181 (232)
T ss_pred ECCCc
Confidence 99976
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.9e-22 Score=195.06 Aligned_cols=142 Identities=20% Similarity=0.212 Sum_probs=112.4
Q ss_pred EEEEccCCcEEEEEEEEcCCceEEEEEEecchhHH-----------------------HHHHHHHHHHHHHHHHhCCCCC
Q 007433 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLE-----------------------KRKKLLRAQTEREILQSLDHPF 274 (604)
Q Consensus 218 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~-----------------------~~~~~~~~~~Ei~iL~~l~Hpn 274 (604)
.+.||+|+||.||+|.+. +|+.||||+++..... .........+|.+.+.++.|++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG 80 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence 468999999999999987 8899999999865211 0011223457899999999998
Q ss_pred ccccceeEecCCeeEEEEeecCCCCHHHH-HHhcCCCCCcHHHHHHHHHHHHHHHHHHHH-cCeEeccCCCCcEEEccCC
Q 007433 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTL-RQRQPGKYFSEQAVKFYVAEVLLALEYLHM-LGIVYRDLKPENVLVREDG 352 (604)
Q Consensus 275 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~l-l~~~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDIKpeNILl~~~g 352 (604)
|.....+.... .||||||++|+++... +.. ..+++..+..++.|++.+|.|||. +||+||||||+|||++ ++
T Consensus 81 i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~---~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~ 154 (190)
T cd05145 81 VPVPEPILLKK--NVLVMEFIGDDGSPAPRLKD---VPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DG 154 (190)
T ss_pred CCCceEEEecC--CEEEEEEecCCCchhhhhhh---ccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CC
Confidence 86555444332 4899999988765433 332 457888999999999999999999 9999999999999998 89
Q ss_pred cEEEeccccccccc
Q 007433 353 HIMLSDFDLSLRCA 366 (604)
Q Consensus 353 ~vkL~DFGla~~~~ 366 (604)
.++|+|||++....
T Consensus 155 ~~~liDFG~a~~~~ 168 (190)
T cd05145 155 KPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEcccceecC
Confidence 99999999996543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.7e-22 Score=206.52 Aligned_cols=236 Identities=24% Similarity=0.297 Sum_probs=151.5
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCC----------CCcccccee--
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH----------PFLPTLYTH-- 281 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~H----------pnIv~l~~~-- 281 (604)
.+...+.||.|+++.||++.+.+|++.+|||++..........+..+.+|.-....+.+ -.++..++.
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 45667789999999999999999999999999876554444455555555544443322 122222221
Q ss_pred -------EecC---C-----eeEEEEeecCCCCHHHHHH---hcCCC--CCcHHHHHHHHHHHHHHHHHHHHcCeEeccC
Q 007433 282 -------FETD---K-----FSCLVMEFCPGGDLHTLRQ---RQPGK--YFSEQAVKFYVAEVLLALEYLHMLGIVYRDL 341 (604)
Q Consensus 282 -------~~~~---~-----~~~lV~E~~~ggsL~~ll~---~~~~~--~l~e~~~~~i~~qil~aL~yLH~~gIvHrDI 341 (604)
+... . ..+++|+-+ -+||..++. ..... .+.......+..|+++.+++||.+||||+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 2211 1 346788888 779988754 22212 2333344556689999999999999999999
Q ss_pred CCCcEEEccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCccccccccc
Q 007433 342 KPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKK 421 (604)
Q Consensus 342 KpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (604)
||+|+|++.+|.++|+||+...+.+...
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~---------------------------------------------------- 199 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGTRY---------------------------------------------------- 199 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTEEE----------------------------------------------------
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCcee----------------------------------------------------
Confidence 9999999999999999999775432100
Q ss_pred ccCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecCC--------CCCccchHHHHHHHHHHHhhCCCCCCC
Q 007433 422 AQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGE--------GHGSAVDWWTFGIFLYELLFGKTPFKG 493 (604)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~--------~~~~~~DiWSLGviL~eLltG~~PF~~ 493 (604)
.....+..|.+||..... .++.+.|.|+||++||.|.+|+.||..
T Consensus 200 ---------------------------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~ 252 (288)
T PF14531_consen 200 ---------------------------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGL 252 (288)
T ss_dssp ---------------------------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCC
T ss_pred ---------------------------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCC
Confidence 001244678899876432 367899999999999999999999986
Q ss_pred CChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCc
Q 007433 494 SENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNR 535 (604)
Q Consensus 494 ~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~R 535 (604)
........ ..|.....+++.+++||.+||.+||.+|
T Consensus 253 ~~~~~~~~------~~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 253 SSPEADPE------WDFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp CGGGSTSG------GGGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred CCcccccc------ccchhcCCcCHHHHHHHHHHccCCcccC
Confidence 54322111 0233333689999999999999999987
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-23 Score=232.94 Aligned_cols=251 Identities=24% Similarity=0.315 Sum_probs=182.0
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchh-HHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKAS-LEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
+|...+.||++.|=+|.+|++... .|+||++-+.. .-.-....+..+|++ ...++|||++.+.-+-++++..|||-
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG--~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvR 100 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREG--LVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVR 100 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCc--eEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHH
Confidence 688889999999999999988764 59999987653 112222233344555 67779999999999988999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
+|+ .-+|++.+.-+ ..+..-+.+.|+.||+.||.-+|..||+|||||.|||||+..+.+.|+||.-- .+++.
T Consensus 101 qyv-khnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsF-----KPtYL 172 (1431)
T KOG1240|consen 101 QYV-KHNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASF-----KPTYL 172 (1431)
T ss_pred HHH-hhhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhccccc-----CCccC
Confidence 999 77999887766 46888889999999999999999999999999999999999999999999743 11111
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcc-cccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPR-FFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
-.+. |+.| . ||..+ .
T Consensus 173 PeDN---------------Padf------------------~fFFDTS--------------------------r----- 188 (1431)
T KOG1240|consen 173 PEDN---------------PADF------------------TFFFDTS--------------------------R----- 188 (1431)
T ss_pred CCCC---------------cccc------------------eEEEecC--------------------------C-----
Confidence 1100 0000 1 11111 1
Q ss_pred ccCccccCcceecCCC-----------CCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCC---CCCC
Q 007433 452 VGTHEYLAPEIIKGEG-----------HGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPE---SPVV 516 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~-----------~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~---~~~~ 516 (604)
--..|+|||.+.... ..++.||||+||+++||++ |++||.- ..+.....+.-..++ ...-
T Consensus 189 -RRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~aYr~~~~~~~e~~Le~Ie 263 (1431)
T KOG1240|consen 189 -RRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLLAYRSGNADDPEQLLEKIE 263 (1431)
T ss_pred -ceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHHhHhccCccCHHHHHHhCc
Confidence 113599999875422 4678999999999999987 7888852 122222221100000 0113
Q ss_pred CHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 517 SFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 517 s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
+..+++||..|+..||.+|++ |++.|+-
T Consensus 264 d~~~Rnlil~Mi~rdPs~RlS----AedyL~~ 291 (1431)
T KOG1240|consen 264 DVSLRNLILSMIQRDPSKRLS----AEDYLQK 291 (1431)
T ss_pred CccHHHHHHHHHccCchhccC----HHHHHHh
Confidence 346899999999999999999 9999976
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.4e-22 Score=191.95 Aligned_cols=202 Identities=20% Similarity=0.219 Sum_probs=140.7
Q ss_pred EEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHH-HHHHHHHHHHHHHhCC-CCCccccceeEecCCeeEEEEe
Q 007433 216 RLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRK-KLLRAQTEREILQSLD-HPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 216 ~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E 293 (604)
.+...|++|+||+||++.. .+..|+.+.+.......+. ....+.+|+++|++|+ |++|++++++ +..|+|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 4567899999999998776 4456777776554332211 1224678999999995 5889999886 34689999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccC-CCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDL-KPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDI-KpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
|+.|.+|...+.. . ...++.|++.+|++||++||||||| ||+|||++.+|.++|+|||++..........
T Consensus 79 yI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~ 149 (218)
T PRK12274 79 YLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWM 149 (218)
T ss_pred eecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHH
Confidence 9999999654321 1 1357889999999999999999999 7999999999999999999985322100000
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
+.+ ...|+. +-...-..
T Consensus 150 -----------------------------------------r~L--------~~rDl~--------------~llk~~~~ 166 (218)
T PRK12274 150 -----------------------------------------RLL--------AREDLR--------------HLLKHKRM 166 (218)
T ss_pred -----------------------------------------HHH--------HHHHHH--------------HHHHHHHh
Confidence 000 000000 00000113
Q ss_pred cCccccCcceecCC-CCC-ccchHHHHHHHHHHHhhCCCCCCCCC
Q 007433 453 GTHEYLAPEIIKGE-GHG-SAVDWWTFGIFLYELLFGKTPFKGSE 495 (604)
Q Consensus 453 GT~~Y~APE~l~~~-~~~-~~~DiWSLGviL~eLltG~~PF~~~~ 495 (604)
+++.|+.|+..+-. ..+ ...+|++.|+.+|.++|+..++.+..
T Consensus 167 y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 167 YCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred cCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 67889999875543 233 57799999999999999999886543
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-21 Score=200.08 Aligned_cols=270 Identities=23% Similarity=0.290 Sum_probs=180.4
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCc-----------------------------------eEEEEEEecchhHH--
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTK-----------------------------------CYFAMKVMDKASLE-- 252 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~-----------------------------------~~vAiK~i~~~~~~-- 252 (604)
+.+++|.+...||+|.-..||.|+....+ -..|||.|-.-...
T Consensus 154 FtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s~ 233 (598)
T KOG4158|consen 154 FTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDSG 233 (598)
T ss_pred cchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCCc
Confidence 34578999999999999999998764311 13567766321111
Q ss_pred HHHHHHHHHHHHH------H--------HHhC--------CCCCccccceeEec--------------------------
Q 007433 253 KRKKLLRAQTERE------I--------LQSL--------DHPFLPTLYTHFET-------------------------- 284 (604)
Q Consensus 253 ~~~~~~~~~~Ei~------i--------L~~l--------~HpnIv~l~~~~~~-------------------------- 284 (604)
....+...-+|.- + .+.+ .|||||++.++|.+
T Consensus 234 ~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g 313 (598)
T KOG4158|consen 234 DAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAG 313 (598)
T ss_pred hHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccC
Confidence 1111111112211 1 1111 59999999998832
Q ss_pred -CCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccC--C--cEEEecc
Q 007433 285 -DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRED--G--HIMLSDF 359 (604)
Q Consensus 285 -~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~--g--~vkL~DF 359 (604)
+..+||||-.. ..+|+.++..+ ..+....+.++.|+++|+.|||.+||.|||+|.+||||.-+ + .+.|+||
T Consensus 314 ~~~tlylvMkrY-~~tLr~yl~~~---~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDF 389 (598)
T KOG4158|consen 314 EPKTLYLVMKRY-RQTLREYLWTR---HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADF 389 (598)
T ss_pred CCceEEEehhcc-hhhHHHHHhcC---CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccc
Confidence 24679999988 67999988764 57788889999999999999999999999999999999633 3 5899999
Q ss_pred cccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccc
Q 007433 360 DLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPEL 439 (604)
Q Consensus 360 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (604)
|.+.-....+ . +.
T Consensus 390 GCcLAd~~hG--l--------------------------------------------------ql--------------- 402 (598)
T KOG4158|consen 390 GCCLADDNHG--L--------------------------------------------------QL--------------- 402 (598)
T ss_pred ceeeeccccc--c--------------------------------------------------cc---------------
Confidence 9763221100 0 00
Q ss_pred ccCCCCCcccccccCccccCcceecCCC------CCccchHHHHHHHHHHHhhCCCCCCCCChHHHH-HHH-HcCCCCCC
Q 007433 440 IAEPTNARSMSFVGTHEYLAPEIIKGEG------HGSAVDWWTFGIFLYELLFGKTPFKGSENRATL-YNV-VGQPLRFP 511 (604)
Q Consensus 440 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~------~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l-~~i-~~~~~~~p 511 (604)
+..+..-...|.-..||||+...-+ ...++|.|+.|.+-||++....||.+......- ... ..+...+|
T Consensus 403 ---py~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp 479 (598)
T KOG4158|consen 403 ---PYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALP 479 (598)
T ss_pred ---ccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCc
Confidence 0001111234777899999975432 145899999999999999999999874332110 111 12223333
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCCh
Q 007433 512 ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNW 556 (604)
Q Consensus 512 ~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~ 556 (604)
+ .+++.+++||..+|..||.+|++.+ .+..+|+--.|..-+|
T Consensus 480 ~--~vpp~~rqlV~~lL~r~pskRvsp~-iAANvl~LsLw~~~~~ 521 (598)
T KOG4158|consen 480 S--RVPPVARQLVFDLLKRDPSKRVSPN-IAANVLNLSLWRMGED 521 (598)
T ss_pred c--cCChHHHHHHHHHhcCCccccCCcc-HHHhHHHHHHhcCchH
Confidence 3 4899999999999999999999843 3556666544443333
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-21 Score=192.91 Aligned_cols=240 Identities=19% Similarity=0.299 Sum_probs=197.2
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.+...++.+|.+...|..|+|++.++. +++|+++-.....+ .-..+..|.-.|+-+.||||+.+++.+....++.++
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~r-isrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRWQGND--IVAKILNVREVTAR-ISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred hhhhhhhhhhccCCCcccccccccCcc--hhhhhhhhhhcchh-hcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 356667788999999999999998875 67788765543322 222456788889999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcC--eEeccCCCCcEEEccCCcEEEe--cccccccccC
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLG--IVYRDLKPENVLVREDGHIMLS--DFDLSLRCAV 367 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~g--IvHrDIKpeNILl~~~g~vkL~--DFGla~~~~~ 367 (604)
..|++-|+|+.+++.+.+-.....++.+++.+|++|++|||+.. |.---|....++|+++...+|. |--+++.+
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfqe-- 343 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE-- 343 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec--
Confidence 99999999999999887777888899999999999999999875 4444577888999888765553 33322110
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
T Consensus 344 -------------------------------------------------------------------------------- 343 (448)
T KOG0195|consen 344 -------------------------------------------------------------------------------- 343 (448)
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccccCccccCcceecCCCC---CccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007433 448 SMSFVGTHEYLAPEIIKGEGH---GSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLI 524 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~~~~---~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI 524 (604)
......+.||+||.+...+- -.++|+|||.++||||.|.+.||....+.+.-++|.-..++...++.++..+..|+
T Consensus 344 -~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~hm~klm 422 (448)
T KOG0195|consen 344 -VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISRHMNKLM 422 (448)
T ss_pred -cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccHHHHHHH
Confidence 01235688999999987654 34789999999999999999999999999999999888888888899999999999
Q ss_pred HHhhhcCCCCccc
Q 007433 525 KGLLVKEPQNRLA 537 (604)
Q Consensus 525 ~~lL~~dP~~Rpt 537 (604)
.-|+..||.+||.
T Consensus 423 ~icmnedpgkrpk 435 (448)
T KOG0195|consen 423 NICMNEDPGKRPK 435 (448)
T ss_pred HHHhcCCCCcCCC
Confidence 9999999999998
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-20 Score=186.49 Aligned_cols=134 Identities=22% Similarity=0.246 Sum_probs=106.1
Q ss_pred EEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-----CCCCccccceeEecCC---eeE
Q 007433 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-----DHPFLPTLYTHFETDK---FSC 289 (604)
Q Consensus 218 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-----~HpnIv~l~~~~~~~~---~~~ 289 (604)
.+.||+|+||.||. +..+... +||++...... ....+.+|+.+++.| +||||+++|++++++. .+|
T Consensus 7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~ 80 (210)
T PRK10345 7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY 80 (210)
T ss_pred cceecCCCceEEEE--CCCCcCe-EEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence 46899999999995 6566544 79998764322 223567899999999 6799999999999863 434
Q ss_pred -EEEee--cCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHH-HHHHHcCeEeccCCCCcEEEccC----CcEEEecccc
Q 007433 290 -LVMEF--CPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLAL-EYLHMLGIVYRDLKPENVLVRED----GHIMLSDFDL 361 (604)
Q Consensus 290 -lV~E~--~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL-~yLH~~gIvHrDIKpeNILl~~~----g~vkL~DFGl 361 (604)
+|||| +.+++|.+++.+. .+++. ..+++|++.++ +|||+++||||||||+|||++.. +.++|+||+-
T Consensus 81 ~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G 155 (210)
T PRK10345 81 DVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG 155 (210)
T ss_pred EEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence 78999 5579999999663 36666 35688888888 99999999999999999999743 3799999543
Q ss_pred c
Q 007433 362 S 362 (604)
Q Consensus 362 a 362 (604)
+
T Consensus 156 ~ 156 (210)
T PRK10345 156 E 156 (210)
T ss_pred C
Confidence 3
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-21 Score=221.37 Aligned_cols=312 Identities=31% Similarity=0.507 Sum_probs=238.0
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.+.+.+.+-+-+|.++.++.+.-..++..+++|+..+...-..........+..++-...||.+++..--|.-....+||
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 45677888889999999999999998888888887665433333344444454555445667777666666667889999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|+|+.|++|...++.-+ ..+++.++.++..+..+++|||...++|||++|.|+|+..+|+.++.|||.....+.-+..
T Consensus 883 ~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~ 960 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPT 960 (1205)
T ss_pred hHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCc
Confidence 99999999999888763 5778888999999999999999999999999999999999999999999966444322221
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCccccccc-ccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKS-KKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
...... ...-.++++... .+.+.. .. ...+...
T Consensus 961 ~~~sg~------------------------------~~~~~~~~~~~~~~~~~l~---------------~~-~~~~~~~ 994 (1205)
T KOG0606|consen 961 TDLSGP------------------------------SSSGTPRRLSRSERRPQLS---------------AD-EARRKHA 994 (1205)
T ss_pred CCcccc------------------------------cccCccccccccccccccc---------------cc-hhhcccc
Confidence 111100 000011111110 000000 00 1123446
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCC-CCCHHHHHHHHHhhh
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESP-VVSFSARDLIKGLLV 529 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~-~~s~~l~dLI~~lL~ 529 (604)
.+||+.|.+||.+.+..++..+|||++|++++|.++|.+||........+.++......++..+ ..+.++++++.++|.
T Consensus 995 ~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~ 1074 (1205)
T KOG0606|consen 995 VVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLT 1074 (1205)
T ss_pred ccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhc
Confidence 7899999999999999999999999999999999999999999999899999988877777644 478899999999999
Q ss_pred cCCCCcccccCCHHHHhcCCCCCCCChhhhhcCCCCCCCCCCc
Q 007433 530 KEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPKPVE 572 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~~~~~~~~~p~~~~ 572 (604)
.+|.+|..+ .++.++..|+||+.++|+.+......++|.+..
T Consensus 1075 ~~~~qr~~a-~~~~e~k~~~~~~~~~~~~l~~q~~~~~p~~~s 1116 (1205)
T KOG0606|consen 1075 EEPTQRLGA-KGAAEVKGHPFFQDVDWENLALQKAEFVPQPES 1116 (1205)
T ss_pred cCchhccCc-ccccccccCCccCCCCccccccccCccCCCCCC
Confidence 999999993 234599999999999999998888888888765
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=7e-20 Score=184.50 Aligned_cols=146 Identities=25% Similarity=0.255 Sum_probs=113.8
Q ss_pred CeEEEEEEccCCcEEEEEEE-EcCCceEEEEEEecchhHHH---------------------HHHHHHHHHHHHHHHhCC
Q 007433 214 HFRLLKKLGCGDIGSVYLSE-LTGTKCYFAMKVMDKASLEK---------------------RKKLLRAQTEREILQSLD 271 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~-~~~~~~~vAiK~i~~~~~~~---------------------~~~~~~~~~Ei~iL~~l~ 271 (604)
.|.+.+.||.|+||.||+|. +..+++.||||+++...... ......+.+|+++++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 58899999999999999998 66788999999997542110 001123568999999997
Q ss_pred CCC--ccccceeEecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcC-eEeccCCCCcEEE
Q 007433 272 HPF--LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLG-IVYRDLKPENVLV 348 (604)
Q Consensus 272 Hpn--Iv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~g-IvHrDIKpeNILl 348 (604)
+.+ +++++++ . ..||||||++|++|..++... ..+....+..++.||+.+|.|||.+| |+||||||+|||+
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli 182 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILV 182 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEE
Confidence 632 3444432 2 358999999888887654332 34667778899999999999999999 9999999999999
Q ss_pred ccCCcEEEeccccccccc
Q 007433 349 REDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 349 ~~~g~vkL~DFGla~~~~ 366 (604)
+ ++.++|+|||++....
T Consensus 183 ~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 183 H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred E-CCCEEEEEChhhhccC
Confidence 9 8899999999985543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.82 E-value=4.8e-20 Score=212.20 Aligned_cols=198 Identities=26% Similarity=0.385 Sum_probs=157.2
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC---CCCccccceeEecC
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD---HPFLPTLYTHFETD 285 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~ 285 (604)
.+....|.|-+.||+|+||+||+|.... ++.||||+-......+ . .--.+++.+|+ -+.|..+...+...
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE--f----YI~~q~~~RLk~~~~~~~~~~~~a~~~~ 766 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE--F----YICLQVMERLKPQMLPSIMHISSAHVFQ 766 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee--e----eehHHHHHhhchhhhcchHHHHHHHccC
Confidence 4555789999999999999999999988 8899999976553321 1 11224445554 23455566655666
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccC-------CcEEEec
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRED-------GHIMLSD 358 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~-------g~vkL~D 358 (604)
+..+||+||.+.|+|.+++.. .+.++|..+.++..|+|.-|+.||..||||+||||+|.||+.. --++|+|
T Consensus 767 ~~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 767 NASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred CcceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 778899999999999999883 4789999999999999999999999999999999999999631 2589999
Q ss_pred ccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcc
Q 007433 359 FDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPE 438 (604)
Q Consensus 359 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (604)
||-+.-+..
T Consensus 845 fG~siDm~l----------------------------------------------------------------------- 853 (974)
T KOG1166|consen 845 FGRSIDMKL----------------------------------------------------------------------- 853 (974)
T ss_pred cccceeeeE-----------------------------------------------------------------------
Confidence 997743321
Q ss_pred cccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCC
Q 007433 439 LIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKT 489 (604)
Q Consensus 439 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~ 489 (604)
.+...+-...++|-.+-.+|+..|..|++.+|.|.|..+++-||+|+.
T Consensus 854 ---fp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 854 ---FPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ---cCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 111123335678899999999999999999999999999999999974
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=6.1e-19 Score=173.50 Aligned_cols=136 Identities=22% Similarity=0.248 Sum_probs=113.3
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhH-----HHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASL-----EKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~-----~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
+.||+|++|.||+|.+ .+..|++|+...... .......++.+|++++..+.|++|+....++.+....++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 5799999999999988 445688998653221 112223456789999999999999888878777788899999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
|++|++|.+++.... . ....++.+++.+|.+||.+|++|||++|.|||++ ++.++|+|||++.
T Consensus 80 ~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~ 142 (211)
T PRK14879 80 YIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAE 142 (211)
T ss_pred EeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCccc
Confidence 999999999886541 2 7788999999999999999999999999999999 7899999999874
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.9e-20 Score=198.14 Aligned_cols=254 Identities=24% Similarity=0.308 Sum_probs=164.4
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCC---ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccce-------eEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGT---KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYT-------HFE 283 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~-------~~~ 283 (604)
.+.+.+-.+..+++.+........ ...+.-|..+.+.+ .......+++-.+....|-+..-+.+ .+.
T Consensus 245 s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~---~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~ 321 (516)
T KOG1033|consen 245 SSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSL---CACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSK 321 (516)
T ss_pred cccccccccccccCCchhhhhcccchhhhhccchhhhccch---hhhhhhhhhhhheeccccCCcccccCCCCchhhhcc
Confidence 445555566666666665443332 23333333332221 12223334444444444433322222 111
Q ss_pred -----cCCeeEEEEeecCCCCHHHHHHh-cCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEe
Q 007433 284 -----TDKFSCLVMEFCPGGDLHTLRQR-QPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLS 357 (604)
Q Consensus 284 -----~~~~~~lV~E~~~ggsL~~ll~~-~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~ 357 (604)
...++|+.|++|.-.+|.+++.+ ..+...+....+.++.|++.|++| +|.+|||+||.||++..++.+||.
T Consensus 322 ~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIg 398 (516)
T KOG1033|consen 322 RNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIG 398 (516)
T ss_pred ccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhh
Confidence 12368999999999999999974 445567788899999999999999 999999999999999999999999
Q ss_pred cccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCc
Q 007433 358 DFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLP 437 (604)
Q Consensus 358 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (604)
|||+.......+ +.+
T Consensus 399 DFgl~ts~~~~~---------------------~~~-------------------------------------------- 413 (516)
T KOG1033|consen 399 DFGLVTSQDKDE---------------------TVA-------------------------------------------- 413 (516)
T ss_pred hhhheeecccCC---------------------ccc--------------------------------------------
Confidence 999974332111 000
Q ss_pred ccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCCCCCCCCCCC
Q 007433 438 ELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSEN-RATLYNVVGQPLRFPESPVV 516 (604)
Q Consensus 438 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~-~~~l~~i~~~~~~~p~~~~~ 516 (604)
+.....+..+||++||+||.+.+..|+.++||||||++||||+. +|..... ..++..+..+.+.-......
T Consensus 414 -----~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~---~f~T~~er~~t~~d~r~g~ip~~~~~d~ 485 (516)
T KOG1033|consen 414 -----PAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI---QFSTQFERIATLTDIRDGIIPPEFLQDY 485 (516)
T ss_pred -----chhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH---HhccHHHHHHhhhhhhcCCCChHHhhcC
Confidence 01123345589999999999999999999999999999999997 2222111 22223333322210011112
Q ss_pred CHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 517 SFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 517 s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
+.-.+|+.+||...|.+||+ +.+.--|+|.
T Consensus 486 -p~e~~ll~~lls~~p~~RP~----~~~~~~~~~~ 515 (516)
T KOG1033|consen 486 -PEEYTLLQQLLSPSPEERPS----AIEVALHEFL 515 (516)
T ss_pred -cHHHHHHHHhcCCCcccCch----HHHHhhhhhc
Confidence 23458999999999999997 7777777664
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.6e-21 Score=213.73 Aligned_cols=263 Identities=23% Similarity=0.348 Sum_probs=207.1
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcC-CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEecCCeeEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTG-TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~l 290 (604)
..|.+.+.||.|+|+.|-++.... ....+|+|.+.... ...........|..+-+.+. |.|++.+++........++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 367888889999999999987744 45567888876554 22333445566888878886 9999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH-HcCeEeccCCCCcEEEccCC-cEEEecccccccccCC
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH-MLGIVYRDLKPENVLVREDG-HIMLSDFDLSLRCAVS 368 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH-~~gIvHrDIKpeNILl~~~g-~vkL~DFGla~~~~~~ 368 (604)
++||..|++++..+.......++...+..++.|+..+|.|+| ..++.||||||+|.+++..+ .++++|||+|..+...
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 999999999998874222226778889999999999999999 99999999999999999999 9999999998433210
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
. ......
T Consensus 179 ~-------------------------------------------------------------------------g~~~~~ 185 (601)
T KOG0590|consen 179 N-------------------------------------------------------------------------GAERSL 185 (601)
T ss_pred C-------------------------------------------------------------------------Ccceee
Confidence 0 000111
Q ss_pred ccccc-CccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHH-HHHHcCCC--CCCCCCCCCHHHHHH
Q 007433 449 MSFVG-THEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATL-YNVVGQPL--RFPESPVVSFSARDL 523 (604)
Q Consensus 449 ~~~~G-T~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l-~~i~~~~~--~~p~~~~~s~~l~dL 523 (604)
...+| ++.|+|||.+.+. ..+...|+||+|+++.-+++|..||......... ..+..... ....+..++....++
T Consensus 186 ~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (601)
T KOG0590|consen 186 KDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSISDQAHDL 265 (601)
T ss_pred ecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCChhhhhc
Confidence 23457 9999999999985 4578999999999999999999999765443322 23333222 234455688899999
Q ss_pred HHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 524 IKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 524 I~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
+.++|..+|..|.+ .+++..++|+..
T Consensus 266 l~k~l~~~~~~r~s----~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 266 LHKILKENPSNRLS----IEELKLDNWLSS 291 (601)
T ss_pred ccccccCCchhccc----cccccccccccc
Confidence 99999999999999 999999999987
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.4e-18 Score=167.84 Aligned_cols=132 Identities=24% Similarity=0.276 Sum_probs=106.9
Q ss_pred EEccCCcEEEEEEEEcCCceEEEEEEecchh-----HHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEee
Q 007433 220 KLGCGDIGSVYLSELTGTKCYFAMKVMDKAS-----LEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEF 294 (604)
Q Consensus 220 ~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~-----~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 294 (604)
.||+|+||.||++.+. +..|++|+..... ........++.+|+++++.+.|+++....-++......++||||
T Consensus 1 ~ig~G~~~~vy~~~~~--~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL--GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeecC--CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 3799999999999864 4578999865332 11222345677899999999988776666566667778999999
Q ss_pred cCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccc
Q 007433 295 CPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 295 ~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
++|++|.+++.... . .++.|++.+|.+||+.|++|||++|+|||++ ++.++|+|||++.
T Consensus 79 ~~g~~l~~~~~~~~--~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~ 137 (199)
T TIGR03724 79 IEGKPLKDVIEEGN--D-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGK 137 (199)
T ss_pred ECCccHHHHHhhcH--H-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCc
Confidence 99999998875531 1 7899999999999999999999999999999 8899999999874
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=9.5e-19 Score=171.16 Aligned_cols=140 Identities=25% Similarity=0.245 Sum_probs=109.4
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHH--H----H-------------HHHHHHHHHHHHHHhCCCCC
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLE--K----R-------------KKLLRAQTEREILQSLDHPF 274 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~--~----~-------------~~~~~~~~Ei~iL~~l~Hpn 274 (604)
.|.+.+.||.|+||.||++.+. +++.||||+++..... . . .......+|..++..+.|.+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 94 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG 94 (198)
T ss_pred hhhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence 3888899999999999999875 6889999997653210 0 0 01123567889999998874
Q ss_pred --ccccceeEecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC
Q 007433 275 --LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG 352 (604)
Q Consensus 275 --Iv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g 352 (604)
++.+++ ....|+||||++|++|..+... .....++.+++.+|.+||++||+||||||+||||+.++
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~ 162 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDE 162 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCC
Confidence 444443 2345899999999999765321 34567889999999999999999999999999999999
Q ss_pred cEEEeccccccccc
Q 007433 353 HIMLSDFDLSLRCA 366 (604)
Q Consensus 353 ~vkL~DFGla~~~~ 366 (604)
.++|+|||++..+.
T Consensus 163 ~~~liDfg~~~~~~ 176 (198)
T cd05144 163 KIYIIDWPQMVSTD 176 (198)
T ss_pred cEEEEECCccccCC
Confidence 99999999986554
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.5e-18 Score=191.95 Aligned_cols=138 Identities=25% Similarity=0.259 Sum_probs=112.2
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecch-----hHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCe
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKA-----SLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKF 287 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 287 (604)
..|...+.||+|+||+||++.+.+.. +++|+.... .........++.+|+++|+.++|++|+..+.++.....
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 45677889999999999999887655 333332211 11222234567789999999999999988877777778
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccc
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
.++||||++|++|.+++. ....++.|++.+|.|||++||+||||||+|||+ .++.++|+|||++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999998775 346789999999999999999999999999999 67899999999984
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.9e-17 Score=159.77 Aligned_cols=139 Identities=23% Similarity=0.247 Sum_probs=99.7
Q ss_pred EEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHH---------------------HHHHHHHHHHHhCCCCC--
Q 007433 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKL---------------------LRAQTEREILQSLDHPF-- 274 (604)
Q Consensus 218 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~---------------------~~~~~Ei~iL~~l~Hpn-- 274 (604)
.+.||+|+||+||+|.+. ++..||||+++.......... .....|...+..+.+..
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 467999999999999987 778999999875432111111 01135666666665433
Q ss_pred ccccceeEecCCeeEEEEeecCCCCHHH-HHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH-cCeEeccCCCCcEEEccCC
Q 007433 275 LPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEYLHM-LGIVYRDLKPENVLVREDG 352 (604)
Q Consensus 275 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~-ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDIKpeNILl~~~g 352 (604)
++++++. ...++||||++|+.+.. .+... ... ..++.++.+++.+|.+||. +||+||||||+|||++ ++
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~ 151 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DG 151 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CC
Confidence 4444443 23589999998854421 11111 011 5678899999999999999 9999999999999999 89
Q ss_pred cEEEeccccccccc
Q 007433 353 HIMLSDFDLSLRCA 366 (604)
Q Consensus 353 ~vkL~DFGla~~~~ 366 (604)
.++|+|||.+....
T Consensus 152 ~~~liDfg~a~~~~ 165 (187)
T cd05119 152 KVYIIDVPQAVEID 165 (187)
T ss_pred cEEEEECccccccc
Confidence 99999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.4e-16 Score=160.86 Aligned_cols=136 Identities=22% Similarity=0.284 Sum_probs=103.7
Q ss_pred EEEc-cCCcEEEEEEEEcCCceEEEEEEecchhH-----H-----HHHHHHHHHHHHHHHHhCCCCCc--cccceeEecC
Q 007433 219 KKLG-CGDIGSVYLSELTGTKCYFAMKVMDKASL-----E-----KRKKLLRAQTEREILQSLDHPFL--PTLYTHFETD 285 (604)
Q Consensus 219 ~~LG-~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~-----~-----~~~~~~~~~~Ei~iL~~l~HpnI--v~l~~~~~~~ 285 (604)
..|| .||.|+||.+... +..++||.+.+..+ . ......++.+|++++..|.|++| +..+++...+
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 3566 7888888888775 45789998865321 0 01223467789999999998875 6677665432
Q ss_pred -C---eeEEEEeecCC-CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccc
Q 007433 286 -K---FSCLVMEFCPG-GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFD 360 (604)
Q Consensus 286 -~---~~~lV~E~~~g-gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFG 360 (604)
. ..+|||||++| .+|.+++... .+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg 187 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA---PLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFD 187 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC---CCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECC
Confidence 2 23599999987 6998887653 455543 5789999999999999999999999999999999999999
Q ss_pred ccc
Q 007433 361 LSL 363 (604)
Q Consensus 361 la~ 363 (604)
.+.
T Consensus 188 ~~~ 190 (239)
T PRK01723 188 RGE 190 (239)
T ss_pred Ccc
Confidence 874
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=1.1e-16 Score=173.71 Aligned_cols=197 Identities=21% Similarity=0.280 Sum_probs=150.1
Q ss_pred HHhCCCCCccccceeEecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCe-EeccCCCCc
Q 007433 267 LQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGI-VYRDLKPEN 345 (604)
Q Consensus 267 L~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gI-vHrDIKpeN 345 (604)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+... ...+++--...++++|+.||.|||.--| .|+.++..|
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n 79 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN 79 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence 46789999999999999999999999999999999998874 3678888889999999999999998654 999999999
Q ss_pred EEEccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCC
Q 007433 346 VLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKP 425 (604)
Q Consensus 346 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (604)
++++..+.+||+|||+...... ...
T Consensus 80 Clvd~~w~lklt~~Gl~~~~~~------~~~------------------------------------------------- 104 (484)
T KOG1023|consen 80 CLVDSRWVLKLTDFGLNSLLEE------TAE------------------------------------------------- 104 (484)
T ss_pred ceeeeeEEEEechhhhcccccc------ccc-------------------------------------------------
Confidence 9999999999999998632110 000
Q ss_pred ccccCCCCCCCcccccCCCCCcccccccCccccCcceecCCC-------CCccchHHHHHHHHHHHhhCCCCCCCC----
Q 007433 426 KNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEG-------HGSAVDWWTFGIFLYELLFGKTPFKGS---- 494 (604)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-------~~~~~DiWSLGviL~eLltG~~PF~~~---- 494 (604)
........-..-|.|||++++.. .+.+.|+||||++++|+++...||...
T Consensus 105 -------------------~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~~ 165 (484)
T KOG1023|consen 105 -------------------PEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLVE 165 (484)
T ss_pred -------------------ccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccccccccC
Confidence 00000011234699999998752 255799999999999999999999762
Q ss_pred ChHHHHHHHHc-CCC-CCCC---CCCCCHHHHHHHHHhhhcCCCCcccc
Q 007433 495 ENRATLYNVVG-QPL-RFPE---SPVVSFSARDLIKGLLVKEPQNRLAC 538 (604)
Q Consensus 495 ~~~~~l~~i~~-~~~-~~p~---~~~~s~~l~dLI~~lL~~dP~~Rpt~ 538 (604)
...+.+..+.+ +.. -.|. ...+.+++..+++.||..+|++||+.
T Consensus 166 ~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~ 214 (484)
T KOG1023|consen 166 DPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSI 214 (484)
T ss_pred ChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccH
Confidence 22344555444 211 1111 11345578899999999999999994
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.4e-16 Score=144.28 Aligned_cols=131 Identities=26% Similarity=0.306 Sum_probs=111.0
Q ss_pred EEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCC--CCccccceeEecCCeeEEEEee
Q 007433 217 LLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH--PFLPTLYTHFETDKFSCLVMEF 294 (604)
Q Consensus 217 l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~~~lV~E~ 294 (604)
+++.||.|.++.||++...+ ..+++|++..... ...+.+|+.+++.+.| .++++++.++...+..+++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 45789999999999999865 5799999866532 2346679999999976 5899999988888899999999
Q ss_pred cCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHc---CeEeccCCCCcEEEccCCcEEEecccccc
Q 007433 295 CPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML---GIVYRDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 295 ~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~---gIvHrDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
+.|+.+..+ +......++.+++.+|.+||.. +++||||+|+|||++.++.++|+|||++.
T Consensus 75 ~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~ 137 (155)
T cd05120 75 IEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAG 137 (155)
T ss_pred cCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEeccccc
Confidence 988877643 4556677889999999999984 79999999999999998999999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.4e-15 Score=163.47 Aligned_cols=260 Identities=22% Similarity=0.231 Sum_probs=193.8
Q ss_pred cCeEEEEEEcc--CCcEEEEEEEE--cCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCe
Q 007433 213 GHFRLLKKLGC--GDIGSVYLSEL--TGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKF 287 (604)
Q Consensus 213 ~~y~l~~~LG~--G~fG~Vy~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 287 (604)
..|.+.+.+|. |.+|.||.+.. ..+...+|+|.-..-. .....-.+-.+|+...+++ .|+|.++.+..++.++.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~ 192 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGI 192 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCcccccCCc
Confidence 46778889999 99999999999 8888899998843211 1111112223566666666 49999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHH----HHHHHHHcCeEeccCCCCcEEEccC-CcEEEeccccc
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLL----ALEYLHMLGIVYRDLKPENVLVRED-GHIMLSDFDLS 362 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~----aL~yLH~~gIvHrDIKpeNILl~~~-g~vkL~DFGla 362 (604)
.|+-+|+| +.+|..+.... ...++...++.++.+... ||.++|..+++|-|+||.||++..+ ...+++|||+.
T Consensus 193 lfiqtE~~-~~sl~~~~~~~-~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 193 LFIQTELC-GESLQSYCHTP-CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred ceeeeccc-cchhHHhhhcc-cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 99999999 78888876654 356899999999999999 9999999999999999999999999 78999999998
Q ss_pred ccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccC
Q 007433 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442 (604)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (604)
..+....-.. ..+.
T Consensus 271 ~~i~~~~~~~----------------------------------------------~~~~-------------------- 284 (524)
T KOG0601|consen 271 SKISDGNFSS----------------------------------------------VFKV-------------------- 284 (524)
T ss_pred EEccCCcccc----------------------------------------------ceee--------------------
Confidence 6554222100 0000
Q ss_pred CCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCC--ChHHHHHHHHcCCCCCCCCCCCCHHH
Q 007433 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS--ENRATLYNVVGQPLRFPESPVVSFSA 520 (604)
Q Consensus 443 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~--~~~~~l~~i~~~~~~~p~~~~~s~~l 520 (604)
...-.|..-|++||.+++. ++...|+++||.++.+-.+|..++... +.-..+.++ .+........+.++
T Consensus 285 -----~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~---~ip~e~~~~~s~~l 355 (524)
T KOG0601|consen 285 -----SKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG---YIPLEFCEGGSSSL 355 (524)
T ss_pred -----eecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc---cCchhhhcCcchhh
Confidence 0011366779999998876 778999999999999999988776554 211111111 11111222356677
Q ss_pred HHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 521 RDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 521 ~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
...+..||..+|-.|++ +..+++|++....
T Consensus 356 ~~~~~~~~d~~~~~~~~----~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 356 RSVTSQMLDEDPRLRLT----AQILTALNVIHSK 385 (524)
T ss_pred hhHHHHhcCcchhhhhH----HHHHhccccccch
Confidence 77999999999999999 9999999998743
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.9e-14 Score=159.77 Aligned_cols=146 Identities=18% Similarity=0.236 Sum_probs=96.9
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHH-------------------------------HHHHHHHH
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEK-------------------------------RKKLLRAQ 261 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~-------------------------------~~~~~~~~ 261 (604)
..|.. +.||+|++|+||+|+++.+|+.||||+++..-... .+....+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 78999999999999999889999999997542110 01111222
Q ss_pred HHHHHHH------hC----CCCCccccceeEec-CCeeEEEEeecCCCCHHHHH--HhcC--CCCCcHHHHHHHHHHHHH
Q 007433 262 TEREILQ------SL----DHPFLPTLYTHFET-DKFSCLVMEFCPGGDLHTLR--QRQP--GKYFSEQAVKFYVAEVLL 326 (604)
Q Consensus 262 ~Ei~iL~------~l----~HpnIv~l~~~~~~-~~~~~lV~E~~~ggsL~~ll--~~~~--~~~l~e~~~~~i~~qil~ 326 (604)
+|+++++ ++ .+.+.+.+-.+|++ ....+|||||+.|+.|.++. .... ...+.+..+..++.||+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif- 277 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF- 277 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-
Confidence 3333332 22 12222222222322 34457999999999998753 2221 01355556666666665
Q ss_pred HHHHHHHcCeEeccCCCCcEEEccCC----cEEEeccccccccc
Q 007433 327 ALEYLHMLGIVYRDLKPENVLVREDG----HIMLSDFDLSLRCA 366 (604)
Q Consensus 327 aL~yLH~~gIvHrDIKpeNILl~~~g----~vkL~DFGla~~~~ 366 (604)
..|++|+|+||.||+++.+| +++++|||+..++.
T Consensus 278 ------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 278 ------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred ------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 59999999999999999988 99999999986654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.6e-13 Score=150.21 Aligned_cols=141 Identities=23% Similarity=0.256 Sum_probs=96.3
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHH-H------------------------------H------HHHH
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRK-K------------------------------L------LRAQ 261 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~-~------------------------------~------~~~~ 261 (604)
+.||.|++|.||+|+.. +|+.||||+.+......-. + . ..+.
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 56999999999999976 5779999998654211000 0 0 0122
Q ss_pred HHHHHHHhC----C-CCC--ccccceeEecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHH-HHHHHHH
Q 007433 262 TEREILQSL----D-HPF--LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLL-ALEYLHM 333 (604)
Q Consensus 262 ~Ei~iL~~l----~-Hpn--Iv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~-aL~yLH~ 333 (604)
+|...+.++ . +++ |+++|..+ ....+|||||++|++|.++...... .+. ...++.+++. .+..+|.
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~--~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~~~l~ql~~ 275 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDR--TSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLARSFLNQVLR 275 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhh--cCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHHHHHHHHHh
Confidence 344444444 2 333 33443222 3456899999999999887653211 122 3445566655 4788999
Q ss_pred cCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 334 LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 334 ~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
.|++|+|+||.||+++.+|.++|+|||++.++.
T Consensus 276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 999999999999999999999999999986654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.47 E-value=3.7e-14 Score=154.29 Aligned_cols=253 Identities=21% Similarity=0.263 Sum_probs=188.7
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEc-CCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCC
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELT-GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDK 286 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 286 (604)
.....+|.++..||.|.|+.|+....+ .++..|++|.+.+.......++. ...|+.+...+ .|.+++.++..|....
T Consensus 261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~-sl~ev~l~~~l~~~~~~~g~~~~W~~~r 339 (524)
T KOG0601|consen 261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIF-SLGEVILEAILGSHLPSVGKNSSWSQLR 339 (524)
T ss_pred eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhc-chhhhhHhhHhhcccccCCCCCCccccc
Confidence 345578999999999999999987655 67889999998766544333332 34577777666 5889999888888777
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccC-CcEEEecccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRED-GHIMLSDFDLSLRC 365 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~-g~vkL~DFGla~~~ 365 (604)
..|+-.|||.++++..-+.- ...+.+...+.+..|++.++.++|+..++|+|+||+||++..+ +..++.|||...++
T Consensus 340 ~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 340 QGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred cccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccc
Confidence 88899999999998765432 2568889999999999999999999999999999999999986 67889999977442
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
+...
T Consensus 418 ~~~~---------------------------------------------------------------------------- 421 (524)
T KOG0601|consen 418 AFSS---------------------------------------------------------------------------- 421 (524)
T ss_pred ceec----------------------------------------------------------------------------
Confidence 2110
Q ss_pred CcccccccCcccc--CcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 007433 446 ARSMSFVGTHEYL--APEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDL 523 (604)
Q Consensus 446 ~~~~~~~GT~~Y~--APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dL 523 (604)
..+.++-+|+ +++.+....+..+.|+++||.-+.|.++|...-.... ....+..+ ..+..+.....+..+
T Consensus 422 ---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~~~~i~~~--~~p~~~~~~~~~q~~ 493 (524)
T KOG0601|consen 422 ---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---QSLTIRSG--DTPNLPGLKLQLQVL 493 (524)
T ss_pred ---ccccccccccccchhhccccccccccccccccccccccccCcccCcccc---cceeeecc--cccCCCchHHhhhhh
Confidence 0112233333 5566667778999999999999999999875432221 22222222 233334455788899
Q ss_pred HHHhhhcCCCCcccccCCHHHHhcCCCCC
Q 007433 524 IKGLLVKEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 524 I~~lL~~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
.+.++..++..|+. +.++..|.=|.
T Consensus 494 ~kv~~~~~~~~~~l----~~~l~~~~~~~ 518 (524)
T KOG0601|consen 494 LKVMINPDRKRRPS----AVELSLHSEFY 518 (524)
T ss_pred hhhhcCCccccchh----hhhhcccchhh
Confidence 99999999999999 88888887664
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.43 E-value=2e-12 Score=142.07 Aligned_cols=122 Identities=20% Similarity=0.213 Sum_probs=99.9
Q ss_pred EEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCCCCHHHHHHhcCCC
Q 007433 231 LSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGK 310 (604)
Q Consensus 231 ~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~ 310 (604)
.|..+.++.+|.|.+.....- .....+.+-++-|+.|+||||+++++.++.++.+|||+|.+. -|..+++..
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l--- 101 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKEL--- 101 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHh---
Confidence 466677777888888866543 222334456788999999999999999999999999999984 466666653
Q ss_pred CCcHHHHHHHHHHHHHHHHHHH-HcCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 311 YFSEQAVKFYVAEVLLALEYLH-MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 311 ~l~e~~~~~i~~qil~aL~yLH-~~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
....+.--+.||+.||.||| +++++|++|.-..|+|+..|+.||++|.+.
T Consensus 102 --~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v 152 (690)
T KOG1243|consen 102 --GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELV 152 (690)
T ss_pred --HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEE
Confidence 36667777999999999998 578999999999999999999999999876
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=3.2e-14 Score=143.98 Aligned_cols=246 Identities=21% Similarity=0.246 Sum_probs=162.0
Q ss_pred EEEEEEEEcCCceEEEEEEecchhHHHHHHHH-HHHHHHHHHHhCCCCCccccceeEecC-----CeeEEEEeecCCCCH
Q 007433 227 GSVYLSELTGTKCYFAMKVMDKASLEKRKKLL-RAQTEREILQSLDHPFLPTLYTHFETD-----KFSCLVMEFCPGGDL 300 (604)
Q Consensus 227 G~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~-~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~ggsL 300 (604)
-.||++.++..+..|..-.+........+... ....-..-|-.+.|.|||+++.|+.+. ....++.||+..|+|
T Consensus 80 d~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~ 159 (458)
T KOG1266|consen 80 DDVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSL 159 (458)
T ss_pred HHHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhH
Confidence 45788888877766654443221110000000 000111234556899999999988654 357899999999999
Q ss_pred HHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHcC--eEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCc
Q 007433 301 HTLRQRQ--PGKYFSEQAVKFYVAEVLLALEYLHMLG--IVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSST 376 (604)
Q Consensus 301 ~~ll~~~--~~~~l~e~~~~~i~~qil~aL~yLH~~g--IvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~ 376 (604)
..++++. ....+.....++|+-||+.||.|||+.. |+|+++...-|++..+|-+|+.--.
T Consensus 160 ~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~a---------------- 223 (458)
T KOG1266|consen 160 KQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVA---------------- 223 (458)
T ss_pred HHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccC----------------
Confidence 9998864 2357889999999999999999999985 9999999999999999988874211
Q ss_pred ccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCcc
Q 007433 377 LESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHE 456 (604)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~ 456 (604)
|+...++...- +.+ ......|-++
T Consensus 224 --------------------p~s~h~s~~~~------~~~------------------------------Ek~~~~~~~g 247 (458)
T KOG1266|consen 224 --------------------PDSTHPSVNST------REA------------------------------EKSVNTSLPG 247 (458)
T ss_pred --------------------ccccchhhhhh------hHh------------------------------hhhccccCCc
Confidence 00011100000 000 0011236678
Q ss_pred ccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCC-C---hHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCC
Q 007433 457 YLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS-E---NRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEP 532 (604)
Q Consensus 457 Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~-~---~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP 532 (604)
|.+||.=.-....-++|||+||.+.+||..|+.--... . ..+.+.+++-. + -...-+++|.+||.-+|
T Consensus 248 ~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~---l-----en~lqr~~i~kcl~~eP 319 (458)
T KOG1266|consen 248 FSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIG---L-----ENGLQRGSITKCLEGEP 319 (458)
T ss_pred cccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheee---c-----cCccccCcCcccccCCC
Confidence 99999866666678999999999999999887542221 1 12222222111 1 01122579999999999
Q ss_pred CCcccccCCHHHHhcCCCCCCCCh
Q 007433 533 QNRLACRRGATEIKQHPFFQGVNW 556 (604)
Q Consensus 533 ~~Rpt~~~~a~elL~Hpff~~~~~ 556 (604)
..||+ +.++|-||.+-+|.-
T Consensus 320 ~~rp~----ar~llfHpllfeVhs 339 (458)
T KOG1266|consen 320 NGRPD----ARLLLFHPLLFEVHS 339 (458)
T ss_pred CCCcc----hhhhhcCceeeecch
Confidence 99999 999999999876653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.42 E-value=5.5e-13 Score=126.19 Aligned_cols=127 Identities=22% Similarity=0.277 Sum_probs=95.1
Q ss_pred EEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCC-ccccceeEecCCeeEEEEeecC
Q 007433 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF-LPTLYTHFETDKFSCLVMEFCP 296 (604)
Q Consensus 218 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~~lV~E~~~ 296 (604)
++.|+.|.++.||+++.. +..|++|+...... ......+|..+++.+.+.+ +++++.+.. ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 467899999999999875 55799999865421 1112356888888886544 455665443 33579999999
Q ss_pred CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCe-----EeccCCCCcEEEccCCcEEEecccccc
Q 007433 297 GGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGI-----VYRDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 297 ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gI-----vHrDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
|.++... . .....++.+++.+|..||..++ +|+|++|.||+++ ++.++|+|||.+.
T Consensus 75 G~~l~~~---~-------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE---D-------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc---c-------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9888643 0 1123456899999999999885 9999999999998 6789999999873
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.1e-12 Score=124.68 Aligned_cols=140 Identities=19% Similarity=0.189 Sum_probs=101.7
Q ss_pred EEEccCCcEEEEEEEEcC------CceEEEEEEecchhH--HH---------------------HHHHHHHHHHHHHHHh
Q 007433 219 KKLGCGDIGSVYLSELTG------TKCYFAMKVMDKASL--EK---------------------RKKLLRAQTEREILQS 269 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~------~~~~vAiK~i~~~~~--~~---------------------~~~~~~~~~Ei~iL~~ 269 (604)
..||.|--+.||.|.... .+..+|||+.+-... .. ......+.+|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468899999999998654 346899999863210 00 0111233489999999
Q ss_pred CCC--CCccccceeEecCCeeEEEEeecCCCCHHH-HHHhcCCCCCcHHHHHHHHHHHHHHHHHH-HHcCeEeccCCCCc
Q 007433 270 LDH--PFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEYL-HMLGIVYRDLKPEN 345 (604)
Q Consensus 270 l~H--pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~-ll~~~~~~~l~e~~~~~i~~qil~aL~yL-H~~gIvHrDIKpeN 345 (604)
+.. -++++.+.+ ..-+|||||+.+..+.. .++. ..+++.....++.|++.+|.+| |..|||||||++.|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~N 155 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYN 155 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 853 567777765 34679999996554432 2222 2456667778889999999999 89999999999999
Q ss_pred EEEccCCcEEEeccccccccc
Q 007433 346 VLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 346 ILl~~~g~vkL~DFGla~~~~ 366 (604)
||+. +|.+.|+|||.+....
T Consensus 156 IL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 156 MLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEEE-CCcEEEEECCCceeCC
Confidence 9997 5789999999885543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.28 E-value=4.2e-11 Score=113.74 Aligned_cols=133 Identities=23% Similarity=0.270 Sum_probs=100.2
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEe-cc----hhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVM-DK----ASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i-~~----~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
..+++|+-+.+|++.+.+-. +.+|.= .| ..+...-...+..+|..+|.++.--.|..-+=++.+.+...|+||
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~--av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLP--AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeeccCcc--eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 35788999999999775433 555542 22 233333334566789999999876666665556667777789999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
|++|..|.+++... ...+++.|-.-+.-||..||||+||.++||++..++ +.++||||+.
T Consensus 80 ~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~ 139 (204)
T COG3642 80 YIEGELLKDALEEA---------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGE 139 (204)
T ss_pred EeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccc
Confidence 99999998887764 145567777778889999999999999999998654 9999999984
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.26 E-value=7e-11 Score=111.83 Aligned_cols=144 Identities=21% Similarity=0.232 Sum_probs=105.5
Q ss_pred EEEEEccCCcEEEEEEEEcCCceEEEEEE-----ecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 217 LLKKLGCGDIGSVYLSELTGTKCYFAMKV-----MDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 217 l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~-----i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.+..|-+|+-+.|+++.+.+. ...||. .+...+...-...+..+|..+|.++.--.|.--.-+|.+...-+|+
T Consensus 11 ~l~likQGAEArv~~~~~~Ge--~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGE--AAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeeccCCc--eeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 677888999999999988765 344443 3333333333445667899999988655555444456666667799
Q ss_pred EeecCC-CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC---cEEEeccccc
Q 007433 292 MEFCPG-GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG---HIMLSDFDLS 362 (604)
Q Consensus 292 ~E~~~g-gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g---~vkL~DFGla 362 (604)
|||++| .++.+++...-...-.......++.+|-+.|.-||.++|||+||..+||+|..+| .+.|+|||++
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls 163 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS 163 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence 999966 4777777665333333333377889999999999999999999999999998765 3589999998
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.22 E-value=4.8e-11 Score=117.46 Aligned_cols=138 Identities=21% Similarity=0.232 Sum_probs=104.0
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCC--CCccccceeEecC---CeeEEEEe
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH--PFLPTLYTHFETD---KFSCLVME 293 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~---~~~~lV~E 293 (604)
+.||.|.++.||++...+ +..|++|+....... .....+.+|.++++.+.+ .++++++.+.... +..|+|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 678999999999998754 468999998654321 122345679999999975 4467787776653 36789999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH----------------------------------------
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM---------------------------------------- 333 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~---------------------------------------- 333 (604)
|++|.+|...+.. ..+++.....++.+++.+|.+||+
T Consensus 81 ~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (223)
T cd05154 81 RVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM 157 (223)
T ss_pred EeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence 9999888764421 246667777777788888877773
Q ss_pred ----------------cCeEeccCCCCcEEEcc--CCcEEEeccccc
Q 007433 334 ----------------LGIVYRDLKPENVLVRE--DGHIMLSDFDLS 362 (604)
Q Consensus 334 ----------------~gIvHrDIKpeNILl~~--~g~vkL~DFGla 362 (604)
..+||+|+++.|||++. ++.+.|+||+.+
T Consensus 158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~ 204 (223)
T cd05154 158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELA 204 (223)
T ss_pred HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccc
Confidence 23699999999999998 667899999976
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.20 E-value=4.1e-10 Score=120.74 Aligned_cols=135 Identities=18% Similarity=0.169 Sum_probs=108.0
Q ss_pred CcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEe----cCCeeEEEEeecCC-CC
Q 007433 225 DIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFE----TDKFSCLVMEFCPG-GD 299 (604)
Q Consensus 225 ~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~----~~~~~~lV~E~~~g-gs 299 (604)
--.+.|++...-+|..|++|+++-.......+. ..-+++|+++.|.|||.+.++|. .+..++||++|.++ ++
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~---t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~T 364 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKD---TSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPT 364 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccccCcccc---hHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCch
Confidence 346789999999999999999954433222221 23568999999999999999997 35678999999865 56
Q ss_pred HHHHHHhc-------------CCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 300 LHTLRQRQ-------------PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 300 L~~ll~~~-------------~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
|.++--.. .+...+|..++.|+.||..||.++|+.|+.-+-|.|.+||+..+.+++|...|+.
T Consensus 365 L~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~ 440 (655)
T KOG3741|consen 365 LYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIM 440 (655)
T ss_pred HHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccce
Confidence 76653221 1235789999999999999999999999999999999999999889999877765
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2.4e-11 Score=134.24 Aligned_cols=168 Identities=20% Similarity=0.338 Sum_probs=119.2
Q ss_pred HHHHHHHHHHHHH-cCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCc
Q 007433 321 VAEVLLALEYLHM-LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSC 399 (604)
Q Consensus 321 ~~qil~aL~yLH~-~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 399 (604)
+.+++.||.|+|. .++||++|.|++|.++.+|..||+.|++.........+
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~---------------------------- 156 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEY---------------------------- 156 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCcc----------------------------
Confidence 3455599999996 58999999999999999999999999976332111000
Q ss_pred CCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHH
Q 007433 400 IQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGI 479 (604)
Q Consensus 400 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGv 479 (604)
|-.-|+++ .+.-..-...|.|||++.+...+.++|+|||||
T Consensus 157 -------p~~~yd~~--------------------------------lp~~~~~~~~f~apE~~~~~~~~~~sd~fSlG~ 197 (700)
T KOG2137|consen 157 -------PFSEYDPP--------------------------------LPLLLQPHLNFLAPEYLLGTTNTPASDVFSLGV 197 (700)
T ss_pred -------ccccCCCC--------------------------------CChhhccCcccccchhhccccccccccceeeee
Confidence 00000000 000112346799999999988899999999999
Q ss_pred HHHHHh-hCCCCCCCCChHHHHH--HHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCCh
Q 007433 480 FLYELL-FGKTPFKGSENRATLY--NVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNW 556 (604)
Q Consensus 480 iL~eLl-tG~~PF~~~~~~~~l~--~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~ 556 (604)
++|-+. .|+..|...+...... ....+-..+.....++.++++-|.++|..+..-||+ +.+++.-|||++..-
T Consensus 198 li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~----~~~l~~~~ff~D~~~ 273 (700)
T KOG2137|consen 198 LIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPT----LDLLLSIPFFSDPGL 273 (700)
T ss_pred EEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcc----hhhhhcccccCCchh
Confidence 999999 5666665543322221 112222334455679999999999999999999998 999999999987654
Q ss_pred hhh
Q 007433 557 ALI 559 (604)
Q Consensus 557 ~~~ 559 (604)
..+
T Consensus 274 ~aL 276 (700)
T KOG2137|consen 274 KAL 276 (700)
T ss_pred hhh
Confidence 433
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.08 E-value=2.5e-09 Score=109.70 Aligned_cols=133 Identities=16% Similarity=0.076 Sum_probs=95.1
Q ss_pred EEEEEEEcCCceEEEEEEecchhHHH-H-------HHHHHHHHHHHHHHhCCCCCc--cccceeEec-----CCeeEEEE
Q 007433 228 SVYLSELTGTKCYFAMKVMDKASLEK-R-------KKLLRAQTEREILQSLDHPFL--PTLYTHFET-----DKFSCLVM 292 (604)
Q Consensus 228 ~Vy~a~~~~~~~~vAiK~i~~~~~~~-~-------~~~~~~~~Ei~iL~~l~HpnI--v~l~~~~~~-----~~~~~lV~ 292 (604)
.|++... .|+.|.||......... . .....+.+|...+.+|..-+| ++++.+++. ....+|||
T Consensus 37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt 114 (268)
T PRK15123 37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT 114 (268)
T ss_pred eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence 3556554 34578888764332111 0 011136788888888854444 445556643 23578999
Q ss_pred eecCCC-CHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc-------CCcEEEeccccc
Q 007433 293 EFCPGG-DLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE-------DGHIMLSDFDLS 362 (604)
Q Consensus 293 E~~~gg-sL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~-------~g~vkL~DFGla 362 (604)
|++++. +|.+++........+......++.+|+..+.-||.+||+|+|+++.||||+. ++.+.|+||+.+
T Consensus 115 e~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 115 EDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred eeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 999775 8998876432244567778899999999999999999999999999999985 468999999976
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.07 E-value=8.5e-10 Score=107.11 Aligned_cols=127 Identities=25% Similarity=0.292 Sum_probs=84.3
Q ss_pred EEEEEEEcCCceEEEEEEecchh--HH---------------------HHHHHHHHHHHHHHHHhCCCC--CccccceeE
Q 007433 228 SVYLSELTGTKCYFAMKVMDKAS--LE---------------------KRKKLLRAQTEREILQSLDHP--FLPTLYTHF 282 (604)
Q Consensus 228 ~Vy~a~~~~~~~~vAiK~i~~~~--~~---------------------~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~~ 282 (604)
.||.|...+ +..+|||+.+... +. .......+.+|.++|.++..- ++++++.+.
T Consensus 1 ~Vy~~~~~~-~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAIDPD-GEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEECT-TEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEECCC-CCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 388888744 4589999986421 00 111234567899999999765 577877553
Q ss_pred ecCCeeEEEEeecC--CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHH-HHHcCeEeccCCCCcEEEccCCcEEEecc
Q 007433 283 ETDKFSCLVMEFCP--GGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEY-LHMLGIVYRDLKPENVLVREDGHIMLSDF 359 (604)
Q Consensus 283 ~~~~~~~lV~E~~~--ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~y-LH~~gIvHrDIKpeNILl~~~g~vkL~DF 359 (604)
.-+|||||++ |..+..+.... ++......++.+++..+.. +|..||||+||.+.|||++.+ .+.|+||
T Consensus 80 ----~~~ivME~I~~~G~~~~~l~~~~----~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf 150 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPLPRLKDVD----LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDF 150 (188)
T ss_dssp ----TTEEEEE--EETTEEGGCHHHCG----GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--G
T ss_pred ----CCEEEEEecCCCccchhhHHhcc----ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEec
Confidence 2369999997 66666554432 3345567778888886665 579999999999999999877 8999999
Q ss_pred ccccc
Q 007433 360 DLSLR 364 (604)
Q Consensus 360 Gla~~ 364 (604)
|.+..
T Consensus 151 ~qav~ 155 (188)
T PF01163_consen 151 GQAVD 155 (188)
T ss_dssp TTEEE
T ss_pred Cccee
Confidence 98854
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=2.7e-08 Score=98.14 Aligned_cols=103 Identities=30% Similarity=0.306 Sum_probs=83.4
Q ss_pred HHHHHHHHHHHhCCCCC--ccccceeEecC----CeeEEEEeecCC-CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHH
Q 007433 258 LRAQTEREILQSLDHPF--LPTLYTHFETD----KFSCLVMEFCPG-GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEY 330 (604)
Q Consensus 258 ~~~~~Ei~iL~~l~Hpn--Iv~l~~~~~~~----~~~~lV~E~~~g-gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~y 330 (604)
.++.+|...+..|..-. +++.+.+.+.. ...+||+|+++| .+|.+++.... .++......++.+++..+.-
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~--~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE--QLDPSQRRELLRALARLIAK 133 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc--ccchhhHHHHHHHHHHHHHH
Confidence 45677888887775433 55666666542 346899999987 48999888742 26777788999999999999
Q ss_pred HHHcCeEeccCCCCcEEEccCC---cEEEeccccc
Q 007433 331 LHMLGIVYRDLKPENVLVREDG---HIMLSDFDLS 362 (604)
Q Consensus 331 LH~~gIvHrDIKpeNILl~~~g---~vkL~DFGla 362 (604)
||++||+|+|+++.||||+.++ .+.|+||+.+
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~ 168 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRM 168 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhc
Confidence 9999999999999999999887 8999999976
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.78 E-value=3.5e-08 Score=99.20 Aligned_cols=136 Identities=28% Similarity=0.306 Sum_probs=102.0
Q ss_pred eEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchh--HHH----H-------------HHHHHHHHHHHHHHhCCCC--
Q 007433 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKAS--LEK----R-------------KKLLRAQTEREILQSLDHP-- 273 (604)
Q Consensus 215 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~--~~~----~-------------~~~~~~~~Ei~iL~~l~Hp-- 273 (604)
+.+...||-|--+.||.|.+. .+..+|||+-+... +.. + -....+++|.++|++|.-.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 456678999999999999987 45589999875321 110 0 1124567899999999655
Q ss_pred CccccceeEecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCc
Q 007433 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGH 353 (604)
Q Consensus 274 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~ 353 (604)
.|+..+++- ..++||||++|--|..+. +.......++..|+.-+.-+-..||||+|+.+=|||+++||.
T Consensus 172 ~VP~P~~~n----RHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~ 240 (304)
T COG0478 172 KVPKPIAWN----RHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGD 240 (304)
T ss_pred CCCCccccc----cceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCC
Confidence 788877653 456999999997776543 133445556667777776666899999999999999999999
Q ss_pred EEEeccccc
Q 007433 354 IMLSDFDLS 362 (604)
Q Consensus 354 vkL~DFGla 362 (604)
+.++||--+
T Consensus 241 ~~vIDwPQ~ 249 (304)
T COG0478 241 IVVIDWPQA 249 (304)
T ss_pred EEEEeCccc
Confidence 999999754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1e-07 Score=100.38 Aligned_cols=236 Identities=19% Similarity=0.232 Sum_probs=150.1
Q ss_pred EEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccc--------cceeEecCCe
Q 007433 217 LLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPT--------LYTHFETDKF 287 (604)
Q Consensus 217 l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~--------l~~~~~~~~~ 287 (604)
+.+.||+|+-+.+|-.-.-.+ -+.|++.+-...-.. .-++.|... .||-+-. |+|- .....
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa~~a------qk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~ 84 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPAAQA------QKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKV 84 (637)
T ss_pred CCccccCCccceeeecchhhc---hhheeecCCCchHHH------HHHHHhccCCCCcchhhhhcccHHHhhCC-Cccce
Confidence 346799999999996543332 245777665332211 122333333 5664332 2211 12234
Q ss_pred eEEEEeecCCCC-HHHHH----HhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 288 SCLVMEFCPGGD-LHTLR----QRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 288 ~~lV~E~~~ggs-L~~ll----~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
+.+.|..++|.. +..+. +++....+.|.-..++++.|+.+.+.||++|.+-+|+.++|+|+.+++.+.|.|-+-.
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 778899887642 22221 1222346789999999999999999999999999999999999999999999987633
Q ss_pred ccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccC
Q 007433 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442 (604)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (604)
..+. ..
T Consensus 165 qi~~-ng------------------------------------------------------------------------- 170 (637)
T COG4248 165 QINA-NG------------------------------------------------------------------------- 170 (637)
T ss_pred eecc-CC-------------------------------------------------------------------------
Confidence 1110 00
Q ss_pred CCCCcccccccCccccCcceec-----CCCCCccchHHHHHHHHHHHhhC-CCCCCCCC-------hHH-HHH------H
Q 007433 443 PTNARSMSFVGTHEYLAPEIIK-----GEGHGSAVDWWTFGIFLYELLFG-KTPFKGSE-------NRA-TLY------N 502 (604)
Q Consensus 443 ~~~~~~~~~~GT~~Y~APE~l~-----~~~~~~~~DiWSLGviL~eLltG-~~PF~~~~-------~~~-~l~------~ 502 (604)
.-...-+|..+|.+||.-. +..-+...|.|.|||+||+||.| +.||.|.. ..+ .+. .
T Consensus 171 ---~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya 247 (637)
T COG4248 171 ---TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYA 247 (637)
T ss_pred ---ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeec
Confidence 0011237899999999754 44456789999999999999987 99998742 111 110 0
Q ss_pred HHcCCCCC-----CCCCCCCHHHHHHHHHhhhc--CCCCccccc
Q 007433 503 VVGQPLRF-----PESPVVSFSARDLIKGLLVK--EPQNRLACR 539 (604)
Q Consensus 503 i~~~~~~~-----p~~~~~s~~l~dLI~~lL~~--dP~~Rpt~~ 539 (604)
-..+.... +....++++++-|..+|+.. ++.-||+.+
T Consensus 248 ~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~ 291 (637)
T COG4248 248 SDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAK 291 (637)
T ss_pred hhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHH
Confidence 00111111 11234678888898889864 366799853
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.65 E-value=2.5e-07 Score=90.86 Aligned_cols=139 Identities=17% Similarity=0.149 Sum_probs=100.2
Q ss_pred ccCCcEEEEEEEEcCCceEEEEEEecch---hHHHHHHHHHHHHHHHHHHhCCCCC--ccccceeEec-----CCeeEEE
Q 007433 222 GCGDIGSVYLSELTGTKCYFAMKVMDKA---SLEKRKKLLRAQTEREILQSLDHPF--LPTLYTHFET-----DKFSCLV 291 (604)
Q Consensus 222 G~G~fG~Vy~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~~~-----~~~~~lV 291 (604)
|.||.+-|++....+. .|=+|.-... .+.-......+.+|...|+.|..-+ +++.. ++.. ....+||
T Consensus 27 ~rgG~SgV~r~~~~g~--~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERNGK--KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeCCc--EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 6689999999876655 4667765311 1000112234567888888884332 55555 3331 2356899
Q ss_pred EeecCC-CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCc--EEEecccccc
Q 007433 292 MEFCPG-GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGH--IMLSDFDLSL 363 (604)
Q Consensus 292 ~E~~~g-gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~--vkL~DFGla~ 363 (604)
+|-+.| .+|.+++....-...++.....++.+|+..|.-||..|+.|+|+-+.|||++.+|. ++++||.-++
T Consensus 104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 998843 68888876654445677888899999999999999999999999999999987777 9999998664
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.64 E-value=9.5e-08 Score=106.01 Aligned_cols=141 Identities=25% Similarity=0.295 Sum_probs=88.2
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHH-------------------------------HHHHHH------H
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKR-------------------------------KKLLRA------Q 261 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~-------------------------------~~~~~~------~ 261 (604)
.-|+.++.|.||+|+... |+.||||+.+..-...- +...++ .
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 568999999999999986 78999999975421100 000011 1
Q ss_pred HHHHHHHhC-----CCCC--ccccceeEecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHH-HHHHHH
Q 007433 262 TEREILQSL-----DHPF--LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLA-LEYLHM 333 (604)
Q Consensus 262 ~Ei~iL~~l-----~Hpn--Iv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~a-L~yLH~ 333 (604)
+|..-+.++ +.++ |+++|. +-...-.|+|||++|.-+.++..... ..++...+ +..++.+ +..+-.
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~w--e~t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~i---a~~~~~~f~~q~~~ 283 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYW--EYTTRRVLTMEWIDGIKISDIAALKS-AGIDRKEL---AELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeeh--hccCCcEEEEEeeCCEecccHHHHHh-cCCCHHHH---HHHHHHHHHHHHHh
Confidence 233333333 1232 333332 22345679999999998888743221 23442222 2222222 233334
Q ss_pred cCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 334 LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 334 ~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
.|++|.|.+|.||+++.+|++.+.|||+..++.
T Consensus 284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred cCccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 899999999999999999999999999986654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.62 E-value=4.8e-07 Score=89.27 Aligned_cols=138 Identities=18% Similarity=0.225 Sum_probs=92.4
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHH------HHHHHHHHHhC---CCCCccccceeE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLR------AQTEREILQSL---DHPFLPTLYTHF 282 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~------~~~Ei~iL~~l---~HpnIv~l~~~~ 282 (604)
.++|.+++.+-......|.+-...+ ..+++|..+......+..+.. ..+++..+.++ .--.+..++-..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~~--~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEIDG--KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEECC--cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4789999999988887777776654 479999987543222222221 23344444444 222333333322
Q ss_pred e-----cCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEe
Q 007433 283 E-----TDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLS 357 (604)
Q Consensus 283 ~-----~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~ 357 (604)
+ -....+|||||++|..|.++.. +++ .+...|..+|.-||..|++|+|.+|.|++++.+ .++++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iI 176 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRII 176 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEE
Confidence 2 2245579999999998876532 233 244567788999999999999999999999855 59999
Q ss_pred ccccc
Q 007433 358 DFDLS 362 (604)
Q Consensus 358 DFGla 362 (604)
||+..
T Consensus 177 D~~~k 181 (229)
T PF06176_consen 177 DTQGK 181 (229)
T ss_pred ECccc
Confidence 99864
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=1.3e-08 Score=111.76 Aligned_cols=244 Identities=18% Similarity=0.179 Sum_probs=166.7
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCC-ccccceeEecCCeeEEEE
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF-LPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~~lV~ 292 (604)
.|...+.+++|+++++|+.+...+...+ .+++... ....-++++|.+++||| .+..++-++.+.+.+++|
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~ 313 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPM 313 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchhh
Confidence 4555566889999999999998888665 7877543 22335889999999999 777777777888999999
Q ss_pred eecCCC-CHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 293 EFCPGG-DLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 293 E~~~gg-sL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
++|.++ +....+... ...|.+-+...+.+.-+++|+|||+.-=+||| |||..+ +..++.||+....+...
T Consensus 314 ~i~s~~rs~~~~~~~s-e~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~--- 384 (829)
T KOG0576|consen 314 RICSTGRSSALEMTVS-EIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRT--- 384 (829)
T ss_pred hhhcCCccccccCChh-hHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcc---
Confidence 999777 222211111 12344445556677778999999998779999 888765 67899999865221100
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
....++
T Consensus 385 --------------------------------------------------------------------------~~~~t~ 390 (829)
T KOG0576|consen 385 --------------------------------------------------------------------------MKPRTA 390 (829)
T ss_pred --------------------------------------------------------------------------cccccC
Confidence 022356
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC---CCCCCHHHHHHHHHhh
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE---SPVVSFSARDLIKGLL 528 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~---~~~~s~~l~dLI~~lL 528 (604)
.+|+.++|||+.....+....|.|++|+--.+|.-|.+|-... ......+-..+..+.. ..+-...-+++...|+
T Consensus 391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P--~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~ 468 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSP--PAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCL 468 (829)
T ss_pred CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCC--ccccCCCCCCCCccccchhhhcCcccccCCccccc
Confidence 7999999999999999999999999998777777777765431 1111111001100000 0000111125778899
Q ss_pred hcCCCCcccccCCHHHHhcCCCCCCCC
Q 007433 529 VKEPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 529 ~~dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
...|..|+. ...++-|.+|++..
T Consensus 469 ~g~P~~pkv----~mgacfsKvfngCp 491 (829)
T KOG0576|consen 469 NGLPPTPKV----HMGACFSKVFNGCP 491 (829)
T ss_pred CCCCCCCcc----hhhHHHHHHhccCc
Confidence 999999998 89999999998753
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.44 E-value=3.1e-06 Score=84.56 Aligned_cols=137 Identities=24% Similarity=0.283 Sum_probs=94.4
Q ss_pred EEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHH---------------------HHHHHHHHHHHHHhCC--CCCcc
Q 007433 220 KLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRK---------------------KLLRAQTEREILQSLD--HPFLP 276 (604)
Q Consensus 220 ~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~---------------------~~~~~~~Ei~iL~~l~--HpnIv 276 (604)
.|..|--+.||+|.. +++..||+|++......... ...-..+|..-|+++. +-.++
T Consensus 55 ~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 55 CISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 566788888999976 45669999999654322111 1112345777777773 45667
Q ss_pred ccceeEecCCeeEEEEeecCCCCH--HHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH-cCeEeccCCCCcEEEccCCc
Q 007433 277 TLYTHFETDKFSCLVMEFCPGGDL--HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM-LGIVYRDLKPENVLVREDGH 353 (604)
Q Consensus 277 ~l~~~~~~~~~~~lV~E~~~ggsL--~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDIKpeNILl~~~g~ 353 (604)
+-+.++. -.|||||+ |... .-.|.. -.+....+..+..++++.+.-|-. .|+||+||..=|||+. +|.
T Consensus 134 ~Pi~~~~----nVLvMEfI-g~~g~pAP~LkD---v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~ 204 (268)
T COG1718 134 EPIAFRN----NVLVMEFI-GDDGLPAPRLKD---VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGE 204 (268)
T ss_pred CceeecC----CeEEEEec-cCCCCCCCCccc---CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCe
Confidence 7776653 46999999 4331 111111 123344678888899999988866 8999999999999999 889
Q ss_pred EEEeccccccccc
Q 007433 354 IMLSDFDLSLRCA 366 (604)
Q Consensus 354 vkL~DFGla~~~~ 366 (604)
+.|+|||-|....
T Consensus 205 p~iID~~QaV~~~ 217 (268)
T COG1718 205 PYIIDVSQAVTID 217 (268)
T ss_pred EEEEECccccccC
Confidence 9999999885443
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.6e-06 Score=85.40 Aligned_cols=133 Identities=12% Similarity=0.093 Sum_probs=83.2
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCC--ccccceeEecCCeeEEEEeecC
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF--LPTLYTHFETDKFSCLVMEFCP 296 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~ 296 (604)
..||.|..+.||+.. +..+++|+...... .....+|.++++.+..-. +++.+.+....+..++|||+++
T Consensus 7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~~-----~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TGKWMLKLYNPGFD-----KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEec----CCCEEEEeCCCCCC-----HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 578999999999842 33577898865331 123467999998886433 5778888878888899999998
Q ss_pred CCC-HH--------------HH-------HHhc--CCCCCcHHHHHHHHH----------HHHHH-HHHHHH----cCeE
Q 007433 297 GGD-LH--------------TL-------RQRQ--PGKYFSEQAVKFYVA----------EVLLA-LEYLHM----LGIV 337 (604)
Q Consensus 297 ggs-L~--------------~l-------l~~~--~~~~l~e~~~~~i~~----------qil~a-L~yLH~----~gIv 337 (604)
|.+ +. .. ++.. +...++.. ...+.. ++... ..+|.. ..++
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~-~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~ 156 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSY-KEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCL 156 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHH-HHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceE
Confidence 864 11 10 1111 11111111 011100 11111 222221 2479
Q ss_pred eccCCCCcEEEccCCcEEEeccccc
Q 007433 338 YRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 338 HrDIKpeNILl~~~g~vkL~DFGla 362 (604)
|+|+.|.||+++.++ +.|+||+.+
T Consensus 157 HgD~~~~Nii~~~~~-~~iIDwe~a 180 (226)
T TIGR02172 157 HGDFQIGNLITSGKG-TYWIDLGDF 180 (226)
T ss_pred ecCCCCCcEEEcCCC-cEEEechhc
Confidence 999999999999888 999999976
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.33 E-value=3.5e-06 Score=84.92 Aligned_cols=135 Identities=18% Similarity=0.139 Sum_probs=83.0
Q ss_pred EEccCCc-EEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEecCCeeEEEEeecCC
Q 007433 220 KLGCGDI-GSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFETDKFSCLVMEFCPG 297 (604)
Q Consensus 220 ~LG~G~f-G~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~g 297 (604)
.|-.|.+ ..||+....+ ..+.||+..... .....+|+++++.+. +--+++++++...++..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~~~--~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGKN--PGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCCC--CcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 3444555 7899997643 468889876542 123456888888873 44577888888777778999999999
Q ss_pred CCHHHHH-------------------HhcC--CCCCcHH--H-HHH---H-------------------HHHHHHHHHHH
Q 007433 298 GDLHTLR-------------------QRQP--GKYFSEQ--A-VKF---Y-------------------VAEVLLALEYL 331 (604)
Q Consensus 298 gsL~~ll-------------------~~~~--~~~l~e~--~-~~~---i-------------------~~qil~aL~yL 331 (604)
..|.... +..+ +..+... . ... . ..+++..|...
T Consensus 77 ~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 156 (244)
T cd05150 77 VPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEAT 156 (244)
T ss_pred ccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhh
Confidence 8776431 1111 1111100 0 000 0 11111111111
Q ss_pred ----HHcCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 332 ----HMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 332 ----H~~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
....++|+|+.|.|||++.++.+.|+||+.+
T Consensus 157 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a 191 (244)
T cd05150 157 RPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRL 191 (244)
T ss_pred CCCcCceEEECCCCCCccEEEeCCcEEEEEEcccc
Confidence 1234899999999999998877889999976
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.7e-05 Score=78.10 Aligned_cols=138 Identities=24% Similarity=0.362 Sum_probs=82.5
Q ss_pred EEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCC--CccccceeEe---cCCeeEEEE
Q 007433 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP--FLPTLYTHFE---TDKFSCLVM 292 (604)
Q Consensus 218 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~~~---~~~~~~lV~ 292 (604)
++.|+.|..+.||+....+ + .+++|+.... .....+.+|..+++.|... .+++++.+.. .....+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~-~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-G-RYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-S-EEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-c-EEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999999877 4 7899998655 1223455788888877433 3667776443 234579999
Q ss_pred eecCCCCHHH----------------HHH---hc--CCCCCcHHH---------HHHH------------HHHHHH-HHH
Q 007433 293 EFCPGGDLHT----------------LRQ---RQ--PGKYFSEQA---------VKFY------------VAEVLL-ALE 329 (604)
Q Consensus 293 E~~~ggsL~~----------------ll~---~~--~~~~l~e~~---------~~~i------------~~qil~-aL~ 329 (604)
++++|..+.. ++. .. ....+.... .... ...+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999988776 111 11 111111000 0000 111222 334
Q ss_pred HHHH-------cCeEeccCCCCcEEEc-cCCcEEEeccccc
Q 007433 330 YLHM-------LGIVYRDLKPENVLVR-EDGHIMLSDFDLS 362 (604)
Q Consensus 330 yLH~-------~gIvHrDIKpeNILl~-~~g~vkL~DFGla 362 (604)
.++. ..++|+|+.|.|||++ .++.+.|+||+.+
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a 195 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDA 195 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccc
Confidence 4432 4599999999999999 6777789999977
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.24 E-value=5.4e-06 Score=92.00 Aligned_cols=140 Identities=20% Similarity=0.247 Sum_probs=87.6
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHH---H-------------------------HHHHHHHH------HH
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEK---R-------------------------KKLLRAQT------ER 264 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~---~-------------------------~~~~~~~~------Ei 264 (604)
+-||.-+.|.||+|+.+. |+.||||+-+..-... . +....+.. |.
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 569999999999999988 8899999986431110 0 00011111 21
Q ss_pred H----HHHhCCCCC------ccccceeEecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHH-HHHHH
Q 007433 265 E----ILQSLDHPF------LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLAL-EYLHM 333 (604)
Q Consensus 265 ~----iL~~l~Hpn------Iv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL-~yLH~ 333 (604)
+ +.+.+.|-+ |+++|..+. ....|+||||+|.-+.++..-.. ..++...+. ..+.++. +-|=.
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~-~gi~~~~i~---~~l~~~~~~qIf~ 319 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDK-RGISPHDIL---NKLVEAYLEQIFK 319 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHH-cCCCHHHHH---HHHHHHHHHHHHh
Confidence 1 222334444 555554433 34679999999988776533221 235544333 3333322 22335
Q ss_pred cCeEeccCCCCcEEEcc----CCcEEEecccccccc
Q 007433 334 LGIVYRDLKPENVLVRE----DGHIMLSDFDLSLRC 365 (604)
Q Consensus 334 ~gIvHrDIKpeNILl~~----~g~vkL~DFGla~~~ 365 (604)
.|++|+|=+|.|||++. ++.+.|.|||+...+
T Consensus 320 ~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 320 TGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred cCCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 78999999999999994 668999999997544
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.20 E-value=1e-05 Score=95.95 Aligned_cols=81 Identities=17% Similarity=0.310 Sum_probs=56.1
Q ss_pred EEEEEccCCcEEEEEEEEcCCc--eEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCc--cccceeEecC---Cee
Q 007433 217 LLKKLGCGDIGSVYLSELTGTK--CYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFL--PTLYTHFETD---KFS 288 (604)
Q Consensus 217 l~~~LG~G~fG~Vy~a~~~~~~--~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnI--v~l~~~~~~~---~~~ 288 (604)
.++.|+.|.+..+|+......+ ..+++|+........ ....+.+|.++|+.|. |.+| ++++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 4678899999999998776542 357777764432111 1123557999999995 6665 7777776653 467
Q ss_pred EEEEeecCCCC
Q 007433 289 CLVMEFCPGGD 299 (604)
Q Consensus 289 ~lV~E~~~ggs 299 (604)
|+||||++|..
T Consensus 120 flVME~v~G~~ 130 (822)
T PLN02876 120 FYIMEYLEGRI 130 (822)
T ss_pred eEEEEecCCcc
Confidence 89999998764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.4e-05 Score=93.70 Aligned_cols=202 Identities=23% Similarity=0.278 Sum_probs=135.4
Q ss_pred HHHHHHHHHHHhCCCCCccccceeEecCCe----eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH
Q 007433 258 LRAQTEREILQSLDHPFLPTLYTHFETDKF----SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333 (604)
Q Consensus 258 ~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~----~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~ 333 (604)
.....|++.+.++.|+|++.++.|-..+.. ..+..|+|...++..+++.- ...+...++.+..+++.||.|+|+
T Consensus 227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHH
Confidence 334457778889999999999988754332 33556889999999888775 578889999999999999999999
Q ss_pred cCeEeccCCCC---cEEEccCCcEEEe--cccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCC
Q 007433 334 LGIVYRDLKPE---NVLVREDGHIMLS--DFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPT 408 (604)
Q Consensus 334 ~gIvHrDIKpe---NILl~~~g~vkL~--DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (604)
+...|.-|... +-.++.++.+.+. ||+....+...
T Consensus 305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~---------------------------------------- 344 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDN---------------------------------------- 344 (1351)
T ss_pred hccceeEEecccccccccCccceeecchhhhcccccCCCc----------------------------------------
Confidence 85444433333 2222333444444 66554222110
Q ss_pred ccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCcc--chHHHHHHHHHHHhh
Q 007433 409 TCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSA--VDWWTFGIFLYELLF 486 (604)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~--~DiWSLGviL~eLlt 486 (604)
....+..-+..|.++|......+..+ .|+|.+|..+..+..
T Consensus 345 -------------------------------------~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~ 387 (1351)
T KOG1035|consen 345 -------------------------------------EKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQ 387 (1351)
T ss_pred -------------------------------------ccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhh
Confidence 01112234456788888777665444 699999999999988
Q ss_pred CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 487 GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 487 G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
|..+-.. ......+.... ......+++.+|+.-+.++|+. +.+++.|+|...
T Consensus 388 ~~~i~~~---~~~~~~~l~~~--------~~~~~~d~~~~~~~~~~~~Rl~----~~~ll~~~f~~~ 439 (1351)
T KOG1035|consen 388 GEDISEK---SAVPVSLLDVL--------STSELLDALPKCLDEDSEERLS----ALELLTHPFLRF 439 (1351)
T ss_pred cCccccc---ccchhhhhccc--------cchhhhhhhhhhcchhhhhccc----hhhhhhchhccc
Confidence 7644221 11222222110 1116789999999999999999 999999999863
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.02 E-value=2.9e-05 Score=77.96 Aligned_cols=73 Identities=12% Similarity=0.156 Sum_probs=45.9
Q ss_pred EEEEccCCcE-EEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCC---CccccceeEecC---CeeEE
Q 007433 218 LKKLGCGDIG-SVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP---FLPTLYTHFETD---KFSCL 290 (604)
Q Consensus 218 ~~~LG~G~fG-~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hp---nIv~l~~~~~~~---~~~~l 290 (604)
++.|+.|+.. .||+.. ..+++|+...... ...+.+|.++|+.|... -++++++..... ...|+
T Consensus 2 ~~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~~-----~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~ 71 (235)
T cd05155 2 IEPVDSGGTDNATFRLG-----DDMSVRLPSAAGY-----AGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWS 71 (235)
T ss_pred ceeccCCCcccceEEcC-----CceEEEcCCccch-----HHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceE
Confidence 3567777776 599762 2467787654321 22466799999888532 355555544332 24589
Q ss_pred EEeecCCCCH
Q 007433 291 VMEFCPGGDL 300 (604)
Q Consensus 291 V~E~~~ggsL 300 (604)
|||+++|.++
T Consensus 72 l~~~i~G~~l 81 (235)
T cd05155 72 VYRWLEGETA 81 (235)
T ss_pred EEEeecCCCC
Confidence 9999999776
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.99 E-value=6.1e-05 Score=73.66 Aligned_cols=128 Identities=26% Similarity=0.322 Sum_probs=90.1
Q ss_pred cCeEEEEEEccCCc-EEEEEEEEcCCceEEEEEEecchh----------HHH--------HHHHHHHHHHHHHHHhC---
Q 007433 213 GHFRLLKKLGCGDI-GSVYLSELTGTKCYFAMKVMDKAS----------LEK--------RKKLLRAQTEREILQSL--- 270 (604)
Q Consensus 213 ~~y~l~~~LG~G~f-G~Vy~a~~~~~~~~vAiK~i~~~~----------~~~--------~~~~~~~~~Ei~iL~~l--- 270 (604)
.+++.++.||.|.- |.||+++..+. .||||++..-. ... ......+..|.+...+|
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~g~--~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEIDGR--IYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEECCe--EEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 68999999999999 99999998654 89999943210 000 01223455677776555
Q ss_pred CCCCc--cccceeEecC------------------CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHH
Q 007433 271 DHPFL--PTLYTHFETD------------------KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEY 330 (604)
Q Consensus 271 ~HpnI--v~l~~~~~~~------------------~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~y 330 (604)
++.++ |+++||+.-. ....||.||++... .+... -+.+|++-|..
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~----~~~~~~~dl~~ 179 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIR----DIPQMLRDLKI 179 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchh----HHHHHHHHHHH
Confidence 55667 8999988321 12467888875533 12222 24677888899
Q ss_pred HHHcCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 331 LHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 331 LH~~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
||..||+-+|+++.|.. + -+|+|||.+
T Consensus 180 ~~k~gI~~~Dv~~~ny~---~--G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLGIVPRDVKPRNYR---G--GKLVDFSSS 206 (207)
T ss_pred HHHCCeeeccCcccccc---C--CEEEecccC
Confidence 99999999999999987 2 488999854
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.0001 Score=72.29 Aligned_cols=130 Identities=22% Similarity=0.301 Sum_probs=89.2
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHH-------------HHHHHHHHHHHHHHHhCC------CCCccccc
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEK-------------RKKLLRAQTEREILQSLD------HPFLPTLY 279 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~-------------~~~~~~~~~Ei~iL~~l~------HpnIv~l~ 279 (604)
..||.|+.=.||.--+.. ..+||++....... ........+|+.-...+. +.+|.++|
T Consensus 7 ~~i~~G~~R~cy~HP~dp---~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 7 DLIAQGGERDCYQHPDDP---NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred cccccCCCceEEECCCCC---CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 468999999999643333 46899987765000 011233445665555554 78899999
Q ss_pred eeEecCCeeEEEEeecCC------CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC-
Q 007433 280 THFETDKFSCLVMEFCPG------GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG- 352 (604)
Q Consensus 280 ~~~~~~~~~~lV~E~~~g------gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g- 352 (604)
|+.+++.-..+|+|.+.+ .+|.+++... .+++ ... ..+-+-.+||-+++|+.+||+|.||++...+
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~ 156 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDS 156 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCC
Confidence 999999999999998633 3567777543 4655 332 3334456788999999999999999997533
Q ss_pred ---cEEEec
Q 007433 353 ---HIMLSD 358 (604)
Q Consensus 353 ---~vkL~D 358 (604)
.+.|+|
T Consensus 157 ~~~~lvlID 165 (199)
T PF10707_consen 157 GEFRLVLID 165 (199)
T ss_pred CceEEEEEe
Confidence 477777
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00028 Score=73.68 Aligned_cols=78 Identities=15% Similarity=0.020 Sum_probs=54.7
Q ss_pred EEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCC---CCccccceeEec---CCeeE
Q 007433 216 RLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH---PFLPTLYTHFET---DKFSC 289 (604)
Q Consensus 216 ~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~H---pnIv~l~~~~~~---~~~~~ 289 (604)
.-.+.||.|..+.||+....+. .+.+|+...... ...+..|.+.|+.|.- -.|+++++++.. .+..+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~--~~~~k~~~~~~~-----~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQG--NPMPLMARSFST-----PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEcCCC--CEEEEEeccccc-----chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 3456799999999999865443 466787532111 1245578888888843 468888887754 36689
Q ss_pred EEEeecCCCCH
Q 007433 290 LVMEFCPGGDL 300 (604)
Q Consensus 290 lV~E~~~ggsL 300 (604)
||||+++|+.+
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999988754
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00011 Score=70.11 Aligned_cols=130 Identities=28% Similarity=0.337 Sum_probs=89.6
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCc-cccceeEecCCeeEEEE
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFL-PTLYTHFETDKFSCLVM 292 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV~ 292 (604)
.-++.+.||.|.+|.||++.+.+. .+|+|+-+.+... ..+..|.++|..+.-.++ +++|.+.++ ++.|
T Consensus 23 ~~~v~~~L~KG~~s~Vyl~~~~~~--~~a~Kvrr~ds~r-----~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~m 91 (201)
T COG2112 23 ELRVEKELAKGTTSVVYLGEWRGG--EVALKVRRRDSPR-----RNLEKEAKILEILAGEGVTPEVYFYGED----FIRM 91 (201)
T ss_pred hhhhhhhhhcccccEEEEeeccCc--eEEEEEecCCcch-----hhHHHHHHHHHHhhhcCCCceEEEechh----hhhh
Confidence 344567899999999999999765 7999997665332 245679999999876655 456655432 3569
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCC-CCcEEEccCCcEEEecccccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLK-PENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIK-peNILl~~~g~vkL~DFGla~ 363 (604)
||+.|..|..+-... .. +-+..+++.---|-..||-|+.|. |..++|-.++.+.|+||.-|.
T Consensus 92 e~i~G~~L~~~~~~~-----~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At 154 (201)
T COG2112 92 EYIDGRPLGKLEIGG-----DR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT 154 (201)
T ss_pred hhhcCcchhhhhhcc-----cH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence 999998887754321 12 223345555444556789998885 455555556699999999874
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00017 Score=71.99 Aligned_cols=75 Identities=21% Similarity=0.348 Sum_probs=49.1
Q ss_pred EEEEccCCcEEEEEEEEcC-CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCC-CCccccceeEecCCeeEEEEeec
Q 007433 218 LKKLGCGDIGSVYLSELTG-TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH-PFLPTLYTHFETDKFSCLVMEFC 295 (604)
Q Consensus 218 ~~~LG~G~fG~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~lV~E~~ 295 (604)
++.|..|-...||+..... .+..|++|+...... ......+|+.+++.+.. -..++++..+.. .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEee
Confidence 4678888889999997654 345788998754311 11122368888888843 334566554432 3899999
Q ss_pred CCCCH
Q 007433 296 PGGDL 300 (604)
Q Consensus 296 ~ggsL 300 (604)
+|.++
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.76 E-value=8.2e-05 Score=72.44 Aligned_cols=97 Identities=24% Similarity=0.233 Sum_probs=78.4
Q ss_pred HHHHHHHHhCCC-CCccccceeEecCCeeEEEEeecCCCCHHHH---HHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---
Q 007433 261 QTEREILQSLDH-PFLPTLYTHFETDKFSCLVMEFCPGGDLHTL---RQRQPGKYFSEQAVKFYVAEVLLALEYLHM--- 333 (604)
Q Consensus 261 ~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~l---l~~~~~~~l~e~~~~~i~~qil~aL~yLH~--- 333 (604)
..|.-+|+.+.+ +++++++|++- .++|.||...+++... +... ...+|..+..|+.++++.+++|+.
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~~~~ 80 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDHGPL 80 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence 358888898876 69999999983 2579999977766432 1111 246899999999999999999987
Q ss_pred cCeEeccCCCCcEEEccCCcEEEecccccc
Q 007433 334 LGIVYRDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 334 ~gIvHrDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
..+.-.|++++|+.++.+|++|++|.+.+.
T Consensus 81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~ 110 (188)
T PF12260_consen 81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVF 110 (188)
T ss_pred CcEEEeecchHHeEEeCCCcEEEEechhcc
Confidence 458889999999999999999999999763
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.73 E-value=6.6e-06 Score=97.99 Aligned_cols=252 Identities=13% Similarity=0.020 Sum_probs=160.6
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCc-eEEEEEEecchhHHH--HHHHHHHHHHHHHHHhCCCCCccccceeEe--cCC
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTK-CYFAMKVMDKASLEK--RKKLLRAQTEREILQSLDHPFLPTLYTHFE--TDK 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~-~~vAiK~i~~~~~~~--~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~--~~~ 286 (604)
..+|++.--+|-|.+ +++.+.+.. ..|.+|+.....+.. +...+....|+.-++...|+++...+.-.. ...
T Consensus 1228 ~e~~EV~l~i~~~~~---~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ 1304 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFH---FRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSEST 1304 (2724)
T ss_pred hhhhheeeeccccee---eccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCCh
Confidence 355665555555544 344443221 246777765543332 122234445666677788998887666554 345
Q ss_pred eeEEEEeecCCCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHc-----CeEeccCCCCcEEEccCCcEEEecc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPG--KYFSEQAVKFYVAEVLLALEYLHML-----GIVYRDLKPENVLVREDGHIMLSDF 359 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~--~~l~e~~~~~i~~qil~aL~yLH~~-----gIvHrDIKpeNILl~~~g~vkL~DF 359 (604)
..|.+++||.+|.+++++-+.-. ..+.+.-+.....+.+.+..-+|.. -.+|++||+-|.+|..+..+++.++
T Consensus 1305 ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~ 1384 (2724)
T KOG1826|consen 1305 EEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKG 1384 (2724)
T ss_pred HHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCccccccc
Confidence 67899999999999998765422 2344555555555557888887764 2799999999999999999999999
Q ss_pred cccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccc
Q 007433 360 DLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPEL 439 (604)
Q Consensus 360 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (604)
|+.+.. ++
T Consensus 1385 gLdKIk-------------------np----------------------------------------------------- 1392 (2724)
T KOG1826|consen 1385 GLDKIK-------------------NP----------------------------------------------------- 1392 (2724)
T ss_pred cccccc-------------------Cc-----------------------------------------------------
Confidence 997410 00
Q ss_pred ccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC----CCCCCC
Q 007433 440 IAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR----FPESPV 515 (604)
Q Consensus 440 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~----~p~~~~ 515 (604)
........++++.|+.+++...-.++.++|+|..|+-+|++..|..+|.. .+..+.++..+ +.....
T Consensus 1393 ----~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~-----flq~~Lkgiidn~tf~sIe~l 1463 (2724)
T KOG1826|consen 1393 ----VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIF-----FLQPALKGIIDNHTFFSIEKL 1463 (2724)
T ss_pred ----hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHH-----HHHHHHcCccccccccccccc
Confidence 00111245688899999998888888889999999999999998887753 22223332221 111112
Q ss_pred CCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 516 VSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 516 ~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
.+.++-.+...+|-+.-.+||. -...+.-+.|
T Consensus 1464 ~pgdaNve~~~~Ll~K~~~rp~----q~isls~d~~ 1495 (2724)
T KOG1826|consen 1464 KPGDANVEALHRLLWKYMERPG----QYISLSRDHF 1495 (2724)
T ss_pred CCCcccHHHHHHHHHHhhhcch----hhhhcccccc
Confidence 2344444445555555667887 5666665555
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00071 Score=73.27 Aligned_cols=81 Identities=21% Similarity=0.206 Sum_probs=55.3
Q ss_pred EEEEEccCCcEEEEEEEEcCCceEEEEEEecchhH---HH-HHHHHHHHHHHHHHHhCC---CCCccccceeEecCCeeE
Q 007433 217 LLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASL---EK-RKKLLRAQTEREILQSLD---HPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 217 l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~---~~-~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~ 289 (604)
-.+.||.|.+..||++.+.+.++.|+||.-..... .. .....+...|.+.|+.+. -.+++++|.+ +....+
T Consensus 30 ~~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~ 107 (401)
T PRK09550 30 TAREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAV 107 (401)
T ss_pred eeeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCE
Confidence 35789999999999999876546799998531100 00 112345667888888762 3468888876 345578
Q ss_pred EEEeecCCCC
Q 007433 290 LVMEFCPGGD 299 (604)
Q Consensus 290 lV~E~~~ggs 299 (604)
+||||+++..
T Consensus 108 lVME~L~~~~ 117 (401)
T PRK09550 108 TVMEDLSDHK 117 (401)
T ss_pred EEEecCCCcc
Confidence 9999997643
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.00061 Score=71.27 Aligned_cols=142 Identities=20% Similarity=0.181 Sum_probs=82.1
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCC--CccccceeE------ecC
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP--FLPTLYTHF------ETD 285 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~~------~~~ 285 (604)
....++.|+.|....||+.... ++ .+++|+....... ..+..|++++..|... .+++++... ..+
T Consensus 23 ~~~~i~~~~~G~~n~~y~v~t~-~~-~~vLK~~~~~~~~-----~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~ 95 (307)
T TIGR00938 23 ELLSLKGIAEGVENSNYLLTTD-VG-RYILTLYEKRVKA-----EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLA 95 (307)
T ss_pred CceeccccCCccccceEEEEeC-CC-cEEEEEecCCCCH-----HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcC
Confidence 3445677888888899998653 34 5778987553111 1233466777666322 244444321 224
Q ss_pred CeeEEEEeecCCCCHH-----------HH---HHhcCCC---------CCc-HHH--HH----------HHHHHHHHHHH
Q 007433 286 KFSCLVMEFCPGGDLH-----------TL---RQRQPGK---------YFS-EQA--VK----------FYVAEVLLALE 329 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~-----------~l---l~~~~~~---------~l~-e~~--~~----------~i~~qil~aL~ 329 (604)
+..++||||++|..+. .. ++..... .+. +.. .. .....+...++
T Consensus 96 g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~ 175 (307)
T TIGR00938 96 GKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELD 175 (307)
T ss_pred CeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHH
Confidence 5678999999885531 11 1110000 011 000 00 01122334555
Q ss_pred HHHH-------cCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 330 YLHM-------LGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 330 yLH~-------~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
++.. .++||+|+++.||+++.++.+.|+||+.+
T Consensus 176 ~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 176 YLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFA 215 (307)
T ss_pred HHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccc
Confidence 5542 68999999999999998887789999976
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.57 E-value=0.00033 Score=72.95 Aligned_cols=76 Identities=22% Similarity=0.331 Sum_probs=49.1
Q ss_pred EEEEccCCcEEEEEEEEcC------CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCC-CccccceeEecCCeeEE
Q 007433 218 LKKLGCGDIGSVYLSELTG------TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP-FLPTLYTHFETDKFSCL 290 (604)
Q Consensus 218 ~~~LG~G~fG~Vy~a~~~~------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hp-nIv~l~~~~~~~~~~~l 290 (604)
++.|..|-...||+..... .++.|++|+...... ......+|.++++.+... -.++++.++.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 3556677778899887654 256788999765421 112335688888887432 34566666642 36
Q ss_pred EEeecCCCCHH
Q 007433 291 VMEFCPGGDLH 301 (604)
Q Consensus 291 V~E~~~ggsL~ 301 (604)
||||++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999887663
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00016 Score=74.81 Aligned_cols=135 Identities=21% Similarity=0.291 Sum_probs=95.0
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHH------HH-----------HH--HHHHHHHHHHHHhCC-C-
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLE------KR-----------KK--LLRAQTEREILQSLD-H- 272 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~------~~-----------~~--~~~~~~Ei~iL~~l~-H- 272 (604)
-+.+...||-|--+.||.+-+.. |..+++|+-+..... .+ .. ...+.+|...|+.|. |
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~-G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEE-GNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEecCC-CCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 35677889999999999998764 447888875432111 11 11 134568888898884 3
Q ss_pred CCccccceeEecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC
Q 007433 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG 352 (604)
Q Consensus 273 pnIv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g 352 (604)
--|++.+++ +..|+|||++.|..|..+.+.. . +..+...+..-+--|-.+|+||+|+.-=||+|.+++
T Consensus 172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v~-----d---~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~ 239 (465)
T KOG2268|consen 172 FPVPKPIDH----NRHCVVMELVDGYPLRQVRHVE-----D---PPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDD 239 (465)
T ss_pred CCCCCcccc----cceeeHHHhhcccceeeeeecC-----C---hHHHHHHHHHHHHHHHHcCceecccchheeEEecCC
Confidence 235666554 3568999999998887654322 2 233344455556668889999999999999999999
Q ss_pred cEEEecccc
Q 007433 353 HIMLSDFDL 361 (604)
Q Consensus 353 ~vkL~DFGl 361 (604)
.++++||--
T Consensus 240 ~i~vIDFPQ 248 (465)
T KOG2268|consen 240 KIVVIDFPQ 248 (465)
T ss_pred CEEEeechH
Confidence 999999964
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.44 E-value=0.0013 Score=68.12 Aligned_cols=139 Identities=19% Similarity=0.182 Sum_probs=82.6
Q ss_pred EEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCC--Ccccccee------EecCCe
Q 007433 216 RLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP--FLPTLYTH------FETDKF 287 (604)
Q Consensus 216 ~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~------~~~~~~ 287 (604)
.-++.|..|....+|+....+ + .+++|+..... ...+..|+++++.|.+. .+++++.. ...++.
T Consensus 17 ~~i~~i~~G~~n~~y~v~~~~-~-~~vLr~~~~~~------~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~ 88 (296)
T cd05153 17 LSFEGISAGIENTNYFVTTDS-G-RYVLTLFEKVS------AEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGK 88 (296)
T ss_pred hheecccCccccceEEEEeCC-C-cEEEEEcCCCC------hHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCc
Confidence 336678888888999986543 3 68889886421 12344577777777432 24554432 233456
Q ss_pred eEEEEeecCCCCHHH--------H------HHhc----CC-----CCCcHHHH--H--------HHHHHHHHHHHHHHH-
Q 007433 288 SCLVMEFCPGGDLHT--------L------RQRQ----PG-----KYFSEQAV--K--------FYVAEVLLALEYLHM- 333 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~--------l------l~~~----~~-----~~l~e~~~--~--------~i~~qil~aL~yLH~- 333 (604)
.++||+|++|..+.. + ++.. .. ....+... . .....+..++.++..
T Consensus 89 ~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~ 168 (296)
T cd05153 89 PAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAF 168 (296)
T ss_pred eEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhh
Confidence 789999999876521 1 1110 00 00111100 0 011122334444443
Q ss_pred ------cCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 334 ------LGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 334 ------~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
.++||+|+.|.|||++.++.+.|+||+.+
T Consensus 169 ~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a 203 (296)
T cd05153 169 DPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFA 203 (296)
T ss_pred hhhcCCCcCCccCcCcccEEEeCCceEEEeehhhh
Confidence 47999999999999998877799999976
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0021 Score=67.44 Aligned_cols=137 Identities=17% Similarity=0.177 Sum_probs=74.3
Q ss_pred EEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCC--Cccccce------eEecCCeeE
Q 007433 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP--FLPTLYT------HFETDKFSC 289 (604)
Q Consensus 218 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~------~~~~~~~~~ 289 (604)
++.|+.|....+|+....+ + .+++|++.... .. .+..|+.+++.|... .+++.+. +....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t~~-g-~~vLK~~~~~~---~~---~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQ-G-EYVLTLFERLT---AE---DLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEeCC-C-cEEEEEeccCC---hH---HhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 4567778888999987543 3 58899885211 11 122355555555321 2444442 122355678
Q ss_pred EEEeecCCCCHH-----------HHHHh---cC-C--------CCCcH-HH-HH-----------HHHHH-HHHHHHHHH
Q 007433 290 LVMEFCPGGDLH-----------TLRQR---QP-G--------KYFSE-QA-VK-----------FYVAE-VLLALEYLH 332 (604)
Q Consensus 290 lV~E~~~ggsL~-----------~ll~~---~~-~--------~~l~e-~~-~~-----------~i~~q-il~aL~yLH 332 (604)
++|||++|..+. ..+.+ .. + ..+.+ .. .. ..+.+ +...++.+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 999999887431 11111 00 0 01111 00 00 11111 111122222
Q ss_pred -------HcCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 333 -------MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 333 -------~~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
..|+||+|++|.|||++.+...-|+||+.+
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~ 215 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFA 215 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECCceEEEEecccc
Confidence 247999999999999986655689999976
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0013 Score=66.80 Aligned_cols=132 Identities=22% Similarity=0.246 Sum_probs=75.6
Q ss_pred EccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCC-ccccceeEecCCeeEEEEeecCCCC
Q 007433 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF-LPTLYTHFETDKFSCLVMEFCPGGD 299 (604)
Q Consensus 221 LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~~lV~E~~~ggs 299 (604)
+..|-...+|+... ++..+++|+...... ..-....+|.++|+.+.... .++++.... -++||||++|..
T Consensus 4 ~~~G~tn~~y~~~~--~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~ 74 (256)
T TIGR02721 4 LSGGLTNRSWRIEH--PGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEV 74 (256)
T ss_pred CCCcCcCCeEEEEe--CCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcc
Confidence 45677788998873 344678887654311 10012346888888885433 355555432 368999998866
Q ss_pred HHH--------------HHHh---cC--CCCCcH-HHHHHHHHHH---------HHHHHHHHH--------cCeEeccCC
Q 007433 300 LHT--------------LRQR---QP--GKYFSE-QAVKFYVAEV---------LLALEYLHM--------LGIVYRDLK 342 (604)
Q Consensus 300 L~~--------------ll~~---~~--~~~l~e-~~~~~i~~qi---------l~aL~yLH~--------~gIvHrDIK 342 (604)
+.. .+.+ .+ +..+.. ..+..+..++ ...++.+-. ..++|+|+.
T Consensus 75 ~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~ 154 (256)
T TIGR02721 75 ITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVH 154 (256)
T ss_pred cccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCC
Confidence 531 1111 11 112221 1222222222 111222211 248999999
Q ss_pred CCcEEEccCCcEEEeccccc
Q 007433 343 PENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 343 peNILl~~~g~vkL~DFGla 362 (604)
|.|||++.++ +.|+||+.+
T Consensus 155 ~~Nil~~~~~-~~lIDwE~a 173 (256)
T TIGR02721 155 AYNLVVTPQG-LKLIDWEYA 173 (256)
T ss_pred cCcEEEeCCC-CEEEecccc
Confidence 9999999877 789999977
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.00 E-value=0.0034 Score=66.53 Aligned_cols=137 Identities=12% Similarity=0.176 Sum_probs=79.8
Q ss_pred EEEEccCCcEEEEEEEEcCC---ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCc-cccceeEecCCeeEEEEe
Q 007433 218 LKKLGCGDIGSVYLSELTGT---KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFL-PTLYTHFETDKFSCLVME 293 (604)
Q Consensus 218 ~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV~E 293 (604)
++.|..|=.-.+|+....+. +..|.+|+...... ......+|..+++.+..-++ +++++++..+ +|.+
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~----~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~ 90 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD----YVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQS 90 (330)
T ss_pred EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC----eEechHHHHHHHHHHHhcCCCCceeEEeCCc----Eeeh
Confidence 34455577778898875542 23688998765321 11223468889988865444 5677666433 5899
Q ss_pred ecCCCCHHH--------------HHHhcCC-----C-CC-cHHHHHHHHHHH----------------------HHHHHH
Q 007433 294 FCPGGDLHT--------------LRQRQPG-----K-YF-SEQAVKFYVAEV----------------------LLALEY 330 (604)
Q Consensus 294 ~~~ggsL~~--------------ll~~~~~-----~-~l-~e~~~~~i~~qi----------------------l~aL~y 330 (604)
|++|..|.. .+.+... . .+ -+..+..+..++ ..-+..
T Consensus 91 fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 170 (330)
T PLN02421 91 FINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVE 170 (330)
T ss_pred hhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHH
Confidence 998776521 1111111 1 11 133333333222 111222
Q ss_pred HH----Hc----CeEeccCCCCcEEEcc-CCcEEEeccccc
Q 007433 331 LH----ML----GIVYRDLKPENVLVRE-DGHIMLSDFDLS 362 (604)
Q Consensus 331 LH----~~----gIvHrDIKpeNILl~~-~g~vkL~DFGla 362 (604)
+. .. -++|.|+.+.|||++. ++.++|+||+.|
T Consensus 171 l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYa 211 (330)
T PLN02421 171 LKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYG 211 (330)
T ss_pred HHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEccccc
Confidence 21 11 2799999999999975 578999999977
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.97 E-value=0.0075 Score=62.34 Aligned_cols=28 Identities=32% Similarity=0.489 Sum_probs=24.2
Q ss_pred CeEeccCCCCcEEEccCCc-EEEeccccc
Q 007433 335 GIVYRDLKPENVLVREDGH-IMLSDFDLS 362 (604)
Q Consensus 335 gIvHrDIKpeNILl~~~g~-vkL~DFGla 362 (604)
.+||+|+++.|||++.++. .-|+||+.+
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a 214 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEA 214 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhc
Confidence 4899999999999997565 569999977
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.89 E-value=0.0052 Score=65.58 Aligned_cols=140 Identities=16% Similarity=0.199 Sum_probs=83.9
Q ss_pred eEEEEEEccCCcEEEEEEEEcC----CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCC-ccccceeEecCCeeE
Q 007433 215 FRLLKKLGCGDIGSVYLSELTG----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF-LPTLYTHFETDKFSC 289 (604)
Q Consensus 215 y~l~~~LG~G~fG~Vy~a~~~~----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~~ 289 (604)
..-++.|-.|-.-.+|++.... .++.|++|+..... ...+.+ .+|..+++.+..-+ -++++++|..+
T Consensus 38 ~~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~idR-~~E~~~~~~l~~~gl~P~~~~~~~~g---- 109 (344)
T PLN02236 38 ALQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFDR-DDEIRTFECMSRHGQGPRLLGRFPNG---- 109 (344)
T ss_pred cEEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeech-HHHHHHHHHHHHcCCCCceEEEECCc----
Confidence 3344566668888999987532 23678899886542 122222 56888988885433 45677776543
Q ss_pred EEEeecCCCCHHHH--------------HHhc-----CCC--CCcHHHHHHHHHHH-----------------HHHHHHH
Q 007433 290 LVMEFCPGGDLHTL--------------RQRQ-----PGK--YFSEQAVKFYVAEV-----------------LLALEYL 331 (604)
Q Consensus 290 lV~E~~~ggsL~~l--------------l~~~-----~~~--~l~e~~~~~i~~qi-----------------l~aL~yL 331 (604)
.|+||++|.+|... +.+. ++. ...+..+..++.++ ...+..|
T Consensus 110 ~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L 189 (344)
T PLN02236 110 RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLL 189 (344)
T ss_pred eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHH
Confidence 58999988776311 1111 111 11233333333222 1111122
Q ss_pred ----H----HcCeEeccCCCCcEEEcc-CCcEEEeccccc
Q 007433 332 ----H----MLGIVYRDLKPENVLVRE-DGHIMLSDFDLS 362 (604)
Q Consensus 332 ----H----~~gIvHrDIKpeNILl~~-~g~vkL~DFGla 362 (604)
. ...++|+|+++.|||+++ ++.+.|+||..+
T Consensus 190 ~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya 229 (344)
T PLN02236 190 EKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYA 229 (344)
T ss_pred HHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhc
Confidence 1 235899999999999986 468999999987
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.0081 Score=64.07 Aligned_cols=76 Identities=18% Similarity=0.146 Sum_probs=49.6
Q ss_pred EEccCCcEEEEEEEEcCCceEEEEEEecchhHH---H-HHHHHHHHHHHHHHHhCC--CC-CccccceeEecCCeeEEEE
Q 007433 220 KLGCGDIGSVYLSELTGTKCYFAMKVMDKASLE---K-RKKLLRAQTEREILQSLD--HP-FLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 220 ~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~---~-~~~~~~~~~Ei~iL~~l~--Hp-nIv~l~~~~~~~~~~~lV~ 292 (604)
.||.|....||++.+.+.++-|+||.-....-. . .....|...|.+.|+... -| +++++|. .+.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 579999999999998654467999875422110 0 123445667888887763 23 4666653 3445566999
Q ss_pred eecCC
Q 007433 293 EFCPG 297 (604)
Q Consensus 293 E~~~g 297 (604)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99954
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.015 Score=61.52 Aligned_cols=136 Identities=24% Similarity=0.282 Sum_probs=89.9
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhH--HH-------------------HHHH--HHHHHHHHHHHhCCCCCc
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASL--EK-------------------RKKL--LRAQTEREILQSLDHPFL 275 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~--~~-------------------~~~~--~~~~~Ei~iL~~l~HpnI 275 (604)
..|..|--+-||.|.... |..||||++.-.-+ .. ..++ ..+.+|+.-|++|+.-.|
T Consensus 150 GCiSTGKEANVYHat~~d-G~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGI 228 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEED-GSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGI 228 (520)
T ss_pred cccccCccceeEeeecCC-CceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCC
Confidence 346668888899987654 55699999853211 00 1122 233467777888865554
Q ss_pred cccceeEecCCeeEEEEeecCCCCHHH--HHHhcCCCCCcHHHHHHHHHHHHHHHHHH-HHcCeEeccCCCCcEEEccCC
Q 007433 276 PTLYTHFETDKFSCLVMEFCPGGDLHT--LRQRQPGKYFSEQAVKFYVAEVLLALEYL-HMLGIVYRDLKPENVLVREDG 352 (604)
Q Consensus 276 v~l~~~~~~~~~~~lV~E~~~ggsL~~--ll~~~~~~~l~e~~~~~i~~qil~aL~yL-H~~gIvHrDIKpeNILl~~~g 352 (604)
+----+.. ....|||+|+ |.+=.. .++. ..++...+..+-.|++.-+.-| |.+++||.||.-=|+|+. +|
T Consensus 229 P~PePIlL--k~hVLVM~Fl-Grdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG 301 (520)
T KOG2270|consen 229 PCPEPILL--KNHVLVMEFL-GRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DG 301 (520)
T ss_pred CCCCceee--ecceEeeeec-cCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CC
Confidence 32221111 1235999999 433221 1222 3577778888888998888877 568999999999999994 78
Q ss_pred cEEEeccccc
Q 007433 353 HIMLSDFDLS 362 (604)
Q Consensus 353 ~vkL~DFGla 362 (604)
.+.|+|-+-+
T Consensus 302 ~lyiIDVSQS 311 (520)
T KOG2270|consen 302 KLYIIDVSQS 311 (520)
T ss_pred EEEEEEcccc
Confidence 9999999866
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.69 E-value=0.0019 Score=70.63 Aligned_cols=81 Identities=21% Similarity=0.201 Sum_probs=57.3
Q ss_pred ccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC----------CCCCCHHHHHHHHHhhhcCCCCccccc
Q 007433 470 SAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE----------SPVVSFSARDLIKGLLVKEPQNRLACR 539 (604)
Q Consensus 470 ~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~----------~~~~s~~l~dLI~~lL~~dP~~Rpt~~ 539 (604)
+++|||++|.++.|+..|...|....+.+.+..+..-...... .-.++....++..+|+-..|..||.
T Consensus 110 pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l-- 187 (725)
T KOG1093|consen 110 PKSDVWSLGFIILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPL-- 187 (725)
T ss_pred cchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccc--
Confidence 4899999999999999999888766555544433321100000 0114455678999999999999998
Q ss_pred CCHHHHhcCCCCCCC
Q 007433 540 RGATEIKQHPFFQGV 554 (604)
Q Consensus 540 ~~a~elL~Hpff~~~ 554 (604)
..++.+|+-|.++
T Consensus 188 --~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 188 --PMELSKRCSFTEV 200 (725)
T ss_pred --hhHHhcCccHHHH
Confidence 8888888888654
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.041 Score=57.22 Aligned_cols=28 Identities=25% Similarity=0.532 Sum_probs=25.0
Q ss_pred cCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 334 LGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 334 ~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
.++||+|+.+.|||++. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccc
Confidence 47999999999999987 67899999965
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.011 Score=63.78 Aligned_cols=78 Identities=21% Similarity=0.293 Sum_probs=51.7
Q ss_pred EEEEccCCcEEEEEEEEcCCceEEEEEEecchhHH--H-HHHHHHHHHHHHHHHhCC--CC-CccccceeEecCCeeEEE
Q 007433 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLE--K-RKKLLRAQTEREILQSLD--HP-FLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 218 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~--~-~~~~~~~~~Ei~iL~~l~--Hp-nIv~l~~~~~~~~~~~lV 291 (604)
++.||.|.-.-||++.+...++-|+||.-....-. + .-...|...|.++|+.+. -| +++++|. .+.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 77899999999999998533457888875322110 0 123456677888888763 23 5666664 344556799
Q ss_pred EeecCC
Q 007433 292 MEFCPG 297 (604)
Q Consensus 292 ~E~~~g 297 (604)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999954
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.45 E-value=0.019 Score=62.33 Aligned_cols=77 Identities=18% Similarity=0.197 Sum_probs=51.9
Q ss_pred EEEEEccCCcEEEEEEEEcCCceEEEEEEecchhH-HHH---HHHHHHHHHHHHHHhCC---CCCccccceeEecCCeeE
Q 007433 217 LLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASL-EKR---KKLLRAQTEREILQSLD---HPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 217 l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~-~~~---~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~ 289 (604)
..+.||.|....||+..+. +..|+||.-..... ... ....+...|.+.|+.+. ..+++++|.+.. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 4678999999999998874 33588988652111 000 13345556777777664 247888888776 4467
Q ss_pred EEEeecCC
Q 007433 290 LVMEFCPG 297 (604)
Q Consensus 290 lV~E~~~g 297 (604)
+|||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 89999977
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.36 E-value=0.006 Score=60.12 Aligned_cols=29 Identities=38% Similarity=0.721 Sum_probs=20.9
Q ss_pred cCeEeccCCCCcEEE-ccCCcEEEeccccc
Q 007433 334 LGIVYRDLKPENVLV-REDGHIMLSDFDLS 362 (604)
Q Consensus 334 ~gIvHrDIKpeNILl-~~~g~vkL~DFGla 362 (604)
.-++|.||.+.|||+ +.++.++|+||..+
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya 172 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYA 172 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHH
Confidence 358999999999999 78899999999977
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.019 Score=59.63 Aligned_cols=76 Identities=22% Similarity=0.252 Sum_probs=46.3
Q ss_pred eEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC---CCCCccccceeEecCCeeEEE
Q 007433 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL---DHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 215 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~~~~~~lV 291 (604)
-+-.+.|+.|....+|+.. .++..+.||+-..... ..+..|.+-|+.| .--.+++.+.+...++..|||
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~------~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGR------DMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGC------CHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChhhH------HHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 3446779999999999987 4555788998863321 1344577777666 345688999999887788999
Q ss_pred EeecCCC
Q 007433 292 MEFCPGG 298 (604)
Q Consensus 292 ~E~~~gg 298 (604)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999766
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.17 E-value=0.02 Score=61.92 Aligned_cols=78 Identities=18% Similarity=0.260 Sum_probs=48.2
Q ss_pred EEEEEEccCCcEEEEEEEEcCCc-e-----EEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCC-CccccceeEecCCee
Q 007433 216 RLLKKLGCGDIGSVYLSELTGTK-C-----YFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP-FLPTLYTHFETDKFS 288 (604)
Q Consensus 216 ~l~~~LG~G~fG~Vy~a~~~~~~-~-----~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hp-nIv~l~~~~~~~~~~ 288 (604)
..++.|..|-...+|++...+.. . .|.+++.... ......-.+|+++++.|... .-+++++.|..
T Consensus 53 i~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~----~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~---- 124 (383)
T PTZ00384 53 IEIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTY----NSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD---- 124 (383)
T ss_pred EEEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCC----CceEeccHHHHHHHHHHHhCCCCCeEEEecCC----
Confidence 34456666888999999764431 1 2444432111 11111224689999999654 45677877753
Q ss_pred EEEEeecCCCCHH
Q 007433 289 CLVMEFCPGGDLH 301 (604)
Q Consensus 289 ~lV~E~~~ggsL~ 301 (604)
++|.||++|..|.
T Consensus 125 g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 FTIQEWVEGNTMG 137 (383)
T ss_pred EEEEEEeccccCC
Confidence 5999999987763
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.01 E-value=0.062 Score=56.53 Aligned_cols=146 Identities=13% Similarity=0.172 Sum_probs=80.9
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCC--ccccceeEecCC--eeE
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF--LPTLYTHFETDK--FSC 289 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~~~~~--~~~ 289 (604)
...+++.+-.|-.-.+|..... ++.+++. .... ...........+|..+|+.+.--- ++..++.+.++. ..|
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~~-~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf 101 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPPR-GDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPF 101 (321)
T ss_pred CCceeeeccCCcccceEEEecC--CceEEEe-cCCc-cccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCce
Confidence 3445555544444455655554 5567777 3210 111122334456888888775423 445555555554 569
Q ss_pred EEEeecCCCCH---------H---------HHHHh---cC-------CC--CCcHHHHHHHHHH--------------HH
Q 007433 290 LVMEFCPGGDL---------H---------TLRQR---QP-------GK--YFSEQAVKFYVAE--------------VL 325 (604)
Q Consensus 290 lV~E~~~ggsL---------~---------~ll~~---~~-------~~--~l~e~~~~~i~~q--------------il 325 (604)
.||+|++|..+ . +++.. -+ +. .+....+..+..+ +.
T Consensus 102 ~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~ 181 (321)
T COG3173 102 YVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD 181 (321)
T ss_pred EEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence 99999988332 1 11111 00 00 0111112222222 23
Q ss_pred HHHHHHHHc--------CeEeccCCCCcEEEccCCcEEEecccccc
Q 007433 326 LALEYLHML--------GIVYRDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 326 ~aL~yLH~~--------gIvHrDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
.-..||+.+ .+||+|+++.||+|+.++-+-+.||+++.
T Consensus 182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~ 227 (321)
T COG3173 182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELAT 227 (321)
T ss_pred HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccc
Confidence 335566543 38999999999999998889999999883
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.081 Score=55.40 Aligned_cols=28 Identities=18% Similarity=0.165 Sum_probs=26.5
Q ss_pred CeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 335 GIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 335 gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
++||+|+.+.|||++.++.+.++||..+
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~ 224 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKA 224 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhc
Confidence 7999999999999999999999999976
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.55 E-value=0.029 Score=59.42 Aligned_cols=85 Identities=22% Similarity=0.282 Sum_probs=60.3
Q ss_pred CCCCccccceeE-ecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHc-CeEeccCCCCcEEE
Q 007433 271 DHPFLPTLYTHF-ETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML-GIVYRDLKPENVLV 348 (604)
Q Consensus 271 ~HpnIv~l~~~~-~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDIKpeNILl 348 (604)
.-++..+++-+- ....+.|++|++- |+.|..+ ..-...++..|+.+.+.-|+-+..+ ..=|||+.-.||||
T Consensus 283 g~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~i------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI 355 (488)
T COG5072 283 GSVFLETLKVVSLDETLYLYLHFKDH-GTPISII------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI 355 (488)
T ss_pred cchhhhcceEEecCCceEEEEEEecC-Cceeeee------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee
Confidence 344444444333 2345678889887 7777532 1234667777888877766666543 58999999999999
Q ss_pred ccCCcEEEecccccc
Q 007433 349 REDGHIMLSDFDLSL 363 (604)
Q Consensus 349 ~~~g~vkL~DFGla~ 363 (604)
+ +|+|.|+||-+++
T Consensus 356 d-~GnvtLIDfklsR 369 (488)
T COG5072 356 D-EGNVTLIDFKLSR 369 (488)
T ss_pred e-cCceEEEEeeeee
Confidence 9 9999999999984
|
|
| >PTZ00296 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.49 E-value=0.09 Score=58.05 Aligned_cols=76 Identities=14% Similarity=0.219 Sum_probs=48.9
Q ss_pred EEEEEccCCcEEEEEEEEcCC--------ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCc-cccceeEecCCe
Q 007433 217 LLKKLGCGDIGSVYLSELTGT--------KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFL-PTLYTHFETDKF 287 (604)
Q Consensus 217 l~~~LG~G~fG~Vy~a~~~~~--------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~ 287 (604)
-++.|..|=.-.+|++..... ++.|.+++...... ..+ ....|..+++.+...+| +++++.|..
T Consensus 109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te---~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~g--- 181 (442)
T PTZ00296 109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVD---ELY-NPISEFEVYKTMSKYRIAPQLLNTFSG--- 181 (442)
T ss_pred EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCcc---cee-CHHHHHHHHHHHHHCCCCCceEEEeCC---
Confidence 566777788888999876522 45788998765421 111 22458888888755444 466666642
Q ss_pred eEEEEeecCCCCH
Q 007433 288 SCLVMEFCPGGDL 300 (604)
Q Consensus 288 ~~lV~E~~~ggsL 300 (604)
+.|.||++|..|
T Consensus 182 -g~I~efi~g~~l 193 (442)
T PTZ00296 182 -GRIEEWLYGDPL 193 (442)
T ss_pred -CEEEEeeCCccC
Confidence 367999988744
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.30 E-value=0.052 Score=53.90 Aligned_cols=116 Identities=14% Similarity=0.098 Sum_probs=69.7
Q ss_pred CCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEeecCCCCHHHH
Q 007433 224 GDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTL 303 (604)
Q Consensus 224 G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~l 303 (604)
++-++.-.+...- | ...+|.++.....-...+ +..+..++.+++ .|++|..- +...+.++.|+|-..
T Consensus 73 ~gNsTl~~~kt~i-G-~L~lKKi~slp~~~~~~~--y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~----- 139 (308)
T PF07387_consen 73 NGNSTLLIGKTKI-G-PLFLKKIRSLPCCINDAL--YFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKI----- 139 (308)
T ss_pred CCceEEEEecccc-c-hhhhhhccCCCcccchhh--hhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCc-----
Confidence 3334444443333 2 355666654332211111 235667777765 37777632 455677999999221
Q ss_pred HHhcCCCCCcHHHHHHHHHHHHHHHHHHHH--cCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 304 RQRQPGKYFSEQAVKFYVAEVLLALEYLHM--LGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 304 l~~~~~~~l~e~~~~~i~~qil~aL~yLH~--~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
+.+. .-+|... +.+|.-.|+ .+.+|||-.|+||+-+.+|.+||.|-+..
T Consensus 140 ------~i~~---~N~i~ag-i~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~L 190 (308)
T PF07387_consen 140 ------KINF---SNFITAG-IKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCL 190 (308)
T ss_pred ------ccch---hHHHHHh-HHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhh
Confidence 1111 1222222 467888894 47999999999999999999999998743
|
The function of this family is unknown. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.28 E-value=0.34 Score=51.26 Aligned_cols=70 Identities=11% Similarity=-0.013 Sum_probs=40.1
Q ss_pred CcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCC--Cccc---cce--eEecCCeeEEEEeecCC
Q 007433 225 DIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP--FLPT---LYT--HFETDKFSCLVMEFCPG 297 (604)
Q Consensus 225 ~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~---l~~--~~~~~~~~~lV~E~~~g 297 (604)
.-..||+....+ +..+++|+.+..... ...+..|++++..|... .|+. .-+ ....++..+.|+++++|
T Consensus 37 ~eN~vy~v~~~~-~~~~vlKv~r~~~~~----~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 37 YENRVYQFGDED-GRRVVAKFYRPERWS----DAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred ccceEEEEecCC-CCEEEEEEcCcccCC----HHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 346789887643 346899998643211 12344577777666321 1222 122 22335678899999987
Q ss_pred CC
Q 007433 298 GD 299 (604)
Q Consensus 298 gs 299 (604)
..
T Consensus 112 ~~ 113 (325)
T PRK11768 112 RA 113 (325)
T ss_pred CC
Confidence 64
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.24 E-value=0.072 Score=57.28 Aligned_cols=62 Identities=26% Similarity=0.191 Sum_probs=47.6
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH-HcCeEeccCCCCcEEEccCC
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH-MLGIVYRDLKPENVLVREDG 352 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH-~~gIvHrDIKpeNILl~~~g 352 (604)
..||-+|..|.++..+++.. ..++...+.++.-.+.||--|- -.+++|.|+.|.||++..+.
T Consensus 320 ~vl~E~~~~Gl~v~~~v~~~---~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~ 382 (565)
T KOG1236|consen 320 LVLVETYERGLSVLRFVKWK---SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK 382 (565)
T ss_pred ceeeeeccccccHHhhhhcc---cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence 45777889999998888764 4567777777777777765554 46899999999999997543
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.91 E-value=0.37 Score=58.79 Aligned_cols=30 Identities=30% Similarity=0.422 Sum_probs=25.4
Q ss_pred cCeEeccCCCCcEEEccCC--cEE-Eecccccc
Q 007433 334 LGIVYRDLKPENVLVREDG--HIM-LSDFDLSL 363 (604)
Q Consensus 334 ~gIvHrDIKpeNILl~~~g--~vk-L~DFGla~ 363 (604)
+++||+|+.+.|||++.++ ++. |+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 5799999999999999875 555 99999763
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.78 E-value=0.27 Score=52.18 Aligned_cols=135 Identities=24% Similarity=0.322 Sum_probs=79.0
Q ss_pred EEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCC------ccccceeEe--cCC--eeE
Q 007433 220 KLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF------LPTLYTHFE--TDK--FSC 289 (604)
Q Consensus 220 ~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn------Iv~l~~~~~--~~~--~~~ 289 (604)
.|.+ .-..||+....+.+ +++|+.+.. ... . .+..|+..|+.|.-.. |+.+-|-.. -.. +.+
T Consensus 33 ~l~s-~eN~~f~~~~~~g~--~iLki~~~~-~~~-~---~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a 104 (331)
T COG2334 33 GLNS-EENSNFRVQTEDGR--YILKIYRPG-WTR-A---EIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPA 104 (331)
T ss_pred cccc-ccCceEEEEecCCC--eEEEEecCC-CCH-H---HHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeE
Confidence 3444 45678988876654 399999876 222 1 2345777777773211 233322221 233 788
Q ss_pred EEEeecCCCCHHH-H--------------HH----hcC----C--CCCcHH----H---------HHHHHHHHHHHHHHH
Q 007433 290 LVMEFCPGGDLHT-L--------------RQ----RQP----G--KYFSEQ----A---------VKFYVAEVLLALEYL 331 (604)
Q Consensus 290 lV~E~~~ggsL~~-l--------------l~----~~~----~--~~l~e~----~---------~~~i~~qil~aL~yL 331 (604)
-|++|++|..+.. . ++ ..+ . ....|. . -.....++...++.+
T Consensus 105 ~lf~~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~ 184 (331)
T COG2334 105 ALFEYLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRL 184 (331)
T ss_pred EEEEecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHH
Confidence 9999999987762 0 11 011 0 011222 0 011233444555555
Q ss_pred HH--------cC--eEeccCCCCcEEEccCCc-EEEeccccc
Q 007433 332 HM--------LG--IVYRDLKPENVLVREDGH-IMLSDFDLS 362 (604)
Q Consensus 332 H~--------~g--IvHrDIKpeNILl~~~g~-vkL~DFGla 362 (604)
.+ .+ +||+|+.|.|||++.+.. +.++|||-+
T Consensus 185 ~~~~~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa 226 (331)
T COG2334 185 LARLPAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDA 226 (331)
T ss_pred HhhchhhCCcccceeeecCCCccceeEcCCCCeeeEEEcccc
Confidence 43 24 999999999999998874 899999976
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 604 | ||||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-34 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-34 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 9e-33 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 9e-33 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-32 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-31 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 4e-19 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-31 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 4e-19 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-31 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 3e-19 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-31 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-19 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-28 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-22 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-27 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 7e-16 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-27 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 9e-16 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-27 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 9e-16 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-27 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 2e-16 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-27 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-16 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-27 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 6e-27 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 4e-16 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 6e-27 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-27 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-27 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-16 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 6e-27 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-16 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-27 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-15 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 7e-27 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-16 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-27 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-16 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-27 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 3e-15 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 8e-27 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-16 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 9e-27 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 9e-27 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 4e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-26 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 6e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-26 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 4e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-26 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 4e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 1e-26 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-16 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-26 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 8e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-26 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-16 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-26 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 8e-16 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-26 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 8e-16 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-26 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 3e-26 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-26 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 4e-16 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-26 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 1e-15 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-26 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-16 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 1e-25 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 7e-16 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-25 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-16 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-25 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 6e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-25 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 8e-15 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-25 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-15 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-25 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 3e-15 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-25 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-15 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 2e-25 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-15 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 2e-25 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-16 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-25 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-16 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-25 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-15 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 2e-25 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-16 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-25 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-16 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 3e-25 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 6e-16 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-25 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-25 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-16 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-25 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 3e-17 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-25 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 6e-18 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-25 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-18 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-25 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-16 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-25 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 6e-18 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-25 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-18 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-25 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-16 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 6e-25 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-16 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 6e-25 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-16 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 7e-25 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-20 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-25 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-16 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 9e-25 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-16 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-24 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-18 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-24 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 8e-19 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-24 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-19 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-24 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 7e-18 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-24 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 3e-18 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-24 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 9e-19 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 2e-24 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-18 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-24 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 3e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-23 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-20 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-23 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-20 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-23 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 6e-17 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 5e-23 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 9e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-23 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-15 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 5e-23 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-15 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 5e-23 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-14 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 5e-23 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 7e-15 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-23 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-14 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 6e-23 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 7e-15 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 6e-23 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 4e-15 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 6e-23 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 7e-15 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-23 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 6e-15 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-23 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-15 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-23 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 7e-15 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 8e-23 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-14 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 8e-23 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 7e-15 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 9e-23 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 7e-15 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-23 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 7e-15 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-22 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-15 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-22 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 8e-15 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 1e-22 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-15 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-22 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 9e-15 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-22 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-16 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 2e-22 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-16 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-22 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-22 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-15 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-22 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-15 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-22 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-16 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-22 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 3e-22 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-21 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-22 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 4e-22 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-22 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-22 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-20 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 2e-21 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-15 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-21 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 3e-15 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 3e-20 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 4e-19 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 8e-20 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 1e-19 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-19 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 4e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-19 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 4e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 8e-19 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 8e-19 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-16 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-18 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-18 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-18 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-18 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 4e-16 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-18 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-18 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-12 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-18 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-18 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-16 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-18 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-18 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 1e-11 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-18 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 3e-18 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 4e-18 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 4e-18 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 4e-18 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 1e-13 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-18 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 5e-18 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 5e-18 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-18 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-18 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-18 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-13 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 6e-18 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-18 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 6e-18 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 7e-18 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 7e-18 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 7e-18 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 7e-18 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 8e-18 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-18 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 8e-18 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-18 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 1e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 1e-17 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-11 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-17 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-17 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-17 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 1e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-17 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-10 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-17 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 8e-10 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-15 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-15 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-05 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-15 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-05 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-15 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-05 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-15 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-05 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-15 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-05 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-15 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-05 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-05 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-15 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-05 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-15 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-05 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-15 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-05 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 7e-15 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-05 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 7e-15 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 4e-05 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-15 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-09 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-14 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-14 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-14 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-14 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 2e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-14 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 6e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-14 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-07 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 2e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 3e-07 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 2e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-07 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 2e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 3e-07 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 3e-07 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-14 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-04 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 2e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 3e-14 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-07 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-07 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-07 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-14 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 2e-06 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-14 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-04 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-14 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 5e-14 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 3e-06 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-14 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-07 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-14 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-07 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-07 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 7e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-07 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 8e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-13 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-04 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-13 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-09 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-07 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-13 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-13 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-12 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 6e-13 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-09 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-13 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-05 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 1e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 2e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 7e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-04 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 6e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 9e-07 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-12 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 2e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 4e-07 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-11 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 2e-07 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 4e-07 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-07 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-11 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-04 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-11 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 2e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-07 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 2e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-08 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-11 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-07 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-07 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-11 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-11 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 3e-11 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 4e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 4e-11 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-08 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 5e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 5e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 5e-11 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 6e-11 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-08 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 8e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 8e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 8e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 8e-11 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 8e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-10 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 1e-10 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 1e-10 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-10 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-10 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-10 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-10 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 1e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-10 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-04 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 1e-10 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-10 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 1e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-06 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-10 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 1e-10 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-10 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 1e-06 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-10 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-10 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-10 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-10 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 9e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-10 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-08 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-10 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-10 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-10 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 3e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-10 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-08 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 4e-10 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 5e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 6e-10 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-08 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 6e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-10 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-06 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 7e-10 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 3e-06 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-10 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 7e-10 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 3e-06 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-10 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 9e-10 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-06 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-10 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 4e-06 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-09 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-05 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 2e-09 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 7e-09 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-09 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-08 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-09 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-06 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-09 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 4e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-09 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-06 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-09 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-06 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-09 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-09 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-09 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-08 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 4e-09 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 1e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-09 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 5e-07 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 5e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 6e-09 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 1e-08 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 6e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 6e-09 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-05 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 8e-09 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-07 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 8e-09 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 8e-09 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 8e-09 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-04 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-08 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-08 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-08 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-08 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-04 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-08 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 2e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-08 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-07 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-08 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-08 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-08 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 3e-04 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-08 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-08 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-08 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 3e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 4e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 4e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 4e-08 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 2e-07 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 4e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 5e-08 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 5e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-08 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-08 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-08 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-08 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-08 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 7e-08 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-08 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 9e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 9e-08 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 4e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 9e-08 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 9e-08 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 9e-08 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 9e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 1e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 1e-07 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-07 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 1e-07 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 1e-07 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-07 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-07 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 1e-07 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-07 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 1e-07 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-07 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-07 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 1e-07 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 1e-07 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 1e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 1e-07 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-07 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-07 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-07 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-07 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 2e-07 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 2e-07 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 2e-07 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-07 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-07 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 2e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 2e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 2e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-06 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-07 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 5e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-07 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-05 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-07 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 9e-06 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 2e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 3e-05 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-07 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 2e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-07 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 8e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 2e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 4e-05 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 2e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 2e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 2e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-04 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 3e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 4e-05 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-07 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-06 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 4e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-07 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-06 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 4e-07 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-07 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 4e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-07 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 1e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 6e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-04 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 6e-07 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 6e-07 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-07 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 7e-07 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 7e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 8e-07 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 8e-07 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 9e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 1e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 1e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 1e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 1e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 1e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-06 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-06 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-06 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-06 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-06 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-06 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 2e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 2e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 2e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 2e-06 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-06 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-04 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-06 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-06 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 2e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 5e-05 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 2e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-06 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-06 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-06 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-05 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 3e-06 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 2e-05 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-06 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-06 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-06 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-06 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-06 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-06 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-06 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 4e-05 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 4e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-04 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 5e-05 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 4e-06 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-06 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-05 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-05 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 4e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 4e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-04 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-06 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 4e-06 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-06 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 4e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-04 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 4e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-05 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 4e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 4e-06 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 4e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 5e-06 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-06 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 5e-05 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 5e-06 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 5e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-06 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 5e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-06 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 5e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-05 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 5e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 6e-06 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-06 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 6e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-06 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 5e-05 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 7e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 5e-05 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 7e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-05 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 7e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-05 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 7e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-05 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 7e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 6e-05 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 5e-05 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 5e-05 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 5e-05 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 5e-05 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 8e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 5e-05 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 8e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 6e-05 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 8e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 5e-05 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 8e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 6e-05 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-04 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-05 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 8e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 8e-06 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 3e-05 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 7e-05 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 5e-05 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 5e-05 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 5e-05 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 8e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 6e-05 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 8e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 6e-05 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 9e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 9e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 5e-05 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 6e-05 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 9e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-05 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 6e-05 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 9e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 5e-05 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 9e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-05 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 1e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-05 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-04 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 1e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-05 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 1e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-05 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-05 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 5e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-05 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 1e-05 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-05 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-04 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-05 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 6e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-05 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-04 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-05 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-05 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-05 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 1e-05 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-05 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-05 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-05 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-05 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 1e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 1e-05 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 1e-05 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-05 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-05 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-05 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 2e-05 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 2e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-05 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-05 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 2e-05 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 2e-05 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 2e-05 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 2e-05 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-05 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-05 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-05 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-05 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-05 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 2e-05 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-05 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-05 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 2e-05 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 2e-05 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 2e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 2e-05 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-04 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 2e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-05 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 7e-04 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 2e-05 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-05 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-05 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-05 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 3e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 3e-05 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-05 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 3e-05 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 3e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-05 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 3e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 3e-04 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 3e-05 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 3e-05 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 4e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 4e-05 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 4e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 4e-05 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 4e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-05 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 4e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-05 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-05 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-05 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 4e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 4e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 4e-05 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-05 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 5e-05 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-05 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 5e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-05 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-05 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-05 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 5e-05 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 5e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-05 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-05 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 5e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 5e-05 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-05 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-05 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 6e-05 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 6e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-05 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 6e-05 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-05 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 6e-05 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-05 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 6e-05 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 6e-05 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-05 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 7e-05 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 7e-05 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 7e-05 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 7e-05 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 7e-05 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 7e-05 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 7e-05 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 7e-05 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-05 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 8e-05 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 8e-05 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 8e-05 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 8e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 8e-05 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 8e-05 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 8e-05 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 8e-05 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 9e-05 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 9e-05 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 9e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 9e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-05 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 9e-05 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 9e-05 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 9e-05 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 1e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-04 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-04 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-04 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 1e-04 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-04 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-04 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 1e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 1e-04 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-04 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-04 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 1e-04 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 1e-04 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 1e-04 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 1e-04 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 1e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-04 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 1e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 1e-04 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-04 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 1e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 2e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-04 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-04 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 2e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 2e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-04 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-04 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-04 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 2e-04 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-04 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 2e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-04 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-04 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 2e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 2e-04 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 2e-04 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-04 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 2e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-04 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-04 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-04 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-04 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 3e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-04 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 3e-04 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 3e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-04 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 3e-04 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 4e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 4e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-04 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-04 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-04 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 4e-04 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-04 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-04 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 5e-04 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 5e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-04 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-04 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 5e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 5e-04 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 5e-04 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 5e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-04 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-04 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-04 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 5e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-04 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 6e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 6e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 6e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 6e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 6e-04 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 6e-04 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 6e-04 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 6e-04 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 7e-04 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 7e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 7e-04 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-04 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-04 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 8e-04 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-04 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 8e-04 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 8e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-04 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 8e-04 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 8e-04 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 8e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-04 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 9e-04 |
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 9e-70
Identities = 64/409 (15%), Positives = 130/409 (31%), Gaps = 121/409 (29%)
Query: 204 RVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQT- 262
VK+ + +R+++ L G + L E +A+K +K+ LEK++ ++
Sbjct: 22 YVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNKF--YALKKYEKSLLEKKRDFTKSNND 79
Query: 263 -------------EREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDL------HTL 303
E +I+ + + + T ++ E+ + +
Sbjct: 80 KISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFV 139
Query: 304 RQRQPGKYFSEQAVKFYVAEVLLALEYLHM-LGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ + Q +K + VL + Y+H I +RD+KP N+L+ ++G + LSDF S
Sbjct: 140 LDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES 199
Query: 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKA 422
+ ++ + + F
Sbjct: 200 -------EYMVDKKIK-----------------------------GSRGTYEFMP----- 218
Query: 423 QKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLY 482
PE + + +G+ VD W+ GI LY
Sbjct: 219 --------------PEFFSN---------------------ESSYNGAKVDIWSLGICLY 243
Query: 483 ELLFGKTPFKGSENRATLY-NVVGQPLRFPESPV-----------------VSFSARDLI 524
+ + PF + L+ N+ + + +P +S D +
Sbjct: 244 VMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFL 303
Query: 525 KGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPKPVEI 573
K L K P R+ + + +H + N +R S K ++
Sbjct: 304 KLFLRKNPAERI----TSEDALKHEWLADTNIEDLREFSKELYKKRKKL 348
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 6e-60
Identities = 61/184 (33%), Positives = 105/184 (57%), Gaps = 1/184 (0%)
Query: 181 SLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCY 240
S + A+ QW VR+K+ L F +LK +G G V + ++ T
Sbjct: 29 GASELAQDKYVADFLQWAEPIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQV 88
Query: 241 FAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDL 300
+AMK+M+K + KR ++ + ER++L + D ++ L+ F+ + + LVME+ GGDL
Sbjct: 89 YAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDL 148
Query: 301 HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFD 360
TL + G+ + +FY+AE+++A++ +H LG V+RD+KP+N+L+ GHI L+DF
Sbjct: 149 LTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFG 207
Query: 361 LSLR 364
L+
Sbjct: 208 SCLK 211
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-39
Identities = 49/136 (36%), Positives = 71/136 (52%), Gaps = 14/136 (10%)
Query: 445 NARSMSFVGTHEYLAPEIIKGEG-------HGSAVDWWTFGIFLYELLFGKTPFKGSENR 497
RS+ VGT +YL+PEI++ G +G DWW G+F YE+ +G+TPF ++
Sbjct: 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA-DST 275
Query: 498 ATLYNVV---GQPLRFPESPV-VSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
A Y + + L P V ARD I+ LL P+ RL GA + + HPFF G
Sbjct: 276 AETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLGR-GGAGDFRTHPFFFG 333
Query: 554 VNWALIRCASPPEIPK 569
++W +R + PP P
Sbjct: 334 LDWDGLRDSVPPFTPD 349
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 2e-59
Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 5/199 (2%)
Query: 179 CSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTK 238
+ NK + N +++D + + ++K +G G G V L T+
Sbjct: 36 LDFPALRKNK-NIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTR 94
Query: 239 CYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGG 298
+AMK++ K + KR ER+I+ + P++ L+ F+ D++ +VME+ PGG
Sbjct: 95 KVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG 154
Query: 299 DLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSD 358
DL L E+ +FY AEV+LAL+ +H +G ++RD+KP+N+L+ + GH+ L+D
Sbjct: 155 DLVNLMSNYD---VPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLAD 211
Query: 359 FDLSLRCAVSPTVVKSSTL 377
F ++ V+ T
Sbjct: 212 FGTCMKMNKEGM-VRCDTA 229
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 2e-41
Identities = 47/134 (35%), Positives = 73/134 (54%), Gaps = 12/134 (8%)
Query: 445 NARSMSFVGTHEYLAPEIIKGEG----HGSAVDWWTFGIFLYELLFGKTPFKGSENRATL 500
R + VGT +Y++PE++K +G +G DWW+ G+FLYE+L G TPF ++
Sbjct: 223 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-DSLVGT 281
Query: 501 YN--VVGQ-PLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557
Y+ + + L FP+ +S A++LI L + + RL R G EIK+H FF+ WA
Sbjct: 282 YSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVRLG-RNGVEEIKRHLFFKNDQWA 339
Query: 558 --LIRCASPPEIPK 569
+R P +P
Sbjct: 340 WETLRDTVAPVVPD 353
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 4e-58
Identities = 65/205 (31%), Positives = 110/205 (53%), Gaps = 5/205 (2%)
Query: 173 VSDESTCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLS 232
+ DE S L + + +W +VK L F +LK +G G G V +
Sbjct: 37 LYDECNNSPLR---REKNILEYLEWAKPFTSKVKQMRLHREDFEILKVIGRGAFGEVAVV 93
Query: 233 ELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292
+L FAMK+++K + KR + + ER++L + D ++ TL+ F+ D LVM
Sbjct: 94 KLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVM 153
Query: 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG 352
++ GGDL TL + + E+ +FY+AE+++A++ +H L V+RD+KP+N+L+ +G
Sbjct: 154 DYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNG 212
Query: 353 HIMLSDFDLSLRCAVSPTVVKSSTL 377
HI L+DF L+ + V+SS
Sbjct: 213 HIRLADFGSCLK-LMEDGTVQSSVA 236
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 146 bits (369), Expect = 2e-38
Identities = 49/179 (27%), Positives = 86/179 (48%), Gaps = 25/179 (13%)
Query: 445 NARSMSFVGTHEYLAPEIIKGE-----GHGSAVDWWTFGIFLYELLFGKTPFKGSENRAT 499
+S VGT +Y++PEI++ +G DWW+ G+ +YE+L+G+TPF E+
Sbjct: 230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA-ESLVE 288
Query: 500 LY-NVVGQPLRFP---ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555
Y ++ RF + VS +A+DLI+ L+ ++RL + G + K+HPFF G++
Sbjct: 289 TYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICS-REHRLG-QNGIEDFKKHPFFSGID 346
Query: 556 WALIRCASPPEIPK-----------PVEIVHSPAPALSTKAKAVAAGNADHNNYLEFDF 603
W IR P IP+ + + + +G+ H ++ F +
Sbjct: 347 WDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMPPPTHTAFSGH--HLPFVGFTY 403
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 7e-58
Identities = 54/168 (32%), Positives = 89/168 (52%), Gaps = 2/168 (1%)
Query: 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQS 269
F+ K LG G +V L+ T +A+K+++K + K K+ ER+++
Sbjct: 27 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSR 86
Query: 270 LDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALE 329
LDHPF LY F+ D+ + + G+L ++ F E +FY AE++ ALE
Sbjct: 87 LDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALE 144
Query: 330 YLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTL 377
YLH GI++RDLKPEN+L+ ED HI ++DF + + ++++
Sbjct: 145 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 192
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 4e-46
Identities = 43/134 (32%), Positives = 68/134 (50%), Gaps = 6/134 (4%)
Query: 438 ELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR 497
L E AR+ SFVGT +Y++PE++ + + D W G +Y+L+ G PF+ N
Sbjct: 179 VLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA-GNE 237
Query: 498 ATLY-NVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLAC--RRGATEIKQHPFFQGV 554
++ ++ FP ARDL++ LLV + RL C G +K HPFF+ V
Sbjct: 238 YLIFQKIIKLEYDFP--EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295
Query: 555 NWALIRCASPPEIP 568
W + +PP++
Sbjct: 296 TWENLHQQTPPKLT 309
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 192 bits (491), Expect = 6e-57
Identities = 63/353 (17%), Positives = 115/353 (32%), Gaps = 87/353 (24%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F + LG G G V + Y+A+K + +KL +E +L SL+H +
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQY 63
Query: 275 LPTLYTHF-------------ETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYV 321
+ Y + + + ME+C G L+ L +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLF 122
Query: 322 AEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEP 381
++L AL Y+H GI++RDLKP N+ + E ++ + DF L+ V S +
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLA-------KNVHRSLDILKL 175
Query: 382 LRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIA 441
+N S + + + + E++
Sbjct: 176 DSQNLP-------------GSSDNLTSAIGTAMYVA-------------------TEVLD 203
Query: 442 EPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY 501
GT Y +D ++ GI +E+++ G E L
Sbjct: 204 -----------GTGHY-----------NEKIDMYSLGIIFFEMIYP--FSTGMERVNILK 239
Query: 502 NVVGQPLRFPE--SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
+ + FP + +I+ L+ +P R GA + +
Sbjct: 240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP----GARTLLNSGWLP 288
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 2e-56
Identities = 53/160 (33%), Positives = 97/160 (60%), Gaps = 2/160 (1%)
Query: 203 VRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQT 262
V ++ + HF +L+ +G G G V + + TK +AMK M+K +R ++
Sbjct: 5 VFDENEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFK 64
Query: 263 EREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVA 322
E +I+Q L+HPFL L+ F+ ++ +V++ GGDL Q+ +F E+ VK ++
Sbjct: 65 ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFIC 122
Query: 323 EVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
E+++AL+YL I++RD+KP+N+L+ E GH+ ++DF+++
Sbjct: 123 ELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA 162
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-37
Identities = 37/135 (27%), Positives = 61/135 (45%), Gaps = 13/135 (9%)
Query: 443 PTNARSMSFVGTHEYLAPEII---KGEGHGSAVDWWTFGIFLYELLFGKTPF--KGSENR 497
P + + GT Y+APE+ KG G+ AVDWW+ G+ YELL G+ P+ + S +
Sbjct: 166 PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS 225
Query: 498 ATLY-NVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNW 556
+ + +P S L+K LL P R + ++++ P+ +NW
Sbjct: 226 KEIVHTFETTVVTYP--SAWSQEMVSLLKKLLEPNPDQRFS---QLSDVQNFPYMNDINW 280
Query: 557 ALI--RCASPPEIPK 569
+ + P IP
Sbjct: 281 DAVFQKRLIPGFIPN 295
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 188 bits (480), Expect = 5e-55
Identities = 56/153 (36%), Positives = 91/153 (59%), Gaps = 2/153 (1%)
Query: 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQS 269
+ F++L+ LG G G V+L Y+AMKV+ K + + K++ ER +L
Sbjct: 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 62
Query: 270 LDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALE 329
+ HPF+ ++ F+ + ++M++ GG+L +L ++ + F KFY AEV LALE
Sbjct: 63 VTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALE 120
Query: 330 YLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
YLH I+YRDLKPEN+L+ ++GHI ++DF +
Sbjct: 121 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFA 153
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-42
Identities = 41/129 (31%), Positives = 68/129 (52%), Gaps = 7/129 (5%)
Query: 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY-NV 503
+ + GT +Y+APE++ + + ++DWW+FGI +YE+L G TPF N Y +
Sbjct: 157 PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFY-DSNTMKTYEKI 215
Query: 504 VGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLAC-RRGATEIKQHPFFQGVNWALI--R 560
+ LRFP P + +DL+ L+ ++ RL + G ++K HP+F+ V W + R
Sbjct: 216 LNAELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSR 273
Query: 561 CASPPEIPK 569
P P
Sbjct: 274 NIETPYEPP 282
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 8e-54
Identities = 60/193 (31%), Positives = 102/193 (52%), Gaps = 7/193 (3%)
Query: 170 SSDVSDESTCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSV 229
++ S S+ + K + +WE + F +K LG G G V
Sbjct: 3 AAAAKKGSEQESVKEFLAKAKEDFLKKWE-----TPSQNTAQLDQFDRIKTLGTGSFGRV 57
Query: 230 YLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289
L + + ++AMK++DK + K K++ E+ ILQ+++ PFL L F+ +
Sbjct: 58 MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLY 117
Query: 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVR 349
+VME+ GG++ + +R FSE +FY A+++L EYLH L ++YRDLKPEN+L+
Sbjct: 118 MVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLID 175
Query: 350 EDGHIMLSDFDLS 362
+ G+I ++DF +
Sbjct: 176 QQGYIQVTDFGFA 188
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-40
Identities = 45/129 (34%), Positives = 65/129 (50%), Gaps = 7/129 (5%)
Query: 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY-NV 503
R+ + GT E LAPEII +G+ AVDWW G+ +YE+ G PF ++ +Y +
Sbjct: 192 KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFF-ADQPIQIYEKI 250
Query: 504 VGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLAC-RRGATEIKQHPFFQGVNWALI--R 560
V +RFP S +DL++ LL + R + G +IK H +F +W I R
Sbjct: 251 VSGKVRFP--SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQR 308
Query: 561 CASPPEIPK 569
P IPK
Sbjct: 309 KVEAPFIPK 317
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 2e-53
Identities = 62/155 (40%), Positives = 90/155 (58%), Gaps = 6/155 (3%)
Query: 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQS 269
+ + F LK LG G G V L T Y+AMK++ K + + ++ TE +LQ+
Sbjct: 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN 61
Query: 270 LDHPFLPTLYTHFETDKFSCLVMEFCPGGDL--HTLRQRQPGKYFSEQAVKFYVAEVLLA 327
HPFL L F+T C VME+ GG+L H R+R F+E+ +FY AE++ A
Sbjct: 62 TRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV----FTEERARFYGAEIVSA 117
Query: 328 LEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
LEYLH +VYRD+K EN+++ +DGHI ++DF L
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 152
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 46/129 (35%), Positives = 75/129 (58%), Gaps = 7/129 (5%)
Query: 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY-NV 503
A +F GT EYLAPE+++ +G AVDWW G+ +YE++ G+ PF ++ L+ +
Sbjct: 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHERLFELI 217
Query: 504 VGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLAC-RRGATEIKQHPFFQGVNWALI--R 560
+ + +RFP + +S A+ L+ GLL K+P+ RL A E+ +H FF +NW + +
Sbjct: 218 LMEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQK 275
Query: 561 CASPPEIPK 569
PP P+
Sbjct: 276 KLLPPFKPQ 284
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 181 bits (463), Expect = 1e-52
Identities = 70/156 (44%), Positives = 104/156 (66%), Gaps = 6/156 (3%)
Query: 210 LGVGHFRLLKKLGCGDIGSVYLSE---LTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI 266
F LLK LG G G V+L + + + +AMKV+ KA+L+ R ++ R + ER+I
Sbjct: 21 ADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRV-RTKMERDI 79
Query: 267 LQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLL 326
L ++HPF+ L+ F+T+ L+++F GGDL T ++ F+E+ VKFY+AE+ L
Sbjct: 80 LVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELAL 137
Query: 327 ALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
AL++LH LGI+YRDLKPEN+L+ E+GHI L+DF LS
Sbjct: 138 ALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLS 173
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 5e-43
Identities = 45/129 (34%), Positives = 71/129 (55%), Gaps = 7/129 (5%)
Query: 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY-NV 503
++ SF GT EY+APE++ GH + DWW+FG+ ++E+L G PF+G ++R +
Sbjct: 180 EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQG-KDRKETMTMI 238
Query: 504 VGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLAC-RRGATEIKQHPFFQGVNWALI--R 560
+ L P+ +S A+ L++ L + P NRL G EIK+H FF ++W + R
Sbjct: 239 LKAKLGMPQF--LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRR 296
Query: 561 CASPPEIPK 569
PP P
Sbjct: 297 EIHPPFKPA 305
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 2e-52
Identities = 60/213 (28%), Positives = 101/213 (47%), Gaps = 5/213 (2%)
Query: 155 DYVESGKSSMCRGSTSSDVSDE---STCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLG 211
++++ + R + + + L + + + +Q ++ +G
Sbjct: 124 SFLDAETVARARAGAGDGLFQPLLRAVLAHLGQAPFQEFLDSLYFLRFLQWKWLEAQPMG 183
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD 271
F + LG G G V+ ++ T +A K ++K L+KRK A E++IL +
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDL--HTLRQRQPGKYFSEQAVKFYVAEVLLALE 329
F+ +L FET CLVM GGD+ H + F E FY A+++ LE
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 330 YLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+LH I+YRDLKPENVL+ +DG++ +SD L+
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA 336
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-39
Identities = 35/136 (25%), Positives = 70/136 (51%), Gaps = 9/136 (6%)
Query: 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKG---SENRATLY 501
++ + GT ++APE++ GE + +VD++ G+ LYE++ + PF+ L
Sbjct: 343 QTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELK 402
Query: 502 -NVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACR-RGATEIKQHPFFQGVNWALI 559
V+ Q + +P+ S +++D + LL K+P+ RL R ++ HP F+ ++W +
Sbjct: 403 QRVLEQAVTYPDK--FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQL 460
Query: 560 --RCASPPEIPKPVEI 573
+PP +P +
Sbjct: 461 EAGMLTPPFVPDSRTV 476
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-52
Identities = 59/157 (37%), Positives = 85/157 (54%), Gaps = 6/157 (3%)
Query: 210 LGVGHFRLLKKLGCGDIGSVYLSE---LTGTKCYFAMKVMDKASL-EKRKKLLRAQTERE 265
+ F LL+ LG G G V+ T FAMKV+ KA + K + ER
Sbjct: 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERN 73
Query: 266 ILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVL 325
IL+ + HPF+ L F+T L++E+ GG+L +R+ F E FY+AE+
Sbjct: 74 ILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEIS 131
Query: 326 LALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+AL +LH GI+YRDLKPEN+++ GH+ L+DF L
Sbjct: 132 MALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLC 168
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 3e-42
Identities = 49/129 (37%), Positives = 69/129 (53%), Gaps = 7/129 (5%)
Query: 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY-NV 503
+ +F GT EY+APEI+ GH AVDWW+ G +Y++L G PF G ENR +
Sbjct: 175 GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTG-ENRKKTIDKI 233
Query: 504 VGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLAC-RRGATEIKQHPFFQGVNWALI--R 560
+ L P ++ ARDL+K LL + +RL A E++ HPFF+ +NW + R
Sbjct: 234 LKCKLNLPPY--LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLAR 291
Query: 561 CASPPEIPK 569
PP P
Sbjct: 292 KVEPPFKPL 300
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 6e-52
Identities = 64/193 (33%), Positives = 101/193 (52%), Gaps = 11/193 (5%)
Query: 173 VSDESTCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLS 232
+S ++++ P + + I + F LK +G G G V L+
Sbjct: 2 ISQPQEPELMNANPAPPPAPS----QQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLA 57
Query: 233 ELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREIL-QSLDHPFLPTLYTHFETDKFSCLV 291
+ ++A+KV+ K ++ K+K+ +ER +L +++ HPFL L+ F+T V
Sbjct: 58 RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFV 117
Query: 292 MEFCPGGDL--HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVR 349
+++ GG+L H R+R F E +FY AE+ AL YLH L IVYRDLKPEN+L+
Sbjct: 118 LDYINGGELFYHLQRERC----FLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLD 173
Query: 350 EDGHIMLSDFDLS 362
GHI+L+DF L
Sbjct: 174 SQGHIVLTDFGLC 186
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 4e-43
Identities = 50/128 (39%), Positives = 74/128 (57%), Gaps = 6/128 (4%)
Query: 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY-NV 503
N+ + +F GT EYLAPE++ + + VDWW G LYE+L+G PF N A +Y N+
Sbjct: 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYS-RNTAEMYDNI 251
Query: 504 VGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALI--RC 561
+ +PL+ P ++ SAR L++GLL K+ RL + EIK H FF +NW + +
Sbjct: 252 LNKPLQLK--PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKK 309
Query: 562 ASPPEIPK 569
+PP P
Sbjct: 310 ITPPFNPN 317
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 7e-52
Identities = 71/256 (27%), Positives = 108/256 (42%), Gaps = 13/256 (5%)
Query: 114 LEDVGEQEKKPSEAGPASAKVSDGTSSLPKTSGSAKISDRGDYVESGKSSMCRGSTSSDV 173
L+ V E E P + A + +L + S D V + C
Sbjct: 84 LDGVAEYEVTPDDKRKACGR------NLTQNFLSHTGPDLIPEVPRQLVTNCTQRLEQGP 137
Query: 174 SDE-------STCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDI 226
+ T LS + + + +Q ++ + FR + LG G
Sbjct: 138 CKDLFQELTRLTHEYLSVAPFADYLDSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGF 197
Query: 227 GSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286
G V ++ T +A K ++K ++KRK A E++IL+ ++ F+ +L +ET
Sbjct: 198 GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKD 257
Query: 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENV 346
CLV+ GGDL F E FY AE+ LE LH IVYRDLKPEN+
Sbjct: 258 ALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENI 317
Query: 347 LVREDGHIMLSDFDLS 362
L+ + GHI +SD L+
Sbjct: 318 LLDDHGHIRISDLGLA 333
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-39
Identities = 46/136 (33%), Positives = 65/136 (47%), Gaps = 11/136 (8%)
Query: 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY- 501
P VGT Y+APE++K E + + DWW G LYE++ G++PF+ +
Sbjct: 337 PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ-RKKKIKRE 395
Query: 502 ----NVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACR-RGATEIKQHPFFQGVNW 556
V P + E S AR L LL K+P RL CR A E+K+HP F+ +N+
Sbjct: 396 EVERLVKEVPEEYSER--FSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF 453
Query: 557 ALI--RCASPPEIPKP 570
+ PP P P
Sbjct: 454 KRLGAGMLEPPFKPDP 469
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 7e-52
Identities = 62/154 (40%), Positives = 91/154 (59%), Gaps = 3/154 (1%)
Query: 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREIL-Q 268
LG+ F LL+ +G G V L L T +AMKV+ K + + + QTE+ + Q
Sbjct: 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ 65
Query: 269 SLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLAL 328
+ +HPFL L++ F+T+ V+E+ GGDL QRQ + E+ +FY AE+ LAL
Sbjct: 66 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLAL 123
Query: 329 EYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
YLH GI+YRDLK +NVL+ +GHI L+D+ +
Sbjct: 124 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 146 bits (372), Expect = 2e-39
Identities = 44/138 (31%), Positives = 76/138 (55%), Gaps = 15/138 (10%)
Query: 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKG--------SEN 496
+ +F GT Y+APEI++GE +G +VDWW G+ ++E++ G++PF
Sbjct: 164 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 223
Query: 497 RATLY-NVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLAC--RRGATEIKQHPFFQG 553
L+ ++ + +R P S +S A ++K L K+P+ RL C + G +I+ HPFF+
Sbjct: 224 EDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281
Query: 554 VNWALI--RCASPPEIPK 569
V+W ++ + PP P
Sbjct: 282 VDWDMMEQKQVVPPFKPN 299
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 5e-51
Identities = 57/154 (37%), Positives = 85/154 (55%), Gaps = 3/154 (1%)
Query: 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQ- 268
L + F L K LG G G V+L+E T +FA+K + K + + E+ +L
Sbjct: 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSL 73
Query: 269 SLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLAL 328
+ +HPFL ++ F+T + VME+ GGDL Q F FY AE++L L
Sbjct: 74 AWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGL 131
Query: 329 EYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++LH GIVYRDLK +N+L+ +DGHI ++DF +
Sbjct: 132 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMC 165
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 143 bits (364), Expect = 2e-38
Identities = 46/128 (35%), Positives = 78/128 (60%), Gaps = 9/128 (7%)
Query: 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY-NV 503
+A++ +F GT +Y+APEI+ G+ + +VDWW+FG+ LYE+L G++PF G ++ L+ ++
Sbjct: 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG-QDEEELFHSI 230
Query: 504 VGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALI--RC 561
+P + A+DL+ L V+EP+ RL +I+QHP F+ +NW + +
Sbjct: 231 RMDNPFYPRW--LEKEAKDLLVKLFVREPEKRLGV---RGDIRQHPLFREINWEELERKE 285
Query: 562 ASPPEIPK 569
PP PK
Sbjct: 286 IDPPFRPK 293
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 179 bits (457), Expect = 6e-51
Identities = 61/154 (39%), Positives = 91/154 (59%), Gaps = 3/154 (1%)
Query: 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREIL-Q 268
LG+ F LL+ +G G V L L T +AM+V+ K + + + QTE+ + Q
Sbjct: 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQ 108
Query: 269 SLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLAL 328
+ +HPFL L++ F+T+ V+E+ GGDL QRQ + E+ +FY AE+ LAL
Sbjct: 109 ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLAL 166
Query: 329 EYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
YLH GI+YRDLK +NVL+ +GHI L+D+ +
Sbjct: 167 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 2e-38
Identities = 44/138 (31%), Positives = 76/138 (55%), Gaps = 15/138 (10%)
Query: 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKG--------SEN 496
+ +F GT Y+APEI++GE +G +VDWW G+ ++E++ G++PF
Sbjct: 207 GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 266
Query: 497 RATLY-NVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLAC--RRGATEIKQHPFFQG 553
L+ ++ + +R P S +S A ++K L K+P+ RL C + G +I+ HPFF+
Sbjct: 267 EDYLFQVILEKQIRIPRS--LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324
Query: 554 VNWALI--RCASPPEIPK 569
V+W ++ + PP P
Sbjct: 325 VDWDMMEQKQVVPPFKPN 342
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 8e-51
Identities = 67/197 (34%), Positives = 108/197 (54%), Gaps = 7/197 (3%)
Query: 171 SDVSDESTCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVY 230
S + +S + +G+ +F LLK LG G G V+
Sbjct: 12 GGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVF 71
Query: 231 LSELT---GTKCYFAMKVMDKASL-EKRKKLLRAQTEREILQSLDH-PFLPTLYTHFETD 285
L T +AMKV+ KA++ +K K +TER++L+ + PFL TL+ F+T+
Sbjct: 72 LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131
Query: 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPEN 345
L++++ GG+L T ++ + F+E V+ YV E++LALE+LH LGI+YRD+K EN
Sbjct: 132 TKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLEN 189
Query: 346 VLVREDGHIMLSDFDLS 362
+L+ +GH++L+DF LS
Sbjct: 190 ILLDSNGHVVLTDFGLS 206
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 5e-40
Identities = 52/134 (38%), Positives = 78/134 (58%), Gaps = 11/134 (8%)
Query: 445 NARSMSFVGTHEYLAPEIIKGE--GHGSAVDWWTFGIFLYELLFGKTPFKGS---ENRAT 499
R+ F GT EY+AP+I++G GH AVDWW+ G+ +YELL G +PF ++A
Sbjct: 214 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAE 273
Query: 500 LY-NVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLAC-RRGATEIKQHPFFQGVNWA 557
+ ++ +P+ +S A+DLI+ LL+K+P+ RL C R A EIK+H FFQ +NW
Sbjct: 274 ISRRILKSEPPYPQE--MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 331
Query: 558 LI--RCASPPEIPK 569
+ + P P
Sbjct: 332 DLAAKKVPAPFKPV 345
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-50
Identities = 53/156 (33%), Positives = 81/156 (51%), Gaps = 7/156 (4%)
Query: 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQS 269
+ + F L LG G G V LSE GT +A+K++ K + + + E+ +L
Sbjct: 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLAL 76
Query: 270 LD-HPFLPTLYTHFETDKFSCLVMEFCPGGDL--HTLRQRQPGKYFSEQAVKFYVAEVLL 326
PFL L++ F+T VME+ GGDL H + + F E FY AE+ +
Sbjct: 77 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR----FKEPHAVFYAAEIAI 132
Query: 327 ALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
L +L GI+YRDLK +NV++ +GHI ++DF +
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMC 168
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-40
Identities = 49/129 (37%), Positives = 78/129 (60%), Gaps = 7/129 (5%)
Query: 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY-NV 503
+ +F GT +Y+APEII + +G +VDWW FG+ LYE+L G+ PF+G E+ L+ ++
Sbjct: 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSI 233
Query: 504 VGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLAC-RRGATEIKQHPFFQGVNWALI--R 560
+ + +P+S +S A + KGL+ K P RL C G +IK+H FF+ ++W + +
Sbjct: 234 MEHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERK 291
Query: 561 CASPPEIPK 569
PP PK
Sbjct: 292 EIQPPYKPK 300
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 2e-50
Identities = 60/156 (38%), Positives = 89/156 (57%), Gaps = 7/156 (4%)
Query: 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQ- 268
LG+ +F ++ LG G G V L+ + T +A+KV+ K + + + TE+ IL
Sbjct: 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSL 79
Query: 269 SLDHPFLPTLYTHFETDKFSCLVMEFCPGGDL--HTLRQRQPGKYFSEQAVKFYVAEVLL 326
+ +HPFL L+ F+T VMEF GGDL H + R+ F E +FY AE++
Sbjct: 80 ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR----FDEARARFYAAEIIS 135
Query: 327 ALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
AL +LH GI+YRDLK +NVL+ +GH L+DF +
Sbjct: 136 ALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC 171
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 44/130 (33%), Positives = 70/130 (53%), Gaps = 8/130 (6%)
Query: 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY-NV 503
+ +F GT +Y+APEI++ +G AVDWW G+ LYE+L G PF+ EN L+ +
Sbjct: 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA-ENEDDLFEAI 236
Query: 504 VGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLAC--RRGATEIKQHPFFQGVNWALI-- 559
+ + +P + A ++K + K P RL + G I +HPFF+ ++WA +
Sbjct: 237 LNDEVVYPTW--LHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNH 294
Query: 560 RCASPPEIPK 569
R PP P+
Sbjct: 295 RQIEPPFRPR 304
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 2e-50
Identities = 66/260 (25%), Positives = 115/260 (44%), Gaps = 17/260 (6%)
Query: 114 LEDVGEQEKKPSEAGPASAKVSDGTSSLPKTSGSAKISDRGDYVESGKSSMCRGSTSSDV 173
E++ + EK +E + + K + +E + + + D+
Sbjct: 86 YEEIKKYEKLETEEERLVCSREIFDTYIMKELLACSHPFSKSAIEHVQGHLVKKQVPPDL 145
Query: 174 SDE---STCSSLSSSVNKPHKAND-----AQWEAIQAVRVKDGVLGVGHFRLLKKLGCGD 225
C +L V + +D QW+ ++ + L + F + + +G G
Sbjct: 146 FQPYIEEICQNLRGDVFQKFIESDKFTRFCQWKNVE----LNIHLTMNDFSVHRIIGRGG 201
Query: 226 IGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQ---SLDHPFLPTLYTHF 282
G VY T +AMK +DK ++ ++ A ER +L + D PF+ + F
Sbjct: 202 FGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF 261
Query: 283 ETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLK 342
T +++ GGDLH + FSE ++FY AE++L LE++H +VYRDLK
Sbjct: 262 HTPDKLSFILDLMNGGDLHYHLSQHGV--FSEADMRFYAAEIILGLEHMHNRFVVYRDLK 319
Query: 343 PENVLVREDGHIMLSDFDLS 362
P N+L+ E GH+ +SD L+
Sbjct: 320 PANILLDEHGHVRISDLGLA 339
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 1e-38
Identities = 50/173 (28%), Positives = 92/173 (53%), Gaps = 13/173 (7%)
Query: 442 EPTNARSMSFVGTHEYLAPEII-KGEGHGSAVDWWTFGIFLYELLFGKTPFKG--SENRA 498
+ + + + VGTH Y+APE++ KG + S+ DW++ G L++LL G +PF+ ++++
Sbjct: 341 DFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 400
Query: 499 TLY-NVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACR-RGATEIKQHPFFQGVNW 556
+ + + P+S S R L++GLL ++ RL C RGA E+K+ PFF+ ++W
Sbjct: 401 EIDRMTLTMAVELPDS--FSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDW 458
Query: 557 ALI--RCASPPEIPKPVEIVHSPAPALSTKA----KAVAAGNADHNNYLEFDF 603
++ + PP IP E+ + A + + K + ++D Y F
Sbjct: 459 QMVFLQKYPPPLIPPRGEVNAADAFDIGSFDEEDTKGIKLLDSDQELYRNFPL 511
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 2e-50
Identities = 68/214 (31%), Positives = 107/214 (50%), Gaps = 5/214 (2%)
Query: 152 DRGDYVESGKSSMCRGSTSSDVSDESTCSSLSSSVNKPHKANDAQWEAIQAVRVKDGV-- 209
+R +VE+ + + V+D + + + +D V +
Sbjct: 85 ERTFHVETPEEREEWTTAIQTVADGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHR 144
Query: 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQS 269
+ + F LK LG G G V L + T Y+AMK++ K + + ++ TE +LQ+
Sbjct: 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN 204
Query: 270 LDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALE 329
HPFL L F+T C VME+ GG+L R+ + FSE +FY AE++ AL+
Sbjct: 205 SRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALD 262
Query: 330 YLHM-LGIVYRDLKPENVLVREDGHIMLSDFDLS 362
YLH +VYRDLK EN+++ +DGHI ++DF L
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 2e-39
Identities = 48/129 (37%), Positives = 75/129 (58%), Gaps = 7/129 (5%)
Query: 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY-NV 503
A +F GT EYLAPE+++ +G AVDWW G+ +YE++ G+ PF ++ L+ +
Sbjct: 303 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYN-QDHEKLFELI 361
Query: 504 VGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLAC-RRGATEIKQHPFFQGVNWALI--R 560
+ + +RFP + + A+ L+ GLL K+P+ RL A EI QH FF G+ W + +
Sbjct: 362 LMEEIRFPRT--LGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVYEK 419
Query: 561 CASPPEIPK 569
SPP P+
Sbjct: 420 KLSPPFKPQ 428
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 2e-49
Identities = 88/367 (23%), Positives = 141/367 (38%), Gaps = 107/367 (29%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLR------------ 259
+ + L ++G G G V L+ Y+AMKV+ K L ++ R
Sbjct: 12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPG 71
Query: 260 ---------AQTEREI--LQSLDHPFLPTLYTHFE--TDKFSCLVMEFCPGGDLHTLRQR 306
Q +EI L+ LDHP + L + + +V E G + +
Sbjct: 72 GCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL 131
Query: 307 QPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366
+P SE +FY +++ +EYLH I++RD+KP N+LV EDGHI ++DF +S
Sbjct: 132 KP---LSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK 188
Query: 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPK 426
S ++ T +P F +
Sbjct: 189 GSDALLS----------------------------------NTVGTPAFMA--------- 205
Query: 427 NEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF 486
PE ++E + G A+D W G+ LY +F
Sbjct: 206 ----------PESLSE----------TRKIF----------SGKALDVWAMGVTLYCFVF 235
Query: 487 GKTPFKGSENRATLYN-VVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEI 545
G+ PF E L++ + Q L FP+ P ++ +DLI +L K P++R+ EI
Sbjct: 236 GQCPFMD-ERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIV----VPEI 290
Query: 546 KQHPFFQ 552
K HP+
Sbjct: 291 KLHPWVT 297
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 9e-48
Identities = 51/159 (32%), Positives = 82/159 (51%), Gaps = 2/159 (1%)
Query: 204 RVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTE 263
+ + F + + LG G G+VYL+ K A+KV+ K+ LEK + + E
Sbjct: 5 EMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRRE 64
Query: 264 REILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAE 323
EI L HP + +Y +F K L++EF P G+L+ Q+ F EQ ++ E
Sbjct: 65 IEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEE 122
Query: 324 VLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ AL Y H +++RD+KPEN+L+ G + ++DF S
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWS 161
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 3e-30
Identities = 41/131 (31%), Positives = 58/131 (44%), Gaps = 10/131 (7%)
Query: 439 LIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRA 498
+ R + GT +YL PE+I+G+ H VD W G+ YE L G PF +
Sbjct: 160 WSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE 219
Query: 499 TLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWAL 558
T +V L+FP P +S ++DLI LL P RL + +HP+ + A
Sbjct: 220 THRRIVNVDLKFP--PFLSDGSKDLISKLLRYHPPQRL----PLKGVMEHPWVK----AN 269
Query: 559 IRCASPPEIPK 569
R PP
Sbjct: 270 SRRVLPPVYQS 280
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-47
Identities = 52/157 (33%), Positives = 81/157 (51%), Gaps = 2/157 (1%)
Query: 206 KDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTERE 265
K + F + + LG G G+VYL+ +K A+KV+ KA LEK + + E E
Sbjct: 2 KKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 61
Query: 266 ILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVL 325
I L HP + LY +F L++E+ P G ++ Q+ F EQ Y+ E+
Sbjct: 62 IQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELA 119
Query: 326 LALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
AL Y H +++RD+KPEN+L+ G + ++DF S
Sbjct: 120 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS 156
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 39/131 (29%), Positives = 57/131 (43%), Gaps = 6/131 (4%)
Query: 439 LIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRA 498
++R GT +YL PE+I+G H VD W+ G+ YE L GK PF+ + +
Sbjct: 155 WSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 214
Query: 499 TLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWAL 558
T + FP+ V+ ARDLI LL P R E+ +HP+ +
Sbjct: 215 TYKRISRVEFTFPDF--VTEGARDLISRLLKHNPSQRP----MLREVLEHPWITANSSKP 268
Query: 559 IRCASPPEIPK 569
C + K
Sbjct: 269 SNCQNKESASK 279
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 169 bits (428), Expect = 4e-47
Identities = 45/387 (11%), Positives = 91/387 (23%), Gaps = 117/387 (30%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKL---------------- 257
LG D + + T F + V +
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 258 ---------LRAQTEREILQSLDHPFLPTLYTHFETDKFS--CLVMEFCPGGDLHTL--- 303
LR ++++ + + + +L T
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEV 192
Query: 304 --RQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDL 361
K A +V+ L LH G+V+ L+P ++++ + G + L+ F+
Sbjct: 193 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH 252
Query: 362 SLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKK 421
+R + S F
Sbjct: 253 LVRDGAR--------------------------------------VVSSVSRGFEP---- 270
Query: 422 AQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFL 481
PEL A ++ + + D W G+ +
Sbjct: 271 ---------------PELEAR------------RATISYHRDRRTLMTFSFDAWALGLVI 303
Query: 482 YELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRG 541
Y + P + P+ R L++G L ++RL
Sbjct: 304 YWIWCADLPITKDAALGGSEWIFRSCKNIPQ------PVRALLEGFLRYPKEDRL----L 353
Query: 542 ATEIKQHPFFQGVNWALIRCASPPEIP 568
+ + P ++ + L +P
Sbjct: 354 PLQAMETPEYEQLRTEL-----SAALP 375
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 4e-47
Identities = 81/389 (20%), Positives = 144/389 (37%), Gaps = 110/389 (28%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPT 277
K LG G + FA+K++ K + Q E L+ + HP +
Sbjct: 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK------RMEANTQKEITALKLCEGHPNIVK 70
Query: 278 LYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGI 336
L+ F + LVME GG+L ++++ K+FSE + + +++ A+ ++H +G+
Sbjct: 71 LHEVFHDQLHTFLVMELLNGGELFERIKKK---KHFSETEASYIMRKLVSAVSHMHDVGV 127
Query: 337 VYRDLKPENVLVR---EDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPA 393
V+RDLKPEN+L ++ I + DF + + +++PL+
Sbjct: 128 VHRDLKPENLLFTDENDNLEIKIIDFGFA----------RLKPPDNQPLK---------- 167
Query: 394 CIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453
T CF+ + +P
Sbjct: 168 --------------TPCFTLHY-----------------AAP------------------ 178
Query: 454 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV--------G 505
E++ G+ + D W+ G+ LY +L G+ PF+ + T + V G
Sbjct: 179 -------ELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG 231
Query: 506 QPLRFPESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCAS 563
F VS A+DLI+GLL +P RL + ++ + + Q + S
Sbjct: 232 D-FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLK----MSGLRYNEWLQDGS-----QLS 281
Query: 564 PPEIPKPVEIVHSPAPALSTKAKAVAAGN 592
+ P + S A + A N
Sbjct: 282 SNPLMTPDILGSSGAAVHTCVKATFHAFN 310
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 165 bits (419), Expect = 1e-46
Identities = 83/366 (22%), Positives = 132/366 (36%), Gaps = 89/366 (24%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQS 269
+G + + LG G G V + T C A+K++ K L + A ++EI L+
Sbjct: 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGE-ANVKKEIQLLRR 62
Query: 270 LDHPFLPTLYT--HFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLA 327
L H + L + E + +VME+C G + + P K F Y +++
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDG 121
Query: 328 LEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPV 387
LEYLH GIV++D+KP N+L+ G + +S ++ T
Sbjct: 122 LEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVA---EALHPFAADDTCR--------- 169
Query: 388 YCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447
T+ SP F PE+
Sbjct: 170 --------------------TSQGSPAFQP-------------------PEIAN------ 184
Query: 448 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY-NVVGQ 506
G + G VD W+ G+ LY + G PF+G +N L+ N+
Sbjct: 185 -----GLDTF----------SGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENIGKG 228
Query: 507 PLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPE 566
P DL+KG+L EP R + R +I+QH +F+ +P
Sbjct: 229 SYAIPGD--CGPPLSDLLKGMLEYEPAKRFSIR----QIRQHSWFRK---KHPPAEAPVP 279
Query: 567 IPKPVE 572
IP +
Sbjct: 280 IPPSPD 285
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 8e-46
Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 7/199 (3%)
Query: 167 GSTSSDVSDESTCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDI 226
GS ++ + + K + A + + + F L LG G
Sbjct: 295 GSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSF 354
Query: 227 GSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQ-SLDHPFLPTLYTHFETD 285
G V LSE GT +A+K++ K + + + E+ +L PFL L++ F+T
Sbjct: 355 GKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414
Query: 286 KFSCLVMEFCPGGDL--HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKP 343
VME+ GGDL H + + F E FY AE+ + L +L GI+YRDLK
Sbjct: 415 DRLYFVMEYVNGGDLMYHIQQVGR----FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKL 470
Query: 344 ENVLVREDGHIMLSDFDLS 362
+NV++ +GHI ++DF +
Sbjct: 471 DNVMLDSEGHIKIADFGMC 489
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-37
Identities = 49/129 (37%), Positives = 78/129 (60%), Gaps = 7/129 (5%)
Query: 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY-NV 503
+ +F GT +Y+APEII + +G +VDWW FG+ LYE+L G+ PF+G E+ L+ ++
Sbjct: 496 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEG-EDEDELFQSI 554
Query: 504 VGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLAC-RRGATEIKQHPFFQGVNWALI--R 560
+ + +P+S +S A + KGL+ K P RL C G +IK+H FF+ ++W + +
Sbjct: 555 MEHNVAYPKS--MSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERK 612
Query: 561 CASPPEIPK 569
PP PK
Sbjct: 613 EIQPPYKPK 621
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 3e-44
Identities = 85/367 (23%), Positives = 142/367 (38%), Gaps = 92/367 (25%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSE--LTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQS 269
+G++RLLK +G G+ V L+ LTG + A+K++DK L L + E I++
Sbjct: 14 IGNYRLLKTIGKGNFAKVKLARHILTGRE--VAIKIIDKTQL-NPTSLQKLFREVRIMKI 70
Query: 270 LDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLAL 328
L+HP + L+ ET+K L+ME+ GG++ L G+ ++A + +++ A+
Sbjct: 71 LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKF-RQIVSAV 127
Query: 329 EYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVY 388
+Y H IV+RDLK EN+L+ D +I ++DF S
Sbjct: 128 QYCHQKRIVHRDLKAENLLLDADMNIKIADFGFS-------NEFTVGGKLD--------- 171
Query: 389 CVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448
C +P + + PEL
Sbjct: 172 -------------------AFCGAPPYAA-------------------PELFQGK----- 188
Query: 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPL 508
+Y PE VD W+ G+ LY L+ G PF G +N L V +
Sbjct: 189 -------KYDGPE----------VDVWSLGVILYTLVSGSLPFDG-QNLKELRERVLRG- 229
Query: 509 RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ-GVNWALIRCASPPEI 567
++ +S +L+K LV P R +I + + G ++ PE+
Sbjct: 230 KYRIPFYMSTDCENLLKRFLVLNPIKRGT----LEQIMKDRWINAGHEEDELKPFVEPEL 285
Query: 568 PKPVEIV 574
+
Sbjct: 286 DISDQKR 292
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 4e-43
Identities = 81/357 (22%), Positives = 130/357 (36%), Gaps = 96/357 (26%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPT 277
LG G V T +A+K+++K R ++ R E E+L H +
Sbjct: 19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFR---EVEMLYQCQGHRNVLE 75
Query: 278 LYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGI 336
L FE + LV E GG + + +R ++F+E V +V AL++LH GI
Sbjct: 76 LIEFFEEEDRFYLVFEKMRGGSILSHIHKR---RHFNELEASVVVQDVASALDFLHNKGI 132
Query: 337 VYRDLKPENVLVR---EDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPA 393
+RDLKPEN+L + + + DFDL ++ S + + L
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGD---CSPISTPELL---------- 179
Query: 394 CIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453
T C S + ++P
Sbjct: 180 --------------TPCGSAEY-----------------MAP------------------ 190
Query: 454 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP------ 507
E + + + D W+ G+ LY LL G PF G ++
Sbjct: 191 --EVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248
Query: 508 ---------LRFPESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
FP+ +S +A+DLI LLV++ + RL+ A ++ QHP+ QG
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLS----AAQVLQHPWVQG 301
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 5e-43
Identities = 69/344 (20%), Positives = 122/344 (35%), Gaps = 86/344 (25%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQS 269
V + L++ LG G G V L+ T+ A+K++D ++EI +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD----CPENIKKEICINKM 61
Query: 270 LDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALE 329
L+H + Y H L +E+C GG+L R E + + +++ +
Sbjct: 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFD-RIEPDIG-MPEPDAQRFFHQLMAGVV 119
Query: 330 YLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYC 389
YLH +GI +RD+KPEN+L+ E ++ +SDF L+ V + L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLA---TVFRYNNRERLLN----------- 165
Query: 390 VQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449
C + V+ PEL+
Sbjct: 166 ------------------KMCGTL-----------------PYVA--PELLKR------- 181
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY-NVVGQPL 508
E+ H VD W+ GI L +L G+ P+ + Y + +
Sbjct: 182 -----REF----------HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226
Query: 509 RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
+ + L+ +LV+ P R+ +IK+ ++
Sbjct: 227 YLNPWKKIDSAPLALLHKILVENPSARITIP----DIKKDRWYN 266
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 3e-42
Identities = 80/342 (23%), Positives = 136/342 (39%), Gaps = 86/342 (25%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD 271
+GH+ L LG G G V + E T A+K++++ + + + + E + L+
Sbjct: 10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR 69
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
HP + LY T +VME+ GG+L + G+ +A + + ++L A++Y
Sbjct: 70 HPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLF-QQILSAVDYC 127
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQ 391
H +V+RDLKPENVL+ + ++DF LS
Sbjct: 128 HRHMVVHRDLKPENVLLDAHMNAKIADFGLS----------------------------- 158
Query: 392 PACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451
+ + T+C SP + + PE+I+
Sbjct: 159 ------NMMSDGEFLRTSCGSPNYAA-------------------PEVISG--------- 184
Query: 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN-VVGQPLRF 510
Y PE VD W+ G+ LY LL G PF E+ TL+ + G
Sbjct: 185 ---RLYAGPE----------VDIWSCGVILYALLCGTLPFDD-EHVPTLFKKIRGGVFYI 230
Query: 511 PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
PE ++ S L+ +L +P R + +I++H +F+
Sbjct: 231 PEY--LNRSVATLLMHMLQVDPLKRATIK----DIREHEWFK 266
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-42
Identities = 69/344 (20%), Positives = 122/344 (35%), Gaps = 86/344 (25%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQS 269
V + L++ LG G G V L+ T+ A+K++D ++EI +
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD----CPENIKKEICINKM 61
Query: 270 LDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALE 329
L+H + Y H L +E+C GG+L R E + + +++ +
Sbjct: 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGELFD-RIEPDIG-MPEPDAQRFFHQLMAGVV 119
Query: 330 YLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYC 389
YLH +GI +RD+KPEN+L+ E ++ +SDF L+ V + L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLA---TVFRYNNRERLLN----------- 165
Query: 390 VQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449
C + V+ PEL+
Sbjct: 166 ------------------KMCGTL-----------------PYVA--PELLKR------- 181
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY-NVVGQPL 508
E+ H VD W+ GI L +L G+ P+ + Y + +
Sbjct: 182 -----REF----------HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT 226
Query: 509 RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
+ + L+ +LV+ P R+ +IK+ ++
Sbjct: 227 YLNPWKKIDSAPLALLHKILVENPSARIT----IPDIKKDRWYN 266
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 5e-41
Identities = 67/389 (17%), Positives = 117/389 (30%), Gaps = 90/389 (23%)
Query: 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQS 269
LG R+ + L G VY ++ G+ +A+K + EK + +++ E ++
Sbjct: 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQ---EVCFMKK 81
Query: 270 L-DHPFLPTLYTHFETDKFS--------CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFY 320
L HP + + K L+ E C G + L++ + S V
Sbjct: 82 LSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKI 141
Query: 321 VAEVLLALEYLHMLG--IVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLE 378
+ A++++H I++RDLK EN+L+ G I L DF + S
Sbjct: 142 FYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA-TTISHYPDYSWSAQR 200
Query: 379 SEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPE 438
+ + T +P + + PE
Sbjct: 201 RALVEEE---------------------ITRNTTPMYRT-------------------PE 220
Query: 439 LIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRA 498
+I ++ G D W G LY L F + PF+
Sbjct: 221 II--------------------DLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR 260
Query: 499 TLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWAL 558
+V P LI+ +L P+ RL E+
Sbjct: 261 ----IVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERL----SIAEVVHQLQ-------E 305
Query: 559 IRCASPPEIPKPVEIVHSPAPALSTKAKA 587
I A P+ + + +
Sbjct: 306 IAAARNVNPKSPITELLEQNGGYGSATLS 334
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 7e-41
Identities = 41/150 (27%), Positives = 60/150 (40%), Gaps = 4/150 (2%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DH 272
F+ L +LG G G V+ +A+K + + R E + + H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA-RKLAEVGSHEKVGQH 116
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
P L +E L E C G L + G E V Y+ + LLAL +LH
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLH 174
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
G+V+ D+KP N+ + G L DF L
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLL 204
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 3e-23
Identities = 24/109 (22%), Positives = 43/109 (39%), Gaps = 8/109 (7%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNV 503
T G Y+APE+++G +G+A D ++ G+ + E+ G E L
Sbjct: 209 TAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQG 267
Query: 504 VGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
P F +S R ++ +L +P+ R A + P +
Sbjct: 268 Y-LPPEFTAG--LSSELRSVLVMMLEPDPKLRA----TAEALLALPVLR 309
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 3e-40
Identities = 81/416 (19%), Positives = 133/416 (31%), Gaps = 109/416 (26%)
Query: 174 SDESTCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSE 233
S S H A A + K+ +++ LG G GSVY
Sbjct: 4 SHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGI 63
Query: 234 LTGTKCYFAMKVMDKASLEKRKKLLR-AQTEREI--LQSLDHPFLP---TLYTHFETDKF 287
A+K ++K + +L + E+ L+ + F L FE
Sbjct: 64 RVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF-SGVIRLLDWFERPDS 122
Query: 288 SCLVMEFC-PGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPEN 345
L++E P DL + +R E+ + + +VL A+ + H G+++RD+K EN
Sbjct: 123 FVLILERPEPVQDLFDFITERGA---LQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 179
Query: 346 VLV-REDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSC 404
+L+ G + L DF ++K +
Sbjct: 180 ILIDLNRGELKLIDFGSG-------ALLKDTVYT-------------------------- 206
Query: 405 IAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIK 464
+ + PE I H Y
Sbjct: 207 ---DFDGTRVYSP-------------------PEWIRY------------HRY------- 225
Query: 465 GEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLI 524
HG + W+ GI LY+++ G PF+ E ++ + F VS + LI
Sbjct: 226 ---HGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR--QRVSSECQHLI 274
Query: 525 KGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPKPVEIVHSPAPA 580
+ L P +R EI+ HP+ Q V P E + SP P+
Sbjct: 275 RWCLALRPSDRPT----FEEIQNHPWMQDVL-------LPQETAEIHLHSLSPGPS 319
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 148 bits (375), Expect = 5e-40
Identities = 81/343 (23%), Positives = 142/343 (41%), Gaps = 89/343 (25%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD 271
+G + + + LG G G V L+ T+ A+K + + L+K +R + E L+ L
Sbjct: 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR 67
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEY 330
HP + LY T +V+E+ GG+L + ++ + ++ +F+ +++ A+EY
Sbjct: 68 HPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFF-QQIICAIEY 123
Query: 331 LHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCV 390
H IV+RDLKPEN+L+ ++ ++ ++DF LS
Sbjct: 124 CHRHKIVHRDLKPENLLLDDNLNVKIADFGLS---------------------------- 155
Query: 391 QPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450
+ + T+C SP + + PE+I
Sbjct: 156 -------NIMTDGNFLKTSCGSPNYAA-------------------PEVING-------- 181
Query: 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN-VVGQPLR 509
Y PE VD W+ GI LY +L G+ PF E L+ V
Sbjct: 182 ----KLYAGPE----------VDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKVNSCVYV 226
Query: 510 FPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
P+ +S A+ LI+ ++V +P R+ + EI++ P+F
Sbjct: 227 MPDF--LSPGAQSLIRRMIVADPMQRITIQ----EIRRDPWFN 263
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 7e-40
Identities = 80/374 (21%), Positives = 127/374 (33%), Gaps = 97/374 (25%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEK-----RKKLLRAQTEREI 266
+ + LG G G V+ + +K + K + + KL + E I
Sbjct: 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAI 82
Query: 267 LQSLDHPFLPTLYTHFETDKFSCLVMEF-CPGGDLHTLRQRQPGKYFSEQAVKFYVAEVL 325
L ++H + + FE F LVME G DL R P E + +++
Sbjct: 83 LSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP--RLDEPLASYIFRQLV 140
Query: 326 LALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKN 385
A+ YL + I++RD+K EN+++ ED I L DF ++ LE L
Sbjct: 141 SAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGS------------AAYLERGKLFY- 187
Query: 386 PVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445
T C + + + PE++
Sbjct: 188 ----------------------TFCGTIEYCA-------------------PEVLMG--- 203
Query: 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG 505
+ Y PE ++ W+ G+ LY L+F + PF L V
Sbjct: 204 ---------NPYRGPE----------LEMWSLGVTLYTLVFEENPFCE------LEETVE 238
Query: 506 QPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF-QGVNWALIRCASP 564
+ P +VS L+ GLL P+ R ++ P+ Q VN A
Sbjct: 239 AAIHPP--YLVSKELMSLVSGLLQPVPERRTT----LEKLVTDPWVTQPVNLADYTWEEV 292
Query: 565 PEIPKPVEIVHSPA 578
+ KP V S A
Sbjct: 293 FRVNKPESGVLSAA 306
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-39
Identities = 46/154 (29%), Positives = 82/154 (53%), Gaps = 7/154 (4%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQS 269
+ F++ LG G VY +E T A+K++DK ++ K + + + E+
Sbjct: 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAG--MVQRVQNEVKIHCQ 67
Query: 270 LDHPFLPTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLAL 328
L HP + LY +FE + LV+E C G++ L+ R K FSE + ++ +++ +
Sbjct: 68 LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGM 125
Query: 329 EYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
YLH GI++RDL N+L+ + +I ++DF L+
Sbjct: 126 LYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 6e-25
Identities = 35/100 (35%), Positives = 47/100 (47%), Gaps = 6/100 (6%)
Query: 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE 512
GT Y++PEI HG D W+ G Y LL G+ PF + TL VV P
Sbjct: 174 GTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPS 233
Query: 513 SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
+S A+DLI LL + P +RL+ + + HPF
Sbjct: 234 F--LSIEAKDLIHQLLRRNPADRLS----LSSVLDHPFMS 267
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 3e-39
Identities = 42/152 (27%), Positives = 70/152 (46%), Gaps = 2/152 (1%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH 272
+FR+ KK+G G VY + A+K + L K E ++L+ L+H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHTL--RQRQPGKYFSEQAVKFYVAEVLLALEY 330
P + Y F D +V+E GDL + ++ + E+ V Y ++ ALE+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 331 LHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+H +++RD+KP NV + G + L D L
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLG 183
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 1e-14
Identities = 29/110 (26%), Positives = 46/110 (41%), Gaps = 8/110 (7%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKG-SENRATLYN 502
+ S VGT Y++PE I G+ D W+ G LYE+ ++PF G N +L
Sbjct: 189 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 248
Query: 503 VVGQPLRFPESPVVSFSA--RDLIKGLLVKEPQNRLACRRGATEIKQHPF 550
+ Q +P P +S R L+ + +P+ R T +
Sbjct: 249 KIEQ-CDYPPLPSDHYSEELRQLVNMCINPDPEK----RPDVTYVYDVAK 293
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 40/149 (26%), Positives = 78/149 (52%), Gaps = 1/149 (0%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+ L+K+G G G L + T + +K ++ + + K+ ++ E +L ++ HP
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHP 83
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
+ FE + +VM++C GGDL Q G F E + + ++ LAL+++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLS 362
I++RD+K +N+ + +DG + L DF ++
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIA 172
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 7e-20
Identities = 26/114 (22%), Positives = 47/114 (41%), Gaps = 7/114 (6%)
Query: 440 IAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRAT 499
+ T + + +GT YL+PEI + + + + D W G LYEL K F+ +
Sbjct: 174 VLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL 233
Query: 500 LYNVV-GQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
+ ++ G S+ R L+ L + P++R + I + F
Sbjct: 234 VLKIISGSFPPVSLH--YSYDLRSLVSQLFKRNPRDRPS----VNSILEKGFIA 281
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 4e-39
Identities = 76/345 (22%), Positives = 132/345 (38%), Gaps = 92/345 (26%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD 271
+GH+ L LG G G V + + T A+K++++ + + + + E + L+
Sbjct: 15 IGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR 74
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDLH---TLRQRQPGKYFSEQAVKFYVAEVLLAL 328
HP + LY T +VME+ GG+L R E+ + ++L +
Sbjct: 75 HPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR-----LDEKESRRLFQQILSGV 129
Query: 329 EYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVY 388
+Y H +V+RDLKPENVL+ + ++DF LS
Sbjct: 130 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLS-------------------------- 163
Query: 389 CVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448
+ + T+C SP + + PE+I+
Sbjct: 164 ---------NMMSDGEFLRTSCGSPNYAA-------------------PEVISG------ 189
Query: 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN-VVGQP 507
Y PE VD W+ G+ LY LL G PF ++ TL+ +
Sbjct: 190 ------RLYAGPE----------VDIWSSGVILYALLCGTLPFDD-DHVPTLFKKICDGI 232
Query: 508 LRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
P+ ++ S L+K +L +P R + +I++H +F+
Sbjct: 233 FYTPQY--LNPSVISLLKHMLQVDPMKRATIK----DIREHEWFK 271
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 8e-38
Identities = 42/225 (18%), Positives = 73/225 (32%), Gaps = 26/225 (11%)
Query: 175 DESTCSSLSSSVNKPHKANDAQWEAIQAV----RVKDGVLGVGHFRLLKKLGCGDIGSVY 230
D+ L S ++KP + +E + + LG + LG G VY
Sbjct: 23 DDKLIFKLLSGLSKPVSSYPNTFEWQCKLPAIKPKTEFQLGSKLVYVHHLLGEGAFAQVY 82
Query: 231 LSELTG-----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD 285
+ K F +KV A+ + + E L+ Y+
Sbjct: 83 EATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQ---LMERLKPSMQHMFMKFYSAHLFQ 139
Query: 286 KFSCLVMEFCPGGDLHTL---RQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLK 342
S LV E G L + P K + V + +L +E +H I++ D+K
Sbjct: 140 NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIK 199
Query: 343 PENVLVR-----------EDGHIMLSDFDLSLRCAVSPTVVKSST 376
P+N ++ + L D S+ + P +
Sbjct: 200 PDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 13/99 (13%), Positives = 33/99 (33%), Gaps = 6/99 (6%)
Query: 438 ELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR 497
++ P + T + E++ + +D++ +Y +LFG +E
Sbjct: 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGG 291
Query: 498 ATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRL 536
+ + R P + + + +L + L
Sbjct: 292 ECKPEGLFR--RLPHLDMWN----EFFHVMLNIPDCHHL 324
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 9e-38
Identities = 73/379 (19%), Positives = 121/379 (31%), Gaps = 109/379 (28%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQT-EREIL--- 267
+RL LG G G+V+ + A+KV+ + + L + T E+
Sbjct: 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLW 89
Query: 268 ---QSLDHPFLPTLYTHFETDKFSCLVMEF-CPGGDLH---TLRQRQPGKYFSEQAVKFY 320
HP + L FET + LV+E P DL T + E + +
Sbjct: 90 KVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGP-----LGEGPSRCF 144
Query: 321 VAEVLLALEYLHMLGIVYRDLKPENVLV-REDGHIMLSDFDLSLRCAVSPTVVKSSTLES 379
+V+ A+++ H G+V+RD+K EN+L+ G L DF ++
Sbjct: 145 FGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG-------ALLHDEPYT- 196
Query: 380 EPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPEL 439
+ + PE
Sbjct: 197 ----------------------------DFDGTRVYSP-------------------PEW 209
Query: 440 IAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRAT 499
I+ H+Y H W+ GI LY+++ G PF+ +
Sbjct: 210 IS------------RHQY----------HALPATVWSLGILLYDMVCGDIPFERDQ---- 243
Query: 500 LYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ-GVNWAL 558
++ L FP VS LI+ L +P +R + EI P+ Q
Sbjct: 244 --EILEAELHFP--AHVSPDCCALIRRCLAPKPSSRPS----LEEILLDPWMQTPAEDVP 295
Query: 559 IRCASPPEIPKPVEIVHSP 577
+ + P P+ P
Sbjct: 296 LNPSKGG--PAPLAWSLLP 312
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-37
Identities = 41/152 (26%), Positives = 73/152 (48%), Gaps = 4/152 (2%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD 271
+ + LG G + TK FA K++ K+ L K + + E I +SL
Sbjct: 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 73
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALEY 330
H + + FE + F +V+E C L ++R K +E ++Y+ +++L +Y
Sbjct: 74 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR---KALTEPEARYYLRQIVLGCQY 130
Query: 331 LHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
LH +++RDLK N+ + ED + + DF L+
Sbjct: 131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 97.3 bits (243), Expect = 2e-22
Identities = 31/100 (31%), Positives = 47/100 (47%), Gaps = 6/100 (6%)
Query: 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE 512
GT Y+APE++ +GH VD W+ G +Y LL GK PF+ S + T + P+
Sbjct: 177 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK 236
Query: 513 SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
++ A LI+ +L +P R E+ FF
Sbjct: 237 H--INPVAASLIQKMLQTDPTARPT----INELLNDEFFT 270
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-36
Identities = 42/151 (27%), Positives = 74/151 (49%), Gaps = 2/151 (1%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD 271
+ + LG G + TK FA K++ K+ L K + + E I +SL
Sbjct: 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA 99
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
H + + FE + F +V+E C L L +R+ K +E ++Y+ +++L +YL
Sbjct: 100 HQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYL 157
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
H +++RDLK N+ + ED + + DF L+
Sbjct: 158 HRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 31/100 (31%), Positives = 47/100 (47%), Gaps = 6/100 (6%)
Query: 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE 512
GT Y+APE++ +GH VD W+ G +Y LL GK PF+ S + T + P+
Sbjct: 203 GTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK 262
Query: 513 SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
++ A LI+ +L +P R E+ FF
Sbjct: 263 H--INPVAASLIQKMLQTDPTARPT----INELLNDEFFT 296
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-36
Identities = 40/158 (25%), Positives = 70/158 (44%), Gaps = 10/158 (6%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+ +L +G G G K +D S+ + +E +L+ L HP
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHP 65
Query: 274 FLPTLYTHF--ETDKFSCLVMEFCPGGDLHTL--RQRQPGKYFSEQAVKFYVAEVLLALE 329
+ Y T+ +VME+C GGDL ++ + + +Y E+ V + ++ LAL+
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 330 YLH-----MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
H +++RDLKP NV + ++ L DF L+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 7e-18
Identities = 27/114 (23%), Positives = 46/114 (40%), Gaps = 7/114 (6%)
Query: 440 IAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRAT 499
I + + +FVGT Y++PE + + D W+ G LYEL PF +
Sbjct: 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL 224
Query: 500 LYNVV-GQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
+ G+ R P S ++I +L + +R + EI ++P
Sbjct: 225 AGKIREGKFRRIPYR--YSDELNEIITRMLNLKDYHRPS----VEEILENPLIL 272
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-36
Identities = 42/217 (19%), Positives = 88/217 (40%), Gaps = 18/217 (8%)
Query: 182 LSSSVNKPHK--ANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKC 239
+ SS + H + + V + H+ ++KLG G V L E
Sbjct: 1 MGSSHHHHHHSSGRENLYFQGHMVII-----DNKHYLFIQKLGEGGFSYVDLVEGLHDGH 55
Query: 240 YFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS----CLVMEFC 295
++A+K + + R++ R E ++ + +HP + L + ++ + L++ F
Sbjct: 56 FYALKRILCHEQQDREEAQR---EADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFF 112
Query: 296 PGGDLHTL--RQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGH 353
G L R + G + +E + + + + LE +H G +RDLKP N+L+ ++G
Sbjct: 113 KRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQ 172
Query: 354 IMLSDFDLSLRCAVSPTVVKSSTLESEPLRKN--PVY 388
+L D + + + + + + Y
Sbjct: 173 PVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISY 209
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 24/127 (18%), Positives = 47/127 (37%), Gaps = 15/127 (11%)
Query: 449 MSFVGTHEYLAPEIIKGEGH---GSAVDWWTFGIFLYELLFGKTPFKG-SENRATLYNVV 504
+ T Y APE+ + H D W+ G LY ++FG+ P+ + ++ V
Sbjct: 201 AAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV 260
Query: 505 GQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASP 564
L P+SP S + L+ ++ +P R + ++ +P
Sbjct: 261 QNQLSIPQSPRHSSALWQLLNSMMTVDPHQRP----HIPLLLSQLEA-------LQPPAP 309
Query: 565 PEIPKPV 571
+ +
Sbjct: 310 GQHTTQI 316
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 1e-35
Identities = 52/153 (33%), Positives = 79/153 (51%), Gaps = 7/153 (4%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
++ + LG G G V L + T A+KV+ K ++++ E ++L+ LDHP
Sbjct: 27 RYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHP 86
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
+ LY FE + LV E GG+L + R K FSE + +VL + Y+H
Sbjct: 87 NIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISR---KRFSEVDAARIIRQVLSGITYMH 143
Query: 333 MLGIVYRDLKPENVLVR---EDGHIMLSDFDLS 362
IV+RDLKPEN+L+ +D +I + DF LS
Sbjct: 144 KNKIVHRDLKPENLLLESKSKDANIRIIDFGLS 176
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 34/108 (31%), Positives = 49/108 (45%), Gaps = 7/108 (6%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR 509
+GT Y+APE++ G + D W+ G+ LY LL G PF G+ L V
Sbjct: 187 DKIGTAYYIAPEVLHGT-YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYT 245
Query: 510 FPESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555
F VS SA+DLI+ +L P R++ A + H + Q
Sbjct: 246 FELPQWKKVSESAKDLIRKMLTYVPSMRIS----ARDALDHEWIQTYT 289
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-35
Identities = 49/154 (31%), Positives = 78/154 (50%), Gaps = 7/154 (4%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
F +KLG G G V+L E + +K ++K + + + E E+L+SLDHP
Sbjct: 23 LFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIE--AEIEVLKSLDHP 80
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDL--HTLRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
+ ++ FE +VME C GG+L + + GK SE V + +++ AL Y
Sbjct: 81 NIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYF 140
Query: 332 HMLGIVYRDLKPENVLVR---EDGHIMLSDFDLS 362
H +V++DLKPEN+L + I + DF L+
Sbjct: 141 HSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLA 174
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 8e-20
Identities = 28/104 (26%), Positives = 49/104 (47%), Gaps = 6/104 (5%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR 509
+ GT Y+APE+ K + D W+ G+ +Y LL G PF G+ +
Sbjct: 185 NAAGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPN 243
Query: 510 FPESP-VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
+ ++ A DL+K +L K+P+ R + A ++ H +F+
Sbjct: 244 YAVECRPLTPQAVDLLKQMLTKDPERRPS----AAQVLHHEWFK 283
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 1e-35
Identities = 52/153 (33%), Positives = 77/153 (50%), Gaps = 10/153 (6%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
++ L +G G G V ++ GT+ A K + K +E + + E EI++SLDHP
Sbjct: 10 YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ---EIEIMKSLDHP 66
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
+ LY FE + LVME C GG+L + + + F E + +VL A+ Y H
Sbjct: 67 NIIRLYETFEDNTDIYLVMELCTGGELFERVVHK---RVFRESDAARIMKDVLSAVAYCH 123
Query: 333 MLGIVYRDLKPENVLVR---EDGHIMLSDFDLS 362
L + +RDLKPEN L D + L DF L+
Sbjct: 124 KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLA 156
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 1e-19
Identities = 31/106 (29%), Positives = 53/106 (50%), Gaps = 7/106 (6%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR 509
+ VGT Y++P++++G +G D W+ G+ +Y LL G PF + + +
Sbjct: 167 TKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFT 225
Query: 510 FPESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
FPE VS A LI+ LL K P+ R+ + + +H +F+
Sbjct: 226 FPEKDWLNVSPQAESLIRRLLTKSPKQRIT----SLQALEHEWFEK 267
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 3e-35
Identities = 50/153 (32%), Positives = 80/153 (52%), Gaps = 10/153 (6%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
F ++ LG G V+L + T FA+K + K+ + L E +L+ + H
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLEN---EIAVLKKIKHE 66
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
+ TL +E+ LVM+ GG+L + +R ++E+ + +VL A++YLH
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG---VYTEKDASLVIQQVLSAVKYLH 123
Query: 333 MLGIVYRDLKPENVLVR---EDGHIMLSDFDLS 362
GIV+RDLKPEN+L E+ IM++DF LS
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLS 156
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 1e-19
Identities = 34/109 (31%), Positives = 50/109 (45%), Gaps = 10/109 (9%)
Query: 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV--GQ 506
+ GT Y+APE++ + + AVD W+ G+ Y LL G PF E + L+ + G
Sbjct: 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE-ETESKLFEKIKEGY 223
Query: 507 PLRFPESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
F +S SA+D I LL K+P R + HP+ G
Sbjct: 224 -YEFESPFWDDISESAKDFICHLLEKDPNERYT----CEKALSHPWIDG 267
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 3e-35
Identities = 42/155 (27%), Positives = 70/155 (45%), Gaps = 9/155 (5%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
+ L LG G +V+ T FA+KV + S + + E E+L+ L+H
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM--REFEVLKKLNHKN 68
Query: 275 LPTLYTHFE--TDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
+ L+ E T + L+MEFCP G L+T L + E + +V+ + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 332 HMLGIVYRDLKPENVLVR----EDGHIMLSDFDLS 362
GIV+R++KP N++ L+DF +
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 74.4 bits (183), Expect = 1e-14
Identities = 22/139 (15%), Positives = 45/139 (32%), Gaps = 39/139 (28%)
Query: 449 MSFVGTHEYLAPEIIKG--------EGHGSAVDWWTFGIFLYELLFGKTPFK----GSEN 496
+S GT EYL P++ + + +G+ VD W+ G+ Y G PF+ N
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232
Query: 497 RATLYNVV---------------GQPLRFPE--------SPVVSFSARDLIKGLLVKEPQ 533
+ +Y ++ P+ + S + ++ +L + +
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
Query: 534 NRLACRRGATEIKQHPFFQ 552
G +
Sbjct: 293 KCW----GFDQFFAETSDI 307
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 4e-35
Identities = 31/164 (18%), Positives = 65/164 (39%), Gaps = 23/164 (14%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F+ ++ +G G G V+ ++ + +K + +K R E + L LDH
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY----NNEKAER---EVKALAKLDHVN 65
Query: 275 LPTLYTHFETDKFS----------------CLVMEFCPGGDLHTLRQRQPGKYFSEQAVK 318
+ ++ + + MEFC G L +++ G+ +
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 319 FYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++ ++Y+H ++ RDLKP N+ + + + + DF L
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLV 169
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 26/105 (24%), Positives = 45/105 (42%), Gaps = 12/105 (11%)
Query: 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQP 507
GT Y++PE I + +G VD + G+ L ELL T F+ S+ L + +
Sbjct: 179 TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETSKFFTDLRDGI--- 235
Query: 508 LRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
+ + L++ LL K+P++R +EI +
Sbjct: 236 --IS--DIFDKKEKTLLQKLLSKKPEDRPN----TSEILRTLTVW 272
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-35
Identities = 52/153 (33%), Positives = 78/153 (50%), Gaps = 8/153 (5%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+ ++ LG G G V + T+ +A+KV++KAS K K E E+L+ LDHP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHP 81
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
+ L+ E +V E GG+L + +R K FSE + +V + Y+H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMH 138
Query: 333 MLGIVYRDLKPENVLVR---EDGHIMLSDFDLS 362
IV+RDLKPEN+L+ +D I + DF LS
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-19
Identities = 34/108 (31%), Positives = 51/108 (47%), Gaps = 7/108 (6%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR 509
+GT Y+APE+++G + D W+ G+ LY LL G PF G L V
Sbjct: 182 DRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA 240
Query: 510 FPESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555
F +S A+DLI+ +L P R+ AT+ +HP+ Q +
Sbjct: 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRIT----ATQCLEHPWIQKYS 284
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 6e-35
Identities = 43/156 (27%), Positives = 68/156 (43%), Gaps = 7/156 (4%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTERE--ILQSLD 271
+ L + +G G V T FA+K++D A L +RE I L
Sbjct: 25 VYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDL--HTLRQRQPGKYFSEQAVKFYVAEVLLALE 329
HP + L + +D +V EF G DL +++ G +SE Y+ ++L AL
Sbjct: 85 HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALR 144
Query: 330 YLHMLGIVYRDLKPENVLVR---EDGHIMLSDFDLS 362
Y H I++RD+KP VL+ + L F ++
Sbjct: 145 YCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA 180
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 5e-19
Identities = 32/105 (30%), Positives = 54/105 (51%), Gaps = 7/105 (6%)
Query: 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRF 510
VGT ++APE++K E +G VD W G+ L+ LL G PF G++ R ++ +
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKM 251
Query: 511 PESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
+S SA+DL++ +L+ +P R+ E HP+ +
Sbjct: 252 NPRQWSHISESAKDLVRRMLMLDPAERIT----VYEALNHPWLKE 292
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 7e-35
Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 7/166 (4%)
Query: 201 QAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRA 260
Q V VK G + ++ +L++LG G G V+ T F K ++ + +
Sbjct: 40 QPVEVKQGSVY-DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKN- 97
Query: 261 QTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFY 320
E I+ L HP L L+ FE L++EF GG+L R SE V Y
Sbjct: 98 --EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFD-RIAAEDYKMSEAEVINY 154
Query: 321 VAEVLLALEYLHMLGIVYRDLKPENVLV--REDGHIMLSDFDLSLR 364
+ + L+++H IV+ D+KPEN++ ++ + + DF L+ +
Sbjct: 155 MRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATK 200
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 1e-19
Identities = 40/104 (38%), Positives = 52/104 (50%), Gaps = 6/104 (5%)
Query: 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFP 511
T E+ APEI+ E G D W G+ Y LL G +PF G ++ TL NV F
Sbjct: 211 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD 270
Query: 512 ES--PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
E VS A+D IK LL KEP+ RL + +HP+ +G
Sbjct: 271 EDAFSSVSPEAKDFIKNLLQKEPRKRLT----VHDALEHPWLKG 310
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 2e-34
Identities = 54/153 (35%), Positives = 77/153 (50%), Gaps = 8/153 (5%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
++ +KKLG G G V L T A+K++ K S+ + E +L+ LDHP
Sbjct: 38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSV-STSSNSKLLEEVAVLKLLDHP 96
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
+ LY FE + LVME GG+L + R F+E + +VL + YLH
Sbjct: 97 NIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHR---MKFNEVDAAVIIKQVLSGVTYLH 153
Query: 333 MLGIVYRDLKPENVLVR---EDGHIMLSDFDLS 362
IV+RDLKPEN+L+ +D I + DF LS
Sbjct: 154 KHNIVHRDLKPENLLLESKEKDALIKIVDFGLS 186
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 92.1 bits (229), Expect = 8e-20
Identities = 33/122 (27%), Positives = 56/122 (45%), Gaps = 7/122 (5%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR 509
+GT Y+APE+++ + + D W+ G+ L+ LL G PF G ++ L V
Sbjct: 197 ERLGTAYYIAPEVLRKK-YDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYT 255
Query: 510 FPESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEI 567
F VS A+DLIK +L + Q R++ A + +HP+ + + P +
Sbjct: 256 FDSPEWKNVSEGAKDLIKQMLQFDSQRRIS----AQQALEHPWIKEMCSKKESGIELPSL 311
Query: 568 PK 569
Sbjct: 312 AN 313
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 2e-34
Identities = 51/153 (33%), Positives = 78/153 (50%), Gaps = 8/153 (5%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+ ++ LG G G V + T+ +A+KV++KAS + K E E+L+ LDHP
Sbjct: 23 RYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHP 81
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
+ L+ E +V E GG+L + +R K FSE + +V + Y+H
Sbjct: 82 NIMKLFEILEDSSSFYIVGELYTGGELFDEIIKR---KRFSEHDAARIIKQVFSGITYMH 138
Query: 333 MLGIVYRDLKPENVLVR---EDGHIMLSDFDLS 362
IV+RDLKPEN+L+ +D I + DF LS
Sbjct: 139 KHNIVHRDLKPENILLESKEKDCDIKIIDFGLS 171
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 84.6 bits (210), Expect = 3e-18
Identities = 34/106 (32%), Positives = 50/106 (47%), Gaps = 7/106 (6%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR 509
+GT Y+APE+++G + D W+ G+ LY LL G PF G L V
Sbjct: 182 DRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYA 240
Query: 510 FPESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
F +S A+DLI+ +L P R+ AT+ +HP+ Q
Sbjct: 241 FDLPQWRTISDDAKDLIRKMLTFHPSLRIT----ATQCLEHPWIQK 282
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 2e-34
Identities = 42/155 (27%), Positives = 70/155 (45%), Gaps = 9/155 (5%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
+ L LG G +V+ T FA+KV + S + + E E+L+ L+H
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQM--REFEVLKKLNHKN 68
Query: 275 LPTLYTHFE--TDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
+ L+ E T + L+MEFCP G L+T L + E + +V+ + +L
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 332 HMLGIVYRDLKPENVLVR----EDGHIMLSDFDLS 362
GIV+R++KP N++ L+DF +
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 2e-12
Identities = 21/125 (16%), Positives = 43/125 (34%), Gaps = 35/125 (28%)
Query: 449 MSFVGTHEYLAPEIIKG--------EGHGSAVDWWTFGIFLYELLFGKTPFK----GSEN 496
+S GT EYL P++ + + +G+ VD W+ G+ Y G PF+ N
Sbjct: 173 VSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN 232
Query: 497 RATLYNVV---------------GQPLRFPE--------SPVVSFSARDLIKGLLVKEPQ 533
+ +Y ++ P+ + S + ++ +L + +
Sbjct: 233 KEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQE 292
Query: 534 NRLAC 538
Sbjct: 293 KCWGF 297
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 4e-34
Identities = 53/240 (22%), Positives = 94/240 (39%), Gaps = 14/240 (5%)
Query: 130 ASAKVSDGTSSLPKTSGSAKISDRGDYVESGKSSMCRGSTSSDVSDESTCSSLSSSVNKP 189
+ + S R + E+ + T S+L+ + P
Sbjct: 10 SGVDLGTENLYFQSMKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAP 69
Query: 190 HKANDAQWEAIQAVRVKDGVLGVGHFRLLKK--LGCGDIGSVYLSELTGTKCYFAMKVMD 247
D + + V + + K LG G G V+ E T T A K++
Sbjct: 70 PAPFDHRIVTAKQGAVNS------FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIK 123
Query: 248 KASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQ 307
++ ++++ E ++ LDH L LY FE+ LVME+ GG+L R
Sbjct: 124 TRGMKDKEEVKN---EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFD-RIID 179
Query: 308 PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV--REDGHIMLSDFDLSLRC 365
+E ++ ++ + ++H + I++ DLKPEN+L R+ I + DF L+ R
Sbjct: 180 ESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRY 239
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 4e-19
Identities = 32/106 (30%), Positives = 52/106 (49%), Gaps = 6/106 (5%)
Query: 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFP 511
GT E+LAPE++ + D W+ G+ Y LL G +PF G + TL N++
Sbjct: 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLE 308
Query: 512 ES--PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555
+ +S A++ I LL+KE R++ A+E +HP+
Sbjct: 309 DEEFQDISEEAKEFISKLLIKEKSWRIS----ASEALKHPWLSDHK 350
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 129 bits (328), Expect = 5e-34
Identities = 46/157 (29%), Positives = 78/157 (49%), Gaps = 11/157 (7%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLE-KRKKLLRAQTERE--ILQSL 270
H+ + ++LG G V GT +A K + K L R+ + R + ERE IL+ +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 271 DHPFLPTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALE 329
HP + TL+ FE L++E GG+L L ++ + +E ++ ++L +
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEK---ESLTEDEATQFLKQILDGVH 122
Query: 330 YLHMLGIVYRDLKPENVLV----REDGHIMLSDFDLS 362
YLH I + DLKPEN+++ + I L DF ++
Sbjct: 123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIA 159
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 3e-20
Identities = 35/105 (33%), Positives = 52/105 (49%), Gaps = 6/105 (5%)
Query: 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRF 510
GT E++APEI+ E G D W+ G+ Y LL G +PF G + TL N+ F
Sbjct: 171 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDF 230
Query: 511 PESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
E S A+D I+ LLVK+P+ R+ + +H + +
Sbjct: 231 DEEYFSNTSELAKDFIRRLLVKDPKRRMT----IAQSLEHSWIKA 271
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-34
Identities = 38/189 (20%), Positives = 74/189 (39%), Gaps = 17/189 (8%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F ++ LG G G V+ ++ C +A+K + + E ++ + E + L L+HP
Sbjct: 7 FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE--KVMREVKALAKLEHPG 64
Query: 275 LPTLYTHFETD------------KFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYV 321
+ + + + + M+ C +L + R +
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 322 AEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEP 381
++ A+E+LH G+++RDLKP N+ D + + DF L A+ + + L P
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV--TAMDQDEEEQTVLTPMP 182
Query: 382 LRKNPVYCV 390
V
Sbjct: 183 AYARHTGQV 191
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 1e-18
Identities = 33/128 (25%), Positives = 51/128 (39%), Gaps = 9/128 (7%)
Query: 429 MGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGK 488
M L P AR VGT Y++PE I G + VD ++ G+ L+ELL
Sbjct: 168 MDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL--- 224
Query: 489 TPFKGSENRATLYNVVGQPLRFPESPV-VSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547
PF R V + L+FP +++ +L P R A I +
Sbjct: 225 YPFSTQMERVRTLTDV-RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPE----AINIIE 279
Query: 548 HPFFQGVN 555
+ F+ ++
Sbjct: 280 NAVFEDLD 287
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 5e-34
Identities = 52/229 (22%), Positives = 87/229 (37%), Gaps = 20/229 (8%)
Query: 139 SSLPKTSGSAKISDRGDYVESGKSSMCRGSTSSDVSDESTCSSLSSSVNKPHKANDAQWE 198
++ G + RG V+ + T S D +P +
Sbjct: 97 TAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVE------- 149
Query: 199 AIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLL 258
I+ V D H+ + ++LG G G V+ T FA K + ++ +
Sbjct: 150 -IKHDHVLD------HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR 202
Query: 259 RAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVK 318
+ E + + L HP L L+ FE D ++ EF GG+L + SE
Sbjct: 203 K---EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFE-KVADEHNKMSEDEAV 258
Query: 319 FYVAEVLLALEYLHMLGIVYRDLKPENVLV--REDGHIMLSDFDLSLRC 365
Y+ +V L ++H V+ DLKPEN++ + + L DF L+
Sbjct: 259 EYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL 307
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 8e-19
Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 6/106 (5%)
Query: 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFP 511
GT E+ APE+ +G+ G D W+ G+ Y LL G +PF G + TL NV
Sbjct: 317 TGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMD 376
Query: 512 ES--PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555
+S +S +D I+ LL+ +P R+ + +HP+ N
Sbjct: 377 DSAFSGISEDGKDFIRKLLLADPNTRMT----IHQALEHPWLTPGN 418
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-33
Identities = 36/151 (23%), Positives = 68/151 (45%), Gaps = 7/151 (4%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+ + + LG G+ G V+ T +K + K + + + + E IL H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKK---EISILNIARHR 61
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
+ L+ FE+ + ++ EF G D+ R +E+ + YV +V AL++LH
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFE-RINTSAFELNEREIVSYVHQVCEALQFLHS 120
Query: 334 LGIVYRDLKPENVLV--REDGHIMLSDFDLS 362
I + D++PEN++ R I + +F +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 33/104 (31%), Positives = 51/104 (49%), Gaps = 6/104 (5%)
Query: 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFP 511
EY APE+ + + +A D W+ G +Y LL G PF N+ + N++ F
Sbjct: 164 FTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFD 223
Query: 512 ESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
E +S A D + LLVKE ++R+ A+E QHP+ +
Sbjct: 224 EEAFKEISIEAMDFVDRLLVKERKSRMT----ASEALQHPWLKQ 263
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 11/157 (7%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRK----KLLRAQTERE--IL 267
++ + LG G V T +A+K++D + LR T +E IL
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 268 QSLD-HPFLPTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVL 325
+ + HP + L +ET+ F LV + G+L L ++ SE+ + + +L
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK---VTLSEKETRKIMRALL 134
Query: 326 LALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ LH L IV+RDLKPEN+L+ +D +I L+DF S
Sbjct: 135 EVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 171
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 9e-19
Identities = 39/118 (33%), Positives = 53/118 (44%), Gaps = 12/118 (10%)
Query: 451 FVGTHEYLAPEIIKG------EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV 504
GT YLAPEII+ G+G VD W+ G+ +Y LL G PF + L ++
Sbjct: 183 VCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242
Query: 505 GQPLRFPESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIR 560
+F S + +DL+ LV +PQ R A E HPFFQ +R
Sbjct: 243 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYT----AEEALAHPFFQQYVVEEVR 296
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 12/155 (7%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKR--KKLLRAQTEREILQSLD 271
++ + ++LG G V T FA K+++ L R +KL R E I + L
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKLQ 63
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALEY 330
HP + L+ + + F LV + GG+L + R +++SE + ++L ++ Y
Sbjct: 64 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAY 120
Query: 331 LHMLGIVYRDLKPENVLVR---EDGHIMLSDFDLS 362
H GIV+R+LKPEN+L+ + + L+DF L+
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 155
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 89.5 bits (223), Expect = 5e-20
Identities = 29/105 (27%), Positives = 46/105 (43%), Gaps = 6/105 (5%)
Query: 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRF 510
F GT YL+PE++K + + VD W G+ LY LL G PF + + +
Sbjct: 167 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY 226
Query: 511 PESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
P V+ A+ LI +L P+ R+ A + + P+
Sbjct: 227 PSPEWDTVTPEAKSLIDSMLTVNPKKRIT----ADQALKVPWICN 267
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 3e-33
Identities = 46/157 (29%), Positives = 76/157 (48%), Gaps = 11/157 (7%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASL-EKRKKLLRAQTERE--ILQSL 270
+ + ++LG G V T +A K + K R+ + R + ERE IL+ +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 271 DHPFLPTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALE 329
HP + TL+ +E L++E GG+L L Q++ SE+ ++ ++L +
Sbjct: 73 LHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVN 129
Query: 330 YLHMLGIVYRDLKPENVLVR----EDGHIMLSDFDLS 362
YLH I + DLKPEN+++ HI L DF L+
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 1e-19
Identities = 38/105 (36%), Positives = 51/105 (48%), Gaps = 6/105 (5%)
Query: 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRF 510
GT E++APEI+ E G D W+ G+ Y LL G +PF G + TL N+ F
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDF 237
Query: 511 PESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
E S A+D I+ LLVKE + RL E +HP+
Sbjct: 238 DEEFFSQTSELAKDFIRKLLVKETRKRLT----IQEALRHPWITP 278
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-33
Identities = 47/191 (24%), Positives = 76/191 (39%), Gaps = 42/191 (21%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTERE--ILQSLD 271
+ L +G G G V ++ T+ A+K+M+K + + + + E +++ L
Sbjct: 27 KYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDL------------------------------- 300
HP + LY +E +++ CLVME C GG L
Sbjct: 87 HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECN 146
Query: 301 -------HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV--RED 351
+ E+ + + ++ AL YLH GI +RD+KPEN L +
Sbjct: 147 EEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKS 206
Query: 352 GHIMLSDFDLS 362
I L DF LS
Sbjct: 207 FEIKLVDFGLS 217
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 4e-21
Identities = 33/106 (31%), Positives = 48/106 (45%), Gaps = 8/106 (7%)
Query: 451 FVGTHEYLAPEIIKGEGH--GSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPL 508
GT ++APE++ G D W+ G+ L+ LL G PF G + T+ V+ + L
Sbjct: 234 KAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKL 293
Query: 509 RFPESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
F V+S ARDL+ LL + R A QHP+
Sbjct: 294 CFENPNYNVLSPLARDLLSNLLNRNVDERF----DAMRALQHPWIS 335
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-33
Identities = 45/160 (28%), Positives = 75/160 (46%), Gaps = 11/160 (6%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASL-EKRKKLLRAQTERE--ILQSL 270
+ + ++LG G V T +A K + K R+ + R + ERE IL+ +
Sbjct: 13 FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 271 DHPFLPTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALE 329
H + TL+ +E L++E GG+L L Q++ SE+ ++ ++L +
Sbjct: 73 LHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKE---SLSEEEATSFIKQILDGVN 129
Query: 330 YLHMLGIVYRDLKPENVLVR----EDGHIMLSDFDLSLRC 365
YLH I + DLKPEN+++ HI L DF L+
Sbjct: 130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 3e-20
Identities = 38/105 (36%), Positives = 51/105 (48%), Gaps = 6/105 (5%)
Query: 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRF 510
GT E++APEI+ E G D W+ G+ Y LL G +PF G + TL N+ F
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDF 237
Query: 511 PESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
E S A+D I+ LLVKE + RL E +HP+
Sbjct: 238 DEEFFSHTSELAKDFIRKLLVKETRKRLT----IQEALRHPWITP 278
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 5e-33
Identities = 52/158 (32%), Positives = 81/158 (51%), Gaps = 13/158 (8%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASL-----EKRKKLLRAQTEREILQ 268
+ + K LG G G V L+ T A+K++ K + L +TE EIL+
Sbjct: 11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 269 SLDHPFLPTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLA 327
L+HP + + F+ + + +V+E GG+L + + E K Y ++LLA
Sbjct: 71 KLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNK---RLKEATCKLYFYQMLLA 126
Query: 328 LEYLHMLGIVYRDLKPENVLVR---EDGHIMLSDFDLS 362
++YLH GI++RDLKPENVL+ ED I ++DF S
Sbjct: 127 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 6e-18
Identities = 36/110 (32%), Positives = 52/110 (47%), Gaps = 12/110 (10%)
Query: 451 FVGTHEYLAPEIIKG---EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV--G 505
GT YLAPE++ G+ AVD W+ G+ L+ L G PF + +L + + G
Sbjct: 176 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 235
Query: 506 QPLRFPESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
+ F VS A DL+K LLV +P+ R E +HP+ Q
Sbjct: 236 K-YNFIPEVWAEVSEKALDLVKKLLVVDPKARFT----TEEALRHPWLQD 280
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-33
Identities = 52/158 (32%), Positives = 81/158 (51%), Gaps = 13/158 (8%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASL-----EKRKKLLRAQTEREILQ 268
+ + K LG G G V L+ T A++++ K + L +TE EIL+
Sbjct: 136 EYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK 195
Query: 269 SLDHPFLPTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLA 327
L+HP + + F+ + + +V+E GG+L + K E K Y ++LLA
Sbjct: 196 KLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGN---KRLKEATCKLYFYQMLLA 251
Query: 328 LEYLHMLGIVYRDLKPENVLVR---EDGHIMLSDFDLS 362
++YLH GI++RDLKPENVL+ ED I ++DF S
Sbjct: 252 VQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 6e-18
Identities = 36/110 (32%), Positives = 52/110 (47%), Gaps = 12/110 (10%)
Query: 451 FVGTHEYLAPEIIKG---EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV--G 505
GT YLAPE++ G+ AVD W+ G+ L+ L G PF + +L + + G
Sbjct: 301 LCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSG 360
Query: 506 QPLRFPESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
+ F VS A DL+K LLV +P+ R E +HP+ Q
Sbjct: 361 K-YNFIPEVWAEVSEKALDLVKKLLVVDPKARFT----TEEALRHPWLQD 405
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 7e-33
Identities = 43/157 (27%), Positives = 76/157 (48%), Gaps = 11/157 (7%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLE-KRKKLLRAQTERE--ILQSL 270
++ ++LG G V T +A K + K + R+ + R ERE IL+ +
Sbjct: 12 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 271 DHPFLPTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALE 329
HP + TL+ +E L++E GG+L L ++ + +E+ ++ ++L +
Sbjct: 72 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVY 128
Query: 330 YLHMLGIVYRDLKPENVLVR----EDGHIMLSDFDLS 362
YLH L I + DLKPEN+++ I + DF L+
Sbjct: 129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 2e-20
Identities = 37/105 (35%), Positives = 53/105 (50%), Gaps = 6/105 (5%)
Query: 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRF 510
GT E++APEI+ E G D W+ G+ Y LL G +PF G + TL NV F
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 511 PESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
+ S A+D I+ LLVK+P+ R+ + QHP+ +
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMT----IQDSLQHPWIKP 277
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 9e-33
Identities = 51/252 (20%), Positives = 93/252 (36%), Gaps = 18/252 (7%)
Query: 120 QEKKPSEAGPASAKVSDGTSSLPKTSGSAKISDRG--DYVESGKSSMCRGSTSSDVSDES 177
+ + + + R + S + +++
Sbjct: 5 HHHSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDA 64
Query: 178 TCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGT 237
+ + D + A + +G G V T
Sbjct: 65 QPKGTENLYFQSMGPEDELPDWAAAKEFYQ------KYDPKDVIGRGVSSVVRRCVHRAT 118
Query: 238 KCYFAMKVMDKASL---EKRKKLLRAQTERE--ILQSL-DHPFLPTLYTHFETDKFSCLV 291
FA+K+M+ + ++ + +R T RE IL+ + HP + TL +E+ F LV
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178
Query: 292 MEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE 350
+ G+L L ++ SE+ + + +L A+ +LH IV+RDLKPEN+L+ +
Sbjct: 179 FDLMRKGELFDYLTEK---VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDD 235
Query: 351 DGHIMLSDFDLS 362
+ I LSDF S
Sbjct: 236 NMQIRLSDFGFS 247
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 80.9 bits (200), Expect = 1e-16
Identities = 37/111 (33%), Positives = 53/111 (47%), Gaps = 14/111 (12%)
Query: 451 FVGTHEYLAPEIIKG------EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV 504
GT YLAPEI+K G+G VD W G+ L+ LL G PF + + ++
Sbjct: 259 LCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWH-RRQILMLRMI 317
Query: 505 GQ-PLRFPESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
+ +F S + +DLI LL +P+ RL A + QHPFF+
Sbjct: 318 MEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLT----AEQALQHPFFE 364
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-33
Identities = 51/163 (31%), Positives = 77/163 (47%), Gaps = 17/163 (10%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRA----------QTE 263
+ ++KLG G G V L + A+KV+ K+ +K + E
Sbjct: 37 SYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 264 REILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVA 322
+L+SLDHP + L+ FE K+ LV EF GG+L + R F E +
Sbjct: 97 ISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINR---HKFDECDAANIMK 153
Query: 323 EVLLALEYLHMLGIVYRDLKPENVLVR---EDGHIMLSDFDLS 362
++L + YLH IV+RD+KPEN+L+ +I + DF LS
Sbjct: 154 QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS 196
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 1e-18
Identities = 28/106 (26%), Positives = 48/106 (45%), Gaps = 7/106 (6%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR 509
+GT Y+APE++K + + D W+ G+ +Y LL G PF G ++ + V
Sbjct: 207 DRLGTAYYIAPEVLKKK-YNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265
Query: 510 FPESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
F + +S A++LIK +L + R A E + +
Sbjct: 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCT----AEEALNSRWIKK 307
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 1e-32
Identities = 44/152 (28%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+ +LK++G G V+ L K +A+K ++ + + L + E L L
Sbjct: 29 IYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQH 86
Query: 274 FLP--TLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEY 330
LY + TD++ +VME C DL++ L+++ K K Y +L A+
Sbjct: 87 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHT 142
Query: 331 LHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+H GIV+ DLKP N L+ DG + L DF ++
Sbjct: 143 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIA 173
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 31/121 (25%), Positives = 53/121 (43%), Gaps = 16/121 (13%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEG-----------HGSAVDWWTFGIFLYELLFGKTPFK 492
T+ S VGT Y+ PE IK D W+ G LY + +GKTPF+
Sbjct: 181 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240
Query: 493 GSENR-ATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551
N+ + L+ ++ + +D++K L ++P+ R++ E+ HP+
Sbjct: 241 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS----IPELLAHPYV 296
Query: 552 Q 552
Q
Sbjct: 297 Q 297
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 3e-32
Identities = 45/155 (29%), Positives = 78/155 (50%), Gaps = 12/155 (7%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKR--KKLLRAQTEREILQSLD 271
++ + ++LG G V T FA K+++ L R +KL R E I + L
Sbjct: 30 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRKLQ 86
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALEY 330
HP + L+ + + F LV + GG+L + R +++SE + ++L ++ Y
Sbjct: 87 HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR---EFYSEADASHCIQQILESIAY 143
Query: 331 LHMLGIVYRDLKPENVLVR---EDGHIMLSDFDLS 362
H GIV+R+LKPEN+L+ + + L+DF L+
Sbjct: 144 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLA 178
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 6e-19
Identities = 29/105 (27%), Positives = 46/105 (43%), Gaps = 6/105 (5%)
Query: 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRF 510
F GT YL+PE++K + + VD W G+ LY LL G PF + + +
Sbjct: 190 FAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDY 249
Query: 511 PESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
P V+ A+ LI +L P+ R+ A + + P+
Sbjct: 250 PSPEWDTVTPEAKSLIDSMLTVNPKKRIT----ADQALKVPWICN 290
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-32
Identities = 40/155 (25%), Positives = 74/155 (47%), Gaps = 12/155 (7%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEK--RKKLLRAQTEREILQSLD 271
++L ++LG G V +A +++ L +KL R E I + L
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER---EARICRLLK 68
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALEY 330
HP + L+ + L+ + GG+L + R +Y+SE + ++L A+ +
Sbjct: 69 HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAR---EYYSEADASHCIQQILEAVLH 125
Query: 331 LHMLGIVYRDLKPENVLVR---EDGHIMLSDFDLS 362
H +G+V+R+LKPEN+L+ + + L+DF L+
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLA 160
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 1e-18
Identities = 37/107 (34%), Positives = 53/107 (49%), Gaps = 10/107 (9%)
Query: 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV--GQPL 508
F GT YL+PE+++ + +G VD W G+ LY LL G PF E++ LY + G
Sbjct: 173 FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD-EDQHRLYQQIKAGA-Y 230
Query: 509 RFPESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
FP V+ A+DLI +L P R+ A E +HP+
Sbjct: 231 DFPSPEWDTVTPEAKDLINKMLTINPSKRIT----AAEALKHPWISH 273
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 44/152 (28%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+ +LK++G G V+ L K +A+K ++ + + L + E L L
Sbjct: 10 IYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQH 67
Query: 274 FLP--TLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEY 330
LY + TD++ +VME C DL++ L+++ K K Y +L A+
Sbjct: 68 SDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKK---KSIDPWERKSYWKNMLEAVHT 123
Query: 331 LHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+H GIV+ DLKP N L+ DG + L DF ++
Sbjct: 124 IHQHGIVHSDLKPANFLI-VDGMLKLIDFGIA 154
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 31/121 (25%), Positives = 53/121 (43%), Gaps = 16/121 (13%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEG-----------HGSAVDWWTFGIFLYELLFGKTPFK 492
T+ S VGT Y+ PE IK D W+ G LY + +GKTPF+
Sbjct: 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221
Query: 493 GSENR-ATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551
N+ + L+ ++ + +D++K L ++P+ R++ E+ HP+
Sbjct: 222 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS----IPELLAHPYV 277
Query: 552 Q 552
Q
Sbjct: 278 Q 278
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 1e-31
Identities = 49/198 (24%), Positives = 86/198 (43%), Gaps = 11/198 (5%)
Query: 168 STSSDVSDESTCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIG 227
S + + + ++ P D +A + V G + +LK++G G
Sbjct: 12 PRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKG-RIYSILKQIGSGGSS 70
Query: 228 SVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLP--TLYTHFETD 285
V+ L K +A+K ++ + + L + E L L LY + TD
Sbjct: 71 KVFQV-LNEKKQIYAIKYVNLEEADN-QTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 128
Query: 286 KFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPE 344
++ +VME C DL++ L++++ K Y +L A+ +H GIV+ DLKP
Sbjct: 129 QYIYMVME-CGNIDLNSWLKKKKS---IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA 184
Query: 345 NVLVREDGHIMLSDFDLS 362
N L+ DG + L DF ++
Sbjct: 185 NFLI-VDGMLKLIDFGIA 201
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 94.1 bits (234), Expect = 7e-21
Identities = 30/121 (24%), Positives = 52/121 (42%), Gaps = 16/121 (13%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEG-----------HGSAVDWWTFGIFLYELLFGKTPFK 492
T+ S VG Y+ PE IK D W+ G LY + +GKTPF+
Sbjct: 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268
Query: 493 GSENR-ATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551
N+ + L+ ++ + +D++K L ++P+ R++ E+ HP+
Sbjct: 269 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRIS----IPELLAHPYV 324
Query: 552 Q 552
Q
Sbjct: 325 Q 325
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-31
Identities = 37/162 (22%), Positives = 64/162 (39%), Gaps = 4/162 (2%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DH 272
F L+K+G G+ GSV+ C +A+K K + A E L H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQ-NALREVYAHAVLGQH 70
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHTL--RQRQPGKYFSEQAVKFYVAEVLLALEY 330
+ ++ + D + E+C GG L + YF E +K + +V L Y
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 331 LHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372
+H + +V+ D+KP N+ + + + S V+
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM 172
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 1e-12
Identities = 16/105 (15%), Positives = 38/105 (36%), Gaps = 9/105 (8%)
Query: 449 MSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP 507
G +LA E+++ H D + + + + + + + G+
Sbjct: 188 QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHEIRQ--GRL 245
Query: 508 LRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
R P+ +S +L+K ++ +P+ R A + +H
Sbjct: 246 PRIPQV--LSQEFTELLKVMIHPDPERRP----SAMALVKHSVLL 284
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 9e-31
Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 9/150 (6%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTERE--ILQSLDH-PFL 275
K+LG G V T +A K + K +R + RA+ E +L+ P +
Sbjct: 35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKR---RRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 276 PTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLG 335
L+ +E L++E+ GG++ +L + + SE V + ++L + YLH
Sbjct: 92 INLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN 151
Query: 336 IVYRDLKPENVLV---REDGHIMLSDFDLS 362
IV+ DLKP+N+L+ G I + DF +S
Sbjct: 152 IVHLDLKPQNILLSSIYPLGDIKIVDFGMS 181
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 7e-20
Identities = 38/109 (34%), Positives = 53/109 (48%), Gaps = 6/109 (5%)
Query: 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRF 510
+GT EYLAPEI+ + +A D W GI Y LL +PF G +N+ T N+ + +
Sbjct: 193 IMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDY 252
Query: 511 PESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557
E VS A D I+ LLVK P+ R A H + Q ++
Sbjct: 253 SEETFSSVSQLATDFIQSLLVKNPEKRPT----AEICLSHSWLQQWDFE 297
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 2e-30
Identities = 56/153 (36%), Positives = 82/153 (53%), Gaps = 12/153 (7%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
F + +LG G VY + GT+ +A+KV+ K KK++R TE +L L HP
Sbjct: 54 FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT---VDKKIVR--TEIGVLLRLSHP 108
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
+ L FET LV+E GG+L + ++ Y+SE+ V ++L A+ YLH
Sbjct: 109 NIIKLKEIFETPTEISLVLELVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAYLH 165
Query: 333 MLGIVYRDLKPENVLVR---EDGHIMLSDFDLS 362
GIV+RDLKPEN+L D + ++DF LS
Sbjct: 166 ENGIVHRDLKPENLLYATPAPDAPLKIADFGLS 198
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 35/110 (31%), Positives = 53/110 (48%), Gaps = 9/110 (8%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV--GQP 507
+ GT Y APEI++G +G VD W+ GI Y LL G PF ++ + +
Sbjct: 209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE- 267
Query: 508 LRFPESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555
F VS +A+DL++ L+V +P+ RL + QHP+ G
Sbjct: 268 YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLT----TFQALQHPWVTGKA 313
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-30
Identities = 40/161 (24%), Positives = 71/161 (44%), Gaps = 12/161 (7%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD 271
G + + ++LG G G V T A+K + K ++ E +I++ L+
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC--LEIQIMKKLN 70
Query: 272 HPFLPTLY------THFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEV 324
HP + + + L ME+C GGDL L Q + E ++ ++++
Sbjct: 71 HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDI 130
Query: 325 LLALEYLHMLGIVYRDLKPENVLVREDGH---IMLSDFDLS 362
AL YLH I++RDLKPEN++++ + D +
Sbjct: 131 SSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 75.5 bits (185), Expect = 2e-14
Identities = 25/128 (19%), Positives = 50/128 (39%), Gaps = 26/128 (20%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV----- 504
FVGT +YLAPE+++ + + VD+W+FG +E + G PF + + V
Sbjct: 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSN 241
Query: 505 ---------GQPLRFPE--------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547
++F S +++ ++ +L+ + R +
Sbjct: 242 EHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRG----TDPQNPN 297
Query: 548 HPFFQGVN 555
FQ ++
Sbjct: 298 VGCFQALD 305
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 120 bits (301), Expect = 1e-29
Identities = 63/398 (15%), Positives = 116/398 (29%), Gaps = 98/398 (24%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-- 270
G + +++KLG G +V+LS K + AMKV+ K++ + A E +L+S+
Sbjct: 37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVV-KSAEHYTE---TALDEIRLLKSVRN 92
Query: 271 ---DHP---FLPTLYTHFETD----KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFY 320
+ P + L F+ C+V E G L + + VK
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKI 151
Query: 321 VAEVLLALEYLHM-LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLES 379
+ +VL L+YLH I++ D+KPEN+L+ + + + S S +
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGS--- 208
Query: 380 EPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPEL 439
+ + + A +
Sbjct: 209 --------AVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQ-- 258
Query: 440 IAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPF-------- 491
Y + E++ G G+ + D W+ +EL G F
Sbjct: 259 -----------------YRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEY 301
Query: 492 ----------------------KGSENRATLYNVVGQPLRFPESPVVS----------FS 519
+ + G + +S
Sbjct: 302 TRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWS 361
Query: 520 ARD------LIKGLLVKEPQNRLACRRGATEIKQHPFF 551
+ + +L P+ R A E +HP+
Sbjct: 362 QEEAAGFTDFLLPMLELIPEKRAT----AAECLRHPWL 395
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-28
Identities = 42/155 (27%), Positives = 74/155 (47%), Gaps = 16/155 (10%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREIL-QSLDH 272
+ + + +G G T FA+K++DK+ + + E EIL + H
Sbjct: 23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTE-------EIEILLRYGQH 75
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
P + TL ++ K+ +V E GG+L + ++ K+FSE+ + + +EYL
Sbjct: 76 PNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ---KFFSEREASAVLFTITKTVEYL 132
Query: 332 HMLGIVYRDLKPENVLVREDGH----IMLSDFDLS 362
H G+V+RDLKP N+L ++ I + DF +
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFA 167
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 5e-21
Identities = 31/117 (26%), Positives = 54/117 (46%), Gaps = 9/117 (7%)
Query: 442 EPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPF--KGSENRAT 499
N M+ T ++APE+++ +G+ +A D W+ G+ LY +L G TPF +
Sbjct: 171 RAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEE 230
Query: 500 LYNVVGQ-PLRFPESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
+ +G VS +A+DL+ +L +P RL A + +HP+
Sbjct: 231 ILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLT----AALVLRHPWIVH 283
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-27
Identities = 43/275 (15%), Positives = 69/275 (25%), Gaps = 35/275 (12%)
Query: 154 GDYVESGKSSMCRG-STSSDVSDESTCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGV 212
G ++E+G S M ++ +L W V +
Sbjct: 1 GSHMEAGDSFMRDLLKREEELIGYCREEALKEPAAMVEAVTATVWPQNAETTVDSLLSQG 60
Query: 213 G-HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD 271
+L++ L GD V+L FA+KV + R +L R L
Sbjct: 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLL 120
Query: 272 HPFLPTLYTHFETDKFS--------------------------CLVMEFCPGGDLHTL-- 303
S L+M DL L
Sbjct: 121 GESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA-SVDLELLFS 179
Query: 304 ---RQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFD 360
A+ A+++ L G+V+ P+N+ + DG +ML D
Sbjct: 180 TLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVS 239
Query: 361 LSLRC-AVSPTVVKSSTLESEPLRKNPVYCVQPAC 394
+ P T A
Sbjct: 240 ALWKVGTRGPASSVPVTYAPREFLNASTATFTHAL 274
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 101 bits (252), Expect = 2e-23
Identities = 21/122 (17%), Positives = 34/122 (27%), Gaps = 13/122 (10%)
Query: 440 IAEPTNARSMSFVGTHEYLAPEIIKGEG--HGSAVDWWTFGIFLYELLFGKTPFKGSEN- 496
R + Y E + A++ W G+ +Y + PF
Sbjct: 240 ALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299
Query: 497 ------RATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPF 550
R +L L F + + LI L + + RL E + P
Sbjct: 300 IKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL----LPLEAMETPE 355
Query: 551 FQ 552
F
Sbjct: 356 FL 357
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 2e-27
Identities = 45/221 (20%), Positives = 72/221 (32%), Gaps = 23/221 (10%)
Query: 145 SGSAKISDRGDYVESGKSSMCRGSTSSDVSDESTCSSLSSSVNKPHKANDAQWEAIQAVR 204
SGS K+ + + E+ + K + E +
Sbjct: 2 SGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVH--- 58
Query: 205 VKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTER 264
++G G G V+ + T A+K + E
Sbjct: 59 ---------WMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------EL 101
Query: 265 EILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEV 324
L P + LY + + ME GG L L ++ E +Y+ +
Sbjct: 102 VACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQ--MGCLPEDRALYYLGQA 159
Query: 325 LLALEYLHMLGIVYRDLKPENVLVREDG-HIMLSDFDLSLR 364
L LEYLH I++ D+K +NVL+ DG L DF +L
Sbjct: 160 LEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALC 200
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 24/116 (20%), Positives = 44/116 (37%), Gaps = 5/116 (4%)
Query: 436 LPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE 495
L + GT ++APE++ G+ + VD W+ + +L G P+
Sbjct: 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260
Query: 496 NRATLYNVVGQPLRFPESP-VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPF 550
+ +P E P + I+ L KEP +R + A E+++
Sbjct: 261 RGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRAS----AMELRRKVG 312
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 4e-27
Identities = 42/155 (27%), Positives = 70/155 (45%), Gaps = 12/155 (7%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQS 269
+ +K +G G+ G L TK A+K +++ + +REI +S
Sbjct: 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIER------GAAIDENVQREIINHRS 72
Query: 270 LDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALE 329
L HP + T ++ME+ GG+L+ R G+ FSE +F+ ++L +
Sbjct: 73 LRHPNIVRFKEVILTPTHLAIIMEYASGGELYE-RICNAGR-FSEDEARFFFQQLLSGVS 130
Query: 330 YLHMLGIVYRDLKPENVLVRED--GHIMLSDFDLS 362
Y H + I +RDLK EN L+ + + DF S
Sbjct: 131 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYS 165
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-17
Identities = 32/109 (29%), Positives = 48/109 (44%), Gaps = 11/109 (10%)
Query: 450 SFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPL 508
S VGT Y+APE++ + G D W+ G+ LY +L G PF+ Y Q +
Sbjct: 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFED-PEEPRDYRKTIQRI 234
Query: 509 -----RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
P+ +S LI + V +P R++ EIK H +F
Sbjct: 235 LSVKYSIPDDIRISPECCHLISRIFVADPATRIS----IPEIKTHSWFL 279
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 4e-27
Identities = 43/188 (22%), Positives = 79/188 (42%), Gaps = 16/188 (8%)
Query: 183 SSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFA 242
+ P Q+ +++K + + + LG G G V T+ FA
Sbjct: 32 PAQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFA 91
Query: 243 MKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFET----DKFSCLVMEFCPG 297
+K++ +R E E+ P + + +E K +VME G
Sbjct: 92 LKMLQDCPKARR--------EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG 143
Query: 298 GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV---REDGHI 354
G+L + Q + + F+E+ + + A++YLH + I +RD+KPEN+L R + +
Sbjct: 144 GELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAIL 203
Query: 355 MLSDFDLS 362
L+DF +
Sbjct: 204 KLTDFGFA 211
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 6e-18
Identities = 31/111 (27%), Positives = 47/111 (42%), Gaps = 10/111 (9%)
Query: 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRAT---LYNVVG 505
+ T Y+APE++ E + + D W+ G+ +Y LL G PF + A + +
Sbjct: 221 TTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280
Query: 506 Q-PLRFPESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
FP VS + LI+ LL EP R+ TE HP+
Sbjct: 281 MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMT----ITEFMNHPWIMQ 327
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 5e-27
Identities = 46/158 (29%), Positives = 71/158 (44%), Gaps = 5/158 (3%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTL 278
LG G G VY + A+K + + + L E + + L H +
Sbjct: 28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPL---HEEIALHKHLKHKNIVQY 84
Query: 279 YTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKY-FSEQAVKFYVAEVLLALEYLHMLGIV 337
F + F + ME PGG L L + + G +EQ + FY ++L L+YLH IV
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 338 YRDLKPENVLV-REDGHIMLSDFDLSLRCAVSPTVVKS 374
+RD+K +NVL+ G + +SDF S R A ++
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET 182
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 32/130 (24%), Positives = 53/130 (40%), Gaps = 15/130 (11%)
Query: 444 TNARSMSFVGTHEYLAPEIIKG--EGHGSAVDWWTFGIFLYELLFGKTPFKGSENR-ATL 500
N + +F GT +Y+APEII G+G A D W+ G + E+ GK PF A +
Sbjct: 176 INPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAM 235
Query: 501 YNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIR 560
+ V + +S A+ I +P R A ++ F ++
Sbjct: 236 FKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRAC----ANDLLVDEF--------LK 283
Query: 561 CASPPEIPKP 570
+S + +P
Sbjct: 284 VSSKKKKTQP 293
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-27
Identities = 34/152 (22%), Positives = 66/152 (43%), Gaps = 16/152 (10%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPT 277
+ LG G G V T A+K++ + ++ E + P +
Sbjct: 35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQ--------EVDHHWQASGGPHIVC 86
Query: 278 LYTHFETDKFSC----LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
+ +E ++ME GG+L + Q + + F+E+ + ++ A+++LH
Sbjct: 87 ILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146
Query: 334 LGIVYRDLKPENVLV---REDGHIMLSDFDLS 362
I +RD+KPEN+L +D + L+DF +
Sbjct: 147 HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 7e-19
Identities = 31/111 (27%), Positives = 47/111 (42%), Gaps = 10/111 (9%)
Query: 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPF---KGSENRATLYNVVG 505
+ T Y+APE++ E + + D W+ G+ +Y LL G PF G + +
Sbjct: 187 QTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR 246
Query: 506 Q-PLRFPESP--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
FP VS A+ LI+ LL +P RL T+ HP+
Sbjct: 247 LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLT----ITQFMNHPWINQ 293
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 40/168 (23%), Positives = 73/168 (43%), Gaps = 16/168 (9%)
Query: 202 AVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQ 261
+++K + + + LG G G V T+ FA+K++ +R
Sbjct: 7 GLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARR------- 59
Query: 262 TEREILQSL-DHPFLPTLYTHFET----DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQA 316
E E+ P + + +E K +VME GG+L + Q + + F+E+
Sbjct: 60 -EVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 118
Query: 317 VKFYVAEVLLALEYLHMLGIVYRDLKPENVLVR---EDGHIMLSDFDL 361
+ + A++YLH + I +RD+KPEN+L + + L+DF
Sbjct: 119 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 28/102 (27%), Positives = 40/102 (39%), Gaps = 11/102 (10%)
Query: 458 LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRAT---LYNVVGQ-PLRFPES 513
A E E + + D W+ G+ +Y LL G PF + A + + FP
Sbjct: 166 FAKETTG-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 224
Query: 514 P--VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
VS + LI+ LL EP R+ TE HP+
Sbjct: 225 EWSEVSEEVKMLIRNLLKTEPTQRMT----ITEFMNHPWIMQ 262
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 3e-26
Identities = 43/185 (23%), Positives = 66/185 (35%), Gaps = 26/185 (14%)
Query: 187 NKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSE-LTGTKCYFAMKV 245
+ P D E V V G F LG G G++ A+K
Sbjct: 3 SSPSLEQDDGDEETSVVIV-----GKISFCPKDVLGHGAEGTIVYRGMFDNRD--VAVKR 55
Query: 246 MDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLR 304
+ A E ++L+ D HP + + + +F + +E C TL+
Sbjct: 56 ILPECFSF------ADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA----TLQ 105
Query: 305 QR--QPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGH-----IMLS 357
+ Q + + L +LH L IV+RDLKP N+L+ M+S
Sbjct: 106 EYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMIS 165
Query: 358 DFDLS 362
DF L
Sbjct: 166 DFGLC 170
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 82.1 bits (203), Expect = 7e-17
Identities = 29/117 (24%), Positives = 48/117 (41%), Gaps = 9/117 (7%)
Query: 442 EPTNARSMSFVGTHEYLAPEIIKG---EGHGSAVDWWTFGIFLYELL-FGKTPFKGSENR 497
+ +R GT ++APE++ E VD ++ G Y ++ G PF S R
Sbjct: 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQR 236
Query: 498 ATLYNVVGQPLRFPE-SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
+ L AR+LI+ ++ +PQ R + A + +HPFF
Sbjct: 237 QANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPS----AKHVLKHPFFWS 289
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 5e-26
Identities = 38/151 (25%), Positives = 67/151 (44%), Gaps = 7/151 (4%)
Query: 213 GHFRLLKKLGCG--DIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQ 268
G + LL +G G D+ +V L+ T Y ++ ++ LE + + E+ +
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRIN---LEACSNEMVTFLQGELHVSK 81
Query: 269 SLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLAL 328
+HP + F D +V F G L +E A+ + + VL AL
Sbjct: 82 LFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 141
Query: 329 EYLHMLGIVYRDLKPENVLVREDGHIMLSDF 359
+Y+H +G V+R +K ++L+ DG + LS
Sbjct: 142 DYIHHMGYVHRSVKASHILISVDGKVYLSGL 172
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 46.8 bits (111), Expect = 1e-05
Identities = 25/149 (16%), Positives = 43/149 (28%), Gaps = 50/149 (33%)
Query: 450 SFVGTHEYLAPEIIK--GEGHGSAVDWWTFGIFLYELLFGKTPF---------------- 491
V +L+PE+++ +G+ + D ++ GI EL G PF
Sbjct: 194 YSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGT 253
Query: 492 ----------------------------KGSENRATLYNVVGQPLRFPESPVVSFSARDL 523
S +T G P S
Sbjct: 254 VPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHF 313
Query: 524 IKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
++ L + P R + A+ + H FF+
Sbjct: 314 VEQCLQRNPDARPS----ASTLLNHSFFK 338
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 46/146 (31%), Positives = 76/146 (52%), Gaps = 4/146 (2%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+ ++ +LG G G VY ++ T A KV++ S E+ + E EIL + DHP
Sbjct: 20 VWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDY---IVEIEILATCDHP 76
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
++ L + D +++EFCPGG + + +E ++ ++L AL +LH
Sbjct: 77 YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRG-LTEPQIQVVCRQMLEALNFLHS 135
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDF 359
I++RDLK NVL+ +G I L+DF
Sbjct: 136 KRIIHRDLKAGNVLMTLEGDIRLADF 161
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-07
Identities = 33/121 (27%), Positives = 51/121 (42%), Gaps = 18/121 (14%)
Query: 444 TNARSMSFVGTHEYLAPEII-----KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSEN-- 496
T + SF+GT ++APE++ K + D W+ GI L E+ + P N
Sbjct: 170 TLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPH-HELNPM 228
Query: 497 RATLYNVVGQP---LRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
R L + L P S RD +K L K P+ R + A ++ +HPF
Sbjct: 229 RV-LLKIAKSDPPTLLTPSK--WSVEFRDFLKIALDKNPETRPS----AAQLLEHPFVSS 281
Query: 554 V 554
+
Sbjct: 282 I 282
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 109 bits (273), Expect = 1e-25
Identities = 45/169 (26%), Positives = 68/169 (40%), Gaps = 29/169 (17%)
Query: 214 HFRLLKKLGCGDIGSVYLS-ELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQ-SLD 271
K LG G G+V G A+K M + A E ++L S D
Sbjct: 16 LVVSEKILGYGSSGTVVFQGSFQGRP--VAVKRMLIDFCD------IALMEIKLLTESDD 67
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDLHTL-----RQRQPGKYFSEQAVKFYVAEVLL 326
HP + Y TD+F + +E C +L L + K E + ++
Sbjct: 68 HPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIAS 126
Query: 327 ALEYLHMLGIVYRDLKPENVLV-------------REDGHIMLSDFDLS 362
+ +LH L I++RDLKP+N+LV E+ I++SDF L
Sbjct: 127 GVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLC 175
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 24/119 (20%), Positives = 51/119 (42%), Gaps = 19/119 (15%)
Query: 450 SFVGTHEYLAPEIIKGEGH-------GSAVDWWTFGIFLYELL-FGKTPFKGSENRAT-- 499
+ GT + APE+++ + ++D ++ G Y +L GK PF +R +
Sbjct: 191 NPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
Query: 500 ---LYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555
++++ ++ + A DLI ++ +P R A ++ +HP F +
Sbjct: 251 IRGIFSL--DEMKCLHDRSLIAEATDLISQMIDHDPLKRPT----AMKVLRHPLFWPKS 303
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-25
Identities = 43/146 (29%), Positives = 70/146 (47%), Gaps = 5/146 (3%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
F L+K+G G G V+ T+ A+K++D E + + Q E +L D P
Sbjct: 23 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDI--QQEITVLSQCDSP 80
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
++ Y + D ++ME+ GG L + P E + + E+L L+YLH
Sbjct: 81 YVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP---LDETQIATILREILKGLDYLHS 137
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDF 359
++RD+K NVL+ E G + L+DF
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADF 163
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-09
Identities = 33/130 (25%), Positives = 51/130 (39%), Gaps = 18/130 (13%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNV 503
T + +FVGT ++APE+IK + S D W+ GI EL G+ P L+ +
Sbjct: 172 TQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI 231
Query: 504 V-GQPLRFPESPVVSFSA--RDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIR 560
P ++S ++ ++ L KEP R A E+ +H F R
Sbjct: 232 PKNNPPTLEG----NYSKPLKEFVEACLNKEPSFRPT----AKELLKHKFIL-------R 276
Query: 561 CASPPEIPKP 570
A
Sbjct: 277 NAKKTSYLTE 286
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 4e-25
Identities = 41/169 (24%), Positives = 74/169 (43%), Gaps = 12/169 (7%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP- 273
+ ++G G +VY T T A + L K + R + E E+L+ L HP
Sbjct: 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPN 86
Query: 274 ---FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEY 330
F + + + K LV E G L T +R K + ++ + ++L L++
Sbjct: 87 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQF 144
Query: 331 LH--MLGIVYRDLKPENVLV-REDGHIMLSDFDLS--LRCAVSPTVVKS 374
LH I++RDLK +N+ + G + + D L+ R + + V+ +
Sbjct: 145 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGT 193
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 3e-16
Identities = 27/112 (24%), Positives = 55/112 (49%), Gaps = 10/112 (8%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNV 503
+ + + +GT E++APE+ + E + +VD + FG+ + E+ + P+ +N A +Y
Sbjct: 183 RASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR 241
Query: 504 VGQ---PLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
V P F + V +++I+G + + R + ++ H FFQ
Sbjct: 242 VTSGVKPASFDK--VAIPEVKEIIEGCIRQNKDERYS----IKDLLNHAFFQ 287
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 6e-25
Identities = 42/145 (28%), Positives = 71/145 (48%), Gaps = 6/145 (4%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
F +L+KLG G GSVY + T A+K + +E + + E I+Q D P
Sbjct: 31 FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP---VESDLQEI--IKEISIMQQCDSPH 85
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ Y + + +VME+C G + + + + +E + + L LEYLH +
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKT-LTEDEIATILQSTLKGLEYLHFM 144
Query: 335 GIVYRDLKPENVLVREDGHIMLSDF 359
++RD+K N+L+ +GH L+DF
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADF 169
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 35/113 (30%), Positives = 55/113 (48%), Gaps = 9/113 (7%)
Query: 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN 502
T A+ + +GT ++APE+I+ G+ D W+ GI E+ GK P+ ++
Sbjct: 177 DTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM 236
Query: 503 VVGQP---LRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
+ P R PE S + D +K LVK P+ R AT++ QHPF +
Sbjct: 237 IPTNPPPTFRKPEL--WSDNFTDFVKQCLVKSPEQRAT----ATQLLQHPFVR 283
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 103 bits (260), Expect = 9e-25
Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 10/164 (6%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
+ +K+G G G+VY + T A++ M+ L+++ K E +++ +P
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPN 78
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ + +VME+ GG L + E + E L ALE+LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLHSN 135
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLSLRCA-VSPTVVKSSTL 377
+++RD+K +N+L+ DG + L+DF CA ++P K ST+
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGF---CAQITPEQSKRSTM 176
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-09
Identities = 34/131 (25%), Positives = 58/131 (44%), Gaps = 17/131 (12%)
Query: 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN 502
P ++ + VGT ++APE++ + +G VD W+ GI E++ G+ P+ LY
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227
Query: 503 VVGQP---LRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALI 559
+ L+ PE +S RD + L + + R + A E+ QH F +
Sbjct: 228 IATNGTPELQNPEK--LSAIFRDFLNRCLEMDVEKRGS----AKELLQHQF--------L 273
Query: 560 RCASPPEIPKP 570
+ A P P
Sbjct: 274 KIAKPLSSLTP 284
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 47/164 (28%), Positives = 79/164 (48%), Gaps = 10/164 (6%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
K+G G G V L+ + A+K+MD L K+++ E I++ H
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHFN 103
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ +Y + + ++MEF GG L + + +E+ + VL AL YLH
Sbjct: 104 VVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYLHAQ 160
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLSLRCA-VSPTVVKSSTL 377
G+++RD+K +++L+ DG + LSDF CA +S V K +L
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGF---CAQISKDVPKRKSL 201
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 3e-09
Identities = 35/131 (26%), Positives = 57/131 (43%), Gaps = 17/131 (12%)
Query: 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN 502
+ S VGT ++APE+I + + VD W+ GI + E++ G+ P+ +
Sbjct: 193 KDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 252
Query: 503 VVGQP---LRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALI 559
+ P L+ VS RD ++ +LV++PQ R A E+ HPF +
Sbjct: 253 LRDSPPPKLKNSHK--VSPVLRDFLERMLVRDPQERAT----AQELLDHPF--------L 298
Query: 560 RCASPPEIPKP 570
PE P
Sbjct: 299 LQTGLPECLVP 309
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 39/152 (25%), Positives = 65/152 (42%), Gaps = 8/152 (5%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+ L + +G G V + K A+K ++ + L E + + HP
Sbjct: 16 DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDEL--LKEIQAMSQCHHP 73
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTL------RQRQPGKYFSEQAVKFYVAEVLLA 327
+ + YT F LVM+ GG + + + E + + EVL
Sbjct: 74 NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 328 LEYLHMLGIVYRDLKPENVLVREDGHIMLSDF 359
LEYLH G ++RD+K N+L+ EDG + ++DF
Sbjct: 134 LEYLHKNGQIHRDVKAGNILLGEDGSVQIADF 165
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-08
Identities = 35/127 (27%), Positives = 51/127 (40%), Gaps = 15/127 (11%)
Query: 436 LPELIAEPTNARSMSFVGTHEYLAPEIIK-GEGHGSAVDWWTFGIFLYELLFGKTPF-KG 493
L N +FVGT ++APE+++ G+ D W+FGI EL G P+ K
Sbjct: 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKY 230
Query: 494 SENRATLYNVVGQP---LRFPESPVV-----SFSARDLIKGLLVKEPQNRLACRRGATEI 545
+ L + L S R +I L K+P+ R A E+
Sbjct: 231 PPMKV-LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT----AAEL 285
Query: 546 KQHPFFQ 552
+H FFQ
Sbjct: 286 LRHKFFQ 292
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 41/146 (28%), Positives = 63/146 (43%), Gaps = 2/146 (1%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
F L+++G G G+VY + A+K M + + +K E LQ L HP
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
+ + + LVME+C G L + K E + L L YLH
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS 172
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDF 359
+++RD+K N+L+ E G + L DF
Sbjct: 173 HNMIHRDVKAGNILLSEPGLVKLGDF 198
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 7e-06
Identities = 30/109 (27%), Positives = 45/109 (41%), Gaps = 13/109 (11%)
Query: 450 SFVGTHEYLAPEII---KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ 506
SFVGT ++APE+I + VD W+ GI EL K P + LY++
Sbjct: 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--- 265
Query: 507 PLRFP---ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
+S S R+ + L K PQ+R + + +H F
Sbjct: 266 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRPT----SEVLLKHRFVL 310
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 46/157 (29%), Positives = 75/157 (47%), Gaps = 11/157 (7%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-D 271
G F L++ +G G G VY T A+KVMD ++ +++ + E +L+
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEI---KQEINMLKKYSH 79
Query: 272 HPFLPTLYTHFETDKFSC------LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVL 325
H + T Y F LVMEFC G + L + G E+ + + E+L
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 326 LALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
L +LH +++RD+K +NVL+ E+ + L DF +S
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 51.2 bits (123), Expect = 4e-07
Identities = 29/114 (25%), Positives = 47/114 (41%), Gaps = 9/114 (7%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGE-----GHGSAVDWWTFGIFLYELLFGKTPFKGSENRA 498
T R +F+GT ++APE+I + + D W+ GI E+ G P
Sbjct: 182 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR 241
Query: 499 TLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
L+ + P +S S + I+ LVK R A ++ +HPF +
Sbjct: 242 ALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPA----TEQLMKHPFIR 291
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 40/147 (27%), Positives = 67/147 (45%), Gaps = 7/147 (4%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMD-KASLEKRKKLLRAQTEREILQSLDHP 273
F + +LG G+ G V+ + A K++ + R +++R E ++L + P
Sbjct: 35 FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIR---ELQVLHECNSP 91
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH- 332
++ Y F +D + ME GG L + ++ EQ + V+ L YL
Sbjct: 92 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLRE 149
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDF 359
I++RD+KP N+LV G I L DF
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDF 176
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 55.2 bits (133), Expect = 2e-08
Identities = 28/151 (18%), Positives = 49/151 (32%), Gaps = 46/151 (30%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNV 503
++ + SFVGT Y++PE ++G + D W+ G+ L E+ G+ P + +
Sbjct: 183 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242
Query: 504 VGQPLRF----------------------------------------PESPVVSFS--AR 521
Q P+ P FS +
Sbjct: 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 302
Query: 522 DLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
D + L+K P R ++ H F +
Sbjct: 303 DFVNKCLIKNPAERAD----LKQLMVHAFIK 329
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 7e-23
Identities = 25/160 (15%), Positives = 45/160 (28%), Gaps = 21/160 (13%)
Query: 442 EPTNARSMSFVGTHEYLAPEIIKGEGHG-----SAVDWWTFGIFLYELLFGKTPFKGSEN 496
+ E A ++ H A D WT G+ +Y + P
Sbjct: 263 ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAA 322
Query: 497 RATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNW 556
+ P+ R L++G L ++RL + + P ++ +
Sbjct: 323 LGGSEWIFRSCKNIPQ------PVRALLEGFLRYPKEDRL----LPLQAMETPEYEQLRT 372
Query: 557 ALIRCAS------PPEIPKPVEIVHSPAPALSTKAKAVAA 590
L P + P + A+AV A
Sbjct: 373 ELSAALPLYQTDGEPTREGGAPPSGTSQPDEAGAAEAVTA 412
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 99.0 bits (246), Expect = 2e-22
Identities = 29/186 (15%), Positives = 57/186 (30%), Gaps = 34/186 (18%)
Query: 213 GHFRLLKK---LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQS 269
R L + LG D + + T F + V + + + E L+
Sbjct: 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRL 134
Query: 270 L----------------------DHPFLPTLYTHFETDKFSCLVMEF----CPGGDLHTL 303
L P + ++ ++ F +L T
Sbjct: 135 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 194
Query: 304 -----RQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSD 358
K A +V+ L LH G+V+ L+P ++++ + G + L+
Sbjct: 195 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 254
Query: 359 FDLSLR 364
F+ +R
Sbjct: 255 FEHLVR 260
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 42/160 (26%), Positives = 77/160 (48%), Gaps = 17/160 (10%)
Query: 208 GVLGVGHFRLLKKLGCGDIGSVYLSE---LTGTKCYFAMKVMDKASLEKRKKLLRAQTER 264
G + G + + + G +G +YL+ + G +K + + + + A ER
Sbjct: 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRP--VVLKGLVHSGDAEAQA--MAMAER 130
Query: 265 EILQSLDHPFLPTLYTHFETDKFSC-----LVMEFCPGGDLHTLRQRQPGKYFSEQAVKF 319
+ L + HP + ++ E +VME+ G +L++ + K +A+
Sbjct: 131 QFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGG---QSLKRSKGQKLPVAEAIA- 186
Query: 320 YVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDF 359
Y+ E+L AL YLH +G+VY DLKPEN+++ E+ + L D
Sbjct: 187 YLLEILPALSYLHSIGLVYNDLKPENIMLTEEQ-LKLIDL 225
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 8e-10
Identities = 25/149 (16%), Positives = 39/149 (26%), Gaps = 29/149 (19%)
Query: 446 ARSM----SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY 501
+ GT + APEI++ G A D +T G L L G +
Sbjct: 228 VSRINSFGYLYGTPGFQAPEIVRT-GPTVATDIYTVGRTLAALTLDLPTRNG----RYVD 282
Query: 502 NVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRC 561
+ L++ + +P+ R A E+ L
Sbjct: 283 GLPEDDPVLKTYDSY----GRLLRRAIDPDPRQRFT---TAEEMSA---------QLTGV 326
Query: 562 ASPPEIPKPVEIVHSPAPALSTKAKAVAA 590
P P LST +
Sbjct: 327 LREVVAQDT----GVPRPGLSTIFSPSRS 351
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 5e-22
Identities = 41/181 (22%), Positives = 76/181 (41%), Gaps = 11/181 (6%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH 272
+RL +K+G G G +YL A+K+ ++ + L E +I + +
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLE---CVKTKHPQLHI--ESKIYKMMQG 63
Query: 273 -PFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
+PT+ ++ +VME G L L K FS + V +++ +EY+
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRK-FSLKTVLLLADQMISRIEYI 121
Query: 332 HMLGIVYRDLKPENVLVREDGH---IMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVY 388
H ++RD+KP+N L+ + + DF L+ + + T E++ L Y
Sbjct: 122 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 181
Query: 389 C 389
Sbjct: 182 A 182
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 8e-22
Identities = 29/152 (19%), Positives = 52/152 (34%), Gaps = 4/152 (2%)
Query: 208 GVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREIL 267
+ G +RLL G + + T A+ +D + L + L
Sbjct: 26 ARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRL 85
Query: 268 QSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLA 327
+D P + + T +V E+ GG L + P A++ + + A
Sbjct: 86 SRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPS---PVGAIR-AMQSLAAA 141
Query: 328 LEYLHMLGIVYRDLKPENVLVREDGHIMLSDF 359
+ H G+ P V V DG ++L+
Sbjct: 142 ADAAHRAGVALSIDHPSRVRVSIDGDVVLAYP 173
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 5e-06
Identities = 13/92 (14%), Positives = 22/92 (23%), Gaps = 12/92 (13%)
Query: 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATL---YNVVGQPL 508
+ + D G LY LL + P + R+ L
Sbjct: 170 LAYPATMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222
Query: 509 RFPES--PVVSFSARDLIKGLLVKEPQNRLAC 538
P + F + + + R A
Sbjct: 223 IEPADIDRDIPFQISAVAARSVQGDGGIRSAS 254
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 3e-21
Identities = 22/151 (14%), Positives = 49/151 (32%), Gaps = 2/151 (1%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH 272
H +++ + + + + D L + + +
Sbjct: 62 EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDW-PLSSPSPMDAPSVKIRRMDPFST 120
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
+ + M+ C +L + +R + ++ A+E+L
Sbjct: 121 KNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFL 180
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
H G+++RDLKP N+ D + + DF L
Sbjct: 181 HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLV 211
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 87.2 bits (216), Expect = 6e-19
Identities = 31/127 (24%), Positives = 51/127 (40%), Gaps = 9/127 (7%)
Query: 429 MGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGK 488
M L P A VGT Y++PE I G + VD ++ G+ L+ELL+
Sbjct: 214 MDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY-- 271
Query: 489 TPFKGSENRATLYNVVGQPLRFPESPVVSFS-ARDLIKGLLVKEPQNRLACRRGATEIKQ 547
F R + V +FP + +++ +L P R AT+I +
Sbjct: 272 -SFSTQMERVRIITDVRNL-KFPLLFTQKYPQEHMMVQDMLSPSPTERP----EATDIIE 325
Query: 548 HPFFQGV 554
+ F+ +
Sbjct: 326 NAIFENL 332
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 15/82 (18%), Positives = 33/82 (40%), Gaps = 2/82 (2%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
F ++ +G G G V+ ++ C +A+K + + E ++ + E + L L+HP
Sbjct: 7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELARE--KVMREVKALAKLEHP 64
Query: 274 FLPTLYTHFETDKFSCLVMEFC 295
+ + + E
Sbjct: 65 GIVRYFNAWLETPPEKWQEEMD 86
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 34/151 (22%), Positives = 64/151 (42%), Gaps = 8/151 (5%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMD-KASLEKRKKLLRAQTEREI-LQSLD 271
+ L ++G G GSV + A+K + +++K+LL + ++ ++S D
Sbjct: 23 DLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLM---DLDVVMRSSD 79
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQ--RQPGKYFSEQAVKFYVAEVLLALE 329
P++ Y + + ME + E+ + + AL
Sbjct: 80 CPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 330 YLH-MLGIVYRDLKPENVLVREDGHIMLSDF 359
+L L I++RD+KP N+L+ G+I L DF
Sbjct: 140 HLKENLKIIHRDIKPSNILLDRSGNIKLCDF 170
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 2e-11
Identities = 29/110 (26%), Positives = 40/110 (36%), Gaps = 12/110 (10%)
Query: 451 FVGTHEYLAPEIIKGEGHGSA----VDWWTFGIFLYELLFGKTPFKGSEN--RATLYNVV 504
G Y+APE I D W+ GI LYEL G+ P+ + V
Sbjct: 185 DAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVK 244
Query: 505 GQPLRFPESPVVSFS--ARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
G P + S FS + + L K+ R E+ +HPF
Sbjct: 245 GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPK----YKELLKHPFIL 290
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 4e-21
Identities = 41/149 (27%), Positives = 71/149 (47%), Gaps = 8/149 (5%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMD-KASLEKRKKLLRAQTEREIL-QSLD 271
L ++G G G V+ T A+K M + E+ K++L + +++ +S D
Sbjct: 26 DLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILM---DLDVVLKSHD 82
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
P++ + F T+ + ME G L++R G E+ + ++ AL YL
Sbjct: 83 CPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGP-IPERILGKMTVAIVKALYYL 140
Query: 332 H-MLGIVYRDLKPENVLVREDGHIMLSDF 359
G+++RD+KP N+L+ E G I L DF
Sbjct: 141 KEKHGVIHRDVKPSNILLDERGQIKLCDF 169
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 4e-12
Identities = 25/110 (22%), Positives = 41/110 (37%), Gaps = 11/110 (10%)
Query: 450 SFVGTHEYLAPEIIK-----GEGHGSAVDWWTFGIFLYELLFGKTPFKGSEN--RATLYN 502
G Y+APE I + D W+ GI L EL G+ P+K +
Sbjct: 183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV 242
Query: 503 VVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
+ +P P S + +K L K+ + R ++ +H F +
Sbjct: 243 LQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPK----YNKLLEHSFIK 288
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 5e-21
Identities = 37/150 (24%), Positives = 68/150 (45%), Gaps = 7/150 (4%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMD-KASLEKRKKLLRAQTEREI-LQSLD 271
+ +LG G G V + A+K + + +++K+LL + +I ++++D
Sbjct: 8 DLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLM---DLDISMRTVD 64
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQ-RQPGKYFSEQAVKFYVAEVLLALEY 330
PF T Y + + ME +Q G+ E + ++ ALE+
Sbjct: 65 CPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 331 LHM-LGIVYRDLKPENVLVREDGHIMLSDF 359
LH L +++RD+KP NVL+ G + + DF
Sbjct: 125 LHSKLSVIHRDVKPSNVLINALGQVKMCDF 154
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 5e-11
Identities = 27/109 (24%), Positives = 37/109 (33%), Gaps = 11/109 (10%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSA----VDWWTFGIFLYELLFGKTPFKGSEN--RATLYNV 503
G Y+APE I E + D W+ GI + EL + P+ + V
Sbjct: 168 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVV 227
Query: 504 VGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
+ P S D L K + R E+ QHPFF
Sbjct: 228 EEPSPQLPADK-FSAEFVDFTSQCLKKNSKERPT----YPELMQHPFFT 271
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 38/153 (24%), Positives = 68/153 (44%), Gaps = 14/153 (9%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
+ + +G G G V ++ A+K ++ S K E L ++HP
Sbjct: 10 IEVEEVVGRGAFGVVCKAKWRAKDV--AIKQIESESERKA-----FIVELRQLSRVNHPN 62
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
+ LY + CLVME+ GG L+ L +P Y++ + + + YLH
Sbjct: 63 IVKLYG-ACLNPV-CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHS 120
Query: 334 L---GIVYRDLKPENVLVREDGHIM-LSDFDLS 362
+ +++RDLKP N+L+ G ++ + DF +
Sbjct: 121 MQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA 153
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 20/92 (21%), Positives = 38/92 (41%), Gaps = 1/92 (1%)
Query: 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRA-TLYNV 503
+ G+ ++APE+ +G + D +++GI L+E++ + PF A +
Sbjct: 157 QTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA 216
Query: 504 VGQPLRFPESPVVSFSARDLIKGLLVKEPQNR 535
V R P + L+ K+P R
Sbjct: 217 VHNGTRPPLIKNLPKPIESLMTRCWSKDPSQR 248
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 4e-20
Identities = 50/180 (27%), Positives = 77/180 (42%), Gaps = 4/180 (2%)
Query: 182 LSSSVNKPHKANDAQWEAIQAVRVKDGVLG--VGHFRLLKKLGCGDIGSVYLSELTGTKC 239
+ SS + H ++ + G G +RL + +G G +G VY +E T +
Sbjct: 1 MGSSHHHHHHSSGLVPRGSHMDGTAESREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRER 60
Query: 240 YFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGD 299
A+K+M + R Q E L P + ++ E D + M G D
Sbjct: 61 IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVD 120
Query: 300 LHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDF 359
L + +RQ G +AV V ++ AL+ H G +RD+KPEN+LV D L DF
Sbjct: 121 LAAMLRRQ-GPLAPPRAVA-IVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDF 178
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 22/98 (22%), Positives = 41/98 (41%), Gaps = 3/98 (3%)
Query: 440 IAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRAT 499
+ + + VGT Y+APE D + LYE L G P++G + +
Sbjct: 184 TTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQG-DQLSV 242
Query: 500 LYNVVGQPLRFPES--PVVSFSARDLIKGLLVKEPQNR 535
+ + Q + P + P + + +I + K P++R
Sbjct: 243 MGAHINQAIPRPSTVRPGIPVAFDAVIARGMAKNPEDR 280
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 90.1 bits (224), Expect = 5e-20
Identities = 54/279 (19%), Positives = 94/279 (33%), Gaps = 66/279 (23%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
+ LG G G T MK + + E ++ L+ E ++++ L+HP
Sbjct: 12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLK---EVKVMRCLEHPN 68
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ DK + E+ GG L + + +Y Q V F ++ + YLH +
Sbjct: 69 VLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSF-AKDIASGMAYLHSM 127
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPAC 394
I++RDL N LVRE+ +++++DF L+ R QP
Sbjct: 128 NIIHRDLNSHNCLVRENKNVVVADFGLA--------------------RLMVDEKTQPEG 167
Query: 395 IEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGT 454
+ T +P + + PE+I
Sbjct: 168 LRSLKKPDRKKRYTVVGNPYWMA-------------------PEMI-------------- 194
Query: 455 HEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKG 493
G + VD ++FGI L E++
Sbjct: 195 ---------NGRSYDEKVDVFSFGIVLCEIIGRVNADPD 224
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 2e-19
Identities = 45/150 (30%), Positives = 73/150 (48%), Gaps = 6/150 (4%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQSLDH 272
F+ ++K+G G G VY + T A+K K L+ + + + REI L+ L+H
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALK---KIRLDTETEGVPSTAIREISLLKELNH 61
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
P + L T+ LV EF DL +K Y+ ++L L + H
Sbjct: 62 PNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 120
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+++RDLKP+N+L+ +G I L+DF L+
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLA 150
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 2e-19
Identities = 35/170 (20%), Positives = 64/170 (37%), Gaps = 19/170 (11%)
Query: 213 GHFRLLKKLGCGDIGSVYL--------SELTGTKCYFAMKV--MDKASLEKRKKLLRAQT 262
++L + G +Y + K F++K+ D ++ RA
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 263 EREI-----LQSLDHPFLPTLYTH-FETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQA 316
++ L S +PT DK+ LV+ G L + P SE++
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERS 160
Query: 317 VKFYVAEVLLALEYLHMLGIVYRDLKPENVLV--REDGHIMLSDFDLSLR 364
V +L ALE+LH V+ ++ EN+ V + + L+ + + R
Sbjct: 161 VLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 45/154 (29%), Positives = 75/154 (48%), Gaps = 19/154 (12%)
Query: 214 HFRLLKKLGCGDIGSVY--LSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL- 270
++L++KLG G V+ ++ K +K K+KK+ R E +IL++L
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKV--VVK---ILKPVKKKKIKR---EIKILENLR 88
Query: 271 DHPFLPTLY--THFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLAL 328
P + TL + LV E D L Q ++ ++FY+ E+L AL
Sbjct: 89 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKAL 143
Query: 329 EYLHMLGIVYRDLKPENVLV-REDGHIMLSDFDL 361
+Y H +GI++RD+KP NV++ E + L D+ L
Sbjct: 144 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGL 177
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 4e-06
Identities = 29/140 (20%), Positives = 46/140 (32%), Gaps = 41/140 (29%)
Query: 452 VGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTP-FKGSENRATLY---NVVGQ 506
V + + PE++ ++D W+ G L ++F K P F G +N L V+G
Sbjct: 191 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGT 250
Query: 507 P------------------LRFPESPVVSFS--------------ARDLIKGLLVKEPQN 534
+ A D + LL + Q+
Sbjct: 251 EDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQS 310
Query: 535 RLACRRGATEIKQHPFFQGV 554
RL A E +HP+F V
Sbjct: 311 RLT----AREAMEHPYFYTV 326
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 3e-19
Identities = 38/183 (20%), Positives = 67/183 (36%), Gaps = 13/183 (7%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH 272
H+++ +++G G G ++ A+K LR E + L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFE---PRRSDAPQLR--DEYRTYKLLAG 64
Query: 273 -PFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
+P +Y + + LV++ G L L K FS + V ++L ++ +
Sbjct: 65 CTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRK-FSVKTVAMAAKQMLARVQSI 122
Query: 332 HMLGIVYRDLKPENVLVREDGH-----IMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNP 386
H +VYRD+KP+N L+ I + DF + T E + L
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 182
Query: 387 VYC 389
Y
Sbjct: 183 RYM 185
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 86.9 bits (216), Expect = 5e-19
Identities = 42/149 (28%), Positives = 74/149 (49%), Gaps = 6/149 (4%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH 272
++++ KLG G + +VYL+E T A+K + EK + L R + E L H
Sbjct: 11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSH 70
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQ--RQPGKYFSEQAVKFYVAEVLLALEY 330
+ ++ E D LVME+ G TL + G + A+ F ++L +++
Sbjct: 71 QNIVSMIDVDEEDDCYYLVMEYIEG---PTLSEYIESHGPLSVDTAINF-TNQILDGIKH 126
Query: 331 LHMLGIVYRDLKPENVLVREDGHIMLSDF 359
H + IV+RD+KP+N+L+ + + + DF
Sbjct: 127 AHDMRIVHRDIKPQNILIDSNKTLKIFDF 155
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 4e-09
Identities = 25/99 (25%), Positives = 45/99 (45%), Gaps = 3/99 (3%)
Query: 440 IAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRAT 499
++E + ++ +GT +Y +PE KGE D ++ GI LYE+L G+ PF G +
Sbjct: 161 LSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI 220
Query: 500 LYNVVGQPLRFPES---PVVSFSARDLIKGLLVKEPQNR 535
+ + + + S ++I K+ NR
Sbjct: 221 AIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANR 259
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 1e-18
Identities = 49/207 (23%), Positives = 89/207 (42%), Gaps = 22/207 (10%)
Query: 166 RGSTSSDVSDESTCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGH----FRLLKKL 221
R T+S ++ S+ + D + V G + K +
Sbjct: 4 RPRTTSF-AESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVI 62
Query: 222 GCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTH 281
G G G VY ++L + A+K K +KR K R E +I++ LDH + L
Sbjct: 63 GNGSFGVVYQAKLCDSGELVAIK---KVLQDKRFKN-R---ELQIMRKLDHCNIVRLRYF 115
Query: 282 F------ETDKFSCLVMEFCPGGDLHTL--RQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
F + + + LV+++ P ++ + + + VK Y+ ++ +L Y+H
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS 174
Query: 334 LGIVYRDLKPENVLVREDGHIM-LSDF 359
GI +RD+KP+N+L+ D ++ L DF
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDF 201
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 9e-06
Identities = 34/124 (27%), Positives = 44/124 (35%), Gaps = 32/124 (25%)
Query: 457 YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATLY---NVVGQP----- 507
Y APE+I G S++D W+ G L ELL G+ F G L V+G P
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQI 281
Query: 508 ---------LRFPESPVVSFS----------ARDLIKGLLVKEPQNRLACRRGATEIKQH 548
+FP+ ++ A L LL P RL E H
Sbjct: 282 REMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT----PLEACAH 337
Query: 549 PFFQ 552
FF
Sbjct: 338 SFFD 341
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 88.0 bits (218), Expect = 1e-18
Identities = 86/472 (18%), Positives = 138/472 (29%), Gaps = 146/472 (30%)
Query: 160 GKSSMCRGSTSSDVSDESTCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLK 219
G S + + + T S + + + ++ A D + + +
Sbjct: 1 GSSHEAAAAQQHNSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPD-RYEIRH 59
Query: 220 KLGCGDIGSVYLSELTGTKCYFAMK----VMDKASLEKRKKLLRAQTEREI--LQSLDHP 273
+G G G V + K A+K V + KR REI L L+H
Sbjct: 60 LIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKR-------ILREIAILNRLNHD 112
Query: 274 --------FLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEV 324
+P F+ + + +V+E D R +E +K + +
Sbjct: 113 HVVKVLDIVIPKDVEKFD-ELY--VVLEIA-DSDFKKLFRTPVY---LTELHIKTLLYNL 165
Query: 325 LLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRK 384
L+ ++Y+H GI++RDLKP N LV +D + + DF L+ R P
Sbjct: 166 LVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLA-RTVDYP--------------- 209
Query: 385 NPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444
+ L
Sbjct: 210 ----------------------------------ENGNSQLPISPREDDMNLVTFPHTKN 235
Query: 445 NARSMS-FVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELL-----------FGKTPF 491
R ++ V T Y APE+I + + A+D W+ G ELL F
Sbjct: 236 LKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLF 295
Query: 492 KGSENRATLY-----------------------NVVGQP-----------------LRFP 511
GS N++G P FP
Sbjct: 296 PGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFP 355
Query: 512 ESPVVSFS---------ARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554
+ + A L+K +LV P R+ E HPFF+ V
Sbjct: 356 KREGTDLAERFPASSADAIHLLKRMLVFNPNKRIT----INECLAHPFFKEV 403
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 85.3 bits (212), Expect = 2e-18
Identities = 42/148 (28%), Positives = 65/148 (43%), Gaps = 11/148 (7%)
Query: 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQSLDHPFL 275
+ K+G G G V+ T A+K K + +++ REI L+ L HP L
Sbjct: 8 IGKIGEGSYGVVFKCRNRDTGQIVAIK---KFLESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 276 PTLYTHFETDKFSCLVMEFCPGGDLHTLRQ--RQPGKYFSEQAVKFYVAEVLLALEYLHM 333
L F + LV E+C HT+ + + E VK + L A+ + H
Sbjct: 65 VNLLEVFRRKRRLHLVFEYCD----HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHK 120
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDL 361
++RD+KPEN+L+ + I L DF
Sbjct: 121 HNCIHRDVKPENILITKHSVIKLCDFGF 148
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 3e-06
Identities = 35/151 (23%), Positives = 56/151 (37%), Gaps = 40/151 (26%)
Query: 454 THE-----YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATLY---NVV 504
E Y +PE++ G+ G VD W G ELL G + G + LY +
Sbjct: 160 DDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTL 219
Query: 505 GQP----------------LRFPES----------PVVSFSARDLIKGLLVKEPQNRLAC 538
G ++ P+ P +S+ A L+KG L +P RL C
Sbjct: 220 GDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTC 279
Query: 539 RRGATEIKQHPFFQGVNWALIRCASPPEIPK 569
++ HP+F+ + + A + P
Sbjct: 280 E----QLLHHPYFENIR-EIEDLAKEHDKPA 305
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 3e-18
Identities = 39/159 (24%), Positives = 69/159 (43%), Gaps = 14/159 (8%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRA----QTEREILQSL 270
K++G G G V+ L K A+K + E +++ Q E I+ +L
Sbjct: 21 IEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNL 80
Query: 271 DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEY 330
+HP + LY + +VMEF P GDL+ + ++ + ++ L +EY
Sbjct: 81 NHPNIVKLYG-LMHNPP-RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRL-MLDIALGIEY 137
Query: 331 LHMLG--IVYRDLKPENVLVREDG-----HIMLSDFDLS 362
+ IV+RDL+ N+ ++ ++DF LS
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS 176
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 5e-09
Identities = 20/92 (21%), Positives = 38/92 (41%), Gaps = 4/92 (4%)
Query: 448 SMSFVGTHEYLAPEIIKGEG--HGSAVDWWTFGIFLYELLFGKTPFKGSENR--ATLYNV 503
+G +++APE I E + D ++F + LY +L G+ PF + +
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242
Query: 504 VGQPLRFPESPVVSFSARDLIKGLLVKEPQNR 535
+ LR R++I+ +P+ R
Sbjct: 243 REEGLRPTIPEDCPPRLRNVIELCWSGDPKKR 274
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 83.8 bits (208), Expect = 4e-18
Identities = 32/153 (20%), Positives = 52/153 (33%), Gaps = 11/153 (7%)
Query: 217 LLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLP 276
L KL G ++ G +KV+ RK E L+ HP +
Sbjct: 14 FLTKLNENHSGELWKGRWQGNDI--VVKVLKVRDWSTRK-SRDFNEECPRLRIFSHPNVL 70
Query: 277 TLY---THFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFS-EQAVKFYVAEVLLALEYLH 332
+ L+ + P G L+ + QAVKF ++ + +LH
Sbjct: 71 PVLGACQSPPAPHP-TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKF-ALDMARGMAFLH 128
Query: 333 MLG--IVYRDLKPENVLVREDGHIMLSDFDLSL 363
L I L +V++ ED +S D+
Sbjct: 129 TLEPLIPRHALNSRSVMIDEDMTARISMADVKF 161
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 60.3 bits (147), Expect = 3e-10
Identities = 22/91 (24%), Positives = 41/91 (45%), Gaps = 3/91 (3%)
Query: 448 SMSFVGTHEYLAPEIIKGEGHGS---AVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV 504
S + ++APE ++ + + + D W+F + L+EL+ + PF N V
Sbjct: 165 SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVA 224
Query: 505 GQPLRFPESPVVSFSARDLIKGLLVKEPQNR 535
+ LR P +S L+K + ++P R
Sbjct: 225 LEGLRPTIPPGISPHVSKLMKICMNEDPAKR 255
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 4e-18
Identities = 41/150 (27%), Positives = 65/150 (43%), Gaps = 7/150 (4%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQSLDH 272
+ L +G G G V T A+K K K+++ REI L+ L H
Sbjct: 27 YENLGLVGEGSYGMVMKCRNKDTGRIVAIK---KFLESDDDKMVKKIAMREIKLLKQLRH 83
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
L L + K LV EF + + P Q V+ Y+ +++ + + H
Sbjct: 84 ENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNG-LDYQVVQKYLFQIINGIGFCH 141
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
I++RD+KPEN+LV + G + L DF +
Sbjct: 142 SHNIIHRDIKPENILVSQSGVVKLCDFGFA 171
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-06
Identities = 38/155 (24%), Positives = 52/155 (33%), Gaps = 44/155 (28%)
Query: 454 THE-----YLAPEIIKGEGH-GSAVDWWTFG-IFLYELLFGKTPFKGSENRATLY---NV 503
E Y APE++ G+ G AVD W G + E+ G+ F G + LY
Sbjct: 182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLV-TEMFMGEPLFPGDSDIDQLYHIMMC 240
Query: 504 VGQP----------------LRFPES----------PVVSFSARDLIKGLLVKEPQNRLA 537
+G +R PE P +S DL K L +P R
Sbjct: 241 LGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF 300
Query: 538 CRRGATEIKQHPFFQGVNWALIRCASPPEIPKPVE 572
C E+ H FFQ E+ V+
Sbjct: 301 CA----ELLHHDFFQMDG---FAERFSQELQLKVQ 328
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 84.4 bits (209), Expect = 7e-18
Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 15/157 (9%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRK-KLLRAQTEREILQSLD 271
+FR+ KK+GCG+ G + L + T Y A+K LE K + + E + L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIK------LEPMKSRAPQLHLEYRFYKQLG 62
Query: 272 H-PFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEY 330
+P +Y K++ +V+E G L L FS + V +++ +EY
Sbjct: 63 SGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRT-FSLKTVLMIAIQLISRMEY 120
Query: 331 LHMLGIVYRDLKPENVLVREDGH-----IMLSDFDLS 362
+H ++YRD+KPEN L+ G+ I + DF L+
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA 157
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 7e-18
Identities = 43/150 (28%), Positives = 77/150 (51%), Gaps = 7/150 (4%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQSLDH 272
+ L+K+G G G+V+ ++ T A+K + L+ + + + REI L+ L H
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALK---RVRLDDDDEGVPSSALREICLLKELKH 60
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
+ L+ +DK LV EFC DL G + VK ++ ++L L + H
Sbjct: 61 KNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGD-LDPEIVKSFLFQLLKGLGFCH 118
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+++RDLKP+N+L+ +G + L++F L+
Sbjct: 119 SRNVLHRDLKPQNLLINRNGELKLANFGLA 148
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 42.9 bits (102), Expect = 2e-04
Identities = 31/151 (20%), Positives = 54/151 (35%), Gaps = 51/151 (33%)
Query: 454 THE-----YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTP-FKGSENRATL---YNV 503
+ E Y P+++ G +++D W+ G EL P F G++ L + +
Sbjct: 159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218
Query: 504 VGQP--------------LRFPES----------PVVSFSARDLIKGLLVKEPQNRLACR 539
+G P +P P ++ + RDL++ LL P R++
Sbjct: 219 LGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS-- 276
Query: 540 RGATEIKQHPFFQGVNWALIRCASPPEIPKP 570
A E QHP+F + P
Sbjct: 277 --AEEALQHPYFS-------------DFCPP 292
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 8e-18
Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 14/157 (8%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTG----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQS 269
H + L++LG G+ GSV + T A+K + ++ E + R E EIL+S
Sbjct: 42 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER---EIEILKS 98
Query: 270 LDHPFLPTLY---THFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVL 325
L H + L+ME+ P G L L++ + + Y +++
Sbjct: 99 LQHDNIVKYKGVCYSAGRRNL-KLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQIC 155
Query: 326 LALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+EYL ++RDL N+LV + + + DF L+
Sbjct: 156 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 192
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 1e-17
Identities = 41/202 (20%), Positives = 78/202 (38%), Gaps = 24/202 (11%)
Query: 183 SSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYL-----SELTGT 237
++ + A E + + +++ +G G G +YL SE G+
Sbjct: 6 AAQAGRQSSAKRHLAEQFAVGEIITDMAA-AAWKVGLPIGQGGFGCIYLADMNSSESVGS 64
Query: 238 KCYFAMKVM--DKASLEKRKKLL-RAQTEREI-----LQSLDHPFLPTLY----THFETD 285
+KV D L K RA +I + L + +P +
Sbjct: 65 DAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGK 124
Query: 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLL-ALEYLHMLGIVYRDLKPE 344
+ ++M+ G DL + + + FS + V ++ +L LEY+H V+ D+K
Sbjct: 125 SYRFMIMDRF-GSDLQKIYEANAKR-FSRKTV-LQLSLRILDILEYIHEHEYVHGDIKAS 181
Query: 345 NVLV--REDGHIMLSDFDLSLR 364
N+L+ + + L D+ L+ R
Sbjct: 182 NLLLNYKNPDQVYLVDYGLAYR 203
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 46/164 (28%), Positives = 70/164 (42%), Gaps = 25/164 (15%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTE-------R 264
F+ L+KLG G +VY T Y A+K + L+ E R
Sbjct: 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALK---EVKLDSE--------EGTPSTAIR 52
Query: 265 EI--LQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTL----RQRQPGKYFSEQAVK 318
EI ++ L H + LY T+ LV EF DL + VK
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK 111
Query: 319 FYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++ ++L L + H I++RDLKP+N+L+ + G + L DF L+
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLA 155
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 2e-05
Identities = 30/164 (18%), Positives = 52/164 (31%), Gaps = 55/164 (33%)
Query: 454 THE-----YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATL------- 500
+ E Y AP+++ G +++D W+ G L E++ GK F G+ + L
Sbjct: 166 SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIM 225
Query: 501 -------------------------YNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNR 535
+ Q L+ + + D + GLL P R
Sbjct: 226 GTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMR 285
Query: 536 LACRRGATEIKQHPFFQGVNWALIRCASPPEIPKPVEIVHSPAP 579
L+ A + HP+F E + S +
Sbjct: 286 LS----AKQALHHPWFA-------------EYYHHASMGGSRSH 312
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 46/158 (29%), Positives = 72/158 (45%), Gaps = 24/158 (15%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTE--------REI 266
+ L KLG G +VY + T A+K +R + E RE+
Sbjct: 4 YIKLDKLGEGTYATVYKGKSKLTDNLVALKE------------IRLEHEEGAPCTAIREV 51
Query: 267 --LQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEV 324
L+ L H + TL+ T+K LV E+ DL G + VK ++ ++
Sbjct: 52 SLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQY-LDDCGNIINMHNVKLFLFQL 109
Query: 325 LLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
L L Y H +++RDLKP+N+L+ E G + L+DF L+
Sbjct: 110 LRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLA 147
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-07
Identities = 36/176 (20%), Positives = 61/176 (34%), Gaps = 44/176 (25%)
Query: 454 THE-----YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATL---YNVV 504
+E Y P+I+ G + +D W G YE+ G+ F GS L + ++
Sbjct: 158 DNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRIL 217
Query: 505 GQP----------------LRFPESPVVSFS---------ARDLIKGLLVKEPQNRLACR 539
G P +P+ + DL+ LL E +NR++
Sbjct: 218 GTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS-- 275
Query: 540 RGATEIKQHPFFQGVNWALIRCASPPEIPKPVEIVHSPAPALSTKAKAVAAGNADH 595
A + +HPFF + ++P I L +A +A + H
Sbjct: 276 --AEDAMKHPFFLSLG------ERIHKLPDTTSIFALKEIQLQKEASLRSAHHHHH 323
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 2e-17
Identities = 39/159 (24%), Positives = 70/159 (44%), Gaps = 26/159 (16%)
Query: 217 LLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP--- 273
+ +K+G G G+V+ +E G+ A+K++ + +++ E I++ L HP
Sbjct: 41 IKEKIGAGSFGTVHRAEWHGSDV--AVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNIV 97
Query: 274 -FL------PTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVL 325
F+ P L +V E+ G L+ L + + E+ +V
Sbjct: 98 LFMGAVTQPPNL----------SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147
Query: 326 LALEYLHMLG--IVYRDLKPENVLVREDGHIMLSDFDLS 362
+ YLH IV+R+LK N+LV + + + DF LS
Sbjct: 148 KGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLS 186
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 24/92 (26%), Positives = 41/92 (44%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNV 503
T S S GT E++APE+++ E D ++FG+ L+EL + P+ + V
Sbjct: 192 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAV 251
Query: 504 VGQPLRFPESPVVSFSARDLIKGLLVKEPQNR 535
+ R ++ +I+G EP R
Sbjct: 252 GFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKR 283
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 82.9 bits (205), Expect = 2e-17
Identities = 51/202 (25%), Positives = 83/202 (41%), Gaps = 27/202 (13%)
Query: 183 SSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFA 242
SS V+ + Q +V D + G + L KK+G G G +YL+ T A
Sbjct: 8 SSGVDLGTENLYFQSMPFPEGKVLDDMEG-NQWVLGKKIGSGGFGLIYLAFPTNKPEKDA 66
Query: 243 MKVMDKASLEKRKK---------LLRAQTEREI-----LQSLDHPFLPTLY----THFET 284
V+ +E ++ R + I + LD+ +P Y T F+
Sbjct: 67 RHVV---KVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKG 123
Query: 285 DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPE 344
+ +VME G DL + + G F + V +L LEY+H V+ D+K
Sbjct: 124 RSYRFMVMERL-GIDLQKISGQN-GT-FKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAA 180
Query: 345 NVLV--REDGHIMLSDFDLSLR 364
N+L+ + + L+D+ LS R
Sbjct: 181 NLLLGYKNPDQVYLADYGLSYR 202
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 2e-17
Identities = 43/151 (28%), Positives = 77/151 (50%), Gaps = 10/151 (6%)
Query: 215 FRLLKKLGCGDIGSVYLS-ELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQSLD 271
++ L+K+G G G VY + + G A+K + L+ + + + REI L+ L
Sbjct: 23 YQKLEKVGEGTYGVVYKAKDSQGRIV--ALK---RIRLDAEDEGIPSTAIREISLLKELH 77
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
HP + +L +++ LV EF DL + + +K Y+ ++L + +
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTG-LQDSQIKIYLYQLLRGVAHC 135
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
H I++RDLKP+N+L+ DG + L+DF L+
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLA 166
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 47.5 bits (114), Expect = 6e-06
Identities = 30/136 (22%), Positives = 54/136 (39%), Gaps = 38/136 (27%)
Query: 454 THE-----YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATL---YNVV 504
THE Y AP+++ G ++VD W+ G E++ GK F G + L ++++
Sbjct: 177 THEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL 236
Query: 505 GQP----------------LRFPESPVVSFS---------ARDLIKGLLVKEPQNRLACR 539
G P F +S DL+ +L +P R++
Sbjct: 237 GTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS-- 294
Query: 540 RGATEIKQHPFFQGVN 555
A + HP+F+ ++
Sbjct: 295 --ARDAMNHPYFKDLD 308
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 3e-17
Identities = 40/157 (25%), Positives = 69/157 (43%), Gaps = 14/157 (8%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTG----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQS 269
H + L++LG G+ GSV + T A+K + ++ E + R E EIL+S
Sbjct: 11 HLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER---EIEILKS 67
Query: 270 LDHPFLPTLY---THFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVL 325
L H + L+ME+ P G L L++ + + Y +++
Sbjct: 68 LQHDNIVKYKGVCYSAGRRNL-KLIMEYLPYGSLRDYLQKHKER--IDHIKLLQYTSQIC 124
Query: 326 LALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+EYL ++RDL N+LV + + + DF L+
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 47/149 (31%), Positives = 68/149 (45%), Gaps = 4/149 (2%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQSLDH 272
+ L LG G +VY + T A+K + + K + REI LQ L H
Sbjct: 12 YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSH 71
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
P + L F LV +F DL + + + +K Y+ L LEYLH
Sbjct: 72 PNIIGLLDAFGHKSNISLVFDFMET-DLEVI-IKDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDL 361
I++RDLKP N+L+ E+G + L+DF L
Sbjct: 130 QHWILHRDLKPNNLLLDENGVLKLADFGL 158
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 1e-05
Identities = 41/173 (23%), Positives = 60/173 (34%), Gaps = 44/173 (25%)
Query: 454 THE-----YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATL---YNVV 504
TH+ Y APE++ G G VD W G L ELL G + L + +
Sbjct: 170 THQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETL 229
Query: 505 GQP--------------LRFPESPVVSFS---------ARDLIKGLLVKEPQNRLACRRG 541
G P + F P + DLI+GL + P R+
Sbjct: 230 GTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT---- 285
Query: 542 ATEIKQHPFFQGVNWALIRCASPPEIPKPVEIVHS----PAPALSTKAKAVAA 590
AT+ + +F ++P+P V + PAL+ K K A
Sbjct: 286 ATQALKMKYF----SNRPGPTPGCQLPRPNCPVETLKEQSNPALAIKRKRTEA 334
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 81.0 bits (201), Expect = 5e-17
Identities = 47/150 (31%), Positives = 74/150 (49%), Gaps = 8/150 (5%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQSLDH 272
+ L+K+G G G VY ++ FA+K K LEK + + + T REI L+ L H
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNN-YGETFALK---KIRLEKEDEGIPSTTIREISILKELKH 59
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
+ LY T K LV E DL L G K ++ ++L + Y H
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGG-LESVTAKSFLLQLLNGIAYCH 117
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+++RDLKP+N+L+ +G + ++DF L+
Sbjct: 118 DRRVLHRDLKPQNLLINREGELKIADFGLA 147
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 47.5 bits (114), Expect = 5e-06
Identities = 27/135 (20%), Positives = 48/135 (35%), Gaps = 37/135 (27%)
Query: 454 THE-----YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATL---YNVV 504
THE Y AP+++ G + +D W+ G E++ G F G L + ++
Sbjct: 158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRIL 217
Query: 505 GQP---------------LRFPESPVVSFS---------ARDLIKGLLVKEPQNRLACRR 540
G P F + + DL+ +L +P R+
Sbjct: 218 GTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT--- 274
Query: 541 GATEIKQHPFFQGVN 555
A + +H +F+ N
Sbjct: 275 -AKQALEHAYFKENN 288
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 83.1 bits (205), Expect = 5e-17
Identities = 41/181 (22%), Positives = 76/181 (41%), Gaps = 11/181 (6%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-D 271
FRL +K+G G G +YL T A+K+ +++ + L E +I + L
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLE---NVKTKHPQLLY--ESKIYRILQG 61
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
+P + ++ LVM+ G L L K S + V +++ +E++
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEFV 119
Query: 332 HMLGIVYRDLKPENVLVREDGH---IMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVY 388
H ++RD+KP+N L+ + + DF L+ + + T E++ L Y
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
Query: 389 C 389
Sbjct: 180 A 180
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 5e-17
Identities = 42/162 (25%), Positives = 66/162 (40%), Gaps = 25/162 (15%)
Query: 214 HFRLLKKLGCGDIGSVYLSELT----GTKCYFAMKVM-DKASLEKRKKLLRAQTEREILQ 268
+ + ++ LG G G V L GT A+K + A + R + E +IL+
Sbjct: 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQ---EIDILR 88
Query: 269 SLDHPFLPTLY---THFETDKFSCLVMEFCPGGDLHT-LRQRQPG----KYFSEQAVKFY 320
+L H + LVME+ P G L L + G F++Q
Sbjct: 89 TLYHEHIIKYKGCCEDAGAASL-QLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQ----- 142
Query: 321 VAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ E + YLH ++RDL NVL+ D + + DF L+
Sbjct: 143 ICE---GMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLA 181
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 5e-17
Identities = 42/218 (19%), Positives = 75/218 (34%), Gaps = 42/218 (19%)
Query: 161 KSSMCRGSTSSDVSDESTCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKK 220
+ + G+T D+ + T S S + + A+ L +
Sbjct: 7 RPFISEGTTLKDLIYDMTTSGSGSGLPLLVQRTIAR-----------------TIVLQES 49
Query: 221 LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQSLDHPFLPTL 278
+G G G V+ + G + A+K+ E EI L H +
Sbjct: 50 IGKGRFGEVWRGKWRGEE--VAVKIFSSREERS------WFREAEIYQTVMLRHENILGF 101
Query: 279 YTHFETDKFS----CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM- 333
D + LV ++ G L R + + + L +LHM
Sbjct: 102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAHLHME 158
Query: 334 -------LGIVYRDLKPENVLVREDGHIMLSDFDLSLR 364
I +RDLK +N+LV+++G ++D L++R
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 196
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 6e-17
Identities = 35/157 (22%), Positives = 70/157 (44%), Gaps = 26/157 (16%)
Query: 216 RLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRA-QTEREILQSLDHP- 273
+ +++G G G+VY + G A+K+++ + + L+A + E +L+ H
Sbjct: 27 TVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQ--QLQAFKNEVGVLRKTRHVN 81
Query: 274 ---FL-----PTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVL 325
F+ P L +V ++C G L+ K+ ++ + +
Sbjct: 82 ILLFMGYSTAPQL----------AIVTQWCEGSSLYHHLHASETKFEMKKLIDI-ARQTA 130
Query: 326 LALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++YLH I++RDLK N+ + ED + + DF L+
Sbjct: 131 RGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 24/98 (24%), Positives = 45/98 (45%), Gaps = 7/98 (7%)
Query: 445 NARSMSFVGTHEYLAPEIIKGEGHG---SAVDWWTFGIFLYELLFGKTPFKGSENRATLY 501
+ + G+ ++APE+I+ + D + FGI LYEL+ G+ P+ NR +
Sbjct: 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 235
Query: 502 NVVGQPLRFPESPVVSFSARDLIKGLLVK----EPQNR 535
+VG+ P+ V + +K L+ + + R
Sbjct: 236 EMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDER 273
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 43/163 (26%), Positives = 70/163 (42%), Gaps = 17/163 (10%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRA---QTEREI-- 266
+ + ++G G G+VY + + + A+K + T RE+
Sbjct: 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALK---SVRVPNGGGGGGGLPISTVREVAL 64
Query: 267 ---LQSLDHPFLPTLYTHFETDKFSC-----LVMEFCPGGDLHTLRQRQPGKYFSEQAVK 318
L++ +HP + L T + LV E DL T + P + +K
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123
Query: 319 FYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDL 361
+ + L L++LH IV+RDLKPEN+LV G + L+DF L
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 47.2 bits (113), Expect = 7e-06
Identities = 25/129 (19%), Positives = 41/129 (31%), Gaps = 34/129 (26%)
Query: 454 THE-----YLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATL---YNVVG 505
T Y APE++ + + VD W+ G E+ K F G+ L ++++G
Sbjct: 177 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236
Query: 506 QP-------------LRFPESPVVSFS---------ARDLIKGLLVKEPQNRLACRRGAT 543
P FP L+ +L P R++ A
Sbjct: 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS----AF 292
Query: 544 EIKQHPFFQ 552
QH +
Sbjct: 293 RALQHSYLH 301
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 2e-16
Identities = 35/173 (20%), Positives = 64/173 (36%), Gaps = 25/173 (14%)
Query: 217 LLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQSLDHPF 274
LL+ +G G G V+ G A+K+ + E E+ L H
Sbjct: 12 LLECVGKGRYGEVWRGSWQGE--NVAVKIFSSRDEKS------WFRETELYNTVMLRHEN 63
Query: 275 LPTLYTHFETDKFS----CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEY 330
+ T + S L+ + G L+ Q ++ V + L +
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDT--VSCLRI-VLSIASGLAH 120
Query: 331 LHML--------GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSS 375
LH+ I +RDLK +N+LV+++G ++D L++ + S +
Sbjct: 121 LHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 43.1 bits (102), Expect = 1e-04
Identities = 15/60 (25%), Positives = 24/60 (40%), Gaps = 6/60 (10%)
Query: 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSA------VDWWTFGIFLYELLFGKTPFKGSEN 496
+ + VGT Y+APE++ VD W FG+ L+E+ E+
Sbjct: 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVED 228
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 2e-16
Identities = 40/157 (25%), Positives = 71/157 (45%), Gaps = 14/157 (8%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTG----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQS 269
H + + +LG G+ GSV L T A+K + + ++++ R E +IL++
Sbjct: 24 HLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQR---EIQILKA 80
Query: 270 LDHPFLPTLY---THFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVL 325
L F+ LVME+ P G L L++ + + Y +++
Sbjct: 81 LHSDFIVKYRGVSYGPGRQSL-RLVMEYLPSGCLRDFLQRHRA--RLDASRLLLYSSQIC 137
Query: 326 LALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+EYL V+RDL N+LV + H+ ++DF L+
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 39/153 (25%), Positives = 66/153 (43%), Gaps = 11/153 (7%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVM-DKASLEKRKKLLRAQTEREILQSLDH 272
L +++G G+ G V+ L A+K + + + K L+ E IL+ H
Sbjct: 115 DLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQ---EARILKQYSH 171
Query: 273 PFLPTLY---THFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALE 329
P + L T + +VME GGD T + + + + ++ V + +E
Sbjct: 172 PNIVRLIGVCTQKQP---IYIVMELVQGGDFLTFLRTEGARLRVKTLLQM-VGDAAAGME 227
Query: 330 YLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
YL ++RDL N LV E + +SDF +S
Sbjct: 228 YLESKCCIHRDLAARNCLVTEKNVLKISDFGMS 260
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 2e-16
Identities = 42/187 (22%), Positives = 68/187 (36%), Gaps = 25/187 (13%)
Query: 184 SSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAM 243
S KP D + + ++ LG G G V L
Sbjct: 4 VSEKKPATEVD-PTHFEKR-----------FLKRIRDLGEGHFGKVELCRYDPEGDNTGE 51
Query: 244 KV-----MDKASLEKRKKLLRAQTEREILQSLDHPFLPTLY---THFETDKFSCLVMEFC 295
+V ++ L + E EIL++L H + T + L+MEF
Sbjct: 52 QVAVKSLKPESGGNHIADLKK---EIEILRNLYHENIVKYKGICTEDGGNGI-KLIMEFL 107
Query: 296 PGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIM 355
P G L + K +Q +K+ ++ ++YL V+RDL NVLV + +
Sbjct: 108 PSGSLKEYLPKNKNKINLKQQLKY-AVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVK 166
Query: 356 LSDFDLS 362
+ DF L+
Sbjct: 167 IGDFGLT 173
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 41/155 (26%), Positives = 76/155 (49%), Gaps = 18/155 (11%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+ K +G G G V+ ++L + A+K K +KR K R E +I++ + HP
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESD-EVAIK---KVLQDKRFKN-R---ELQIMRIVKHP 92
Query: 274 FLPTL----YTHFETDKFSC--LVMEFCPGGDLHTL--RQRQPGKYFSEQAVKFYVAEVL 325
+ L Y++ + LV+E+ P ++ + + +K Y+ ++L
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLL 151
Query: 326 LALEYLHMLGIVYRDLKPENVLV-REDGHIMLSDF 359
+L Y+H +GI +RD+KP+N+L+ G + L DF
Sbjct: 152 RSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF 186
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 8e-06
Identities = 40/142 (28%), Positives = 54/142 (38%), Gaps = 32/142 (22%)
Query: 457 YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATLY---NVVGQP----- 507
Y APE+I G + + +D W+ G + EL+ G+ F G L V+G P
Sbjct: 207 YRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQI 266
Query: 508 ---------LRFPESPVVSFS----------ARDLIKGLLVKEPQNRLACRRGATEIKQH 548
+FP+ FS A DLI LL P RL A E H
Sbjct: 267 KTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT----AIEALCH 322
Query: 549 PFFQGVNWALIRCASPPEIPKP 570
PFF + R + E+P
Sbjct: 323 PFFDELRTGEARMPNGRELPPL 344
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 2e-16
Identities = 47/173 (27%), Positives = 69/173 (39%), Gaps = 27/173 (15%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQSLDH 272
+LL+ +G G G+VY L A+KV A+ R+ + E+ I + ++H
Sbjct: 15 LKLLELIGRGRYGAVYKGSLDER--PVAVKVFSFAN---RQNFIN---EKNIYRVPLMEH 66
Query: 273 PFLPTLYTHFETDKFS-----CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLA 327
+ E LVME+ P G L + S + V
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTR---G 123
Query: 328 LEYLHM---------LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371
L YLH I +RDL NVLV+ DG ++SDF LS+R + V
Sbjct: 124 LAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLV 176
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 2e-04
Identities = 16/70 (22%), Positives = 30/70 (42%), Gaps = 7/70 (10%)
Query: 434 SPLPELIAEPTNARSMSFVGTHEYLAPEIIKG-------EGHGSAVDWWTFGIFLYELLF 486
+ + + ++S VGT Y+APE+++G E VD + G+ +E+
Sbjct: 171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
Query: 487 GKTPFKGSEN 496
T E+
Sbjct: 231 RCTDLFPGES 240
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 78.8 bits (195), Expect = 4e-16
Identities = 39/157 (24%), Positives = 72/157 (45%), Gaps = 13/157 (8%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQS 269
+ +R + KLG G G VY + T T A+K + LE ++ + RE+ L+
Sbjct: 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIK---RIRLEHEEEGVPGTAIREVSLLKE 89
Query: 270 LDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALE 329
L H + L + + L+ E+ DL + P S + +K ++ +++ +
Sbjct: 90 LQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPD--VSMRVIKSFLYQLINGVN 146
Query: 330 YLHMLGIVYRDLKPENVLV-----REDGHIMLSDFDL 361
+ H ++RDLKP+N+L+ E + + DF L
Sbjct: 147 FCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGL 183
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 31/133 (23%), Positives = 47/133 (35%), Gaps = 38/133 (28%)
Query: 454 THE-----YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATL---YNVV 504
THE Y PEI+ G H ++VD W+ E+L F G L + V+
Sbjct: 195 THEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVL 254
Query: 505 GQP---------------LRFPESPVVSFS----------ARDLIKGLLVKEPQNRLACR 539
G P FP+ + DL+ +L +P R++
Sbjct: 255 GLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS-- 312
Query: 540 RGATEIKQHPFFQ 552
A +HP+F
Sbjct: 313 --AKNALEHPYFS 323
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 4e-16
Identities = 41/183 (22%), Positives = 68/183 (37%), Gaps = 39/183 (21%)
Query: 216 RLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRA-QTEREILQSLDHP- 273
L + +G G G VY + G + A+K E + + + E ++ L HP
Sbjct: 10 TLEEIIGIGGFGKVYRAFWIGDEV--AVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 274 ---FL------PTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEV 324
P L CLVMEF GG L+ + + + V + ++
Sbjct: 68 IIALRGVCLKEPNL----------CLVMEFARGGPLNRVLSGKRIPP--DILVNW-AVQI 114
Query: 325 LLALEYLHMLG---IVYRDLKPENVLVREDGHIM--------LSDFDLSLRCAVSPTVVK 373
+ YLH I++RDLK N+L+ + ++DF L+ T
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA--REWHRTTKM 172
Query: 374 SST 376
S+
Sbjct: 173 SAA 175
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 2e-13
Identities = 26/92 (28%), Positives = 42/92 (45%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNV 503
MS G + ++APE+I+ D W++G+ L+ELL G+ PF+G + A Y V
Sbjct: 167 HRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV 226
Query: 504 VGQPLRFPESPVVSFSARDLIKGLLVKEPQNR 535
L P L++ +P +R
Sbjct: 227 AMNKLALPIPSTCPEPFAKLMEDCWNPDPHSR 258
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 4e-16
Identities = 36/151 (23%), Positives = 68/151 (45%), Gaps = 6/151 (3%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH 272
+ L + LG G + V+L+ A+KV+ LR + E + +L+H
Sbjct: 12 DRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 71
Query: 273 PFLPTLY----THFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLAL 328
P + +Y +VME+ G L + + G ++A++ +A+ AL
Sbjct: 72 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIE-VIADACQAL 129
Query: 329 EYLHMLGIVYRDLKPENVLVREDGHIMLSDF 359
+ H GI++RD+KP N+++ + + DF
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDF 160
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 2e-09
Identities = 34/153 (22%), Positives = 65/153 (42%), Gaps = 14/153 (9%)
Query: 441 AEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATL 500
+ + ++ + +GT +YL+PE +G+ + D ++ G LYE+L G+ PF G +
Sbjct: 169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 228
Query: 501 YNVVGQPLRFPES--PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWAL 558
Y V + P + +S ++ L K P+NR A E++ L
Sbjct: 229 YQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ---TAAEMRA---------DL 276
Query: 559 IRCASPPEIPKPVEIVHSPAPALSTKAKAVAAG 591
+R + P + + +L + A +G
Sbjct: 277 VRVHNGEPPEAPKVLTDAERTSLLSSAAGNLSG 309
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 5e-16
Identities = 37/150 (24%), Positives = 65/150 (43%), Gaps = 6/150 (4%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+ KLG G G VY A+K + K + ++ L+ E +++ + HP
Sbjct: 14 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLK---EAAVMKEIKHP 69
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
L L + ++ EF G+L LR+ + + + ++ A+EYL
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM-ATQISSAMEYLE 128
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++RDL N LV E+ + ++DF LS
Sbjct: 129 KKNFIHRDLAARNCLVGENHLVKVADFGLS 158
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 33/157 (21%), Positives = 66/157 (42%), Gaps = 28/157 (17%)
Query: 217 LLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRA-QTEREILQSLDHP-- 273
+ + +G G G VY G A++++D + L+A + E + H
Sbjct: 37 IGELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNE--DQLKAFKREVMAYRQTRHENV 91
Query: 274 --FL------PTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVL 325
F+ P L ++ C G L+++ + + + E++
Sbjct: 92 VLFMGACMSPPHL----------AIITSLCKGRTLYSVVRDAKIVLDVNKTRQI-AQEIV 140
Query: 326 LALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ YLH GI+++DLK +NV ++G ++++DF L
Sbjct: 141 KGMGYLHAKGILHKDLKSKNVFY-DNGKVVITDFGLF 176
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-09
Identities = 21/97 (21%), Positives = 36/97 (37%), Gaps = 11/97 (11%)
Query: 449 MSFVGTHEYLAPEIIKGEGHGS---------AVDWWTFGIFLYELLFGKTPFKGSENRAT 499
G +LAPEII+ + D + G YEL + PFK A
Sbjct: 192 RIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAI 251
Query: 500 LYNVVGQPLRFPESPV-VSFSARDLIKGLLVKEPQNR 535
++ +G ++ S + + D++ E + R
Sbjct: 252 IW-QMGTGMKPNLSQIGMGKEISDILLFCWAFEQEER 287
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 5e-16
Identities = 33/174 (18%), Positives = 64/174 (36%), Gaps = 25/174 (14%)
Query: 217 LLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQSLDHPF 274
++K++G G G V++ + G A+KV + E EI + H
Sbjct: 41 MVKQIGKGRYGEVWMGKWRGE--KVAVKVFFTTEEASWFR------ETEIYQTVLMRHEN 92
Query: 275 LPTLYTHFETDKFS----CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEY 330
+ S L+ ++ G L+ + + +K + L +
Sbjct: 93 ILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDA--KSMLKL-AYSSVSGLCH 149
Query: 331 LHML--------GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSST 376
LH I +RDLK +N+LV+++G ++D L+++ V
Sbjct: 150 LHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 6e-04
Identities = 12/60 (20%), Positives = 24/60 (40%), Gaps = 6/60 (10%)
Query: 442 EPTNARSMSFVGTHEYLAPEIIKGEGHGS------AVDWWTFGIFLYELLFGKTPFKGSE 495
+ + VGT Y+ PE++ + + D ++FG+ L+E+ E
Sbjct: 197 NEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 79.4 bits (196), Expect = 7e-16
Identities = 36/150 (24%), Positives = 65/150 (43%), Gaps = 6/150 (4%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+ KLG G G VY A+K + K + ++ L+ E +++ + HP
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLK---EAAVMKEIKHP 276
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
L L + ++ EF G+L LR+ + + + ++ A+EYL
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYM-ATQISSAMEYLE 335
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++R+L N LV E+ + ++DF LS
Sbjct: 336 KKNFIHRNLAARNCLVGENHLVKVADFGLS 365
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 7e-16
Identities = 49/160 (30%), Positives = 71/160 (44%), Gaps = 15/160 (9%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI--LQS 269
V + L K+G G G V+ + T A+K K +E K+ REI LQ
Sbjct: 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALK---KVLMENEKEGFPITALREIKILQL 72
Query: 270 LDHPFLPTLY-------THFETDKFSC-LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYV 321
L H + L + + K S LV +FC DL L F+ +K +
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGL-LSNVLVKFTLSEIKRVM 130
Query: 322 AEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDL 361
+L L Y+H I++RD+K NVL+ DG + L+DF L
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 2e-04
Identities = 29/145 (20%), Positives = 47/145 (32%), Gaps = 42/145 (28%)
Query: 443 PTNARSMSFVGTHE-----YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSEN 496
N++ + T+ Y PE++ GE G +D W G + E+ +G+
Sbjct: 177 AKNSQPNRY--TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 234
Query: 497 RATL---YNVVGQP----------------LRFPESP-----------VVSFSARDLIKG 526
+ L + G L + V A DLI
Sbjct: 235 QHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK 294
Query: 527 LLVKEPQNRLACRRGATEIKQHPFF 551
LLV +P R+ + + H FF
Sbjct: 295 LLVLDPAQRID----SDDALNHDFF 315
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 77.8 bits (192), Expect = 9e-16
Identities = 32/177 (18%), Positives = 62/177 (35%), Gaps = 23/177 (12%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+LL+ G G V+ ++L Y A+K+ K+ + + E L + H
Sbjct: 25 PLQLLEVKARGRFGCVWKAQLLNE--YVAVKIFPIQD----KQSWQNEYEVYSLPGMKHE 78
Query: 274 FLPTLYTHFETDKFS----CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALE 329
+ + L+ F G L + + + + L
Sbjct: 79 NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSW--NELCHIAE-TMARGLA 135
Query: 330 YLHM----------LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSST 376
YLH I +RD+K +NVL++ + ++DF L+L+ + +
Sbjct: 136 YLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHG 192
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 42.4 bits (100), Expect = 2e-04
Identities = 23/105 (21%), Positives = 40/105 (38%), Gaps = 9/105 (8%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSA-----VDWWTFGIFLYELLFGKTPFKGS--EN 496
+ + VGT Y+APE+++G + +D + G+ L+EL T G E
Sbjct: 186 SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245
Query: 497 RATLYNVVGQPLRFPE--SPVVSFSARDLIKGLLVKEPQNRLACR 539
+GQ + VV R +++ K + C
Sbjct: 246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCE 290
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 2e-15
Identities = 48/194 (24%), Positives = 73/194 (37%), Gaps = 14/194 (7%)
Query: 176 ESTCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELT 235
E+ + + E +A R + + K +G GD G V L
Sbjct: 12 ENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLR 71
Query: 236 GTKCYF---AMKVM-DKASLEKRKKLLRAQTEREILQSLDHPFLPTLY---THFETDKFS 288
A+K + + +R+ L E I+ DHP + L T +
Sbjct: 72 VPGQRDVPVAIKALKAGYTERQRRDFLS---EASIMGQFDHPNIIRLEGVVTRGRL---A 125
Query: 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV 348
+V E+ G L T + G++ Q V + V + YL LG V+RDL NVLV
Sbjct: 126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGM-LRGVGAGMRYLSDLGYVHRDLAARNVLV 184
Query: 349 REDGHIMLSDFDLS 362
+ +SDF LS
Sbjct: 185 DSNLVCKVSDFGLS 198
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 75.7 bits (187), Expect = 3e-15
Identities = 46/151 (30%), Positives = 66/151 (43%), Gaps = 10/151 (6%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+LL+ +G G+ G V L + G K A+K + + + L E ++ L H
Sbjct: 22 ELKLLQTIGKGEFGDVMLGDYRGNKV--AVKCIKNDATAQ--AFLA---EASVMTQLRHS 74
Query: 274 FLPTLY-THFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
L L E +V E+ G L LR R + +KF +V A+EYL
Sbjct: 75 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-SLDVCEAMEYL 133
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
V+RDL NVLV ED +SDF L+
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 164
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 35/157 (22%), Positives = 63/157 (40%), Gaps = 15/157 (9%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDK-----ASLEKRKKLLRAQTEREILQ 268
K +G G+ G VY L + + V K + ++R L E I+
Sbjct: 45 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLG---EAGIMG 101
Query: 269 SLDHPFLPTLY---THFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVL 325
H + L + ++ ++ E+ G L + + G++ Q V + +
Sbjct: 102 QFSHHNIIRLEGVISKYKP---MMIITEYMENGALDKFLREKDGEFSVLQLVGM-LRGIA 157
Query: 326 LALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++YL + V+RDL N+LV + +SDF LS
Sbjct: 158 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLS 194
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 41/158 (25%), Positives = 78/158 (49%), Gaps = 15/158 (9%)
Query: 215 FRLLKKLGCGDIGSVYLS-ELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI-----LQ 268
+ + ++G G G V+ + +L + A+K + ++ ++ + T RE+ L+
Sbjct: 13 YECVAEIGEGAYGKVFKARDLKNGGRFVALK---RVRVQTGEEGMPLSTIREVAVLRHLE 69
Query: 269 SLDHPFLPTLY-----THFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAE 323
+ +HP + L+ + + + LV E DL T + P + +K + +
Sbjct: 70 TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQ 128
Query: 324 VLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDL 361
+L L++LH +V+RDLKP+N+LV G I L+DF L
Sbjct: 129 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 166
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 3e-06
Identities = 32/156 (20%), Positives = 51/156 (32%), Gaps = 47/156 (30%)
Query: 454 THE-----YLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY---NVVG 505
T Y APE++ + + VD W+ G E+ K F+GS + L +V+G
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236
Query: 506 QP-------------LRFPESPVVSFS---------ARDLIKGLLVKEPQNRLACRRGAT 543
P F +DL+ L P R++ A
Sbjct: 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AY 292
Query: 544 EIKQHPFFQGVNWALIRCASPPEIPKPVEIVHSPAP 579
HP+FQ ++ + E + S P
Sbjct: 293 SALSHPYFQ-------------DLERCKENLDSHLP 315
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 43/181 (23%), Positives = 73/181 (40%), Gaps = 28/181 (15%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMK---VMDKASLEKRKKLLRAQTEREI--LQ 268
F+L LG G G V + T A+K DK R T REI L+
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALR-------TLREIKILK 64
Query: 269 SLDHP--------FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFY 320
H P + +F + + ++ E DLH + Q S+ ++++
Sbjct: 65 HFKHENIITIFNIQRPDSFENFN-EVY--IIQELM-QTDLHRVISTQM---LSDDHIQYF 117
Query: 321 VAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESE 380
+ + L A++ LH +++RDLKP N+L+ + + + DF L+ R S +
Sbjct: 118 IYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLA-RIIDESAADNSEPTGQQ 176
Query: 381 P 381
Sbjct: 177 S 177
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 32/133 (24%), Positives = 47/133 (35%), Gaps = 35/133 (26%)
Query: 452 VGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATLY---NVVGQP 507
V T Y APE++ A+D W+ G L EL + F G + R L ++G P
Sbjct: 183 VATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP 242
Query: 508 ------------------LRFPESPVVSFS---------ARDLIKGLLVKEPQNRLACRR 540
P P DL++ +LV +P R+
Sbjct: 243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT--- 299
Query: 541 GATEIKQHPFFQG 553
A E +HP+ Q
Sbjct: 300 -AKEALEHPYLQT 311
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 3e-15
Identities = 46/153 (30%), Positives = 66/153 (43%), Gaps = 14/153 (9%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+LL+ +G G+ G V L + G K A+K + K + L E ++ L H
Sbjct: 194 ELKLLQTIGKGEFGDVMLGDYRGNKV--AVKCI-KND-ATAQAFLA---EASVMTQLRHS 246
Query: 274 FLPTLY---THFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALE 329
L L + +V E+ G L LR R + +KF +V A+E
Sbjct: 247 NLVQLLGVIVEEKGGL--YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKF-SLDVCEAME 303
Query: 330 YLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
YL V+RDL NVLV ED +SDF L+
Sbjct: 304 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLT 336
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 48/163 (29%), Positives = 71/163 (43%), Gaps = 27/163 (16%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMK----VMDKASLEKRKKLLRAQTEREI--L 267
+R L+ +G G G+V + T A+K KR RE+ L
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKR-------AYRELRLL 78
Query: 268 QSLDHP--------FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKF 319
+ + H F P TD + LVM F G DL L + + E ++F
Sbjct: 79 KHMRHENVIGLLDVFTPDETLDDFTDFY--LVMPFM-GTDLGKLMKHEK---LGEDRIQF 132
Query: 320 YVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
V ++L L Y+H GI++RDLKP N+ V ED + + DF L+
Sbjct: 133 LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 175
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-07
Identities = 38/143 (26%), Positives = 56/143 (39%), Gaps = 39/143 (27%)
Query: 446 ARSMS-----FVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRAT 499
AR +V T Y APE+I VD W+ G + E++ GKT FKGS++
Sbjct: 175 ARQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 234
Query: 500 L---YNVVGQP-----------------LRFPESPVVSFS---------ARDLIKGLLVK 530
L V G P PE F+ A +L++ +LV
Sbjct: 235 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVL 294
Query: 531 EPQNRLACRRGATEIKQHPFFQG 553
+ + R+ A E HP+F+
Sbjct: 295 DAEQRVT----AGEALAHPYFES 313
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 45/163 (27%), Positives = 71/163 (43%), Gaps = 27/163 (16%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMK----VMDKASLEKRKKLLRAQTEREI--L 267
++ L +G G GSV + T T A+K KR T RE+ L
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-------TYRELRLL 82
Query: 268 QSLDHP--------FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKF 319
+ + H F P D + LV G DL+ + + Q ++ V+F
Sbjct: 83 KHMKHENVIGLLDVFTPARSLEEFNDVY--LVTHLM-GADLNNIVKCQK---LTDDHVQF 136
Query: 320 YVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ ++L L+Y+H I++RDLKP N+ V ED + + DF L+
Sbjct: 137 LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA 179
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 1e-07
Identities = 36/142 (25%), Positives = 57/142 (40%), Gaps = 39/142 (27%)
Query: 446 ARSMS-----FVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRAT 499
AR + +V T Y APEI+ H VD W+ G + ELL G+T F G+++
Sbjct: 179 ARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 238
Query: 500 L---YNVVGQP-----------------LRFPESPVVSFS---------ARDLIKGLLVK 530
L +VG P + P ++F+ A DL++ +LV
Sbjct: 239 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVL 298
Query: 531 EPQNRLACRRGATEIKQHPFFQ 552
+ R+ A + H +F
Sbjct: 299 DSDKRIT----AAQALAHAYFA 316
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 5e-15
Identities = 44/164 (26%), Positives = 69/164 (42%), Gaps = 30/164 (18%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMK----VMDKASLEKRKKLLRAQTEREI--L 267
+ +G G GSV + + A+K KR RE+ L
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKR-------AYRELLLL 77
Query: 268 QSLDHP--------FLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVK 318
+ + H F P D + LVM F DL + + FSE+ ++
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFY--LVMPFM-QTDLQKIMGLK-----FSEEKIQ 129
Query: 319 FYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ V ++L L+Y+H G+V+RDLKP N+ V ED + + DF L+
Sbjct: 130 YLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 173
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 40/143 (27%), Positives = 55/143 (38%), Gaps = 39/143 (27%)
Query: 446 ARSMS-----FVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRAT 499
AR +V T Y APE+I H VD W+ G + E+L GKT FKG +
Sbjct: 173 ARHADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 232
Query: 500 L---YNVVGQP-----------------LRFPESPVVSFS---------ARDLIKGLLVK 530
L V G P P++P F+ A DL++ +L
Sbjct: 233 LTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLEL 292
Query: 531 EPQNRLACRRGATEIKQHPFFQG 553
+ RL A + HPFF+
Sbjct: 293 DVDKRLT----AAQALTHPFFEP 311
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 6e-15
Identities = 40/178 (22%), Positives = 71/178 (39%), Gaps = 22/178 (12%)
Query: 191 KANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKV----- 245
N A ++ K +K LG G G+VY + V
Sbjct: 3 APNQALLRILKETEFK----------KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL 52
Query: 246 MDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LR 304
+ S + K++L E ++ S+D+P + L T L+ + P G L +R
Sbjct: 53 REATSPKANKEILD---EAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVR 108
Query: 305 QRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ + Q + + ++ + YL +V+RDL NVLV+ H+ ++DF L+
Sbjct: 109 EHKDN--IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 6e-15
Identities = 36/162 (22%), Positives = 65/162 (40%), Gaps = 27/162 (16%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMK---VMDKASLEKRKKLLRAQTEREI--LQ 268
+ L +G G G V + K A+K + + +R T REI L
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQR-------TLREIKILL 80
Query: 269 SLDHP--------FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFY 320
H + D + +V + DL+ L + Q S + ++
Sbjct: 81 RFRHENIIGINDIIRAPTIEQMK-DVY--IVQDLM-ETDLYKLLKTQH---LSNDHICYF 133
Query: 321 VAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ ++L L+Y+H +++RDLKP N+L+ + + DF L+
Sbjct: 134 LYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA 175
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 29/132 (21%), Positives = 45/132 (34%), Gaps = 34/132 (25%)
Query: 452 VGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATLY---NVVGQP 507
V T Y APEI+ ++D W+ G L E+L + F G L ++G P
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251
Query: 508 -----------------LRFPESPVVSFS---------ARDLIKGLLVKEPQNRLACRRG 541
L P V ++ A DL+ +L P R+
Sbjct: 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE---- 307
Query: 542 ATEIKQHPFFQG 553
+ HP+ +
Sbjct: 308 VEQALAHPYLEQ 319
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 38/151 (25%), Positives = 68/151 (45%), Gaps = 10/151 (6%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTG-TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH 272
+L KKLG G G V+++ TK A+K M K + L E ++++L H
Sbjct: 189 SLKLEKKLGAGQFGEVWMATYNKHTKV--AVKTM-KPGSMSVEAFLA---EANVMKTLQH 242
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
L L+ T + ++ EF G L L+ + K + + F A++ + ++
Sbjct: 243 DKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDF-SAQIAEGMAFI 300
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++RDL+ N+LV ++DF L+
Sbjct: 301 EQRNYIHRDLRAANILVSASLVCKIADFGLA 331
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 6e-15
Identities = 41/149 (27%), Positives = 73/149 (48%), Gaps = 12/149 (8%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYF--AMKVM--DKASLEKRKKLLRAQTEREILQSLDHPF 274
K+LG G+ G+V K A+K++ + + +LL E ++Q LD+P+
Sbjct: 23 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLA---EANVMQQLDNPY 79
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
+ + E + + LVME G L+ L+Q ++ ++ + V +V + ++YL
Sbjct: 80 IVRMIGICEAESW-MLVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEE 135
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLS 362
V+RDL NVL+ + +SDF LS
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLS 164
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 76.3 bits (188), Expect = 6e-15
Identities = 44/188 (23%), Positives = 74/188 (39%), Gaps = 30/188 (15%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMK----VMDKASLEKRKKLLRAQTEREI--L 267
++ + +G G G VYL+ T+ A+K + + KR REI L
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKR-------ILREITIL 79
Query: 268 QSLDHP--------FLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVK 318
L +P F+ + + +V+E DL + +E+ +K
Sbjct: 80 NRLKSDYIIRLYDLIIPDDLLKFD-ELY--IVLEIA-DSDLKKLFKTPIF---LTEEHIK 132
Query: 319 FYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLE 378
+ +LL ++H GI++RDLKP N L+ +D + + DF L+ R S
Sbjct: 133 TILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLA-RTINSEKDTNIVNDL 191
Query: 379 SEPLRKNP 386
E P
Sbjct: 192 EENEEPGP 199
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 39/162 (24%), Positives = 66/162 (40%), Gaps = 25/162 (15%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMK-VMDKASLEKRKKLLRAQTEREI--LQSL 270
F++ + G G G+V L + T A+K V+ R + + L L
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNR-------ELQIMQDLAVL 76
Query: 271 DHP--------FLPTLYTHFETDKFSCLVMEFCPGGDLHTL--RQRQPGKYFSEQAVKFY 320
HP F D + +VME+ P LH + +K +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRR-DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVF 134
Query: 321 VAEVLLALEYLHM--LGIVYRDLKPENVLV-REDGHIMLSDF 359
+ +++ ++ LH+ + + +RD+KP NVLV DG + L DF
Sbjct: 135 LFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 4e-05
Identities = 33/126 (26%), Positives = 50/126 (39%), Gaps = 35/126 (27%)
Query: 457 YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATLY---NVVGQP----- 507
Y APE+I G H +AVD W+ G E++ G+ F+G + L+ V+G P
Sbjct: 197 YRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVL 256
Query: 508 ---------LRFPESPVVSFS-------------ARDLIKGLLVKEPQNRLACRRGATEI 545
+ S + +S A DL+ LL P+ R+ E
Sbjct: 257 RKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMK----PYEA 312
Query: 546 KQHPFF 551
HP+F
Sbjct: 313 LCHPYF 318
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 9e-15
Identities = 40/151 (26%), Positives = 69/151 (45%), Gaps = 10/151 (6%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTG-TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH 272
RL KLG G G V++ G T+ A+K + K + L+ E ++++ L H
Sbjct: 185 SLRLEVKLGQGCFGEVWMGTWNGTTRV--AIKTL-KPGTMSPEAFLQ---EAQVMKKLRH 238
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
L LY +++ +V E+ G L L+ Q V A++ + Y+
Sbjct: 239 EKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM-AAQIASGMAYV 296
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ V+RDL+ N+LV E+ ++DF L+
Sbjct: 297 ERMNYVHRDLRAANILVGENLVCKVADFGLA 327
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 43/181 (23%), Positives = 74/181 (40%), Gaps = 32/181 (17%)
Query: 204 RVKDG-VLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLR--A 260
G + L++KLG G +V+L++ + AMK++ + K+ A
Sbjct: 9 PAFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV------RGDKVYTEAA 62
Query: 261 QTEREILQSL--------DHPFLP---TLYTHFE----TDKFSCLVMEFCPGGDLHTLRQ 305
+ E ++LQ + D L HF +V E G +L L +
Sbjct: 63 EDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIK 121
Query: 306 RQPGKYFSEQAVKFYVAEVLLALEYLH-MLGIVYRDLKPENVLVRE------DGHIMLSD 358
+ + VK ++LL L+Y+H GI++ D+KPENVL+ I ++D
Sbjct: 122 KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIAD 181
Query: 359 F 359
Sbjct: 182 L 182
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 52.8 bits (127), Expect = 2e-07
Identities = 24/152 (15%), Positives = 48/152 (31%), Gaps = 54/152 (35%)
Query: 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN------- 502
+ + T EY +PE++ G G D W+ ++EL+ G F+ E + +
Sbjct: 194 NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 253
Query: 503 --VVGQP---------------------------------------LRFPESPVVSFSAR 521
++G+ +F + S
Sbjct: 254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEIS-- 311
Query: 522 DLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
D + +L +P+ R A + HP+ +
Sbjct: 312 DFLSPMLQLDPRKRAD----AGGLVNHPWLKD 339
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 1e-14
Identities = 46/199 (23%), Positives = 79/199 (39%), Gaps = 32/199 (16%)
Query: 180 SSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTG--- 236
S L ++ + I + L K LG G+ GSV L
Sbjct: 12 SGLVPRGSEELQNKLEDVV-IDRNLLI----------LGKILGEGEFGSVMEGNLKQEDG 60
Query: 237 --TKCYFAMKVM--DKASLEKRKKLLRAQTEREILQSLDHPFLPTLY-----THFETDKF 287
K A+K M D +S + ++ L E ++ HP + L +
Sbjct: 61 TSLKV--AVKTMKLDNSSQREIEEFLS---EAACMKDFSHPNVIRLLGVCIEMSSQGIPK 115
Query: 288 SCLVMEFCPGGDLHT-LRQRQP---GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKP 343
+++ F GDLHT L + K+ Q + ++ ++ L +EYL ++RDL
Sbjct: 116 PMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAA 175
Query: 344 ENVLVREDGHIMLSDFDLS 362
N ++R+D + ++DF LS
Sbjct: 176 RNCMLRDDMTVCVADFGLS 194
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 39/164 (23%), Positives = 71/164 (43%), Gaps = 22/164 (13%)
Query: 216 RLLKKLGCGDIGSVYLSELTG-----TKCYFAMKVM--DKASLEKRKKLLRAQTEREILQ 268
L + LG G+ GSV ++L K A+K++ D + ++ LR E ++
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKV--AVKMLKADIIASSDIEEFLR---EAACMK 80
Query: 269 SLDHPFLPTLY------THFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVK--- 318
DHP + L +++ F GDLH L + G+ ++
Sbjct: 81 EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLV 140
Query: 319 FYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++ ++ +EYL ++RDL N ++ ED + ++DF LS
Sbjct: 141 RFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLS 184
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 2e-14
Identities = 33/153 (21%), Positives = 66/153 (43%), Gaps = 11/153 (7%)
Query: 216 RLLKKLGCGDIGSVY---LSELTGTKCYFAMKVM-DKASLEKRKKLLRAQTEREILQSLD 271
+ +G G G VY L + G K + A+K + + + + L E I++
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLT---EGIIMKDFS 84
Query: 272 HPFLPTLY-THFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALE 329
HP + +L ++ +V+ + GDL +R + + + + +V ++
Sbjct: 85 HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN--PTVKDLIGFGLQVAKGMK 142
Query: 330 YLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
YL V+RDL N ++ E + ++DF L+
Sbjct: 143 YLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 175
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 2e-14
Identities = 36/163 (22%), Positives = 71/163 (43%), Gaps = 21/163 (12%)
Query: 216 RLLKKLGCGDIGSVYLSELTG-------TKCYFAMKVM-DKASLEKRKKLLRAQTEREIL 267
+ ++LG G G VY G T+ A+K + + AS+ +R + L E ++
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRV--AIKTVNEAASMRERIEFLN---EASVM 82
Query: 268 QSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLL 326
+ + + L + + ++ME GDL + LR +P + +++++
Sbjct: 83 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142
Query: 327 -------ALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ YL+ V+RDL N +V ED + + DF ++
Sbjct: 143 MAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT 185
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 3e-14
Identities = 40/154 (25%), Positives = 65/154 (42%), Gaps = 11/154 (7%)
Query: 214 HFRLLKKLGCGDIGSVY---LSELTGTKCYFAMKVM-DKASLEKRKKLLRAQTEREILQS 269
L + +G G G V+ A+K + S R+K L+ E ++
Sbjct: 391 RIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQ---EALTMRQ 447
Query: 270 LDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLAL 328
DHP + L + ++ME C G+L + L+ R+ ++ Y ++ AL
Sbjct: 448 FDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKFS--LDLASLILYAYQLSTAL 504
Query: 329 EYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
YL V+RD+ NVLV + + L DF LS
Sbjct: 505 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 538
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 40/154 (25%), Positives = 65/154 (42%), Gaps = 11/154 (7%)
Query: 214 HFRLLKKLGCGDIGSVY---LSELTGTKCYFAMKVM-DKASLEKRKKLLRAQTEREILQS 269
L + +G G G V+ A+K + S R+K L+ E ++
Sbjct: 16 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQ---EALTMRQ 72
Query: 270 LDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLAL 328
DHP + L + ++ME C G+L + L+ R+ ++ Y ++ AL
Sbjct: 73 FDHPHIVKLIGVITENPV-WIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTAL 129
Query: 329 EYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
YL V+RD+ NVLV + + L DF LS
Sbjct: 130 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 163
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 5e-14
Identities = 43/236 (18%), Positives = 83/236 (35%), Gaps = 20/236 (8%)
Query: 133 KVSDGTSSLPKTSGSAKISDRGDYVESGKSSMCRGSTSSDVSDESTCSSLSSSVNKPHKA 192
+ S L S GS + +T S++N P
Sbjct: 18 RASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALN-PELV 76
Query: 193 NDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVY---LSELTGTKCYFAMKVM-DK 248
Q I + + +G G G VY L + G K + A+K +
Sbjct: 77 QAVQHVVIGPSSLI--------VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI 128
Query: 249 ASLEKRKKLLRAQTEREILQSLDHPFLPTLY-THFETDKFSCLVMEFCPGGDLHT-LRQR 306
+ + + L E I++ HP + +L ++ +V+ + GDL +R
Sbjct: 129 TDIGEVSQFLT---EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 185
Query: 307 QPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ + + + +V +++L V+RDL N ++ E + ++DF L+
Sbjct: 186 THN--PTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 239
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 6e-14
Identities = 40/178 (22%), Positives = 71/178 (39%), Gaps = 22/178 (12%)
Query: 191 KANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKV----- 245
N A ++ K +K LG G G+VY + V
Sbjct: 3 APNQALLRILKETEFK----------KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKEL 52
Query: 246 MDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LR 304
+ S + K++L E ++ S+D+P + L T L+ + P G L +R
Sbjct: 53 REATSPKANKEILD---EAYVMASVDNPHVCRLLGICLTSTV-QLITQLMPFGCLLDYVR 108
Query: 305 QRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ + Q + + ++ + YL +V+RDL NVLV+ H+ ++DF L+
Sbjct: 109 EHKDN--IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLA 164
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 73.8 bits (181), Expect = 6e-14
Identities = 40/151 (26%), Positives = 69/151 (45%), Gaps = 10/151 (6%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTG-TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH 272
RL KLG G G V++ G T+ A+K + K + L+ E ++++ L H
Sbjct: 268 SLRLEVKLGQGCFGEVWMGTWNGTTRV--AIKTL-KPGTMSPEAFLQ---EAQVMKKLRH 321
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
L LY +++ +V E+ G L L+ Q V A++ + Y+
Sbjct: 322 EKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM-AAQIASGMAYV 379
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ V+RDL+ N+LV E+ ++DF L+
Sbjct: 380 ERMNYVHRDLRAANILVGENLVCKVADFGLA 410
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 71.5 bits (176), Expect = 8e-14
Identities = 40/155 (25%), Positives = 60/155 (38%), Gaps = 11/155 (7%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYF---AMKVM---DKASLEKRKKLLRAQTEREIL 267
RLL+KLG G G V E A+K + + E +R E +
Sbjct: 19 DLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIR---EVNAM 75
Query: 268 QSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLA 327
SLDH L LY T +V E P G L ++ G + ++ +V
Sbjct: 76 HSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGHFLLGTLSRY-AVQVAEG 133
Query: 328 LEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ YL ++RDL N+L+ + + DF L
Sbjct: 134 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLM 168
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 9e-14
Identities = 41/170 (24%), Positives = 66/170 (38%), Gaps = 29/170 (17%)
Query: 216 RLLKKLGCGDIGSVYLSELTGTKCYF-----AMKVM-DKASLEKRKKLLRAQTEREILQS 269
R +++LG G VY L G A+K + DKA R++ E +
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRH---EAMLRAR 68
Query: 270 LDHPFLPTLY---THFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVL 325
L HP + L T + ++ +C GDLH L R P V L
Sbjct: 69 LQHPNVVCLLGVVTKDQP---LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 326 LALEYLHML-------------GIVYRDLKPENVLVREDGHIMLSDFDLS 362
+++H++ +V++DL NVLV + ++ +SD L
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 73.1 bits (179), Expect = 1e-13
Identities = 42/148 (28%), Positives = 69/148 (46%), Gaps = 10/148 (6%)
Query: 219 KKLGCGDIGSVYLSELTGTKCYF--AMKVM-DKASLEKRKKLLRAQTEREILQSLDHPFL 275
+LGCG+ GSV K A+KV+ ++++R E +I+ LD+P++
Sbjct: 342 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR---EAQIMHQLDNPYI 398
Query: 276 PTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
L + + LVME GG LH L + + V + +V + ++YL
Sbjct: 399 VRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGMKYLEEK 455
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLS 362
V+R+L NVL+ + +SDF LS
Sbjct: 456 NFVHRNLAARNVLLVNRHYAKISDFGLS 483
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 42/169 (24%), Positives = 63/169 (37%), Gaps = 28/169 (16%)
Query: 216 RLLKKLGCGDIGSVYLSELTGT-----KCYFAMKVMDKASLEKRKKLLRAQTEREILQSL 270
L ++LG G G V+L+E K A+K + +L RK R E E+L +L
Sbjct: 18 VLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQR---EAELLTNL 74
Query: 271 DHPFLPTLY---THFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLL 326
H + Y + +V E+ GDL+ LR P L
Sbjct: 75 QHEHIVKFYGVCGDGDP---LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELG 131
Query: 327 ALEYLHM-------------LGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ LH+ V+RDL N LV + + + DF +S
Sbjct: 132 LSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 72.6 bits (178), Expect = 1e-13
Identities = 36/161 (22%), Positives = 70/161 (43%), Gaps = 24/161 (14%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMK----VMDKASLEKRKKLLRAQTEREI--L 267
++ LK +G G G V + A+K + KR RE+ +
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKR-------AYRELVLM 115
Query: 268 QSLDHPFLPTLY------THFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYV 321
+ ++H + +L E + LVME +L + + + + + +
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQV-IQME---LDHERMSYLL 170
Query: 322 AEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++L +++LH GI++RDLKP N++V+ D + + DF L+
Sbjct: 171 YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 211
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 3e-06
Identities = 34/155 (21%), Positives = 54/155 (34%), Gaps = 51/155 (32%)
Query: 446 ARSMS-------FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRA 498
AR+ +V T Y APE+I G G+ VD W+ G + E++ K F G +
Sbjct: 211 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 270
Query: 499 TL---YNVVGQP----------------LRFPESPVVSFS-------------------- 519
+G P P+ ++F
Sbjct: 271 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKAS 330
Query: 520 -ARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
ARDL+ +LV +P R++ + QHP+
Sbjct: 331 QARDLLSKMLVIDPAKRIS----VDDALQHPYINV 361
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 36/155 (23%), Positives = 65/155 (41%), Gaps = 12/155 (7%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYF----AMKVM-DKASLEKRKKLLRAQTEREILQ 268
R LK LG G G+V+ +KV+ DK+ + + + +
Sbjct: 14 ELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTD---HMLAIG 70
Query: 269 SLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLA 327
SLDH + L LV ++ P G L +RQ + Q + + ++
Sbjct: 71 SLDHAHIVRLLGLCPGSSL-QLVTQYLPLGSLLDHVRQHRGA--LGPQLLLNWGVQIAKG 127
Query: 328 LEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ YL G+V+R+L NVL++ + ++DF ++
Sbjct: 128 MYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVA 162
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 36/156 (23%), Positives = 68/156 (43%), Gaps = 14/156 (8%)
Query: 214 HFRLLKKLGCGDIGSVYLSEL---TGTKCYFAMKVM-DKASLEKRKKLLRAQTEREILQS 269
+ + K +G G+ G V L + + A+K + + ++R+ L E I+
Sbjct: 46 NISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLG---EASIMGQ 102
Query: 270 LDHPFLPTLY---THFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLL 326
DHP + L T + +V E+ G L + ++ ++ Q V + +
Sbjct: 103 FDHPNIIRLEGVVTKSKP---VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGM-LRGIAS 158
Query: 327 ALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++YL +G V+RDL N+L+ + +SDF L
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLG 194
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 2e-13
Identities = 38/156 (24%), Positives = 69/156 (44%), Gaps = 19/156 (12%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLR--AQTEREILQSL-- 270
+ +LK +G G G V + + A+K++ + +K A E IL+ L
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMV------RNEKRFHRQAAEEIRILEHLRK 152
Query: 271 -----DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVL 325
+ + +F C+ E +L+ L ++ + FS V+ + +L
Sbjct: 153 QDKDNTMNVI-HMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSIL 210
Query: 326 LALEYLHMLGIVYRDLKPENVLVREDGH--IMLSDF 359
L+ LH I++ DLKPEN+L+++ G I + DF
Sbjct: 211 QCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDF 246
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 2e-06
Identities = 29/154 (18%), Positives = 45/154 (29%), Gaps = 61/154 (39%)
Query: 457 YLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR---ATLYNVVGQP------ 507
Y APE+I G +G +D W+ G L ELL G G + A + ++G P
Sbjct: 265 YRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324
Query: 508 --------------------LRFPESPVVSFSAR-------------------------- 521
+ VV R
Sbjct: 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384
Query: 522 --DLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
D +K L +P R+ + +HP+ +
Sbjct: 385 FLDFLKQCLEWDPAVRMTPG----QALRHPWLRR 414
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 71.3 bits (175), Expect = 2e-13
Identities = 45/187 (24%), Positives = 73/187 (39%), Gaps = 49/187 (26%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+ L K LG G G V + FA+K K + R K R E +I++ LDH
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALK---KVLQDPRYKN-R---ELDIMKVLDHV 60
Query: 274 FLPTLYTHFETDKFSC--------------------------------------LVMEFC 295
+ L +F T ++ME+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 296 PGGDLHTL--RQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV-REDG 352
P LH + + G+ + Y+ ++ A+ ++H LGI +RD+KP+N+LV +D
Sbjct: 121 PD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 353 HIMLSDF 359
+ L DF
Sbjct: 180 TLKLCDF 186
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 32/130 (24%), Positives = 51/130 (39%), Gaps = 32/130 (24%)
Query: 450 SFVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATLY---NVVG 505
+++ + Y APE++ G ++D W+ G EL+ GK F G + L ++G
Sbjct: 200 AYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMG 259
Query: 506 QP--------------LRFPESPVVSFS----------ARDLIKGLLVKEPQNRLACRRG 541
P +RFP + A DL++ +L EP R+
Sbjct: 260 TPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN---- 315
Query: 542 ATEIKQHPFF 551
E HPFF
Sbjct: 316 PYEAMAHPFF 325
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 43/154 (27%), Positives = 71/154 (46%), Gaps = 11/154 (7%)
Query: 214 HFRLLK-KLGCGDIGSVYLSELTGTKCYF--AMKVM-DKASLEKRKKLLRAQTEREILQS 269
+ + +LGCG+ GSV K A+KV+ ++++R E +I+
Sbjct: 10 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMR---EAQIMHQ 66
Query: 270 LDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLAL 328
LD+P++ L + + LVME GG LH L + + V + +V + +
Sbjct: 67 LDNPYIVRLIGVCQAEAL-MLVMEMAGGGPLHKFLVGK--REEIPVSNVAELLHQVSMGM 123
Query: 329 EYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+YL V+RDL NVL+ + +SDF LS
Sbjct: 124 KYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS 157
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 37/166 (22%), Positives = 68/166 (40%), Gaps = 24/166 (14%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRK-----KLLRAQ-TEREI- 266
+ + + + G G+V + + A+K + + R + REI
Sbjct: 23 PYTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 267 -LQSLDHP--------FLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQA 316
L HP F+ + LV E DL + ++ S Q
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMH-KLY--LVTELM-RTDLAQVIHDQR--IVISPQH 135
Query: 317 VKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+++++ +LL L LH G+V+RDL P N+L+ ++ I + DF+L+
Sbjct: 136 IQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA 181
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 50.4 bits (121), Expect = 1e-06
Identities = 33/146 (22%), Positives = 51/146 (34%), Gaps = 42/146 (28%)
Query: 446 ARSMS-------FVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENR 497
AR + +V Y APE++ VD W+ G + E+ K F+GS
Sbjct: 181 AREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240
Query: 498 ATLY---NVVGQP------------------LRFPESPVVSFS---------ARDLIKGL 527
L VVG P P +++ A DLI +
Sbjct: 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKM 300
Query: 528 LVKEPQNRLACRRGATEIKQHPFFQG 553
L PQ R++ + +HP+F+
Sbjct: 301 LEFNPQRRIS----TEQALRHPYFES 322
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 2e-13
Identities = 29/165 (17%), Positives = 56/165 (33%), Gaps = 21/165 (12%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYF-------AMKVMDKASLEKRKKLLRAQTEREI 266
+ LG G ++ Y +KV+DKA + +
Sbjct: 9 DLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFE---AASM 65
Query: 267 LQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVL 325
+ L H L Y + LV EF G L T L++ + + ++
Sbjct: 66 MSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNC--INILWKLEVAKQLA 123
Query: 326 LALEYLHMLGIVYRDLKPENVLVREDGHIM--------LSDFDLS 362
A+ +L +++ ++ +N+L+ + LSD +S
Sbjct: 124 AAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS 168
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 42/165 (25%), Positives = 64/165 (38%), Gaps = 21/165 (12%)
Query: 216 RLLKKLGCGDIGSVYLSELTGT-----KCYFAMKVMDKASLEKRKKLLRAQTEREILQSL 270
L +LG G G V+L+E K A+K + +AS R+ R E E+L L
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQR---EAELLTML 100
Query: 271 DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKF---------- 319
H + + + +V E+ GDL+ LR P
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 320 --YVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++V + YL L V+RDL N LV + + + DF +S
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 2e-13
Identities = 34/151 (22%), Positives = 65/151 (43%), Gaps = 10/151 (6%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTG-TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH 272
+L+++LG G G V++ G TK A+K + K L E +++ L H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHTKV--AVKSL-KQGSMSPDAFLA---EANLMKQLQH 67
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
L LY + ++ E+ G L L+ K + + A++ + ++
Sbjct: 68 QRLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDM-AAQIAEGMAFI 125
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++RDL+ N+LV + ++DF L+
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 69.1 bits (170), Expect = 3e-13
Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 11/154 (7%)
Query: 214 HFRLLKKLGCGDIGSVYLSELT---GTKCYFAMKVM-DKASLEKRKKLLRAQTEREILQS 269
L + LG G G VY T G K A+K +L+ ++K + E I+++
Sbjct: 13 DVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS---EAVIMKN 69
Query: 270 LDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLAL 328
LDHP + L E + ++ME P G+L L + + + Y ++ A+
Sbjct: 70 LDHPHIVKLIGIIEEEPT-WIIMELYPYGELGHYLERNKNS--LKVLTLVLYSLQICKAM 126
Query: 329 EYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
YL + V+RD+ N+LV + L DF LS
Sbjct: 127 AYLESINCVHRDIAVRNILVASPECVKLGDFGLS 160
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 70.1 bits (172), Expect = 4e-13
Identities = 38/159 (23%), Positives = 66/159 (41%), Gaps = 19/159 (11%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLR--AQTEREILQSL 270
+ + +G G G V + + + A+K++ K KK AQ E +L+ +
Sbjct: 54 DRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKII------KNKKAFLNQAQIEVRLLELM 107
Query: 271 ------DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEV 324
++ L HF CLV E +L+ L + + S + + ++
Sbjct: 108 NKHDTEMKYYIVHLKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQM 166
Query: 325 LLALEYLHM--LGIVYRDLKPENVLVREDGH--IMLSDF 359
AL +L L I++ DLKPEN+L+ I + DF
Sbjct: 167 CTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDF 205
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 8e-06
Identities = 13/41 (31%), Positives = 22/41 (53%)
Query: 457 YLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR 497
Y +PE++ G + A+D W+ G L E+ G+ F G+
Sbjct: 224 YRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEV 264
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 5e-13
Identities = 39/151 (25%), Positives = 61/151 (40%), Gaps = 10/151 (6%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTG-TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH 272
LLK+LG G G V L + G A+K++ K + + E + + L H
Sbjct: 9 EITLLKELGSGQFGVVKLGKWKGQYDV--AVKMI-KEGSMSEDEFFQ---EAQTMMKLSH 62
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
P L Y + +V E+ G L LR GK + +V + +L
Sbjct: 63 PKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFL 120
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++RDL N LV D + +SDF ++
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMT 151
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 5e-13
Identities = 36/164 (21%), Positives = 70/164 (42%), Gaps = 30/164 (18%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMK----VMDKASLEKRKKLLRAQTEREI--L 267
++ LK +G G G V + + A+K + KR RE+ +
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKR-------AYRELVLM 78
Query: 268 QSLDHP--------FLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVK 318
+ ++H F P D + +VME +L ++ + +
Sbjct: 79 KCVNHKNIIGLLNVFTPQKSLEEFQDVY--IVMELM-DANLCQVIQME-----LDHERMS 130
Query: 319 FYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ + ++L +++LH GI++RDLKP N++V+ D + + DF L+
Sbjct: 131 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 8e-07
Identities = 35/155 (22%), Positives = 54/155 (34%), Gaps = 51/155 (32%)
Query: 446 ARSMS-------FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRA 498
AR+ +V T Y APE+I G G+ VD W+ G + E++ G F G+++
Sbjct: 174 ARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID 233
Query: 499 TL---YNVVGQP----------------LRFPESPVVSFS-------------------- 519
+G P P+ SF
Sbjct: 234 QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKAS 293
Query: 520 -ARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
ARDL+ +LV + R++ E QHP+
Sbjct: 294 QARDLLSKMLVIDASKRIS----VDEALQHPYINV 324
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 47/182 (25%), Positives = 79/182 (43%), Gaps = 21/182 (11%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMK----VMDKASLEKRKKLLRAQTEREI--L 267
+ L+KKLG G G V+ S T A+K ++ +R T REI L
Sbjct: 10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQR-------TFREIMIL 62
Query: 268 QSL-DHPFLPTLYTHFETDKFSC--LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEV 324
L H + L D LV ++ DLH + + ++ V ++
Sbjct: 63 TELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIRANI---LEPVHKQYVVYQL 118
Query: 325 LLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRK 384
+ ++YLH G+++RD+KP N+L+ + H+ ++DF LS R V+ V ++ S
Sbjct: 119 IKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLS-RSFVNIRRVTNNIPLSINENT 177
Query: 385 NP 386
Sbjct: 178 EN 179
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 7e-13
Identities = 35/155 (22%), Positives = 66/155 (42%), Gaps = 15/155 (9%)
Query: 216 RLLKKLGCGDIGSVYLSELTG-----TKCYFAMKVM-DKASLEKRKKLLRAQTEREILQS 269
+ +G G G VY E +C A+K + +++ + LR E +++
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQC--AIKSLSRITEMQQVEAFLR---EGLLMRG 78
Query: 270 LDHPFLPTLY-THFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLA 327
L+HP + L + +++ + GDL +R Q + + F +V
Sbjct: 79 LNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDL-ISF-GLQVARG 136
Query: 328 LEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+EYL V+RDL N ++ E + ++DF L+
Sbjct: 137 MEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 8e-13
Identities = 41/165 (24%), Positives = 69/165 (41%), Gaps = 21/165 (12%)
Query: 216 RLLKKLGCGDIGSVYLSELT--GTKCYFAMKVM-DKASLEKRKKLLRAQTEREILQSL-D 271
+ +G G+ G V + + G + A+K M + AS + + E E+L L
Sbjct: 28 KFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAG---ELEVLCKLGH 84
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEY 330
HP + L E + L +E+ P G+L LR+ + + A+ A L + +
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 331 LHML-------------GIVYRDLKPENVLVREDGHIMLSDFDLS 362
LH ++RDL N+LV E+ ++DF LS
Sbjct: 145 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 189
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 9e-13
Identities = 40/168 (23%), Positives = 70/168 (41%), Gaps = 30/168 (17%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMK--VMDKASLEKRKKLLRAQTEREI--LQS 269
+ LK LGCG G V+ + A+K V+ K REI ++
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKH-------ALREIKIIRR 64
Query: 270 LDHP--------FLPTLYTHFETDKFSC------LVMEFCPGGDLHTLRQRQPGKYFSEQ 315
LDH P+ + +V E+ DL + ++ P E+
Sbjct: 65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGP---LLEE 120
Query: 316 AVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV-REDGHIMLSDFDLS 362
+ ++ ++L L+Y+H +++RDLKP N+ + ED + + DF L+
Sbjct: 121 HARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA 168
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 2e-06
Identities = 26/142 (18%), Positives = 45/142 (31%), Gaps = 34/142 (23%)
Query: 442 EPTNARSMS-FVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRAT 499
++ +S + T Y +P ++ + A+D W G E+L GKT F G+
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQ 233
Query: 500 LY---NVVGQP----------------LRFPESPVVSFS---------ARDLIKGLLVKE 531
+ + P + A D ++ +L
Sbjct: 234 MQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFS 293
Query: 532 PQNRLACRRGATEIKQHPFFQG 553
P +RL A E HP+
Sbjct: 294 PMDRLT----AEEALSHPYMSI 311
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 68.0 bits (167), Expect = 9e-13
Identities = 41/150 (27%), Positives = 67/150 (44%), Gaps = 8/150 (5%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
++++G G G V+L K A+K + + + + E E++ L HP
Sbjct: 9 ELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTI-REGAMSEEDFIE---EAEVMMKLSHP 63
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
L LY CLV EF G L LR ++ G + +E + +V + YL
Sbjct: 64 KLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR-GLFAAETLLGM-CLDVCEGMAYLE 121
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+++RDL N LV E+ I +SDF ++
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMT 151
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 1e-12
Identities = 40/180 (22%), Positives = 66/180 (36%), Gaps = 41/180 (22%)
Query: 216 RLLKKLGCGDIGSVYLSELTG-------TKCYFAMKVM-DKASLEKRKKLLRAQTEREIL 267
++ +G G G V+ + G T A+K++ ++AS + + R E ++
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMV--AVKMLKEEASADMQADFQR---EAALM 104
Query: 268 QSLDHPFLPTLY---THFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAE 323
D+P + L K CL+ E+ GDL+ LR P S
Sbjct: 105 AEFDNPNIVKLLGVCAV---GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161
Query: 324 VLLAL---------------------EYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ + YL V+RDL N LV E+ + ++DF LS
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 2e-12
Identities = 40/150 (26%), Positives = 71/150 (47%), Gaps = 8/150 (5%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
LK+LG G G V + G + A+K++ K + + E +++ +L H
Sbjct: 25 DLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMI-KEGSMSEDEFIE---EAKVMMNLSHE 79
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
L LY + ++ E+ G L LR+ + ++ ++Q ++ +V A+EYL
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEM-CKDVCEAMEYLE 137
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++RDL N LV + G + +SDF LS
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLS 167
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 2e-12
Identities = 44/188 (23%), Positives = 78/188 (41%), Gaps = 28/188 (14%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLR--AQTEREILQSL 270
F +++K+G G G V L + K Y+A+KV+ + K A+ E +IL+ +
Sbjct: 35 NAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVV------RNIKKYTRSAKIEADILKKI 88
Query: 271 ------DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEV 324
++ + + F CL+ E G L+ + R F + +K Y E+
Sbjct: 89 QNDDINNNNIV-KYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEI 146
Query: 325 LLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA-------VSPTVVK---- 373
L AL YL + + + DLKPEN+L+ + + T +K
Sbjct: 147 LKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206
Query: 374 -SSTLESE 380
+T +S+
Sbjct: 207 GCATFKSD 214
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 28/140 (20%), Positives = 46/140 (32%), Gaps = 48/140 (34%)
Query: 457 YLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY---NVVGQP------ 507
Y APE+I G + D W+FG L EL G F+ E+ L +++
Sbjct: 225 YRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLY 284
Query: 508 -----------------LRFPESPVVSFSAR------------------DLIKGLLVKEP 532
L +PE+ S + D + +L +P
Sbjct: 285 EATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP 344
Query: 533 QNRLACRRGATEIKQHPFFQ 552
R + E+ +H F +
Sbjct: 345 TLRPSPA----ELLKHKFLE 360
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 38/171 (22%), Positives = 71/171 (41%), Gaps = 29/171 (16%)
Query: 216 RLLKKLGCGDIGSVYLSELTG-------TKCYFAMKVM-DKASLEKRKKLLRAQTEREIL 267
+L K LG G G V ++ G A+K++ + A+ + + L+ E +IL
Sbjct: 30 KLGKPLGRGAFGQVIEADAFGIDKTATCRTV--AVKMLKEGATHSEHRALMS---ELKIL 84
Query: 268 QSLD-HPFLPTLYTH-FETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEV 324
+ H + L + +++EFC G+L T LR ++ + A + +
Sbjct: 85 IHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 144
Query: 325 L-------------LALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
L +E+L ++RDL N+L+ E + + DF L+
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLA 195
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.9 bits (164), Expect = 3e-12
Identities = 33/166 (19%), Positives = 63/166 (37%), Gaps = 27/166 (16%)
Query: 216 RLLKKLGCGDIGSVYLSELTG-------TKCYFAMKVM-DKASLEKRKKLLRAQTEREIL 267
L++ LG G G VY +++G + A+K + + S + L E I+
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQV--AVKTLPEVCSEQDELDFLM---EALII 87
Query: 268 QSLDHPFLPTLY---THFETDKFSCLVMEFCPGGDLHT-LRQRQP----GKYFSEQAVKF 319
+H + ++ME GGDL + LR+ +P + +
Sbjct: 88 SKFNHQNIVRCIGVSLQSLP---RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 320 YVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIML---SDFDLS 362
++ +YL ++RD+ N L+ G + DF ++
Sbjct: 145 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 190
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 4e-12
Identities = 32/166 (19%), Positives = 63/166 (37%), Gaps = 27/166 (16%)
Query: 216 RLLKKLGCGDIGSVYLSELTG-------TKCYFAMKVM-DKASLEKRKKLLRAQTEREIL 267
L++ LG G G VY +++G + A+K + + S + L E I+
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQV--AVKTLPEVCSEQDELDFLM---EALII 128
Query: 268 QSLDHPFLPTLY---THFETDKFSCLVMEFCPGGDLHT-LRQRQP----GKYFSEQAVKF 319
+H + +++E GGDL + LR+ +P + +
Sbjct: 129 SKFNHQNIVRCIGVSLQSLP---RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 320 YVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIML---SDFDLS 362
++ +YL ++RD+ N L+ G + DF ++
Sbjct: 186 VARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMA 231
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 67.1 bits (164), Expect = 5e-12
Identities = 35/162 (21%), Positives = 65/162 (40%), Gaps = 23/162 (14%)
Query: 216 RLLKKLGCGDIGSVY--LSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
K+G G G VY + +A+K ++ + + A E +L+ L HP
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHP 78
Query: 274 FLPTLY---THFETDKFSCLVMEFCPGGDLHTL-------RQRQPGKYFSEQAVKFYVAE 323
+ +L K L+ ++ DL + + + VK + +
Sbjct: 79 NVISLQKVFLSHADRKVW-LLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQ 136
Query: 324 VLLALEYLHMLGIVYRDLKPENVLVRED----GHIMLSDFDL 361
+L + YLH +++RDLKP N+LV + G + ++D
Sbjct: 137 ILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 178
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 41.3 bits (97), Expect = 6e-04
Identities = 33/187 (17%), Positives = 48/187 (25%), Gaps = 53/187 (28%)
Query: 457 YLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSE-------------------- 495
Y APE++ G H A+D W G ELL + F +
Sbjct: 201 YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 260
Query: 496 -------------------------NRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530
R T N A L++ LL
Sbjct: 261 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTM 320
Query: 531 EPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPKP---VEIVHSPAPALSTKAKA 587
+P R+ + + Q P+F + +IP P P K +
Sbjct: 321 DPIKRIT----SEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEPDDKGDKKNQQ 376
Query: 588 VAAGNAD 594
GN
Sbjct: 377 QQQGNNH 383
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 5e-12
Identities = 41/180 (22%), Positives = 72/180 (40%), Gaps = 41/180 (22%)
Query: 216 RLLKKLGCGDIGSVYLSELTG-------TKCYFAMKVM-DKASLEKRKKLLRAQTEREIL 267
L K LG G+ G V + T A+K++ + AS + + LL E +L
Sbjct: 26 VLGKTLGEGEFGKVVKATAFHLKGRAGYTTV--AVKMLKENASPSELRDLLS---EFNVL 80
Query: 268 QSLDHPFLPTLY---THFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKF---- 319
+ ++HP + LY + L++E+ G L LR+ + +
Sbjct: 81 KQVNHPHVIKLYGACSQDGP---LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 320 -----------------YVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ ++ ++YL + +V+RDL N+LV E + +SDF LS
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLS 197
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 6e-12
Identities = 54/246 (21%), Positives = 94/246 (38%), Gaps = 46/246 (18%)
Query: 147 SAKISDRGDYVESGKSSMCRGSTSSDVSDESTCSSLSS-----SVNKPHKANDAQWEAIQ 201
+ +I R S +SS S + V + SS + V++ D +WE
Sbjct: 21 TKRIPLRRQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWE-FP 79
Query: 202 AVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTG---------TKCYFAMKVM-DKASL 251
++ L K LG G G V ++E G A+K++ D A+
Sbjct: 80 RDKLT----------LGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTV--AVKMLKDDATE 127
Query: 252 EKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPG 309
+ L+ E E+++ + H + L D +++E+ G+L LR R+P
Sbjct: 128 KDLSDLVS---EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPP 184
Query: 310 KYFSEQAVKFYVAEVLL-------------ALEYLHMLGIVYRDLKPENVLVREDGHIML 356
+ E + +EYL ++RDL NVLV E+ + +
Sbjct: 185 GMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKI 244
Query: 357 SDFDLS 362
+DF L+
Sbjct: 245 ADFGLA 250
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 7e-12
Identities = 41/170 (24%), Positives = 70/170 (41%), Gaps = 26/170 (15%)
Query: 216 RLLKKLGCGDIGSVYLSELTGTKCYF-------AMKVM-DKASLEKRKKLLRAQTEREIL 267
L K LG G G V ++E G A+K++ D A+ + L+ E E++
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVS---EMEMM 94
Query: 268 QSL-DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVL 325
+ + H + L D +++E+ G+L LR R+P + E +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 326 L-------------ALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+EYL ++RDL NVLV E+ + ++DF L+
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLA 204
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 35/184 (19%), Positives = 67/184 (36%), Gaps = 24/184 (13%)
Query: 213 GHFRLLKKLGCGDIGSVYL-SELTGTKCYFAMKVMDKASLEKRKKLLR--AQTEREILQS 269
+ ++ LG G G V + K A+K++ + R A+ E +L+
Sbjct: 19 ERYEIVGNLGEGTFGKVVECLDHARGKSQVALKII------RNVGKYREAARLEINVLKK 72
Query: 270 L-------DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVA 322
+ + + F C+ E G + + + + V+
Sbjct: 73 IKEKDKENKFLCV-LMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAY 130
Query: 323 EVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC-AVSPTVVK-----SST 376
++ AL +LH + + DLKPEN+L L + S +V T ++ S+T
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSAT 190
Query: 377 LESE 380
+ E
Sbjct: 191 FDHE 194
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 31/140 (22%), Positives = 46/140 (32%), Gaps = 46/140 (32%)
Query: 457 YLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY---NVVGQP------ 507
Y PE+I G D W+ G L+E G T F+ ENR L ++G
Sbjct: 205 YRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIH 264
Query: 508 ------------LRFPESPVVSFSAR---------------------DLIKGLLVKEPQN 534
L + E+ + DL++ +L +P
Sbjct: 265 RTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324
Query: 535 RLACRRGATEIKQHPFFQGV 554
R+ E HPFF G+
Sbjct: 325 RIT----LAEALLHPFFAGL 340
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 33/191 (17%), Positives = 68/191 (35%), Gaps = 38/191 (19%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTKCY--------FAMKVMDKASLEKRKKLLR--AQT 262
+ ++ LG G G V +C A+K++ K A++
Sbjct: 14 ARYEIVDTLGEGAFGKVV-------ECIDHKAGGRHVAVKIV------KNVDRYCEAARS 60
Query: 263 EREILQSL-------DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQ 315
E ++L+ L + + FE C+V E G + + F
Sbjct: 61 EIQVLEHLNTTDPNSTFRCV-QMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLD 118
Query: 316 AVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDL-SLRCAVSPTVVK- 373
++ ++ ++ +LH + + DLKPEN+L + + + + + +K
Sbjct: 119 HIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKV 178
Query: 374 ----SSTLESE 380
S+T + E
Sbjct: 179 VDFGSATYDDE 189
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 29/140 (20%), Positives = 43/140 (30%), Gaps = 46/140 (32%)
Query: 457 YLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY---NVVGQP------ 507
Y APE+I G D W+ G L E G T F +++ L ++G
Sbjct: 200 YRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQ 259
Query: 508 ------------LRFPESPVVSFSAR---------------------DLIKGLLVKEPQN 534
L + E DLI+ +L +P
Sbjct: 260 KTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAK 319
Query: 535 RLACRRGATEIKQHPFFQGV 554
R+ E +HPFF +
Sbjct: 320 RIT----LREALKHPFFDLL 335
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 4e-11
Identities = 36/172 (20%), Positives = 65/172 (37%), Gaps = 30/172 (17%)
Query: 216 RLLKKLGCGDIGSVYLSELTG-------TKCYFAMKVM-DKASLEKRKKLLRAQTEREIL 267
K LG G G V + G A+K++ A L +R+ L+ E ++L
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTV--AVKMLKPSAHLTEREALMS---ELKVL 80
Query: 268 QSL-DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYV---- 321
L +H + L + ++ E+C GDL LR+++ S+ +
Sbjct: 81 SYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140
Query: 322 -----------AEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+V + +L ++RDL N+L+ + DF L+
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 63.5 bits (155), Expect = 5e-11
Identities = 43/172 (25%), Positives = 70/172 (40%), Gaps = 30/172 (17%)
Query: 216 RLLKKLGCGDIGSVYLSELTG---------TKCYFAMKVM-DKASLEKRKKLLRAQTERE 265
L K LG G G V L+E G TK A+K++ A+ + L+ E E
Sbjct: 72 VLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKV--AVKMLKSDATEKDLSDLIS---EME 126
Query: 266 ILQSL-DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKF---- 319
+++ + H + L D +++E+ G+L L+ R+P
Sbjct: 127 MMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEE 186
Query: 320 ---------YVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+V +EYL ++RDL NVLV ED + ++DF L+
Sbjct: 187 QLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 238
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 4e-10
Identities = 40/211 (18%), Positives = 76/211 (36%), Gaps = 43/211 (20%)
Query: 176 ESTCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELT 235
ES + + ++ + +WE ++ K LG G G V +
Sbjct: 20 ESYEGNSYTFIDPTQLPYNEKWE-FPRNNLQ----------FGKTLGAGAFGKVVEATAF 68
Query: 236 G-------TKCYFAMKVM-DKASLEKRKKLLRAQTEREILQSLD-HPFLPTLY---THFE 283
G K A+K++ A ++++ L+ E +I+ L H + L TH
Sbjct: 69 GLGKEDAVLKV--AVKMLKSTAHADEKEALMS---ELKIMSHLGQHENIVNLLGACTHGG 123
Query: 284 TDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKF-----------YVAEVLLALEYL 331
++ E+C GDL LR++ + ++V + +L
Sbjct: 124 P---VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFL 180
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++RD+ NVL+ + DF L+
Sbjct: 181 ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 40/175 (22%), Positives = 63/175 (36%), Gaps = 31/175 (17%)
Query: 216 RLLKKLGCGDIGSVYLSELTG-TKCYFAMKV---M--DKASLEKRKKLLRAQTEREILQS 269
K LG G G V + G +K +++V M +KA +R+ L+ E +++
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMS---ELKMMTQ 104
Query: 270 L-DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVLLA 327
L H + L L+ E+C GDL LR ++ E +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 328 L--------------------EYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
E+L V+RDL NVLV + + DF L+
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 58.4 bits (140), Expect = 2e-09
Identities = 37/194 (19%), Positives = 62/194 (31%), Gaps = 52/194 (26%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVM-----DKASLEKRKKLLRAQTEREILQS 269
+ +K+G G G V+ + T A+K++ D + +K E I +
Sbjct: 22 LQRCEKIGEGVFGEVFQTIADHTP--VAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKE 79
Query: 270 LDH--------------------------PFLPTLYTHFETDKFSC-------------L 290
L P L + H+ + K S +
Sbjct: 80 LSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFI 139
Query: 291 VMEFCPGG-DLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH-MLGIVYRDLKPENVLV 348
V+EF GG DL + K S K + ++ +L L +RDL NVL+
Sbjct: 140 VLEFEFGGIDLE----QMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195
Query: 349 REDGHIMLSDFDLS 362
++ L
Sbjct: 196 KKTSLKKLHYTLNG 209
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 9e-09
Identities = 42/153 (27%), Positives = 66/153 (43%), Gaps = 12/153 (7%)
Query: 215 FRLLKKLGCGDIGSVYLSELT-GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
F +G G G VY L G K A+K S + ++ +TE E L HP
Sbjct: 41 FDHKFLIGHGVFGKVYKGVLRDGAK--VALKRRTPESSQGIEEF---ETEIETLSFCRHP 95
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDL--HTLRQRQPGKYFS-EQAVKFYVA-EVLLALE 329
L +L + L+ ++ G+L H P S EQ ++ + L
Sbjct: 96 HLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLE--ICIGAARGLH 153
Query: 330 YLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
YLH I++RD+K N+L+ E+ ++DF +S
Sbjct: 154 YLHTRAIIHRDVKSINILLDENFVPKITDFGIS 186
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 54.1 bits (131), Expect = 4e-08
Identities = 42/154 (27%), Positives = 65/154 (42%), Gaps = 12/154 (7%)
Query: 215 FRLLKKLGCGDIGSVYLSELT-GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
F LG G G VY L GT A+K + + + + QTE E++ H
Sbjct: 32 FSNKNILGRGGFGKVYKGRLADGTL--VAVKRLKEERTQGGELQF--QTEVEMISMAVHR 87
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLA--LEY 330
L L T LV + G + LR+R + + + +A + A L Y
Sbjct: 88 NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIA-LGSARGLAY 146
Query: 331 LH---MLGIVYRDLKPENVLVREDGHIMLSDFDL 361
LH I++RD+K N+L+ E+ ++ DF L
Sbjct: 147 LHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 50.6 bits (122), Expect = 5e-07
Identities = 35/147 (23%), Positives = 56/147 (38%), Gaps = 10/147 (6%)
Query: 220 KLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRA-QTEREILQSLDHPFLPTL 278
K+G G G VY + T A+K + ++L + E +++ H L L
Sbjct: 38 KMGEGGFGVVYKGYVNNTT--VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95
Query: 279 YTHFETDKFSCLVMEFCPGGD----LHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
CLV + P G L L P + + A + +LH
Sbjct: 96 LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAAN---GINFLHEN 152
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDL 361
++RD+K N+L+ E +SDF L
Sbjct: 153 HHIHRDIKSANILLDEAFTAKISDFGL 179
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 26/107 (24%), Positives = 42/107 (39%), Gaps = 14/107 (13%)
Query: 253 KRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYF 312
+ A+ E LQ L +P +Y ++ME +L+ +R P +
Sbjct: 144 SVLAIRSARNEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRVRVENPDEVL 199
Query: 313 SEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDF 359
+L + + GIV+ DL NVLV E+ I + DF
Sbjct: 200 DM---------ILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 236
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 7e-04
Identities = 35/177 (19%), Positives = 63/177 (35%), Gaps = 19/177 (10%)
Query: 215 FRLLKKLGCGDIGSVYLSELTG-----TKCYFAMKVM-DKASLEKRKKLLRAQTEREILQ 268
+L K LG G G V ++ G T A+K++ + A+ + + L+ E +IL
Sbjct: 24 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS---ELKILI 80
Query: 269 SLD-HPFLPTLYTH-FETDKFSCLVMEFCPGGDLHT-LRQRQPGKYFSEQAVKFYVAEVL 325
+ H + L + +++EFC G+L T LR ++ Y +
Sbjct: 81 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRN-------EFVPYKTKGA 133
Query: 326 LALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPL 382
+ +G + DLK + S F + L + L
Sbjct: 134 RFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFL 190
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 604 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.93 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.75 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.41 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.26 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.2 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.08 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.87 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.69 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.67 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.51 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.39 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.32 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.24 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.13 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.94 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.78 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.75 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.6 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.46 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.41 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.4 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.34 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.34 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.31 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.13 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.1 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.09 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.82 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.33 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.11 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 87.78 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 84.3 | |
| 2x6h_A | 696 | GH13170P, VPS34, phosphotidylinositol 3 kinase 59F | 83.29 | |
| 3ls8_A | 614 | Phosphatidylinositol 3-kinase catalytic subunit ty | 80.12 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-67 Score=543.31 Aligned_cols=277 Identities=34% Similarity=0.645 Sum_probs=248.8
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+++|+.|+|||||+++++|++++++||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 58999999999999999999999999999999999877666566678889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
|||+||+|.+++.+. +.|++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|..+....
T Consensus 112 Ey~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~--- 186 (311)
T 4aw0_A 112 SYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--- 186 (311)
T ss_dssp CCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT---
T ss_pred ecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC---
Confidence 999999999999876 579999999999999999999999999999999999999999999999999995432110
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
......+++
T Consensus 187 -----------------------------------------------------------------------~~~~~~~~~ 195 (311)
T 4aw0_A 187 -----------------------------------------------------------------------KQARANSFV 195 (311)
T ss_dssp -----------------------------------------------------------------------TCCCBCCCC
T ss_pred -----------------------------------------------------------------------CcccccCcc
Confidence 111234678
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEP 532 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP 532 (604)
||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+.++....+.+|. .++.++++||.+||++||
T Consensus 196 GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~dli~~lL~~dp 273 (311)
T 4aw0_A 196 GTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE--KFFPKARDLVEKLLVLDA 273 (311)
T ss_dssp SCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--TCCHHHHHHHHHHSCSSG
T ss_pred cCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc--ccCHHHHHHHHHHccCCH
Confidence 999999999999999999999999999999999999999999999999999988888775 489999999999999999
Q ss_pred CCcccccC--CHHHHhcCCCCCCCChhhhhcCCCCCC
Q 007433 533 QNRLACRR--GATEIKQHPFFQGVNWALIRCASPPEI 567 (604)
Q Consensus 533 ~~Rpt~~~--~a~elL~Hpff~~~~~~~~~~~~~~~~ 567 (604)
++|+++.+ ...+|++||||++++|..++...||.+
T Consensus 274 ~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~~pP~l 310 (311)
T 4aw0_A 274 TKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKL 310 (311)
T ss_dssp GGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCC
T ss_pred hHCcChHHHcCCHHHHCCCCcCCCCHHHhcCCCCCCC
Confidence 99999432 334579999999999999987776654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-64 Score=523.98 Aligned_cols=270 Identities=41% Similarity=0.781 Sum_probs=232.4
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEc---CCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCe
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELT---GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKF 287 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 287 (604)
..++|++++.||+|+||+||+|++. .+++.||||++++...... ...++.+|+++|++|+|||||+++++|++++.
T Consensus 22 ~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~ 100 (304)
T 3ubd_A 22 DPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGK 100 (304)
T ss_dssp CGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTE
T ss_pred CccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCE
Confidence 3468999999999999999999874 4678999999986543211 12246679999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccC
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAV 367 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~ 367 (604)
+|||||||+||+|.+++.+. ..|++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|+....
T Consensus 101 ~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 101 LYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999999999876 5799999999999999999999999999999999999999999999999999843211
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
....
T Consensus 179 ----------------------------------------------------------------------------~~~~ 182 (304)
T 3ubd_A 179 ----------------------------------------------------------------------------HEKK 182 (304)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred ----------------------------------------------------------------------------CCcc
Confidence 0112
Q ss_pred ccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007433 448 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGL 527 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~l 527 (604)
..+++||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.++....+.+|. .+|.++++||.+|
T Consensus 183 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~ 260 (304)
T 3ubd_A 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQ--FLSPEAQSLLRML 260 (304)
T ss_dssp CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHH
T ss_pred ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC--cCCHHHHHHHHHH
Confidence 23568999999999999999999999999999999999999999999999999999988877765 4999999999999
Q ss_pred hhcCCCCccccc-CCHHHHhcCCCCCCCChhhhhc
Q 007433 528 LVKEPQNRLACR-RGATEIKQHPFFQGVNWALIRC 561 (604)
Q Consensus 528 L~~dP~~Rpt~~-~~a~elL~Hpff~~~~~~~~~~ 561 (604)
|++||++||++. ..++|+++||||++++|..+..
T Consensus 261 L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~ 295 (304)
T 3ubd_A 261 FKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYR 295 (304)
T ss_dssp TCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHT
T ss_pred cccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHh
Confidence 999999999963 4579999999999999987743
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-62 Score=519.53 Aligned_cols=260 Identities=25% Similarity=0.460 Sum_probs=227.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
+++|+++++||+|+||+||+|++..+++.||||++++..... ....++.+|+++|++|+|||||+++++|++++.+|||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSS-KEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCH-HHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 479999999999999999999999999999999998765443 3456788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
||||+||+|.+++....+..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.+...
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--- 178 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--- 178 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH---
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC---
Confidence 99999999999998776678899999999999999999999999999999999999999999999999998432100
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
.....++
T Consensus 179 -------------------------------------------------------------------------~~~~~~~ 185 (350)
T 4b9d_A 179 -------------------------------------------------------------------------VELARAC 185 (350)
T ss_dssp -------------------------------------------------------------------------HHHHHHH
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0012356
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~d 531 (604)
+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.+++...+. +....++.++++||.+||++|
T Consensus 186 ~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~-~~~~~~s~~~~~li~~~L~~d 264 (350)
T 4b9d_A 186 IGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP-PVSLHYSYDLRSLVSQLFKRN 264 (350)
T ss_dssp HSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCCTTSCHHHHHHHHHHTCSS
T ss_pred CCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCCccCCHHHHHHHHHHccCC
Confidence 8999999999999999999999999999999999999999999998988888876543 334568999999999999999
Q ss_pred CCCcccccCCHHHHhcCCCCCC
Q 007433 532 PQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 532 P~~Rpt~~~~a~elL~Hpff~~ 553 (604)
|++||+ ++|+|+||||+.
T Consensus 265 P~~R~s----~~e~l~hp~~~~ 282 (350)
T 4b9d_A 265 PRDRPS----VNSILEKGFIAK 282 (350)
T ss_dssp GGGSCC----HHHHHTSHHHHT
T ss_pred hhHCcC----HHHHhcCHHhhc
Confidence 999999 999999999964
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-62 Score=515.87 Aligned_cols=256 Identities=28% Similarity=0.456 Sum_probs=227.9
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
..+|+++++||+|+||+||+|+++.+++.||||++++..... ...+.+|+++|+.|+|||||+++++|++++.+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 367999999999999999999999999999999997654332 23466899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
||||+||+|.+++.+. .|++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|..+...
T Consensus 150 mEy~~gg~L~~~l~~~---~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--- 223 (346)
T 4fih_A 150 MEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--- 223 (346)
T ss_dssp ECCCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS---
T ss_pred EeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCC---
Confidence 9999999999999763 5999999999999999999999999999999999999999999999999998543210
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
.....++
T Consensus 224 -------------------------------------------------------------------------~~~~~~~ 230 (346)
T 4fih_A 224 -------------------------------------------------------------------------VPRRKSL 230 (346)
T ss_dssp -------------------------------------------------------------------------SCCBCCC
T ss_pred -------------------------------------------------------------------------CCccccc
Confidence 1122356
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC-CCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ-PLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~-~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+..+... ...++....++.++++||.+||++
T Consensus 231 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~ 310 (346)
T 4fih_A 231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVR 310 (346)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHHHSCS
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHHHcCC
Confidence 8999999999999999999999999999999999999999998888888887764 334455567899999999999999
Q ss_pred CCCCcccccCCHHHHhcCCCCCC
Q 007433 531 EPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
||++||+ +.|+|+||||+.
T Consensus 311 dP~~R~t----a~e~l~Hp~~~~ 329 (346)
T 4fih_A 311 DPAQRAT----AAELLKHPFLAK 329 (346)
T ss_dssp STTTSCC----HHHHTTCGGGGG
T ss_pred ChhHCcC----HHHHhcCHhhcC
Confidence 9999999 999999999974
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-62 Score=499.74 Aligned_cols=255 Identities=32% Similarity=0.514 Sum_probs=216.8
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++++.||+|+||+||+|++..+++.||||++++..........++.+|+++|+.|+|||||+++++|++++.+|||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMV 91 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 47999999999999999999999999999999999887666555666788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||| +|+|.+++.+. ..|++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|.....
T Consensus 92 mEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---- 164 (275)
T 3hyh_A 92 IEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---- 164 (275)
T ss_dssp EECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred EeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC----
Confidence 9999 78999998876 5799999999999999999999999999999999999999999999999999843210
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
.....+.
T Consensus 165 -------------------------------------------------------------------------~~~~~~~ 171 (275)
T 3hyh_A 165 -------------------------------------------------------------------------GNFLKTS 171 (275)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -------------------------------------------------------------------------CCccCCe
Confidence 0012246
Q ss_pred ccCccccCcceecCCCC-CccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 452 VGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~-~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
+||+.|||||++.+..| +.++|||||||+||||++|+.||.+.+....+.++....+.+|. .++.++++||.+||++
T Consensus 172 ~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~ 249 (275)
T 3hyh_A 172 CGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPK--FLSPGAAGLIKRMLIV 249 (275)
T ss_dssp ---CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--TSCHHHHHHHHHHSCS
T ss_pred eECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHccC
Confidence 79999999999999886 57999999999999999999999998888888888888777765 4899999999999999
Q ss_pred CCCCcccccCCHHHHhcCCCCC
Q 007433 531 EPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
||++||| ++|+|+||||+
T Consensus 250 dP~~R~s----~~eil~hpw~k 267 (275)
T 3hyh_A 250 NPLNRIS----IHEIMQDDWFK 267 (275)
T ss_dssp SGGGSCC----HHHHHHCHHHH
T ss_pred ChhHCcC----HHHHHcCcccc
Confidence 9999999 99999999996
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-61 Score=519.66 Aligned_cols=256 Identities=28% Similarity=0.456 Sum_probs=228.5
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|+++++||+|+||+||+|+++.+++.||||++++..... ...+.+|+.+|+.|+|||||+++++|++++.+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 368999999999999999999999999999999997654322 23466899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
||||+||+|.+++... .|++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|..+...
T Consensus 227 mEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~--- 300 (423)
T 4fie_A 227 MEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--- 300 (423)
T ss_dssp EECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSS---
T ss_pred EeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCC---
Confidence 9999999999999764 5999999999999999999999999999999999999999999999999998543210
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
.....++
T Consensus 301 -------------------------------------------------------------------------~~~~~~~ 307 (423)
T 4fie_A 301 -------------------------------------------------------------------------VPRRKSL 307 (423)
T ss_dssp -------------------------------------------------------------------------CCCBCCC
T ss_pred -------------------------------------------------------------------------Ccccccc
Confidence 1122357
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC-CCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ-PLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~-~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
+||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+..+... ...++....++.++++||.+||++
T Consensus 308 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~~L~~ 387 (423)
T 4fie_A 308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVR 387 (423)
T ss_dssp EECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHHHSCS
T ss_pred ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHHHcCC
Confidence 8999999999999999999999999999999999999999999888888887765 334555667999999999999999
Q ss_pred CCCCcccccCCHHHHhcCCCCCC
Q 007433 531 EPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
||++||+ +.|||+||||+.
T Consensus 388 dP~~R~t----a~ell~Hp~~~~ 406 (423)
T 4fie_A 388 DPAQRAT----AAELLKHPFLAK 406 (423)
T ss_dssp STTTSCC----HHHHTTCGGGGG
T ss_pred ChhHCcC----HHHHhcCHHhcC
Confidence 9999999 999999999974
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-59 Score=484.58 Aligned_cols=255 Identities=26% Similarity=0.455 Sum_probs=217.8
Q ss_pred cCe-EEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec----CCe
Q 007433 213 GHF-RLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET----DKF 287 (604)
Q Consensus 213 ~~y-~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~ 287 (604)
++| ++.++||+|+||+||+|.+..++..||||++.+..... ....++.+|+++|++|+|||||+++++|++ ++.
T Consensus 25 gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~ 103 (290)
T 3fpq_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEE
T ss_pred CceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcE
Confidence 465 78889999999999999999999999999998765433 334577899999999999999999999975 457
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcC--eEeccCCCCcEEEc-cCCcEEEeccccccc
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLG--IVYRDLKPENVLVR-EDGHIMLSDFDLSLR 364 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~g--IvHrDIKpeNILl~-~~g~vkL~DFGla~~ 364 (604)
+|||||||+||+|.+++.+. ..+++..++.|+.||+.||+|||++| ||||||||+||||+ .+|.+||+|||+|..
T Consensus 104 ~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~ 181 (290)
T 3fpq_A 104 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEe
Confidence 89999999999999999876 57999999999999999999999999 99999999999998 489999999999832
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
..
T Consensus 182 ~~------------------------------------------------------------------------------ 183 (290)
T 3fpq_A 182 KR------------------------------------------------------------------------------ 183 (290)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred CC------------------------------------------------------------------------------
Confidence 10
Q ss_pred CCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC-CCCCCCCCHHHHHH
Q 007433 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR-FPESPVVSFSARDL 523 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~-~p~~~~~s~~l~dL 523 (604)
.....+++||+.|||||++.+ .|+.++|||||||+||||++|+.||.+..+...+.+.+..... ......+++++++|
T Consensus 184 ~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l 262 (290)
T 3fpq_A 184 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 262 (290)
T ss_dssp TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCccCCHHHHHH
Confidence 011235689999999999876 5999999999999999999999999887776666655544322 22334578899999
Q ss_pred HHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 524 IKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 524 I~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
|.+||.+||++||+ +.|+|+||||++
T Consensus 263 i~~~L~~dP~~R~s----~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 263 IEGCIRQNKDERYS----IKDLLNHAFFQE 288 (290)
T ss_dssp HHHHSCSSGGGSCC----HHHHHTSGGGC-
T ss_pred HHHHccCChhHCcC----HHHHhcCccccC
Confidence 99999999999999 999999999974
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-59 Score=526.18 Aligned_cols=281 Identities=33% Similarity=0.620 Sum_probs=239.4
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHH---HHHHHHHHhCCCCCccccceeEecC
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRA---QTEREILQSLDHPFLPTLYTHFETD 285 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~---~~Ei~iL~~l~HpnIv~l~~~~~~~ 285 (604)
.+.+++|++++.||+|+||+||+|+++.+++.||||++.+..+........+ ..++.+++.++|||||+++++|+++
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 3456899999999999999999999999999999999988765433332233 3446677788999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
+++|||||||+||+|..++.+. ..|++..+++|++||+.||+|||++|||||||||+||||+.+|++||+|||+|..+
T Consensus 265 ~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 265 DKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp SEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence 9999999999999999999876 57999999999999999999999999999999999999999999999999998532
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
..
T Consensus 343 ~~------------------------------------------------------------------------------ 344 (689)
T 3v5w_A 343 SK------------------------------------------------------------------------------ 344 (689)
T ss_dssp SS------------------------------------------------------------------------------
T ss_pred CC------------------------------------------------------------------------------
Confidence 10
Q ss_pred CcccccccCccccCcceec-CCCCCccchHHHHHHHHHHHhhCCCCCCCC---ChHHHHHHHHcCCCCCCCCCCCCHHHH
Q 007433 446 ARSMSFVGTHEYLAPEIIK-GEGHGSAVDWWTFGIFLYELLFGKTPFKGS---ENRATLYNVVGQPLRFPESPVVSFSAR 521 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~-~~~~~~~~DiWSLGviL~eLltG~~PF~~~---~~~~~l~~i~~~~~~~p~~~~~s~~l~ 521 (604)
....+++||+.|||||++. +..|+.++|||||||+||||++|++||.+. +.......+....+.+|. .+|.+++
T Consensus 345 ~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~--~~S~~a~ 422 (689)
T 3v5w_A 345 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD--SFSPELR 422 (689)
T ss_dssp CCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCT--TSCHHHH
T ss_pred CCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCc--cCCHHHH
Confidence 1123568999999999996 568999999999999999999999999764 233455566777776665 4999999
Q ss_pred HHHHHhhhcCCCCcccc-cCCHHHHhcCCCCCCCChhhhhc--CCCCCCCCCC
Q 007433 522 DLIKGLLVKEPQNRLAC-RRGATEIKQHPFFQGVNWALIRC--ASPPEIPKPV 571 (604)
Q Consensus 522 dLI~~lL~~dP~~Rpt~-~~~a~elL~Hpff~~~~~~~~~~--~~~~~~p~~~ 571 (604)
+||.+||++||.+|+++ ..+++||++||||++++|..+.. ..||.+|...
T Consensus 423 dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~~ 475 (689)
T 3v5w_A 423 SLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRG 475 (689)
T ss_dssp HHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCTT
T ss_pred HHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCcCccCCCC
Confidence 99999999999999995 46799999999999999998743 4566666543
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-59 Score=494.20 Aligned_cols=258 Identities=24% Similarity=0.330 Sum_probs=222.5
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.+.|++.++||+|+||+||+|+++.+++.||||++++.... .+|+.+|+.|+|||||+++++|++++.+|||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 36799999999999999999999999999999999865332 3699999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC-cEEEecccccccccCCCc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG-HIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g-~vkL~DFGla~~~~~~~~ 370 (604)
||||+||+|.+++++. ..|++..++.|+.||+.||+|||++|||||||||+||||+.+| ++||+|||+|+.+.....
T Consensus 129 mEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~ 206 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL 206 (336)
T ss_dssp ECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred EeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence 9999999999999876 5799999999999999999999999999999999999999988 699999999954321100
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
. ........
T Consensus 207 ~-----------------------------------------------------------------------~~~~~~~~ 215 (336)
T 4g3f_A 207 G-----------------------------------------------------------------------KSLLTGDY 215 (336)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred c-----------------------------------------------------------------------cceecCCc
Confidence 0 00011224
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC-CCCCCCHHHHHHHHHhhh
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFP-ESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p-~~~~~s~~l~dLI~~lL~ 529 (604)
++||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+.++...+..+. .++.++.++++||.+||+
T Consensus 216 ~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~~L~ 295 (336)
T 4g3f_A 216 IPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAIQEGLR 295 (336)
T ss_dssp CCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHHHHHHHHTC
T ss_pred cccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHHHHHHHHcc
Confidence 6899999999999999999999999999999999999999999887778888887765432 345699999999999999
Q ss_pred cCCCCcccccCCHHHH-------------hcCCCCCCC
Q 007433 530 KEPQNRLACRRGATEI-------------KQHPFFQGV 554 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~el-------------L~Hpff~~~ 554 (604)
+||++||+ +.|| |+|||+...
T Consensus 296 ~dP~~R~s----a~el~~~l~~~l~~~~~l~hPw~~~~ 329 (336)
T 4g3f_A 296 KEPVHRAS----AMELRRKVGKALQEVGGLKSPWKGEY 329 (336)
T ss_dssp SSGGGSCC----HHHHHHHHHHHHHHTTSSCSCSSSSC
T ss_pred CCHhHCcC----HHHHHHHHHHHHhhhhhccCCCcCCC
Confidence 99999999 8887 579998754
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-57 Score=490.83 Aligned_cols=264 Identities=24% Similarity=0.364 Sum_probs=220.7
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec------CC
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET------DK 286 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------~~ 286 (604)
++|++++.||+|+||+||+|+++.+++.||||++.+.... .....++.+|+++|+.|+|||||++++++.. .+
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccc-hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 5899999999999999999999999999999999765332 2334567789999999999999999998763 46
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
++||||||| +|+|.+++... ..|++..++.|++||+.||+|||++|||||||||+||||+.+|.+||+|||+|+.+.
T Consensus 133 ~~~ivmE~~-~g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 133 SVYVVLDLM-ESDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CEEEEEECC-SEEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred EEEEEEeCC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 889999999 57899988765 679999999999999999999999999999999999999999999999999985432
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
.... ....
T Consensus 210 ~~~~------------------------------------------------------------------------~~~~ 217 (398)
T 4b99_A 210 TSPA------------------------------------------------------------------------EHQY 217 (398)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred cCcc------------------------------------------------------------------------cccc
Confidence 1100 0011
Q ss_pred cccccccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC----------------
Q 007433 447 RSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR---------------- 509 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~---------------- 509 (604)
...+++||++|||||++.+. .|+.++|||||||+||||++|++||.+.+..+.+..|......
T Consensus 218 ~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~ 297 (398)
T 4b99_A 218 FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRA 297 (398)
T ss_dssp CCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHH
T ss_pred ccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhh
Confidence 23357899999999999886 4699999999999999999999999999888887766532111
Q ss_pred ----CCC---------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCCh
Q 007433 510 ----FPE---------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNW 556 (604)
Q Consensus 510 ----~p~---------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~ 556 (604)
++. .+.++.+++|||.+||++||++||| +.|+|+||||+...+
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 298 YIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARIS----AAAALRHPFLAKYHD 353 (398)
T ss_dssp HHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCC----HHHHTTSGGGTTTCC
T ss_pred hhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcC----HHHHhcCHhhCcCCC
Confidence 111 1347889999999999999999999 999999999987643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-58 Score=477.30 Aligned_cols=270 Identities=24% Similarity=0.413 Sum_probs=203.9
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC------
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK------ 286 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~------ 286 (604)
++|++++.||+|+||+||+|+++.+++.||||++..... .....++.+|+++|+.|+|||||+++++|.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~ 82 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQ 82 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccc
Confidence 579999999999999999999999999999999976532 223346788999999999999999999997543
Q ss_pred ------eeEEEEeecCCCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecc
Q 007433 287 ------FSCLVMEFCPGGDLHTLRQRQPG-KYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDF 359 (604)
Q Consensus 287 ------~~~lV~E~~~ggsL~~ll~~~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DF 359 (604)
++|||||||+||+|.+++..... ....+..++.|+.||+.||+|||++|||||||||+||||+.+|++||+||
T Consensus 83 ~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DF 162 (299)
T 4g31_A 83 PSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDF 162 (299)
T ss_dssp ----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC
T ss_pred ccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccC
Confidence 47999999999999999986522 23456778999999999999999999999999999999999999999999
Q ss_pred cccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccc
Q 007433 360 DLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPEL 439 (604)
Q Consensus 360 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (604)
|+|..+......... .
T Consensus 163 Gla~~~~~~~~~~~~----------------------------------------------------------------~ 178 (299)
T 4g31_A 163 GLVTAMDQDEEEQTV----------------------------------------------------------------L 178 (299)
T ss_dssp CCC-----------------------------------------------------------------------------
T ss_pred ccceecCCCcccccc----------------------------------------------------------------c
Confidence 999654321110000 0
Q ss_pred ccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHcCCCCCC-CCCCCC
Q 007433 440 IAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR-ATLYNVVGQPLRFP-ESPVVS 517 (604)
Q Consensus 440 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~-~~l~~i~~~~~~~p-~~~~~s 517 (604)
.......+..+.+||+.|||||++.+..|+.++|||||||+||||++ ||.+..+. ..+..+... .+| .....+
T Consensus 179 ~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~--~~p~~~~~~~ 253 (299)
T 4g31_A 179 TPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNL--KFPPLFTQKY 253 (299)
T ss_dssp -------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTT--CCCHHHHHHC
T ss_pred cccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcC--CCCCCCcccC
Confidence 00011123346789999999999999999999999999999999996 88654332 233334332 222 112345
Q ss_pred HHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 518 FSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 518 ~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
+.+.+||.+||.+||++||+ +.|+|+||||++++|.
T Consensus 254 ~~~~~li~~~L~~dP~~Rps----~~eil~h~~~~~~~~p 289 (299)
T 4g31_A 254 PCEYVMVQDMLSPSPMERPE----AINIIENAVFEDLDFP 289 (299)
T ss_dssp HHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGCCC---
T ss_pred HHHHHHHHHHcCCChhHCcC----HHHHhcCHhhCCCCCC
Confidence 67889999999999999999 9999999999999884
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-56 Score=474.58 Aligned_cols=281 Identities=25% Similarity=0.387 Sum_probs=211.3
Q ss_pred cCeEEEEEEccCCcEEEEEEEEc---CCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCee
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELT---GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 288 (604)
++|+++++||+|+||+||+|+++ .+++.||||++.+... ..++.+|+++|+.+ +||||++++++|++++++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~-----~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH-----PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC-----HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC-----HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 68999999999999999999874 5688999999876532 23466899999998 699999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccC-CcEEEecccccccccC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRED-GHIMLSDFDLSLRCAV 367 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~-g~vkL~DFGla~~~~~ 367 (604)
|||||||+||+|.+++. .+++..++.|++||+.||+|||++|||||||||+||||+.+ +++||+|||+|+....
T Consensus 96 ~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp EEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred EEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 99999999999999883 48999999999999999999999999999999999999876 8999999999965543
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
............. . ...|.+..| .........
T Consensus 171 ~~~~~~~~~~~~~----~----------~~~~~~~~~----------------------------------~~~~~~~~~ 202 (361)
T 4f9c_A 171 TKIELLKFVQSEA----Q----------QERCSQNKC----------------------------------SICLSRRQQ 202 (361)
T ss_dssp CSCGGGGGC-----------------------------------------------------------------------
T ss_pred ccccccccccccc----c----------ccccccccc----------------------------------ccccccccc
Confidence 2211100000000 0 000000000 000011122
Q ss_pred ccccccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCC-ChHHHHHHHHcC-------------------
Q 007433 448 SMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGS-ENRATLYNVVGQ------------------- 506 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~-~~~~~l~~i~~~------------------- 506 (604)
..+.+||++|||||++.+. .|+.++|||||||++|||++|+.||... ++.+.+..|...
T Consensus 203 ~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~ 282 (361)
T 4f9c_A 203 VAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILC 282 (361)
T ss_dssp ---CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEE
T ss_pred ccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccc
Confidence 3457899999999999876 4899999999999999999999999654 444444333210
Q ss_pred ---------------------------------CCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 507 ---------------------------------PLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 507 ---------------------------------~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
......+..++++++|||.+||++||++|+| ++|+|+||||++
T Consensus 283 ~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~t----a~eaL~Hp~f~~ 358 (361)
T 4f9c_A 283 SKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRIT----AEEALLHPFFKD 358 (361)
T ss_dssp SSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCC----HHHHHTSGGGTT
T ss_pred cccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcC----HHHHhcCcccCC
Confidence 0011223568899999999999999999999 999999999998
Q ss_pred CC
Q 007433 554 VN 555 (604)
Q Consensus 554 ~~ 555 (604)
++
T Consensus 359 i~ 360 (361)
T 4f9c_A 359 MS 360 (361)
T ss_dssp C-
T ss_pred CC
Confidence 75
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-55 Score=496.59 Aligned_cols=261 Identities=28% Similarity=0.429 Sum_probs=233.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
+++|++++.||+|+||+||+|+++.+++.||||++.+..... ...+.+|+++|+.|+|||||+|+++|++++.+|||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~---~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv 232 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 232 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhh---HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 479999999999999999999999999999999998764433 34567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccC--CcEEEecccccccccCCC
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRED--GHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~--g~vkL~DFGla~~~~~~~ 369 (604)
||||+||+|.+++... ...|++..++.|++||+.||+|||++||+||||||+||||+.+ |++||+|||++..+...
T Consensus 233 ~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~- 310 (573)
T 3uto_A 233 YEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 310 (573)
T ss_dssp EECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred EeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence 9999999999988654 2579999999999999999999999999999999999999854 89999999998543211
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
....
T Consensus 311 ----------------------------------------------------------------------------~~~~ 314 (573)
T 3uto_A 311 ----------------------------------------------------------------------------QSVK 314 (573)
T ss_dssp ----------------------------------------------------------------------------SEEE
T ss_pred ----------------------------------------------------------------------------Ccee
Confidence 1122
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC--CCCCCHHHHHHHHHh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE--SPVVSFSARDLIKGL 527 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~--~~~~s~~l~dLI~~l 527 (604)
..+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.++....+.++. ...++.++++||.+|
T Consensus 315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~~ 394 (573)
T 3uto_A 315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL 394 (573)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHHHTT
T ss_pred eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence 457999999999999999999999999999999999999999999999999999887766654 356899999999999
Q ss_pred hhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 528 LVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
|.+||.+||+ +.|+|+||||+..+|.
T Consensus 395 L~~dp~~R~t----~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 395 LLADPNTRMT----IHQALEHPWLTPGNAP 420 (573)
T ss_dssp SCSSGGGSCC----HHHHHHSTTTSCCCCT
T ss_pred ccCChhHCcC----HHHHhcCcCcCCCCCC
Confidence 9999999999 9999999999988775
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-55 Score=454.50 Aligned_cols=260 Identities=22% Similarity=0.334 Sum_probs=218.5
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEc-----CCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELT-----GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET 284 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 284 (604)
+..++|.+.++||+|+||+||+|++. .++..||||+++.... ....++.+|+++|++|+|||||++++++.+
T Consensus 10 I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 86 (299)
T 4asz_A 10 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD---NARKDFHREAELLTNLQHEHIVKFYGVCVE 86 (299)
T ss_dssp CCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCCh---HHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence 44578999999999999999999875 3578899999976543 233467789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHhc-----------CCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCc
Q 007433 285 DKFSCLVMEFCPGGDLHTLRQRQ-----------PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGH 353 (604)
Q Consensus 285 ~~~~~lV~E~~~ggsL~~ll~~~-----------~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~ 353 (604)
++.+|||||||++|+|.++++.. ....|++..+..|+.||+.||+|||+++||||||||+||||+.+++
T Consensus 87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~ 166 (299)
T 4asz_A 87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLL 166 (299)
T ss_dssp SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCc
Confidence 99999999999999999999764 2357999999999999999999999999999999999999999999
Q ss_pred EEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCC
Q 007433 354 IMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQV 433 (604)
Q Consensus 354 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (604)
+||+|||+|+.......
T Consensus 167 ~Ki~DFGla~~~~~~~~--------------------------------------------------------------- 183 (299)
T 4asz_A 167 VKIGDFGMSRDVYSTDY--------------------------------------------------------------- 183 (299)
T ss_dssp EEECCCSCHHHHTGGGC---------------------------------------------------------------
T ss_pred EEECCcccceecCCCCc---------------------------------------------------------------
Confidence 99999999954321100
Q ss_pred CCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCC
Q 007433 434 SPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPE 512 (604)
Q Consensus 434 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~ 512 (604)
.......+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+..+.+..+..+. ..+.
T Consensus 184 -----------~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~-~~~~ 251 (299)
T 4asz_A 184 -----------YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR-VLQR 251 (299)
T ss_dssp -----------EEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC-CCCC
T ss_pred -----------eeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CCCC
Confidence 001123469999999999999999999999999999999998 999999998888887776643 2333
Q ss_pred CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 513 SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 513 ~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
+..++.++.+||.+||..||++||+ +.|| |+|++.
T Consensus 252 p~~~~~~~~~li~~cl~~dP~~RPs----~~~i--~~~L~~ 286 (299)
T 4asz_A 252 PRTCPQEVYELMLGCWQREPHMRKN----IKGI--HTLLQN 286 (299)
T ss_dssp CTTCCHHHHHHHHHHTCSSGGGSCC----HHHH--HHHHHH
T ss_pred CccchHHHHHHHHHHcCCChhHCcC----HHHH--HHHHHH
Confidence 4569999999999999999999999 8888 446653
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=456.83 Aligned_cols=257 Identities=22% Similarity=0.311 Sum_probs=213.9
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEc-----CCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELT-----GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET 284 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 284 (604)
+...+|.+.++||+|+||+||+|++. .++..||||+++..... ....+.+|+++|++|+|||||++++++.+
T Consensus 38 i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~---~~~~f~~E~~il~~l~HpnIV~l~g~~~~ 114 (329)
T 4aoj_A 38 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASES---ARQDFQREAELLTMLQHQHIVRFFGVCTE 114 (329)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHH---HHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred cCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence 34468999999999999999999875 36789999999765432 33467789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHhcC-------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccC
Q 007433 285 DKFSCLVMEFCPGGDLHTLRQRQP-------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRED 351 (604)
Q Consensus 285 ~~~~~lV~E~~~ggsL~~ll~~~~-------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~ 351 (604)
++.+|||||||++|+|.++++... ...|++..+..|+.||+.||+|||+++||||||||+||||+.+
T Consensus 115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~ 194 (329)
T 4aoj_A 115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQG 194 (329)
T ss_dssp SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETT
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCC
Confidence 999999999999999999987642 2469999999999999999999999999999999999999999
Q ss_pred CcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCC
Q 007433 352 GHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGN 431 (604)
Q Consensus 352 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (604)
+++||+|||+++.+.....
T Consensus 195 ~~~Ki~DFGla~~~~~~~~------------------------------------------------------------- 213 (329)
T 4aoj_A 195 LVVKIGDFGMSRDIYSTDY------------------------------------------------------------- 213 (329)
T ss_dssp TEEEECCCC-----------------------------------------------------------------------
T ss_pred CcEEEcccccceeccCCCc-------------------------------------------------------------
Confidence 9999999999853321100
Q ss_pred CCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCC
Q 007433 432 QVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRF 510 (604)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~ 510 (604)
.......+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.++.+.+..+.... +.
T Consensus 214 -------------~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~-~~ 279 (329)
T 4aoj_A 214 -------------YRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGR-EL 279 (329)
T ss_dssp -------------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTC-CC
T ss_pred -------------ceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-CC
Confidence 001123579999999999999999999999999999999998 999999998888877776542 33
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 511 PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 511 p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
+.+..++.++.+||.+||..||++||+ +.||+++
T Consensus 280 ~~p~~~~~~~~~li~~cl~~dP~~RPs----~~ei~~~ 313 (329)
T 4aoj_A 280 ERPRACPPEVYAIMRGCWQREPQQRHS----IKDVHAR 313 (329)
T ss_dssp CCCTTCCHHHHHHHHHHCCSSTTTSCC----HHHHHHH
T ss_pred CCcccccHHHHHHHHHHcCcChhHCcC----HHHHHHH
Confidence 444569999999999999999999999 8888765
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-55 Score=452.74 Aligned_cols=254 Identities=21% Similarity=0.343 Sum_probs=208.8
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCee
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 288 (604)
++..++|++.++||+|+||+||+|++.+ .||||+++..... ......+.+|+++|++|+|||||++++++.. +.+
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~-~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~ 106 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPT-PEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNL 106 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeE
Confidence 3456789999999999999999998764 4999999754332 2345678899999999999999999998764 568
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|||||||+||+|.+++.... ..+++..+..|+.||+.||+|||+++||||||||+||||+.++++||+|||+|......
T Consensus 107 ~iVmEy~~gGsL~~~l~~~~-~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~ 185 (307)
T 3omv_A 107 AIVTQWCEGSSLYKHLHVQE-TKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRW 185 (307)
T ss_dssp EEEEECCSSCBHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC----
T ss_pred EEEEEcCCCCCHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccC
Confidence 99999999999999997653 57999999999999999999999999999999999999999999999999998432110
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
. .....
T Consensus 186 ~--------------------------------------------------------------------------~~~~~ 191 (307)
T 3omv_A 186 S--------------------------------------------------------------------------GSQQV 191 (307)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred C--------------------------------------------------------------------------cceee
Confidence 0 00112
Q ss_pred cccccCccccCcceecCC---CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC----CCCCCHHHH
Q 007433 449 MSFVGTHEYLAPEIIKGE---GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE----SPVVSFSAR 521 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~---~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~----~~~~s~~l~ 521 (604)
...+||+.|||||++.+. .|+.++|||||||+||||++|+.||.+.++...+..++......|. ...++.++.
T Consensus 192 ~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~ 271 (307)
T 3omv_A 192 EQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMK 271 (307)
T ss_dssp --CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHH
T ss_pred cccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHH
Confidence 345799999999999754 5889999999999999999999999988877777766655443332 345889999
Q ss_pred HHHHHhhhcCCCCcccccCCHHHHh
Q 007433 522 DLIKGLLVKEPQNRLACRRGATEIK 546 (604)
Q Consensus 522 dLI~~lL~~dP~~Rpt~~~~a~elL 546 (604)
+||.+||..||++||+ +.||+
T Consensus 272 ~li~~cl~~dP~~RPs----~~ei~ 292 (307)
T 3omv_A 272 RLVADCVKKVKEERPL----FPQIL 292 (307)
T ss_dssp HHHHHHTCSSSTTSCC----HHHHH
T ss_pred HHHHHHcCCCHhHCcC----HHHHH
Confidence 9999999999999999 66554
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-54 Score=451.05 Aligned_cols=280 Identities=38% Similarity=0.694 Sum_probs=243.4
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
..++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+|+.++||||++++++|.+.+.+||
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~l 82 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEE
Confidence 35799999999999999999999999999999999987655444455677889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
||||++||+|..++.+. ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||++.....
T Consensus 83 v~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--- 157 (337)
T 1o6l_A 83 VMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--- 157 (337)
T ss_dssp EEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred EEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc---
Confidence 99999999999998875 5799999999999999999999999999999999999999999999999998842110
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
.......
T Consensus 158 -------------------------------------------------------------------------~~~~~~~ 164 (337)
T 1o6l_A 158 -------------------------------------------------------------------------DGATMKT 164 (337)
T ss_dssp -------------------------------------------------------------------------TTCCBCC
T ss_pred -------------------------------------------------------------------------CCCcccc
Confidence 0011234
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
++||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+....+..+....+.+|. .++.++++||.+||..
T Consensus 165 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~~ 242 (337)
T 1o6l_A 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGLLKK 242 (337)
T ss_dssp CEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCS
T ss_pred cccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhc
Confidence 67999999999999999999999999999999999999999998888888888887777765 4899999999999999
Q ss_pred CCCCccccc-CCHHHHhcCCCCCCCChhhhh--cCCCCCCCCC
Q 007433 531 EPQNRLACR-RGATEIKQHPFFQGVNWALIR--CASPPEIPKP 570 (604)
Q Consensus 531 dP~~Rpt~~-~~a~elL~Hpff~~~~~~~~~--~~~~~~~p~~ 570 (604)
||++||+.. ..+.|+++||||.+++|..+. ...||..|..
T Consensus 243 dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~ 285 (337)
T 1o6l_A 243 DPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQV 285 (337)
T ss_dssp STTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred CHHHhcCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCC
Confidence 999999321 239999999999999998764 3445555543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-54 Score=456.88 Aligned_cols=280 Identities=35% Similarity=0.689 Sum_probs=241.7
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCee
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 288 (604)
+..++|++++.||+|+||+||+|++..+++.||||++.+.............+|+.+|+.+ +||||++++++|.+++.+
T Consensus 20 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 99 (353)
T 3txo_A 20 LGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRL 99 (353)
T ss_dssp ---CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEE
Confidence 4467999999999999999999999999999999999887655555666778899999988 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|||||||+||+|..++.+. ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||++.....
T Consensus 100 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~- 176 (353)
T 3txo_A 100 FFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC- 176 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc-
Confidence 9999999999999998876 5699999999999999999999999999999999999999999999999999842110
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
.....
T Consensus 177 ---------------------------------------------------------------------------~~~~~ 181 (353)
T 3txo_A 177 ---------------------------------------------------------------------------NGVTT 181 (353)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ---------------------------------------------------------------------------CCccc
Confidence 00112
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
..++||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.++....+.+|.. ++.++++||++||
T Consensus 182 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~--~~~~~~~li~~lL 259 (353)
T 3txo_A 182 ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW--LHEDATGILKSFM 259 (353)
T ss_dssp ----CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT--SCHHHHHHHHHHT
T ss_pred cccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCC--CCHHHHHHHHHHh
Confidence 34679999999999999999999999999999999999999999999999999999888777754 8999999999999
Q ss_pred hcCCCCcccc--cCCHHHHhcCCCCCCCChhhhhc--CCCCCCCC
Q 007433 529 VKEPQNRLAC--RRGATEIKQHPFFQGVNWALIRC--ASPPEIPK 569 (604)
Q Consensus 529 ~~dP~~Rpt~--~~~a~elL~Hpff~~~~~~~~~~--~~~~~~p~ 569 (604)
.+||.+||++ ..++.|+++||||++++|..+.. ..||..|.
T Consensus 260 ~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~ 304 (353)
T 3txo_A 260 TKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPR 304 (353)
T ss_dssp CSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred hhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCC
Confidence 9999999994 23459999999999999997643 34555554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=450.36 Aligned_cols=258 Identities=21% Similarity=0.297 Sum_probs=217.4
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEc-----CCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELT-----GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET 284 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 284 (604)
+..++++++++||+|+||+||+|++. .+++.||||+++..... .....+.+|+.+|++|+|||||++++++.+
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~--~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEG--PLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC---CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccCh--HHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 45578999999999999999999874 35678999999754321 223467789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHhcC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc
Q 007433 285 DKFSCLVMEFCPGGDLHTLRQRQP--------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE 350 (604)
Q Consensus 285 ~~~~~lV~E~~~ggsL~~ll~~~~--------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~ 350 (604)
++.+|||||||++|+|.+++.... ...|++..+..|+.||+.||+|||+++||||||||+||||+.
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 999999999999999999997532 236899999999999999999999999999999999999999
Q ss_pred CCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccC
Q 007433 351 DGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMG 430 (604)
Q Consensus 351 ~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (604)
++++||+|||+++.+....
T Consensus 181 ~~~~Ki~DFGlar~~~~~~------------------------------------------------------------- 199 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAAD------------------------------------------------------------- 199 (308)
T ss_dssp GGCEEECCSCCBCGGGGGG-------------------------------------------------------------
T ss_pred CCCEEECCcccceeccCCC-------------------------------------------------------------
Confidence 9999999999985432100
Q ss_pred CCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCC
Q 007433 431 NQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLR 509 (604)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~ 509 (604)
........+||+.|||||++.+..|+.++|||||||+||||++ |+.||.+.+..+.+..+..+ ..
T Consensus 200 -------------~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~-~~ 265 (308)
T 4gt4_A 200 -------------YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR-QV 265 (308)
T ss_dssp -------------CBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT-CC
T ss_pred -------------ceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CC
Confidence 0011223579999999999999999999999999999999998 89999999888877777654 33
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 510 FPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 510 ~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
.+.+..++.++.+||.+||..||++||+ +.||+++
T Consensus 266 ~~~p~~~~~~~~~li~~C~~~dP~~RPs----~~ei~~~ 300 (308)
T 4gt4_A 266 LPCPDDCPAWVYALMIECWNEFPSRRPR----FKDIHSR 300 (308)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCcccchHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 4555679999999999999999999999 8888765
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-53 Score=444.41 Aligned_cols=268 Identities=35% Similarity=0.702 Sum_probs=239.5
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
..++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+|+.++||||++++++|.+...+|+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 35799999999999999999999999999999999987655444455667789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
|||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.+|++||+|||++.....
T Consensus 84 v~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--- 158 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--- 158 (318)
T ss_dssp EECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS---
T ss_pred EEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC---
Confidence 99999999999999875 5799999999999999999999999999999999999999999999999999843210
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
....
T Consensus 159 ----------------------------------------------------------------------------~~~~ 162 (318)
T 1fot_A 159 ----------------------------------------------------------------------------VTYT 162 (318)
T ss_dssp ----------------------------------------------------------------------------CBCC
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 1123
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
.+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+....+.++....+.+|. .++.++++||.+||..
T Consensus 163 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~lL~~ 240 (318)
T 1fot_A 163 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP--FFNEDVKDLLSRLITR 240 (318)
T ss_dssp CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCS
T ss_pred ccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHhcc
Confidence 57999999999999999999999999999999999999999998888888888888777764 4899999999999999
Q ss_pred CCCCccccc-CCHHHHhcCCCCCCCChhhhhc
Q 007433 531 EPQNRLACR-RGATEIKQHPFFQGVNWALIRC 561 (604)
Q Consensus 531 dP~~Rpt~~-~~a~elL~Hpff~~~~~~~~~~ 561 (604)
||++|++.. .+++|+++||||++++|..+..
T Consensus 241 dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~~~ 272 (318)
T 1fot_A 241 DLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLS 272 (318)
T ss_dssp CTTTCTTSSTTTTHHHHTSGGGSSCCHHHHHT
T ss_pred CHHHcCCCcCCCHHHHhcCccccCCCHHHHHh
Confidence 999999532 2499999999999999987743
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-53 Score=449.57 Aligned_cols=281 Identities=35% Similarity=0.667 Sum_probs=244.7
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCee
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 288 (604)
+..++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+|..+ +||||++++++|.+.+.+
T Consensus 17 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 96 (353)
T 2i0e_A 17 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 96 (353)
T ss_dssp --CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEE
T ss_pred CchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEE
Confidence 3457999999999999999999999999999999999887554444556677899999988 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|||||||+||+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||++.....
T Consensus 97 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 173 (353)
T 2i0e_A 97 YFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW- 173 (353)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc-
Confidence 9999999999999998875 4699999999999999999999999999999999999999999999999998842110
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
.....
T Consensus 174 ---------------------------------------------------------------------------~~~~~ 178 (353)
T 2i0e_A 174 ---------------------------------------------------------------------------DGVTT 178 (353)
T ss_dssp ---------------------------------------------------------------------------TTCCB
T ss_pred ---------------------------------------------------------------------------CCccc
Confidence 00112
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
..++||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+.++....+.+|. .++.++++||.+||
T Consensus 179 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL 256 (353)
T 2i0e_A 179 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK--SMSKEAVAICKGLM 256 (353)
T ss_dssp CCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHT
T ss_pred ccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHHHHh
Confidence 3457999999999999999999999999999999999999999998888888889888777765 48999999999999
Q ss_pred hcCCCCcccc-cCCHHHHhcCCCCCCCChhhhh--cCCCCCCCCC
Q 007433 529 VKEPQNRLAC-RRGATEIKQHPFFQGVNWALIR--CASPPEIPKP 570 (604)
Q Consensus 529 ~~dP~~Rpt~-~~~a~elL~Hpff~~~~~~~~~--~~~~~~~p~~ 570 (604)
.+||.+||++ ..++.+|++||||++++|..+. ...||..|..
T Consensus 257 ~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~ 301 (353)
T 2i0e_A 257 TKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKA 301 (353)
T ss_dssp CSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred hcCHHHcCCCCCCCHHHHhcCccccCCCHHHHHhCCCCCCcCCCC
Confidence 9999999974 2348999999999999998874 3455555543
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-53 Score=456.28 Aligned_cols=281 Identities=37% Similarity=0.719 Sum_probs=237.8
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCee
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 288 (604)
+..++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+|+.+ +||||++++++|.+++.+
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 3457999999999999999999999999999999999887665555556677899999876 899999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|||||||+||+|..++.+. ..|++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||++.....
T Consensus 129 ~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~- 205 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR- 205 (396)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc-
Confidence 9999999999999998876 5799999999999999999999999999999999999999999999999999842110
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
.....
T Consensus 206 ---------------------------------------------------------------------------~~~~~ 210 (396)
T 4dc2_A 206 ---------------------------------------------------------------------------PGDTT 210 (396)
T ss_dssp ---------------------------------------------------------------------------TTCCB
T ss_pred ---------------------------------------------------------------------------CCCcc
Confidence 00112
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCC---------hHHHHHHHHcCCCCCCCCCCCCHH
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE---------NRATLYNVVGQPLRFPESPVVSFS 519 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~---------~~~~l~~i~~~~~~~p~~~~~s~~ 519 (604)
..++||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.. .......+....+.+|.. ++.+
T Consensus 211 ~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~--~s~~ 288 (396)
T 4dc2_A 211 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRS--LSVK 288 (396)
T ss_dssp CCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTT--SCHH
T ss_pred ccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCc--CCHH
Confidence 35679999999999999999999999999999999999999996431 223445666677776654 8999
Q ss_pred HHHHHHHhhhcCCCCccccc--CCHHHHhcCCCCCCCChhhhhc--CCCCCCCCC
Q 007433 520 ARDLIKGLLVKEPQNRLACR--RGATEIKQHPFFQGVNWALIRC--ASPPEIPKP 570 (604)
Q Consensus 520 l~dLI~~lL~~dP~~Rpt~~--~~a~elL~Hpff~~~~~~~~~~--~~~~~~p~~ 570 (604)
+++||++||.+||.+||++. .+++||++||||++++|..+.. ..||..|..
T Consensus 289 ~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~ 343 (396)
T 4dc2_A 289 AASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNI 343 (396)
T ss_dssp HHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCC
T ss_pred HHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCC
Confidence 99999999999999999963 3478999999999999987743 345555543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-53 Score=449.42 Aligned_cols=276 Identities=37% Similarity=0.722 Sum_probs=237.7
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCee
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 288 (604)
+..++|++++.||+|+||+||+|++..+++.||||++.+..............|+.+|+.+ +||||++++++|.+.+.+
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~ 93 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENL 93 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEE
Confidence 4468999999999999999999999999999999999876544444455677899999876 999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|||||||+||+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||++.....
T Consensus 94 ~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~- 170 (345)
T 1xjd_A 94 FFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML- 170 (345)
T ss_dssp EEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC-
T ss_pred EEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc-
Confidence 9999999999999999875 5699999999999999999999999999999999999999999999999998842110
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
.....
T Consensus 171 ---------------------------------------------------------------------------~~~~~ 175 (345)
T 1xjd_A 171 ---------------------------------------------------------------------------GDAKT 175 (345)
T ss_dssp ---------------------------------------------------------------------------TTCCB
T ss_pred ---------------------------------------------------------------------------CCCcc
Confidence 00112
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
..++||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......++. .++.++++||.+||
T Consensus 176 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL 253 (345)
T 1xjd_A 176 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--WLEKEAKDLLVKLF 253 (345)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHS
T ss_pred cCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCc--ccCHHHHHHHHHHh
Confidence 3467999999999999999999999999999999999999999998888888888877766664 48999999999999
Q ss_pred hcCCCCcccccCCHH-HHhcCCCCCCCChhhhhc--CCCCCCCC
Q 007433 529 VKEPQNRLACRRGAT-EIKQHPFFQGVNWALIRC--ASPPEIPK 569 (604)
Q Consensus 529 ~~dP~~Rpt~~~~a~-elL~Hpff~~~~~~~~~~--~~~~~~p~ 569 (604)
..||++||+ +. +|++||||++++|..+.. ..||..|.
T Consensus 254 ~~dp~~R~~----~~~~i~~hp~f~~~~w~~l~~~~~~~p~~p~ 293 (345)
T 1xjd_A 254 VREPEKRLG----VRGDIRQHPLFREINWEELERKEIDPPFRPK 293 (345)
T ss_dssp CSSGGGSBT----TBSCGGGSGGGTTCCHHHHHTTCSCC-----
T ss_pred cCCHhHcCC----ChHHHHcCccccCCCHHHHhhCCCCCCcCCC
Confidence 999999999 66 999999999999987744 34444443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-53 Score=453.71 Aligned_cols=279 Identities=38% Similarity=0.691 Sum_probs=236.2
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHH-HHhCCCCCccccceeEecCCeeE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREI-LQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~i-L~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
..++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|..+ ++.++||||++++++|.+.+.+|
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~ 115 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLY 115 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEE
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEE
Confidence 34789999999999999999999999999999999988765444445556677776 57789999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
||||||+||+|..++.+. ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||++......
T Consensus 116 lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~- 192 (373)
T 2r5t_A 116 FVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH- 192 (373)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-
T ss_pred EEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC-
Confidence 999999999999998875 57999999999999999999999999999999999999999999999999998432100
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
.....
T Consensus 193 ---------------------------------------------------------------------------~~~~~ 197 (373)
T 2r5t_A 193 ---------------------------------------------------------------------------NSTTS 197 (373)
T ss_dssp ---------------------------------------------------------------------------CCCCC
T ss_pred ---------------------------------------------------------------------------CCccc
Confidence 01123
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
.++||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+.+.+++...+.++. .++.++++||.+||.
T Consensus 198 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~~li~~lL~ 275 (373)
T 2r5t_A 198 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP--NITNSARHLLEGLLQ 275 (373)
T ss_dssp SBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCS--SSCHHHHHHHHHHTC
T ss_pred cccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCC--CCCHHHHHHHHHHcc
Confidence 467999999999999999999999999999999999999999998888888888888777664 489999999999999
Q ss_pred cCCCCcccccCCHHHHhcCCCCCCCChhhhh--cCCCCCCCC
Q 007433 530 KEPQNRLACRRGATEIKQHPFFQGVNWALIR--CASPPEIPK 569 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~~--~~~~~~~p~ 569 (604)
+||.+|+++...+.++++||||++++|..+. ...||..|.
T Consensus 276 ~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~ 317 (373)
T 2r5t_A 276 KDRTKRLGAKDDFMEIKSHVFFSLINWDDLINKKITPPFNPN 317 (373)
T ss_dssp SSGGGSTTTTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCS
T ss_pred cCHHhCCCCCCCHHHHhCCccccCCCHHHHHhCCCCCCCCCC
Confidence 9999999987788999999999999998763 345555554
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-54 Score=453.78 Aligned_cols=259 Identities=21% Similarity=0.324 Sum_probs=218.4
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCC-----ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCC-CCccccceeEe
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGT-----KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH-PFLPTLYTHFE 283 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~ 283 (604)
+..++|++.+.||+|+||+||+|++.++ ++.||||++...... .....+.+|+++|+++.| ||||+++++|.
T Consensus 61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~--~~~~~~~~E~~il~~l~hhpnIV~l~g~~~ 138 (353)
T 4ase_A 61 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACT 138 (353)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccCh--HHHHHHHHHHHHHHHcCCCCcEEEEEEEEE
Confidence 4568999999999999999999998764 468999999765432 233467789999999965 89999999986
Q ss_pred c-CCeeEEEEeecCCCCHHHHHHhcC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEE
Q 007433 284 T-DKFSCLVMEFCPGGDLHTLRQRQP--------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV 348 (604)
Q Consensus 284 ~-~~~~~lV~E~~~ggsL~~ll~~~~--------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl 348 (604)
. ++.+|||||||++|+|.++++... ...|++..+..|+.||+.||+|||+++||||||||+||||
T Consensus 139 ~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl 218 (353)
T 4ase_A 139 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 218 (353)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred ecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceee
Confidence 5 567899999999999999997642 2458999999999999999999999999999999999999
Q ss_pred ccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccc
Q 007433 349 REDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNE 428 (604)
Q Consensus 349 ~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 428 (604)
+.++.+||+|||+|+.+.....
T Consensus 219 ~~~~~vKi~DFGlar~~~~~~~---------------------------------------------------------- 240 (353)
T 4ase_A 219 SEKNVVKICDFGLARDIYKDPD---------------------------------------------------------- 240 (353)
T ss_dssp CGGGCEEECCCGGGSCTTTCTT----------------------------------------------------------
T ss_pred CCCCCEEECcchhhhhcccCCC----------------------------------------------------------
Confidence 9999999999999954321111
Q ss_pred cCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCC
Q 007433 429 MGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQP 507 (604)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~ 507 (604)
.......+||+.|||||++.+..|+.++|||||||+||||++ |+.||.+....+.+.+++...
T Consensus 241 ----------------~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g 304 (353)
T 4ase_A 241 ----------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 304 (353)
T ss_dssp ----------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHT
T ss_pred ----------------ceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcC
Confidence 011234579999999999999999999999999999999998 999999877666666655554
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 508 LRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 508 ~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
.+++.+..+++++.+||.+||..||++||+ +.||++|
T Consensus 305 ~~~~~p~~~~~~~~~li~~c~~~dP~~RPt----~~eil~~ 341 (353)
T 4ase_A 305 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 341 (353)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcCcChhHCcC----HHHHHHH
Confidence 555555669999999999999999999999 9999987
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-53 Score=445.68 Aligned_cols=278 Identities=36% Similarity=0.659 Sum_probs=246.3
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCee
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 288 (604)
....++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+.+|+.++||||++++++|.+++.+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 34568999999999999999999999999999999999877655545566778899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
||||||++||+|.+++.+. ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||++.....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~- 193 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS-
T ss_pred EEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC-
Confidence 9999999999999999876 4699999999999999999999999999999999999999999999999999843210
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
..
T Consensus 194 ------------------------------------------------------------------------------~~ 195 (350)
T 1rdq_E 194 ------------------------------------------------------------------------------RT 195 (350)
T ss_dssp ------------------------------------------------------------------------------CB
T ss_pred ------------------------------------------------------------------------------Cc
Confidence 11
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
...+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+.++....+.+|. .++.++++||.+||
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~lL 273 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLL 273 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TCCHHHHHHHHHHS
T ss_pred ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHh
Confidence 2457999999999999999999999999999999999999999998888888888888777665 48999999999999
Q ss_pred hcCCCCcccc-cCCHHHHhcCCCCCCCChhhhh--cCCCCCCCC
Q 007433 529 VKEPQNRLAC-RRGATEIKQHPFFQGVNWALIR--CASPPEIPK 569 (604)
Q Consensus 529 ~~dP~~Rpt~-~~~a~elL~Hpff~~~~~~~~~--~~~~~~~p~ 569 (604)
..||.+||+. +.+++||++||||++++|..+. ...+|.+|.
T Consensus 274 ~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~ 317 (350)
T 1rdq_E 274 QVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPK 317 (350)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred hcCHHhccCCccCCHHHHHhCcCcCCCCHHHHhhccCCCCCCCC
Confidence 9999999984 4568999999999999998764 344555554
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=443.19 Aligned_cols=279 Identities=37% Similarity=0.720 Sum_probs=237.8
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCeeE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~ 289 (604)
..++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+.+|+.+ +||||++++++|.+++.+|
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 86 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLF 86 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEE
Confidence 457999999999999999999999999999999999887655555566778899999988 8999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
|||||++||+|..++.+. ..+++..++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||++.....
T Consensus 87 lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~-- 162 (345)
T 3a8x_A 87 FVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR-- 162 (345)
T ss_dssp EEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC--
T ss_pred EEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC--
Confidence 999999999999998875 5699999999999999999999999999999999999999999999999999842110
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
......
T Consensus 163 --------------------------------------------------------------------------~~~~~~ 168 (345)
T 3a8x_A 163 --------------------------------------------------------------------------PGDTTS 168 (345)
T ss_dssp --------------------------------------------------------------------------TTCCBC
T ss_pred --------------------------------------------------------------------------CCCccc
Confidence 001122
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCC---------ChHHHHHHHHcCCCCCCCCCCCCHHH
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS---------ENRATLYNVVGQPLRFPESPVVSFSA 520 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~---------~~~~~l~~i~~~~~~~p~~~~~s~~l 520 (604)
.++||+.|+|||++.+..++.++|||||||+||||++|+.||... ........+......+|. .++.++
T Consensus 169 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~--~~s~~~ 246 (345)
T 3a8x_A 169 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR--SLSVKA 246 (345)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCT--TSCHHH
T ss_pred ccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCC--CCCHHH
Confidence 457999999999999999999999999999999999999999752 223344556666666664 489999
Q ss_pred HHHHHHhhhcCCCCccccc--CCHHHHhcCCCCCCCChhhhhc--CCCCCCCC
Q 007433 521 RDLIKGLLVKEPQNRLACR--RGATEIKQHPFFQGVNWALIRC--ASPPEIPK 569 (604)
Q Consensus 521 ~dLI~~lL~~dP~~Rpt~~--~~a~elL~Hpff~~~~~~~~~~--~~~~~~p~ 569 (604)
++||.+||.+||.+||++. .++.|+++||||++++|..+.. ..||..|.
T Consensus 247 ~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p~ 299 (345)
T 3a8x_A 247 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPN 299 (345)
T ss_dssp HHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred HHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCC
Confidence 9999999999999999953 3468999999999999987643 34444443
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=463.99 Aligned_cols=285 Identities=35% Similarity=0.628 Sum_probs=244.4
Q ss_pred cCceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC
Q 007433 206 KDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD 285 (604)
Q Consensus 206 ~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 285 (604)
.+..+..++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+|..++||||++++++|.++
T Consensus 67 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~ 146 (437)
T 4aw2_A 67 KQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD 146 (437)
T ss_dssp HHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS
T ss_pred hcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC
Confidence 34445678999999999999999999999999999999999876544433334467899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
+.+|||||||+||+|.+++.+. ...+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||++..+
T Consensus 147 ~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~ 225 (437)
T 4aw2_A 147 NNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL 225 (437)
T ss_dssp SEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhc
Confidence 9999999999999999999874 357999999999999999999999999999999999999999999999999998543
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
.....
T Consensus 226 ~~~~~--------------------------------------------------------------------------- 230 (437)
T 4aw2_A 226 MEDGT--------------------------------------------------------------------------- 230 (437)
T ss_dssp CTTSC---------------------------------------------------------------------------
T ss_pred ccCCC---------------------------------------------------------------------------
Confidence 21100
Q ss_pred CcccccccCccccCcceec-----CCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC--CCCCCCC-CCCC
Q 007433 446 ARSMSFVGTHEYLAPEIIK-----GEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ--PLRFPES-PVVS 517 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~-----~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~--~~~~p~~-~~~s 517 (604)
......+||+.|+|||++. ...|+.++|||||||+||||++|+.||.+.+..+.+.+++.. .+.+|.. ..++
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s 310 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVS 310 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCSC
T ss_pred cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccCC
Confidence 0112357999999999997 456899999999999999999999999998888888887653 2444443 4589
Q ss_pred HHHHHHHHHhhhcCCCC--cccccCCHHHHhcCCCCCCCChhhhhcCCCCCCCCC
Q 007433 518 FSARDLIKGLLVKEPQN--RLACRRGATEIKQHPFFQGVNWALIRCASPPEIPKP 570 (604)
Q Consensus 518 ~~l~dLI~~lL~~dP~~--Rpt~~~~a~elL~Hpff~~~~~~~~~~~~~~~~p~~ 570 (604)
.++++||++||+.+|++ |++ ++|+++||||++++|..++...+|.+|..
T Consensus 311 ~~~~dLi~~lL~~~~~r~~r~~----~~eil~Hpff~~i~w~~l~~~~~p~~P~~ 361 (437)
T 4aw2_A 311 ENAKDLIRRLICSREHRLGQNG----IEDFKKHPFFSGIDWDNIRNCEAPYIPEV 361 (437)
T ss_dssp HHHHHHHHTTSSCGGGCTTTTT----THHHHTSGGGTTCCTTTGGGSCCSCCCCC
T ss_pred HHHHHHHHHHhcccccccCCCC----HHHHhCCCccCCCCHHHHhhCCCCCCCcC
Confidence 99999999999998887 888 99999999999999999988878777754
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=460.70 Aligned_cols=289 Identities=36% Similarity=0.664 Sum_probs=244.7
Q ss_pred eecCceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEe
Q 007433 204 RVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFE 283 (604)
Q Consensus 204 ~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 283 (604)
.+.+..+..++|++++.||+|+||+||+|+++.+++.||||++++...........+.+|+.+|..++||||++++++|.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34445566789999999999999999999999999999999998765544445556778999999999999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccc
Q 007433 284 TDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 284 ~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
+++.+|||||||+||+|.+++.+. +..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||++.
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~ 210 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCL 210 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhhe
Confidence 999999999999999999999875 2479999999999999999999999999999999999999999999999999985
Q ss_pred cccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCC
Q 007433 364 RCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEP 443 (604)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (604)
......
T Consensus 211 ~~~~~~-------------------------------------------------------------------------- 216 (412)
T 2vd5_A 211 KLRADG-------------------------------------------------------------------------- 216 (412)
T ss_dssp ECCTTS--------------------------------------------------------------------------
T ss_pred eccCCC--------------------------------------------------------------------------
Confidence 432110
Q ss_pred CCCcccccccCccccCcceec-------CCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC--CCCCCC-C
Q 007433 444 TNARSMSFVGTHEYLAPEIIK-------GEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ--PLRFPE-S 513 (604)
Q Consensus 444 ~~~~~~~~~GT~~Y~APE~l~-------~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~--~~~~p~-~ 513 (604)
.......+||+.|+|||++. +..|+.++|||||||+||||++|+.||.+.+..+.+.+++.. .+.+|. .
T Consensus 217 -~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 295 (412)
T 2vd5_A 217 -TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD 295 (412)
T ss_dssp -CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC---
T ss_pred -ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccc
Confidence 00122457999999999997 356899999999999999999999999998888888777653 234443 2
Q ss_pred CCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhhhhcCCCCCCCCC
Q 007433 514 PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPKP 570 (604)
Q Consensus 514 ~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~~~~~~~~~p~~ 570 (604)
..++.++++||++||+ +|.+|+. +.+++|+++||||++++|..++...||.+|..
T Consensus 296 ~~~s~~~~dli~~lL~-~p~~Rlg-r~~~~ei~~Hpff~~i~w~~l~~~~~p~~p~~ 350 (412)
T 2vd5_A 296 EGVPEEARDFIQRLLC-PPETRLG-RGGAGDFRTHPFFFGLDWDGLRDSVPPFTPDF 350 (412)
T ss_dssp -CCCHHHHHHHHTTSS-CGGGCTT-TTTHHHHHTSGGGTTCCSTTSTTSCCSCCCC-
T ss_pred cCCCHHHHHHHHHHcC-ChhhcCC-CCCHHHHhcCCCcCCCCHHHHhhcCCCCCCcC
Confidence 4689999999999999 9999974 23499999999999999999987777777753
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-53 Score=456.98 Aligned_cols=281 Identities=34% Similarity=0.638 Sum_probs=242.1
Q ss_pred ceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCe
Q 007433 208 GVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKF 287 (604)
Q Consensus 208 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 287 (604)
..+..++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+.+|+.++||||++++++|.+++.
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 34566899999999999999999999999999999999987654433333456789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccC
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAV 367 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~ 367 (604)
+|||||||+||+|.+++... .+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||++.....
T Consensus 144 ~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~ 220 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNK 220 (410)
T ss_dssp EEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeecc
Confidence 99999999999999998764 599999999999999999999999999999999999999999999999999854321
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
.. ...
T Consensus 221 ~~---------------------------------------------------------------------------~~~ 225 (410)
T 3v8s_A 221 EG---------------------------------------------------------------------------MVR 225 (410)
T ss_dssp TS---------------------------------------------------------------------------EEE
T ss_pred CC---------------------------------------------------------------------------ccc
Confidence 10 001
Q ss_pred ccccccCccccCcceecCCC----CCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC--CCCCCCCCCCCHHHH
Q 007433 448 SMSFVGTHEYLAPEIIKGEG----HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ--PLRFPESPVVSFSAR 521 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~~~----~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~--~~~~p~~~~~s~~l~ 521 (604)
..+.+||+.|+|||++.+.. |+.++|||||||+||||++|+.||.+.+....+.+++.. .+.+|....++.+++
T Consensus 226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~ 305 (410)
T 3v8s_A 226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAK 305 (410)
T ss_dssp CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHHH
T ss_pred ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHHH
Confidence 22457999999999998776 788999999999999999999999998888888888764 356677677999999
Q ss_pred HHHHHhhhcCCCC--cccccCCHHHHhcCCCCCCCChh--hhhcCCCCCCCCC
Q 007433 522 DLIKGLLVKEPQN--RLACRRGATEIKQHPFFQGVNWA--LIRCASPPEIPKP 570 (604)
Q Consensus 522 dLI~~lL~~dP~~--Rpt~~~~a~elL~Hpff~~~~~~--~~~~~~~~~~p~~ 570 (604)
+||.+||..+|.+ |++ ++||++||||++++|. ..+...+|.+|..
T Consensus 306 ~li~~lL~~~~~rlgR~~----~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~ 354 (410)
T 3v8s_A 306 NLICAFLTDREVRLGRNG----VEEIKRHLFFKNDQWAWETLRDTVAPVVPDL 354 (410)
T ss_dssp HHHHHHSSCGGGCTTSSC----HHHHHTSGGGCCSSCCSTTGGGSCCSCCCCC
T ss_pred HHHHHHccChhhhCCCCC----HHHHhcCccccCCCHHHHhhcccCCCCCCcC
Confidence 9999999988888 888 9999999999999986 3455667766653
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=443.09 Aligned_cols=280 Identities=30% Similarity=0.607 Sum_probs=239.2
Q ss_pred CceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 207 DGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 207 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
.+.+..++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+++|+.++||||++++++|.+.+
T Consensus 9 ~~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~ 88 (384)
T 4fr4_A 9 NEDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEE 88 (384)
T ss_dssp CCCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 34556789999999999999999999999999999999998876555555667889999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
.+|+|||||.||+|..++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||++..+.
T Consensus 89 ~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~ 166 (384)
T 4fr4_A 89 DMFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP 166 (384)
T ss_dssp EEEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc
Confidence 999999999999999998875 579999999999999999999999999999999999999999999999999984321
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
. ..
T Consensus 167 ~-----------------------------------------------------------------------------~~ 169 (384)
T 4fr4_A 167 R-----------------------------------------------------------------------------ET 169 (384)
T ss_dssp T-----------------------------------------------------------------------------TC
T ss_pred C-----------------------------------------------------------------------------CC
Confidence 1 01
Q ss_pred cccccccCccccCcceecC---CCCCccchHHHHHHHHHHHhhCCCCCCCC---ChHHHHHHHHcCCCCCCCCCCCCHHH
Q 007433 447 RSMSFVGTHEYLAPEIIKG---EGHGSAVDWWTFGIFLYELLFGKTPFKGS---ENRATLYNVVGQPLRFPESPVVSFSA 520 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~---~~~~~~~DiWSLGviL~eLltG~~PF~~~---~~~~~l~~i~~~~~~~p~~~~~s~~l 520 (604)
....++||+.|+|||++.+ ..|+.++|||||||+||||++|+.||.+. .....+..+......++. .++..+
T Consensus 170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~--~~s~~~ 247 (384)
T 4fr4_A 170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS--AWSQEM 247 (384)
T ss_dssp CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCT--TSCHHH
T ss_pred ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCC--cCCHHH
Confidence 1224579999999999974 45899999999999999999999999753 334444555555555554 489999
Q ss_pred HHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhhhhc--CCCCCCCCC
Q 007433 521 RDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRC--ASPPEIPKP 570 (604)
Q Consensus 521 ~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~~~--~~~~~~p~~ 570 (604)
.+||.+||..||.+||+. +++|++||||++++|..+.. ..|+.+|..
T Consensus 248 ~~li~~lL~~dP~~R~s~---~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~~ 296 (384)
T 4fr4_A 248 VSLLKKLLEPNPDQRFSQ---LSDVQNFPYMNDINWDAVFQKRLIPGFIPNK 296 (384)
T ss_dssp HHHHHHHSCSSGGGSCCS---HHHHHTSGGGTTCCHHHHHTTCSCCCCCCSC
T ss_pred HHHHHHHhcCCHhHhccc---HHHHHcChhhhcCCHHHHHhCCCCCCCCCCC
Confidence 999999999999999984 89999999999999987643 445666654
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=430.81 Aligned_cols=260 Identities=30% Similarity=0.501 Sum_probs=231.0
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
...++|++++.||+|+||.||+|++..+++.||||++.+..... ....++.+|+++|+.++||||+++++++.+++.+|
T Consensus 12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNP-TSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEE
Confidence 34679999999999999999999999999999999998764432 34456778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
+||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~- 167 (328)
T 3fe3_A 91 LIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVG- 167 (328)
T ss_dssp EEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred EEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence 999999999999998776 56999999999999999999999999999999999999999999999999998432210
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
....
T Consensus 168 ----------------------------------------------------------------------------~~~~ 171 (328)
T 3fe3_A 168 ----------------------------------------------------------------------------GKLD 171 (328)
T ss_dssp ----------------------------------------------------------------------------CGGG
T ss_pred ----------------------------------------------------------------------------Cccc
Confidence 0122
Q ss_pred ccccCccccCcceecCCCCC-ccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 450 SFVGTHEYLAPEIIKGEGHG-SAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~-~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
..+||+.|+|||++.+..+. .++|||||||+||||++|+.||.+.+..+....+....+.+|.. ++.++.+||.+||
T Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~li~~~L 249 (328)
T 3fe3_A 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY--MSTDCENLLKRFL 249 (328)
T ss_dssp TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT--SCHHHHHHHHHHC
T ss_pred cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC--CCHHHHHHHHHHC
Confidence 45799999999999988875 79999999999999999999999998888888888887776654 8999999999999
Q ss_pred hcCCCCcccccCCHHHHhcCCCCCCCC
Q 007433 529 VKEPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 529 ~~dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
..||.+||+ ++|+|+||||+...
T Consensus 250 ~~dP~~R~t----~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 250 VLNPIKRGT----LEQIMKDRWINAGH 272 (328)
T ss_dssp CSSTTTSCC----HHHHTTCTTTTTTC
T ss_pred CCChhHCcC----HHHHhcCHhhcCCC
Confidence 999999999 99999999998654
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-52 Score=473.77 Aligned_cols=281 Identities=35% Similarity=0.669 Sum_probs=246.3
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCee
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~ 288 (604)
+..++|++++.||+|+||+||+|++..+++.||||++.+...........+..|+.+|..+ +|+||+.++++|++.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 4568999999999999999999999999999999999877554445556677899999988 799999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
||||||++||+|..++... ..|++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||++......
T Consensus 418 ~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~ 495 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 495 (674)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCT
T ss_pred EEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccC
Confidence 9999999999999999876 56999999999999999999999999999999999999999999999999998432100
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
....
T Consensus 496 ----------------------------------------------------------------------------~~~~ 499 (674)
T 3pfq_A 496 ----------------------------------------------------------------------------GVTT 499 (674)
T ss_dssp ----------------------------------------------------------------------------TCCB
T ss_pred ----------------------------------------------------------------------------Cccc
Confidence 0112
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
..++||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..++...+.+|. .++.++++||++||
T Consensus 500 ~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL 577 (674)
T 3pfq_A 500 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK--SMSKEAVAICKGLM 577 (674)
T ss_dssp CCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCT--TSCHHHHHHHHHHS
T ss_pred ccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHHHHc
Confidence 3567999999999999999999999999999999999999999999999999999988887775 49999999999999
Q ss_pred hcCCCCcccc-cCCHHHHhcCCCCCCCChhhhhc--CCCCCCCCC
Q 007433 529 VKEPQNRLAC-RRGATEIKQHPFFQGVNWALIRC--ASPPEIPKP 570 (604)
Q Consensus 529 ~~dP~~Rpt~-~~~a~elL~Hpff~~~~~~~~~~--~~~~~~p~~ 570 (604)
.+||++|+++ ..+++||++||||++++|..+.. ..||..|..
T Consensus 578 ~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~ 622 (674)
T 3pfq_A 578 TKHPGKRLGCGPEGERDIKEHAFFRYIDWEKLERKEIQPPYKPKA 622 (674)
T ss_dssp CSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBC
T ss_pred cCCHHHCCCCCCCcHHHHhcCccccCCCHHHHHhCCCCCCCCCcC
Confidence 9999999995 34469999999999999997743 445656543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-51 Score=456.38 Aligned_cols=283 Identities=32% Similarity=0.616 Sum_probs=244.0
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
+..++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+++|+.++||||++++++|.+...+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 45689999999999999999999999999999999998876655555667788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccC
Q 007433 290 LVMEFCPGGDLHTLRQRQP--GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAV 367 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~--~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~ 367 (604)
||||||+||+|..++.... ...+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||++..+..
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 9999999999999987653 35799999999999999999999999999999999999999999999999999854321
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
. ...
T Consensus 342 ~----------------------------------------------------------------------------~~~ 345 (543)
T 3c4z_A 342 G----------------------------------------------------------------------------QTK 345 (543)
T ss_dssp T----------------------------------------------------------------------------CCC
T ss_pred C----------------------------------------------------------------------------Ccc
Confidence 0 001
Q ss_pred ccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCC----hHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 007433 448 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE----NRATLYNVVGQPLRFPESPVVSFSARDL 523 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~----~~~~l~~i~~~~~~~p~~~~~s~~l~dL 523 (604)
...++||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.. .......+......++. .++.++++|
T Consensus 346 ~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~l 423 (543)
T 3c4z_A 346 TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPD--KFSPASKDF 423 (543)
T ss_dssp BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCT--TSCHHHHHH
T ss_pred cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCc--ccCHHHHHH
Confidence 123579999999999999999999999999999999999999998753 34555666666666654 589999999
Q ss_pred HHHhhhcCCCCcccccC-CHHHHhcCCCCCCCChhhhhc--CCCCCCCCC
Q 007433 524 IKGLLVKEPQNRLACRR-GATEIKQHPFFQGVNWALIRC--ASPPEIPKP 570 (604)
Q Consensus 524 I~~lL~~dP~~Rpt~~~-~a~elL~Hpff~~~~~~~~~~--~~~~~~p~~ 570 (604)
|.+||.+||++||++.. ++++|++||||++++|..+.. ..||.+|.+
T Consensus 424 i~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P~~ 473 (543)
T 3c4z_A 424 CEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDS 473 (543)
T ss_dssp HHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHHHTTCSCCSCCCCS
T ss_pred HHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHHHcCCCCCCCCCCc
Confidence 99999999999998643 579999999999999987753 456666654
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=449.69 Aligned_cols=271 Identities=38% Similarity=0.718 Sum_probs=228.1
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
+..++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+.+|+.++||||++++++|.+++.+|
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 34578999999999999999999999999999999998765544555566778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH-cCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM-LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
||||||+||+|..++... ..+++..++.|+.||+.||+|||+ +|||||||||+||||+.+|++||+|||++......
T Consensus 225 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 302 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302 (446)
T ss_dssp EEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-
T ss_pred EEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCC
Confidence 999999999999998876 579999999999999999999998 99999999999999999999999999988321100
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
....
T Consensus 303 ----------------------------------------------------------------------------~~~~ 306 (446)
T 4ejn_A 303 ----------------------------------------------------------------------------GATM 306 (446)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ----------------------------------------------------------------------------Cccc
Confidence 0112
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
...+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+....+..+......++. .++.++++||.+||
T Consensus 307 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~~~L 384 (446)
T 4ejn_A 307 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR--TLGPEAKSLLSGLL 384 (446)
T ss_dssp CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHT
T ss_pred ccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHHHHc
Confidence 2457999999999999999999999999999999999999999998888888888887777665 48999999999999
Q ss_pred hcCCCCcccc-cCCHHHHhcCCCCCCCChhhhh
Q 007433 529 VKEPQNRLAC-RRGATEIKQHPFFQGVNWALIR 560 (604)
Q Consensus 529 ~~dP~~Rpt~-~~~a~elL~Hpff~~~~~~~~~ 560 (604)
.+||.+||+. ...+.|+|+||||++++|..+.
T Consensus 385 ~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~~ 417 (446)
T 4ejn_A 385 KKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHVY 417 (446)
T ss_dssp CSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHHH
T ss_pred ccCHHHhCCCCCCCHHHHHhCccccCCCHHHHh
Confidence 9999999911 1129999999999999998764
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-51 Score=427.78 Aligned_cols=272 Identities=38% Similarity=0.700 Sum_probs=228.2
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEc---CCceEEEEEEecchhHHH-HHHHHHHHHHHHHHHhCCCCCccccceeEecC
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELT---GTKCYFAMKVMDKASLEK-RKKLLRAQTEREILQSLDHPFLPTLYTHFETD 285 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 285 (604)
+..++|++++.||+|+||.||+|++. .+++.||||++.+..... ......+.+|+.+|+.++||||++++++|.++
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 93 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG 93 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC
Confidence 34579999999999999999999985 678899999998764322 23344567899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
+.+|||||||+|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|++||+|||++...
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 94 GKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp SCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred CEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 9999999999999999998875 56999999999999999999999999999999999999999999999999987421
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
... .
T Consensus 172 ~~~----------------------------------------------------------------------------~ 175 (327)
T 3a62_A 172 IHD----------------------------------------------------------------------------G 175 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccC----------------------------------------------------------------------------C
Confidence 100 0
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIK 525 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~ 525 (604)
......+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+....+..+......++. .++.++++||.
T Consensus 176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~--~~~~~~~~li~ 253 (327)
T 3a62_A 176 TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP--YLTQEARDLLK 253 (327)
T ss_dssp ---CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCT--TSCHHHHHHHH
T ss_pred ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCC--CCCHHHHHHHH
Confidence 0112357999999999999999999999999999999999999999998888888888887766654 48999999999
Q ss_pred HhhhcCCCCccccc-CCHHHHhcCCCCCCCChhhhhc
Q 007433 526 GLLVKEPQNRLACR-RGATEIKQHPFFQGVNWALIRC 561 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~-~~a~elL~Hpff~~~~~~~~~~ 561 (604)
+||..||++||++. ..+.|+++||||++++|..+..
T Consensus 254 ~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~~~~ 290 (327)
T 3a62_A 254 KLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEELLA 290 (327)
T ss_dssp HHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHHHHT
T ss_pred HHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHHHhh
Confidence 99999999999643 2499999999999999987643
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-51 Score=435.52 Aligned_cols=264 Identities=30% Similarity=0.462 Sum_probs=232.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHH---HHHHHHHHHHHHHHhCCCCCccccceeEecCCee
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKR---KKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 288 (604)
.++|++++.||+|+||+||+|++..+++.||||++.+...... .....+.+|+.+|+.++||||++++++|.++..+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 3689999999999999999999999999999999987543211 1234567899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC----cEEEeccccccc
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG----HIMLSDFDLSLR 364 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g----~vkL~DFGla~~ 364 (604)
|||||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..
T Consensus 91 ~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~ 168 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (361)
T ss_dssp EEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence 9999999999999998764 5799999999999999999999999999999999999998877 799999999843
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
+...
T Consensus 169 ~~~~---------------------------------------------------------------------------- 172 (361)
T 2yab_A 169 IEDG---------------------------------------------------------------------------- 172 (361)
T ss_dssp CCTT----------------------------------------------------------------------------
T ss_pred cCCC----------------------------------------------------------------------------
Confidence 2210
Q ss_pred CCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC--CCCCCHHHHH
Q 007433 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE--SPVVSFSARD 522 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~--~~~~s~~l~d 522 (604)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+.++....+.++. +..++..+++
T Consensus 173 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 251 (361)
T 2yab_A 173 -VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELAKD 251 (361)
T ss_dssp -CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHH
T ss_pred -CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCCHHHHH
Confidence 0112346999999999999999999999999999999999999999999888888888887766653 2568999999
Q ss_pred HHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhh
Q 007433 523 LIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWAL 558 (604)
Q Consensus 523 LI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~ 558 (604)
||.+||.+||.+||+ +.|+|+||||+.++|..
T Consensus 252 li~~~L~~dP~~R~t----~~e~l~hp~~~~~~~~~ 283 (361)
T 2yab_A 252 FIRKLLVKETRKRLT----IQEALRHPWITPVDTQQ 283 (361)
T ss_dssp HHHHHSCSSTTTSCC----HHHHHTSTTTSCSSHHH
T ss_pred HHHHHCCCChhHCcC----HHHHhcCcCcCCCchhh
Confidence 999999999999999 99999999999999864
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-51 Score=458.62 Aligned_cols=283 Identities=35% Similarity=0.592 Sum_probs=241.2
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCee
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 288 (604)
.+..++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+++|+.++||||++++++|.+++.+
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l 259 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDAL 259 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEE
Confidence 35568999999999999999999999999999999999887655545556678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|||||||+||+|..++.......+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||++..+...
T Consensus 260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~ 339 (576)
T 2acx_A 260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339 (576)
T ss_dssp EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence 99999999999999998765556999999999999999999999999999999999999999999999999998432110
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
...
T Consensus 340 -----------------------------------------------------------------------------~~~ 342 (576)
T 2acx_A 340 -----------------------------------------------------------------------------QTI 342 (576)
T ss_dssp -----------------------------------------------------------------------------CCE
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 011
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCC----hHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE----NRATLYNVVGQPLRFPESPVVSFSARDLI 524 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~----~~~~l~~i~~~~~~~p~~~~~s~~l~dLI 524 (604)
...+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.. .......+...+..++ ..++.++++||
T Consensus 343 ~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p--~~~s~~~~dLI 420 (576)
T 2acx_A 343 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS--ERFSPQARSLC 420 (576)
T ss_dssp ECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC--TTSCHHHHHHH
T ss_pred cccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC--ccCCHHHHHHH
Confidence 23479999999999999999999999999999999999999998753 2334445555555555 45899999999
Q ss_pred HHhhhcCCCCccccc-CCHHHHhcCCCCCCCChhhhhc--CCCCCCCCC
Q 007433 525 KGLLVKEPQNRLACR-RGATEIKQHPFFQGVNWALIRC--ASPPEIPKP 570 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~-~~a~elL~Hpff~~~~~~~~~~--~~~~~~p~~ 570 (604)
.+||.+||.+||++. .++.||++||||++++|..+.. ..||..|.+
T Consensus 421 ~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~~ 469 (576)
T 2acx_A 421 SQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDP 469 (576)
T ss_dssp HHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred HHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHHhcCCCCCCCCCCc
Confidence 999999999999432 1399999999999999987754 345555554
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=432.84 Aligned_cols=273 Identities=23% Similarity=0.349 Sum_probs=222.7
Q ss_pred eecCeEEEEEEccC--CcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCee
Q 007433 211 GVGHFRLLKKLGCG--DIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 211 ~~~~y~l~~~LG~G--~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 288 (604)
..++|++++.||+| +||+||+|++..+++.||||++....... .....+.+|+.+|+.++||||++++++|.+++.+
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 101 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSN-EMVTFLQGELHVSKLFNHPNIVPYRATFIADNEL 101 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccCh-HHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEE
Confidence 34799999999999 99999999999999999999998764332 3455677899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|||||||++++|.+++.......+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||++......
T Consensus 102 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~ 181 (389)
T 3gni_B 102 WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISH 181 (389)
T ss_dssp EEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEET
T ss_pred EEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccc
Confidence 99999999999999998876677999999999999999999999999999999999999999999999999987543211
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
..... ......
T Consensus 182 ~~~~~---------------------------------------------------------------------~~~~~~ 192 (389)
T 3gni_B 182 GQRQR---------------------------------------------------------------------VVHDFP 192 (389)
T ss_dssp TEECS---------------------------------------------------------------------CBCCCC
T ss_pred ccccc---------------------------------------------------------------------cccccc
Confidence 10000 000011
Q ss_pred cccccCccccCcceecC--CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC------------------
Q 007433 449 MSFVGTHEYLAPEIIKG--EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPL------------------ 508 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~--~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~------------------ 508 (604)
...+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.+....+..++....
T Consensus 193 ~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (389)
T 3gni_B 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSP 272 (389)
T ss_dssp TTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-----------------------
T ss_pred ccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccc
Confidence 23469999999999988 5789999999999999999999999988766555544332211
Q ss_pred --------------------------CCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 509 --------------------------RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 509 --------------------------~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
..+....++.++++||.+||.+||++||+ +.|+|+||||+.+.|.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt----a~ell~hp~f~~~~~~ 343 (389)
T 3gni_B 273 SRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPS----ASTLLNHSFFKQIKRR 343 (389)
T ss_dssp ---------------------------------CCHHHHHHHHHHTCSCTTTSCC----HHHHTTSGGGGGC---
T ss_pred cccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCC----HHHHhcCHHHHHHhhc
Confidence 11123457889999999999999999999 9999999999988764
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-50 Score=413.45 Aligned_cols=256 Identities=25% Similarity=0.407 Sum_probs=223.2
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++++.||+|+||+||+|.+..+++.||||++....... ...+.+|+.+|+.++||||++++++|..++.+|+|
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 95 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEE
Confidence 478999999999999999999999999999999997654322 23466899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
||||+|++|.+++... .+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus 96 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--- 169 (297)
T 3fxz_A 96 MEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--- 169 (297)
T ss_dssp EECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST---
T ss_pred EECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCc---
Confidence 9999999999998874 5999999999999999999999999999999999999999999999999988433210
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
.......
T Consensus 170 -------------------------------------------------------------------------~~~~~~~ 176 (297)
T 3fxz_A 170 -------------------------------------------------------------------------QSKRSTM 176 (297)
T ss_dssp -------------------------------------------------------------------------TCCBCCC
T ss_pred -------------------------------------------------------------------------ccccCCc
Confidence 0012235
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc-CCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG-QPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~-~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+....+..+.. ....+.....++..+++||.+||..
T Consensus 177 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 256 (297)
T 3fxz_A 177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLEM 256 (297)
T ss_dssp CSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHHHHHHSCS
T ss_pred cCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHHHHHHccC
Confidence 699999999999999999999999999999999999999998887776665543 3334444456899999999999999
Q ss_pred CCCCcccccCCHHHHhcCCCCCC
Q 007433 531 EPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
||++||+ +.|+|+||||+.
T Consensus 257 dp~~Rps----~~ell~h~~~~~ 275 (297)
T 3fxz_A 257 DVEKRGS----AKELLQHQFLKI 275 (297)
T ss_dssp STTTSCC----HHHHTTCGGGGG
T ss_pred ChhHCcC----HHHHhhChhhcc
Confidence 9999999 999999999974
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-50 Score=417.54 Aligned_cols=264 Identities=28% Similarity=0.464 Sum_probs=229.3
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHH---HHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKR---KKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
++|++.+.||+|+||.||+|++..++..||||++.+...... .....+.+|+.+|+.++||||++++++|.++...|
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 689999999999999999999999999999999976533211 12345678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC----cEEEecccccccc
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG----HIMLSDFDLSLRC 365 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g----~vkL~DFGla~~~ 365 (604)
+|||||+|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||++..+
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 91 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999999999998764 5799999999999999999999999999999999999999887 8999999998443
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
...
T Consensus 169 ~~~----------------------------------------------------------------------------- 171 (326)
T 2y0a_A 169 DFG----------------------------------------------------------------------------- 171 (326)
T ss_dssp CTT-----------------------------------------------------------------------------
T ss_pred CCC-----------------------------------------------------------------------------
Confidence 210
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC--CCCCCHHHHHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE--SPVVSFSARDL 523 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~--~~~~s~~l~dL 523 (604)
......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+.+..+......++. ...++..+++|
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 251 (326)
T 2y0a_A 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 251 (326)
T ss_dssp SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHH
T ss_pred CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCCHHHHHH
Confidence 0011346999999999999999999999999999999999999999998888888877766555542 24588999999
Q ss_pred HHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhhh
Q 007433 524 IKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALI 559 (604)
Q Consensus 524 I~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~ 559 (604)
|.+||..||++||+ +.|+|+||||+..+|...
T Consensus 252 i~~~L~~dP~~Rpt----~~e~l~hp~~~~~~~~~~ 283 (326)
T 2y0a_A 252 IRRLLVKDPKKRMT----IQDSLQHPWIKPKDTQQA 283 (326)
T ss_dssp HHHHSCSSGGGSCC----HHHHHHSTTTSCCSHHHH
T ss_pred HHHHccCChhhCCC----HHHHhcCCCccCCcchhh
Confidence 99999999999999 999999999999887543
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=411.19 Aligned_cols=259 Identities=33% Similarity=0.574 Sum_probs=219.9
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHH-----------------------HHHHHHHHHHHHH
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKR-----------------------KKLLRAQTEREIL 267 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~-----------------------~~~~~~~~Ei~iL 267 (604)
..++|++.+.||+|+||.||+|++..+++.||||++.+...... .....+.+|+++|
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 45799999999999999999999999999999999976543211 1234577899999
Q ss_pred HhCCCCCccccceeEec--CCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCc
Q 007433 268 QSLDHPFLPTLYTHFET--DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPEN 345 (604)
Q Consensus 268 ~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeN 345 (604)
+.++||||+++++++.+ +..+|+||||+++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 91 ~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 91 KKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 99999999999999986 6789999999999999876433 469999999999999999999999999999999999
Q ss_pred EEEccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCC
Q 007433 346 VLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKP 425 (604)
Q Consensus 346 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 425 (604)
|||+.++.+||+|||++..+....
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~-------------------------------------------------------- 191 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSD-------------------------------------------------------- 191 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSS--------------------------------------------------------
T ss_pred EEECCCCCEEEecCCCcccccccc--------------------------------------------------------
Confidence 999999999999999984432100
Q ss_pred ccccCCCCCCCcccccCCCCCcccccccCccccCcceecCCC---CCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHH
Q 007433 426 KNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEG---HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN 502 (604)
Q Consensus 426 ~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~---~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~ 502 (604)
......+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.........
T Consensus 192 --------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~ 251 (298)
T 2zv2_A 192 --------------------ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSK 251 (298)
T ss_dssp --------------------CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred --------------------ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHHHHH
Confidence 0111346999999999998765 37789999999999999999999998887777777
Q ss_pred HHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCC
Q 007433 503 VVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 503 i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
+......++....++.++++||.+||..||++||+ +.|+|+||||+
T Consensus 252 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s----~~e~l~hp~~~ 297 (298)
T 2zv2_A 252 IKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIV----VPEIKLHPWVT 297 (298)
T ss_dssp HHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCC----HHHHTTCHHHH
T ss_pred HhcccCCCCCccccCHHHHHHHHHHhhcChhhCCC----HHHHhcCcccc
Confidence 77777777777789999999999999999999999 99999999995
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=418.19 Aligned_cols=251 Identities=21% Similarity=0.263 Sum_probs=192.4
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC----ee
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK----FS 288 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----~~ 288 (604)
.+|.+.++||+|+||+||+|+++ |+.||||+++..... .. ....|+.++..++|||||++++++.+++ .+
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~--g~~VAvK~l~~~~~~--~~--~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~ 76 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREER--SW--FREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET--TEEEEEEEECGGGHH--HH--HHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC--CEEEEEEEECccchh--hH--HHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEE
Confidence 47999999999999999999984 678999999765322 11 2235666777899999999999998653 68
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHc--------CeEeccCCCCcEEEccCCcEEEeccc
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML--------GIVYRDLKPENVLVREDGHIMLSDFD 360 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~--------gIvHrDIKpeNILl~~~g~vkL~DFG 360 (604)
|||||||+||+|.++++.. .+++..+..|+.|++.||+|||++ +||||||||+||||+.+|++||+|||
T Consensus 77 ~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFG 153 (303)
T 3hmm_A 77 WLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCC
Confidence 9999999999999999874 589999999999999999999987 99999999999999999999999999
Q ss_pred ccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccc
Q 007433 361 LSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELI 440 (604)
Q Consensus 361 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (604)
+++........
T Consensus 154 la~~~~~~~~~--------------------------------------------------------------------- 164 (303)
T 3hmm_A 154 LAVRHDSATDT--------------------------------------------------------------------- 164 (303)
T ss_dssp TCEEEETTTTE---------------------------------------------------------------------
T ss_pred CCccccCCCCc---------------------------------------------------------------------
Confidence 98554321110
Q ss_pred cCCCCCcccccccCccccCcceecCC------CCCccchHHHHHHHHHHHhhCCCCCCCCC--------------hHHHH
Q 007433 441 AEPTNARSMSFVGTHEYLAPEIIKGE------GHGSAVDWWTFGIFLYELLFGKTPFKGSE--------------NRATL 500 (604)
Q Consensus 441 ~~~~~~~~~~~~GT~~Y~APE~l~~~------~~~~~~DiWSLGviL~eLltG~~PF~~~~--------------~~~~l 500 (604)
........+||+.|||||++.+. .|+.++|||||||+||||++|..||.... ....+
T Consensus 165 ---~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~ 241 (303)
T 3hmm_A 165 ---IDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241 (303)
T ss_dssp ---ESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred ---eeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHH
Confidence 01112245799999999999865 35679999999999999999987664221 22333
Q ss_pred HH-HHcCCCC--CCCC---CCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 501 YN-VVGQPLR--FPES---PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 501 ~~-i~~~~~~--~p~~---~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
.+ +....++ +|.. ...+..+.+||.+||..||++||| +.||++.
T Consensus 242 ~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt----~~ei~~~ 291 (303)
T 3hmm_A 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT----ALRIKKT 291 (303)
T ss_dssp HHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCC----HHHHHHH
T ss_pred HHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcC----HHHHHHH
Confidence 33 3333332 2211 112346789999999999999999 8888764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=405.61 Aligned_cols=259 Identities=34% Similarity=0.582 Sum_probs=228.4
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
+..++|++++.||+|+||+||+|.+..++..||||++.+...........+.+|+.+++.++||||++++++|.++...|
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVY 85 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEE
Confidence 45689999999999999999999999999999999998766555444566788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
+||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||||+.++.++|+|||++.....
T Consensus 86 lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~-- 161 (279)
T 3fdn_A 86 LILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS-- 161 (279)
T ss_dssp EEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc--
Confidence 999999999999998876 5699999999999999999999999999999999999999999999999998732110
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
....
T Consensus 162 ----------------------------------------------------------------------------~~~~ 165 (279)
T 3fdn_A 162 ----------------------------------------------------------------------------SRRT 165 (279)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0111
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
...||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+.+..+......++. .++..+++||.+||.
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~ 243 (279)
T 3fdn_A 166 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--FVTEGARDLISRLLK 243 (279)
T ss_dssp --CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT--TSCHHHHHHHHHHCC
T ss_pred ccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCC--cCCHHHHHHHHHHhc
Confidence 346899999999999999999999999999999999999999998888887777776665554 489999999999999
Q ss_pred cCCCCcccccCCHHHHhcCCCCCCC
Q 007433 530 KEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
.||.+||+ +.|+|+||||+..
T Consensus 244 ~~p~~Rps----~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 244 HNPSQRPM----LREVLEHPWITAN 264 (279)
T ss_dssp SSGGGSCC----HHHHHHCHHHHHH
T ss_pred cChhhCCC----HHHHhhCccccCC
Confidence 99999999 9999999999753
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=422.73 Aligned_cols=258 Identities=27% Similarity=0.503 Sum_probs=226.6
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++++.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.+|+.|+||||++++++|.+++..|+|
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 368999999999999999999999999999999998664432 3345678899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC---cEEEecccccccccCC
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG---HIMLSDFDLSLRCAVS 368 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g---~vkL~DFGla~~~~~~ 368 (604)
||||.||+|.+++... ..+++..+..++.||+.||+|||++||+||||||+||||+.++ .+||+|||++......
T Consensus 107 ~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~ 184 (362)
T 2bdw_A 107 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184 (362)
T ss_dssp ECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred EecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence 9999999999988765 5799999999999999999999999999999999999998654 5999999998432110
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
...
T Consensus 185 -----------------------------------------------------------------------------~~~ 187 (362)
T 2bdw_A 185 -----------------------------------------------------------------------------EAW 187 (362)
T ss_dssp -----------------------------------------------------------------------------CSC
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 011
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCC--CCCCHHHHHHHHH
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPES--PVVSFSARDLIKG 526 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~--~~~s~~l~dLI~~ 526 (604)
...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+..+....+.++.. ..++.++++||.+
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 267 (362)
T 2bdw_A 188 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 267 (362)
T ss_dssp CCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHHHHHHH
T ss_pred ccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHH
Confidence 23469999999999999999999999999999999999999999988888888888776666543 4689999999999
Q ss_pred hhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 527 LLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 527 lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
||..||++||+ +.++|+||||..
T Consensus 268 ~L~~dP~~R~t----~~e~l~hp~~~~ 290 (362)
T 2bdw_A 268 MLTVNPKKRIT----ADQALKVPWICN 290 (362)
T ss_dssp HSCSSGGGSCC----HHHHTTSHHHHT
T ss_pred HcCCChhhCcC----HHHHhcCcccCC
Confidence 99999999999 999999999964
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=411.46 Aligned_cols=262 Identities=26% Similarity=0.447 Sum_probs=214.2
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|+++++||+|+||+||+|++.. ++.||||++...... ......+.+|+++|+.++||||+++++++.+++.+|+|
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 97 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQ-GRIVALKRIRLDAED-EGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLV 97 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETT-SCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECC-CCEEEEEEEeccccc-chhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEE
Confidence 4799999999999999999999864 789999999765322 22335667899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
||||+ ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 98 ~e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~-- 173 (311)
T 3niz_A 98 FEFME-KDLKKVLDENK-TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-- 173 (311)
T ss_dssp EECCS-EEHHHHHHTCT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC--
T ss_pred EcCCC-CCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc--
Confidence 99996 58888777653 569999999999999999999999999999999999999999999999999985432100
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 174 --------------------------------------------------------------------------~~~~~~ 179 (311)
T 3niz_A 174 --------------------------------------------------------------------------RSYTHE 179 (311)
T ss_dssp --------------------------------------------------------------------------C---CC
T ss_pred --------------------------------------------------------------------------ccccCC
Confidence 001123
Q ss_pred ccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHH---cCCCCC--C--------------
Q 007433 452 VGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV---GQPLRF--P-------------- 511 (604)
Q Consensus 452 ~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~---~~~~~~--p-------------- 511 (604)
+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..+. +.+... +
T Consensus 180 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (311)
T 3niz_A 180 VVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQ 259 (311)
T ss_dssp CCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCC
T ss_pred cccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccc
Confidence 68999999999987 458999999999999999999999998876665554443 221110 0
Q ss_pred ---------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 512 ---------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 512 ---------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
..+.++.++.+||.+||.+||++||+ +.|+|+||||+++++.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~ 310 (311)
T 3niz_A 260 VFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS----ARDAMNHPYFKDLDPQ 310 (311)
T ss_dssp CCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCC----HHHHHTSGGGTTSCTT
T ss_pred cccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCC----HHHHhcCcccccCCcc
Confidence 01346788999999999999999999 9999999999998764
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=424.38 Aligned_cols=257 Identities=30% Similarity=0.507 Sum_probs=220.2
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
..++|++++.||+|+||.||+|++..+++.||||++.+..........++.+|+.+|+.++||||+++++++.+++..|+
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l 86 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVM 86 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 35799999999999999999999999999999999987655444444567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
||||+ +|+|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++......
T Consensus 87 v~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~-- 161 (336)
T 3h4j_B 87 VIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG-- 161 (336)
T ss_dssp EECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS--
T ss_pred EEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC--
Confidence 99999 78999888765 56999999999999999999999999999999999999999999999999988432100
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
.....
T Consensus 162 ---------------------------------------------------------------------------~~~~~ 166 (336)
T 3h4j_B 162 ---------------------------------------------------------------------------NFLKT 166 (336)
T ss_dssp ---------------------------------------------------------------------------BTTCC
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 01123
Q ss_pred cccCccccCcceecCCCC-CccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 451 FVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~-~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
.+||+.|+|||++.+..+ +.++|||||||+||+|++|+.||.+......+..+......+| ..++.++++||.+||.
T Consensus 167 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~~L~ 244 (336)
T 3h4j_B 167 SCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP--DFLSPGAQSLIRRMIV 244 (336)
T ss_dssp CTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCC--TTSCHHHHHHHHTTSC
T ss_pred ccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCc--ccCCHHHHHHHHHHcC
Confidence 469999999999998876 7899999999999999999999987655444333333333333 3589999999999999
Q ss_pred cCCCCcccccCCHHHHhcCCCCCC
Q 007433 530 KEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
.||.+||+ +.|+++||||+.
T Consensus 245 ~dP~~Rpt----~~eil~hp~~~~ 264 (336)
T 3h4j_B 245 ADPMQRIT----IQEIRRDPWFNV 264 (336)
T ss_dssp SSGGGSCC----HHHHTTCHHHHT
T ss_pred CChhHCcC----HHHHHhChhhcc
Confidence 99999999 999999999974
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=416.44 Aligned_cols=257 Identities=26% Similarity=0.401 Sum_probs=226.6
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++++.||+|+||+||+|.+..+++.||+|++..... ....+.+|+.+|+.++||||++++++|.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 79 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcc----cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEE
Confidence 3699999999999999999999999999999999975532 223466899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc--CCcEEEecccccccccCCC
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE--DGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~--~g~vkL~DFGla~~~~~~~ 369 (604)
||||+|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++..+...
T Consensus 80 ~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~- 157 (321)
T 1tki_A 80 FEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp ECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC-
Confidence 9999999999988654 346999999999999999999999999999999999999987 789999999998443210
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
....
T Consensus 158 ----------------------------------------------------------------------------~~~~ 161 (321)
T 1tki_A 158 ----------------------------------------------------------------------------DNFR 161 (321)
T ss_dssp ----------------------------------------------------------------------------CEEE
T ss_pred ----------------------------------------------------------------------------Cccc
Confidence 0112
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC--CCCCCHHHHHHHHHh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE--SPVVSFSARDLIKGL 527 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~--~~~~s~~l~dLI~~l 527 (604)
..+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+.+.++......++. ...++.++++||.+|
T Consensus 162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 241 (321)
T 1tki_A 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTT
T ss_pred cccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHHH
Confidence 346999999999999988999999999999999999999999999888888888887766553 246899999999999
Q ss_pred hhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 528 LVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
|..||.+||+ +.|+|+||||+..
T Consensus 242 L~~dp~~Rpt----~~e~l~hp~~~~~ 264 (321)
T 1tki_A 242 LVKERKSRMT----ASEALQHPWLKQK 264 (321)
T ss_dssp SCSSGGGSCC----HHHHHHSHHHHSC
T ss_pred cCCChhHCcC----HHHHhcChhhccC
Confidence 9999999999 9999999999754
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=430.78 Aligned_cols=258 Identities=27% Similarity=0.494 Sum_probs=226.5
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++++.||+|+||+||+|.+..+++.||+|++.+..... .....+.+|+++|+.++||||++++++|.+++..|+||
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~-~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSA-RDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHH-HHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 68999999999999999999999999999999998765433 33456778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEc---cCCcEEEecccccccccCCC
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVR---EDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~---~~g~vkL~DFGla~~~~~~~ 369 (604)
|||.||+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+ .++.+||+|||++......
T Consensus 90 E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~- 166 (444)
T 3soa_A 90 DLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE- 166 (444)
T ss_dssp CCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT-
T ss_pred EeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC-
Confidence 999999999988876 5699999999999999999999999999999999999998 4678999999998432210
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
.....
T Consensus 167 ---------------------------------------------------------------------------~~~~~ 171 (444)
T 3soa_A 167 ---------------------------------------------------------------------------QQAWF 171 (444)
T ss_dssp ---------------------------------------------------------------------------CCBCC
T ss_pred ---------------------------------------------------------------------------Cceee
Confidence 00112
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC--CCCCCHHHHHHHHHh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE--SPVVSFSARDLIKGL 527 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~--~~~~s~~l~dLI~~l 527 (604)
..+||+.|+|||++.+..|+.++|||||||+||+|++|..||.+.+....+..+....+.++. +..++.++++||.+|
T Consensus 172 ~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 251 (444)
T 3soa_A 172 GFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKM 251 (444)
T ss_dssp CSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHHH
T ss_pred cccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHH
Confidence 357999999999999999999999999999999999999999999888888888877666554 357899999999999
Q ss_pred hhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 528 LVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
|..||++||+ +.|+|+||||+.
T Consensus 252 L~~dP~~Rpt----a~e~L~hp~~~~ 273 (444)
T 3soa_A 252 LTINPSKRIT----AAEALKHPWISH 273 (444)
T ss_dssp SCSSTTTSCC----HHHHHHSCTTHH
T ss_pred cCCChhHCCC----HHHHhcCccccC
Confidence 9999999999 999999999964
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=405.36 Aligned_cols=259 Identities=26% Similarity=0.420 Sum_probs=212.0
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|+++++||+|+||+||+|++..+++.||||++...... ......+.+|+.+|+.++||||+++++++.+++.+||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSS-TTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCc-CCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEE
Confidence 6899999999999999999999999999999999765322 122345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
|||.+ +|..++... ...+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 81 e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 155 (292)
T 3o0g_A 81 EFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV--- 155 (292)
T ss_dssp ECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC---
T ss_pred ecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc---
Confidence 99965 666655543 2579999999999999999999999999999999999999999999999999985432100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
......+
T Consensus 156 -------------------------------------------------------------------------~~~~~~~ 162 (292)
T 3o0g_A 156 -------------------------------------------------------------------------RCYSAEV 162 (292)
T ss_dssp -------------------------------------------------------------------------SCCCSCC
T ss_pred -------------------------------------------------------------------------ccccCCc
Confidence 0111346
Q ss_pred cCccccCcceecCCC-CCccchHHHHHHHHHHHhhCCCCC-CCCChHHHHHHHHc---CCCC------------------
Q 007433 453 GTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPF-KGSENRATLYNVVG---QPLR------------------ 509 (604)
Q Consensus 453 GT~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~PF-~~~~~~~~l~~i~~---~~~~------------------ 509 (604)
||+.|+|||++.+.. ++.++|||||||++|||++|..|| .+.+..+.+..+.. .+..
T Consensus 163 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (292)
T 3o0g_A 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242 (292)
T ss_dssp SCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCC
T ss_pred cccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccc
Confidence 899999999998776 799999999999999999888774 55555555544432 1100
Q ss_pred ------CCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 510 ------FPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 510 ------~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
....+.++.++++||.+||..||++||+ ++|+|+||||+++
T Consensus 243 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS----AEEALQHPYFSDF 289 (292)
T ss_dssp CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTC
T ss_pred cCCcchhhcccccChHHHHHHHHHhccChhhCCC----HHHHhcCcccccC
Confidence 0111347889999999999999999999 9999999999864
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-49 Score=434.97 Aligned_cols=295 Identities=27% Similarity=0.385 Sum_probs=206.8
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec-----CC
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET-----DK 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-----~~ 286 (604)
.++|++++.||+|+||+||+|++..+++.||||++.+... ......++.+|+++|+.++||||++++++|.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~ 130 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFE-DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD 130 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhc-CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCc
Confidence 3689999999999999999999999999999999976422 23345577899999999999999999999943 36
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
.+||||||+ +++|..++... ..+++..++.|++||+.||+|||++|||||||||+||||+.++++||+|||++....
T Consensus 131 ~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 131 ELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred eEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 799999998 78999988765 579999999999999999999999999999999999999999999999999996543
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
.......... . .++. .++ .............
T Consensus 208 ~~~~~~~~~~-----~-----------------------------~~~~-----------~~~----~~~~~~~~~~~~~ 238 (458)
T 3rp9_A 208 YPENGNSQLP-----I-----------------------------SPRE-----------DDM----NLVTFPHTKNLKR 238 (458)
T ss_dssp SCTTCCCCCC----------------------------------------------------------------------
T ss_pred Cccccccccc-----c-----------------------------Cccc-----------ccc----ccccccccccccc
Confidence 2211000000 0 0000 000 0000000000111
Q ss_pred cccccccCccccCccee-cCCCCCccchHHHHHHHHHHHhh-----------CCCCCCCCCh------------------
Q 007433 447 RSMSFVGTHEYLAPEII-KGEGHGSAVDWWTFGIFLYELLF-----------GKTPFKGSEN------------------ 496 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l-~~~~~~~~~DiWSLGviL~eLlt-----------G~~PF~~~~~------------------ 496 (604)
.....+||++|+|||++ .+..|+.++|||||||+||||++ |+++|.+.+.
T Consensus 239 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~ 318 (458)
T 3rp9_A 239 QLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTR 318 (458)
T ss_dssp ------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CH
T ss_pred cccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCcccccccccccccccccccc
Confidence 23457899999999986 56679999999999999999998 7788876531
Q ss_pred --HHH---HHHHHcCCCC-----------------C---------CCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHH
Q 007433 497 --RAT---LYNVVGQPLR-----------------F---------PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEI 545 (604)
Q Consensus 497 --~~~---l~~i~~~~~~-----------------~---------p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~el 545 (604)
.+. +.++++.+.. + ...+.++.++.+||.+||.+||++||+ ++|+
T Consensus 319 ~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----~~e~ 394 (458)
T 3rp9_A 319 GNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRIT----INEC 394 (458)
T ss_dssp HHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCC----HHHH
T ss_pred CCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCC----HHHH
Confidence 122 2222222110 0 012346899999999999999999999 9999
Q ss_pred hcCCCCCCCChhhhhcCC
Q 007433 546 KQHPFFQGVNWALIRCAS 563 (604)
Q Consensus 546 L~Hpff~~~~~~~~~~~~ 563 (604)
|+||||++++|.......
T Consensus 395 L~Hp~f~~~~~~~~e~~~ 412 (458)
T 3rp9_A 395 LAHPFFKEVRIAEVETNA 412 (458)
T ss_dssp HHSGGGTTTCCGGGCCCC
T ss_pred hcCHhhhhcCCCccCCCC
Confidence 999999999998765433
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=416.47 Aligned_cols=266 Identities=29% Similarity=0.419 Sum_probs=225.0
Q ss_pred HHhheeecCceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-----CC
Q 007433 199 AIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-----HP 273 (604)
Q Consensus 199 ~~~~~~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-----Hp 273 (604)
+...+.+.++.+..++|+++++||+|+||+||+|++..+++.||||++.... ........|+.+|+.+. ||
T Consensus 21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~ 96 (360)
T 3llt_A 21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNN 96 (360)
T ss_dssp GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGG
T ss_pred cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCC
Confidence 4566778888888899999999999999999999999999999999997542 22234567999999986 99
Q ss_pred CccccceeEecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc---
Q 007433 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE--- 350 (604)
Q Consensus 274 nIv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~--- 350 (604)
||++++++|...+..||||||+ +++|.+++.......+++..++.|+.||+.||+|||++|||||||||+||||+.
T Consensus 97 ~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~ 175 (360)
T 3llt_A 97 NIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYF 175 (360)
T ss_dssp GBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTC
T ss_pred CeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccc
Confidence 9999999999999999999999 999999998876667999999999999999999999999999999999999975
Q ss_pred ----------------------CCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCC
Q 007433 351 ----------------------DGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPT 408 (604)
Q Consensus 351 ----------------------~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 408 (604)
++.+||+|||++.....
T Consensus 176 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~----------------------------------------- 214 (360)
T 3llt_A 176 EKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD----------------------------------------- 214 (360)
T ss_dssp CEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----------------------------------------
T ss_pred cccccchhcccccccccccccCCCCEEEEeccCceecCC-----------------------------------------
Confidence 78999999998842110
Q ss_pred ccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCC
Q 007433 409 TCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGK 488 (604)
Q Consensus 409 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~ 488 (604)
.....+||+.|+|||++.+..++.++|||||||+||||++|+
T Consensus 215 --------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 256 (360)
T 3llt_A 215 --------------------------------------YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGS 256 (360)
T ss_dssp --------------------------------------CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSS
T ss_pred --------------------------------------CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCC
Confidence 011346999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHcCCCCC--------------------------CCC------------------CCCCHHHHHHH
Q 007433 489 TPFKGSENRATLYNVVGQPLRF--------------------------PES------------------PVVSFSARDLI 524 (604)
Q Consensus 489 ~PF~~~~~~~~l~~i~~~~~~~--------------------------p~~------------------~~~s~~l~dLI 524 (604)
.||.+.+..+.+..+......+ +.. ...+..+.+||
T Consensus 257 ~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 336 (360)
T 3llt_A 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFL 336 (360)
T ss_dssp CSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHH
T ss_pred CCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHH
Confidence 9999887766665443321111 110 01236778999
Q ss_pred HHhhhcCCCCcccccCCHHHHhcCCCCC
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
.+||..||++||+ +.|+|+||||+
T Consensus 337 ~~~L~~dP~~Rpt----a~elL~hp~f~ 360 (360)
T 3llt_A 337 YSILQIDPTLRPS----PAELLKHKFLE 360 (360)
T ss_dssp HHHCCSSGGGSCC----HHHHTTSGGGC
T ss_pred HHHhcCChhhCCC----HHHHhcCcccC
Confidence 9999999999999 99999999995
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=419.25 Aligned_cols=264 Identities=28% Similarity=0.449 Sum_probs=222.0
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHH--HHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKR--KKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
.++|++++.||+|+||+||+|.+..+++.||||++........ .....+.+|+.+|+.++||||++++++|.+++.+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3689999999999999999999999999999999976533211 12345678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCc---EEEeccccccc
Q 007433 290 LVMEFCPGGDLHTLRQRQ--PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGH---IMLSDFDLSLR 364 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~--~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~---vkL~DFGla~~ 364 (604)
||||||+|++|.+++... .+..+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|||++..
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999998776543 2346899999999999999999999999999999999999987654 99999999854
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
+....
T Consensus 183 ~~~~~--------------------------------------------------------------------------- 187 (351)
T 3c0i_A 183 LGESG--------------------------------------------------------------------------- 187 (351)
T ss_dssp CCTTS---------------------------------------------------------------------------
T ss_pred ecCCC---------------------------------------------------------------------------
Confidence 32100
Q ss_pred CCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC--CCCCCHHHHH
Q 007433 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE--SPVVSFSARD 522 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~--~~~~s~~l~d 522 (604)
......+||+.|+|||++.+..++.++|||||||+||+|++|+.||.+. ....+..+....+.++. ...++.++++
T Consensus 188 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~ 265 (351)
T 3c0i_A 188 -LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSHISESAKD 265 (351)
T ss_dssp -CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred -eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCccccccCCHHHHH
Confidence 0112346999999999999999999999999999999999999999875 34555666655544432 2468999999
Q ss_pred HHHHhhhcCCCCcccccCCHHHHhcCCCCCCCCh
Q 007433 523 LIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNW 556 (604)
Q Consensus 523 LI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~ 556 (604)
||.+||..||++||+ +.|+|+||||+..++
T Consensus 266 li~~~L~~dP~~R~s----~~e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 266 LVRRMLMLDPAERIT----VYEALNHPWLKERDR 295 (351)
T ss_dssp HHHHHTCSSTTTSCC----HHHHHTSHHHHTHHH
T ss_pred HHHHHCCCChhHCcC----HHHHhcChhhcCCcc
Confidence 999999999999999 999999999987554
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=421.32 Aligned_cols=279 Identities=28% Similarity=0.423 Sum_probs=210.6
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEecC--Cee
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFETD--KFS 288 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~--~~~ 288 (604)
.++|++++.||+|+||+||+|.+..+++.||||++.+... ......+..+|+.+|+.+. ||||++++++|..+ ..+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQ-NSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--C-CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 4799999999999999999999999999999999965422 2234456778999999997 99999999999754 478
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|||||||+ ++|..++... .+++..++.++.||+.||+|||++|||||||||+||||+.++.+||+|||++..+...
T Consensus 87 ~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 87 YLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp EEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred EEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 99999995 6999988763 6999999999999999999999999999999999999999999999999999654321
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
............ . . ...........
T Consensus 163 ~~~~~~~~~~~~---~----------------------------------------~------------~~~~~~~~~~~ 187 (388)
T 3oz6_A 163 RRVTNNIPLSIN---E----------------------------------------N------------TENFDDDQPIL 187 (388)
T ss_dssp CCCCCCGGGCCC--------------------------------------------------------------------
T ss_pred cccccccccccc---c----------------------------------------c------------ccccccccccc
Confidence 111000000000 0 0 00000011123
Q ss_pred cccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC----------------
Q 007433 449 MSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFP---------------- 511 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p---------------- 511 (604)
..++||++|+|||++.+ ..|+.++|||||||+||||++|++||.+.+..+.+..++.. +.+|
T Consensus 188 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~p~~~~~~~~~~~~~~~~ 266 (388)
T 3oz6_A 188 TDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV-IDFPSNEDVESIQSPFAKTM 266 (388)
T ss_dssp --CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH-HCCCCHHHHHTSCCSSHHHH
T ss_pred cCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh-cCCCCHHHHHhccCHHHHHH
Confidence 45689999999999987 57899999999999999999999999998887777666421 0000
Q ss_pred ------------------------------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCC
Q 007433 512 ------------------------------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 512 ------------------------------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
....++.++.+||.+||..||++||+ ++|+|+||||+.+.
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t----~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 267 IESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS----ANDALKHPFVSIFH 336 (388)
T ss_dssp HHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC----HHHHTTSTTTTTTC
T ss_pred HHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC----HHHHhCCHHHHHhc
Confidence 11257889999999999999999999 99999999997654
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=401.60 Aligned_cols=258 Identities=34% Similarity=0.581 Sum_probs=228.5
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
+..++|++.+.||+|+||.||+|++..++..||||++.+...........+.+|+++++.++||||+++++++.+++..|
T Consensus 11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 90 (284)
T 2vgo_A 11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIY 90 (284)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEE
Confidence 44679999999999999999999999999999999998765444333456778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 91 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~-- 166 (284)
T 2vgo_A 91 LMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPS-- 166 (284)
T ss_dssp EEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSS--
T ss_pred EEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcc--
Confidence 999999999999998876 4699999999999999999999999999999999999999999999999998733210
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
....
T Consensus 167 ----------------------------------------------------------------------------~~~~ 170 (284)
T 2vgo_A 167 ----------------------------------------------------------------------------LRRR 170 (284)
T ss_dssp ----------------------------------------------------------------------------SCBC
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0011
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
...||+.|+|||++.+..++.++|||||||++|+|++|..||......+....+......++. .++..+++||.+||.
T Consensus 171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~ 248 (284)
T 2vgo_A 171 TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP--FLSDGSKDLISKLLR 248 (284)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT--TSCHHHHHHHHHHSC
T ss_pred cccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCC--cCCHHHHHHHHHHhh
Confidence 346999999999999999999999999999999999999999998888887788776665553 489999999999999
Q ss_pred cCCCCcccccCCHHHHhcCCCCCC
Q 007433 530 KEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
.||.+||+ +.++++||||+.
T Consensus 249 ~~p~~Rps----~~~ll~h~~~~~ 268 (284)
T 2vgo_A 249 YHPPQRLP----LKGVMEHPWVKA 268 (284)
T ss_dssp SSGGGSCC----HHHHHTCHHHHH
T ss_pred cCHhhCCC----HHHHhhCHHHHh
Confidence 99999999 999999999974
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-49 Score=412.81 Aligned_cols=261 Identities=25% Similarity=0.414 Sum_probs=219.2
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++++.||+|+||+||+|++..+++.||||++....... ....+.+|+.+++.++||||+++++++.+++..|||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 83 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVD--CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLF 83 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccc--hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 369999999999999999999999999999999997553322 223566899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
||||+|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+.....
T Consensus 84 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 160 (323)
T 3tki_A 84 LEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR- 160 (323)
T ss_dssp EECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE-
T ss_pred EEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc-
Confidence 9999999999988654 5699999999999999999999999999999999999999999999999999854321100
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
.......
T Consensus 161 -------------------------------------------------------------------------~~~~~~~ 167 (323)
T 3tki_A 161 -------------------------------------------------------------------------ERLLNKM 167 (323)
T ss_dssp -------------------------------------------------------------------------ECCBCSC
T ss_pred -------------------------------------------------------------------------ccccCCC
Confidence 0011235
Q ss_pred ccCccccCcceecCCCC-CccchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 452 VGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENR-ATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~-~~~~DiWSLGviL~eLltG~~PF~~~~~~-~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
+||+.|+|||++.+..+ +.++|||||||+||+|++|+.||.+.... ..+..+.......+....++..+.+||.+||.
T Consensus 168 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 247 (323)
T 3tki_A 168 CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILV 247 (323)
T ss_dssp CSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSC
T ss_pred ccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHHHHHHHcc
Confidence 79999999999988775 77899999999999999999999876554 33444444444445456689999999999999
Q ss_pred cCCCCcccccCCHHHHhcCCCCCCC
Q 007433 530 KEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
.||++||+ +.|+|+||||+..
T Consensus 248 ~dP~~R~t----~~eil~h~~~~~~ 268 (323)
T 3tki_A 248 ENPSARIT----IPDIKKDRWYNKP 268 (323)
T ss_dssp SSTTTSCC----HHHHTTCTTTTCC
T ss_pred CChhhCcC----HHHHhhChhhccc
Confidence 99999999 9999999999764
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-49 Score=433.89 Aligned_cols=262 Identities=28% Similarity=0.468 Sum_probs=231.6
Q ss_pred CceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 207 DGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 207 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
.+.+..++|.+++.||+|+||.||+|++..+++.||||++.+...........+.+|+.+|+.++||||+++++++.+.+
T Consensus 10 ~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~ 89 (476)
T 2y94_A 10 DGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS 89 (476)
T ss_dssp CSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred CCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 45566789999999999999999999999999999999998765544444567789999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
.+|||||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++....
T Consensus 90 ~~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~ 167 (476)
T 2y94_A 90 DIFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 167 (476)
T ss_dssp EEEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECC
T ss_pred EEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcc
Confidence 999999999999999998764 579999999999999999999999999999999999999999999999999984321
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
.. .
T Consensus 168 ~~-----------------------------------------------------------------------------~ 170 (476)
T 2y94_A 168 DG-----------------------------------------------------------------------------E 170 (476)
T ss_dssp TT-----------------------------------------------------------------------------C
T ss_pred cc-----------------------------------------------------------------------------c
Confidence 10 0
Q ss_pred cccccccCccccCcceecCCCC-CccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007433 447 RSMSFVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIK 525 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~~-~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~ 525 (604)
.....+||+.|+|||++.+..+ +.++|||||||+||||++|+.||.+......+.++....+..+. .++.++++||.
T Consensus 171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~Li~ 248 (476)
T 2y94_A 171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQ--YLNPSVISLLK 248 (476)
T ss_dssp CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCT--TCCHHHHHHHH
T ss_pred cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCc--cCCHHHHHHHH
Confidence 1123469999999999998876 68999999999999999999999998888888888877665554 48999999999
Q ss_pred HhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 526 GLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
+||..||.+||+ +.|+++||||+.
T Consensus 249 ~~L~~dP~~Rpt----~~eil~hp~~~~ 272 (476)
T 2y94_A 249 HMLQVDPMKRAT----IKDIREHEWFKQ 272 (476)
T ss_dssp HHTCSSTTTSCC----HHHHHTCHHHHT
T ss_pred HHcCCCchhCcC----HHHHHhCHHhhh
Confidence 999999999999 999999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=414.03 Aligned_cols=262 Identities=24% Similarity=0.387 Sum_probs=214.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++++.||+|+||+||+|++..+++.||||++...... ......+.+|+++|+.++||||+++++++.+++.+|||
T Consensus 33 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 33 IDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEE-EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccc-cccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 47999999999999999999999999999999999765432 23334566899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEc-----cCCcEEEeccccccccc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVR-----EDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~-----~~g~vkL~DFGla~~~~ 366 (604)
|||++ ++|.+++... ..+++..++.|+.||+.||+|||++||+||||||+||||+ .++.+||+|||++..+.
T Consensus 112 ~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~ 188 (329)
T 3gbz_A 112 FEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188 (329)
T ss_dssp EECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred EecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence 99995 5999998876 4699999999999999999999999999999999999994 45569999999985432
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
... .
T Consensus 189 ~~~----------------------------------------------------------------------------~ 192 (329)
T 3gbz_A 189 IPI----------------------------------------------------------------------------R 192 (329)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred Ccc----------------------------------------------------------------------------c
Confidence 110 0
Q ss_pred cccccccCccccCcceecCCC-CCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---CCC-------------
Q 007433 447 RSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---PLR------------- 509 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~~~------------- 509 (604)
.....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+....+.+..+... +..
T Consensus 193 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 272 (329)
T 3gbz_A 193 QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWK 272 (329)
T ss_dssp -------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhh
Confidence 111346899999999998754 799999999999999999999999998888777766532 100
Q ss_pred --CCCC----------CCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 510 --FPES----------PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 510 --~p~~----------~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
++.. ..++.++++||.+||..||++||+ +.|+|+||||++++|.
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~ 328 (329)
T 3gbz_A 273 QSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS----AKNALEHPYFSHNDFD 328 (329)
T ss_dssp TTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGSSSCSC
T ss_pred hhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCC----HHHHhCCcccCCCCCC
Confidence 0000 116789999999999999999999 9999999999999986
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=395.57 Aligned_cols=264 Identities=27% Similarity=0.481 Sum_probs=229.6
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++++.||+|+||.||+|.+..+++.||+|++....... .....+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 83 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 83 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCH-HHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence 369999999999999999999999999999999997665432 3345677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCc---EEEecccccccccCC
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGH---IMLSDFDLSLRCAVS 368 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~---vkL~DFGla~~~~~~ 368 (604)
|||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++. +||+|||++......
T Consensus 84 ~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 161 (284)
T 3kk8_A 84 FDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161 (284)
T ss_dssp ECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence 9999999999888765 56999999999999999999999999999999999999986655 999999988432210
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
...
T Consensus 162 -----------------------------------------------------------------------------~~~ 164 (284)
T 3kk8_A 162 -----------------------------------------------------------------------------EAW 164 (284)
T ss_dssp -----------------------------------------------------------------------------CBC
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 001
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC--CCCCCHHHHHHHHH
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE--SPVVSFSARDLIKG 526 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~--~~~~s~~l~dLI~~ 526 (604)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+......++. ...++.++.+||.+
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 244 (284)
T 3kk8_A 165 HGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDS 244 (284)
T ss_dssp CCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred cCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHHHHH
Confidence 1346999999999999999999999999999999999999999998888888777776655543 34689999999999
Q ss_pred hhhcCCCCcccccCCHHHHhcCCCCCCCChhhh
Q 007433 527 LLVKEPQNRLACRRGATEIKQHPFFQGVNWALI 559 (604)
Q Consensus 527 lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~ 559 (604)
||..||++||+ +.|+|+||||+..++...
T Consensus 245 ~l~~dp~~Rps----~~~~l~h~~~~~~~~~~~ 273 (284)
T 3kk8_A 245 MLTVNPKKRIT----ADQALKVPWICNRERVAS 273 (284)
T ss_dssp HSCSSTTTSCC----HHHHTTSHHHHSCCCGGG
T ss_pred HcccChhhCCC----HHHHhcCccccCChhHHh
Confidence 99999999999 999999999987765543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-48 Score=407.17 Aligned_cols=265 Identities=29% Similarity=0.454 Sum_probs=230.0
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHH---HHHHHHHHHHHHHHhCCCCCccccceeEecCCee
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKR---KKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 288 (604)
.++|++.+.||+|+||.||+|++..+++.||||++.+...... .....+.+|+.+|+.++||||+++++++.+++..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 3689999999999999999999999999999999976532210 1134567899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC----cEEEeccccccc
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG----HIMLSDFDLSLR 364 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g----~vkL~DFGla~~ 364 (604)
|+||||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .++|+|||++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~ 168 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE 168 (321)
T ss_dssp EEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred EEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence 9999999999999999765 5799999999999999999999999999999999999999888 799999998843
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
....
T Consensus 169 ~~~~---------------------------------------------------------------------------- 172 (321)
T 2a2a_A 169 IEDG---------------------------------------------------------------------------- 172 (321)
T ss_dssp CCTT----------------------------------------------------------------------------
T ss_pred cCcc----------------------------------------------------------------------------
Confidence 2210
Q ss_pred CCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCC--CCCCHHHHH
Q 007433 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPES--PVVSFSARD 522 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~--~~~s~~l~d 522 (604)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+.+..+......++.. ..++..+++
T Consensus 173 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 251 (321)
T 2a2a_A 173 -VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELAKD 251 (321)
T ss_dssp -CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHH
T ss_pred -ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccCHHHHH
Confidence 00113469999999999999999999999999999999999999999988888888887765554421 458899999
Q ss_pred HHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhhh
Q 007433 523 LIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALI 559 (604)
Q Consensus 523 LI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~ 559 (604)
||.+||..||++||+ +.|+|+||||+.++|...
T Consensus 252 li~~~l~~dp~~Rps----~~e~l~hp~~~~~~~~~~ 284 (321)
T 2a2a_A 252 FIRKLLVKETRKRLT----IQEALRHPWITPVDNQQA 284 (321)
T ss_dssp HHHTTSCSSTTTSCC----HHHHHHSTTTSCSSHHHH
T ss_pred HHHHHcCCChhhCcC----HHHHhcCccccCCCcccc
Confidence 999999999999999 999999999999988653
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=406.61 Aligned_cols=263 Identities=26% Similarity=0.401 Sum_probs=211.7
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHH--HHHHHHHHHHHHHHHhC---CCCCccccceeEec
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEK--RKKLLRAQTEREILQSL---DHPFLPTLYTHFET 284 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~--~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~ 284 (604)
+..++|++++.||+|+||+||+|++..+++.||||++....... ........+|+++++.+ +||||++++++|..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 34579999999999999999999999999999999997532110 00111334566666655 59999999999986
Q ss_pred CC-----eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecc
Q 007433 285 DK-----FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDF 359 (604)
Q Consensus 285 ~~-----~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DF 359 (604)
.. .+|+||||+. ++|.+++.......+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 54 6899999995 69999998876666999999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccc
Q 007433 360 DLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPEL 439 (604)
Q Consensus 360 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (604)
|++.....
T Consensus 165 g~a~~~~~------------------------------------------------------------------------ 172 (308)
T 3g33_A 165 GLARIYSY------------------------------------------------------------------------ 172 (308)
T ss_dssp SCTTTSTT------------------------------------------------------------------------
T ss_pred ccccccCC------------------------------------------------------------------------
Confidence 98843210
Q ss_pred ccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---CCC--CC---
Q 007433 440 IAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---PLR--FP--- 511 (604)
Q Consensus 440 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~~~--~p--- 511 (604)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.+..+... +.. ++
T Consensus 173 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 247 (308)
T 3g33_A 173 -----QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV 247 (308)
T ss_dssp -----CCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSC
T ss_pred -----CcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchh
Confidence 00112357999999999999999999999999999999999999999998887777666431 110 00
Q ss_pred -----------------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 512 -----------------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 512 -----------------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
..+.++..+.+||.+||.+||++||+ +.|+|+||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~h~~~~~~ 303 (308)
T 3g33_A 248 SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS----AFRALQHSYLHKD 303 (308)
T ss_dssp SSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSTTC---
T ss_pred hccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCC----HHHHhcCccccCC
Confidence 01347889999999999999999999 9999999999753
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=410.90 Aligned_cols=264 Identities=28% Similarity=0.430 Sum_probs=204.6
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++++.||+|+||+||+|.+..+++.||||++...... .....+.+|+++|+.++||||+++++++.+++.+|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEE--GTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTT--CSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccccc--ccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 36899999999999999999999999999999999765321 1223466899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcC----CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccC
Q 007433 292 MEFCPGGDLHTLRQRQP----GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAV 367 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~ 367 (604)
|||++ ++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++..+..
T Consensus 82 ~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 99996 69998877532 24589999999999999999999999999999999999999999999999999854321
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
.. ..
T Consensus 161 ~~----------------------------------------------------------------------------~~ 164 (317)
T 2pmi_A 161 PV----------------------------------------------------------------------------NT 164 (317)
T ss_dssp CC----------------------------------------------------------------------------CC
T ss_pred Cc----------------------------------------------------------------------------cc
Confidence 00 00
Q ss_pred ccccccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc---CCCC--------------
Q 007433 448 SMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG---QPLR-------------- 509 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~---~~~~-------------- 509 (604)
....+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+.+..+.. .+..
T Consensus 165 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 244 (317)
T 2pmi_A 165 FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNP 244 (317)
T ss_dssp CCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCT
T ss_pred CCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhccc
Confidence 1134689999999999874 589999999999999999999999999887776665542 1100
Q ss_pred -C--------------CCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhh
Q 007433 510 -F--------------PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWAL 558 (604)
Q Consensus 510 -~--------------p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~ 558 (604)
+ .....++.++++||.+||..||++||+ +.|+|+||||++..|..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~~ 304 (317)
T 2pmi_A 245 NIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLS----AKQALHHPWFAEYYHHA 304 (317)
T ss_dssp TCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGGGGGCC--
T ss_pred ccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCC----HHHHhCChhhhcccchh
Confidence 0 011247889999999999999999999 99999999998876653
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=417.39 Aligned_cols=261 Identities=31% Similarity=0.450 Sum_probs=227.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++++.||+|+||+||+|.+..+++.||+|++....... ...+.+|+++|+.++||||++++++|.++..+|||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~---~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 126 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 126 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhh---HHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEE
Confidence 378999999999999999999999999999999997654322 23567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc--CCcEEEecccccccccCCC
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE--DGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~--~g~vkL~DFGla~~~~~~~ 369 (604)
||||+|++|.+++... ...+++..++.++.||+.||+|||++||+||||||+||||+. ++.+||+|||++..+...
T Consensus 127 ~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~- 204 (387)
T 1kob_A 127 LEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 204 (387)
T ss_dssp EECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCC-
Confidence 9999999999988654 346999999999999999999999999999999999999974 578999999998543210
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
....
T Consensus 205 ----------------------------------------------------------------------------~~~~ 208 (387)
T 1kob_A 205 ----------------------------------------------------------------------------EIVK 208 (387)
T ss_dssp ----------------------------------------------------------------------------SCEE
T ss_pred ----------------------------------------------------------------------------ccee
Confidence 0111
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC--CCCCCHHHHHHHHHh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE--SPVVSFSARDLIKGL 527 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~--~~~~s~~l~dLI~~l 527 (604)
..+||+.|+|||++.+..++.++|||||||+||||++|..||.+.+..+.+.++......++. ...++.++++||.+|
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 288 (387)
T 1kob_A 209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 288 (387)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTT
T ss_pred eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHHHHH
Confidence 346999999999999999999999999999999999999999998888888888776555443 346899999999999
Q ss_pred hhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 528 LVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
|..||.+||+ +.|+|+||||++..+.
T Consensus 289 L~~dP~~Rpt----~~ell~hp~~~~~~~~ 314 (387)
T 1kob_A 289 LQKEPRKRLT----VHDALEHPWLKGDHSN 314 (387)
T ss_dssp SCSSGGGSCC----HHHHHTSTTTSSCCTT
T ss_pred cCCChhHCcC----HHHHhhCccccCCccc
Confidence 9999999999 9999999999876543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-49 Score=416.18 Aligned_cols=254 Identities=28% Similarity=0.473 Sum_probs=213.9
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++++.||+|+||+||+|++..+++.||||++.+..... ..+.+|+.+++.++||||++++++|.+++.+|+|
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 94 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLAII 94 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEE
Confidence 479999999999999999999999999999999997653222 2456899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCc--EEEecccccccccCCC
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGH--IMLSDFDLSLRCAVSP 369 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~--vkL~DFGla~~~~~~~ 369 (604)
||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|||++.....
T Consensus 95 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~-- 170 (361)
T 3uc3_A 95 MEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVL-- 170 (361)
T ss_dssp EECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred EEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccc--
Confidence 9999999999998775 46999999999999999999999999999999999999987765 99999998732110
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
.....
T Consensus 171 ---------------------------------------------------------------------------~~~~~ 175 (361)
T 3uc3_A 171 ---------------------------------------------------------------------------HSQPK 175 (361)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ---------------------------------------------------------------------------cCCCC
Confidence 00112
Q ss_pred ccccCccccCcceecCCCCCcc-chHHHHHHHHHHHhhCCCCCCCCCh----HHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSA-VDWWTFGIFLYELLFGKTPFKGSEN----RATLYNVVGQPLRFPESPVVSFSARDLI 524 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~-~DiWSLGviL~eLltG~~PF~~~~~----~~~l~~i~~~~~~~p~~~~~s~~l~dLI 524 (604)
..+||+.|+|||++.+..+..+ +|||||||+||+|++|+.||.+... ...+..+......++....++.++++||
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 255 (361)
T 3uc3_A 176 STVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLI 255 (361)
T ss_dssp -----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCCHHHHHHH
T ss_pred CCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCCHHHHHHH
Confidence 3469999999999998887655 8999999999999999999987533 4556667777777777777999999999
Q ss_pred HHhhhcCCCCcccccCCHHHHhcCCCCC
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
.+||.+||++||+ +.|+++||||.
T Consensus 256 ~~~L~~dP~~Rps----~~ell~hp~f~ 279 (361)
T 3uc3_A 256 SRIFVADPATRIS----IPEIKTHSWFL 279 (361)
T ss_dssp HHHSCSCTTTSCC----HHHHHTSHHHH
T ss_pred HHHccCChhHCcC----HHHHHhCcchh
Confidence 9999999999999 99999999994
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-49 Score=401.55 Aligned_cols=258 Identities=25% Similarity=0.392 Sum_probs=212.3
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++++.||+|+||+||+|++ .+++.||||++....... .....+.+|+++|+.++||||+++++++.+++..|+||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDE-GIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVF 79 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGG-CCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEE
T ss_pred ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccccc-ccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEE
Confidence 6899999999999999999998 667899999997653221 12235668999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+. ++|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++.......
T Consensus 80 e~~~-~~l~~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 154 (288)
T 1ob3_A 80 EHLD-QDLKKLLDVCE-GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV--- 154 (288)
T ss_dssp ECCS-EEHHHHHHTST-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EecC-CCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc---
Confidence 9995 59999887653 569999999999999999999999999999999999999999999999999985432100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
......+
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (288)
T 1ob3_A 155 -------------------------------------------------------------------------RKYTHEI 161 (288)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0011336
Q ss_pred cCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc---CCCC---------------CC--
Q 007433 453 GTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG---QPLR---------------FP-- 511 (604)
Q Consensus 453 GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~---~~~~---------------~p-- 511 (604)
||+.|+|||++.+. .++.++|||||||++|||++|+.||.+....+.+..+.. .+.. +.
T Consensus 162 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (288)
T 1ob3_A 162 VTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVY 241 (288)
T ss_dssp CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCC
T ss_pred ccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccc
Confidence 89999999999875 489999999999999999999999999887776665542 1100 00
Q ss_pred -------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 512 -------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 512 -------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
....++.++++||.+||..||++||+ +.|+|+||||++.
T Consensus 242 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 242 EPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT----AKQALEHAYFKEN 287 (288)
T ss_dssp CCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGGC-
T ss_pred cCccHHHHhhhcCHHHHHHHHHHcCCCcccCCC----HHHHhcCcchhhc
Confidence 01347889999999999999999999 9999999999864
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=396.65 Aligned_cols=260 Identities=32% Similarity=0.580 Sum_probs=201.5
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++.+.||+|+||.||+|++..+++.||||++.+..........++.+|+.+++.++||||+++++++.+++..|+|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 36899999999999999999999999999999999876544444456778899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 90 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-- 166 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPH-- 166 (278)
T ss_dssp EECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred EecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCC--
Confidence 9999999999998764 3579999999999999999999999999999999999999999999999999884322100
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 167 --------------------------------------------------------------------------~~~~~~ 172 (278)
T 3cok_A 167 --------------------------------------------------------------------------EKHYTL 172 (278)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------Ccceec
Confidence 011134
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~d 531 (604)
.||+.|+|||++.+..++.++|||||||++|||++|+.||........+..+......++ ..++.++++||.+||..|
T Consensus 173 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~d 250 (278)
T 3cok_A 173 CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMP--SFLSIEAKDLIHQLLRRN 250 (278)
T ss_dssp -------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCC--TTSCHHHHHHHHHHSCSS
T ss_pred cCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCc--cccCHHHHHHHHHHcccC
Confidence 689999999999999999999999999999999999999988766655555544444333 458999999999999999
Q ss_pred CCCcccccCCHHHHhcCCCCCCC
Q 007433 532 PQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 532 P~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
|++||+ +.++|+||||...
T Consensus 251 p~~Rps----~~~~l~h~~~~~~ 269 (278)
T 3cok_A 251 PADRLS----LSSVLDHPFMSRN 269 (278)
T ss_dssp GGGSCC----HHHHTTSTTTC--
T ss_pred HhhCCC----HHHHhcCccccCC
Confidence 999999 9999999999753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-49 Score=411.70 Aligned_cols=270 Identities=31% Similarity=0.498 Sum_probs=225.4
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHH--HHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLE--KRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~--~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
++|++++.||+|+||+||+|.+..++..||||++.+.... .......+.+|+++|+.++||||++++++|.+++..||
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 105 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICL 105 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEE
Confidence 6899999999999999999999999999999999876432 22344567889999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhc--------------------------------------CCCCCcHHHHHHHHHHHHHHHHHHH
Q 007433 291 VMEFCPGGDLHTLRQRQ--------------------------------------PGKYFSEQAVKFYVAEVLLALEYLH 332 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~--------------------------------------~~~~l~e~~~~~i~~qil~aL~yLH 332 (604)
|||||+||+|.+++... ....+++..++.++.||+.||+|||
T Consensus 106 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH 185 (345)
T 3hko_A 106 VMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH 185 (345)
T ss_dssp EEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999999999987521 0123578889999999999999999
Q ss_pred HcCeEeccCCCCcEEEccCC--cEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCcc
Q 007433 333 MLGIVYRDLKPENVLVREDG--HIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTC 410 (604)
Q Consensus 333 ~~gIvHrDIKpeNILl~~~g--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (604)
++||+||||||+||||+.++ .+||+|||++..+......
T Consensus 186 ~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~--------------------------------------- 226 (345)
T 3hko_A 186 NQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNG--------------------------------------- 226 (345)
T ss_dssp HTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC---------------------------------------
T ss_pred HCCccccCCChhhEEEecCCCceEEEeeccccccccccCcc---------------------------------------
Confidence 99999999999999998776 8999999998543211000
Q ss_pred CCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecC--CCCCccchHHHHHHHHHHHhhCC
Q 007433 411 FSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKG--EGHGSAVDWWTFGIFLYELLFGK 488 (604)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~~~DiWSLGviL~eLltG~ 488 (604)
.........||+.|+|||++.+ ..++.++|||||||+||||++|+
T Consensus 227 ---------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~ 273 (345)
T 3hko_A 227 ---------------------------------EYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273 (345)
T ss_dssp -----------------------------------------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred ---------------------------------ccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 0001123469999999999976 56889999999999999999999
Q ss_pred CCCCCCChHHHHHHHHcCCCCCCCC--CCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhh
Q 007433 489 TPFKGSENRATLYNVVGQPLRFPES--PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWAL 558 (604)
Q Consensus 489 ~PF~~~~~~~~l~~i~~~~~~~p~~--~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~ 558 (604)
.||.+....+.+..+......++.. ..++..+++||.+||..||.+||+ +.++|+||||+++.|..
T Consensus 274 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~l~hp~~~~~~~~~ 341 (345)
T 3hko_A 274 VPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFD----AMRALQHPWISQFSDKI 341 (345)
T ss_dssp CSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCC----HHHHHHSHHHHTTSSCS
T ss_pred CCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCC----HHHHhcChhhccChHhh
Confidence 9999999888888888776655433 348899999999999999999999 99999999999876643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=402.26 Aligned_cols=264 Identities=28% Similarity=0.432 Sum_probs=216.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++++.||+|+||+||+|++..+++.||||++...... ......+.+|+++|+.++||||+++++++.+++..|+|
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDD-PVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLV 80 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEE
Confidence 36899999999999999999999999999999998665332 23344567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
||||++++|..++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.++|+|||++.......
T Consensus 81 ~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-- 156 (311)
T 4agu_A 81 FEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-- 156 (311)
T ss_dssp EECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc--
Confidence 9999999999987765 569999999999999999999999999999999999999999999999999984322100
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 157 --------------------------------------------------------------------------~~~~~~ 162 (311)
T 4agu_A 157 --------------------------------------------------------------------------DYYDDE 162 (311)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------cccCCC
Confidence 001134
Q ss_pred ccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC-------------------CCCCC
Q 007433 452 VGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ-------------------PLRFP 511 (604)
Q Consensus 452 ~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~-------------------~~~~p 511 (604)
+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..+... ....+
T Consensus 163 ~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (311)
T 4agu_A 163 VATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIP 242 (311)
T ss_dssp ---GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCC
T ss_pred cCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCC
Confidence 68999999999987 56799999999999999999999999998777665544321 01111
Q ss_pred C----------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhh
Q 007433 512 E----------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWAL 558 (604)
Q Consensus 512 ~----------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~ 558 (604)
. .+.++..+.+||.+||..||.+||+ ++|+|+||||+++.|..
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~~ 295 (311)
T 4agu_A 243 DPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLT----CEQLLHHPYFENIREIE 295 (311)
T ss_dssp CCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCC----HHHHHTSGGGTTCC---
T ss_pred CccccchhhhhcccccHHHHHHHHHHccCChhhcCC----HHHHhcChHHHhccCHH
Confidence 1 1357888999999999999999999 99999999999887653
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=419.72 Aligned_cols=290 Identities=27% Similarity=0.399 Sum_probs=215.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC-----C
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD-----K 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~ 286 (604)
.++|++++.||+|+||.||+|++..+++.||||++.+... ......++.+|+.+|+.++|+||+++++++... .
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~ 103 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFE-DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTT-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhc-ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence 3799999999999999999999999999999999976422 234455778999999999999999999999865 6
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
.+||||||+ +++|.+++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++....
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~ 180 (432)
T 3n9x_A 104 ELYIVLEIA-DSDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180 (432)
T ss_dssp CEEEEEECC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-
T ss_pred eEEEEEecC-CcCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccc
Confidence 799999999 57999998765 579999999999999999999999999999999999999999999999999996543
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
............... .+.........
T Consensus 181 ~~~~~~~~~~~~~~~------------------------------------------------------~~~~~~~~~~~ 206 (432)
T 3n9x_A 181 SEKDTNIVNDLEENE------------------------------------------------------EPGPHNKNLKK 206 (432)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccccccccccccc------------------------------------------------------cccccccchhc
Confidence 221100000000000 00000000011
Q ss_pred cccccccCccccCccee-cCCCCCccchHHHHHHHHHHHhh-----------CCCCCCCCCh-----------------H
Q 007433 447 RSMSFVGTHEYLAPEII-KGEGHGSAVDWWTFGIFLYELLF-----------GKTPFKGSEN-----------------R 497 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l-~~~~~~~~~DiWSLGviL~eLlt-----------G~~PF~~~~~-----------------~ 497 (604)
.....+||++|+|||++ .+..|+.++|||||||+||||++ |.++|.+.+. .
T Consensus 207 ~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~ 286 (432)
T 3n9x_A 207 QLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNR 286 (432)
T ss_dssp ----CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHH
T ss_pred cccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchH
Confidence 23467899999999986 55669999999999999999998 4555554331 1
Q ss_pred HHH---HHHHcCC---------------------CCCCC-----CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 498 ATL---YNVVGQP---------------------LRFPE-----SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 498 ~~l---~~i~~~~---------------------~~~p~-----~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
+.+ .++++.+ ...+. .+.++.++.+||.+||..||++||+ ++|+|+|
T Consensus 287 ~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~H 362 (432)
T 3n9x_A 287 DQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRIT----IDQALDH 362 (432)
T ss_dssp HHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHTC
T ss_pred HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCC----HHHHhcC
Confidence 222 2222211 11110 1357999999999999999999999 9999999
Q ss_pred CCCCCCChhhhhcCC
Q 007433 549 PFFQGVNWALIRCAS 563 (604)
Q Consensus 549 pff~~~~~~~~~~~~ 563 (604)
|||++++|.......
T Consensus 363 p~f~~~~~~~~e~~~ 377 (432)
T 3n9x_A 363 PYLKDVRKKKLENFS 377 (432)
T ss_dssp GGGTTTCCTTTC---
T ss_pred hhhhhccCcccCcCC
Confidence 999999987654433
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-48 Score=410.49 Aligned_cols=256 Identities=34% Similarity=0.511 Sum_probs=210.4
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++.+.||+|+||+||+|++..+++.||||++..... ...+.+|+++|+.++||||++++++|.+++..|+|
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 126 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVD-----KKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV 126 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchh-----HHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence 4689999999999999999999999999999999976531 23456899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc---CCcEEEecccccccccCC
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE---DGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~---~g~vkL~DFGla~~~~~~ 368 (604)
|||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++......
T Consensus 127 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 127 LELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp ECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 9999999999988765 56999999999999999999999999999999999999975 889999999988432100
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
...
T Consensus 205 -----------------------------------------------------------------------------~~~ 207 (349)
T 2w4o_A 205 -----------------------------------------------------------------------------VLM 207 (349)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 001
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHH-HHHHHHcCCCCCC--CCCCCCHHHHHHHH
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRA-TLYNVVGQPLRFP--ESPVVSFSARDLIK 525 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~-~l~~i~~~~~~~p--~~~~~s~~l~dLI~ 525 (604)
...+||+.|+|||++.+..++.++|||||||+||||++|+.||.+..... .+..+......++ ....++.++++||.
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~ 287 (349)
T 2w4o_A 208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVR 287 (349)
T ss_dssp -----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHH
T ss_pred ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHH
Confidence 23469999999999999999999999999999999999999998766555 4556666554443 33568999999999
Q ss_pred HhhhcCCCCcccccCCHHHHhcCCCCCCCC
Q 007433 526 GLLVKEPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
+||..||++||+ +.|+|+||||.+..
T Consensus 288 ~~L~~dP~~Rpt----~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 288 KLIVLDPKKRLT----TFQALQHPWVTGKA 313 (349)
T ss_dssp TTSCSSGGGSCC----HHHHHHSTTTTSTT
T ss_pred HHccCChhhCcC----HHHHhcCcccCCCc
Confidence 999999999999 99999999998654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=409.63 Aligned_cols=262 Identities=29% Similarity=0.448 Sum_probs=213.1
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++++.||+|+||+||+|++..+++.||||++...... .....+.+|+++|+.++||||+++++++.+++..|+||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 79 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEe
Confidence 6899999999999999999999999999999999765321 11113346999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+. ++|.+++... +..+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++......
T Consensus 80 e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~---- 153 (324)
T 3mtl_A 80 EYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIP---- 153 (324)
T ss_dssp ECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred cccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCC----
Confidence 9995 6998888765 357999999999999999999999999999999999999999999999999998432110
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.......+
T Consensus 154 ------------------------------------------------------------------------~~~~~~~~ 161 (324)
T 3mtl_A 154 ------------------------------------------------------------------------TKTYDNEV 161 (324)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00111346
Q ss_pred cCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc---CCCC----------------CC-
Q 007433 453 GTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG---QPLR----------------FP- 511 (604)
Q Consensus 453 GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~---~~~~----------------~p- 511 (604)
||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+.. .+.. ++
T Consensus 162 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (324)
T 3mtl_A 162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPK 241 (324)
T ss_dssp -CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCC
T ss_pred CcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccccc
Confidence 8999999999987 5689999999999999999999999999887776655432 2111 00
Q ss_pred --------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhh
Q 007433 512 --------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWAL 558 (604)
Q Consensus 512 --------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~ 558 (604)
..+.++.++++||.+||.+||++||+ +.|+|+||||.++.+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~~ 292 (324)
T 3mtl_A 242 YRAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS----AEDAMKHPFFLSLGERI 292 (324)
T ss_dssp CCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGGGGGCSTT
T ss_pred ccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCC----HHHHhcChhhhhccccc
Confidence 11346889999999999999999999 99999999998876543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-49 Score=414.41 Aligned_cols=257 Identities=30% Similarity=0.514 Sum_probs=218.2
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCeeEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~l 290 (604)
.++|++++.||+|+||.||+|.+..+++.||||++.+... ...+|+++|.++ +||||++++++|.+++.+|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 4689999999999999999999999999999999976532 123588888887 79999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccC----CcEEEeccccccccc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRED----GHIMLSDFDLSLRCA 366 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~----g~vkL~DFGla~~~~ 366 (604)
|||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+..+ +.+||+|||++....
T Consensus 94 v~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~ 171 (342)
T 2qr7_A 94 VTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR 171 (342)
T ss_dssp EECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECB
T ss_pred EEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCc
Confidence 99999999999998775 579999999999999999999999999999999999998543 359999999985432
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
.. ..
T Consensus 172 ~~----------------------------------------------------------------------------~~ 175 (342)
T 2qr7_A 172 AE----------------------------------------------------------------------------NG 175 (342)
T ss_dssp CT----------------------------------------------------------------------------TC
T ss_pred CC----------------------------------------------------------------------------CC
Confidence 10 00
Q ss_pred cccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCC---ChHHHHHHHHcCCCCCCC--CCCCCHHHH
Q 007433 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS---ENRATLYNVVGQPLRFPE--SPVVSFSAR 521 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~---~~~~~l~~i~~~~~~~p~--~~~~s~~l~ 521 (604)
.....+||+.|+|||++.+..|+.++|||||||+||||++|..||.+. ...+.+..+....+.++. +..++.+++
T Consensus 176 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~ 255 (342)
T 2qr7_A 176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAK 255 (342)
T ss_dssp CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHH
T ss_pred ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHH
Confidence 112346999999999999888999999999999999999999999863 445556666666555543 356899999
Q ss_pred HHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhhh
Q 007433 522 DLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALI 559 (604)
Q Consensus 522 dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~ 559 (604)
+||.+||..||++||+ +.++|+||||. +|..+
T Consensus 256 ~li~~~L~~dP~~R~t----~~~il~hp~~~--~~~~~ 287 (342)
T 2qr7_A 256 DLVSKMLHVDPHQRLT----AALVLRHPWIV--HWDQL 287 (342)
T ss_dssp HHHHHHTCSSTTTSCC----HHHHTTSHHHH--TGGGS
T ss_pred HHHHHHCCCChhHCcC----HHHHhcCCeec--Ccccc
Confidence 9999999999999999 99999999995 46544
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=428.60 Aligned_cols=256 Identities=27% Similarity=0.415 Sum_probs=209.7
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC-----
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD----- 285 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~----- 285 (604)
..++|++++.||+|+||+||+|++..+++.||||++.+... ......++.+|+.+|+.++||||++++++|...
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 60 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp EETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGG-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECcccc-ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCcccc
Confidence 35899999999999999999999999999999999976532 233455678999999999999999999999654
Q ss_pred -CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccc
Q 007433 286 -KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLR 364 (604)
Q Consensus 286 -~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~ 364 (604)
..+||||||+. ++|...+.. .+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++..
T Consensus 139 ~~~~~lv~E~~~-~~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~ 213 (464)
T 3ttj_A 139 FQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 213 (464)
T ss_dssp CCEEEEEEECCS-EEHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred CCeEEEEEeCCC-CCHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence 46799999995 456666543 489999999999999999999999999999999999999999999999999843
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
....
T Consensus 214 ~~~~---------------------------------------------------------------------------- 217 (464)
T 3ttj_A 214 AGTS---------------------------------------------------------------------------- 217 (464)
T ss_dssp ---C----------------------------------------------------------------------------
T ss_pred cCCC----------------------------------------------------------------------------
Confidence 2110
Q ss_pred CCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---CC-------------
Q 007433 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---PL------------- 508 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~~------------- 508 (604)
......+||++|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..++.. +.
T Consensus 218 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~ 296 (464)
T 3ttj_A 218 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN 296 (464)
T ss_dssp -CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHH
T ss_pred -cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhh
Confidence 0112457999999999999999999999999999999999999999998877776665431 10
Q ss_pred ---CCCCCCC---------------------CCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 509 ---RFPESPV---------------------VSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 509 ---~~p~~~~---------------------~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
..+.... .+.++++||.+||.+||++||| ++|+|+||||+.
T Consensus 297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~~~~ 361 (464)
T 3ttj_A 297 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS----VDDALQHPYINV 361 (464)
T ss_dssp HHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC----HHHHHTSTTTGG
T ss_pred HhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCC----HHHHhcChhhhh
Confidence 0000000 1456899999999999999999 999999999974
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-48 Score=405.18 Aligned_cols=258 Identities=29% Similarity=0.491 Sum_probs=227.9
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|.+.+.||+|+||.||++++..+++.||+|++.+...........+.+|+.+++.++|+||+++++++.+++..|+|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 36899999999999999999999999999999999876544444455677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 120 ~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-- 195 (335)
T 2owb_A 120 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-- 195 (335)
T ss_dssp ECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred EecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc--
Confidence 9999999999998875 579999999999999999999999999999999999999999999999999984432100
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 196 --------------------------------------------------------------------------~~~~~~ 201 (335)
T 2owb_A 196 --------------------------------------------------------------------------ERKKVL 201 (335)
T ss_dssp --------------------------------------------------------------------------CCBCCC
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 011234
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~d 531 (604)
.||+.|+|||++.+..++.++|||||||+||||++|+.||......+.+..+......++. .++..+.+||.+||..|
T Consensus 202 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~d 279 (335)
T 2owb_A 202 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTD 279 (335)
T ss_dssp CSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCT--TSCHHHHHHHHHHTCSS
T ss_pred CCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCc--cCCHHHHHHHHHHccCC
Confidence 6999999999999999999999999999999999999999998887777777776665554 48999999999999999
Q ss_pred CCCcccccCCHHHHhcCCCCCC
Q 007433 532 PQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 532 P~~Rpt~~~~a~elL~Hpff~~ 553 (604)
|++||+ +.|+|+||||..
T Consensus 280 p~~Rps----~~ell~~~~~~~ 297 (335)
T 2owb_A 280 PTARPT----INELLNDEFFTS 297 (335)
T ss_dssp GGGSCC----GGGGGGSHHHHT
T ss_pred hhHCcC----HHHHhcCccccC
Confidence 999999 999999999975
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=394.81 Aligned_cols=258 Identities=29% Similarity=0.491 Sum_probs=227.5
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+++..|+|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 36899999999999999999999999999999999876543344455677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 94 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-- 169 (294)
T 2rku_A 94 LELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG-- 169 (294)
T ss_dssp EECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT--
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc--
Confidence 9999999999998775 579999999999999999999999999999999999999999999999999884322100
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 170 --------------------------------------------------------------------------~~~~~~ 175 (294)
T 2rku_A 170 --------------------------------------------------------------------------ERKKVL 175 (294)
T ss_dssp --------------------------------------------------------------------------CCBCCC
T ss_pred --------------------------------------------------------------------------cccccc
Confidence 011134
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~d 531 (604)
.||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+.+..+......++. .++..+.+||.+||..|
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~ 253 (294)
T 2rku_A 176 CGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK--HINPVAASLIQKMLQTD 253 (294)
T ss_dssp CSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT--TSCHHHHHHHHHHTCSS
T ss_pred cCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCcc--ccCHHHHHHHHHHcccC
Confidence 6999999999999999999999999999999999999999998887777777776655554 58999999999999999
Q ss_pred CCCcccccCCHHHHhcCCCCCC
Q 007433 532 PQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 532 P~~Rpt~~~~a~elL~Hpff~~ 553 (604)
|++||+ +.|+++||||..
T Consensus 254 p~~Rps----~~~ll~~~~~~~ 271 (294)
T 2rku_A 254 PTARPT----INELLNDEFFTS 271 (294)
T ss_dssp GGGSCC----GGGGGGSHHHHT
T ss_pred hhhCcC----HHHHhhChheec
Confidence 999999 999999999975
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=415.80 Aligned_cols=259 Identities=29% Similarity=0.462 Sum_probs=219.5
Q ss_pred CeEE--EEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 214 HFRL--LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 214 ~y~l--~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.|.+ .+.||+|+||.||+|.+..+++.||+|++....... ...+.+|+++|+.++||||++++++|.+.+.+|||
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~---~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccccc---HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 4554 678999999999999999999999999998764432 34567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEE--ccCCcEEEecccccccccCCC
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV--REDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl--~~~g~vkL~DFGla~~~~~~~ 369 (604)
||||++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||++..+....
T Consensus 165 ~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~ 243 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE 243 (373)
T ss_dssp EECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred EeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence 9999999999888654 2469999999999999999999999999999999999999 456789999999985432100
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
...
T Consensus 244 -----------------------------------------------------------------------------~~~ 246 (373)
T 2x4f_A 244 -----------------------------------------------------------------------------KLK 246 (373)
T ss_dssp -----------------------------------------------------------------------------BCC
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 011
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC--CCCCCHHHHHHHHHh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE--SPVVSFSARDLIKGL 527 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~--~~~~s~~l~dLI~~l 527 (604)
..+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+.++......++. ...++.++++||.+|
T Consensus 247 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~ 326 (373)
T 2x4f_A 247 VNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKL 326 (373)
T ss_dssp CCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHHHTT
T ss_pred cccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHHHHH
Confidence 236999999999999999999999999999999999999999999988888888877655543 246899999999999
Q ss_pred hhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 528 LVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
|.+||.+||+ +.|+|+||||++..|.
T Consensus 327 L~~dp~~Rps----~~e~l~hp~~~~~~~~ 352 (373)
T 2x4f_A 327 LIKEKSWRIS----ASEALKHPWLSDHKLH 352 (373)
T ss_dssp SCSSGGGSCC----HHHHHHSHHHHCHHHH
T ss_pred cCCChhhCCC----HHHHhcCcCcCCCchh
Confidence 9999999999 9999999999887654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=407.04 Aligned_cols=267 Identities=29% Similarity=0.420 Sum_probs=227.4
Q ss_pred ecCeEEE-EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCeeE
Q 007433 212 VGHFRLL-KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 212 ~~~y~l~-~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~ 289 (604)
.++|.+. +.||+|+||.||+|++..+++.||||++.+..... .....+.+|+.+|+.+ +||||++++++|.+++.+|
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~ 105 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEII 105 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEE
Confidence 3678888 88999999999999999999999999997653221 1233567899999999 5699999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc---CCcEEEeccccccccc
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE---DGHIMLSDFDLSLRCA 366 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~---~g~vkL~DFGla~~~~ 366 (604)
+|||||.+++|.+++.......+++..++.++.||+.||+|||++||+||||||+||||+. ++.+||+|||++....
T Consensus 106 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~ 185 (327)
T 3lm5_A 106 LILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185 (327)
T ss_dssp EEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC-
T ss_pred EEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccC
Confidence 9999999999999887665578999999999999999999999999999999999999997 7899999999985432
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
.. .
T Consensus 186 ~~-----------------------------------------------------------------------------~ 188 (327)
T 3lm5_A 186 HA-----------------------------------------------------------------------------C 188 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred Cc-----------------------------------------------------------------------------c
Confidence 10 0
Q ss_pred cccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC--CCCCCCHHHHHHH
Q 007433 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFP--ESPVVSFSARDLI 524 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p--~~~~~s~~l~dLI 524 (604)
.....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+......++ ....++..+++||
T Consensus 189 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li 268 (327)
T 3lm5_A 189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFI 268 (327)
T ss_dssp -----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHHH
T ss_pred ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCHHHHHHH
Confidence 01134699999999999999999999999999999999999999999888888777766554443 3356899999999
Q ss_pred HHhhhcCCCCcccccCCHHHHhcCCCCCCCChhhhh
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIR 560 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~~ 560 (604)
.+||..||++||+ ++++|+||||++++|..+.
T Consensus 269 ~~~L~~dP~~Rpt----~~~ll~h~~~~~~~~~~~~ 300 (327)
T 3lm5_A 269 QSLLVKNPEKRPT----AEICLSHSWLQQWDFENLF 300 (327)
T ss_dssp HHHSCSSGGGSCC----HHHHTTCGGGCCCCTTCC-
T ss_pred HHHcCCChhhCcC----HHHHhCCHhhccccccccc
Confidence 9999999999999 9999999999999998553
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-48 Score=391.30 Aligned_cols=262 Identities=29% Similarity=0.481 Sum_probs=220.8
Q ss_pred CceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 207 DGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 207 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
.+.+..++|++.+.||+|+||.||+|++..+++.||||++.............+.+|+.+|+.++||||+++++++.+++
T Consensus 5 ~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 84 (276)
T 2h6d_A 5 DGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPT 84 (276)
T ss_dssp --CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred cCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 34556789999999999999999999999999999999998765444444567788999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
..|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 85 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 162 (276)
T 2h6d_A 85 DFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS 162 (276)
T ss_dssp EEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCC
T ss_pred eEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccC
Confidence 999999999999999998876 469999999999999999999999999999999999999999999999999884321
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
.. .
T Consensus 163 ~~-----------------------------------------------------------------------------~ 165 (276)
T 2h6d_A 163 DG-----------------------------------------------------------------------------E 165 (276)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred CC-----------------------------------------------------------------------------c
Confidence 10 0
Q ss_pred cccccccCccccCcceecCCCC-CccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007433 447 RSMSFVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIK 525 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~~-~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~ 525 (604)
......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........+..+......++. .++..+.+||.
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~l~~li~ 243 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPE--YLNRSVATLLM 243 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHH
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCch--hcCHHHHHHHH
Confidence 0112358999999999998776 68999999999999999999999988777777777766555543 48899999999
Q ss_pred HhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 526 GLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
+||..||.+||+ +.|+++||||+.
T Consensus 244 ~~l~~~p~~Rps----~~~~l~h~~~~~ 267 (276)
T 2h6d_A 244 HMLQVDPLKRAT----IKDIREHEWFKQ 267 (276)
T ss_dssp HHTCSSGGGSCC----HHHHHHSHHHHT
T ss_pred HHccCChhhCCC----HHHHHhChhhcc
Confidence 999999999999 999999999964
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=392.11 Aligned_cols=266 Identities=31% Similarity=0.453 Sum_probs=226.0
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchh------HHHHHHHHHHHHHHHHHHhCC-CCCccccceeEec
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKAS------LEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFET 284 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~------~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~ 284 (604)
.++|++.+.||+|+||.||+|.+..+++.||||++.... .........+.+|+++|+++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 379999999999999999999999999999999997542 112233456778999999995 9999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccc
Q 007433 285 DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLR 364 (604)
Q Consensus 285 ~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~ 364 (604)
++..|+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~ 173 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ 173 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence 99999999999999999998875 5699999999999999999999999999999999999999999999999998843
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
....
T Consensus 174 ~~~~---------------------------------------------------------------------------- 177 (298)
T 1phk_A 174 LDPG---------------------------------------------------------------------------- 177 (298)
T ss_dssp CCTT----------------------------------------------------------------------------
T ss_pred cCCC----------------------------------------------------------------------------
Confidence 2210
Q ss_pred CCcccccccCccccCcceec------CCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCC--CCC
Q 007433 445 NARSMSFVGTHEYLAPEIIK------GEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPES--PVV 516 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l~------~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~--~~~ 516 (604)
.......||+.|+|||++. ...++.++|||||||++|+|++|+.||.+......+..+......++.. ..+
T Consensus 178 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 256 (298)
T 1phk_A 178 -EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 256 (298)
T ss_dssp -CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGS
T ss_pred -cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCccccccc
Confidence 0111346899999999985 4567889999999999999999999999988877777777766555432 458
Q ss_pred CHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhhhh
Q 007433 517 SFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIR 560 (604)
Q Consensus 517 s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~~ 560 (604)
+..+.+||.+||..||++||+ +.|+|+||||+...|..++
T Consensus 257 ~~~l~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~~~~ 296 (298)
T 1phk_A 257 SDTVKDLVSRFLVVQPQKRYT----AEEALAHPFFQQYVVEEVR 296 (298)
T ss_dssp CHHHHHHHHHHCCSSGGGSCC----HHHHTTSGGGCTTC-----
T ss_pred CHHHHHHHHHHccCCcccCCC----HHHHHhChHhhhccchhhc
Confidence 899999999999999999999 9999999999988876554
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=417.90 Aligned_cols=253 Identities=28% Similarity=0.446 Sum_probs=208.1
Q ss_pred ecCeEEE-EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHH-HhCCCCCccccceeEec----C
Q 007433 212 VGHFRLL-KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREIL-QSLDHPFLPTLYTHFET----D 285 (604)
Q Consensus 212 ~~~y~l~-~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL-~~l~HpnIv~l~~~~~~----~ 285 (604)
.++|.+. +.||.|+||+||+|.+..+++.||||++.... .+.+|++++ +.++||||++++++|.. +
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~~--------~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~ 131 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYENLYAGR 131 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcch--------hHHHHHHHHHHhcCCCCcceEeEEEeecccCC
Confidence 4688887 68999999999999999999999999996431 345688876 55689999999999875 6
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc---CCcEEEeccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE---DGHIMLSDFDLS 362 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~---~g~vkL~DFGla 362 (604)
.++|||||||+||+|.+++.......|++..++.|+.||+.||+|||++|||||||||+||||+. ++.+||+|||++
T Consensus 132 ~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 132 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred cEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccc
Confidence 78999999999999999998765567999999999999999999999999999999999999997 789999999998
Q ss_pred ccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccC
Q 007433 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442 (604)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (604)
......
T Consensus 212 ~~~~~~-------------------------------------------------------------------------- 217 (400)
T 1nxk_A 212 KETTSH-------------------------------------------------------------------------- 217 (400)
T ss_dssp EECC----------------------------------------------------------------------------
T ss_pred cccCCC--------------------------------------------------------------------------
Confidence 432100
Q ss_pred CCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHH----HHHHHHcCCCCCC--CCCCC
Q 007433 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRA----TLYNVVGQPLRFP--ESPVV 516 (604)
Q Consensus 443 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~----~l~~i~~~~~~~p--~~~~~ 516 (604)
......+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+..... ....+....+.++ .+..+
T Consensus 218 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 294 (400)
T 1nxk_A 218 ---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 294 (400)
T ss_dssp ------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTS
T ss_pred ---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccC
Confidence 01123579999999999999999999999999999999999999998754322 3344554544444 33568
Q ss_pred CHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 517 SFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 517 s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
+.++++||.+||..||++||+ +.|+|+||||..
T Consensus 295 s~~~~~li~~~L~~dP~~Rpt----~~eil~hp~~~~ 327 (400)
T 1nxk_A 295 SEEVKMLIRNLLKTEPTQRMT----ITEFMNHPWIMQ 327 (400)
T ss_dssp CHHHHHHHHTTSCSSGGGSCC----HHHHHHSHHHHT
T ss_pred CHHHHHHHHHHCCCChhHCcC----HHHHhcCccccC
Confidence 999999999999999999999 999999999964
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=412.74 Aligned_cols=273 Identities=42% Similarity=0.769 Sum_probs=221.8
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEc---CCceEEEEEEecchhHH-HHHHHHHHHHHHHHHHhC-CCCCccccceeEecC
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELT---GTKCYFAMKVMDKASLE-KRKKLLRAQTEREILQSL-DHPFLPTLYTHFETD 285 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~ 285 (604)
..++|++++.||+|+||+||+|++. .+++.||||++.+.... .......+.+|+++|+.+ +||||+++++++..+
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~ 131 (355)
T 1vzo_A 52 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 131 (355)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred cccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC
Confidence 4579999999999999999999984 57889999999754321 011122345699999999 799999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
+.+|||||||++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 132 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~ 209 (355)
T 1vzo_A 132 TKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209 (355)
T ss_dssp TEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred ceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeec
Confidence 9999999999999999998875 46999999999999999999999999999999999999999999999999998543
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
.... .
T Consensus 210 ~~~~---------------------------------------------------------------------------~ 214 (355)
T 1vzo_A 210 VADE---------------------------------------------------------------------------T 214 (355)
T ss_dssp CGGG---------------------------------------------------------------------------G
T ss_pred ccCC---------------------------------------------------------------------------C
Confidence 2100 0
Q ss_pred CcccccccCccccCcceecCC--CCCccchHHHHHHHHHHHhhCCCCCCCCC----hHHHHHHHHcCCCCCCCCCCCCHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGE--GHGSAVDWWTFGIFLYELLFGKTPFKGSE----NRATLYNVVGQPLRFPESPVVSFS 519 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~--~~~~~~DiWSLGviL~eLltG~~PF~~~~----~~~~l~~i~~~~~~~p~~~~~s~~ 519 (604)
.....++||+.|+|||++.+. .++.++|||||||+||||++|+.||.... .......+......++ ..++..
T Consensus 215 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~ 292 (355)
T 1vzo_A 215 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--QEMSAL 292 (355)
T ss_dssp GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC--TTSCHH
T ss_pred CcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC--cccCHH
Confidence 112245799999999999863 47889999999999999999999997543 2333444444444444 458999
Q ss_pred HHHHHHHhhhcCCCCccccc-CCHHHHhcCCCCCCCChhhhhcC
Q 007433 520 ARDLIKGLLVKEPQNRLACR-RGATEIKQHPFFQGVNWALIRCA 562 (604)
Q Consensus 520 l~dLI~~lL~~dP~~Rpt~~-~~a~elL~Hpff~~~~~~~~~~~ 562 (604)
+++||.+||..||.+||++. ..+.|+++||||+.++|..+...
T Consensus 293 ~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~l~~~ 336 (355)
T 1vzo_A 293 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAK 336 (355)
T ss_dssp HHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTT
T ss_pred HHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhHhhhc
Confidence 99999999999999999321 12999999999999999877544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-48 Score=391.96 Aligned_cols=254 Identities=33% Similarity=0.547 Sum_probs=223.3
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++.+.||+|+||.||+|.+..++..||+|++.+..... ..++.+|+++|+.++||||++++++|.+++..|+||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 68999999999999999999999999999999997654322 345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEE---ccCCcEEEecccccccccCCC
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV---REDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl---~~~g~vkL~DFGla~~~~~~~ 369 (604)
||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||| +.++.++|+|||++..+...
T Consensus 86 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~- 162 (277)
T 3f3z_A 86 ELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG- 162 (277)
T ss_dssp ECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT-
T ss_pred eccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc-
Confidence 999999999988775 569999999999999999999999999999999999999 77889999999988443210
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
....
T Consensus 163 ----------------------------------------------------------------------------~~~~ 166 (277)
T 3f3z_A 163 ----------------------------------------------------------------------------KMMR 166 (277)
T ss_dssp ----------------------------------------------------------------------------SCBC
T ss_pred ----------------------------------------------------------------------------cchh
Confidence 0111
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCC--CCCCHHHHHHHHHh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPES--PVVSFSARDLIKGL 527 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~--~~~s~~l~dLI~~l 527 (604)
...||+.|+|||++.+. ++.++|||||||++|||++|+.||.+....+.+..+......++.. ..++..+.+||.+|
T Consensus 167 ~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 245 (277)
T 3f3z_A 167 TKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIRRL 245 (277)
T ss_dssp CCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHH
T ss_pred ccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHHHH
Confidence 34699999999998765 8999999999999999999999999988888888888776665542 35899999999999
Q ss_pred hhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 528 LVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
|..||++||+ +.++|+||||+.
T Consensus 246 l~~dp~~R~s----~~~~l~h~~~~~ 267 (277)
T 3f3z_A 246 LTKSPKQRIT----SLQALEHEWFEK 267 (277)
T ss_dssp TCSSTTTSCC----HHHHTTSHHHHH
T ss_pred ccCChhhCcC----HHHHhcCHHHhc
Confidence 9999999999 999999999964
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=431.37 Aligned_cols=261 Identities=33% Similarity=0.485 Sum_probs=228.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++++.||+|+||.||+|++..+++.||||++.+...........+.+|+.+|+.++||||++++++|.+.+.+|+|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 46899999999999999999999999999999999765433223345677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEE---ccCCcEEEecccccccccCC
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV---REDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl---~~~g~vkL~DFGla~~~~~~ 368 (604)
||||.|++|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||| +.++.+||+|||++..+...
T Consensus 105 ~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~ 182 (484)
T 3nyv_A 105 GEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS 182 (484)
T ss_dssp ECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred EecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence 9999999999988765 579999999999999999999999999999999999999 46789999999998543211
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
...
T Consensus 183 -----------------------------------------------------------------------------~~~ 185 (484)
T 3nyv_A 183 -----------------------------------------------------------------------------KKM 185 (484)
T ss_dssp -----------------------------------------------------------------------------CSH
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 011
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC--CCCCCCHHHHHHHHH
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFP--ESPVVSFSARDLIKG 526 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p--~~~~~s~~l~dLI~~ 526 (604)
...+||+.|+|||++.+ .|+.++|||||||++|+|++|+.||.+.+..+.+..+....+.++ .+..++.++++||.+
T Consensus 186 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 264 (484)
T 3nyv_A 186 KDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 264 (484)
T ss_dssp HHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHHHHHH
T ss_pred ccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHHHHHH
Confidence 23469999999999987 589999999999999999999999999999888888887765544 345689999999999
Q ss_pred hhhcCCCCcccccCCHHHHhcCCCCCCCCh
Q 007433 527 LLVKEPQNRLACRRGATEIKQHPFFQGVNW 556 (604)
Q Consensus 527 lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~ 556 (604)
||.+||.+||+ +.|+|+||||+...+
T Consensus 265 ~L~~dp~~R~s----~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 265 MLTYVPSMRIS----ARDALDHEWIQTYTK 290 (484)
T ss_dssp HTCSSGGGSCC----HHHHHTSHHHHHHTC
T ss_pred HCCCChhHCcC----HHHHhhChhhccccc
Confidence 99999999999 999999999976544
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-48 Score=409.77 Aligned_cols=258 Identities=31% Similarity=0.443 Sum_probs=212.2
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC------
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD------ 285 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------ 285 (604)
.++|++++.||+|+||.||+|.+..+++.||||++..... ......++.+|+++|+.++||||++++++|..+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~ 102 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 102 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccC
Confidence 4789999999999999999999999999999999965432 223445678999999999999999999999865
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
..+|+||||+ +++|.+++... .+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++...
T Consensus 103 ~~~~lv~e~~-~~~L~~~~~~~---~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 178 (367)
T 1cm8_A 103 TDFYLVMPFM-GTDLGKLMKHE---KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 178 (367)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecC-CCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence 3569999999 89999998873 5999999999999999999999999999999999999999999999999998432
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
..
T Consensus 179 ~~------------------------------------------------------------------------------ 180 (367)
T 1cm8_A 179 DS------------------------------------------------------------------------------ 180 (367)
T ss_dssp CS------------------------------------------------------------------------------
T ss_pred cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred CcccccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---CC-------------
Q 007433 446 ARSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---PL------------- 508 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~~------------- 508 (604)
.....+||++|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+... +.
T Consensus 181 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~ 259 (367)
T 1cm8_A 181 -EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 259 (367)
T ss_dssp -SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred -ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHH
Confidence 0123469999999999987 67899999999999999999999999998877766655421 10
Q ss_pred ------------CC-CCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 509 ------------RF-PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 509 ------------~~-p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
.+ .....++..+.+||.+||..||.+||+ +.|+|+||||+.+.+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t----~~e~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 260 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT----AGEALAHPYFESLHDT 317 (367)
T ss_dssp HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGTTTC--
T ss_pred HHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCC----HHHHhcChHHHhhcCC
Confidence 00 011346889999999999999999999 9999999999987654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=404.11 Aligned_cols=263 Identities=24% Similarity=0.387 Sum_probs=220.2
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC----
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK---- 286 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~---- 286 (604)
..++|++++.||+|+||.||+|++..+++.||||++............++.+|+++++.++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEE
T ss_pred ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCc
Confidence 3479999999999999999999999999999999998765545555667889999999999999999999997654
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
..|+||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 90 ~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 167 (311)
T 3ork_A 90 LPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167 (311)
T ss_dssp EEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred ccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence 349999999999999999875 469999999999999999999999999999999999999999999999999984432
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
.... ...
T Consensus 168 ~~~~-------------------------------------------------------------------------~~~ 174 (311)
T 3ork_A 168 DSGN-------------------------------------------------------------------------SVT 174 (311)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccc-------------------------------------------------------------------------ccc
Confidence 1100 000
Q ss_pred cccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC--CCCCCCHHHHHHH
Q 007433 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFP--ESPVVSFSARDLI 524 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p--~~~~~s~~l~dLI 524 (604)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.........+.......+ ....++.++.+||
T Consensus 175 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 254 (311)
T 3ork_A 175 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVV 254 (311)
T ss_dssp -------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCCHHHHHHH
T ss_pred cccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCCHHHHHHH
Confidence 11235699999999999999999999999999999999999999999888777777665543322 1245899999999
Q ss_pred HHhhhcCCCCcccccCCHHHHhcCCCCC
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
.+||..||++||+ +.++++|+|++
T Consensus 255 ~~~l~~dP~~R~~----~~~~l~~~l~~ 278 (311)
T 3ork_A 255 LKALAKNPENRYQ----TAAEMRADLVR 278 (311)
T ss_dssp HHHTCSSGGGSCS----SHHHHHHHHHH
T ss_pred HHHHhcCHhhChh----hHHHHHHHHHH
Confidence 9999999999999 89999999985
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=416.42 Aligned_cols=259 Identities=27% Similarity=0.450 Sum_probs=212.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec------C
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET------D 285 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------~ 285 (604)
..+|++++.||+|+||.||+|++..+++.||||++..... ...+|+++|+.|+||||++++++|.. .
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~ 125 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 125 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCcc
Confidence 3579999999999999999999999999999999975421 12369999999999999999999853 2
Q ss_pred CeeEEEEeecCCCCHHHHHHh--cCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccC-CcEEEeccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQR--QPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRED-GHIMLSDFDLS 362 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~--~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~-g~vkL~DFGla 362 (604)
.+++|||||++ ++|..++.. .....+++..++.|+.||+.||+|||++|||||||||+||||+.+ +.+||+|||++
T Consensus 126 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a 204 (420)
T 1j1b_A 126 VYLNLVLDYVP-ETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA 204 (420)
T ss_dssp EEEEEEEECCC-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred eeEEeehhccc-ccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhh
Confidence 35789999995 467666543 234679999999999999999999999999999999999999965 57899999998
Q ss_pred ccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccC
Q 007433 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442 (604)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (604)
..+...
T Consensus 205 ~~~~~~-------------------------------------------------------------------------- 210 (420)
T 1j1b_A 205 KQLVRG-------------------------------------------------------------------------- 210 (420)
T ss_dssp EECCTT--------------------------------------------------------------------------
T ss_pred hhcccC--------------------------------------------------------------------------
Confidence 542210
Q ss_pred CCCCcccccccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---------------
Q 007433 443 PTNARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ--------------- 506 (604)
Q Consensus 443 ~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~--------------- 506 (604)
......+||+.|+|||++.+. .|+.++|||||||+||||++|+.||.+.+..+.+.+++..
T Consensus 211 ---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~ 287 (420)
T 1j1b_A 211 ---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN 287 (420)
T ss_dssp ---CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSC
T ss_pred ---CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChh
Confidence 011235799999999999875 6899999999999999999999999998877776665431
Q ss_pred --CCCCCC----------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhhh
Q 007433 507 --PLRFPE----------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALI 559 (604)
Q Consensus 507 --~~~~p~----------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~ 559 (604)
.+.++. ...++.++++||.+||.+||.+||+ +.|+|+||||+++.+...
T Consensus 288 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~~~ 348 (420)
T 1j1b_A 288 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT----PLEACAHSFFDELRDPNV 348 (420)
T ss_dssp CCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGGGGGCTTC
T ss_pred hhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCC----HHHHhCCHhhcccccccc
Confidence 122221 1346889999999999999999999 999999999998776543
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=405.54 Aligned_cols=255 Identities=28% Similarity=0.389 Sum_probs=222.4
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++++.||+|+||+||+|++..+++.||||++.............+.+|+++|+.++||||++++++|..++..||||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 57999999999999999999999999999999997654444455567889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+. |+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++....
T Consensus 134 e~~~-g~l~~~l~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~------ 205 (348)
T 1u5q_A 134 EYCL-GSASDLLEVHK-KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------ 205 (348)
T ss_dssp ECCS-EEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS------
T ss_pred ecCC-CCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecC------
Confidence 9995 68888776542 579999999999999999999999999999999999999999999999999873211
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.....+
T Consensus 206 --------------------------------------------------------------------------~~~~~~ 211 (348)
T 1u5q_A 206 --------------------------------------------------------------------------PANSFV 211 (348)
T ss_dssp --------------------------------------------------------------------------SBCCCC
T ss_pred --------------------------------------------------------------------------CCCccc
Confidence 011346
Q ss_pred cCccccCcceec---CCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 453 GTHEYLAPEIIK---GEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 453 GT~~Y~APE~l~---~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
||+.|+|||++. +..++.++|||||||+||||++|+.||.+.+....+..+............++..+++||.+||.
T Consensus 212 gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 291 (348)
T 1u5q_A 212 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 291 (348)
T ss_dssp SCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTC
T ss_pred CCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcc
Confidence 999999999985 45688999999999999999999999999888887777766554444445689999999999999
Q ss_pred cCCCCcccccCCHHHHhcCCCCCC
Q 007433 530 KEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
.||++||+ +.++|+||||..
T Consensus 292 ~dP~~Rps----~~~ll~h~~~~~ 311 (348)
T 1u5q_A 292 KIPQDRPT----SEVLLKHRFVLR 311 (348)
T ss_dssp SSGGGSCC----HHHHTTCHHHHS
T ss_pred cChhhCcC----HHHHhhChhhhc
Confidence 99999999 999999999964
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=404.11 Aligned_cols=253 Identities=29% Similarity=0.480 Sum_probs=198.0
Q ss_pred cCeEEE---EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEecCCee
Q 007433 213 GHFRLL---KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFETDKFS 288 (604)
Q Consensus 213 ~~y~l~---~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~ 288 (604)
++|.+. +.||+|+||+||+|.+..+++.||||++.+... ....+|+.+|+.+. ||||++++++|.++...
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGH------HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhh------hhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 467765 789999999999999999999999999976522 24557999999997 99999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC---cEEEecccccccc
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG---HIMLSDFDLSLRC 365 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g---~vkL~DFGla~~~ 365 (604)
|||||||+|++|.+++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.++ .+||+|||++...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~ 159 (325)
T 3kn6_A 82 FLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLK 159 (325)
T ss_dssp EEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEEC
T ss_pred EEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceec
Confidence 9999999999999999875 5799999999999999999999999999999999999998766 8999999998432
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
... .
T Consensus 160 ~~~----------------------------------------------------------------------------~ 163 (325)
T 3kn6_A 160 PPD----------------------------------------------------------------------------N 163 (325)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred CCC----------------------------------------------------------------------------C
Confidence 110 0
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCCh-------HHHHHHHHcCCCCCCCC--CCC
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSEN-------RATLYNVVGQPLRFPES--PVV 516 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~-------~~~l~~i~~~~~~~p~~--~~~ 516 (604)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+. .+.+..+....+.++.. ..+
T Consensus 164 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (325)
T 3kn6_A 164 QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNV 243 (325)
T ss_dssp --------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTS
T ss_pred CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCC
Confidence 011234689999999999999999999999999999999999999986432 34555666555544432 358
Q ss_pred CHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 517 SFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 517 s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
+.++++||.+||..||.+||+ +.|+++||||++
T Consensus 244 s~~~~~li~~~L~~dP~~Rpt----~~ell~h~w~~~ 276 (325)
T 3kn6_A 244 SQEAKDLIQGLLTVDPNKRLK----MSGLRYNEWLQD 276 (325)
T ss_dssp CHHHHHHHHHHHCCCTTTCCC----TTTSTTCGGGCT
T ss_pred CHHHHHHHHHHCCCChhHCCC----HHHHhcChhhcc
Confidence 999999999999999999999 999999999975
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=399.31 Aligned_cols=255 Identities=28% Similarity=0.461 Sum_probs=220.7
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEe
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVME 293 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E 293 (604)
.|...+.||+|+||.||+|++..+++.||||++...... ....+.+|+.+|+.++||||+++++++..++..|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC---SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 588899999999999999999999999999999765322 22346689999999999999999999999999999999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccc
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVK 373 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~ 373 (604)
|++|++|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++.......
T Consensus 123 ~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~---- 195 (321)
T 2c30_A 123 FLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV---- 195 (321)
T ss_dssp CCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS----
T ss_pred cCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc----
Confidence 9999999998865 369999999999999999999999999999999999999999999999999884332100
Q ss_pred cCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccccc
Q 007433 374 SSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453 (604)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G 453 (604)
......+|
T Consensus 196 ------------------------------------------------------------------------~~~~~~~g 203 (321)
T 2c30_A 196 ------------------------------------------------------------------------PKRKSLVG 203 (321)
T ss_dssp ------------------------------------------------------------------------CCBCCCCS
T ss_pred ------------------------------------------------------------------------cccccccC
Confidence 01123469
Q ss_pred CccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC-CCCCCCCCCHHHHHHHHHhhhcCC
Q 007433 454 THEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPL-RFPESPVVSFSARDLIKGLLVKEP 532 (604)
Q Consensus 454 T~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~-~~p~~~~~s~~l~dLI~~lL~~dP 532 (604)
|+.|+|||++.+..++.++|||||||++|||++|+.||.+......+..+..... .+.....++..+++||.+||..||
T Consensus 204 t~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp 283 (321)
T 2c30_A 204 TPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDP 283 (321)
T ss_dssp CGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHSCSST
T ss_pred CccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHccCCh
Confidence 9999999999999999999999999999999999999998887777776665432 233344588999999999999999
Q ss_pred CCcccccCCHHHHhcCCCCCCC
Q 007433 533 QNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 533 ~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
++||+ +.|+|+||||...
T Consensus 284 ~~Rps----~~ell~hp~~~~~ 301 (321)
T 2c30_A 284 QERAT----AQELLDHPFLLQT 301 (321)
T ss_dssp TTSCC----HHHHHTSGGGGGC
T ss_pred hhCcC----HHHHhcChhhccC
Confidence 99999 9999999999753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=395.57 Aligned_cols=255 Identities=26% Similarity=0.430 Sum_probs=209.5
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEec--CCe
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFET--DKF 287 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~--~~~ 287 (604)
..++|++++.||+|+||+||+|++..+++.||||++..... ..+.+|+++|+.+. ||||+++++++.+ ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~------~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCH------HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccch------HHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 34799999999999999999999999999999999975432 24668999999997 9999999999987 678
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC-cEEEeccccccccc
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG-HIMLSDFDLSLRCA 366 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g-~vkL~DFGla~~~~ 366 (604)
.|+||||+.+++|..++.. +++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||++..+.
T Consensus 108 ~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~ 182 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYH 182 (330)
T ss_dssp EEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred eEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcC
Confidence 9999999999999988743 88999999999999999999999999999999999999777 89999999984322
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
...
T Consensus 183 ~~~----------------------------------------------------------------------------- 185 (330)
T 3nsz_A 183 PGQ----------------------------------------------------------------------------- 185 (330)
T ss_dssp TTC-----------------------------------------------------------------------------
T ss_pred CCC-----------------------------------------------------------------------------
Confidence 100
Q ss_pred cccccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCC-ChHHHHHHHHc-------------CCCC--
Q 007433 447 RSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGS-ENRATLYNVVG-------------QPLR-- 509 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~-~~~~~l~~i~~-------------~~~~-- 509 (604)
.....+||+.|+|||++.+ ..++.++|||||||+||||++|+.||... ...+.+..+.. ....
T Consensus 186 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 265 (330)
T 3nsz_A 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 265 (330)
T ss_dssp CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccc
Confidence 0113468999999999987 66899999999999999999999999543 33333222111 1110
Q ss_pred --------------------CCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 510 --------------------FPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 510 --------------------~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
......++.++++||.+||.+||++||+ ++|+|+||||+++.|.
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----a~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 266 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT----AREAMEHPYFYTVVKD 329 (330)
T ss_dssp THHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCC----HHHHHTSGGGTTCC--
T ss_pred cchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCC----HHHHhcCccHhhhccC
Confidence 0111227899999999999999999999 9999999999998764
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=397.23 Aligned_cols=254 Identities=24% Similarity=0.332 Sum_probs=206.4
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHH-HhCCCCCccccceeEecCCeeEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREIL-QSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL-~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
.++|+++++||+|+||+||+|++..+++.||||++........... +...|+..+ +.++|+||++++++|.+++.+||
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~-~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRA-RKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHH-HHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHH-HHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3689999999999999999999999999999999865433222222 333455554 44599999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
||||+ +++|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++......
T Consensus 135 v~e~~-~~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-- 210 (311)
T 3p1a_A 135 QTELC-GPSLQQHCEAWG-ASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-- 210 (311)
T ss_dssp EEECC-CCBHHHHHHHHC-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred EEecc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccC--
Confidence 99999 789998887653 57999999999999999999999999999999999999999999999999997432210
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
.....
T Consensus 211 ---------------------------------------------------------------------------~~~~~ 215 (311)
T 3p1a_A 211 ---------------------------------------------------------------------------GAGEV 215 (311)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred ---------------------------------------------------------------------------CCCcc
Confidence 00112
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
..||+.|+|||++.+ .++.++|||||||+||||++|..||.+... ...+............++.++.+||.+||..
T Consensus 216 ~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 291 (311)
T 3p1a_A 216 QEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRSVLVMMLEP 291 (311)
T ss_dssp CCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHHHHHHHSCS
T ss_pred cCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHHHHHHHcCC
Confidence 359999999999887 689999999999999999999877765332 2333333222122345889999999999999
Q ss_pred CCCCcccccCCHHHHhcCCCCCC
Q 007433 531 EPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
||++||+ +.|+|+||||+.
T Consensus 292 dP~~Rpt----~~ell~hp~~~~ 310 (311)
T 3p1a_A 292 DPKLRAT----AEALLALPVLRQ 310 (311)
T ss_dssp STTTSCC----HHHHHTSGGGSC
T ss_pred ChhhCcC----HHHHHhCccccC
Confidence 9999999 999999999974
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-48 Score=425.52 Aligned_cols=259 Identities=33% Similarity=0.492 Sum_probs=220.2
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++++.||+|+||+||+|++..++..||||++.+..... .....+.+|+.+|+.++||||++++++|.+...+|+||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 58999999999999999999999999999999998754322 22345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc---CCcEEEecccccccccCCC
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE---DGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~---~g~vkL~DFGla~~~~~~~ 369 (604)
|||.||+|.+++... ..+++..++.|+.||+.||.|||++|||||||||+||||+. ++.+||+|||++..+...
T Consensus 116 e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~- 192 (494)
T 3lij_A 116 ECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ- 192 (494)
T ss_dssp ECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-
T ss_pred ecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-
Confidence 999999999888765 56999999999999999999999999999999999999976 455999999998443210
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
....
T Consensus 193 ----------------------------------------------------------------------------~~~~ 196 (494)
T 3lij_A 193 ----------------------------------------------------------------------------KKMK 196 (494)
T ss_dssp ----------------------------------------------------------------------------BCBC
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 0112
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC--CCCCCHHHHHHHHHh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE--SPVVSFSARDLIKGL 527 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~--~~~~s~~l~dLI~~l 527 (604)
..+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+....+.+..+....+.++. +..++..+++||.+|
T Consensus 197 ~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 275 (494)
T 3lij_A 197 ERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQM 275 (494)
T ss_dssp CCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHHHHHHH
T ss_pred ccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHHHHHHH
Confidence 3469999999999874 5899999999999999999999999999988888888877665543 356899999999999
Q ss_pred hhcCCCCcccccCCHHHHhcCCCCCCCCh
Q 007433 528 LVKEPQNRLACRRGATEIKQHPFFQGVNW 556 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~Hpff~~~~~ 556 (604)
|..||.+||+ +.|+|+||||+...+
T Consensus 276 L~~dp~~R~s----~~e~l~hp~~~~~~~ 300 (494)
T 3lij_A 276 LQFDSQRRIS----AQQALEHPWIKEMCS 300 (494)
T ss_dssp TCSSTTTSCC----HHHHHTCHHHHHHHH
T ss_pred CCCChhhCcc----HHHHhcCcccccCcc
Confidence 9999999999 999999999976543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=405.75 Aligned_cols=266 Identities=29% Similarity=0.403 Sum_probs=214.0
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHH--HHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKR--KKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
.++|++++.||+|+||.||+|++..+++.||||++........ .....+.+|+++|+.++||||++++++|.+.+..|
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 4789999999999999999999999999999999976433221 11235678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
+||||+++ +|..++... ...+++..++.++.||+.||+|||++||+||||||+||||+.+|.+||+|||++..+...
T Consensus 89 lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~- 165 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP- 165 (346)
T ss_dssp EEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC-
T ss_pred EEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC-
Confidence 99999965 888887664 357899999999999999999999999999999999999999999999999998432210
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
.....
T Consensus 166 ---------------------------------------------------------------------------~~~~~ 170 (346)
T 1ua2_A 166 ---------------------------------------------------------------------------NRAYT 170 (346)
T ss_dssp ---------------------------------------------------------------------------CCCCC
T ss_pred ---------------------------------------------------------------------------cccCC
Confidence 00112
Q ss_pred ccccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---CC--CCCC-----------
Q 007433 450 SFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---PL--RFPE----------- 512 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~~--~~p~----------- 512 (604)
..+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+....+.+.++... +. .++.
T Consensus 171 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (346)
T 1ua2_A 171 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 250 (346)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred cccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCccccccc
Confidence 34689999999999765 4789999999999999999999999998887777666531 10 0000
Q ss_pred ----------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhhh
Q 007433 513 ----------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALI 559 (604)
Q Consensus 513 ----------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~ 559 (604)
...++.++++||.+||..||.+||+ +.|+|+||||+...|...
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~h~~f~~~~~~~~ 303 (346)
T 1ua2_A 251 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT----ATQALKMKYFSNRPGPTP 303 (346)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCC----HHHHHTSGGGTSSSCCCC
T ss_pred ccCCCChHHhhccCCHHHHHHHHHHhccChhhCCC----HHHHhcChhhhcCCCCCC
Confidence 1345789999999999999999999 999999999987655433
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=392.02 Aligned_cols=257 Identities=30% Similarity=0.467 Sum_probs=216.1
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|.+.++||+|+||.||+|++..++..||+|++...... .....+.+|+++|+.++||||+++++++.+....|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 6899999999999999999999999999999999765422 12345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEE---ccCCcEEEecccccccccC
Q 007433 293 EFCPGGDLHTLRQRQ--PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV---REDGHIMLSDFDLSLRCAV 367 (604)
Q Consensus 293 E~~~ggsL~~ll~~~--~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl---~~~g~vkL~DFGla~~~~~ 367 (604)
||+++++|.+++... .+..+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||++..+..
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 999999999887542 23579999999999999999999999999999999999999 4567899999998843211
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
. ..
T Consensus 180 ~-----------------------------------------------------------------------------~~ 182 (285)
T 3is5_A 180 D-----------------------------------------------------------------------------EH 182 (285)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c-----------------------------------------------------------------------------cc
Confidence 0 01
Q ss_pred ccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC-CCCCCHHHHHHHHH
Q 007433 448 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE-SPVVSFSARDLIKG 526 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~-~~~~s~~l~dLI~~ 526 (604)
.....||+.|+|||++.+ .++.++|||||||++|||++|+.||.+....+....+......+.. ...++.++.+||.+
T Consensus 183 ~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 261 (285)
T 3is5_A 183 STNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQ 261 (285)
T ss_dssp ----CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC--CCCCHHHHHHHHH
T ss_pred CcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccccCcCCHHHHHHHHH
Confidence 123469999999999864 5889999999999999999999999998877776666554443332 23478999999999
Q ss_pred hhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 527 LLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 527 lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
||..||++||+ +.|+|+||||+.
T Consensus 262 ~L~~dP~~Rps----~~e~l~hp~f~~ 284 (285)
T 3is5_A 262 MLTKDPERRPS----AAQVLHHEWFKQ 284 (285)
T ss_dssp HTCSCTTTSCC----HHHHHTSGGGGC
T ss_pred HccCChhhCcC----HHHHhcCHHhhc
Confidence 99999999999 999999999974
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-48 Score=400.64 Aligned_cols=267 Identities=30% Similarity=0.460 Sum_probs=213.0
Q ss_pred cCeEEE-EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCeeEE
Q 007433 213 GHFRLL-KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 213 ~~y~l~-~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~l 290 (604)
++|++. +.||+|+||+||+|++..+++.||||++.+.... ...++.+|+++|+++ +||||++++++|.+++.+|+
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGH---IRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSC---CHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcch---hHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 589986 7899999999999999999999999999765322 233567899999885 79999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCc---EEEecccccccccC
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGH---IMLSDFDLSLRCAV 367 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~---vkL~DFGla~~~~~ 367 (604)
|||||+|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++. +||+|||++.....
T Consensus 89 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 166 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166 (316)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred EEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence 99999999999999876 56999999999999999999999999999999999999998776 99999998843321
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
..... ......
T Consensus 167 ~~~~~---------------------------------------------------------------------~~~~~~ 177 (316)
T 2ac3_A 167 NGDCS---------------------------------------------------------------------PISTPE 177 (316)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CCccc---------------------------------------------------------------------cccccc
Confidence 10000 000001
Q ss_pred ccccccCccccCcceecC-----CCCCccchHHHHHHHHHHHhhCCCCCCCCCh---------------HHHHHHHHcCC
Q 007433 448 SMSFVGTHEYLAPEIIKG-----EGHGSAVDWWTFGIFLYELLFGKTPFKGSEN---------------RATLYNVVGQP 507 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~-----~~~~~~~DiWSLGviL~eLltG~~PF~~~~~---------------~~~l~~i~~~~ 507 (604)
....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+... ...+..+....
T Consensus 178 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~ 257 (316)
T 2ac3_A 178 LLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK 257 (316)
T ss_dssp ----CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCC
T ss_pred cccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccC
Confidence 123469999999999976 4578899999999999999999999987542 23445555665
Q ss_pred CCCCCC--CCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 508 LRFPES--PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 508 ~~~p~~--~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
+.++.. ..++.++++||.+||..||.+||+ +.|+|+||||++..|.
T Consensus 258 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps----~~e~l~hp~~~~~~~~ 305 (316)
T 2ac3_A 258 YEFPDKDWAHISCAAKDLISKLLVRDAKQRLS----AAQVLQHPWVQGCAPE 305 (316)
T ss_dssp CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHHSTTCC-----
T ss_pred cccCchhcccCCHHHHHHHHHHhhCChhhCCC----HHHHhcChhhcCCCCc
Confidence 555532 458899999999999999999999 9999999999976554
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=393.43 Aligned_cols=263 Identities=29% Similarity=0.489 Sum_probs=225.5
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHH---HHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKR---KKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
++|++++.||+|+||.||+|++..+++.||+|++........ .....+.+|+.+|+.++||||+++++++.++...|
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 589999999999999999999999999999999976533211 12345678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC----cEEEecccccccc
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG----HIMLSDFDLSLRC 365 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g----~vkL~DFGla~~~ 365 (604)
+||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++ .++|+|||++...
T Consensus 85 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 85 LILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999999999998765 5699999999999999999999999999999999999999877 8999999988432
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
...
T Consensus 163 ~~~----------------------------------------------------------------------------- 165 (283)
T 3bhy_A 163 EAG----------------------------------------------------------------------------- 165 (283)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred cCC-----------------------------------------------------------------------------
Confidence 110
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC--CCCCCHHHHHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE--SPVVSFSARDL 523 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~--~~~~s~~l~dL 523 (604)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+.+..+......++. ...++..+.+|
T Consensus 166 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 245 (283)
T 3bhy_A 166 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELAKDF 245 (283)
T ss_dssp ------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHHHHHH
T ss_pred CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHHHHHH
Confidence 0011345899999999999999999999999999999999999999998888887777765554432 24578999999
Q ss_pred HHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhh
Q 007433 524 IKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWAL 558 (604)
Q Consensus 524 I~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~ 558 (604)
|.+||..||++||+ +.++|+||||+.++|..
T Consensus 246 i~~~l~~dp~~Rps----~~~~l~h~~~~~~~~~~ 276 (283)
T 3bhy_A 246 IRRLLVKDPKRRMT----IAQSLEHSWIKAIRRRN 276 (283)
T ss_dssp HHTTSCSSGGGSCC----HHHHHHCHHHHHHHHCC
T ss_pred HHHHccCCHhHCcC----HHHHHhCHHHHHHHHHh
Confidence 99999999999999 99999999998776553
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=425.04 Aligned_cols=258 Identities=33% Similarity=0.516 Sum_probs=223.5
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++++.||+|+||+||+|++..+++.||||++.+..... .....+.+|+++|+.++||||+++++++.+...+|+||
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 68999999999999999999999999999999997653221 22345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEc---cCCcEEEecccccccccCCC
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVR---EDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~---~~g~vkL~DFGla~~~~~~~ 369 (604)
|||.|++|.+++... ..+++..++.|+.||+.||.|||++|||||||||+||||+ .++.+||+|||++..+...
T Consensus 101 e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~- 177 (486)
T 3mwu_A 101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177 (486)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred EcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC-
Confidence 999999999988765 5699999999999999999999999999999999999995 4568999999998432110
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
....
T Consensus 178 ----------------------------------------------------------------------------~~~~ 181 (486)
T 3mwu_A 178 ----------------------------------------------------------------------------TKMK 181 (486)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ----------------------------------------------------------------------------CccC
Confidence 0112
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC--CCCCCCCHHHHHHHHHh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRF--PESPVVSFSARDLIKGL 527 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~--p~~~~~s~~l~dLI~~l 527 (604)
..+||+.|+|||++.+. |+.++|||||||++|+|++|+.||.+....+.+..+....+.+ +.+..++.++++||.+|
T Consensus 182 ~~~gt~~y~aPE~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 260 (486)
T 3mwu_A 182 DRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKM 260 (486)
T ss_dssp CCTTGGGGCCGGGGGSC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHHHHH
T ss_pred CCcCCCCCCCHHHhCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHHHHH
Confidence 34699999999999874 8999999999999999999999999998888888888766544 34456899999999999
Q ss_pred hhcCCCCcccccCCHHHHhcCCCCCCCC
Q 007433 528 LVKEPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
|..||.+||+ +.++|+||||+...
T Consensus 261 L~~dp~~R~t----~~~~l~hp~~~~~~ 284 (486)
T 3mwu_A 261 LTFHPSLRIT----ATQCLEHPWIQKYS 284 (486)
T ss_dssp TCSSTTTSCC----HHHHHHCHHHHHTC
T ss_pred cCCChhhCcC----HHHHhcCHhhccCc
Confidence 9999999999 99999999997543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=424.24 Aligned_cols=259 Identities=31% Similarity=0.452 Sum_probs=222.2
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHH----------HHHHHHHHHHHHHHhCCCCCcccccee
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKR----------KKLLRAQTEREILQSLDHPFLPTLYTH 281 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~----------~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 281 (604)
.++|+++++||+|+||+||+|++..++..||||++.+...... .....+.+|+.+|+.++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 4799999999999999999999999999999999987543321 234567789999999999999999999
Q ss_pred EecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC---cEEEec
Q 007433 282 FETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG---HIMLSD 358 (604)
Q Consensus 282 ~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g---~vkL~D 358 (604)
|.++..+|||||||+||+|.+++... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++ .+||+|
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D 192 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVD 192 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence 99999999999999999999988765 5699999999999999999999999999999999999999776 699999
Q ss_pred ccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcc
Q 007433 359 FDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPE 438 (604)
Q Consensus 359 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (604)
||++..+...
T Consensus 193 fg~a~~~~~~---------------------------------------------------------------------- 202 (504)
T 3q5i_A 193 FGLSSFFSKD---------------------------------------------------------------------- 202 (504)
T ss_dssp CTTCEECCTT----------------------------------------------------------------------
T ss_pred CCCCEEcCCC----------------------------------------------------------------------
Confidence 9998433210
Q ss_pred cccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC--CCCC
Q 007433 439 LIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE--SPVV 516 (604)
Q Consensus 439 ~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~--~~~~ 516 (604)
......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+....+.++. +..+
T Consensus 203 -------~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 274 (504)
T 3q5i_A 203 -------YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNI 274 (504)
T ss_dssp -------SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTS
T ss_pred -------CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCCC
Confidence 01123469999999999875 5899999999999999999999999999988888888877665542 3568
Q ss_pred CHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 517 SFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 517 s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
+.++++||.+||.+||.+||+ +.|+|+||||+..
T Consensus 275 s~~~~~li~~~L~~dp~~R~t----~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 275 SDEAKELIKLMLTYDYNKRCT----AEEALNSRWIKKY 308 (504)
T ss_dssp CHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHHT
T ss_pred CHHHHHHHHHHcCCChhHCCC----HHHHhcCHhhhhc
Confidence 999999999999999999999 9999999999754
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=393.61 Aligned_cols=264 Identities=27% Similarity=0.440 Sum_probs=221.5
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHH-HHHHHHHHHHHHHHHhCCCCCccccceeEe--cCCee
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEK-RKKLLRAQTEREILQSLDHPFLPTLYTHFE--TDKFS 288 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~--~~~~~ 288 (604)
.++|++.+.||+|+||.||+|.+..+++.||||++.+..... ......+.+|+++|+.++||||+++++++. +....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 368999999999999999999999999999999998764332 123456778999999999999999999984 45689
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|+||||+.++ |.+++.......+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999766 888887766678999999999999999999999999999999999999999999999999988433210
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
. .....
T Consensus 163 ~--------------------------------------------------------------------------~~~~~ 168 (305)
T 2wtk_C 163 A--------------------------------------------------------------------------ADDTC 168 (305)
T ss_dssp C--------------------------------------------------------------------------SSCEE
T ss_pred c--------------------------------------------------------------------------ccccc
Confidence 0 00011
Q ss_pred cccccCccccCcceecCCCC--CccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007433 449 MSFVGTHEYLAPEIIKGEGH--GSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKG 526 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~--~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~ 526 (604)
....||+.|+|||++.+... +.++|||||||++|||++|+.||.+......+..+......++. .++..+.+||.+
T Consensus 169 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~--~~~~~l~~li~~ 246 (305)
T 2wtk_C 169 RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPG--DCGPPLSDLLKG 246 (305)
T ss_dssp CCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCS--SSCHHHHHHHHH
T ss_pred ccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCC--ccCHHHHHHHHH
Confidence 23459999999999987544 77999999999999999999999998887777777776655543 589999999999
Q ss_pred hhhcCCCCcccccCCHHHHhcCCCCCCCCh
Q 007433 527 LLVKEPQNRLACRRGATEIKQHPFFQGVNW 556 (604)
Q Consensus 527 lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~ 556 (604)
||..||.+||+ +.|+++||||+....
T Consensus 247 ~l~~dp~~Rps----~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 247 MLEYEPAKRFS----IRQIRQHSWFRKKHP 272 (305)
T ss_dssp HTCSSTTTSCC----HHHHHHSHHHHSCCC
T ss_pred HccCChhhCCC----HHHHhcCcccccCCC
Confidence 99999999999 999999999986543
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=408.24 Aligned_cols=266 Identities=27% Similarity=0.412 Sum_probs=222.5
Q ss_pred cCceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC
Q 007433 206 KDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD 285 (604)
Q Consensus 206 ~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 285 (604)
..+.+..++|++++.||+|+||+||+|++..++..||+|++..... ......+.+|+.+|+.++||||++++++|.++
T Consensus 26 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 103 (360)
T 3eqc_A 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSD 103 (360)
T ss_dssp TCCCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCC--HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET
T ss_pred cccccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccC--HHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC
Confidence 3455667899999999999999999999999999999999976532 23344677899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHc-CeEeccCCCCcEEEccCCcEEEeccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML-GIVYRDLKPENVLVREDGHIMLSDFDLSLR 364 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDIKpeNILl~~~g~vkL~DFGla~~ 364 (604)
+..|+||||++|++|.+++... ..+++..+..++.||+.||.|||++ ||+||||||+||||+.++.++|+|||++..
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 181 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQ 181 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHH
T ss_pred CEEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcc
Confidence 9999999999999999999876 4699999999999999999999995 999999999999999999999999998743
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
....
T Consensus 182 ~~~~---------------------------------------------------------------------------- 185 (360)
T 3eqc_A 182 LIDS---------------------------------------------------------------------------- 185 (360)
T ss_dssp HHHH----------------------------------------------------------------------------
T ss_pred cccc----------------------------------------------------------------------------
Confidence 2100
Q ss_pred CCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHH-----------------------
Q 007433 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY----------------------- 501 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~----------------------- 501 (604)
.....+||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+...
T Consensus 186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (360)
T 3eqc_A 186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 263 (360)
T ss_dssp --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence 0113469999999999999999999999999999999999999998765433221
Q ss_pred -------------------HHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 502 -------------------NVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 502 -------------------~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
.+............++.++++||.+||..||++||+ +.|+|+||||+..+|.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~~~~~ 334 (360)
T 3eqc_A 264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD----LKQLMVHAFIKRSDAE 334 (360)
T ss_dssp ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCC----HHHHHTSHHHHHHHHS
T ss_pred ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCC----HHHHhhChHhhcchHh
Confidence 112222222222347889999999999999999999 9999999999876654
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=404.48 Aligned_cols=257 Identities=32% Similarity=0.489 Sum_probs=222.4
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchh-----HHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCC
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKAS-----LEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDK 286 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~-----~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 286 (604)
++|++.+.||+|+||.||+|.+..+++.||||++.... .........+.+|+.+|+.+ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 68999999999999999999999999999999997543 11223345677899999999 8999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
..||||||++|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+|.++|+|||++..+.
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~ 251 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE 251 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence 999999999999999998865 569999999999999999999999999999999999999999999999999884432
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
.. .
T Consensus 252 ~~-----------------------------------------------------------------------------~ 254 (365)
T 2y7j_A 252 PG-----------------------------------------------------------------------------E 254 (365)
T ss_dssp TT-----------------------------------------------------------------------------C
T ss_pred CC-----------------------------------------------------------------------------c
Confidence 10 0
Q ss_pred cccccccCccccCcceecCC------CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC--CCCCCH
Q 007433 447 RSMSFVGTHEYLAPEIIKGE------GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE--SPVVSF 518 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~------~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~--~~~~s~ 518 (604)
.....+||+.|+|||++.+. .++.++|||||||+||||++|+.||.+......+..+......++. +..++.
T Consensus 255 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 334 (365)
T 2y7j_A 255 KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSS 334 (365)
T ss_dssp CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHSSSCH
T ss_pred ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCCH
Confidence 11234699999999998643 5788999999999999999999999988887777777766555432 346889
Q ss_pred HHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCC
Q 007433 519 SARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 519 ~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
.+.+||.+||..||++||+ +.++|+||||+
T Consensus 335 ~~~~li~~~L~~dP~~Rps----~~ell~hp~f~ 364 (365)
T 2y7j_A 335 TVKDLISRLLQVDPEARLT----AEQALQHPFFE 364 (365)
T ss_dssp HHHHHHHHHSCSSTTTSCC----HHHHHHSGGGC
T ss_pred HHHHHHHHHcCCChhHCcC----HHHHhcCcccC
Confidence 9999999999999999999 99999999996
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=405.17 Aligned_cols=271 Identities=27% Similarity=0.400 Sum_probs=214.3
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC----
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK---- 286 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~---- 286 (604)
..++|++++.||+|+||.||+|.+..+++.||||++...... .....++.+|+.+|+.++||||++++++|...+
T Consensus 23 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 23 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTT
T ss_pred hhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCC-hHHHHHHHHHHHHHHhcCCCCccceEEeecccccccc
Confidence 358999999999999999999999999999999999764322 234456778999999999999999999997654
Q ss_pred --eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccc
Q 007433 287 --FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLR 364 (604)
Q Consensus 287 --~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~ 364 (604)
.+|+|||||. ++|.+++.. .+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus 102 ~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~ 176 (371)
T 2xrw_A 102 FQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176 (371)
T ss_dssp CCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred ccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence 7899999995 578887753 489999999999999999999999999999999999999999999999999843
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
....
T Consensus 177 ~~~~---------------------------------------------------------------------------- 180 (371)
T 2xrw_A 177 AGTS---------------------------------------------------------------------------- 180 (371)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccc----------------------------------------------------------------------------
Confidence 2100
Q ss_pred CCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC---------------
Q 007433 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR--------------- 509 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~--------------- 509 (604)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..++.....
T Consensus 181 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 259 (371)
T 2xrw_A 181 -FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRT 259 (371)
T ss_dssp ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHH
T ss_pred -cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 0112346999999999999999999999999999999999999999998887777766543110
Q ss_pred ----CCCCC---------------------CCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhhhhcCCC
Q 007433 510 ----FPESP---------------------VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASP 564 (604)
Q Consensus 510 ----~p~~~---------------------~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~~~~~~ 564 (604)
.+... ..+.++++||.+||..||++||+ +.|+|+||||+...........+
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t----~~e~l~hp~~~~~~~~~~~~~~~ 335 (371)
T 2xrw_A 260 YVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS----VDEALQHPYINVWYDPSEAEAPP 335 (371)
T ss_dssp HHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCC----HHHHHHSHHHHTTCCHHHHTCCC
T ss_pred HHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCC----HHHHhCCcchhhhcCccccCCCC
Confidence 00000 01467899999999999999999 99999999998644333333334
Q ss_pred CCCC
Q 007433 565 PEIP 568 (604)
Q Consensus 565 ~~~p 568 (604)
|.+|
T Consensus 336 ~~~~ 339 (371)
T 2xrw_A 336 PKIP 339 (371)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 4443
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=411.99 Aligned_cols=271 Identities=28% Similarity=0.461 Sum_probs=214.8
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC--
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK-- 286 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~-- 286 (604)
.....+|++++.||+|+||+||+|++..++. ||+|.+..... ...+|+++|+.++||||++++++|....
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence 3345689999999999999999999988886 78877754321 1136999999999999999999996433
Q ss_pred ----eeEEEEeecCCCCHHHHHH-hcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEc-cCCcEEEeccc
Q 007433 287 ----FSCLVMEFCPGGDLHTLRQ-RQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVR-EDGHIMLSDFD 360 (604)
Q Consensus 287 ----~~~lV~E~~~ggsL~~ll~-~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~-~~g~vkL~DFG 360 (604)
++|+|||||+++.+..+.. ......+++..++.|+.||+.||+|||++||+||||||+||||+ .++.+||+|||
T Consensus 108 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 108 KDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp SSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 4889999996654444332 12236799999999999999999999999999999999999999 79999999999
Q ss_pred ccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccc
Q 007433 361 LSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELI 440 (604)
Q Consensus 361 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (604)
++..+...
T Consensus 188 ~a~~~~~~------------------------------------------------------------------------ 195 (394)
T 4e7w_A 188 SAKILIAG------------------------------------------------------------------------ 195 (394)
T ss_dssp TCEECCTT------------------------------------------------------------------------
T ss_pred CcccccCC------------------------------------------------------------------------
Confidence 98543110
Q ss_pred cCCCCCcccccccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---C---------
Q 007433 441 AEPTNARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---P--------- 507 (604)
Q Consensus 441 ~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~--------- 507 (604)
......+||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.+..+.+..++.. +
T Consensus 196 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 270 (394)
T 4e7w_A 196 -----EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMN 270 (394)
T ss_dssp -----CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHC
T ss_pred -----CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhC
Confidence 011235689999999999875 4899999999999999999999999998877776665431 0
Q ss_pred -----CCCCC----------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhhhhcCCCCCCC
Q 007433 508 -----LRFPE----------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIP 568 (604)
Q Consensus 508 -----~~~p~----------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~~~~~~~~~p 568 (604)
..++. ...++.++++||.+||.+||.+||+ +.|+|+||||++++|..........+|
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~~~~~~~~~~~~~~~ 342 (394)
T 4e7w_A 271 PNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLT----AIEALCHPFFDELRTGEARMPNGRELP 342 (394)
T ss_dssp GGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC----HHHHHTSGGGSTTTSSCCCCTTSSCCC
T ss_pred hhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCC----HHHHhcChhhhhhccccccCCCCCCCC
Confidence 11111 1347889999999999999999999 999999999999988755443333333
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-48 Score=403.53 Aligned_cols=271 Identities=23% Similarity=0.413 Sum_probs=229.6
Q ss_pred cCceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHH--------------HHHHHHHHHHHHHhCC
Q 007433 206 KDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRK--------------KLLRAQTEREILQSLD 271 (604)
Q Consensus 206 ~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~--------------~~~~~~~Ei~iL~~l~ 271 (604)
..+....++|++++.||+|+||.||+|++ +++.||||++......... ....+.+|+++|+.++
T Consensus 24 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 101 (348)
T 2pml_X 24 KEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK 101 (348)
T ss_dssp SSSCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC
T ss_pred hhcccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC
Confidence 34445568999999999999999999999 7889999999765432111 1146778999999999
Q ss_pred CCCccccceeEecCCeeEEEEeecCCCCHHHH------HHhcCCCCCcHHHHHHHHHHHHHHHHHHHH-cCeEeccCCCC
Q 007433 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDLHTL------RQRQPGKYFSEQAVKFYVAEVLLALEYLHM-LGIVYRDLKPE 344 (604)
Q Consensus 272 HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~l------l~~~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDIKpe 344 (604)
||||+++++++.+++..|+||||+++++|.++ +.......+++..++.++.||+.||.|||+ +||+||||||+
T Consensus 102 h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~ 181 (348)
T 2pml_X 102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPS 181 (348)
T ss_dssp CTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGG
T ss_pred CCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChH
Confidence 99999999999999999999999999999998 655445789999999999999999999999 99999999999
Q ss_pred cEEEccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccC
Q 007433 345 NVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQK 424 (604)
Q Consensus 345 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 424 (604)
||||+.++.++|+|||++......
T Consensus 182 Nil~~~~~~~kl~dfg~~~~~~~~-------------------------------------------------------- 205 (348)
T 2pml_X 182 NILMDKNGRVKLSDFGESEYMVDK-------------------------------------------------------- 205 (348)
T ss_dssp GEEECTTSCEEECCCTTCEECBTT--------------------------------------------------------
T ss_pred hEEEcCCCcEEEeccccccccccc--------------------------------------------------------
Confidence 999999999999999988432110
Q ss_pred CccccCCCCCCCcccccCCCCCcccccccCccccCcceecCC-CCCc-cchHHHHHHHHHHHhhCCCCCCCCCh-HHHHH
Q 007433 425 PKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGE-GHGS-AVDWWTFGIFLYELLFGKTPFKGSEN-RATLY 501 (604)
Q Consensus 425 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~-~~DiWSLGviL~eLltG~~PF~~~~~-~~~l~ 501 (604)
......||+.|+|||++.+. .++. ++|||||||++|||++|+.||.+... .+.+.
T Consensus 206 ----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 263 (348)
T 2pml_X 206 ----------------------KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFN 263 (348)
T ss_dssp ----------------------EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHH
T ss_pred ----------------------cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence 11134589999999999987 5665 99999999999999999999998776 66666
Q ss_pred HHHcCCCCCCCC-----------------CCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhhhh
Q 007433 502 NVVGQPLRFPES-----------------PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIR 560 (604)
Q Consensus 502 ~i~~~~~~~p~~-----------------~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~~ 560 (604)
.+......++.. ..++.++.+||.+||..||.+||+ +.|+|+||||++++|..+.
T Consensus 264 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps----~~e~l~hp~f~~~~~~~~~ 335 (348)
T 2pml_X 264 NIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERIT----SEDALKHEWLADTNIEDLR 335 (348)
T ss_dssp HHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCC----HHHHHTSGGGTTCCHHHHH
T ss_pred HHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCC----HHHHhcCccccCCCHHHHH
Confidence 776666555532 468999999999999999999999 9999999999999987653
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=393.07 Aligned_cols=255 Identities=31% Similarity=0.485 Sum_probs=221.7
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++++.||+|+||.||+|++..+++.||||++....... ...+.+|+.+|+.++||||+++++++.+++..|+|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccc---hHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEE
Confidence 368999999999999999999999999999999998653222 23566899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEE---ccCCcEEEecccccccccCC
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV---REDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl---~~~g~vkL~DFGla~~~~~~ 368 (604)
|||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||++.....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~- 161 (304)
T 2jam_A 85 MQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN- 161 (304)
T ss_dssp ECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-
T ss_pred EEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-
Confidence 9999999999988765 469999999999999999999999999999999999999 7788999999998732100
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
...
T Consensus 162 -----------------------------------------------------------------------------~~~ 164 (304)
T 2jam_A 162 -----------------------------------------------------------------------------GIM 164 (304)
T ss_dssp -----------------------------------------------------------------------------BTT
T ss_pred -----------------------------------------------------------------------------Ccc
Confidence 011
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC--CCCCCHHHHHHHHH
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE--SPVVSFSARDLIKG 526 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~--~~~~s~~l~dLI~~ 526 (604)
....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+......+..+......++. ...++.++.+||.+
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~ 244 (304)
T 2jam_A 165 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICH 244 (304)
T ss_dssp HHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHHH
T ss_pred ccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHHH
Confidence 1346999999999999999999999999999999999999999998888877777776555433 35689999999999
Q ss_pred hhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 527 LLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 527 lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
||..||++||+ +.|+|+||||++
T Consensus 245 ~l~~dp~~Rps----~~~~l~h~~~~~ 267 (304)
T 2jam_A 245 LLEKDPNERYT----CEKALSHPWIDG 267 (304)
T ss_dssp HHCSSTTTSCC----HHHHHTSHHHHS
T ss_pred HcCCChhHCcC----HHHHhcCccccC
Confidence 99999999999 999999999975
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-48 Score=399.62 Aligned_cols=269 Identities=22% Similarity=0.374 Sum_probs=208.0
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC-----
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK----- 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----- 286 (604)
.++|++++.||+|+||.||+|++..+++.||||++...... .....+.+|+++|+.++||||++++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 82 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRE--LAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQ 82 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTT--THHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhh
Confidence 36899999999999999999999999999999999754321 22345678999999999999999999986543
Q ss_pred ----------------------------------------------------eeEEEEeecCCCCHHHHHHhcCC-CCCc
Q 007433 287 ----------------------------------------------------FSCLVMEFCPGGDLHTLRQRQPG-KYFS 313 (604)
Q Consensus 287 ----------------------------------------------------~~~lV~E~~~ggsL~~ll~~~~~-~~l~ 313 (604)
+.|+|||||+|++|.+++..... ...+
T Consensus 83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~ 162 (332)
T 3qd2_B 83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162 (332)
T ss_dssp HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence 38999999999999999987532 2456
Q ss_pred HHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCC
Q 007433 314 EQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPA 393 (604)
Q Consensus 314 e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 393 (604)
+..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.............
T Consensus 163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~------------------ 224 (332)
T 3qd2_B 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVL------------------ 224 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC-------------------------
T ss_pred hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhcccc------------------
Confidence 67789999999999999999999999999999999999999999999986543221100000
Q ss_pred CCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccch
Q 007433 394 CIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVD 473 (604)
Q Consensus 394 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~D 473 (604)
...+........+||+.|+|||++.+..++.++|
T Consensus 225 ----------------------------------------------~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D 258 (332)
T 3qd2_B 225 ----------------------------------------------TPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVD 258 (332)
T ss_dssp -----------------------------------------------------CCCSCC-CGGGSCHHHHHCCCCCTHHH
T ss_pred ----------------------------------------------ccccccccccccCCCcCccChHHhcCCCCcchhh
Confidence 0000011123457999999999999999999999
Q ss_pred HHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC-CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCC
Q 007433 474 WWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE-SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 474 iWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~-~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
||||||++|||++|..|+.. ....+..+.... ++. ....+.++.+||.+||..||++||+ +.|+|+||||+
T Consensus 259 i~slG~il~el~~~~~~~~~--~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~~l~~~~f~ 330 (332)
T 3qd2_B 259 IFSLGLILFELLYSFSTQME--RVRIITDVRNLK--FPLLFTQKYPQEHMMVQDMLSPSPTERPE----ATDIIENAIFE 330 (332)
T ss_dssp HHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTC--CCHHHHHHCHHHHHHHHHHHCSSGGGSCC----HHHHHHSTTCC
T ss_pred HHHHHHHHHHHHHcCCChhH--HHHHHHHhhccC--CCcccccCChhHHHHHHHHccCCCCcCCC----HHHHhhchhhh
Confidence 99999999999998776532 122222333221 111 1235678899999999999999999 99999999998
Q ss_pred CC
Q 007433 553 GV 554 (604)
Q Consensus 553 ~~ 554 (604)
++
T Consensus 331 ~~ 332 (332)
T 3qd2_B 331 NL 332 (332)
T ss_dssp CC
T ss_pred cC
Confidence 64
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=392.96 Aligned_cols=261 Identities=24% Similarity=0.363 Sum_probs=217.5
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
+..++|++++.||+|+||.||+|++..++..||||++............++.+|+.+++.++||||+++++++.+++.+|
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 34579999999999999999999999999999999997654444455667889999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
+||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 88 lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 164 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET- 164 (294)
T ss_dssp EEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----
T ss_pred EEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc-
Confidence 999999999999999876 46999999999999999999999999999999999999999999999999988432110
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
......
T Consensus 165 --------------------------------------------------------------------------~~~~~~ 170 (294)
T 4eqm_A 165 --------------------------------------------------------------------------SLTQTN 170 (294)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------cccccC
Confidence 000112
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC---CCCCCCCHHHHHHHHH
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRF---PESPVVSFSARDLIKG 526 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~---p~~~~~s~~l~dLI~~ 526 (604)
..+||+.|+|||++.+..++.++|||||||++|||++|+.||.+........+........ .....++..+.++|.+
T Consensus 171 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 250 (294)
T 4eqm_A 171 HVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILR 250 (294)
T ss_dssp ----CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHH
T ss_pred ccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHH
Confidence 3469999999999999999999999999999999999999999988777766665543321 1234588999999999
Q ss_pred hhhcCCCCcccccCCHHHHhcCCCC
Q 007433 527 LLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 527 lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
||..||++||+ ..+.+.+.|.
T Consensus 251 ~l~~dp~~R~~----~~~~l~~~l~ 271 (294)
T 4eqm_A 251 ATEKDKANRYK----TIQEMKDDLS 271 (294)
T ss_dssp HSCSSGGGSCS----SHHHHHHHHH
T ss_pred HhcCCHhHccc----cHHHHHHHHH
Confidence 99999999996 4444444444
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-47 Score=386.48 Aligned_cols=255 Identities=25% Similarity=0.434 Sum_probs=215.5
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec----CCee
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET----DKFS 288 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~~ 288 (604)
..|++.+.||+|+||+||+|.+..++..||+|++....... .....+.+|+.+|+.++||||++++++|.. +..+
T Consensus 26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 104 (290)
T 1t4h_A 26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 104 (290)
T ss_dssp CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceE
Confidence 45899999999999999999999999999999997654433 334567789999999999999999999875 4678
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcC--eEeccCCCCcEEEc-cCCcEEEecccccccc
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLG--IVYRDLKPENVLVR-EDGHIMLSDFDLSLRC 365 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~g--IvHrDIKpeNILl~-~~g~vkL~DFGla~~~ 365 (604)
|+||||+++++|.+++... ..+++..++.|+.||+.||.|||++| |+||||||+||||+ .++.+||+|||++...
T Consensus 105 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 105 VLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 9999999999999999875 56999999999999999999999999 99999999999998 7899999999987321
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
..
T Consensus 183 ~~------------------------------------------------------------------------------ 184 (290)
T 1t4h_A 183 RA------------------------------------------------------------------------------ 184 (290)
T ss_dssp CT------------------------------------------------------------------------------
T ss_pred cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC-CCCCCCCCCHHHHHHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPL-RFPESPVVSFSARDLI 524 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~-~~p~~~~~s~~l~dLI 524 (604)
.......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+......+...+.... ........+.++.+||
T Consensus 185 ~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 263 (290)
T 1t4h_A 185 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 263 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHHH
T ss_pred cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCHHHHHHH
Confidence 01123469999999998875 489999999999999999999999998666665555444332 2223345778999999
Q ss_pred HHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
.+||..||.+||+ +.|+|+||||++
T Consensus 264 ~~~l~~dp~~Rps----~~ell~h~~f~~ 288 (290)
T 1t4h_A 264 EGCIRQNKDERYS----IKDLLNHAFFQE 288 (290)
T ss_dssp HHHSCSSGGGSCC----HHHHHTSGGGC-
T ss_pred HHHccCChhhCCC----HHHHhhCccccc
Confidence 9999999999999 999999999975
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-47 Score=410.85 Aligned_cols=254 Identities=26% Similarity=0.395 Sum_probs=213.7
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC------CCCCccccceeEecC
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL------DHPFLPTLYTHFETD 285 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l------~HpnIv~l~~~~~~~ 285 (604)
..+|++++.||+|+||+||+|.+..+++.||||++..... ....+.+|+.+|+.+ +|+||++++++|...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKR----FHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccc----hHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 4689999999999999999999999999999999976532 223455677777766 678999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCc--EEEecccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGH--IMLSDFDLSL 363 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~--vkL~DFGla~ 363 (604)
+++||||||+ +++|.+++.......+++..++.|+.||+.||+|||++|||||||||+||||+.++. +||+|||++.
T Consensus 172 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 172 NHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 9999999999 579999998876667999999999999999999999999999999999999999887 9999999873
Q ss_pred cccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCC
Q 007433 364 RCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEP 443 (604)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (604)
...
T Consensus 251 ~~~----------------------------------------------------------------------------- 253 (429)
T 3kvw_A 251 YEH----------------------------------------------------------------------------- 253 (429)
T ss_dssp ETT-----------------------------------------------------------------------------
T ss_pred ecC-----------------------------------------------------------------------------
Confidence 211
Q ss_pred CCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---CC------------
Q 007433 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---PL------------ 508 (604)
Q Consensus 444 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~~------------ 508 (604)
......+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..++.. +.
T Consensus 254 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~ 331 (429)
T 3kvw_A 254 --QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKN 331 (429)
T ss_dssp --CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHH
T ss_pred --CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhh
Confidence 0112347999999999999999999999999999999999999999998877776554421 00
Q ss_pred -----CCC-----------------------------C--------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHh
Q 007433 509 -----RFP-----------------------------E--------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIK 546 (604)
Q Consensus 509 -----~~p-----------------------------~--------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL 546 (604)
.++ . ....+..+.+||.+||.+||++||| +.|+|
T Consensus 332 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpt----a~e~L 407 (429)
T 3kvw_A 332 FVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMT----PGQAL 407 (429)
T ss_dssp HBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCC----HHHHH
T ss_pred ccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCC----HHHHh
Confidence 000 0 0123678999999999999999999 99999
Q ss_pred cCCCCCC
Q 007433 547 QHPFFQG 553 (604)
Q Consensus 547 ~Hpff~~ 553 (604)
+||||+.
T Consensus 408 ~Hpw~~~ 414 (429)
T 3kvw_A 408 RHPWLRR 414 (429)
T ss_dssp TSTTTC-
T ss_pred CChhhcc
Confidence 9999975
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=401.11 Aligned_cols=260 Identities=24% Similarity=0.380 Sum_probs=215.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC-----C
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD-----K 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~ 286 (604)
.++|++++.||+|+||.||+|++..++..||||++..... .....++.+|+++|+.++||||+++++++... .
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTC--HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccC--cHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence 4699999999999999999999999999999999975432 23345677899999999999999999999754 4
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
..|+||||+. ++|.+++... .+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++....
T Consensus 104 ~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 179 (364)
T 3qyz_A 104 DVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD 179 (364)
T ss_dssp CEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecC
Confidence 7899999995 6999988764 59999999999999999999999999999999999999999999999999984432
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
.... ...
T Consensus 180 ~~~~-------------------------------------------------------------------------~~~ 186 (364)
T 3qyz_A 180 PDHD-------------------------------------------------------------------------HTG 186 (364)
T ss_dssp GGGC-------------------------------------------------------------------------BCC
T ss_pred CCCC-------------------------------------------------------------------------ccc
Confidence 1100 000
Q ss_pred cccccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc---CCC--------------
Q 007433 447 RSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG---QPL-------------- 508 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~---~~~-------------- 508 (604)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.+..+.. .+.
T Consensus 187 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 266 (364)
T 3qyz_A 187 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARN 266 (364)
T ss_dssp TTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHH
T ss_pred cccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHH
Confidence 1123579999999998765 4589999999999999999999999998877666655542 110
Q ss_pred ---CCC---------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 509 ---RFP---------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 509 ---~~p---------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
.++ ..+.++.++.+||.+||.+||++||+ +.|+|+||||+..
T Consensus 267 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~~~~~ 320 (364)
T 3qyz_A 267 YLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE----VEQALAHPYLEQY 320 (364)
T ss_dssp HHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGTTT
T ss_pred HHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCcchhhc
Confidence 000 01347889999999999999999999 9999999999875
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=385.02 Aligned_cols=260 Identities=25% Similarity=0.412 Sum_probs=219.2
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++++.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+++.++||||+++++++.+++..|+||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 84 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCT--THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccch--hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEE
Confidence 6899999999999999999999999999999999755322 12345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.++|+|||++........
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~-- 160 (276)
T 2yex_A 85 EYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR-- 160 (276)
T ss_dssp ECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE--
T ss_pred EecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc--
Confidence 999999999987654 5799999999999999999999999999999999999999999999999998843321100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
........
T Consensus 161 ------------------------------------------------------------------------~~~~~~~~ 168 (276)
T 2yex_A 161 ------------------------------------------------------------------------ERLLNKMC 168 (276)
T ss_dssp ------------------------------------------------------------------------ECCBCCCC
T ss_pred ------------------------------------------------------------------------hhcccCCc
Confidence 00112346
Q ss_pred cCccccCcceecCCCC-CccchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 453 GTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENR-ATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~-~~~~DiWSLGviL~eLltG~~PF~~~~~~-~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+.... ..+..+.......+....++..+++||.+||..
T Consensus 169 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 248 (276)
T 2yex_A 169 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVE 248 (276)
T ss_dssp SCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCS
T ss_pred cccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHHHHHHHCCC
Confidence 9999999999988775 67899999999999999999999876543 334444444444444456899999999999999
Q ss_pred CCCCcccccCCHHHHhcCCCCCCC
Q 007433 531 EPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
||.+||+ +.|+++||||+..
T Consensus 249 ~p~~Rps----~~~il~~~~~~~~ 268 (276)
T 2yex_A 249 NPSARIT----IPDIKKDRWYNKP 268 (276)
T ss_dssp STTTSCC----HHHHTTCTTTTCC
T ss_pred CchhCCC----HHHHhcCccccCh
Confidence 9999999 9999999999753
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-47 Score=400.13 Aligned_cols=259 Identities=28% Similarity=0.417 Sum_probs=213.6
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCC--CCccccceeEecCCee
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH--PFLPTLYTHFETDKFS 288 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~~ 288 (604)
..++|++++.||+|+||.||+|.+. +++.||||++...... ......+.+|+.+|+.+.| +||+++++++.+++.+
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccc-hHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 3468999999999999999999885 5779999999765432 2344567789999999976 9999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|||||+ .+++|.+++... ..+++..++.|+.||+.||+|||++||+||||||+||||+ ++.+||+|||++..+...
T Consensus 85 ~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~ 160 (343)
T 3dbq_A 85 YMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 160 (343)
T ss_dssp EEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred EEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence 999995 589999999876 5799999999999999999999999999999999999996 689999999998433211
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
.. ....
T Consensus 161 ~~--------------------------------------------------------------------------~~~~ 166 (343)
T 3dbq_A 161 TT--------------------------------------------------------------------------SVVK 166 (343)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cc--------------------------------------------------------------------------cccC
Confidence 00 0011
Q ss_pred cccccCccccCcceecC-----------CCCCccchHHHHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCCCCCCCCCCC
Q 007433 449 MSFVGTHEYLAPEIIKG-----------EGHGSAVDWWTFGIFLYELLFGKTPFKGSEN-RATLYNVVGQPLRFPESPVV 516 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~-----------~~~~~~~DiWSLGviL~eLltG~~PF~~~~~-~~~l~~i~~~~~~~p~~~~~ 516 (604)
...+||+.|+|||++.+ ..++.++|||||||+||||++|+.||....+ ...+..++............
T Consensus 167 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (343)
T 3dbq_A 167 DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIP 246 (343)
T ss_dssp ---CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCCCCS
T ss_pred CCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCCcccC
Confidence 23579999999999975 5688899999999999999999999987544 45556666655555555567
Q ss_pred CHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 517 SFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 517 s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
+.++.+||.+||..||.+||+ +.|+|+||||+.
T Consensus 247 ~~~l~~li~~~L~~dp~~Rpt----~~e~l~hp~~~~ 279 (343)
T 3dbq_A 247 EKDLQDVLKCCLKRDPKQRIS----IPELLAHPYVQI 279 (343)
T ss_dssp CHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHS
T ss_pred CHHHHHHHHHHcCCChhHCCC----HHHHHhCccccc
Confidence 889999999999999999999 999999999974
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=396.82 Aligned_cols=265 Identities=29% Similarity=0.422 Sum_probs=221.0
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEec---
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFET--- 284 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~--- 284 (604)
....++|++++.||+|+||.||+|++..+++.||||++...... ...+.+|+.+|+.+ +||||++++++|..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~ 95 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNP 95 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST----THHHHHHHHHHHHHCCSTTBCCEEEEEEECC-
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc----HHHHHHHHHHHHhccCCCCeeeeeeEEeeccC
Confidence 33458999999999999999999999999999999999754322 23456799999998 89999999999986
Q ss_pred ---CCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccc
Q 007433 285 ---DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDL 361 (604)
Q Consensus 285 ---~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGl 361 (604)
++.+|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+.++.++|+|||+
T Consensus 96 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~ 175 (326)
T 2x7f_A 96 PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 175 (326)
T ss_dssp -CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTT
T ss_pred ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcC
Confidence 56899999999999999999876556799999999999999999999999999999999999999999999999998
Q ss_pred cccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccccc
Q 007433 362 SLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIA 441 (604)
Q Consensus 362 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (604)
+......
T Consensus 176 ~~~~~~~------------------------------------------------------------------------- 182 (326)
T 2x7f_A 176 SAQLDRT------------------------------------------------------------------------- 182 (326)
T ss_dssp TC------------------------------------------------------------------------------
T ss_pred ceecCcC-------------------------------------------------------------------------
Confidence 7432100
Q ss_pred CCCCCcccccccCccccCcceec-----CCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 007433 442 EPTNARSMSFVGTHEYLAPEIIK-----GEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVV 516 (604)
Q Consensus 442 ~~~~~~~~~~~GT~~Y~APE~l~-----~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~ 516 (604)
........||+.|+|||++. +..++.++|||||||+||+|++|..||.+......+..+............+
T Consensus 183 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (326)
T 2x7f_A 183 ---VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW 259 (326)
T ss_dssp -----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCSCS
T ss_pred ---ccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccCCcccc
Confidence 00112346999999999997 5568899999999999999999999999888777777776655444444568
Q ss_pred CHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 517 SFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 517 s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
+..+++||.+||..||.+||+ +.++++||||+...+.
T Consensus 260 ~~~l~~li~~~l~~dp~~Rps----~~~ll~hp~~~~~~~~ 296 (326)
T 2x7f_A 260 SKKFQSFIESCLVKNHSQRPA----TEQLMKHPFIRDQPNE 296 (326)
T ss_dssp CHHHHHHHHHHCCSSGGGSCC----HHHHHTSHHHHCCTTH
T ss_pred CHHHHHHHHHHhccChhhCCC----HHHHhhChHHhhCccc
Confidence 999999999999999999999 9999999999876543
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=404.48 Aligned_cols=250 Identities=28% Similarity=0.447 Sum_probs=212.2
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHH-----HHHHHHHHHHHHHHhCCCCCccccceeEecCCe
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKR-----KKLLRAQTEREILQSLDHPFLPTLYTHFETDKF 287 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~-----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 287 (604)
++|++++.||+|+||+||+|++..+++.||||++.+...... .....+.+|+.+|+.++||||++++++|.+++.
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~ 103 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF 103 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence 689999999999999999999999999999999986532111 122244579999999999999999999999999
Q ss_pred eEEEEeecCCC-CHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 288 SCLVMEFCPGG-DLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 288 ~~lV~E~~~gg-sL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
+|+||||+.+| +|..++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++....
T Consensus 104 ~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 104 FQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 99999998666 999998875 469999999999999999999999999999999999999999999999999884322
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
.. .
T Consensus 182 ~~-----------------------------------------------------------------------------~ 184 (335)
T 3dls_A 182 RG-----------------------------------------------------------------------------K 184 (335)
T ss_dssp TT-----------------------------------------------------------------------------C
T ss_pred CC-----------------------------------------------------------------------------C
Confidence 10 0
Q ss_pred cccccccCccccCcceecCCCC-CccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007433 447 RSMSFVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIK 525 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~~-~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~ 525 (604)
.....+||+.|+|||++.+..+ +.++|||||||++|||++|+.||..... ...... .....++.++.+||.
T Consensus 185 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~--~~~~~~~~~l~~li~ 256 (335)
T 3dls_A 185 LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAI--HPPYLVSKELMSLVS 256 (335)
T ss_dssp CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCC--CCSSCCCHHHHHHHH
T ss_pred ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhcc--CCCcccCHHHHHHHH
Confidence 1123569999999999998887 7899999999999999999999976322 122222 223348999999999
Q ss_pred HhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 526 GLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
+||..||++||+ +.++++||||+.
T Consensus 257 ~~L~~dP~~Rps----~~ell~hp~~~~ 280 (335)
T 3dls_A 257 GLLQPVPERRTT----LEKLVTDPWVTQ 280 (335)
T ss_dssp HHTCSSGGGSCC----HHHHHHCTTTTC
T ss_pred HHccCChhhCcC----HHHHhcCccccC
Confidence 999999999999 999999999965
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=415.65 Aligned_cols=262 Identities=32% Similarity=0.516 Sum_probs=209.5
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHH-----HHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLE-----KRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
.++|.+.+.||+|+||+||+|.+..+++.||||++.+.... .......+.+|+.+|++++||||++++++|.. +
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~ 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-E 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-S
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-C
Confidence 36899999999999999999999999999999999865422 12223346789999999999999999999865 4
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC---cEEEecccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG---HIMLSDFDLSL 363 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g---~vkL~DFGla~ 363 (604)
..|||||||++++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++ .+||+|||++.
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~ 290 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 290 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred ceEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccce
Confidence 579999999999999887654 5799999999999999999999999999999999999997544 59999999984
Q ss_pred cccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCC
Q 007433 364 RCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEP 443 (604)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (604)
.+...
T Consensus 291 ~~~~~--------------------------------------------------------------------------- 295 (419)
T 3i6u_A 291 ILGET--------------------------------------------------------------------------- 295 (419)
T ss_dssp SCC-----------------------------------------------------------------------------
T ss_pred ecCCC---------------------------------------------------------------------------
Confidence 32100
Q ss_pred CCCcccccccCccccCcceecC---CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHH-HHHHcCCCCCCC--CCCCC
Q 007433 444 TNARSMSFVGTHEYLAPEIIKG---EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATL-YNVVGQPLRFPE--SPVVS 517 (604)
Q Consensus 444 ~~~~~~~~~GT~~Y~APE~l~~---~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l-~~i~~~~~~~p~--~~~~s 517 (604)
......+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+......+ ..+......+.. ...++
T Consensus 296 --~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 373 (419)
T 3i6u_A 296 --SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVS 373 (419)
T ss_dssp -----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHHHTTSC
T ss_pred --ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchhhcccC
Confidence 01123579999999999864 56788999999999999999999999875543333 334444333321 24589
Q ss_pred HHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 518 FSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 518 ~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
..+.+||.+||..||++||+ +.|+|+||||++.+|.
T Consensus 374 ~~~~~li~~~L~~dP~~Rps----~~e~l~hp~~~~~~~~ 409 (419)
T 3i6u_A 374 EKALDLVKKLLVVDPKARFT----TEEALRHPWLQDEDMK 409 (419)
T ss_dssp HHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGCCHHHH
T ss_pred HHHHHHHHHHccCChhHCcC----HHHHhCCcccCChhHH
Confidence 99999999999999999999 9999999999987764
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=408.73 Aligned_cols=256 Identities=29% Similarity=0.494 Sum_probs=212.0
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec-------
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET------- 284 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------- 284 (604)
.++|++++.||+|+||+||+|++..+++.||||++..... ...+|+++|+.++||||++++++|..
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 4799999999999999999999999999999999865422 12369999999999999999999943
Q ss_pred -------------------------------CCeeEEEEeecCCCCHHHHHHh--cCCCCCcHHHHHHHHHHHHHHHHHH
Q 007433 285 -------------------------------DKFSCLVMEFCPGGDLHTLRQR--QPGKYFSEQAVKFYVAEVLLALEYL 331 (604)
Q Consensus 285 -------------------------------~~~~~lV~E~~~ggsL~~ll~~--~~~~~l~e~~~~~i~~qil~aL~yL 331 (604)
+.++|+||||++ ++|.+++.. ..+..+++..++.|+.||+.||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 345899999996 688777653 2346799999999999999999999
Q ss_pred HHcCeEeccCCCCcEEEc-cCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCcc
Q 007433 332 HMLGIVYRDLKPENVLVR-EDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTC 410 (604)
Q Consensus 332 H~~gIvHrDIKpeNILl~-~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 410 (604)
|++||+||||||+||||+ .++.+||+|||++..+...
T Consensus 158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~------------------------------------------ 195 (383)
T 3eb0_A 158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS------------------------------------------ 195 (383)
T ss_dssp HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTT------------------------------------------
T ss_pred HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCC------------------------------------------
Confidence 999999999999999998 6889999999998543211
Q ss_pred CCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecCCC-CCccchHHHHHHHHHHHhhCCC
Q 007433 411 FSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKT 489 (604)
Q Consensus 411 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~ 489 (604)
......+||+.|+|||++.+.. ++.++|||||||++|||++|+.
T Consensus 196 -----------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 240 (383)
T 3eb0_A 196 -----------------------------------EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240 (383)
T ss_dssp -----------------------------------SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSC
T ss_pred -----------------------------------CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCC
Confidence 0112346899999999998765 8999999999999999999999
Q ss_pred CCCCCChHHHHHHHHc---C--------------CCCCCC----------CCCCCHHHHHHHHHhhhcCCCCcccccCCH
Q 007433 490 PFKGSENRATLYNVVG---Q--------------PLRFPE----------SPVVSFSARDLIKGLLVKEPQNRLACRRGA 542 (604)
Q Consensus 490 PF~~~~~~~~l~~i~~---~--------------~~~~p~----------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a 542 (604)
||.+....+.+..++. . ...++. ...++.++.+||.+||.+||.+||+ +
T Consensus 241 pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~ 316 (383)
T 3eb0_A 241 LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRIN----P 316 (383)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCC----H
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCC----H
Confidence 9999888777766643 1 111111 2347888999999999999999999 9
Q ss_pred HHHhcCCCCCCCCh
Q 007433 543 TEIKQHPFFQGVNW 556 (604)
Q Consensus 543 ~elL~Hpff~~~~~ 556 (604)
.|+|+||||+.+++
T Consensus 317 ~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 317 YEAMAHPFFDHLRN 330 (383)
T ss_dssp HHHHTSGGGHHHHH
T ss_pred HHHhcCHHHHHHHh
Confidence 99999999987654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=401.09 Aligned_cols=264 Identities=29% Similarity=0.399 Sum_probs=219.2
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
..++|++++.||+|+||.||+|++..+++.||||++....... .....+.+|+.+|+.++||||+++++++.+++..|+
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 101 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDK-MVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYL 101 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCch-HHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEE
Confidence 3579999999999999999999999999999999986553322 233456689999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
||||+++++|..++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 102 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 178 (331)
T 4aaa_A 102 VFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG- 178 (331)
T ss_dssp EEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred EEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc-
Confidence 99999999998876654 469999999999999999999999999999999999999999999999999884322100
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
.....
T Consensus 179 ---------------------------------------------------------------------------~~~~~ 183 (331)
T 4aaa_A 179 ---------------------------------------------------------------------------EVYDD 183 (331)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ---------------------------------------------------------------------------cccCC
Confidence 00112
Q ss_pred cccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC-------------------CCCC
Q 007433 451 FVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ-------------------PLRF 510 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~-------------------~~~~ 510 (604)
..||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+....+.+..+... ...+
T Consensus 184 ~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 263 (331)
T 4aaa_A 184 EVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRL 263 (331)
T ss_dssp CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCC
T ss_pred CcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccC
Confidence 3689999999999876 6899999999999999999999999998877766554321 1111
Q ss_pred CC----------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 511 PE----------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 511 p~----------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
+. .+.++..+.+||.+||..||++||+ +.|+|+||||+...|.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~ 316 (331)
T 4aaa_A 264 PEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPF----CAELLHHDFFQMDGFA 316 (331)
T ss_dssp CCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC----GGGGGGSHHHHGGGHH
T ss_pred ccccccchhhhcccchhHHHHHHHHHHhccCcccCCC----HHHHhcCchhccCChh
Confidence 11 1347889999999999999999999 9999999999876654
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-47 Score=394.36 Aligned_cols=262 Identities=23% Similarity=0.347 Sum_probs=215.6
Q ss_pred cCceeeecCeEEEEEEccCCcEEEEEEEE-cCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCC------Ccccc
Q 007433 206 KDGVLGVGHFRLLKKLGCGDIGSVYLSEL-TGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP------FLPTL 278 (604)
Q Consensus 206 ~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~-~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hp------nIv~l 278 (604)
..+....++|++++.||+|+||+||+|.+ ..+++.||||++.... .....+.+|+++++.++|+ +|+++
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 34455568999999999999999999998 5678899999997542 2234566789999888655 59999
Q ss_pred ceeEecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc--------
Q 007433 279 YTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE-------- 350 (604)
Q Consensus 279 ~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~-------- 350 (604)
+++|.++++.|+||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+||||+.
T Consensus 83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence 99999999999999999 999999998876567999999999999999999999999999999999999987
Q ss_pred -----------CCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCccccccc
Q 007433 351 -----------DGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKS 419 (604)
Q Consensus 351 -----------~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (604)
++.+||+|||++.....
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~---------------------------------------------------- 189 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDE---------------------------------------------------- 189 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTS----------------------------------------------------
T ss_pred CccccccccccCCCceEeeCcccccCcc----------------------------------------------------
Confidence 66899999998742110
Q ss_pred ccccCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHH
Q 007433 420 KKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRAT 499 (604)
Q Consensus 420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~ 499 (604)
.....+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.
T Consensus 190 ---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~ 242 (339)
T 1z57_A 190 ---------------------------HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEH 242 (339)
T ss_dssp ---------------------------CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHH
T ss_pred ---------------------------ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHH
Confidence 01134699999999999999999999999999999999999999998776655
Q ss_pred HHHHHcCCCCCC------------------------------------------CCCCCCHHHHHHHHHhhhcCCCCccc
Q 007433 500 LYNVVGQPLRFP------------------------------------------ESPVVSFSARDLIKGLLVKEPQNRLA 537 (604)
Q Consensus 500 l~~i~~~~~~~p------------------------------------------~~~~~s~~l~dLI~~lL~~dP~~Rpt 537 (604)
+..+......++ .....+.++.+||.+||..||.+||+
T Consensus 243 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt 322 (339)
T 1z57_A 243 LAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRIT 322 (339)
T ss_dssp HHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccC
Confidence 443321100000 01123467889999999999999999
Q ss_pred ccCCHHHHhcCCCCCCCC
Q 007433 538 CRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 538 ~~~~a~elL~Hpff~~~~ 555 (604)
+.|+|+||||+.++
T Consensus 323 ----~~ell~hp~f~~~~ 336 (339)
T 1z57_A 323 ----LREALKHPFFDLLK 336 (339)
T ss_dssp ----HHHHTTSGGGGGGG
T ss_pred ----HHHHhcCHHHHHHh
Confidence 99999999998654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=399.89 Aligned_cols=264 Identities=28% Similarity=0.355 Sum_probs=213.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec-------
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET------- 284 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------- 284 (604)
.++|++++.||+|+||+||+|++..+++.||||++....... .....+.+|+++|+.++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 94 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 94 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence 479999999999999999999999999999999986553221 122345689999999999999999999986
Q ss_pred -CCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccc
Q 007433 285 -DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 285 -~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
++.+|||||||. ++|...+.... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++.
T Consensus 95 ~~~~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~ 172 (351)
T 3mi9_A 95 CKGSIYLVFDFCE-HDLAGLLSNVL-VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 172 (351)
T ss_dssp --CEEEEEEECCS-EEHHHHHHCTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCE
T ss_pred CCceEEEEEeccC-CCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcc
Confidence 457899999995 57777766542 469999999999999999999999999999999999999999999999999985
Q ss_pred cccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCC
Q 007433 364 RCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEP 443 (604)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (604)
.+......
T Consensus 173 ~~~~~~~~------------------------------------------------------------------------ 180 (351)
T 3mi9_A 173 AFSLAKNS------------------------------------------------------------------------ 180 (351)
T ss_dssp ECCCCSSS------------------------------------------------------------------------
T ss_pred cccccccc------------------------------------------------------------------------
Confidence 43211000
Q ss_pred CCCcccccccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC--CCCC-----
Q 007433 444 TNARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFP--ESPV----- 515 (604)
Q Consensus 444 ~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p--~~~~----- 515 (604)
........+||+.|+|||++.+. .++.++|||||||++|||++|+.||.+......+..+......++ ..+.
T Consensus 181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 260 (351)
T 3mi9_A 181 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 260 (351)
T ss_dssp SCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCG
T ss_pred cccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccch
Confidence 00112245699999999999874 579999999999999999999999999887766655543111111 0000
Q ss_pred -----------------------CCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 516 -----------------------VSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 516 -----------------------~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
.+..+++||.+||.+||++||+ +.|+|+||||...
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t----~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 261 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID----SDDALNHDFFWSD 318 (351)
T ss_dssp GGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGGSS
T ss_pred hhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCC----HHHHhCCCCcCCC
Confidence 2677999999999999999999 9999999999753
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-47 Score=406.21 Aligned_cols=258 Identities=28% Similarity=0.433 Sum_probs=215.1
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC--CCCccccceeEecCCeeEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD--HPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~~~~~~l 290 (604)
.+|++++.||+|+||+||+|.+.. ++.||||++...... ......+.+|+.+|+.|. |+||+++++++..++.+||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEeccccc-HHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 569999999999999999999876 789999999765432 234456789999999996 5999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
||| +.+++|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+ ++.+||+|||++..+.....
T Consensus 134 v~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~ 209 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 209 (390)
T ss_dssp EEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----
T ss_pred EEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc
Confidence 999 5589999999876 4789999999999999999999999999999999999995 68999999999843321100
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
......
T Consensus 210 --------------------------------------------------------------------------~~~~~~ 215 (390)
T 2zmd_A 210 --------------------------------------------------------------------------SVVKDS 215 (390)
T ss_dssp ------------------------------------------------------------------------------CC
T ss_pred --------------------------------------------------------------------------cccCCC
Confidence 001123
Q ss_pred cccCccccCcceecC-----------CCCCccchHHHHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCCCCCCCCCCCCH
Q 007433 451 FVGTHEYLAPEIIKG-----------EGHGSAVDWWTFGIFLYELLFGKTPFKGSEN-RATLYNVVGQPLRFPESPVVSF 518 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~-----------~~~~~~~DiWSLGviL~eLltG~~PF~~~~~-~~~l~~i~~~~~~~p~~~~~s~ 518 (604)
.+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+..+ ...+..++.....+......+.
T Consensus 216 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 295 (390)
T 2zmd_A 216 QVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEK 295 (390)
T ss_dssp SCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCCCSCH
T ss_pred CCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCccchH
Confidence 579999999999976 3688899999999999999999999987543 4566677766655555556789
Q ss_pred HHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 519 SARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 519 ~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
++.+||.+||..||.+||+ +.|+|+||||+..
T Consensus 296 ~~~~li~~~L~~dP~~Rps----~~ell~hp~~~~~ 327 (390)
T 2zmd_A 296 DLQDVLKCCLKRDPKQRIS----IPELLAHPYVQIQ 327 (390)
T ss_dssp HHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHSC
T ss_pred HHHHHHHHHcccChhhCCC----HHHHhhCcCcccc
Confidence 9999999999999999999 9999999999754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=404.83 Aligned_cols=258 Identities=28% Similarity=0.413 Sum_probs=202.5
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC------
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD------ 285 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~------ 285 (604)
.++|++++.||+|+||.||+|.+..+++.||||++..... ......++.+|+.+|+.++||||++++++|...
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccC
Confidence 4799999999999999999999999999999999975422 223445677899999999999999999999754
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
..+|+||||+ +++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++...
T Consensus 107 ~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~ 182 (367)
T 2fst_X 107 NDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT 182 (367)
T ss_dssp CCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred CeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence 6689999999 8999998875 46999999999999999999999999999999999999999999999999988432
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
..
T Consensus 183 ~~------------------------------------------------------------------------------ 184 (367)
T 2fst_X 183 AD------------------------------------------------------------------------------ 184 (367)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred CcccccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc---CC--------------
Q 007433 446 ARSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG---QP-------------- 507 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~---~~-------------- 507 (604)
.....+||++|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+.. .+
T Consensus 185 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~ 263 (367)
T 2fst_X 185 -EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 263 (367)
T ss_dssp -------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHH
T ss_pred -cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence 0123479999999999987 6789999999999999999999999999887766655432 11
Q ss_pred ------CCCCC------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 508 ------LRFPE------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 508 ------~~~p~------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
...+. ...++..+.+||.+||..||.+||+ +.|+|+||||+.+...
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t----~~e~L~hp~~~~~~~~ 321 (367)
T 2fst_X 264 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQALAHAYFAQYHDP 321 (367)
T ss_dssp HHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTTCCG
T ss_pred HHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcC----HHHHhcChhhhhccCC
Confidence 00010 1246788999999999999999999 9999999999876543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-47 Score=385.21 Aligned_cols=261 Identities=24% Similarity=0.325 Sum_probs=206.0
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
+..++|++++.||+|+||+||+|++..+++.||||++....... .....+.++..+++.++||||+++++++.+++..|
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQ-EQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcH-HHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 34579999999999999999999999999999999997653322 22233344556688899999999999999999999
Q ss_pred EEEeecCCCCHHHHHHh--cCCCCCcHHHHHHHHHHHHHHHHHHHHc-CeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 290 LVMEFCPGGDLHTLRQR--QPGKYFSEQAVKFYVAEVLLALEYLHML-GIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~--~~~~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
+||||++ ++|.+++.. ..+..+++..++.++.||+.||+|||++ ||+||||||+||||+.++.+||+|||++....
T Consensus 83 lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 83 ICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9999995 588777654 2346799999999999999999999998 99999999999999999999999999884321
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
.. .
T Consensus 162 ~~-----------------------------------------------------------------------------~ 164 (290)
T 3fme_A 162 DD-----------------------------------------------------------------------------V 164 (290)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cc-----------------------------------------------------------------------------c
Confidence 10 0
Q ss_pred cccccccCccccCccee----cCCCCCccchHHHHHHHHHHHhhCCCCCCC-CChHHHHHHHHcCCCCCCCCCCCCHHHH
Q 007433 447 RSMSFVGTHEYLAPEII----KGEGHGSAVDWWTFGIFLYELLFGKTPFKG-SENRATLYNVVGQPLRFPESPVVSFSAR 521 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l----~~~~~~~~~DiWSLGviL~eLltG~~PF~~-~~~~~~l~~i~~~~~~~p~~~~~s~~l~ 521 (604)
......||+.|+|||++ .+..++.++|||||||++|||++|+.||.. ......+..+............++.++.
T Consensus 165 ~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (290)
T 3fme_A 165 AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFV 244 (290)
T ss_dssp -----CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTTTSCHHHH
T ss_pred cccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccccCCHHHH
Confidence 01123599999999996 556688999999999999999999999986 3444555555544433333456899999
Q ss_pred HHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 522 DLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 522 dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
+||.+||..||++||+ +.|+++||||+.
T Consensus 245 ~li~~~l~~~p~~Rpt----~~e~l~hp~f~~ 272 (290)
T 3fme_A 245 DFTSQCLKKNSKERPT----YPELMQHPFFTL 272 (290)
T ss_dssp HHHHHHTCSSGGGSCC----HHHHTTSHHHHH
T ss_pred HHHHHHhhcChhhCcC----HHHHHhCccccc
Confidence 9999999999999999 999999999963
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-47 Score=405.10 Aligned_cols=258 Identities=25% Similarity=0.383 Sum_probs=208.4
Q ss_pred ceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC--------CCCccccc
Q 007433 208 GVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD--------HPFLPTLY 279 (604)
Q Consensus 208 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~--------HpnIv~l~ 279 (604)
+.+..++|+++++||+|+||+||+|++..+++.||||++.... .....+.+|+.+|+.+. |+||++++
T Consensus 32 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~ 107 (397)
T 1wak_A 32 GDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQLL 107 (397)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEE
T ss_pred hhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceeeeee
Confidence 3444589999999999999999999999999999999997652 22345678999999885 78899999
Q ss_pred eeEe----cCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHc-CeEeccCCCCcEEEccCC--
Q 007433 280 THFE----TDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML-GIVYRDLKPENVLVREDG-- 352 (604)
Q Consensus 280 ~~~~----~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDIKpeNILl~~~g-- 352 (604)
++|. .+.++||||||+ +++|.+++.......+++..++.|+.||+.||+|||++ |||||||||+||||+.++
T Consensus 108 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~ 186 (397)
T 1wak_A 108 DDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQY 186 (397)
T ss_dssp EEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHH
T ss_pred cceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchh
Confidence 9998 567899999999 77777776665556799999999999999999999998 999999999999999775
Q ss_pred -----------------------------------------------cEEEecccccccccCCCcccccCcccCCcccCC
Q 007433 353 -----------------------------------------------HIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKN 385 (604)
Q Consensus 353 -----------------------------------------------~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~ 385 (604)
.+||+|||++.....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~------------------ 248 (397)
T 1wak_A 187 IRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK------------------ 248 (397)
T ss_dssp HHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB------------------
T ss_pred hhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc------------------
Confidence 799999998843210
Q ss_pred CccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecC
Q 007433 386 PVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKG 465 (604)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~ 465 (604)
.....+||+.|+|||++.+
T Consensus 249 -------------------------------------------------------------~~~~~~gt~~y~aPE~~~~ 267 (397)
T 1wak_A 249 -------------------------------------------------------------HFTEDIQTRQYRSLEVLIG 267 (397)
T ss_dssp -------------------------------------------------------------CSCSCCSCGGGCCHHHHHT
T ss_pred -------------------------------------------------------------cCccCCCCCcccCChhhcC
Confidence 0112369999999999999
Q ss_pred CCCCccchHHHHHHHHHHHhhCCCCCCCCCh------HHHHHH---HHcCCC---------C------------------
Q 007433 466 EGHGSAVDWWTFGIFLYELLFGKTPFKGSEN------RATLYN---VVGQPL---------R------------------ 509 (604)
Q Consensus 466 ~~~~~~~DiWSLGviL~eLltG~~PF~~~~~------~~~l~~---i~~~~~---------~------------------ 509 (604)
..++.++|||||||+||||++|+.||.+... ...+.. +.+... .
T Consensus 268 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 347 (397)
T 1wak_A 268 SGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKP 347 (397)
T ss_dssp SCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCC
T ss_pred CCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCC
Confidence 9999999999999999999999999986542 222222 222110 0
Q ss_pred ----------CCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 510 ----------FPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 510 ----------~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
+......+..+++||.+||.+||++||+ +.|||+||||++
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~~~~ 397 (397)
T 1wak_A 348 WGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT----AAECLRHPWLNS 397 (397)
T ss_dssp CCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCC----HHHHHTSGGGGC
T ss_pred cchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCC----HHHHhhCccccC
Confidence 0001123456889999999999999999 999999999963
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-47 Score=388.80 Aligned_cols=264 Identities=28% Similarity=0.439 Sum_probs=220.9
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
...++|++++.||+|+||.||+|++..++..||+|++..... .....+.+|+++|+.++||||+++++++..++..|
T Consensus 16 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 92 (302)
T 2j7t_A 16 DPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLW 92 (302)
T ss_dssp CGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEE
T ss_pred CCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCH---HHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEE
Confidence 345799999999999999999999999999999999975432 23446678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
+||||+++++|..++.... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 93 lv~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 170 (302)
T 2j7t_A 93 IMIEFCPGGAVDAIMLELD-RGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT- 170 (302)
T ss_dssp EEEECCTTEEHHHHHHHHT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHH-
T ss_pred EEEEeCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccc-
Confidence 9999999999999887642 56999999999999999999999999999999999999999999999999987321100
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
.....
T Consensus 171 ---------------------------------------------------------------------------~~~~~ 175 (302)
T 2j7t_A 171 ---------------------------------------------------------------------------LQKRD 175 (302)
T ss_dssp ---------------------------------------------------------------------------HHC--
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00011
Q ss_pred ccccCccccCcceec-----CCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC-CCCCCCCCCHHHHHH
Q 007433 450 SFVGTHEYLAPEIIK-----GEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPL-RFPESPVVSFSARDL 523 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~-----~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~-~~p~~~~~s~~l~dL 523 (604)
...||+.|+|||++. +..++.++|||||||++|+|++|+.||...+....+..+..... .......++..+.+|
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 255 (302)
T 2j7t_A 176 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLTPSKWSVEFRDF 255 (302)
T ss_dssp ---CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHH
T ss_pred cccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCCccccCHHHHHH
Confidence 346999999999984 66788999999999999999999999998887777766655432 233345578999999
Q ss_pred HHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 524 IKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 524 I~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
|.+||..||++||+ +.++++||||+.+.|.
T Consensus 256 i~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 256 LKIALDKNPETRPS----AAQLLEHPFVSSITSN 285 (302)
T ss_dssp HHHHSCSCTTTSCC----HHHHTTSTTTTTCCCC
T ss_pred HHHHcccChhhCCC----HHHHhcChHHhhhccc
Confidence 99999999999999 9999999999988764
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=394.00 Aligned_cols=270 Identities=27% Similarity=0.422 Sum_probs=216.5
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC-----C
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD-----K 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~ 286 (604)
.++|++.+.||+|+||.||+|.+..+++.||||++..... .....++.+|+++|+.++||||+++++++..+ .
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 87 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDK--PLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN 87 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSS--HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccccc--chHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence 4799999999999999999999999999999999965422 23344567899999999999999999988654 6
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
..|+||||+. ++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 88 ~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 88 EVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp CEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 8899999995 699998876 369999999999999999999999999999999999999999999999999985543
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
........ ......
T Consensus 164 ~~~~~~~~------------------------------------------------------------------~~~~~~ 177 (353)
T 2b9h_A 164 ESAADNSE------------------------------------------------------------------PTGQQS 177 (353)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccccccC------------------------------------------------------------------cccccc
Confidence 21100000 000001
Q ss_pred cccccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc---CCC--------------
Q 007433 447 RSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG---QPL-------------- 508 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~---~~~-------------- 508 (604)
....++||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.+..+.+..+.. .+.
T Consensus 178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (353)
T 2b9h_A 178 GMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAR 257 (353)
T ss_dssp --CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHH
T ss_pred chhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhh
Confidence 1224579999999998765 6789999999999999999999999999877665544332 111
Q ss_pred -------CCCC------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 509 -------RFPE------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 509 -------~~p~------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
..+. .+.++.++++||.+||..||++||+ +.|+|+||||+.+.|.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~~~~~ 315 (353)
T 2b9h_A 258 EYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT----AKEALEHPYLQTYHDP 315 (353)
T ss_dssp HHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTTCCT
T ss_pred HHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCC----HHHHhcCccccccCCc
Confidence 0010 1357889999999999999999999 9999999999987654
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=399.01 Aligned_cols=258 Identities=19% Similarity=0.282 Sum_probs=216.2
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEc-------CCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCcccccee
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELT-------GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTH 281 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~ 281 (604)
+..++|++.+.||+|+||+||+|++. .++..||||++..... ......+.+|+++|+.+ +||||++++++
T Consensus 78 ~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 155 (370)
T 2psq_A 78 FPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGA 155 (370)
T ss_dssp CCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCB--HHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred ccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcC--HHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence 34579999999999999999999875 3566899999976532 23455678899999999 89999999999
Q ss_pred EecCCeeEEEEeecCCCCHHHHHHhcC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEE
Q 007433 282 FETDKFSCLVMEFCPGGDLHTLRQRQP--------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVL 347 (604)
Q Consensus 282 ~~~~~~~~lV~E~~~ggsL~~ll~~~~--------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNIL 347 (604)
|.+++.+|+||||+++|+|.+++.... ...+++..+..++.||+.||+|||++|||||||||+|||
T Consensus 156 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 235 (370)
T 2psq_A 156 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 235 (370)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred EccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEE
Confidence 999999999999999999999988653 235899999999999999999999999999999999999
Q ss_pred EccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCcc
Q 007433 348 VREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKN 427 (604)
Q Consensus 348 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 427 (604)
|+.+|.+||+|||++..+.....
T Consensus 236 l~~~~~~kl~DFG~a~~~~~~~~--------------------------------------------------------- 258 (370)
T 2psq_A 236 VTENNVMKIADFGLARDINNIDY--------------------------------------------------------- 258 (370)
T ss_dssp ECTTCCEEECCCSSCEETTCCCT---------------------------------------------------------
T ss_pred ECCCCCEEEccccCCcccCcccc---------------------------------------------------------
Confidence 99999999999999854321100
Q ss_pred ccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcC
Q 007433 428 EMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQ 506 (604)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~ 506 (604)
........||+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+...
T Consensus 259 -----------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 321 (370)
T 2psq_A 259 -----------------YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 321 (370)
T ss_dssp -----------------TCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTT
T ss_pred -----------------eecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC
Confidence 001112357899999999999999999999999999999999 99999988776666555443
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 507 PLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 507 ~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
........++.++.+||.+||..||++||+ +.|++++
T Consensus 322 -~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt----~~ell~~ 358 (370)
T 2psq_A 322 -HRMDKPANCTNELYMMMRDCWHAVPSQRPT----FKQLVED 358 (370)
T ss_dssp -CCCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred -CCCCCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 333344568999999999999999999999 8888865
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=399.49 Aligned_cols=258 Identities=30% Similarity=0.414 Sum_probs=215.0
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCee---
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS--- 288 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~--- 288 (604)
.++|.+.+.||+|+||+||+|.+..+++.||||++...... .....++.+|+.+|+.++||||++++++|...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccc-hhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccc
Confidence 37999999999999999999999999999999999764322 23445677899999999999999999999876654
Q ss_pred ---EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 289 ---CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 289 ---~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
|+||||+. ++|..++. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++...
T Consensus 120 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 194 (371)
T 4exu_A 120 YDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 194 (371)
T ss_dssp CCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred eeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence 99999995 78877663 34999999999999999999999999999999999999999999999999988422
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
..
T Consensus 195 ~~------------------------------------------------------------------------------ 196 (371)
T 4exu_A 195 DA------------------------------------------------------------------------------ 196 (371)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred CcccccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---C--------------
Q 007433 446 ARSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---P-------------- 507 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~-------------- 507 (604)
.....+||+.|+|||++.+ ..++.++|||||||+||+|++|+.||.+.+..+.+..+... +
T Consensus 197 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 275 (371)
T 4exu_A 197 -EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 275 (371)
T ss_dssp ----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHH
T ss_pred -CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhh
Confidence 0113468999999999987 67899999999999999999999999998877766655421 0
Q ss_pred ------CCCC------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhh
Q 007433 508 ------LRFP------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWAL 558 (604)
Q Consensus 508 ------~~~p------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~ 558 (604)
...+ ..+.++..+++||.+||..||++||+ +.|+|+||||+.+.+..
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~~~~ 334 (371)
T 4exu_A 276 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT----AAQALTHPFFEPFRDPE 334 (371)
T ss_dssp HHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCC----HHHHHTSGGGTTTCCGG
T ss_pred hhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCC----HHHHhcCcccccCCCcc
Confidence 0000 01346899999999999999999999 99999999999876543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=380.47 Aligned_cols=253 Identities=21% Similarity=0.321 Sum_probs=207.7
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCeeEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV 291 (604)
++|++++.||+|+||+||+|.+..+++.||||++....... .....+.+|+.++..+ +||||+++++++.+++..|+|
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 68999999999999999999999999999999997643222 2234566899999999 999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC-----------------
Q 007433 292 MEFCPGGDLHTLRQRQP--GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG----------------- 352 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~--~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g----------------- 352 (604)
|||++|++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||||+.++
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 99999999999987642 25689999999999999999999999999999999999998544
Q ss_pred --cEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccC
Q 007433 353 --HIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMG 430 (604)
Q Consensus 353 --~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 430 (604)
.++|+|||++.....
T Consensus 170 ~~~~kl~Dfg~~~~~~~--------------------------------------------------------------- 186 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISS--------------------------------------------------------------- 186 (289)
T ss_dssp CCCEEECCCTTCEETTC---------------------------------------------------------------
T ss_pred ceEEEEcccccccccCC---------------------------------------------------------------
Confidence 799999998743210
Q ss_pred CCCCCCcccccCCCCCcccccccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC
Q 007433 431 NQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR 509 (604)
Q Consensus 431 ~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~ 509 (604)
.....||+.|+|||++.+. .++.++|||||||++|+|++|.++|.... ....+......
T Consensus 187 -----------------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~~~~~~~~ 246 (289)
T 1x8b_A 187 -----------------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHEIRQGRLP 246 (289)
T ss_dssp -----------------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHHHHTTCCC
T ss_pred -----------------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHHHHcCCCC
Confidence 0122489999999999876 45689999999999999999998876543 23333333221
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 510 FPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 510 ~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
.....++.++.+||.+||..||++||+ +.|+++||||.+.
T Consensus 247 -~~~~~~~~~~~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 247 -RIPQVLSQEFTELLKVMIHPDPERRPS----AMALVKHSVLLSA 286 (289)
T ss_dssp -CCSSCCCHHHHHHHHHHTCSSGGGSCC----HHHHHTCTTC---
T ss_pred -CCCcccCHHHHHHHHHHhCCCcccCCC----HHHHhhChHhhhh
Confidence 223458999999999999999999999 9999999999753
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-47 Score=389.46 Aligned_cols=271 Identities=27% Similarity=0.393 Sum_probs=200.9
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
+..++|++++.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+|+.++||||+++++++..++..|
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 89 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQ--TSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW 89 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcc--hhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence 4457999999999999999999999999999999999765322 23445678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhc------CCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccc
Q 007433 290 LVMEFCPGGDLHTLRQRQ------PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~------~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
+||||++|++|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.
T Consensus 90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 999999999999988741 23569999999999999999999999999999999999999999999999999985
Q ss_pred cccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCC
Q 007433 364 RCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEP 443 (604)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (604)
.+.......
T Consensus 170 ~~~~~~~~~----------------------------------------------------------------------- 178 (303)
T 2vwi_A 170 FLATGGDIT----------------------------------------------------------------------- 178 (303)
T ss_dssp HCC-----------------------------------------------------------------------------
T ss_pred eeccCCCcc-----------------------------------------------------------------------
Confidence 432111000
Q ss_pred CCCcccccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC-C-------CCCC
Q 007433 444 TNARSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR-F-------PESP 514 (604)
Q Consensus 444 ~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~-~-------p~~~ 514 (604)
.........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........+......... . ....
T Consensus 179 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (303)
T 2vwi_A 179 RNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLK 258 (303)
T ss_dssp ---------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCC
T ss_pred chhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhh
Confidence 0001123469999999999976 56899999999999999999999999987776665555433211 1 1124
Q ss_pred CCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 515 VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 515 ~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
.++.++++||.+||..||.+||+ +.++++||||+...+.
T Consensus 259 ~~~~~~~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~ 297 (303)
T 2vwi_A 259 KYGKSFRKMISLCLQKDPEKRPT----AAELLRHKFFQKAKNK 297 (303)
T ss_dssp CCCHHHHHHHHHHCCSSGGGSCC----HHHHHTSTTC------
T ss_pred hhhHHHHHHHHHHccCChhhCcC----HHHHhhChhhhcCCCC
Confidence 57889999999999999999999 9999999999876543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-46 Score=393.71 Aligned_cols=267 Identities=23% Similarity=0.337 Sum_probs=217.6
Q ss_pred ecCceeeecCeEEEEEEccCCcEEEEEEEEcCCc-eEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCC------ccc
Q 007433 205 VKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTK-CYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF------LPT 277 (604)
Q Consensus 205 ~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~-~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn------Iv~ 277 (604)
...+....++|++++.||+|+||+||+|.+..++ ..||||++.... .....+.+|+.+|+.+.|++ |+.
T Consensus 11 ~~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~ 86 (355)
T 2eu9_A 11 CRIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVL 86 (355)
T ss_dssp CCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCC
T ss_pred cccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEE
Confidence 3344555689999999999999999999998776 799999997642 22335567999999887655 899
Q ss_pred cceeEecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEE---------
Q 007433 278 LYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV--------- 348 (604)
Q Consensus 278 l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl--------- 348 (604)
+++++...++.||||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+||||
T Consensus 87 ~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~ 165 (355)
T 2eu9_A 87 MSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLY 165 (355)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEE
T ss_pred eeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccc
Confidence 999999999999999999 7778777776655679999999999999999999999999999999999999
Q ss_pred ----------ccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccc
Q 007433 349 ----------REDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSK 418 (604)
Q Consensus 349 ----------~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 418 (604)
+.++.+||+|||++.....
T Consensus 166 ~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~--------------------------------------------------- 194 (355)
T 2eu9_A 166 NEHKSCEEKSVKNTSIRVADFGSATFDHE--------------------------------------------------- 194 (355)
T ss_dssp CCC-CCCEEEESCCCEEECCCTTCEETTS---------------------------------------------------
T ss_pred cccccccccccCCCcEEEeecCccccccc---------------------------------------------------
Confidence 5678999999998843110
Q ss_pred cccccCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHH
Q 007433 419 SKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRA 498 (604)
Q Consensus 419 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~ 498 (604)
.....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+....+
T Consensus 195 ----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~ 246 (355)
T 2eu9_A 195 ----------------------------HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246 (355)
T ss_dssp ----------------------------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred ----------------------------cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 0113469999999999999999999999999999999999999999877765
Q ss_pred HHHHHHcCCCCCC------------------------------------------CCCCCCHHHHHHHHHhhhcCCCCcc
Q 007433 499 TLYNVVGQPLRFP------------------------------------------ESPVVSFSARDLIKGLLVKEPQNRL 536 (604)
Q Consensus 499 ~l~~i~~~~~~~p------------------------------------------~~~~~s~~l~dLI~~lL~~dP~~Rp 536 (604)
.+..+......+| .....+.++.+||.+||..||++||
T Consensus 247 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp 326 (355)
T 2eu9_A 247 HLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRI 326 (355)
T ss_dssp HHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSC
T ss_pred HHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCc
Confidence 5443322100000 0111245788999999999999999
Q ss_pred cccCCHHHHhcCCCCCCCChhhh
Q 007433 537 ACRRGATEIKQHPFFQGVNWALI 559 (604)
Q Consensus 537 t~~~~a~elL~Hpff~~~~~~~~ 559 (604)
+ +.|+|+||||++++|...
T Consensus 327 t----~~e~l~hp~f~~~~~~~~ 345 (355)
T 2eu9_A 327 T----LAEALLHPFFAGLTPEER 345 (355)
T ss_dssp C----HHHHTTSGGGGGCCHHHH
T ss_pred C----HHHHhcChhhcCCChhhc
Confidence 9 999999999999988644
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-48 Score=409.17 Aligned_cols=263 Identities=19% Similarity=0.222 Sum_probs=201.4
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC--CCCCccccc-------eeEe
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL--DHPFLPTLY-------THFE 283 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l--~HpnIv~l~-------~~~~ 283 (604)
.+|++++.||+|+||+||+|++..+++.||||++.............+.+|+.+++.| +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 4599999999999999999999999999999999886554445555667775544444 799988755 4443
Q ss_pred cC-----------------CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHH------HHHHHHHHHHHHHHHHcCeEecc
Q 007433 284 TD-----------------KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAV------KFYVAEVLLALEYLHMLGIVYRD 340 (604)
Q Consensus 284 ~~-----------------~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~------~~i~~qil~aL~yLH~~gIvHrD 340 (604)
.. ..+|||||||+ ++|.+++.... ..+.+..+ ..++.||+.||+|||++||||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD 219 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH 219 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence 22 34899999997 89999988642 33455555 67779999999999999999999
Q ss_pred CCCCcEEEccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccc
Q 007433 341 LKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSK 420 (604)
Q Consensus 341 IKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (604)
|||+||||+.+|.+||+|||++.....
T Consensus 220 ikp~NIll~~~~~~kL~DFG~a~~~~~----------------------------------------------------- 246 (371)
T 3q60_A 220 FTPDNLFIMPDGRLMLGDVSALWKVGT----------------------------------------------------- 246 (371)
T ss_dssp CSGGGEEECTTSCEEECCGGGEEETTC-----------------------------------------------------
T ss_pred CCHHHEEECCCCCEEEEecceeeecCC-----------------------------------------------------
Confidence 999999999999999999999843210
Q ss_pred cccCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecC--CCCCccchHHHHHHHHHHHhhCCCCCCCCChHH
Q 007433 421 KAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKG--EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRA 498 (604)
Q Consensus 421 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~--~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~ 498 (604)
......||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.....
T Consensus 247 --------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~ 300 (371)
T 3q60_A 247 --------------------------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI 300 (371)
T ss_dssp --------------------------EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTC
T ss_pred --------------------------CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccc
Confidence 0012357799999999987 678999999999999999999999998763321
Q ss_pred H--H-----HHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhhhh
Q 007433 499 T--L-----YNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIR 560 (604)
Q Consensus 499 ~--l-----~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~~ 560 (604)
. + .......+.++....++..+++||.+||..||++||+ +.++|+||||++++|....
T Consensus 301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~~~~ 365 (371)
T 3q60_A 301 KGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLL----PLEAMETPEFLQLQNEISS 365 (371)
T ss_dssp TTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCC----HHHHTTSHHHHHHHHHHHH
T ss_pred ccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCC----HHHHhcCHHHHHHHHHHhh
Confidence 0 0 0011223445555678999999999999999999999 9999999999998887543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=387.43 Aligned_cols=257 Identities=23% Similarity=0.314 Sum_probs=213.2
Q ss_pred ceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCe
Q 007433 208 GVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKF 287 (604)
Q Consensus 208 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 287 (604)
..+..++|++.+.||+|+||+||+|++. +..||||++....... ....++.+|+++|++++||||+++++++.+++.
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~~--~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEWH--GSDVAVKILMEQDFHA-ERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEECCCCCSH-HHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEEC--CCcEEEEEecCCCCCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 3455689999999999999999999874 6689999997654332 334567789999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHcC--eEeccCCCCcEEEccCCcEEEeccccccc
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPG-KYFSEQAVKFYVAEVLLALEYLHMLG--IVYRDLKPENVLVREDGHIMLSDFDLSLR 364 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~-~~l~e~~~~~i~~qil~aL~yLH~~g--IvHrDIKpeNILl~~~g~vkL~DFGla~~ 364 (604)
.|+||||+++++|.+++..... ..+++..+..++.||+.||+|||++| |+||||||+||||+.++.+||+|||++..
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 9999999999999999886421 23999999999999999999999999 99999999999999999999999998842
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
....
T Consensus 189 ~~~~---------------------------------------------------------------------------- 192 (309)
T 3p86_A 189 KAST---------------------------------------------------------------------------- 192 (309)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccc----------------------------------------------------------------------------
Confidence 1100
Q ss_pred CCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007433 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLI 524 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI 524 (604)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.+..+............++.++.+||
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 272 (309)
T 3p86_A 193 FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAII 272 (309)
T ss_dssp ---------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHHHHH
T ss_pred ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCHHHHHHH
Confidence 00112346999999999999999999999999999999999999999998887777766544444455566999999999
Q ss_pred HHhhhcCCCCcccccCCHHHHhc
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
.+||..||.+||+ +.++++
T Consensus 273 ~~~l~~dP~~Rps----~~~ll~ 291 (309)
T 3p86_A 273 EGCWTNEPWKRPS----FATIMD 291 (309)
T ss_dssp HHHTCSSGGGSCC----HHHHHH
T ss_pred HHHccCChhhCcC----HHHHHH
Confidence 9999999999999 888876
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=386.10 Aligned_cols=260 Identities=29% Similarity=0.474 Sum_probs=218.9
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++++.||+|+||.||+|.+..+++.||||++..... ...+.+|+.+|+.++||||+++++++..++..|+|
T Consensus 28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 102 (314)
T 3com_A 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD-----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV 102 (314)
T ss_dssp --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC-----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH-----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence 4689999999999999999999999999999999976432 23566899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 103 ~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-- 179 (314)
T 3com_A 103 MEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM-- 179 (314)
T ss_dssp EECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB--
T ss_pred eecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc--
Confidence 9999999999998743 3579999999999999999999999999999999999999999999999999884322100
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......
T Consensus 180 --------------------------------------------------------------------------~~~~~~ 185 (314)
T 3com_A 180 --------------------------------------------------------------------------AKRNTV 185 (314)
T ss_dssp --------------------------------------------------------------------------SCBCCC
T ss_pred --------------------------------------------------------------------------cccCcc
Confidence 011234
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-CCCCCCCCCCHHHHHHHHHhhhc
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP-LRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~-~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
.||+.|+|||++.+..++.++|||||||++|+|++|+.||........+..+.... ..+.....++..+.+||.+||..
T Consensus 186 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 265 (314)
T 3com_A 186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFTDFVKQCLVK 265 (314)
T ss_dssp CSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHHHHHHHHTCS
T ss_pred CCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHHHHHHHHccC
Confidence 69999999999999999999999999999999999999999887776666554432 33333445789999999999999
Q ss_pred CCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 531 EPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
||.+||+ +.++|+||||++..+.
T Consensus 266 dp~~Rpt----~~~ll~~~~~~~~~~~ 288 (314)
T 3com_A 266 SPEQRAT----ATQLLQHPFVRSAKGV 288 (314)
T ss_dssp CTTTSCC----HHHHTTSHHHHTCCCG
T ss_pred ChhhCcC----HHHHHhCHHHhcCCcc
Confidence 9999999 9999999999877644
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=415.55 Aligned_cols=253 Identities=17% Similarity=0.210 Sum_probs=201.8
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHH---HHHHhCCCCCccccc-------ee
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTER---EILQSLDHPFLPTLY-------TH 281 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei---~iL~~l~HpnIv~l~-------~~ 281 (604)
.++|++.+.||+|+||+||+|++..+++.||||++.+...........+.+|+ ++|+.++||||++++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 46899999999999999999999999999999999765333333445677899 455566899999998 66
Q ss_pred EecCC-----------------eeEEEEeecCCCCHHHHHHhcC-----CCCCcHHHHHHHHHHHHHHHHHHHHcCeEec
Q 007433 282 FETDK-----------------FSCLVMEFCPGGDLHTLRQRQP-----GKYFSEQAVKFYVAEVLLALEYLHMLGIVYR 339 (604)
Q Consensus 282 ~~~~~-----------------~~~lV~E~~~ggsL~~ll~~~~-----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHr 339 (604)
+++++ ..||||||+ +|+|.+++.... ...+++..+..|+.||+.||+|||++|||||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 65543 388999999 789999988641 1123458888999999999999999999999
Q ss_pred cCCCCcEEEccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCccccccc
Q 007433 340 DLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKS 419 (604)
Q Consensus 340 DIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 419 (604)
||||+||||+.+|.+||+|||++....
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~~----------------------------------------------------- 257 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRDG----------------------------------------------------- 257 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEETT-----------------------------------------------------
T ss_pred CCCHHHEEEcCCCCEEEEechhheecC-----------------------------------------------------
Confidence 999999999999999999999984311
Q ss_pred ccccCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecCC-----------CCCccchHHHHHHHHHHHhhCC
Q 007433 420 KKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGE-----------GHGSAVDWWTFGIFLYELLFGK 488 (604)
Q Consensus 420 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----------~~~~~~DiWSLGviL~eLltG~ 488 (604)
......+| +.|+|||++.+. .++.++|||||||+||||++|+
T Consensus 258 --------------------------~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~ 310 (377)
T 3byv_A 258 --------------------------ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310 (377)
T ss_dssp --------------------------CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSS
T ss_pred --------------------------CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCC
Confidence 01123468 999999999988 8999999999999999999999
Q ss_pred CCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCC
Q 007433 489 TPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 489 ~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
.||.+......+..+.. ....++.++.+||.+||..||++||+ +.|+|+||||+++.
T Consensus 311 ~Pf~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~L~~dp~~Rpt----~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 311 LPITKDAALGGSEWIFR------SCKNIPQPVRALLEGFLRYPKEDRLL----PLQAMETPEYEQLR 367 (377)
T ss_dssp CCC------CCSGGGGS------SCCCCCHHHHHHHHHHTCSSGGGCCC----HHHHHTSHHHHHHH
T ss_pred CCCcccccccchhhhhh------hccCCCHHHHHHHHHHcCCCchhCCC----HHHHhhChHHHHHH
Confidence 99987654433322222 22468999999999999999999999 99999999998654
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=399.98 Aligned_cols=265 Identities=25% Similarity=0.380 Sum_probs=215.4
Q ss_pred eecCceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CC-----Cccc
Q 007433 204 RVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HP-----FLPT 277 (604)
Q Consensus 204 ~~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-Hp-----nIv~ 277 (604)
.+..+....++|++++.||+|+||+||+|++..+++.||||++.... .....+.+|+.+++.+. |+ +|++
T Consensus 45 ~~~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~ 120 (382)
T 2vx3_A 45 IVKNGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVH 120 (382)
T ss_dssp CCCTTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCC
T ss_pred EeecCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEE
Confidence 34455556789999999999999999999999999999999997542 22345567888888874 44 4999
Q ss_pred cceeEecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH--HcCeEeccCCCCcEEEc--cCCc
Q 007433 278 LYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH--MLGIVYRDLKPENVLVR--EDGH 353 (604)
Q Consensus 278 l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH--~~gIvHrDIKpeNILl~--~~g~ 353 (604)
++++|..++..||||||+ +++|.+++.......+++..++.++.||+.||.||| ++|||||||||+||||+ .++.
T Consensus 121 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~ 199 (382)
T 2vx3_A 121 LKRHFMFRNHLCLVFEML-SYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSA 199 (382)
T ss_dssp EEEEEEETTEEEEEEECC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCC
T ss_pred eeeeeccCCceEEEEecC-CCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCc
Confidence 999999999999999999 569999998876567999999999999999999999 57999999999999995 4778
Q ss_pred EEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCC
Q 007433 354 IMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQV 433 (604)
Q Consensus 354 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (604)
+||+|||++.....
T Consensus 200 ~kL~DFG~a~~~~~------------------------------------------------------------------ 213 (382)
T 2vx3_A 200 IKIVDFGSSCQLGQ------------------------------------------------------------------ 213 (382)
T ss_dssp EEECCCTTCEETTC------------------------------------------------------------------
T ss_pred EEEEeccCceeccc------------------------------------------------------------------
Confidence 99999999843210
Q ss_pred CCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC----
Q 007433 434 SPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR---- 509 (604)
Q Consensus 434 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~---- 509 (604)
.....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+..+......
T Consensus 214 -------------~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~ 280 (382)
T 2vx3_A 214 -------------RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH 280 (382)
T ss_dssp -------------CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred -------------ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 011346999999999999999999999999999999999999999998887776665431000
Q ss_pred --------------CCC-------------------CCC-------------------------CCHHHHHHHHHhhhcC
Q 007433 510 --------------FPE-------------------SPV-------------------------VSFSARDLIKGLLVKE 531 (604)
Q Consensus 510 --------------~p~-------------------~~~-------------------------~s~~l~dLI~~lL~~d 531 (604)
++. ... .+.++++||.+||.+|
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d 360 (382)
T 2vx3_A 281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD 360 (382)
T ss_dssp HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence 000 000 0136899999999999
Q ss_pred CCCcccccCCHHHHhcCCCCCCCCh
Q 007433 532 PQNRLACRRGATEIKQHPFFQGVNW 556 (604)
Q Consensus 532 P~~Rpt~~~~a~elL~Hpff~~~~~ 556 (604)
|++||| +.|+|+||||+...|
T Consensus 361 P~~Rpt----a~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 361 PKTRIQ----PYYALQHSFFKKTAD 381 (382)
T ss_dssp TTTSCC----HHHHTTSGGGCC---
T ss_pred hhhCCC----HHHHhcCcccccCCC
Confidence 999999 999999999987543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-47 Score=392.66 Aligned_cols=261 Identities=33% Similarity=0.519 Sum_probs=212.0
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHH-----HHHHHHHHHHHHHHHHhCCCCCccccceeEecCCe
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLE-----KRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKF 287 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 287 (604)
++|++++.||+|+||.||+|.+..+++.||||++.+.... .......+.+|+++|+.++||||+++++++..+.
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~- 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED- 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-
Confidence 6899999999999999999999999999999999765331 1122335678999999999999999999998765
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCc---EEEeccccccc
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGH---IMLSDFDLSLR 364 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~---vkL~DFGla~~ 364 (604)
.|+||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.++. +||+|||++..
T Consensus 89 ~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 89999999999999988764 57999999999999999999999999999999999999987664 99999998843
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
....
T Consensus 167 ~~~~---------------------------------------------------------------------------- 170 (322)
T 2ycf_A 167 LGET---------------------------------------------------------------------------- 170 (322)
T ss_dssp CCCC----------------------------------------------------------------------------
T ss_pred cccc----------------------------------------------------------------------------
Confidence 2100
Q ss_pred CCcccccccCccccCcceec---CCCCCccchHHHHHHHHHHHhhCCCCCCCCChHH-HHHHHHcCCCCCCC--CCCCCH
Q 007433 445 NARSMSFVGTHEYLAPEIIK---GEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRA-TLYNVVGQPLRFPE--SPVVSF 518 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l~---~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~-~l~~i~~~~~~~p~--~~~~s~ 518 (604)
.......||+.|+|||++. ...++.++|||||||++|+|++|..||....... ....+......+.. ...++.
T Consensus 171 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (322)
T 2ycf_A 171 -SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSE 249 (322)
T ss_dssp -HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHHTTSCH
T ss_pred -cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhhhhcCH
Confidence 0012346999999999974 4568899999999999999999999998754432 22333333333211 235789
Q ss_pred HHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 519 SARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 519 ~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
.+.+||.+||..||++||+ +.++|+||||+..+|.
T Consensus 250 ~~~~li~~~l~~dP~~Rps----~~~~l~h~~~~~~~~~ 284 (322)
T 2ycf_A 250 KALDLVKKLLVVDPKARFT----TEEALRHPWLQDEDMK 284 (322)
T ss_dssp HHHHHHHHHSCSSTTTSCC----HHHHHTSGGGCCHHHH
T ss_pred HHHHHHHHHcccCHhhCCC----HHHHhhCcCcCCHHHH
Confidence 9999999999999999999 9999999999987764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-46 Score=388.61 Aligned_cols=263 Identities=26% Similarity=0.398 Sum_probs=216.7
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEc-CCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC---CCCCccccceeEe----
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELT-GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL---DHPFLPTLYTHFE---- 283 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~---- 283 (604)
.++|++++.||+|+||.||+|++. .+++.||||++....... .....+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 479999999999999999999995 678899999997543211 1111234566666655 8999999999987
Q ss_pred -cCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 284 -TDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 284 -~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
.....|+||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~ 167 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 167 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence 5678999999996 69999998876667999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccC
Q 007433 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442 (604)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (604)
......
T Consensus 168 ~~~~~~-------------------------------------------------------------------------- 173 (326)
T 1blx_A 168 RIYSFQ-------------------------------------------------------------------------- 173 (326)
T ss_dssp CCCCGG--------------------------------------------------------------------------
T ss_pred ccccCC--------------------------------------------------------------------------
Confidence 432100
Q ss_pred CCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---CC--CC-------
Q 007433 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---PL--RF------- 510 (604)
Q Consensus 443 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~~--~~------- 510 (604)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+.+..++.. +. .+
T Consensus 174 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 250 (326)
T 1blx_A 174 ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 250 (326)
T ss_dssp ---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSC
T ss_pred ---CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccc
Confidence 0111346899999999999999999999999999999999999999998887777666531 10 00
Q ss_pred -------------CCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 511 -------------PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 511 -------------p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
.....++..+++||.+||..||++||+ +.|+|+||||+.+++.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~~~~~~~~ 306 (326)
T 1blx_A 251 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSALSHPYFQDLERC 306 (326)
T ss_dssp GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGTTCCCC
T ss_pred hhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCC----HHHHhcCccccccchh
Confidence 012357889999999999999999999 9999999999988764
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=390.64 Aligned_cols=257 Identities=24% Similarity=0.391 Sum_probs=209.7
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC--e
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK--F 287 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--~ 287 (604)
...++|++.+.||+|+||+||+|++..+++.||||++....... ....+.+|+++|+.++||||+++++++.... .
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCce
Confidence 33578999999999999999999999999999999997654322 2334568999999999999999999998654 8
Q ss_pred eEEEEeecCCCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEE----ccCCcEEEeccccc
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPG-KYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV----REDGHIMLSDFDLS 362 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl----~~~g~vkL~DFGla 362 (604)
.||||||+++++|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a 163 (319)
T 4euu_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (319)
T ss_dssp EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence 8999999999999999886532 349999999999999999999999999999999999999 77788999999998
Q ss_pred ccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccC
Q 007433 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442 (604)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (604)
..+...
T Consensus 164 ~~~~~~-------------------------------------------------------------------------- 169 (319)
T 4euu_A 164 RELEDD-------------------------------------------------------------------------- 169 (319)
T ss_dssp EECCTT--------------------------------------------------------------------------
T ss_pred eecCCC--------------------------------------------------------------------------
Confidence 443210
Q ss_pred CCCCcccccccCccccCcceec--------CCCCCccchHHHHHHHHHHHhhCCCCCCCCC----hHHHHHHHHcCCC--
Q 007433 443 PTNARSMSFVGTHEYLAPEIIK--------GEGHGSAVDWWTFGIFLYELLFGKTPFKGSE----NRATLYNVVGQPL-- 508 (604)
Q Consensus 443 ~~~~~~~~~~GT~~Y~APE~l~--------~~~~~~~~DiWSLGviL~eLltG~~PF~~~~----~~~~l~~i~~~~~-- 508 (604)
......+||+.|+|||++. +..++.++|||||||+||||++|+.||.... ..+.+.++.....
T Consensus 170 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~ 246 (319)
T 4euu_A 170 ---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246 (319)
T ss_dssp ---CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTT
T ss_pred ---CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcc
Confidence 0112346999999999986 5678999999999999999999999997532 3445555554322
Q ss_pred -----------------CCCCCC----CCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCC
Q 007433 509 -----------------RFPESP----VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHP 549 (604)
Q Consensus 509 -----------------~~p~~~----~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hp 549 (604)
.++... .++..+.+||.+||..||++||+ +.|+|+||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s----~~ell~h~ 304 (319)
T 4euu_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG----FDQFFAET 304 (319)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC----HHHHHHHH
T ss_pred cchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhcc----HHHhhhcc
Confidence 122211 23456889999999999999999 99999997
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=390.04 Aligned_cols=257 Identities=30% Similarity=0.407 Sum_probs=213.2
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCe----
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKF---- 287 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~---- 287 (604)
.++|.+.+.||+|+||.||+|.+..+++.||||++...... .....++.+|+.+|+.++||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccc
Confidence 47999999999999999999999999999999999764322 2344567789999999999999999999987654
Q ss_pred --eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 288 --SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 288 --~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
+|+||||+. ++|.+++. ..+++..++.++.||+.||+|||++||+||||||+||||+.++.+||+|||++...
T Consensus 102 ~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~ 176 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA 176 (353)
T ss_dssp CCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred eeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence 499999995 68887663 34999999999999999999999999999999999999999999999999987321
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
..
T Consensus 177 ~~------------------------------------------------------------------------------ 178 (353)
T 3coi_A 177 DA------------------------------------------------------------------------------ 178 (353)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CC------------------------------------------------------------------------------
Confidence 10
Q ss_pred CcccccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC------------------
Q 007433 446 ARSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ------------------ 506 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~------------------ 506 (604)
.....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+..+...
T Consensus 179 -~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 257 (353)
T 3coi_A 179 -EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK 257 (353)
T ss_dssp ------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHH
T ss_pred -CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHH
Confidence 0113468999999999987 67899999999999999999999999988776665554321
Q ss_pred ----------CCCCC-CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 507 ----------PLRFP-ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 507 ----------~~~~p-~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
...+. ....++.++++||.+||..||++||+ +.++|+||||+.+.+.
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt----~~e~l~hp~f~~~~~~ 315 (353)
T 3coi_A 258 SYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLT----AAQALTHPFFEPFRDP 315 (353)
T ss_dssp HHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCC----HHHHHTSGGGTTTCCG
T ss_pred HHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCC----HHHHhcCcchhhccCc
Confidence 00111 12357899999999999999999999 9999999999877654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=389.81 Aligned_cols=277 Identities=21% Similarity=0.325 Sum_probs=206.0
Q ss_pred ecCceeeecCeEEEEEEccCCcEEEEEEEEcCCce---EEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCcccccee
Q 007433 205 VKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKC---YFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTH 281 (604)
Q Consensus 205 ~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 281 (604)
+.+..+..++|++++.||+|+||.||+|++..++. .||||++...... .....++.+|+++|+.++||||++++++
T Consensus 15 ~~~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 93 (323)
T 3qup_A 15 LEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEFDHPHVAKLVGV 93 (323)
T ss_dssp -CTTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEE
T ss_pred hhhcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHCCCCceehhhce
Confidence 34455667899999999999999999999887765 8999999765322 2334567889999999999999999999
Q ss_pred EecCCee------EEEEeecCCCCHHHHHHhcC----CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccC
Q 007433 282 FETDKFS------CLVMEFCPGGDLHTLRQRQP----GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRED 351 (604)
Q Consensus 282 ~~~~~~~------~lV~E~~~ggsL~~ll~~~~----~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~ 351 (604)
+...... |+||||+.+++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||||+.+
T Consensus 94 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~ 173 (323)
T 3qup_A 94 SLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAED 173 (323)
T ss_dssp EECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTT
T ss_pred eeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCC
Confidence 9876655 99999999999999886532 1259999999999999999999999999999999999999999
Q ss_pred CcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCC
Q 007433 352 GHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGN 431 (604)
Q Consensus 352 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (604)
+.+||+|||++........
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~------------------------------------------------------------- 192 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDY------------------------------------------------------------- 192 (323)
T ss_dssp SCEEECCCCC----------------------------------------------------------------------
T ss_pred CCEEEeecccccccccccc-------------------------------------------------------------
Confidence 9999999999844321100
Q ss_pred CCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCC
Q 007433 432 QVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRF 510 (604)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~ 510 (604)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+.... ..
T Consensus 193 -------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~-~~ 258 (323)
T 3qup_A 193 -------------YRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGN-RL 258 (323)
T ss_dssp ---------------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CC
T ss_pred -------------ccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCC-CC
Confidence 000112347889999999999999999999999999999999 999999988877777666543 33
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCccccc---CCHHHHhcCCCCCCCChh
Q 007433 511 PESPVVSFSARDLIKGLLVKEPQNRLACR---RGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 511 p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~---~~a~elL~Hpff~~~~~~ 557 (604)
+....++.++.+||.+||..||++||++. +.++++++|+|+....+.
T Consensus 259 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~ 308 (323)
T 3qup_A 259 KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD 308 (323)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred CCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence 44456899999999999999999999942 346788899999765444
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=386.50 Aligned_cols=264 Identities=24% Similarity=0.356 Sum_probs=210.8
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEe------
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFE------ 283 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~------ 283 (604)
...++|++++.||+|+||.||+|.+..+++.||||++..... .....+.+|+++|+.++||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSH---HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBC
T ss_pred ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCCh---HHHHHHHHHHHHHHhcCCCCeeEEEEecccccccc
Confidence 335799999999999999999999999999999999976532 33456778999999999999999999874
Q ss_pred --------cCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEc-cCCcE
Q 007433 284 --------TDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVR-EDGHI 354 (604)
Q Consensus 284 --------~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~-~~g~v 354 (604)
.....|+||||+. |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||||+ .++.+
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~ 160 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVL 160 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEE
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeE
Confidence 4478899999996 699998865 4689999999999999999999999999999999999997 56799
Q ss_pred EEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCC
Q 007433 355 MLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVS 434 (604)
Q Consensus 355 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (604)
||+|||++........
T Consensus 161 kl~Dfg~~~~~~~~~~---------------------------------------------------------------- 176 (320)
T 2i6l_A 161 KIGDFGLARIMDPHYS---------------------------------------------------------------- 176 (320)
T ss_dssp EECCCTTCBCC---------------------------------------------------------------------
T ss_pred EEccCccccccCCCcc----------------------------------------------------------------
Confidence 9999998843221000
Q ss_pred CCcccccCCCCCcccccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCC----
Q 007433 435 PLPELIAEPTNARSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLR---- 509 (604)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~---- 509 (604)
.........||..|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.+..+......
T Consensus 177 ---------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 247 (320)
T 2i6l_A 177 ---------HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEE 247 (320)
T ss_dssp ------------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHH
T ss_pred ---------cccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchh
Confidence 0001123468999999999876 67899999999999999999999999998877666655432110
Q ss_pred ------------------CC------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 510 ------------------FP------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 510 ------------------~p------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
.+ ....++.++++||.+||..||++||+ +.|+|+||||+...|.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~~~~p 315 (320)
T 2i6l_A 248 DRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLT----AEEALSHPYMSIYSFP 315 (320)
T ss_dssp HHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCC----HHHHHTSHHHHTTCC-
T ss_pred hhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCC----HHHHhCCcccccccCc
Confidence 00 11357899999999999999999999 9999999999887664
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=383.69 Aligned_cols=259 Identities=32% Similarity=0.492 Sum_probs=222.1
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++++.||+|+||.||+|++..+++.||||++...... ......+.+|+++|+.++||||+++++++.+.+..|+||
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 6899999999999999999999999999999999765332 122345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccC---CcEEEecccccccccCCC
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRED---GHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~---g~vkL~DFGla~~~~~~~ 369 (604)
||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||||+.+ +.+||+|||++......
T Consensus 101 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~- 177 (287)
T 2wei_A 101 ELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN- 177 (287)
T ss_dssp CCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC-
T ss_pred EccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCC-
Confidence 999999999888765 469999999999999999999999999999999999999754 47999999988432100
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
....
T Consensus 178 ----------------------------------------------------------------------------~~~~ 181 (287)
T 2wei_A 178 ----------------------------------------------------------------------------TKMK 181 (287)
T ss_dssp ----------------------------------------------------------------------------SSCS
T ss_pred ----------------------------------------------------------------------------Cccc
Confidence 0111
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC--CCCCCCHHHHHHHHHh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFP--ESPVVSFSARDLIKGL 527 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p--~~~~~s~~l~dLI~~l 527 (604)
...||+.|+|||++.+. ++.++|||||||++|+|++|..||.+....+.+..+......++ ....++.++.+||.+|
T Consensus 182 ~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 260 (287)
T 2wei_A 182 DRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKM 260 (287)
T ss_dssp CHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHHHHHH
T ss_pred cccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHHHHHH
Confidence 33589999999998875 88999999999999999999999999888877777776654433 3356899999999999
Q ss_pred hhcCCCCcccccCCHHHHhcCCCCCCCCh
Q 007433 528 LVKEPQNRLACRRGATEIKQHPFFQGVNW 556 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~Hpff~~~~~ 556 (604)
|..||++||+ +.|+|+||||+..+|
T Consensus 261 l~~dp~~Rps----~~ell~hp~~~~~~~ 285 (287)
T 2wei_A 261 LTFHPSLRIT----ATQCLEHPWIQKYSS 285 (287)
T ss_dssp TCSSGGGSCC----HHHHHHSHHHHHHCC
T ss_pred cccChhhCcC----HHHHhcCHHHhcccc
Confidence 9999999999 999999999986544
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=394.51 Aligned_cols=259 Identities=22% Similarity=0.326 Sum_probs=216.0
Q ss_pred eeecCeEEEEEEccCCcEEEEEEE-----EcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEe
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSE-----LTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFE 283 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~ 283 (604)
+..++|++.+.||+|+||.||+|+ ...+++.||||++...... .....+.+|+++|+.+ +||||+++++++.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCH--HHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 445899999999999999999999 5567789999999765332 2344677899999999 8999999999998
Q ss_pred cC-CeeEEEEeecCCCCHHHHHHhcCC-----------------------------------------------------
Q 007433 284 TD-KFSCLVMEFCPGGDLHTLRQRQPG----------------------------------------------------- 309 (604)
Q Consensus 284 ~~-~~~~lV~E~~~ggsL~~ll~~~~~----------------------------------------------------- 309 (604)
.. ..+|+|||||++|+|.+++.....
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 75 459999999999999999986532
Q ss_pred -----------CCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcccccCccc
Q 007433 310 -----------KYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLE 378 (604)
Q Consensus 310 -----------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~ 378 (604)
..+++..++.|+.||+.||.|||++|||||||||+||||+.++.+||+|||++..+.....
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~-------- 248 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-------- 248 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTT--------
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeeccccc--------
Confidence 1289999999999999999999999999999999999999999999999999843321100
Q ss_pred CCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCcccc
Q 007433 379 SEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYL 458 (604)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~ 458 (604)
........||+.|+
T Consensus 249 ------------------------------------------------------------------~~~~~~~~~t~~y~ 262 (359)
T 3vhe_A 249 ------------------------------------------------------------------YVRKGDARLPLKWM 262 (359)
T ss_dssp ------------------------------------------------------------------CEEC--CEECGGGC
T ss_pred ------------------------------------------------------------------chhccccCCCceeE
Confidence 00112346899999
Q ss_pred CcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCccc
Q 007433 459 APEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLA 537 (604)
Q Consensus 459 APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt 537 (604)
|||++.+..++.++|||||||++|||++ |..||.+......+...+......+....++.++.+||.+||..||.+||+
T Consensus 263 aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps 342 (359)
T 3vhe_A 263 APETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT 342 (359)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred ChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCC
Confidence 9999999999999999999999999998 999999877666655555444444555568999999999999999999999
Q ss_pred ccCCHHHHhcC
Q 007433 538 CRRGATEIKQH 548 (604)
Q Consensus 538 ~~~~a~elL~H 548 (604)
+.|+++|
T Consensus 343 ----~~ell~~ 349 (359)
T 3vhe_A 343 ----FSELVEH 349 (359)
T ss_dssp ----HHHHHHH
T ss_pred ----HHHHHHH
Confidence 9999887
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-46 Score=387.74 Aligned_cols=259 Identities=25% Similarity=0.331 Sum_probs=216.5
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCc---eEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTK---CYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD 285 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 285 (604)
.+..++|++.+.||+|+||.||+|++..++ ..||||++...... .....+.+|+.+|+.++||||+++++++.++
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 122 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTE--RQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECGG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC
Confidence 345689999999999999999999997554 45999999764322 2334677899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
+..||||||++|++|.+++... ...+++..+..|+.||+.||+|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 123 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 123 RLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GCCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 9999999999999999998765 357999999999999999999999999999999999999999999999999998543
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
.......
T Consensus 202 ~~~~~~~------------------------------------------------------------------------- 208 (325)
T 3kul_A 202 EDDPDAA------------------------------------------------------------------------- 208 (325)
T ss_dssp C----CC-------------------------------------------------------------------------
T ss_pred ccCccce-------------------------------------------------------------------------
Confidence 2111000
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLI 524 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI 524 (604)
.......||+.|+|||++.+..++.++|||||||+||||++ |..||.+....+.+..+... ...+....++..+.+||
T Consensus 209 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li 287 (325)
T 3kul_A 209 YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLPAPMGCPHALHQLM 287 (325)
T ss_dssp EECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHH
T ss_pred eeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcC-CCCCCCCCcCHHHHHHH
Confidence 00112347889999999999999999999999999999999 99999998887777666554 44555567999999999
Q ss_pred HHhhhcCCCCcccccCCHHHHhcC
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
.+||..||++||+ +.+|++.
T Consensus 288 ~~~l~~dp~~Rps----~~eil~~ 307 (325)
T 3kul_A 288 LDCWHKDRAQRPR----FSQIVSV 307 (325)
T ss_dssp HHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHccCChhhCcC----HHHHHHH
Confidence 9999999999999 7777753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=405.78 Aligned_cols=262 Identities=25% Similarity=0.368 Sum_probs=195.4
Q ss_pred cCeEE-EEEEccCCcEEEEEEEEc--CCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEe--cCCe
Q 007433 213 GHFRL-LKKLGCGDIGSVYLSELT--GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFE--TDKF 287 (604)
Q Consensus 213 ~~y~l-~~~LG~G~fG~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~--~~~~ 287 (604)
+.|.+ .++||+|+||+||+|++. .+++.||||++....... .+.+|+.+|+.|+||||++++++|. .+..
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~-----~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISM-----SACREIALLRELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCH-----HHHHHHHHHHHCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCH-----HHHHHHHHHHhcCCCCeeeEeeEEecCCCCe
Confidence 46777 457999999999999976 567899999997654322 4567999999999999999999995 4789
Q ss_pred eEEEEeecCCCCHHHHHHhcC-------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEE----ccCCcEEE
Q 007433 288 SCLVMEFCPGGDLHTLRQRQP-------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV----REDGHIML 356 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~-------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl----~~~g~vkL 356 (604)
+||||||+ +++|.+++.... ...+++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||
T Consensus 95 ~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl 173 (405)
T 3rgf_A 95 VWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKI 173 (405)
T ss_dssp EEEEEECC-SEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEE
T ss_pred EEEEEeCC-CCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEE
Confidence 99999999 568887765321 1259999999999999999999999999999999999999 67789999
Q ss_pred ecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCC
Q 007433 357 SDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPL 436 (604)
Q Consensus 357 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (604)
+|||++..+.....
T Consensus 174 ~Dfg~a~~~~~~~~------------------------------------------------------------------ 187 (405)
T 3rgf_A 174 ADMGFARLFNSPLK------------------------------------------------------------------ 187 (405)
T ss_dssp CCTTCCC-------------------------------------------------------------------------
T ss_pred EECCCceecCCCCc------------------------------------------------------------------
Confidence 99999854321000
Q ss_pred cccccCCCCCcccccccCccccCcceecCCC-CCccchHHHHHHHHHHHhhCCCCCCCCCh---------HHHHHHH---
Q 007433 437 PELIAEPTNARSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSEN---------RATLYNV--- 503 (604)
Q Consensus 437 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~PF~~~~~---------~~~l~~i--- 503 (604)
........+||+.|+|||++.+.. ++.++|||||||+||||++|+.||.+... .+.+..+
T Consensus 188 -------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~ 260 (405)
T 3rgf_A 188 -------PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNV 260 (405)
T ss_dssp ----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHH
T ss_pred -------ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHh
Confidence 000112457999999999998854 89999999999999999999999976543 2333332
Q ss_pred HcCCCCC---------------------------------CCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCC
Q 007433 504 VGQPLRF---------------------------------PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPF 550 (604)
Q Consensus 504 ~~~~~~~---------------------------------p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpf 550 (604)
++.+... ......+..+.+||.+||.+||.+||| ++|+|+|||
T Consensus 261 ~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~t----a~e~L~hp~ 336 (405)
T 3rgf_A 261 MGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRIT----SEQAMQDPY 336 (405)
T ss_dssp HCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCC----HHHHHTSGG
T ss_pred hCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCC----HHHHhcChh
Confidence 2221110 000123678899999999999999999 999999999
Q ss_pred CCCCChh
Q 007433 551 FQGVNWA 557 (604)
Q Consensus 551 f~~~~~~ 557 (604)
|.+..|.
T Consensus 337 f~~~~~~ 343 (405)
T 3rgf_A 337 FLEDPLP 343 (405)
T ss_dssp GTSSSCC
T ss_pred hccCCCC
Confidence 9876554
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=394.70 Aligned_cols=260 Identities=28% Similarity=0.436 Sum_probs=199.2
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC-----
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK----- 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----- 286 (604)
.++|++++.||+|+||+||+|++..+++.||||++...... ..+..+|++.|+.++||||++++++|....
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTT
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhcccccccc
Confidence 47999999999999999999999999999999998654321 123446778888899999999999996533
Q ss_pred --eeEEEEeecCCCCHHHHHHh--cCCCCCcHHHHHHHHHHHHHHHHHHH--HcCeEeccCCCCcEEEcc-CCcEEEecc
Q 007433 287 --FSCLVMEFCPGGDLHTLRQR--QPGKYFSEQAVKFYVAEVLLALEYLH--MLGIVYRDLKPENVLVRE-DGHIMLSDF 359 (604)
Q Consensus 287 --~~~lV~E~~~ggsL~~ll~~--~~~~~l~e~~~~~i~~qil~aL~yLH--~~gIvHrDIKpeNILl~~-~g~vkL~DF 359 (604)
++|+||||+++ +|...+.. .....+++..++.++.||+.||.||| ++||+||||||+||||+. ++.+||+||
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Df 176 (360)
T 3e3p_A 98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDF 176 (360)
T ss_dssp CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCC
T ss_pred ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeC
Confidence 38999999965 55544332 23467899999999999999999999 999999999999999996 899999999
Q ss_pred cccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccc
Q 007433 360 DLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPEL 439 (604)
Q Consensus 360 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (604)
|++..+...
T Consensus 177 g~a~~~~~~----------------------------------------------------------------------- 185 (360)
T 3e3p_A 177 GSAKKLSPS----------------------------------------------------------------------- 185 (360)
T ss_dssp TTCBCCCTT-----------------------------------------------------------------------
T ss_pred CCceecCCC-----------------------------------------------------------------------
Confidence 998432210
Q ss_pred ccCCCCCcccccccCccccCcceecCCC-CCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---C--------
Q 007433 440 IAEPTNARSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---P-------- 507 (604)
Q Consensus 440 ~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~-------- 507 (604)
......+||+.|+|||++.+.. ++.++|||||||+||||++|+.||.+.+....+..+... +
T Consensus 186 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (360)
T 3e3p_A 186 ------EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259 (360)
T ss_dssp ------SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred ------CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence 0112346899999999997655 899999999999999999999999998877776655431 1
Q ss_pred ------CC------------C-CCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 508 ------LR------------F-PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 508 ------~~------------~-p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
.. + ......+.++++||.+||.+||.+||+ +.|+|+||||+++.+.
T Consensus 260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMK----PYEALCHPYFDELHDP 324 (360)
T ss_dssp CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCC----HHHHTTSGGGGGGGCT
T ss_pred ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCC----HHHHhcCccccccCCc
Confidence 00 0 011225678999999999999999999 9999999999987544
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=377.79 Aligned_cols=260 Identities=25% Similarity=0.384 Sum_probs=219.7
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEe--cCCeeE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFE--TDKFSC 289 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~--~~~~~~ 289 (604)
.++|++++.||+|+||.||+|++..+++.||+|++....... .....+.+|+.+|+.++||||+++++++. .+...|
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 83 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 83 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCH-HHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCH-HHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence 468999999999999999999999999999999998654332 33456778999999999999999999885 467899
Q ss_pred EEEeecCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHcC-----eEeccCCCCcEEEccCCcEEEeccccc
Q 007433 290 LVMEFCPGGDLHTLRQRQ--PGKYFSEQAVKFYVAEVLLALEYLHMLG-----IVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~--~~~~l~e~~~~~i~~qil~aL~yLH~~g-----IvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
+||||+++++|.+++... ....+++..+..++.||+.||+|||++| |+||||||+|||++.++.+||+|||++
T Consensus 84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~ 163 (279)
T 2w5a_A 84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 163 (279)
T ss_dssp EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence 999999999999998753 2345999999999999999999999999 999999999999999999999999988
Q ss_pred ccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccC
Q 007433 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442 (604)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (604)
.......
T Consensus 164 ~~~~~~~------------------------------------------------------------------------- 170 (279)
T 2w5a_A 164 RILNHDT------------------------------------------------------------------------- 170 (279)
T ss_dssp HHC---C-------------------------------------------------------------------------
T ss_pred eeecccc-------------------------------------------------------------------------
Confidence 4322100
Q ss_pred CCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 007433 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARD 522 (604)
Q Consensus 443 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~d 522 (604)
.......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+...... .....++.++.+
T Consensus 171 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~-~~~~~~~~~l~~ 246 (279)
T 2w5a_A 171 ---SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-RIPYRYSDELNE 246 (279)
T ss_dssp ---HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCC-CCCTTSCHHHHH
T ss_pred ---ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccc-cCCcccCHHHHH
Confidence 0011346899999999999999999999999999999999999999988877776666655432 222358999999
Q ss_pred HHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 523 LIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 523 LI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
||.+||..||++||+ +.||++|+|+.+
T Consensus 247 li~~~l~~~p~~Rps----~~~ll~~~~~~~ 273 (279)
T 2w5a_A 247 IITRMLNLKDYHRPS----VEEILENPLILE 273 (279)
T ss_dssp HHHHHTCSSGGGSCC----HHHHHTSTTCCG
T ss_pred HHHHHcCCCcccCCC----HHHHHhChhhhh
Confidence 999999999999999 999999999964
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=380.57 Aligned_cols=254 Identities=28% Similarity=0.429 Sum_probs=219.8
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++++.||+|+||.||+|.+..+++.||||++...... .....+.+|+.+|+.++||||+++++++.++...|+||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 99 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM 99 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS--TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH--HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence 5799999999999999999999999999999999765322 23446778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||||+.++.++|+|||++.......
T Consensus 100 e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~--- 173 (303)
T 3a7i_A 100 EYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--- 173 (303)
T ss_dssp ECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB---
T ss_pred EeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc---
Confidence 99999999998865 469999999999999999999999999999999999999999999999999884432100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.......
T Consensus 174 -------------------------------------------------------------------------~~~~~~~ 180 (303)
T 3a7i_A 174 -------------------------------------------------------------------------IKRNTFV 180 (303)
T ss_dssp -------------------------------------------------------------------------CCBCCCC
T ss_pred -------------------------------------------------------------------------cccCccC
Confidence 0112346
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEP 532 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP 532 (604)
||+.|+|||++.+..++.++|||||||++|+|++|+.||........+..+..... ......++..+.+||.+||..||
T Consensus 181 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp 259 (303)
T 3a7i_A 181 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP-PTLEGNYSKPLKEFVEACLNKEP 259 (303)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCCSSCCHHHHHHHHHHCCSSG
T ss_pred CCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCC-CCCccccCHHHHHHHHHHcCCCh
Confidence 99999999999999999999999999999999999999998877766666554322 12234589999999999999999
Q ss_pred CCcccccCCHHHHhcCCCCC
Q 007433 533 QNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 533 ~~Rpt~~~~a~elL~Hpff~ 552 (604)
.+||+ +.++++||||.
T Consensus 260 ~~Rps----~~~ll~~~~~~ 275 (303)
T 3a7i_A 260 SFRPT----AKELLKHKFIL 275 (303)
T ss_dssp GGSCC----HHHHTTCHHHH
T ss_pred hhCcC----HHHHhhChhhh
Confidence 99999 99999999995
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=397.71 Aligned_cols=262 Identities=18% Similarity=0.260 Sum_probs=218.0
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEE-----cCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSEL-----TGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET 284 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 284 (604)
+..++|++++.||+|+||+||+|++ ..+++.||||++...... .....+.+|+.+|+.++||||+++++++..
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccCh--hhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 3357899999999999999999994 456789999999654322 223356789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHhcCC-----CCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC---cEEE
Q 007433 285 DKFSCLVMEFCPGGDLHTLRQRQPG-----KYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG---HIML 356 (604)
Q Consensus 285 ~~~~~lV~E~~~ggsL~~ll~~~~~-----~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g---~vkL 356 (604)
+...|||||||+||+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+||||+.+| .+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 9999999999999999999886532 4589999999999999999999999999999999999999655 5999
Q ss_pred ecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCC
Q 007433 357 SDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPL 436 (604)
Q Consensus 357 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (604)
+|||++..+.....
T Consensus 226 ~DFG~a~~~~~~~~------------------------------------------------------------------ 239 (367)
T 3l9p_A 226 GDFGMARDIYRAGY------------------------------------------------------------------ 239 (367)
T ss_dssp CCCHHHHHHHHHSS------------------------------------------------------------------
T ss_pred CCCccccccccccc------------------------------------------------------------------
Confidence 99999854321000
Q ss_pred cccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 007433 437 PELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPV 515 (604)
Q Consensus 437 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~ 515 (604)
........||+.|+|||++.+..++.++|||||||+||||++ |..||.+....+.+..+.... .......
T Consensus 240 --------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~ 310 (367)
T 3l9p_A 240 --------YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMDPPKN 310 (367)
T ss_dssp --------CTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCCTT
T ss_pred --------cccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CCCCCcc
Confidence 001123468999999999999999999999999999999998 999999988877776666543 3333456
Q ss_pred CCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCC
Q 007433 516 VSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 516 ~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
++..+.+||.+||..||++||+ +.+|++|.++-
T Consensus 311 ~~~~l~~li~~~l~~dP~~Rps----~~eil~~l~~~ 343 (367)
T 3l9p_A 311 CPGPVYRIMTQCWQHQPEDRPN----FAIILERIEYC 343 (367)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHHHH
T ss_pred CCHHHHHHHHHHcCCCHhHCcC----HHHHHHHHHHH
Confidence 8999999999999999999999 99999997764
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=390.90 Aligned_cols=260 Identities=27% Similarity=0.407 Sum_probs=209.0
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhH--------HHHHHHHHHHHHHHHHHhCCCCCccccceeEe
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASL--------EKRKKLLRAQTEREILQSLDHPFLPTLYTHFE 283 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~--------~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 283 (604)
.++|++++.||+|+||.||+|.+.. +..||||++..... .......++.+|+++|+.++||||++++++|.
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 4799999999999999999999866 78999999865321 22334467789999999999999999999995
Q ss_pred c-----CCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEec
Q 007433 284 T-----DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSD 358 (604)
Q Consensus 284 ~-----~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~D 358 (604)
. ...+|+||||+. |+|.+++... ...+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|
T Consensus 100 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~D 177 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICD 177 (362)
T ss_dssp ECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred eccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEe
Confidence 3 447899999995 6888887754 35799999999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcc
Q 007433 359 FDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPE 438 (604)
Q Consensus 359 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (604)
||++.....
T Consensus 178 fg~~~~~~~----------------------------------------------------------------------- 186 (362)
T 3pg1_A 178 FNLAREDTA----------------------------------------------------------------------- 186 (362)
T ss_dssp TTC-----------------------------------------------------------------------------
T ss_pred cCccccccc-----------------------------------------------------------------------
Confidence 998832110
Q ss_pred cccCCCCCcccccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---C-------
Q 007433 439 LIAEPTNARSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---P------- 507 (604)
Q Consensus 439 ~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~------- 507 (604)
........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+.+..+... +
T Consensus 187 ------~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~ 260 (362)
T 3pg1_A 187 ------DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVM 260 (362)
T ss_dssp ---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred ------ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhh
Confidence 001123468999999999987 67899999999999999999999999998776666555321 0
Q ss_pred --------------CCCC------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCC
Q 007433 508 --------------LRFP------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 508 --------------~~~p------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
...+ ..+..+..+.+||.+||..||++||+ +.|+|+||||+.+.
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt----~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 261 FSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIS----TEQALRHPYFESLF 324 (362)
T ss_dssp TSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGTTTC
T ss_pred ccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCC----HHHHHcCchhhhcc
Confidence 0011 11346788999999999999999999 99999999999764
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=386.32 Aligned_cols=259 Identities=19% Similarity=0.293 Sum_probs=218.1
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEE-----cCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEe
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSEL-----TGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFE 283 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~ 283 (604)
+..++|++.+.||+|+||.||+|++ ..++..||||++..... ......+.+|+.+|+.+ +||||+++++++.
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 119 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACT 119 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 4457999999999999999999997 34677899999975432 23345677899999999 9999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHhcCC---------------------CCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCC
Q 007433 284 TDKFSCLVMEFCPGGDLHTLRQRQPG---------------------KYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLK 342 (604)
Q Consensus 284 ~~~~~~lV~E~~~ggsL~~ll~~~~~---------------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIK 342 (604)
.++..||||||+++|+|.+++..... ..+++..++.++.||+.||+|||++||+|||||
T Consensus 120 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dik 199 (344)
T 1rjb_A 120 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 199 (344)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence 99999999999999999999986532 248999999999999999999999999999999
Q ss_pred CCcEEEccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccc
Q 007433 343 PENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKA 422 (604)
Q Consensus 343 peNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (604)
|+||||+.++.+||+|||++..+.....
T Consensus 200 p~NIll~~~~~~kL~Dfg~~~~~~~~~~---------------------------------------------------- 227 (344)
T 1rjb_A 200 ARNVLVTHGKVVKICDFGLARDIMSDSN---------------------------------------------------- 227 (344)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTT----------------------------------------------------
T ss_pred hhhEEEcCCCcEEeCCCccCcccccCcc----------------------------------------------------
Confidence 9999999999999999999854321100
Q ss_pred cCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHH
Q 007433 423 QKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLY 501 (604)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~ 501 (604)
........||+.|+|||++.+..++.++|||||||+||||++ |..||.+......+.
T Consensus 228 ----------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 285 (344)
T 1rjb_A 228 ----------------------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 285 (344)
T ss_dssp ----------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred ----------------------ceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHH
Confidence 001113458899999999999999999999999999999998 999999887777777
Q ss_pred HHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 502 NVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 502 ~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
.++......+....++.++.+||.+||..||.+||+ +.+|++|
T Consensus 286 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~l~~~ 328 (344)
T 1rjb_A 286 KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS----FPNLTSF 328 (344)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcC----HHHHHHH
Confidence 777666666666678999999999999999999999 8999886
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-45 Score=372.33 Aligned_cols=253 Identities=23% Similarity=0.362 Sum_probs=216.0
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
+..++|++++.||+|+||.||+|++.. +..||+|++....... ..+.+|+++|++++||||+++++++.+++..|
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 81 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred eChhhceeeheecCCCccEEEEEEecC-CCeEEEEEecccccCH----HHHHHHHHHHHhCCCCCEeeEEEEEecCCceE
Confidence 445799999999999999999999875 5579999998764332 24668999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
+||||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 82 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 160 (269)
T 4hcu_A 82 LVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 160 (269)
T ss_dssp EEEECCTTCBHHHHHHTTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEeCCCCcHHHHHHhcC-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc
Confidence 9999999999999987653 569999999999999999999999999999999999999999999999999984322100
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
. ....
T Consensus 161 ~---------------------------------------------------------------------------~~~~ 165 (269)
T 4hcu_A 161 Y---------------------------------------------------------------------------TSST 165 (269)
T ss_dssp H---------------------------------------------------------------------------HSTT
T ss_pred c---------------------------------------------------------------------------cccc
Confidence 0 0011
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
...||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+....+.+..+... ........++..+.+||.+||
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l 244 (269)
T 4hcu_A 166 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQIMNHCW 244 (269)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTSCHHHHHHHHHHT
T ss_pred CcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcC-ccCCCCCcCCHHHHHHHHHHc
Confidence 2347889999999999999999999999999999999 99999998887777776654 333344568999999999999
Q ss_pred hcCCCCcccccCCHHHHhcC
Q 007433 529 VKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 529 ~~dP~~Rpt~~~~a~elL~H 548 (604)
..||++||+ +.++++|
T Consensus 245 ~~~p~~Rps----~~~ll~~ 260 (269)
T 4hcu_A 245 RERPEDRPA----FSRLLRQ 260 (269)
T ss_dssp CSSGGGSCC----HHHHHHH
T ss_pred cCCcccCcC----HHHHHHH
Confidence 999999999 8999876
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=371.53 Aligned_cols=252 Identities=26% Similarity=0.445 Sum_probs=209.6
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHH-HHHHHHHHHHHHHHHhCCCCCccccceeEecCCee
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEK-RKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 288 (604)
+..++|++.+.||+|+||.||+|.+. +..||||++....... ......+.+|+++++.++||||+++++++.+++..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 4 IDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred cchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 34579999999999999999999986 6689999997653322 23345678899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcC---eEeccCCCCcEEEcc--------CCcEEEe
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLG---IVYRDLKPENVLVRE--------DGHIMLS 357 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~g---IvHrDIKpeNILl~~--------~g~vkL~ 357 (604)
|+||||+++++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++. ++.++|+
T Consensus 82 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~ 158 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKIT 158 (271)
T ss_dssp EEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEEC
T ss_pred EEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEc
Confidence 999999999999998854 46999999999999999999999999 999999999999986 7789999
Q ss_pred cccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCc
Q 007433 358 DFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLP 437 (604)
Q Consensus 358 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (604)
|||++......
T Consensus 159 Dfg~~~~~~~~--------------------------------------------------------------------- 169 (271)
T 3dtc_A 159 DFGLAREWHRT--------------------------------------------------------------------- 169 (271)
T ss_dssp CCCC----------------------------------------------------------------------------
T ss_pred cCCcccccccc---------------------------------------------------------------------
Confidence 99988432100
Q ss_pred ccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCC
Q 007433 438 ELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVS 517 (604)
Q Consensus 438 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s 517 (604)
......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+.......+....++
T Consensus 170 ---------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (271)
T 3dtc_A 170 ---------TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPSTCP 240 (271)
T ss_dssp ---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred ---------cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCcccC
Confidence 01123589999999999999999999999999999999999999999888888888877776666667799
Q ss_pred HHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 518 FSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 518 ~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
..+.+||.+||..||.+||+ +.|+++|
T Consensus 241 ~~~~~li~~~l~~~p~~Rps----~~e~l~~ 267 (271)
T 3dtc_A 241 EPFAKLMEDCWNPDPHSRPS----FTNILDQ 267 (271)
T ss_dssp HHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHHHhcCCcccCcC----HHHHHHH
Confidence 99999999999999999999 8888875
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=382.29 Aligned_cols=270 Identities=20% Similarity=0.293 Sum_probs=213.8
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCee
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 288 (604)
.+..++|++.+.||+|+||+||+|.+..+++.||+|++..... .....+.+|+++|+.++||||+++++++.+++..
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDE---ETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCH---HHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence 4556899999999999999999999999999999999865432 3344677899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|+||||+++++|.+++... ...+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 83 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp EEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred EEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 9999999999999999875 357999999999999999999999999999999999999999999999999998554321
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
....... .....+.....
T Consensus 162 ~~~~~~~--------------------------------------------------------------~~~~~~~~~~~ 179 (310)
T 3s95_A 162 KTQPEGL--------------------------------------------------------------RSLKKPDRKKR 179 (310)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccccc--------------------------------------------------------------ccccccccccc
Confidence 1100000 00000011122
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHH-----HHHHHHcCCCCCCCCCCCCHHHHHH
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRA-----TLYNVVGQPLRFPESPVVSFSARDL 523 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~-----~l~~i~~~~~~~p~~~~~s~~l~dL 523 (604)
...+||+.|+|||++.+..++.++|||||||+||||++|..||....... ........ .....++..+.+|
T Consensus 180 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~l 255 (310)
T 3s95_A 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR----YCPPNCPPSFFPI 255 (310)
T ss_dssp CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH----TCCTTCCTTHHHH
T ss_pred cccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc----cCCCCCCHHHHHH
Confidence 35679999999999999999999999999999999999999997632211 01111111 1124578899999
Q ss_pred HHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 524 IKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 524 I~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
|.+||..||++||+ +.+|++ |++.+
T Consensus 256 i~~~l~~dP~~Rps----~~~l~~--~L~~l 280 (310)
T 3s95_A 256 TVRCCDLDPEKRPS----FVKLEH--WLETL 280 (310)
T ss_dssp HHHHTCSSGGGSCC----HHHHHH--HHHHH
T ss_pred HHHHccCChhhCcC----HHHHHH--HHHHH
Confidence 99999999999999 888887 55543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=390.27 Aligned_cols=257 Identities=25% Similarity=0.408 Sum_probs=207.0
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-----------CCCcccc
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-----------HPFLPTL 278 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-----------HpnIv~l 278 (604)
+..++|++++.||+|+||+||+|++..+++.||||++...... ...+.+|+.+|+.+. |+||+++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY----TEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccc----hhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 3457999999999999999999999999999999999765322 234567888888875 8999999
Q ss_pred ceeEecCC----eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHc-CeEeccCCCCcEEEcc---
Q 007433 279 YTHFETDK----FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML-GIVYRDLKPENVLVRE--- 350 (604)
Q Consensus 279 ~~~~~~~~----~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDIKpeNILl~~--- 350 (604)
+++|...+ .+|+||||+ +++|.+++.......+++..++.++.||+.||+|||++ ||+||||||+||||+.
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 99998654 889999999 99999999887666799999999999999999999998 9999999999999954
Q ss_pred ---CCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCcc
Q 007433 351 ---DGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKN 427 (604)
Q Consensus 351 ---~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 427 (604)
.+.+||+|||++.....
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~------------------------------------------------------------ 190 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDE------------------------------------------------------------ 190 (373)
T ss_dssp TTTEEEEEECCCTTCEETTB------------------------------------------------------------
T ss_pred CcCcceEEEcccccccccCC------------------------------------------------------------
Confidence 34799999998843210
Q ss_pred ccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCC------hHHHHH
Q 007433 428 EMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE------NRATLY 501 (604)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~------~~~~l~ 501 (604)
.....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.. ..+.+.
T Consensus 191 -------------------~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 251 (373)
T 1q8y_A 191 -------------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA 251 (373)
T ss_dssp -------------------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred -------------------CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHH
Confidence 0112368999999999999999999999999999999999999998654 222222
Q ss_pred HHH---cCCC-------------------------------------CCCCCCCCCHHHHHHHHHhhhcCCCCcccccCC
Q 007433 502 NVV---GQPL-------------------------------------RFPESPVVSFSARDLIKGLLVKEPQNRLACRRG 541 (604)
Q Consensus 502 ~i~---~~~~-------------------------------------~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~ 541 (604)
.+. +... .+.....++.++.+||.+||..||++||+
T Consensus 252 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt---- 327 (373)
T 1q8y_A 252 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD---- 327 (373)
T ss_dssp HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC----
T ss_pred HHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCC----
Confidence 222 1100 00111224567889999999999999999
Q ss_pred HHHHhcCCCCCCC
Q 007433 542 ATEIKQHPFFQGV 554 (604)
Q Consensus 542 a~elL~Hpff~~~ 554 (604)
+.|||+||||++.
T Consensus 328 ~~ell~hp~f~~~ 340 (373)
T 1q8y_A 328 AGGLVNHPWLKDT 340 (373)
T ss_dssp HHHHHTCGGGTTC
T ss_pred HHHHhhChhhhcc
Confidence 9999999999864
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-45 Score=378.32 Aligned_cols=260 Identities=21% Similarity=0.292 Sum_probs=217.2
Q ss_pred ceeeecCeEEEEEEccCCcEEEEEEEEc-----CCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeE
Q 007433 208 GVLGVGHFRLLKKLGCGDIGSVYLSELT-----GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHF 282 (604)
Q Consensus 208 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 282 (604)
..+..++|++.+.||+|+||.||+|.+. .++..||||++..... ......+.+|+++|+.++||||+++++++
T Consensus 18 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 18 WEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENAS--PSELRDLLSEFNVLKQVNHPHVIKLYGAC 95 (314)
T ss_dssp TBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred cccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence 3455689999999999999999999984 4558999999976532 23445677899999999999999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHhcCC----------------------CCCcHHHHHHHHHHHHHHHHHHHHcCeEecc
Q 007433 283 ETDKFSCLVMEFCPGGDLHTLRQRQPG----------------------KYFSEQAVKFYVAEVLLALEYLHMLGIVYRD 340 (604)
Q Consensus 283 ~~~~~~~lV~E~~~ggsL~~ll~~~~~----------------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrD 340 (604)
.+++..|+||||+++++|.+++..... ..+++..++.++.||+.||+|||++||+|||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~d 175 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRD 175 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccc
Confidence 999999999999999999999987532 3489999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccc
Q 007433 341 LKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSK 420 (604)
Q Consensus 341 IKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (604)
|||+||||+.++.+||+|||++.........
T Consensus 176 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~------------------------------------------------- 206 (314)
T 2ivs_A 176 LAARNILVAEGRKMKISDFGLSRDVYEEDSY------------------------------------------------- 206 (314)
T ss_dssp CSGGGEEEETTTEEEECCCTTCEECTTTSCE-------------------------------------------------
T ss_pred cchheEEEcCCCCEEEccccccccccccccc-------------------------------------------------
Confidence 9999999999999999999998543211100
Q ss_pred cccCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHH
Q 007433 421 KAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRAT 499 (604)
Q Consensus 421 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~ 499 (604)
.......||+.|+|||++.+..++.++|||||||++|||++ |..||.+......
T Consensus 207 -------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~ 261 (314)
T 2ivs_A 207 -------------------------VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERL 261 (314)
T ss_dssp -------------------------ECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred -------------------------eeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence 00112357889999999999989999999999999999999 9999998777665
Q ss_pred HHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 500 LYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 500 l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
...+... ........++..+.+||.+||..||++||+ +.+++++
T Consensus 262 ~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps----~~~l~~~ 305 (314)
T 2ivs_A 262 FNLLKTG-HRMERPDNCSEEMYRLMLQCWKQEPDKRPV----FADISKD 305 (314)
T ss_dssp HHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHhhcC-CcCCCCccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 5544433 333444568999999999999999999999 8888875
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=374.08 Aligned_cols=272 Identities=23% Similarity=0.397 Sum_probs=209.6
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec--------
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET-------- 284 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-------- 284 (604)
++|++++.||+|+||.||+|++..+++.||||++.... .....+.+|+.+|+.++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH----HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 68999999999999999999999999999999997542 234567789999999999999999998864
Q ss_pred -----CCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecc
Q 007433 285 -----DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDF 359 (604)
Q Consensus 285 -----~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DF 359 (604)
....|+||||+++++|.+++... ...+++..++.++.||+.||+|||++||+||||||+||||+.++.++|+||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~df 160 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeC
Confidence 46789999999999999999865 356889999999999999999999999999999999999999999999999
Q ss_pred cccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccc
Q 007433 360 DLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPEL 439 (604)
Q Consensus 360 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (604)
|++.............. .
T Consensus 161 g~~~~~~~~~~~~~~~~--------------------------------------------------------------~ 178 (303)
T 1zy4_A 161 GLAKNVHRSLDILKLDS--------------------------------------------------------------Q 178 (303)
T ss_dssp CCCSCTTC------------------------------------------------------------------------
T ss_pred cchhhcccccchhcccc--------------------------------------------------------------c
Confidence 99854321111000000 0
Q ss_pred ccCCCCCcccccccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCC-hHHHHHHHHcCCCCCCC--CCC
Q 007433 440 IAEPTNARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSE-NRATLYNVVGQPLRFPE--SPV 515 (604)
Q Consensus 440 ~~~~~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~-~~~~l~~i~~~~~~~p~--~~~ 515 (604)
.............||+.|+|||++.+. .++.++|||||||++|||++ ||.... ....+..+......++. ...
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (303)
T 1zy4_A 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDN 255 (303)
T ss_dssp ---------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTT
T ss_pred cccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCcccccc
Confidence 000001112345799999999999875 58999999999999999998 665432 33344444444444332 234
Q ss_pred CCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhh
Q 007433 516 VSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWAL 558 (604)
Q Consensus 516 ~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~ 558 (604)
.+..+++||.+||..||.+||+ +.++++||||....+..
T Consensus 256 ~~~~~~~li~~~l~~dp~~Rps----~~~ll~h~~~~~~~~~~ 294 (303)
T 1zy4_A 256 KMKVEKKIIRLLIDHDPNKRPG----ARTLLNSGWLPVKHQDE 294 (303)
T ss_dssp TSHHHHHHHHHHTCSSGGGSCC----HHHHHHSSCSCCCCHHH
T ss_pred chHHHHHHHHHHHhcCcccCcC----HHHHhCCCCcCCCChHH
Confidence 6778999999999999999999 99999999998766543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=370.02 Aligned_cols=250 Identities=19% Similarity=0.286 Sum_probs=216.5
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC--Ce
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD--KF 287 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~--~~ 287 (604)
+..++|++++.||+|+||.||+|++. +..||||++....... .....+.+|+.+|+.++||||+++++++.+. +.
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 83 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWST-RKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCH-HHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSS
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCH-HHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCC
Confidence 45679999999999999999999986 6689999998654322 2335677899999999999999999999876 78
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcC--eEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLG--IVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~g--IvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
.|+||||+++++|.+++.......+++..+..++.||+.||.|||++| |+||||||+|||++.+|.++|+|||++...
T Consensus 84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 84 PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp CEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred eEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee
Confidence 999999999999999998875557999999999999999999999999 999999999999999999999999976211
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
.
T Consensus 164 ~------------------------------------------------------------------------------- 164 (271)
T 3kmu_A 164 Q------------------------------------------------------------------------------- 164 (271)
T ss_dssp S-------------------------------------------------------------------------------
T ss_pred c-------------------------------------------------------------------------------
Confidence 0
Q ss_pred CcccccccCccccCcceecCCCCCc---cchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGS---AVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARD 522 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~---~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~d 522 (604)
.....||+.|+|||++.+..++. ++|||||||++|||++|+.||.+.........+............++..+.+
T Consensus 165 --~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (271)
T 3kmu_A 165 --SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHVSK 242 (271)
T ss_dssp --CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTTCCHHHHH
T ss_pred --ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCCCCHHHHH
Confidence 11235899999999998876544 7999999999999999999999988888877777666655556679999999
Q ss_pred HHHHhhhcCCCCcccccCCHHHHhc
Q 007433 523 LIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 523 LI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
||.+||..||++||+ +.++++
T Consensus 243 li~~~l~~~p~~Rps----~~~il~ 263 (271)
T 3kmu_A 243 LMKICMNEDPAKRPK----FDMIVP 263 (271)
T ss_dssp HHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHcCCChhhCcC----HHHHHH
Confidence 999999999999999 888875
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=368.46 Aligned_cols=254 Identities=23% Similarity=0.317 Sum_probs=215.7
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCee
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 288 (604)
.+..++|++++.||+|+||.||+|++.. +..||+|++....... ..+.+|+++|+.++||||+++++++.+++..
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWKG-QYDVAVKMIKEGSMSE----DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECBTTBCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred EechhheeeeeeeccCCCceEEEEEecC-ceeEEEEEeccCCCcH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 3456899999999999999999998875 5579999998764433 2456899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|+||||+++++|.+++... +..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 157 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD 157 (268)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred EEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchh
Confidence 9999999999999998775 246999999999999999999999999999999999999999999999999998443211
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
.. ...
T Consensus 158 ~~---------------------------------------------------------------------------~~~ 162 (268)
T 3sxs_A 158 QY---------------------------------------------------------------------------VSS 162 (268)
T ss_dssp CE---------------------------------------------------------------------------EEC
T ss_pred hh---------------------------------------------------------------------------hcc
Confidence 00 001
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGL 527 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~l 527 (604)
....||+.|+|||++.+..++.++|||||||++|||++ |+.||...........+.... ........+..+.+||.+|
T Consensus 163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~ 241 (268)
T 3sxs_A 163 VGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGH-RLYRPHLASDTIYQIMYSC 241 (268)
T ss_dssp CSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTC-CCCCCTTSCHHHHHHHHHT
T ss_pred cCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCC-CCCCCCcChHHHHHHHHHH
Confidence 12347788999999999889999999999999999999 999999888877777666543 2233345789999999999
Q ss_pred hhcCCCCcccccCCHHHHhcC
Q 007433 528 LVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~H 548 (604)
|..||++||+ +.++++|
T Consensus 242 l~~~p~~Rps----~~~ll~~ 258 (268)
T 3sxs_A 242 WHELPEKRPT----FQQLLSS 258 (268)
T ss_dssp TCSSGGGSCC----HHHHHHH
T ss_pred cCCChhhCcC----HHHHHHH
Confidence 9999999999 8999876
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=378.28 Aligned_cols=259 Identities=20% Similarity=0.298 Sum_probs=219.0
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEE-----cCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEe
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSEL-----TGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFE 283 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~ 283 (604)
+..++|++.+.||+|+||.||+|.+ ..+++.||||++...... .....+.+|+.+|+.+ +||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~ 97 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHMNIVNLLGACT 97 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhH--HHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence 3457999999999999999999985 457789999999765332 2334677899999999 9999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHhcCCC----------------CCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEE
Q 007433 284 TDKFSCLVMEFCPGGDLHTLRQRQPGK----------------YFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVL 347 (604)
Q Consensus 284 ~~~~~~lV~E~~~ggsL~~ll~~~~~~----------------~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNIL 347 (604)
+++..|+||||+++|+|.+++...... .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil 177 (313)
T 1t46_A 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (313)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEE
Confidence 999999999999999999998875322 4899999999999999999999999999999999999
Q ss_pred EccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCcc
Q 007433 348 VREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKN 427 (604)
Q Consensus 348 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 427 (604)
|+.++.+||+|||++.........
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~-------------------------------------------------------- 201 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNY-------------------------------------------------------- 201 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTS--------------------------------------------------------
T ss_pred EcCCCCEEEccccccccccccccc--------------------------------------------------------
Confidence 999999999999998443211000
Q ss_pred ccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcC
Q 007433 428 EMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQ 506 (604)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~ 506 (604)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+......+...+..
T Consensus 202 ------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 263 (313)
T 1t46_A 202 ------------------VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 263 (313)
T ss_dssp ------------------EECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHH
T ss_pred ------------------eeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhcc
Confidence 00112358899999999999999999999999999999998 99999988776666666655
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 507 PLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 507 ~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
.........++..+.+||.+||..||.+||+ +.|++++
T Consensus 264 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 301 (313)
T 1t46_A 264 GFRMLSPEHAPAEMYDIMKTCWDADPLKRPT----FKQIVQL 301 (313)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCCcccCCHHHHHHHHHHcCCCchhCcC----HHHHHHH
Confidence 5555555678999999999999999999999 8888875
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=382.09 Aligned_cols=259 Identities=20% Similarity=0.304 Sum_probs=217.8
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcC-----CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEe
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTG-----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFE 283 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 283 (604)
.+..++|++++.||+|+||.||+|++.+ +++.||||++..... ......+.+|+.+|+.++||||+++++++.
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 120 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDNPNIVKLLGVCA 120 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence 3456899999999999999999999974 558999999976532 233456778999999999999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHhcC----------------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccC
Q 007433 284 TDKFSCLVMEFCPGGDLHTLRQRQP----------------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDL 341 (604)
Q Consensus 284 ~~~~~~lV~E~~~ggsL~~ll~~~~----------------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDI 341 (604)
+++..|+||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||
T Consensus 121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dl 200 (343)
T 1luf_A 121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDL 200 (343)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 9999999999999999999988742 156999999999999999999999999999999
Q ss_pred CCCcEEEccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCccccccccc
Q 007433 342 KPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKK 421 (604)
Q Consensus 342 KpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 421 (604)
||+||||+.++.+||+|||++..+.....
T Consensus 201 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--------------------------------------------------- 229 (343)
T 1luf_A 201 ATRNCLVGENMVVKIADFGLSRNIYSADY--------------------------------------------------- 229 (343)
T ss_dssp SGGGEEECGGGCEEECCCSCHHHHTGGGC---------------------------------------------------
T ss_pred CcceEEECCCCeEEEeecCCCcccccCcc---------------------------------------------------
Confidence 99999999999999999999854321100
Q ss_pred ccCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHH
Q 007433 422 AQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATL 500 (604)
Q Consensus 422 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l 500 (604)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+
T Consensus 230 -----------------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~ 286 (343)
T 1luf_A 230 -----------------------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI 286 (343)
T ss_dssp -----------------------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred -----------------------ccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHH
Confidence 000112358899999999999999999999999999999999 99999998887777
Q ss_pred HHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 501 YNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 501 ~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
..+..... .+....++..+.+||.+||..||++||+ +.+++++
T Consensus 287 ~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~~~~~ 329 (343)
T 1luf_A 287 YYVRDGNI-LACPENCPLELYNLMRLCWSKLPADRPS----FCSIHRI 329 (343)
T ss_dssp HHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHhCCCc-CCCCCCCCHHHHHHHHHHcccCcccCCC----HHHHHHH
Confidence 77665433 2233468999999999999999999999 8888764
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=386.70 Aligned_cols=253 Identities=27% Similarity=0.397 Sum_probs=186.6
Q ss_pred ecCeEEEE-EEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec----CC
Q 007433 212 VGHFRLLK-KLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET----DK 286 (604)
Q Consensus 212 ~~~y~l~~-~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~ 286 (604)
.++|++++ .||+|+||+||+|++..+++.||||++...... ..+....++.++||||++++++|.. +.
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-------~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 99 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA-------RQEVDHHWQASGGPHIVCILDVYENMHHGKR 99 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHH-------HHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHH-------HHHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence 47999976 599999999999999999999999999764211 1122344677899999999999976 55
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc---CCcEEEecccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE---DGHIMLSDFDLSL 363 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~---~g~vkL~DFGla~ 363 (604)
.+|||||||+||+|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+. ++.+||+|||++.
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~ 179 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence 6899999999999999998876668999999999999999999999999999999999999986 4559999999884
Q ss_pred cccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCC
Q 007433 364 RCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEP 443 (604)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (604)
....
T Consensus 180 ~~~~---------------------------------------------------------------------------- 183 (336)
T 3fhr_A 180 ETTQ---------------------------------------------------------------------------- 183 (336)
T ss_dssp EC------------------------------------------------------------------------------
T ss_pred eccc----------------------------------------------------------------------------
Confidence 3210
Q ss_pred CCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHH----HHHHcCCC--CCCCCCCCC
Q 007433 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATL----YNVVGQPL--RFPESPVVS 517 (604)
Q Consensus 444 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l----~~i~~~~~--~~p~~~~~s 517 (604)
......+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....... ..+..... ..+....++
T Consensus 184 --~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (336)
T 3fhr_A 184 --NALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVS 261 (336)
T ss_dssp ----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCC
T ss_pred --cccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCC
Confidence 0011346899999999999888999999999999999999999999876543331 12222222 233345689
Q ss_pred HHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 518 FSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 518 ~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
.++++||.+||..||.+||+ +.|+|+||||+.
T Consensus 262 ~~~~~li~~~L~~dP~~Rpt----~~ell~hp~~~~ 293 (336)
T 3fhr_A 262 EDAKQLIRLLLKTDPTERLT----ITQFMNHPWINQ 293 (336)
T ss_dssp HHHHHHHHHHSCSSGGGSCC----HHHHHHSHHHHT
T ss_pred HHHHHHHHHHCCCChhHCcC----HHHHhcCccccc
Confidence 99999999999999999999 999999999975
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-45 Score=381.04 Aligned_cols=269 Identities=20% Similarity=0.276 Sum_probs=222.6
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEc-----CCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEe
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELT-----GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFE 283 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 283 (604)
.+..++|++.+.||+|+||.||+|.+. .++..||||++...... .....+.+|+.+|+.++||||+++++++.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 98 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVS 98 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH--HHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCH--HHHHHHHHHHHHHHhcCCCCEeeeEEEEc
Confidence 345679999999999999999999887 35778999999765322 23345778999999999999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHhcC--------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEE
Q 007433 284 TDKFSCLVMEFCPGGDLHTLRQRQP--------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIM 355 (604)
Q Consensus 284 ~~~~~~lV~E~~~ggsL~~ll~~~~--------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vk 355 (604)
+++..|+||||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+|
T Consensus 99 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~k 178 (322)
T 1p4o_A 99 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 178 (322)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEE
T ss_pred cCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEE
Confidence 9999999999999999999987532 13578999999999999999999999999999999999999999999
Q ss_pred EecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCC
Q 007433 356 LSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSP 435 (604)
Q Consensus 356 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (604)
|+|||++........
T Consensus 179 l~Dfg~~~~~~~~~~----------------------------------------------------------------- 193 (322)
T 1p4o_A 179 IGDFGMTRDIYETDY----------------------------------------------------------------- 193 (322)
T ss_dssp ECCTTCCCGGGGGGC-----------------------------------------------------------------
T ss_pred ECcCccccccccccc-----------------------------------------------------------------
Confidence 999998843221000
Q ss_pred CcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCC
Q 007433 436 LPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESP 514 (604)
Q Consensus 436 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~ 514 (604)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+..... .+...
T Consensus 194 ---------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~ 263 (322)
T 1p4o_A 194 ---------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL-LDKPD 263 (322)
T ss_dssp ---------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC-CCCCT
T ss_pred ---------cccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc-CCCCC
Confidence 001112358899999999999999999999999999999999 8999998887777766665432 23345
Q ss_pred CCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC------CCCCCCChhh
Q 007433 515 VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH------PFFQGVNWAL 558 (604)
Q Consensus 515 ~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H------pff~~~~~~~ 558 (604)
.++..+.+||.+||..||.+||+ +.|+++| ++|+.++|..
T Consensus 264 ~~~~~l~~li~~~l~~dp~~Rps----~~e~l~~L~~~~~~~~~~~~~~~ 309 (322)
T 1p4o_A 264 NCPDMLFELMRMCWQYNPKMRPS----FLEIISSIKEEMEPGFREVSFYY 309 (322)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHGGGSCTTHHHHCSTT
T ss_pred CCCHHHHHHHHHHcCCCcccCcC----HHHHHHHHHHhhccCCccccccc
Confidence 68999999999999999999999 8888766 7777666553
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-45 Score=374.46 Aligned_cols=261 Identities=28% Similarity=0.380 Sum_probs=211.4
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
..++|.....||+|+||.||+|.+..++..||||++..... .....+.+|+.+++.++||||+++++++...+..|+
T Consensus 20 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 96 (295)
T 2clq_A 20 EYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKI 96 (295)
T ss_dssp CBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC------HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCch---HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEE
Confidence 34456666689999999999999999999999999976532 223456789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc-CCcEEEecccccccccCC
Q 007433 291 VMEFCPGGDLHTLRQRQP-GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE-DGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~-~g~vkL~DFGla~~~~~~ 368 (604)
||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||||+. ++.++|+|||++......
T Consensus 97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~ 176 (295)
T 2clq_A 97 FMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176 (295)
T ss_dssp EEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred EEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence 999999999999988653 235779999999999999999999999999999999999987 899999999988432210
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
....
T Consensus 177 ----------------------------------------------------------------------------~~~~ 180 (295)
T 2clq_A 177 ----------------------------------------------------------------------------NPCT 180 (295)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ----------------------------------------------------------------------------CCcc
Confidence 0001
Q ss_pred cccccCccccCcceecCCC--CCccchHHHHHHHHHHHhhCCCCCCCCChHHH-HHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007433 449 MSFVGTHEYLAPEIIKGEG--HGSAVDWWTFGIFLYELLFGKTPFKGSENRAT-LYNVVGQPLRFPESPVVSFSARDLIK 525 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~--~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~-l~~i~~~~~~~p~~~~~s~~l~dLI~ 525 (604)
....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||........ +...............++.++.+||.
T Consensus 181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 260 (295)
T 2clq_A 181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKAFIL 260 (295)
T ss_dssp CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHHHHH
T ss_pred cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHHHHH
Confidence 1346999999999997654 78999999999999999999999976543322 22221111222223458999999999
Q ss_pred HhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 526 GLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
+||..||++||+ +.++|+||||+..
T Consensus 261 ~~l~~dp~~Rps----~~~ll~~~~~~~~ 285 (295)
T 2clq_A 261 KCFEPDPDKRAC----ANDLLVDEFLKVS 285 (295)
T ss_dssp HTTCSSTTTSCC----HHHHHTSGGGCC-
T ss_pred HHccCChhhCCC----HHHHhcChhhhhc
Confidence 999999999999 9999999999754
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-45 Score=381.70 Aligned_cols=265 Identities=22% Similarity=0.326 Sum_probs=212.2
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCeeEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~l 290 (604)
.++|++++.||+|+||+||+|++..+++.||||++...... ..+.+|+++|+.| +||||+++++++..++..||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l 82 (330)
T 2izr_A 8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM 82 (330)
T ss_dssp TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence 47899999999999999999999999999999999754321 2456799999999 99999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCc-----EEEecccccccc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGH-----IMLSDFDLSLRC 365 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~-----vkL~DFGla~~~ 365 (604)
||||+ +++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+||||+.++. +||+|||++..+
T Consensus 83 v~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 83 VLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 99999 99999999875 357999999999999999999999999999999999999998887 999999998554
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
........ ...
T Consensus 161 ~~~~~~~~---------------------------------------------------------------------~~~ 171 (330)
T 2izr_A 161 IDPETKKH---------------------------------------------------------------------IPY 171 (330)
T ss_dssp BCTTTCCB---------------------------------------------------------------------CCC
T ss_pred ecCCCCcc---------------------------------------------------------------------ccc
Confidence 32111000 000
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCC---hHHHHHHHHcCCCCCCC---CCCCCHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE---NRATLYNVVGQPLRFPE---SPVVSFS 519 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~---~~~~l~~i~~~~~~~p~---~~~~s~~ 519 (604)
......+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.. ..+.+..+.......+. ...++ +
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~ 250 (330)
T 2izr_A 172 REHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-E 250 (330)
T ss_dssp CCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-H
T ss_pred cccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-H
Confidence 01234579999999999999999999999999999999999999998743 23334444322222111 11244 8
Q ss_pred HHHHHHHhhhcCCCCcccccCCHHHHhc----------CCCCCCCChh
Q 007433 520 ARDLIKGLLVKEPQNRLACRRGATEIKQ----------HPFFQGVNWA 557 (604)
Q Consensus 520 l~dLI~~lL~~dP~~Rpt~~~~a~elL~----------Hpff~~~~~~ 557 (604)
+.+||..||..||.+||+ +.+|++ ..+...++|.
T Consensus 251 ~~~li~~~l~~~p~~RP~----~~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 251 MATYLRYVRRLDFFEKPD----YDYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp HHHHHHHHHHCCTTCCCC----HHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred HHHHHHHHHhCCCCCCCC----HHHHHHHHHHHHHHcCCCCCCCccCC
Confidence 999999999999999999 555553 3445567887
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=370.68 Aligned_cols=254 Identities=22% Similarity=0.325 Sum_probs=212.8
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCee
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 288 (604)
.+..++|++++.||+|+||.||+|.+. ++..||||++....... ..+.+|+++|+.++|+||+++++++.+++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 94 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI 94 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCH----HHHHHHHHHHhcCCCCCEeeEEEEEecCCCe
Confidence 345679999999999999999999887 45689999998664332 2456899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|+||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+||||+.++.++|+|||++......
T Consensus 95 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~ 173 (283)
T 3gen_A 95 FIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDD 173 (283)
T ss_dssp EEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCH
T ss_pred EEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccc
Confidence 99999999999999987642 46999999999999999999999999999999999999999999999999998433210
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
.. ...
T Consensus 174 ~~---------------------------------------------------------------------------~~~ 178 (283)
T 3gen_A 174 EY---------------------------------------------------------------------------TSS 178 (283)
T ss_dssp HH---------------------------------------------------------------------------HST
T ss_pred cc---------------------------------------------------------------------------ccc
Confidence 00 001
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGL 527 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~l 527 (604)
....||+.|+|||++.+..++.++|||||||++|||++ |+.||...........+... ........++..+.+||.+|
T Consensus 179 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~ 257 (283)
T 3gen_A 179 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYRPHLASEKVYTIMYSC 257 (283)
T ss_dssp TSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHT
T ss_pred cCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcc-cCCCCCCcCCHHHHHHHHHH
Confidence 12247889999999999999999999999999999998 99999998887777666654 33334456899999999999
Q ss_pred hhcCCCCcccccCCHHHHhcC
Q 007433 528 LVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~H 548 (604)
|..||++||+ +.++++|
T Consensus 258 l~~~p~~Rps----~~~ll~~ 274 (283)
T 3gen_A 258 WHEKADERPT----FKILLSN 274 (283)
T ss_dssp TCSSGGGSCC----HHHHHHH
T ss_pred ccCChhHCcC----HHHHHHH
Confidence 9999999999 8898876
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=372.32 Aligned_cols=256 Identities=21% Similarity=0.302 Sum_probs=219.5
Q ss_pred ceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCe
Q 007433 208 GVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKF 287 (604)
Q Consensus 208 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 287 (604)
..+..++|++.+.||+|+||+||+|.+..++..||+|++...... ...+.+|+++|+.++||||+++++++.+++.
T Consensus 8 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 8 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp TBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTH----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred ccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHH----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence 345568999999999999999999999999999999999765432 3356689999999999999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccC
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAV 367 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~ 367 (604)
.|+||||++|++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 84 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~ 163 (288)
T 3kfa_A 84 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG 163 (288)
T ss_dssp EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence 99999999999999999887667899999999999999999999999999999999999999999999999999843221
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
.. ...
T Consensus 164 ~~---------------------------------------------------------------------------~~~ 168 (288)
T 3kfa_A 164 DT---------------------------------------------------------------------------YTA 168 (288)
T ss_dssp SS---------------------------------------------------------------------------SEE
T ss_pred Cc---------------------------------------------------------------------------ccc
Confidence 10 001
Q ss_pred ccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007433 448 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKG 526 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~ 526 (604)
.....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+.......+. ..........++..+.+||.+
T Consensus 169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~ 247 (288)
T 3kfa_A 169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-KDYRMERPEGCPEKVYELMRA 247 (288)
T ss_dssp ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHH
T ss_pred ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh-ccCCCCCCCCCCHHHHHHHHH
Confidence 112357889999999999999999999999999999999 999999877665554444 344445556789999999999
Q ss_pred hhhcCCCCcccccCCHHHHhc
Q 007433 527 LLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 527 lL~~dP~~Rpt~~~~a~elL~ 547 (604)
||..||.+||+ +.++++
T Consensus 248 ~l~~dp~~Rps----~~~~~~ 264 (288)
T 3kfa_A 248 CWQWNPSDRPS----FAEIHQ 264 (288)
T ss_dssp HTCSSGGGSCC----HHHHHH
T ss_pred HhCCChhhCcC----HHHHHH
Confidence 99999999999 888865
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=373.74 Aligned_cols=257 Identities=22% Similarity=0.301 Sum_probs=208.2
Q ss_pred eeecCeEEEEEEccCCcEEEEEEE----EcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec-
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSE----LTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET- 284 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~- 284 (604)
+..++|++++.||+|+||+||+|+ +..+++.||||++..... .....+.+|+++|+.++||||+++++++..
T Consensus 7 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 83 (295)
T 3ugc_A 7 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDFEREIEILKSLQHDNIVKYKGVCYSA 83 (295)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEECHH
T ss_pred CCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence 445799999999999999999998 567889999999976532 334467789999999999999999999864
Q ss_pred -CCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccc
Q 007433 285 -DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 285 -~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
...+|+|||||++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++.
T Consensus 84 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 84 GRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HHTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 456899999999999999998753 469999999999999999999999999999999999999999999999999985
Q ss_pred cccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCC
Q 007433 364 RCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEP 443 (604)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (604)
.+.......
T Consensus 163 ~~~~~~~~~----------------------------------------------------------------------- 171 (295)
T 3ugc_A 163 VLPQDKEFF----------------------------------------------------------------------- 171 (295)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccCCccee-----------------------------------------------------------------------
Confidence 432111000
Q ss_pred CCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChH---------------HHHHHHHcCCC
Q 007433 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR---------------ATLYNVVGQPL 508 (604)
Q Consensus 444 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~---------------~~l~~i~~~~~ 508 (604)
.......||..|+|||++.+..++.++|||||||++|||++|..||...... ..+...+....
T Consensus 172 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (295)
T 3ugc_A 172 --KVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 249 (295)
T ss_dssp ------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTC
T ss_pred --eeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccC
Confidence 0011234788899999999999999999999999999999999998753211 01222233344
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 509 RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 509 ~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
..+....++.++.+||.+||..||++||+ +.|+++
T Consensus 250 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~el~~ 284 (295)
T 3ugc_A 250 RLPRPDGCPDEIYMIMTECWNNNVNQRPS----FRDLAL 284 (295)
T ss_dssp CCCCCTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHH
T ss_pred cCCCCcCcCHHHHHHHHHHcCCChhhCCC----HHHHHH
Confidence 55556679999999999999999999999 888775
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=374.04 Aligned_cols=254 Identities=25% Similarity=0.338 Sum_probs=206.3
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++++.||+|+||.||+|++..+++.||||++.............+.+|+.+++.++||||+++++++..++..|+|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 47999999999999999999999999999999999876554445556778999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+.++.++|+|||++.......
T Consensus 113 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-- 188 (309)
T 2h34_A 113 MRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK-- 188 (309)
T ss_dssp EECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred EEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc--
Confidence 9999999999999875 469999999999999999999999999999999999999999999999999874321100
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
.......
T Consensus 189 -------------------------------------------------------------------------~~~~~~~ 195 (309)
T 2h34_A 189 -------------------------------------------------------------------------LTQLGNT 195 (309)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0011234
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCC--CCCCCCCHHHHHHHHHhhh
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRF--PESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~--p~~~~~s~~l~dLI~~lL~ 529 (604)
.||+.|+|||++.+..++.++|||||||++|||++|+.||.+.... .+...+...... .....++.++.+||.+||.
T Consensus 196 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 274 (309)
T 2h34_A 196 VGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQAIPRPSTVRPGIPVAFDAVIARGMA 274 (309)
T ss_dssp -CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSCCCCGGGTSTTCCTHHHHHHHHHTC
T ss_pred CCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccCCCCccccCCCCCHHHHHHHHHhcc
Confidence 6999999999999999999999999999999999999999986654 333333332221 2235688999999999999
Q ss_pred cCCCCcc-cccCCHHHHhc
Q 007433 530 KEPQNRL-ACRRGATEIKQ 547 (604)
Q Consensus 530 ~dP~~Rp-t~~~~a~elL~ 547 (604)
.||++|| + ++++++
T Consensus 275 ~dP~~Rp~s----~~~l~~ 289 (309)
T 2h34_A 275 KNPEDRYVT----CGDLSA 289 (309)
T ss_dssp SSGGGSCSS----HHHHHH
T ss_pred CCHHHHHHh----HHHHHH
Confidence 9999999 6 666654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=369.73 Aligned_cols=256 Identities=24% Similarity=0.354 Sum_probs=206.5
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCC---ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGT---KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD 285 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 285 (604)
.+..++|++.+.||+|+||.||+|.+..+ +..||+|++..... ......+.+|+.+|+.++||||+++++++. +
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--DSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 87 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence 34567999999999999999999998654 45799999876432 233446778999999999999999999985 5
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
+..|+||||+++++|.+++... ...+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++...
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 166 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 166 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred CccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECcccccccc
Confidence 6789999999999999999865 346999999999999999999999999999999999999999999999999998433
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
.....
T Consensus 167 ~~~~~--------------------------------------------------------------------------- 171 (281)
T 1mp8_A 167 EDSTY--------------------------------------------------------------------------- 171 (281)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred Ccccc---------------------------------------------------------------------------
Confidence 21000
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLI 524 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI 524 (604)
.......||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+.+..+.... ..+....++..+.+||
T Consensus 172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~li 250 (281)
T 1mp8_A 172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYSLM 250 (281)
T ss_dssp -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTCCHHHHHHH
T ss_pred cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHH
Confidence 00112347889999999999999999999999999999996 999999888777776665542 3344456899999999
Q ss_pred HHhhhcCCCCcccccCCHHHHhcC
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
.+||..||++||+ +.+++++
T Consensus 251 ~~~l~~~p~~Rps----~~~l~~~ 270 (281)
T 1mp8_A 251 TKCWAYDPSRRPR----FTELKAQ 270 (281)
T ss_dssp HHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHccCChhhCcC----HHHHHHH
Confidence 9999999999999 8888764
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=385.39 Aligned_cols=258 Identities=22% Similarity=0.307 Sum_probs=216.8
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcC-------CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCcccccee
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTG-------TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTH 281 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~ 281 (604)
+..++|++.+.||+|+||+||+|++.+ .+..||||++..... .....++.+|+++|+.+ +||||++++++
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 143 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGA 143 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccC--HHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence 345799999999999999999999754 346899999976532 23445677899999999 99999999999
Q ss_pred EecCCeeEEEEeecCCCCHHHHHHhcC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEE
Q 007433 282 FETDKFSCLVMEFCPGGDLHTLRQRQP--------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVL 347 (604)
Q Consensus 282 ~~~~~~~~lV~E~~~ggsL~~ll~~~~--------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNIL 347 (604)
+..++..|+||||+++|+|.+++.... ...+++..++.|+.||+.||+|||++|||||||||+|||
T Consensus 144 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 223 (382)
T 3tt0_A 144 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 223 (382)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred eccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEE
Confidence 999999999999999999999998753 245999999999999999999999999999999999999
Q ss_pred EccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCcc
Q 007433 348 VREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKN 427 (604)
Q Consensus 348 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 427 (604)
|+.++.+||+|||++........
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~~~--------------------------------------------------------- 246 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHIDY--------------------------------------------------------- 246 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCCCT---------------------------------------------------------
T ss_pred EcCCCcEEEcccCcccccccccc---------------------------------------------------------
Confidence 99999999999999843221000
Q ss_pred ccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcC
Q 007433 428 EMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQ 506 (604)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~ 506 (604)
........||+.|+|||++.+..++.++|||||||+||||++ |..||.+....+.+..+...
T Consensus 247 -----------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 309 (382)
T 3tt0_A 247 -----------------YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEG 309 (382)
T ss_dssp -----------------TCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTT
T ss_pred -----------------cccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence 001112357899999999999999999999999999999999 99999988776665555443
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 507 PLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 507 ~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
........++.++.+||.+||..||++||+ +.||+++
T Consensus 310 -~~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 346 (382)
T 3tt0_A 310 -HRMDKPSNCTNELYMMMRDCWHAVPSQRPT----FKQLVED 346 (382)
T ss_dssp -CCCCCCSSCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred -CCCCCCccCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 344444568999999999999999999999 8898886
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=369.21 Aligned_cols=252 Identities=25% Similarity=0.349 Sum_probs=209.0
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHH----HHHHHHHHHHHHHHhCCCCCccccceeEecC
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKR----KKLLRAQTEREILQSLDHPFLPTLYTHFETD 285 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~----~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 285 (604)
+..++|++.+.||+|+||+||+|++..+++.||||++........ ....++.+|+++|+.++||||+++++++.+.
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP 95 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT
T ss_pred hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC
Confidence 345799999999999999999999999999999999965432211 1125677899999999999999999999776
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcC--eEeccCCCCcEEEccCCc-----EEEec
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLG--IVYRDLKPENVLVREDGH-----IMLSD 358 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~g--IvHrDIKpeNILl~~~g~-----vkL~D 358 (604)
. ++||||+++++|.+++... ...+++..+..++.||+.||+|||++| |+||||||+||||+.++. +||+|
T Consensus 96 ~--~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 96 P--RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp T--EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred C--eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 5 6999999999998887654 357999999999999999999999999 999999999999988776 99999
Q ss_pred ccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcc
Q 007433 359 FDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPE 438 (604)
Q Consensus 359 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 438 (604)
||++.....
T Consensus 173 fg~~~~~~~----------------------------------------------------------------------- 181 (287)
T 4f0f_A 173 FGLSQQSVH----------------------------------------------------------------------- 181 (287)
T ss_dssp CTTCBCCSS-----------------------------------------------------------------------
T ss_pred CCccccccc-----------------------------------------------------------------------
Confidence 998732110
Q ss_pred cccCCCCCcccccccCccccCcceec--CCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHH--HHHHHcCCCCCCCCC
Q 007433 439 LIAEPTNARSMSFVGTHEYLAPEIIK--GEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRAT--LYNVVGQPLRFPESP 514 (604)
Q Consensus 439 ~~~~~~~~~~~~~~GT~~Y~APE~l~--~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~--l~~i~~~~~~~p~~~ 514 (604)
......||+.|+|||++. ...++.++|||||||++|||++|+.||........ ...+...........
T Consensus 182 --------~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (287)
T 4f0f_A 182 --------SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPE 253 (287)
T ss_dssp --------CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCCCCT
T ss_pred --------cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCCCCc
Confidence 011346999999999994 44578899999999999999999999987554333 444455555545556
Q ss_pred CCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 515 VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 515 ~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
.++..+.+||.+||..||++||+ +.++++
T Consensus 254 ~~~~~l~~li~~~l~~dp~~Rps----~~~ll~ 282 (287)
T 4f0f_A 254 DCPPRLRNVIELCWSGDPKKRPH----FSYIVK 282 (287)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred ccCHHHHHHHHHHhcCChhhCcC----HHHHHH
Confidence 78999999999999999999999 888875
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=375.50 Aligned_cols=264 Identities=27% Similarity=0.405 Sum_probs=214.3
Q ss_pred cCceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC--CCCccccceeEe
Q 007433 206 KDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD--HPFLPTLYTHFE 283 (604)
Q Consensus 206 ~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~ 283 (604)
....+..++|++++.||+|+||.||+|.+.. ++.||||++...... ......+.+|+++|+.+. |+||+++++++.
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEAD-NQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECSSCC-HHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCC-CcEEEEEEecccccc-ccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 3344555789999999999999999999864 779999999765332 234456778999999997 599999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccc
Q 007433 284 TDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 284 ~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
+++..|+|||+ .+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++.
T Consensus 99 ~~~~~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~ 174 (313)
T 3cek_A 99 TDQYIYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN 174 (313)
T ss_dssp CSSEEEEEECC-CSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSC
T ss_pred cCCEEEEEEec-CCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccc
Confidence 99999999995 589999999875 5789999999999999999999999999999999999996 5899999999884
Q ss_pred cccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCC
Q 007433 364 RCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEP 443 (604)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (604)
.+.....
T Consensus 175 ~~~~~~~------------------------------------------------------------------------- 181 (313)
T 3cek_A 175 QMQPDTT------------------------------------------------------------------------- 181 (313)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred cccCccc-------------------------------------------------------------------------
Confidence 3221000
Q ss_pred CCCcccccccCccccCcceecC-----------CCCCccchHHHHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCCCCCC
Q 007433 444 TNARSMSFVGTHEYLAPEIIKG-----------EGHGSAVDWWTFGIFLYELLFGKTPFKGSEN-RATLYNVVGQPLRFP 511 (604)
Q Consensus 444 ~~~~~~~~~GT~~Y~APE~l~~-----------~~~~~~~DiWSLGviL~eLltG~~PF~~~~~-~~~l~~i~~~~~~~p 511 (604)
........||+.|+|||++.+ ..++.++|||||||++|||++|+.||..... ...+..+........
T Consensus 182 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 260 (313)
T 3cek_A 182 -SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 260 (313)
T ss_dssp ---------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred -cccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccC
Confidence 001123469999999999976 4678899999999999999999999987543 445555665555544
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 512 ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 512 ~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
.....+.++.+||.+||..||.+||+ +.|+|+||||+.
T Consensus 261 ~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~h~~~~~ 298 (313)
T 3cek_A 261 FPDIPEKDLQDVLKCCLKRDPKQRIS----IPELLAHPYVQI 298 (313)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHC
T ss_pred CcccchHHHHHHHHHHccCCcccCcC----HHHHhcCccccC
Confidence 45567899999999999999999999 999999999975
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-45 Score=372.71 Aligned_cols=249 Identities=18% Similarity=0.220 Sum_probs=207.1
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCc-------eEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTK-------CYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHF 282 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~-------~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~ 282 (604)
+..++|++.+.||+|+||+||+|++..++ ..||+|++...... ....+.+|+.+|+.++||||+++++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRN---YSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGG---GHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHH---HHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 34579999999999999999999998766 57999999765332 234567899999999999999999999
Q ss_pred ecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCc--------E
Q 007433 283 ETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGH--------I 354 (604)
Q Consensus 283 ~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~--------v 354 (604)
.+++..|+||||++|++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||||+.++. +
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNK-NCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999999998752 45999999999999999999999999999999999999998887 9
Q ss_pred EEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCC
Q 007433 355 MLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVS 434 (604)
Q Consensus 355 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (604)
||+|||++....
T Consensus 161 kl~Dfg~~~~~~-------------------------------------------------------------------- 172 (289)
T 4fvq_A 161 KLSDPGISITVL-------------------------------------------------------------------- 172 (289)
T ss_dssp EECCCCSCTTTS--------------------------------------------------------------------
T ss_pred eeccCccccccc--------------------------------------------------------------------
Confidence 999999873211
Q ss_pred CCcccccCCCCCcccccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCC
Q 007433 435 PLPELIAEPTNARSMSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPES 513 (604)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~ 513 (604)
......||+.|+|||++.+ ..++.++|||||||++|||++|..|+...........+......++.
T Consensus 173 ------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~- 239 (289)
T 4fvq_A 173 ------------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPA- 239 (289)
T ss_dssp ------------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC-
T ss_pred ------------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhccCCCCC-
Confidence 0112458899999999988 67899999999999999999955444443344444444444444443
Q ss_pred CCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 514 PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 514 ~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
..+.++.+||.+||..||++||+ +.++++|
T Consensus 240 -~~~~~l~~li~~~l~~dp~~Rps----~~~ll~~ 269 (289)
T 4fvq_A 240 -PKAAELANLINNCMDYEPDHRPS----FRAIIRD 269 (289)
T ss_dssp -CSSCTTHHHHHHHSCSSGGGSCC----HHHHHHH
T ss_pred -CCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 36888999999999999999999 8999887
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=375.97 Aligned_cols=259 Identities=22% Similarity=0.327 Sum_probs=214.2
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEE-----cCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEe
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSEL-----TGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFE 283 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~-----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~ 283 (604)
+..++|++.+.||+|+||+||+|++ ..+++.||||++...... .....+.+|+.+|+.+ +||||+++++++.
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCc--HHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 3457999999999999999999985 456789999999765332 2334677899999999 7999999999987
Q ss_pred cC-CeeEEEEeecCCCCHHHHHHhcCC--------------CCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEE
Q 007433 284 TD-KFSCLVMEFCPGGDLHTLRQRQPG--------------KYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV 348 (604)
Q Consensus 284 ~~-~~~~lV~E~~~ggsL~~ll~~~~~--------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl 348 (604)
.. ..+|+||||+++++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+||||
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 64 469999999999999999987542 228999999999999999999999999999999999999
Q ss_pred ccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccc
Q 007433 349 REDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNE 428 (604)
Q Consensus 349 ~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 428 (604)
+.++.+||+|||++..+.....
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~---------------------------------------------------------- 203 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPD---------------------------------------------------------- 203 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTT----------------------------------------------------------
T ss_pred CCCCCEEECCCccccccccCcc----------------------------------------------------------
Confidence 9999999999999843321100
Q ss_pred cCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCC
Q 007433 429 MGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQP 507 (604)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~ 507 (604)
........||+.|+|||++.+..++.++|||||||++|||++ |..||.+......+...+...
T Consensus 204 ----------------~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~ 267 (316)
T 2xir_A 204 ----------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 267 (316)
T ss_dssp ----------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHT
T ss_pred ----------------ceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccC
Confidence 001123468999999999999999999999999999999998 999998876555554444433
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 508 LRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 508 ~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
...+....++..+.+||.+||..||.+||+ +.|+++|
T Consensus 268 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 304 (316)
T 2xir_A 268 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 304 (316)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred ccCCCCCCCCHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 334444568999999999999999999999 9999887
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=378.55 Aligned_cols=256 Identities=21% Similarity=0.299 Sum_probs=206.9
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceE----EEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCY----FAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD 285 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 285 (604)
+..++|++++.||+|+||+||+|++..++.. ||+|.+.... ......++.+|+.+|+.++||||+++++++.++
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 89 (327)
T 3poz_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS
T ss_pred cCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence 4457899999999999999999999887765 4777765432 223345677899999999999999999999876
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
. .++||||+.+|+|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 90 ~-~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 90 T-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp S-EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred C-eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 5 779999999999999988753 57999999999999999999999999999999999999999999999999998543
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
......
T Consensus 168 ~~~~~~-------------------------------------------------------------------------- 173 (327)
T 3poz_A 168 GAEEKE-------------------------------------------------------------------------- 173 (327)
T ss_dssp TTTCC---------------------------------------------------------------------------
T ss_pred cCCccc--------------------------------------------------------------------------
Confidence 211100
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLI 524 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI 524 (604)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+.........+ ......+....++.++.+||
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li 252 (327)
T 3poz_A 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL-EKGERLPQPPICTIDVYMIM 252 (327)
T ss_dssp ------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-HTTCCCCCCTTBCHHHHHHH
T ss_pred ccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHH-HcCCCCCCCccCCHHHHHHH
Confidence 01112357889999999999999999999999999999999 99999987765554444 34445555667899999999
Q ss_pred HHhhhcCCCCcccccCCHHHHhcC
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
.+||..||++||+ +.++++|
T Consensus 253 ~~~l~~~p~~Rps----~~ell~~ 272 (327)
T 3poz_A 253 VKCWMIDADSRPK----FRELIIE 272 (327)
T ss_dssp HHHTCSCGGGSCC----HHHHHHH
T ss_pred HHHcCCChhhCCC----HHHHHHH
Confidence 9999999999999 8888876
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-45 Score=388.99 Aligned_cols=257 Identities=25% Similarity=0.327 Sum_probs=215.8
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCee
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 288 (604)
.+..++|.+.+.||+|+||.||+|++..+++.||||++..... ......+.+|+++|+.++||||+++++++..++.+
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 187 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP--PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSC--HHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCC--HHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCc
Confidence 3456799999999999999999999999999999999975422 22334567899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|||||||++|+|.+++... +..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++......
T Consensus 188 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~ 266 (377)
T 3cbl_A 188 YIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADG 266 (377)
T ss_dssp EEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTS
T ss_pred EEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCC
Confidence 9999999999999998764 246899999999999999999999999999999999999999999999999998432110
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
.. ....
T Consensus 267 ~~--------------------------------------------------------------------------~~~~ 272 (377)
T 3cbl_A 267 VY--------------------------------------------------------------------------AASG 272 (377)
T ss_dssp EE--------------------------------------------------------------------------ECCS
T ss_pred ce--------------------------------------------------------------------------eecC
Confidence 00 0000
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGL 527 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~l 527 (604)
....+++.|+|||++.+..++.++|||||||+||||++ |..||.+....+....+. ...+.+....++.++.+||.+|
T Consensus 273 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~c 351 (377)
T 3cbl_A 273 GLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE-KGGRLPCPELCPDAVFRLMEQC 351 (377)
T ss_dssp SCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHH-TTCCCCCCTTCCHHHHHHHHHH
T ss_pred CCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCCCCCCCCCHHHHHHHHHH
Confidence 11236788999999998889999999999999999998 999999887766555444 3345555566899999999999
Q ss_pred hhcCCCCcccccCCHHHHhc
Q 007433 528 LVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~ 547 (604)
|..||++||+ +.+|++
T Consensus 352 l~~dP~~Rps----~~~i~~ 367 (377)
T 3cbl_A 352 WAYEPGQRPS----FSTIYQ 367 (377)
T ss_dssp TCSSGGGSCC----HHHHHH
T ss_pred cCCCchhCcC----HHHHHH
Confidence 9999999999 888765
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=368.80 Aligned_cols=258 Identities=18% Similarity=0.227 Sum_probs=208.8
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCe
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKF 287 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~ 287 (604)
.+..++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.+ +|+||+.+++++..+..
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~ 80 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLH 80 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCce
Confidence 34457999999999999999999999999999999998754321 2355799999999 89999999999999999
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCc-----EEEeccccc
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGH-----IMLSDFDLS 362 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~-----vkL~DFGla 362 (604)
.|+||||+ +++|.+++... +..+++..+..++.||+.||+|||++||+||||||+||||+.++. +||+|||++
T Consensus 81 ~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 81 NVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred eEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 99999999 99999999875 346999999999999999999999999999999999999987776 999999998
Q ss_pred ccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccC
Q 007433 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442 (604)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (604)
..+........
T Consensus 159 ~~~~~~~~~~~--------------------------------------------------------------------- 169 (298)
T 1csn_A 159 KFYRDPVTKQH--------------------------------------------------------------------- 169 (298)
T ss_dssp EESBCTTTCCB---------------------------------------------------------------------
T ss_pred ccccccccccc---------------------------------------------------------------------
Confidence 54432110000
Q ss_pred CCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCC---hHHHHHHHHcCCCCCC---CCCCC
Q 007433 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE---NRATLYNVVGQPLRFP---ESPVV 516 (604)
Q Consensus 443 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~---~~~~l~~i~~~~~~~p---~~~~~ 516 (604)
..........||+.|+|||++.+..++.++|||||||+||||++|+.||.+.. ....+..+.......+ ....+
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (298)
T 1csn_A 170 IPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGF 249 (298)
T ss_dssp CCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTS
T ss_pred ccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhC
Confidence 00011234579999999999999999999999999999999999999998743 3333433332211111 12358
Q ss_pred CHHHHHHHHHhhhcCCCCcccccCCHHHHh
Q 007433 517 SFSARDLIKGLLVKEPQNRLACRRGATEIK 546 (604)
Q Consensus 517 s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL 546 (604)
+.++.+||.+||..||++||+ +.+|+
T Consensus 250 ~~~l~~li~~~l~~dp~~RP~----~~~l~ 275 (298)
T 1csn_A 250 PEEFYKYMHYARNLAFDATPD----YDYLQ 275 (298)
T ss_dssp CHHHHHHHHHHHHCCTTCCCC----HHHHH
T ss_pred cHHHHHHHHHHhcCCcccCCC----HHHHH
Confidence 899999999999999999999 66665
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-45 Score=379.95 Aligned_cols=259 Identities=19% Similarity=0.296 Sum_probs=218.1
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCce-----EEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEe
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKC-----YFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFE 283 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~-----~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~ 283 (604)
+..++|++.+.||+|+||.||+|.+..++. .||+|++...... .....+.+|+.+|+.+ +||||+++++++.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHA--DEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccCh--HHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 345799999999999999999999977654 7999999765322 2334677899999999 8999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHhcC------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccC
Q 007433 284 TDKFSCLVMEFCPGGDLHTLRQRQP------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRED 351 (604)
Q Consensus 284 ~~~~~~lV~E~~~ggsL~~ll~~~~------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~ 351 (604)
+++..|+||||+++|+|.+++.... ...+++..+..++.||+.||+|||++||+||||||+||||+.+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence 9999999999999999999987532 3468999999999999999999999999999999999999999
Q ss_pred CcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCC
Q 007433 352 GHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGN 431 (604)
Q Consensus 352 g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (604)
+.+||+|||++.........
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~------------------------------------------------------------ 220 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNY------------------------------------------------------------ 220 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTS------------------------------------------------------------
T ss_pred CeEEECccccccccccccce------------------------------------------------------------
Confidence 99999999998433211000
Q ss_pred CCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCC
Q 007433 432 QVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRF 510 (604)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~ 510 (604)
.......||+.|+|||++.+..++.++|||||||++|||++ |..||.+......+..++......
T Consensus 221 --------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 286 (333)
T 2i1m_A 221 --------------IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQM 286 (333)
T ss_dssp --------------EECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCC
T ss_pred --------------eecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCC
Confidence 00112357889999999999999999999999999999998 999999877766666666655555
Q ss_pred CCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 511 PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 511 p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
+....++..+.+||.+||..||.+||+ +.+|+++
T Consensus 287 ~~~~~~~~~l~~li~~~l~~~p~~Rps----~~~l~~~ 320 (333)
T 2i1m_A 287 AQPAFAPKNIYSIMQACWALEPTHRPT----FQQICSF 320 (333)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCcC----HHHHHHH
Confidence 555668999999999999999999999 8888874
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=371.68 Aligned_cols=259 Identities=26% Similarity=0.369 Sum_probs=206.0
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
...++|++.+.||+|+||.||+|.+..+++.||||++.............+.+|+.+|+.++||||+++++++..++..|
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 108 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELN 108 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEE
Confidence 34578999999999999999999999999999999997643333344556778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccC
Q 007433 290 LVMEFCPGGDLHTLRQRQ--PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAV 367 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~--~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~ 367 (604)
+||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+||||+.+|.++|+|||++.....
T Consensus 109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 999999999999988752 245799999999999999999999999999999999999999999999999998743211
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
.. ..
T Consensus 189 ~~----------------------------------------------------------------------------~~ 192 (310)
T 2wqm_A 189 KT----------------------------------------------------------------------------TA 192 (310)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CC----------------------------------------------------------------------------cc
Confidence 00 01
Q ss_pred ccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCC--hHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007433 448 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE--NRATLYNVVGQPLRFPESPVVSFSARDLIK 525 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~--~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~ 525 (604)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.. .......+............++.++.+||.
T Consensus 193 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 272 (310)
T 2wqm_A 193 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVN 272 (310)
T ss_dssp ------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSCHHHHHHHH
T ss_pred ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccCHHHHHHHH
Confidence 113468999999999999999999999999999999999999997643 233344444433332233568999999999
Q ss_pred HhhhcCCCCcccccCCHHHHhcC
Q 007433 526 GLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
+||..||.+||+ +.+++++
T Consensus 273 ~~l~~dp~~Rps----~~~il~~ 291 (310)
T 2wqm_A 273 MCINPDPEKRPD----VTYVYDV 291 (310)
T ss_dssp HHTCSSGGGSCC----HHHHHHH
T ss_pred HHcCCChhhCCC----HHHHHHH
Confidence 999999999999 8888864
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=378.31 Aligned_cols=253 Identities=27% Similarity=0.410 Sum_probs=204.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHH---HHHHHHHHHHHHHHhC----CCCCccccceeEec
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKR---KKLLRAQTEREILQSL----DHPFLPTLYTHFET 284 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~iL~~l----~HpnIv~l~~~~~~ 284 (604)
.++|++.+.||+|+||.||+|++..+++.||||++........ .....+.+|+.+++++ +|+||+++++++..
T Consensus 30 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~ 109 (312)
T 2iwi_A 30 EAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFET 109 (312)
T ss_dssp ---CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC--
T ss_pred hhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEec
Confidence 4789999999999999999999999999999999976543221 1222345689999988 89999999999999
Q ss_pred CCeeEEEEee-cCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEc-cCCcEEEeccccc
Q 007433 285 DKFSCLVMEF-CPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVR-EDGHIMLSDFDLS 362 (604)
Q Consensus 285 ~~~~~lV~E~-~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~-~~g~vkL~DFGla 362 (604)
++..|+|||| +.+++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||++ .++.++|+|||++
T Consensus 110 ~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~ 187 (312)
T 2iwi_A 110 QEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSG 187 (312)
T ss_dssp ---CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred CCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchh
Confidence 9999999999 7899999999875 4699999999999999999999999999999999999999 8899999999988
Q ss_pred ccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccC
Q 007433 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442 (604)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (604)
......
T Consensus 188 ~~~~~~-------------------------------------------------------------------------- 193 (312)
T 2iwi_A 188 ALLHDE-------------------------------------------------------------------------- 193 (312)
T ss_dssp EECCSS--------------------------------------------------------------------------
T ss_pred hhcccC--------------------------------------------------------------------------
Confidence 432210
Q ss_pred CCCCcccccccCccccCcceecCCCCC-ccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHH
Q 007433 443 PTNARSMSFVGTHEYLAPEIIKGEGHG-SAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSAR 521 (604)
Q Consensus 443 ~~~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~ 521 (604)
......||+.|+|||++.+..+. .++|||||||++|||++|+.||.... .+......++ ..++..++
T Consensus 194 ----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~--~~~~~~~~ 261 (312)
T 2iwi_A 194 ----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFP--AHVSPDCC 261 (312)
T ss_dssp ----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCC--TTSCHHHH
T ss_pred ----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCc--ccCCHHHH
Confidence 01134589999999999877764 58999999999999999999997532 2333344444 45899999
Q ss_pred HHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCCh
Q 007433 522 DLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNW 556 (604)
Q Consensus 522 dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~ 556 (604)
+||.+||..||++||+ +.|+++||||+....
T Consensus 262 ~li~~~l~~~p~~Rps----~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 262 ALIRRCLAPKPSSRPS----LEEILLDPWMQTPAE 292 (312)
T ss_dssp HHHHHHTCSSTTTSCC----HHHHHHSTTTCC---
T ss_pred HHHHHHccCChhhCcC----HHHHhcChhhcCchh
Confidence 9999999999999999 999999999987543
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=382.64 Aligned_cols=256 Identities=26% Similarity=0.388 Sum_probs=213.6
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHH---HHHHHHHHHHHHHHhCC--CCCccccceeEec
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKR---KKLLRAQTEREILQSLD--HPFLPTLYTHFET 284 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~ 284 (604)
...++|++.+.||+|+||.||+|.+..+++.||||++........ ....++.+|+.+|+.+. |+||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 345799999999999999999999999999999999976532210 01123456999999996 5999999999999
Q ss_pred CCeeEEEEeecCC-CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEc-cCCcEEEeccccc
Q 007433 285 DKFSCLVMEFCPG-GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVR-EDGHIMLSDFDLS 362 (604)
Q Consensus 285 ~~~~~lV~E~~~g-gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~-~~g~vkL~DFGla 362 (604)
++..|+|||++.+ ++|.+++... ..+++..++.++.||+.||+|||++||+||||||+||||+ .++.+||+|||++
T Consensus 120 ~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 120 PDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred CCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 9999999999976 8999998875 5799999999999999999999999999999999999999 7899999999988
Q ss_pred ccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccC
Q 007433 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442 (604)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (604)
......
T Consensus 198 ~~~~~~-------------------------------------------------------------------------- 203 (320)
T 3a99_A 198 ALLKDT-------------------------------------------------------------------------- 203 (320)
T ss_dssp EECCSS--------------------------------------------------------------------------
T ss_pred cccccc--------------------------------------------------------------------------
Confidence 432100
Q ss_pred CCCCcccccccCccccCcceecCCCC-CccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHH
Q 007433 443 PTNARSMSFVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSAR 521 (604)
Q Consensus 443 ~~~~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~ 521 (604)
......||+.|+|||++.+..+ +.++|||||||+||||++|+.||.... .+......++ ..++.++.
T Consensus 204 ----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~--~~~~~~~~ 271 (320)
T 3a99_A 204 ----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR--QRVSSECQ 271 (320)
T ss_dssp ----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS--SCCCHHHH
T ss_pred ----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccccc--ccCCHHHH
Confidence 0113459999999999987776 678999999999999999999997532 2223333333 45899999
Q ss_pred HHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 522 DLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 522 dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
+||.+||..||++||+ +.||++||||+++.+.
T Consensus 272 ~li~~~l~~dp~~Rps----~~~ll~hp~~~~~~~~ 303 (320)
T 3a99_A 272 HLIRWCLALRPSDRPT----FEEIQNHPWMQDVLLP 303 (320)
T ss_dssp HHHHHHTCSSGGGSCC----HHHHHTSGGGSSCCCH
T ss_pred HHHHHHccCChhhCcC----HHHHhcCHhhcCccCc
Confidence 9999999999999999 9999999999987644
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=369.34 Aligned_cols=258 Identities=23% Similarity=0.278 Sum_probs=209.7
Q ss_pred eeecCeEEEEEEccCCcEEEEEEE----EcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSE----LTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD 285 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 285 (604)
+...+|++++.||+|+||.||+|+ +..+++.||||++.... .......+.+|+++|+.++||||+++++++...
T Consensus 18 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 95 (302)
T 4e5w_A 18 FEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTED 95 (302)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-
T ss_pred hhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC
Confidence 445689999999999999999999 56788999999997553 222345677899999999999999999999876
Q ss_pred --CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccc
Q 007433 286 --KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 286 --~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
..+|+||||+++++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+||||+.++.++|+|||++.
T Consensus 96 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 96 GGNGIKLIMEFLPSGSLKEYLPKNK-NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp --CCEEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCceEEEEEEeCCCCcHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence 67899999999999999986653 569999999999999999999999999999999999999999999999999985
Q ss_pred cccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCC
Q 007433 364 RCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEP 443 (604)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (604)
.........
T Consensus 175 ~~~~~~~~~----------------------------------------------------------------------- 183 (302)
T 4e5w_A 175 AIETDKEYY----------------------------------------------------------------------- 183 (302)
T ss_dssp ECCTTCCEE-----------------------------------------------------------------------
T ss_pred cccCCCcce-----------------------------------------------------------------------
Confidence 432111000
Q ss_pred CCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCC--------------ChHHHHHHHHcCCCC
Q 007433 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS--------------ENRATLYNVVGQPLR 509 (604)
Q Consensus 444 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~--------------~~~~~l~~i~~~~~~ 509 (604)
.......||..|+|||++.+..++.++|||||||++|||++|..||... .....+...+.....
T Consensus 184 --~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (302)
T 4e5w_A 184 --TVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKR 261 (302)
T ss_dssp --ECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCC
T ss_pred --eccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCC
Confidence 0111235889999999999999999999999999999999999886432 222333444444455
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 510 FPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 510 ~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
.+....++..+.+||.+||..||.+||+ +.++++
T Consensus 262 ~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~ll~ 295 (302)
T 4e5w_A 262 LPCPPNCPDEVYQLMRKCWEFQPSNRTS----FQNLIE 295 (302)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCC----HHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCCCCCCC----HHHHHH
Confidence 5666679999999999999999999999 888775
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=372.27 Aligned_cols=261 Identities=26% Similarity=0.386 Sum_probs=202.8
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
...++|++++.||+|+||.||+|++..+++.||||++....... .....+.++..+++.++||||+++++++.+++..|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHH-HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccch-HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 34579999999999999999999999999999999997654322 22223344556788899999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHc-CeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML-GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
+||||+ ++.+..++... ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++..+...
T Consensus 101 lv~e~~-~~~~~~l~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRM-QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD 178 (318)
T ss_dssp EEECCC-SEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEecc-CCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence 999999 67777666543 35799999999999999999999995 9999999999999999999999999987432110
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
...
T Consensus 179 -----------------------------------------------------------------------------~~~ 181 (318)
T 2dyl_A 179 -----------------------------------------------------------------------------KAK 181 (318)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -----------------------------------------------------------------------------ccc
Confidence 001
Q ss_pred cccccCccccCcceec-----CCCCCccchHHHHHHHHHHHhhCCCCCCCC-ChHHHHHHHHcC-CCCCCCCCCCCHHHH
Q 007433 449 MSFVGTHEYLAPEIIK-----GEGHGSAVDWWTFGIFLYELLFGKTPFKGS-ENRATLYNVVGQ-PLRFPESPVVSFSAR 521 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~-----~~~~~~~~DiWSLGviL~eLltG~~PF~~~-~~~~~l~~i~~~-~~~~p~~~~~s~~l~ 521 (604)
....||+.|+|||++. +..++.++|||||||+||||++|+.||... ...+.+..+... ...++....++.++.
T Consensus 182 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 261 (318)
T 2dyl_A 182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFSGDFQ 261 (318)
T ss_dssp -----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSCCCHHHH
T ss_pred cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCCCCHHHH
Confidence 1235899999999995 456788999999999999999999999874 444555555443 334455556899999
Q ss_pred HHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 522 DLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 522 dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
+||.+||..||.+||+ +.++++||||+..
T Consensus 262 ~li~~~l~~dp~~Rps----~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 262 SFVKDCLTKDHRKRPK----YNKLLEHSFIKRY 290 (318)
T ss_dssp HHHHHHTCSCTTTSCC----HHHHTTSHHHHHH
T ss_pred HHHHHHccCChhHCcC----HHHHhhCHHHHhc
Confidence 9999999999999999 9999999999754
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=379.18 Aligned_cols=263 Identities=25% Similarity=0.340 Sum_probs=192.8
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHH-HHHhCCCCCccccceeEecCCee
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTERE-ILQSLDHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~-iL~~l~HpnIv~l~~~~~~~~~~ 288 (604)
+..++|++++.||+|+||.||+|.+..+++.||||++....... ...++.+|+. +++.++||||+++++++..++..
T Consensus 19 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~ 96 (327)
T 3aln_A 19 FTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK--EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDC 96 (327)
T ss_dssp CCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHH--HHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEE
T ss_pred cCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCch--HHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCce
Confidence 34579999999999999999999999999999999997653222 2223444555 77888999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHh---cCCCCCcHHHHHHHHHHHHHHHHHHHHc-CeEeccCCCCcEEEccCCcEEEeccccccc
Q 007433 289 CLVMEFCPGGDLHTLRQR---QPGKYFSEQAVKFYVAEVLLALEYLHML-GIVYRDLKPENVLVREDGHIMLSDFDLSLR 364 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~---~~~~~l~e~~~~~i~~qil~aL~yLH~~-gIvHrDIKpeNILl~~~g~vkL~DFGla~~ 364 (604)
|+||||+. ++|.+++.. .....+++..+..++.|++.||.|||++ ||+||||||+||||+.++.+||+|||++..
T Consensus 97 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~ 175 (327)
T 3aln_A 97 WICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175 (327)
T ss_dssp EEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC
T ss_pred EEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCcee
Confidence 99999996 588777653 2246799999999999999999999998 999999999999999999999999998843
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
....
T Consensus 176 ~~~~---------------------------------------------------------------------------- 179 (327)
T 3aln_A 176 LVDS---------------------------------------------------------------------------- 179 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccc----------------------------------------------------------------------------
Confidence 2100
Q ss_pred CCcccccccCccccCccee----cCCCCCccchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHcC-CCCCC--CCCCC
Q 007433 445 NARSMSFVGTHEYLAPEII----KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR-ATLYNVVGQ-PLRFP--ESPVV 516 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l----~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~-~~l~~i~~~-~~~~p--~~~~~ 516 (604)
.......||+.|+|||++ .+..++.++|||||||++|||++|+.||.+.... +.+..+... ...++ ....+
T Consensus 180 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (327)
T 3aln_A 180 -IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREF 258 (327)
T ss_dssp ---------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCC
T ss_pred -cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccC
Confidence 001123599999999999 4566899999999999999999999999875432 222222221 11222 12458
Q ss_pred CHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCCh
Q 007433 517 SFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNW 556 (604)
Q Consensus 517 s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~ 556 (604)
+..+.+||.+||..||++||+ +.+|++||||....+
T Consensus 259 ~~~l~~li~~~l~~dp~~Rps----~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 259 SPSFINFVNLCLTKDESKRPK----YKELLKHPFILMYEE 294 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCC----HHHHTTSHHHHHHHH
T ss_pred CHHHHHHHHHHhhCChhhCcC----HHHHHhChHHHHhHh
Confidence 899999999999999999999 999999999976544
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=361.79 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=214.9
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
+..++|++++.||+|+||.||+|.+. ++..||+|++....... ..+.+|+++++.++||||+++++++.+++..|
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 79 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPIC 79 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCH----HHHHHHHHHHHTCCCTTBCCEEEEECSSSSCE
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCH----HHHHHHHHHHHhCCCCCEeeEEEEEccCCCeE
Confidence 44579999999999999999999987 45689999998764332 34668999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 80 lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 80 LVTEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp EEECCCTTCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEeCCCCCcHHHHHhhCc-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 9999999999999988753 568999999999999999999999999999999999999999999999999884321100
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
.....
T Consensus 159 ---------------------------------------------------------------------------~~~~~ 163 (267)
T 3t9t_A 159 ---------------------------------------------------------------------------YTSST 163 (267)
T ss_dssp ---------------------------------------------------------------------------HHSTT
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 00011
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
...||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+.........+.... .......++..+.+||.+||
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~li~~~l 242 (267)
T 3t9t_A 164 GTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-RLYKPRLASTHVYQIMNHCW 242 (267)
T ss_dssp STTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CCCCCTTSCHHHHHHHHHHT
T ss_pred cccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC-cCCCCccCcHHHHHHHHHHc
Confidence 2347889999999999999999999999999999999 999999888777776665542 33334458999999999999
Q ss_pred hcCCCCcccccCCHHHHhcC
Q 007433 529 VKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 529 ~~dP~~Rpt~~~~a~elL~H 548 (604)
..||++||+ +.+++++
T Consensus 243 ~~~p~~Rps----~~~ll~~ 258 (267)
T 3t9t_A 243 RERPEDRPA----FSRLLRQ 258 (267)
T ss_dssp CSSGGGSCC----HHHHHHH
T ss_pred cCChhhCcC----HHHHHHH
Confidence 999999999 8888875
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=369.62 Aligned_cols=261 Identities=23% Similarity=0.335 Sum_probs=210.7
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcC-C--ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTG-T--KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD 285 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~-~--~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 285 (604)
.+..++|++++.||+|+||+||+|++.. + +..||||++.............+.+|+++|+.++||||+++++++.++
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 3455799999999999999999998643 2 346999999876544445566778999999999999999999999876
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
. .++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred C-ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 5 889999999999999887652 46999999999999999999999999999999999999999999999999998543
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
.......
T Consensus 172 ~~~~~~~------------------------------------------------------------------------- 178 (291)
T 1u46_A 172 PQNDDHY------------------------------------------------------------------------- 178 (291)
T ss_dssp CC-CCEE-------------------------------------------------------------------------
T ss_pred cccccch-------------------------------------------------------------------------
Confidence 2111000
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLI 524 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI 524 (604)
.......||+.|+|||++.+..++.++|||||||++|+|++ |+.||.+....+.+..+......++....++.++.+||
T Consensus 179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 258 (291)
T 1u46_A 179 VMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVM 258 (291)
T ss_dssp EC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHH
T ss_pred hhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcCHHHHHHH
Confidence 00112357889999999999889999999999999999999 99999998888888888777666666677999999999
Q ss_pred HHhhhcCCCCcccccCCHHHHhcC
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
.+||..||++||+ +.+++++
T Consensus 259 ~~~l~~~p~~Rps----~~~l~~~ 278 (291)
T 1u46_A 259 VQCWAHKPEDRPT----FVALRDF 278 (291)
T ss_dssp HHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHccCCcccCcC----HHHHHHH
Confidence 9999999999999 8888874
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=375.19 Aligned_cols=259 Identities=24% Similarity=0.350 Sum_probs=213.7
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEE----EcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEe-
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSE----LTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFE- 283 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~- 283 (604)
.+..++|++++.||+|+||.||+|+ +..+++.||||++..... .....+.+|+++|+.++|+||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 95 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGP---DQQRDFQREIQILKALHSDFIVKYRGVSYG 95 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCH---HHHHHHHHHHHHHHhcCCCceeEEEEEEec
Confidence 3455899999999999999999999 567889999999976543 23345678999999999999999999887
Q ss_pred -cCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 284 -TDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 284 -~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
+....|+||||+++++|.+++.... ..+++..++.|+.||+.||+|||++||+||||||+||||+.++.+||+|||++
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~ 174 (327)
T 3lxl_A 96 PGRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLA 174 (327)
T ss_dssp SSSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGC
T ss_pred CCCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccc
Confidence 4677999999999999999988642 46999999999999999999999999999999999999999999999999998
Q ss_pred ccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccC
Q 007433 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442 (604)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (604)
..........
T Consensus 175 ~~~~~~~~~~---------------------------------------------------------------------- 184 (327)
T 3lxl_A 175 KLLPLDKDYY---------------------------------------------------------------------- 184 (327)
T ss_dssp EECCTTCSEE----------------------------------------------------------------------
T ss_pred eecccCCccc----------------------------------------------------------------------
Confidence 5432111000
Q ss_pred CCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCCh--------------HHHHHHHHcCCC
Q 007433 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSEN--------------RATLYNVVGQPL 508 (604)
Q Consensus 443 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~--------------~~~l~~i~~~~~ 508 (604)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ...+...+....
T Consensus 185 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (327)
T 3lxl_A 185 ---VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ 261 (327)
T ss_dssp ---ECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTC
T ss_pred ---eeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhccc
Confidence 001123588999999999999899999999999999999999999965322 123334444455
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 509 RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 509 ~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
..+....++..+.+||.+||..||++||+ +.||++|
T Consensus 262 ~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 297 (327)
T 3lxl_A 262 RLPAPPACPAEVHELMKLCWAPSPQDRPS----FSALGPQ 297 (327)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCCcccHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 55666679999999999999999999999 8888544
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=365.19 Aligned_cols=259 Identities=22% Similarity=0.278 Sum_probs=211.0
Q ss_pred CceeeecCeEEEE-EEccCCcEEEEEEEE--cCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEe
Q 007433 207 DGVLGVGHFRLLK-KLGCGDIGSVYLSEL--TGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFE 283 (604)
Q Consensus 207 ~~~~~~~~y~l~~-~LG~G~fG~Vy~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~ 283 (604)
+..+..++|++.+ .||+|+||+||+|.+ ..+++.||||++..... ......++.+|+++|+.++||||+++++++
T Consensus 10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 4445568999999 999999999999954 56778999999976532 223345677899999999999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccc
Q 007433 284 TDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 284 ~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
..+..|+||||+++++|.+++... ..+++..+..++.||+.||+|||++||+||||||+||||+.++.++|+|||++.
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 165 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSK 165 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCCCcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcce
Confidence 566789999999999999999875 569999999999999999999999999999999999999999999999999985
Q ss_pred cccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCC
Q 007433 364 RCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEP 443 (604)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (604)
..........
T Consensus 166 ~~~~~~~~~~---------------------------------------------------------------------- 175 (291)
T 1xbb_A 166 ALRADENYYK---------------------------------------------------------------------- 175 (291)
T ss_dssp ECCTTCSEEE----------------------------------------------------------------------
T ss_pred eeccCCCccc----------------------------------------------------------------------
Confidence 4321111000
Q ss_pred CCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHH
Q 007433 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARD 522 (604)
Q Consensus 444 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~d 522 (604)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+... ........++..+.+
T Consensus 176 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ 251 (291)
T 1xbb_A 176 ---AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGCPAGCPREMYD 251 (291)
T ss_dssp ---C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHH
T ss_pred ---ccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHH
Confidence 0112247789999999999889999999999999999999 99999988776666555543 233334568999999
Q ss_pred HHHHhhhcCCCCcccccCCHHHHhc
Q 007433 523 LIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 523 LI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
||.+||..||.+||+ +.++++
T Consensus 252 li~~~l~~dp~~Rps----~~~l~~ 272 (291)
T 1xbb_A 252 LMNLCWTYDVENRPG----FAAVEL 272 (291)
T ss_dssp HHHHHTCSSTTTSCC----HHHHHH
T ss_pred HHHHHcCCChhhCcC----HHHHHH
Confidence 999999999999999 777765
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=375.07 Aligned_cols=255 Identities=22% Similarity=0.328 Sum_probs=212.2
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEE--EEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCC
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYF--AMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDK 286 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~v--AiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 286 (604)
+..++|++.+.||+|+||.||+|++..++..+ |+|.+.... .......+.+|+++|+++ +||||+++++++.+++
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 34579999999999999999999998888755 999987542 223344577899999999 9999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQP--------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG 352 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~--------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g 352 (604)
..|+||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||||+.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999987652 24799999999999999999999999999999999999999999
Q ss_pred cEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCC
Q 007433 353 HIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQ 432 (604)
Q Consensus 353 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (604)
.+||+|||++......
T Consensus 180 ~~kL~Dfg~~~~~~~~---------------------------------------------------------------- 195 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY---------------------------------------------------------------- 195 (327)
T ss_dssp CEEECCTTCEESSCEE----------------------------------------------------------------
T ss_pred eEEEcccCcCcccccc----------------------------------------------------------------
Confidence 9999999987321100
Q ss_pred CCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCC
Q 007433 433 VSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFP 511 (604)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p 511 (604)
.......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+... ....
T Consensus 196 -------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-~~~~ 261 (327)
T 1fvr_A 196 -------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YRLE 261 (327)
T ss_dssp -------------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT-CCCC
T ss_pred -------------ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC-CCCC
Confidence 00112247889999999999889999999999999999998 99999988776666555443 3344
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 512 ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 512 ~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
....++..+.+||.+||..||.+||+ +.++++|
T Consensus 262 ~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 294 (327)
T 1fvr_A 262 KPLNCDDEVYDLMRQCWREKPYERPS----FAQILVS 294 (327)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 44568999999999999999999999 8888876
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-45 Score=379.78 Aligned_cols=257 Identities=19% Similarity=0.246 Sum_probs=209.3
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCceE----EEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTKCY----FAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET 284 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~----vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 284 (604)
.+..++|++++.||+|+||+||+|++..++.. ||+|++..... ......+.+|+.+++.++||||+++++++.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~- 85 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP- 85 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-
Confidence 34557999999999999999999999888765 77777654321 112234557999999999999999999886
Q ss_pred CCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccc
Q 007433 285 DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLR 364 (604)
Q Consensus 285 ~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~ 364 (604)
+...|+||||+++|+|.+++... ...+++..+..|+.||+.||+|||++||+||||||+||||+.++++||+|||++..
T Consensus 86 ~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 164 (325)
T 3kex_A 86 GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADL 164 (325)
T ss_dssp BSSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred CCccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccc
Confidence 45688999999999999998764 35799999999999999999999999999999999999999999999999999854
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
+.....
T Consensus 165 ~~~~~~-------------------------------------------------------------------------- 170 (325)
T 3kex_A 165 LPPDDK-------------------------------------------------------------------------- 170 (325)
T ss_dssp SCCCTT--------------------------------------------------------------------------
T ss_pred cCcccc--------------------------------------------------------------------------
Confidence 321100
Q ss_pred CCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 007433 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDL 523 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dL 523 (604)
........||..|+|||++.+..++.++|||||||++|||++ |+.||.+.........+... ........++.++.+|
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l 249 (325)
T 3kex_A 171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-ERLAQPQICTIDVYMV 249 (325)
T ss_dssp CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTT-CBCCCCTTBCTTTTHH
T ss_pred cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcC-CCCCCCCcCcHHHHHH
Confidence 001123458889999999999999999999999999999999 99999987766665555443 3334444588899999
Q ss_pred HHHhhhcCCCCcccccCCHHHHhcC
Q 007433 524 IKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 524 I~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
|.+||..||.+||+ +.++++|
T Consensus 250 i~~~l~~dp~~Rps----~~el~~~ 270 (325)
T 3kex_A 250 MVKCWMIDENIRPT----FKELANE 270 (325)
T ss_dssp HHHHTCSCTTTSCC----HHHHHHH
T ss_pred HHHHcCCChhhCcC----HHHHHHH
Confidence 99999999999999 8888877
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=363.43 Aligned_cols=258 Identities=23% Similarity=0.334 Sum_probs=213.6
Q ss_pred eeeecCeEEEE-EEccCCcEEEEEEEEc--CCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC
Q 007433 209 VLGVGHFRLLK-KLGCGDIGSVYLSELT--GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD 285 (604)
Q Consensus 209 ~~~~~~y~l~~-~LG~G~fG~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 285 (604)
.+..++|.+++ .||+|+||.||+|.+. .++..||||++..... ......+.+|+++|+.++||||+++++++. .
T Consensus 5 ~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~ 81 (287)
T 1u59_A 5 FLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQ-A 81 (287)
T ss_dssp BCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-S
T ss_pred cccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccc--hhHHHHHHHHHHHHHhCCCCCEeEEEEEec-C
Confidence 34457899988 9999999999999864 4677899999976532 234456778999999999999999999994 5
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
+..|+||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.++|+|||++...
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 82 EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCcEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 5689999999999999998754 356999999999999999999999999999999999999999999999999998543
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
.......
T Consensus 161 ~~~~~~~------------------------------------------------------------------------- 167 (287)
T 1u59_A 161 GADDSYY------------------------------------------------------------------------- 167 (287)
T ss_dssp TTCSCEE-------------------------------------------------------------------------
T ss_pred ccCccee-------------------------------------------------------------------------
Confidence 2111000
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLI 524 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI 524 (604)
.......||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+....+.... ..+....++.++.+||
T Consensus 168 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~li 246 (287)
T 1u59_A 168 TARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK-RMECPPECPPELYALM 246 (287)
T ss_dssp CCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTC-CCCCCTTCCHHHHHHH
T ss_pred eccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCC-cCCCCCCcCHHHHHHH
Confidence 00112347899999999998889999999999999999998 999999887777666655432 2333456899999999
Q ss_pred HHhhhcCCCCcccccCCHHHHhcC
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
.+||..||++||+ +.++++|
T Consensus 247 ~~~l~~~p~~Rps----~~~l~~~ 266 (287)
T 1u59_A 247 SDCWIYKWEDRPD----FLTVEQR 266 (287)
T ss_dssp HHTTCSSGGGSCC----HHHHHHH
T ss_pred HHHcCCChhhCcC----HHHHHHH
Confidence 9999999999999 8999887
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=376.41 Aligned_cols=261 Identities=18% Similarity=0.247 Sum_probs=212.7
Q ss_pred eecCeEEEEEEccCCcEEEEEEE-----EcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSE-----LTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD 285 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~-----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 285 (604)
..++|++++.||+|+||.||+|+ +..++..||||++...... ....++.+|+.+|+.++||||+++++++.++
T Consensus 28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (327)
T 2yfx_A 28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSE--QDELDFLMEALIISKFNHQNIVRCIGVSLQS 105 (327)
T ss_dssp CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccch--hhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC
Confidence 35799999999999999999999 4567789999999654322 2334567899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCC-----CCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccC---CcEEEe
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPG-----KYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRED---GHIMLS 357 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~-----~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~---g~vkL~ 357 (604)
...|+||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||||+.+ +.++|+
T Consensus 106 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 106 LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEEC
Confidence 999999999999999999987532 358999999999999999999999999999999999999844 469999
Q ss_pred cccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCc
Q 007433 358 DFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLP 437 (604)
Q Consensus 358 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (604)
|||++........
T Consensus 186 Dfg~~~~~~~~~~------------------------------------------------------------------- 198 (327)
T 2yfx_A 186 DFGMARDIYRASY------------------------------------------------------------------- 198 (327)
T ss_dssp CCHHHHHHHC----------------------------------------------------------------------
T ss_pred ccccccccccccc-------------------------------------------------------------------
Confidence 9999853321100
Q ss_pred ccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 007433 438 ELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVV 516 (604)
Q Consensus 438 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~ 516 (604)
........||+.|+|||++.+..++.++|||||||+||+|++ |..||.+....+.+..+.... .......+
T Consensus 199 -------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~ 270 (327)
T 2yfx_A 199 -------YRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG-RMDPPKNC 270 (327)
T ss_dssp ----------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC-CCCCCTTC
T ss_pred -------cccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC-CCCCCCCC
Confidence 001123468999999999999999999999999999999998 999999887766666555442 23334568
Q ss_pred CHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCC
Q 007433 517 SFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 517 s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
+..+.+||.+||..||.+||+ +.+|++|.|+-
T Consensus 271 ~~~l~~li~~~l~~dp~~Rps----~~~ll~~l~~~ 302 (327)
T 2yfx_A 271 PGPVYRIMTQCWQHQPEDRPN----FAIILERIEYC 302 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCC----HHHHHHHHHHH
T ss_pred CHHHHHHHHHHhcCChhhCcC----HHHHHHHHHHH
Confidence 999999999999999999999 99999998764
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=375.36 Aligned_cols=254 Identities=21% Similarity=0.284 Sum_probs=200.1
Q ss_pred CceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 207 DGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 207 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
+..+..++|++++.||+|+||+||+|++. ++.||||++...... .....+|+.+|+.++||||+++++++....
T Consensus 18 n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 91 (322)
T 3soc_A 18 NLYFQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQ----SWQNEYEVYSLPGMKHENILQFIGAEKRGT 91 (322)
T ss_dssp CEEETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred ccccchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchH----HHHHHHHHHHHhcCCCCCchhhcceeccCC
Confidence 33455689999999999999999999886 578999999765322 223446889999999999999999998743
Q ss_pred ----eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHc----------CeEeccCCCCcEEEccCC
Q 007433 287 ----FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML----------GIVYRDLKPENVLVREDG 352 (604)
Q Consensus 287 ----~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~----------gIvHrDIKpeNILl~~~g 352 (604)
.+|+|||||++|+|.+++... .+++..++.++.||+.||.|||++ ||+||||||+||||+.++
T Consensus 92 ~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~ 168 (322)
T 3soc_A 92 SVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168 (322)
T ss_dssp SSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred CCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence 479999999999999999874 499999999999999999999999 999999999999999999
Q ss_pred cEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCC
Q 007433 353 HIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQ 432 (604)
Q Consensus 353 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (604)
.+||+|||++..+.....
T Consensus 169 ~~kL~DFg~a~~~~~~~~-------------------------------------------------------------- 186 (322)
T 3soc_A 169 TACIADFGLALKFEAGKS-------------------------------------------------------------- 186 (322)
T ss_dssp CEEECCCTTCEEECTTSC--------------------------------------------------------------
T ss_pred eEEEccCCcccccccccC--------------------------------------------------------------
Confidence 999999999854321100
Q ss_pred CCCCcccccCCCCCcccccccCccccCcceecCC-----CCCccchHHHHHHHHHHHhhCCCCCCCCCh-----------
Q 007433 433 VSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGE-----GHGSAVDWWTFGIFLYELLFGKTPFKGSEN----------- 496 (604)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~-----~~~~~~DiWSLGviL~eLltG~~PF~~~~~----------- 496 (604)
.......+||+.|+|||++.+. .++.++|||||||+||||++|+.||.+...
T Consensus 187 ------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~ 254 (322)
T 3soc_A 187 ------------AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIG 254 (322)
T ss_dssp ------------CCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHC
T ss_pred ------------ccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhc
Confidence 0011234699999999999874 345688999999999999999999976421
Q ss_pred ----HHHHHHHHcCCCCCCCCC------CCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 497 ----RATLYNVVGQPLRFPESP------VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 497 ----~~~l~~i~~~~~~~p~~~------~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
...+...+......+... ..+.++.+||.+||..||++||+ +.||++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~ell~ 311 (322)
T 3soc_A 255 QHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLS----AGCVGE 311 (322)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred cCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcC----HHHHHH
Confidence 222222222222222111 12345899999999999999999 888875
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=396.97 Aligned_cols=255 Identities=21% Similarity=0.306 Sum_probs=218.5
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCee
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 288 (604)
.+...+|++.+.||+|+||.||+|.+..++..||||++...... ...+.+|+.+|+.++||||+++++++..+..+
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~ 291 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 291 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc----hHHHHHHHHHHHhcCCCCEeeEEEEEecCCcE
Confidence 34567899999999999999999999999999999999765432 34567899999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|||||||++|+|.+++.......+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||++......
T Consensus 292 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 292 YIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp EEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred EEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 99999999999999998866677999999999999999999999999999999999999999999999999998543210
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
.. ...
T Consensus 372 ~~---------------------------------------------------------------------------~~~ 376 (495)
T 1opk_A 372 TY---------------------------------------------------------------------------TAH 376 (495)
T ss_dssp CE---------------------------------------------------------------------------ECC
T ss_pred ce---------------------------------------------------------------------------eec
Confidence 00 000
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGL 527 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~l 527 (604)
....+|..|+|||++.+..++.++|||||||+||||++ |..||.+.+..+.+..+ ....+.+....++..+.+||.+|
T Consensus 377 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~c 455 (495)
T 1opk_A 377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL-EKDYRMERPEGCPEKVYELMRAC 455 (495)
T ss_dssp TTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH-HTTCCCCCCTTCCHHHHHHHHHH
T ss_pred CCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCCCCCCCCHHHHHHHHHH
Confidence 12247789999999999999999999999999999999 99999988776555444 44455555567999999999999
Q ss_pred hhcCCCCcccccCCHHHHhc
Q 007433 528 LVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~ 547 (604)
|..||++||+ +.+|++
T Consensus 456 l~~dP~~RPs----~~el~~ 471 (495)
T 1opk_A 456 WQWNPSDRPS----FAEIHQ 471 (495)
T ss_dssp TCSSGGGSCC----HHHHHH
T ss_pred cCcChhHCcC----HHHHHH
Confidence 9999999999 778765
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-44 Score=384.88 Aligned_cols=258 Identities=22% Similarity=0.307 Sum_probs=206.6
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEc---CCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELT---GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD 285 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~---~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 285 (604)
.+..++|++.+.||+|+||.||+|++. .++..||||++..... ......+.+|+.+|+.++||||+++++++.++
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCC--HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 345579999999999999999999987 5677899999976432 22344677899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
+..||||||+++++|.+++... +..+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++...
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 197 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL 197 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence 9999999999999999999765 357999999999999999999999999999999999999999999999999998543
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
...... .
T Consensus 198 ~~~~~~-------------------------------------------------------------------------~ 204 (373)
T 2qol_A 198 EDDPEA-------------------------------------------------------------------------A 204 (373)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccCCcc-------------------------------------------------------------------------c
Confidence 211000 0
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLI 524 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI 524 (604)
.......+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+.. ....+....++..+.+||
T Consensus 205 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li 283 (373)
T 2qol_A 205 YTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDE-GYRLPPPMDCPAALYQLM 283 (373)
T ss_dssp ---------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHT-TEECCCCTTCBHHHHHHH
T ss_pred eeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCccccHHHHHHH
Confidence 00011236789999999999999999999999999999997 9999998877766655543 344555567899999999
Q ss_pred HHhhhcCCCCcccccCCHHHHhc
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
.+||..||++||+ +.+|++
T Consensus 284 ~~cl~~dp~~RPs----~~~i~~ 302 (373)
T 2qol_A 284 LDCWQKDRNNRPK----FEQIVS 302 (373)
T ss_dssp HHHTCSSGGGSCC----HHHHHH
T ss_pred HHHhCcChhhCcC----HHHHHH
Confidence 9999999999999 777765
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-44 Score=373.12 Aligned_cols=258 Identities=19% Similarity=0.286 Sum_probs=213.8
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEc-------CCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCcccccee
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELT-------GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTH 281 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~-------~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~ 281 (604)
+..++|++.+.||+|+||.||+|++. .++..||||++..... ......+.+|+++|+.+ +||||++++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCc--HHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 44579999999999999999999986 3567899999976532 23345677899999999 89999999999
Q ss_pred EecCCeeEEEEeecCCCCHHHHHHhcCC--------------CCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEE
Q 007433 282 FETDKFSCLVMEFCPGGDLHTLRQRQPG--------------KYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVL 347 (604)
Q Consensus 282 ~~~~~~~~lV~E~~~ggsL~~ll~~~~~--------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNIL 347 (604)
+.+++.+|+||||+++++|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEE
Confidence 9999999999999999999999986531 34899999999999999999999999999999999999
Q ss_pred EccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCcc
Q 007433 348 VREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKN 427 (604)
Q Consensus 348 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 427 (604)
|+.++.+||+|||++.........
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~-------------------------------------------------------- 213 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYY-------------------------------------------------------- 213 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSE--------------------------------------------------------
T ss_pred EcCCCCEEEccccccccccccccc--------------------------------------------------------
Confidence 999999999999998543211000
Q ss_pred ccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcC
Q 007433 428 EMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQ 506 (604)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~ 506 (604)
.......||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+....+...
T Consensus 214 ------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~ 275 (334)
T 2pvf_A 214 ------------------KKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEG 275 (334)
T ss_dssp ------------------ECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT
T ss_pred ------------------cccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcC
Confidence 00112347889999999999889999999999999999999 99999988776666555443
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 507 PLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 507 ~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
. ..+....++..+.+||.+||..||.+||+ +.|++++
T Consensus 276 ~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~ell~~ 312 (334)
T 2pvf_A 276 H-RMDKPANCTNELYMMMRDCWHAVPSQRPT----FKQLVED 312 (334)
T ss_dssp C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred C-CCCCCccCCHHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 2 33344568999999999999999999999 8888875
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=366.05 Aligned_cols=259 Identities=23% Similarity=0.369 Sum_probs=202.2
Q ss_pred ecCceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec
Q 007433 205 VKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET 284 (604)
Q Consensus 205 ~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 284 (604)
...+.+..++|++.++||+|+||+||+|++.. .||||++...... ......+.+|+++|+.++||||+++++++ .
T Consensus 16 ~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~ 90 (289)
T 3og7_A 16 ADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYS-T 90 (289)
T ss_dssp --CCBCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEE-C
T ss_pred CCCCccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCC-HHHHHHHHHHHHHHHhCCCCcEEEEEeec-c
Confidence 34456667899999999999999999998765 4999999765332 23445677899999999999999999955 5
Q ss_pred CCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccc
Q 007433 285 DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLR 364 (604)
Q Consensus 285 ~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~ 364 (604)
....++|||||++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.++|+|||++..
T Consensus 91 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~ 169 (289)
T 3og7_A 91 APQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATE 169 (289)
T ss_dssp SSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----
T ss_pred CCccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccc
Confidence 56789999999999999988654 35799999999999999999999999999999999999999999999999998843
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
..... .
T Consensus 170 ~~~~~--------------------------------------------------------------------------~ 175 (289)
T 3og7_A 170 KSRWS--------------------------------------------------------------------------G 175 (289)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccccc--------------------------------------------------------------------------c
Confidence 21100 0
Q ss_pred CCcccccccCccccCcceec---CCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC----CCCCCC
Q 007433 445 NARSMSFVGTHEYLAPEIIK---GEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFP----ESPVVS 517 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l~---~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p----~~~~~s 517 (604)
........||+.|+|||++. +..++.++|||||||++|||++|+.||.+....+.+..++......+ ....++
T Consensus 176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (289)
T 3og7_A 176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP 255 (289)
T ss_dssp --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSC
T ss_pred cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCC
Confidence 00112346999999999987 56678899999999999999999999998777666655543322111 123578
Q ss_pred HHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 518 FSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 518 ~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
..+.+||.+||..||.+||+ +.++++
T Consensus 256 ~~l~~li~~~l~~~p~~Rps----~~ell~ 281 (289)
T 3og7_A 256 KRMKRLMAECLKKKRDERPS----FPRILA 281 (289)
T ss_dssp HHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHHHHHHHHccCChhhCCC----HHHHHH
Confidence 99999999999999999999 888875
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=386.98 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=212.1
Q ss_pred ceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC-
Q 007433 208 GVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK- 286 (604)
Q Consensus 208 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~- 286 (604)
..+..++|++++.||+|+||.||+|.+. ++.||||+++... ....+.+|+.+|+.++||||+++++++....
T Consensus 188 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 188 WALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 260 (450)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTS
T ss_pred cccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCC
Confidence 3456789999999999999999999986 5689999997653 2235678999999999999999999987654
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
.+|||||||++|+|.+++.......+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||++....
T Consensus 261 ~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 261 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 79999999999999999988755568999999999999999999999999999999999999999999999999984211
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
.
T Consensus 341 ~------------------------------------------------------------------------------- 341 (450)
T 1k9a_A 341 S------------------------------------------------------------------------------- 341 (450)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred c-------------------------------------------------------------------------------
Confidence 0
Q ss_pred cccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007433 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIK 525 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~ 525 (604)
......+|..|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+... .+.+....++..+.+||.
T Consensus 342 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~ 420 (450)
T 1k9a_A 342 TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPAVYDVMK 420 (450)
T ss_dssp -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTT-CCCCCCTTCCHHHHHHHH
T ss_pred cccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHHH
Confidence 0011247889999999999999999999999999999998 99999988776666665543 445555679999999999
Q ss_pred HhhhcCCCCcccccCCHHHHhc
Q 007433 526 GLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
+||..||++||+ +.+|++
T Consensus 421 ~cl~~dp~~Rpt----~~~l~~ 438 (450)
T 1k9a_A 421 NCWHLDAATRPT----FLQLRE 438 (450)
T ss_dssp HHTCSSGGGSCC----HHHHHH
T ss_pred HHcCCChhHCcC----HHHHHH
Confidence 999999999999 777764
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-44 Score=362.39 Aligned_cols=255 Identities=25% Similarity=0.332 Sum_probs=210.3
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcC---CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTG---TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
+..++|++.+.||+|+||+||+|.+.. ++..||+|++.+.... ....++.+|+.+|+.++||||+++++++.++
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 85 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTL--DNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE- 85 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCH--HHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCc--hHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-
Confidence 345799999999999999999998654 4567999999865322 2335677899999999999999999998754
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
..|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNK-NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHT-TTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred CCEEEEecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 5689999999999999997653 568999999999999999999999999999999999999999999999999884322
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
.... .
T Consensus 165 ~~~~---------------------------------------------------------------------------~ 169 (281)
T 3cc6_A 165 DEDY---------------------------------------------------------------------------Y 169 (281)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cccc---------------------------------------------------------------------------c
Confidence 1000 0
Q ss_pred cccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007433 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIK 525 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~ 525 (604)
......||+.|+|||++.+..++.++|||||||++|||++ |+.||...........+... ...+....++..+.+||.
T Consensus 170 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~ 248 (281)
T 3cc6_A 170 KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-DRLPKPDLCPPVLYTLMT 248 (281)
T ss_dssp ---CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT-CCCCCCTTCCHHHHHHHH
T ss_pred ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC-CCCCCCCCCCHHHHHHHH
Confidence 0112347889999999999999999999999999999998 99999887776665555443 233444568999999999
Q ss_pred HhhhcCCCCcccccCCHHHHhcC
Q 007433 526 GLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
+||..||++||+ +.|++++
T Consensus 249 ~~l~~~p~~Rps----~~ell~~ 267 (281)
T 3cc6_A 249 RCWDYDPSDRPR----FTELVCS 267 (281)
T ss_dssp HHTCSSGGGSCC----HHHHHHH
T ss_pred HHccCCchhCcC----HHHHHHH
Confidence 999999999999 8888875
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=366.59 Aligned_cols=264 Identities=22% Similarity=0.300 Sum_probs=210.2
Q ss_pred ecCceeeecCeEEEEEEccCCcEEEEEEEEcC---CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCcccccee
Q 007433 205 VKDGVLGVGHFRLLKKLGCGDIGSVYLSELTG---TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTH 281 (604)
Q Consensus 205 ~~~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~ 281 (604)
+.+..+..++|++.+.||+|+||.||+|.+.. ++..||||++....... .....+.+|+.+|+.++||||++++++
T Consensus 26 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~ 104 (313)
T 3brb_A 26 LEDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQ-REIEEFLSEAACMKDFSHPNVIRLLGV 104 (313)
T ss_dssp TTTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCH-HHHHHHHHHHHHHHTCCCTTBCCCCEE
T ss_pred HHhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccch-hHHHHHHHHHHHHhcCCCCCeeeeeEE
Confidence 34555667899999999999999999998765 56689999997653322 334567789999999999999999999
Q ss_pred EecCC-----eeEEEEeecCCCCHHHHHHhc----CCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC
Q 007433 282 FETDK-----FSCLVMEFCPGGDLHTLRQRQ----PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG 352 (604)
Q Consensus 282 ~~~~~-----~~~lV~E~~~ggsL~~ll~~~----~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g 352 (604)
+.+.. ..|+||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+||||+.++
T Consensus 105 ~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 105 CIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDM 184 (313)
T ss_dssp EEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTS
T ss_pred EeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCC
Confidence 98654 459999999999999988532 235799999999999999999999999999999999999999999
Q ss_pred cEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCC
Q 007433 353 HIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQ 432 (604)
Q Consensus 353 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (604)
.+||+|||++..+.....
T Consensus 185 ~~kl~Dfg~~~~~~~~~~-------------------------------------------------------------- 202 (313)
T 3brb_A 185 TVCVADFGLSKKIYSGDY-------------------------------------------------------------- 202 (313)
T ss_dssp CEEECSCSCC----------------------------------------------------------------------
T ss_pred cEEEeecCcceecccccc--------------------------------------------------------------
Confidence 999999998844321100
Q ss_pred CCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCC
Q 007433 433 VSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFP 511 (604)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p 511 (604)
........|++.|+|||++.+..++.++|||||||+||||++ |..||.+.........+.... ...
T Consensus 203 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~ 269 (313)
T 3brb_A 203 ------------YRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH-RLK 269 (313)
T ss_dssp --------------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-CCC
T ss_pred ------------cCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC-CCC
Confidence 000112347889999999999999999999999999999999 999999887777666665442 333
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 512 ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 512 ~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
....++..+.+||.+||..||.+||+ +.+|++|
T Consensus 270 ~~~~~~~~l~~li~~~l~~dp~~Rps----~~~l~~~ 302 (313)
T 3brb_A 270 QPEDCLDELYEIMYSCWRTDPLDRPT----FSVLRLQ 302 (313)
T ss_dssp CBTTCCHHHHHHHHHTTCSSGGGSCC----HHHHHHH
T ss_pred CCccccHHHHHHHHHHcCCChhhCcC----HHHHHHH
Confidence 34568999999999999999999999 8888875
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=371.13 Aligned_cols=259 Identities=22% Similarity=0.285 Sum_probs=212.2
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCC----ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGT----KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET 284 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~----~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 284 (604)
.+..++|++.+.||+|+||+||+|.+..+ +..||||++...... .....+.+|+.+|+.++||||+++++++.+
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE--KQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 34567999999999999999999998755 346999999765322 233457789999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccc
Q 007433 285 DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLR 364 (604)
Q Consensus 285 ~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~ 364 (604)
.+..||||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 196 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRV 196 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred CCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchh
Confidence 99999999999999999998765 35799999999999999999999999999999999999999999999999999854
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
.......
T Consensus 197 ~~~~~~~------------------------------------------------------------------------- 203 (333)
T 1mqb_A 197 LEDDPEA------------------------------------------------------------------------- 203 (333)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred hcccccc-------------------------------------------------------------------------
Confidence 3211000
Q ss_pred CCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 007433 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDL 523 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dL 523 (604)
........||+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+... ...+....++..+.+|
T Consensus 204 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~l 282 (333)
T 1mqb_A 204 TYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLPTPMDCPSAIYQL 282 (333)
T ss_dssp -------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTT-CCCCCCTTCBHHHHHH
T ss_pred ccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCC-CcCCCcccCCHHHHHH
Confidence 000112247889999999999999999999999999999998 99999988877766666543 3445556689999999
Q ss_pred HHHhhhcCCCCcccccCCHHHHhcC
Q 007433 524 IKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 524 I~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
|.+||..||++||+ +.+++++
T Consensus 283 i~~~l~~~p~~Rps----~~~l~~~ 303 (333)
T 1mqb_A 283 MMQCWQQERARRPK----FADIVSI 303 (333)
T ss_dssp HHHHTCSSTTTSCC----HHHHHHH
T ss_pred HHHHcCCChhhCcC----HHHHHHH
Confidence 99999999999999 7787764
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=372.87 Aligned_cols=256 Identities=21% Similarity=0.304 Sum_probs=207.3
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEE----EEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYF----AMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD 285 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~v----AiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 285 (604)
+..++|++++.||+|+||+||+|++..++..| |+|.+..... ......+.+|+.+|+.++||||+++++++..+
T Consensus 12 l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSS--CCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred cCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccC--HHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 34579999999999999999999998887655 6666643221 12234567899999999999999999999876
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
. .++||||+.+|+|.+++.... ..+++..++.|+.||+.||.|||++||+||||||+||||+.++.+||+|||++..+
T Consensus 90 ~-~~~v~~~~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~ 167 (327)
T 3lzb_A 90 T-VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp S-EEEEECCCSSCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC----
T ss_pred C-ceEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEc
Confidence 5 789999999999999988753 56999999999999999999999999999999999999999999999999998543
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
..... .
T Consensus 168 ~~~~~--------------------------------------------------------------------------~ 173 (327)
T 3lzb_A 168 GAEEK--------------------------------------------------------------------------E 173 (327)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCccc--------------------------------------------------------------------------c
Confidence 21100 0
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLI 524 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI 524 (604)
.......||+.|+|||++.+..++.++|||||||+||||++ |..||.+.........+. .....+....++.++.+||
T Consensus 174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li 252 (327)
T 3lzb_A 174 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-KGERLPQPPICTIDVYMIM 252 (327)
T ss_dssp ------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH-TTCCCCCCTTBCHHHHHHH
T ss_pred ccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH-cCCCCCCCccCCHHHHHHH
Confidence 00112347889999999999999999999999999999999 999999877666554444 3445555667899999999
Q ss_pred HHhhhcCCCCcccccCCHHHHhcC
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
.+||..||.+||+ +.|+++.
T Consensus 253 ~~~l~~dp~~Rps----~~ell~~ 272 (327)
T 3lzb_A 253 RKCWMIDADSRPK----FRELIIE 272 (327)
T ss_dssp HHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHcCCChhHCcC----HHHHHHH
Confidence 9999999999999 8888864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=363.61 Aligned_cols=245 Identities=22% Similarity=0.368 Sum_probs=207.9
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec--------
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET-------- 284 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-------- 284 (604)
++|++++.||+|+||.||+|++..+++.||||++..... .+.+|+++|+.++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-------~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNE-------KAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSG-------GGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccH-------HHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 689999999999999999999999999999999976531 34579999999999999999999864
Q ss_pred --------CCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEE
Q 007433 285 --------DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIML 356 (604)
Q Consensus 285 --------~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL 356 (604)
...+|+||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+.++.++|
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 456899999999999999998765567999999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCC
Q 007433 357 SDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPL 436 (604)
Q Consensus 357 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (604)
+|||++.......
T Consensus 164 ~Dfg~~~~~~~~~------------------------------------------------------------------- 176 (284)
T 2a19_B 164 GDFGLVTSLKNDG------------------------------------------------------------------- 176 (284)
T ss_dssp CCCTTCEESSCCS-------------------------------------------------------------------
T ss_pred Ccchhheeccccc-------------------------------------------------------------------
Confidence 9999884432100
Q ss_pred cccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 007433 437 PELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVV 516 (604)
Q Consensus 437 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~ 516 (604)
......||+.|+|||++.+..++.++|||||||++|||++|..||... ......+.... + ...+
T Consensus 177 ----------~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~~~~--~--~~~~ 240 (284)
T 2a19_B 177 ----------KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLRDGI--I--SDIF 240 (284)
T ss_dssp ----------CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHHTTC--C--CTTS
T ss_pred ----------cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhhccc--c--cccC
Confidence 011235899999999999999999999999999999999999988532 22223333222 2 2458
Q ss_pred CHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 517 SFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 517 s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
+..+++||.+||..||.+||+ +.|+++|.++
T Consensus 241 ~~~~~~li~~~l~~dp~~Rps----~~e~l~~l~~ 271 (284)
T 2a19_B 241 DKKEKTLLQKLLSKKPEDRPN----TSEILRTLTV 271 (284)
T ss_dssp CHHHHHHHHHHTCSSGGGSCC----HHHHHHHHHH
T ss_pred CHHHHHHHHHHccCChhhCcC----HHHHHHHHHH
Confidence 899999999999999999999 9999999765
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=360.50 Aligned_cols=255 Identities=18% Similarity=0.224 Sum_probs=205.9
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCc---eEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCee-E
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTK---CYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS-C 289 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~-~ 289 (604)
.|.+.+.||+|+||+||+|++..++ ..||+|++..... ......+.+|+.+|+.++||||+++++++.+.+.. |
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 99 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITE--MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPH 99 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCS--HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccccc--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcE
Confidence 5778899999999999999976544 3799999975432 23445677899999999999999999999876554 9
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
+||||+.+++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus 100 ~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 100 VLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999999998764 3678999999999999999999999999999999999999999999999999984332100
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
.. ......
T Consensus 179 ~~------------------------------------------------------------------------~~~~~~ 186 (298)
T 3pls_A 179 YY------------------------------------------------------------------------SVQQHR 186 (298)
T ss_dssp GG------------------------------------------------------------------------CSCCSS
T ss_pred cc------------------------------------------------------------------------ccccCc
Confidence 00 000112
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCC-CCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKT-PFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~-PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
...||+.|+|||++.+..++.++|||||||++|+|++|.. ||...+..+....+. .....+....++..+.+||.+||
T Consensus 187 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l 265 (298)
T 3pls_A 187 HARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA-QGRRLPQPEYCPDSLYQVMQQCW 265 (298)
T ss_dssp CTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHH-TTCCCCCCTTCCHHHHHHHHHHT
T ss_pred CCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhh-cCCCCCCCccchHHHHHHHHHHc
Confidence 3458899999999999999999999999999999999554 455555544444443 33445555668999999999999
Q ss_pred hcCCCCcccccCCHHHHhcC
Q 007433 529 VKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 529 ~~dP~~Rpt~~~~a~elL~H 548 (604)
..||.+||+ +.++++.
T Consensus 266 ~~~p~~Rps----~~~ll~~ 281 (298)
T 3pls_A 266 EADPAVRPT----FRVLVGE 281 (298)
T ss_dssp CSSGGGSCC----HHHHHHH
T ss_pred cCChhhCcC----HHHHHHH
Confidence 999999999 7777753
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-44 Score=378.73 Aligned_cols=274 Identities=15% Similarity=0.199 Sum_probs=205.8
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCC-----ceEEEEEEecchhHHHHHH---H-----HHHHHHHHHHHhCCCCCcccc
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGT-----KCYFAMKVMDKASLEKRKK---L-----LRAQTEREILQSLDHPFLPTL 278 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~-----~~~vAiK~i~~~~~~~~~~---~-----~~~~~Ei~iL~~l~HpnIv~l 278 (604)
.++|++++.||+|+||.||+|.+..+ ++.||||++.......... + .....|+.+++.++|+||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 35899999999999999999998765 5789999987653211111 1 123356677888999999999
Q ss_pred ceeEecC----CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEc--cCC
Q 007433 279 YTHFETD----KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVR--EDG 352 (604)
Q Consensus 279 ~~~~~~~----~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~--~~g 352 (604)
++++... .+.||||||| |++|.+++... ...+++..++.|+.||+.||+|||++||+||||||+||||+ .++
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~ 191 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD 191 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence 9999764 5689999999 99999998875 35799999999999999999999999999999999999999 889
Q ss_pred cEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCC
Q 007433 353 HIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQ 432 (604)
Q Consensus 353 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (604)
.+||+|||++..+.......
T Consensus 192 ~~kl~DFG~a~~~~~~~~~~------------------------------------------------------------ 211 (364)
T 3op5_A 192 QVYLVDYGLAYRYCPEGVHK------------------------------------------------------------ 211 (364)
T ss_dssp CEEECCCTTCEESSGGGCCC------------------------------------------------------------
T ss_pred eEEEEECCcceecccCCccc------------------------------------------------------------
Confidence 99999999985543111000
Q ss_pred CCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC----CC
Q 007433 433 VSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ----PL 508 (604)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~----~~ 508 (604)
.........++||+.|+|||++.+..++.++|||||||+||||++|+.||.+......+...... .+
T Consensus 212 ---------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 282 (364)
T 3op5_A 212 ---------AYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENI 282 (364)
T ss_dssp ---------CSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCH
T ss_pred ---------ccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhH
Confidence 00001123457999999999999999999999999999999999999999864322222111100 00
Q ss_pred -C----CCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHh----------cCCCCCCCChhhhh
Q 007433 509 -R----FPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIK----------QHPFFQGVNWALIR 560 (604)
Q Consensus 509 -~----~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL----------~Hpff~~~~~~~~~ 560 (604)
. ......++.++.+||..||..||++||+ +.+|+ ..++...++|....
T Consensus 283 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~----~~~l~~~l~~~~~~~~~~~~~~~dw~~~~ 345 (364)
T 3op5_A 283 ASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPL----YENLRDILLQGLKAIGSKDDGKLDLSVVE 345 (364)
T ss_dssp HHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCC----HHHHHHHHHHHHHHTTCCCCCCCCC----
T ss_pred HHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCC----HHHHHHHHHHHHHHcCCCcCCccceEecc
Confidence 0 0011357899999999999999999999 55555 34555667777543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-44 Score=389.88 Aligned_cols=253 Identities=21% Similarity=0.315 Sum_probs=213.2
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCee
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 288 (604)
.+..++|++.+.||+|+||.||+|.+.. +..||||++...... ...+.+|+.+|+.++||||+++++++. ++..
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~ 257 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVKLHAVVT-KEPI 257 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSBC----HHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred eechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCcc----HHHHHHHHHHHhhCCCCCEeeEEEEEe-CCcc
Confidence 3456799999999999999999999875 557999999865432 345678999999999999999999986 6678
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|||||||++|+|.+++....+..+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||++......
T Consensus 258 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~ 337 (454)
T 1qcf_A 258 YIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN 337 (454)
T ss_dssp EEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred EEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence 99999999999999998654446899999999999999999999999999999999999999999999999998543210
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
.. ...
T Consensus 338 ~~---------------------------------------------------------------------------~~~ 342 (454)
T 1qcf_A 338 EY---------------------------------------------------------------------------TAR 342 (454)
T ss_dssp HH---------------------------------------------------------------------------HTT
T ss_pred ce---------------------------------------------------------------------------ecc
Confidence 00 000
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGL 527 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~l 527 (604)
....+|..|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+... .+.+....++.++.+||.+|
T Consensus 343 ~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~-~~~~~~~~~~~~l~~li~~c 421 (454)
T 1qcf_A 343 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPRPENCPEELYNIMMRC 421 (454)
T ss_dssp CSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHT-CCCCCCTTSCHHHHHHHHHH
T ss_pred CCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHHH
Confidence 12246789999999999999999999999999999999 99999998887777666543 45555567899999999999
Q ss_pred hhcCCCCcccccCCHHHHhc
Q 007433 528 LVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~ 547 (604)
|..||++||+ +.+|++
T Consensus 422 l~~dp~~RPt----~~~i~~ 437 (454)
T 1qcf_A 422 WKNRPEERPT----FEYIQS 437 (454)
T ss_dssp TCSSGGGSCC----HHHHHH
T ss_pred ccCChhHCcC----HHHHHH
Confidence 9999999999 777754
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=360.16 Aligned_cols=252 Identities=20% Similarity=0.324 Sum_probs=210.5
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
+..++|++++.||+|+||.||+|.+.. +..||||++...... ...+.+|+++|+.++||||+++++++.. +..|
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 83 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNG-HTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETT-TEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcC-CcEEEEEEecCCccc----HHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcE
Confidence 445799999999999999999999864 568999999765432 2346689999999999999999999874 5689
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
+||||+++++|.+++....+..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.......
T Consensus 84 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 163 (279)
T 1qpc_A 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (279)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence 99999999999999876433469999999999999999999999999999999999999999999999999985432110
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
. ....
T Consensus 164 ~---------------------------------------------------------------------------~~~~ 168 (279)
T 1qpc_A 164 Y---------------------------------------------------------------------------TARE 168 (279)
T ss_dssp E---------------------------------------------------------------------------ECCT
T ss_pred c---------------------------------------------------------------------------cccc
Confidence 0 0011
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
...||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+.+..+... ........++..+.+||.+||
T Consensus 169 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l 247 (279)
T 1qpc_A 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMVRPDNCPEELYQLMRLCW 247 (279)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHT
T ss_pred CCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcc-cCCCCcccccHHHHHHHHHHh
Confidence 2347889999999998889999999999999999999 99999988877776666543 333444568999999999999
Q ss_pred hcCCCCcccccCCHHHHhc
Q 007433 529 VKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 529 ~~dP~~Rpt~~~~a~elL~ 547 (604)
..||++||+ +.++++
T Consensus 248 ~~~p~~Rps----~~~l~~ 262 (279)
T 1qpc_A 248 KERPEDRPT----FDYLRS 262 (279)
T ss_dssp CSSGGGSCC----HHHHHH
T ss_pred ccChhhCCC----HHHHHH
Confidence 999999999 777765
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-45 Score=379.41 Aligned_cols=260 Identities=22% Similarity=0.218 Sum_probs=207.1
Q ss_pred CceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 207 DGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 207 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
+.....++|++.+.||+|+||+||+|++. +++.||||++...... ....+.+|+++|+.++||||+++++++.+++
T Consensus 33 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 33 DLEEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQ---GIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp CCCCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSS---HHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred HHHHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChH---HHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 33345689999999999999999999975 5779999998765322 2345678999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQP--GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLR 364 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~--~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~ 364 (604)
..|+||||+++++|.+++.... ...+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++..
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 188 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEE
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccc
Confidence 9999999999999999886543 23589999999999999999999999999999999999999999999999998843
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
..... .
T Consensus 189 ~~~~~--------------------------------------------------------------------------~ 194 (321)
T 2qkw_B 189 GTELD--------------------------------------------------------------------------Q 194 (321)
T ss_dssp CSSSS--------------------------------------------------------------------------C
T ss_pred ccccc--------------------------------------------------------------------------c
Confidence 21100 0
Q ss_pred CCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHH------HHH-HHcCCCC--------
Q 007433 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRAT------LYN-VVGQPLR-------- 509 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~------l~~-i~~~~~~-------- 509 (604)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+. ... .....+.
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (321)
T 2qkw_B 195 THLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLA 274 (321)
T ss_dssp CCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCT
T ss_pred cccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhc
Confidence 0011234699999999999999999999999999999999999999976432211 011 1111110
Q ss_pred CCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 510 FPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 510 ~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
.......+..+.+||.+||..||++||+ +.|+++|
T Consensus 275 ~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 309 (321)
T 2qkw_B 275 DKIRPESLRKFGDTAVKCLALSSEDRPS----MGDVLWK 309 (321)
T ss_dssp TCSCHHHHHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred cccCHHHHHHHHHHHHHHcCCCcccCcC----HHHHHHH
Confidence 0111223467889999999999999999 9999876
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=361.80 Aligned_cols=268 Identities=18% Similarity=0.273 Sum_probs=207.4
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeE-ecCCeeEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHF-ETDKFSCL 290 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~-~~~~~~~l 290 (604)
.++|++.+.||+|+||+||+|++..+++.||||++...... ..+.+|+++++.+.|++++..+.++ ..+...|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C-----CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc-----hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 36899999999999999999999999999999997654321 2356799999999988776666555 67888999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEE---ccCCcEEEecccccccccC
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV---REDGHIMLSDFDLSLRCAV 367 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl---~~~g~vkL~DFGla~~~~~ 367 (604)
||||+ +++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++.....
T Consensus 83 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 160 (296)
T 4hgt_A 83 VMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEECC-CCBHHHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEcc-CCCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence 99999 999999988542 569999999999999999999999999999999999999 7899999999999854332
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
...... .....
T Consensus 161 ~~~~~~---------------------------------------------------------------------~~~~~ 171 (296)
T 4hgt_A 161 ARTHQH---------------------------------------------------------------------IPYRE 171 (296)
T ss_dssp TTTCCB---------------------------------------------------------------------CCCCC
T ss_pred cccCcc---------------------------------------------------------------------CCCCc
Confidence 110000 00001
Q ss_pred ccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCCh---HHHHHHHHcCCCCCC---CCCCCCHHHH
Q 007433 448 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSEN---RATLYNVVGQPLRFP---ESPVVSFSAR 521 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~---~~~l~~i~~~~~~~p---~~~~~s~~l~ 521 (604)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+... ...+..+.......+ ....++.++.
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 251 (296)
T 4hgt_A 172 NKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFA 251 (296)
T ss_dssp SCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHH
T ss_pred ccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHH
Confidence 2245799999999999999999999999999999999999999987432 222333322222222 1134789999
Q ss_pred HHHHHhhhcCCCCcccccCCHHHHhc----------CCCCCCCChhhh
Q 007433 522 DLIKGLLVKEPQNRLACRRGATEIKQ----------HPFFQGVNWALI 559 (604)
Q Consensus 522 dLI~~lL~~dP~~Rpt~~~~a~elL~----------Hpff~~~~~~~~ 559 (604)
+||.+||..||++||+ +.++++ ..|...++|..+
T Consensus 252 ~li~~~l~~~p~~Rpt----~~~l~~~l~~~~~~~~~~~~~~~dw~~~ 295 (296)
T 4hgt_A 252 TYLNFCRSLRFDDKPD----YSYLRQLFRNLFHRQGFSYDYVFDWNML 295 (296)
T ss_dssp HHHHHHHTSCTTCCCC----HHHHHHHHHHHHHHHTCCTTCCCGGGGC
T ss_pred HHHHHHHhcCCCCCCC----HHHHHHHHHHHHHHhCCCccCccchhhc
Confidence 9999999999999999 777664 455566677654
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-44 Score=383.64 Aligned_cols=254 Identities=24% Similarity=0.397 Sum_probs=205.0
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC--e
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK--F 287 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~--~ 287 (604)
...++|++.+.||+|+||+||+|++..+++.||||++....... ....+.+|+++|+.++||||+++++++.... .
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 83 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRH 83 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCC
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCe
Confidence 34578999999999999999999999999999999997654322 2334568999999999999999999998654 7
Q ss_pred eEEEEeecCCCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEE----ccCCcEEEeccccc
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPG-KYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV----REDGHIMLSDFDLS 362 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~-~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl----~~~g~vkL~DFGla 362 (604)
.|||||||+||+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||| +.++.+||+|||++
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a 163 (396)
T 4eut_A 84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163 (396)
T ss_dssp EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence 8999999999999999876432 349999999999999999999999999999999999999 67778999999998
Q ss_pred ccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccC
Q 007433 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442 (604)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (604)
..+...
T Consensus 164 ~~~~~~-------------------------------------------------------------------------- 169 (396)
T 4eut_A 164 RELEDD-------------------------------------------------------------------------- 169 (396)
T ss_dssp EECCCG--------------------------------------------------------------------------
T ss_pred eEccCC--------------------------------------------------------------------------
Confidence 432210
Q ss_pred CCCCcccccccCccccCcceecC--------CCCCccchHHHHHHHHHHHhhCCCCCCC----CChHHHHHHHHcCCC--
Q 007433 443 PTNARSMSFVGTHEYLAPEIIKG--------EGHGSAVDWWTFGIFLYELLFGKTPFKG----SENRATLYNVVGQPL-- 508 (604)
Q Consensus 443 ~~~~~~~~~~GT~~Y~APE~l~~--------~~~~~~~DiWSLGviL~eLltG~~PF~~----~~~~~~l~~i~~~~~-- 508 (604)
......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.. ....+.+.++.....
T Consensus 170 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~ 246 (396)
T 4eut_A 170 ---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246 (396)
T ss_dssp ---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTT
T ss_pred ---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcc
Confidence 01113469999999999875 4567899999999999999999999964 334556666655432
Q ss_pred -----------------CCCCCCC----CCHHHHHHHHHhhhcCCCCcccccCCHHHHh
Q 007433 509 -----------------RFPESPV----VSFSARDLIKGLLVKEPQNRLACRRGATEIK 546 (604)
Q Consensus 509 -----------------~~p~~~~----~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL 546 (604)
.++.... ++..+.+||.+||.+||++||+ +.+++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s----~~e~l 301 (396)
T 4eut_A 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG----FDQFF 301 (396)
T ss_dssp CCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCC----HHHHH
T ss_pred cchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhcc----HHHHH
Confidence 1122222 3456789999999999999999 66664
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=366.45 Aligned_cols=264 Identities=23% Similarity=0.357 Sum_probs=207.8
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEe----cCC
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFE----TDK 286 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~----~~~ 286 (604)
..++|++++.||+|+||.||+|++..+++.||||++..... .....+.+|+++++.++||||+++++++. ...
T Consensus 27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 103 (317)
T 2buj_A 27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQ---QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH 103 (317)
T ss_dssp TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSH---HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCH---HHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence 34789999999999999999999999999999999876432 23445678999999999999999999997 345
Q ss_pred eeEEEEeecCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQ--PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLR 364 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~--~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~ 364 (604)
..|+||||+.+++|.+++... .+..+++..++.++.||+.||.|||++||+||||||+||||+.++.++|+|||++..
T Consensus 104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~ 183 (317)
T 2buj_A 104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183 (317)
T ss_dssp EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEE
T ss_pred eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchh
Confidence 889999999999999988763 346799999999999999999999999999999999999999999999999998743
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
......... ....
T Consensus 184 ~~~~~~~~~-------------------------------------------------------------------~~~~ 196 (317)
T 2buj_A 184 ACIHVEGSR-------------------------------------------------------------------QALT 196 (317)
T ss_dssp SCEEEESHH-------------------------------------------------------------------HHHH
T ss_pred ccccccccc-------------------------------------------------------------------cccc
Confidence 221000000 0000
Q ss_pred CCcccccccCccccCcceecCCC---CCccchHHHHHHHHHHHhhCCCCCCCCCh-HHHHHHHHcCCCCCCCCCCCCHHH
Q 007433 445 NARSMSFVGTHEYLAPEIIKGEG---HGSAVDWWTFGIFLYELLFGKTPFKGSEN-RATLYNVVGQPLRFPESPVVSFSA 520 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l~~~~---~~~~~DiWSLGviL~eLltG~~PF~~~~~-~~~l~~i~~~~~~~p~~~~~s~~l 520 (604)
........||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... ...+.........++....++..+
T Consensus 197 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 276 (317)
T 2buj_A 197 LQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSAL 276 (317)
T ss_dssp HHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHH
T ss_pred ccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCCCccccCCHHH
Confidence 00011346899999999998665 68899999999999999999999964211 011222233345566667789999
Q ss_pred HHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 521 RDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 521 ~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
.+||.+||..||.+||+ +.++++|
T Consensus 277 ~~li~~~l~~dp~~Rps----~~~ll~~ 300 (317)
T 2buj_A 277 WQLLNSMMTVDPHQRPH----IPLLLSQ 300 (317)
T ss_dssp HHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHhhcChhhCCC----HHHHHHH
Confidence 99999999999999999 9999886
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=388.94 Aligned_cols=261 Identities=26% Similarity=0.371 Sum_probs=199.8
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCeeE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~ 289 (604)
+..+|.+.+.||+|+||+||. ....+++.||||++...... .+.+|+++|+.+ +||||+++++++.++...|
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~ 94 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQY 94 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEE
T ss_pred ccEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEE
Confidence 345799999999999999764 33456779999999764322 235799999999 7999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc---CC--cEEEeccccccc
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE---DG--HIMLSDFDLSLR 364 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~---~g--~vkL~DFGla~~ 364 (604)
|||||| +|+|.+++.... ..+.+..+..++.||+.||+|||++|||||||||+||||+. ++ .+||+|||++..
T Consensus 95 lv~E~~-~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~ 172 (432)
T 3p23_A 95 IAIELC-AATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172 (432)
T ss_dssp EEEECC-SEEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEEC
T ss_pred EEEECC-CCCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceee
Confidence 999999 569999988653 34555667889999999999999999999999999999953 23 588999999854
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
+..... .
T Consensus 173 ~~~~~~-------------------------------------------------------------------------~ 179 (432)
T 3p23_A 173 LAVGRH-------------------------------------------------------------------------S 179 (432)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred ccCCCc-------------------------------------------------------------------------c
Confidence 321100 0
Q ss_pred CCcccccccCccccCcceecC---CCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCC-CCCCCCHH
Q 007433 445 NARSMSFVGTHEYLAPEIIKG---EGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFP-ESPVVSFS 519 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l~~---~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p-~~~~~s~~ 519 (604)
.......+||+.|+|||++.+ ..++.++|||||||+||||++ |..||...........+........ .....+..
T Consensus 180 ~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (432)
T 3p23_A 180 FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVI 259 (432)
T ss_dssp ------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCHHHHH
T ss_pred eeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCccccccHH
Confidence 011223579999999999984 557789999999999999999 9999976544433222222122111 11223556
Q ss_pred HHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 520 ARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 520 l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
+++||.+||..||.+||+ +.|+|+||||.++.|.
T Consensus 260 ~~~li~~~L~~dP~~Rps----~~evl~hp~f~~~~~~ 293 (432)
T 3p23_A 260 ARELIEKMIAMDPQKRPS----AKHVLKHPFFWSLEKQ 293 (432)
T ss_dssp HHHHHHHHSCSSGGGSCC----HHHHHTSTTTCCHHHH
T ss_pred HHHHHHHHHhCCHhhCCC----HHHHHhCccccChHHH
Confidence 899999999999999999 9999999999998885
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=359.74 Aligned_cols=255 Identities=17% Similarity=0.244 Sum_probs=206.6
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCC---ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeE-ecCCee
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGT---KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHF-ETDKFS 288 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~-~~~~~~ 288 (604)
.+|++.+.||+|+||+||+|.+..+ ...||+|.+..... ......+.+|+.+|+.++||||+++++++ ..++..
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCS--HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCC--HHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 4799999999999999999997543 34689999876432 23445677899999999999999999985 456788
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|+||||+++++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 103 ~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~ 181 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 181 (298)
T ss_dssp EEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCG
T ss_pred EEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECccccccccccc
Confidence 9999999999999999764 357899999999999999999999999999999999999999999999999998543210
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
... .....
T Consensus 182 ~~~------------------------------------------------------------------------~~~~~ 189 (298)
T 3f66_A 182 EYY------------------------------------------------------------------------SVHNK 189 (298)
T ss_dssp GGC------------------------------------------------------------------------BC---
T ss_pred chh------------------------------------------------------------------------ccccc
Confidence 000 00011
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGL 527 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~l 527 (604)
....||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+....+....+..... ......++..+.+||.+|
T Consensus 190 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~ 268 (298)
T 3f66_A 190 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR-LLQPEYCPDPLYEVMLKC 268 (298)
T ss_dssp --CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC-CCCCTTCCHHHHHHHHHH
T ss_pred cCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC-CCCCccCCHHHHHHHHHH
Confidence 23458899999999999999999999999999999999 6777877766666665554432 233345899999999999
Q ss_pred hhcCCCCcccccCCHHHHhc
Q 007433 528 LVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~ 547 (604)
|..||++||+ +.|+++
T Consensus 269 l~~~p~~Rps----~~ell~ 284 (298)
T 3f66_A 269 WHPKAEMRPS----FSELVS 284 (298)
T ss_dssp TCSSGGGSCC----HHHHHH
T ss_pred cCCChhhCcC----HHHHHH
Confidence 9999999999 777775
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=367.14 Aligned_cols=261 Identities=24% Similarity=0.323 Sum_probs=189.6
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEe-------
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFE------- 283 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~------- 283 (604)
..+|++.+.||+|+||.||+|++..+++.||||++..... .....+.+|+.+|+++. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEE---EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSH---HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCch---HHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 4589999999999999999999999999999999866533 23345678999999995 999999999983
Q ss_pred -cCCeeEEEEeecCCCCHHHHHHh-cCCCCCcHHHHHHHHHHHHHHHHHHHHcC--eEeccCCCCcEEEccCCcEEEecc
Q 007433 284 -TDKFSCLVMEFCPGGDLHTLRQR-QPGKYFSEQAVKFYVAEVLLALEYLHMLG--IVYRDLKPENVLVREDGHIMLSDF 359 (604)
Q Consensus 284 -~~~~~~lV~E~~~ggsL~~ll~~-~~~~~l~e~~~~~i~~qil~aL~yLH~~g--IvHrDIKpeNILl~~~g~vkL~DF 359 (604)
....+|+||||+ +|+|.+++.. .....+++..++.|+.||+.||.|||++| |+||||||+||||+.++.+||+||
T Consensus 104 ~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 104 TGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp TSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred cCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecC
Confidence 445689999999 5799888765 23356999999999999999999999999 999999999999999999999999
Q ss_pred cccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccc
Q 007433 360 DLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPEL 439 (604)
Q Consensus 360 Gla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 439 (604)
|++..+...........
T Consensus 183 g~~~~~~~~~~~~~~~~--------------------------------------------------------------- 199 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQ--------------------------------------------------------------- 199 (337)
T ss_dssp TTCBCCSSCC----------------------------------------------------------------------
T ss_pred ccceeccccCccccccc---------------------------------------------------------------
Confidence 99854432111000000
Q ss_pred ccCCCCCcccccccCccccCccee---cCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCC
Q 007433 440 IAEPTNARSMSFVGTHEYLAPEII---KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVV 516 (604)
Q Consensus 440 ~~~~~~~~~~~~~GT~~Y~APE~l---~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~ 516 (604)
............||+.|+|||++ .+..++.++|||||||++|||++|+.||.+..... +.......+.....
T Consensus 200 -~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----~~~~~~~~~~~~~~ 274 (337)
T 3ll6_A 200 -RRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----IVNGKYSIPPHDTQ 274 (337)
T ss_dssp -------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC----------------CCCCTTCCS
T ss_pred -ccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----hhcCcccCCccccc
Confidence 00000112245699999999998 56678899999999999999999999998654433 33334445555667
Q ss_pred CHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 517 SFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 517 s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
+..+.+||.+||..||.+||+ +.|+++|
T Consensus 275 ~~~~~~li~~~l~~~p~~Rps----~~e~l~~ 302 (337)
T 3ll6_A 275 YTVFHSLIRAMLQVNPEERLS----IAEVVHQ 302 (337)
T ss_dssp SGGGHHHHHHHSCSSGGGSCC----HHHHHHH
T ss_pred chHHHHHHHHHccCChhhCcC----HHHHHHH
Confidence 889999999999999999999 9999987
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=359.14 Aligned_cols=247 Identities=21% Similarity=0.324 Sum_probs=204.3
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec-CCee
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET-DKFS 288 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~ 288 (604)
+..++|++++.||+|+||+||+|++. ++.||||++.... ....+.+|+++|+.++||||+++++++.. ++..
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 90 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred CChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence 45689999999999999999999885 6689999997653 22356789999999999999999998754 4578
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|+||||+++++|.+++.......+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++.....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~- 169 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 169 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc-
Confidence 9999999999999998875434589999999999999999999999999999999999999999999999998732210
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
..
T Consensus 170 ------------------------------------------------------------------------------~~ 171 (278)
T 1byg_A 170 ------------------------------------------------------------------------------TQ 171 (278)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ------------------------------------------------------------------------------cc
Confidence 00
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGL 527 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~l 527 (604)
....+|+.|+|||++.+..++.++|||||||++|||++ |+.||......+....+... ........++..+.+||.+|
T Consensus 172 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~ 250 (278)
T 1byg_A 172 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPAVYEVMKNC 250 (278)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-CCCCCCTTCCHHHHHHHHHH
T ss_pred cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-CCCCCcccCCHHHHHHHHHH
Confidence 11247889999999999999999999999999999998 99999987766666555433 33444556899999999999
Q ss_pred hhcCCCCcccccCCHHHHhc
Q 007433 528 LVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~ 547 (604)
|..||++||+ +.++++
T Consensus 251 l~~~p~~Rps----~~~l~~ 266 (278)
T 1byg_A 251 WHLDAAMRPS----FLQLRE 266 (278)
T ss_dssp TCSSGGGSCC----HHHHHH
T ss_pred hcCChhhCCC----HHHHHH
Confidence 9999999999 777765
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=385.31 Aligned_cols=252 Identities=26% Similarity=0.366 Sum_probs=210.9
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
+..++|++.++||+|+||.||+|.+..+ ..||||++....... ..+.+|+++|+.++||||+++++++.+ +..|
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~ 254 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 254 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCCCCH----HHHHHHHHHHHhCCCCCEeeEEEEEcC-CceE
Confidence 4457899999999999999999999875 469999998654322 346789999999999999999999876 6789
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
|||||+++|+|.+++....+..+++..+..++.||+.||+|||++|||||||||+||||+.++.+||+|||++.......
T Consensus 255 iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 334 (452)
T 1fmk_A 255 IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334 (452)
T ss_dssp EEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence 99999999999999976544679999999999999999999999999999999999999999999999999984322100
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
. ....
T Consensus 335 ~---------------------------------------------------------------------------~~~~ 339 (452)
T 1fmk_A 335 Y---------------------------------------------------------------------------TARQ 339 (452)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred e---------------------------------------------------------------------------eccc
Confidence 0 0011
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
...||..|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+.. ..+.+....++..+.+||.+||
T Consensus 340 ~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~cl 418 (452)
T 1fmk_A 340 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQCW 418 (452)
T ss_dssp ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTSCHHHHHHHHHHT
T ss_pred CCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHHc
Confidence 2347889999999999999999999999999999999 9999999888777766654 3455555678999999999999
Q ss_pred hcCCCCcccccCCHHHHhc
Q 007433 529 VKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 529 ~~dP~~Rpt~~~~a~elL~ 547 (604)
..||++||+ +.+|++
T Consensus 419 ~~dP~~Rpt----~~~l~~ 433 (452)
T 1fmk_A 419 RKEPEERPT----FEYLQA 433 (452)
T ss_dssp CSSGGGSCC----HHHHHH
T ss_pred cCChhhCcC----HHHHHH
Confidence 999999999 887775
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=359.96 Aligned_cols=249 Identities=25% Similarity=0.335 Sum_probs=195.4
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHh--CCCCCccccceeEec----C
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQS--LDHPFLPTLYTHFET----D 285 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~----~ 285 (604)
.++|++++.||+|+||+||+|++ +++.||||++..... ....+|.+++.. ++||||+++++++.. .
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~------~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~ 78 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDE------KSWFRETELYNTVMLRHENILGFIASDMTSRHSS 78 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGH------HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccc------hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCC
Confidence 47999999999999999999988 577899999976532 123446666666 899999999998654 4
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH--------HcCeEeccCCCCcEEEccCCcEEEe
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH--------MLGIVYRDLKPENVLVREDGHIMLS 357 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH--------~~gIvHrDIKpeNILl~~~g~vkL~ 357 (604)
..+|+||||+++|+|.++++. ..+++..+..++.||+.||+||| ++||+||||||+||||+.++.+||+
T Consensus 79 ~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 79 TQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEEC
T ss_pred ceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEe
Confidence 568999999999999999954 46999999999999999999999 9999999999999999999999999
Q ss_pred cccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCc
Q 007433 358 DFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLP 437 (604)
Q Consensus 358 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (604)
|||++..........
T Consensus 156 Dfg~a~~~~~~~~~~----------------------------------------------------------------- 170 (301)
T 3q4u_A 156 DLGLAVMHSQSTNQL----------------------------------------------------------------- 170 (301)
T ss_dssp CCTTCEEEETTTTEE-----------------------------------------------------------------
T ss_pred eCCCeeecccccccc-----------------------------------------------------------------
Confidence 999985432111000
Q ss_pred ccccCCCCCcccccccCccccCcceecCC------CCCccchHHHHHHHHHHHhhC----------CCCCCCC----ChH
Q 007433 438 ELIAEPTNARSMSFVGTHEYLAPEIIKGE------GHGSAVDWWTFGIFLYELLFG----------KTPFKGS----ENR 497 (604)
Q Consensus 438 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~------~~~~~~DiWSLGviL~eLltG----------~~PF~~~----~~~ 497 (604)
.......+||+.|+|||++.+. .++.++|||||||++|||++| ..||... ...
T Consensus 171 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~ 243 (301)
T 3q4u_A 171 -------DVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSF 243 (301)
T ss_dssp -------ECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred -------cccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcch
Confidence 0011234699999999999887 345799999999999999999 8898653 223
Q ss_pred HHHHHHHcCCCCCCCC------CCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 498 ATLYNVVGQPLRFPES------PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 498 ~~l~~i~~~~~~~p~~------~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
..+..........+.. ...+..+.+||.+||..||++||+ +.+|++
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~~i~~ 295 (301)
T 3q4u_A 244 EDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLT----ALRIKK 295 (301)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCC----HHHHHH
T ss_pred hhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCC----HHHHHH
Confidence 3444443322222211 124467999999999999999999 888875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-43 Score=371.72 Aligned_cols=253 Identities=21% Similarity=0.286 Sum_probs=202.6
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCC--------ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccc-------
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGT--------KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPT------- 277 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~--------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~------- 277 (604)
++|++.+.||+|+||.||+|++..+ ++.||||++.+. ..+.+|+++|+.++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~ 113 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYS 113 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhcc
Confidence 7999999999999999999999874 789999999765 13567999999999998887
Q ss_pred --------cceeEec-CCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEE
Q 007433 278 --------LYTHFET-DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV 348 (604)
Q Consensus 278 --------l~~~~~~-~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl 348 (604)
+++++.. +...||||||+ +++|.+++.......+++..++.|+.||+.||.|||++||+||||||+||||
T Consensus 114 ~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~ 192 (352)
T 2jii_A 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192 (352)
T ss_dssp CTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred CCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence 5667665 78899999999 9999999987655679999999999999999999999999999999999999
Q ss_pred ccCC--cEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCc
Q 007433 349 REDG--HIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPK 426 (604)
Q Consensus 349 ~~~g--~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 426 (604)
+.++ .+||+|||++..+........
T Consensus 193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~----------------------------------------------------- 219 (352)
T 2jii_A 193 DPEDQSQVTLAGYGFAFRYCPSGKHVA----------------------------------------------------- 219 (352)
T ss_dssp ETTEEEEEEECCGGGCBCSSGGGCCCC-----------------------------------------------------
T ss_pred cCCCCceEEEecCcceeeccCCCcccc-----------------------------------------------------
Confidence 9988 999999999854331110000
Q ss_pred cccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCC-hHHHHHHH--
Q 007433 427 NEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE-NRATLYNV-- 503 (604)
Q Consensus 427 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~-~~~~l~~i-- 503 (604)
..........||+.|+|||++.+..++.++|||||||+||||++|+.||.+.. ....+...
T Consensus 220 ----------------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~ 283 (352)
T 2jii_A 220 ----------------YVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQ 283 (352)
T ss_dssp ----------------CCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHH
T ss_pred ----------------ccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHH
Confidence 00011123479999999999999999999999999999999999999998754 33333222
Q ss_pred --HcCCCCCCC----CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 504 --VGQPLRFPE----SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 504 --~~~~~~~p~----~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
......+.. ...++.++.+||.+||..||++||+ +.+|++
T Consensus 284 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~l~~ 329 (352)
T 2jii_A 284 KFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPP----YAMLRN 329 (352)
T ss_dssp HHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCC----HHHHHH
T ss_pred hccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCC----HHHHHH
Confidence 222222221 1247899999999999999999999 777764
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-43 Score=388.13 Aligned_cols=272 Identities=19% Similarity=0.274 Sum_probs=215.4
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCC-CCccccceeEecCCeeEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH-PFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~l 290 (604)
.++|+++++||+|+||.||+|++..+++.||||++...... ..+.+|+++++.|.| ++|+.+..++..++..||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 47999999999999999999999999999999998754322 135679999999987 556666667778889999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEE---ccCCcEEEecccccccccC
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV---REDGHIMLSDFDLSLRCAV 367 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl---~~~g~vkL~DFGla~~~~~ 367 (604)
||||+ +++|.+++... ...|++..++.|+.||+.||+|||++|||||||||+|||| +.++.+||+|||++..+..
T Consensus 81 vme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~ 158 (483)
T 3sv0_A 81 VMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRD 158 (483)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccC
Confidence 99999 99999999864 3579999999999999999999999999999999999999 6889999999999865432
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
....... ....
T Consensus 159 ~~~~~~~---------------------------------------------------------------------~~~~ 169 (483)
T 3sv0_A 159 TSTHQHI---------------------------------------------------------------------PYRE 169 (483)
T ss_dssp TTTCCBC---------------------------------------------------------------------CCCC
T ss_pred Ccccccc---------------------------------------------------------------------cccc
Confidence 1110000 0001
Q ss_pred ccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCCh---HHHHHHHHcCCCCCC---CCCCCCHHHH
Q 007433 448 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSEN---RATLYNVVGQPLRFP---ESPVVSFSAR 521 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~---~~~l~~i~~~~~~~p---~~~~~s~~l~ 521 (604)
....+||+.|+|||++.+..++.++|||||||+||||++|+.||.+... ...+..+........ ....++.++.
T Consensus 170 ~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~ 249 (483)
T 3sv0_A 170 NKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFA 249 (483)
T ss_dssp CCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHH
T ss_pred ccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHH
Confidence 2245799999999999999999999999999999999999999987543 233333322211110 1134789999
Q ss_pred HHHHHhhhcCCCCcccccCCHHHHh----------cCCCCCCCChhhhhcCC
Q 007433 522 DLIKGLLVKEPQNRLACRRGATEIK----------QHPFFQGVNWALIRCAS 563 (604)
Q Consensus 522 dLI~~lL~~dP~~Rpt~~~~a~elL----------~Hpff~~~~~~~~~~~~ 563 (604)
+||.+||..||++||+ +.+|+ .++|+..++|..+....
T Consensus 250 ~li~~cl~~dP~~RPs----~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~~ 297 (483)
T 3sv0_A 250 SYFHYCRSLRFDDKPD----YSYLKRLFRDLFIREGFQFDYVFDWTILKYQQ 297 (483)
T ss_dssp HHHHHHHTCCTTCCCC----HHHHHHHHHHHHHHTTCCCSSCCHHHHHTC--
T ss_pred HHHHHHhcCChhhCcC----HHHHHHHHHHHHHHcCCCccCCcCchhhcccc
Confidence 9999999999999999 44443 58999999999876543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-43 Score=357.06 Aligned_cols=256 Identities=18% Similarity=0.265 Sum_probs=203.5
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeE-ecCCeeEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHF-ETDKFSCL 290 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~-~~~~~~~l 290 (604)
.++|++.+.||+|+||.||+|++..+++.||||++...... ..+.+|+.+++.+.|++++..+.++ ..++..|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 47999999999999999999999999999999998765322 2356799999999988766655555 56788999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEE---ccCCcEEEecccccccccC
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV---REDGHIMLSDFDLSLRCAV 367 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl---~~~g~vkL~DFGla~~~~~ 367 (604)
||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||| +.++.+||+|||++.....
T Consensus 83 v~e~~-~~~L~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~ 160 (296)
T 3uzp_A 83 VMELL-GPSLEDLFNFCS-RKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 160 (296)
T ss_dssp EEECC-CCBHHHHHHHTT-TCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred EEEec-CCCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccc
Confidence 99999 999999987542 579999999999999999999999999999999999999 4888999999999854432
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
...... .....
T Consensus 161 ~~~~~~---------------------------------------------------------------------~~~~~ 171 (296)
T 3uzp_A 161 ARTHQH---------------------------------------------------------------------IPYRE 171 (296)
T ss_dssp TTTCCB---------------------------------------------------------------------CCCCC
T ss_pred cccccc---------------------------------------------------------------------ccccc
Confidence 111000 00001
Q ss_pred ccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCC---hHHHHHHHHcCCCCCC---CCCCCCHHHH
Q 007433 448 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE---NRATLYNVVGQPLRFP---ESPVVSFSAR 521 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~---~~~~l~~i~~~~~~~p---~~~~~s~~l~ 521 (604)
.....||+.|+|||++.+..++.++|||||||+||||++|+.||.+.. ....+..+.......+ ....++.++.
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 251 (296)
T 3uzp_A 172 NKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFA 251 (296)
T ss_dssp SCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHH
T ss_pred ccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHH
Confidence 224579999999999999999999999999999999999999998743 2233333332222222 1135789999
Q ss_pred HHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 522 DLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 522 dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
+||.+||..||.+||+ +.+|++
T Consensus 252 ~li~~~l~~dp~~Rps----~~~l~~ 273 (296)
T 3uzp_A 252 TYLNFCRSLRFDDKPD----YSYLRQ 273 (296)
T ss_dssp HHHHHHHTSCTTCCCC----HHHHHH
T ss_pred HHHHHHHhcCcCcCCC----HHHHHH
Confidence 9999999999999999 666664
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-45 Score=378.60 Aligned_cols=262 Identities=21% Similarity=0.233 Sum_probs=206.0
Q ss_pred CceeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 207 DGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 207 ~~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
+.....++|++.+.||+|+||.||+|++. +++.||||++....... ....+.+|+++|+.++||||+++++++.+++
T Consensus 24 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 100 (326)
T 3uim_A 24 ELQVASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPT 100 (326)
T ss_dssp HHHTTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSS
T ss_pred HHHHHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEecCC
Confidence 33445689999999999999999999854 57799999997653221 2224678999999999999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhcCC--CCCcHHHHHHHHHHHHHHHHHHHHc---CeEeccCCCCcEEEccCCcEEEecccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPG--KYFSEQAVKFYVAEVLLALEYLHML---GIVYRDLKPENVLVREDGHIMLSDFDL 361 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~--~~l~e~~~~~i~~qil~aL~yLH~~---gIvHrDIKpeNILl~~~g~vkL~DFGl 361 (604)
..|+||||+++|+|.+++..... ..+++..+..++.||+.||+|||++ ||+||||||+||||+.++.+||+|||+
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~ 180 (326)
T 3uim_A 101 ERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180 (326)
T ss_dssp CCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSS
T ss_pred ceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcc
Confidence 99999999999999999987532 3599999999999999999999999 999999999999999999999999999
Q ss_pred cccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccccc
Q 007433 362 SLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIA 441 (604)
Q Consensus 362 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (604)
+.......
T Consensus 181 ~~~~~~~~------------------------------------------------------------------------ 188 (326)
T 3uim_A 181 AKLMDYKD------------------------------------------------------------------------ 188 (326)
T ss_dssp CEECCSSS------------------------------------------------------------------------
T ss_pred ccccCccc------------------------------------------------------------------------
Confidence 85432110
Q ss_pred CCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCC----CChHHHHHHHHcCCCCC-------
Q 007433 442 EPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKG----SENRATLYNVVGQPLRF------- 510 (604)
Q Consensus 442 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~----~~~~~~l~~i~~~~~~~------- 510 (604)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.. ......+..++......
T Consensus 189 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 265 (326)
T 3uim_A 189 ---THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALV 265 (326)
T ss_dssp ---SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSS
T ss_pred ---ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhc
Confidence 0011234599999999999998899999999999999999999999952 11111122222211110
Q ss_pred ------CCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCC
Q 007433 511 ------PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPF 550 (604)
Q Consensus 511 ------p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpf 550 (604)
......+..+.+||.+||..||.+||+ +.||++|-.
T Consensus 266 ~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~ell~~L~ 307 (326)
T 3uim_A 266 DVDLQGNYKDEEVEQLIQVALLCTQSSPMERPK----MSEVVRMLE 307 (326)
T ss_dssp CTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCC----HHHHHHHHH
T ss_pred ChhhccccCHHHHHHHHHHHHHHhCcCCccCCC----HHHHHHHhc
Confidence 011112367899999999999999999 999998743
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-43 Score=360.69 Aligned_cols=232 Identities=28% Similarity=0.467 Sum_probs=191.3
Q ss_pred ecCeEEE-EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHH-HhCCCCCccccceeEec----C
Q 007433 212 VGHFRLL-KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREIL-QSLDHPFLPTLYTHFET----D 285 (604)
Q Consensus 212 ~~~y~l~-~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL-~~l~HpnIv~l~~~~~~----~ 285 (604)
.++|.++ +.||+|+||.||+|.+..+++.||||++.... ...+|++++ +.++||||++++++|.. +
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 87 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYENLYAGR 87 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecccH--------HHHHHHHHHHHhccCCCchhHHhhhhhhcCCC
Confidence 3689888 77999999999999999999999999996532 344688887 66799999999999987 7
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc---CCcEEEeccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE---DGHIMLSDFDLS 362 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~---~g~vkL~DFGla 362 (604)
..+||||||++|++|.+++.......+++..++.++.||+.||.|||++||+||||||+||||+. ++.++|+|||++
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 88 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred ceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 78999999999999999999876668999999999999999999999999999999999999998 789999999987
Q ss_pred ccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccC
Q 007433 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442 (604)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (604)
...
T Consensus 168 ~~~----------------------------------------------------------------------------- 170 (299)
T 3m2w_A 168 KET----------------------------------------------------------------------------- 170 (299)
T ss_dssp EEC-----------------------------------------------------------------------------
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 321
Q ss_pred CCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHH----cCCCCCCC--CCCC
Q 007433 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV----GQPLRFPE--SPVV 516 (604)
Q Consensus 443 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~----~~~~~~p~--~~~~ 516 (604)
.+..++.++|||||||+||||++|+.||.+.........+. .....++. ...+
T Consensus 171 ---------------------~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (299)
T 3m2w_A 171 ---------------------TGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 229 (299)
T ss_dssp ---------------------TTCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTS
T ss_pred ---------------------ccccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccC
Confidence 11335678999999999999999999998765433321111 11112221 1457
Q ss_pred CHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 517 SFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 517 s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
+.++++||.+||..||.+||+ +.|+|+||||+.
T Consensus 230 ~~~~~~li~~~l~~dP~~Rps----~~e~l~hp~~~~ 262 (299)
T 3m2w_A 230 SEEVKMLIRNLLKTEPTQRMT----ITEFMNHPWIMQ 262 (299)
T ss_dssp CHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHT
T ss_pred CHHHHHHHHHHcccChhhCCC----HHHHhcChhhcc
Confidence 899999999999999999999 999999999975
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=365.73 Aligned_cols=253 Identities=23% Similarity=0.295 Sum_probs=206.4
Q ss_pred cCe-EEEEEEccCCcEEEEEEEE----cCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec--C
Q 007433 213 GHF-RLLKKLGCGDIGSVYLSEL----TGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET--D 285 (604)
Q Consensus 213 ~~y-~l~~~LG~G~fG~Vy~a~~----~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~ 285 (604)
++| ++++.||+|+||+||++.. ..+++.||||++..... ......+.+|+++|+.++||||+++++++.+ .
T Consensus 30 ~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 107 (318)
T 3lxp_A 30 KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAG--PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGA 107 (318)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTT
T ss_pred HHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccC--hHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCC
Confidence 455 9999999999999988754 45788999999986532 2334567789999999999999999999987 4
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
..+|+||||+++++|.+++... .+++..+..++.||+.||.|||++||+||||||+||||+.++.++|+|||++..+
T Consensus 108 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~ 184 (318)
T 3lxp_A 108 ASLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 184 (318)
T ss_dssp TEEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred ceEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence 6889999999999999998765 4999999999999999999999999999999999999999999999999998543
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
.......
T Consensus 185 ~~~~~~~------------------------------------------------------------------------- 191 (318)
T 3lxp_A 185 PEGHEYY------------------------------------------------------------------------- 191 (318)
T ss_dssp CTTCSEE-------------------------------------------------------------------------
T ss_pred ccccccc-------------------------------------------------------------------------
Confidence 2111000
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChH--------------HHHHHHHcCCCCCC
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR--------------ATLYNVVGQPLRFP 511 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~--------------~~l~~i~~~~~~~p 511 (604)
.......||..|+|||++.+..++.++|||||||++|||++|..||...... ..+...+......+
T Consensus 192 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (318)
T 3lxp_A 192 RVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLP 271 (318)
T ss_dssp EC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCC
T ss_pred ccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCC
Confidence 0011235888999999999998999999999999999999999999753211 12233444445555
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 512 ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 512 ~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
....++.++.+||.+||..||++||+ +.|+++
T Consensus 272 ~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~ 303 (318)
T 3lxp_A 272 RPDKCPAEVYHLMKNCWETEASFRPT----FENLIP 303 (318)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCccccHHHHHHHHHHcCCCcccCcC----HHHHHH
Confidence 66679999999999999999999999 888875
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=373.49 Aligned_cols=260 Identities=21% Similarity=0.235 Sum_probs=198.7
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcC---CceEEEEEEecchhHH--HH-H-----HHHHHHHHHHHHHhCCCCCcccccee
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTG---TKCYFAMKVMDKASLE--KR-K-----KLLRAQTEREILQSLDHPFLPTLYTH 281 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~---~~~~vAiK~i~~~~~~--~~-~-----~~~~~~~Ei~iL~~l~HpnIv~l~~~ 281 (604)
++|++.+.||+|+||.||+|.+.. ++..||||++...... .. . ....+.+|+.+++.++||||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 689999999999999999999987 7889999999765321 11 1 11234578899999999999999999
Q ss_pred Eec----CCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC--cEE
Q 007433 282 FET----DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG--HIM 355 (604)
Q Consensus 282 ~~~----~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g--~vk 355 (604)
+.. +...||||||| |++|.+++... ..+++..++.|+.||+.||+|||++||+||||||+||||+.++ .+|
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~k 193 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY 193 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEE
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEE
Confidence 987 78999999999 99999998765 3799999999999999999999999999999999999999887 999
Q ss_pred EecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCC
Q 007433 356 LSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSP 435 (604)
Q Consensus 356 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (604)
|+|||++..+.......
T Consensus 194 L~Dfg~a~~~~~~~~~~--------------------------------------------------------------- 210 (345)
T 2v62_A 194 LADYGLSYRYCPNGNHK--------------------------------------------------------------- 210 (345)
T ss_dssp ECCCTTCEESSGGGCCC---------------------------------------------------------------
T ss_pred EEeCCCceecccccccc---------------------------------------------------------------
Confidence 99999985543111000
Q ss_pred CcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCC-ChHHHHHHHH-cCCCCCC--
Q 007433 436 LPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS-ENRATLYNVV-GQPLRFP-- 511 (604)
Q Consensus 436 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~-~~~~~l~~i~-~~~~~~p-- 511 (604)
...........||+.|+|||++.+..++.++|||||||+||||++|+.||.+. .....+.... .....++
T Consensus 211 ------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 284 (345)
T 2v62_A 211 ------QYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQS 284 (345)
T ss_dssp ------CCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHH
T ss_pred ------cchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHH
Confidence 00001123457999999999999999999999999999999999999999653 2222221111 1001111
Q ss_pred -----CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 512 -----ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 512 -----~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
....++.++.+||.+||..||++||+ +.+|++.
T Consensus 285 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~l~~~ 322 (345)
T 2v62_A 285 VLKWAPSGSSCCEIAQFLVCAHSLAYDEKPN----YQALKKI 322 (345)
T ss_dssp HHHHSCTTSCCHHHHHHHHHHHTCCTTCCCC----HHHHHHH
T ss_pred HHhhccccccHHHHHHHHHHHhhcCcccCCC----HHHHHHH
Confidence 11258899999999999999999999 7777653
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=374.36 Aligned_cols=242 Identities=19% Similarity=0.222 Sum_probs=195.0
Q ss_pred eeecCeEEEEEEccCCcEEEEEE-----EEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC---CCCcccccee
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLS-----ELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD---HPFLPTLYTH 281 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a-----~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~ 281 (604)
+..++|++.+.||+|+||+||+| .+..+++.||||++...... .+.+|+++++.++ |+||+.++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~------~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW------EFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHH------HHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChh------HHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 44578999999999999999999 46778889999999765322 3456778888876 8999999999
Q ss_pred EecCCeeEEEEeecCCCCHHHHHHhc---CCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc--------
Q 007433 282 FETDKFSCLVMEFCPGGDLHTLRQRQ---PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE-------- 350 (604)
Q Consensus 282 ~~~~~~~~lV~E~~~ggsL~~ll~~~---~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~-------- 350 (604)
+..++..|||||||+||+|.+++... ....+++..++.|+.||+.||+|||++|||||||||+||||+.
T Consensus 136 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~ 215 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDE 215 (365)
T ss_dssp EECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC---
T ss_pred eecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccc
Confidence 99999999999999999999998752 3467999999999999999999999999999999999999998
Q ss_pred ---CCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCcc
Q 007433 351 ---DGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKN 427 (604)
Q Consensus 351 ---~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 427 (604)
++.+||+|||++..+....
T Consensus 216 ~~~~~~~kl~DFG~a~~~~~~~---------------------------------------------------------- 237 (365)
T 3e7e_A 216 DDLSAGLALIDLGQSIDMKLFP---------------------------------------------------------- 237 (365)
T ss_dssp ---CTTEEECCCTTCEEGGGSC----------------------------------------------------------
T ss_pred ccccCCEEEeeCchhhhhhccC----------------------------------------------------------
Confidence 8999999999985432100
Q ss_pred ccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC
Q 007433 428 EMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP 507 (604)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~ 507 (604)
........+||+.|+|||++.+..|+.++|||||||+||||++|+.||......... ...
T Consensus 238 ----------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~---~~~- 297 (365)
T 3e7e_A 238 ----------------KGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK---PEG- 297 (365)
T ss_dssp ----------------TTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE---ECS-
T ss_pred ----------------CCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee---ech-
Confidence 001122457999999999999999999999999999999999999999654321100 011
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCCCCccc
Q 007433 508 LRFPESPVVSFSARDLIKGLLVKEPQNRLA 537 (604)
Q Consensus 508 ~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt 537 (604)
.+.. ...+..+.+|+..||..+|.+|++
T Consensus 298 -~~~~-~~~~~~~~~~~~~~l~~~p~~r~~ 325 (365)
T 3e7e_A 298 -LFRR-LPHLDMWNEFFHVMLNIPDCHHLP 325 (365)
T ss_dssp -CCTT-CSSHHHHHHHHHHHHCCCCTTCCC
T ss_pred -hccc-cCcHHHHHHHHHHHcCCCCCCcch
Confidence 1111 124678899999999999999977
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=357.47 Aligned_cols=246 Identities=23% Similarity=0.383 Sum_probs=198.9
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
+..++|++.+.||+|+||+||+|++. ++.||||++.... ....+.+|+++|++++||||+++++++.+ ..|
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~ 75 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACLN--PVC 75 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTT-----HHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTE
T ss_pred CCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChh-----HHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcE
Confidence 34579999999999999999999986 5689999997543 22356789999999999999999998874 478
Q ss_pred EEEeecCCCCHHHHHHhcCC-CCCcHHHHHHHHHHHHHHHHHHHH---cCeEeccCCCCcEEEccCCc-EEEeccccccc
Q 007433 290 LVMEFCPGGDLHTLRQRQPG-KYFSEQAVKFYVAEVLLALEYLHM---LGIVYRDLKPENVLVREDGH-IMLSDFDLSLR 364 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~-~~l~e~~~~~i~~qil~aL~yLH~---~gIvHrDIKpeNILl~~~g~-vkL~DFGla~~ 364 (604)
+||||++|++|.+++..... ..+++..+..++.||+.||+|||+ +||+||||||+||||+.++. +||+|||++..
T Consensus 76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~ 155 (307)
T 2eva_A 76 LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155 (307)
T ss_dssp EEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred EEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence 99999999999999986532 247899999999999999999999 89999999999999998886 79999998732
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
...
T Consensus 156 ~~~----------------------------------------------------------------------------- 158 (307)
T 2eva_A 156 IQT----------------------------------------------------------------------------- 158 (307)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc-----------------------------------------------------------------------------
Confidence 210
Q ss_pred CCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCCh--HHHHHHHHcCCCCCCCCCCCCHHHHH
Q 007433 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSEN--RATLYNVVGQPLRFPESPVVSFSARD 522 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~--~~~l~~i~~~~~~~p~~~~~s~~l~d 522 (604)
......||+.|+|||++.+..++.++|||||||++|||++|+.||..... ......+.. ....+....++..+.+
T Consensus 159 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~l~~ 235 (307)
T 2eva_A 159 --HMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN-GTRPPLIKNLPKPIES 235 (307)
T ss_dssp --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHT-TCCCCCBTTCCHHHHH
T ss_pred --ccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhc-CCCCCcccccCHHHHH
Confidence 00123589999999999999999999999999999999999999986433 222223322 2233334568999999
Q ss_pred HHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 523 LIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 523 LI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
||.+||..||++||+ +.+++++
T Consensus 236 li~~~l~~dp~~Rps----~~ell~~ 257 (307)
T 2eva_A 236 LMTRCWSKDPSQRPS----MEEIVKI 257 (307)
T ss_dssp HHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHhcCChhhCcC----HHHHHHH
Confidence 999999999999999 8888763
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=379.53 Aligned_cols=256 Identities=26% Similarity=0.356 Sum_probs=194.8
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCeeEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~lV 291 (604)
+.|.+.+.||+|+||+||.+. ..+++.||||++..... ..+.+|+++|+.+ +||||+++++++.+++.+|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv 87 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFC------DIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIA 87 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGH------HHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEE
Confidence 467778899999999998754 45678999999976532 2356799999876 899999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCC-----CcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccC-------------Cc
Q 007433 292 MEFCPGGDLHTLRQRQPGKY-----FSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRED-------------GH 353 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~-----l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~-------------g~ 353 (604)
|||| +|+|.+++....... ..+..+..++.||+.||+|||++|||||||||+||||+.+ ++
T Consensus 88 ~E~~-~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~ 166 (434)
T 2rio_A 88 LELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166 (434)
T ss_dssp ECCC-SEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCE
T ss_pred EecC-CCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceE
Confidence 9999 569999998653211 1333467899999999999999999999999999999754 48
Q ss_pred EEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCC
Q 007433 354 IMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQV 433 (604)
Q Consensus 354 vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 433 (604)
+||+|||++..+.......
T Consensus 167 ~kL~DFG~a~~~~~~~~~~------------------------------------------------------------- 185 (434)
T 2rio_A 167 ILISDFGLCKKLDSGQSSF------------------------------------------------------------- 185 (434)
T ss_dssp EEECCCTTCEECCC------------------------------------------------------------------
T ss_pred EEEcccccceecCCCCccc-------------------------------------------------------------
Confidence 9999999985432111000
Q ss_pred CCCcccccCCCCCcccccccCccccCcceecC-------CCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHc
Q 007433 434 SPLPELIAEPTNARSMSFVGTHEYLAPEIIKG-------EGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVG 505 (604)
Q Consensus 434 ~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-------~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~ 505 (604)
.......+||+.|+|||++.+ ..++.++|||||||+||||++ |+.||.+..... .++..
T Consensus 186 -----------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~ 252 (434)
T 2rio_A 186 -----------RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIR 252 (434)
T ss_dssp --------------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHH
T ss_pred -----------eeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhc
Confidence 001123469999999999976 568999999999999999999 999997654433 33444
Q ss_pred CCCCCCCCC-----CCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 506 QPLRFPESP-----VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 506 ~~~~~p~~~-----~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
....++... .++.++++||.+||..||.+||+ +.++++||||...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps----~~eil~hp~f~~~ 302 (434)
T 2rio_A 253 GIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPT----AMKVLRHPLFWPK 302 (434)
T ss_dssp TCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCC----HHHHHTSGGGSCH
T ss_pred CCCCcccccccccccchHHHHHHHHHHhhCChhhCCC----HHHHHhCCccCCc
Confidence 433333221 23578999999999999999999 9999999999653
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=391.35 Aligned_cols=253 Identities=26% Similarity=0.363 Sum_probs=213.7
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCee
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 288 (604)
.+..++|++.++||+|+||.||+|.+..+ ..||||++....... ..+.+|+++|+.|+|+||+++++++.+ +.+
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~ 336 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 336 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCCCCH----HHHHHHHHHHHhCCCCCEeeEEEEEee-ccc
Confidence 35567899999999999999999999875 479999998654322 346789999999999999999999876 678
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|||||||.+|+|.+++....+..+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||++..+...
T Consensus 337 ~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 416 (535)
T 2h8h_A 337 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416 (535)
T ss_dssp EEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCH
T ss_pred eEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCC
Confidence 99999999999999997654467999999999999999999999999999999999999999999999999998432110
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
.. ...
T Consensus 417 ~~---------------------------------------------------------------------------~~~ 421 (535)
T 2h8h_A 417 EY---------------------------------------------------------------------------TAR 421 (535)
T ss_dssp HH---------------------------------------------------------------------------HTT
T ss_pred ce---------------------------------------------------------------------------ecc
Confidence 00 000
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGL 527 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~l 527 (604)
....+|..|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+.. ..+.+....++..+.+||.+|
T Consensus 422 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li~~c 500 (535)
T 2h8h_A 422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER-GYRMPCPPECPESLHDLMCQC 500 (535)
T ss_dssp CSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHH
T ss_pred cCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCCCCCHHHHHHHHHH
Confidence 12247889999999999999999999999999999999 9999999888777766654 345555567899999999999
Q ss_pred hhcCCCCcccccCCHHHHhc
Q 007433 528 LVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~ 547 (604)
|..||++||+ +.+|++
T Consensus 501 l~~dP~~RPt----~~~l~~ 516 (535)
T 2h8h_A 501 WRKEPEERPT----FEYLQA 516 (535)
T ss_dssp TCSSGGGSCC----HHHHHH
T ss_pred cCCChhHCcC----HHHHHH
Confidence 9999999999 777765
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=394.53 Aligned_cols=255 Identities=22% Similarity=0.330 Sum_probs=207.9
Q ss_pred eeecCeEEEE-EEccCCcEEEEEEEEc--CCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 210 LGVGHFRLLK-KLGCGDIGSVYLSELT--GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 210 ~~~~~y~l~~-~LG~G~fG~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
+..++|.+.+ .||+|+||.||+|.+. .++..||||+++.... ......+.+|+++|+.++||||+++++++.. +
T Consensus 332 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 332 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp CCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCS--STTHHHHHHHHHHHTTCCCTTBCCEEEEEES-S
T ss_pred ccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-C
Confidence 4456777777 8999999999999875 4567899999976522 1233467789999999999999999999976 5
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
.+|||||||++|+|.+++... ...+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||++..+.
T Consensus 409 ~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~ 487 (613)
T 2ozo_A 409 ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALG 487 (613)
T ss_dssp SEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC
T ss_pred CeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCccccc
Confidence 689999999999999998754 3579999999999999999999999999999999999999999999999999985432
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
...... .
T Consensus 488 ~~~~~~-------------------------------------------------------------------------~ 494 (613)
T 2ozo_A 488 ADDSYY-------------------------------------------------------------------------T 494 (613)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CCCcee-------------------------------------------------------------------------e
Confidence 110000 0
Q ss_pred cccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007433 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIK 525 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~ 525 (604)
......+|+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+.+..+... .+.+....++.++.+||.
T Consensus 495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~ 573 (613)
T 2ozo_A 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECPPECPPELYALMS 573 (613)
T ss_dssp -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTT-CCCCCCTTCCHHHHHHHH
T ss_pred eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHHH
Confidence 0011246789999999999999999999999999999998 99999998887777666543 344445569999999999
Q ss_pred HhhhcCCCCcccccCCHHHHh
Q 007433 526 GLLVKEPQNRLACRRGATEIK 546 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~elL 546 (604)
+||..||++||+ +.+|+
T Consensus 574 ~cl~~dP~~RPs----~~~l~ 590 (613)
T 2ozo_A 574 DCWIYKWEDRPD----FLTVE 590 (613)
T ss_dssp HTTCSSTTTSCC----HHHHH
T ss_pred HHcCCChhHCcC----HHHHH
Confidence 999999999999 77764
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=361.82 Aligned_cols=257 Identities=22% Similarity=0.304 Sum_probs=208.2
Q ss_pred eeecCeEEEEEEccCCcEEEEEEE----EcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSE----LTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD 285 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~----~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 285 (604)
+..++|++++.||+|+||.||+|+ +..+++.||||++..... .....+.+|+++|+.++||||+++++++...
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 114 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDFEREIEILKSLQHDNIVKYKGVCYSA 114 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCS---HHHHHHHHHHHHHHTCCCTTBCCEEEEECC-
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCH---HHHHHHHHHHHHHHhCCCCCeeeEEEEEEec
Confidence 345789999999999999999998 466889999999976532 2334677899999999999999999998764
Q ss_pred --CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccc
Q 007433 286 --KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 286 --~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
..+|+||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++.
T Consensus 115 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 115 GRRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp ---CCEEEECCCTTCBHHHHHHHST-TSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred CCCceEEEEECCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 47899999999999999998763 469999999999999999999999999999999999999999999999999985
Q ss_pred cccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCC
Q 007433 364 RCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEP 443 (604)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (604)
..........
T Consensus 194 ~~~~~~~~~~---------------------------------------------------------------------- 203 (326)
T 2w1i_A 194 VLPQDKEYYK---------------------------------------------------------------------- 203 (326)
T ss_dssp ECCSSCSEEE----------------------------------------------------------------------
T ss_pred hccccccccc----------------------------------------------------------------------
Confidence 4321110000
Q ss_pred CCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCCh------------H---HHHHHHHcCCC
Q 007433 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSEN------------R---ATLYNVVGQPL 508 (604)
Q Consensus 444 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~------------~---~~l~~i~~~~~ 508 (604)
......||..|+|||++.+..++.++|||||||++|||++|..||..... . ..+...+....
T Consensus 204 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (326)
T 2w1i_A 204 ---VKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNG 280 (326)
T ss_dssp ---CSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTC
T ss_pred ---cccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCC
Confidence 01123478889999999998899999999999999999999999864211 0 11223333334
Q ss_pred CCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 509 RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 509 ~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
..+....++.++.+||.+||..||++||+ +.||++
T Consensus 281 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~el~~ 315 (326)
T 2w1i_A 281 RLPRPDGCPDEIYMIMTECWNNNVNQRPS----FRDLAL 315 (326)
T ss_dssp CCCCCTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHH
T ss_pred CCCCCCcccHHHHHHHHHHcCCChhhCcC----HHHHHH
Confidence 45555678999999999999999999999 888875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=393.02 Aligned_cols=255 Identities=22% Similarity=0.284 Sum_probs=207.1
Q ss_pred eecCeEEEE-EEccCCcEEEEEEEE--cCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCe
Q 007433 211 GVGHFRLLK-KLGCGDIGSVYLSEL--TGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKF 287 (604)
Q Consensus 211 ~~~~y~l~~-~LG~G~fG~Vy~a~~--~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 287 (604)
....+.+.. .||+|+||.||+|.+ ..+++.||||++...... ......+.+|+++|+.|+||||+++++++.. +.
T Consensus 366 ~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~ 443 (635)
T 4fl3_A 366 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND-PALKDELLAEANVMQQLDNPYIVRMIGICEA-ES 443 (635)
T ss_dssp CGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGC-GGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SS
T ss_pred cchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CC
Confidence 334555544 799999999999955 566789999999765322 2234567789999999999999999999975 45
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccC
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAV 367 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~ 367 (604)
+|||||||++|+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++..+..
T Consensus 444 ~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~ 521 (635)
T 4fl3_A 444 WMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA 521 (635)
T ss_dssp EEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC
T ss_pred EEEEEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCcccccc
Confidence 78999999999999999765 5799999999999999999999999999999999999999999999999999854432
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
..... ..
T Consensus 522 ~~~~~-------------------------------------------------------------------------~~ 528 (635)
T 4fl3_A 522 DENYY-------------------------------------------------------------------------KA 528 (635)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred Ccccc-------------------------------------------------------------------------cc
Confidence 11100 00
Q ss_pred ccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007433 448 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKG 526 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~ 526 (604)
.....||+.|+|||++.+..++.++|||||||+||||++ |+.||.+....+....+... ...+....++.++.+||.+
T Consensus 529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~ 607 (635)
T 4fl3_A 529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGCPAGCPREMYDLMNL 607 (635)
T ss_dssp ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHH
T ss_pred ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCCCCHHHHHHHHH
Confidence 112347889999999999999999999999999999998 99999998887766666543 3344445689999999999
Q ss_pred hhhcCCCCcccccCCHHHHhc
Q 007433 527 LLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 527 lL~~dP~~Rpt~~~~a~elL~ 547 (604)
||..||++||+ +.+|++
T Consensus 608 cl~~dP~~RPs----~~~l~~ 624 (635)
T 4fl3_A 608 CWTYDVENRPG----FAAVEL 624 (635)
T ss_dssp HTCSSTTTSCC----HHHHHH
T ss_pred HcCCCHhHCcC----HHHHHH
Confidence 99999999999 777764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-43 Score=372.75 Aligned_cols=256 Identities=17% Similarity=0.243 Sum_probs=201.9
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCC---ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEe-cCCee
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGT---KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFE-TDKFS 288 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-~~~~~ 288 (604)
..|++.+.||+|+||+||+|.+..+ +..||+|.+..... .....++.+|+.+|+.++||||+++++++. .++..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSC--SHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 3589999999999999999987543 35689999875322 233456778999999999999999999865 56688
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|+||||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+||||+.++.+||+|||++..+...
T Consensus 167 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~ 245 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 245 (373)
T ss_dssp EEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccc
Confidence 9999999999999999764 356899999999999999999999999999999999999999999999999998543211
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
... .....
T Consensus 246 ~~~------------------------------------------------------------------------~~~~~ 253 (373)
T 3c1x_A 246 EFD------------------------------------------------------------------------SVHNK 253 (373)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc------------------------------------------------------------------------ccccc
Confidence 000 00011
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGL 527 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~l 527 (604)
....||+.|+|||++.+..++.++|||||||+||||++ |.+||.+....+....+.... .......++..+.+||.+|
T Consensus 254 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~-~~~~p~~~~~~l~~li~~c 332 (373)
T 3c1x_A 254 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR-RLLQPEYCPDPLYEVMLKC 332 (373)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC-CCCCCTTCCHHHHHHHHHH
T ss_pred CCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHH
Confidence 12358889999999999999999999999999999999 788898776666655555433 2333456899999999999
Q ss_pred hhcCCCCcccccCCHHHHhcC
Q 007433 528 LVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~H 548 (604)
|..||++||+ +.|++++
T Consensus 333 l~~dp~~RPs----~~ell~~ 349 (373)
T 3c1x_A 333 WHPKAEMRPS----FSELVSR 349 (373)
T ss_dssp TCSSGGGSCC----HHHHHHH
T ss_pred cCCChhhCcC----HHHHHHH
Confidence 9999999999 8888764
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=357.70 Aligned_cols=250 Identities=22% Similarity=0.348 Sum_probs=195.4
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC--CCCCccccceeEecC----
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL--DHPFLPTLYTHFETD---- 285 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l--~HpnIv~l~~~~~~~---- 285 (604)
.++|++++.||+|+||.||+|++. ++.||||++...... ...+|.+++..+ +||||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~------~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEA------SWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHH------HHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccc------hhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 368999999999999999999986 678999999654321 223455665554 999999999999876
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHc--------CeEeccCCCCcEEEccCCcEEEe
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML--------GIVYRDLKPENVLVREDGHIMLS 357 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~--------gIvHrDIKpeNILl~~~g~vkL~ 357 (604)
...|+|||||++|+|.+++... .+++..+..++.||+.||.|||++ |||||||||+||||+.++.+||+
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~ 184 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEEC
T ss_pred CceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEE
Confidence 7899999999999999999764 599999999999999999999998 99999999999999999999999
Q ss_pred cccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCc
Q 007433 358 DFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLP 437 (604)
Q Consensus 358 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (604)
|||++..+......
T Consensus 185 Dfg~a~~~~~~~~~------------------------------------------------------------------ 198 (337)
T 3mdy_A 185 DLGLAVKFISDTNE------------------------------------------------------------------ 198 (337)
T ss_dssp CCTTCEECC-----------------------------------------------------------------------
T ss_pred eCCCceeecccccc------------------------------------------------------------------
Confidence 99998543211100
Q ss_pred ccccCCCCCcccccccCccccCcceecCCCCCcc------chHHHHHHHHHHHhhC----------CCCCCCC----ChH
Q 007433 438 ELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSA------VDWWTFGIFLYELLFG----------KTPFKGS----ENR 497 (604)
Q Consensus 438 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~------~DiWSLGviL~eLltG----------~~PF~~~----~~~ 497 (604)
........+||+.|+|||++.+..+... +|||||||++|||++| ..||... ...
T Consensus 199 ------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~ 272 (337)
T 3mdy_A 199 ------VDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY 272 (337)
T ss_dssp ----------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred ------ccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCch
Confidence 0001123479999999999988877665 9999999999999999 7777643 222
Q ss_pred HHHHHHHcC-CCC--CCC---CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 498 ATLYNVVGQ-PLR--FPE---SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 498 ~~l~~i~~~-~~~--~p~---~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
..+...... ... ++. ...++.++.+||.+||..||++||+ +.+|++|
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps----~~ell~~ 325 (337)
T 3mdy_A 273 EDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLT----ALRVKKT 325 (337)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCC----HHHHHHH
T ss_pred hhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCC----HHHHHHH
Confidence 333333322 111 111 1134567999999999999999999 8898876
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=383.94 Aligned_cols=254 Identities=17% Similarity=0.181 Sum_probs=198.9
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCC-CCccccc------------
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH-PFLPTLY------------ 279 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~------------ 279 (604)
..|++.+.||+|+||+||+|++..+++.||||++.............+.+|+.+++.+.| .|+..++
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 468899999999999999999999999999999985444444445667889999999987 3221111
Q ss_pred ---------eeEec-----CCeeEEEEeecCCCCHHHHHH-----hcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEecc
Q 007433 280 ---------THFET-----DKFSCLVMEFCPGGDLHTLRQ-----RQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRD 340 (604)
Q Consensus 280 ---------~~~~~-----~~~~~lV~E~~~ggsL~~ll~-----~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrD 340 (604)
.++.. ...+|++|+++ +++|.++++ ......+++..+..++.||+.||+|||++||||||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 11111 22467888877 899999885 22235688999999999999999999999999999
Q ss_pred CCCCcEEEccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccc
Q 007433 341 LKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSK 420 (604)
Q Consensus 341 IKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 420 (604)
|||+||||+.+|.+||+|||++.....
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~----------------------------------------------------- 263 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGA----------------------------------------------------- 263 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTE-----------------------------------------------------
T ss_pred cccceEEEecCCeEEEEeccceeecCC-----------------------------------------------------
Confidence 999999999999999999999743210
Q ss_pred cccCCccccCCCCCCCcccccCCCCCcccccccCccccCccee----------cCCCCCccchHHHHHHHHHHHhhCCCC
Q 007433 421 KAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEII----------KGEGHGSAVDWWTFGIFLYELLFGKTP 490 (604)
Q Consensus 421 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l----------~~~~~~~~~DiWSLGviL~eLltG~~P 490 (604)
.....+| +.|+|||++ .+..++.++|||||||+||||++|+.|
T Consensus 264 --------------------------~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~P 316 (413)
T 3dzo_A 264 --------------------------SAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316 (413)
T ss_dssp --------------------------EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCC
T ss_pred --------------------------ccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCC
Confidence 0123468 999999999 555578899999999999999999999
Q ss_pred CCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 491 FKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 491 F~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
|.+.........+ +.....++.++++||.+||..||++||+ +.++++||||+.+...
T Consensus 317 f~~~~~~~~~~~~------~~~~~~~~~~~~~li~~~l~~dP~~Rpt----~~~~l~~~~~~~~~~~ 373 (413)
T 3dzo_A 317 NTDDAALGGSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLL----PLQAMETPEYEQLRTE 373 (413)
T ss_dssp CCTTGGGSCSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGSCC----HHHHTTSHHHHHHHHH
T ss_pred CCCcchhhhHHHH------HhhcccCCHHHHHHHHHHccCChhhCcC----HHHHHhCHHHHHHHHH
Confidence 9876554333222 2223458899999999999999999999 9999999999877544
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=359.48 Aligned_cols=263 Identities=26% Similarity=0.366 Sum_probs=192.9
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEe-----c
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFE-----T 284 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~-----~ 284 (604)
+..++|++++.||+|+||.||+|++ +++.||||++....... . ....|+..+..++|+||+++++++. .
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~--~--~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 83 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQN--F--INEKNIYRVPLMEHDNIARFIVGDERVTADG 83 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHH--H--HHHHHHHTSTTCCCTTBCCEEEEEEEECTTS
T ss_pred cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhh--H--HHHHHHHHHHhccCcchhhheecccccccCC
Confidence 4568999999999999999999977 56799999997653221 1 1123444455689999999998654 2
Q ss_pred CCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHc---------CeEeccCCCCcEEEccCCcEE
Q 007433 285 DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML---------GIVYRDLKPENVLVREDGHIM 355 (604)
Q Consensus 285 ~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~---------gIvHrDIKpeNILl~~~g~vk 355 (604)
...+|||||||++|+|.+++... .+++..+..++.||+.||.|||++ |||||||||+||||+.++.+|
T Consensus 84 ~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 84 RMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp CEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred CceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 34679999999999999999775 468999999999999999999999 999999999999999999999
Q ss_pred EecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCC
Q 007433 356 LSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSP 435 (604)
Q Consensus 356 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 435 (604)
|+|||++..+........
T Consensus 161 L~DFG~a~~~~~~~~~~~-------------------------------------------------------------- 178 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRP-------------------------------------------------------------- 178 (336)
T ss_dssp ECCCTTCEECSSSSCC----------------------------------------------------------------
T ss_pred EeeccceeecccccccCc--------------------------------------------------------------
Confidence 999999855432110000
Q ss_pred CcccccCCCCCcccccccCccccCcceecC-------CCCCccchHHHHHHHHHHHhhCCCCCCCCC-------------
Q 007433 436 LPELIAEPTNARSMSFVGTHEYLAPEIIKG-------EGHGSAVDWWTFGIFLYELLFGKTPFKGSE------------- 495 (604)
Q Consensus 436 ~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-------~~~~~~~DiWSLGviL~eLltG~~PF~~~~------------- 495 (604)
..........+||+.|+|||++.+ ..++.++|||||||+||||++|..||....
T Consensus 179 ------~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~ 252 (336)
T 3g2f_A 179 ------GEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEV 252 (336)
T ss_dssp -------------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHH
T ss_pred ------cccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhccc
Confidence 000111224579999999999987 345678999999999999999977764321
Q ss_pred ----hHHHHHHHHcCC---CCCCCC----CCCCHHHHHHHHHhhhcCCCCcccccCCHHHHh------cCCCCCC
Q 007433 496 ----NRATLYNVVGQP---LRFPES----PVVSFSARDLIKGLLVKEPQNRLACRRGATEIK------QHPFFQG 553 (604)
Q Consensus 496 ----~~~~l~~i~~~~---~~~p~~----~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL------~Hpff~~ 553 (604)
....+...+... ..++.. ..++..+.+||.+||..||++||+ +.|++ .++|-+.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps----~~e~l~~L~~ll~~~~~~ 323 (336)
T 3g2f_A 253 GNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT----AQXAEERMAELMMIWERN 323 (336)
T ss_dssp CSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCC----HHHHHHHHHHHHHCCCC-
T ss_pred CCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcc----hHHHHHHHHHHHHHHHhc
Confidence 111222222221 122211 113447999999999999999999 77874 4566543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-43 Score=362.81 Aligned_cols=264 Identities=19% Similarity=0.253 Sum_probs=209.8
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCee
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 288 (604)
.+..++|++.+.||+|+||.||+|++.+ .||+|++....... .....+.+|+.+++.++|+||+++++++.+++.+
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNE-DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCC-CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCH-HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 3456899999999999999999999865 39999997542211 1122345799999999999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|+||||++|++|.+++... +..+++..+..++.||+.||+|||++||+||||||+|||++ ++.++|+|||++......
T Consensus 105 ~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~ 182 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL 182 (319)
T ss_dssp EEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred EEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence 9999999999999998764 35799999999999999999999999999999999999998 789999999987432110
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
... ......
T Consensus 183 ~~~-----------------------------------------------------------------------~~~~~~ 191 (319)
T 2y4i_B 183 QAG-----------------------------------------------------------------------RREDKL 191 (319)
T ss_dssp ----------------------------------------------------------------------------CCSC
T ss_pred ccc-----------------------------------------------------------------------cccccc
Confidence 000 000111
Q ss_pred cccccCccccCcceecC---------CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHH
Q 007433 449 MSFVGTHEYLAPEIIKG---------EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFS 519 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~---------~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~ 519 (604)
....||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+......+..+............++.+
T Consensus 192 ~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (319)
T 2y4i_B 192 RIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIGMGKE 271 (319)
T ss_dssp BCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCCSSCCTT
T ss_pred ccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCcCCCCHH
Confidence 23459999999999875 347889999999999999999999999988877777766554433333458889
Q ss_pred HHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCC
Q 007433 520 ARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 520 l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
+.+||.+||..||++||+ +.++++. |+.+.
T Consensus 272 l~~li~~~l~~~p~~Rpt----~~~l~~~--l~~l~ 301 (319)
T 2y4i_B 272 ISDILLFCWAFEQEERPT----FTKLMDM--LEKLP 301 (319)
T ss_dssp HHHHHHHHHCSSTTTSCC----HHHHHHH--HTTC-
T ss_pred HHHHHHHHhcCChhhCcC----HHHHHHH--HHHHH
Confidence 999999999999999999 8888873 44443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=375.12 Aligned_cols=245 Identities=19% Similarity=0.212 Sum_probs=189.0
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHH-----HHHHHHHHHHHHHHHHhCC---------------
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLE-----KRKKLLRAQTEREILQSLD--------------- 271 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~-----~~~~~~~~~~Ei~iL~~l~--------------- 271 (604)
.++|++++.||+|+||+||+|++ +++.||||++.+.... .......+.+|+.+|+.++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 47899999999999999999998 5689999999865321 1112245667888888886
Q ss_pred -----------CCCccccceeEec-------------CCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHH
Q 007433 272 -----------HPFLPTLYTHFET-------------DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLA 327 (604)
Q Consensus 272 -----------HpnIv~l~~~~~~-------------~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~a 327 (604)
||||++++++|.+ ++.+|||||||++|+|.+.+.+ ..+++..++.|+.||+.|
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHHHHHH
Confidence 5555555555554 7899999999999976555533 468999999999999999
Q ss_pred HHHHH-HcCeEeccCCCCcEEEccCC--------------------cEEEecccccccccCCCcccccCcccCCcccCCC
Q 007433 328 LEYLH-MLGIVYRDLKPENVLVREDG--------------------HIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNP 386 (604)
Q Consensus 328 L~yLH-~~gIvHrDIKpeNILl~~~g--------------------~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~ 386 (604)
|+||| ++|||||||||+||||+.+| .+||+|||++.....
T Consensus 174 L~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~------------------- 234 (336)
T 2vuw_A 174 LAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD------------------- 234 (336)
T ss_dssp HHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------------------
T ss_pred HHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------------------
Confidence 99999 99999999999999999987 899999999843210
Q ss_pred ccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecCC
Q 007433 387 VYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGE 466 (604)
Q Consensus 387 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~ 466 (604)
...+||+.|+|||++.+.
T Consensus 235 --------------------------------------------------------------~~~~gt~~y~aPE~~~g~ 252 (336)
T 2vuw_A 235 --------------------------------------------------------------GIVVFCDVSMDEDLFTGD 252 (336)
T ss_dssp --------------------------------------------------------------TEEECCCCTTCSGGGCCC
T ss_pred --------------------------------------------------------------CcEEEeecccChhhhcCC
Confidence 123699999999999987
Q ss_pred CCCccchHHHHHHH-HHHHhhCCCCCCCCChHH-HHHHHHcC-CCCCCC----CCCCCHHHHHHHHHhhhcCCCCccccc
Q 007433 467 GHGSAVDWWTFGIF-LYELLFGKTPFKGSENRA-TLYNVVGQ-PLRFPE----SPVVSFSARDLIKGLLVKEPQNRLACR 539 (604)
Q Consensus 467 ~~~~~~DiWSLGvi-L~eLltG~~PF~~~~~~~-~l~~i~~~-~~~~p~----~~~~s~~l~dLI~~lL~~dP~~Rpt~~ 539 (604)
. +.++||||||++ .++++.|..||.+..... ....+... ...... ...++.++++||.+||++| +
T Consensus 253 ~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----s-- 324 (336)
T 2vuw_A 253 G-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----S-- 324 (336)
T ss_dssp S-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----S--
T ss_pred C-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----C--
Confidence 7 889999998777 778889999996422111 22222211 111111 1236788999999999987 6
Q ss_pred CCHHHHh-cCCCCC
Q 007433 540 RGATEIK-QHPFFQ 552 (604)
Q Consensus 540 ~~a~elL-~Hpff~ 552 (604)
+.|+| +||||+
T Consensus 325 --a~e~l~~Hp~f~ 336 (336)
T 2vuw_A 325 --ATDLLCQHSLFK 336 (336)
T ss_dssp --HHHHHHHCGGGC
T ss_pred --HHHHHhcCCCcC
Confidence 99999 999995
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=356.37 Aligned_cols=254 Identities=20% Similarity=0.238 Sum_probs=199.1
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhH-HHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASL-EKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
.|...+.||+|+||.||+|.+ ++..||||++..... ........+.+|+.+|+.++||||+++++++.+++..|+||
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence 344558999999999999987 456899999875421 12223446778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 293 EFCPGGDLHTLRQRQP-GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
||+++++|.+++.... ...+++..+..++.||+.||.|||++||+||||||+||||+.++.++|+|||++........
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~- 188 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ- 188 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS-
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc-
Confidence 9999999999987532 34699999999999999999999999999999999999999999999999998843221000
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
.......
T Consensus 189 -------------------------------------------------------------------------~~~~~~~ 195 (307)
T 2nru_A 189 -------------------------------------------------------------------------TVMTSRI 195 (307)
T ss_dssp -------------------------------------------------------------------------CEECSSC
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0011134
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHH----HHHHcCCC--------CCC-CCCCCCH
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATL----YNVVGQPL--------RFP-ESPVVSF 518 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l----~~i~~~~~--------~~p-~~~~~s~ 518 (604)
.||+.|+|||++.+. ++.++|||||||++|+|++|..||.+......+ ..+..... .++ .....+.
T Consensus 196 ~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 274 (307)
T 2nru_A 196 VGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVE 274 (307)
T ss_dssp CSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHH
T ss_pred CCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHH
Confidence 699999999998764 789999999999999999999999875432221 11111110 111 1122456
Q ss_pred HHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 519 SARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 519 ~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
.+.+||.+||..||.+||+ +.+++++
T Consensus 275 ~l~~li~~cl~~~p~~Rps----~~~l~~~ 300 (307)
T 2nru_A 275 AMYSVASQCLHEKKNKRPD----IKKVQQL 300 (307)
T ss_dssp HHHHHHHHHTCSSTTTSCC----HHHHHHH
T ss_pred HHHHHHHHHcCCCcccCcC----HHHHHHH
Confidence 7899999999999999999 8888865
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=397.96 Aligned_cols=261 Identities=25% Similarity=0.389 Sum_probs=207.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec------C
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET------D 285 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------~ 285 (604)
.++|++.+.||.|+||.||+|.+..+++.||||++..... .....++.+|+++|+.++||||+++++++.. +
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~--~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~ 90 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELS--PKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPN 90 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCC--HHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTT
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCC--HHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCC
Confidence 3799999999999999999999999999999999876422 2334567789999999999999999998765 7
Q ss_pred CeeEEEEeecCCCCHHHHHHhcC-CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCc---EEEecccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQP-GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGH---IMLSDFDL 361 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~-~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~---vkL~DFGl 361 (604)
+..|+|||||+|++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||||+.++. ++|+|||+
T Consensus 91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence 78899999999999999988743 236999999999999999999999999999999999999997765 99999998
Q ss_pred cccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccccc
Q 007433 362 SLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIA 441 (604)
Q Consensus 362 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (604)
+......
T Consensus 171 a~~~~~~------------------------------------------------------------------------- 177 (676)
T 3qa8_A 171 AKELDQG------------------------------------------------------------------------- 177 (676)
T ss_dssp CCBTTSC-------------------------------------------------------------------------
T ss_pred ccccccc-------------------------------------------------------------------------
Confidence 8432110
Q ss_pred CCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHH--------------HcCC
Q 007433 442 EPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNV--------------VGQP 507 (604)
Q Consensus 442 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i--------------~~~~ 507 (604)
.......||+.|+|||++.+..++.++|||||||++|+|++|..||.+......+... ..+.
T Consensus 178 ----~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~ 253 (676)
T 3qa8_A 178 ----ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGA 253 (676)
T ss_dssp ----CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSS
T ss_pred ----cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccc
Confidence 0112346999999999999999999999999999999999999999875433221100 0111
Q ss_pred CCC----CC----CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCC
Q 007433 508 LRF----PE----SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 508 ~~~----p~----~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
..+ +. ...++..+.+||.+||.+||++||+ +.++|+||||+.++
T Consensus 254 ~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPT----a~elL~hp~F~~l~ 305 (676)
T 3qa8_A 254 VKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGT----DPQNPNVGCFQALD 305 (676)
T ss_dssp CCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---C----CTTCCCCTTHHHHH
T ss_pred cccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcC----HHHHhcCHHHHHHH
Confidence 111 11 1225678999999999999999999 89999999998654
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=354.14 Aligned_cols=250 Identities=22% Similarity=0.288 Sum_probs=198.5
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHh--CCCCCccccceeEecCC---
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQS--LDHPFLPTLYTHFETDK--- 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~--l~HpnIv~l~~~~~~~~--- 286 (604)
.++|++.+.||+|+||.||+|++. ++.||||++..... ..+.+|+++++. ++||||+++++++..+.
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~------~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~ 112 (342)
T 1b6c_B 41 ARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREE------RSWFREAEIYQTVMLRHENILGFIAADNKDNGTW 112 (342)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEECGGGH------HHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSC
T ss_pred cccEEEEeeecCCCCcEEEEEEEc--CccEEEEEeCchhH------HHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcc
Confidence 368999999999999999999984 77999999976532 234568888887 79999999999998765
Q ss_pred -eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH--------HcCeEeccCCCCcEEEccCCcEEEe
Q 007433 287 -FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH--------MLGIVYRDLKPENVLVREDGHIMLS 357 (604)
Q Consensus 287 -~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH--------~~gIvHrDIKpeNILl~~~g~vkL~ 357 (604)
..|+||||+++|+|.+++... .+++..+..++.||+.||.||| ++||+||||||+||||+.++.+||+
T Consensus 113 ~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 113 TQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp CCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEEC
T ss_pred ceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEE
Confidence 899999999999999999764 5999999999999999999999 8999999999999999999999999
Q ss_pred cccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCc
Q 007433 358 DFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLP 437 (604)
Q Consensus 358 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 437 (604)
|||++..........
T Consensus 190 Dfg~~~~~~~~~~~~----------------------------------------------------------------- 204 (342)
T 1b6c_B 190 DLGLAVRHDSATDTI----------------------------------------------------------------- 204 (342)
T ss_dssp CCTTCEEEETTTTEE-----------------------------------------------------------------
T ss_pred ECCCceecccccccc-----------------------------------------------------------------
Confidence 999985432111000
Q ss_pred ccccCCCCCcccccccCccccCcceecCCC------CCccchHHHHHHHHHHHhhC----------CCCCCCCC----hH
Q 007433 438 ELIAEPTNARSMSFVGTHEYLAPEIIKGEG------HGSAVDWWTFGIFLYELLFG----------KTPFKGSE----NR 497 (604)
Q Consensus 438 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~------~~~~~DiWSLGviL~eLltG----------~~PF~~~~----~~ 497 (604)
........||+.|+|||++.+.. ++.++|||||||+||||++| ..||.... ..
T Consensus 205 -------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~ 277 (342)
T 1b6c_B 205 -------DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSV 277 (342)
T ss_dssp -------EECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred -------ccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccH
Confidence 00112346999999999998763 23689999999999999999 88987642 22
Q ss_pred HHHHHHH-cCCCCCCCC-----CCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 498 ATLYNVV-GQPLRFPES-----PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 498 ~~l~~i~-~~~~~~p~~-----~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
..+...+ ......... ..++..+.+||.+||..||++||+ +.+|++|
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~~i~~~ 330 (342)
T 1b6c_B 278 EEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT----ALRIKKT 330 (342)
T ss_dssp HHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCC----HHHHHHH
Confidence 3333333 332221111 123357889999999999999999 8888876
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=349.71 Aligned_cols=227 Identities=18% Similarity=0.159 Sum_probs=188.3
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
+..++|++++.||+|+||.||+|++..+++.||||++............++.+|+.+++.++||||+++++++.+++..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 44578999999999999999999999999999999998765443445567788999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
|||||++|++|.++++.. .....+..|+.||+.||+|||++||+||||||+||||+.+|.+||+++|
T Consensus 108 lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~--------- 174 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA--------- 174 (286)
T ss_dssp EEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC---------
T ss_pred EEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc---------
Confidence 999999999999998542 3455688899999999999999999999999999999999999998554
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
T Consensus 175 -------------------------------------------------------------------------------- 174 (286)
T 3uqc_A 175 -------------------------------------------------------------------------------- 174 (286)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------------
Confidence
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHH---HHHcCCCCC--CCCCCCCHHHHHHH
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY---NVVGQPLRF--PESPVVSFSARDLI 524 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~---~i~~~~~~~--p~~~~~s~~l~dLI 524 (604)
|++ .++.++|||||||+||||++|+.||.+.+....+. ......... .....++.++.+||
T Consensus 175 -------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 240 (286)
T 3uqc_A 175 -------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVA 240 (286)
T ss_dssp -------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHH
T ss_pred -------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHH
Confidence 222 26789999999999999999999999865533221 111111111 11245889999999
Q ss_pred HHhhhcCCCCcccccCCHHHHhcC
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
.+||.+||++| + +.|+++.
T Consensus 241 ~~~l~~dP~~R-s----~~el~~~ 259 (286)
T 3uqc_A 241 ARSVQGDGGIR-S----ASTLLNL 259 (286)
T ss_dssp HHHHCTTSSCC-C----HHHHHHH
T ss_pred HHHcccCCccC-C----HHHHHHH
Confidence 99999999999 9 8888764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-41 Score=383.62 Aligned_cols=255 Identities=24% Similarity=0.358 Sum_probs=211.0
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCC---ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGT---KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
+..++|++.+.||+|+||.||+|.+..+ +..||||++..... ......+.+|+.+|+.++||||+++++++. ++
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTS--DSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 4457899999999999999999998653 46799999875432 223346778999999999999999999985 45
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
..|+||||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+||||+.+|.+||+|||++....
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~ 542 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 542 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred ceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence 689999999999999999865 3469999999999999999999999999999999999999999999999999984322
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
... ..
T Consensus 543 ~~~---------------------------------------------------------------------------~~ 547 (656)
T 2j0j_A 543 DST---------------------------------------------------------------------------YY 547 (656)
T ss_dssp C-------------------------------------------------------------------------------
T ss_pred CCc---------------------------------------------------------------------------ce
Confidence 100 00
Q ss_pred cccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007433 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIK 525 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~ 525 (604)
......||+.|+|||++.+..++.++|||||||+||||++ |..||.+....+.+..+.... ..+....++..+.+||.
T Consensus 548 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~l~~li~ 626 (656)
T 2j0j_A 548 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYSLMT 626 (656)
T ss_dssp ------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTC-CCCCCTTCCHHHHHHHH
T ss_pred eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCC-CCCCCccccHHHHHHHH
Confidence 0112347889999999999999999999999999999997 999999988877777766542 23344568999999999
Q ss_pred HhhhcCCCCcccccCCHHHHhcC
Q 007433 526 GLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
+||..||++||+ +.+|+++
T Consensus 627 ~~l~~dP~~RPs----~~el~~~ 645 (656)
T 2j0j_A 627 KCWAYDPSRRPR----FTELKAQ 645 (656)
T ss_dssp HHTCSSGGGSCC----HHHHHHH
T ss_pred HHcCCChhHCcC----HHHHHHH
Confidence 999999999999 8888753
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=384.79 Aligned_cols=246 Identities=24% Similarity=0.324 Sum_probs=198.2
Q ss_pred ceeeecCeEEEEEEccCCcEEEEEEEEcC-CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 208 GVLGVGHFRLLKKLGCGDIGSVYLSELTG-TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 208 ~~~~~~~y~l~~~LG~G~fG~Vy~a~~~~-~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
+.+..++|++++.||+|+||+||+|.+.. +++.||||++..... ......+.+|+++|+.++||||++++++|...+
T Consensus 75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~ 152 (681)
T 2pzi_A 75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGD--AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTD 152 (681)
T ss_dssp TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCC--HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEEC
T ss_pred CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCC--HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecC
Confidence 34445899999999999999999999976 788999999865422 223345678999999999999999999998765
Q ss_pred e-----eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccc
Q 007433 287 F-----SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDL 361 (604)
Q Consensus 287 ~-----~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGl 361 (604)
. .||||||++|++|.+++.. .+++..++.|+.||+.||+|||++|||||||||+||||+.+ .+||+|||+
T Consensus 153 ~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~ 227 (681)
T 2pzi_A 153 RHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGA 227 (681)
T ss_dssp TTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTT
T ss_pred CCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEeccc
Confidence 5 7999999999999987654 59999999999999999999999999999999999999875 899999998
Q ss_pred cccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCccccc
Q 007433 362 SLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIA 441 (604)
Q Consensus 362 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 441 (604)
+.....
T Consensus 228 a~~~~~-------------------------------------------------------------------------- 233 (681)
T 2pzi_A 228 VSRINS-------------------------------------------------------------------------- 233 (681)
T ss_dssp CEETTC--------------------------------------------------------------------------
T ss_pred chhccc--------------------------------------------------------------------------
Confidence 843210
Q ss_pred CCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHH
Q 007433 442 EPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSAR 521 (604)
Q Consensus 442 ~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~ 521 (604)
....+||+.|+|||++.+. ++.++|||||||+||+|++|..||.+.... ...........+..+.
T Consensus 234 ------~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~--------~~~~~~~~~~~~~~l~ 298 (681)
T 2pzi_A 234 ------FGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVD--------GLPEDDPVLKTYDSYG 298 (681)
T ss_dssp ------CSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECS--------SCCTTCHHHHHCHHHH
T ss_pred ------CCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccc--------cccccccccccCHHHH
Confidence 0134699999999999875 488999999999999999999998753210 0000000011357889
Q ss_pred HHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 522 DLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 522 dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
+||.+||.+||.+||+ ..+.+.|+|+.-
T Consensus 299 ~li~~~l~~dP~~R~~----~~~~l~~~l~~~ 326 (681)
T 2pzi_A 299 RLLRRAIDPDPRQRFT----TAEEMSAQLTGV 326 (681)
T ss_dssp HHHHHHTCSSGGGSCS----SHHHHHHHHHHH
T ss_pred HHHhhhccCChhhCCC----HHHHHHHHHHHH
Confidence 9999999999999999 788888888753
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-34 Score=323.96 Aligned_cols=190 Identities=17% Similarity=0.121 Sum_probs=135.5
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchh-------HHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCCeeEE
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKAS-------LEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~-------~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~~~~l 290 (604)
..++.|++|.+..++..-.|..||+|++.+.. ........++.+|+++|+++ .|+||++++++|++++.+||
T Consensus 240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL 319 (569)
T 4azs_A 240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL 319 (569)
T ss_dssp CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence 34678888888888888888899999997642 12334456788999999999 79999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
|||||+|++|.+++.+. ..+++. .|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|+.....
T Consensus 320 VMEyv~G~~L~d~i~~~--~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~-- 392 (569)
T 4azs_A 320 VMEKLPGRLLSDMLAAG--EEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD-- 392 (569)
T ss_dssp EEECCCSEEHHHHHHTT--CCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC----
T ss_pred EEecCCCCcHHHHHHhC--CCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC--
Confidence 99999999999999875 567664 47899999999999999999999999999999999999999998432110
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
.....+
T Consensus 393 --------------------------------------------------------------------------~~~~~t 398 (569)
T 4azs_A 393 --------------------------------------------------------------------------CSWPTN 398 (569)
T ss_dssp ---------------------------------------------------------------------------CCSHH
T ss_pred --------------------------------------------------------------------------CccccC
Confidence 112335
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCC
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTP 490 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~P 490 (604)
.+||+.|||||++.+. +..++|+|++|+++++|+++..+
T Consensus 399 ~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~ 437 (569)
T 4azs_A 399 LVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSN 437 (569)
T ss_dssp HHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred ceechhhccHHHhCCC-CCCcccccccccchhhhccccch
Confidence 6899999999999875 56789999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.6e-28 Score=274.34 Aligned_cols=194 Identities=15% Similarity=0.124 Sum_probs=145.5
Q ss_pred EEEEEEccCCcEEEEEEEEcCCceEEEEEEecchh-----HHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 216 RLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKAS-----LEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 216 ~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~-----~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
...+.||+|+||+||+|... +..+|+|.+.... ........++.+|+++|++++||||+++..++...+..||
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~--~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYL--DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEECS--SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEEEC--CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 44568999999999999544 4578888864322 2233335567899999999999999977777777778899
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
|||||+|++|.+++.. +..|+.||+.||+|||++||+||||||+||||+. ++||+|||++........
T Consensus 417 VmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~ 484 (540)
T 3en9_A 417 MMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDED 484 (540)
T ss_dssp EEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHH
T ss_pred EEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccc
Confidence 9999999999998765 5689999999999999999999999999999998 999999999854321100
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
... .......+
T Consensus 485 ~~~---------------------------------------------------------------------~~~~~~~~ 495 (540)
T 3en9_A 485 KAV---------------------------------------------------------------------DLIVFKKA 495 (540)
T ss_dssp HHH---------------------------------------------------------------------HHHHHHHH
T ss_pred ccc---------------------------------------------------------------------chhhhhhh
Confidence 000 00001135
Q ss_pred cccCccccCcceecC--CCCCccchHHHHHHHHHHHhhCCCCCC
Q 007433 451 FVGTHEYLAPEIIKG--EGHGSAVDWWTFGIFLYELLFGKTPFK 492 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~--~~~~~~~DiWSLGviL~eLltG~~PF~ 492 (604)
++||+.|||||++.+ ..|+..+|+|+..+-.++.+.++.+|.
T Consensus 496 ~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 496 VLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred hcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 689999999999987 667888999999999988888777664
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.3e-26 Score=234.86 Aligned_cols=134 Identities=20% Similarity=0.139 Sum_probs=109.3
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHH---------------HHHHHHHHHHHHHHhCCCCCcccc
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKR---------------KKLLRAQTEREILQSLDHPFLPTL 278 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~---------------~~~~~~~~Ei~iL~~l~HpnIv~l 278 (604)
.|.+.+.||+|+||.||+|.+ .+++.||||+++....... .....+.+|+++|+.++ | +.+
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 455669999999999999999 8889999999975432111 23456778999999999 5 777
Q ss_pred ceeEecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEec
Q 007433 279 YTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSD 358 (604)
Q Consensus 279 ~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~D 358 (604)
++++.. +..|+|||||+|++|.+ +.. .....++.||+.||.|||++||+||||||+||||+ +|.++|+|
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~--------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~D 235 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV--------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIID 235 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC--------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch--------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence 776654 55699999999999987 311 22457999999999999999999999999999999 99999999
Q ss_pred cccc
Q 007433 359 FDLS 362 (604)
Q Consensus 359 FGla 362 (604)
||++
T Consensus 236 FG~a 239 (282)
T 1zar_A 236 FPQS 239 (282)
T ss_dssp CTTC
T ss_pred CCCC
Confidence 9987
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=9.8e-22 Score=198.70 Aligned_cols=140 Identities=19% Similarity=0.193 Sum_probs=109.0
Q ss_pred eEEEEEEccCCcEEEEEEEEcCCceE--EEEEEecchhHHH---------------------HHHHHHHHHHHHHHHhCC
Q 007433 215 FRLLKKLGCGDIGSVYLSELTGTKCY--FAMKVMDKASLEK---------------------RKKLLRAQTEREILQSLD 271 (604)
Q Consensus 215 y~l~~~LG~G~fG~Vy~a~~~~~~~~--vAiK~i~~~~~~~---------------------~~~~~~~~~Ei~iL~~l~ 271 (604)
|.+.+.||+|+||.||+|.+..++.. ||||+++...... ......+.+|+.+|+.|.
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 78999999999999999999777888 9999976542110 111235678999999998
Q ss_pred CCCc--cccceeEecCCeeEEEEeecCC-C----CHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH-HcCeEeccCCC
Q 007433 272 HPFL--PTLYTHFETDKFSCLVMEFCPG-G----DLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH-MLGIVYRDLKP 343 (604)
Q Consensus 272 HpnI--v~l~~~~~~~~~~~lV~E~~~g-g----sL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH-~~gIvHrDIKp 343 (604)
|++| +.++.+ +..||||||+.+ | .|.++... +++..+..++.||+.||.||| ++|||||||||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 8864 444432 356899999932 3 66665332 345567899999999999999 99999999999
Q ss_pred CcEEEccCCcEEEecccccccc
Q 007433 344 ENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 344 eNILl~~~g~vkL~DFGla~~~ 365 (604)
+||||+. .++|+|||++...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999988 9999999999654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.75 E-value=1.5e-18 Score=184.72 Aligned_cols=140 Identities=14% Similarity=0.170 Sum_probs=101.9
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHH-----------------HHHH--HHHHHHHHHHHHhCCCCC
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLE-----------------KRKK--LLRAQTEREILQSLDHPF 274 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~-----------------~~~~--~~~~~~Ei~iL~~l~Hpn 274 (604)
-|++.+.||.|+||.||+|.+. +|+.||||+++..... .... ...+.+|...|.+|.+.+
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g 174 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG 174 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence 3999999999999999999985 5789999997532110 0011 122346777888885554
Q ss_pred ccccceeEecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC--
Q 007433 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG-- 352 (604)
Q Consensus 275 Iv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g-- 352 (604)
+.... .+... ..+|||||++|+.|..+.. ...+..++.||+.+|.|||++|||||||||.||||+.+|
T Consensus 175 v~vp~-p~~~~-~~~LVME~i~G~~L~~l~~--------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 175 FPVPE-PIAQS-RHTIVMSLVDALPMRQVSS--------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp CSCCC-EEEEE-TTEEEEECCSCEEGGGCCC--------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCCe-eeecc-CceEEEEecCCccHhhhcc--------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 43222 22212 2379999999988865421 123467889999999999999999999999999999877
Q ss_pred --------cEEEeccccccc
Q 007433 353 --------HIMLSDFDLSLR 364 (604)
Q Consensus 353 --------~vkL~DFGla~~ 364 (604)
.+.|+||+-+..
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEE
T ss_pred ccccccccceEEEEeCCccc
Confidence 389999997643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.41 E-value=5.1e-13 Score=133.95 Aligned_cols=138 Identities=17% Similarity=0.156 Sum_probs=110.0
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEecCCeeEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV 291 (604)
+.|++...+|.|+++.||++... +..+++|+........ ...+.+|+++|+.|. +..++++++++.+++..|+|
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 57999999999999999999754 4589999987532111 123567999999884 67789999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM-------------------------------------- 333 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~-------------------------------------- 333 (604)
|||++|.+|..... +......++.+++.+|..||+
T Consensus 89 ~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T 3tm0_A 89 MSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTT
T ss_pred EEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhcccccccccccccc
Confidence 99999999976521 112234678899999999998
Q ss_pred ---------------------cCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 334 ---------------------LGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 334 ---------------------~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
..++|+|++|.|||++.++.+.|+||+.+
T Consensus 162 ~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a 211 (263)
T 3tm0_A 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRS 211 (263)
T ss_dssp CSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTC
T ss_pred ccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhc
Confidence 55999999999999986555679999976
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.26 E-value=5.6e-12 Score=125.24 Aligned_cols=133 Identities=16% Similarity=0.055 Sum_probs=97.1
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCC--ccccceeEecCCeeEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF--LPTLYTHFETDKFSCL 290 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~~~~~~~~~~~l 290 (604)
..|.+....+.|..+.||++.. .++..|++|+...... ..+.+|+.+|+.+.+.+ +++++.++..++..|+
T Consensus 20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~------~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~ 92 (264)
T 1nd4_A 20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWL 92 (264)
T ss_dssp TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEE
T ss_pred CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccc------hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEE
Confidence 4566654444666799999965 4456799999765411 23457889998885434 6779998888888999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcC-----------------------------------
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLG----------------------------------- 335 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~g----------------------------------- 335 (604)
||||++|.+|. .. ... ...++.+++..|..||...
T Consensus 93 v~e~i~G~~l~--~~-----~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 93 LLGEVPGQDLL--SS-----HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEECCSSEETT--TS-----CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred EEEecCCcccC--cC-----cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 99999998884 11 111 1245667777777777643
Q ss_pred -----------------------eEeccCCCCcEEEccCCcEEEeccccc
Q 007433 336 -----------------------IVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 336 -----------------------IvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
++|+|++|.|||++.++.+.|+|||.+
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a 212 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL 212 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhc
Confidence 999999999999987666679999987
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.20 E-value=2.9e-11 Score=127.16 Aligned_cols=140 Identities=17% Similarity=0.226 Sum_probs=105.1
Q ss_pred EEEEEEccCCcEEEEEEEEcCCceEEEEEEec--chhHHHHHHHHHHHHHHHHHHhCC--CCCccccceeEecC---Cee
Q 007433 216 RLLKKLGCGDIGSVYLSELTGTKCYFAMKVMD--KASLEKRKKLLRAQTEREILQSLD--HPFLPTLYTHFETD---KFS 288 (604)
Q Consensus 216 ~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~--~~~~~~~~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~~---~~~ 288 (604)
..++.|+.|.++.||+....+ ..+++|+.. ..... .....+.+|..+|+.|. +..+++++.++.+. +..
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~--~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPG--QTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSS--CEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred ceEEEcCCcccceEEEEEECC--ceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 346789999999999988754 468888876 33211 11234567999999986 45688999888766 458
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM----------------------------------- 333 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~----------------------------------- 333 (604)
|+||||++|..|.+. . ...++......++.+++..|..||.
T Consensus 117 ~~vme~v~G~~l~~~--~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQ--S--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp EEEEECCCCBCCCCT--T--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred EEEEEecCCeecCCC--c--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 999999999887531 1 1347788888999999999999997
Q ss_pred -----------------------cCeEeccCCCCcEEEccCCc--EEEecccccc
Q 007433 334 -----------------------LGIVYRDLKPENVLVREDGH--IMLSDFDLSL 363 (604)
Q Consensus 334 -----------------------~gIvHrDIKpeNILl~~~g~--vkL~DFGla~ 363 (604)
..+||||+++.|||++.++. +.|+||+.+.
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~ 247 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELST 247 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccc
Confidence 36999999999999997753 6899999873
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.08 E-value=2.9e-11 Score=124.29 Aligned_cols=131 Identities=16% Similarity=0.137 Sum_probs=96.5
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCC--ccccceeEecCC---eeEEEE
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPF--LPTLYTHFETDK---FSCLVM 292 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~Hpn--Iv~l~~~~~~~~---~~~lV~ 292 (604)
+.++.|.+..||+.. ..+++|+.... .....+.+|.++|+.+ .+.. +++++.+...+. ..|+||
T Consensus 26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm 95 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGF 95 (304)
T ss_dssp CEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEE
T ss_pred EecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEE
Confidence 458999999999864 24889986543 2234567899999887 3433 455555544333 458999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM--------------------------------------- 333 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~--------------------------------------- 333 (604)
|+++|..|...... .++......++.|++..|..||.
T Consensus 96 ~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (304)
T 3sg8_A 96 TKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMK 171 (304)
T ss_dssp ECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHH
T ss_pred cccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHH
Confidence 99999988754332 36777778888888888888885
Q ss_pred -------------------cCeEeccCCCCcEEEcc--CCcEEEecccccc
Q 007433 334 -------------------LGIVYRDLKPENVLVRE--DGHIMLSDFDLSL 363 (604)
Q Consensus 334 -------------------~gIvHrDIKpeNILl~~--~g~vkL~DFGla~ 363 (604)
..++|+|++|.|||++. ++.+.|+||+.+.
T Consensus 172 ~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~ 222 (304)
T 3sg8_A 172 KVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAA 222 (304)
T ss_dssp HHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCE
T ss_pred HHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCc
Confidence 13799999999999998 4568899999873
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.69 E-value=1.5e-07 Score=96.87 Aligned_cols=131 Identities=15% Similarity=0.100 Sum_probs=91.2
Q ss_pred EEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCC---CccccceeEe-cCCeeEEEEe
Q 007433 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP---FLPTLYTHFE-TDKFSCLVME 293 (604)
Q Consensus 218 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hp---nIv~l~~~~~-~~~~~~lV~E 293 (604)
++.++.|....||+. +..+++|+-... .....+.+|.++|+.|.+. .|++++.+.. .++..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~-----~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKSQ-----QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESSH-----HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCCc-----hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456788999999988 345788885432 2234567899999999652 3677777764 4566789999
Q ss_pred ecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHc---------------------------------------
Q 007433 294 FCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML--------------------------------------- 334 (604)
Q Consensus 294 ~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~--------------------------------------- 334 (604)
|++|..|....-. .++......++.++...|..||..
T Consensus 94 ~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~ 169 (306)
T 3tdw_A 94 KVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLR 169 (306)
T ss_dssp CCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHH
T ss_pred ccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhH
Confidence 9999888763211 234444455555555555555531
Q ss_pred ---------------------CeEeccCCCCcEEEcc---CCc-EEEeccccc
Q 007433 335 ---------------------GIVYRDLKPENVLVRE---DGH-IMLSDFDLS 362 (604)
Q Consensus 335 ---------------------gIvHrDIKpeNILl~~---~g~-vkL~DFGla 362 (604)
.++|+|+++.|||++. ++. +.|+||+.+
T Consensus 170 ~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a 222 (306)
T 3tdw_A 170 DYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDA 222 (306)
T ss_dssp HHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTC
T ss_pred HHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhc
Confidence 4699999999999987 455 489999977
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.67 E-value=1.6e-07 Score=93.93 Aligned_cols=131 Identities=18% Similarity=0.134 Sum_probs=92.0
Q ss_pred EEccCCcE-EEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEecCCeeEEEEeecCC
Q 007433 220 KLGCGDIG-SVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFETDKFSCLVMEFCPG 297 (604)
Q Consensus 220 ~LG~G~fG-~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~g 297 (604)
.+..|..| .||+......+..+.+|+-.... ...+.+|..+|+.|. +--|++++.++.+++..|+|||+++|
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~------~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G 104 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGSV------ANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPG 104 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETHH------HHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCS
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCCC------HhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCC
Confidence 34445444 79998887777788999875442 223557889988874 33478899999999999999999999
Q ss_pred CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 007433 298 GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM-------------------------------------------- 333 (604)
Q Consensus 298 gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~-------------------------------------------- 333 (604)
.++.+...... .....++.++...|.-||.
T Consensus 105 ~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 178 (272)
T 4gkh_A 105 KTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ 178 (272)
T ss_dssp EEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred ccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence 88876543321 1122334444444444442
Q ss_pred --------------cCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 334 --------------LGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 334 --------------~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
..++|+|+.+.|||++.++.+-|+||+.+
T Consensus 179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a 221 (272)
T 4gkh_A 179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRV 221 (272)
T ss_dssp HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTC
T ss_pred HHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccc
Confidence 12799999999999997777789999987
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=8.1e-07 Score=94.42 Aligned_cols=80 Identities=15% Similarity=0.129 Sum_probs=50.3
Q ss_pred EEEEEccCCcEEEEEEEEcCCceEEEEEEecchhH-HHH---HHHHHHHHHHHHHHhCCC---CCccccceeEecCCeeE
Q 007433 217 LLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASL-EKR---KKLLRAQTEREILQSLDH---PFLPTLYTHFETDKFSC 289 (604)
Q Consensus 217 l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~-~~~---~~~~~~~~Ei~iL~~l~H---pnIv~l~~~~~~~~~~~ 289 (604)
-++.||.|.++.||++.+..+++.|+||....... ... ....+...|.++|+.+.. ..+++++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 46789999999999998766667899998653211 000 012345678888887732 345566643 344568
Q ss_pred EEEeecCCC
Q 007433 290 LVMEFCPGG 298 (604)
Q Consensus 290 lV~E~~~gg 298 (604)
+||||++|.
T Consensus 112 lvmE~l~g~ 120 (397)
T 2olc_A 112 TVMEDLSHL 120 (397)
T ss_dssp EEECCCTTS
T ss_pred EEEEeCCCc
Confidence 999999763
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.32 E-value=5e-06 Score=85.54 Aligned_cols=137 Identities=14% Similarity=0.144 Sum_probs=78.3
Q ss_pred EEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC--CCCccccce------eEecCCee
Q 007433 217 LLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD--HPFLPTLYT------HFETDKFS 288 (604)
Q Consensus 217 l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~--HpnIv~l~~------~~~~~~~~ 288 (604)
-++.|+.|..+.||+....+ + .+++|+..... . .+..|..+++.|. .-.+++++. +...++..
T Consensus 36 ~~~~l~gG~~n~~~~v~~~~-~-~~vlk~~~~~~----~---~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~ 106 (346)
T 2q83_A 36 KIDVIQGNQMALVWKVHTDS-G-AVCLKRIHRPE----K---KALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFL 106 (346)
T ss_dssp EEEECC----CEEEEEEETT-E-EEEEEEECSCH----H---HHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEE
T ss_pred EeeeccccccCcEEEEEeCC-C-CEEEEecCCCH----H---HHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEE
Confidence 34567777889999987643 4 48899987531 1 1223445554442 113444443 22346778
Q ss_pred EEEEeecCCCCHH-----------HH---HHh----c--CCC------CCcHHH--------------------------
Q 007433 289 CLVMEFCPGGDLH-----------TL---RQR----Q--PGK------YFSEQA-------------------------- 316 (604)
Q Consensus 289 ~lV~E~~~ggsL~-----------~l---l~~----~--~~~------~l~e~~-------------------------- 316 (604)
++||||++|..+. .. ++. . +.. ...+..
T Consensus 107 ~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 186 (346)
T 2q83_A 107 FVVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQ 186 (346)
T ss_dssp EEEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHH
T ss_pred EEEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHH
Confidence 9999999886542 01 111 1 100 001110
Q ss_pred -----HHHHHHHHHHHHHHHHH-------------cCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 317 -----VKFYVAEVLLALEYLHM-------------LGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 317 -----~~~i~~qil~aL~yLH~-------------~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
+..+..++..++++|+. .++||+|+++.|||++.++.+.|+||+.+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a 250 (346)
T 2q83_A 187 LYLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTV 250 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTC
T ss_pred HHHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhc
Confidence 11122234446666653 57999999999999988889999999976
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.13 E-value=6.4e-06 Score=85.89 Aligned_cols=87 Identities=10% Similarity=0.034 Sum_probs=56.2
Q ss_pred eEEEEEE-ccCCcEEEEEEEEc---C---CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-C--CCccccceeEec
Q 007433 215 FRLLKKL-GCGDIGSVYLSELT---G---TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-H--PFLPTLYTHFET 284 (604)
Q Consensus 215 y~l~~~L-G~G~fG~Vy~a~~~---~---~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-H--pnIv~l~~~~~~ 284 (604)
...++.| +.|....+|+.... . ++..+++|+..............+.+|+.+|+.|. + -.+++++.+..+
T Consensus 22 v~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~ 101 (357)
T 3ats_A 22 VTVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT 101 (357)
T ss_dssp EEEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS
T ss_pred eEEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC
Confidence 3446778 89999999998754 1 15578899875432000000023456888888774 2 357888887765
Q ss_pred C---CeeEEEEeecCCCCHH
Q 007433 285 D---KFSCLVMEFCPGGDLH 301 (604)
Q Consensus 285 ~---~~~~lV~E~~~ggsL~ 301 (604)
+ +..|+||||++|..|.
T Consensus 102 ~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp STTTSSCEEEEECCCCBCCC
T ss_pred CCccCCceEEEEecCCCChh
Confidence 4 3568999999886643
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.94 E-value=6.6e-05 Score=77.46 Aligned_cols=77 Identities=17% Similarity=0.166 Sum_probs=59.4
Q ss_pred EEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC---CCCccccceeEecCCeeEEEE
Q 007433 216 RLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD---HPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 216 ~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~---HpnIv~l~~~~~~~~~~~lV~ 292 (604)
.-++.|+.|.+..+|+.... +..+++|+..... ...+..|.+.|+.|. ...+++++.+...++..|+||
T Consensus 39 ~~~~~l~gG~~n~~y~v~~~--~~~~vlK~~~~~~------~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvm 110 (312)
T 3jr1_A 39 KHKEKLYSGEMNEIWLINDE--VQTVFVKINERSY------RSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLL 110 (312)
T ss_dssp CEEEEECCSSSSEEEEEESS--SCEEEEEEEEGGG------HHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEE
T ss_pred eeeEEeCCccceeeeEEEEC--CCeEEEEeCCccc------HHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEE
Confidence 34678999999999998753 4578889876442 224567888888873 356889999888888899999
Q ss_pred eecCCCCH
Q 007433 293 EFCPGGDL 300 (604)
Q Consensus 293 E~~~ggsL 300 (604)
||++|..+
T Consensus 111 e~l~G~~~ 118 (312)
T 3jr1_A 111 EALNKSKN 118 (312)
T ss_dssp ECCCCCCC
T ss_pred EeccCCCC
Confidence 99998765
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.78 E-value=0.00011 Score=78.73 Aligned_cols=31 Identities=23% Similarity=0.382 Sum_probs=27.1
Q ss_pred HHcCeEeccCCCCcEEEccCCcEEEecccccc
Q 007433 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 332 H~~gIvHrDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
+...++|+|+++.|||++.++ +.|+||+.+.
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~ 260 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSF 260 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCE
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccc
Confidence 356799999999999998776 9999999873
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.75 E-value=0.0002 Score=73.26 Aligned_cols=142 Identities=19% Similarity=0.138 Sum_probs=79.9
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCC--Ccccccee------EecC
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP--FLPTLYTH------FETD 285 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hp--nIv~l~~~------~~~~ 285 (604)
...-++.|+.|....||+....+ + .+++|+..... ....+..|+.+++.|... .+++++.. ...+
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~~-g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~ 95 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELS 95 (322)
T ss_dssp CEEEEEEECC---EEEEEEEESS-C-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred cceEeeccCCCcccceEEEEeCC-c-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEEC
Confidence 44556788899999999997654 3 57899987531 011233577777666321 24444421 1234
Q ss_pred CeeEEEEeecCCCCHHH-----------H---HHhc----CCCC---Cc---HHHHH-H-----------HHHHHHHHHH
Q 007433 286 KFSCLVMEFCPGGDLHT-----------L---RQRQ----PGKY---FS---EQAVK-F-----------YVAEVLLALE 329 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~-----------l---l~~~----~~~~---l~---e~~~~-~-----------i~~qil~aL~ 329 (604)
+..++||+|++|..+.. . ++.. .... .. +.... . +...+...++
T Consensus 96 g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~ 175 (322)
T 2ppq_A 96 GRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEID 175 (322)
T ss_dssp TEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHH
T ss_pred CEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHH
Confidence 66789999998865310 0 1111 0000 11 11100 0 0112344555
Q ss_pred HHHH-------cCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 330 YLHM-------LGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 330 yLH~-------~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
+|+. .++||+|+++.|||++.++.+.|+||+.+
T Consensus 176 ~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a 215 (322)
T 2ppq_A 176 YLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFA 215 (322)
T ss_dssp HHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred HHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhc
Confidence 6653 47999999999999987665689999976
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00011 Score=74.88 Aligned_cols=132 Identities=12% Similarity=0.085 Sum_probs=74.4
Q ss_pred EEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCc-cccceeEecCCeeEEEEeec-
Q 007433 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFL-PTLYTHFETDKFSCLVMEFC- 295 (604)
Q Consensus 218 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-v~l~~~~~~~~~~~lV~E~~- 295 (604)
++.|+.|....+|+. ..+++|+...... ......+|..+++.+....+ ++++.++ ...-++|+||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~----~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTE----EYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCcc----ceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecC
Confidence 688999999999999 2488898865311 11112357777776632222 5666544 33346899999
Q ss_pred CCCCHHH---------------HH---HhcCC---CCCc-HHHHHHHHHH--------------HHHHHHHHH-------
Q 007433 296 PGGDLHT---------------LR---QRQPG---KYFS-EQAVKFYVAE--------------VLLALEYLH------- 332 (604)
Q Consensus 296 ~ggsL~~---------------ll---~~~~~---~~l~-e~~~~~i~~q--------------il~aL~yLH------- 332 (604)
+|..|.. .+ +..+. ..+. ...+..+... +...+..|.
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 6655421 01 11110 0011 1222222111 111222221
Q ss_pred -HcCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 333 -MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 333 -~~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
...++|+|+.+.||| ..++.+.|+||..+
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a 200 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYS 200 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTC
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccc
Confidence 124899999999999 56778999999976
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.46 E-value=0.00023 Score=76.63 Aligned_cols=75 Identities=19% Similarity=0.260 Sum_probs=50.2
Q ss_pred EEEEEccCCcEEEEEEEEcC-------CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEecCCee
Q 007433 217 LLKKLGCGDIGSVYLSELTG-------TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFETDKFS 288 (604)
Q Consensus 217 l~~~LG~G~fG~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~ 288 (604)
-++.|+.|-...||++.... .+..|.+|+...... . ..+.+|..+++.|. +...+++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~---~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--E---SHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--H---HHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--H---HHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 45778999999999998753 246789999843211 0 12235888888774 3334778776653
Q ss_pred EEEEeecCCCCH
Q 007433 289 CLVMEFCPGGDL 300 (604)
Q Consensus 289 ~lV~E~~~ggsL 300 (604)
.+||||++|..|
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 289999987443
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.41 E-value=0.00023 Score=75.43 Aligned_cols=138 Identities=16% Similarity=0.201 Sum_probs=83.0
Q ss_pred EEEEccCCcEEEEEEEEcC-------CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEecCCeeE
Q 007433 218 LKKLGCGDIGSVYLSELTG-------TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 218 ~~~LG~G~fG~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~ 289 (604)
++.|..|-...+|++.... .+..|.+|+..... .......+|..+++.|. +.-.+++++++.++
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~g---- 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPEG---- 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETTE----
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCCc----
Confidence 3567778888999998742 34678899864321 11223347888888773 33347788776542
Q ss_pred EEEeecCCCCHHH--------------HHH---hcC---CCCC--cHHHHHHHHHHHHH-------------------HH
Q 007433 290 LVMEFCPGGDLHT--------------LRQ---RQP---GKYF--SEQAVKFYVAEVLL-------------------AL 328 (604)
Q Consensus 290 lV~E~~~ggsL~~--------------ll~---~~~---~~~l--~e~~~~~i~~qil~-------------------aL 328 (604)
+||||++|..|.. .+. ... ++.. -+..+..+..++.. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 9999998865421 111 110 1112 24566666655422 23
Q ss_pred HHHHH--------cCeEeccCCCCcEEEccC----CcEEEecccccc
Q 007433 329 EYLHM--------LGIVYRDLKPENVLVRED----GHIMLSDFDLSL 363 (604)
Q Consensus 329 ~yLH~--------~gIvHrDIKpeNILl~~~----g~vkL~DFGla~ 363 (604)
+.|.. ..++|+|+.+.|||++.+ +.+.|+||..+.
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 44432 359999999999999876 789999999873
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.40 E-value=0.00042 Score=71.40 Aligned_cols=30 Identities=23% Similarity=0.346 Sum_probs=26.3
Q ss_pred cCeEeccCCCCcEEEccC----CcEEEecccccc
Q 007433 334 LGIVYRDLKPENVLVRED----GHIMLSDFDLSL 363 (604)
Q Consensus 334 ~gIvHrDIKpeNILl~~~----g~vkL~DFGla~ 363 (604)
..+||||+.+.|||++.+ +.+.|+||+.+.
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~ 216 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAK 216 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcC
Confidence 469999999999999874 689999999873
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00029 Score=73.85 Aligned_cols=76 Identities=17% Similarity=0.250 Sum_probs=45.5
Q ss_pred EEEEEccCCcEEEEEEEEcCC--------ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCC-ccccceeEecCCe
Q 007433 217 LLKKLGCGDIGSVYLSELTGT--------KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF-LPTLYTHFETDKF 287 (604)
Q Consensus 217 l~~~LG~G~fG~Vy~a~~~~~--------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~ 287 (604)
-++.|+.|....||+....+. +..+++|+...... .+.....|.++|+.|...+ ++++++.+.
T Consensus 37 ~~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~~~~E~~~l~~L~~~g~~P~~~~~~~---- 108 (369)
T 3c5i_A 37 RVKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD----ELYNTISEFEVYKTMSKYKIAPQLLNTFN---- 108 (369)
T ss_dssp EEEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG----GTSCHHHHHHHHHHHHHTTSSCCEEEEET----
T ss_pred EEEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc----ceecHHHHHHHHHHHHhcCCCCceEEecC----
Confidence 356788888899999987541 25788998764321 1111245778887774223 567776552
Q ss_pred eEEEEeecCCCCH
Q 007433 288 SCLVMEFCPGGDL 300 (604)
Q Consensus 288 ~~lV~E~~~ggsL 300 (604)
-++||||++|..|
T Consensus 109 ~~~v~e~i~G~~l 121 (369)
T 3c5i_A 109 GGRIEEWLYGDPL 121 (369)
T ss_dssp TEEEEECCCSEEC
T ss_pred CcEEEEEecCCcC
Confidence 2689999987543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.34 E-value=0.00049 Score=74.74 Aligned_cols=76 Identities=13% Similarity=0.191 Sum_probs=49.8
Q ss_pred EEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCC-ccccceeEecCCeeEEEEeec
Q 007433 217 LLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF-LPTLYTHFETDKFSCLVMEFC 295 (604)
Q Consensus 217 l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~~lV~E~~ 295 (604)
-++.|+.|-...+|++...+.+..|++|+...... .+....+|..+|+.|...+ .+++++++.. .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~----~~idR~~E~~vl~~L~~~gl~P~ll~~~~~----G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTD----EIINREREKKISCILYNKNIAKKIYVFFTN----GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CC----SCSCHHHHHHHHHHHTTSSSBCCEEEEETT----EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChh----hhcCHHHHHHHHHHHHhcCCCCCEEEEeCC----eEEEEee
Confidence 46788989999999998866456788998754310 0101136888888886444 4678877742 2599999
Q ss_pred CCCCH
Q 007433 296 PGGDL 300 (604)
Q Consensus 296 ~ggsL 300 (604)
+|..|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87544
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.31 E-value=0.00092 Score=68.40 Aligned_cols=136 Identities=15% Similarity=0.099 Sum_probs=75.8
Q ss_pred EEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCC--CCcccccee-----EecCCeeEEE
Q 007433 219 KKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH--PFLPTLYTH-----FETDKFSCLV 291 (604)
Q Consensus 219 ~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~-----~~~~~~~~lV 291 (604)
..|+ |....||+.... +++.+++|+.+...... ..+..|..+++.|.. -.+++++.. ...++..++|
T Consensus 32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~----~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTA----DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCH----HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCH----HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 888899987653 34468999986432111 133457777776632 124555543 2235567899
Q ss_pred EeecCCCCHH-----HH---------HHh----cCC---CCCcHHHH----------------------HHHHHHHHHHH
Q 007433 292 MEFCPGGDLH-----TL---------RQR----QPG---KYFSEQAV----------------------KFYVAEVLLAL 328 (604)
Q Consensus 292 ~E~~~ggsL~-----~l---------l~~----~~~---~~l~e~~~----------------------~~i~~qil~aL 328 (604)
|||++|..+. .+ ++. .+. ..+..... ...+.+++..+
T Consensus 106 ~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l 185 (328)
T 1zyl_A 106 FPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAV 185 (328)
T ss_dssp EECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHH
T ss_pred EEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHH
Confidence 9999875431 11 111 110 11111110 11112222222
Q ss_pred HHH----HHcCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 329 EYL----HMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 329 ~yL----H~~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
+-+ +...++|+|+++.|||++ + .+.|+||+.+
T Consensus 186 ~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a 221 (328)
T 1zyl_A 186 TAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDA 221 (328)
T ss_dssp HHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTC
T ss_pred HHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCC
Confidence 222 234589999999999998 4 8999999876
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0024 Score=64.35 Aligned_cols=79 Identities=15% Similarity=0.034 Sum_probs=53.7
Q ss_pred CeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCC---CCccccceeEecCCeeEE
Q 007433 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH---PFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 214 ~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~H---pnIv~l~~~~~~~~~~~l 290 (604)
...-++.+|.|..+.||+.+.. +|+.|.+|+-....... ...+..|...|+.|.- --+++++.+. ..++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred CeEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence 5667889999999999999875 45689999865432111 1134568888888742 2355666542 2478
Q ss_pred EEeecCCCCH
Q 007433 291 VMEFCPGGDL 300 (604)
Q Consensus 291 V~E~~~ggsL 300 (604)
||||++++..
T Consensus 88 v~e~l~~~~~ 97 (288)
T 3f7w_A 88 AMEWVDERPP 97 (288)
T ss_dssp EEECCCCCCC
T ss_pred EEEeecccCC
Confidence 9999987654
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0033 Score=61.01 Aligned_cols=59 Identities=14% Similarity=0.018 Sum_probs=45.0
Q ss_pred CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHH-HcCeEeccCCCCcEEEccCCcEEEe
Q 007433 298 GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH-MLGIVYRDLKPENVLVREDGHIMLS 357 (604)
Q Consensus 298 gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH-~~gIvHrDIKpeNILl~~~g~vkL~ 357 (604)
.+|.++++.+ +..|+|++++.++.|.+.+|.-+- ...-..+=+-|..|+|..+|.|.+.
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~ 92 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLA 92 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEEC
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceecc
Confidence 4789998877 478999999999999999987662 1122234445789999999988765
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.09 E-value=0.0032 Score=65.25 Aligned_cols=29 Identities=28% Similarity=0.418 Sum_probs=26.4
Q ss_pred cCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 334 LGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 334 ~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
..++|+|+.+.|||++.++.+.|+||+.+
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~ 234 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEP 234 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSC
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCC
Confidence 36999999999999998888999999876
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.33 E-value=0.017 Score=61.83 Aligned_cols=76 Identities=16% Similarity=0.301 Sum_probs=49.2
Q ss_pred EEEEEccCCcEEEEEEEEcCC-------ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEecCCee
Q 007433 217 LLKKLGCGDIGSVYLSELTGT-------KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFETDKFS 288 (604)
Q Consensus 217 l~~~LG~G~fG~Vy~a~~~~~-------~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~ 288 (604)
-++.|..|-...+|+...... +..|++|+..... ..+....+|..+++.|. +.-.+++++.+. -
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t----~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~ 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV----GKFYDSKVELDVFRYLSNINIAPNIIADFP----E 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----T
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc----chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----C
Confidence 456777888899999987531 4578899875431 11111235778887773 333567776443 2
Q ss_pred EEEEeecCCCCH
Q 007433 289 CLVMEFCPGGDL 300 (604)
Q Consensus 289 ~lV~E~~~ggsL 300 (604)
++||||++|..|
T Consensus 146 ~~I~efI~G~~l 157 (424)
T 3mes_A 146 GRIEEFIDGEPL 157 (424)
T ss_dssp EEEEECCCSEEC
T ss_pred CEEEEEeCCccC
Confidence 689999988653
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.11 E-value=0.073 Score=56.27 Aligned_cols=28 Identities=32% Similarity=0.483 Sum_probs=24.2
Q ss_pred eEeccCCCCcEEEc------cCCcEEEecccccc
Q 007433 336 IVYRDLKPENVLVR------EDGHIMLSDFDLSL 363 (604)
Q Consensus 336 IvHrDIKpeNILl~------~~g~vkL~DFGla~ 363 (604)
++|+|+.+.|||+. +++.+.++||..|.
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 78999999999993 45679999999873
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=87.78 E-value=1.1 Score=43.26 Aligned_cols=84 Identities=13% Similarity=0.109 Sum_probs=59.0
Q ss_pred CCCCccccceeEecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc
Q 007433 271 DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE 350 (604)
Q Consensus 271 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~ 350 (604)
.||+++.. .+-++++.+.+.++.-. +...+-.- ..++.....+++.+|+....+++ .=+|--|.|+||+++.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~--~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~ 114 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDIND--NHTPFDNI---KSFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTR 114 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCT--TSEEGGGG---GGSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECT
T ss_pred cCCcccce-EEEEcccEEEEEEEcCc--ccCCHHHH---HhcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcC
Confidence 67888866 45566676666666543 22222221 24678888888988888774443 3478889999999999
Q ss_pred CCcEEEeccccc
Q 007433 351 DGHIMLSDFDLS 362 (604)
Q Consensus 351 ~g~vkL~DFGla 362 (604)
++.+++.-.|+-
T Consensus 115 ~~~p~i~~RGik 126 (215)
T 4ann_A 115 DGLPIAKTRGLQ 126 (215)
T ss_dssp TSCEEESCCEET
T ss_pred CCCEEEEEccCc
Confidence 999999988853
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=84.30 E-value=1.8 Score=41.75 Aligned_cols=83 Identities=6% Similarity=-0.093 Sum_probs=57.7
Q ss_pred CCCCccccceeEecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHH-HHHHcCeEeccCCCCcEEEc
Q 007433 271 DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALE-YLHMLGIVYRDLKPENVLVR 349 (604)
Q Consensus 271 ~HpnIv~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~-yLH~~gIvHrDIKpeNILl~ 349 (604)
.||++ -...-.+++.+.+.++.-+++.=...++ .++.....+++.+|+.... ++ ..-+|--|.|+||+++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~ 118 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFN 118 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEEC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEe
Confidence 67777 3334466777766666643332222332 3678888888888877555 44 4457888999999999
Q ss_pred cCCcEEEeccccc
Q 007433 350 EDGHIMLSDFDLS 362 (604)
Q Consensus 350 ~~g~vkL~DFGla 362 (604)
.++.++|.-.|+-
T Consensus 119 ~~~~p~i~hRGi~ 131 (219)
T 4ano_A 119 RALEPFFLHVGVK 131 (219)
T ss_dssp TTCCEEESCCEET
T ss_pred CCCcEEEEEcCCc
Confidence 9999999999975
|
| >2x6h_A GH13170P, VPS34, phosphotidylinositol 3 kinase 59F; transferase; 2.90A {Drosophila melanogaster} PDB: 2x6f_A 2x6i_A* 2x6j_A* 2x6k_A* | Back alignment and structure |
|---|
Probab=83.29 E-value=14 Score=41.60 Aligned_cols=83 Identities=20% Similarity=0.362 Sum_probs=50.5
Q ss_pred cccceeEecCCeeEEEEeecCCCCHHHHHHhcC-----------C--CCC--cHHHHHHHHHHHHH--HHHHHHHcCeEe
Q 007433 276 PTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQP-----------G--KYF--SEQAVKFYVAEVLL--ALEYLHMLGIVY 338 (604)
Q Consensus 276 v~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~~-----------~--~~l--~e~~~~~i~~qil~--aL~yLH~~gIvH 338 (604)
++.|.+.-...... +.|+++..+|.+++.... . ..+ .......|++.++- -+.|+ .||
T Consensus 476 i~~Y~Vipls~~~G-LIE~V~s~tl~~i~~~~~~l~~~f~~~~p~~~~~~~~~~~ar~nF~~SlA~~Svv~YI--LGl-- 550 (696)
T 2x6h_A 476 LTPYKVLATSSKHG-FLQYVDSCTVAEVLAREGNIHNFFRKHHPCDNGPYGISAEVMDTYIKSCAGYCVITYL--LGV-- 550 (696)
T ss_dssp CCCCCEEESSTTCE-EEECCCCEEHHHHHHHSSSHHHHHHHHSBCTTSSSSBCHHHHHHHHHHHHHHHHHHHH--HTC--
T ss_pred EeccEEEeccCCCC-eeeeCCCccHHHHHHhcChHHHHHHHHCCCccchhhhHHHHHHHHHHHHHHHHHHHHH--ccC--
Confidence 44555555544443 357777667766655431 1 011 22344555555542 23344 333
Q ss_pred ccCCCCcEEEccCCcEEEecccccc
Q 007433 339 RDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 339 rDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
+|-+++||||+.+|++.-+|||...
T Consensus 551 GDRH~~NILid~tG~v~HIDFG~~f 575 (696)
T 2x6h_A 551 GDRHLDNLLLTTNGKLFHIDFGYIL 575 (696)
T ss_dssp CCCCTTTEEECTTSCEEECCCCSCT
T ss_pred CCCCCcceEEeCCCCEEEEeehhhh
Confidence 6999999999999999999999873
|
| >3ls8_A Phosphatidylinositol 3-kinase catalytic subunit type 3; alpha/beta protein, PIK3C3, compound 15E, structural genomics, SGC stockholm; HET: AJZ; 2.25A {Homo sapiens} PDB: 3ihy_A | Back alignment and structure |
|---|
Probab=80.12 E-value=35 Score=37.85 Aligned_cols=83 Identities=23% Similarity=0.378 Sum_probs=52.0
Q ss_pred cccceeEecCCeeEEEEeecCCCCHHHHHHhc-----------CCC----CCcHHHHHHHHHHHHH--HHHHHHHcCeEe
Q 007433 276 PTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQ-----------PGK----YFSEQAVKFYVAEVLL--ALEYLHMLGIVY 338 (604)
Q Consensus 276 v~l~~~~~~~~~~~lV~E~~~ggsL~~ll~~~-----------~~~----~l~e~~~~~i~~qil~--aL~yLH~~gIvH 338 (604)
++.|.+.-...... ++|++++.++.+++... +.. ...+.....|++.++- -+.|+ .||
T Consensus 402 i~~Y~Vipls~~~G-lIE~V~~~tl~~il~~~~~l~~~f~~~~~~~~~~~~~~~~a~~nF~~S~A~ySvv~YI--LGi-- 476 (614)
T 3ls8_A 402 LTPYKVLATSTKHG-FMQFIQSVPVAEVLDTEGSIQNFFRKYAPSENGPNGISAEVMDTYVKSCAGYCVITYI--LGV-- 476 (614)
T ss_dssp CCCCCEEESSSSEE-EEECCCCEEHHHHHHHTSSHHHHHHHHSBCTTSGGGBCHHHHHHHHHHHHHHHHHHHH--HTC--
T ss_pred eeccEEEEecCCCc-eEEEeCCccHHHHHHccChHHHHHHHhCCCccccccccHHHHHHHHHHHHHHhHhhee--eec--
Confidence 55666666655543 46788776666554321 111 1124455666665543 33444 343
Q ss_pred ccCCCCcEEEccCCcEEEecccccc
Q 007433 339 RDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 339 rDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
+|=+++||||+.+|++.=+|||...
T Consensus 477 gDRH~~NILld~tG~v~HIDFG~~f 501 (614)
T 3ls8_A 477 GDRHLDNLLLTKTGKLFHIDFGYIL 501 (614)
T ss_dssp CCCCTTSEEECTTSCEEECCCSSCT
T ss_pred cCCCCcceeEcCCCCEeeeehHHhh
Confidence 6889999999999999999999873
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 604 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-45 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 5e-24 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-45 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 5e-43 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-35 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-42 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-28 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 4e-42 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-22 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 5e-42 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-26 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 3e-41 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-23 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-40 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 9e-28 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-40 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-25 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 7e-40 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-39 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-22 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-39 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-39 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 3e-26 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 5e-39 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-24 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-38 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 3e-28 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 3e-38 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-38 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 9e-18 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 6e-38 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-38 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-37 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-31 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-37 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-21 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-36 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 7e-27 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-36 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-33 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 4e-36 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-36 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-36 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-16 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 5e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 8e-28 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-36 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 2e-15 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-36 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-35 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 5e-17 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-35 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-13 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-35 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-32 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-35 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-15 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-35 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-17 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-35 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 4e-15 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-35 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-23 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-35 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-34 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-21 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-34 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-26 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-34 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-16 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 4e-33 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-19 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-33 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-18 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-33 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 9e-18 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-33 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 4e-12 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-32 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-16 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-31 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 3e-30 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-31 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-23 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 2e-31 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 5e-12 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 4e-31 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 6e-31 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 7e-14 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-30 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-15 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-30 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-15 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 1e-29 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 9e-16 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 6e-29 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-29 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-13 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-28 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 8e-15 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-28 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-08 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-27 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 8e-15 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 3e-27 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-14 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-26 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 8e-16 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-16 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 2e-45
Identities = 48/149 (32%), Positives = 76/149 (51%), Gaps = 4/149 (2%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+ ++ +LG G G VY ++ T A KV+D S E+ + + E +IL S DHP
Sbjct: 13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMV---EIDILASCDHP 69
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
+ L F + +++EFC GG + + + +E ++ + L AL YLH
Sbjct: 70 NIVKLLDAFYYENNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHD 128
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLS 362
I++RDLK N+L DG I L+DF +S
Sbjct: 129 NKIIHRDLKAGNILFTLDGDIKLADFGVS 157
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 5e-24
Identities = 31/125 (24%), Positives = 50/125 (40%), Gaps = 10/125 (8%)
Query: 442 EPTNARSMSFVGTHEYLAPEII-----KGEGHGSAVDWWTFGIFLYELLFGKTPFKGSEN 496
T R SF+GT ++APE++ K + D W+ GI L E+ + P
Sbjct: 161 TRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 220
Query: 497 RATLYNVV-GQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555
L + +P + S + +D +K L K R +++ QHPF +
Sbjct: 221 MRVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARW----TTSQLLQHPFVTVDS 276
Query: 556 WALIR 560
IR
Sbjct: 277 NKPIR 281
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 161 bits (407), Expect = 3e-45
Identities = 74/348 (21%), Positives = 127/348 (36%), Gaps = 61/348 (17%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DH 272
++L++KLG G V+ + +K++ K+KK+ R E +IL++L
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKR---EIKILENLRGG 89
Query: 273 PFLPTLYTHFE--TDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEY 330
P + TL + + LV E D L Q ++ ++FY+ E+L AL+Y
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDY 144
Query: 331 LHMLGIVYRDLKPENVLV-REDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYC 389
H +GI++RD+KP NV++ E + L D+ L+ P ++ V
Sbjct: 145 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--------------HPGQEYNVRV 190
Query: 390 VQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449
P + + + + L ++A +
Sbjct: 191 ASRYFKGPELLVDYQMYDYSL---------------------DMWSLGCMLASMIFRKEP 229
Query: 450 SFVGTHEYLAPE-IIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPL 508
F G Y I K G D+ + F + S R + +
Sbjct: 230 FFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWE------RFV 283
Query: 509 RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNW 556
+VS A D + LL + Q+RL A E +HP+F V
Sbjct: 284 HSENQHLVSPEALDFLDKLLRYDHQSRL----TAREAMEHPYFYTVVK 327
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 5e-43
Identities = 54/168 (32%), Positives = 89/168 (52%), Gaps = 2/168 (1%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
F+ K LG G +V L+ T +A+K+++K + K K+ ER+++ LDHP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
F LY F+ D+ + + G+L ++ F E +FY AE++ ALEYLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHG 126
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEP 381
GI++RDLKPEN+L+ ED HI ++DF + + ++++
Sbjct: 127 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 174
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-35
Identities = 42/129 (32%), Positives = 65/129 (50%), Gaps = 4/129 (3%)
Query: 442 EPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY 501
E AR+ SFVGT +Y++PE++ + + D W G +Y+L+ G PF+
Sbjct: 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ 220
Query: 502 NVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACR--RGATEIKQHPFFQGVNWALI 559
++ FPE ARDL++ LLV + RL C G +K HPFF+ V W +
Sbjct: 221 KIIKLEYDFPEK--FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 278
Query: 560 RCASPPEIP 568
+PP++
Sbjct: 279 HQQTPPKLT 287
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 1e-42
Identities = 54/165 (32%), Positives = 84/165 (50%), Gaps = 2/165 (1%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
F + + LG G G+VYL+ +K A+KV+ KA LEK + + E EI L HP
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
+ LY +F L++E+ P G ++ Q+ F EQ Y+ E+ AL Y H
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHS 124
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLE 378
+++RD+KPEN+L+ G + ++DF S+ S TL+
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLD 169
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 2e-28
Identities = 37/115 (32%), Positives = 54/115 (46%), Gaps = 6/115 (5%)
Query: 439 LIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRA 498
++R + GT +YL PE+I+G H VD W+ G+ YE L GK PF+ + +
Sbjct: 152 WSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 211
Query: 499 TLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553
T + FP+ V+ ARDLI LL P R E+ +HP+
Sbjct: 212 TYKRISRVEFTFPDF--VTEGARDLISRLLKHNPSQRP----MLREVLEHPWITA 260
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 4e-42
Identities = 39/150 (26%), Positives = 65/150 (43%), Gaps = 5/150 (3%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
F + +LG G+ G V+ + A K++ + + E ++L + P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN--QIIRELQVLHECNSP 64
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH- 332
++ Y F +D + ME GG L + ++ EQ + V+ L YL
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLRE 122
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
I++RD+KP N+LV G I L DF +S
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVS 152
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.1 bits (236), Expect = 5e-22
Identities = 29/155 (18%), Positives = 52/155 (33%), Gaps = 46/155 (29%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR------ 497
++ + SFVGT Y++PE ++G + D W+ G+ L E+ G+ P + +
Sbjct: 156 IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 215
Query: 498 ------------------------------------ATLYNVVGQPLRFPESPVVSFSAR 521
L +V +P S V S +
Sbjct: 216 GCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 275
Query: 522 DLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNW 556
D + L+K P R ++ H F + +
Sbjct: 276 DFVNKCLIKNPAERA----DLKQLMVHAFIKRSDA 306
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 152 bits (386), Expect = 5e-42
Identities = 46/169 (27%), Positives = 77/169 (45%), Gaps = 7/169 (4%)
Query: 196 QWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRK 255
+ Q V VK G + ++ +L++LG G G V+ T F K ++ +
Sbjct: 13 KKYVPQPVEVKQGSV-YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKY 71
Query: 256 KLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQ 315
+ E I+ L HP L L+ FE L++EF GG+L + K SE
Sbjct: 72 TVKN---EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYK-MSEA 127
Query: 316 AVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVR--EDGHIMLSDFDLS 362
V Y+ + L+++H IV+ D+KPEN++ + + + DF L+
Sbjct: 128 EVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA 176
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 107 bits (269), Expect = 4e-26
Identities = 43/149 (28%), Positives = 60/149 (40%), Gaps = 6/149 (4%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNV 503
+ T E+ APEI+ E G D W G+ Y LL G +PF G ++ TL NV
Sbjct: 181 PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV 240
Query: 504 VGQPLRFPES--PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRC 561
F E VS A+D IK LL KEP+ RL + +HP+ +G + L
Sbjct: 241 KRCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL----TVHDALEHPWLKGDHSNLTSR 296
Query: 562 ASPPEIPKPVEIVHSPAPALSTKAKAVAA 590
K + + A+
Sbjct: 297 IPSSRYNKIRQKIKEKYADWPAPQPAIGR 325
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 149 bits (378), Expect = 3e-41
Identities = 43/159 (27%), Positives = 68/159 (42%), Gaps = 2/159 (1%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
F L+++G G G+VY + A+K M + + +K E LQ L HP
Sbjct: 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
+ + + LVME+C G L + K E + L L YLH
Sbjct: 76 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHS 133
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372
+++RD+K N+L+ E G + L DF + A + + V
Sbjct: 134 HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV 172
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 98.9 bits (246), Expect = 2e-23
Identities = 31/109 (28%), Positives = 46/109 (42%), Gaps = 7/109 (6%)
Query: 447 RSMSFVGTHEYLAPEIIKGEGHG---SAVDWWTFGIFLYELLFGKTPFKGSENRATLYNV 503
+ SFVGT ++APE+I G VD W+ GI EL K P + LY++
Sbjct: 167 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI 226
Query: 504 VGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
+S S R+ + L K PQ+R + + +H F
Sbjct: 227 AQNESPALQSGHWSEYFRNFVDSCLQKIPQDRP----TSEVLLKHRFVL 271
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 149 bits (376), Expect = 1e-40
Identities = 42/151 (27%), Positives = 69/151 (45%), Gaps = 6/151 (3%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
H+ + ++LG G G V+ T FA K + ++ + + E + + L HP
Sbjct: 27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVLRHP 83
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
L L+ FE D ++ EF GG+L + K SE Y+ +V L ++H
Sbjct: 84 TLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCHMHE 142
Query: 334 LGIVYRDLKPENVLV--REDGHIMLSDFDLS 362
V+ DLKPEN++ + + L DF L+
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLT 173
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 112 bits (281), Expect = 9e-28
Identities = 34/128 (26%), Positives = 53/128 (41%), Gaps = 6/128 (4%)
Query: 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ 506
GT E+ APE+ +G+ G D W+ G+ Y LL G +PF G + TL NV
Sbjct: 181 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC 240
Query: 507 PLRFPES--PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASP 564
+S +S +D I+ LL+ +P R+ + +HP+ N P
Sbjct: 241 DWNMDDSAFSGISEDGKDFIRKLLLADPNTRM----TIHQALEHPWLTPGNAPGRDSQIP 296
Query: 565 PEIPKPVE 572
+
Sbjct: 297 SSRYTKIR 304
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (368), Expect = 3e-40
Identities = 42/151 (27%), Positives = 74/151 (49%), Gaps = 4/151 (2%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD 271
V + L++ LG G G V L+ T+ A+K++D + + E I + L+
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE--NIKKEICINKMLN 61
Query: 272 HPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
H + Y H L +E+C GG+L + E + + +++ + YL
Sbjct: 62 HENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYL 119
Query: 332 HMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
H +GI +RD+KPEN+L+ E ++ +SDF L+
Sbjct: 120 HGIGITHRDIKPENLLLDERDNLKISDFGLA 150
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (256), Expect = 5e-25
Identities = 25/116 (21%), Positives = 45/116 (38%), Gaps = 6/116 (5%)
Query: 439 LIAEPTNARSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSENR 497
GT Y+APE++K H VD W+ GI L +L G+ P+ +
Sbjct: 153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 212
Query: 498 ATLY-NVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
Y + + + + L+ +LV+ P R+ +IK+ ++
Sbjct: 213 CQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI----TIPDIKKDRWYN 264
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 7e-40
Identities = 69/358 (19%), Positives = 112/358 (31%), Gaps = 65/358 (18%)
Query: 217 LLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTERE--ILQSLDHPF 274
L LG G +VY + T A+K + + K + RE +LQ L HP
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ L F LV +F ++ + +K Y+ L LEYLH
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPAC 394
I++RDLKP N+L+ E+G + L+DF L+ P R V
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSF-------------GSPNRAYTHQVVTRWY 166
Query: 395 IEPSCIQPSCIAPTTC--FSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452
P + + + ++ E+ +V LP
Sbjct: 167 RAPELLFGARMYGVGVDMWAVGCI---------LAELLLRVPFLPG-------------- 203
Query: 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE 512
+ I + G + W + F P +
Sbjct: 204 DSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHI--------------- 248
Query: 513 SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEIPKP 570
DLI+GL + P R+ AT+ + +F ++P+P
Sbjct: 249 FSAAGDDLLDLIQGLFLFNPCARI----TATQALKMKYFSNRPGP----TPGCQLPRP 298
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (363), Expect = 1e-39
Identities = 42/169 (24%), Positives = 75/169 (44%), Gaps = 10/169 (5%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
+ +L +G G G K +D S+ + +K +E +L+ L HP
Sbjct: 6 YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQ-MLVSEVNLLRELKHPN 64
Query: 275 LPTLYTHF--ETDKFSCLVMEFCPGGDLHTL--RQRQPGKYFSEQAVKFYVAEVLLALEY 330
+ Y T+ +VME+C GGDL ++ + + +Y E+ V + ++ LAL+
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 331 LHMLG-----IVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKS 374
H +++RDLKP NV + ++ L DF L+ + K+
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.7 bits (235), Expect = 3e-22
Identities = 27/112 (24%), Positives = 45/112 (40%), Gaps = 7/112 (6%)
Query: 440 IAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRAT 499
I + + +FVGT Y++PE + + D W+ G LYEL PF +
Sbjct: 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL 222
Query: 500 LYNVV-GQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPF 550
+ G+ R P S ++I +L + +R EI ++P
Sbjct: 223 AGKIREGKFRRIPYR--YSDELNEIITRMLNLKDYHRP----SVEEILENPL 268
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 2e-39
Identities = 68/339 (20%), Positives = 116/339 (34%), Gaps = 56/339 (16%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
+ L+K+G G G+V+ ++ T A+K + ++ A E +L+ L H
Sbjct: 4 YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPS-SALREICLLKELKHKN 62
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ L+ +DK LV EFC + VK ++ ++L L + H
Sbjct: 63 IVRLHDVLHSDKKLTLVFEFCDQDLKKY--FDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPAC 394
+++RDLKP+N+L+ +G + L++F L+ +
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR------------------------ 156
Query: 395 IEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGT 454
S T + P K +M + EL NA F G
Sbjct: 157 ------CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELA----NAGRPLFPGN 206
Query: 455 HEY-LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPES 513
I + G + W + + P S
Sbjct: 207 DVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNV--------------V 252
Query: 514 PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
P ++ + RDL++ LL P R+ A E QHP+F
Sbjct: 253 PKLNATGRDLLQNLLKCNPVQRI----SAEEALQHPYFS 287
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 4e-39
Identities = 36/150 (24%), Positives = 68/150 (45%), Gaps = 6/150 (4%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH 272
+ +K+G G G+VY + T A++ M+ K++ ++ E +++ +
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN---EILVMRENKN 76
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
P + + +VME+ GG L + E + E L ALE+LH
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC---MDEGQIAAVCRECLQALEFLH 133
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+++RD+K +N+L+ DG + L+DF
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (266), Expect = 3e-26
Identities = 28/112 (25%), Positives = 49/112 (43%), Gaps = 5/112 (4%)
Query: 442 EPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY 501
P ++ + VGT ++APE++ + +G VD W+ GI E++ G+ P+ LY
Sbjct: 167 TPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY 226
Query: 502 NVV-GQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
+ +S RD + L + + R A E+ QH F +
Sbjct: 227 LIATNGTPELQNPEKLSAIFRDFLNRCLDMDVEKRG----SAKELLQHQFLK 274
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 142 bits (359), Expect = 5e-39
Identities = 44/156 (28%), Positives = 73/156 (46%), Gaps = 9/156 (5%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASL------EKRKKLLRAQTEREIL 267
++ + LG G V T +A+K++D E ++ E +IL
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 268 QSL-DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLL 326
+ + HP + L +ET+ F LV + G+L + SE+ + + +L
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLE 121
Query: 327 ALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ LH L IV+RDLKPEN+L+ +D +I L+DF S
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 157
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 101 bits (252), Expect = 2e-24
Identities = 40/117 (34%), Positives = 54/117 (46%), Gaps = 12/117 (10%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGE------GHGSAVDWWTFGIFLYELLFGKTPFKGSENR 497
+ GT YLAPEII+ G+G VD W+ G+ +Y LL G PF +
Sbjct: 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 221
Query: 498 ATLYNVVGQPLRF--PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
L ++ +F PE S + +DL+ LV +PQ R A E HPFFQ
Sbjct: 222 LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY----TAEEALAHPFFQ 274
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 1e-38
Identities = 64/363 (17%), Positives = 114/363 (31%), Gaps = 68/363 (18%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
+ K +G G G VY ++L + A+K + + K + E +I++ LDH
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNR-------ELQIMRKLDHCN 74
Query: 275 LPTLYTHFET------DKFSCLVMEFCPGGDLHTLRQR-QPGKYFSEQAVKFYVAEVLLA 327
+ L F + + + LV+++ P R + + VK Y+ ++ +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 328 LEYLHMLGIVYRDLKPENVLVREDGHIM-LSDFDLSLRCAVSPTVVKSSTLESEPLRKNP 386
L Y+H GI +RD+KP+N+L+ D ++ L DF +
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA------------------------ 170
Query: 387 VYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446
+ + S + + V ++AE
Sbjct: 171 -----------KQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLG 219
Query: 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ 506
+ + + EIIK G + E F +
Sbjct: 220 QPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIK--------------AH 265
Query: 507 PLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPE 566
P P A L LL P RL E H FF + ++ + +
Sbjct: 266 PWTKVFRPRTPPEAIALCSRLLEYTPTARL----TPLEACAHSFFDELRDPNVKLPNGRD 321
Query: 567 IPK 569
P
Sbjct: 322 TPA 324
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 143 bits (362), Expect = 2e-38
Identities = 52/156 (33%), Positives = 83/156 (53%), Gaps = 5/156 (3%)
Query: 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTERE---I 266
L + F + + +G G G VY T +AMK +DK ++ ++ A ER +
Sbjct: 1 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSL 60
Query: 267 LQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLL 326
+ + D PF+ + F T +++ GGDLH + FSE ++FY AE++L
Sbjct: 61 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIIL 118
Query: 327 ALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
LE++H +VYRDLKP N+L+ E GH+ +SD L+
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLA 154
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 114 bits (285), Expect = 3e-28
Identities = 49/161 (30%), Positives = 86/161 (53%), Gaps = 13/161 (8%)
Query: 424 KPKNEMGNQVSPLP----ELIAEPTNARSMSFVGTHEYLAPEII-KGEGHGSAVDWWTFG 478
KP N + ++ + L + + + + VGTH Y+APE++ KG + S+ DW++ G
Sbjct: 134 KPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLG 193
Query: 479 IFLYELLFGKTPFKGSENRATLY---NVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNR 535
L++LL G +PF+ + + + + P+S S R L++GLL ++ R
Sbjct: 194 CMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS--FSPELRSLLEGLLQRDVNRR 251
Query: 536 LAC-RRGATEIKQHPFFQGVNWALI--RCASPPEIPKPVEI 573
L C RGA E+K+ PFF+ ++W ++ + PP IP E+
Sbjct: 252 LGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEV 292
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-38
Identities = 57/345 (16%), Positives = 106/345 (30%), Gaps = 58/345 (16%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH 272
+ L +G G G V + K A+K + + + R E +IL H
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQ--RTLREIKILLRFRH 65
Query: 273 PFLPTLYTHFETDKFS----CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLAL 328
+ + ++ G DL+ L + Q S + +++ ++L L
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH---LSNDHICYFLYQILRGL 122
Query: 329 EYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVY 388
+Y+H +++RDLKP N+L+ + + DF L+ + + + + Y
Sbjct: 123 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA----------RVADPDHDHTGFLTEY 172
Query: 389 CVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448
P + S ++ + L E++ +
Sbjct: 173 VATRWYRAPEIMLNSKGYT-----------------KSIDIWSVGCILAEML-----SNR 210
Query: 449 MSFVGTHEY-LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP 507
F G H I+ G S D P K L+
Sbjct: 211 PIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF------ 264
Query: 508 LRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
P A DL+ +L P R+ + HP+ +
Sbjct: 265 ------PNADSKALDLLDKMLTFNPHKRI----EVEQALAHPYLE 299
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 3e-38
Identities = 35/165 (21%), Positives = 70/165 (42%), Gaps = 6/165 (3%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH 272
G + +++G G G+VY + G A+K+++ + ++L + E +L+ H
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRH 63
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
+ + T +V ++C G L+ K F + + ++YLH
Sbjct: 64 VNILLFM-GYSTAPQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGMDYLH 121
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTL 377
I++RDLK N+ + ED + + DF L+ + + L
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQL 166
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.6 bits (201), Expect = 9e-18
Identities = 25/112 (22%), Positives = 46/112 (41%), Gaps = 11/112 (9%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHG---SAVDWWTFGIFLYELLFGKTPFKGSENRATL 500
+ + G+ ++APE+I+ + D + FGI LYEL+ G+ P+ NR +
Sbjct: 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI 218
Query: 501 YNVVGQPLRFPE----SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548
+VG+ P+ + + L+ L K+ R +I
Sbjct: 219 IFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPL----FPQILAS 266
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 6e-38
Identities = 66/373 (17%), Positives = 124/373 (33%), Gaps = 54/373 (14%)
Query: 203 VRVKDGVLGV-GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQ 261
V V D V ++ LK +G G G V + A+K + + + + RA
Sbjct: 6 VEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAY 64
Query: 262 TEREILQSLDHPFLPTLYTHFETDKFS------CLVMEFCPGGDLHTLRQRQPGKYFSEQ 315
E +++ ++H + +L F K LVME ++ +
Sbjct: 65 RELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELD-----HE 119
Query: 316 AVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSS 375
+ + + ++L +++LH GI++RDLKP N++V+ D + + DF L+ S +
Sbjct: 120 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP-- 177
Query: 376 TLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSP 435
Y V P I K ++ +
Sbjct: 178 ------------YVVTRYYRAPEVIL------------------GMGYKENVDIWSVGCI 207
Query: 436 LPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE 495
+ E++ + F G + + ++ P
Sbjct: 208 MGEMV-----RHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGL 262
Query: 496 NRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555
L+ P + + + ARDL+ +LV +P R+ + QHP+
Sbjct: 263 TFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI----SVDDALQHPYINVWY 318
Query: 556 WALIRCASPPEIP 568
A PP+I
Sbjct: 319 DPAEVEAPPPQIY 331
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 6e-38
Identities = 67/349 (19%), Positives = 109/349 (31%), Gaps = 56/349 (16%)
Query: 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD 271
V + L K+G G G V+ + T A+K + + EK + A E +ILQ L
Sbjct: 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLK 67
Query: 272 HPFLPTLYTHFETDKFS--------CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAE 323
H + L T LV +FC L SE +K +
Sbjct: 68 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVMQM 125
Query: 324 VLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLR 383
+L L Y+H I++RD+K NVL+ DG + L+DF L+
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA--------------------- 164
Query: 384 KNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEP 443
+ + + + + ++AE
Sbjct: 165 ---------RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEM 215
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNV 503
+ T ++ I + G + W + + + + L
Sbjct: 216 WTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAY 275
Query: 504 VGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
V P A DLI LLV +P R+ + + H FF
Sbjct: 276 VRDP-----------YALDLIDKLLVLDPAQRI----DSDDALNHDFFW 309
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 139 bits (350), Expect = 2e-37
Identities = 56/149 (37%), Positives = 89/149 (59%), Gaps = 2/149 (1%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
F++L+ LG G G V+L Y+AMKV+ K + + K++ ER +L + HP
Sbjct: 5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 64
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
F+ ++ F+ + ++M++ GG+L +L ++ F KFY AEV LALEYLH
Sbjct: 65 FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ--RFPNPVAKFYAAEVCLALEYLHS 122
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLS 362
I+YRDLKPEN+L+ ++GHI ++DF +
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFA 151
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 122 bits (306), Expect = 2e-31
Identities = 43/132 (32%), Positives = 70/132 (53%), Gaps = 5/132 (3%)
Query: 441 AEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATL 500
A+ + + GT +Y+APE++ + + ++DWW+FGI +YE+L G TPF S T
Sbjct: 151 AKYVPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY 210
Query: 501 YNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRR-GATEIKQHPFFQGVNWA-- 557
++ LRFP P + +DL+ L+ ++ RL + G ++K HP+F+ V W
Sbjct: 211 EKILNAELRFP--PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 268
Query: 558 LIRCASPPEIPK 569
L R P P
Sbjct: 269 LSRNIETPYEPP 280
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 136 bits (344), Expect = 5e-37
Identities = 38/168 (22%), Positives = 72/168 (42%), Gaps = 6/168 (3%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH 272
+ L + LG G + V+L+ A+KV+ LR + E + +L+H
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNH 66
Query: 273 PFLPTLYTHFETD----KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLAL 328
P + +Y E + +VME+ G L + + + + +A+ AL
Sbjct: 67 PAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQAL 124
Query: 329 EYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSST 376
+ H GI++RD+KP N+++ + + DF ++ A S V +
Sbjct: 125 NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 172
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 90.6 bits (224), Expect = 8e-21
Identities = 28/106 (26%), Positives = 51/106 (48%), Gaps = 5/106 (4%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNV 503
+ ++ + +GT +YL+PE +G+ + D ++ G LYE+L G+ PF G + Y
Sbjct: 167 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQH 226
Query: 504 VGQPLRFPES--PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547
V + P + +S ++ L K P+NR A E++
Sbjct: 227 VREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQT---AAEMRA 269
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 136 bits (344), Expect = 1e-36
Identities = 51/152 (33%), Positives = 80/152 (52%), Gaps = 7/152 (4%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+ LG G V L+E T+ A+K + K +LE ++ + E +L + HP
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEG--SMENEIAVLHKIKHP 67
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
+ L +E+ L+M+ GG+L + +++E+ + +VL A++YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHD 125
Query: 334 LGIVYRDLKPENVLVR---EDGHIMLSDFDLS 362
LGIV+RDLKPEN+L ED IM+SDF LS
Sbjct: 126 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLS 157
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 108 bits (272), Expect = 7e-27
Identities = 33/117 (28%), Positives = 53/117 (45%), Gaps = 6/117 (5%)
Query: 442 EPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY 501
E + + GT Y+APE++ + + AVD W+ G+ Y LL G PF +
Sbjct: 160 EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFE 219
Query: 502 NVVGQPLRF--PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNW 556
++ F P +S SA+D I+ L+ K+P+ R + QHP+ G
Sbjct: 220 QILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF----TCEQALQHPWIAGDTA 272
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 2e-36
Identities = 69/343 (20%), Positives = 113/343 (32%), Gaps = 56/343 (16%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+F+ ++K+G G G VY + T A+K + + E A E +L+ L+HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHP 61
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
+ L T+ LV EF + K Y+ ++L L + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLI-KSYLFQLLQGLAFCHS 120
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPA 393
+++RDLKP+N+L+ +G I L+DF L+ P+R V
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF-------------GVPVRTYTHEVVTLW 167
Query: 394 CIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVG 453
P + K ++ + E++ R F G
Sbjct: 168 YRAPEILL-----------------GCKYYSTAVDIWSLGCIFAEMV-----TRRALFPG 205
Query: 454 THEY-LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE 512
E I + G V W + + + Q
Sbjct: 206 DSEIDQLFRIFRTLGTPDEVVW-------------PGVTSMPDYKPSFPKWARQDFS-KV 251
Query: 513 SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555
P + R L+ +L +P R+ A HPFFQ V
Sbjct: 252 VPPLDEDGRSLLSQMLHYDPNKRI----SAKAALAHPFFQDVT 290
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 2e-36
Identities = 56/149 (37%), Positives = 83/149 (55%), Gaps = 3/149 (2%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQ-SLDHP 273
F L K LG G G V+L+E T +FA+K + K + + E+ +L + +HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
FL ++ F+T + VME+ GGDL Q F FY AE++L L++LH
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATFYAAEIILGLQFLHS 121
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLS 362
GIVYRDLK +N+L+ +DGHI ++DF +
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMC 150
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 3e-33
Identities = 53/173 (30%), Positives = 90/173 (52%), Gaps = 17/173 (9%)
Query: 442 EPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY 501
+A++ +F GT +Y+APEI+ G+ + +VDWW+FG+ LYE+L G++PF G + +
Sbjct: 154 MLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH 213
Query: 502 NVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALI-- 559
++ +P + A+DL+ L V+EP+ RL +I+QHP F+ +NW +
Sbjct: 214 SIRMDNPFYPRW--LEKEAKDLLVKLFVREPEKRLGV---RGDIRQHPLFREINWEELER 268
Query: 560 RCASPPEIPKPV---------EIVHSPAPALSTKAKAVAAGNADHNNYLEFDF 603
+ PP PK + + P LS +A+ + D N + F F
Sbjct: 269 KEIDPPFRPKVKSPFDCSNFDKEFLNEKPRLSFADRALIN-SMDQNMFRNFSF 320
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 4e-36
Identities = 71/363 (19%), Positives = 126/363 (34%), Gaps = 68/363 (18%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+R L+ +G G G+V + T A+K + + + RA E +L+ + H
Sbjct: 19 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKHMRHE 77
Query: 274 FLPTLYTHFETDKFS------CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLA 327
+ L F D+ LVM F ++ + E ++F V ++L
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK----LGEDRIQFLVYQMLKG 133
Query: 328 LEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPV 387
L Y+H GI++RDLKP N+ V ED + + DF L+ + T
Sbjct: 134 LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT----------------G 177
Query: 388 YCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447
Y V P I T + + ++AE +
Sbjct: 178 YVVTRWYRAPEVILNWMRYTQTVD---------------------IWSVGCIMAEMITGK 216
Query: 448 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP 507
++ H EI+K G A + P ++ A++
Sbjct: 217 TLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASIL------ 270
Query: 508 LRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALIRCASPPEI 567
S A +L++ +LV + + R+ A E HP+F+ ++ P++
Sbjct: 271 ------TNASPLAVNLLEKMLVLDAEQRV----TAGEALAHPYFESLHDT----EDEPQV 316
Query: 568 PKP 570
K
Sbjct: 317 QKY 319
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 135 bits (339), Expect = 4e-36
Identities = 67/339 (19%), Positives = 116/339 (34%), Gaps = 58/339 (17%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
+ L+K+G G G VY ++ FA+K + E E IL+ L H
Sbjct: 4 YHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEK-EDEGIPSTTIREISILKELKHSN 61
Query: 275 LPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHML 334
+ LY T K LV E L + G K ++ ++L + Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGG--LESVTAKSFLLQLLNGIAYCHDR 119
Query: 335 GIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPAC 394
+++RDLKP+N+L+ +G + ++DF L+ P+RK V
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAF-------------GIPVRKYTHEIVTLWY 166
Query: 395 IEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGT 454
P + S TT + + + AE N + +
Sbjct: 167 RAPDVLMGSKKYSTTI---------------------DIWSVGCIFAEMVNGTPLFPGVS 205
Query: 455 HEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE-S 513
I + G ++ +W P + V +PL +
Sbjct: 206 EADQLMRIFRILGTPNSKNW---------------PNVTELPKYDPNFTVYEPLPWESFL 250
Query: 514 PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
+ S DL+ +L +P R+ A + +H +F+
Sbjct: 251 KGLDESGIDLLSKMLKLDPNQRI----TAKQALEHAYFK 285
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 4e-36
Identities = 39/149 (26%), Positives = 65/149 (43%), Gaps = 6/149 (4%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
LK+LG G G V + G A+K++ + S+ + E +++ +L H
Sbjct: 5 DLTFLKELGTGQFGVVKYGKWRGQYDV-AIKMIKEGSMSED----EFIEEAKVMMNLSHE 59
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
L LY + ++ E+ G L + + F Q + +V A+EYL
Sbjct: 60 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYLES 118
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++RDL N LV + G + +SDF LS
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLS 147
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.2 bits (192), Expect = 1e-16
Identities = 20/114 (17%), Positives = 41/114 (35%), Gaps = 6/114 (5%)
Query: 436 LPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKGS 494
L + + S+ + PE++ S D W FG+ ++E+ GK P++
Sbjct: 146 LSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF 205
Query: 495 ENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548
N T ++ Q LR + S ++ ++ R + +
Sbjct: 206 TNSETAEHIA-QGLRLYRPHLASEKVYTIMYSCWHEKADERPT----FKILLSN 254
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (342), Expect = 5e-36
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 11/198 (5%)
Query: 168 STSSDVSDESTCSSLSSSVNKPHKANDAQWEAIQAVRVKDGVLGVGHFRLLKKLGCGDIG 227
+ ES L+ + K +WE + F +K LG G G
Sbjct: 5 AAKKGSEQESVKEFLAKAKEDFLK----KWE-----TPSQNTAQLDQFDRIKTLGTGSFG 55
Query: 228 SVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKF 287
V L + + ++AMK++DK + K K++ E+ ILQ+++ PFL L F+ +
Sbjct: 56 RVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSN 115
Query: 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVL 347
+VME+ GG++ + +R FSE +FY A+++L EYLH L ++YRDLKPEN+L
Sbjct: 116 LYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL 173
Query: 348 VREDGHIMLSDFDLSLRC 365
+ + G+I ++DF + R
Sbjct: 174 IDQQGYIQVTDFGFAKRV 191
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 112 bits (281), Expect = 8e-28
Identities = 45/133 (33%), Positives = 64/133 (48%), Gaps = 5/133 (3%)
Query: 440 IAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRAT 499
A+ R+ + GT E LAPEII +G+ AVDWW G+ +YE+ G PF +
Sbjct: 187 FAKRVKGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQI 246
Query: 500 LYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRR-GATEIKQHPFFQGVNWAL 558
+V +RFP S +DL++ LL + R + G +IK H +F +W
Sbjct: 247 YEKIVSGKVRFPSH--FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIA 304
Query: 559 I--RCASPPEIPK 569
I R P IPK
Sbjct: 305 IYQRKVEAPFIPK 317
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (337), Expect = 6e-36
Identities = 40/146 (27%), Positives = 67/146 (45%), Gaps = 6/146 (4%)
Query: 219 KKLGCGDIGSVYLSEL--TGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLP 276
+LGCG+ GSV + A+KV+ + + + + E +I+ LD+P++
Sbjct: 15 IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTE--EMMREAQIMHQLDNPYIV 72
Query: 277 TLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGI 336
L + + LVME GG LH + + V + +V + ++YL
Sbjct: 73 RLIGVCQAEAL-MLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLEEKNF 130
Query: 337 VYRDLKPENVLVREDGHIMLSDFDLS 362
V+RDL NVL+ + +SDF LS
Sbjct: 131 VHRDLAARNVLLVNRHYAKISDFGLS 156
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.1 bits (184), Expect = 2e-15
Identities = 18/112 (16%), Positives = 41/112 (36%), Gaps = 3/112 (2%)
Query: 442 EPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKGSENRATL 500
+ + ++ APE I S D W++G+ ++E L +G+ P+K +
Sbjct: 163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK-MKGPEV 221
Query: 501 YNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
+ Q R P L+ + + ++R + + ++
Sbjct: 222 MAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLT-VEQRMRACYYS 272
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 6e-36
Identities = 61/354 (17%), Positives = 114/354 (32%), Gaps = 67/354 (18%)
Query: 212 VGHFRLLKKLGCGDIGSVYL-SELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL 270
+ + ++G G G V+ +L + A+K + + E+ L E +L+ L
Sbjct: 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPL-STIREVAVLRHL 64
Query: 271 ---DHPFLPTLYTHFETDKFS-----CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVA 322
+HP + L+ + LV E + P + +K +
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT-YLDKVPEPGVPTETIKDMMF 123
Query: 323 EVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPL 382
++L L++LH +V+RDLKP+N+LV G I L+DF L+
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA-------------------- 163
Query: 383 RKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442
+ + AP + + + + + AE
Sbjct: 164 ----RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPV------------DLWSVGCIFAE 207
Query: 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN 502
+ + + +I+ G DW P + R ++
Sbjct: 208 MFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW---------------PRDVALPRQAFHS 252
Query: 503 VVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNW 556
QP+ + +DL+ L P R+ A HP+FQ +
Sbjct: 253 KSAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRI----SAYSALSHPYFQDLER 301
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 1e-35
Identities = 39/147 (26%), Positives = 60/147 (40%), Gaps = 8/147 (5%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+LL+ +G G+ G V L + G K A+K + + + E ++ L H
Sbjct: 8 ELKLLQTIGKGEFGDVMLGDYRGNK--VAVKCIKNDATAQA-----FLAEASVMTQLRHS 60
Query: 274 FLPTLYTHF-ETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
L L E +V E+ G L + + + + +V A+EYL
Sbjct: 61 NLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDF 359
V+RDL NVLV ED +SDF
Sbjct: 121 GNNFVHRDLAARNVLVSEDNVAKVSDF 147
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.9 bits (194), Expect = 5e-17
Identities = 13/104 (12%), Positives = 38/104 (36%), Gaps = 4/104 (3%)
Query: 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVV 504
++ + ++ APE ++ + + D W+FGI L+E+ + V
Sbjct: 154 SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV 213
Query: 505 GQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548
+ + + +++K + R + ++++
Sbjct: 214 EKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPS----FLQLREQ 253
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 133 bits (335), Expect = 1e-35
Identities = 43/231 (18%), Positives = 79/231 (34%), Gaps = 7/231 (3%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+ KLG G G VY A+K + + ++E E +++ + HP
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE----EFLKEAAVMKEIKHP 73
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
L L + ++ EF G+L + + S + + ++ A+EYL
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPA 393
++RDL N LV E+ + ++DF LS R T + + P
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNK 192
Query: 394 CIEPSCIQPSCIAPTTCFSPR--FFSKSKKAQKPKNEMGNQVSPLPELIAE 442
S + + + + +Q + + PE E
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPE 243
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 68.6 bits (167), Expect = 3e-13
Identities = 16/98 (16%), Positives = 33/98 (33%)
Query: 438 ELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR 497
L+ T ++ APE + D W FG+ L+E+ +
Sbjct: 163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 222
Query: 498 ATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNR 535
+ +Y ++ + R +L++ P +R
Sbjct: 223 SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 260
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-35
Identities = 60/149 (40%), Positives = 86/149 (57%), Gaps = 2/149 (1%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
F LK LG G G V L T Y+AMK++ K + + ++ TE +LQ+ HP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
FL L F+T C VME+ GG+L R+ F+E+ +FY AE++ ALEYLH
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSALEYLHS 123
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+VYRD+K EN+++ +DGHI ++DF L
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLC 152
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (312), Expect = 5e-32
Identities = 45/130 (34%), Positives = 73/130 (56%), Gaps = 5/130 (3%)
Query: 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN 502
A +F GT EYLAPE+++ +G AVDWW G+ +YE++ G+ PF ++
Sbjct: 157 SDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL 216
Query: 503 VVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLAC-RRGATEIKQHPFFQGVNWALI-- 559
++ + +RFP + +S A+ L+ GLL K+P+ RL A E+ +H FF +NW +
Sbjct: 217 ILMEEIRFPRT--LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQ 274
Query: 560 RCASPPEIPK 569
+ PP P+
Sbjct: 275 KKLLPPFKPQ 284
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-35
Identities = 30/149 (20%), Positives = 63/149 (42%), Gaps = 6/149 (4%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+L+++LG G G V++ G A+K + + S+ E +++ L H
Sbjct: 14 TLKLVERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPD----AFLAEANLMKQLQHQ 68
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
L LY + ++ E+ G L + G + + A++ + ++
Sbjct: 69 RLVRLYAVVTQEPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE 127
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLS 362
++RDL+ N+LV + ++DF L+
Sbjct: 128 RNYIHRDLRAANILVSDTLSCKIADFGLA 156
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.9 bits (181), Expect = 3e-15
Identities = 20/119 (16%), Positives = 36/119 (30%), Gaps = 6/119 (5%)
Query: 435 PLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGS 494
L LI + ++ APE I D W+FGI L E++
Sbjct: 154 GLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPG 213
Query: 495 ENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ--HPFF 551
+ + + R L++ + P++R ++ FF
Sbjct: 214 MTNPEVIQNLERGYRMVRPDNCPEELYQLMRLCWKERPEDRPT----FDYLRSVLEDFF 268
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 3e-35
Identities = 47/199 (23%), Positives = 73/199 (36%), Gaps = 10/199 (5%)
Query: 209 VLGVGHFRLLKKLGCGDIGSVYLSEL---TGTKCYFAMKVMDKASLEKRKKLLRAQTERE 265
++G RLL+KLG G G V E +G A+K + L + + + E
Sbjct: 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVN 63
Query: 266 ILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVL 325
+ SLDH L LY T +V E P G L ++ G F + Y +V
Sbjct: 64 AMHSLDHRNLIRLYGVVLTPPM-KMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVA 121
Query: 326 LALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKN 385
+ YL ++RDL N+L+ + + DF L + RK
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE-----HRKV 176
Query: 386 PVYCVQPACIEPSCIQPSC 404
P P ++ +
Sbjct: 177 PFAWCAPESLKTRTFSHAS 195
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.3 bits (200), Expect = 1e-17
Identities = 19/95 (20%), Positives = 37/95 (38%), Gaps = 1/95 (1%)
Query: 442 EPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKGSENRATL 500
+ + APE +K A D W FG+ L+E+ +G+ P+ G L
Sbjct: 165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQIL 224
Query: 501 YNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNR 535
+ + + R P +++ +P++R
Sbjct: 225 HKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 259
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 132 bits (333), Expect = 3e-35
Identities = 37/165 (22%), Positives = 73/165 (44%), Gaps = 6/165 (3%)
Query: 201 QAVRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGT---KCYFAMKVMDKASLEKRKKL 257
+AVR + + ++ + +G G+ G V L + + A+K + EK+++
Sbjct: 14 EAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRR- 72
Query: 258 LRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAV 317
+E I+ DHP + L ++ EF G L + ++ G++ + +
Sbjct: 73 -DFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF-TVIQL 130
Query: 318 KFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ + ++YL + V+RDL N+LV + +SDF LS
Sbjct: 131 VGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLS 175
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 74.0 bits (181), Expect = 4e-15
Identities = 24/118 (20%), Positives = 50/118 (42%), Gaps = 5/118 (4%)
Query: 436 LPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKGS 494
L + ++PT ++ + APE I+ SA D W++GI ++E++ +G+ P+
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWD- 236
Query: 495 ENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACR---RGATEIKQHP 549
+ N + Q R P + L+ K+ +R ++ ++P
Sbjct: 237 MTNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (334), Expect = 5e-35
Identities = 35/151 (23%), Positives = 68/151 (45%), Gaps = 7/151 (4%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
+ + + LG G+ G V+ T +K + K + ++ + E IL H
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQV----LVKKEISILNIARHR 61
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
+ L+ FE+ + ++ EF G D+ + +E+ + YV +V AL++LH
Sbjct: 62 NILHLHESFESMEELVMIFEFISGLDIFERINTSAFE-LNEREIVSYVHQVCEALQFLHS 120
Query: 334 LGIVYRDLKPENVLV--REDGHIMLSDFDLS 362
I + D++PEN++ R I + +F +
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQA 151
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 1e-23
Identities = 33/108 (30%), Positives = 51/108 (47%), Gaps = 6/108 (5%)
Query: 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ 506
EY APE+ + + +A D W+ G +Y LL G PF N+ + N++
Sbjct: 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA 218
Query: 507 PLRFPES--PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
F E +S A D + LLVKE ++R+ A+E QHP+ +
Sbjct: 219 EYTFDEEAFKEISIEAMDFVDRLLVKERKSRM----TASEALQHPWLK 262
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 6e-35
Identities = 65/166 (39%), Positives = 103/166 (62%), Gaps = 7/166 (4%)
Query: 210 LGVGHFRLLKKLGCGDIGSVYLSELT---GTKCYFAMKVMDKASLEKRKKLL-RAQTERE 265
+G+ +F LLK LG G G V+L T +AMKV+ KA++ ++ K +TER+
Sbjct: 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQ 80
Query: 266 ILQSLDH-PFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEV 324
+L+ + PFL TL+ F+T+ L++++ GG+L T ++ F+E V+ YV E+
Sbjct: 81 VLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEI 138
Query: 325 LLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370
+LALE+LH LGI+YRD+K EN+L+ +GH++L+DF LS T
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET 184
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 2e-27
Identities = 52/137 (37%), Positives = 75/137 (54%), Gaps = 7/137 (5%)
Query: 440 IAEPTNARSMSFVGTHEYLAPEIIKG--EGHGSAVDWWTFGIFLYELLFGKTPFKGSENR 497
R+ F GT EY+AP+I++G GH AVDWW+ G+ +YELL G +PF +
Sbjct: 179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 238
Query: 498 ATLYNVVGQPLRF--PESPVVSFSARDLIKGLLVKEPQNRLAC-RRGATEIKQHPFFQGV 554
+ + + L+ P +S A+DLI+ LL+K+P+ RL C R A EIK+H FFQ +
Sbjct: 239 NSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 298
Query: 555 NWALIRCAS--PPEIPK 569
NW + P P
Sbjct: 299 NWDDLAAKKVPAPFKPV 315
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (330), Expect = 2e-34
Identities = 41/169 (24%), Positives = 81/169 (47%), Gaps = 18/169 (10%)
Query: 203 VRVKDGVLGVGHFRLLKK-LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQ 261
+++K + + +++ + LG G G V T+ FA+K++ +A+
Sbjct: 2 LQIKKNAI-IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KAR 52
Query: 262 TEREIL-QSLDHPFLPTLYTHFET----DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQA 316
E E+ ++ P + + +E K +VME GG+L + Q + + F+E+
Sbjct: 53 REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTERE 112
Query: 317 VKFYVAEVLLALEYLHMLGIVYRDLKPENVLV---REDGHIMLSDFDLS 362
+ + A++YLH + I +RD+KPEN+L R + + L+DF +
Sbjct: 113 ASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 92.9 bits (230), Expect = 3e-21
Identities = 31/116 (26%), Positives = 49/116 (42%), Gaps = 10/116 (8%)
Query: 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN 502
++ + T Y+APE++ E + + D W+ G+ +Y LL G PF + A
Sbjct: 165 TSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 224
Query: 503 VVGQ------PLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
+ + PE VS + LI+ LL EP R+ TE HP+
Sbjct: 225 MKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM----TITEFMNHPWIM 276
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 2e-34
Identities = 40/155 (25%), Positives = 70/155 (45%), Gaps = 10/155 (6%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
+ ++G G +VY T T A + L K ++ R + E E+L+ L HP
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEMLKGLQHPN 69
Query: 275 LPTLYTHFET----DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEY 330
+ Y +E+ K LV E G L T +R K + ++ + ++L L++
Sbjct: 70 IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGLQF 127
Query: 331 LHMLG--IVYRDLKPENVLVR-EDGHIMLSDFDLS 362
LH I++RDLK +N+ + G + + D L+
Sbjct: 128 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (267), Expect = 1e-26
Identities = 24/107 (22%), Positives = 51/107 (47%), Gaps = 6/107 (5%)
Query: 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ 506
+ + +GT E++APE+ + + +VD + FG+ + E+ + P+ +N A +Y V
Sbjct: 169 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 227
Query: 507 PLRFPESP-VVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
++ V +++I+G + + R ++ H FFQ
Sbjct: 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERY----SIKDLLNHAFFQ 270
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (325), Expect = 8e-34
Identities = 43/259 (16%), Positives = 77/259 (29%), Gaps = 32/259 (12%)
Query: 214 HFRLLKKLGCGDIGSVYLSEL-----TGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQ 268
+ K LG G G V + TG A+K++ + + ++ +E +++
Sbjct: 38 NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSERE--ALMSELKMMT 95
Query: 269 SL-DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKY---------------- 311
L H + L L+ E+C GDL + + K+
Sbjct: 96 QLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE 155
Query: 312 -----FSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366
+ + + + +V +E+L V+RDL NVLV + + DF L+
Sbjct: 156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPT---TCFSPRFFSKSKKAQ 423
V P + S + I + + A
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
Query: 424 KPKNEMGNQVSPLPELIAE 442
K P E
Sbjct: 276 FYKLIQNGFKMDQPFYATE 294
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.3 bits (192), Expect = 2e-16
Identities = 15/112 (13%), Positives = 43/112 (38%), Gaps = 5/112 (4%)
Query: 438 ELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKGSEN 496
+++++ + +++APE + + D W++GI L+E+ G P+ G
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272
Query: 497 RATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548
A Y ++ + + + +++ + + R + +
Sbjct: 273 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS----FPNLTSF 320
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 4e-33
Identities = 40/160 (25%), Positives = 72/160 (45%), Gaps = 6/160 (3%)
Query: 219 KKLGCGDIGSVYLSEL--TGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLP 276
K+LG G+ G+V A+K++ + + K E ++Q LD+P++
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD-ELLAEANVMQQLDNPYIV 71
Query: 277 TLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGI 336
+ E + + LVME G L+ Q+ ++ ++ + V +V + ++YL
Sbjct: 72 RMIGICEAESW-MLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNF 128
Query: 337 VYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSST 376
V+RDL NVL+ + +SDF LS K+ T
Sbjct: 129 VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT 168
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.9 bits (212), Expect = 3e-19
Identities = 22/118 (18%), Positives = 45/118 (38%), Gaps = 11/118 (9%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKGSENRATLYN 502
++ APE I S D W+FG+ ++E +G+ P++G +
Sbjct: 163 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 222
Query: 503 VV-GQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIK---QHPFFQGVNW 556
+ G+ + P DL+ + +NR G ++ ++ ++ VN
Sbjct: 223 LEKGERMGCPAG--CPREMYDLMNLCWTYDVENRP----GFAAVELRLRNYYYDVVNE 274
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 4e-33
Identities = 38/149 (25%), Positives = 66/149 (44%), Gaps = 6/149 (4%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
RL KLG G G V++ GT A+K + ++ E ++++ L H
Sbjct: 18 SLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPE----AFLQEAQVMKKLRHE 72
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
L LY + +V E+ G L + + GKY + A++ + Y+
Sbjct: 73 KLVQLYAVVSEEPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER 131
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ V+RDL+ N+LV E+ ++DF L+
Sbjct: 132 MNYVHRDLRAANILVGENLVCKVADFGLA 160
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.7 bits (201), Expect = 9e-18
Identities = 26/119 (21%), Positives = 38/119 (31%), Gaps = 6/119 (5%)
Query: 436 LPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE 495
L LI + ++ APE D W+FGI L EL
Sbjct: 159 LARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 218
Query: 496 NRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ--HPFFQ 552
+ + V + R P P S DL+ KEP+ R ++ +F
Sbjct: 219 VNREVLDQVERGYRMPCPPECPESLHDLMCQCWRKEPEERPT----FEYLQAFLEDYFT 273
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 4e-33
Identities = 38/148 (25%), Positives = 63/148 (42%), Gaps = 6/148 (4%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
++++G G G V+L A+K + + ++ + E E++ L HP
Sbjct: 6 ELTFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSEE----DFIEEAEVMMKLSHP 60
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM 333
L LY CLV EF G L + Q F+ + + +V + YL
Sbjct: 61 KLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYLEE 119
Query: 334 LGIVYRDLKPENVLVREDGHIMLSDFDL 361
+++RDL N LV E+ I +SDF +
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGM 147
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 81.3 bits (200), Expect = 9e-18
Identities = 14/113 (12%), Positives = 42/113 (37%), Gaps = 4/113 (3%)
Query: 436 LPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE 495
+ + + S ++ +PE+ + S D W+FG+ ++E+ +
Sbjct: 147 MTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 206
Query: 496 NRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548
+ + + + R + + S ++ + P++R A + + +
Sbjct: 207 SNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWKERPEDRPA----FSRLLRQ 255
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (317), Expect = 7e-33
Identities = 30/171 (17%), Positives = 62/171 (36%), Gaps = 24/171 (14%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTG-----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQ 268
K LG G G V + G A+K++ ++ ++ +E ++L
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTERE--ALMSELKVLS 81
Query: 269 SL-DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKY---------------- 311
L +H + L + ++ E+C GDL +R+ +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 312 FSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ + + +V + +L ++RDL N+L+ + DF L+
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.2 bits (158), Expect = 4e-12
Identities = 21/99 (21%), Positives = 41/99 (41%), Gaps = 1/99 (1%)
Query: 438 ELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKGSEN 496
++ + + +++APE I + D W++GIFL+EL G +P+ G
Sbjct: 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253
Query: 497 RATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNR 535
+ Y ++ + R D++K +P R
Sbjct: 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 6e-32
Identities = 36/152 (23%), Positives = 63/152 (41%), Gaps = 7/152 (4%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTK---CYFAMKVMDKASLEKRKKLLRAQTEREILQSL 270
L + +G G G V+ + A+K + + ++ + E ++
Sbjct: 8 RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVRE--KFLQEALTMRQF 65
Query: 271 DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEY 330
DHP + L T+ ++ME C G+L + Q + ++ Y ++ AL Y
Sbjct: 66 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTALAY 123
Query: 331 LHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
L V+RD+ NVLV + + L DF LS
Sbjct: 124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLS 155
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.0 bits (186), Expect = 7e-16
Identities = 23/113 (20%), Positives = 40/113 (35%), Gaps = 4/113 (3%)
Query: 436 LPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSE 495
L + + T ++ +++APE I SA D W FG+ ++E+L
Sbjct: 154 LSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV 213
Query: 496 NRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548
+ + R P P + L+ +P R TE+K
Sbjct: 214 KNNDVIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPR----FTELKAQ 262
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (307), Expect = 1e-31
Identities = 38/159 (23%), Positives = 74/159 (46%), Gaps = 9/159 (5%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLL---RAQTEREILQSL 270
++ ++LG G V T +A K + K + ++ + + E IL+ +
Sbjct: 11 YYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEI 70
Query: 271 DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEY 330
HP + TL+ +E L++E GG+L + + +E+ ++ ++L + Y
Sbjct: 71 QHPNVITLHEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYY 128
Query: 331 LHMLGIVYRDLKPENVLVREDG----HIMLSDFDLSLRC 365
LH L I + DLKPEN+++ + I + DF L+ +
Sbjct: 129 LHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 3e-30
Identities = 41/129 (31%), Positives = 60/129 (46%), Gaps = 8/129 (6%)
Query: 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN 502
+ GT E++APEI+ E G D W+ G+ Y LL G +PF G + TL N
Sbjct: 168 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLAN 227
Query: 503 VVGQPLRFPES--PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNW--AL 558
V F + S A+D I+ LLVK+P+ R+ + QHP+ + + AL
Sbjct: 228 VSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM----TIQDSLQHPWIKPKDTQQAL 283
Query: 559 IRCASPPEI 567
S P+
Sbjct: 284 SSAWSHPQF 292
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (304), Expect = 2e-31
Identities = 36/156 (23%), Positives = 65/156 (41%), Gaps = 7/156 (4%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKL---LRAQTEREILQS 269
+++ LG G GSVY A+K ++K + +L R E +L+
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 270 LD--HPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLA 327
+ + L FE L++E + G E+ + + +VL A
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGA-LQEELARSFFWQVLEA 122
Query: 328 LEYLHMLGIVYRDLKPENVLVRED-GHIMLSDFDLS 362
+ + H G+++RD+K EN+L+ + G + L DF
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 158
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.7 bits (240), Expect = 6e-23
Identities = 32/112 (28%), Positives = 49/112 (43%), Gaps = 13/112 (11%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN 502
+ F GT Y PE I+ HG + W+ GI LY+++ G PF+ E
Sbjct: 162 KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------E 215
Query: 503 VVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554
++ + F + VS + LI+ L P +R EI+ HP+ Q V
Sbjct: 216 IIRGQVFFRQR--VSSECQHLIRWCLALRPSDRP----TFEEIQNHPWMQDV 261
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 121 bits (304), Expect = 2e-31
Identities = 37/187 (19%), Positives = 71/187 (37%), Gaps = 14/187 (7%)
Query: 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQ 268
V+G H+++ +++G G G ++ A+K + S + + E +
Sbjct: 2 VVG-VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQ-----LRDEYRTYK 55
Query: 269 SLDH-PFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLA 327
L +P +Y + + LV++ L G+ FS + V ++L
Sbjct: 56 LLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC--GRKFSVKTVAMAAKQMLAR 113
Query: 328 LEYLHMLGIVYRDLKPENVLVRE-----DGHIMLSDFDLSLRCAVSPTVVKSSTLESEPL 382
++ +H +VYRD+KP+N L+ I + DF + T E + L
Sbjct: 114 VQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNL 173
Query: 383 RKNPVYC 389
Y
Sbjct: 174 SGTARYM 180
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 64.4 bits (156), Expect = 5e-12
Identities = 11/95 (11%), Positives = 21/95 (22%), Gaps = 6/95 (6%)
Query: 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ 506
+ GT Y++ G D G L G P++G +
Sbjct: 169 EKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228
Query: 507 PLRFPESPV------VSFSARDLIKGLLVKEPQNR 535
+ +P+ +
Sbjct: 229 GEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 4e-31
Identities = 59/345 (17%), Positives = 107/345 (31%), Gaps = 64/345 (18%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHP 273
++ L +G G GSV + T T A+K + + + R E +L+ + H
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELRLLKHMKHE 77
Query: 274 FLPTLYTHFET-----DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLAL 328
+ L F + ++ G DL+ + + Q ++ V+F + ++L L
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK---LTDDHVQFLIYQILRGL 134
Query: 329 EYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVY 388
+Y+H I++RDLKP N+ V ED + + DF L+
Sbjct: 135 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA-------------------------- 168
Query: 389 CVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448
+A +P + + L
Sbjct: 169 ------RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTL---- 218
Query: 449 MSFVGTHEY-LAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP 507
F GT I++ G A N A ++
Sbjct: 219 --FPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF------ 270
Query: 508 LRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQ 552
+ A DL++ +LV + R+ A + H +F
Sbjct: 271 ------IGANPLAVDLLEKMLVLDSDKRI----TAAQALAHAYFA 305
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 120 bits (301), Expect = 6e-31
Identities = 41/213 (19%), Positives = 73/213 (34%), Gaps = 30/213 (14%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTG-----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQ 268
+ ++ +G G G V+ + G A+K++ + + + Q E ++
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQA--DFQREAALMA 71
Query: 269 SLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKY----------------- 311
D+P + L K CL+ E+ GDL+ +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 312 -----FSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366
S +V + YL V+RDL N LV E+ + ++DF LS R
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS-RNI 190
Query: 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSC 399
S K+ ++ P+R P +
Sbjct: 191 YSADYYKADGNDAIPIRWMPPESIFYNRYTTES 223
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 70.3 bits (171), Expect = 7e-14
Identities = 21/91 (23%), Positives = 39/91 (42%), Gaps = 4/91 (4%)
Query: 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKGSENRATLYNVV- 504
+ ++ PE I + + D W +G+ L+E+ +G P+ G + +Y V
Sbjct: 198 ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRD 257
Query: 505 GQPLRFPESPVVSFSARDLIKGLLVKEPQNR 535
G L PE+ +L++ K P +R
Sbjct: 258 GNILACPEN--CPLELYNLMRLCWSKLPADR 286
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (297), Expect = 3e-30
Identities = 36/164 (21%), Positives = 61/164 (37%), Gaps = 4/164 (2%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKA--SLEKRKKLLRAQTEREILQSLDH 272
F+ +K LG G G+VY + V K K E ++ S+D+
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 273 PFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLH 332
P + L T L+ + P G L + Q + + ++ + YL
Sbjct: 71 PHVCRLLGICLTSTV-QLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGMNYLE 128
Query: 333 MLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSST 376
+V+RDL NVLV+ H+ ++DF L+ +
Sbjct: 129 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 172
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.4 bits (182), Expect = 4e-15
Identities = 22/145 (15%), Positives = 54/145 (37%), Gaps = 10/145 (6%)
Query: 439 LIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRA 498
L AE + +++A E I + D W++G+ ++EL+ + +
Sbjct: 161 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 220
Query: 499 TLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWAL 558
+ +++ + R P+ P+ + ++ + + +R E+ +
Sbjct: 221 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPK----FRELIIEFSK------M 270
Query: 559 IRCASPPEIPKPVEIVHSPAPALST 583
R + + E +H P+P S
Sbjct: 271 ARDPQRYLVIQGDERMHLPSPTDSN 295
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 118 bits (295), Expect = 5e-30
Identities = 36/181 (19%), Positives = 71/181 (39%), Gaps = 11/181 (6%)
Query: 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH 272
+RL +K+G G G +YL A+K+ + + E +I + +
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ-----LHIESKIYKMMQG 61
Query: 273 P-FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYL 331
+PT+ ++ +VME + FS + V +++ +EY+
Sbjct: 62 GVGIPTIRWCGAEGDYNVMVMELLGPSLED--LFNFCSRKFSLKTVLLLADQMISRIEYI 119
Query: 332 HMLGIVYRDLKPENVLVREDGH---IMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVY 388
H ++RD+KP+N L+ + + DF L+ + + T E++ L Y
Sbjct: 120 HSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARY 179
Query: 389 C 389
Sbjct: 180 A 180
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 74.1 bits (181), Expect = 4e-15
Identities = 14/117 (11%), Positives = 33/117 (28%), Gaps = 8/117 (6%)
Query: 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ 506
+ + GT Y + G D + G L G P++G +
Sbjct: 169 ENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 228
Query: 507 PLRFPESPV------VSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFF-QGVNW 556
+ +P+ + ++ ++ ++ F QG ++
Sbjct: 229 SEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSY-LRQLFRNLFHRQGFSY 284
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 1e-29
Identities = 34/163 (20%), Positives = 60/163 (36%), Gaps = 15/163 (9%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHP 273
+ +G G+ G V + + + + E E+L L HP
Sbjct: 12 IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71
Query: 274 FLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQR--------------QPGKYFSEQAVKF 319
+ L E + L +E+ P G+L ++ S Q +
Sbjct: 72 NIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLH 131
Query: 320 YVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+ A+V ++YL ++RDL N+LV E+ ++DF LS
Sbjct: 132 FAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 174
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.4 bits (187), Expect = 9e-16
Identities = 17/106 (16%), Positives = 37/106 (34%), Gaps = 4/106 (3%)
Query: 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN 502
+ ++A E + + + D W++G+ L+E++ A LY
Sbjct: 178 EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237
Query: 503 VVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548
+ Q R + DL++ ++P R + +I
Sbjct: 238 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERPS----FAQILVS 279
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 116 bits (290), Expect = 6e-29
Identities = 59/379 (15%), Positives = 132/379 (34%), Gaps = 49/379 (12%)
Query: 203 VRVKDGVLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQT 262
+ + L++KLG G +V+L++ + AMK++ + +
Sbjct: 4 AFKGE-PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKL 62
Query: 263 EREI-------LQSLDHPFLPTLYTHFET---DKFSCLVMEFCPGGDLHTLRQRQPGKYF 312
+ + S+ + L HF + +++ G +L L ++ +
Sbjct: 63 LQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGI 122
Query: 313 SEQAVKFYVAEVLLALEYLHM-LGIVYRDLKPENVLVREDGHIM-LSDFDLS-LRCAVSP 369
VK ++LL L+Y+H GI++ D+KPENVL+ L ++ L A
Sbjct: 123 PLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 182
Query: 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEM 429
++++++ R V P +C+ F + K++
Sbjct: 183 DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD- 241
Query: 430 GNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKT 489
+ ++ + EL+ E P + G + + + G+
Sbjct: 242 -DHIAQIIELLGEL----------------PSYLLRNGKYTRTFFNSRGLLRNISKLKFW 284
Query: 490 PFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHP 549
P + +V+ + +F + + D + +L +P+ R A + HP
Sbjct: 285 PLE---------DVLTEKYKFSKD--EAKEISDFLSPMLQLDPRKRA----DAGGLVNHP 329
Query: 550 FFQGVNWALIRCASPPEIP 568
+ + + + P+
Sbjct: 330 WLK--DTLGMEEIRVPDRE 346
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (286), Expect = 8e-29
Identities = 36/184 (19%), Positives = 71/184 (38%), Gaps = 23/184 (12%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTG-----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQ 268
+L K LG G G V ++ G T A+K++ + + + +E +IL
Sbjct: 14 RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR--ALMSELKILI 71
Query: 269 SLDHPFLPTLYTH--FETDKFSCLVMEFCPGGDLHTLRQRQPGKY--------------F 312
+ H + +++EFC G+L T + + ++
Sbjct: 72 HIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 131
Query: 313 SEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372
+ + + Y +V +E+L ++RDL N+L+ E + + DF L+ P V
Sbjct: 132 TLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYV 191
Query: 373 KSST 376
+
Sbjct: 192 RKGD 195
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.1 bits (168), Expect = 2e-13
Identities = 20/111 (18%), Positives = 40/111 (36%), Gaps = 5/111 (4%)
Query: 439 LIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFG-KTPFKGSENR 497
+ +P R +++APE I + D W+FG+ L+E+ +P+ G +
Sbjct: 184 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 498 ATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548
+ + R + + EP R +E+ +H
Sbjct: 244 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 290
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (281), Expect = 3e-28
Identities = 40/171 (23%), Positives = 67/171 (39%), Gaps = 24/171 (14%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGTK-------CYFAMKVMDKASLEKRKKLLRAQTEREI 266
L K LG G G V L+E G A+K++ + EK +E E+
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLS--DLISEMEM 71
Query: 267 LQSL-DHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTL--------------RQRQPGKY 311
++ + H + L D +++E+ G+L P +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 312 FSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
S + + +V +EYL ++RDL NVLV ED + ++DF L+
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLA 182
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.4 bits (179), Expect = 8e-15
Identities = 13/94 (13%), Positives = 34/94 (36%)
Query: 442 EPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLY 501
++ + +++APE + + D W+FG+ L+E+ L+
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247
Query: 502 NVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNR 535
++ + R + + +++ P R
Sbjct: 248 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 281
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 112 bits (280), Expect = 5e-28
Identities = 33/174 (18%), Positives = 65/174 (37%), Gaps = 21/174 (12%)
Query: 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF 274
L + +G G G V+ + G + A+K+ + ++ + E L H
Sbjct: 5 IVLQESIGKGRFGEVWRGKWRGEE--VAVKIFSS----REERSWFREAEIYQTVMLRHEN 58
Query: 275 LPTLYTHFETDKFS----CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEY 330
+ D + LV ++ G L R + + + L +
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT---VTVEGMIKLALSTASGLAH 115
Query: 331 LHM--------LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSST 376
LHM I +RDLK +N+LV+++G ++D L++R + + +
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 169
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.9 bits (126), Expect = 4e-08
Identities = 22/132 (16%), Positives = 39/132 (29%), Gaps = 30/132 (22%)
Query: 442 EPTNARSMSFVGTHEYLAPEIIKGEGH------GSAVDWWTFGIFLYELLFGKTPFKGSE 495
+ + VGT Y+APE++ + D + G+ +E+ + E
Sbjct: 163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222
Query: 496 NRATLYN---------------VVGQPLR-----FPESPVVSFSARDLIKGLLVKEPQNR 535
+ Y V Q LR +S +++ R
Sbjct: 223 DYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAAR 282
Query: 536 LACRRGATEIKQ 547
L A IK+
Sbjct: 283 LT----ALRIKK 290
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 2e-27
Identities = 39/174 (22%), Positives = 68/174 (39%), Gaps = 7/174 (4%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTGT----KCYFAMKVMDKASLEKRKKLLRAQTEREILQS 269
K +G G+ G VY L + + A+K + EK++ E I+
Sbjct: 8 CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRV--DFLGEAGIMGQ 65
Query: 270 LDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALE 329
H + L K ++ E+ G L + + G FS + + + ++
Sbjct: 66 FSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG-EFSVLQLVGMLRGIAAGMK 124
Query: 330 YLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLR 383
YL + V+RDL N+LV + +SDF LS P +++ P+R
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.9 bits (178), Expect = 8e-15
Identities = 17/88 (19%), Positives = 30/88 (34%)
Query: 448 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP 507
+ + APE I SA D W+FGI ++E++ + + +
Sbjct: 170 TSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG 229
Query: 508 LRFPESPVVSFSARDLIKGLLVKEPQNR 535
R P + L+ +E R
Sbjct: 230 FRLPTPMDCPSAIYQLMMQCWQQERARR 257
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (274), Expect = 3e-27
Identities = 33/188 (17%), Positives = 67/188 (35%), Gaps = 15/188 (7%)
Query: 214 HFRLLKKLGCGDIGSVYLSELTG-----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQ 268
+ ++LG G G VY G + A+K +++A+ + + E +++
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI--EFLNEASVMK 78
Query: 269 SLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKY--------FSEQAVKFY 320
+ + L + + ++ME GDL + + S +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 321 VAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESE 380
E+ + YL+ V+RDL N +V ED + + DF ++ + K
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 381 PLRKNPVY 388
+P
Sbjct: 199 VRWMSPES 206
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 70.3 bits (171), Expect = 7e-14
Identities = 22/121 (18%), Positives = 50/121 (41%), Gaps = 4/121 (3%)
Query: 438 ELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELL-FGKTPFKGSEN 496
++ + + +++PE +K + D W+FG+ L+E+ + P++G N
Sbjct: 182 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 241
Query: 497 RATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ--HPFFQGV 554
L V+ + + +L++ P+ R + + IK+ P F+ V
Sbjct: 242 EQVLRFVM-EGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREV 300
Query: 555 N 555
+
Sbjct: 301 S 301
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 108 bits (270), Expect = 1e-26
Identities = 33/153 (21%), Positives = 68/153 (44%), Gaps = 9/153 (5%)
Query: 214 HFRLLKKLGCGDIGSVYLSEL---TGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL 270
HF + +G G G VY L G K + A+K +++ + + TE I++
Sbjct: 30 HFN--EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVS--QFLTEGIIMKDF 85
Query: 271 DHPFLPTLY-THFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALE 329
HP + +L ++ +V+ + GDL + + + + + + +V ++
Sbjct: 86 SHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN-PTVKDLIGFGLQVAKGMK 144
Query: 330 YLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+L V+RDL N ++ E + ++DF L+
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLA 177
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 76.4 bits (187), Expect = 8e-16
Identities = 15/105 (14%), Positives = 38/105 (36%), Gaps = 4/105 (3%)
Query: 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNV 503
+ +++A E ++ + + D W+FG+ L+EL+ P N +
Sbjct: 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY 246
Query: 504 VGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548
+ Q R + +++ + + R + +E+
Sbjct: 247 LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPS----FSELVSR 287
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 76.4 bits (187), Expect = 1e-16
Identities = 29/161 (18%), Positives = 49/161 (30%), Gaps = 30/161 (18%)
Query: 217 LLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRK---------------KLLRAQ 261
+ K +G G +V+ +K +K + A+
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFG-ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSAR 62
Query: 262 TEREILQSLDHPFLPTLYTHFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYV 321
E LQ L +P +Y ++ME + +
Sbjct: 63 NEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAK---------ELYRVRVENPDEVL 109
Query: 322 AEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362
+L + + GIV+ DL NVLV + I + DF S
Sbjct: 110 DMILEEVAKFYHRGIVHGDLSQYNVLV-SEEGIWIIDFPQS 149
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 604 | |||
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.48 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.11 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.98 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.22 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.08 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.82 |
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-63 Score=507.19 Aligned_cols=279 Identities=34% Similarity=0.638 Sum_probs=245.5
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+++|++++||||++++++|.+++.+|||
T Consensus 7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~iv 86 (288)
T d1uu3a_ 7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFG 86 (288)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEE
Confidence 36899999999999999999999999999999999887665555667788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
||||+||+|.+++... +.+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||++..+....
T Consensus 87 mEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~-- 162 (288)
T d1uu3a_ 87 LSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES-- 162 (288)
T ss_dssp ECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC--
Confidence 9999999999998876 579999999999999999999999999999999999999999999999999985432110
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
......+.
T Consensus 163 ------------------------------------------------------------------------~~~~~~~~ 170 (288)
T d1uu3a_ 163 ------------------------------------------------------------------------KQARANSF 170 (288)
T ss_dssp -------------------------------------------------------------------------------C
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 01122345
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~d 531 (604)
+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.++....+.+|. .++.++++||.+||++|
T Consensus 171 ~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~d 248 (288)
T d1uu3a_ 171 VGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE--KFFPKARDLVEKLLVLD 248 (288)
T ss_dssp CCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCT--TCCHHHHHHHHTTSCSS
T ss_pred cCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCc--cCCHHHHHHHHHHccCC
Confidence 7999999999999999999999999999999999999999999888888999888777765 48999999999999999
Q ss_pred CCCcccccC--CHHHHhcCCCCCCCChhhhhcCCCCCCC
Q 007433 532 PQNRLACRR--GATEIKQHPFFQGVNWALIRCASPPEIP 568 (604)
Q Consensus 532 P~~Rpt~~~--~a~elL~Hpff~~~~~~~~~~~~~~~~p 568 (604)
|.+|||+.+ ...++++||||++++|..++...||++|
T Consensus 249 P~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~~pP~l~ 287 (288)
T d1uu3a_ 249 ATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQTPPKLT 287 (288)
T ss_dssp GGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGSCCCCCC
T ss_pred HhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcCCCCCCC
Confidence 999999432 2334799999999999999988888775
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-61 Score=502.72 Aligned_cols=279 Identities=38% Similarity=0.699 Sum_probs=247.3
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
.+++|++++.||+|+||+||+|+++.+++.||||++++...........+.+|+.+|+.++||||++++++|++++.+|+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~i 82 (337)
T d1o6la_ 3 TMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCF 82 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEE
T ss_pred chHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccc
Confidence 45799999999999999999999999999999999998766555566778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
|||||+||+|..++.+. ..+++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||+|......
T Consensus 83 v~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-- 158 (337)
T d1o6la_ 83 VMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-- 158 (337)
T ss_dssp EEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT--
T ss_pred ceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccC--
Confidence 99999999999998876 57999999999999999999999999999999999999999999999999998432110
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
......
T Consensus 159 --------------------------------------------------------------------------~~~~~~ 164 (337)
T d1o6la_ 159 --------------------------------------------------------------------------GATMKT 164 (337)
T ss_dssp --------------------------------------------------------------------------TCCBCC
T ss_pred --------------------------------------------------------------------------Cccccc
Confidence 111235
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
++||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+.+..+....+.+|. .++.++++||++||++
T Consensus 165 ~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~dli~~~L~~ 242 (337)
T d1o6la_ 165 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR--TLSPEAKSLLAGLLKK 242 (337)
T ss_dssp CEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCS
T ss_pred ceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCc--cCCHHHHHHHHhhccC
Confidence 68999999999999999999999999999999999999999999988888888888877765 4999999999999999
Q ss_pred CCCCcccccC-CHHHHhcCCCCCCCChhhhhc--CCCCCCCC
Q 007433 531 EPQNRLACRR-GATEIKQHPFFQGVNWALIRC--ASPPEIPK 569 (604)
Q Consensus 531 dP~~Rpt~~~-~a~elL~Hpff~~~~~~~~~~--~~~~~~p~ 569 (604)
||.+|++... .++|+++||||++++|..+.. ..||..|.
T Consensus 243 dP~~R~~~~~~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~ 284 (337)
T d1o6la_ 243 DPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQ 284 (337)
T ss_dssp STTTSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred CchhhcccccccHHHHHcCcccccCCHHHHHhCCCCCCCCCC
Confidence 9999997533 489999999999999987643 33444443
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-61 Score=485.37 Aligned_cols=256 Identities=34% Similarity=0.593 Sum_probs=232.5
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
.+++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+++|+.++||||++++++|.+++.+||
T Consensus 4 ~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i 83 (263)
T d2j4za1 4 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 83 (263)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred chhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEE
Confidence 35789999999999999999999999999999999988766655556678899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
|||||+||+|.+++.+. ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||++.....
T Consensus 84 vmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~--- 158 (263)
T d2j4za1 84 ILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 158 (263)
T ss_dssp EEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCC---
T ss_pred EEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCC---
Confidence 99999999999999876 5699999999999999999999999999999999999999999999999999843210
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
.....
T Consensus 159 ---------------------------------------------------------------------------~~~~~ 163 (263)
T d2j4za1 159 ---------------------------------------------------------------------------SRRTT 163 (263)
T ss_dssp ---------------------------------------------------------------------------CCCEE
T ss_pred ---------------------------------------------------------------------------Ccccc
Confidence 01124
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
.+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.++....+.+|. .++.++++||.+||.+
T Consensus 164 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~ 241 (263)
T d2j4za1 164 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD--FVTEGARDLISRLLKH 241 (263)
T ss_dssp TTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCT--TSCHHHHHHHHHHTCS
T ss_pred cCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCc--cCCHHHHHHHHHHccC
Confidence 57999999999999999999999999999999999999999998888888888887777665 4899999999999999
Q ss_pred CCCCcccccCCHHHHhcCCCCC
Q 007433 531 EPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
||++||| ++|+|+||||+
T Consensus 242 dp~~R~t----~~eil~hp~~~ 259 (263)
T d2j4za1 242 NPSQRPM----LREVLEHPWIT 259 (263)
T ss_dssp SGGGSCC----HHHHHTCHHHH
T ss_pred CHhHCcC----HHHHHcCcCcC
Confidence 9999999 99999999995
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.8e-60 Score=492.45 Aligned_cols=267 Identities=35% Similarity=0.709 Sum_probs=240.8
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
+++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+.+|+.++|||||+++++|.+++.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 46899999999999999999999999999999999887665555667788999999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
||||+||+|..++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||++.....
T Consensus 83 mE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~---- 156 (316)
T d1fota_ 83 MDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD---- 156 (316)
T ss_dssp ECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred eeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc----
Confidence 9999999999988876 5789999999999999999999999999999999999999999999999999843210
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
...+.
T Consensus 157 ---------------------------------------------------------------------------~~~~~ 161 (316)
T d1fota_ 157 ---------------------------------------------------------------------------VTYTL 161 (316)
T ss_dssp ---------------------------------------------------------------------------CBCCC
T ss_pred ---------------------------------------------------------------------------ccccc
Confidence 11245
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~d 531 (604)
+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.++......+|. .++.++++||.+||.+|
T Consensus 162 ~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~d 239 (316)
T d1fota_ 162 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPP--FFNEDVKDLLSRLITRD 239 (316)
T ss_dssp CSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHTCSC
T ss_pred cCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCC--CCCHHHHHHHHHHhhhC
Confidence 7999999999999999999999999999999999999999999988888999888776654 48999999999999999
Q ss_pred CCCcccc-cCCHHHHhcCCCCCCCChhhhhc
Q 007433 532 PQNRLAC-RRGATEIKQHPFFQGVNWALIRC 561 (604)
Q Consensus 532 P~~Rpt~-~~~a~elL~Hpff~~~~~~~~~~ 561 (604)
|.+|++. +..++++|+||||++++|..+..
T Consensus 240 p~~R~~~~r~t~~~il~Hp~f~~i~~~~l~~ 270 (316)
T d1fota_ 240 LSQRLGNLQNGTEDVKNHPWFKEVVWEKLLS 270 (316)
T ss_dssp TTTCTTSSTTTTHHHHTSGGGSSCCHHHHHT
T ss_pred HHhccccchhhHHHHHcCcccccCCHHHHHh
Confidence 9999853 33699999999999999997643
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.6e-59 Score=493.63 Aligned_cols=276 Identities=36% Similarity=0.665 Sum_probs=245.2
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
.+++|++++.||+|+||+||+|+++.+++.||||++.+...........+.+|+++|+.++|||||+++++|.+...+|+
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 35799999999999999999999999999999999988766555566778899999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
||||+.||+|..++.+. ..|++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||++..+..
T Consensus 119 v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~--- 193 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp EEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred ccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccc---
Confidence 99999999999998876 5799999999999999999999999999999999999999999999999999854320
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
...+
T Consensus 194 ----------------------------------------------------------------------------~~~~ 197 (350)
T d1rdqe_ 194 ----------------------------------------------------------------------------RTWT 197 (350)
T ss_dssp ----------------------------------------------------------------------------CBCC
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 1124
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
.+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+....+.++....+.++. .++.++.+||++||.+
T Consensus 198 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~~L~~ 275 (350)
T d1rdqe_ 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS--HFSSDLKDLLRNLLQV 275 (350)
T ss_dssp CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TCCHHHHHHHHHHSCS
T ss_pred ccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCc--cCCHHHHHHHHHHhhh
Confidence 57999999999999999999999999999999999999999999888888888888776664 5999999999999999
Q ss_pred CCCCcc-cccCCHHHHhcCCCCCCCChhhhhc--CCCCCCCC
Q 007433 531 EPQNRL-ACRRGATEIKQHPFFQGVNWALIRC--ASPPEIPK 569 (604)
Q Consensus 531 dP~~Rp-t~~~~a~elL~Hpff~~~~~~~~~~--~~~~~~p~ 569 (604)
||.+|+ +.+..++|||+||||++++|..+.. ..+|.+|.
T Consensus 276 dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~ 317 (350)
T d1rdqe_ 276 DLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPK 317 (350)
T ss_dssp CTTTCTTSSTTTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred CHHhccccccccHHHHHcCccccCCCHHHHHhcCCCcCccCC
Confidence 999996 3344599999999999999987643 34444543
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-59 Score=479.07 Aligned_cols=259 Identities=25% Similarity=0.413 Sum_probs=219.3
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|++++.||+|+||+||+|+++.+++.||||++++.... ....++.+|+++|++++||||++++++|.+++.+||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence 6899999999999999999999999999999999876432 22346778999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
|||+||+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|++||+|||+|..+....
T Consensus 83 Ey~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~--- 157 (271)
T d1nvra_ 83 EYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN--- 157 (271)
T ss_dssp ECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT---
T ss_pred eccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCC---
Confidence 999999999988654 579999999999999999999999999999999999999999999999999985432110
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
......+.+
T Consensus 158 -----------------------------------------------------------------------~~~~~~~~~ 166 (271)
T d1nvra_ 158 -----------------------------------------------------------------------RERLLNKMC 166 (271)
T ss_dssp -----------------------------------------------------------------------EECCBCCCC
T ss_pred -----------------------------------------------------------------------cccccccee
Confidence 001122457
Q ss_pred cCccccCcceecCCCC-CccchHHHHHHHHHHHhhCCCCCCCCChHHHH-HHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 453 GTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATL-YNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~-~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l-~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
||+.|||||++.+..+ +.++|||||||+||||++|+.||....+.... ..+.......+....++.++++||.+||.+
T Consensus 167 GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 246 (271)
T d1nvra_ 167 GTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVE 246 (271)
T ss_dssp SCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHHHHHHSCS
T ss_pred eCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHHHHHHcCC
Confidence 9999999999998876 57899999999999999999999876554433 344444444444556899999999999999
Q ss_pred CCCCcccccCCHHHHhcCCCCCC
Q 007433 531 EPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
||++||+ ++|+|+||||+.
T Consensus 247 dP~~R~t----~~eil~hpwf~~ 265 (271)
T d1nvra_ 247 NPSARIT----IPDIKKDRWYNK 265 (271)
T ss_dssp STTTSCC----HHHHTTCTTTTC
T ss_pred ChhHCcC----HHHHhcCHhhCc
Confidence 9999999 999999999963
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-59 Score=478.36 Aligned_cols=254 Identities=25% Similarity=0.419 Sum_probs=225.0
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|+++++||+|+||+||+|++..+++.||||++.+..... ...+.+|+++|+.++|||||+++++|.+++++||||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 96 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence 58999999999999999999999999999999998654332 235678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
|||+||+|.+++.+. .+++..++.|++||+.||+|||++|||||||||+||||+.+|++||+|||++..+...
T Consensus 97 Ey~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~---- 169 (293)
T d1yhwa1 97 EYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE---- 169 (293)
T ss_dssp ECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST----
T ss_pred EecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccc----
Confidence 999999999988764 5999999999999999999999999999999999999999999999999998543211
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.......+
T Consensus 170 ------------------------------------------------------------------------~~~~~~~~ 177 (293)
T d1yhwa1 170 ------------------------------------------------------------------------QSKRSTMV 177 (293)
T ss_dssp ------------------------------------------------------------------------TCCBCCCC
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 01122457
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC-CCCCCCCCCCCHHHHHHHHHhhhcC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ-PLRFPESPVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~-~~~~p~~~~~s~~l~dLI~~lL~~d 531 (604)
||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+..+... ...++.+..++.++++||.+||.+|
T Consensus 178 gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d 257 (293)
T d1yhwa1 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRCLDMD 257 (293)
T ss_dssp SCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHHHHTCSS
T ss_pred cCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHHHHccCC
Confidence 999999999999999999999999999999999999999998888777776543 3445555668999999999999999
Q ss_pred CCCcccccCCHHHHhcCCCCC
Q 007433 532 PQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 532 P~~Rpt~~~~a~elL~Hpff~ 552 (604)
|++||+ +.|+|+||||+
T Consensus 258 P~~R~s----~~eil~Hp~~~ 274 (293)
T d1yhwa1 258 VEKRGS----AKELLQHQFLK 274 (293)
T ss_dssp TTTSCC----HHHHTTCGGGG
T ss_pred hhHCcC----HHHHhcCHhhC
Confidence 999999 99999999996
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-58 Score=481.05 Aligned_cols=265 Identities=37% Similarity=0.726 Sum_probs=234.5
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHH-hCCCCCccccceeEecCCeeEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQ-SLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~-~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
++|.+++.||+|+||+||+|++..+++.||||++.+...........+.+|+.++. .++|||||+++++|.+++.+|||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 68999999999999999999999999999999998776554445556667777765 68999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
||||+||+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+|||++.+|++||+|||++......
T Consensus 82 mEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~--- 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG--- 156 (320)
T ss_dssp EECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT---
T ss_pred EeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc---
Confidence 9999999999999876 56999999999999999999999999999999999999999999999999998432110
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
.......
T Consensus 157 -------------------------------------------------------------------------~~~~~~~ 163 (320)
T d1xjda_ 157 -------------------------------------------------------------------------DAKTNTF 163 (320)
T ss_dssp -------------------------------------------------------------------------TCCBCCC
T ss_pred -------------------------------------------------------------------------ccccccc
Confidence 0111234
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~d 531 (604)
+||+.|+|||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.++....+.+|. .++.++++||++||.+|
T Consensus 164 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~--~~s~~~~dli~~~L~~d 241 (320)
T d1xjda_ 164 CGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPR--WLEKEAKDLLVKLFVRE 241 (320)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCT--TSCHHHHHHHHHHSCSS
T ss_pred CCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc--cCCHHHHHHHHHhcccC
Confidence 6999999999999999999999999999999999999999999988888888887766654 48999999999999999
Q ss_pred CCCcccccCCHH-HHhcCCCCCCCChhhhhc
Q 007433 532 PQNRLACRRGAT-EIKQHPFFQGVNWALIRC 561 (604)
Q Consensus 532 P~~Rpt~~~~a~-elL~Hpff~~~~~~~~~~ 561 (604)
|++||+ +. ||++||||++++|..+..
T Consensus 242 P~~R~s----~~~~l~~hpff~~~~~~~l~~ 268 (320)
T d1xjda_ 242 PEKRLG----VRGDIRQHPLFREINWEELER 268 (320)
T ss_dssp GGGSBT----TBSCGGGSGGGTTCCHHHHHT
T ss_pred CCCCcC----HHHHHHhCchhccCCHHHHHh
Confidence 999999 74 899999999999987643
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-58 Score=472.41 Aligned_cols=264 Identities=28% Similarity=0.464 Sum_probs=228.8
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHH---HHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKR---KKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
++|++++.||+|+||+||+|+++.+++.||||++.+...... .....+.+|+++|++|+|||||+++++|.+++++|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 689999999999999999999999999999999976543221 12346778999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC----cEEEecccccccc
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG----HIMLSDFDLSLRC 365 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g----~vkL~DFGla~~~ 365 (604)
||||||+||+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.+| .+||+|||++..+
T Consensus 90 iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~ 167 (293)
T d1jksa_ 90 LILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 167 (293)
T ss_dssp EEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhc
Confidence 999999999999999876 5799999999999999999999999999999999999998776 5999999998443
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
...
T Consensus 168 ~~~----------------------------------------------------------------------------- 170 (293)
T d1jksa_ 168 DFG----------------------------------------------------------------------------- 170 (293)
T ss_dssp TTS-----------------------------------------------------------------------------
T ss_pred CCC-----------------------------------------------------------------------------
Confidence 210
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC--CCCCCHHHHHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE--SPVVSFSARDL 523 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~--~~~~s~~l~dL 523 (604)
....+.+||+.|+|||++.+..++.++|||||||+||||++|+.||.+.+..+.+.++......++. ...++.++++|
T Consensus 171 ~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l 250 (293)
T d1jksa_ 171 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDF 250 (293)
T ss_dssp CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSCHHHHHH
T ss_pred ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCCHHHHHH
Confidence 0112356999999999999999999999999999999999999999999999999998887766553 25689999999
Q ss_pred HHHhhhcCCCCcccccCCHHHHhcCCCCCCCChhhh
Q 007433 524 IKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWALI 559 (604)
Q Consensus 524 I~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~~~ 559 (604)
|++||.+||++||+ ++|+|+||||+..+|...
T Consensus 251 i~~~L~~dP~~R~s----~~eil~hp~~~~~~~~~~ 282 (293)
T d1jksa_ 251 IRRLLVKDPKKRMT----IQDSLQHPWIKPKDTQQA 282 (293)
T ss_dssp HHTTSCSSGGGSCC----HHHHHHSTTTCC------
T ss_pred HHHHccCChhHCcC----HHHHhcCcccCCCChhHh
Confidence 99999999999999 999999999999888644
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.8e-58 Score=477.27 Aligned_cols=257 Identities=32% Similarity=0.512 Sum_probs=215.1
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++++.||+|+||+||+|+++.+++.||||++.+...... ...+.+|+.+|+.++|||||+++++|.+++.+|||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~--~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK--EGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhH--HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 3679999999999999999999999999999999987654332 24567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEc---cCCcEEEecccccccccCC
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVR---EDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~---~~g~vkL~DFGla~~~~~~ 368 (604)
||||+||+|.+++... ..|++..++.|+.||+.||+|||++|||||||||+|||+. .+|.+||+|||++.....
T Consensus 86 mE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~- 162 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP- 162 (307)
T ss_dssp ECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred EeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccC-
Confidence 9999999999999775 5799999999999999999999999999999999999995 478999999999843210
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
....
T Consensus 163 ----------------------------------------------------------------------------~~~~ 166 (307)
T d1a06a_ 163 ----------------------------------------------------------------------------GSVL 166 (307)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ----------------------------------------------------------------------------CCee
Confidence 0012
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC--CCCCCCHHHHHHHHH
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFP--ESPVVSFSARDLIKG 526 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p--~~~~~s~~l~dLI~~ 526 (604)
.+.+||+.|||||++.+..|+.++|||||||+||||++|+.||.+....+...++......++ ....+|+++++||.+
T Consensus 167 ~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ 246 (307)
T d1a06a_ 167 STACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRH 246 (307)
T ss_dssp ------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHHH
T ss_pred eeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHHHHH
Confidence 245799999999999999999999999999999999999999999988888888887766554 345789999999999
Q ss_pred hhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 527 LLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 527 lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
||.+||++||+ +.|+|+||||++
T Consensus 247 ~L~~dP~~R~s----~~eil~hp~~~~ 269 (307)
T d1a06a_ 247 LMEKDPEKRFT----CEQALQHPWIAG 269 (307)
T ss_dssp HSCSSGGGSCC----HHHHHHSTTTTS
T ss_pred HccCCHhHCcC----HHHHhcCHhhCC
Confidence 99999999999 999999999975
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-59 Score=486.48 Aligned_cols=261 Identities=26% Similarity=0.404 Sum_probs=218.1
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
..++|+++++||+|+||+||+|++..+++.||||++++.... ....++.+|+.+|+.++|||||+++++|.+++++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT--THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCH--HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 457899999999999999999999999999999999765322 223467789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH-cCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM-LGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
|||||+||+|.+++.+. ..+++..++.++.||+.||.|||+ +|||||||||+||||+.+|++||+|||+|..+..
T Consensus 82 VmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~-- 157 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-- 157 (322)
T ss_dssp EEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH--
T ss_pred EEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC--
Confidence 99999999999999876 569999999999999999999997 5999999999999999999999999999853210
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
....
T Consensus 158 ----------------------------------------------------------------------------~~~~ 161 (322)
T d1s9ja_ 158 ----------------------------------------------------------------------------SMAN 161 (322)
T ss_dssp ----------------------------------------------------------------------------HTC-
T ss_pred ----------------------------------------------------------------------------Cccc
Confidence 0122
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHH-----------------------------
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATL----------------------------- 500 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l----------------------------- 500 (604)
+++||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+.....
T Consensus 162 ~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (322)
T d1s9ja_ 162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG 241 (322)
T ss_dssp --CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------------
T ss_pred cccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccc
Confidence 468999999999999999999999999999999999999999875432211
Q ss_pred -------------HHHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 501 -------------YNVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 501 -------------~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
..+............++.+++|||.+||++||++||| ++|+|+||||+..+|.
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~t----a~e~L~Hpf~~~~~~~ 307 (322)
T d1s9ja_ 242 MDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD----LKQLMVHAFIKRSDAE 307 (322)
T ss_dssp ----CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCC----HHHHHTSHHHHHHHHS
T ss_pred cccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcC----HHHHhhCHhhCcCCcc
Confidence 0111111111111246889999999999999999999 9999999999876654
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=7.7e-58 Score=482.24 Aligned_cols=261 Identities=28% Similarity=0.436 Sum_probs=231.2
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
+++|++++.||+|+||+||+|++..+++.||||++.+..... ...+.+|+.+|++|+|||||+++++|.+++.+|||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 101 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMI 101 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHH---HHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhh---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 479999999999999999999999999999999998765432 34567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc--CCcEEEecccccccccCCC
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE--DGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~--~g~vkL~DFGla~~~~~~~ 369 (604)
||||+||+|.+++.... ..+++..++.|+.||+.||+|||++|||||||||+||||+. +|.+||+|||++..+...
T Consensus 102 mE~~~gg~L~~~l~~~~-~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~- 179 (350)
T d1koaa2 102 YEFMSGGELFEKVADEH-NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179 (350)
T ss_dssp ECCCCSCBHHHHHTCTT-SCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred EEcCCCCCHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence 99999999999886542 46999999999999999999999999999999999999964 678999999998543210
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
....
T Consensus 180 ----------------------------------------------------------------------------~~~~ 183 (350)
T d1koaa2 180 ----------------------------------------------------------------------------QSVK 183 (350)
T ss_dssp ----------------------------------------------------------------------------SCEE
T ss_pred ----------------------------------------------------------------------------cccc
Confidence 1122
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCC--CCCCHHHHHHHHHh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPES--PVVSFSARDLIKGL 527 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~--~~~s~~l~dLI~~l 527 (604)
..+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.++......++.. ..++.++++||.+|
T Consensus 184 ~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 263 (350)
T d1koaa2 184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKL 263 (350)
T ss_dssp EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHHHH
T ss_pred eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence 4579999999999999999999999999999999999999999998888898888877665543 45899999999999
Q ss_pred hhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 528 LVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
|++||++||| ++|+|+||||+..+|.
T Consensus 264 L~~dP~~R~t----~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 264 LLADPNTRMT----IHQALEHPWLTPGNAP 289 (350)
T ss_dssp CCSSGGGSCC----HHHHHHSTTTSCTTCC
T ss_pred ccCChhHCcC----HHHHhcCcccCCCCCC
Confidence 9999999999 9999999999987764
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.5e-57 Score=482.62 Aligned_cols=276 Identities=33% Similarity=0.630 Sum_probs=228.8
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHH---HHHHHHHHHHHhCCCCCccccceeEecCCee
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKL---LRAQTEREILQSLDHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~---~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 288 (604)
+++|++++.||+|+||+||+|++..+++.||||++.+......... .+..+|+.+|+.++|||||+++++|.+++.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 5799999999999999999999999999999999987655433322 2333457778888999999999999999999
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|||||||+||+|.+++.+. ..+++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||+|..+..
T Consensus 83 ~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~- 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK- 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS-
T ss_pred EEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC-
Confidence 9999999999999999876 5789999999999999999999999999999999999999999999999999843221
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
...
T Consensus 160 -----------------------------------------------------------------------------~~~ 162 (364)
T d1omwa3 160 -----------------------------------------------------------------------------KKP 162 (364)
T ss_dssp -----------------------------------------------------------------------------SCC
T ss_pred -----------------------------------------------------------------------------Ccc
Confidence 011
Q ss_pred cccccCccccCcceec-CCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHH---HHHHHcCCCCCCCCCCCCHHHHHHH
Q 007433 449 MSFVGTHEYLAPEIIK-GEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRAT---LYNVVGQPLRFPESPVVSFSARDLI 524 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~-~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~---l~~i~~~~~~~p~~~~~s~~l~dLI 524 (604)
...+||+.|||||++. +..|+.++|||||||+||||++|+.||.+...... ...+......+ +..++.++++||
T Consensus 163 ~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~li 240 (364)
T d1omwa3 163 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL--PDSFSPELRSLL 240 (364)
T ss_dssp CSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCC--CSSSCHHHHHHH
T ss_pred cccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCC--CCCCCHHHHHHH
Confidence 2346999999999986 46789999999999999999999999987543322 22223333333 345999999999
Q ss_pred HHhhhcCCCCcccc-cCCHHHHhcCCCCCCCChhhhhc--CCCCCCCC
Q 007433 525 KGLLVKEPQNRLAC-RRGATEIKQHPFFQGVNWALIRC--ASPPEIPK 569 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~-~~~a~elL~Hpff~~~~~~~~~~--~~~~~~p~ 569 (604)
.+||.+||++||++ ...++|+|+||||++++|..+.. ..+|.+|.
T Consensus 241 ~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~ 288 (364)
T d1omwa3 241 EGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIPP 288 (364)
T ss_dssp HHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCC
T ss_pred HHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHHhcCCCCcCcCCC
Confidence 99999999999995 45689999999999999987643 33444443
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-58 Score=475.87 Aligned_cols=255 Identities=28% Similarity=0.390 Sum_probs=227.7
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
..|++++.||+|+||+||+|++..+++.||||++.+...........+.+|+++|++|+|||||+++++|.+++.+||||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 35999999999999999999999999999999998776655666677889999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
|||.+|+|..++... ..+++..++.|+.||+.||.|||++|||||||||+||||+.+|++||+|||++....
T Consensus 95 E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~------ 166 (309)
T d1u5ra_ 95 EYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA------ 166 (309)
T ss_dssp ECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSS------
T ss_pred EecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccC------
Confidence 999999998766654 579999999999999999999999999999999999999999999999999983211
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.....+
T Consensus 167 --------------------------------------------------------------------------~~~~~~ 172 (309)
T d1u5ra_ 167 --------------------------------------------------------------------------PANSFV 172 (309)
T ss_dssp --------------------------------------------------------------------------SBCCCC
T ss_pred --------------------------------------------------------------------------CCCccc
Confidence 012346
Q ss_pred cCccccCcceecCC---CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 453 GTHEYLAPEIIKGE---GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 453 GT~~Y~APE~l~~~---~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
||+.|||||++.+. .|+.++|||||||+||||++|+.||.+....+.+.++............+++++++||.+||.
T Consensus 173 GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~li~~~L~ 252 (309)
T d1u5ra_ 173 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNFVDSCLQ 252 (309)
T ss_dssp SCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHHHHHHTC
T ss_pred cCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHHHHHHCc
Confidence 99999999999753 478999999999999999999999999888888888877665555556789999999999999
Q ss_pred cCCCCcccccCCHHHHhcCCCCCC
Q 007433 530 KEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
+||++||| ++|+|+||||..
T Consensus 253 ~dP~~Rpt----~~ell~Hp~~~~ 272 (309)
T d1u5ra_ 253 KIPQDRPT----SEVLLKHRFVLR 272 (309)
T ss_dssp SSGGGSCC----HHHHTTCHHHHS
T ss_pred CChhHCcC----HHHHHhCHHhcC
Confidence 99999999 999999999953
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-58 Score=473.36 Aligned_cols=257 Identities=29% Similarity=0.444 Sum_probs=224.2
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
+.|++++.||+|+||+||+|++..+++.||||++.+.... ....+.+|+++|++|+|||||+++++|.+++.+||||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG---GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHH---HHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEE
Confidence 5799999999999999999999999999999999765322 2345678999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
|||+||+|..++.+. +..|++..++.|+.||+.||+|||++|||||||||+||||+.+|.+||+|||++......
T Consensus 89 Ey~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~---- 163 (288)
T d2jfla1 89 EFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT---- 163 (288)
T ss_dssp ECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH----
T ss_pred ecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCC----
Confidence 999999999987764 256999999999999999999999999999999999999999999999999998432100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.....+.+
T Consensus 164 ------------------------------------------------------------------------~~~~~~~~ 171 (288)
T d2jfla1 164 ------------------------------------------------------------------------IQRRDSFI 171 (288)
T ss_dssp ------------------------------------------------------------------------HHHHTCCC
T ss_pred ------------------------------------------------------------------------cccccccc
Confidence 00112457
Q ss_pred cCccccCcceec-----CCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCC-CCCCCCCCCCHHHHHHHHH
Q 007433 453 GTHEYLAPEIIK-----GEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQP-LRFPESPVVSFSARDLIKG 526 (604)
Q Consensus 453 GT~~Y~APE~l~-----~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~-~~~p~~~~~s~~l~dLI~~ 526 (604)
||+.|||||++. +..|+.++|||||||+||||++|+.||.+.+..+.+.++.... ..+.....++.++++||.+
T Consensus 172 Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~~li~~ 251 (288)
T d2jfla1 172 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSNFKDFLKK 251 (288)
T ss_dssp SCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSSGGGSCHHHHHHHHH
T ss_pred cccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence 999999999984 4567899999999999999999999999988888888887654 3344455689999999999
Q ss_pred hhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 527 LLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 527 lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
||.+||++||| +.|+|+||||+.
T Consensus 252 ~L~~dp~~R~t----~~ell~hp~~~~ 274 (288)
T d2jfla1 252 CLEKNVDARWT----TSQLLQHPFVTV 274 (288)
T ss_dssp HSCSSTTTSCC----HHHHTTSGGGCC
T ss_pred HccCChhHCcC----HHHHhcCcccCC
Confidence 99999999999 999999999974
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-58 Score=464.80 Aligned_cols=257 Identities=25% Similarity=0.388 Sum_probs=214.9
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec--CCeeEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET--DKFSCL 290 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~--~~~~~l 290 (604)
++|++++.||+|+||+||+|+++.+++.||||++.+..... .....+.+|+++|++++|||||+++++|.+ ++.+||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTE-AEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCH-HHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCH-HHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 68999999999999999999999999999999998765543 334567899999999999999999999864 567899
Q ss_pred EEeecCCCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHcC-----eEeccCCCCcEEEccCCcEEEecccccc
Q 007433 291 VMEFCPGGDLHTLRQRQ--PGKYFSEQAVKFYVAEVLLALEYLHMLG-----IVYRDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~--~~~~l~e~~~~~i~~qil~aL~yLH~~g-----IvHrDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
|||||+||+|.+++.+. .+..+++..++.|+.||+.||+|||++| ||||||||+||||+.+|.+||+|||++.
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999988642 2467999999999999999999999976 9999999999999999999999999985
Q ss_pred cccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCC
Q 007433 364 RCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEP 443 (604)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (604)
.+...
T Consensus 163 ~~~~~--------------------------------------------------------------------------- 167 (269)
T d2java1 163 ILNHD--------------------------------------------------------------------------- 167 (269)
T ss_dssp HC------------------------------------------------------------------------------
T ss_pred ecccC---------------------------------------------------------------------------
Confidence 43210
Q ss_pred CCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHH
Q 007433 444 TNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDL 523 (604)
Q Consensus 444 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dL 523 (604)
.....+.+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.++...... +.+..++.++++|
T Consensus 168 -~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~s~~l~~l 245 (269)
T d2java1 168 -TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFR-RIPYRYSDELNEI 245 (269)
T ss_dssp ---------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC-CCCTTSCHHHHHH
T ss_pred -CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCC-CCCcccCHHHHHH
Confidence 01122457999999999999999999999999999999999999999998888888888766543 2234589999999
Q ss_pred HHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 524 IKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 524 I~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
|.+||..||++||+ +.|||+|||+
T Consensus 246 i~~~L~~dp~~Rps----~~ell~hp~i 269 (269)
T d2java1 246 ITRMLNLKDYHRPS----VEEILENPLI 269 (269)
T ss_dssp HHHHTCSSGGGSCC----HHHHHTSTTC
T ss_pred HHHHcCCChhHCcC----HHHHHhCCcC
Confidence 99999999999999 9999999995
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.7e-57 Score=477.36 Aligned_cols=259 Identities=31% Similarity=0.459 Sum_probs=229.6
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++++.||+|+||+||+|++..+++.||||++.+..... ...+.+|+++|++|+|||||+++++|.+++.+|||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 104 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLI 104 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 368999999999999999999999999999999998764333 23567899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEc--cCCcEEEecccccccccCCC
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVR--EDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~--~~g~vkL~DFGla~~~~~~~ 369 (604)
||||+||+|.+++... +..|++..++.|+.||+.||+|||++|||||||||+||||+ .+|.+||+|||++..+...
T Consensus 105 mE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~- 182 (352)
T d1koba_ 105 LEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182 (352)
T ss_dssp EECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred EEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCC-
Confidence 9999999999876554 35699999999999999999999999999999999999998 5789999999998543210
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
....
T Consensus 183 ----------------------------------------------------------------------------~~~~ 186 (352)
T d1koba_ 183 ----------------------------------------------------------------------------EIVK 186 (352)
T ss_dssp ----------------------------------------------------------------------------SCEE
T ss_pred ----------------------------------------------------------------------------Ccee
Confidence 1122
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC--CCCCCHHHHHHHHHh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE--SPVVSFSARDLIKGL 527 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~--~~~~s~~l~dLI~~l 527 (604)
...||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.++....+.++. ...++.++++||.+|
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 266 (352)
T d1koba_ 187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNL 266 (352)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHHTT
T ss_pred eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHHHH
Confidence 456999999999999999999999999999999999999999999999999988887766554 356899999999999
Q ss_pred hhcCCCCcccccCCHHHHhcCCCCCCCC
Q 007433 528 LVKEPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
|++||.+||+ +.|+|+||||++..
T Consensus 267 L~~dp~~R~s----~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 267 LQKEPRKRLT----VHDALEHPWLKGDH 290 (352)
T ss_dssp SCSSGGGSCC----HHHHHTSTTTSSCC
T ss_pred ccCChhHCcC----HHHHhcCHhhCCCc
Confidence 9999999999 99999999998753
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-57 Score=459.66 Aligned_cols=254 Identities=26% Similarity=0.453 Sum_probs=215.6
Q ss_pred cCe-EEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec----CCe
Q 007433 213 GHF-RLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET----DKF 287 (604)
Q Consensus 213 ~~y-~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~----~~~ 287 (604)
++| ++.++||+|+||+||+|++..++..||+|++....... ....++.+|+++|++++|||||+++++|++ +..
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 86 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 86 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCH-HHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCE
Confidence 455 77889999999999999999999999999997765433 334567899999999999999999999874 457
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcC--eEeccCCCCcEEEc-cCCcEEEeccccccc
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLG--IVYRDLKPENVLVR-EDGHIMLSDFDLSLR 364 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~g--IvHrDIKpeNILl~-~~g~vkL~DFGla~~ 364 (604)
+|||||||+||+|.+++.+. ..+++..++.|+.||+.||+|||++| ||||||||+||||+ .++.+||+|||++..
T Consensus 87 ~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 87 IVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence 89999999999999999876 57999999999999999999999999 99999999999997 578999999999832
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
..
T Consensus 165 ~~------------------------------------------------------------------------------ 166 (270)
T d1t4ha_ 165 KR------------------------------------------------------------------------------ 166 (270)
T ss_dssp CC------------------------------------------------------------------------------
T ss_pred cc------------------------------------------------------------------------------
Confidence 11
Q ss_pred CCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC-CCCCCCCCCHHHHHH
Q 007433 445 NARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPL-RFPESPVVSFSARDL 523 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~-~~p~~~~~s~~l~dL 523 (604)
.....+.+||+.|||||++.+ .|+.++|||||||+||||++|+.||.+..+...+.+.+.... .......+++++++|
T Consensus 167 ~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~l 245 (270)
T d1t4ha_ 167 ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEI 245 (270)
T ss_dssp TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCHHHHHH
T ss_pred CCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCccCCHHHHHH
Confidence 011224579999999999876 599999999999999999999999988766666555444332 222334578999999
Q ss_pred HHHhhhcCCCCcccccCCHHHHhcCCCCC
Q 007433 524 IKGLLVKEPQNRLACRRGATEIKQHPFFQ 552 (604)
Q Consensus 524 I~~lL~~dP~~Rpt~~~~a~elL~Hpff~ 552 (604)
|.+||.+||++||| ++|+|+||||+
T Consensus 246 i~~~l~~dp~~R~s----~~ell~Hp~fk 270 (270)
T d1t4ha_ 246 IEGCIRQNKDERYS----IKDLLNHAFFQ 270 (270)
T ss_dssp HHHHSCSSGGGSCC----HHHHHTSGGGC
T ss_pred HHHHccCCHhHCcC----HHHHhCCcccC
Confidence 99999999999999 99999999996
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=9.4e-56 Score=451.67 Aligned_cols=258 Identities=31% Similarity=0.457 Sum_probs=226.4
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHH------HHHHHHHHHHHHHHHHhCC-CCCccccceeEecC
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLE------KRKKLLRAQTEREILQSLD-HPFLPTLYTHFETD 285 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~------~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~ 285 (604)
++|++++.||+|+||+||+|++..+++.||||++.+.... ......++.+|+.+|++|+ ||||++++++|.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999999999999999999765321 1233456789999999997 99999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
+++|||||||+||+|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++..+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 9999999999999999999876 57999999999999999999999999999999999999999999999999998543
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
...
T Consensus 161 ~~~----------------------------------------------------------------------------- 163 (277)
T d1phka_ 161 DPG----------------------------------------------------------------------------- 163 (277)
T ss_dssp CTT-----------------------------------------------------------------------------
T ss_pred cCC-----------------------------------------------------------------------------
Confidence 210
Q ss_pred CcccccccCccccCcceecC------CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCC--CCCCC
Q 007433 446 ARSMSFVGTHEYLAPEIIKG------EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPE--SPVVS 517 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~------~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~--~~~~s 517 (604)
......+||+.|+|||++.+ ..++.++|||||||+||||++|+.||.+.+....+.++......++. ...+|
T Consensus 164 ~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 243 (277)
T d1phka_ 164 EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYS 243 (277)
T ss_dssp CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGGGSC
T ss_pred CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccccCC
Confidence 11123579999999999864 34688999999999999999999999999888888888877655443 34689
Q ss_pred HHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 518 FSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 518 ~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
+++++||.+||.+||++||+ ++|||+||||+.
T Consensus 244 ~~~~~li~~~L~~~p~~R~s----~~eil~h~~~~~ 275 (277)
T d1phka_ 244 DTVKDLVSRFLVVQPQKRYT----AEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHHHHHCCSSGGGSCC----HHHHTTSGGGCT
T ss_pred HHHHHHHHHHccCChhHCcC----HHHHHcCHHHHH
Confidence 99999999999999999999 999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-56 Score=462.85 Aligned_cols=256 Identities=26% Similarity=0.414 Sum_probs=227.0
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|++++.||+|+||+||+|.+..+++.||||++++..... ..+.+|+++|+.++|||||+++++|++++++|||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~----~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lv 79 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIARHRNILHLHESFESMEELVMI 79 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHH----HHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccH----HHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 478999999999999999999999999999999998764332 3466899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccC--CcEEEecccccccccCCC
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRED--GHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~--g~vkL~DFGla~~~~~~~ 369 (604)
||||+||+|.+++... +..+++..++.|+.||+.||+|||++|||||||||+||||+.+ +.+||+|||++......
T Consensus 80 mE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~- 157 (321)
T d1tkia_ 80 FEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG- 157 (321)
T ss_dssp ECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred EecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence 9999999999998765 3469999999999999999999999999999999999999854 48999999998432210
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
....
T Consensus 158 ----------------------------------------------------------------------------~~~~ 161 (321)
T d1tkia_ 158 ----------------------------------------------------------------------------DNFR 161 (321)
T ss_dssp ----------------------------------------------------------------------------CEEE
T ss_pred ----------------------------------------------------------------------------Cccc
Confidence 0112
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCC--CCCCHHHHHHHHHh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPES--PVVSFSARDLIKGL 527 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~--~~~s~~l~dLI~~l 527 (604)
..+||+.|+|||++.+..|+.++|||||||+||+|++|+.||.+.+..+.+.++....+.++.. ..++.++++||.+|
T Consensus 162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~ 241 (321)
T d1tkia_ 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRL 241 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHTT
T ss_pred ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHHH
Confidence 3569999999999999999999999999999999999999999999999999998877766542 46899999999999
Q ss_pred hhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 528 LVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
|.+||++||+ +.|+|+||||+.
T Consensus 242 L~~dp~~R~s----~~eil~hp~~~~ 263 (321)
T d1tkia_ 242 LVKERKSRMT----ASEALQHPWLKQ 263 (321)
T ss_dssp SCSSGGGSCC----HHHHHHSHHHHS
T ss_pred ccCChhHCcC----HHHHhcCHhhcc
Confidence 9999999999 999999999964
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-55 Score=454.81 Aligned_cols=256 Identities=29% Similarity=0.403 Sum_probs=210.0
Q ss_pred EEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHH--HHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEEee
Q 007433 217 LLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKR--KKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVMEF 294 (604)
Q Consensus 217 l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~--~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~E~ 294 (604)
.++.||+|+||+||+|+++.+++.||||++++...... ....++.+|+++|+.++|||||+++++|.+++++||||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 46899999999999999999999999999976543322 2234677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccccc
Q 007433 295 CPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVVKS 374 (604)
Q Consensus 295 ~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~~~ 374 (604)
|.++++..++.. +..+++..++.|++||+.||+|||++|||||||||+|||++.+|.+||+|||++..+...
T Consensus 82 ~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~------ 153 (299)
T d1ua2a_ 82 METDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP------ 153 (299)
T ss_dssp CSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC------
T ss_pred hcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCC------
Confidence 988777665543 367999999999999999999999999999999999999999999999999998432210
Q ss_pred CcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccccC
Q 007433 375 STLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFVGT 454 (604)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT 454 (604)
.......+||
T Consensus 154 ----------------------------------------------------------------------~~~~~~~~gt 163 (299)
T d1ua2a_ 154 ----------------------------------------------------------------------NRAYTHQVVT 163 (299)
T ss_dssp ----------------------------------------------------------------------CCCCCCSCCC
T ss_pred ----------------------------------------------------------------------cccccceecC
Confidence 0112245799
Q ss_pred ccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---CCC-----------------CCC-
Q 007433 455 HEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---PLR-----------------FPE- 512 (604)
Q Consensus 455 ~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~~~-----------------~p~- 512 (604)
+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.++.+.+.++... +.. ++.
T Consensus 164 ~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (299)
T d1ua2a_ 164 RWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGI 243 (299)
T ss_dssp CTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCC
T ss_pred hhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCC
Confidence 999999998755 5799999999999999999999999999888887766531 100 000
Q ss_pred -----CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 513 -----SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 513 -----~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
...++.++++||.+||++||++||| ++|+|+||||++.
T Consensus 244 ~~~~~~~~~s~~~~dll~~~L~~dP~~R~s----a~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 244 PLHHIFSAAGDDLLDLIQGLFLFNPCARIT----ATQALKMKYFSNR 286 (299)
T ss_dssp CHHHHCTTCCHHHHHHHHHHHCSSTTTSCC----HHHHHTSGGGTSS
T ss_pred ChHHhcccCCHHHHHHHHHHccCChhhCcC----HHHHhCCHhhCCC
Confidence 1246789999999999999999999 9999999999753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.5e-55 Score=450.03 Aligned_cols=260 Identities=29% Similarity=0.443 Sum_probs=216.5
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|+++++||+|+||+||+|++..+++.||||++...... .....++.+|+++|++++|||||+++++|.+++++|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTET-EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEE
Confidence 6899999999999999999999999999999999765432 233456788999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
|||. +.+..++.......+++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~---- 155 (298)
T d1gz8a_ 81 EFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP---- 155 (298)
T ss_dssp ECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC----
T ss_pred eecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCC----
Confidence 9995 56666666555678999999999999999999999999999999999999999999999999998543211
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.......+
T Consensus 156 ------------------------------------------------------------------------~~~~~~~~ 163 (298)
T d1gz8a_ 156 ------------------------------------------------------------------------VRTYTHEV 163 (298)
T ss_dssp ------------------------------------------------------------------------SBCTTCCB
T ss_pred ------------------------------------------------------------------------cccceeec
Confidence 01122347
Q ss_pred cCccccCcceecCCCC-CccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---CCC---------------CCC-
Q 007433 453 GTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---PLR---------------FPE- 512 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~-~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~~~---------------~p~- 512 (604)
||+.|+|||++....+ +.++|||||||++|+|++|+.||.+.+..+.+.++... +.. ++.
T Consensus 164 gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (298)
T d1gz8a_ 164 VTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKW 243 (298)
T ss_dssp CCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCC
T ss_pred ccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccc
Confidence 9999999999887764 78999999999999999999999998888877765421 100 000
Q ss_pred --------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 513 --------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 513 --------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
...++.++++||++||.+||++||| +.|||+||||+++
T Consensus 244 ~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t----~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 244 ARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRIS----AKAALAHPFFQDV 289 (298)
T ss_dssp CCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGTTC
T ss_pred cccchhhhccCCCHHHHHHHHHHccCChhHCcC----HHHHhCCHhhccC
Confidence 1246788999999999999999999 9999999999865
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-55 Score=456.56 Aligned_cols=253 Identities=28% Similarity=0.441 Sum_probs=211.3
Q ss_pred ecCeEEEEE-EccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHH-hCCCCCccccceeEec----C
Q 007433 212 VGHFRLLKK-LGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQ-SLDHPFLPTLYTHFET----D 285 (604)
Q Consensus 212 ~~~y~l~~~-LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~-~l~HpnIv~l~~~~~~----~ 285 (604)
.++|+++.+ ||+|+||+||+|++..+++.||||++++.. ...+|++++. .++|||||+++++|++ +
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~--------~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~ 81 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYENLYAGR 81 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCcH--------HHHHHHHHHHHhcCCCCCCeEEEEEeecccCC
Confidence 479999865 999999999999999999999999997542 3457998865 4589999999999975 5
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc---CCcEEEeccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE---DGHIMLSDFDLS 362 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~---~g~vkL~DFGla 362 (604)
.++|||||||+||+|.+++.......|++..++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|||++
T Consensus 82 ~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 82 KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred CEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccccccccccccccccccccccee
Confidence 77999999999999999998765568999999999999999999999999999999999999985 567999999998
Q ss_pred ccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccC
Q 007433 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442 (604)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (604)
..+...
T Consensus 162 ~~~~~~-------------------------------------------------------------------------- 167 (335)
T d2ozaa1 162 KETTSH-------------------------------------------------------------------------- 167 (335)
T ss_dssp EECCCC--------------------------------------------------------------------------
T ss_pred eeccCC--------------------------------------------------------------------------
Confidence 433210
Q ss_pred CCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHH----HcCCCCCCCC--CCC
Q 007433 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNV----VGQPLRFPES--PVV 516 (604)
Q Consensus 443 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i----~~~~~~~p~~--~~~ 516 (604)
......+||+.|||||++.+..|+.++|||||||+||+|++|+.||.+.+.......+ ....+.++.. ..+
T Consensus 168 ---~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 244 (335)
T d2ozaa1 168 ---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 244 (335)
T ss_dssp ---CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHS
T ss_pred ---CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccC
Confidence 0112346999999999999999999999999999999999999999876654443333 2333444432 358
Q ss_pred CHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 517 SFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 517 s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
+.++++||++||++||++||+ +.|+|+||||..
T Consensus 245 s~~~~~li~~~L~~dP~~R~s----~~eil~hp~~~~ 277 (335)
T d2ozaa1 245 SEEVKMLIRNLLKTEPTQRMT----ITEFMNHPWIMQ 277 (335)
T ss_dssp CHHHHHHHHHHSCSSTTTSCC----HHHHHHSHHHHT
T ss_pred CHHHHHHHHHHccCChhHCcC----HHHHHcCHHhhC
Confidence 899999999999999999999 999999999953
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-54 Score=441.76 Aligned_cols=255 Identities=20% Similarity=0.288 Sum_probs=221.1
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
+..++|++.++||+|+||+||+|++..+++.||||+++++... ..++.+|+++|++++|||||+++++|.+++.+|
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME----VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFY 89 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch----HHHHHHHHHHHHhCCCCCEecCCccEeeCCeeE
Confidence 4457899999999999999999999999999999999766432 235678999999999999999999999999999
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
||||||++|+|..++.......+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++.......
T Consensus 90 iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~ 169 (287)
T d1opja_ 90 IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDT 169 (287)
T ss_dssp EEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSS
T ss_pred EEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCC
Confidence 99999999999999987767789999999999999999999999999999999999999999999999999984322100
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
.....
T Consensus 170 ---------------------------------------------------------------------------~~~~~ 174 (287)
T d1opja_ 170 ---------------------------------------------------------------------------YTAHA 174 (287)
T ss_dssp ---------------------------------------------------------------------------SEEET
T ss_pred ---------------------------------------------------------------------------ceeec
Confidence 00111
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
...||+.|+|||++.+..|+.++|||||||+||||++|..||....+...+.+++....+.+.+..++.++++||.+||.
T Consensus 175 ~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~ 254 (287)
T d1opja_ 175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMRACWQ 254 (287)
T ss_dssp TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCCCccchHHHHHHHHHHcC
Confidence 23589999999999999999999999999999999997777665556666666666666666667799999999999999
Q ss_pred cCCCCcccccCCHHHHhc
Q 007433 530 KEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~ 547 (604)
.||++||+ +.||++
T Consensus 255 ~dP~~Rps----~~ei~~ 268 (287)
T d1opja_ 255 WNPSDRPS----FAEIHQ 268 (287)
T ss_dssp SSGGGSCC----HHHHHH
T ss_pred CCHhHCcC----HHHHHH
Confidence 99999999 888876
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.1e-55 Score=443.14 Aligned_cols=250 Identities=27% Similarity=0.407 Sum_probs=211.5
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHH---HHHHHHHHHHHHHHhCC--CCCccccceeEecCCe
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKR---KKLLRAQTEREILQSLD--HPFLPTLYTHFETDKF 287 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~---~~~~~~~~Ei~iL~~l~--HpnIv~l~~~~~~~~~ 287 (604)
++|++.+.||+|+||+||+|++..+++.||||++.+...... ....++.+|+.+|++++ |||||+++++|.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 689999999999999999999999999999999986543211 11123457999999986 8999999999999999
Q ss_pred eEEEEeecCC-CCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc-CCcEEEecccccccc
Q 007433 288 SCLVMEFCPG-GDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE-DGHIMLSDFDLSLRC 365 (604)
Q Consensus 288 ~~lV~E~~~g-gsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~-~g~vkL~DFGla~~~ 365 (604)
.|+||||+.+ ++|.+++... ..+++..++.|+.||+.||+|||++|||||||||+||||+. ++.+||+|||++...
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~ 161 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL 161 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence 9999999976 6888887765 57999999999999999999999999999999999999985 479999999998432
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
..
T Consensus 162 ~~------------------------------------------------------------------------------ 163 (273)
T d1xwsa_ 162 KD------------------------------------------------------------------------------ 163 (273)
T ss_dssp CS------------------------------------------------------------------------------
T ss_pred cc------------------------------------------------------------------------------
Confidence 10
Q ss_pred CcccccccCccccCcceecCCCC-CccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGH-GSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLI 524 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~-~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI 524 (604)
....+++||+.|+|||++.+..+ +.++|||||||+||||++|+.||.+.+ ++......++ ..+|.++++||
T Consensus 164 ~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~--~~~s~~~~~li 235 (273)
T d1xwsa_ 164 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR--QRVSSECQHLI 235 (273)
T ss_dssp SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS--SCCCHHHHHHH
T ss_pred ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCC--CCCCHHHHHHH
Confidence 01124579999999999988765 577999999999999999999998632 2344444444 35899999999
Q ss_pred HHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
.+||.+||++||| ++|+|+||||+++
T Consensus 236 ~~~L~~dp~~R~s----~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 236 RWCLALRPSDRPT----FEEIQNHPWMQDV 261 (273)
T ss_dssp HHHTCSSGGGSCC----HHHHHTSGGGSSC
T ss_pred HHHccCCHhHCcC----HHHHhcCHhhCCC
Confidence 9999999999999 9999999999865
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-54 Score=443.80 Aligned_cols=262 Identities=26% Similarity=0.384 Sum_probs=212.4
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCC-ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC---CCCCccccceeEec---
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGT-KCYFAMKVMDKASLEKRKKLLRAQTEREILQSL---DHPFLPTLYTHFET--- 284 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~-~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l---~HpnIv~l~~~~~~--- 284 (604)
.++|+++++||+|+||+||+|++..+ ++.||||++....... .....+.+|+.+|+.| +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 36999999999999999999999765 6789999997653321 1112344677776655 89999999999853
Q ss_pred --CCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 285 --DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 285 --~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
+.++|+|||||.++.+.... ......+++..++.|+.||+.||+|||++|||||||||+|||++.+|.+||+|||++
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~ 163 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 163 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred ccCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhh
Confidence 45789999999776665443 344578999999999999999999999999999999999999999999999999987
Q ss_pred ccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccC
Q 007433 363 LRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAE 442 (604)
Q Consensus 363 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 442 (604)
.....
T Consensus 164 ~~~~~--------------------------------------------------------------------------- 168 (305)
T d1blxa_ 164 RIYSF--------------------------------------------------------------------------- 168 (305)
T ss_dssp CCCCG---------------------------------------------------------------------------
T ss_pred hhhcc---------------------------------------------------------------------------
Confidence 32110
Q ss_pred CCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC---CCC--C-------
Q 007433 443 PTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ---PLR--F------- 510 (604)
Q Consensus 443 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~---~~~--~------- 510 (604)
.......+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.++... +.. +
T Consensus 169 --~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 246 (305)
T d1blxa_ 169 --QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALP 246 (305)
T ss_dssp --GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSC
T ss_pred --cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccch
Confidence 00122457999999999999999999999999999999999999999998888877766421 100 0
Q ss_pred -------------CCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCCh
Q 007433 511 -------------PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNW 556 (604)
Q Consensus 511 -------------p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~ 556 (604)
.....++..+++||.+||.+||++||| +.|+|+||||+++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~s----a~e~L~Hpff~~i~~ 301 (305)
T d1blxa_ 247 RQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS----AYSALSHPYFQDLER 301 (305)
T ss_dssp GGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGTTCCC
T ss_pred hhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcC----HHHHhcChhhcCchh
Confidence 012347889999999999999999999 999999999998864
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=5.1e-54 Score=438.08 Aligned_cols=261 Identities=25% Similarity=0.406 Sum_probs=216.0
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC----e
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK----F 287 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----~ 287 (604)
.++|++++.||+|+||+||+|++..+++.||||++.+..........++.+|+++|+.++||||+++++++..++ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 368999999999999999999999999999999998776555556677889999999999999999999998643 4
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccC
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAV 367 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~ 367 (604)
+|||||||+|++|..++... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++.++|+|||++.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~ 163 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIAD 163 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred EEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhcc
Confidence 89999999999999988776 5799999999999999999999999999999999999999999999999998743221
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
... ....
T Consensus 164 ~~~-------------------------------------------------------------------------~~~~ 170 (277)
T d1o6ya_ 164 SGN-------------------------------------------------------------------------SVTQ 170 (277)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ccc-------------------------------------------------------------------------cccc
Confidence 100 0112
Q ss_pred ccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC--CCCCCCHHHHHHHH
Q 007433 448 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFP--ESPVVSFSARDLIK 525 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p--~~~~~s~~l~dLI~ 525 (604)
....+||+.|||||++.+..|+.++|||||||+||||++|+.||.+.+..+.+.+++......+ ....+|.++++||.
T Consensus 171 ~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~ 250 (277)
T d1o6ya_ 171 TAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVL 250 (277)
T ss_dssp --------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCHHHHHHHH
T ss_pred cccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCHHHHHHHH
Confidence 2346799999999999999999999999999999999999999999888888888776654433 23568999999999
Q ss_pred HhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 526 GLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
+||.+||.+||+. ++++ .|+|+
T Consensus 251 ~~L~~dp~~R~~s---a~~l-~~~l~ 272 (277)
T d1o6ya_ 251 KALAKNPENRYQT---AAEM-RADLV 272 (277)
T ss_dssp HHTCSSGGGSCSS---HHHH-HHHHH
T ss_pred HHccCCHhHCHhH---HHHH-HHHHH
Confidence 9999999999951 5554 45444
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=445.36 Aligned_cols=259 Identities=19% Similarity=0.286 Sum_probs=219.7
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCc-----eEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEe
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTK-----CYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFE 283 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~-----~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~ 283 (604)
+..++|++++.||+|+||+||+|++.+++ ..||+|.+..... ......+.+|+.+|.++ +|||||+++++|.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKAD--SSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccC--HHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 34578999999999999999999987654 3699999876532 23334667899999988 8999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHhcCC---------------------CCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCC
Q 007433 284 TDKFSCLVMEFCPGGDLHTLRQRQPG---------------------KYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLK 342 (604)
Q Consensus 284 ~~~~~~lV~E~~~ggsL~~ll~~~~~---------------------~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIK 342 (604)
+.+.+|||||||++|+|.+++..... ..+++..++.|+.||+.||+|||++||||||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlK 191 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLA 191 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCS
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCc
Confidence 99999999999999999999976432 358999999999999999999999999999999
Q ss_pred CCcEEEccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccc
Q 007433 343 PENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKA 422 (604)
Q Consensus 343 peNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (604)
|+|||++.++++||+|||+|+.......
T Consensus 192 p~Nill~~~~~~Kl~DFGla~~~~~~~~---------------------------------------------------- 219 (325)
T d1rjba_ 192 ARNVLVTHGKVVKICDFGLARDIMSDSN---------------------------------------------------- 219 (325)
T ss_dssp GGGEEEETTTEEEECCCGGGSCGGGCTT----------------------------------------------------
T ss_pred hhccccccCCeEEEeeccccccccCCCc----------------------------------------------------
Confidence 9999999999999999999843321110
Q ss_pred cCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHH
Q 007433 423 QKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLY 501 (604)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~ 501 (604)
.....+..||+.|||||++.+..|+.++|||||||+||||++ |+.||.+.+..+.+.
T Consensus 220 ----------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~ 277 (325)
T d1rjba_ 220 ----------------------YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY 277 (325)
T ss_dssp ----------------------SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH
T ss_pred ----------------------eeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 001123568999999999999999999999999999999997 899999988878888
Q ss_pred HHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 502 NVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 502 ~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
+++....+++.+..++.++++||.+||..||++||| ++||++|
T Consensus 278 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt----~~ei~~~ 320 (325)
T d1rjba_ 278 KLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPS----FPNLTSF 320 (325)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 888877777777789999999999999999999999 9999876
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=1.5e-53 Score=436.11 Aligned_cols=258 Identities=24% Similarity=0.380 Sum_probs=213.6
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
+++|+++++||+|+||+||+|+++ +++.||||++...... .....++.+|+.+|++++||||++++++|.+++..|+|
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKED-EGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGG-GCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcC-hHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 369999999999999999999986 6789999999765432 22345677899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+.++.+..+.... ..+++..++.|+.||+.||+|||++|||||||||+||||+.++.+||+|||++......
T Consensus 79 ~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~--- 153 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP--- 153 (286)
T ss_dssp EECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred EEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccC---
Confidence 9999777776665544 67999999999999999999999999999999999999999999999999998543210
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
.......
T Consensus 154 -------------------------------------------------------------------------~~~~~~~ 160 (286)
T d1ob3a_ 154 -------------------------------------------------------------------------VRKYTHE 160 (286)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred -------------------------------------------------------------------------cccccee
Confidence 0012234
Q ss_pred ccCccccCcceecCCC-CCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc---CCC---------------CC--
Q 007433 452 VGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG---QPL---------------RF-- 510 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~---~~~---------------~~-- 510 (604)
+||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+.+.++.. .+. .+
T Consensus 161 ~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (286)
T d1ob3a_ 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTV 240 (286)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCC
T ss_pred cccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccccccc
Confidence 6899999999997654 68999999999999999999999999888777766542 100 00
Q ss_pred -------CCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 511 -------PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 511 -------p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
.....++.+++|||++||++||++||+ +.|+|+||||++
T Consensus 241 ~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s----~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 241 YEPLPWESFLKGLDESGIDLLSKMLKLDPNQRIT----AKQALEHAYFKE 286 (286)
T ss_dssp CCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCC----HHHHHTSGGGGC
T ss_pred ccCcchhhhcccCCHHHHHHHHHHccCChhHCcC----HHHHhcCcccCc
Confidence 012346889999999999999999999 999999999974
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-53 Score=443.23 Aligned_cols=258 Identities=30% Similarity=0.423 Sum_probs=211.0
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC-----
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK----- 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----- 286 (604)
.++|+++++||+|+||+||+|.+..+++.||||++++.... .....++.+|+++|+.++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQS-ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSS-HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcC-hHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccccc
Confidence 47999999999999999999999999999999999865432 344567789999999999999999999997654
Q ss_pred -eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 287 -FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 287 -~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
++||||||| |.+|..+++. ..|++..++.|+.||+.||+|||++|||||||||+|||++.++.+||+|||++...
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~ 171 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA 171 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred ceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence 579999999 7888888765 36999999999999999999999999999999999999999999999999998432
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
..
T Consensus 172 ~~------------------------------------------------------------------------------ 173 (346)
T d1cm8a_ 172 DS------------------------------------------------------------------------------ 173 (346)
T ss_dssp CS------------------------------------------------------------------------------
T ss_pred CC------------------------------------------------------------------------------
Confidence 10
Q ss_pred CcccccccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC----------------
Q 007433 446 ARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPL---------------- 508 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~---------------- 508 (604)
.....+||+.|+|||++.+. .++.++|||||||+||||++|+.||.+.+..+.+..+.....
T Consensus 174 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (346)
T d1cm8a_ 174 -EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAK 252 (346)
T ss_dssp -SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHH
T ss_pred -ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhh
Confidence 11234699999999998875 468999999999999999999999999877666544332100
Q ss_pred -------CC------CCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 509 -------RF------PESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 509 -------~~------p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
.. .....++.+++|||.+||.+||.+||| +.|||+||||+++++.
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~eiL~Hp~f~~~~~~ 310 (346)
T d1cm8a_ 253 NYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVT----AGEALAHPYFESLHDT 310 (346)
T ss_dssp HHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGTTTC--
T ss_pred hhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcC----HHHHhcChhhCcCCCc
Confidence 00 011347889999999999999999999 9999999999987644
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=431.25 Aligned_cols=257 Identities=19% Similarity=0.317 Sum_probs=213.8
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeE
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSC 289 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~ 289 (604)
+..++|+++++||+|+||+||+|+++ ++..||||+++...... ..+.+|+++|++++|||||++++++.+ +.+|
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~----~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~ 83 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSP----DAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIY 83 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCH----HHHHHHHHHHHhCCCCCEeEEEeeecc-CCeE
Confidence 44579999999999999999999986 45689999998754332 346789999999999999999998754 5679
Q ss_pred EEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCC
Q 007433 290 LVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSP 369 (604)
Q Consensus 290 lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~ 369 (604)
||||||++|+|.+++....+..+++..+..|+.||+.||.|||++|||||||||+||||+.++.+||+|||+++.+....
T Consensus 84 iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 84 IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp EEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred EEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc
Confidence 99999999999987765544569999999999999999999999999999999999999999999999999985432110
Q ss_pred cccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccc
Q 007433 370 TVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSM 449 (604)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 449 (604)
. ....
T Consensus 164 ~---------------------------------------------------------------------------~~~~ 168 (272)
T d1qpca_ 164 Y---------------------------------------------------------------------------TARE 168 (272)
T ss_dssp E---------------------------------------------------------------------------ECCT
T ss_pred c---------------------------------------------------------------------------cccc
Confidence 0 0111
Q ss_pred ccccCccccCcceecCCCCCccchHHHHHHHHHHHhhC-CCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhh
Q 007433 450 SFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFG-KTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLL 528 (604)
Q Consensus 450 ~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG-~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL 528 (604)
...||+.|||||++.+..++.++|||||||+||||++| .+||......+.+..+.. ..+.+.+..++.++.+||.+||
T Consensus 169 ~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~-~~~~~~p~~~~~~l~~li~~cl 247 (272)
T d1qpca_ 169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER-GYRMVRPDNCPEELYQLMRLCW 247 (272)
T ss_dssp TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHT
T ss_pred ccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHh-cCCCCCcccChHHHHHHHHHHc
Confidence 34699999999999998999999999999999999995 555666666555555544 3445555679999999999999
Q ss_pred hcCCCCcccccCCHHHHhc--CCCCC
Q 007433 529 VKEPQNRLACRRGATEIKQ--HPFFQ 552 (604)
Q Consensus 529 ~~dP~~Rpt~~~~a~elL~--Hpff~ 552 (604)
..||++||| +.||++ |+||.
T Consensus 248 ~~~P~~Rpt----~~ei~~~L~~~ft 269 (272)
T d1qpca_ 248 KERPEDRPT----FDYLRSVLEDFFT 269 (272)
T ss_dssp CSSGGGSCC----HHHHHHHHHHHHH
T ss_pred CCCHhHCcC----HHHHHHHhhhhhh
Confidence 999999999 999987 77874
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-53 Score=434.27 Aligned_cols=256 Identities=22% Similarity=0.344 Sum_probs=209.7
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCee
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 288 (604)
++..++|++.++||+|+||+||+|++.+ .||||+++...... .....+.+|+++|++++|||||++++++. ++.+
T Consensus 4 ei~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~ 78 (276)
T d1uwha_ 4 EIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTP-QQLQAFKNEVGVLRKTRHVNILLFMGYST-APQL 78 (276)
T ss_dssp BCCTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSCCT-THHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSC
T ss_pred ccccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccCCH-HHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEE
Confidence 3556899999999999999999998654 59999997653322 33456788999999999999999999865 4568
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|||||||+||+|.+++.... ..+++..+..|+.||+.||+|||++|||||||||+||||+.++++||+|||++......
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~-~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~ 157 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIE-TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRW 157 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSC-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----
T ss_pred EEEEecCCCCCHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeecccc
Confidence 99999999999999987653 56999999999999999999999999999999999999999999999999998432210
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
. .....
T Consensus 158 ~--------------------------------------------------------------------------~~~~~ 163 (276)
T d1uwha_ 158 S--------------------------------------------------------------------------GSHQF 163 (276)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred C--------------------------------------------------------------------------Ccccc
Confidence 0 00112
Q ss_pred cccccCccccCcceecCC---CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCC----CCCCCCHHHH
Q 007433 449 MSFVGTHEYLAPEIIKGE---GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFP----ESPVVSFSAR 521 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~---~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p----~~~~~s~~l~ 521 (604)
.+..||+.|||||++.+. .|+.++|||||||+||||++|+.||.+......+..++......| ....++.+++
T Consensus 164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~ 243 (276)
T d1uwha_ 164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMK 243 (276)
T ss_dssp --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHH
T ss_pred cccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHH
Confidence 245799999999999754 478899999999999999999999998877766665554433322 2345889999
Q ss_pred HHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 522 DLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 522 dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
+||.+||..||++||| +.||++|
T Consensus 244 ~li~~cl~~dp~~RPt----~~~il~~ 266 (276)
T d1uwha_ 244 RLMAECLKKKRDERPL----FPQILAS 266 (276)
T ss_dssp HHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred HHHHHHcCCCHhHCcC----HHHHHHH
Confidence 9999999999999999 9999886
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-52 Score=433.16 Aligned_cols=261 Identities=21% Similarity=0.316 Sum_probs=209.3
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCce---EEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTKC---YFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD 285 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~---~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 285 (604)
.+..++|++.+.||+|+||+||+|+++.+++ .||||.+...... ....++.+|+++|++|+|||||++++++.++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~ 99 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE--KQRRDFLSEASIMGQFDHPNVIHLEGVVTKS 99 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCH--HHHHHHHHHHHHHHhCCCCCCccEEEEEeeC
Confidence 3456799999999999999999999976653 6899998764332 2334677999999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
+.+|||||||++|+|.+++.... ..+++..+..|+.||+.||+|||++|||||||||+||||+.++++||+|||++..+
T Consensus 100 ~~~~iv~Ey~~~g~L~~~~~~~~-~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 100 TPVMIITEFMENGSLDSFLRQND-GQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp SSCEEEEECCTTEEHHHHHHTTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred CEEEEEEEecCCCcceeeecccc-CCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEc
Confidence 99999999999999999887653 56999999999999999999999999999999999999999999999999998543
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
...... ...
T Consensus 179 ~~~~~~-----------------------------------------------------------------------~~~ 187 (299)
T d1jpaa_ 179 EDDTSD-----------------------------------------------------------------------PTY 187 (299)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCCCCc-----------------------------------------------------------------------cee
Confidence 211100 000
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLI 524 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI 524 (604)
.......||+.|||||++.+..++.++|||||||+||||++ |+.||.+....+.+..+.. ..+.+....++.++.+||
T Consensus 188 ~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~l~~li 266 (299)
T d1jpaa_ 188 TSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ-DYRLPPPMDCPSALHQLM 266 (299)
T ss_dssp --------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHT-TCCCCCCTTCCHHHHHHH
T ss_pred eecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHc-CCCCCCCccchHHHHHHH
Confidence 11123468999999999999999999999999999999998 8999999888777766654 345555667999999999
Q ss_pred HHhhhcCCCCcccccCCHHHHhcC
Q 007433 525 KGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 525 ~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
.+||..||++||+ +.||+++
T Consensus 267 ~~cl~~~P~~RPs----~~ei~~~ 286 (299)
T d1jpaa_ 267 LDCWQKDRNHRPK----FGQIVNT 286 (299)
T ss_dssp HHHTCSSTTTSCC----HHHHHHH
T ss_pred HHHcCCCHhHCcC----HHHHHHH
Confidence 9999999999999 7777654
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-53 Score=429.97 Aligned_cols=259 Identities=22% Similarity=0.305 Sum_probs=210.1
Q ss_pred eEEE-EEEccCCcEEEEEEEEc--CCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 215 FRLL-KKLGCGDIGSVYLSELT--GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 215 y~l~-~~LG~G~fG~Vy~a~~~--~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
+.+. ++||+|+||+||+|.+. .+++.||||++..... ......++.+|+++|++++|||||++++++.++ ..|||
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lv 85 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLV 85 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEE
T ss_pred CeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEE
Confidence 3443 46999999999999864 4567899999975432 223345678999999999999999999999755 56899
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
||||++|+|.+++... ..+++..+..|+.||+.||+|||++|||||||||+||||+.+|.+||+|||++..+......
T Consensus 86 mE~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~ 163 (277)
T d1xbba_ 86 MEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY 163 (277)
T ss_dssp EECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred EEcCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence 9999999999998875 57999999999999999999999999999999999999999999999999998543211110
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
. ......
T Consensus 164 ~-------------------------------------------------------------------------~~~~~~ 170 (277)
T d1xbba_ 164 Y-------------------------------------------------------------------------KAQTHG 170 (277)
T ss_dssp E-------------------------------------------------------------------------EC----
T ss_pred c-------------------------------------------------------------------------cccccc
Confidence 0 011234
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
.||+.|||||++.+..++.++|||||||+||||++ |+.||.+.+..+....+..+ .+.+.+..++.++++||.+||..
T Consensus 171 ~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMGCPAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcC-CCCCCCcccCHHHHHHHHHHcCC
Confidence 69999999999999999999999999999999997 99999998877766666543 34444456999999999999999
Q ss_pred CCCCcccccCCHHHH---hcCCCCCCCC
Q 007433 531 EPQNRLACRRGATEI---KQHPFFQGVN 555 (604)
Q Consensus 531 dP~~Rpt~~~~a~el---L~Hpff~~~~ 555 (604)
||++||+ +.+| |+|+|++.++
T Consensus 250 dp~~RPs----~~~i~~~L~~~~~~~~~ 273 (277)
T d1xbba_ 250 DVENRPG----FAAVELRLRNYYYDVVN 273 (277)
T ss_dssp STTTSCC----HHHHHHHHHHHHHHHHH
T ss_pred CHhHCcC----HHHHHHHhhCHHhhcCC
Confidence 9999999 7776 6787775443
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-52 Score=424.11 Aligned_cols=252 Identities=23% Similarity=0.360 Sum_probs=207.6
Q ss_pred eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEE
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~l 290 (604)
..++|++++.||+|+||+||+|++.. +..||||++++..... ..+.+|+++|++++||||+++++++..++.+||
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~~-~~~vAvK~i~~~~~~~----~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~l 77 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICL 77 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEETT-TEEEEEEECCSSSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEECC-CCEEEEEEECCCcCcH----HHHHHHHHHHHhcCCCCcccccceeccCCceEE
Confidence 34689999999999999999999875 5589999998764433 246789999999999999999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPT 370 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~ 370 (604)
|||||++|+|.+++... ...+++..+..|+.||+.||+|||+++|+||||||+||||+.++.+||+|||++..+....
T Consensus 78 v~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~- 155 (263)
T d1sm2a_ 78 VFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ- 155 (263)
T ss_dssp EEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred EEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC-
Confidence 99999999999988765 3578999999999999999999999999999999999999999999999999984322100
Q ss_pred ccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccc
Q 007433 371 VVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMS 450 (604)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 450 (604)
......
T Consensus 156 --------------------------------------------------------------------------~~~~~~ 161 (263)
T d1sm2a_ 156 --------------------------------------------------------------------------YTSSTG 161 (263)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred --------------------------------------------------------------------------ceeecc
Confidence 001123
Q ss_pred cccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhh
Q 007433 451 FVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLV 529 (604)
Q Consensus 451 ~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~ 529 (604)
..||+.|+|||++.+..|+.++|||||||+||||++ |.+||......+.+..+... .+.+.+..++.++.+||.+||.
T Consensus 162 ~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~ 240 (263)
T d1sm2a_ 162 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLYKPRLASTHVYQIMNHCWK 240 (263)
T ss_dssp ---CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHT-CCCCCCTTSCHHHHHHHHHHTC
T ss_pred eecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhc-CCCCCccccCHHHHHHHHHHcc
Confidence 469999999999999999999999999999999999 57777776666666666543 3344445689999999999999
Q ss_pred cCCCCcccccCCHHHHhcC
Q 007433 530 KEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 530 ~dP~~Rpt~~~~a~elL~H 548 (604)
.||++||+ ++||++|
T Consensus 241 ~~p~~Rps----~~~il~~ 255 (263)
T d1sm2a_ 241 ERPEDRPA----FSRLLRQ 255 (263)
T ss_dssp SSGGGSCC----HHHHHHH
T ss_pred CCHhHCcC----HHHHHHH
Confidence 99999999 9999887
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-53 Score=442.78 Aligned_cols=274 Identities=41% Similarity=0.766 Sum_probs=225.2
Q ss_pred eecCeEEEEEEccCCcEEEEEEEE---cCCceEEEEEEecchhHH-HHHHHHHHHHHHHHHHhCCC-CCccccceeEecC
Q 007433 211 GVGHFRLLKKLGCGDIGSVYLSEL---TGTKCYFAMKVMDKASLE-KRKKLLRAQTEREILQSLDH-PFLPTLYTHFETD 285 (604)
Q Consensus 211 ~~~~y~l~~~LG~G~fG~Vy~a~~---~~~~~~vAiK~i~~~~~~-~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~ 285 (604)
.+++|++++.||+|+||+||+|++ ..+++.||||++++.... ......++.+|+++|++++| |||+++++++.+.
T Consensus 22 ~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~ 101 (322)
T d1vzoa_ 22 GIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101 (322)
T ss_dssp CGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET
T ss_pred chhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC
Confidence 457899999999999999999987 447889999999765321 11223356689999999966 8999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
..+|+||||+.+|+|..++... ..+++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||++..+
T Consensus 102 ~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 102 TKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp TEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred CceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 9999999999999999998876 56889999999999999999999999999999999999999999999999998543
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
.... .
T Consensus 180 ~~~~---------------------------------------------------------------------------~ 184 (322)
T d1vzoa_ 180 VADE---------------------------------------------------------------------------T 184 (322)
T ss_dssp CGGG---------------------------------------------------------------------------G
T ss_pred cccc---------------------------------------------------------------------------c
Confidence 2110 0
Q ss_pred CcccccccCccccCcceecCCC--CCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHH----HHcCCCCCCCCCCCCHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEG--HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN----VVGQPLRFPESPVVSFS 519 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~--~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~----i~~~~~~~p~~~~~s~~ 519 (604)
....+..||+.|+|||.+.+.. ++.++|||||||+||||++|+.||.+....+.... .......++ ..++.+
T Consensus 185 ~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~--~~~s~~ 262 (322)
T d1vzoa_ 185 ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP--QEMSAL 262 (322)
T ss_dssp GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC--TTSCHH
T ss_pred ccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCc--ccCCHH
Confidence 1122456999999999997653 67899999999999999999999987654433332 333333333 458999
Q ss_pred HHHHHHHhhhcCCCCccccc-CCHHHHhcCCCCCCCChhhhhcCC
Q 007433 520 ARDLIKGLLVKEPQNRLACR-RGATEIKQHPFFQGVNWALIRCAS 563 (604)
Q Consensus 520 l~dLI~~lL~~dP~~Rpt~~-~~a~elL~Hpff~~~~~~~~~~~~ 563 (604)
+++||.+||.+||++||++. ..++|+|+||||++++|..+....
T Consensus 263 ~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~~l~~~~ 307 (322)
T d1vzoa_ 263 AKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKK 307 (322)
T ss_dssp HHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHHHHTTC
T ss_pred HHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHHHHHhCC
Confidence 99999999999999999754 359999999999999998776543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-52 Score=440.76 Aligned_cols=255 Identities=28% Similarity=0.456 Sum_probs=209.6
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec------CC
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET------DK 286 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------~~ 286 (604)
-+|+.++.||+|+||+||+|++..+++.||||++.+... ...+|+++|++|+||||++++++|.. ..
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCce
Confidence 379999999999999999999999999999999976532 12369999999999999999999853 34
Q ss_pred eeEEEEeecCCCCHHHHHH-hcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC-cEEEeccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQ-RQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG-HIMLSDFDLSLR 364 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~-~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g-~vkL~DFGla~~ 364 (604)
++|||||||+++.+..+.. ......|++..++.|++||+.||+|||++|||||||||+||||+.++ .+||+|||++..
T Consensus 93 ~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~ 172 (350)
T d1q5ka_ 93 YLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ 172 (350)
T ss_dssp EEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEE
T ss_pred EEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhh
Confidence 6899999996654444433 23346799999999999999999999999999999999999999775 899999999843
Q ss_pred ccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCC
Q 007433 365 CAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPT 444 (604)
Q Consensus 365 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 444 (604)
+...
T Consensus 173 ~~~~---------------------------------------------------------------------------- 176 (350)
T d1q5ka_ 173 LVRG---------------------------------------------------------------------------- 176 (350)
T ss_dssp CCTT----------------------------------------------------------------------------
T ss_pred ccCC----------------------------------------------------------------------------
Confidence 3210
Q ss_pred CCcccccccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc---C--------------
Q 007433 445 NARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG---Q-------------- 506 (604)
Q Consensus 445 ~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~---~-------------- 506 (604)
....+.+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.+..+.+.++.. .
T Consensus 177 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~ 255 (350)
T d1q5ka_ 177 -EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYT 255 (350)
T ss_dssp -SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---
T ss_pred -cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchh
Confidence 011235799999999998764 689999999999999999999999999888777766542 1
Q ss_pred CCCCC----------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCC
Q 007433 507 PLRFP----------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVN 555 (604)
Q Consensus 507 ~~~~p----------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~ 555 (604)
...++ ....+++++.+||.+||.+||++||| +.|+|+||||+++.
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t----a~e~L~Hp~f~~~~ 310 (350)
T d1q5ka_ 256 EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT----PLEACAHSFFDELR 310 (350)
T ss_dssp CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGGGGG
T ss_pred hccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcC----HHHHhcCHhhcccc
Confidence 01111 12357889999999999999999999 99999999998764
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-52 Score=427.73 Aligned_cols=261 Identities=22% Similarity=0.327 Sum_probs=215.4
Q ss_pred eeecCeEEEEE-EccCCcEEEEEEEEcC--CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 210 LGVGHFRLLKK-LGCGDIGSVYLSELTG--TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 210 ~~~~~y~l~~~-LG~G~fG~Vy~a~~~~--~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
+..++|.+.+. ||+|+||+||+|.++. ++..||||++++... .....++.+|+++|++++|||||++++++.++
T Consensus 5 l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~- 81 (285)
T d1u59a_ 5 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTE--KADTEEMMREAQIMHQLDNPYIVRLIGVCQAE- 81 (285)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred ecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcC--HHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-
Confidence 34568888884 9999999999998754 455899999976532 23345678999999999999999999998754
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
.+|||||||++|+|.+++... ...+++..+..|+.||+.||+|||++|||||||||+||||+.++.+||+|||++..+.
T Consensus 82 ~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 82 ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred eEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 578999999999999987654 3579999999999999999999999999999999999999999999999999985543
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
...... .
T Consensus 161 ~~~~~~-------------------------------------------------------------------------~ 167 (285)
T d1u59a_ 161 ADDSYY-------------------------------------------------------------------------T 167 (285)
T ss_dssp TCSCEE-------------------------------------------------------------------------C
T ss_pred cccccc-------------------------------------------------------------------------c
Confidence 211100 0
Q ss_pred cccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007433 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIK 525 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~ 525 (604)
......||+.|||||++.+..++.++|||||||+||||++ |+.||.+....+.+..+..+ .+.+.+..++.++.+||.
T Consensus 168 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~ 246 (285)
T d1u59a_ 168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECPPECPPELYALMS 246 (285)
T ss_dssp CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTT-CCCCCCTTCCHHHHHHHH
T ss_pred cccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcC-CCCCCCCcCCHHHHHHHH
Confidence 1123469999999999999999999999999999999998 99999998877777666543 333444569999999999
Q ss_pred HhhhcCCCCcccccCCHHHH---hcCCCCC
Q 007433 526 GLLVKEPQNRLACRRGATEI---KQHPFFQ 552 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~el---L~Hpff~ 552 (604)
+||..||++||+ +.+| |+|+|+.
T Consensus 247 ~cl~~~p~~RPs----~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 247 DCWIYKWEDRPD----FLTVEQRMRACYYS 272 (285)
T ss_dssp HTTCSSGGGSCC----HHHHHHHHHHHHHH
T ss_pred HHcCCCHhHCcC----HHHHHHHHHHHHHH
Confidence 999999999999 6555 6787763
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.9e-52 Score=434.89 Aligned_cols=254 Identities=26% Similarity=0.431 Sum_probs=208.8
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEec--CCee
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFET--DKFS 288 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~--~~~~ 288 (604)
.++|+++++||+|+||+||+|++..+++.||||++.+... .++.+|+++|+.+. ||||++++++|.. ...+
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~------~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCH------HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHH------HHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 4689999999999999999999999999999999976532 34678999999995 9999999999974 4679
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC-cEEEecccccccccC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG-HIMLSDFDLSLRCAV 367 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g-~vkL~DFGla~~~~~ 367 (604)
|+|||||.+++|..+. +.|++..++.|++||+.||+|||++|||||||||+||||+.++ .+||+|||++..+..
T Consensus 108 ~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp EEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC
Confidence 9999999999997653 4599999999999999999999999999999999999998655 699999999843221
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
. ..
T Consensus 183 ~-----------------------------------------------------------------------------~~ 185 (328)
T d3bqca1 183 G-----------------------------------------------------------------------------QE 185 (328)
T ss_dssp T-----------------------------------------------------------------------------CC
T ss_pred C-----------------------------------------------------------------------------Cc
Confidence 0 01
Q ss_pred ccccccCccccCcceecCCC-CCccchHHHHHHHHHHHhhCCCCCCCCCh-HHHHHHH---Hc----------CC-----
Q 007433 448 SMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSEN-RATLYNV---VG----------QP----- 507 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~PF~~~~~-~~~l~~i---~~----------~~----- 507 (604)
....+||+.|+|||++.+.. ++.++|||||||++|||++|+.||..... .+....+ .+ ..
T Consensus 186 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~ 265 (328)
T d3bqca1 186 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 265 (328)
T ss_dssp CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCG
T ss_pred ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCc
Confidence 12346999999999988764 79999999999999999999999976543 2222111 11 00
Q ss_pred -----------------CCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCCChh
Q 007433 508 -----------------LRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGVNWA 557 (604)
Q Consensus 508 -----------------~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~~~~ 557 (604)
........++.+++|||++||++||++||| ++|+|+||||++|.|+
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~e~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 266 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT----AREAMEHPYFYTVVKD 328 (328)
T ss_dssp GGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTSCCC
T ss_pred ccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcC----HHHHhcCcccCCCCCC
Confidence 001112347889999999999999999999 9999999999999885
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-51 Score=422.58 Aligned_cols=259 Identities=25% Similarity=0.395 Sum_probs=215.3
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLVM 292 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV~ 292 (604)
++|+++++||+|+||+||+|++..+++.||||+++.... ......++.+|+.+|+.++||||++++++|.+....++||
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEe
Confidence 689999999999999999999999999999999976542 2234567789999999999999999999999999999999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
|++.+++|..++... +.+++..++.++.|++.||+|||++|||||||||+||||+.++.+||+|||++..+.....
T Consensus 81 ~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~-- 156 (292)
T d1unla_ 81 EFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR-- 156 (292)
T ss_dssp ECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS--
T ss_pred eeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc--
Confidence 999999998887665 6789999999999999999999999999999999999999999999999999854321100
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
......
T Consensus 157 --------------------------------------------------------------------------~~~~~~ 162 (292)
T d1unla_ 157 --------------------------------------------------------------------------CYSAEV 162 (292)
T ss_dssp --------------------------------------------------------------------------CCCSCC
T ss_pred --------------------------------------------------------------------------cceeec
Confidence 111235
Q ss_pred cCccccCcceecCCC-CCccchHHHHHHHHHHHhhCCCCCCC-CChHHHHHHHH---cCCC-------------------
Q 007433 453 GTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKG-SENRATLYNVV---GQPL------------------- 508 (604)
Q Consensus 453 GT~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~PF~~-~~~~~~l~~i~---~~~~------------------- 508 (604)
+++.|+|||++.+.. ++.++|||||||++|||++|+.||.. .+..+.+.++. ..+.
T Consensus 163 ~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (292)
T d1unla_ 163 VTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242 (292)
T ss_dssp SCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCC
T ss_pred cccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccc
Confidence 788999999988765 68999999999999999999998654 44444444332 1110
Q ss_pred -----CCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 509 -----RFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 509 -----~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
.......++..+++||++||++||.+||| ++|+|+||||+++
T Consensus 243 ~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~s----a~e~L~Hp~f~~~ 289 (292)
T d1unla_ 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS----AEEALQHPYFSDF 289 (292)
T ss_dssp CTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHTTSGGGSSC
T ss_pred cccchhhhccccCCHHHHHHHHHHccCChhHCcC----HHHHhcChhhcCC
Confidence 00112346789999999999999999999 9999999999864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-52 Score=432.61 Aligned_cols=263 Identities=27% Similarity=0.340 Sum_probs=208.5
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec-------
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET------- 284 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~------- 284 (604)
.++|+++++||+|+||+||+|++..+++.||||++.+.... .....++.+|+++|++++||||++++++|..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~ 87 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR 87 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC-------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccc
Confidence 57999999999999999999999999999999999765332 2233456789999999999999999999854
Q ss_pred -CCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccc
Q 007433 285 -DKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSL 363 (604)
Q Consensus 285 -~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~ 363 (604)
++++|+|||||.++.+..+.. ....+++..++.|++||+.||+|||++|||||||||+||||+.++.+||+|||++.
T Consensus 88 ~~~~~~iv~e~~~~~~~~~~~~--~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~ 165 (318)
T d3blha1 88 CKGSIYLVFDFCEHDLAGLLSN--VLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLAR 165 (318)
T ss_dssp ---CEEEEEECCCEEHHHHHTC--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred cCceEEEEEeccCCCccchhhh--cccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceee
Confidence 456899999997666654333 34679999999999999999999999999999999999999999999999999985
Q ss_pred cccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCC
Q 007433 364 RCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEP 443 (604)
Q Consensus 364 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 443 (604)
.+......
T Consensus 166 ~~~~~~~~------------------------------------------------------------------------ 173 (318)
T d3blha1 166 AFSLAKNS------------------------------------------------------------------------ 173 (318)
T ss_dssp ECCC----------------------------------------------------------------------------
T ss_pred eccccccc------------------------------------------------------------------------
Confidence 43211000
Q ss_pred CCCcccccccCccccCcceecCC-CCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCC---------
Q 007433 444 TNARSMSFVGTHEYLAPEIIKGE-GHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPES--------- 513 (604)
Q Consensus 444 ~~~~~~~~~GT~~Y~APE~l~~~-~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~--------- 513 (604)
......+.+||+.|+|||++.+. .|+.++|||||||++|||++|+.||.+.++...+..+......++..
T Consensus 174 ~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 253 (318)
T d3blha1 174 QPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYE 253 (318)
T ss_dssp -CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-
T ss_pred ccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhh
Confidence 00112245799999999999876 68999999999999999999999999888777665543211110000
Q ss_pred ---------------------CCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCC
Q 007433 514 ---------------------PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQG 553 (604)
Q Consensus 514 ---------------------~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~ 553 (604)
...+.+++|||.+||.+||++||| ++|+|+||||+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~s----a~elL~Hpff~~ 310 (318)
T d3blha1 254 LYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRID----SDDALNHDFFWS 310 (318)
T ss_dssp ------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCC----HHHHHHSGGGSS
T ss_pred hhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcC----HHHHHcChhhcc
Confidence 012567889999999999999999 999999999963
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-51 Score=431.72 Aligned_cols=260 Identities=24% Similarity=0.393 Sum_probs=208.2
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC----ee
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK----FS 288 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----~~ 288 (604)
.+|+++++||+|+||+||+|++..+++.||||++++... .....++.+|+++|+.|+||||+++++++..+. ..
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTC--HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcC--hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccce
Confidence 589999999999999999999999999999999986542 233456788999999999999999999997543 23
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
+++|+|+.||+|.+++... .|++..++.++.||+.||+|||++|||||||||+||||+.+|.+||+|||++......
T Consensus 86 ~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~ 162 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 162 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence 4444556699999999764 5999999999999999999999999999999999999999999999999998543211
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
.. .....
T Consensus 163 ~~-------------------------------------------------------------------------~~~~~ 169 (345)
T d1pmea_ 163 HD-------------------------------------------------------------------------HTGFL 169 (345)
T ss_dssp GC-------------------------------------------------------------------------BCCTT
T ss_pred Cc-------------------------------------------------------------------------cceee
Confidence 00 00112
Q ss_pred cccccCccccCcceecC-CCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHc---CC-----------------
Q 007433 449 MSFVGTHEYLAPEIIKG-EGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVG---QP----------------- 507 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~-~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~---~~----------------- 507 (604)
...+||+.|+|||++.. ..++.++|||||||++|||++|+.||.+.+..+....... .+
T Consensus 170 ~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (345)
T d1pmea_ 170 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYL 249 (345)
T ss_dssp CCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHH
T ss_pred ccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhccc
Confidence 24579999999999854 5678999999999999999999999998776555443321 00
Q ss_pred CCCC---------CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 508 LRFP---------ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 508 ~~~p---------~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
...+ ..+.++.++++||.+||++||.+||+ ++|+|+||||+..
T Consensus 250 ~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t----a~e~L~hpf~~~~ 301 (345)
T d1pmea_ 250 LSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIE----VEQALAHPYLEQY 301 (345)
T ss_dssp HTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCC----HHHHHTSGGGTTT
T ss_pred ccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcC----HHHHhcCHhhccC
Confidence 0011 12357889999999999999999999 9999999999854
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-52 Score=418.28 Aligned_cols=251 Identities=22% Similarity=0.328 Sum_probs=217.6
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCeeEEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~~lV 291 (604)
.++|+++++||+|+||+||+|+++ +++.||||++++..... ..+.+|+.+|++++||||+++++++.+++.+|+|
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~----~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCH----HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred hHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCH----HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 468999999999999999999985 67789999998765543 2466899999999999999999999999999999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCcc
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTV 371 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~ 371 (604)
|||+++|+|..++.... ..+++..+..|+.||+.||+|||++||+||||||+||||+.++.+||+|||++..+....
T Consensus 78 ~Ey~~~g~l~~~~~~~~-~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-- 154 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-- 154 (258)
T ss_dssp EECCTTEEHHHHHHSGG-GCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS--
T ss_pred EEccCCCcHHHhhhccc-cCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCC--
Confidence 99999999999876553 568999999999999999999999999999999999999999999999999984321100
Q ss_pred cccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCccccc
Q 007433 372 VKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSF 451 (604)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 451 (604)
.......
T Consensus 155 -------------------------------------------------------------------------~~~~~~~ 161 (258)
T d1k2pa_ 155 -------------------------------------------------------------------------YTSSVGS 161 (258)
T ss_dssp -------------------------------------------------------------------------CCCCCCS
T ss_pred -------------------------------------------------------------------------ceeeccc
Confidence 0011234
Q ss_pred ccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhc
Q 007433 452 VGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGLLVK 530 (604)
Q Consensus 452 ~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~ 530 (604)
.||+.|+|||++.+..++.++|||||||++|||++ |+.||.+....+...++... .+.+.+..++.++++||.+||..
T Consensus 162 ~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~-~~~~~p~~~~~~l~~li~~cl~~ 240 (258)
T d1k2pa_ 162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYRPHLASEKVYTIMYSCWHE 240 (258)
T ss_dssp CCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHTTCS
T ss_pred CCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhC-CCCCCcccccHHHHHHHHHHccC
Confidence 69999999999999999999999999999999998 89999999888877777653 45555567899999999999999
Q ss_pred CCCCcccccCCHHHHhcC
Q 007433 531 EPQNRLACRRGATEIKQH 548 (604)
Q Consensus 531 dP~~Rpt~~~~a~elL~H 548 (604)
||++||+ +.||++|
T Consensus 241 dP~~RPt----~~eil~~ 254 (258)
T d1k2pa_ 241 KADERPT----FKILLSN 254 (258)
T ss_dssp SGGGSCC----HHHHHHH
T ss_pred CHhHCcC----HHHHHHH
Confidence 9999999 9999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.9e-52 Score=424.18 Aligned_cols=259 Identities=25% Similarity=0.347 Sum_probs=213.1
Q ss_pred eeeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCee
Q 007433 209 VLGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKFS 288 (604)
Q Consensus 209 ~~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~~ 288 (604)
.+..++|++.+.||+|+||+||+|++..+. .||||++....... ..+.+|+.+|++++|||||++++++.+ +.+
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~-~vAiK~l~~~~~~~----~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~ 86 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSP----EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPI 86 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTE-EEEEEECCTTSSCH----HHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred EcCHHHEEEeeEEeeCCCeEEEEEEECCCC-EEEEEEECcccCCH----HHHHHHHHHHHhcccCCEeEEEEEEec-CCe
Confidence 345689999999999999999999998765 69999997664432 356789999999999999999999854 567
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|+|||||++|+|..++.......|++..+..|+.||+.||+|||++||+||||||+||||+.++.+||+|||+++.+...
T Consensus 87 ~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~ 166 (285)
T d1fmka3 87 YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 166 (285)
T ss_dssp EEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----
T ss_pred EEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCC
Confidence 89999999999998887654567999999999999999999999999999999999999999999999999998432211
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
. ....
T Consensus 167 ~---------------------------------------------------------------------------~~~~ 171 (285)
T d1fmka3 167 E---------------------------------------------------------------------------YTAR 171 (285)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred C---------------------------------------------------------------------------ceee
Confidence 0 0011
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCC-CCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTP-FKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGL 527 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~P-F~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~l 527 (604)
....||+.|+|||++.+..++.++|||||||+||||++|..| |.+....+.+..+. ...+.+....++.++++||.+|
T Consensus 172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~-~~~~~~~~~~~~~~l~~li~~c 250 (285)
T d1fmka3 172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-RGYRMPCPPECPESLHDLMCQC 250 (285)
T ss_dssp ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH-TTCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH-hcCCCCCCcccCHHHHHHHHHH
Confidence 234699999999999999999999999999999999996555 55555555555544 3445566677999999999999
Q ss_pred hhcCCCCcccccCCHHHHhc--CCCCCC
Q 007433 528 LVKEPQNRLACRRGATEIKQ--HPFFQG 553 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~--Hpff~~ 553 (604)
|..||++||+ +++|++ |+||..
T Consensus 251 l~~dP~~Rps----~~~i~~~L~~~~~~ 274 (285)
T d1fmka3 251 WRKEPEERPT----FEYLQAFLEDYFTS 274 (285)
T ss_dssp TCSSGGGSCC----HHHHHHHHHTTTSC
T ss_pred cccCHhHCcC----HHHHHHHHhhhhcC
Confidence 9999999999 999887 888864
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=417.72 Aligned_cols=258 Identities=21% Similarity=0.248 Sum_probs=208.0
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCc----eEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTK----CYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD 285 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~----~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~ 285 (604)
+..+.|++.+.||+|+||+||+|.++.++ ..||||++....... ....+.+|+++|++++|||||++++++.+.
T Consensus 4 i~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~--~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 4 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEK--QRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHH--HHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChH--HHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 44578999999999999999999987654 579999997654332 234577899999999999999999999999
Q ss_pred CeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccc
Q 007433 286 KFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRC 365 (604)
Q Consensus 286 ~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~ 365 (604)
+..++|||||.+++|.+++.... ..+++..+..|+.||+.||+|||+++||||||||+||||+.++.+||+|||+++.+
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~-~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKD-GEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTT-TCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CceEEEEEecccCcchhhhhccc-ccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcc
Confidence 99999999999999998877653 57999999999999999999999999999999999999999999999999998543
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
...... .
T Consensus 161 ~~~~~~-------------------------------------------------------------------------~ 167 (283)
T d1mqba_ 161 EDDPEA-------------------------------------------------------------------------T 167 (283)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred cCCCcc-------------------------------------------------------------------------c
Confidence 211100 0
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIK 525 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~ 525 (604)
.......||+.|||||++.+..++.++|||||||+||||++|..||........+...+....+.+.+..++.++.+||.
T Consensus 168 ~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 247 (283)
T d1mqba_ 168 YTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQLMM 247 (283)
T ss_dssp ------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHHHHHHH
T ss_pred eEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHHHHHHH
Confidence 01123458999999999999999999999999999999999655554443444444445555666666679999999999
Q ss_pred HhhhcCCCCcccccCCHHHHhc
Q 007433 526 GLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
+||..||++||+ +.||++
T Consensus 248 ~cl~~~p~~RPt----~~eil~ 265 (283)
T d1mqba_ 248 QCWQQERARRPK----FADIVS 265 (283)
T ss_dssp HHTCSSTTTSCC----HHHHHH
T ss_pred HHCcCCHhHCcC----HHHHHH
Confidence 999999999999 888876
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=433.53 Aligned_cols=268 Identities=26% Similarity=0.394 Sum_probs=210.4
Q ss_pred heeecCcee-eecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccce
Q 007433 202 AVRVKDGVL-GVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYT 280 (604)
Q Consensus 202 ~~~~~~~~~-~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~ 280 (604)
.+.+++..+ ..++|+++++||+|+||+||+|++..+++.||||++.+.... .....++.+|+.+|++++||||+++++
T Consensus 5 ~~~~~~~~f~i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~-~~~~~~~~~Ei~il~~l~hpnIv~~~~ 83 (355)
T d2b1pa1 5 SVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLN 83 (355)
T ss_dssp EEEETTEEEEEETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred EEEeCCcceeecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcC-HHHHHHHHHHHHHHHhcCCCCeeEEEE
Confidence 345556443 458999999999999999999999999999999999866443 334457889999999999999999999
Q ss_pred eEe------cCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcE
Q 007433 281 HFE------TDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHI 354 (604)
Q Consensus 281 ~~~------~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~v 354 (604)
+|. +..++|+|||||.+ +|...+. ..+++..++.+++||+.||+|||++||+||||||+|||++.++.+
T Consensus 84 ~f~~~~~~~~~~~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~ 158 (355)
T d2b1pa1 84 VFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 158 (355)
T ss_dssp EECSCCSTTTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCE
T ss_pred EEecccccccCceeEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccce
Confidence 996 34789999999955 4544443 458999999999999999999999999999999999999999999
Q ss_pred EEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCC
Q 007433 355 MLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVS 434 (604)
Q Consensus 355 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 434 (604)
+|+|||++.....
T Consensus 159 kl~df~~~~~~~~------------------------------------------------------------------- 171 (355)
T d2b1pa1 159 KILDFGLARTAGT------------------------------------------------------------------- 171 (355)
T ss_dssp EECCCCC-------------------------------------------------------------------------
T ss_pred eeechhhhhcccc-------------------------------------------------------------------
Confidence 9999998732210
Q ss_pred CCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcC--------
Q 007433 435 PLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQ-------- 506 (604)
Q Consensus 435 ~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~-------- 506 (604)
.......+||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+....+.+++..
T Consensus 172 ----------~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~ 241 (355)
T d2b1pa1 172 ----------SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241 (355)
T ss_dssp -------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred ----------ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHH
Confidence 01122446999999999999999999999999999999999999999988776655444311
Q ss_pred --------------CCCCCC------------------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 507 --------------PLRFPE------------------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 507 --------------~~~~p~------------------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
...... ....+.++++||++||.+||++||| |+|||+||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t----a~elL~Hpw~~~~ 317 (355)
T d2b1pa1 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS----VDDALQHPYINVW 317 (355)
T ss_dssp HTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCC----HHHHHTSTTTGGG
T ss_pred HHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcC----HHHHhcCcccCCC
Confidence 000000 0113567899999999999999999 9999999999864
Q ss_pred Ch
Q 007433 555 NW 556 (604)
Q Consensus 555 ~~ 556 (604)
.|
T Consensus 318 ~~ 319 (355)
T d2b1pa1 318 YD 319 (355)
T ss_dssp CC
T ss_pred CC
Confidence 43
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=432.65 Aligned_cols=256 Identities=26% Similarity=0.385 Sum_probs=210.9
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecC-----C
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETD-----K 286 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~-----~ 286 (604)
.++|+++++||+|+||+||+|++..+++.||||++.+..... ....++.+|+++|+.|+|||||+++++|... .
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSI-IHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSH-HHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcCh-HHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccC
Confidence 478999999999999999999999999999999998654322 3345677899999999999999999999632 3
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
..++||||+.||+|.+++.. ..|++..++.|++||+.||+|||++|||||||||+|||++.+|.+||+|||++....
T Consensus 96 ~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~ 172 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 172 (348)
T ss_dssp CCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred ceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC
Confidence 34566777779999999865 469999999999999999999999999999999999999999999999999873211
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
.
T Consensus 173 -------------------------------------------------------------------------------~ 173 (348)
T d2gfsa1 173 -------------------------------------------------------------------------------D 173 (348)
T ss_dssp -------------------------------------------------------------------------------G
T ss_pred -------------------------------------------------------------------------------c
Confidence 0
Q ss_pred cccccccCccccCcceecCCC-CCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHHHHcCCC-----------------
Q 007433 447 RSMSFVGTHEYLAPEIIKGEG-HGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYNVVGQPL----------------- 508 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~-~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~i~~~~~----------------- 508 (604)
...+..||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+.......+.....
T Consensus 174 ~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 253 (348)
T d2gfsa1 174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN 253 (348)
T ss_dssp GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHH
T ss_pred ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhh
Confidence 112346999999999977765 58899999999999999999999999887766655542211
Q ss_pred ------CCCC------CCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcCCCCCCC
Q 007433 509 ------RFPE------SPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQHPFFQGV 554 (604)
Q Consensus 509 ------~~p~------~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~Hpff~~~ 554 (604)
..+. ...++.+++|||.+||.+||.+||| +.|+|+||||+.+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~t----a~elL~Hp~f~~~ 307 (348)
T d2gfsa1 254 YIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRIT----AAQALAHAYFAQY 307 (348)
T ss_dssp HHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCC----HHHHHTSGGGTTT
T ss_pred hhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcC----HHHHhcCHhhCCC
Confidence 1111 1347889999999999999999999 9999999999865
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-51 Score=417.93 Aligned_cols=258 Identities=23% Similarity=0.330 Sum_probs=211.1
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCC---ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGT---KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
+..++|++++.||+|+||+||+|++... ...||||++.+..........++.+|+++|++++||||+++++++.+ +
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~ 83 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-P 83 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-c
Confidence 4457899999999999999999986533 34789999987766555666778899999999999999999999976 4
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
..|+|||||++|+|.+++.... ..|++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.
T Consensus 84 ~~~lv~e~~~~~~l~~~~~~~~-~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 84 PMKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SCEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred chheeeeeecCcchhhhhhccc-CCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 6789999999999998776653 469999999999999999999999999999999999999999999999999985432
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
...... .
T Consensus 163 ~~~~~~-------------------------------------------------------------------------~ 169 (273)
T d1u46a_ 163 QNDDHY-------------------------------------------------------------------------V 169 (273)
T ss_dssp C-CCEE-------------------------------------------------------------------------E
T ss_pred cCCCcc-------------------------------------------------------------------------e
Confidence 211100 0
Q ss_pred cccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007433 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIK 525 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~ 525 (604)
......||..|+|||++.+..++.++|||||||+||||++ |+.||.+.+..+.+.++.....+++....++.++++||.
T Consensus 170 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~ 249 (273)
T d1u46a_ 170 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVMV 249 (273)
T ss_dssp C-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHH
T ss_pred ecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHHHHHHH
Confidence 1123458889999999999999999999999999999997 899999999999999998888877777889999999999
Q ss_pred HhhhcCCCCcccccCCHHHHh
Q 007433 526 GLLVKEPQNRLACRRGATEIK 546 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~elL 546 (604)
+||..||++||+ +.||+
T Consensus 250 ~cl~~dp~~RPt----~~ei~ 266 (273)
T d1u46a_ 250 QCWAHKPEDRPT----FVALR 266 (273)
T ss_dssp HHTCSSGGGSCC----HHHHH
T ss_pred HHcCCChhHCcC----HHHHH
Confidence 999999999999 88875
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-51 Score=415.28 Aligned_cols=255 Identities=24% Similarity=0.358 Sum_probs=208.5
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCC---ceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGT---KCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK 286 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~---~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~ 286 (604)
+..++|++.+.||+|+||+||+|++..+ +..||||.++.... ......+.+|+++|++++||||+++++++. ++
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 80 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--DSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 80 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SS
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cC
Confidence 4457999999999999999999998654 35689999865432 233446778999999999999999999996 56
Q ss_pred eeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEeccccccccc
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCA 366 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~ 366 (604)
.+|+|||||++|+|..++... ...+++..++.++.||+.||+|||++|||||||||+|||++.++.+||+|||++..+.
T Consensus 81 ~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 81 PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp SCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred eEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheecc
Confidence 789999999999999987665 3579999999999999999999999999999999999999999999999999984332
Q ss_pred CCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCC
Q 007433 367 VSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNA 446 (604)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 446 (604)
... ..
T Consensus 160 ~~~---------------------------------------------------------------------------~~ 164 (273)
T d1mp8a_ 160 DST---------------------------------------------------------------------------YY 164 (273)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred CCc---------------------------------------------------------------------------ce
Confidence 100 00
Q ss_pred cccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHH
Q 007433 447 RSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIK 525 (604)
Q Consensus 447 ~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~ 525 (604)
......||+.|+|||++.+..|+.++|||||||+||||++ |.+||.+....+.+..+..+. ..+.+..++.++.+||.
T Consensus 165 ~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~li~ 243 (273)
T d1mp8a_ 165 KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE-RLPMPPNCPPTLYSLMT 243 (273)
T ss_dssp ------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTC-CCCCCTTCCHHHHHHHH
T ss_pred eccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCCCCCCCCHHHHHHHH
Confidence 1123468999999999999999999999999999999997 899999988888877776543 34555679999999999
Q ss_pred HhhhcCCCCcccccCCHHHHhcC
Q 007433 526 GLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 526 ~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
+||..||++||+ +.||++|
T Consensus 244 ~cl~~dp~~Rps----~~ei~~~ 262 (273)
T d1mp8a_ 244 KCWAYDPSRRPR----FTELKAQ 262 (273)
T ss_dssp HHTCSSGGGSCC----HHHHHHH
T ss_pred HHcCCCHhHCcC----HHHHHHH
Confidence 999999999999 9999876
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-51 Score=418.54 Aligned_cols=259 Identities=21% Similarity=0.314 Sum_probs=205.6
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcC-----CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEe
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTG-----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFE 283 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~ 283 (604)
+..++|+++++||+|+||+||+|++.. +++.||||++....... ....+.+|..++.++ +|+||+.+++++.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~--~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHS--EHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcH--HHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 334789999999999999999999754 45789999997653322 233455677777666 7899999999876
Q ss_pred c-CCeeEEEEeecCCCCHHHHHHhcC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEE
Q 007433 284 T-DKFSCLVMEFCPGGDLHTLRQRQP--------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLV 348 (604)
Q Consensus 284 ~-~~~~~lV~E~~~ggsL~~ll~~~~--------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl 348 (604)
. +..+|+|||||++|+|.+++.... ...+++..++.|+.||+.||+|||++|||||||||+||||
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl 167 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 167 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeE
Confidence 5 557899999999999999987542 2358999999999999999999999999999999999999
Q ss_pred ccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccc
Q 007433 349 REDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNE 428 (604)
Q Consensus 349 ~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 428 (604)
+.++++||+|||+++.+.....
T Consensus 168 ~~~~~~Kl~DFGla~~~~~~~~---------------------------------------------------------- 189 (299)
T d1ywna1 168 SEKNVVKICDFGLARDIYKDPD---------------------------------------------------------- 189 (299)
T ss_dssp CGGGCEEECC------CCSCTT----------------------------------------------------------
T ss_pred CCCCcEEEccCcchhhcccccc----------------------------------------------------------
Confidence 9999999999999853321110
Q ss_pred cCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhC-CCCCCCCChHHHHHHHHcCC
Q 007433 429 MGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFG-KTPFKGSENRATLYNVVGQP 507 (604)
Q Consensus 429 ~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG-~~PF~~~~~~~~l~~i~~~~ 507 (604)
.......+||+.|||||++.+..++.++|||||||++|||++| .+||.+....+.+..++...
T Consensus 190 ----------------~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~ 253 (299)
T d1ywna1 190 ----------------YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEG 253 (299)
T ss_dssp ----------------SCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHT
T ss_pred ----------------ccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC
Confidence 0112245799999999999999999999999999999999986 56888877666666666555
Q ss_pred CCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 508 LRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 508 ~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
.+++....++.++++||.+||..||++||+ +.||++|
T Consensus 254 ~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt----~~eil~~ 290 (299)
T d1ywna1 254 TRMRAPDYTTPEMYQTMLDCWHGEPSQRPT----FSELVEH 290 (299)
T ss_dssp CCCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 555555679999999999999999999999 9999987
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-50 Score=419.51 Aligned_cols=254 Identities=21% Similarity=0.291 Sum_probs=207.2
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCce----EEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCCe
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKC----YFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDKF 287 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~~ 287 (604)
.++|++++.||+|+||+||+|++..+++ .||+|.+.... ......++.+|+++|++++|||||++++++.++ .
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~ 84 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 84 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-S
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-C
Confidence 3689999999999999999999988775 57888876432 222345678899999999999999999999875 4
Q ss_pred eEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccC
Q 007433 288 SCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAV 367 (604)
Q Consensus 288 ~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~ 367 (604)
.++||||+.+++|.+++... ...+++..++.|+.||+.||+|||++|||||||||+||||+.++++||+|||++..+..
T Consensus 85 ~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 85 VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred eeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 67888999999999887765 36799999999999999999999999999999999999999999999999999854321
Q ss_pred CCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCc
Q 007433 368 SPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNAR 447 (604)
Q Consensus 368 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 447 (604)
... ...
T Consensus 164 ~~~--------------------------------------------------------------------------~~~ 169 (317)
T d1xkka_ 164 EEK--------------------------------------------------------------------------EYH 169 (317)
T ss_dssp TCC-----------------------------------------------------------------------------
T ss_pred ccc--------------------------------------------------------------------------ccc
Confidence 110 001
Q ss_pred ccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHH
Q 007433 448 SMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKG 526 (604)
Q Consensus 448 ~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~ 526 (604)
.....||+.|||||++.+..|+.++|||||||+||||++ |.+||.+.+..+....+.. ..+.+.+..++.++.+||.+
T Consensus 170 ~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~-~~~~~~p~~~~~~~~~li~~ 248 (317)
T d1xkka_ 170 AEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK-GERLPQPPICTIDVYMIMVK 248 (317)
T ss_dssp -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHH-TCCCCCCTTBCHHHHHHHHH
T ss_pred ccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCCCCCCcccCHHHHHHHHH
Confidence 123469999999999999999999999999999999998 8999998776665544443 34445556799999999999
Q ss_pred hhhcCCCCcccccCCHHHHhcC
Q 007433 527 LLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 527 lL~~dP~~Rpt~~~~a~elL~H 548 (604)
||..||.+||+ +.||++|
T Consensus 249 cl~~dP~~RPs----~~eil~~ 266 (317)
T d1xkka_ 249 CWMIDADSRPK----FRELIIE 266 (317)
T ss_dssp HTCSSGGGSCC----HHHHHHH
T ss_pred hCCCChhhCcC----HHHHHHH
Confidence 99999999999 9999988
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.6e-49 Score=409.69 Aligned_cols=257 Identities=20% Similarity=0.293 Sum_probs=216.0
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcC-----CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTG-----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET 284 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 284 (604)
+..++|++++.||+|+||+||+|++.+ +++.||||+++..... ....++.+|+++|++++||||+++++++..
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDNPNIVKLLGVCAV 87 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcCh--HHHHHHHHHHHHHHhcCCCCcccceeeecc
Confidence 345789999999999999999999764 5678999999765432 234567899999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHhcC----------------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCC
Q 007433 285 DKFSCLVMEFCPGGDLHTLRQRQP----------------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLK 342 (604)
Q Consensus 285 ~~~~~lV~E~~~ggsL~~ll~~~~----------------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIK 342 (604)
.+..++||||+++|+|.+++.... ...|++..+..|+.||+.||+|||+++|||||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK 167 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence 999999999999999999986532 2358899999999999999999999999999999
Q ss_pred CCcEEEccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccc
Q 007433 343 PENVLVREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKA 422 (604)
Q Consensus 343 peNILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 422 (604)
|+||||+.++.+||+|||++..+.....
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~---------------------------------------------------- 195 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADY---------------------------------------------------- 195 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGC----------------------------------------------------
T ss_pred ccceEECCCCcEEEccchhheeccCCcc----------------------------------------------------
Confidence 9999999999999999999853321100
Q ss_pred cCCccccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCC-CCCCCCChHHHHH
Q 007433 423 QKPKNEMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGK-TPFKGSENRATLY 501 (604)
Q Consensus 423 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~-~PF~~~~~~~~l~ 501 (604)
.....+..||+.|+|||++.+..|+.++|||||||+||||++|. +||.+.+..+.+.
T Consensus 196 ----------------------~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~ 253 (301)
T d1lufa_ 196 ----------------------YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIY 253 (301)
T ss_dssp ----------------------BC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred ----------------------ccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHH
Confidence 00122456999999999999999999999999999999999985 6898888888887
Q ss_pred HHHcCCCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 502 NVVGQPLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 502 ~i~~~~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
.+..+. ..+.+..++.++.+||.+||..||++||+ +.||++
T Consensus 254 ~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt----~~ev~~ 294 (301)
T d1lufa_ 254 YVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPS----FCSIHR 294 (301)
T ss_dssp HHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred HHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcC----HHHHHH
Confidence 776654 33444568999999999999999999999 888864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-50 Score=413.35 Aligned_cols=255 Identities=22% Similarity=0.306 Sum_probs=212.1
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceE--EEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEecCC
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCY--FAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFETDK 286 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~--vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~~~~ 286 (604)
+..++|++.+.||+|+||+||+|+++.++.. ||||.+..... ......+.+|+++|+++ +|||||++++++.+++
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccC--hHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 3457999999999999999999999888764 67777754432 23345678899999999 7999999999999999
Q ss_pred eeEEEEeecCCCCHHHHHHhc--------------CCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCC
Q 007433 287 FSCLVMEFCPGGDLHTLRQRQ--------------PGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDG 352 (604)
Q Consensus 287 ~~~lV~E~~~ggsL~~ll~~~--------------~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g 352 (604)
.+|+|||||+||+|.++++.. ....|++..+..++.||+.||.|||++|||||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999998754 236799999999999999999999999999999999999999999
Q ss_pred cEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCC
Q 007433 353 HIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQ 432 (604)
Q Consensus 353 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 432 (604)
.+||+|||++......
T Consensus 165 ~~kl~DfG~a~~~~~~---------------------------------------------------------------- 180 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVY---------------------------------------------------------------- 180 (309)
T ss_dssp CEEECCTTCEESSCEE----------------------------------------------------------------
T ss_pred ceEEcccccccccccc----------------------------------------------------------------
Confidence 9999999998432100
Q ss_pred CCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCC-CCCCCCChHHHHHHHHcCCCCCC
Q 007433 433 VSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGK-TPFKGSENRATLYNVVGQPLRFP 511 (604)
Q Consensus 433 ~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~-~PF~~~~~~~~l~~i~~~~~~~p 511 (604)
.......||..|+|||.+.+..|+.++|||||||++|||++|. +||.+.+..+.+..+.. ..+.+
T Consensus 181 -------------~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~-~~~~~ 246 (309)
T d1fvra_ 181 -------------VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ-GYRLE 246 (309)
T ss_dssp -------------CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGG-TCCCC
T ss_pred -------------ccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHh-cCCCC
Confidence 0111345899999999999999999999999999999999965 57887777666666554 34455
Q ss_pred CCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 512 ESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 512 ~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
.+..+++++++||.+||..||++||+ +.||++|
T Consensus 247 ~~~~~~~~~~~li~~cl~~dP~~RPs----~~eil~~ 279 (309)
T d1fvra_ 247 KPLNCDDEVYDLMRQCWREKPYERPS----FAQILVS 279 (309)
T ss_dssp CCTTBCHHHHHHHHHHTCSSGGGSCC----HHHHHHH
T ss_pred CCccCCHHHHHHHHHHcCCChhHCcC----HHHHHHH
Confidence 55669999999999999999999999 9999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-50 Score=405.39 Aligned_cols=248 Identities=21% Similarity=0.321 Sum_probs=206.8
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec-CCee
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET-DKFS 288 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~ 288 (604)
+..++|++++.||+|+||.||+|+++ +..||||++++... ...+++|+++|++++||||+++++++.+ .+.+
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~ 76 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 76 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHH-----HHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcE
Confidence 45679999999999999999999985 55799999976532 2356789999999999999999998854 5678
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCC
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~ 368 (604)
|||||||++|+|.+++.......+++..++.|+.||+.||.|||+++||||||||+|||++.+|.+||+|||++.....
T Consensus 77 ~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~- 155 (262)
T d1byga_ 77 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 155 (262)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCC-
Confidence 9999999999999998765444689999999999999999999999999999999999999999999999998732110
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
..
T Consensus 156 ------------------------------------------------------------------------------~~ 157 (262)
T d1byga_ 156 ------------------------------------------------------------------------------TQ 157 (262)
T ss_dssp --------------------------------------------------------------------------------
T ss_pred ------------------------------------------------------------------------------CC
Confidence 01
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcCCCCCCCCCCCCHHHHHHHHHh
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQPLRFPESPVVSFSARDLIKGL 527 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~~~~~p~~~~~s~~l~dLI~~l 527 (604)
....||..|+|||++.+..++.++|||||||++|||++ |++||...+..+.+..+.. ..+.+....++.++++||.+|
T Consensus 158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~-~~~~~~~~~~~~~~~~li~~c 236 (262)
T d1byga_ 158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK-GYKMDAPDGCPPAVYEVMKNC 236 (262)
T ss_dssp ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTT-TCCCCCCTTCCHHHHHHHHHH
T ss_pred ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHc-CCCCCCCccCCHHHHHHHHHH
Confidence 12358899999999999999999999999999999998 7999988877777666654 344445556899999999999
Q ss_pred hhcCCCCcccccCCHHHHhcC
Q 007433 528 LVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 528 L~~dP~~Rpt~~~~a~elL~H 548 (604)
|..||++||+ +.+|+++
T Consensus 237 l~~dP~~Rps----~~~l~~~ 253 (262)
T d1byga_ 237 WHLDAAMRPS----FLQLREQ 253 (262)
T ss_dssp TCSSGGGSCC----HHHHHHH
T ss_pred cccCHhHCcC----HHHHHHH
Confidence 9999999999 8888764
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-49 Score=407.54 Aligned_cols=258 Identities=20% Similarity=0.293 Sum_probs=219.1
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEc-----CCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCccccceeEe
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELT-----GTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTHFE 283 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~-----~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~~~ 283 (604)
+..++|++.+.||+|+||.||+|++. .+++.||||++.+.... .....+.+|+.+++++ +|||||++++++.
T Consensus 20 ~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~ 97 (311)
T d1t46a_ 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHMNIVNLLGACT 97 (311)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCH--HHHHHHHHHHHHHHhccCCCCEEEEEEEEe
Confidence 34579999999999999999999863 46789999999865432 2334677899999999 7999999999999
Q ss_pred cCCeeEEEEeecCCCCHHHHHHhcC----------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEE
Q 007433 284 TDKFSCLVMEFCPGGDLHTLRQRQP----------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVL 347 (604)
Q Consensus 284 ~~~~~~lV~E~~~ggsL~~ll~~~~----------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNIL 347 (604)
+++..|||||||++|+|.+++.... ...+++..++.|+.||+.||+|||++|||||||||+|||
T Consensus 98 ~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl 177 (311)
T d1t46a_ 98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL 177 (311)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccc
Confidence 9999999999999999999987642 235899999999999999999999999999999999999
Q ss_pred EccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCcc
Q 007433 348 VREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKN 427 (604)
Q Consensus 348 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 427 (604)
|+.++.++|+|||++..+.....
T Consensus 178 ~~~~~~~ki~DfG~~~~~~~~~~--------------------------------------------------------- 200 (311)
T d1t46a_ 178 LTHGRITKICDFGLARDIKNDSN--------------------------------------------------------- 200 (311)
T ss_dssp EETTTEEEECCCGGGSCTTSCTT---------------------------------------------------------
T ss_pred ccccCcccccccchheeccCCCc---------------------------------------------------------
Confidence 99999999999999854321110
Q ss_pred ccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcC
Q 007433 428 EMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQ 506 (604)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~ 506 (604)
.......+||+.|+|||++.+..++.++|||||||+||||++ |.+||.+....+.+.+++..
T Consensus 201 -----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~ 263 (311)
T d1t46a_ 201 -----------------YVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKE 263 (311)
T ss_dssp -----------------SEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHH
T ss_pred -----------------ceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhc
Confidence 001123579999999999999999999999999999999998 67777777777777787777
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 507 PLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 507 ~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
..+......++.++.+||.+||.+||.+||+ +.+|++
T Consensus 264 ~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs----~~~il~ 300 (311)
T d1t46a_ 264 GFRMLSPEHAPAEMYDIMKTCWDADPLKRPT----FKQIVQ 300 (311)
T ss_dssp TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCCCCCcccccHHHHHHHHHHcCCChhHCcC----HHHHHH
Confidence 6666666678999999999999999999999 888875
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-49 Score=405.02 Aligned_cols=257 Identities=22% Similarity=0.316 Sum_probs=210.9
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcCCc-------eEEEEEEecchhHHHHHHHHHHHHHHHHHHhC-CCCCcccccee
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTGTK-------CYFAMKVMDKASLEKRKKLLRAQTEREILQSL-DHPFLPTLYTH 281 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~~~-------~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l-~HpnIv~l~~~ 281 (604)
+..++|++++.||+|+||.||+|++..++ ..||||++++.... .....+.+|+.++.++ +|||||+++++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccCh--HHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 44579999999999999999999986654 47999999876432 2334567788888887 89999999999
Q ss_pred EecCCeeEEEEeecCCCCHHHHHHhcC--------------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEE
Q 007433 282 FETDKFSCLVMEFCPGGDLHTLRQRQP--------------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVL 347 (604)
Q Consensus 282 ~~~~~~~~lV~E~~~ggsL~~ll~~~~--------------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNIL 347 (604)
|.+++.+|+|||||++|+|.+++.... ...|++..++.|+.||+.||+|||++|||||||||+|||
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiL 167 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL 167 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccccee
Confidence 999999999999999999999987542 246899999999999999999999999999999999999
Q ss_pred EccCCcEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCcc
Q 007433 348 VREDGHIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKN 427 (604)
Q Consensus 348 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 427 (604)
++.+|.+||+|||++.......
T Consensus 168 l~~~~~~kl~dfg~~~~~~~~~---------------------------------------------------------- 189 (299)
T d1fgka_ 168 VTEDNVMKIADFGLARDIHHID---------------------------------------------------------- 189 (299)
T ss_dssp ECTTCCEEECSTTCCCCGGGCC----------------------------------------------------------
T ss_pred ecCCCCeEeccchhhccccccc----------------------------------------------------------
Confidence 9999999999999984332110
Q ss_pred ccCCCCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhh-CCCCCCCCChHHHHHHHHcC
Q 007433 428 EMGNQVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLF-GKTPFKGSENRATLYNVVGQ 506 (604)
Q Consensus 428 ~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLlt-G~~PF~~~~~~~~l~~i~~~ 506 (604)
........+||+.|+|||++.+..|+.++|||||||+||||++ |.+||.+....+.+..+ ..
T Consensus 190 ----------------~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i-~~ 252 (299)
T d1fgka_ 190 ----------------YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL-KE 252 (299)
T ss_dssp ----------------TTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH-HT
T ss_pred ----------------cccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHH-Hc
Confidence 0111234569999999999999999999999999999999998 79999887766555444 44
Q ss_pred CCCCCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhc
Q 007433 507 PLRFPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQ 547 (604)
Q Consensus 507 ~~~~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~ 547 (604)
..+++.+..++.++++||.+||.+||.+||+ +.||++
T Consensus 253 ~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps----~~eil~ 289 (299)
T d1fgka_ 253 GHRMDKPSNCTNELYMMMRDCWHAVPSQRPT----FKQLVE 289 (299)
T ss_dssp TCCCCCCSSCCHHHHHHHHHHTCSSGGGSCC----HHHHHH
T ss_pred CCCCCCCccchHHHHHHHHHHccCCHhHCcC----HHHHHH
Confidence 5556666679999999999999999999999 888886
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-49 Score=409.37 Aligned_cols=263 Identities=20% Similarity=0.273 Sum_probs=220.6
Q ss_pred eeecCeEEEEEEccCCcEEEEEEEEcC-----CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec
Q 007433 210 LGVGHFRLLKKLGCGDIGSVYLSELTG-----TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET 284 (604)
Q Consensus 210 ~~~~~y~l~~~LG~G~fG~Vy~a~~~~-----~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~ 284 (604)
+..++|+++++||+|+||+||+|.+.+ ++..||||++++.... .....+.+|+++|++++||||+++++++..
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~ 94 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSQ 94 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH--HHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccCh--HHHHHHHHHHHHHHHcCCCCEeeeeeEEec
Confidence 455899999999999999999998863 3568999999865432 234467799999999999999999999999
Q ss_pred CCeeEEEEeecCCCCHHHHHHhcC--------CCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEE
Q 007433 285 DKFSCLVMEFCPGGDLHTLRQRQP--------GKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIML 356 (604)
Q Consensus 285 ~~~~~lV~E~~~ggsL~~ll~~~~--------~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL 356 (604)
++..++|||||++|+|.+++.... -..+++..+..|+.||+.||.|||+++||||||||+||||+.++++||
T Consensus 95 ~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl 174 (308)
T d1p4oa_ 95 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 174 (308)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEE
Confidence 999999999999999999876431 134789999999999999999999999999999999999999999999
Q ss_pred ecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCC
Q 007433 357 SDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPL 436 (604)
Q Consensus 357 ~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 436 (604)
+|||++........
T Consensus 175 ~DFGla~~~~~~~~------------------------------------------------------------------ 188 (308)
T d1p4oa_ 175 GDFGMTRDIYETDY------------------------------------------------------------------ 188 (308)
T ss_dssp CCTTCCCGGGGGGC------------------------------------------------------------------
T ss_pred eecccceeccCCcc------------------------------------------------------------------
Confidence 99999854321110
Q ss_pred cccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhC-CCCCCCCChHHHHHHHHcCCCCCCCCCC
Q 007433 437 PELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFG-KTPFKGSENRATLYNVVGQPLRFPESPV 515 (604)
Q Consensus 437 ~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG-~~PF~~~~~~~~l~~i~~~~~~~p~~~~ 515 (604)
.......+||+.|+|||.+.+..++.++|||||||+||||++| ++||.+.+..+.+..+.... ..+....
T Consensus 189 --------~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~-~~~~p~~ 259 (308)
T d1p4oa_ 189 --------YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG-LLDKPDN 259 (308)
T ss_dssp --------EEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC-CCCCCTT
T ss_pred --------eeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCC-CCCCccc
Confidence 0112234699999999999999999999999999999999998 58898888888877776543 3444567
Q ss_pred CCHHHHHHHHHhhhcCCCCcccccCCHHHHhc------CCCCCC
Q 007433 516 VSFSARDLIKGLLVKEPQNRLACRRGATEIKQ------HPFFQG 553 (604)
Q Consensus 516 ~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~------Hpff~~ 553 (604)
++..+.+||.+||..||++||+ +.+|++ +|+|++
T Consensus 260 ~~~~l~~li~~cl~~~P~~RPs----~~~il~~L~~~~~~~~~~ 299 (308)
T d1p4oa_ 260 CPDMLFELMRMCWQYNPKMRPS----FLEIISSIKEEMEPGFRE 299 (308)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCC----HHHHHHHHGGGSCTTHHH
T ss_pred chHHHHHHHHHHcCCChhHCcC----HHHHHHHHHHhcCCCCcC
Confidence 8999999999999999999999 888886 677654
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-47 Score=395.06 Aligned_cols=252 Identities=17% Similarity=0.233 Sum_probs=202.2
Q ss_pred EEEEEccCCcEEEEEEEEcCCc---eEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEec-CCeeEEEE
Q 007433 217 LLKKLGCGDIGSVYLSELTGTK---CYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFET-DKFSCLVM 292 (604)
Q Consensus 217 l~~~LG~G~fG~Vy~a~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~-~~~~~lV~ 292 (604)
+.++||+|+||+||+|++..++ ..||||++++.. ......++.+|+++|++++||||+++++++.. ++..|+||
T Consensus 31 ~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 31 FNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred cceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 3578999999999999986543 469999997542 23445678899999999999999999999764 67899999
Q ss_pred eecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecccccccccCCCccc
Q 007433 293 EFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDFDLSLRCAVSPTVV 372 (604)
Q Consensus 293 E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DFGla~~~~~~~~~~ 372 (604)
|||++|+|.+++... ...+++..+..++.||+.||.|||+++|+||||||+||||+.++.+||+|||++.........
T Consensus 109 E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~- 186 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD- 186 (311)
T ss_dssp ECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC-
T ss_pred EEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccc-
Confidence 999999999988765 356888899999999999999999999999999999999999999999999998543211000
Q ss_pred ccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcccccc
Q 007433 373 KSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARSMSFV 452 (604)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 452 (604)
.........
T Consensus 187 -----------------------------------------------------------------------~~~~~~~~~ 195 (311)
T d1r0pa_ 187 -----------------------------------------------------------------------SVHNKTGAK 195 (311)
T ss_dssp -----------------------------------------------------------------------CTTCTTCSS
T ss_pred -----------------------------------------------------------------------cceeccccc
Confidence 000112346
Q ss_pred cCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChH-HHHHHHHcCCCCCCCCCCCCHHHHHHHHHhhhcC
Q 007433 453 GTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR-ATLYNVVGQPLRFPESPVVSFSARDLIKGLLVKE 531 (604)
Q Consensus 453 GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~-~~l~~i~~~~~~~p~~~~~s~~l~dLI~~lL~~d 531 (604)
||+.|+|||++.+..++.++|||||||+||||++|..||...... +....+..+ .+.+.+..++.++.+||.+||..|
T Consensus 196 gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g-~~~~~p~~~~~~l~~li~~cl~~d 274 (311)
T d1r0pa_ 196 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLLQPEYCPDPLYEVMLKCWHPK 274 (311)
T ss_dssp CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred ccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC-CCCCCcccCcHHHHHHHHHHcCCC
Confidence 999999999999999999999999999999999988777654433 333344333 344445568999999999999999
Q ss_pred CCCcccccCCHHHHhcC
Q 007433 532 PQNRLACRRGATEIKQH 548 (604)
Q Consensus 532 P~~Rpt~~~~a~elL~H 548 (604)
|++||+ +.||++|
T Consensus 275 P~~RPs----~~ei~~~ 287 (311)
T d1r0pa_ 275 AEMRPS----FSELVSR 287 (311)
T ss_dssp GGGSCC----HHHHHHH
T ss_pred HhHCcC----HHHHHHH
Confidence 999999 9999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.2e-47 Score=394.74 Aligned_cols=262 Identities=18% Similarity=0.263 Sum_probs=200.8
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCC-ccccceeEecCCeeEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF-LPTLYTHFETDKFSCLV 291 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn-Iv~l~~~~~~~~~~~lV 291 (604)
++|++++.||+|+||+||+|++..+++.||||++...... .++.+|+++++.++|+| |+.++.++.+++..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 5799999999999999999999999999999998765322 23567999999998766 45556666788899999
Q ss_pred EeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc---CCcEEEecccccccccCC
Q 007433 292 MEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE---DGHIMLSDFDLSLRCAVS 368 (604)
Q Consensus 292 ~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~---~g~vkL~DFGla~~~~~~ 368 (604)
|||| +++|...+... ...+++..+..++.||+.||+|||++|||||||||+|||++. ++.++|+|||+|..+...
T Consensus 82 me~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~ 159 (299)
T d1ckia_ 82 MELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA 159 (299)
T ss_dssp EECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCT
T ss_pred EEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccc
Confidence 9999 67777666544 367999999999999999999999999999999999999863 457999999999654321
Q ss_pred CcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCCCcc
Q 007433 369 PTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTNARS 448 (604)
Q Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 448 (604)
..... ......
T Consensus 160 ~~~~~---------------------------------------------------------------------~~~~~~ 170 (299)
T d1ckia_ 160 RTHQH---------------------------------------------------------------------IPYREN 170 (299)
T ss_dssp TTCCB---------------------------------------------------------------------CCCCBC
T ss_pred ccccc---------------------------------------------------------------------eecccc
Confidence 11000 000112
Q ss_pred cccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChHHHHHH---HHcCCCCCC---CCCCCCHHHHH
Q 007433 449 MSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENRATLYN---VVGQPLRFP---ESPVVSFSARD 522 (604)
Q Consensus 449 ~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~~~l~~---i~~~~~~~p---~~~~~s~~l~d 522 (604)
..++||+.|||||++.+..++.++|||||||++|||++|+.||.+......... ........+ ....++.++.+
T Consensus 171 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~ 250 (299)
T d1ckia_ 171 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFAT 250 (299)
T ss_dssp CSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHH
T ss_pred CCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHH
Confidence 356799999999999999999999999999999999999999987654433222 111111111 12358899999
Q ss_pred HHHHhhhcCCCCcccccCCHHHHhcCCCC
Q 007433 523 LIKGLLVKEPQNRLACRRGATEIKQHPFF 551 (604)
Q Consensus 523 LI~~lL~~dP~~Rpt~~~~a~elL~Hpff 551 (604)
||.+||..||++||++.. +.++|+|+|.
T Consensus 251 li~~cl~~~p~~RP~~~~-i~~~l~~~~~ 278 (299)
T d1ckia_ 251 YLNFCRSLRFDDKPDYSY-LRQLFRNLFH 278 (299)
T ss_dssp HHHHHHHSCTTCCCCHHH-HHHHHHHHHH
T ss_pred HHHHHccCChhHCcCHHH-HHHHHHHHHH
Confidence 999999999999999321 3466777654
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.3e-46 Score=383.49 Aligned_cols=251 Identities=18% Similarity=0.231 Sum_probs=202.2
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCC-CCccccceeEecCCeeEE
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH-PFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~H-pnIv~l~~~~~~~~~~~l 290 (604)
.++|++++.||+|+||+||+|++..+++.||||++...... ..+.+|+++++.|.| +||+.+++++..+...|+
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 36999999999999999999999999999999998664321 134578899999965 899999999999999999
Q ss_pred EEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEcc-----CCcEEEecccccccc
Q 007433 291 VMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVRE-----DGHIMLSDFDLSLRC 365 (604)
Q Consensus 291 V~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~-----~g~vkL~DFGla~~~ 365 (604)
||||| +++|.+++... +..+++..+..++.|++.||+|||++|||||||||+||||+. ++.+||+|||++..+
T Consensus 79 vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp EEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred EEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 99999 89999988765 357999999999999999999999999999999999999974 578999999999654
Q ss_pred cCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccccCCCC
Q 007433 366 AVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELIAEPTN 445 (604)
Q Consensus 366 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 445 (604)
........ ...
T Consensus 157 ~~~~~~~~---------------------------------------------------------------------~~~ 167 (293)
T d1csna_ 157 RDPVTKQH---------------------------------------------------------------------IPY 167 (293)
T ss_dssp BCTTTCCB---------------------------------------------------------------------CCC
T ss_pred ccCccccc---------------------------------------------------------------------eee
Confidence 32111000 000
Q ss_pred CcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCCh---HHHHHHHHcCCCCCC---CCCCCCHH
Q 007433 446 ARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSEN---RATLYNVVGQPLRFP---ESPVVSFS 519 (604)
Q Consensus 446 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~---~~~l~~i~~~~~~~p---~~~~~s~~ 519 (604)
....+++||+.|||||++.+..++.++|||||||++|||++|+.||.+... ...+..+.......+ ....++.+
T Consensus 168 ~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~ 247 (293)
T d1csna_ 168 REKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEE 247 (293)
T ss_dssp CCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHH
T ss_pred cccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHH
Confidence 112356899999999999999999999999999999999999999986432 233333322111111 11347899
Q ss_pred HHHHHHHhhhcCCCCcccc
Q 007433 520 ARDLIKGLLVKEPQNRLAC 538 (604)
Q Consensus 520 l~dLI~~lL~~dP~~Rpt~ 538 (604)
+.+|+..|+..+|++||++
T Consensus 248 l~~ii~~~~~~~~~~rP~y 266 (293)
T d1csna_ 248 FYKYMHYARNLAFDATPDY 266 (293)
T ss_dssp HHHHHHHHHHCCTTCCCCH
T ss_pred HHHHHHHHhcCCcccCcCH
Confidence 9999999999999999984
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-45 Score=381.23 Aligned_cols=251 Identities=22% Similarity=0.268 Sum_probs=191.4
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCccccceeEecCC----ee
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFLPTLYTHFETDK----FS 288 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnIv~l~~~~~~~~----~~ 288 (604)
.+|.+.++||+|+||+||+|++ +++.||||+++..... .. ....|+..+..++||||+++++++.+++ .+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~--~~--~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~ 76 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREER--SW--FREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHH--HH--HHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchh--HH--HHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEE
Confidence 4799999999999999999987 4678999999765322 11 1224555666789999999999997643 68
Q ss_pred EEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH--------cCeEeccCCCCcEEEccCCcEEEeccc
Q 007433 289 CLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM--------LGIVYRDLKPENVLVREDGHIMLSDFD 360 (604)
Q Consensus 289 ~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~--------~gIvHrDIKpeNILl~~~g~vkL~DFG 360 (604)
|||||||++|+|..++++. .+++..+..++.|++.||+|||+ +|||||||||+||||+.+|.+||+|||
T Consensus 77 ~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFG 153 (303)
T d1vjya_ 77 WLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 153 (303)
T ss_dssp EEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCT
T ss_pred EEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecC
Confidence 9999999999999999875 58999999999999999999996 599999999999999999999999999
Q ss_pred ccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCCCCCCCcccc
Q 007433 361 LSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGNQVSPLPELI 440 (604)
Q Consensus 361 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 440 (604)
++..+....+..
T Consensus 154 l~~~~~~~~~~~-------------------------------------------------------------------- 165 (303)
T d1vjya_ 154 LAVRHDSATDTI-------------------------------------------------------------------- 165 (303)
T ss_dssp TCEEEETTTTEE--------------------------------------------------------------------
T ss_pred ccccccCCCcce--------------------------------------------------------------------
Confidence 985543211100
Q ss_pred cCCCCCcccccccCccccCcceecCCC------CCccchHHHHHHHHHHHhhCCCCCCCCC--------------hHHHH
Q 007433 441 AEPTNARSMSFVGTHEYLAPEIIKGEG------HGSAVDWWTFGIFLYELLFGKTPFKGSE--------------NRATL 500 (604)
Q Consensus 441 ~~~~~~~~~~~~GT~~Y~APE~l~~~~------~~~~~DiWSLGviL~eLltG~~PF~~~~--------------~~~~l 500 (604)
.......+||+.|||||++.+.. ++.++|||||||+||||++|..||.... ....+
T Consensus 166 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T d1vjya_ 166 ----DIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241 (303)
T ss_dssp ----CC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred ----eccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHH
Confidence 01122457999999999988753 4668999999999999999998874321 22333
Q ss_pred HHHH-cCCCC--CCCC---CCCCHHHHHHHHHhhhcCCCCcccccCCHHHHhcC
Q 007433 501 YNVV-GQPLR--FPES---PVVSFSARDLIKGLLVKEPQNRLACRRGATEIKQH 548 (604)
Q Consensus 501 ~~i~-~~~~~--~p~~---~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~elL~H 548 (604)
.+.. ...++ ++.. ......+.+|+.+||..||++||+ +.||+++
T Consensus 242 ~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps----~~ei~~~ 291 (303)
T d1vjya_ 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLT----ALRIKKT 291 (303)
T ss_dssp HHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCC----HHHHHHH
T ss_pred HHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcC----HHHHHHH
Confidence 3333 22222 1111 112235889999999999999999 8888764
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-45 Score=384.95 Aligned_cols=255 Identities=25% Similarity=0.399 Sum_probs=196.8
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-----------CCCcccccee
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-----------HPFLPTLYTH 281 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-----------HpnIv~l~~~ 281 (604)
++|+++++||+|+||+||+|++..+++.||||++++..... ....+|+.+|+.++ |+||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~----~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHH----HHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccch----HHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 67999999999999999999999999999999998764322 34567888888774 5789999998
Q ss_pred Eec--CCeeEEEEeecCCCCH-HHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH-cCeEeccCCCCcEEEccCC-----
Q 007433 282 FET--DKFSCLVMEFCPGGDL-HTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHM-LGIVYRDLKPENVLVREDG----- 352 (604)
Q Consensus 282 ~~~--~~~~~lV~E~~~ggsL-~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~-~gIvHrDIKpeNILl~~~g----- 352 (604)
+.. ....++||+++..+.. ...........+++..++.++.||+.||+|||+ +||+||||||+||||+.++
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 864 4567777777655443 344444555789999999999999999999998 8999999999999998765
Q ss_pred -cEEEecccccccccCCCcccccCcccCCcccCCCccccCCCCCCCCcCCCCCCCCCccCCcccccccccccCCccccCC
Q 007433 353 -HIMLSDFDLSLRCAVSPTVVKSSTLESEPLRKNPVYCVQPACIEPSCIQPSCIAPTTCFSPRFFSKSKKAQKPKNEMGN 431 (604)
Q Consensus 353 -~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 431 (604)
.++|+|||.+.....
T Consensus 169 ~~~kl~dfg~s~~~~~---------------------------------------------------------------- 184 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE---------------------------------------------------------------- 184 (362)
T ss_dssp EEEEECCCTTCEETTB----------------------------------------------------------------
T ss_pred ceeeEeeccccccccc----------------------------------------------------------------
Confidence 399999998732210
Q ss_pred CCCCCcccccCCCCCcccccccCccccCcceecCCCCCccchHHHHHHHHHHHhhCCCCCCCCChH------HHHH---H
Q 007433 432 QVSPLPELIAEPTNARSMSFVGTHEYLAPEIIKGEGHGSAVDWWTFGIFLYELLFGKTPFKGSENR------ATLY---N 502 (604)
Q Consensus 432 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiWSLGviL~eLltG~~PF~~~~~~------~~l~---~ 502 (604)
.....+||+.|+|||++.+..|+.++|||||||+++||++|+.||...... +.+. .
T Consensus 185 ---------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~ 249 (362)
T d1q8ya_ 185 ---------------HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249 (362)
T ss_dssp ---------------CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHH
T ss_pred ---------------ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHH
Confidence 112346999999999999999999999999999999999999999764321 1111 1
Q ss_pred HHcCC---------------------CC----------------CCCCCCCCHHHHHHHHHhhhcCCCCcccccCCHHHH
Q 007433 503 VVGQP---------------------LR----------------FPESPVVSFSARDLIKGLLVKEPQNRLACRRGATEI 545 (604)
Q Consensus 503 i~~~~---------------------~~----------------~p~~~~~s~~l~dLI~~lL~~dP~~Rpt~~~~a~el 545 (604)
+.+.. .. +......+.+++|||.+||++||.+||| ++|+
T Consensus 250 ~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt----a~e~ 325 (362)
T d1q8ya_ 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD----AGGL 325 (362)
T ss_dssp HHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC----HHHH
T ss_pred HhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC----HHHH
Confidence 11110 00 0011123567899999999999999999 9999
Q ss_pred hcCCCCCCC
Q 007433 546 KQHPFFQGV 554 (604)
Q Consensus 546 L~Hpff~~~ 554 (604)
|+||||+++
T Consensus 326 L~Hp~f~~~ 334 (362)
T d1q8ya_ 326 VNHPWLKDT 334 (362)
T ss_dssp HTCGGGTTC
T ss_pred hcCcccCCC
Confidence 999999854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=8.6e-26 Score=215.80 Aligned_cols=135 Identities=22% Similarity=0.210 Sum_probs=106.5
Q ss_pred eEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHH---------------HHHHHHHHHHHHHHHHhCCCCCccccc
Q 007433 215 FRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLE---------------KRKKLLRAQTEREILQSLDHPFLPTLY 279 (604)
Q Consensus 215 y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~---------------~~~~~~~~~~Ei~iL~~l~HpnIv~l~ 279 (604)
|.+.++||+|+||+||+|++. +++.||||+++..... .........+|..+|.++.|.+++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 467899999999999999985 5789999997632111 112223456788999999999999887
Q ss_pred eeEecCCeeEEEEeecCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHcCeEeccCCCCcEEEccCCcEEEecc
Q 007433 280 THFETDKFSCLVMEFCPGGDLHTLRQRQPGKYFSEQAVKFYVAEVLLALEYLHMLGIVYRDLKPENVLVREDGHIMLSDF 359 (604)
Q Consensus 280 ~~~~~~~~~~lV~E~~~ggsL~~ll~~~~~~~l~e~~~~~i~~qil~aL~yLH~~gIvHrDIKpeNILl~~~g~vkL~DF 359 (604)
++.. .+|||||+++..+.. +++..+..++.||+.+|.|||++||+||||||+|||++++ .++|+||
T Consensus 81 ~~~~----~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDF 146 (191)
T d1zara2 81 AWEG----NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDF 146 (191)
T ss_dssp EEET----TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCC
T ss_pred EecC----CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEEC
Confidence 6532 379999998765532 4455577899999999999999999999999999999865 5899999
Q ss_pred ccccc
Q 007433 360 DLSLR 364 (604)
Q Consensus 360 Gla~~ 364 (604)
|+|..
T Consensus 147 G~a~~ 151 (191)
T d1zara2 147 PQSVE 151 (191)
T ss_dssp TTCEE
T ss_pred CCccc
Confidence 98843
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.48 E-value=1.7e-07 Score=90.84 Aligned_cols=85 Identities=16% Similarity=0.146 Sum_probs=59.9
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEecCCeeEEE
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFETDKFSCLV 291 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~~~~~~lV 291 (604)
..|++.+..+.++.+.||+... ++..+.||+........ ...+.+|..+|+.|. +--+++++.++.+++..|+|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~~--~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEEC--SSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEEe--CCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 5788777766666679998753 34457788876543211 123456888887773 44478889888888999999
Q ss_pred EeecCCCCHHH
Q 007433 292 MEFCPGGDLHT 302 (604)
Q Consensus 292 ~E~~~ggsL~~ 302 (604)
|++++|..+..
T Consensus 89 ~~~l~G~~~~~ 99 (263)
T d1j7la_ 89 MSEADGVLCSE 99 (263)
T ss_dssp EECCSSEEHHH
T ss_pred EEecccccccc
Confidence 99999877743
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.11 E-value=4.1e-06 Score=86.70 Aligned_cols=80 Identities=16% Similarity=0.171 Sum_probs=49.8
Q ss_pred EEEEccCCcEEEEEEEEcCCceEEEEEEecchh-HHH---HHHHHHHHHHHHHHHhCC-C--CCccccceeEecCCeeEE
Q 007433 218 LKKLGCGDIGSVYLSELTGTKCYFAMKVMDKAS-LEK---RKKLLRAQTEREILQSLD-H--PFLPTLYTHFETDKFSCL 290 (604)
Q Consensus 218 ~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~-~~~---~~~~~~~~~Ei~iL~~l~-H--pnIv~l~~~~~~~~~~~l 290 (604)
.+.||.|....||+..+..+++.|+||.-.... ... .....+...|.++|+.+. + ..+++++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 567999999999999988878889999753211 000 011234556888887662 2 356677654 4445679
Q ss_pred EEeecCCCC
Q 007433 291 VMEFCPGGD 299 (604)
Q Consensus 291 V~E~~~ggs 299 (604)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997644
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.98 E-value=6.2e-06 Score=79.08 Aligned_cols=136 Identities=17% Similarity=0.086 Sum_probs=82.3
Q ss_pred EEccCCc-EEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCC--CCccccceeEecCCeeEEEEeecC
Q 007433 220 KLGCGDI-GSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDH--PFLPTLYTHFETDKFSCLVMEFCP 296 (604)
Q Consensus 220 ~LG~G~f-G~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~ 296 (604)
.+..|.. +.||+....+ +..+.+|........ .+..|..+|+.|.. -.+++++.+..+++..++||+|++
T Consensus 17 ~~~~G~s~~~v~r~~~~~-~~~~vlK~~~~~~~~------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQG-RPVLFVKTDLSGALN------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEECTT-SCCEEEEEECSCTTS------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEeCC-CCEEEEEeCCccCHh------HHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 4455553 6799987654 446888987654321 24467777776632 336788888888889999999998
Q ss_pred CCCHHH--------------HHHhcC-----CCCCc--HH-----HHHHHH---------------HHHHHHHHHHHH--
Q 007433 297 GGDLHT--------------LRQRQP-----GKYFS--EQ-----AVKFYV---------------AEVLLALEYLHM-- 333 (604)
Q Consensus 297 ggsL~~--------------ll~~~~-----~~~l~--e~-----~~~~i~---------------~qil~aL~yLH~-- 333 (604)
|.++.. ++.+.. ...+. .. ....+. ......+..+..
T Consensus 90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 169 (255)
T d1nd4a_ 90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARM 169 (255)
T ss_dssp SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTC
T ss_pred ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhC
Confidence 866522 111110 00011 00 000000 011222333433
Q ss_pred -----cCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 334 -----LGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 334 -----~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
..+||+|+.|.|||++.++.+.|+||+.+
T Consensus 170 ~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~ 203 (255)
T d1nd4a_ 170 PDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRL 203 (255)
T ss_dssp CSSCCEEEECSSCCGGGEEEETTEEEEECCCTTC
T ss_pred CccCCceEEeCCCCCcceEEeCCceEEEEEchhc
Confidence 23899999999999997766789999977
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.22 E-value=0.00038 Score=71.34 Aligned_cols=78 Identities=22% Similarity=0.324 Sum_probs=52.7
Q ss_pred cCeEEEEEEccCCcEEEEEEEEcC-------CceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCC-CCCccccceeEec
Q 007433 213 GHFRLLKKLGCGDIGSVYLSELTG-------TKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLD-HPFLPTLYTHFET 284 (604)
Q Consensus 213 ~~y~l~~~LG~G~fG~Vy~a~~~~-------~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~-HpnIv~l~~~~~~ 284 (604)
+.++ ++.|+.|-.=.+|++.... ....|.+++....... ....+|..+++.+. +.-.++++++|.+
T Consensus 43 ~~l~-v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~-----idr~~E~~i~~~ls~~gl~Pkll~~~~~ 116 (395)
T d1nw1a_ 43 EHLR-ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETE-----SHLVAESVIFTLLSERHLGPKLYGIFSG 116 (395)
T ss_dssp GGEE-EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCH-----HHHHHHHHHHHHHHHTTSSSCEEEEETT
T ss_pred cceE-EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchh-----hHHHHHHHHHHHHHhCCCCCeEEEEcCC
Confidence 3444 4678889999999998753 2356888887532211 12346888888874 4445688888753
Q ss_pred CCeeEEEEeecCCCCH
Q 007433 285 DKFSCLVMEFCPGGDL 300 (604)
Q Consensus 285 ~~~~~lV~E~~~ggsL 300 (604)
.+||||++|..|
T Consensus 117 ----g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 ----GRLEEYIPSRPL 128 (395)
T ss_dssp ----EEEECCCCEEEC
T ss_pred ----ceEEEEeccccC
Confidence 589999987554
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.08 E-value=0.00089 Score=66.55 Aligned_cols=68 Identities=15% Similarity=0.117 Sum_probs=42.3
Q ss_pred EEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCCc-----ccc--ceeEecCCeeEEEEeecCCCC
Q 007433 227 GSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPFL-----PTL--YTHFETDKFSCLVMEFCPGGD 299 (604)
Q Consensus 227 G~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~HpnI-----v~l--~~~~~~~~~~~lV~E~~~ggs 299 (604)
-.||++... +|..|++|+.+...... ..+..|+..|..|....| +.. -..+..++..+.|++++.|..
T Consensus 36 N~vy~v~~~-dg~~~VlK~~rp~~~s~----~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 36 NRVYQFQDE-DRRRFVVKFYRPERWTA----DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SEEEEECCT-TCCCEEEEEECTTTSCH----HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred ceeEEEEcC-CCCEEEEEEeCCCCCCH----HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence 579999874 45578999987643222 234457777777632222 111 123355778899999997743
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.82 E-value=0.0021 Score=63.02 Aligned_cols=144 Identities=18% Similarity=0.108 Sum_probs=77.7
Q ss_pred ecCeEEEEEEccCCcEEEEEEEEcCCceEEEEEEecchhHHHHHHHHHHHHHHHHHHhCCCCC--ccccc----e--eEe
Q 007433 212 VGHFRLLKKLGCGDIGSVYLSELTGTKCYFAMKVMDKASLEKRKKLLRAQTEREILQSLDHPF--LPTLY----T--HFE 283 (604)
Q Consensus 212 ~~~y~l~~~LG~G~fG~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~iL~~l~Hpn--Iv~l~----~--~~~ 283 (604)
++...-++.|..|---+.|+..... + .|++|++.... ....+..|+++|..|...+ ++... + +..
T Consensus 17 lg~~~~~~~i~~G~~N~ny~v~t~~-g-~yVLri~~~~~-----~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~ 89 (316)
T d2ppqa1 17 VGSLTSYKGIAEGVENSNFLLHTTK-D-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGE 89 (316)
T ss_dssp CCCEEEEEEECC---EEEEEEEESS-C-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEE
T ss_pred CCCceEeecCCCCcccCeEEEEECC-C-cEEEEEcCCCC-----CHHHHHHHHHHHHhhhhccccccccceecCCCccee
Confidence 4556667778888889999988654 4 48899986531 1112334667777663322 11111 1 122
Q ss_pred cCCeeEEEEeecCCCCHHH--------------HHHhc----C----CCCCc-----------------HHHHHHHHHHH
Q 007433 284 TDKFSCLVMEFCPGGDLHT--------------LRQRQ----P----GKYFS-----------------EQAVKFYVAEV 324 (604)
Q Consensus 284 ~~~~~~lV~E~~~ggsL~~--------------ll~~~----~----~~~l~-----------------e~~~~~i~~qi 324 (604)
.....+.++.++.|..... .++.. . ..... .......+..+
T Consensus 90 ~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 169 (316)
T d2ppqa1 90 LSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPE 169 (316)
T ss_dssp ETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHH
T ss_pred eecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHH
Confidence 3455667777776644411 00000 0 00000 00112222333
Q ss_pred HHHHHHHH----HcCeEeccCCCCcEEEccCCcEEEeccccc
Q 007433 325 LLALEYLH----MLGIVYRDLKPENVLVREDGHIMLSDFDLS 362 (604)
Q Consensus 325 l~aL~yLH----~~gIvHrDIKpeNILl~~~g~vkL~DFGla 362 (604)
...+.-.+ ..|+||+|+.++|||++.+...-|+||+.+
T Consensus 170 ~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~ 211 (316)
T d2ppqa1 170 IDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFA 211 (316)
T ss_dssp HHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTC
T ss_pred HHhhhccCccccccccccCCcchhhhhcccccceeEeccccc
Confidence 33333333 257999999999999998877799999987
|